PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zivkovic, ML; Zareba-Koziol, M; Zhukova, L; Poznanski, J; Zhukov, I; Wyslouch-Cieszynska, A				Zivkovic, Martina Lenarcic; Zareba-Koziol, Monika; Zhukova, Liliya; Poznanski, Jaroslaw; Zhukov, Igor; Wyslouch-Cieszynska, Aleksandra			Post-translational S-Nitrosylation Is an Endogenous Factor Fine Tuning the Properties of Human S100A1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; 3-DIMENSIONAL SOLUTION STRUCTURE; CALCIUM-BINDING PROPERTIES; NMR CHEMICAL-SHIFTS; EF-HAND TYPE; DIPOLAR COUPLINGS; APO-S100A1 PROTEIN; FUNCTIONAL ROLES; CALBINDIN D-9K; HEART-FAILURE	S100A1 is a member of the Ca2+-binding S100 protein family. It is expressed in brain and heart tissue, where it plays a crucial role as a modulator of Ca2+ homeostasis, energy metabolism, neurotransmitter release, and contractile performance. Biological effects of S100A1 have been attributed to its direct interaction with a variety of target proteins. The (patho) physiological relevance of S100A1 makes it an important molecular target for future therapeutic intervention. S-Nitrosylation is a post-translational modification of proteins, which plays a role in cellular signal transduction under physiological and pathological conditions. In this study, we confirmed that S100A1 protein is endogenously modified by Cys(85) S-nitrosylation in PC12 cells, which are a well established model system for studying S100A1 function. We used isothermal calorimetry to show that S-nitrosylation facilitates the formation of Ca2+-loaded S100A1 at physiological ionic strength conditions. To establish the unique influence of the S-nitroso group, our study describes high resolution three-dimensional structures of human apo-S100A1 protein with the Cys(85) thiol group in reduced and S-nitrosylated states. Solution structures of the proteins are based on NMR data obtained at physiological ionic strength. Comparative analysis shows that S-nitrosylation fine tunes the overall architecture of S100A1 protein. Although the typical S100 protein intersubunit four-helix bundle is conserved upon S-nitrosylation, the conformation of S100A1 protein is reorganized at the sites most important for target recognition (i.e. the C-terminal helix and the linker connecting two EF-hand domains). In summary, this study discloses cysteine S-nitrosylation as a new factor responsible for increasing functional diversity of S100A1 and helps explain the role of S100A1 as a Ca2+ signal transmitter sensitive to NO/redox equilibrium within cells.	[Zivkovic, Martina Lenarcic; Zhukov, Igor] Slovenian NMR Ctr, Natl Inst Chem, Ljubljana 1001, Slovenia; [Zareba-Koziol, Monika; Zhukova, Liliya; Poznanski, Jaroslaw; Zhukov, Igor; Wyslouch-Cieszynska, Aleksandra] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland	National Institute of Chemistry - Slovenia; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Zhukov, I (corresponding author), Slovenian NMR Ctr, Natl Inst Chem, Hajdrihova 19, Ljubljana 1001, Slovenia.	igor@ibb.waw.pl; olawyslouch@ibb.waw.pl	poznanski, jarek/G-7064-2013; Poznanski, Jaroslaw/F-7705-2014; Zareba-Koziol, Monika/E-1276-2015; Zhukov, Igor/J-4069-2015	Poznanski, Jaroslaw/0000-0003-2684-1775; Zareba-Koziol, Monika/0000-0003-3544-6259; Zhukova, Lilia/0000-0001-8607-2918; Wyslouch Cieszynska, Aleksandra/0000-0002-7006-2456; Zhukov, Igor/0000-0002-9912-1018	Polish Ministry of Education [3P04A01424]; Slovenian Research Agency; Ministry of Higher Education, Science, and Technology of Republic of Slovenia [P1-0242]; EN-FIST Center of Excellence; East-NMR FP7 Project [228461]; European Union [POIG.01.01.02-00-048/09]	Polish Ministry of Education; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Ministry of Higher Education, Science, and Technology of Republic of Slovenia; EN-FIST Center of Excellence; East-NMR FP7 Project; European Union(European Commission)	This work was supported by Polish Ministry of Education Grant 3P04A01424 and Slovenian Research Agency and Ministry of Higher Education, Science, and Technology of Republic of Slovenia Program P1-0242 (to M. L. Z.). This work was also supported in part by the EN-FIST Center of Excellence (to I. Z.), East-NMR FP7 Project (Contract 228461), and Transnational Access Program and Innovative Economy Program Grant POIG.01.01.02-00-048/09 co-financed by European Union resources (to A. W.).	Al-Hashimi HM, 2000, J MAGN RESON, V142, P153, DOI 10.1006/jmre.1999.1937; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; BAUDIER J, 1986, J BIOL CHEM, V261, P8204; BAUDIER J, 1986, BIOCHEMISTRY-US, V25, P6934, DOI 10.1021/bi00370a029; Benfenati F, 2004, J NEUROCHEM, V89, P1260, DOI 10.1111/j.1471-4159.2004.02419.x; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Boerries M, 2007, MOL CELL BIOL, V27, P4365, DOI 10.1128/MCB.02045-06; Bolewska K, 1997, ACTA BIOCHIM POL, V44, P275; Brinks H, 2011, J AM COLL CARDIOL, V58, P966, DOI 10.1016/j.jacc.2011.03.054; Chan NL, 1998, BIOCHEMISTRY-US, V37, P16459, DOI 10.1021/bi9816711; Chen YY, 2008, J BIOL CHEM, V283, P35265, DOI 10.1074/jbc.M805287200; Clore GM, 1998, P NATL ACAD SCI USA, V95, P5891, DOI 10.1073/pnas.95.11.5891; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deloulme Jean Christophe, 2002, Methods Mol Biol, V172, P185; Derakhshan B, 2007, CARDIOVASC RES, V75, P210, DOI 10.1016/j.cardiores.2007.04.023; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Drohat AC, 1998, BIOCHEMISTRY-US, V37, P2729, DOI 10.1021/bi972635p; Drohat AC, 1999, PROTEIN SCI, V8, P800; Drohat AC, 1997, PROTEIN SCI, V6, P1577, DOI 10.1002/pro.5560060721; Garbuglia M, 1999, BIOCHEM BIOPH RES CO, V254, P36, DOI 10.1006/bbrc.1998.9881; Goch G, 2005, FEBS J, V272, P2557, DOI 10.1111/j.1742-4658.2005.04680.x; Goddart T. D., 2008, SPARKY VERSION 3; Groves P, 1997, PROTEIN SCI, V6, P323; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; IKURA M, 1990, BIOCHEMISTRY-US, V29, P4659, DOI 10.1021/bi00471a022; Jaffrey S. R., 2001, SCI STKE, pp11; Job P, 1928, ANN CHIM FRANCE, V9, P113; Johnson E, 2006, J MOL BIOL, V357, P1237, DOI 10.1016/j.jmb.2006.01.031; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kraus C, 2009, J MOL CELL CARDIOL, V47, P445, DOI 10.1016/j.yjmcc.2009.06.003; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Landar A, 1998, BIOCHEMISTRY-US, V37, P17429, DOI 10.1021/bi9817921; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lima B, 2010, CIRC RES, V106, P633, DOI 10.1161/CIRCRESAHA.109.207381; Malik S, 2008, PROTEINS, V73, P28, DOI 10.1002/prot.22037; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Markowitz J, 2005, BIOCHEMISTRY-US, V44, P7305, DOI 10.1021/bi050321t; Marquardt D., 1963, INT J COMPUT VISION, V11, P431, DOI DOI 10.1137/0111030; Most P, 2005, J CELL SCI, V118, P421, DOI 10.1242/jcs.01614; Most P, 2007, AM J PHYSIOL-REG I, V293, pR568, DOI 10.1152/ajpregu.00075.2007; Most P, 2006, CIRCULATION, V114, P1258, DOI 10.1161/CIRCULATIONAHA.106.622415; Nakamura T, 2011, CELL DEATH DIFFER, V18, P1478, DOI 10.1038/cdd.2011.65; Nelson MR, 2002, PROTEIN SCI, V11, P198, DOI 10.1110/ps.33302; Nowakowski M, 2011, J STRUCT BIOL, V174, P391, DOI 10.1016/j.jsb.2011.01.011; Okada M, 2002, BIOCHEM BIOPH RES CO, V292, P1023, DOI 10.1006/bbrc.2002.6761; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Ottiger M, 1998, J BIOMOL NMR, V12, P361, DOI 10.1023/A:1008366116644; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REID KSC, 1985, FEBS LETT, V190, P209, DOI 10.1016/0014-5793(85)81285-0; Rohde D, 2011, J MOL CELL CARDIOL, V50, P777, DOI 10.1016/j.yjmcc.2010.08.012; Rohde D, 2010, J CARDIOVASC TRANSL, V3, P525, DOI 10.1007/s12265-010-9211-9; Rustandi RR, 2002, BIOCHEMISTRY-US, V41, P788, DOI 10.1021/bi0118308; Salonen LM, 2011, ANGEW CHEM INT EDIT, V50, P4808, DOI 10.1002/anie.201007560; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Schreiter ER, 2007, J BIOL CHEM, V282, P19773, DOI 10.1074/jbc.M701363200; Seth D, 2011, CURR OPIN CHEM BIOL, V15, P129, DOI 10.1016/j.cbpa.2010.10.012; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sun JH, 2010, CIRC RES, V106, P285, DOI 10.1161/CIRCRESAHA.109.209452; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; van Dieck J, 2009, J MOL BIOL, V394, P922, DOI 10.1016/j.jmb.2009.10.002; Volkers M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/178614; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wang X, 2008, PROTEIN SCI, V17, P899, DOI 10.1110/ps.073395108; Weichsel A, 2007, BIOCHEMISTRY-US, V46, P1219, DOI 10.1021/bi061878r; Williams JG, 2003, P NATL ACAD SCI USA, V100, P6376, DOI 10.1073/pnas.1037299100; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wolfram Research Inc., 2010, MATHEMATICA; Wright NT, 2008, J BIOMOL NMR, V42, P279, DOI 10.1007/s10858-008-9282-y; Wright NT, 2009, J MOL BIOL, V386, P1265, DOI 10.1016/j.jmb.2009.01.022; Wright NT, 2005, J MOL BIOL, V353, P410, DOI 10.1016/j.jmb.2005.08.027; Zhukov I, 2008, BIOCHEMISTRY-US, V47, P640, DOI 10.1021/bi701762v; Zhukova L, 2004, BBA-MOL CELL RES, V1742, P191, DOI 10.1016/j.bbamcr.2004.10.002; Zimmer DB, 2005, CELL MOL BIOL, V51, P201, DOI 10.1170/T620; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297; Zimmer DB, 1998, J BIOL CHEM, V273, P4705, DOI 10.1074/jbc.273.8.4705	78	15	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40457	40470		10.1074/jbc.M112.418392	http://dx.doi.org/10.1074/jbc.M112.418392			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	22989881	Green Published, hybrid			2022-12-25	WOS:000311448800037
J	Autry, JM; Rubin, JE; Svensson, B; Li, J; Thomas, DD				Autry, Joseph M.; Rubin, John E.; Svensson, Bengt; Li, Ji; Thomas, David D.			Nucleotide Activation of the Ca-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; TIME-RESOLVED FLUORESCENCE; RESONANCE ENERGY-TRANSFER; CALCIUM-PUMP; PHOSPHORYL-TRANSFER; SKELETAL-MUSCLE; ADENOSINE-TRIPHOSPHATASE; CATALYTIC CYCLE; BINDING DOMAIN; RECONSTITUTED PROTEOLIPOSOMES	We have used fluorescence spectroscopy, molecular modeling, and limited proteolysis to examine structural dynamics of the sarcoplasmic reticulum Ca-ATPase (SERCA). The Ca-ATPase in sarcoplasmic reticulum vesicles from fast twitch muscle (SERCA1a isoform) was selectively labeled with fluorescein isothiocyanate (FITC), a probe that specifically reacts with Lys-515 in the nucleotide-binding site. Conformation-specific proteolysis demonstrated that FITC labeling does not induce closure of the cytoplasmic headpiece, thereby assigning FITC-SERCA as a nucleotide-free enzyme. We used enzyme reverse mode to synthesize FITC monophosphate (FMP) on SERCA, producing a phosphorylated pseudosubstrate tethered to the nucleotide-binding site of a Ca2+-free enzyme (E2 state to prevent FMP hydrolysis). Conformation-specific proteolysis demonstrated that FMP formation induces SERCA headpiece closure similar to ATP binding, presumably due to the high energy phosphoryl group on the fluorescent probe (ATP.E2 analog). Subnanosecond-resolved detection of fluorescence lifetime, anisotropy, and quenching was used to characterize FMP-SERCA (ATP.E2 state) versus FITC-SERCA in Ca2+-free, Ca2+-bound, and actively cycling phosphoenzyme states (E2, E1, and EP). Time-resolved spectroscopy revealed that FMP-SERCA exhibits increased probe dynamics but decreased probe accessibility compared with FITC-SERCA, indicating that ATP exhibits enhanced dynamics within a closed cytoplasmic headpiece. Molecular modeling was used to calculate the solvent-accessible surface area of FITC and FMP bound to SERCA crystal structures, revealing a positive correlation of solvent-accessible surface area with quenching but not anisotropy. Thus, headpiece closure is coupled to substrate binding but not active site dynamics. We propose that dynamics in the nucleotide-binding site of SERCA is important for Ca2+ binding (distal allostery) and phosphoenzyme formation (direct activation).	[Autry, Joseph M.; Rubin, John E.; Svensson, Bengt; Li, Ji; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Thomas, DD (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall, Minneapolis, MN 55455 USA.	ddt@umn.edu	Autry, Joseph M./X-6839-2019	Autry, Joseph M./0000-0002-1144-725X; Thomas, David D./0000-0002-8822-2040	National Institutes of Health [R01 GM27906, P30 AR0507220, T32 AR007612]; University of Minnesota; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG042996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Minnesota(University of Minnesota System); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM27906, P30 AR0507220, and T32 AR007612 (to D. D. T.).; Supported by a doctoral dissertation fellowship from the University of Minnesota.	Abu-Abed M, 2004, BIOCHEM J, V379, P235, DOI 10.1042/BJ20040168; Abu-Abed M, 2002, BIOCHEMISTRY-US, V41, P1156, DOI 10.1021/bi015703n; ALLEN G, 1976, FEBS LETT, V63, P188, DOI 10.1016/0014-5793(76)80223-2; Autry JM, 2011, J BIOL CHEM, V286, P31697, DOI 10.1074/jbc.M111.246843; BENDERS AAGM, 1992, BIOCHIM BIOPHYS ACTA, V1112, P89, DOI 10.1016/0005-2736(92)90258-N; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; BIGELOW DJ, 1992, BIOCHIM BIOPHYS ACTA, V1113, P323, DOI 10.1016/0304-4157(92)90005-U; BIRMACHU W, 1990, BIOCHEMISTRY-US, V29, P3904, DOI 10.1021/bi00468a017; BIRMACHU W, 1989, BIOCHEMISTRY-US, V28, P3940, DOI 10.1021/bi00435a047; BODLEY AL, 1987, J BIOL CHEM, V262, P13997; Boehr DD, 2010, P NATL ACAD SCI USA, V107, P1373, DOI 10.1073/pnas.0914163107; BRANDT NR, 1980, J BIOL CHEM, V255, P6290; BRIGGS FN, 1986, BIOCHEM BIOPH RES CO, V135, P864; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; Champeil P, 2001, J BIOL CHEM, V276, P5795, DOI 10.1074/jbc.M006980200; Chen LTL, 2009, BIOCHEMISTRY-US, V48, P2411, DOI 10.1021/bi8021526; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; Delavoie F, 2003, ANN NY ACAD SCI, V986, P17, DOI 10.1111/j.1749-6632.2003.tb07133.x; Espinoza-Fonseca LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026936; FERNANDEZ JL, 1980, BIOCHIM BIOPHYS ACTA, V599, P552, DOI 10.1016/0005-2736(80)90199-6; FERNANDEZBELDA F, 1988, ARCH BIOCHEM BIOPHYS, V260, P118, DOI 10.1016/0003-9861(88)90431-6; FERREIRA ST, 1989, J BIOL CHEM, V264, P15392; Freire MM, 2002, BBA-BIOENERGETICS, V1553, P238, DOI 10.1016/S0005-2728(01)00245-6; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; HASSELBACH W, 1978, BIOCHIM BIOPHYS ACTA, V515, P23, DOI 10.1016/0304-4157(78)90007-2; Henao F, 2001, J BIOL CHEM, V276, P24284, DOI 10.1074/jbc.M103905200; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; HIGHSMITH S, 1986, BIOCHEMISTRY-US, V25, P1049, DOI 10.1021/bi00353a015; Hou ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040369; Hua SM, 2002, BIOCHEMISTRY-US, V41, P2264, DOI 10.1021/bi015684h; Huang Z, 1999, J BIOMOL SCREEN, V4, P327, DOI 10.1177/108705719900400608; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huntley JJA, 2000, BIOCHEMISTRY-US, V39, P13356, DOI 10.1021/bi001210r; INESI G, 1985, ANNU REV PHYSIOL, V47, P573, DOI 10.1146/annurev.ph.47.030185.003041; INESI G, 1980, J BIOL CHEM, V255, P3025; Inesi G, 2008, J BIOL CHEM, V283, P1189, DOI 10.1074/jbc.M707189200; Inesi G, 2006, BIOCHEMISTRY-US, V45, P13769, DOI 10.1021/bi061255d; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; JONES LR, 1977, J BIOL CHEM, V252, P3315; Karon BS, 1999, BIOCHEMISTRY-US, V38, P9301, DOI 10.1021/bi990190u; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; KIRLEY TL, 1985, BIOCHEM BIOPH RES CO, V130, P732, DOI 10.1016/0006-291X(85)90477-2; Korman VL, 2006, J MOL BIOL, V356, P1107, DOI 10.1016/j.jmb.2005.10.024; Lakowicz J. R., 2013, PRINCIPLES FLUORESCE, P1; Lassila JK, 2011, ANNU REV BIOCHEM, V80, P669, DOI 10.1146/annurev-biochem-060409-092741; Laursen M, 2009, J BIOL CHEM, V284, P13513, DOI 10.1074/jbc.C900031200; LEVY D, 1990, J BIOL CHEM, V265, P19524; Li F, 2002, J MOL BIOL, V315, P459, DOI 10.1006/jmbi.2001.5256; Ma HL, 2003, J BIOL CHEM, V278, P28938, DOI 10.1074/jbc.M304120200; MacLennan DH, 1997, J BIOL CHEM, V272, P28815, DOI 10.1074/jbc.272.46.28815; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; McIntosh DB, 2008, BIOCHEMISTRY-US, V47, P6386, DOI 10.1021/bi800290q; McIntosh DB, 1999, J BIOL CHEM, V274, P25227, DOI 10.1074/jbc.274.36.25227; McIntosh DB, 2004, J BIOL CHEM, V279, P32515, DOI 10.1074/jbc.M403242200; MCINTOSH DB, 1994, J BIOL CHEM, V269, P21587; MCINTOSH DB, 1992, J BIOL CHEM, V267, P5301; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; MITCHINSON C, 1982, FEBS LETT, V146, P87, DOI 10.1016/0014-5793(82)80710-2; Moller JV, 2010, Q REV BIOPHYS, V43, P501, DOI 10.1017/S003358351000017X; Moller JV, 2005, CURR OPIN STRUC BIOL, V15, P387, DOI 10.1016/j.sbi.2005.06.005; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Mueller B, 2004, BIOCHEMISTRY-US, V43, P12846, DOI 10.1021/bi0489457; Muretta JM, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3480647; Nesmelov YE, 2011, P NATL ACAD SCI USA, V108, P1891, DOI 10.1073/pnas.1012320108; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Palmgren MG, 2011, ANNU REV BIOPHYS, V40, P243, DOI 10.1146/annurev.biophys.093008.131331; PAPP S, 1987, BIOPHYS J, V51, P205, DOI 10.1016/S0006-3495(87)83326-X; Pei Q, 2007, MATER TRANS, V48, P735, DOI 10.2320/matertrans.48.735; PICK U, 1980, BIOCHIM BIOPHYS ACTA, V626, P255, DOI 10.1016/0005-2795(80)90216-0; PICK U, 1981, FEBS LETT, V123, P131, DOI 10.1016/0014-5793(81)80036-1; PICK U, 1981, FEBS LETT, V123, P127, DOI 10.1016/0014-5793(81)80035-X; PICK U, 1981, EUR J BIOCHEM, V121, P187, DOI 10.1111/j.1432-1033.1981.tb06448.x; PICK U, 1982, J BIOL CHEM, V257, P6120; SASSAROLI M, 1986, BIOPHYS CHEM, V25, P283, DOI 10.1016/0301-4622(86)80020-5; She MD, 1997, BIOPHYS J, V73, P1042, DOI 10.1016/S0006-3495(97)78137-2; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Stokes DL, 2005, J BIOL CHEM, V280, P18063, DOI 10.1074/jbc.M500031200; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; Toyoshima C, 2008, ARCH BIOCHEM BIOPHYS, V476, P3, DOI 10.1016/j.abb.2008.04.017; Toyoshima C, 2011, P NATL ACAD SCI USA, V108, P1833, DOI 10.1073/pnas.1017659108; Tran K, 2009, BIOPHYS J, V96, P2029, DOI 10.1016/j.bpj.2008.11.045; VOSS JC, 1995, BIOCHEMISTRY-US, V34, P930, DOI 10.1021/bi00003a027; WAWRZYNOW A, 1993, BIOCHIM BIOPHYS ACTA, V1203, P60, DOI 10.1016/0167-4838(93)90036-Q; Winters DL, 2008, BIOCHEMISTRY-US, V47, P4246, DOI 10.1021/bi702089j; Xu C, 2002, J MOL BIOL, V316, P201, DOI 10.1006/jmbi.2001.5330; YAMAMOTO H, 1989, J BIOCHEM-TOKYO, V106, P1121, DOI 10.1093/oxfordjournals.jbchem.a122976; YU X, 1993, BIOPHYS J, V64, P1232, DOI 10.1016/S0006-3495(93)81489-9	93	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39070	39082		10.1074/jbc.M112.404434	http://dx.doi.org/10.1074/jbc.M112.404434			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22977248	Green Published, hybrid			2022-12-25	WOS:000310982800063
J	Barreteau, H; Tiouajni, M; Graille, M; Josseaume, N; Bouhss, A; Patin, D; Blanot, D; Fourgeaud, M; Mainardi, JL; Arthur, M; van Tilbeurgh, H; Mengin-Lecreulx, D; Touze, T				Barreteau, Helene; Tiouajni, Mounira; Graille, Marc; Josseaume, Nathalie; Bouhss, Ahmed; Patin, Delphine; Blanot, Didier; Fourgeaud, Martine; Mainardi, Jean-Luc; Arthur, Michel; van Tilbeurgh, Herman; Mengin-Lecreulx, Dominique; Touze, Thierry			Functional and Structural Characterization of PaeM, a Colicin M-like Bacteriocin Produced by Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M IMMUNITY PROTEIN; ESCHERICHIA-COLI; PEPTIDOGLYCAN PRECURSORS; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; BIOSYNTHESIS; EVOLUTION; TOXICITY; OUTS; FKPA	Colicin M (ColM) is the only enzymatic colicin reported to date that inhibits cell wall peptidoglycan biosynthesis. It catalyzes the specific degradation of the lipid intermediates involved in this pathway, thereby provoking lysis of susceptible Escherichia coli cells. A gene encoding a homologue of ColM was detected within the exo U-containing genomic island A carried by certain pathogenic Pseudomonas aeruginosa strains. This bacteriocin (pyocin) that we have named PaeM was crystallized, and its structure with and without an Mg2+ ion bound was solved. In parallel, site-directed mutagenesis of conserved PaeM residues from the C-terminal domain was performed, confirming their essentiality for the protein activity both in vitro (lipid II-degrading activity) and in vivo (cytotoxicity against a susceptible P. aeruginosa strain). Although PaeM is structurally similar to ColM, the conformation of their active sites differs radically; in PaeM, residues essential for enzymatic activity and cytotoxicity converge toward a same pocket, whereas in ColM they are spread along a particularly elongated active site. We have also isolated a minimal domain corresponding to the C-terminal half of the PaeM protein and exhibiting a 70-fold higher enzymatic activity as compared with the full-length protein. This isolated domain of the PaeM bacteriocin was further shown to kill E. coli cells when addressed to the periplasm of these bacteria.	[Mengin-Lecreulx, Dominique] Univ Paris 11, UMR CNRS 8619, IBBMC,Lab Enveloppes Bacteriennes & Antibiot, Inst Biochim & Biophys Mol & Cellulaire,UMR 8619, F-91405 Orsay, France; [Barreteau, Helene; Tiouajni, Mounira; Graille, Marc; Bouhss, Ahmed; Patin, Delphine; Blanot, Didier; van Tilbeurgh, Herman; Mengin-Lecreulx, Dominique; Touze, Thierry] CNRS, UMR 8619, F-91405 Orsay, France; [Josseaume, Nathalie; Fourgeaud, Martine; Mainardi, Jean-Luc; Arthur, Michel] Univ Paris 06, UMR S 872, Lab Rech Mol Antibiot, Ctr Rech Cordeliers, F-75006 Paris 6, France; [Josseaume, Nathalie; Fourgeaud, Martine; Mainardi, Jean-Luc; Arthur, Michel] Univ Paris 05, F-75006 Paris, France; [Josseaume, Nathalie; Fourgeaud, Martine; Mainardi, Jean-Luc; Arthur, Michel] Hop Europeen Georges Pompidou, AP HP, F-75015 Paris, France; [Josseaume, Nathalie; Fourgeaud, Martine; Mainardi, Jean-Luc; Arthur, Michel] INSERM, U872, F-75006 Paris, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mengin-Lecreulx, D (corresponding author), Univ Paris 11, UMR CNRS 8619, IBBMC,Lab Enveloppes Bacteriennes & Antibiot, Inst Biochim & Biophys Mol & Cellulaire,UMR 8619, Bat 430, F-91405 Orsay, France.	dominique.mengin-lecreulx@u-psud.fr	Arthur, Michel/G-3680-2013; GRAILLE, Marc/D-3242-2014; Touzé, Thierry/GLT-1308-2022; MAINARDI, Jean-Luc/E-2714-2014	Arthur, Michel/0000-0003-1007-636X; GRAILLE, Marc/0000-0002-7853-5852; MAINARDI, Jean-Luc/0000-0002-4159-0129; MENGIN-LECREULX, Dominique/0000-0003-3205-0275; Touze, Thierry/0000-0002-2176-6537	Agence Nationale de la Recherche (PEPGLYCOL project) [ANR-07-MIME-020]; Centre National de la Recherche Scientifique [UMR 8619]	Agence Nationale de la Recherche (PEPGLYCOL project)(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the Agence Nationale de la Recherche (PEPGLYCOL project, ANR-07-MIME-020) and the Centre National de la Recherche Scientifique (UMR 8619).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AMREIN KE, 1995, P NATL ACAD SCI USA, V92, P1048, DOI 10.1073/pnas.92.4.1048; Barneoud-Arnoulet A, 2010, J BACTERIOL, V192, P5212, DOI 10.1128/JB.00431-10; Barreteau H, 2012, MICROB DRUG RESIST, V18, P222, DOI 10.1089/mdr.2011.0230; Barreteau H, 2010, J BIOL CHEM, V285, P12378, DOI 10.1074/jbc.M109.093583; Barreteau H, 2009, J BACTERIOL, V191, P3657, DOI 10.1128/JB.01824-08; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAUN V, 1973, BIOCHIM BIOPHYS ACTA, V323, P87, DOI 10.1016/0005-2736(73)90433-1; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gerard F, 2011, J BACTERIOL, V193, P205, DOI 10.1128/JB.01119-10; Grinter R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033033; Helbig S, 2011, J BIOL CHEM, V286, P6280, DOI 10.1074/jbc.M110.165274; Helbig S, 2011, J BACTERIOL, V193, P815, DOI 10.1128/JB.01206-10; Hullmann J, 2008, MOL MICROBIOL, V69, P926, DOI 10.1111/j.1365-2958.2008.06327.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Miller J. H., 1972, EXPT MOL GENETICS, P431; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Patin D, 2012, BIOCHIMIE, V94, P985, DOI 10.1016/j.biochi.2011.12.019; PILSL H, 1993, MOL GEN GENET, V240, P103, DOI 10.1007/BF00276889; PUGSLEY AP, 1984, MICROBIOL SCI, V1, P203; PUGSLEY AP, 1984, MICROBIOL SCI, V1, P168; Sambrook J., 2002, MOL CLONING LAB MANU; SCHALLER K, 1982, J BACTERIOL, V152, P994; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Uson I, 2012, J STRUCT BIOL, V178, P45, DOI 10.1016/j.jsb.2012.02.004; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Zeth K, 2008, J BIOL CHEM, V283, P25324, DOI 10.1074/jbc.M802591200	34	22	23	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37395	37405		10.1074/jbc.M112.406439	http://dx.doi.org/10.1074/jbc.M112.406439			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977250	hybrid, Green Published			2022-12-25	WOS:000310588500070
J	Chaikuad, A; Alfano, I; Kerr, G; Sanvitale, CE; Boergermann, JH; Triffitt, JT; von Delft, F; Knapp, S; Knaus, P; Bullock, AN				Chaikuad, Apirat; Alfano, Ivan; Kerr, Georgina; Sanvitale, Caroline E.; Boergermann, Jan H.; Triffitt, James T.; von Delft, Frank; Knapp, Stefan; Knaus, Petra; Bullock, Alex N.			Structure of the Bone Morphogenetic Protein Receptor ALK2 and Implications for Fibrodysplasia Ossificans Progressiva	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA RECEPTOR; CRYSTAL-STRUCTURE; I RECEPTOR; CELL-MEMBRANE; MUTATION; DOMAIN; ACTIVATION; FAMILY; MODEL; DIFFERENTIATION	Bone morphogenetic protein (BMP) receptor kinases are tightly regulated to control development and tissue homeostasis. Mutant receptor kinase domains escape regulation leading to severely degenerative diseases and represent an important therapeutic target. Fibrodysplasia ossificans progressiva (FOP) is a rare but devastating disorder of extraskeletal bone formation. FOP-associated mutations in the BMP receptor ALK2 reduce binding of the inhibitor FKBP12 and promote leaky signaling in the absence of ligand. To establish structural mechanisms of receptor regulation and to address the effects of FOP mutation, we determined the crystal structure of the cytoplasmic domain of ALK2 in complex with the inhibitors FKBP12 and dorsomorphin. FOP mutations break critical interactions that stabilize the inactive state of the kinase, thereby facilitating structural rearrangements that diminish FKBP12 binding and promote the correct positioning of the glycine-serine-rich loop and alpha C helix for kinase activation. The balance of these effects accounts for the comparable activity of R206H and L196P. Kinase activation in the clinically benign mutant L196P is far weaker than R206H but yields equivalent signals due to the stronger interaction of FKBP12 with R206H. The presented ALK2 structure offers a valuable template for the further design of specific inhibitors of BMP signaling.	[Chaikuad, Apirat; Alfano, Ivan; Kerr, Georgina; Sanvitale, Caroline E.; von Delft, Frank; Knapp, Stefan; Bullock, Alex N.] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Boergermann, Jan H.; Knaus, Petra] Free Univ Berlin, Inst Chem Biochem, D-14195 Berlin, Germany; [Triffitt, James T.] Univ Oxford, Botnar Res Ctr, Oxford OX3 7LD, England	University of Oxford; Free University of Berlin; University of Oxford	Bullock, AN (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England.	alex.bullock@sgc.ox.ac.uk	Knapp, Stefan/AAG-2347-2019	Knapp, Stefan/0000-0001-5995-6494; von Delft, Frank/0000-0003-0378-0017; Chaikuad, Apirat/0000-0003-1120-2209	Roemex postdoctoral fellowship; University of Oxford FOP Research Fund; German Research Foundation Collaborative Research Centre [SFB 760]; Canadian Institutes for Health Research; Genome Canada; GlaxoSmithKline; Lilly Canada; Novartis Research Foundation; Pfizer; Takeda; AbbVie; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Wellcome Trust [092809/Z/10/Z]	Roemex postdoctoral fellowship; University of Oxford FOP Research Fund; German Research Foundation Collaborative Research Centre(German Research Foundation (DFG)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Lilly Canada(Eli Lilly); Novartis Research Foundation; Pfizer(Pfizer); Takeda(Takeda Pharmaceutical Company Ltd); AbbVie(AbbVie); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Ministry of Economic Development and Innovation; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by a Roemex postdoctoral fellowship (to G. K.), the University of Oxford FOP Research Fund (to C. E. S.), and German Research Foundation Collaborative Research Centre Grant SFB 760 (to P. K.).; We thank Kirsten Petrie and Binesh Shrestra for help with ALK2 expression and staff at the Diamond Light Source for help with diffraction data collection. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, Genome Canada, GlaxoSmithKline, Lilly Canada, the Novartis Research Foundation, Pfizer, Takeda, AbbVie, the Canada Foundation for Innovation, the Ontario Ministry of Economic Development and Innovation, and the Wellcome Trust Grant 092809/Z/10/Z.	Blake, 2007, SCI STKE, DOI DOI 10.1126/STKE.3992007CM1; Bocciardi R, 2009, EUR J HUM GENET, V17, P311, DOI 10.1038/ejhg.2008.178; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fukuda T, 2008, BIOCHEM BIOPH RES CO, V377, P905, DOI 10.1016/j.bbrc.2008.10.093; Fukuda T, 2009, J BIOL CHEM, V284, P7149, DOI 10.1074/jbc.M801681200; Furuya H, 2008, AM J MED GENET A, V146A, P459, DOI 10.1002/ajmg.a.32151; Gregson CL, 2011, BONE, V48, P654, DOI 10.1016/j.bone.2010.10.164; Groppe JC, 2011, CELLS TISSUES ORGANS, V194, P291, DOI 10.1159/000324230; Han S, 2007, PROTEIN SCI, V16, P2272, DOI 10.1110/ps.073068407; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Huse M, 1999, CELL, V96, P425, DOI 10.1016/S0092-8674(00)80555-3; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Kan LX, 2004, AM J PATHOL, V165, P1107, DOI 10.1016/S0002-9440(10)63372-X; Kaplan FS, 2006, ANN NY ACAD SCI, V1068, P54, DOI 10.1196/annals.1346.008; Kaplan Frederick S, 2009, Hum Mutat, V30, P379, DOI 10.1002/humu.20868; Lavery K, 2008, J BIOL CHEM, V283, P20948, DOI 10.1074/jbc.M800850200; Le VQ, 2012, DEV DYNAM, V241, P200, DOI 10.1002/dvdy.22779; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Mueller TD, 2012, FEBS LETT, V586, P1846, DOI 10.1016/j.febslet.2012.02.043; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohte S, 2011, BIOCHEM BIOPH RES CO, V407, P213, DOI 10.1016/j.bbrc.2011.03.001; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Petrie KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005005; Qin BY, 2001, MOL CELL, V8, P1303, DOI 10.1016/S1097-2765(01)00417-8; Shen Q, 2009, J CLIN INVEST, V119, P3462, DOI 10.1172/JCI37412; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shore EM, 2010, NAT REV RHEUMATOL, V6, P518, DOI 10.1038/nrrheum.2010.122; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Song GA, 2010, J BIOL CHEM, V285, P22542, DOI 10.1074/jbc.M109.094557; van Dinther M, 2010, J BONE MINER RES, V25, P1208, DOI [10.1002/jbmr.091110, 10.1359/jbmr.091110]; WANG TW, 1994, SCIENCE, V265, P674, DOI 10.1126/science.7518616; Wang TW, 1996, CELL, V86, P435, DOI 10.1016/S0092-8674(00)80116-6; Whyte MP, 2012, J BONE MINER RES, V27, P729, DOI 10.1002/jbmr.1473; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu JW, 2001, MOL CELL, V8, P1277, DOI 10.1016/S1097-2765(01)00421-X; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	49	134	139	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36990	36998		10.1074/jbc.M112.365932	http://dx.doi.org/10.1074/jbc.M112.365932			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977237	hybrid, Green Published			2022-12-25	WOS:000310588500034
J	Hart, JA; Detwiler, KM; Gilbert, CC; Burrell, AS; Fuller, JL; Emetshu, M; Hart, TB; Vosper, A; Sargis, EJ; Tosi, AJ				Hart, John A.; Detwiler, Kate M.; Gilbert, Christopher C.; Burrell, Andrew S.; Fuller, James L.; Emetshu, Maurice; Hart, Terese B.; Vosper, Ashley; Sargis, Eric J.; Tosi, Anthony J.			Lesula: A New Species of Cercopithecus Monkey Endemic to the Democratic Republic of Congo and Implications for Conservation of Congo's Central Basin	PLOS ONE			English	Article							BIEGA-NATIONAL-PARK; Y-CHROMOSOME; EVOLUTIONARY HISTORY; DIVERSITY; PRIMATES; FOREST; INFERENCE; MRBAYES; WINDOW; ZAIRE	In June 2007, a previously undescribed monkey known locally as "lesula" was found in the forests of the middle Lomami Basin in central Democratic Republic of Congo (DRC). We describe this new species as Cercopithecus lomamiensis sp. nov., and provide data on its distribution, morphology, genetics, ecology and behavior. C. lomamiensis is restricted to the lowland rain forests of central DRC between the middle Lomami and the upper Tshuapa Rivers. Morphological and molecular data confirm that C. lomamiensis is distinct from its nearest congener, C. hamlyni, from which it is separated geographically by both the Congo (Lualaba) and the Lomami Rivers. C. lomamiensis, like C. hamlyni, is semi-terrestrial with a diet containing terrestrial herbaceous vegetation. The discovery of C. lomamiensis highlights the biogeographic significance and importance for conservation of central Congo's interfluvial TL2 region, defined from the upper Tshuapa River through the Lomami Basin to the Congo (Lualaba) River. The TL2 region has been found to contain a high diversity of anthropoid primates including three forms, in addition to C. lomamiensis, that are endemic to the area. We recommend the common name, lesula, for this new species, as it is the vernacular name used over most of its known range.	[Hart, John A.; Emetshu, Maurice; Hart, Terese B.] Lukuru Wildlife Res Fdn, Kinshasa, Gombe, DEM REP CONGO; [Hart, John A.; Hart, Terese B.; Sargis, Eric J.] Yale Peabody Museum Nat Hist, Div Vertebrate Zool, New Haven, CT USA; [Detwiler, Kate M.] Florida Atlantic Univ, Dept Anthropol, Boca Raton, FL 33431 USA; [Gilbert, Christopher C.] CUNY Hunter Coll, Dept Anthropol, New York, NY USA; [Gilbert, Christopher C.; Fuller, James L.] New York Consortium Evolutionary Primatol, New York, NY USA; [Burrell, Andrew S.; Tosi, Anthony J.] NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA; [Fuller, James L.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY USA; [Vosper, Ashley] Wildlife Conservat Soc Congo, Wildlife Conservat Soc Zanaga Project, Brazzaville, Rep Congo; [Sargis, Eric J.] Yale Univ, Dept Anthropol, New Haven, CT 06520 USA	Yale University; State University System of Florida; Florida Atlantic University; City University of New York (CUNY) System; Hunter College (CUNY); New York University; Columbia University; Yale University	Hart, JA (corresponding author), Lukuru Wildlife Res Fdn, Kinshasa, Gombe, DEM REP CONGO.	kdetwile@fau.edu		Gilbert, Christopher/0000-0001-8768-3171	Arcus Foundation; United States Fish and Wildlife Service; Abraham Foundation; Margot Marsh Biodiversity Foundation; Yale Institute for Biospheric Studies	Arcus Foundation; United States Fish and Wildlife Service(US Fish & Wildlife Service); Abraham Foundation; Margot Marsh Biodiversity Foundation; Yale Institute for Biospheric Studies	The research was supported by Arcus Foundation (http://www.arcusfoundation.org/), United States Fish and Wildlife Service (http://www.fws.gov/grants/), a grant from Edith McBean, Abraham Foundation (http://abrahamfoundation.org/cms/), Margot Marsh Biodiversity Foundation Grant, and a Gaylord Donnelley Environmental Postdoctoral Fellowship from the Yale Institute for Biospheric Studies (http://www.yale.edu/yibs/programs_donnelley.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Butynski Thomas M., 2002, P3; Chapman Colin A., 2002, P325; COLYN M, 1987, FOLIA PRIMATOL, V49, P203, DOI 10.1159/000156324; COLYN M, 1991, ANN SCI ZOOLOGIQUES, V264, P1; COLYN M M, 1987, Revue de Zoologie Africaine, V101, P183; Dowsett RJ, 1990, ENQUETE FAUNISTIQUE, P111; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Fleagle JG, 2010, AM J PHYS ANTHROPOL, V142, P565, DOI 10.1002/ajpa.21272; GAUTIER J-P, 1971, Biologia Gabonica, V7, P229; Groves C, 2004, INT J PRIMATOL, V25, P1105, DOI 10.1023/B:IJOP.0000043354.36778.55; Groves CP, 2001, PRIMATE TAXONOMY; Grubb P, 2003, INT J PRIMATOL, V24, P1301, DOI 10.1023/B:IJOP.0000005994.86792.b9; Hall JS, 2003, AFR PRIMATES, V6, P35; Hamilton A.C., 1988, P13; HANKE M, 1994, BIOTECHNIQUES, V17, P858; Harcourt AH, 2012, INT J PRIMATOL, V33, P168, DOI 10.1007/s10764-011-9558-z; Hart JA, 2012, MAMMALS AFRICA, V2; Hart TB, 2009, ANNEX 7 BUSHMEAT CRI; Hart TB, 2009, DOCUMENTATION ESTABL; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Inogwabini BI, 2000, AFR J ECOL, V38, P269, DOI 10.1046/j.1365-2028.2000.00223.x; IUCN Standards and Petitions Subcommittee, 2010, GUID US IUCN RED LIS; Kaessmann H, 1999, SCIENCE, V286, P1159, DOI 10.1126/science.286.5442.1159; KINGDON J S, 1980, Transactions of the Zoological Society of London, V35, P425; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maruhashi T, 1989, INTERSPECIES RELATIO, P53; Nagaraja R, 1997, GENOME RES, V7, P210, DOI 10.1101/gr.7.3.210; O'Higgins P, 1998, J ANAT, V193, P251, DOI 10.1046/j.1469-7580.1998.19320251.x; Oates J.F., 1988, P79; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Raaum RL, 2006, DVLR MSI V 0 4 9; Rambaut A, 2014, TRACER V1 6; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Slice DE, 2005, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/0-387-27614-9_1; Smithe F, 1975, NATURALISTS COLOR 1; Struhsaker TT, 2010, RED COLOBUS MONKEYS: VARIATION IN DEMOGRAPHY, BEHAVIOR, AND ECOLOGY OF ENDANGERED SPECIES, P1, DOI 10.1093/acprof:oso/9780198529583.001.0001; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Sys C, 1960, NOTICE EXPLICATIVE C; THOMAS SC, 1991, BIOTROPICA, V23, P68, DOI 10.2307/2388690; Ting N, 2008, J HUM EVOL, V55, P312, DOI 10.1016/j.jhevol.2008.02.011; Tosi AJ, 2000, MOL PHYLOGENET EVOL, V17, P133, DOI 10.1006/mpev.2000.0834; Tosi AJ, 2005, MOL PHYLOGENET EVOL, V36, P58, DOI 10.1016/j.ympev.2005.01.009; Tosi AJ, 2003, MOL PHYLOGENET EVOL, V27, P510, DOI 10.1016/S1055-7903(03)00024-1; Tosi AJ, 2008, ZOOL J LINN SOC-LOND, V154, P408, DOI 10.1111/j.1096-3642.2008.00419.x; Vogel T, 1998, CYTOGENET CELL GENET, V80, P209, DOI 10.1159/000014982; Yamagiwa J, 1989, INTERSPECIES RELATIO, P5; Young A, 1980, CAMBRIDGE GEOGRAPHIC; Zwickl DJ, 2006, THESIS	50	38	41	1	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44271	10.1371/journal.pone.0044271	http://dx.doi.org/10.1371/journal.pone.0044271			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984482	gold, Green Submitted, Green Published			2022-12-25	WOS:000308738500041
J	Kohn, G; Delvaux, D; Lakaye, B; Servais, AC; Scholer, G; Fillet, M; Elias, B; Derochette, JM; Crommen, J; Wins, P; Bettendorff, L				Kohn, Gregory; Delvaux, David; Lakaye, Bernard; Servais, Anne-Catherine; Scholer, Georges; Fillet, Marianne; Elias, Benjamin; Derochette, Jean-Michel; Crommen, Jacques; Wins, Pierre; Bettendorff, Lucien			High Inorganic Triphosphatase Activities in Bacteria and Mammalian Cells: Identification of the Enzymes Involved	PLOS ONE			English	Article							TUNNEL METALLOENZYME SUPERFAMILY; ESCHERICHIA-COLI; THIAMINE TRIPHOSPHATASE; ADENYLYL-CYCLASE; RNA TRIPHOSPHATASE; CATALYTIC-MECHANISM; TRYPANOSOMA-BRUCEI; POLYPHOSPHATE; PYROPHOSPHATASE; TRIPOLYPHOSPHATE	Background: We recently characterized a specific inorganic triphosphatase (PPPase) from Nitrosomonas europaea. This enzyme belongs to the CYTH superfamily of proteins. Many bacterial members of this family are annotated as predicted adenylate cyclases, because one of the founding members is CyaB adenylate cyclase from A. hydrophila. The aim of the present study is to determine whether other members of the CYTH protein family also have a PPPase activity, if there are PPPase activities in animal tissues and what enzymes are responsible for these activities. Methodology/Principal Findings: Recombinant enzymes were expressed and purified as GST- or His-tagged fusion proteins and the enzyme activities were determined by measuring the release of inorganic phosphate. We show that the hitherto uncharacterized E. coli CYTH protein ygiF is a specific PPPase, but it contributes only marginally to the total PPPase activity in this organism, where the main enzyme responsible for hydrolysis of inorganic triphosphate (PPPi) is inorganic pyrophosphatase. We further show that CyaB hydrolyzes PPPi but this activity is low compared to its adenylate cyclase activity. Finally we demonstrate a high PPPase activity in mammalian and quail tissue, particularly in the brain. We show that this activity is mainly due to Prune, an exopolyphosphatase overexpressed in metastatic tumors where it promotes cell motility. Conclusions and General Significance: We show for the first time that PPPase activities are widespread in bacteria and animals. We identified the enzymes responsible for these activities but we were unable to detect significant amounts of PPPi in E. coli or brain extracts using ion chromatography and capillary electrophoresis. The role of these enzymes may be to hydrolyze PPPi, which could be cytotoxic because of its high affinity for Ca2+, thereby interfering with Ca2+ signaling.	[Kohn, Gregory; Delvaux, David; Lakaye, Bernard; Wins, Pierre; Bettendorff, Lucien] Univ Liege, GIGA Neurosci, Liege, Belgium; [Servais, Anne-Catherine; Fillet, Marianne; Crommen, Jacques] Univ Liege, Dept Pharmaceut Sci, Lab Analyt Pharmaceut Chem, CIRM, Liege, Belgium; [Scholer, Georges; Elias, Benjamin] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium; [Derochette, Jean-Michel] Prayon SA, Engis, Belgium	University of Liege; University of Liege; Universite Catholique Louvain	Kohn, G (corresponding author), Univ Liege, GIGA Neurosci, Liege, Belgium.	L.Bettendorff@ulg.ac.be		Fillet, Marianne/0000-0002-1453-6282; Elias, Benjamin/0000-0001-5037-3313	Fonds de la Recherche Fondamendale collective [2.4558.04, 2.4508.10]	Fonds de la Recherche Fondamendale collective	LB is a Research Director and BL is a Research Associate at the Funds for Scientific Research - FNRS (Belgium). DD is a Research Fellows of the Fonds pour la Formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.). This work was supported by grants of the "Fonds de la Recherche Fondamendale collective" (Grants and 2.4558.04 and 2.4508.10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA M, 1993, J BIOL CHEM, V268, P633; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; Avaeva S, 1996, FEBS LETT, V399, P99, DOI 10.1016/S0014-5793(96)01296-3; Baltscheffsky M, 1998, BBA-BIOENERGETICS, V1364, P301, DOI 10.1016/S0005-2728(98)00062-0; Bettendorff L, 2003, ANAL BIOCHEM, V322, P190, DOI 10.1016/j.ab.2003.08.013; Carotenuto P, 2006, J BIOENERG BIOMEMBR, V38, P233, DOI 10.1007/s10863-006-9044-z; CHANG DM, 1983, J AM OIL CHEM SOC, V60, P618, DOI 10.1007/BF02679800; Cui H, 2000, J CHROMATOGR A, V884, P89, DOI 10.1016/S0021-9673(00)00055-8; Delvaux D, 2011, J BIOL CHEM, V286, P34023, DOI 10.1074/jbc.M111.233585; Gallagher DT, 2011, J MOL BIOL, V405, P787, DOI 10.1016/j.jmb.2010.11.026; Gong CL, 2006, RNA, V12, P1468, DOI 10.1261/rna.119806; Gong CL, 2003, J BIOL CHEM, V278, P50843, DOI 10.1074/jbc.M309188200; Himeno S, 2007, J SEP SCI, V30, P1077, DOI 10.1002/jssc.200600501; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33; Jain Ruchi, 2008, J Biol Chem, V283, P31047, DOI 10.1074/jbc.M805392200; JOSSE J, 1966, J BIOL CHEM, V241, P1938; Keppetipola N, 2007, J BIOL CHEM, V282, P11941, DOI 10.1074/jbc.M611328200; KORNBERG SR, 1958, J BIOL CHEM, V233, P159; KUKKOKALSKE E, 1989, J BACTERIOL, V171, P4498, DOI 10.1128/JB.171.8.4498-4500.1989; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Kuroda A, 1997, J BIOL CHEM, V272, P21240, DOI 10.1074/jbc.272.34.21240; Lakaye B, 2002, J BIOL CHEM, V277, P13771, DOI 10.1074/jbc.M111241200; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Linster CL, 2011, J BIOL CHEM, V286, P42992, DOI 10.1074/jbc.M111.281527; Makarchikov AF, 2003, CELL MOL LIFE SCI, V60, P1477, DOI 10.1007/s00018-003-3098-4; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; Moreno B, 2000, J BIOL CHEM, V275, P28356, DOI 10.1074/jbc.M003893200; Pavlov E, 2010, J BIOL CHEM, V285, P9420, DOI 10.1074/jbc.M109.013011; Simonovic AD, 2004, ANAL BIOCHEM, V334, P312, DOI 10.1016/j.ab.2004.07.010; Sismeiro O, 1998, J BACTERIOL, V180, P3339, DOI 10.1128/JB.180.13.3339-3344.1998; Song JK, 2008, J BIOL CHEM, V283, P10939, DOI 10.1074/jbc.M709675200; Tammenkoski M, 2008, BIOCHEMISTRY-US, V47, P9707, DOI 10.1021/bi8010847; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; TSUTSUI K, 1986, J BIOL CHEM, V261, P2645; VANHEESWIJK WC, 1993, MOL MICROBIOL, V9, P443; Zyryanov AB, 2002, BIOCHEM J, V367, P901, DOI 10.1042/BJ20020880	40	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43879	10.1371/journal.pone.0043879	http://dx.doi.org/10.1371/journal.pone.0043879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984449	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500026
J	Kotipatruni, RR; Nalla, AK; Asuthkar, S; Gondi, CS; Dinh, DH; Rao, JS				Kotipatruni, Ramaprasada Rao; Nalla, Arun Kumar; Asuthkar, Swapna; Gondi, Christopher S.; Dinh, Dzung H.; Rao, Jasti S.			Apoptosis Induced by Knockdown of uPAR and MMP-9 is Mediated by Inactivation of EGFR/STAT3 Signaling in Medulloblastoma	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; DOWN-REGULATION; MATRIX METALLOPROTEINASES; MITOCHONDRIAL APOPTOSIS; RNA INTERFERENCE; GENE-EXPRESSION; CELL-DEATH; FACTOR EGF; IN-VIVO	Background: Medulloblastoma is a highly invasive cancer of central nervous system diagnosed mainly in children. Matrix metalloproteinase-9 (MMP-9) and urokinase plasminogen activator receptor (uPAR) are over expressed in several cancers and well established for their roles in tumor progression. The present study is aimed to determine the consequences of targeting these molecules on medulloblastoma progression. Methodology/Principal Findings: Radiation is one of the foremost methods applied for treating cancer and considerable evidence showed that radiation elevated uPAR and MMP-9 expression in medulloblastoma cell. Therefore efforts are made to target these molecules in non-irradiated and irradiated medulloblastoma cells. Our results showed that siRNA-mediated knockdown of uPAR and MMP-9, either alone or in combination with radiation modulated a series of events leading to apoptosis. Down regulation of uPAR and MMP-9 inhibited the expression of anti-apoptotic molecules like Bcl-2, Bcl-xL, survivin, XIAP and cIAPI; activated BID cleavage, enhanced the expression of Bak and translocated cyctochrome C to cytosol. Capsase-3 and -9 activities were also increased in uPAR-and MMP-9-downregulated cells. The apoptosis induced by targeting MMP-9 and uPAR was initiated by inhibiting epidermal growth factor receptor (EGFR) mediated activation of STAT3 and NF-kappa B related signaling molecules. Silencing uPAR and MMP-9 inhibited DNA binding activity of STAT3 and also reduced the recruitment of STAT3 protein at the promoter region of Bcl-2 and survivin genes. Our results suggest that inhibiting uPAR and MMP-9 reduced the expression of anti-apoptotic molecules by inactivating the transcriptional activity of STAT3. In addition, treating pre-established medulloblastoma with siRNAs against uPAR and MMP-9 both alone or in combination with radiation suppressed uPAR, MMP-9, EGFR, STAT3 expression and induced Bak activation leading to apoptosis. Conclusion/Significance: Taken together, our results illustrated that RNAi mediated targeting of uPAR and MMP-9 might have therapeutic potential against medulloblastoma.	[Kotipatruni, Ramaprasada Rao; Nalla, Arun Kumar; Asuthkar, Swapna; Gondi, Christopher S.; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA; [Dinh, Dzung H.; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Neurosurg, Peoria, IL USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Kotipatruni, RR (corresponding author), Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA.	jsrao@uic.edu	K, R/F-5701-2011	K, R/0000-0001-9853-2686; Gondi, Christopher/0000-0002-3036-9920	National Institutes of Health [CA138409]; NATIONAL CANCER INSTITUTE [R01CA138409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by award number CA138409 (to J.S.R.) from the National Institutes of Health. Contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Brunelle JK, 2009, J CELL SCI, V122, P437, DOI 10.1242/jcs.031682; Cattaneo E, 1998, ANTICANCER RES, V18, P2381; Chen FX, 2010, J MOL NEUROSCI, V40, P353, DOI 10.1007/s12031-009-9323-3; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; David M, 1996, J BIOL CHEM, V271, P9185, DOI 10.1074/jbc.271.16.9185; Dolled-Filhart M, 2003, CLIN CANCER RES, V9, P594; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fan YJ, 2008, ADV EXP MED BIOL, V615, P223, DOI 10.1007/978-1-4020-6554-5_11; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Ganji PCN, 2011, MOL CANCER RES, V9, P51, DOI 10.1158/1541-7786.MCR-10-0399; GERSCHENSON LE, 1992, FASEB J, V6, P2450, DOI 10.1096/fasebj.6.7.1563596; GHOSH G, 1995, NATURE, V373, P303, DOI 10.1038/373303a0; Gondi CS, 2008, INT J ONCOL, V33, P783, DOI 10.3892/ijo_00000065; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Guerrero J, 2004, EXP CELL RES, V292, P201, DOI 10.1016/j.yexcr.2003.08.011; Hemmati PG, 2006, ONCOGENE, V25, P6582, DOI 10.1038/sj.onc.1209668; Henson ES, 2006, CELL SIGNAL, V18, P2089, DOI 10.1016/j.cellsig.2006.05.015; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kargiotis O, 2008, INT J ONCOL, V33, P937, DOI 10.3892/ijo_00000081; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kim KW, 2006, MOL CANCER THER, V5, P2659, DOI 10.1158/1535-7163.MCT-06-0261; Kumar A, 2002, EUR J CANCER, V38, P505, DOI 10.1016/S0959-8049(01)00392-6; Kunigal S, 2009, INT J ONCOL, V34, P1209, DOI 10.3892/ijo_00000249; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Lo HW, 2008, CLIN CANCER RES, V14, P6042, DOI 10.1158/1078-0432.CCR-07-4923; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Motamed K, 2002, J CELL BIOCHEM, V84, P759, DOI 10.1002/jcb.10095; MURPHY G, 1992, AM J RESP CELL MOL, V7, P120, DOI 10.1165/ajrcmb/7.2.120; Nalla AK, 2010, CANCER GENE THER, V17, P599, DOI 10.1038/cgt.2010.16; Nalla AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013006; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Pulukuri SM, 2005, J BIOL CHEM, V280, P36529, DOI 10.1074/jbc.M503111200; Rao JS, 2007, CANCER RES, V67, P4956, DOI 10.1158/0008-5472.CAN-07-0380; Rao JS, 2003, NAT REV CANCER, V3, P489, DOI 10.1038/nrc1121; Rood BR, 2004, SEMIN ONCOL, V31, P666, DOI 10.1053/j.seminoncol.2004.07.009; Rossi A, 2008, CLIN CANCER RES, V14, P971, DOI 10.1158/1078-0432.CCR-07-2072; Schaefer LK, 2002, ONCOGENE, V21, P2058, DOI 10.1038/sj.onc.1205263; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu XT, 2007, J CANCER RES CLIN, V133, P145, DOI 10.1007/s00432-006-0139-z	49	25	28	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44798	10.1371/journal.pone.0044798	http://dx.doi.org/10.1371/journal.pone.0044798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984561	Green Published, gold			2022-12-25	WOS:000308738500086
J	Mechiche, H; Grassin-Delyle, S; Robinet, A; Nazeyrollas, P; Devillier, P				Mechiche, Hakima; Grassin-Delyle, Stanislas; Robinet, Arnaud; Nazeyrollas, Pierre; Devillier, Philippe			Prostanoid Receptors Involved in Regulation of the Beating Rate of Neonatal Rat Cardiomyocytes	PLOS ONE			English	Article							IN-VIVO; CALCIUM MOBILIZATION; INTERNATIONAL UNION; SIGNALING PATHWAYS; PROSTAGLANDINS; SUBTYPES; HEART; CLASSIFICATION; ARRHYTHMIAS; MYOCYTES	Although prostanoids are known to be involved in regulation of the spontaneous beating rate of cultured neonatal rat cardiomyocytes, the various subtypes of prostanoid receptors have not been investigated in detail. In our experiments, prostaglandin (PG)(F2 alpha) and prostanoid FP receptor agonists (fluprostenol, latanoprost and cloprostenol) produced a decrease in the beating rate. Two prostanoid IP receptor agonists (iloprost and beraprost) induced first a marked drop in the beating rate and then definitive abrogation of beating. In contrast, the prostanoid DP receptor agonists (PGD(2) and BW245C) and TP receptor agonists (U-46619) produced increases in the beating rate. Sulprostone (a prostanoid EP1 and EP3 receptor agonist) induced marked increases in the beating rate, which were suppressed by SC-19220 (a selective prostanoid EP1 antagonist). Butaprost (a selective prostanoid EP2 receptor agonist), misoprostol (a prostanoid EP2 and EP3 receptor agonist), 11-deoxy-PGE(1) (a prostanoid EP2, EP3 and EP4 receptor agonist) did not alter the beating rate. Our results strongly suggest that prostanoid EP1 receptors are involved in positive regulation of the beating rate. Prostanoid EP1 receptor expression was confirmed by western blotting with a selective antibody. Hence, neonatal rat cardiomyocytes express both prostanoid IP and FP receptors (which negatively regulate the spontaneous beating rate) and prostanoid TP, DP1 and EP1 receptors (which positively regulate the spontaneous beating rate).	[Mechiche, Hakima; Robinet, Arnaud; Nazeyrollas, Pierre; Devillier, Philippe] Univ Reims, Lab Cardiovasc Pharmacol, Reims, France; [Mechiche, Hakima; Grassin-Delyle, Stanislas; Devillier, Philippe] Univ Versailles St Quentin Yvelines, Hop Foch, UPRES EA 220, Suresnes, France	Universite de Reims Champagne-Ardenne; Hospital Foch; UDICE-French Research Universities; Universite Paris Saclay	Mechiche, H (corresponding author), Univ Reims, Lab Cardiovasc Pharmacol, Reims, France.	p.devillier@hopital-foch.org	Grassin-Delyle, Stanislas/AAC-5921-2021	Grassin-Delyle, Stanislas/0000-0001-5747-4432	French Society of Pharmacology	French Society of Pharmacology	HM received a grant from the French Society of Pharmacology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz M, 2000, BBA-MOL CELL BIOL L, V1483, P285, DOI 10.1016/S1388-1981(99)00164-X; Adams JW, 1996, J BIOL CHEM, V271, P1179, DOI 10.1074/jbc.271.2.1179; Aicindor D, 2004, ANESTHESIOLOGY, V100, P547, DOI 10.1097/00000542-200403000-00013; ALSINAWI LAH, 1985, PROSTAGLANDINS, V29, P99; Arad M, 1996, MOL CELL BIOCHEM, V161, P249; ATHIAS P, 1979, PATHOL BIOL, V27, P13; Birincioglu M, 1997, PHARMACOL RES, V36, P299, DOI 10.1006/phrs.1997.0232; Boie Y, 1997, EUR J PHARMACOL, V340, P227, DOI 10.1016/S0014-2999(97)01383-6; Bolli R, 2002, CARDIOVASC RES, V55, P506, DOI 10.1016/S0008-6363(02)00414-5; COLEMAN RA, 1994, PHARMACOL REV, V46, P205; Cracowski JL, 2001, J VASC RES, V38, P93, DOI 10.1159/000051036; Griffin BW, 1998, J PHARMACOL EXP THER, V286, P411; Griffin BW, 1997, J PHARMACOL EXP THER, V281, P845; Ishizuka T, 2003, EUR J PHARMACOL, V468, P27, DOI 10.1016/S0014-2999(03)01626-1; Jenkins CM, 2009, CARDIOVASC RES, V82, P240, DOI 10.1093/cvr/cvn346; JOHNSTON SL, 1992, BRIT J CLIN PHARMACO, V34, P402, DOI 10.1111/j.1365-2125.1992.tb05649.x; Jones RL, 2009, BRIT J PHARMACOL, V158, P104, DOI 10.1111/j.1476-5381.2009.00317.x; Jovanovic N, 2006, PROSTAG OTH LIPID M, V80, P110, DOI 10.1016/j.prostaglandins.2006.05.014; KARMAZYN M, 1983, CAN J PHYSIOL PHARM, V61, P1207, DOI 10.1139/y83-180; KENNEDY I, 1982, PROSTAGLANDINS, V24, P667, DOI 10.1016/0090-6980(82)90036-3; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; Kunapuli P, 1998, J BIOL CHEM, V273, P22442, DOI 10.1074/jbc.273.35.22442; Li YY, 1997, PROSTAGLANDINS, V54, P511, DOI 10.1016/S0090-6980(97)00122-6; LYDFORD SJ, 1994, BRIT J PHARMACOL, V112, P133, DOI 10.1111/j.1476-5381.1994.tb13042.x; Mattera R, 2001, CIRCULATION, V103, P2395; Meja KK, 1997, BRIT J PHARMACOL, V122, P149, DOI 10.1038/sj.bjp.0701360; Miyatake S, 2007, J CARDIOVASC PHARM, V50, P548, DOI 10.1097/FJC.0b013e318145ae2e; Morrison K, 2010, J PHARMACOL EXP THER, V335, P249, DOI 10.1124/jpet.110.169748; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Ocklind A, 1997, PROSTAG LEUKOTR ESS, V57, P527, DOI 10.1016/S0952-3278(97)90555-X; ORCHARD MA, 1983, BRIT J CLIN PHARMACO, V15, P509, DOI 10.1111/j.1365-2125.1983.tb02083.x; OUDOT F, 1995, AM J PHYSIOL-HEART C, V268, pH308, DOI 10.1152/ajpheart.1995.268.1.H308; Shichijo M, 2003, J PHARMACOL EXP THER, V307, P518, DOI 10.1124/jpet.103.055442; Shinmura K, 2005, AM J PHYSIOL-HEART C, V288, pH2093, DOI 10.1152/ajpheart.01003.2004; Takayama K, 2005, NAT MED, V11, P562, DOI 10.1038/nm1231; TOSAKI A, 1990, EUR J PHARMACOL, V191, P69, DOI 10.1016/0014-2999(90)94097-H; Walch L, 1999, BRIT J PHARMACOL, V126, P859, DOI 10.1038/sj.bjp.0702393; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; WOODWARD DF, 1995, J PHARMACOL EXP THER, V273, P285	39	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45273	10.1371/journal.pone.0045273	http://dx.doi.org/10.1371/journal.pone.0045273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984630	gold, Green Submitted, Green Published			2022-12-25	WOS:000308738500128
J	Wu, P; Wee, P; Jiang, J; Chen, XM; Wang, ZX				Wu, Peng; Wee, Ping; Jiang, Jennifer; Chen, Xinmei; Wang, Zhixiang			Differential Regulation of Transcription Factors by Location-Specific EGF Receptor Signaling via a Spatio-Temporal Interplay of ERK Activation	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE; BETA(2)-ADRENERGIC RECEPTOR; INTRACELLULAR TRAFFICKING; TYROSINE PHOSPHORYLATION; MEDIATED ENDOCYTOSIS; CELL-CYCLE; ENDOSOMES; INTERNALIZATION; STIMULATION	It is well established that EGFR signals from both the plasma membrane (PM) and endosome (EN). However, very little is known about whether and how the EGFR signals at the PM and EN to differentially regulate various signaling pathways and the physiological outcomes. In this communication, we established a system that allowed the specific activations of EGFR at different cell locations: PM and EN. PM activation of EGFR is achieved by activation of endocytosis-deficient mutant EGFR1010LL/AA stably expressed in CHO cells (CHO-LL/AA cell). EN activation of EGFR is achieved by activating the wild type EGFR stably expressed in CHO cells (CHO-EGFR cell) after its internalization into EN with a previously reported protocol. We showed that both EGFR activations at PM and EN activated ERK to a similar level, but differentially stimulated transcriptional factors c-jun and c-fos. We further showed that EGFR activations at PM and EN resulted in differential spatio-temporal dynamics of phosphorylated ERK which caused the differential activation of two downstream substrates ELK1 and RSK. Finally we showed that EGFR signaling from PM and EN led to different physiological outcomes. CHO-LL/AA cells that only generate PM EGFR signals have a larger cell size and slower proliferation rate than CHO-EGFR cells. We conclude that location-specific EGFR activation differentially regulates cell functions through a spatio-temporal interplay of ERK activation.	[Wu, Peng] Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB, Canada; Univ Alberta, Fac Med & Dent, Signal Transduct Res Grp, Edmonton, AB, Canada	University of Alberta; University of Alberta	Wu, P (corresponding author), Univ Alberta, Fac Med & Dent, Dept Med Genet, Edmonton, AB, Canada.	zhixiang.wang@ualberta.ca			Canadian Institutes of Health Research - CIHR [RES0006924, CIHR ICI 111387]	Canadian Institutes of Health Research - CIHR(Canadian Institutes of Health Research (CIHR))	This work is funded by an operating grant (Project: RES0006924, Title: CIHR ICI 111387 Wang) from the Canadian Institutes of Health Research - CIHR (Weblink: http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; Ahsan A, 2009, CANCER RES, V69, P5108, DOI 10.1158/0008-5472.CAN-09-0466; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Avruch J, 2007, BBA-MOL CELL RES, V1773, P1150, DOI 10.1016/j.bbamcr.2006.11.006; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bodart JFL, 2010, J CELL BIOCHEM, V109, P850, DOI 10.1002/jcb.22477; Bruns AF, 2010, TRAFFIC, V11, P161, DOI 10.1111/j.1600-0854.2009.01001.x; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Clague MJ, 2001, J CELL SCI, V114, P3075; COHEN S, 1985, J BIOL CHEM, V260, P2351; Demory ML, 2009, J BIOL CHEM, V284, P36592, DOI 10.1074/jbc.M109.000760; Di Fiore PP, 1999, CURR OPIN CELL BIOL, V11, P483, DOI 10.1016/S0955-0674(99)80069-6; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Fukazawa T, 1996, J BIOL CHEM, V271, P14554, DOI 10.1074/jbc.271.24.14554; Grandal MV, 2008, J CELL MOL MED, V12, P1527, DOI 10.1111/j.1582-4934.2008.00298.x; Ha JH, 2008, J CELL BIOL, V181, P1027, DOI 10.1083/jcb.200803150; Harrington AW, 2011, CELL, V146, P421, DOI 10.1016/j.cell.2011.07.008; Haugh JM, 1999, J BIOL CHEM, V274, P34350, DOI 10.1074/jbc.274.48.34350; JANKNECHT R, 1994, ONCOGENE, V9, P1273; Joffre C, 2011, NAT CELL BIOL, V13, P827, DOI 10.1038/ncb2257; Johannessen LE, 2000, EXP CELL RES, V260, P136, DOI 10.1006/excr.2000.5004; KAY DG, 1986, J BIOL CHEM, V261, P8473; Kermorgant S, 2008, J CELL BIOL, V182, P855, DOI 10.1083/jcb.200806076; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; LAI WH, 1989, J CELL BIOL, V109, P2751, DOI 10.1083/jcb.109.6.2751; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lavaur J, 2007, J NEUROSCI, V27, P14448, DOI 10.1523/JNEUROSCI.2279-07.2007; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu L, 2011, TRAFFIC, V12, P201, DOI 10.1111/j.1600-0854.2010.01141.x; Macdonald-Obermann JL, 2012, P NATL ACAD SCI USA, V109, P137, DOI 10.1073/pnas.1111316109; Maudsley S, 2000, J BIOL CHEM, V275, P9572, DOI 10.1074/jbc.275.13.9572; McCaffrey G, 2009, TRAFFIC, V10, P938, DOI 10.1111/j.1600-0854.2009.00909.x; Miller WE, 2001, CURR OPIN CELL BIOL, V13, P139, DOI 10.1016/S0955-0674(00)00190-3; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Murphy JE, 2009, P NATL ACAD SCI USA, V106, P17615, DOI 10.1073/pnas.0906541106; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ohba Y, 2003, EMBO J, V22, P859, DOI 10.1093/emboj/cdg087; Okamoto I, 2010, FEBS J, V277, P309, DOI 10.1111/j.1742-4658.2009.07449.x; Pawson T, 1997, NATURE, V385, P582, DOI 10.1038/385582b0; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Pennock S, 2003, MOL CELL BIOL, V23, P5803, DOI 10.1128/MCB.23.16.5803-5815.2003; Philippidou P, 2011, P NATL ACAD SCI USA, V108, P852, DOI 10.1073/pnas.1015981108; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Rocks O, 2006, CURR OPIN CELL BIOL, V18, P351, DOI 10.1016/j.ceb.2006.06.007; Romano AC, 2003, INVEST OPHTH VIS SCI, V44, P5125, DOI 10.1167/iovs.03-0628; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Shen YJ, 2001, MOL CELL BIOL, V21, P595, DOI 10.1128/MCB.21.2.595-602.2001; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; STOKOE D, 1994, SCIENCE, V266, P1792, DOI 10.1126/science.266.5192.1792-a; Tengholm A, 2009, VITAM HORM, V80, P287, DOI 10.1016/S0083-6729(08)00611-0; Valdez G, 2005, J NEUROSCI, V25, P5236, DOI 10.1523/JNEUROSCI.5104-04.2005; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang Q, 2007, EXP CELL RES, V313, P3349, DOI 10.1016/j.yexcr.2007.06.014; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Wang Y., 2002, SCI STKE, V161, pl17; Wang ZX, 1996, CELL GROWTH DIFFER, V7, P123; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; Whitehurst AW, 2004, J BIOL CHEM, V279, P12840, DOI 10.1074/jbc.M310031200; Winckler B, 2011, TRAFFIC, V12, P1099, DOI 10.1111/j.1600-0854.2011.01213.x; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	70	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e41354	10.1371/journal.pone.0041354	http://dx.doi.org/10.1371/journal.pone.0041354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984397	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500003
J	Gadziola, MA; Grimsley, JMS; Faure, PA; Wenstrup, JJ				Gadziola, Marie A.; Grimsley, Jasmine M. S.; Faure, Paul A.; Wenstrup, Jeffrey J.			Social Vocalizations of Big Brown Bats Vary with Behavioral Context	PLOS ONE			English	Article							EPTESICUS-FUSCUS; ALARM CALLS; ACOUSTIC FEATURES; MYOTIS-LUCIFUGUS; ECHOLOCATION; RESPONSES; SOUNDS; SPECIFICITY; EXPRESSION; IDENTITY	Bats are among the most gregarious and vocal mammals, with some species demonstrating a diverse repertoire of syllables under a variety of behavioral contexts. Despite extensive characterization of big brown bat (Eptesicus fuscus) biosonar signals, there have been no detailed studies of adult social vocalizations. We recorded and analyzed social vocalizations and associated behaviors of captive big brown bats under four behavioral contexts: low aggression, medium aggression, high aggression, and appeasement. Even limited to these contexts, big brown bats possess a rich repertoire of social vocalizations, with 18 distinct syllable types automatically classified using a spectrogram cross-correlation procedure. For each behavioral context, we describe vocalizations in terms of syllable acoustics, temporal emission patterns, and typical syllable sequences. Emotion-related acoustic cues are evident within the call structure by context-specific syllable types or variations in the temporal emission pattern. We designed a paradigm that could evoke aggressive vocalizations while monitoring heart rate as an objective measure of internal physiological state. Changes in the magnitude and duration of elevated heart rate scaled to the level of evoked aggression, confirming the behavioral state classifications assessed by vocalizations and behavioral displays. These results reveal a complex acoustic communication system among big brown bats in which acoustic cues and call structure signal the emotional state of a caller.	[Gadziola, Marie A.; Grimsley, Jasmine M. S.; Wenstrup, Jeffrey J.] NE Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA; [Gadziola, Marie A.; Wenstrup, Jeffrey J.] Kent State Univ, Sch Biomed Sci, Kent, OH 44242 USA; [Faure, Paul A.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	Northeast Ohio Medical University (NEOMED); University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; McMaster University	Gadziola, MA (corresponding author), NE Ohio Med Univ, Dept Anat & Neurobiol, Rootstown, OH USA.	jjw@neomed.edu		Grimsley, Jasmine/0000-0002-7993-9699; WENSTRUP, JEFFREY/0000-0002-3566-2480	National Institute on Deafness and Other Communication Disorders [R01 DC00937-20]; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Ontario Innovation Trust; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000937] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and Other Communication Disorders grant R01 DC00937-20 and supplements 18S1 and 19S1 to J.J.W., and by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada to P. A. F. The McMaster Bat Lab was supported by infrastructure grants from the Canada Foundation for Innovation and the Ontario Innovation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARVOLA A, 1974, Annales Zoologici Fennici, V11, P1; BARCLAY RMR, 1979, J MAMMAL, V60, P632, DOI 10.2307/1380109; BARCLAY RMR, 1979, BEHAV ECOL SOCIOBIOL, V6, P137, DOI 10.1007/BF00292560; Bastian A, 2008, J ACOUST SOC AM, V124, P598, DOI 10.1121/1.2924123; Behr O, 2004, BEHAV ECOL SOCIOBIOL, V56, P106, DOI 10.1007/s00265-004-0768-7; Bohn KM, 2008, J ACOUST SOC AM, V124, P1838, DOI 10.1121/1.2953314; Bohn KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006746; Boughman JW, 1997, BEHAV ECOL SOCIOBIOL, V40, P61, DOI 10.1007/s002650050316; Boughman JW, 1998, P ROY SOC B-BIOL SCI, V265, P227, DOI 10.1098/rspb.1998.0286; Carter GG, 2009, CAN J ZOOL, V87, P604, DOI 10.1139/Z09-051; Carter GG, 2008, ANIM BEHAV, V76, P1343, DOI 10.1016/j.anbehav.2008.04.023; CLARK CW, 1987, ETHOLOGY, V76, P101; Clement Matthew J., 2006, P57; Davidson SM, 2004, ANIM BEHAV, V67, P883, DOI 10.1016/j.anbehav.2003.06.016; DAVIS WH, 1968, J MAMMAL, V49, P44, DOI 10.2307/1377726; ESSER KH, 1994, NEUROREPORT, V5, P1718, DOI 10.1097/00001756-199409080-00007; Faure PA, 2003, J NEUROSCI, V23, P3052; Fenton B, 1985, COMMUNICATION CHIROP; Fenton MB, 2003, MAMMAL REV, V33, P193, DOI 10.1046/j.1365-2907.2003.00019.x; Fichtel C, 2002, ETHOLOGY, V108, P763, DOI 10.1046/j.1439-0310.2002.00816.x; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fischer J, 2001, ETHOLOGY, V107, P33, DOI 10.1046/j.1439-0310.2001.00630.x; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; Gadziola MA, 2012, J NEUROPHYSIOL, V107, P1047, DOI 10.1152/jn.00422.2011; GOULD E, 1975, DEV PSYCHOBIOL, V8, P333, DOI 10.1002/dev.420080407; GOULD E, 1975, J MAMMAL, V56, P15, DOI 10.2307/1379603; GOULD E, 1971, Communications in Behavioral Biology Part A Original Articles, V5, P263; Gould E., 1983, Special Publication American Society of Mammalogists, P265; GOULD E, 1973, J MAMMAL, V54, P998, DOI 10.2307/1379103; Hendrickx AG, 1995, NONHUMAN PRIMATES BI, P335; Janssen S, 2009, J COMP PHYSIOL A, V195, P663, DOI 10.1007/s00359-009-0441-8; JONES G, 1993, P ROY SOC B-BIOL SCI, V252, P125, DOI 10.1098/rspb.1993.0055; KANWAL JS, 1994, J ACOUST SOC AM, V96, P1229, DOI 10.1121/1.410273; Kazial KA, 2004, ANIM BEHAV, V67, P855, DOI 10.1016/j.anbehav.2003.04.016; Knornschild M, 2006, NATURWISSENSCHAFTEN, V93, P451, DOI 10.1007/s00114-006-0127-9; Knornschild M, 2010, BIOL LETTERS, V6, P156, DOI 10.1098/rsbl.2009.0685; Kurta A., 1990, MAMM SPECIES, V356, P1, DOI DOI 10.2307/3504258; LEGER DW, 1978, BEHAV ECOL SOCIOBIOL, V3, P177, DOI 10.1007/BF00294989; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; MASTERS WM, 1995, ANIM BEHAV, V50, P1243, DOI 10.1016/0003-3472(95)80041-7; MASTERS WM, 1991, J ACOUST SOC AM, V89, P1402, DOI 10.1121/1.400660; Mateo JM, 2010, BIOL LETTERS, V6, P623, DOI 10.1098/rsbl.2010.0118; Mellinger D. K., 2004, Canadian Acoustics, V32, P55; Mellinger DK, 2011, J ACOUST SOC AM, V129, P4055, DOI 10.1121/1.3531926; Mellinger DK, 2000, J ACOUST SOC AM, V107, P3518, DOI 10.1121/1.429434; Monroy JA, 2011, J COMP PHYSIOL A, V197, P459, DOI 10.1007/s00359-010-0614-5; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; MOSS CF, 1988, ANIMAL SONAR PROCESS, P115; Neuweiler G., 2000, BIOL BATS; Owren MJ, 2001, EVOL ANTHROPOL, V10, P58, DOI 10.1002/evan.1014; Pfalzer G, 2003, J ZOOL, V261, P21, DOI 10.1017/S0952836903003935; Pongracz P, 2006, APPL ANIMAL BEHAV SC, P1; Pozzi L, 2010, AM J PRIMATOL, V72, P337, DOI 10.1002/ajp.20786; Ren Y, 2009, ALGORITHMS, V2, P1410, DOI 10.3390/a2041410; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; Russ JM, 2005, ANIM BEHAV, V70, P397, DOI 10.1016/j.anbehav.2004.11.006; Russ JM, 1998, ANIM BEHAV, V55, P705, DOI 10.1006/anbe.1997.0665; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; Schneider JN, 2011, J ACOUST SOC AM, V130, P2275, DOI 10.1121/1.3628331; Simmons JA, 1998, P NATL ACAD SCI USA, V95, P12647, DOI 10.1073/pnas.95.21.12647; SIMMONS JA, 1979, SCIENCE, V203, P16, DOI 10.1126/science.758674; Soltis J, 2009, J COMP PSYCHOL, V123, P222, DOI 10.1037/a0015223; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Suthers RA, 2006, J EXP BIOL, V209, P4984, DOI 10.1242/jeb.02594; WAIPING V, 1988, J MAMMAL, V69, P641, DOI 10.2307/1381364; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016	67	58	61	1	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44550	10.1371/journal.pone.0044550	http://dx.doi.org/10.1371/journal.pone.0044550			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970247	Green Published, gold, Green Submitted			2022-12-25	WOS:000308462000028
J	Hughes, AR; Rooker, K; Murdock, M; Kimbro, DL				Hughes, A. Randall; Rooker, Kelly; Murdock, Meagan; Kimbro, David L.			Predator Cue and Prey Density Interactively Influence Indirect Effects on Basal Resources in Intertidal Oyster Reefs	PLOS ONE			English	Article							TEMPORAL VARIATION; TROPHIC CASCADES; RISK ALLOCATION; HABITAT; COMPLEXITY; RESPONSES; COMMUNITY; BEHAVIOR; AVOIDANCE; STRENGTH	Predators can influence prey abundance and traits by direct consumption, as well as by non-consumptive effects of visual, olfactory, or tactile cues. The strength of these non-consumptive effects (NCEs) can be influenced by a variety of factors, including predator foraging mode, temporal variation in predator cues, and the density of competing prey. Testing the relative importance of these factors for determining NCEs is critical to our understanding of predator-prey interactions in a variety of settings. We addressed this knowledge gap by conducting two mesocosm experiments in a tri-trophic intertidal oyster reef food web. More specifically, we tested how a predatory fish (hardhead catfish, Ariopsis felis) directly influenced their prey (mud crabs, Panopeus spp.) and indirectly affected basal resources (juvenile oysters, Crassostrea virginica), as well as whether these direct and indirect effects changed across a density gradient of competing prey. Per capita crab foraging rates were inversely influenced by crab density, but they were not affected by water-borne predator cues. As a result, direct consumptive effects on prey foraging rates were stronger than non-consumptive effects. In contrast, predator cue and crab density interactively influenced indirect predator effects on oyster mortality in two experiments, with trait-mediated and density-mediated effects of similar magnitude operating to enhance oyster abundance. Consistent differences between a variable predator cue environment and other predator cue treatments (no cue and constant cue) suggests that an understanding of the natural risk environment experienced by prey is critical to testing and interpreting trait-mediated indirect interactions. Further, the prey response to the risk environment may be highly dependent on prey density, particularly in prey populations with strong intra-specific interactions.	[Hughes, A. Randall; Rooker, Kelly; Murdock, Meagan; Kimbro, David L.] Florida State Univ, Coastal & Marine Lab, St Teresa, FL USA; [Rooker, Kelly] Bridgewater Coll, Dept Biol, Bridgewater, VA USA	State University System of Florida; Florida State University	Hughes, AR (corresponding author), Florida State Univ, Coastal & Marine Lab, St Teresa, FL USA.	rhughes@bio.fsu.edu			National Science Foundation (NSF) [OCE-0961633]; companion Research Experience for Undergraduates (REU) supplement; Division Of Ocean Sciences [1338372] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); companion Research Experience for Undergraduates (REU) supplement; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	his work was supported by National Science Foundation (NSF) grant OCE-0961633 and a companion Research Experience for Undergraduates (REU) supplement to D.L.K. and A.R.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS PA, 1995, AM NAT, V146, P112, DOI 10.1086/285789; BAHR LM, 1976, ECOLOGY, V57, P121, DOI 10.2307/1936403; Bednekoff PA, 2004, P ROY SOC B-BIOL SCI, V271, P1491, DOI 10.1098/rspb.2004.2739; Belovsky GE, 2011, ECOL LETT, V14, P335, DOI 10.1111/j.1461-0248.2011.01591.x; Bolker B, 2008, ECOLOGICAL MODELS DA; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K. P., 1998, MODEL SELECTION INFE; Byrnes J, 2006, ECOL LETT, V9, P61, DOI 10.1111/j.1461-0248.2005.00842.x; Chivers DP, 2001, CAN J ZOOL, V79, P867, DOI 10.1139/cjz-79-5-867; Enquist BJ, 2003, NATURE, V423, P639, DOI 10.1038/nature01671; Ferrari MCO, 2010, BEHAV ECOL, V21, P532, DOI 10.1093/beheco/arq023; Ferrari MCO, 2009, ANIM BEHAV, V78, P579, DOI 10.1016/j.anbehav.2009.05.034; Freeman AS, 2006, SCIENCE, V313, P831, DOI 10.1126/science.1125485; Grabowski JH, 2005, ECOLOGY, V86, P1926, DOI 10.1890/04-0690; Grabowski JH, 2005, ECOLOGY, V86, P1312, DOI 10.1890/04-1216; Grabowski JH, 2004, MAR ECOL PROG SER, V277, P291, DOI 10.3354/meps277291; Grabowski JH, 2004, ECOLOGY, V85, P995, DOI 10.1890/03-0067; Grabowski JH, 2008, ECOLOGY, V89, P3413, DOI 10.1890/07-1057.1; Grason EW, 2012, OECOLOGIA, V169, P105, DOI 10.1007/s00442-011-2188-5; Hawlena D, 2010, P NATL ACAD SCI USA, V107, P15503, DOI 10.1073/pnas.1009300107; Hughes AR, 2006, OECOLOGIA, V149, P256, DOI 10.1007/s00442-006-0439-7; Kimbro DL, 2012, ECOLOGY, V93, P334, DOI 10.1890/11-0596.1; Large SI, 2011, MAR ECOL PROG SER, V422, P41, DOI 10.3354/meps08930; Laurila A, 2004, OIKOS, V107, P90, DOI 10.1111/j.0030-1299.2004.13126.x; Lehnert RL, 2002, ESTUARIES, V25, P1015, DOI 10.1007/BF02691348; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Luckenbach MW, 2005, J COASTAL RES, P64; Okuyama T, 2007, ECOL LETT, V10, P264, DOI 10.1111/j.1461-0248.2007.01019.x; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preisser EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002465; Reynolds PL, 2011, J ECOL, V99, P1272, DOI 10.1111/j.1365-2745.2011.01837.x; Richards SA, 2005, ECOLOGY, V86, P2805, DOI 10.1890/05-0074; Sanford E, 2003, SCIENCE, V300, P1135, DOI 10.1126/science.1083437; Sanford E, 2009, ECOLOGY, V90, P3108, DOI 10.1890/08-2055.1; Schmitz OJ, 2000, AM NAT, V155, P141, DOI 10.1086/303311; Schmitz OJ, 2004, ECOL LETT, V7, P403, DOI 10.1111/j.1461-0248.2004.00592.x; Schmitz OJ, 2008, SCIENCE, V319, P952, DOI 10.1126/science.1152355; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Sih A, 2002, ANIM BEHAV, V63, P437, DOI 10.1006/anbe.2001.1921; Tinker MT, 2009, EVOL ECOL RES, V11, P841; Trussell GC, 2008, ECOLOGY, V89, P2798, DOI 10.1890/08-0250.1; Trussell GC, 2006, ECOL LETT, V9, P1245, DOI 10.1111/j.1461-0248.2006.00981.x; Trussell GC, 2011, ECOLOGY, V92, P1799, DOI 10.1890/10-2222.1; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2	46	13	13	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44839	10.1371/journal.pone.0044839	http://dx.doi.org/10.1371/journal.pone.0044839			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970316	gold, Green Published, Green Submitted			2022-12-25	WOS:000308462000052
J	Yates, LA; Fuzery, AK; Bonet, R; Campbell, ID; Gilbert, RJC				Yates, Luke A.; Fuezery, Anna K.; Bonet, Roman; Campbell, Iain D.; Gilbert, Robert J. C.			Biophysical Analysis of Kindlin-3 Reveals an Elongated Conformation and Maps Integrin Binding to the Membrane-distal beta-Subunit NPXY Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; TALIN HEAD; CYTOPLASMIC TAILS; KINDLER-SYNDROME; STRUCTURAL BASIS; DISTINCT ROLES; ACTIVATION; DOMAIN; PROTEINS; ADHESION	Kindlin-3, a 75-kDa protein, has been shown to be critical for hemostasis, immunity, and bone metabolism via its role in integrin activation. The Kindlin family is hallmarked by a FERM domain comprised of F1, F2, and F3 subdomains together with an N-terminal F0 domain and a pleckstrin homology domain inserted in the F2 domain. Recombinant Kindlin-3 was cloned, expressed, and purified, and its domain organization was studied by x-ray scattering and other techniques to reveal an extended conformation. This unusual elongated structure is similar to that found in the paralogue Talin head domain. Analytical ultracentrifugation experiments indicated that Kindlin-3 forms a ternary complex with the Talin and beta-integrin cytoplasmic tails. NMR showed that Kindlin-3 specifically recognizes the membrane-distal tail NPXY motif in both the beta(1A) and beta(1D) isoforms, although the interaction is stronger with beta(1A). An upstream Ser/Thr cluster in the tails also plays a critical role. Overall these data support current biological, clinical, and mutational data on Kindlin-3/beta-tail binding and provide novel insights into the overall conformation and interactions of Kindlin-3.	[Yates, Luke A.; Gilbert, Robert J. C.] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Fuezery, Anna K.; Bonet, Roman; Campbell, Iain D.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford	Gilbert, RJC (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	gilbert@strubi.ox.ac.uk		Gilbert, Robert/0000-0001-9336-5604; Yates, Luke/0000-0002-5023-0803	Medical Research Council (MRC); National Institutes of Health [U54 GM06434]; MRC [G0900052 1/1]; Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics [090532/Z/09/Z]; MRC [G0900052] Funding Source: UKRI; Medical Research Council [G0900052] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a Medical Research Council (MRC) graduate studentship.; Supported by Grant U54 GM06434 from the National Institutes of Health-funded Cell Migration Consortium. Present address: Dept. of Pathology, Johns Hopkins University, Baltimore, MD 21287.; Supported by MRC Grant G0900052 1/1.; We thank Dr. Michele Erat for assistance with the SAXS data collection. The Oxford Division of Structural Biology is part of the Wellcome Trust Centre for Human Genetics (Wellcome Trust Core Award Grant 090532/Z/09/Z).	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Anthis NJ, 2010, STRUCTURE, V18, P1654, DOI 10.1016/j.str.2010.09.018; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Bledzka K, 2012, J BIOL CHEM, V287, P24585, DOI 10.1074/jbc.M111.336743; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; Bottcher RT, 2012, NAT CELL BIOL, V14, P584, DOI 10.1038/ncb2501; Boyd RS, 2003, LEUKEMIA, V17, P1605, DOI 10.1038/sj.leu.2402993; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Feng C, 2012, J BIOL CHEM, V287, P10714, DOI 10.1074/jbc.M111.299594; de la Torre JG, 2007, J PHYS CHEM B, V111, P955, DOI 10.1021/jp0647941; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Goddard T.D., 2000, SPARKY; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Goult BT, 2009, J MOL BIOL, V394, P944, DOI 10.1016/j.jmb.2009.09.061; Grigorieff N, 2000, ACTA CRYSTALLOGR D, V56, P1270, DOI 10.1107/S0907444900009549; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Has C, 2009, AM J PATHOL, V175, P1442, DOI 10.2353/ajpath.2009.090203; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kahner BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034056; Kelley LA, 1997, PROTEIN SCI, V6, P2628; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KRATKY O, 1951, Z ELEKTROCHEM, V55, P53; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Legate KR, 2009, J CELL SCI, V122, P187, DOI 10.1242/jcs.041624; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Margadant C, 2012, CURR BIOL, V22, P1554, DOI 10.1016/j.cub.2012.06.060; Merrington CL, 1997, MOL BIOTECHNOL, V8, P283, DOI 10.1007/BF02760782; Meves A, 2009, TRENDS CELL BIOL, V19, P504, DOI 10.1016/j.tcb.2009.07.006; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Oxley CL, 2008, J BIOL CHEM, V283, P5420, DOI 10.1074/jbc.M709435200; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qadota H, 2012, J BIOL CHEM, V287, P28537, DOI 10.1074/jbc.M112.354852; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Schmidt S, 2011, J CELL BIOL, V192, P883, DOI 10.1083/jcb.201007141; Siegel DH, 2003, AM J HUM GENET, V73, P174, DOI 10.1086/376609; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048	58	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.415208	http://dx.doi.org/10.1074/jbc.M112.415208			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989875	hybrid, Green Published			2022-12-25	WOS:000310642200012
J	Kocieda, VP; Adhikary, S; Emig, F; Yen, JH; Toscano, MG; Ganea, D				Kocieda, Virginia P.; Adhikary, Sabina; Emig, Frances; Yen, Jui-Hung; Toscano, Miguel G.; Ganea, Doina			Prostaglandin E2-induced IL-23p19 Subunit Is Regulated by cAMP-responsive Element-binding Protein and C/AATT Enhancer-binding Protein beta in Bone Marrow-derived Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; T-CELLS; EP4 RECEPTOR; C-REL; INFLAMMATORY DISEASES; TH17 EXPANSION; E-2; P19; EXPRESSION; INTERLEUKIN-23	We reported previously that prostaglandin E2 (PGE2)up-regulates IL- 23 in vitro in bone marrow-derived dendritic cells and in vivo in models of collagen-induced arthritis and inflammatory bowel disease, leading to preferential Th17 development and activity. There is very little information on the molecular mechanisms involved in the PGE2-induced up-regulation of Il23a gene expression. In this study we investigated the signaling pathways and transcription factors involved in the stimulatory effect of PGE2. Although PGE2 does not induce IL-23p19 expression by itself, it synergizes with both extra- and intracellular Toll-like receptor ligands and with inflammatory cytokines such as TNF alpha. We established that the effect of PGE2 in conjunction with either LPS or TNF alpha is mediated through the EP4 receptor and the cAMP-dependent activation of both protein kinase A (PKA) and exchange protein activated by cAMP (EPAC). Using the EP4 agonist PGE(1)OH in conjunction with TNF alpha, we found that PKA-induced phosphorylation of cAMP-response element-binding protein ((CREB)-C-P) and EPAC-induced phosphorylation of C/AATT enhancer-binding protein beta (C-P/EBP beta) mediate the stimulatory effect of PGE2 on IL-23p19 expression. This is the first report of CREB and C/EBP beta involvement in Il23a promoter activation. Mutation within the putative CREB and C/EBP sites combined with in vivo DNA binding (ChIP) assays identified the distal CREB site (-1125) and the two proximal C/EBP sites (-274 and -232) as essential for PKA-activated CREB and EPAC-activated C/EBP beta-induced IL-23p19 expression.	[Kocieda, Virginia P.; Emig, Frances; Yen, Jui-Hung; Toscano, Miguel G.; Ganea, Doina] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA; [Adhikary, Sabina] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Toscano, Miguel G.] Univ Granada, Pfizer, Human DNA Variabil Dept, Junta de Andalucia Ctr Genom & Oncol Res GENYO, Granada 18018, Spain	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pfizer; University of Granada	Ganea, D (corresponding author), Temple Univ, Sch Med, Dept Microbiol & Immunol, 3500 N Broad St, Philadelphia, PA 19140 USA.	dganea@temple.edu	Yen, Jui-Hung/AAV-3455-2020; Toscano, Miguel G./I-1053-2015	Toscano, Miguel G./0000-0002-6384-3123; Yen, Jui-Hung Jimmy/0000-0002-7325-9756	National Institutes of Health [2RO1AI052306, 2T32AI007101-30, 3RO1AI084065-03S1]; National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007101, R01AI084065, R01AI052306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants 2RO1AI052306, 2T32AI007101-30, and 3RO1AI084065-03S1 (to D. G.) and by Bridge To Doctorate funding (National Science Foundation; to V. P. K.).	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Al-Salleeh F, 2008, J IMMUNOL, V181, P4523, DOI 10.4049/jimmunol.181.7.4523; Becher B, 2011, CURR OPIN IMMUNOL, V23, P707, DOI 10.1016/j.coi.2011.08.005; Billington CK, 2012, BRIT J PHARMACOL, V166, P401, DOI 10.1111/j.1476-5381.2011.01719.x; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; Carmody RJ, 2007, J IMMUNOL, V178, P186, DOI 10.4049/jimmunol.178.1.186; Chen Q, 2010, BRIT J PHARMACOL, V160, P292, DOI 10.1111/j.1476-5381.2010.00647.x; Chizzolini C, 2008, BLOOD, V112, P3696, DOI 10.1182/blood-2008-05-155408; Duvallet E, 2011, ANN MED, V43, P503, DOI 10.3109/07853890.2011.577093; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Jing H, 2003, J LEUKOCYTE BIOL, V74, P868, DOI 10.1189/jlb.0303116; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Khayrullina T, 2008, J IMMUNOL, V181, P721, DOI 10.4049/jimmunol.181.1.721; Kim HR, 2007, RHEUMATOLOGY, V46, P57, DOI 10.1093/rheumatology/kel159; Li YH, 2008, EXP MOL PATHOL, V84, P1, DOI 10.1016/j.yexmp.2007.09.004; Liang XB, 2011, J CLIN INVEST, V121, P4362, DOI 10.1172/JCI46279; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Matsuoka T, 2007, THESCIENTIFICWORLDJO, V7, P1329, DOI 10.1100/tsw.2007.182; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; Migita K, 2010, CLIN EXP IMMUNOL, V162, P244, DOI 10.1111/j.1365-2249.2010.04242.x; Minami M, 2008, J BIOL CHEM, V283, P9692, DOI 10.1074/jbc.M709663200; Mise-Omata S, 2007, J IMMUNOL, V179, P6596, DOI 10.4049/jimmunol.179.10.6596; Myer RG, 2010, EXP GERONTOL, V45, P834, DOI 10.1016/j.exger.2010.06.007; Narumiya S, 2009, J MOL MED, V87, P1015, DOI 10.1007/s00109-009-0500-1; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Roos AB, 2012, J ENDOCRINOL, V212, P291, DOI 10.1530/JOE-11-0369; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sakata D, 2010, IUBMB LIFE, V62, P591, DOI 10.1002/iub.356; Sands WA, 2012, METHODS MOL BIOL, V809, P201, DOI 10.1007/978-1-61779-376-9_14; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Sheibanie AF, 2004, FASEB J, V18, P1318, DOI 10.1096/fj.03-1367fje; Sheibanie AF, 2007, ARTHRITIS RHEUM-US, V56, P2608, DOI 10.1002/art.22794; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Sheikh SZ, 2011, J BIOL CHEM, V286, P1174, DOI 10.1074/jbc.M110.147884; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Stefanelli P, 2012, PROSTAG OTH LIPID M, V99, P24, DOI 10.1016/j.prostaglandins.2012.04.002; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tang CL, 2012, IMMUNOLOGY, V135, P112, DOI 10.1111/j.1365-2567.2011.03522.x; Tang EHC, 2012, J CARDIOVASC PHARM, V59, P116, DOI 10.1097/FJC.0b013e3182244a12; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Yang L, 2012, MOL IMMUNOL, V51, P51, DOI 10.1016/j.molimm.2012.02.004; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Yarwood SJ, 2008, J BIOL CHEM, V283, P6843, DOI 10.1074/jbc.M710342200; Yen JH, 2008, BLOOD, V111, P260, DOI 10.1182/blood-2007-05-090613; Yen JH, 2011, J BIOL CHEM, V286, P38913, DOI 10.1074/jbc.M111.252932; Zhu LX, 2011, MOL IMMUNOL, V48, P647, DOI 10.1016/j.molimm.2010.11.008; Zhu S, 2012, CLIN SCI, V122, P487, DOI 10.1042/CS20110496	53	35	35	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36922	36935		10.1074/jbc.M112.402958	http://dx.doi.org/10.1074/jbc.M112.402958			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977257	Green Published, hybrid			2022-12-25	WOS:000310588500029
J	Garcia-Quiroz, J; Garcia-Becerra, R; Barrera, D; Santos, N; Avila, E; Ordaz-Rosado, D; Rivas-Suarez, M; Halhali, A; Rodriguez, P; Gamboa-Dominguez, A; Medina-Franco, H; Camacho, J; Larrea, F; Diaz, L				Garcia-Quiroz, Janice; Garcia-Becerra, Rocio; Barrera, David; Santos, Nancy; Avila, Euclides; Ordaz-Rosado, David; Rivas-Suarez, Mariana; Halhali, Ali; Rodriguez, Pamela; Gamboa-Dominguez, Armando; Medina-Franco, Heriberto; Camacho, Javier; Larrea, Fernando; Diaz, Lorenza			Astemizole Synergizes Calcitriol Antiproliferative Activity by Inhibiting CYP24A1 and Upregulating VDR: A Novel Approach for Breast Cancer Therapy	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; GO POTASSIUM CHANNELS; HIGH-DOSE CALCITRIOL; PHASE-I TRIAL; CELL-CYCLE; 1,25-DIHYDROXYVITAMIN-D3 RECEPTOR; K+ CHANNELS; EXPRESSION; CYP3A4; KI-67	Background: Calcitriol antiproliferative effects include inhibition of the oncogenic ether-a-go-go-1 potassium channel (Eag1) expression, which is necessary for cell cycle progression and tumorigenesis. Astemizole, a new promising antineoplastic drug, targets Eag1 by blocking ion currents. Herein, we characterized the interaction between calcitriol and astemizole as well as their conjoint antiproliferative action in SUM-229PE, T-47D and primary tumor-derived breast cancer cells. Methodology/Principal Findings: Molecular markers were studied by immunocytochemistry, Western blot and real time PCR. Inhibitory concentrations were determined by dose-response curves and metabolic activity assays. At clinically achievable drug concentrations, synergistic antiproliferative interaction was observed between calcitriol and astemizole, as calculated by combination index analysis (CI <1). Astemizole significantly enhanced calcitriol's growth-inhibitory effects (311 folds, P<0.01). Mean IC20 values were 1.82 +/- 2.41 nM and 1.62 +/- 0.75 mu M; for calcitriol (in estrogen receptor negative cells) and astemizole, respectively. Real time PCR showed that both drugs alone downregulated, while simultaneous treatment further reduced Ki-67 and Eag1 gene expression (P<0.05). Astemizole inhibited basal and calcitriol-induced CYP24A1 and CYP3A4 mRNA expression (cytochromes involved in calcitriol and astemizole degradation) in breast and hepatoma cancer cells, respectively, while upregulated vitamin D receptor (VDR) expression. Conclusions/Significance: Astemizole synergized calcitriol antiproliferative effects by downregulating CYP24A1, upregulating VDR and targeting Eag1. This study provides insight into the molecular mechanisms involved in astemizole-calcitriol combined antineoplastic effect, offering scientific support to test both compounds in combination in further preclinical and clinical studies of neoplasms expressing VDR and Eag1. VDR-negative tumors might also be sensitized to calcitriol antineoplastic effects by the use of astemizole. Herein we suggest a novel combined adjuvant therapy for the management of VDR/Eag1-expressing breast cancer tumors. Since astemizole improves calcitriol bioavailability and activity, decreased calcitriol dosing is advised for conjoint administration.	[Garcia-Quiroz, Janice; Garcia-Becerra, Rocio; Barrera, David; Santos, Nancy; Avila, Euclides; Ordaz-Rosado, David; Rivas-Suarez, Mariana; Halhali, Ali; Rodriguez, Pamela; Larrea, Fernando; Diaz, Lorenza] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Reprod Biol, Mexico City, DF, Mexico; [Garcia-Quiroz, Janice; Santos, Nancy; Camacho, Javier] IPN, Ctr Invest & Estudios Avanzados, Dept Farmacol, Mexico City 07738, DF, Mexico; [Medina-Franco, Heriberto] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Cirugia, Mexico City, DF, Mexico; [Gamboa-Dominguez, Armando] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Patol, Mexico City, DF, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico	Garcia-Quiroz, J (corresponding author), Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Reprod Biol, Mexico City, DF, Mexico.	lorenzadiaz@gmail.com	Ordaz, David/AAF-9757-2021; García-Becerra, Rocío/A-2171-2019; Díaz, Lorenza/AAJ-9052-2021; Larrea, Fernando/AAC-1900-2021; , Javier/AAS-1379-2021	Ordaz, David/0000-0003-2044-4584; García-Becerra, Rocío/0000-0002-2482-3963; Díaz, Lorenza/0000-0002-5947-4222; Avila, Euclides/0000-0003-3063-5093; GARCIA-QUIROZ, JANICE/0000-0002-3311-2258; Barrera, David/0000-0003-2692-8213	Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico [153862, 129315]; CONACyT	Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT), Mexico (grants number 153862 and 129315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge with thanks to Hoffmann-La Roche Ltd and Liomont for calcitriol and astemizole donation, respectively. JGQ is a Ph.D. student from Centro de Investigacion y Estudios Avanzados, Instituto Politecnico Nacional, Mexico, under a fellowship from CONACyT.	Avila E, 2010, ANTICANCER RES, V30, P2667; Beer TM, 2003, UROL ONCOL-SEMIN ORI, V21, P399, DOI 10.1016/S1078-1439(03)00170-4; Beer TM, 2004, MOL CANCER THER, V3, P373; Beer TM, 2001, CANCER-AM CANCER SOC, V91, P2431, DOI 10.1002/1097-0142(20010615)91:12<2431::AID-CNCR1278>3.0.CO;2-3; Beer TM, 2001, SEMIN ONCOL, V28, P49, DOI 10.1053/sonc.2001.26901; BERGER U, 1991, CANCER RES, V51, P239; Bortner CD, 1997, J BIOL CHEM, V272, P32436, DOI 10.1074/jbc.272.51.32436; Camacho J, 2006, CANCER LETT, V233, P1, DOI 10.1016/j.canlet.2005.02.016; Chen Y, PLOS ONE, V6; Chou TC, CANC RES, V70, P440; COSTA EM, 1987, ENDOCRINOLOGY, V120, P1173, DOI 10.1210/endo-120-3-1173; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Diaz L, 2011, CYTOKINE, V55, P188, DOI 10.1016/j.cyto.2011.04.013; Drocourt L, 2002, J BIOL CHEM, V277, P25125, DOI 10.1074/jbc.M201323200; DUMANOIR S, 1991, CYTOMETRY, V12, P455; Fakih MG, 2007, CLIN CANCER RES, V13, P1216, DOI 10.1158/1078-0432.CCR-06-1165; Farias LMB, 2004, CANCER RES, V64, P6996, DOI 10.1158/0008-5472.CAN-04-1204; Fischer MJE, 1997, EUR J PHARMACOL, V322, P97, DOI 10.1016/S0014-2999(96)00981-8; Friedrich M, 2003, RECENT RES CANCER, V164, P239; Garcia-Becerra R, 2010, EXP CELL RES, V316, P433, DOI 10.1016/j.yexcr.2009.11.008; Garcia-Ferreiro RE, 2004, J GEN PHYSIOL, V124, P301, DOI 10.1085/jgp.200409041; Garcia-Quiroz J, 2011, ANTI-CANCER AGENT ME, V11, P307, DOI 10.2174/187152011795347513; Guyton KZ, 2003, NUTR REV, V61, P227, DOI 10.1301/nr.2003.jul.227-238; Hansen CM, 2001, FRONT BIOSCI-LANDMRK, V6, pD820, DOI 10.2741/Hansen; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kill IR, 1996, J CELL SCI, V109, P1253; Li Z, 1998, CANCER RES, V58, P5271; Lopes N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-483; Muindi JR, 2010, ENDOCRINOLOGY, V151, P4301, DOI 10.1210/en.2009-1156; Muindi JR, 2002, CLIN PHARMACOL THER, V72, P648, DOI 10.1067/mcp.2002.129305; Ouadid-Ahidouch H, 2004, AM J PHYSIOL-CELL PH, V287, pC125, DOI 10.1152/ajpcell.00488.2003; Ouadid-Ahidouch H, 2001, RECEPTOR CHANNEL, V7, P345; Ouadid-Ahidouch H, 2008, J MEMBRANE BIOL, V221, P1, DOI 10.1007/s00232-007-9080-6; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 2008, EXPERT OPIN THER TAR, V12, P837, DOI [10.1517/14728222.12.7.837, 10.1517/14728222.12.7.837 ]; Peehl DM, 2001, UROLOGY, V58, P123, DOI 10.1016/S0090-4295(01)01254-7; Pramanik R, 2004, CELL IMMUNOL, V232, P137, DOI 10.1016/j.cellimm.2005.03.004; Sanderson JT, 2006, TOXICOL SCI, V94, P3, DOI 10.1093/toxsci/kfl051; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schulz M, 2003, PHARMAZIE, V58, P447; Slominski AT, 2011, AM J PHYSIOL-CELL PH, V300, pC526, DOI 10.1152/ajpcell.00203.2010; Theodoropoulos C, 2003, CLIN ENDOCRINOL, V58, P489, DOI 10.1046/j.1365-2265.2003.01743.x; Thompson PD, 2002, BIOCHEM BIOPH RES CO, V299, P730, DOI 10.1016/S0006-291X(02)02742-0; Thummel KE, 2001, MOL PHARMACOL, V60, P1399, DOI 10.1124/mol.60.6.1399; Trump DL, 2010, CANCER J, V16, P1, DOI 10.1097/PPO.0b013e3181c51ee6; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Wang QM, 1996, CANCER RES, V56, P264; Weber C, 2006, J BIOL CHEM, V281, P13030, DOI 10.1074/jbc.M600883200; Welsh J, 2007, ACTA PHARMACOL SIN, V28, P1373, DOI 10.1111/j.1745-7254.2007.00700.x; WIESE RJ, 1992, J BIOL CHEM, V267, P20082; Xu Y, 2006, MOL PHARMACOL, V69, P56, DOI 10.1124/mol.105.017392; Yin Y, 2009, CLIN CANCER RES, V15, P190, DOI 10.1158/1078-0432.CCR-08-0910; YU XP, 1991, P NATL ACAD SCI USA, V88, P8347, DOI 10.1073/pnas.88.19.8347; Zinser GA, 2004, J STEROID BIOCHEM, V89-90, P433, DOI 10.1016/j.jsbmb.2004.03.012; Zinser GM, 2004, CARCINOGENESIS, V25, P2361, DOI 10.1093/carcin/bgh271	56	50	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45063	10.1371/journal.pone.0045063	http://dx.doi.org/10.1371/journal.pone.0045063			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984610	gold, Green Submitted, Green Published			2022-12-25	WOS:000308738500111
J	Maffioli, C; Grandgirard, D; Leib, SL; Engler, O				Maffioli, Carola; Grandgirard, Denis; Leib, Stephen L.; Engler, Olivier			SiRNA Inhibits Replication of Langat Virus, a Member of the Tick-Borne Encephalitis Virus Complex in Organotypic Rat Brain Slices	PLOS ONE			English	Article							SMALL INTERFERING RNA; INFECTION; CULTURES; PATHOGENESIS; MICE; NEUROINVASIVENESS; THERAPEUTICS; DELIVERY; NEURONS; MODELS	Tick-borne encephalitis virus is the causative agent of tick-borne encephalitis, a potentially fatal neurological infection. Tick-borne encephalitis virus belongs to the family of flaviviruses and is transmitted by infected ticks. Despite the availability of vaccines, approximately 2000-3000 cases of tick-borne encephalitis occur annually in Europe for which no curative therapy is available. The antiviral effects of RNA mediated interference by small interfering RNA ( siRNA) was evaluated in cell culture and organotypic hippocampal cultures. Langat virus, a flavivirus highly related to Tick-borne encephalitis virus exhibits low pathogenicity for humans but retains neurovirulence for rodents. Langat virus was used for the establishment of an in vitro model of tick-borne encephalitis. We analyzed the efficacy of 19 siRNA sequences targeting different regions of the Langat genome to inhibit virus replication in the two in vitro systems. The most efficient suppression of virus replication was achieved by siRNA sequences targeting structural genes and the 39 untranslated region. When siRNA was administered to HeLa cells before the infection with Langat virus, a 96.5% reduction of viral RNA and more than 98% reduction of infectious virus particles was observed on day 6 post infection, while treatment after infection decreased the viral replication by more than 98%. In organotypic hippocampal cultures the replication of Langat virus was reduced by 99.7% by siRNA sequence D3. Organotypic hippocampal cultures represent a suitable in vitro model to investigate neuronal infection mechanisms and treatment strategies in a preserved three-dimensional tissue architecture. Our results demonstrate that siRNA is an efficient approach to limit Langat virus replication in vitro.	[Maffioli, Carola; Grandgirard, Denis; Leib, Stephen L.] Univ Bern, Neuroinfect Lab, Inst Infect Dis, Bern, Switzerland; [Leib, Stephen L.; Engler, Olivier] Fed Off Civil Protect, Div Biol, Spiez Lab, Spiez, Switzerland	University of Bern	Maffioli, C (corresponding author), Univ Bern, Neuroinfect Lab, Inst Infect Dis, Bern, Switzerland.	stephen.leib@ifik.unibe.ch	Leib, Stephen/M-3786-2019; Leib, Stephen L/A-7866-2011; Grandgirard, Denis/AAB-8786-2020; Kummer, Juerg/B-3322-2011	Leib, Stephen/0000-0002-1106-6123; Leib, Stephen L/0000-0002-1106-6123; Grandgirard, Denis/0000-0002-4151-5196; 	Swiss Federal Office for Civil Protection [353001545]; Swiss National Science Foundation [138094]	Swiss Federal Office for Civil Protection; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss Federal Office for Civil Protection (Research Contract No 353001545). Additional support was received by the Swiss National Science Foundation (grant No. 138094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achazi K, 2012, ANTIVIR RES, V93, P94, DOI 10.1016/j.antiviral.2011.10.023; Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; Anesti AM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn371; Anthony KG, 2009, ANTIVIR RES, V82, P166, DOI 10.1016/j.antiviral.2008.12.007; Chambers TJ, 2003, ADV VIRUS RES, V60, P273, DOI 10.1016/S0065-3527(03)60008-4; Charrel RN, 2004, CLIN MICROBIOL INFEC, V10, P1040, DOI 10.1111/j.1469-0691.2004.01022.x; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; DeVincenzo J, 2008, ANTIVIR RES, V77, P225, DOI 10.1016/j.antiviral.2007.11.009; Dorrbecker B, 2010, TRAVEL MED INFECT DI, V8, P213, DOI 10.1016/j.tmaid.2010.05.010; Gadkari DA, 2005, INDIAN J MED RES, V121, P147; Gantier MP, 2007, CYTOKINE GROWTH F R, V18, P363, DOI 10.1016/j.cytogfr.2007.06.016; Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506; Gianinazzi C, 2005, PARASITOLOGY, V131, P797, DOI 10.1017/S0031182005008619; Gianinazzi C, 2004, J NEUROPATH EXP NEUR, V63, P610, DOI 10.1093/jnen/63.6.610; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Haglund M, 2003, VACCINE, V21, pS11, DOI 10.1016/S0264-410X(02)00811-3; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hayasaka D, 2009, VIROLOGY, V390, P139, DOI 10.1016/j.virol.2009.04.026; Higuchi Y, 2010, BIODRUGS, V24, P195, DOI 10.2165/11534450-000000000-00000; Holbrook MR, 2005, J INFECT DIS, V191, P100, DOI 10.1086/426397; Holzmann H, 2009, EMERG INFECT DIS, V15, P1671, DOI 10.3201/eid1510.090743; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; ILLAVIA SJ, 1970, LANCET, V2, P284; Kaiser R, 1999, BRAIN, V122, P2067, DOI 10.1093/brain/122.11.2067; Kawasaki Hideya, 2003, Congenital Anomalies, V43, P105, DOI 10.1111/j.1741-4520.2003.tb01034.x; Kedmi R, 2010, BIOMATERIALS, V31, P6867, DOI 10.1016/j.biomaterials.2010.05.027; Kim SS, 2009, TRENDS MOL MED, V15, P491, DOI 10.1016/j.molmed.2009.09.001; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Kumar S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008615; Leung RKM, 2005, PHARMACOL THERAPEUT, V107, P222, DOI 10.1016/j.pharmthera.2005.03.004; Ma Z, 2005, BIOCHEM BIOPH RES CO, V330, P755, DOI 10.1016/j.bbrc.2005.03.041; Mandl CW, 2005, VIRUS RES, V111, P161, DOI 10.1016/j.virusres.2005.04.007; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Moshkin MP, 2009, BIOESSAYS, V31, P620, DOI 10.1002/bies.200800196; Murakami M, 2005, MICROBIOL IMMUNOL, V49, P1047, DOI 10.1111/j.1348-0421.2005.tb03701.x; Nguyen T, 2008, CURR OPIN MOL THER, V10, P158; Pletnev AG, 2001, VIROLOGY, V282, P288, DOI 10.1006/viro.2001.0846; PRICE WH, 1970, B WORLD HEALTH ORGAN, V42, P89; Raineteau O, 2004, MOL CELL NEUROSCI, V26, P241, DOI 10.1016/j.mcn.2004.01.003; Rumyantsev AA, 2006, J VIROL, V80, P1427, DOI 10.1128/JVI.80.3.1427-1439.2006; Ruzek D, 2010, TRAVEL MED INFECT DI, V8, P223, DOI 10.1016/j.tmaid.2010.06.004; SEAMER J, 1967, BRIT J EXP PATHOL, V48, P403; Sledz Carol A, 2003, Discov Med, V3, P30; Stein DA, 2011, J VIROL, V85, P10154, DOI 10.1128/JVI.05298-11; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stram Y, 2006, VIRUS GENES, V32, P299, DOI 10.1007/s11262-005-6914-0; Subramanya S, 2010, J VIROL, V84, P2490, DOI 10.1128/JVI.02105-08; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; SUSS J, 2008, EURO SURVEILL, V13; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; von Eije KJ, 2008, J VIROL, V82, P2895, DOI 10.1128/JVI.02035-07; WALKER DH, 1979, BRIT J EXP PATHOL, V60, P604; Wu XW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-270; Ye CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017889	58	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44703	10.1371/journal.pone.0044703	http://dx.doi.org/10.1371/journal.pone.0044703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984545	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500076
J	Otsuji, TG; Kurose, Y; Suemori, H; Tada, M; Nakatsuji, N				Otsuji, Tomomi G.; Kurose, Yuko; Suemori, Hirofumi; Tada, Masako; Nakatsuji, Norio			Dynamic Link between Histone H3 Acetylation and an Increase in the Functional Characteristics of Human ESC/iPSC-Derived Cardiomyocytes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MYOSIN HEAVY-CHAIN; DEVELOPMENTAL-CHANGES; GENE-EXPRESSION; MOUSE HEART; DIFFERENTIATION; HYPERTROPHY; GENERATION; CONTRIBUTE; CHROMATIN	Cardiomyocytes (CMs) derived from human embryonic stem cells (hESCs) or human induced pluripotent stem cells (hiPSCs) are functionally heterogeneous, display insufficient biological efficacy and generally possess the electrophysiological properties seen in fetal CMs. However, a homogenous population of hESC/hiPSC-CMs, with properties similar to those of adult human ventricular cells, is required for use in drug cardiotoxicity screening. Unfortunately, despite the requirement for the functional characteristics of post-mitotic beating cell aggregates to mimic the behavior of mature cardiomyocytes in vitro, few technological improvements have been made in this field to date. Previously, we showed that culturing hESC-CMs under low-adhesion conditions with cyclic replating confers continuous contractility on the cells, leading to a functional increase in cardiac gene expression and electrophysiological properties over time. The current study reveals that culturing hESC/hiPSC-CMs under non-adhesive culture conditions enhances the electrophysiological properties of the CMs through an increase in the acetylation of histone H3 lysine residues, as confirmed by western blot analyses. Histone H3 acetylation was induced chemically by treating primitive hESC/hiPSC-CMs with Trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, resulting in an immediate increase in global cardiac gene expression. In functional analyses using multi-electrode array (MEA) recordings, TSA-treated hESC/hiPSC-CM colonies showed appropriate responses to particular concentrations of known potassium ion channel inhibitors. Thus, the combination of a cell-autonomous functional increase in response to non-adhesive culture and short-term TSA treatment of hESC/hiPSC-CM colonies cultured on MEA electrodes will help to make cardiac toxicity tests more accurate and reproducible via genome-wide chromatin activation.	[Otsuji, Tomomi G.; Kurose, Yuko; Tada, Masako] Stem Cell & Drug Discovery Inst, Kyoto, Japan; [Otsuji, Tomomi G.; Suemori, Hirofumi; Nakatsuji, Norio] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto, Japan; [Otsuji, Tomomi G.; Nakatsuji, Norio] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto, Japan; [Tada, Masako] Tottori Univ, Chromosome Engn Res Ctr, Yonago, Tottori, Japan	Kyoto University; Kyoto University; Tottori University	Otsuji, TG (corresponding author), Stem Cell & Drug Discovery Inst, Kyoto, Japan.	matada@med.tottori-u.ac.jp			New Energy and Industrial Technology Development Organization [06990420-0]	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This research was supported by a grant from the New Energy and Industrial Technology Development Organization (06990420-0). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Cao DJ, 2011, P NATL ACAD SCI USA, V108, P4123, DOI 10.1073/pnas.1015081108; Chavan AV, 2010, MINI-REV MED CHEM, V10, P1263; Dambrot C, 2011, BIOCHEM J, V434, P25, DOI 10.1042/BJ20101707; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Harrell MD, 2007, PHYSIOL GENOMICS, V28, P273, DOI 10.1152/physiolgenomics.00163.2006; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; Hosseinkhani M, 2007, BIOCHEM BIOPH RES CO, V356, P386, DOI 10.1016/j.bbrc.2007.02.151; Hoyer K, 2007, J MOL CELL CARDIOL, V42, P214, DOI 10.1016/j.yjmcc.2006.08.116; JECK CD, 1992, CIRC RES, V71, P1390, DOI 10.1161/01.RES.71.6.1390; Jonsson MKB, 2010, STEM CELL RES, V4, P189, DOI 10.1016/j.scr.2010.02.001; Kawamura T, 2005, J BIOL CHEM, V280, P19682, DOI 10.1074/jbc.M412428200; Kim YB, 2005, J BIOL CHEM, V280, P28357, DOI 10.1074/jbc.M412608200; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; MUMMERY CL, 1991, DIFFERENTIATION, V46, P51, DOI 10.1111/j.1432-0436.1991.tb00865.x; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Narolska NA, 2005, J MUSCLE RES CELL M, V26, P39, DOI 10.1007/s10974-005-9005-x; Obreztchikova MN, 2003, CARDIOVASC RES, V59, P339, DOI 10.1016/S0008-6363(03)00360-2; Otsuji TG, 2010, STEM CELL RES, V4, P201, DOI 10.1016/j.scr.2010.01.002; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Rajala K, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/383709; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Reiser PJ, 2001, AM J PHYSIOL-HEART C, V280, pH1814, DOI 10.1152/ajpheart.2001.280.4.H1814; Salameh A, 2010, CIRC RES, V106, P1592, DOI 10.1161/CIRCRESAHA.109.214429; Sartiani L, 2007, STEM CELLS, V25, P1136, DOI 10.1634/stemcells.2006-0466; Snir M, 2003, AM J PHYSIOL-HEART C, V285, pH2355, DOI 10.1152/ajpheart.00020.2003; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vidarsson H, 2010, STEM CELL REV REP, V6, P108, DOI 10.1007/s12015-010-9113-x; Yamauchi K, 2010, GENES CELLS, V15, P1216, DOI 10.1111/j.1365-2443.2010.01455.x; Yanagi K, 2007, STEM CELLS, V25, P2712, DOI 10.1634/stemcells.2006-0388; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	40	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45010	10.1371/journal.pone.0045010	http://dx.doi.org/10.1371/journal.pone.0045010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984602	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500107
J	Quintana-Hayashi, MP; Thakur, S				Quintana-Hayashi, Macarena P.; Thakur, Siddhartha			Phylogenetic Analysis Reveals Common Antimicrobial Resistant Campylobacter coli Population in Antimicrobial-Free (ABF) and Commercial Swine Systems	PLOS ONE			English	Article							GROWTH PROMOTERS; JEJUNI; PREVALENCE; STRAINS; PIGS; MECHANISMS; DIVERSITY; SLAUGHTER; PATTERNS; POULTRY	The objective of this study was to compare the population biology of antimicrobial resistant (AR) Campylobacter coli isolated from swine reared in the conventional and antimicrobial-free (ABF) swine production systems at farm, slaughter and environment. A total of 200 C. coli isolates selected from fecal, environmental, and carcass samples of ABF (n = 100) and conventional (n = 100) swine production systems were typed by multilocus sequence typing (MLST). Sequence data from seven housekeeping genes was analyzed for the identification of allelic profiles, sequence types (STs) and clonal complex determination. Phylogenetic trees were generated to establish the relationships between the genotyped isolates. A total of 51 STs were detected including two novel alleles (glnA 424 and glyA 464) and 14 novel STs reported for the first time. The majority of the C. coli isolates belonged to ST-854 (ABF: 31, conventional: 17), and were grouped in clonal complex ST-828 (ABF: 68%, conventional: 66%). The mean genetic diversity (H) for the ABF (0.3963+/-0.0806) and conventional (0.4655+/-0.0714) systems were similar. The index of association (I-A(s)) for the ABF (I-A(s) = 0.1513) and conventional (I-A(s) = 0.0991) C. coli populations were close to linkage equilibrium, indicative of a freely recombining population. Identical STs were detected between the pigs and their environment both at farm and slaughter. A minimum spanning tree revealed the close clustering of C. coli STs that originated from swine and carcass with those from the environment. In conclusion, our study reveals a genotypic diverse C. coli population that shares a common ancestry in the conventional and ABF swine production systems. This could potentially explain the high prevalence of antimicrobial resistant C. coli in the ABF system in the absence of antimicrobial selection pressure.	[Quintana-Hayashi, Macarena P.; Thakur, Siddhartha] N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Quintana-Hayashi, MP (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.	sthakur@ncsu.edu		Thakur, Siddhartha/0000-0003-3787-9939	USDA-National Research Initiative grant; USDA-National Integrated Food Safety Initiative grant; College of Veterinary Medicine at NC State University grant	USDA-National Research Initiative grant; USDA-National Integrated Food Safety Initiative grant; College of Veterinary Medicine at NC State University grant	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was funded by the USDA-National Research Initiative grant, USDA-National Integrated Food Safety Initiative grant and the College of Veterinary Medicine at NC State University grant.	Castanon JIR, 2007, POULTRY SCI, V86, P2466, DOI 10.3382/ps.2007-00249; Chatre P, 2010, J FOOD PROTECT, V73, P825, DOI 10.4315/0362-028X-73.5.825; Colles FM, 2010, INT J FOOD MICROBIOL, V137, P259, DOI 10.1016/j.ijfoodmicro.2009.12.021; de Boer P, 2002, MOL MICROBIOL, V44, P351, DOI 10.1046/j.1365-2958.2002.02930.x; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; Dingle KE, 2005, J CLIN MICROBIOL, V43, P340, DOI 10.1128/JCM.43.1.340-347.2005; Engberg J, 2001, EMERG INFECT DIS, V7, P24, DOI 10.3201/eid0701.010104; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Gripp E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-584; Grove-White DH, 2010, EPIDEMIOL INFECT, V138, P549, DOI 10.1017/S0950268809991051; Gu WM, 2009, APPL ENVIRON MICROB, V75, P474, DOI 10.1128/AEM.02012-08; Gurtler M, 2005, EPIDEMIOL INFECT, V133, P1081, DOI 10.1017/S0950268805004164; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Hermans D, 2012, VECTOR-BORNE ZOONOT, V12, P89, DOI 10.1089/vbz.2011.0676; Hume ME, 2002, CURR MICROBIOL, V45, P128, DOI 10.1007/s00284-001-0096-3; Johnsen G, 2006, POULTRY SCI, V85, P2278, DOI 10.1093/ps/85.12.2278; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Levesque S, 2012, APPL ENVIRON MICROB, V78, P2470, DOI 10.1128/AEM.06527-11; Litrup E, 2007, J APPL MICROBIOL, V103, P210, DOI 10.1111/j.1365-2672.2006.03214.x; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; McEwen SA, 2002, CLIN INFECT DIS, V34, pS93, DOI 10.1086/340246; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miller WG, 2006, MICROBIOL-SGM, V152, P245, DOI 10.1099/mic.0.28348-0; Quintana-Hayashi MP, 2012, APPL ENVIRON MICROB, V78, P2698, DOI 10.1128/AEM.07723-11; Rollo SN, 2010, JAVMA-J AM VET MED A, V236, P201, DOI 10.2460/javma.236.2.201; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Tadesse DA, 2011, FOODBORNE PATHOG DIS, V8, P367, DOI 10.1089/fpd.2010.0665; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thakur S, 2005, J CLIN MICROBIOL, V43, P5705, DOI 10.1128/JCM.43.11.5705-5714.2005; Thakur S, 2010, ZOONOSES PUBLIC HLTH, V57, P100, DOI 10.1111/j.1863-2378.2010.01363.x; Thakur S, 2009, J APPL MICROBIOL, V106, P1722, DOI 10.1111/j.1365-2672.2008.04142.x; Thakur S, 2006, APPL ENVIRON MICROB, V72, P5666, DOI 10.1128/AEM.00658-06	36	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44662	10.1371/journal.pone.0044662	http://dx.doi.org/10.1371/journal.pone.0044662			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984540	gold, Green Submitted, Green Published			2022-12-25	WOS:000308738500073
J	Taylor, PJ; Stoffberg, S; Monadjem, A; Schoeman, MC; Bayliss, J; Cotterill, FPD				Taylor, Peter J.; Stoffberg, Samantha; Monadjem, Ara; Schoeman, Martinus Corrie; Bayliss, Julian; Cotterill, Fenton P. D.			Four New Bat Species (Rhinolophus hildebrandtii Complex) Reflect Plio-Pleistocene Divergence of Dwarfs and Giants across an Afromontane Archipelago	PLOS ONE			English	Article							ECHOLOCATION CALL FREQUENCY; EASTERN ARC MOUNTAINS; HORSESHOE BAT; GEOMETRIC MORPHOMETRICS; INSECTIVOROUS BATS; ACTIVITY PATTERNS; PREY SELECTION; ISLAND RULE; HABITAT USE; EVOLUTION	Gigantism and dwarfism evolve in vertebrates restricted to islands. We describe four new species in the Rhinolophus hildebrandtii species-complex of horseshoe bats, whose evolution has entailed adaptive shifts in body size. We postulate that vicissitudes of palaeoenvironments resulted in gigantism and dwarfism in habitat islands fragmented across eastern and southern Africa. Mitochondrial and nuclear DNA sequences recovered two clades of R. hildebrandtii senso lato which are paraphyletic with respect to a third lineage (R. eloquens). Lineages differ by 7.7 to 9.0% in cytochrome b sequences. Clade 1 includes R. hildebrandtii sensu stricto from the east African highlands and three additional vicariants that speciated across an Afromontane archipelago through the Plio-Pleistocene, extending from the Kenyan Highlands through the Eastern Arc, northern Mozambique and the Zambezi Escarpment to the eastern Great Escarpment of South Africa. Clade 2 comprises one species confined to lowland savanna habitats (Mozambique and Zimbabwe). A third clade comprises R. eloquens from East Africa. Speciation within Clade 1 is associated with fixed differences in echolocation call frequency, and cranial shape and size in populations isolated since the late Pliocene (ca 3.74 Mya). Relative to the intermediate-sized savanna population (Clade 2), these island-populations within Clade 1 are characterised by either gigantism (South African eastern Great Escarpment and Mts Mabu and Inago in Mozambique) or dwarfism (Lutope-Ngolangola Gorge, Zimbabwe and Soutpansberg Mountains, South Africa). Sympatry between divergent clades (Clade 1 and Clade 2) at Lutope-Ngolangola Gorge (NW Zimbabwe) is attributed to recent range expansions. We propose an "Allometric Speciation Hypothesis", which attributes the evolution of this species complex of bats to divergence in constant frequency (CF) sonar calls. The origin of species-specific peak frequencies (overall range = 32 to 46 kHz) represents the allometric effect of adaptive divergence in skull size, represented in the evolution of gigantism and dwarfism in habitat islands.	[Taylor, Peter J.] Univ Venda, Dept Ecol & Resource Management, Thohoyandou, South Africa; [Taylor, Peter J.] Durban Nat Sci Museum, Durban, South Africa; [Stoffberg, Samantha] Univ Stellenbosch, Dept Bot & Zool, Evolutionary Genom Grp, ZA-7600 Stellenbosch, South Africa; [Monadjem, Ara] Univ Swaziland, Dept Biol Sci, All Out Africa Res Unit, Kwaluseni, Eswatini; [Taylor, Peter J.; Schoeman, Martinus Corrie] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa; [Bayliss, Julian] Mulanje Mt Conservat Trust, Mulanje, Malawi; [Bayliss, Julian] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England; [Cotterill, Fenton P. D.] Univ Stellenbosch, Dept Bot & Zool, Africa Earth Observ Network, ZA-7600 Stellenbosch, South Africa	University of Venda; Stellenbosch University; University of Kwazulu Natal; University of Cambridge; National Research Foundation - South Africa; Stellenbosch University	Taylor, PJ (corresponding author), Univ Venda, Dept Ecol & Resource Management, Thohoyandou, South Africa.	peter.taylor@univen.ac.za	Monadjem, Ara/K-7279-2014; Schoeman, Corrie/G-2616-2010; Taylor, Peter John/N-3172-2019; Taylor, Peter/E-8655-2011	Monadjem, Ara/0000-0003-1906-4023; Taylor, Peter/0000-0001-9048-7366; Bayliss, Julian/0000-0002-1480-294X; Cotterill, Fenton/0000-0003-4561-018X	Darwin Initiative [15/036]; Mulanje Mountain Conservation Trust; African Butterfly Research Institute; Instituto de Investigacao Agraria de Mocambique; National Research Foundation of South Africa; Claude Leon Foundation; All Out Africa	Darwin Initiative; Mulanje Mountain Conservation Trust; African Butterfly Research Institute; Instituto de Investigacao Agraria de Mocambique; National Research Foundation of South Africa(National Research Foundation - South Africa); Claude Leon Foundation; All Out Africa	This research was supported by logistic and financial support from the Darwin Initiative (Darwin Initiative Award 15/036: Monitoring and Managing Biodiversity Loss in South-East Africa's Montane Ecosystems), the Mulanje Mountain Conservation Trust, the African Butterfly Research Institute and the Instituto de Investigacao Agraria de Mocambique to JB. PJT and SS received grants from the National Research Foundation of South Africa. SS was further supported by a Claude Leon Foundation Postdoctoral Fellowships. FPDC thanks the Bay Foundations for support over the period core data were collected. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Lientjie Cohen provided invaluable support with collection of samples from Mpumalanga Province. Michael Curran and Mirjam Kopp collected one of the specimens from Mt Mabu and kindly provided acoustic data of two individuals from Mt Mabu - both were working under the the British government funded Darwin Initiative project 'Monitoring and Managing Biodiversity Loss on South-East Africa's Montane Ecosystems' (Award 15/036). This collaborative project, led by the Royal Botanic Gardens, Kew, also included BirdLife International, the Instituto de Investigacao Agraria de Mocambique, the Mulanje Mountain Conservation Trust, Malawi, and the Forest Research Institute of Malawi. April Reside and Julien Cornut assisted with the capture of Mozambican specimens. Leigh Richards (Durban Natural Science Museum) and Teresa Kearney (Ditsong National Natural Science Museum) provided invaluable assistance with loans of specimens and queries about specimens. Alick Ndlovu, Kith Mkwananzi and John Minshull enthustiastically helped with successful collecting in Zimbabwe. MCS and SS are very grateful to Pieter Malan, Gerhard Groenewald and the Toyota Enviro Outreach for logistical support. AM received financial and logistic support from All Out Africa. We are grateful to Dr J. M. Bishop for the use of unpublished cytochrome b primers. Support from Africa Earth Observatory Network (AEON) enabled geobiological inputs into the present paper. This is AEON Publication No. 105.	Abebe T, 2010, TERRA NOVA, V22, P470, DOI 10.1111/j.1365-3121.2010.00968.x; Addinsoft, 2007, XLSTAT VERS 2007 5; ALDRIDGE HDJN, 1987, J ANIM ECOL, V56, P763, DOI 10.2307/4947; Alpers DL, 2004, MOL ECOL, V13, P1771, DOI 10.1111/j.1365-294X.2004.02204.x; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Baldwin SL, 2012, ANNU REV EARTH PL SC, V40, P495, DOI 10.1146/annurev-earth-040809-152540; Bates P. J. J., 1997, BATS INDIAN SUBCONTI; Bauer FU, 2010, INT J EARTH SCI, V99, P1575, DOI 10.1007/s00531-010-0549-7; Bayliss J, 2010, BIODIVERSITY CONSERV; Blackburn DC, 2009, MOL ECOL, V18, P1904, DOI 10.1111/j.1365-294X.2009.04156.x; Branch WR, 2010, AFR J HERPETOL, V59, P157, DOI 10.1080/21564574.2010.516275; Branch WR, 2009, ZOOTAXA, P41, DOI 10.11646/zootaxa.2113.1.2; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Chen SF, 2009, P ROY SOC B-BIOL SCI, V276, P3901, DOI 10.1098/rspb.2009.1185; Congdon C., 2010, METAMORPHOSIS, V21, P45; CORTI M, 1993, TRENDS ECOL EVOL, V8, P302, DOI 10.1016/0169-5347(93)90261-M; Cotterill F.P.D., 2003, P59; Cotterill FPD, 2011, S AFR J GEOL, V114, P489, DOI 10.2113/gssajg.114.3-4.489; Cotterill FPD, 2002, J ZOOL, V256, P165, DOI 10.1017/S0952836902000201; Cracraft J, 1989, WHAT PHILOS BIOL IS, P33; Crisp MD, 2011, TRENDS ECOL EVOL, V26, P66, DOI 10.1016/j.tree.2010.11.005; Csorba G, 2003, HORSESHOE BATS WORLD; Daniels S, 2011, ZOOLOGICAL J LINNEAN, V164, P498; Datzmann T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-165; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; deMenocal PB, 2011, SCIENCE, V331, P540, DOI 10.1126/science.1190683; Droxler AW, 2003, GEOPHYS MONOGRAPH; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eastman JM, 2011, SYST BIOL, V60, P503, DOI 10.1093/sysbio/syr020; Eick GN, 2005, MOL BIOL EVOL, V22, P1869, DOI 10.1093/molbev/msi180; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fenton M. B., 1985, TRANSV MUS B, V21, P5; FENTON MB, 1981, J MAMMAL, V62, P233, DOI 10.2307/1380701; FENTON MB, 1977, BIOTROPICA, V9, P73, DOI 10.2307/2387662; FENTON MB, 1980, BIOTROPICA, V12, P81, DOI 10.2307/2387723; FENTON MB, 1979, J COMP PHYSIOL, V132, P77, DOI 10.1007/BF00617734; Fenton MB, 1975, LIFE SCI CONTRIBUTIO, P104; Fjeldsa J, 2008, AFR J ECOL, V46, P235, DOI 10.1111/j.1365-2028.2008.00992.x; Francis Charles M., 1998, P169; Galley C, 2007, P ROY SOC B-BIOL SCI, V274, P535, DOI 10.1098/rspb.2006.0046; Goodier SAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028775; Goodman Steven M., 2010, Zootaxa, V2551, P1; GRANTHAM TA, 1995, ANNU REV ECOL SYST, V26, P301; Groves C., 2011, UNGULATE TAXONOMY; Groves CP, 2001, PRIMATE TAXONOMY; Guillen Servent Antonio, 2003, pxii; Hall R, 2002, J ASIAN EARTH SCI, V20, P353, DOI 10.1016/S1367-9120(01)00069-4; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HARTLEY DJ, 1988, J ACOUST SOC AM, V84, P1201, DOI 10.1121/1.396621; HELLER KG, 1989, OECOLOGIA, V80, P178, DOI 10.1007/BF00380148; HILL J. E., 1987, B BRIT MUS NAT HIST, V72, P225; Houston R. D., 2004, ECHOLOCATION BATS DO, P339, DOI DOI 10.1016/0370-1573(95)00083-6; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunn CA, 2001, SYST BIOL, V50, P391, DOI 10.1080/713849647; Jacobs DS, 2007, OECOLOGIA, V152, P583, DOI 10.1007/s00442-007-0679-1; Jacobs DS, 1996, FUNCT ECOL, V10, P622, DOI 10.2307/2390172; JANIS CM, 1993, ANNU REV ECOL SYST, V24, P467, DOI 10.1146/annurev.es.24.110193.002343; JONES G, 1993, P ROY SOC B-BIOL SCI, V251, P119, DOI 10.1098/rspb.1993.0017; Jones G., 1992, P87, DOI 10.1109/TFTSA.1992.274228; Jones G, 1999, J EXP BIOL, V202, P3359; Jones G, 1996, SYM ZOOL S, P111; Jones G., 2004, ECHOLOCATION BATS DO, P345; Juste J, 2007, ACTA CHIROPTEROL, V9, P27, DOI 10.3161/1733-5329(2007)9[27:TOLBBM]2.0.CO;2; Kearney TC, 2002, ACTA CHIROPTEROL, V4, P55, DOI 10.3161/001.004.0107; Kingston T, 2004, NATURE, V429, P654, DOI 10.1038/nature02487; Kingston T, 2001, P ROY SOC B-BIOL SCI, V268, P1381, DOI 10.1098/rspb.2001.1630; Kjer KM, 2007, MOL PHYLOGENET EVOL, V43, P999, DOI 10.1016/j.ympev.2007.02.028; Lawes MJ, 2007, J BIOGEOGR, V34, P1246, DOI 10.1111/j.1365-2699.2007.01696.x; Lawson LP, 2010, MOL ECOL, V19, P4046, DOI 10.1111/j.1365-294X.2010.04788.x; LIDICKER WZ, 1968, J MAMMAL, V49, P609, DOI 10.2307/1378724; Lomolino MV, 2005, J BIOGEOGR, V32, P1683, DOI 10.1111/j.1365-2699.2005.01314.x; Mao XG, 2010, MOL ECOL, V19, P2754, DOI 10.1111/j.1365-294X.2010.04704.x; Marcus LF, 1996, NATO ADV SCI I A-LIF, V284, P1; McNab BK, 2001, J COMP PHYSIOL B, V171, P201, DOI 10.1007/s003600000163; Meiri S, 2008, P ROY SOC B-BIOL SCI, V275, P141, DOI 10.1098/rspb.2007.1056; Meiri S, 2006, J BIOGEOGR, V33, P1571, DOI 10.1111/j.1365-2699.2006.01523.x; Monadjem A, 2007, S AFR J WILDL RES, V37, P9, DOI 10.3957/0379-4369-37.1.9; Monadjem A, 2010, ACTA CHIROPTEROL, V12, P371, DOI 10.3161/150811010X537963; Mucina Ladislav, 2006, V19, P2; National Research Council, 2010, UND CLIM INFL HUM EV; Nicolas V, 2006, MOL PHYLOGENET EVOL, V38, P779, DOI 10.1016/j.ympev.2005.11.024; OBRIST MK, 1995, BEHAV ECOL SOCIOBIOL, V36, P207, DOI 10.1007/s002650050142; PALMEIRIM JM, 1991, MAMMALIA, V55, P381, DOI 10.1515/mamm.1991.55.3.381; Palumbi S., 1991, SIMPLE FOOLS GUIDE P; Partridge TC., 2010, CENOZOIC MAMMALS AFR, P3, DOI DOI 10.1525/CALIFORNIA/9780520257214.003.0001; Paterson H.E.H., 1985, Transvaal Museum Monograph, P21; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prendini Lorenzo, 2001, P113; Quigley MC, 2010, GEOL SOC SPEC PUBL, V346, P243, DOI 10.1144/SP346.13; Rabosky DL, 2010, TRENDS ECOL EVOL, V25, P68, DOI 10.1016/j.tree.2009.07.002; Robinson MF, 1996, J ZOOL, V239, P389, DOI 10.1111/j.1469-7998.1996.tb05459.x; Rohlf F.J., 2009, TPSDIG VERSION 214; Rohlf F. James, 2002, VVolume 64, P175; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1998, SYST BIOL, V47, P147, DOI 10.1080/106351598261094; Rohlf FJ, 2008, TPSRELW VERSION 1 48; Rohling EJ, 2010, EARTH PLANET SC LETT, V291, P97, DOI 10.1016/j.epsl.2009.12.054; Russo D, 2007, J BIOGEOGR, V34, P2129, DOI 10.1111/j.1365-2699.2007.01762.x; Schmidt NM, 1993, CONSERV ECOL, V7, P6; Schoeman MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003715; Siemers BM, 2005, ACTA CHIROPTEROL, V7, P259, DOI 10.3161/1733-5329(2005)7[259:ISISAO]2.0.CO;2; Simmons NB, 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Smithers RHN, 1983, MAMMALS SO AFRICAN S; Speigel C, 2010, GEOLOGY, V35, P427, DOI [10.1130/G23108A, DOI 10.1130/G23108A]; Stadelmann B, 2004, ACTA CHIROPTEROL, V6, P177, DOI 10.3161/001.006.0201; Stanley William T., 2011, Fieldiana-Life and Earth Sciences, V4, P34; Stanley WT, 2010, BIOL J LINN SOC, V100, P669, DOI 10.1111/j.1095-8312.2010.01448.x; Stanley WT, 2005, J ZOOL, V266, P341, DOI 10.1017/S0952836905007016; STOFFBERG S, 2007, THESIS U CAPE TOWN C; Stoffberg S, 2010, MOL PHYLOGENET EVOL, V54, P1, DOI 10.1016/j.ympev.2009.09.021; SUTHERS RA, 1988, J COMP PHYSIOL A, V162, P799, DOI 10.1007/BF00610969; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Taylor P. J., 2009, AFRICAN ZOOLOGY, V277, P317; TAYLOR P. J., 2010, BATS SO CENTRAL AFRI; Taylor Peter J., 2005, Durban Museum Novitates, V30, P24; Taylor Peter J., 2011, Zootaxa, V3024, P1; Taylor PJ, 2009, BIOL J LINN SOC, V96, P913, DOI 10.1111/j.1095-8312.2008.01153.x; Teeling EC, 2003, MOL PHYLOGENET EVOL, V28, P308, DOI 10.1016/S1055-7903(03)00117-9; Thabah A, 2006, BIOL J LINN SOC, V88, P119, DOI 10.1111/j.1095-8312.2006.00602.x; Van Valen L, 1973, EVOL THEORY, V49, P31, DOI DOI 10.1007/S13398-014-0173-7.2; Voelker G, 2010, GLOBAL ECOL BIOGEOGR, V19, P111, DOI 10.1111/j.1466-8238.2009.00500.x; WHITE F, 1981, AFR J ECOL, V19, P33, DOI 10.1111/j.1365-2028.1981.tb00651.x; White F, 1983, NATURAL RESOURCES RE, P161; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zhou ZM, 2009, J MAMMAL, V90, P57, DOI 10.1644/08-MAMM-A-048.1	127	65	65	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e41744	10.1371/journal.pone.0041744	http://dx.doi.org/10.1371/journal.pone.0041744			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984399	gold, Green Published			2022-12-25	WOS:000308738500005
J	Wang, CS; Shi, JH; Sun, B; Liu, DS; Li, P; Gong, YL; He, Y; Liu, SJ; Xu, GW; Li, JY; Luo, AL; Li, EY				Wang, Changsong; Shi, Jinghui; Sun, Bo; Liu, Desheng; Li, Peng; Gong, Yulei; He, Ying; Liu, Shujuan; Xu, Guowang; Li, Jianyi; Luo, Ailin; Li, Enyou			Breath Pentane as a Potential Biomarker for Survival in Hepatic Ischemia and Reperfusion Injury-A Pilot Study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; MEDIATED LIPID-PEROXIDATION; OXIDATIVE STRESS; DIPHENYL DISELENIDE; HYDROGEN-PEROXIDE; PROPOFOL; LIVER; RAT; CELL; EXPRESSION	Background: Exhaled pentane, which is produced as a consequence of reactive oxygen species-mediated lipid peroxidation, is a marker of oxidative stress. Propofol is widely used as a hypnotic agent in intensive care units and the operating room. Moreover, this agent has been reported to inhibit lipid peroxidation by directly scavenging reactive oxygen species. In this study, using a porcine liver ischemia-reperfusion injury model, we have evaluated the hypothesis that high concentrations of breath pentane are related to adverse outcome and that propofol could reduce breath pentane and improve liver injury and outcome in swine in this situation. Methodology/Principal Findings: Twenty male swine were assigned to two groups: propofol (n = 10) and chloral hydrate groups (n = 10). Hepatic ischemia was induced by occluding the portal inflow vessels. Ischemia lasted for 30 min, followed by reperfusion for 360 min. Exhaled and blood pentane concentrations in the chloral hydrate group markedly increased 1 min after reperfusion and then decreased to baseline. Breath and blood pentane concentrations in the propofol group increased 1 min after reperfusion but were significantly lower than in the chloral hydrate group. A negative correlation was found between breath pentane levels and survival in the chloral hydrate group. The median overall survival was 251 min after reperfusion (range 150-360 min) in the chloral hydrate group. All of the swine were alive in the propofol group. Conclusions: Monitoring of exhaled pentane may be useful for evaluating the severity of hepatic ischemia-reperfusion injury and aid in predicting the outcome; propofol may improve the outcome in this situation.	[Wang, Changsong; Sun, Bo; Liu, Desheng; Li, Peng; Gong, Yulei; He, Ying; Liu, Shujuan; Li, Enyou] Harbin Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Harbin, Peoples R China; [Shi, Jinghui; Luo, Ailin] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Anesthesiol, Wuhan 430074, Peoples R China; [Xu, Guowang] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Li, Jianyi] Third High Sch Harbin, Harbin, Peoples R China	Harbin Medical University; Huazhong University of Science & Technology; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS	Wang, CS (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Anesthesiol, Harbin, Peoples R China.	enyouli@yahoo.cn	Xu, Guowang/L-6910-2014	Xu, Guowang/0000-0003-4298-3554; wang, changsong/0000-0002-0079-5259	National Natural Science Foundation of China [30571783, 30972839]; Ministry of Education of China [20092307110005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	Financial support by grants from the National Natural Science Foundation of China (No. 30571783 and 30972839) and Doctoral Fund of Ministry of Education of China (No. 20092307110005) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva R, 2004, ANESTHESIOLOGY, V101, P1363; Andreoni KA, 1999, FREE RADICAL BIO MED, V26, P439, DOI 10.1016/S0891-5849(98)00220-2; Brown RH, 2009, J BREATH RES, V3, DOI 10.1088/1752-7155/3/1/016002; Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO;2-6; CASINI AF, 1985, AM J PATHOL, V118, P225; Cavalca V, 2008, ANESTHESIOLOGY, V108, P988, DOI 10.1097/ALN.0b013e318173efb4; Chao CM, 2002, CHINESE J PHYSIOL, V45, P123; Clark D., 1996, GUIDE CARE USE LAB A; Collard CD, 2001, ANESTHESIOLOGY, V94, P1133, DOI 10.1097/00000542-200106000-00030; Crohns M, 2009, FREE RADICAL RES, V43, P965, DOI 10.1080/10715760903159162; De la Cruz JP, 1998, ANESTH ANALG, V87, P1141, DOI 10.1097/00000539-199811000-00031; DUMELIN EE, 1977, LIPIDS, V12, P894, DOI 10.1007/BF02533308; Giakoustidis D, 2001, FREE RADICAL RES, V35, P103, DOI 10.1080/10715760100300641; Goodyear-Bruch C, 2002, AM J CRIT CARE, V11, P543, DOI 10.4037/ajcc2002.11.6.543; Hassan W, 2009, ENVIRON TOXICOL PHAR, V28, P152, DOI 10.1016/j.etap.2009.02.004; Hassan W, 2009, CHEM-BIOL INTERACT, V180, P47, DOI 10.1016/j.cbi.2008.12.013; Hassan W, 2009, BRAIN RES, V1258, P71, DOI 10.1016/j.brainres.2008.12.046; He Jing, 2008, Nan Fang Yi Ke Da Xue Xue Bao, V28, P1064; Ikeda H, 1998, GUT, V42, P530, DOI 10.1136/gut.42.4.530; Jaeschke H, 2011, J GASTROEN HEPATOL, V26, P173, DOI 10.1111/j.1440-1746.2010.06592.x; Kamada N, 2008, CAN J ANAESTH, V55, P595, DOI 10.1007/BF03021433; Kanakura H, 2007, J ANESTH, V21, P354, DOI 10.1007/s00540-007-0533-y; Kanoria S, 2004, TRANSPL P, V36, P2586, DOI 10.1016/j.transproceed.2004.10.031; Kato R, 2002, CAN J ANAESTH, V49, P777, DOI 10.1007/BF03017409; KAZUI M, 1992, FREE RADICAL BIO MED, V13, P509, DOI 10.1016/0891-5849(92)90145-7; KAZUI M, 1994, J VASC SURG, V19, P473, DOI 10.1016/S0741-5214(94)70074-5; Lee SM, 2000, SHOCK, V13, P279, DOI 10.1097/00024382-200004000-00005; Li P, 2009, EUR J ANAESTH, V26, P513, DOI 10.1097/EJA.0b013e328326f7b7; Luo T, 2005, ANESTH ANALG, V100, P1653, DOI 10.1213/01.ANE.0000150945.95254.D8; MATHEWS WR, 1994, FREE RADICAL BIO MED, V16, P763, DOI 10.1016/0891-5849(94)90191-0; Navapurkar VU, 1998, ANESTH ANALG, V87, P1152, DOI 10.1097/00000539-199811000-00033; Nycyk JA, 1998, ARCH DIS CHILD-FETAL, V79, pF67, DOI 10.1136/fn.79.1.F67; PITKANEN OM, 1990, J PEDIATR-US, V116, P760, DOI 10.1016/S0022-3476(05)82668-X; RISBY TH, 1994, SURGERY, V115, P94; Risby TH, 1999, FREE RADICAL BIO MED, V27, P1182, DOI 10.1016/S0891-5849(99)00212-9; Runzer TD, 2002, ANESTH ANALG, V94, P89, DOI 10.1097/00000539-200201000-00017; SCHOENIGER LO, 1994, GASTROENTEROLOGY, V106, P177, DOI 10.1016/S0016-5085(94)95209-4; Scholpp J, 2002, CLIN CHEM LAB MED, V40, P587, DOI 10.1515/CCLM.2002.101; Schubert JK, 2004, EXPERT REV MOL DIAGN, V4, P619, DOI 10.1586/14737159.4.5.619; Spinhirne JP, 2003, BIOSYST ENG, V84, P239, DOI 10.1016/S1537-5110(02)00240-4; Taniguchi T, 2000, CRIT CARE MED, V28, P1101, DOI 10.1097/00003246-200004000-00032; Tsai KL, 1997, J PHYSIOL-LONDON, V502, P161, DOI 10.1111/j.1469-7793.1997.161bl.x; Wang H, 2008, ANESTH ANALG, V107, P534, DOI 10.1213/ane.0b013e3181770be9; Yuzawa H, 2005, HEPATO-GASTROENTEROL, V52, P839; Zhu SM, 2009, ANESTH ANALG, V109, P1493, DOI 10.1213/ANE.0b013e3181b893f3	45	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44940	10.1371/journal.pone.0044940	http://dx.doi.org/10.1371/journal.pone.0044940			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984587	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700100
J	Kim, YW; Bae, SM; Lim, H; Kim, YJ; Ahn, WS				Kim, Yong-Wan; Bae, Su Mi; Lim, Hyunsun; Kim, Yoon Ji; Ahn, Woong Shick			Development of Multiplexed Bead-Based Immunoassays for the Detection of Early Stage Ovarian Cancer Using a Combination of Serum Biomarkers	PLOS ONE			English	Article							BIOLOGICAL VARIATION; ANALYTICAL IMPRECISION; PROTEOMIC BIOMARKERS; APOLIPOPROTEIN A1; TUMOR-MARKERS; CA-125 LEVELS; CA 125; CA125; PROTEIN; TRANSTHYRETIN	CA125 as a biomarker of ovarian cancer is ineffective for the general population. The aim of this study was to evaluate multiplexed bead-based immunoassay of multiple ovarian cancer-associated biomarkers such as transthyretin and apolipoprotein A1, together with CA125, to improve the identification and evaluation of prognosis of ovarian cancer. We measured the serum levels of CA125, transthyretin, and apolipoprotein A1 from the serum of 61 healthy individuals, 84 patients with benign ovarian disease, and 118 patients with ovarian cancer using a multiplex liquid assay system, Luminex 100. The results were then analyzed according to healthy and/or benign versus ovarian cancer subjects. When CA125 was combined with the other biomarkers, the overall sensitivity and specificity were significantly improved in the ROC curve, which showed 95% and 97% sensitivity and specificity, respectively. At 95% specificity for all stages the sensitivity increased to 95.5% compared to 67% for CA125 alone. For stage I+II, the sensitivity increased from 30% for CA125 alone to 93.9%. For stage III+IV, the corresponding values were 96.5% and 91.6%, respectively. Also, the three biomarkers were sufficient for maximum separation between noncancer (healthy plus benign group) and stage I+II or all stages (I-IV) of disease. The new combination of transthyretin, and apolipoprotein A1 with CA125 improved both the sensitivity and the specificity of ovarian cancer diagnosis compared with those of individual biomarkers. These findings suggest the benefit of the combination of these markers for the diagnosis of ovarian cancer.	[Kim, Yong-Wan; Bae, Su Mi; Kim, Yoon Ji] Catholic Univ Korea, Catholic Res Inst Med Sci, Coll Med, Seoul, South Korea; [Lim, Hyunsun] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Biomed Res Ctr, Seoul, South Korea; [Ahn, Woong Shick] Catholic Univ Korea, Dept Obstet & Gynecol, Coll Med, Seoul, South Korea	Catholic University of Korea; Yonsei University; Yonsei University Health System; Catholic University of Korea	Kim, YW (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Coll Med, Seoul, South Korea.	ahnlab1@catholic.ac.kr			National Research Foundation of Korea (NRF), Seoul, Republic of Korea [5-2011-A0154-00119]	National Research Foundation of Korea (NRF), Seoul, Republic of Korea	The study was supported by the National Research Foundation of Korea (NRF), Seoul, Republic of Korea (Grant # 5-2011-A0154-00119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GL, 2010, JNCI-J NATL CANCER I, V102, P26, DOI 10.1093/jnci/djp438; Aslam N, 2000, BRIT J OBSTET GYNAEC, V107, P689, DOI 10.1111/j.1471-0528.2000.tb13314.x; Badgwell D, 2007, DIS MARKERS, V23, P397, DOI 10.1155/2007/309382; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Bast RC, 2004, T AM CLIN CLIMAT ASS, V115, P247; Bast Robert C Jr, 2004, Trans Am Clin Climatol Assoc, V115, P233; Bertenshaw GP, 2008, CANCER EPIDEM BIOMAR, V17, P2872, DOI 10.1158/1055-9965.EPI-08-0464; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Clarke CH, 2011, GYNECOL ONCOL, V122, P548, DOI 10.1016/j.ygyno.2011.06.002; Diamandis EP, 2010, J NATL CANCER I, V102, P1462, DOI 10.1093/jnci/djq306; Donach M, 2010, TUMOR BIOL, V31, P209, DOI 10.1007/s13277-010-0032-x; EINHORN N, 1992, OBSTET GYNECOL, V80, P14; Ellington AA, 2010, CLIN CHEM, V56, P186, DOI 10.1373/clinchem.2009.127514; Giusti L, 2008, J PROTEOME RES, V7, P4079, DOI 10.1021/pr8000404; Greene MH, 2008, CLIN CANCER RES, V14, P7574, DOI 10.1158/1078-0432.CCR-08-2232; GRUNDY SM, 1990, ARCH INTERN MED, V150, P1579; Grzegorzewska Alicja E, 2004, Adv Perit Dial, V20, P185; Gupta D, 2009, J OVARIAN RES, V2, DOI 10.1186/1757-2215-2-13; HELZLSOUER KJ, 1993, JAMA-J AM MED ASSOC, V269, P1123, DOI 10.1001/jama.269.9.1123; Hensley ML, 2010, J CLIN ONCOL, V28, P2128, DOI 10.1200/JCO.2009.26.6346; INGENBLEEK Y, 1994, ANNU REV NUTR, V14, P495, DOI 10.1146/annurev.nu.14.070194.002431; JACOBS I, 1989, HUM REPROD, V4, P1; Jacobs IJ, 2004, MOL CELL PROTEOMICS, V3, P355, DOI 10.1074/mcp.R400006-MCP200; Kim KA, 2004, AM J ROENTGENOL, V182, P1259, DOI 10.2214/ajr.182.5.1821259; Kim YW, 2012, ONCOL REP, V28, P585, DOI 10.3892/or.2012.1829; Kozak KR, 2005, PROTEOMICS, V5, P4589, DOI 10.1002/pmic.200500093; Liede A, 2002, J CLIN ONCOL, V20, P1570, DOI 10.1200/JCO.20.6.1570; Ling MM, 2007, EXPERT REV MOL DIAGN, V7, P87, DOI 10.1586/14737159.7.1.87; Liu MY, 2005, CLIN CHEM, V51, P1102, DOI 10.1373/clinchem.2004.047084; Lopez LA, 1996, AGE AGEING, V25, P45, DOI 10.1093/ageing/25.1.45; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; Maggino T, 2000, EUR J GYNAECOL ONCOL, V21, P64; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Menon U, 2000, CURR OPIN OBSTET GYN, V12, P39, DOI 10.1097/00001703-200002000-00007; Moore LE, 2006, CANCER EPIDEM BIOMAR, V15, P1641, DOI 10.1158/1055-9965.EPI-05-0980; Moore LE, 2012, CANCER-AM CANCER SOC, V118, P91, DOI 10.1002/cncr.26241; Moore RG, 2009, GYNECOL ONCOL, V112, P40, DOI 10.1016/j.ygyno.2008.08.031; Morice P, 2003, ANN ONCOL, V14, P74, DOI 10.1093/annonc/mdg003; Murakoshi Y, 2011, CANCER SCI, V102, P630, DOI 10.1111/j.1349-7006.2010.01818.x; Nicholas BL, 2010, AM J RESP CRIT CARE, V181, P1049, DOI 10.1164/rccm.200906-0857OC; Nosov V, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.042; Nossov V, 2008, AM J OBSTET GYNECOL, V199, P215, DOI 10.1016/j.ajog.2008.04.009; Palmer C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002633; Power DM, 2000, GEN COMP ENDOCR, V119, P241, DOI 10.1006/gcen.2000.7520; Predanic M, 2000, FERTIL STERIL, V73, P522, DOI 10.1016/S0015-0282(99)00554-3; Rein BJD, 2011, J ONCOL, V2011, DOI 10.1155/2011/475983; Rosen DG, 2005, GYNECOL ONCOL, V99, P267, DOI 10.1016/j.ygyno.2005.06.040; Sasaroli D, 2009, BIOMARK MED, V3, P275, DOI 10.2217/BMM.09.21; Schweigert Florian J, 2004, Proteome Sci, V2, P5, DOI 10.1186/1477-5956-2-5; Su F, 2010, P NATL ACAD SCI USA, V107, P19997, DOI 10.1073/pnas.1009010107; Suh KS, 2010, EXPERT REV MOL DIAGN, V10, P1069, DOI 10.1586/ERM.10.87; Tcherkassova J, 2011, TUMOR BIOL, V32, P831, DOI 10.1007/s13277-011-0186-1; Trape J, 2005, CLIN CHEM, V51, P219; Tuxen MK, 2001, CLIN CHEM LAB MED, V39, P531, DOI 10.1515/CCLM.2001.089; Tuxen MK, 1999, GYNECOL ONCOL, V74, P12, DOI 10.1006/gyno.1999.5414; West-Norager M, 2007, J CHROMATOGR B, V847, P30, DOI 10.1016/j.jchromb.2006.09.048; Yurkovetsky Z, 2010, J CLIN ONCOL, V28, P2159, DOI 10.1200/JCO.2008.19.2484; Zhang B, 2010, ANN CLIN LAB SCI, V40, P218; Zhang Z, 2004, CANCER RES, V64, P5882, DOI 10.1158/0008-5472.CAN-04-0746	59	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44960	10.1371/journal.pone.0044960	http://dx.doi.org/10.1371/journal.pone.0044960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970327	Green Submitted, gold, Green Published			2022-12-25	WOS:000308748400037
J	Lins, RMMA; Souza, NA; Brazil, RP; Maingon, RDC; Peixoto, AA				Lins, Rachel M. M. A.; Souza, Nataly A.; Brazil, Reginaldo P.; Maingon, Rhayza D. C.; Peixoto, Alexandre A.			Fixed Differences in the paralytic Gene Define Two Lineages within the Lutzomyia longipalpis Complex Producing Different Types of Courtship Songs	PLOS ONE			English	Article							MALE SEX-PHEROMONES; BRAZILIAN POPULATIONS; SPECIES COMPLEX; PERIOD GENE; VISCERAL LEISHMANIASIS; FEMALE PREFERENCE; CRUZI MANGABEIRA; DIPTERA; PSYCHODIDAE; DIVERGENCE	The sand fly Lutzomyia longipalpis (Diptera: Psychodidae: Phlebotominae), the most important vector of American visceral leishmaniasis, is widely distributed in Latin America. There is currently a consensus that it represents a species complex, however, the number and distribution of the different siblings is still uncertain. Previous analyses have indicated that Brazilian populations of this vector can be divided into two main groups according to the type of courtship song (Burst vs. Pulse) males produce during copulation. Nevertheless, no diagnostic differences have been observed between these two groups with most molecular markers used to date. We analyzed the molecular divergence in a fragment of the paralytic (para) gene, a locus involved in the control of courtship songs in Drosophila, among a number of Lu. longipalpis populations from Brazil producing Burst and Pulse-type songs. Our results revealed a very high level of divergence and fixed differences between populations producing the two types of songs. We also compared Lu. longipalpis with a very closely related species, Lutzomyia cruzi, which produces Burst-type songs. The results indicated a higher number of fixed differences between Lu. cruzi and the Pulse-type populations of Lu. longipalpis than with those producing Burst-type songs. The data confirmed our previous assumptions that the presence of different sibling species of the Lu. longipalpis complex in Brazil can be divided into two main groups, one representing a single species and a second more heterogeneous group that probably represents a number of incipient species. We hypothesize that para might be one of the genes directly involved in the control of the courtship song differences between these two groups or that it is linked to other loci associated with reproductive isolation of the Brazilian species.	[Lins, Rachel M. M. A.; Peixoto, Alexandre A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21045900 Rio De Janeiro, Brazil; [Souza, Nataly A.] Fiocruz MS, Inst Oswaldo Cruz, Lab Transmissores Leishmanioses, BR-21045900 Rio De Janeiro, Brazil; [Brazil, Reginaldo P.] Fiocruz MS, Inst Oswaldo Cruz, Lab Bioquim & Fisiol Insetos, BR-21045900 Rio De Janeiro, Brazil; [Maingon, Rhayza D. C.] Keele Univ, Sch Life Sci, Inst Sci & Technol Med, Ctr Appl Entomol & Parasitol, Keele, Staffs, England; [Peixoto, Alexandre A.] INCT EM, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Keele University	Lins, RMMA (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Insetos, BR-21045900 Rio De Janeiro, Brazil.	apeixoto@ioc.fiocruz.br	Brazil, Reginaldo Peçanha/AAF-6777-2019		Howard Hughes Medical Institute; CNPq; Capes; FAPERJ; FIOCRUZ	Howard Hughes Medical Institute(Howard Hughes Medical Institute); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FIOCRUZ	This work was supported by grants from the Howard Hughes Medical Institute, CNPq, Capes, FAPERJ and FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki AS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000365; Arrivillaga J, 2003, J MED ENTOMOL, V40, P615, DOI 10.1603/0022-2585-40.5.615; Arrivillaga JC, 2001, J MED ENTOMOL, V38, P783, DOI 10.1603/0022-2585-38.6.783; Bauzer LGSR, 2002, INSECT MOL BIOL, V11, P315, DOI 10.1046/j.1365-2583.2002.00340.x; Bauzer LGSR, 2002, MOL BIOL EVOL, V19, P1624, DOI 10.1093/oxfordjournals.molbev.a004224; Bauzer LGSR, 2007, MEM I OSWALDO CRUZ, V102, P1, DOI 10.1590/S0074-02762007000100001; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bottecchia M, 2004, J MOL EVOL, V58, P754, DOI 10.1007/s00239-004-2586-y; Brazil RP, 2002, MEM I OSWALDO CRUZ, V97, P435, DOI 10.1590/S0074-02762002000300030; Butlin R, 2012, TRENDS ECOL EVOL, V27, P27, DOI 10.1016/j.tree.2011.09.002; Cator LJ, 2009, SCIENCE, V323, P1077, DOI 10.1126/science.1166541; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Pita-Pereira D, 2008, ACTA TROP, V107, P66, DOI 10.1016/j.actatropica.2008.04.015; de Souza NA, 2002, T ROY SOC TROP MED H, V96, P102, DOI 10.1016/S0035-9203(02)90258-0; Ewing AW, 1989, ARTHROPOD BIOACOUSTI; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Filatov DA, 2002, MOL ECOL NOTES, V2, P621, DOI 10.1046/j.1471-8286.2002.00313.x; FU YX, 1993, GENETICS, V133, P693; Gleason JM, 2005, BEHAV GENET, V35, P265, DOI 10.1007/s10519-005-3219-y; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hamilton JGC, 1999, CHEM COMMUN, P355, DOI 10.1039/a900242a; Hamilton JGC, 2005, MED VET ENTOMOL, V19, P480, DOI 10.1111/j.1365-2915.2005.00594.x; Hamilton JGC, 2004, J MED ENTOMOL, V41, P1021, DOI 10.1603/0022-2585-41.6.1021; Hamilton JGC, 1999, CHEM COMMUN, P2335, DOI 10.1039/a907910f; Hausdorf B, 2011, EVOLUTION, V65, P923, DOI 10.1111/j.1558-5646.2011.01231.x; Joseph Sambrook DR, 2001, MOL CLONING LAB MANU; Jowett T, 1998, DROSOPHILA PRACTICAL, P347; Klappert K, 2007, EVOLUTION, V61, P1481, DOI 10.1111/j.1558-5646.2007.00125.x; Lainson R, 2005, MEM I OSWALDO CRUZ, V100, P811, DOI 10.1590/S0074-02762005000800001; LANZARO GC, 1993, AM J TROP MED HYG, V48, P839, DOI 10.4269/ajtmh.1993.48.839; LANZARO GC, 1995, PARASITOL TODAY, V11, P151, DOI 10.1016/0169-4758(95)80137-5; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lins RMMA, 2008, MEM I OSWALDO CRUZ, V103, P736, DOI 10.1590/S0074-02762008000700019; Maingon RDC, 2003, MOL ECOL, V12, P1879, DOI 10.1046/j.1365-294X.2003.01871.x; Maingon RDC, 2008, TRENDS PARASITOL, V24, P12, DOI 10.1016/j.pt.2007.10.003; Peixoto AA, 2002, ADV GENET, V47, P117, DOI 10.1016/S0065-2660(02)47004-6; Peixoto AA, 1998, GENETICS, V148, P827; Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040; Pinho C, 2010, ANNU REV ECOL EVOL S, V41, P215, DOI 10.1146/annurev-ecolsys-102209-144644; Pinto IS, 2010, J MED ENTOMOL, V47, P16, DOI 10.1603/033.047.0102; Ritchie MG, 1998, ANIM BEHAV, V56, P713, DOI 10.1006/anbe.1998.0799; Ritchie MG, 1999, ANIM BEHAV, V58, P649, DOI 10.1006/anbe.1999.1167; Saarikettu M, 2005, BEHAV GENET, V35, P257, DOI 10.1007/s10519-005-3218-z; Sant'Anna MRV, 2008, INSECT BIOCHEM MOLEC, V38, P652, DOI 10.1016/j.ibmb.2008.03.012; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Souza NA, 2004, J MED ENTOMOL, V41, P906, DOI 10.1603/0022-2585-41.5.906; Souza NA, 2008, MEM I OSWALDO CRUZ, V103, P216, DOI 10.1590/S0074-02762008000200017; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vigoder FM, 2010, INFECT GENET EVOL, V10, P734, DOI 10.1016/j.meegid.2010.05.004; Ward RD, 1988, BIOSYSTEMATICS HAEMA, P258; Warren B, 2009, CURR BIOL, V19, P485, DOI 10.1016/j.cub.2009.01.059; Watts PC, 2005, AM J TROP MED HYG, V73, P734, DOI 10.4269/ajtmh.2005.73.734; Wen SY, 2011, ZOOL SCI, V28, P469, DOI 10.2108/zsj.28.469; Woerner AE, 2007, BIOINFORMATICS, V23, P1851, DOI 10.1093/bioinformatics/btm253; Yin HZ, 1999, MED VET ENTOMOL, V13, P72, DOI 10.1046/j.1365-2915.1999.00139.x	59	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44323	10.1371/journal.pone.0044323	http://dx.doi.org/10.1371/journal.pone.0044323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970200	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000018
J	Cook, M; Mani, P; Wentzell, JS; Kretzschmar, D				Cook, Mandy; Mani, Priya; Wentzell, Jill S.; Kretzschmar, Doris			Increased RhoA Prenylation in the loechrig (loe) Mutant Leads to Progressive Neurodegeneration	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; RAS-LIKE GTPASES; DROSOPHILA-MELANOGASTER; NEURITE OUTGROWTH; CELL; ISOPRENOIDS; ENERGY; INHIBITION; EXPRESSION; REDUCTASE	The Drosophila mutant loechrig (loe) shows age-dependent degeneration of the nervous system and is caused by the loss of a neuronal isoform of the AMP-activated protein kinase (AMPK) c-subunit (also known as SNF4Ac). The trimeric AMPK complex is activated by low energy levels and metabolic insults and regulates multiple important signal pathways that control cell metabolism. A well-known downstream target of AMPK is hydroxyl-methylglutaryl-CoA reductase (HMGR), a key enzyme in isoprenoid synthesis, and we have previously shown that HMGR genetically interacts with loe and affects the severity of the degenerative phenotype. Prenylation of proteins like small G-proteins is an important posttranslational modification providing lipid moieties that allow the association of these proteins with membranes, thereby facilitating their subsequent activation. Rho proteins have been extensively studied in neuronal outgrowth, however, much less is known about their function in neuronal maintenance. Here we show that the loe mutation interferes with isoprenoid synthesis, leading to increased prenylation of the small GTPase Rho1, the fly orthologue of vertebrate RhoA. We also demonstrate that increased prenylation and Rho1 activity causes neurodegeneration and aggravates the behavioral and degenerative phenotypes of loe. Because we cannot detect defects in the development of the central nervous system in loe, this suggests that loe only interferes with the function of the RhoA pathway in maintaining neuronal integrity during adulthood. In addition, our results show that alterations in isoprenoids can result in progressive neurodegeneration, supporting findings in vertebrates that prenylation may play a role in neurodegenerative diseases like Alzheimer's Disease.	[Cook, Mandy; Mani, Priya; Wentzell, Jill S.; Kretzschmar, Doris] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA	Oregon Health & Science University	Cook, M (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA.	kretzsch@ohsu.edu		kretzschmar, doris/0000-0002-0519-2377	National Institutes of Health [P30NS061800]; Alzheimer Forschung Initiative e.V.; Medical Research Foundation of Oregon; Oregon Tax Check-off program (on Aging & Alzheimer's Disease Center - Oregon Partnership); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Forschung Initiative e.V.; Medical Research Foundation of Oregon; Oregon Tax Check-off program (on Aging & Alzheimer's Disease Center - Oregon Partnership); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by National Institutes of Health grant P30NS061800, Alzheimer Forschung Initiative e. V. (www.alzheimer-forschung.de), Medical Research Foundation of Oregon (www. ohsu.edu/xd/about/foundation/./medical-research-foundation), and the Oregon Tax Check-off program (on Aging & Alzheimer's Disease Center - Oregon Partnership for ...www.ohsu.edu/xd/research/centers./tax-checkoff-giving.cfm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND AH, 1993, DEVELOPMENT, V118, P401; Burwinkel B, 2005, AM J HUM GENET, V76, P1034, DOI 10.1086/430840; CARLSON CA, 1973, J BIOL CHEM, V248, P378; Cole SL, 2006, NEUROBIOL DIS, V22, P209, DOI 10.1016/j.nbd.2005.11.007; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Holstein SA, 2004, LIPIDS, V39, P293, DOI 10.1007/s11745-004-1233-3; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Kretzschmar D, 2005, GLIA, V49, P59, DOI 10.1002/glia.20098; KRETZSCHMAR D, 1992, EMBO J, V11, P2531, DOI 10.1002/j.1460-2075.1992.tb05318.x; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Mirouse V, 2007, J CELL BIOL, V177, P387, DOI 10.1083/jcb.200702053; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Novelli G, 2012, J INHERIT METAB DIS; ORGAD S, 1987, EUR J BIOCHEM, V164, P31, DOI 10.1111/j.1432-1033.1987.tb10988.x; Ostrowski SM, 2007, J BIOL CHEM, V282, P26832, DOI 10.1074/jbc.M702640200; Pedrini S, 2005, PLOS MED, V2, P69, DOI 10.1371/journal.pmed.0020018; Samuel F, 2010, MOL NEUROBIOL, V42, P133, DOI 10.1007/s12035-010-8144-2; Santos AC, 2004, DEV CELL, V6, P283, DOI 10.1016/S1534-5807(04)00023-1; Seabra MC, 1998, CELL SIGNAL, V10, P167, DOI 10.1016/S0898-6568(97)00120-4; Spasic MR, 2008, J NEUROSCI, V28, P6419, DOI 10.1523/JNEUROSCI.1646-08.2008; Spindler SR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039581; Spradling AC, 1999, GENETICS, V153, P135; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Swanson TL, 2005, DEV BIOL, V288, P160, DOI 10.1016/j.ydbio.2005.09.029; Tschape JA, 2002, EMBO J, V21, P6367, DOI 10.1093/emboj/cdf636; Tschape JA, 2003, J NEURAL TRANSM-SUPP, P51; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; Woo S, 2006, J NEUROSCI, V26, P1418, DOI 10.1523/JNEUROSCI.4209-05.2006; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154	39	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44440	10.1371/journal.pone.0044440	http://dx.doi.org/10.1371/journal.pone.0044440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970217	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400070
J	Lose, F; Srinivasan, S; O'Mara, T; Marquart, L; Chambers, S; Gardiner, RA; Aitken, JF; Spurdle, AB; Batra, J; Clements, JA				Lose, Felicity; Srinivasan, Srilakshmi; O'Mara, Tracy; Marquart, Louise; Chambers, Suzanne; Gardiner, Robert A.; Aitken, Joanne F.; Spurdle, Amanda B.; Batra, Jyotsna; Clements, Judith A.		Australian Prostate Canc BioResour	Genetic Association of the KLK4 Locus with Risk of Prostate Cancer	PLOS ONE			English	Article							ANDROGEN RECEPTOR; SERINE-PROTEASE; HUMAN GENOME; KALLIKREIN-4; EXPRESSION; TISSUES; ANTIGEN; POLYMORPHISMS; PROMOTER; HEALTHY	The Kallikrein-related peptidase, KLK4, has been shown to be significantly overexpressed in prostate tumours in numerous studies and is suggested to be a potential biomarker for prostate cancer. KLK4 may also play a role in prostate cancer progression through its involvement in epithelial-mesenchymal transition, a more aggressive phenotype, and metastases to bone. It is well known that genetic variation has the potential to affect gene expression and/or various protein characteristics and hence we sought to investigate the possible role of single nucleotide polymorphisms (SNPs) in the KLK4 gene in prostate cancer. Assessment of 61 SNPs in the KLK4 locus (+/- 610 kb) in approximately 1300 prostate cancer cases and 1300 male controls for associations with prostate cancer risk and/or prostate tumour aggressiveness Gleason score <7 versus >= 7) revealed 7 SNPs to be associated with a decreased risk of prostate cancer at the P-trend<0.05 significance level. Three of these SNPs, rs268923, rs56112930 and the HapMap tagSNP rs7248321, are located several kb upstream of KLK4; rs1654551 encodes a non-synonymous serine to alanine substitution at position 22 of the long isoform of the KLK4 protein, and the remaining 3 risk-associated SNPs, rs1701927, rs1090649 and rs806019, are located downstream of KLK4 and are in high linkage disequilibrium with each other (r(2)>= 0.98). Our findings provide suggestive evidence of a role for genetic variation in the KLK4 locus in prostate cancer predisposition.	[Lose, Felicity; O'Mara, Tracy; Spurdle, Amanda B.; Batra, Jyotsna] Queensland Inst Med Res, Genet & Populat Hlth Div, Mol Canc Epidemiol Grp, Brisbane, Qld 4006, Australia; [Srinivasan, Srilakshmi; O'Mara, Tracy; Clements, Judith A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Australian Prostate Canc Res Ctr Queensland, Brisbane, Qld 4001, Australia; [Marquart, Louise] Queensland Inst Med Res, Stat Unit, Brisbane, Qld 4006, Australia; [Chambers, Suzanne; Aitken, Joanne F.] Griffith Univ, Griffith Hlth Inst, Brisbane, Qld 4111, Australia; [Chambers, Suzanne; Aitken, Joanne F.] Canc Council Queensland, Viertel Ctr Canc Res, Brisbane, Qld, Australia; [Chambers, Suzanne; Gardiner, Robert A.] Univ Queensland, Royal Brisbane Hosp, Clin Res Ctr, Brisbane, Qld, Australia; [Lose, Felicity; Spurdle, Amanda B.; Australian Prostate Canc BioResour] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia	QIMR Berghofer Medical Research Institute; Queensland University of Technology (QUT); QIMR Berghofer Medical Research Institute; Griffith University; Menzies Health Institute Queensland; Cancer Council Queensland; Royal Brisbane & Women's Hospital; University of Queensland; Queensland University of Technology (QUT)	Lose, F (corresponding author), Queensland Inst Med Res, Genet & Populat Hlth Div, Mol Canc Epidemiol Grp, 300 Herston Rd, Brisbane, Qld 4006, Australia.	jyotsna.batra@qut.edu.au	O'Mara, Tracy/M-7508-2016; Batra, Jyotsna/B-4130-2011; Marquart-Wilson, Louise/CAI-1964-2022; Spurdle, Amanda B/A-4978-2011; Srilakshmi, Srinivasan/AAR-5334-2021; Samaratunga, Hemamali M L/D-1559-2013; Chambers, Suzanne K/H-5957-2012	O'Mara, Tracy/0000-0002-5436-3232; Spurdle, Amanda B/0000-0003-1337-7897; Samaratunga, Hemamali M L/0000-0001-5796-1791; Chambers, Suzanne K/0000-0003-2369-6111; Marquart, Louise/0000-0003-4607-9060; Clements, Judith/0000-0001-6026-1964; Lose, Felicity/0000-0001-8337-3547; batra, Jyotsna/0000-0003-4646-6247; Aitken, Joanne Frances/0000-0001-6859-2186	National Health and Medical Research Council (Early Career Fellowship); National Health and Medical Research Council (Career Development Award); National Health and Medical Research Council (Senior Research Fellowship); National Health and Medical Research Council (Principal Research Fellowship); National Health and Medical Research Council [390130, 614296]; Prostate Cancer Foundation of Australia [PG7]; Research infrastructure grant; Cancer Council Queensland, Prostate Cancer Research Program; Queensland Government Smart State award; Australian Postgraduate Award; Institute of Health and Biomedical Innovation	National Health and Medical Research Council (Early Career Fellowship)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (Career Development Award)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (Senior Research Fellowship)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council (Principal Research Fellowship)(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Prostate Cancer Foundation of Australia; Research infrastructure grant; Cancer Council Queensland, Prostate Cancer Research Program(Cancer Council Queensland); Queensland Government Smart State award; Australian Postgraduate Award(Australian Government); Institute of Health and Biomedical Innovation(National Institute of Biomedical Innovation)	This work was supported by the National Health and Medical Research Council (Early Career Fellowship [to JB], Career Development Award [to SC], Senior Research Fellowship [to ABS], Principal Research Fellowship [to JAC], Project Grant [390130] and Enabling Grant [614296 to Australian Prostate Cancer BioResource]; the Prostate Cancer Foundation of Australia (Project Grant [PG7] and Research infrastructure grant [to Australian Prostate Cancer BioResource]); The Cancer Council Queensland, Prostate Cancer Research Program [to SC]; Queensland Government Smart State award [to TO]; Australian Postgraduate Award [to SS and TO]; and the Institute of Health and Biomedical Innovation [to JB, SS and TO]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2002, TFSEARCH SEARCHING T; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Amigo J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-428; Avgeris M, 2011, PROSTATE, V71, P1780, DOI 10.1002/pros.21395; Baade PD, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-452; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Catalona WJ, 2011, J UROLOGY, V185, P1650, DOI 10.1016/j.juro.2010.12.032; Ciampa J, 2011, CANCER RES, V71, P3287, DOI 10.1158/0008-5472.CAN-10-2646; Day CH, 2002, ONCOGENE, V21, P7114, DOI 10.1038/sj.onc.1205786; Dong Y, 2005, ENDOCR-RELAT CANCER, V12, P875, DOI 10.1677/erc.1.01062; Eeles R, 2008, NAT GENET, V40, P1035, DOI 10.1038/ng0908-1035; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Gao J, 2007, PROSTATE, V67, P348, DOI 10.1002/pros.20465; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Goard CA, 2007, MOL ONCOL, V1, P303, DOI 10.1016/j.molonc.2007.09.001; Gonzalez MI, 2001, J BIOL CHEM, V276, P6420, DOI 10.1074/jbc.M008689200; Grabe N., 2000, ALIBABA2 1; Gronberg H, 2003, LANCET, V361, P859, DOI 10.1016/S0140-6736(03)12713-4; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hindorff L. A., 2010, CATALOG PUBLISHED GE; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kaushal A, 2008, PROSTATE, V68, P381, DOI 10.1002/pros.20685; Klein RJ, 2010, CANCER PREV RES, V3, P611, DOI 10.1158/1940-6207.CAPR-09-0206; Klokk TI, 2007, CANCER RES, V67, P5221, DOI 10.1158/0008-5472.CAN-06-4728; Kote-Jarai Z, 2011, HUM GENET, V129, P687, DOI 10.1007/s00439-011-0981-1; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Kurlender L, 2005, BBA-REV CANCER, V1755, P1, DOI 10.1016/j.bbcan.2005.02.001; Lai J, 2007, CARCINOGENESIS, V28, P1032, DOI 10.1093/carcin/bgl236; Lai J, 2009, MOL CANCER RES, V7, P129, DOI 10.1158/1541-7786.MCR-08-0218; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; Lee JY, 2009, CARCINOGENESIS, V30, P1528, DOI 10.1093/carcin/bgp084; Lose F., 2011, UROL ONCOL; Lose F, 2010, GYNECOL ONCOL, V119, P479, DOI 10.1016/j.ygyno.2010.08.014; Mavridis K, 2010, FUTURE ONCOL, V6, P269, DOI 10.2217/FON.09.149; Mikolajczyk SD, 2001, CANCER RES, V61, P6958; Mize GJ, 2008, MOL CANCER RES, V6, P1043, DOI 10.1158/1541-7786.MCR-08-0096; Nelson PS, 1999, P NATL ACAD SCI USA, V96, P3114, DOI 10.1073/pnas.96.6.3114; Obiezu CV, 2005, CLIN CHEM, V51, P1432, DOI 10.1373/clinchem.2005.049692; Obiezu CV, 2002, CLIN CHEM, V48, P1232; Obinata D, 2012, INT J CANCER, V130, P1021, DOI 10.1002/ijc.26043; Riva A, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-33; Seiz L, 2010, BIOL CHEM, V391, P391, DOI 10.1515/BC.2010.033; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Veveris-Lowe TL, 2005, ENDOCR-RELAT CANCER, V12, P631, DOI 10.1677/erc.1.00958; Wilkinson R, 2012, CANCER IMMUNOL IMMUN, V61, P169, DOI 10.1007/s00262-011-1095-2; Xi ZJ, 2004, CANCER RES, V64, P2365, DOI 10.1158/0008-5472.CAN-03-2025; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Yousef GM, 1999, CANCER RES, V59, P4252; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44520	10.1371/journal.pone.0044520	http://dx.doi.org/10.1371/journal.pone.0044520			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970239	Green Submitted, Green Published, gold			2022-12-25	WOS:000308458400083
J	Paini, DR; Yemshanov, D				Paini, Dean R.; Yemshanov, Denys			Modelling the Arrival of Invasive Organisms via the International Marine Shipping Network: A Khapra Beetle Study	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; SPREAD; SENSITIVITY; DISPERSAL; INTRODUCTIONS; TRANSPORT; THREAT; ERA; MAP	Species can sometimes spread significant distances beyond their natural dispersal ability by anthropogenic means. International shipping routes and the transport of shipping containers, in particular are a commonly recognised pathway for the introduction of invasive species. Species can gain access to a shipping container and remain inside, hidden and undetected for long periods. Currently, government biosecurity agencies charged with intercepting and removing these invasive species when they arrive to a county's border only assess the most immediate point of loading in evaluating a shipping container's risk profile. However, an invasive species could have infested a container previous to this point and travelled undetected before arriving at the border. To assess arrival risk for an invasive species requires analysing the international shipping network in order to identify the most likely source countries and the domestic ports of entry where the species is likely to arrive. We analysed an international shipping network and generated pathway simulations using a first-order Markov chain model to identify possible source ports and countries for the arrival of Khapra beetle (Trogoderma granarium) to Australia. We found Kaohsiung (Taiwan) and Busan (Republic of Korea) to be the most likely sources for Khapra beetle arrival, while the port of Melbourne was the most likely point of entry to Australia. Sensitivity analysis revealed significant stability in the rankings of foreign and Australian ports. This methodology provides a reliable modelling tool to identify and rank possible sources for an invasive species that could arrive at some time in the future. Such model outputs can be used by biosecurity agencies concerned with inspecting incoming shipping containers and wishing to optimise their inspection protocols.	[Paini, Dean R.] Cooperat Res Ctr Natl Plant Biosecur, Bruce, Australia; [Paini, Dean R.] CSIRO, Ecosyst Sci, Acton, Australia; [Yemshanov, Denys] Great Lakes Forestry Ctr, Canada Canadian Forest Serv, Sault Ste Marie, ON, Canada	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Natural Resources Canada; Canadian Forest Service; Great Lakes Forestry Centre	Paini, DR (corresponding author), Cooperat Res Ctr Natl Plant Biosecur, Bruce, Australia.	Dean.Paini@csiro.au	Paini, Dean R/C-2341-2009		Cooperative Research Corporation for National Plant Biosecurity [CRC 10161]; Australian Government's Cooperative Research Centres Program	Cooperative Research Corporation for National Plant Biosecurity(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centres Program(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by the Cooperative Research Corporation for National Plant Biosecurity (http://www.crcplantbiosecurity.com.au/), CRC 10161. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DRP acknowledges the support of the Australian Government's Cooperative Research Centres Program. We extend our thanks to Peter Caley and Tom Harwood for comments on earlier versions of the manuscript; Marty Siltanen and Kirsty Wilson for technical diligence with preparing the data and help with running the pathway model simulations. Thanks also go to the Australian Federal Department of Agriculture, Fisheries and Forestry for providing the shipping network data.	Allen EA, 2002, CAN J PLANT PATHOL, V24, P103, DOI 10.1080/07060660309506983; Andrews CI, 2004, RISK ANAL, V24, P1323, DOI 10.1111/j.0272-4332.2004.00529.x; BELL CH, 1994, J STORED PROD RES, V30, P99, DOI 10.1016/0022-474X(94)90189-9; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; Bossenbroek JM, 2001, ECOL APPL, V11, P1778, DOI 10.2307/3061095; BRASIER CM, 1973, NATURE, V242, P607, DOI 10.1038/242607a0; Buchan LAJ, 1999, ECOL APPL, V9, P254, DOI 10.2307/2641184; CABI CPC, 2011, CAB INT CROP PROT CO; Cook DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026084; Cook DC, 2011, AUST J AGR RESOUR EC, V55, P599, DOI 10.1111/j.1467-8489.2011.00558.x; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Global Invasive Species Database, 2012, GLOBAL INVASIVE SPEC; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hayes KR, 2003, MAR POLLUT BULL, V46, P91, DOI 10.1016/S0025-326X(02)00321-1; HendersonSellers B, 1996, ECOL MODEL, V86, P291, DOI 10.1016/0304-3800(95)00066-6; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Hurlock ET, 1961, PEST TECHNOL, V3, P144; IMO, 2011, INT SHIPP FACTS FIG; Kaluza Pablo, 2010, J R Soc Interface, V7, P1093, DOI 10.1098/rsif.2009.0495; Kammer F, 2005, LECT NOTES COMPUT SC, V3418, P143; Keller RP, 2011, DIVERS DISTRIB, V17, P93, DOI 10.1111/j.1472-4642.2010.00696.x; Kiritani Keizi, 2003, P44; Koch FH, 2011, BIOL INVASIONS, V13, P969, DOI 10.1007/s10530-010-9883-8; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Li HB, 2006, SCALING AND UNCERTAINTY ANALYSIS IN ECOLOGY: METHODS AND APPLICATIONS, P45; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Melbourne BA, 2009, SCIENCE, V325, P1536, DOI 10.1126/science.1176138; Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Paini DR, 2010, J APPL ECOL, V47, P290, DOI 10.1111/j.1365-2664.2010.01782.x; Pitt JPW, 2009, ECOL APPL, V19, P1176, DOI 10.1890/08-1777.1; Plant Health Australia, 2005, IND BIOS PLAN GRAINS; Prasad AM, 2010, LANDSCAPE ECOL, V25, P353, DOI 10.1007/s10980-009-9434-9; Ridsell-Smith J, 2008, IMPACT EXOTIC PEST I; Swartzman G. L., 1987, ECOLOGICAL SIMULATIO; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; Tatem AJ, 2007, P ROY SOC B-BIOL SCI, V274, P1489, DOI 10.1098/rspb.2007.0148; Walker W.E., 2003, INTEGRATED ASSESSMEN, DOI [10.1076/iaij.4.1.5.16466, 10.1076/iaij, DOI 10.1076/IAIJ, DOI 10.1076/IAIJ.4.1.5.16466]; Wasserman S, 1994, SOCIAL NETWORK ANAL; Webster J, 2008, PINE WILT DISEASE: A WORLDWIDE THREAT TO FOREST ECOSYSTEMS, P1; Yemshanov D, 2012, BIOL INVASIONS, V14, P797, DOI 10.1007/s10530-011-0117-5; Yemshanov D, 2012, DIVERS DISTRIB, V18, P33, DOI 10.1111/j.1472-4642.2011.00848.x	43	29	29	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44589	10.1371/journal.pone.0044589	http://dx.doi.org/10.1371/journal.pone.0044589			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970258	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400092
J	Zhao, RY; Mifsud, NA; Xiao, K; Chan, KF; Oveissi, S; Jackson, HM; Dimopoulos, N; Guillaume, P; Knights, AJ; Lowen, T; Robson, NC; Russell, SE; Scotet, E; Davis, ID; Maraskovsky, E; Cebon, J; Luescher, IF; Chen, WS				Zhao, Rona Y.; Mifsud, Nicole A.; Xiao, Kun; Chan, Kok-Fei; Oveissi, Sara; Jackson, Heather M.; Dimopoulos, Nektaria; Guillaume, Philippe; Knights, Ashley J.; Lowen, Tamara; Robson, Neil C.; Russell, Sarah E.; Scotet, Emmanuel; Davis, Ian D.; Maraskovsky, Eugene; Cebon, Jonathan; Luescher, Immanuel F.; Chen, Weisan			A Novel HLA-B18 Restricted CD8+T Cell Epitope Is Efficiently Cross-Presented by Dendritic Cells from Soluble Tumor Antigen	PLOS ONE			English	Article							CD8(+) T-CELLS; NEWLY SYNTHESIZED PROTEINS; HUMAN-MALIGNANT-MELANOMA; IMMUNODOMINANCE HIERARCHY; ISCOMATRIX ADJUVANT; STANDARD PROTEASOME; NY-ESO-1 PROTEIN; SURFACE ANTIGENS; UP-REGULATION; IN-VIVO	NY-ESO-1 has been a major target of many immunotherapy trials because it is expressed by various cancers and is highly immunogenic. In this study, we have identified a novel HLA-B*1801-restricted CD8(+) T cell epitope, NY-ESO-1(88-96) (LEFYLAMPF) and compared its direct- and cross-presentation to that of the reported NY-ESO-1(157-165) epitope restricted to HLA-A*0201. Although both epitopes were readily cross-presented by DCs exposed to various forms of full-length NY-ESO-1 antigen, remarkably NY-ESO-1(88-96) is much more efficiently cross-presented from the soluble form, than NY-ESO-1(157-165). On the other hand, NY-ESO-1(157-165) is efficiently presented by NY-ESO-1-expressing tumor cells and its presentation was not enhanced by IFN-gamma treatment, which induced immunoproteasome as demonstrated by Western blots and functionally a decreased presentation of Melan A(26-35); whereas NY-ESO-1(88-96) was very inefficiently presented by the same tumor cell lines, except for one that expressed high level of immunoproteasome. It was only presented when the tumor cells were first IFN-gamma treated, followed by infection with recombinant vaccinia virus encoding NY-ESO-1, which dramatically increased NY-ESO-1 expression. These data indicate that the presentation of NY-ESO-1(88-96) is immunoproteasome dependent. Furthermore, a survey was conducted on multiple samples collected from HLA-B18(+) melanoma patients. Surprisingly, all the detectable responses to NY-ESO-1(88-96) from patients, including those who received NY-ESO-1 ISCOMATRIX (TM) vaccine were induced spontaneously. Taken together, these results imply that some epitopes can be inefficiently presented by tumor cells although the corresponding CD8(+) T cell responses are efficiently primed in vivo by DCs cross-presenting these epitopes. The potential implications for cancer vaccine strategies are further discussed.	[Zhao, Rona Y.; Mifsud, Nicole A.; Xiao, Kun; Chan, Kok-Fei; Oveissi, Sara; Jackson, Heather M.; Dimopoulos, Nektaria; Knights, Ashley J.; Lowen, Tamara; Robson, Neil C.; Russell, Sarah E.; Davis, Ian D.; Cebon, Jonathan; Chen, Weisan] Austin Hlth, Melbourne Austin Branch, Ludwig Inst Canc Res, Heidelberg, Vic, Australia; [Guillaume, Philippe; Luescher, Immanuel F.] Ludwig Inst Canc Res, Lausanne Branch, Lausanne, Switzerland; [Scotet, Emmanuel] Inst Biol, Nantes, France; [Maraskovsky, Eugene] CSL Ltd, Parkville, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Ludwig Institute for Cancer Research; Ludwig Institute for Cancer Research; CSL	Zhao, RY (corresponding author), Austin Hlth, Melbourne Austin Branch, Ludwig Inst Canc Res, Heidelberg, Vic, Australia.	weisan.chen@latrobe.edu.au	Oveissi, Sara/W-9426-2019; SCOTET, Emmanuel/L-2576-2015; SCOTET, Emmanuel/AAC-9971-2019; Cebon, Jonathan S/H-1643-2013; Chen, Weisan/E-7828-2012; Davis, Ian D/A-1430-2012	Oveissi, Sara/0000-0002-7353-5108; SCOTET, Emmanuel/0000-0001-8010-9556; SCOTET, Emmanuel/0000-0001-8010-9556; Chen, Weisan/0000-0002-5221-9771; Davis, Ian D/0000-0002-9066-8244; Cebon, Jonathan/0000-0002-3898-950X; Mifsud, Nicole/0000-0001-8647-2102	NHMRC [433608, 542508, 603104]; Cancer Council Victoria grant [381409]; Victorian Cancer Agency Clinician Researcher Fellowship	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria grant(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Victorian Cancer Agency Clinician Researcher Fellowship	This project was partly supported by the NHMRC project grants 433608 and 542508, and the Cancer Council Victoria grant 381409 to WC. WC is an NHMRC Senior Research Fellow (603104). IDD is supported in part by a Victorian Cancer Agency Clinician Researcher Fellowship and is an Honorary Practitioner Fellow of the Australian National Health and Medical Research Council (NHMRC). JC is an NHMRC Practitioner Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; Ahmad M, 2004, CANCER IMMUNOL IMMUN, V53, P844, DOI 10.1007/s00262-004-0540-x; Burgdorf S, 2008, NAT IMMUNOL, V9, P558, DOI 10.1038/ni.1601; CAREY TE, 1976, P NATL ACAD SCI USA, V73, P3278, DOI 10.1073/pnas.73.9.3278; Chapatte L, 2006, CANCER RES, V66, P5461, DOI 10.1158/0008-5472.CAN-05-4310; Chapiro J, 2006, J IMMUNOL, V176, P1053, DOI 10.4049/jimmunol.176.2.1053; Chen W, 2004, J IMMUNOL, V173, P5021, DOI 10.4049/jimmunol.173.8.5021; Chen WS, 2006, ADV CANCER RES, V95, P203, DOI 10.1016/S0065-230X(06)95006-4; Chen WS, 2001, J EXP MED, V193, P1319, DOI 10.1084/jem.193.11.1319; Chiodoni C, 1999, J EXP MED, V190, P125, DOI 10.1084/jem.190.1.125; Crowe SR, 2003, J EXP MED, V198, P399, DOI 10.1084/jem.20022151; Dannull J, 2007, BLOOD, V110, P4341, DOI 10.1182/blood-2007-04-083188; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; den Haan JMM, 2001, CURR OPIN IMMUNOL, V13, P437, DOI 10.1016/S0952-7915(00)00238-7; Dimopoulos N, 2009, J IMMUNOL METHODS, V340, P90, DOI 10.1016/j.jim.2008.09.023; DIPPOLD WG, 1980, P NATL ACAD SCI-BIOL, V77, P6114, DOI 10.1073/pnas.77.10.6114; Donohue KB, 2006, IMMUNOLOGY, V119, P63, DOI 10.1111/j.1365-2567.2006.02406.x; Dutoit V, 2002, J CLIN INVEST, V110, P1813, DOI 10.1172/JCI200216428; Ebert LM, 2009, CANCER RES, V69, P1046, DOI 10.1158/0008-5472.CAN-08-2926; Fonsatti E, 2007, CLIN CANCER RES, V13, P3333, DOI 10.1158/1078-0432.CCR-06-3091; GACZYNSKA M, 1993, ENZYME PROTEIN, V47, P354, DOI 10.1159/000468693; Jackson H, 2006, J IMMUNOL, V176, P5908, DOI 10.4049/jimmunol.176.10.5908; Jackson HM, 2004, J IMMUNOL METHODS, V291, P51, DOI 10.1016/j.jim.2004.04.017; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Kammertoens T, 2005, TRENDS MOL MED, V11, P225, DOI 10.1016/j.molmed.2005.03.002; Macagno A, 2001, EUR J IMMUNOL, V31, P3271, DOI 10.1002/1521-4141(200111)31:11<3271::AID-IMMU3271>3.0.CO;2-2; Maraskovsky E, 2004, CLIN CANCER RES, V10, P2879, DOI 10.1158/1078-0432.CCR-03-0245; Melief CJM, 2003, EUR J IMMUNOL, V33, P2645, DOI 10.1002/eji.200324341; Morel S, 2000, IMMUNITY, V12, P107, DOI 10.1016/S1074-7613(00)80163-6; Murphy R, 2005, PREP BIOCHEM BIOTECH, V35, P119, DOI 10.1081/PB-200054732; Nicholaou T, 2009, CLIN CANCER RES, V15, P2166, DOI 10.1158/1078-0432.CCR-08-2484; Norbury CC, 2004, SCIENCE, V304, P1318, DOI 10.1126/science.1096378; Ochsenbein AF, 2001, NATURE, V411, P1058, DOI 10.1038/35082583; Odunsi K, 2003, CANCER RES, V63, P6076; Pang KC, 2006, J IMMUNOL, V177, P7680, DOI 10.4049/jimmunol.177.11.7680; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Robson NC, 2010, BLOOD, V116, P218, DOI 10.1182/blood-2009-10-249458; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; Schnurr M, 2005, BLOOD, V105, P2465, DOI 10.1182/blood-2004-08-3105; Schreiber H, 2002, SEMIN CANCER BIOL, V12, P25, DOI 10.1006/scbi.2001.0401; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Schultz ES, 2002, J EXP MED, V195, P391, DOI 10.1084/jem.20011974; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; Strehl B, 2005, IMMUNOL REV, V207, P19, DOI 10.1111/j.0105-2896.2005.00308.x; Sugita Y, 2004, CANCER RES, V64, P2199, DOI 10.1158/0008-5472.CAN-03-3070; Toes REM, 2001, J EXP MED, V194, P1, DOI 10.1084/jem.194.1.1; TOWNSEND SE, 1993, SCIENCE, V259, P368, DOI 10.1126/science.7678351; VANKAER L, 1994, IMMUNITY, V1, P533, DOI 10.1016/1074-7613(94)90043-4; Wang HY, 2004, IMMUNITY, V20, P107, DOI 10.1016/S1074-7613(03)00359-5	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44707	10.1371/journal.pone.0044707	http://dx.doi.org/10.1371/journal.pone.0044707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970293	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000308458400108
J	Bridier, A; Sanchez-Vizuete, MD; Le Coq, D; Aymerich, S; Meylheuc, T; Maillard, JY; Thomas, V; Dubois-Brissonnet, F; Briandet, R				Bridier, Arnaud; Sanchez-Vizuete, Maria del Pilar; Le Coq, Dominique; Aymerich, Stephane; Meylheuc, Thierry; Maillard, Jean-Yves; Thomas, Vincent; Dubois-Brissonnet, Florence; Briandet, Romain			Biofilms of a Bacillus subtilis Hospital Isolate Protect Staphylococcus aureus from Biocide Action	PLOS ONE			English	Article							BACTERIAL BIOFILMS; LISTERIA-MONOCYTOGENES; SPECIES BIOFILMS; RESISTANCE; CONTAMINATION; INFECTION; OUTBREAK; AGENTS; PENETRATION; GLYCOCALYX	The development of a biofilm constitutes a survival strategy by providing bacteria a protective environment safe from stresses such as microbicide action and can thus lead to important health-care problems. In this study, biofilm resistance of a Bacillus subtilis strain (called hereafter NDmedical) recently isolated from endoscope washer-disinfectors to peracetic acid was investigated and its ability to protect the pathogen Staphylococcus aureus in mixed biofilms was evaluated. Biocide action within Bacillus subtilis biofilms was visualised in real time using a non-invasive 4D confocal imaging method. The resistance of single species and mixed biofilms to peracetic acid was quantified using standard plate counting methods and their architecture was explored using confocal imaging and electronic microscopy. The results showed that the NDmedical strain demonstrates the ability to make very large amount of biofilm together with hyper-resistance to the concentration of PAA used in many formulations (3500 ppm). Evidences strongly suggest that the enhanced resistance of the NDmedical strain was related to the specific three-dimensional structure of the biofilm and the large amount of the extracellular matrix produced which can hinder the penetration of peracetic acid. When grown in mixed biofilm with Staphylococcus aureus, the NDmedical strain demonstrated the ability to protect the pathogen from PAA action, thus enabling its persistence in the environment. This work points out the ability of bacteria to adapt to an extremely hostile environment, and the necessity of considering multi-organism ecosystems instead of single species model to decipher the mechanisms of biofilm resistance to antimicrobials agents.	[Bridier, Arnaud; Sanchez-Vizuete, Maria del Pilar; Le Coq, Dominique; Aymerich, Stephane; Meylheuc, Thierry; Dubois-Brissonnet, Florence; Briandet, Romain] INRA, UMR MICALIS 1319, Jouy En Josas, France; [Bridier, Arnaud; Sanchez-Vizuete, Maria del Pilar; Le Coq, Dominique; Aymerich, Stephane; Meylheuc, Thierry; Dubois-Brissonnet, Florence; Briandet, Romain] AgroParisTech, UMR MICALIS, Jouy En Josas, France; [Le Coq, Dominique] CNRS, Jouy En Josas, France; [Maillard, Jean-Yves] Cardiff Univ, Welsh Sch Pharm, Cardiff, S Glam, Wales; [Thomas, Vincent] STERIS, Fontenay Aux Roses, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Cardiff University	Bridier, A (corresponding author), INRA, UMR MICALIS 1319, Jouy En Josas, France.	romain.briandet@jouy.inra.fr	Maillard, Jean-Yves/N-4113-2014; Thomas, Vincent/A-8941-2012; Thomas, Vincent/AAB-8982-2019; Thomas, Vincent/AAB-6394-2022; Briandet, Romain/AAD-2102-2020; bridier, arnaud/D-7183-2013	Maillard, Jean-Yves/0000-0002-8617-9288; Thomas, Vincent/0000-0003-4034-9525; Thomas, Vincent/0000-0003-4034-9525; Briandet, Romain/0000-0002-8123-3492; bridier, arnaud/0000-0003-4812-3301; Le Coq, Dominique/0000-0001-5756-2280; Dubois-Brissonnet, Florence/0000-0003-2998-7518; Bridier, Arnaud/0000-0002-7221-8944	Medicen, Ile-de-France, competitiveness cluster; National Institute for Agronomic Research; Essonne department	Medicen, Ile-de-France, competitiveness cluster; National Institute for Agronomic Research; Essonne department	This project was funded by the Medicen, Ile-de-France, competitiveness cluster and the National Institute for Agronomic Research. Financial support of the confopcal microscope was provided by the the Essonne department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Branda SS, 2006, MOL MICROBIOL, V59, P1229, DOI 10.1111/j.1365-2958.2005.05020.x; Branda SS, 2004, J BACTERIOL, V186, P3970, DOI 10.1128/JB.186.12.3970-3979.2004; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Bridier A, 2011, BIOFOULING, V27, P1017, DOI 10.1080/08927014.2011.626899; Bridier A, 2011, ANTIMICROB AGENTS CH, V55, P2648, DOI 10.1128/AAC.01760-10; Bridier A, 2010, J MICROBIOL METH, V82, P64, DOI 10.1016/j.mimet.2010.04.006; Bridier A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016177; Burmolle M, 2006, APPL ENVIRON MICROB, V72, P3916, DOI 10.1128/AEM.03022-05; Cooper IR, 2010, J HOSP INFECT, V74, P152, DOI 10.1016/j.jhin.2009.07.005; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DEBEER D, 1994, APPL ENVIRON MICROB, V60, P4339, DOI 10.1128/AEM.60.12.4339-4344.1994; Deva AK, 1998, J HOSP INFECT, V39, P149, DOI 10.1016/S0195-6701(98)90329-2; DiazGranados CA, 2009, INFECT CONT HOSP EP, V30, P550, DOI 10.1086/597235; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Erlandsen SL, 2004, J HISTOCHEM CYTOCHEM, V52, P1427, DOI 10.1369/jhc.4A6428.2004; Fassel TA, 1999, METHOD ENZYMOL, V310, P194; Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Gardam M A, 2000, Can J Infect Dis, V11, P202; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Grobe KJ, 2002, J IND MICROBIOL BIOT, V29, P10, DOI 10.1038/sj.jim.7000256; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Ito A, 2009, APPL ENVIRON MICROB, V75, P4093, DOI 10.1128/AEM.02949-08; Jang A, 2006, APPL MICROBIOL BIOT, V72, P368, DOI 10.1007/s00253-005-0274-5; Kara D, 2006, EUR J ORAL SCI, V114, P58, DOI 10.1111/j.1600-0722.2006.00262.x; Kressel AB, 2001, INFECT CONT HOSP EP, V22, P414, DOI 10.1086/501926; Lee RM, 1998, GASTROINTEST ENDOSC, V47, P377, DOI 10.1016/S0016-5107(98)70222-6; Leriche V, 2003, ENVIRON MICROBIOL, V5, P64, DOI 10.1046/j.1462-2920.2003.00394.x; Machado Alexandre P., 2006, Arq. Gastroenterol., V43, P255, DOI 10.1590/S0004-28032006000400002; Malone CL, 2009, J MICROBIOL METH, V77, P251, DOI 10.1016/j.mimet.2009.02.011; Martin DJH, 2008, J HOSP INFECT, V69, P377, DOI 10.1016/j.jhin.2008.04.010; Pan Y, 2006, APPL ENVIRON MICROB, V72, P7711, DOI 10.1128/AEM.01065-06; Perl TM, 1998, ANN PHARMACOTHER, V32, pS7, DOI 10.1177/106002809803200104; Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Romling U, 2004, CELLULOSE, V11, P413, DOI 10.1023/B:CELL.0000046411.74345.8f; Rutala WA, 2004, J HOSP INFECT, V56, pS27, DOI 10.1016/j.jhin.2003.12.035; Shemesh M, 2010, J BACTERIOL, V192, P6352, DOI 10.1128/JB.01025-10; Simoes LC, 2010, APPL ENVIRON MICROB, V76, P6673, DOI 10.1128/AEM.00872-10; Simoes M, 2009, WATER RES, V43, P229, DOI 10.1016/j.watres.2008.10.010; SPACH DH, 1993, ANN INTERN MED, V118, P117, DOI 10.7326/0003-4819-118-2-199301150-00008; Srinivasan A, 2003, NEW ENGL J MED, V348, P221, DOI 10.1056/NEJMoa021808; van der Veen S, 2011, INT J FOOD MICROBIOL, V144, P421, DOI 10.1016/j.ijfoodmicro.2010.10.029; 1997, 1040 NF EN AFNOR	48	74	74	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44506	10.1371/journal.pone.0044506	http://dx.doi.org/10.1371/journal.pone.0044506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973457	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000308577600064
J	Wang, K; Yang, ZF; Liu, X; Mao, K; Nair, U; Klionsky, DJ				Wang, Ke; Yang, Zhifen; Liu, Xu; Mao, Kai; Nair, Usha; Klionsky, Daniel J.			Phosphatidylinositol 4-Kinases Are Required for Autophagic Membrane Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; SELECTIVE AUTOPHAGY; BUDDING YEAST; GENE ENCODES; PATHWAYS; PROTEIN; GOLGI; MITOPHAGY; TRANSPORT	Macroautophagy (hereafter autophagy) is a degradative cellular pathway that protects eukaryotic cells from stress, starvation, and microbial infection. This process must be tightly controlled because too little or too much autophagy can be deleterious to cellular physiology. The phosphatidylinositol (PtdIns) 3-kinase Vps34 is a lipid kinase that regulates autophagy, but the role of other PtdIns kinases has not been examined. Here we demonstrate a role for PtdIns 4-kinases and PtdIns4P 5-kinases in selective and nonselective types of autophagy in yeast. The PtdIns 4-kinase Pik1 is involved in Atg9 trafficking through the Golgi and is involved in both nonselective and selective types of autophagy, whereas the PtdIns4P 5-kinase Mss4 is specifically involved in mitophagy but not nonselective autophagy. Our data indicate that phosphoinositide kinases have multiple roles in the regulation of autophagic pathways.	[Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Cellular Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Dev Biol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Klionsky, DJ (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	klionsky@umich.edu			National Institutes of Health [GM053396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM053396 (to D. J. K.).	Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Audhya A, 2002, DEV CELL, V2, P593, DOI 10.1016/S1534-5807(02)00168-5; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Cao Y, 2007, AUTOPHAGY, V3, P17, DOI 10.4161/auto.3371; Desrivieres S, 1998, J BIOL CHEM, V273, P15787, DOI 10.1074/jbc.273.25.15787; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Ferguson CJ, 2009, HUM MOL GENET, V18, P4868, DOI 10.1093/hmg/ddp460; Geng JF, 2010, MOL BIOL CELL, V21, P2257, DOI 10.1091/mbc.E09-11-0969; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hama H, 1999, J BIOL CHEM, V274, P34294, DOI 10.1074/jbc.274.48.34294; Han GS, 2002, J BIOL CHEM, V277, P47709, DOI 10.1074/jbc.M207996200; He CC, 2007, AUTOPHAGY, V3, P271, DOI 10.4161/auto.3912; He CC, 2008, MOL BIOL CELL, V19, P5506, DOI 10.1091/mbc.E08-05-0544; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; Ho CY, 2012, TRAFFIC, V13, P1, DOI 10.1111/j.1600-0854.2011.01246.x; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kanki T, 2010, AUTOPHAGY, V6, P278, DOI 10.4161/auto.6.2.10901; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Klionsky DJ, 2011, AUTOPHAGY, V7, P1273, DOI 10.4161/auto.7.11.17661; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; Labbe S, 1999, METHOD ENZYMOL, V306, P145; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Manjithaya R, 2010, J CELL BIOL, V189, P303, DOI 10.1083/jcb.200909154; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Mari M, 2010, J CELL BIOL, V190, P1005, DOI 10.1083/jcb.200912089; Monastyrska I, 2008, MOL BIOL CELL, V19, P1962, DOI 10.1091/mbc.E07-09-0892; Nair U, 2011, CELL, V146, P290, DOI 10.1016/j.cell.2011.06.022; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Reggiori F, 2005, MOL BIOL CELL, V16, P5843, DOI 10.1091/mbc.E05-07-0629; Reggiori F, 2004, DEV CELL, V6, P79, DOI 10.1016/S1534-5807(03)00402-7; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Shahnazari S, 2010, CELL HOST MICROBE, V8, P137, DOI 10.1016/j.chom.2010.07.002; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Strahl T, 2005, J CELL BIOL, V171, P967, DOI 10.1083/jcb.200504104; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; van der Vaart A, 2010, MOL BIOL CELL, V21, P2270, DOI 10.1091/mbc.E09-04-0345; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yamashita SI, 2006, J CELL BIOL, V173, P709, DOI 10.1083/jcb.200512142; YOSHIDA S, 1994, J BIOL CHEM, V269, P1166	45	50	53	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.371591	http://dx.doi.org/10.1074/jbc.M112.371591			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977244	Green Published, hybrid			2022-12-25	WOS:000310642200031
J	Kim, C; Milheirico, C; Gardete, S; Holmes, MA; Holden, MTG; de Lencastre, H; Tomasz, A				Kim, Choonkeun; Milheirico, Catarina; Gardete, Susana; Holmes, Mark A.; Holden, Matt T. G.; de Lencastre, Herminia; Tomasz, Alexander			Properties of a Novel PBP2A Protein Homolog from Staphylococcus aureus Strain LGA251 and Its Contribution to the beta-Lactam-resistant Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENICILLIN-BINDING PROTEINS; METHICILLIN-RESISTANT; CELL-WALL; STREPTOCOCCUS-PNEUMONIAE; MECA GENE; ANTIBIOTICS; CEFTOBIPROLE; CEFTAROLINE; EXPRESSION; AFFINITY	Methicillin-resistant Staphylococcus aureus (MRSA) strains show strain-to-strain variation in resistance level, in genetic background, and also in the structure of the chromosomal cassette (SCCmec) that carries the resistance gene mecA. In contrast, strain-to-strain variation in the sequence of the mecA determinant was found to be much more limited among MRSA isolates examined so far. The first exception to this came with the recent identification of MRSA strain LGA251, which carries a new homolog of this gene together with regulatory elements mecI/mecR that also have novel, highly divergent structures. After cloning and purification in Escherichia coli, PBP2A(LGA), the protein product of the new mecA homolog, showed aberrant mobility in SDS-PAGE, structural instability and loss of activity at 37 degrees C, and a higher relative affinity for oxacillin as compared with cefoxitin. The mecA homolog free of its regulatory elements was cloned into a plasmid and introduced into the background of the beta-lactam-susceptible S. aureus strain COL-S. In this background, the mecA homolog expressed a high-level resistance to cefoxitin (MIC = 400 mu g/ml) and a somewhat lower resistance to oxacillin (minimal inhibitory concentration = 200 mu g/ml). Similar to PBP2A, the protein homolog PBP2A(LGA) was able to replace the essential function of the S. aureus PBP2 for growth. In contrast to PBP2A, PBP2A(LGA) did not depend on the transglycosylase activity of the native PBP2 for expression of high level resistance to oxacillin, suggesting that the PBP2A homolog may preferentially cooperate with a monofunctional transglycosylase as the alternative source of transglycosylase activity.	[Kim, Choonkeun; Gardete, Susana; de Lencastre, Herminia; Tomasz, Alexander] Rockefeller Univ, Lab Microbiol & Infect Dis, New York, NY 10065 USA; [Milheirico, Catarina; Gardete, Susana; de Lencastre, Herminia] Univ Nova Lisboa, Mol Genet Lab, Inst Tecnol Quim & Biol, P-2780 Oeiras, Portugal; [Holmes, Mark A.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [Holden, Matt T. G.] Wellcome Trust Sanger Inst, Cambridge CB10 1RQ, England	Rockefeller University; Universidade Nova de Lisboa; University of Cambridge; Wellcome Trust Sanger Institute	Tomasz, A (corresponding author), Rockefeller Univ, Lab Microbiol & Infect Dis, 1230 York Ave, New York, NY 10065 USA.	tomasz@rockefeller.edu	Holden, Matthew TG/K-6449-2014; /AAT-3815-2021	Holden, Matthew TG/0000-0002-4958-2166; Holmes, Mark/0000-0002-5454-1625; /0000-0001-6816-8932; Milheirico, Catarina/0000-0002-2825-8850; Tomasz, Alexander/0000-0003-1520-1983; Kim, Choon/0000-0003-0306-8935	United States Public Health Service Grant [2 RO1 AI457838-13]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [PEst-OE/EQB/LA0004/2011]; FCT [SFRH/BPD/63992/2009, SFRH/BPD/25403/2005]; Palm Beach Infectious Disease Institute, Florida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045738] Funding Source: NIH RePORTER; Medical Research Council [G1001787] Funding Source: researchfish; MRC [G1001787] Funding Source: UKRI	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Palm Beach Infectious Disease Institute, Florida; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Partial support for this work was provided by United States Public Health Service Grant 2 RO1 AI457838-13 (to A. T.). This work was also supported by Fundacao para a Ciencia e Tecnologia (FCT) project PEst-OE/EQB/LA0004/2011, Portugal; by FCT Grants SFRH/BPD/63992/2009 (to C. M.) and SFRH/BPD/25403/2005 (to S. G.); and by a fellowship from the Palm Beach Infectious Disease Institute, Florida.	Antignac A, 2009, ANTIMICROB AGENTS CH, V53, P435, DOI 10.1128/AAC.01099-08; CHAMBERS HF, 1990, J INFECT DIS, V161, P1170, DOI 10.1093/infdis/161.6.1170; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Chung M, 2008, ANTIMICROB AGENTS CH, V52, P2709, DOI 10.1128/AAC.00266-08; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; Davies TA, 2007, ANTIMICROB AGENTS CH, V51, P2621, DOI 10.1128/AAC.00029-07; DELENCASTRE H, 1991, ANTIMICROB AGENTS CH, V35, P632, DOI 10.1128/AAC.35.4.632; Figueiredo TA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002508; Fuda C, 2006, J BIOL CHEM, V281, P10035, DOI 10.1074/jbc.M508846200; Fuda C, 2004, J BIOL CHEM, V279, P40802, DOI 10.1074/jbc.M403589200; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Gardete S, 2006, MICROBIOL-SGM, V152, P2549, DOI 10.1099/mic.0.29078-0; Gardete S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002505; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; HARTMAN BJ, 1986, ANTIMICROB AGENTS CH, V29, P85, DOI 10.1128/AAC.29.1.85; Ito T, 1999, ANTIMICROB AGENTS CH, V43, P1449, DOI 10.1128/AAC.43.6.1449; JEVONS MP, 1961, BRIT MED J, V1, P124, DOI 10.1136/bmj.1.5219.124-a; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kosowska-Shick K, 2010, ANTIMICROB AGENTS CH, V54, P1670, DOI 10.1128/AAC.00019-10; KRAEMER GR, 1990, CURR MICROBIOL, V21, P373, DOI 10.1007/BF02199440; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lovering AL, 2007, SCIENCE, V315, P1402, DOI 10.1126/science.1136611; Moisan H, 2010, J ANTIMICROB CHEMOTH, V65, P713, DOI 10.1093/jac/dkp503; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; OSHIDA T, 1992, J BACTERIOL, V174, P4952, DOI 10.1128/JB.174.15.4952-4959.1992; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Pereira SFF, 2007, J BACTERIOL, V189, P3525, DOI 10.1128/JB.00044-07; Pinho MG, 2001, P NATL ACAD SCI USA, V98, P10886, DOI 10.1073/pnas.191260798; Pinho MG, 2001, J BACTERIOL, V183, P6525, DOI 10.1128/JB.183.22.6525-6531.2001; Reed P, 2011, J BACTERIOL, V193, P2549, DOI 10.1128/JB.01474-10; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Wu SW, 2001, J BACTERIOL, V183, P2417, DOI 10.1128/JB.183.8.2417-2424.2001; Zhao GS, 1999, ANTIMICROB AGENTS CH, V43, P1124, DOI 10.1128/AAC.43.5.1124; Zhou YJ, 2008, J BACTERIOL, V190, P508, DOI 10.1128/JB.01549-07	36	91	97	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36854	36863		10.1074/jbc.M112.395962	http://dx.doi.org/10.1074/jbc.M112.395962			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977239	Green Published, hybrid			2022-12-25	WOS:000310588500022
J	Rogers, H; Wang, L; Yu, XB; Alnaeeli, M; Cui, KR; Zhao, KJ; Bieker, JJ; Prchal, J; Huang, SM; Weksler, B; Noguchi, CT				Rogers, Heather; Wang, Li; Yu, Xiaobing; Alnaeeli, Mawadda; Cui, Kairong; Zhao, Keji; Bieker, James J.; Prchal, Josef; Huang, Suming; Weksler, Babette; Noguchi, Constance Tom			T-cell Acute Leukemia 1 (TAL1) Regulation of Erythropoietin Receptor and Association with Excessive Erythrocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTOR GATA-1; ERYTHROID-CELLS; HEMATOPOIETIC DEVELOPMENT; FAMILIAL ERYTHROCYTOSIS; CHROMATIN OCCUPANCY; OXYGEN HOMEOSTASIS; POLYCYTHEMIA-VERA; GENE-EXPRESSION; POSITIVE ROLE	During erythropoiesis, erythropoietin stimulates induction of erythroid transcription factors that activate expression of erythroid genes including the erythropoietin receptor (EPO-R) that results in increased sensitivity to erythropoietin. DNA binding of the basic helix-loop-helix transcription factor, TAL1/SCL, is required for normal erythropoiesis. A link between elevated TAL1 and excessive erythrocytosis is suggested by erythroid progenitor cells from a patient that exhibits unusually high sensitivity to erythropoietin with concomitantly elevated TAL1 and EPO-R expression. We found that TAL1 regulates EPO-R expression mediated via three conserved E-box binding motifs (CAGCTG) in the EPO-R 5' untranslated transcribed region. TAL1 increases association of the GATA-1.TAL1.LMO2.LDB1 transcription activation complex to the region that includes the transcription start site and the 5' GATA and 3' E-box motifs flanking the EPO-R transcription start site suggesting that TAL1 promotes accessibility of this region. Nucleosome shifting has been demonstrated to facilitate TAL1 but not GATA-1 binding to regulate target gene expression. Accordingly, we observed that with induced expression of EPO-R in hemotopoietic progenitor cells, nucleosome phasing shifts to increase the linker region containing the EPO-R transcription start site and TAL1 binds to the flanking 5' GATA and 3' E-box regions of the promoter. These data suggest that TAL1 binds to the EPO-R promoter to activate EPO-R expression and provides a potential link to elevated EPO-R expression leading to hypersensitivity to erythropoietin and the resultant excessive erythrocytosis.	[Rogers, Heather; Wang, Li; Yu, Xiaobing; Alnaeeli, Mawadda; Noguchi, Constance Tom] NIDDK, Mol Med Branch, Bethesda, MD 20892 USA; [Cui, Kairong; Zhao, Keji] NHLBI, NIH, Lab Mol Immunol, Bethesda, MD 20892 USA; [Bieker, James J.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Prchal, Josef] Univ Utah, Div Hematol, Salt Lake City, UT 84132 USA; [Prchal, Josef] VAH, Salt Lake City, UT 84132 USA; [Huang, Suming] Univ Florida, Coll Med, Dept Biochem & Mol Biol, Gainesville, FL USA; [Huang, Suming] Univ Florida, Coll Med, Shands Canc Ctr, Gainesville, FL USA; [Weksler, Babette] Cornell Univ, Weill Med Coll, Div Hematol Oncol, New York, NY 10065 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Icahn School of Medicine at Mount Sinai; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Cornell University	Noguchi, CT (corresponding author), Bldg 10,Rm 9N319,10 Ctr Dr,MSC 1822, Bethesda, MD 20892 USA.	connien@helix.nih.gov	cheng, yong/I-4270-2012		National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL CANCER INSTITUTE [P01CA108671] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006030, ZIAHL006031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025061, R01DK046865] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the NIDDK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the NIDDK.	Agarwal N, 2007, ADV EXP MED BIOL, V618, P195; Anderson KP, 2000, BLOOD, V95, P1652, DOI 10.1182/blood.V95.5.1652.005k23_1652_1655; Ang SO, 2002, NAT GENET, V32, P614, DOI 10.1038/ng1019; [Anonymous], SCI; Aplan PD, 2006, TRENDS GENET, V22, P46, DOI 10.1016/j.tig.2005.10.002; APLAN PD, 1992, BLOOD, V79, P1327; Arcasoy MO, 1999, EXP HEMATOL, V27, P63, DOI 10.1016/S0301-472X(98)00003-4; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bockamp EO, 1997, J BIOL CHEM, V272, P8781, DOI 10.1074/jbc.272.13.8781; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; CHIN K, 1995, NUCLEIC ACIDS RES, V23, P3041, DOI 10.1093/nar/23.15.3041; Delabesse E, 2005, MOL CELL BIOL, V25, P5215, DOI 10.1128/MCB.25.12.5215-5225.2005; Elefanty AG, 1997, BLOOD, V90, P1435, DOI 10.1182/blood.V90.4.1435.1435_1435_1447; Fernandez LA, 2001, MOL CELL BIOL, V21, P196, DOI 10.1128/MCB.21.1.196-208.2001; Fibach E, 1998, HEMOGLOBIN, V22, P445, DOI 10.3109/03630269809071542; Fine BM, 2004, BLOOD, V103, P1043, DOI 10.1182/blood-2003-05-1518; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Gottgens B, 2002, EMBO J, V21, P3039, DOI 10.1093/emboj/cdf286; Hall MA, 2005, MOL CELL BIOL, V25, P6355, DOI 10.1128/MCB.25.15.6355-6362.2005; Hu GQ, 2011, GENOME RES, V21, P1650, DOI 10.1101/gr.121145.111; Hu X, 2009, EPIGENETICS-US, V4, P257, DOI 10.4161/epi.4.6.9711; Hu X, 2009, P NATL ACAD SCI USA, V106, P10141, DOI 10.1073/pnas.0900437106; Huang S, 2000, MOL CELL BIOL, V20, P2248, DOI 10.1128/MCB.20.6.2248-2259.2000; Huang SM, 2000, EMBO J, V19, P6792, DOI 10.1093/emboj/19.24.6792; Ismailoglu I, 2008, EXP HEMATOL, V36, P1593, DOI 10.1016/j.exphem.2008.07.005; Kassouf MT, 2008, BLOOD, V112, P1056, DOI 10.1182/blood-2007-12-128900; Kassouf MT, 2010, GENOME RES, V20, P1064, DOI 10.1101/gr.104935.110; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Meier N, 2006, DEVELOPMENT, V133, P4913, DOI 10.1242/dev.02656; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; NOGUCHI CT, 1991, BLOOD, V78, P2548; Nussenzveig RH, 2007, EXP HEMATOL, V35, P32, DOI 10.1016/j.exphem.2006.11.012; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Percy MJ, 2006, P NATL ACAD SCI USA, V103, P654, DOI 10.1073/pnas.0508423103; Pope NJ, 2010, NUCLEIC ACIDS RES, V38, P2190, DOI 10.1093/nar/gkp1159; Ravet E, 2004, BLOOD, V103, P3326, DOI 10.1182/blood-2003-05-1689; Rogers HM, 2008, EXP HEMATOL, V36, P17, DOI 10.1016/j.exphem.2007.08.014; Russell LJ, 2009, LEUKEMIA, V23, P614, DOI 10.1038/leu.2008.250; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schuh AH, 2005, MOL CELL BIOL, V25, P10235, DOI 10.1128/MCB.25.23.10235-10250.2005; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Sengupta T, 2009, P NATL ACAD SCI USA, V106, P4213, DOI 10.1073/pnas.0808347106; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Vyas P, 1999, DEVELOPMENT, V126, P2799; Wang L, 2012, J BIOL CHEM, V287, P30157, DOI 10.1074/jbc.M112.376640; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Xu ZX, 2003, MOL CELL BIOL, V23, P7585, DOI 10.1128/MCB.23.21.7585-7599.2003; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10638, DOI 10.1073/pnas.88.23.10638	53	10	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36720	36731		10.1074/jbc.M112.378398	http://dx.doi.org/10.1074/jbc.M112.378398			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22982397	Green Published, hybrid			2022-12-25	WOS:000310588500010
J	Bogie, JFJ; Timmermans, S; Van, AHT; Irrthum, A; Smeets, HJM; Gustafsson, JA; Steffensen, KR; Mulder, M; Stinissen, P; Hellings, N; Hendriks, JJA				Bogie, Jeroen F. J.; Timmermans, Silke; Van Anh Huynh-Thu; Irrthum, Alexandre; Smeets, Hubert J. M.; Gustafsson, Jan-Ake; Steffensen, Knut R.; Mulder, Monique; Stinissen, Piet; Hellings, Niels; Hendriks, Jerome J. A.			Myelin-Derived Lipids Modulate Macrophage Activity by Liver X Receptor Activation	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; INTERACTING PROTEIN KINASE-2; MULTIPLE-SCLEROSIS LESIONS; HIGH-DENSITY-LIPOPROTEINS; CHOLESTEROL EFFLUX; CELLULAR CHOLESTEROL; NUCLEAR RECEPTORS	Multiple sclerosis is a chronic, inflammatory, demyelinating disease of the central nervous system in which macrophages and microglia play a central role. Foamy macrophages and microglia, containing degenerated myelin, are abundantly found in active multiple sclerosis lesions. Recent studies have described an altered macrophage phenotype after myelin internalization. However, it is unclear by which mechanisms myelin affects the phenotype of macrophages and how this phenotype can influence lesion progression. Here we demonstrate, by using genome wide gene expression analysis, that myelin-phagocytosing macrophages have an enhanced expression of genes involved in migration, phagocytosis and inflammation. Interestingly, myelin internalization also induced the expression of genes involved in liver-X-receptor signaling and cholesterol efflux. In vitro validation shows that myelin-phagocytosing macrophages indeed have an increased capacity to dispose intracellular cholesterol. In addition, myelin suppresses the secretion of the pro-inflammatory mediator IL-6 by macrophages, which was mediated by activation of liver-X-receptor beta. Our data show that myelin modulates the phenotype of macrophages by nuclear receptor activation, which may subsequently affect lesion progression in demyelinating diseases such as multiple sclerosis.	[Bogie, Jeroen F. J.; Timmermans, Silke; Stinissen, Piet; Hellings, Niels; Hendriks, Jerome J. A.] Hasselt Univ Transnat Univ Limburg, Biomed Res Inst, Sch Life Sci, Diepenbeek, Belgium; [Van Anh Huynh-Thu] Univ Liege, GIGA Res Bioinformat & Modeling, Liege, Belgium; [Irrthum, Alexandre] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium; [Smeets, Hubert J. M.] Maastricht UMC, Sch Cardiovasc Res, Dept Genet Celbiol, Maastricht, Netherlands; [Smeets, Hubert J. M.] Maastricht UMC, Sch Oncol & Dev Biol, Dept Genet Celbiol, Maastricht, Netherlands; [Gustafsson, Jan-Ake; Steffensen, Knut R.] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Mulder, Monique] Rotterdam Univ, Dept Internal Med, Div Pharmacol Vasc & Metab Dis, Rotterdam, Netherlands	Hasselt University; University of Liege; University of Liege; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Maastricht University Medical Centre (MUMC); Karolinska Institutet; Erasmus University Rotterdam	Bogie, JFJ (corresponding author), Hasselt Univ Transnat Univ Limburg, Biomed Res Inst, Sch Life Sci, Diepenbeek, Belgium.	Jerome.hendriks@uhasselt.be	HELLINGS, Niels/AAS-5033-2020; Hendriks, Jerome J/C-7698-2013	Hendriks, Jerome J/0000-0002-7717-8582; Stinissen, Piet/0000-0002-4830-4084; Steffensen, Knut/0000-0001-6093-2801; Hellings, Niels/0000-0003-2308-406X	Agentschap voor Innovatie van Wetenschap en Technology (IWT); Fonds Wetenschappelijk Onderzoek (FWO); transnational University Limburg; Limburg Sterk Merk and Alma-in-Silico [EMR INT4.-1.3.-2008-03/003]; Interuniversity Attraction Poles Programme [IAP P6/25 BIOMAGNET]; European Network of Excellence PASCAL2; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.)	Agentschap voor Innovatie van Wetenschap en Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fonds Wetenschappelijk Onderzoek (FWO)(FWO); transnational University Limburg; Limburg Sterk Merk and Alma-in-Silico; Interuniversity Attraction Poles Programme(Belgian Federal Science Policy Office); European Network of Excellence PASCAL2; Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by Agentschap voor Innovatie van Wetenschap en Technology (IWT), Fonds Wetenschappelijk Onderzoek (FWO), transnational University Limburg, Limburg Sterk Merk and Alma-in-Silico (EMR INT4.-1.3.-2008-03/003). This work was partially funded by the Interuniversity Attraction Poles Programme (IAP P6/25 BIOMAGNET), initiated by the Belgian State, Science Policy Office, by the French Community of Belgium (ARC Biomod), and by the European Network of Excellence PASCAL2. VAHT is recipient of a Fonds pour la formation a la Recherche dans l'Industrie et dans l'Agriculture (F.R.I.A.) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Alfaro C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017922; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; Barnett MH, 2006, MULT SCLER, V12, P121, DOI 10.1191/135248506ms1304rr; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bjorkhem I, 2004, ARTERIOSCL THROM VAS, V24, P806, DOI 10.1161/01.ATV.0000120374.59826.1b; Bogie JFJ, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-85; Boven LA, 2006, BRAIN, V129, P517, DOI 10.1093/brain/awh707; BROSNAN CF, 1981, J IMMUNOL, V126, P614; CANNELLA B, 1995, ANN NEUROL, V37, P424, DOI 10.1002/ana.410370404; Castano T, 2009, CHEMMEDCHEM, V4, P866, DOI 10.1002/cmdc.200900043; Castrillo A, 2003, J BIOL CHEM, V278, P10443, DOI 10.1074/jbc.M213071200; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Cui GL, 2011, J CLIN INVEST, V121, P658, DOI 10.1172/JCI42974; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; de Vos AF, 2002, J IMMUNOL, V169, P5415, DOI 10.4049/jimmunol.169.10.5415; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Espinosa JM, 2001, MOL CELL, V8, P57, DOI 10.1016/S1097-2765(01)00283-0; Essayan DM, 1999, BIOCHEM PHARMACOL, V57, P965, DOI 10.1016/S0006-2952(98)00331-1; Flavin MP, 1997, NEUROSCIENCE, V80, P437, DOI 10.1016/S0306-4522(97)00078-X; Fox R, 2007, EMBO J, V26, P505, DOI 10.1038/sj.emboj.7601522; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Giorelli M, 2007, EXP NEUROL, V204, P759, DOI 10.1016/j.expneurol.2007.01.013; Gitik M, 2010, FASEB J, V24, P2211, DOI 10.1096/fj.09-146118; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Gredler V, 2010, CLIN IMMUNOL, V134, P296, DOI 10.1016/j.clim.2009.11.003; Guo RF, 2004, SHOCK, V21, P1, DOI 10.1097/01.shk.0000105502.75189.5e; Hellings N, 2002, IMMUNOL RES, V25, P27, DOI 10.1385/IR:25:1:27; Hendriks JJA, 2008, J NEUROIMMUNOL, V204, P52, DOI 10.1016/j.jneuroim.2008.07.015; Hendriks JJA, 2005, BRAIN RES REV, V48, P185, DOI 10.1016/j.brainresrev.2004.12.008; Hindinger C, 2006, J NEUROSCI RES, V84, P1225, DOI 10.1002/jnr.21038; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; HUITINGA I, 1995, CLIN EXP IMMUNOL, V100, P344; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Jeyakumar M, 2002, NEUROPATH APPL NEURO, V28, P343, DOI 10.1046/j.1365-2990.2002.00422.x; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Jou I, 2006, AM J PATHOL, V168, P1619, DOI 10.2353/ajpath.2006.050924; Kadl A, 2010, CIRC RES, V107, P737, DOI 10.1161/CIRCRESAHA.109.215715; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Lai Y, 2011, INT J BIOL SCI, V7, P782, DOI 10.7150/ijbs.7.782; Liu Y, 2006, J NEUROSCI, V26, P12904, DOI 10.1523/JNEUROSCI.2531-06.2006; Matsumoto T, 1997, J LEUKOCYTE BIOL, V62, P581, DOI 10.1002/jlb.62.5.581; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Miller Elzbieta, 2009, Pol Merkur Lekarski, V27, P499; Mosley K, 1996, NEUROCHEM RES, V21, P481, DOI 10.1007/BF02527713; Nelissen K, 2010, J NEUROSCI METH, V187, P78, DOI 10.1016/j.jneumeth.2009.12.018; NORTON WT, 1973, J NEUROCHEM, V21, P759, DOI 10.1111/j.1471-4159.1973.tb07520.x; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Ogden CA, 2005, AUTOIMMUNITY, V38, P259, DOI 10.1080/08916930500124452; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Oram JF, 1996, J LIPID RES, V37, P2473; Papenfuss Tracey L, 2007, ScientificWorldJournal, V7, P112; Park EJ, 2007, SHOCK, V28, P112, DOI 10.1097/SHK.0b013e3180310fec; Paterniti I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015937; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; PIANI D, 1991, NEUROSCI LETT, V133, P159, DOI 10.1016/0304-3940(91)90559-C; Pineau I, 2007, J COMP NEUROL, V500, P267, DOI 10.1002/cne.21149; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Robinson S, 1999, DEV BIOL, V216, P359, DOI 10.1006/dbio.1999.9466; SELMAJ K, 1991, J CLIN INVEST, V87, P949, DOI 10.1172/JCI115102; Smith JD, 2004, J LIPID RES, V45, P635, DOI 10.1194/jlr.M300336-JLR200; Smythies LE, 2006, J LEUKOCYTE BIOL, V80, P492, DOI 10.1189/jlb.1005566; Sordi V, 2006, TRANSPLANTATION, V82, P826, DOI 10.1097/01.tp.0000235433.03554.4f; Sun X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009380; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; Valledor AF, 2005, IMMUNOBIOLOGY, V210, P127, DOI 10.1016/j.imbio.2005.05.007; van Rossum D, 2008, GLIA, V56, P271, DOI 10.1002/glia.20611; van Zwam M, 2010, J NEUROIMMUNOL, V225, P112, DOI 10.1016/j.jneuroim.2010.04.021; van Zwam M, 2009, J MOL MED, V87, P273, DOI 10.1007/s00109-008-0421-4; vanderLaan LJW, 1996, J NEUROIMMUNOL, V70, P145, DOI 10.1016/S0165-5728(96)00110-5; Vanderlocht J, 2007, CRIT REV IMMUNOL, V27, P1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vaughan AM, 2005, J BIOL CHEM, V280, P30150, DOI 10.1074/jbc.M505368200; Vega FM, 2011, J CELL BIOL, V193, P655, DOI 10.1083/jcb.201011038; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; Weinstein SL, 2000, J LEUKOCYTE BIOL, V67, P405, DOI 10.1002/jlb.67.3.405; WILLIAMS K, 1994, J NEUROSCI RES, V38, P433, DOI 10.1002/jnr.490380409; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xu JH, 2009, J LEUKOCYTE BIOL, V86, P401, DOI 10.1189/jlb.1008600; Zhang YH, 2006, AM J PHYSIOL-RENAL, V290, pF1065, DOI 10.1152/ajprenal.00131.2005; Zhang Z, 2011, J NEUROIMMUNOL, V237, P73, DOI 10.1016/j.jneuroim.2011.06.006	92	44	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44998	10.1371/journal.pone.0044998	http://dx.doi.org/10.1371/journal.pone.0044998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984598	gold, Green Published			2022-12-25	WOS:000308738500104
J	Cardozo, BL; Crawford, CG; Eriksson, C; Zhu, J; Sabin, M; Ager, A; Foy, D; Snider, L; Scholte, W; Kaiser, R; Olff, M; Rijnen, B; Simon, W				Cardozo, Barbara Lopes; Crawford, Carol Gotway; Eriksson, Cynthia; Zhu, Julia; Sabin, Miriam; Ager, Alastair; Foy, David; Snider, Leslie; Scholte, Willem; Kaiser, Reinhard; Olff, Miranda; Rijnen, Bas; Simon, Winnifred			Psychological Distress, Depression, Anxiety, and Burnout among International Humanitarian Aid Workers: A Longitudinal Study	PLOS ONE			English	Article							HOPKINS SYMPTOM CHECKLIST-25; MENTAL-HEALTH; SUPPORT	Background: International humanitarian aid workers providing care in emergencies are subjected to numerous chronic and traumatic stressors. Objectives: To examine consequences of such experiences on aid workers' mental health and how the impact is influenced by moderating variables. Methodology: We conducted a longitudinal study in a sample of international non-governmental organizations. Study outcomes included anxiety, depression, burnout, and life and job satisfaction. We performed bivariate regression analyses at three time points. We fitted generalized estimating equation multivariable regression models for the longitudinal analyses. Results: Study participants from 19 NGOs were assessed at three time points: 212 participated at pre-deployment; 169 (80%) post-deployment; and 154 (73%) within 3-6 months after deployment. Prior to deployment, 12 (3.8%) participants reported anxiety symptoms, compared to 20 (11.8%) at post-deployment (p = 0.0027); 22 (10.4%) reported depression symptoms, compared to 33 (19.5%) at post-deployment (p = 0.0117) and 31 (20.1%) at follow-up (p = .00083). History of mental illness (adjusted odds ratio [AOR] 4.2; 95% confidence interval [CI] 1.45-12.50) contributed to an increased risk for anxiety. The experience of extraordinary stress was a contributor to increased risk for burnout depersonalization (AOR 1.5; 95% CI 1.17-1.83). Higher levels of chronic stress exposure during deployment were contributors to an increased risk for depression (AOR 1.1; 95% CI 1.02-1.20) comparing post-versus pre-deployment, and increased risk for burnout emotional exhaustion (AOR 1.1; 95% CI 1.04-1.19). Social support was associated with lower levels of depression (AOR 0.9; 95% CI 0.84-0.95), psychological distress (AOR = 0.9; [CI] 0.85-0.97), burnout lack of personal accomplishment (AOR 0.95; 95% CI 0.91-0.98), and greater life satisfaction (p = 0.0213). Conclusions: When recruiting and preparing aid workers for deployment, organizations should consider history of mental illness and take steps to decrease chronic stressors, and strengthen social support networks.	[Cardozo, Barbara Lopes; Sabin, Miriam; Kaiser, Reinhard] Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Int Emergency & Refugee Hlth Branch, Atlanta, GA USA; [Crawford, Carol Gotway; Zhu, Julia] Ctr Dis Control & Prevent CDC, Off Surveillance Epidemiol & Lab Serv, Atlanta, GA USA; [Scholte, Willem; Olff, Miranda] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Foy, David] Pepperdine Univ, Malibu, CA 90265 USA; [Eriksson, Cynthia] Fuller Theol Seminary, Pasadena, CA 91101 USA; [Snider, Leslie] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Ager, Alastair; Rijnen, Bas; Simon, Winnifred] Antares Fdn, Amsterdam, Netherlands	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Amsterdam; Academic Medical Center Amsterdam; Pepperdine University; Tulane University	Cardozo, BL (corresponding author), Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Int Emergency & Refugee Hlth Branch, Atlanta, GA USA.	bhc8@cdc.gov	Scholte, Willem/AAJ-1088-2020; Olff, Miranda/S-6235-2019	Olff, Miranda/0000-0003-1016-9515; Sabin, Miriam/0000-0002-7758-8338; Ager, Alastair/0000-0002-9474-3563	Antares Foundation	Antares Foundation	This study was funded by the Antares Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ager A., 1999, APPL PSYCHOL, P226; AMIRKHAN JH, 1994, J PERS ASSESS, V62, P242, DOI 10.1207/s15327752jpa6202_6; Bliese PD, 1996, J APPL SOC PSYCHOL, V26, P1171, DOI 10.1111/j.1559-1816.1996.tb02291.x; Brayfield AH, 1951, J APPL PSYCHOL, V35, P307, DOI 10.1037/h0055617; Cardozo BL, 2005, DISASTERS, V29, P152, DOI 10.1111/j.0361-3666.2005.00278.x; Centers for Disease Control and Prevention, 2010, BEH RISK FACT SURV S; Coyne JC, 2000, J CONSULT CLIN PSYCH, V68, P864, DOI 10.1037/0022-006X.68.5.864; CUTRONA CE, 1989, J PERS SOC PSYCHOL, V57, P723, DOI 10.1037/0022-3514.57.4.723; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Ehrenreich JH, 2001, COPING DISASTERS GUI; Eriksson C. B., 2003, STRESS TRAUMA HDB ST, P68; Eriksson CB, 2001, J TRAUMA STRESS, V14, P205, DOI 10.1023/A:1007804119319; Eriksson CB, 2012, TRAUMATOLOGY; Goldberg R, 1996, ACAD EMERG MED, V3, P1156, DOI 10.1111/j.1553-2712.1996.tb03379.x; HACKMAN JR, 1976, ORGAN BEHAV HUM PERF, V16, P250, DOI 10.1016/0030-5073(76)90016-7; Holtz TH, 2002, J TRAUMA STRESS, V15, P389, DOI 10.1023/A:1020133308188; Knutson J, 1988, HDB PEDIAT PSYCHOL; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1996, MASLACH BURNOUT INVE; McCall M, 1999, BRIT MED J, V318, P113, DOI 10.1136/bmj.318.7176.113; MOLLICA RF, 1987, AM J PSYCHIAT, V144, P497; Ostell A., 2006, CBT OCCUPATIONAL STR, P59; Purvanova RK, 2010, J VOCAT BEHAV, V77, P168, DOI 10.1016/j.jvb.2010.04.006; Resnick H., 1996, MEASUREMENT STRESS T; Salama P., 2001, SHARING FRONT LINE B, P242; Sandanger I, 1999, SOC PSYCH PSYCH EPID, V34, P53, DOI 10.1007/s001270050112; Sheik M, 2000, BRIT MED J, V321, P166, DOI 10.1136/bmj.321.7254.166; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Thormar SB, 2010, J NERV MENT DIS, V198, P529, DOI 10.1097/NMD.0b013e3181ea1fa9; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	32	109	109	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44948	10.1371/journal.pone.0044948	http://dx.doi.org/10.1371/journal.pone.0044948			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984592	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500099
J	Kim, SJ; Park, JH; Lee, MJ; Park, YG; Ahn, MJ; Bang, OY				Kim, Suk Jae; Park, Jae Hyun; Lee, Mi-Ji; Park, Yun Gyoung; Ahn, Myung-Ju; Bang, Oh Young			Clues to Occult Cancer in Patients with Ischemic Stroke	PLOS ONE			English	Article							ACUTE PULMONARY-EMBOLISM; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; CARCINOMA; PROGNOSIS; PATTERNS	Background: We hypothesized that hidden malignancy could be detected in patients with cryptogenic stroke without active cancer when they showed the distinctive characteristics of cancer-related stroke. Methods and Findings: Among 2,562 consecutive patients with acute ischemic stroke, patients with cryptogenic stroke were analyzed and categorized into two groups according to the presence of active cancer: cryptogenic stroke with active cancer (cancer-related stroke, CA-stroke) group and without active cancer (CR-stroke) group. Patients with active lung cancer without stroke were also recruited for comparison purposes (CA-control). Clinical factors, lesion patterns on diffusion-weighted MRI (DWI), and laboratory findings were analyzed among groups. A total of 348 patients with cryptogenic stroke were enrolled in this study. Among them, 71 (20.4%) patients had active cancer at the time of stroke. The D-dimer levels were significantly higher in patients with CA-stroke than those with CR-stroke or CA-control (both p < 0.001). Regarding lesion patterns, patients with CA-stroke mostly had multiple lesions in multiple vascular territories, while more than 80% of patients with CR-stroke had single/multiple lesions in a single vascular territory (P < 0.001). D-dimer levels (OR 1.11 per 1 mu g/mL increase; 95% CI 1.06-1.15; P < 0.001) and DWI lesion patterns (OR 7.13; 95% CI 3.42-14.87; P < 0.001) were independently associated with CA-stroke. Workup for hidden malignancy was performed during hospitalization in 10 patients who showed elevated D-dimer levels and multiple infarcts involving multiple vascular territories but had no known cancer, and it revealed hidden malignancies in all the patients. Conclusion: Patients with CA-stroke have distinctive D-dimer levels and lesion patterns. These characteristics can serve as clues to occult cancer in patients with cryptogenic stroke.	[Kim, Suk Jae; Park, Jae Hyun; Lee, Mi-Ji; Bang, Oh Young] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea; [Park, Yun Gyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea; [Ahn, Myung-Ju] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Hematooncol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, SJ (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, Seoul, South Korea.	nmboy@unitel.co.kr		Lee, Mi Ji/0000-0003-1364-1969	Ministry of Health Welfare [A110208]	Ministry of Health Welfare	This study was supported by the Korean Healthcare Technology Research & Development Project, Ministry of Health & Welfare (A110208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ay H, 2005, ANN NEUROL, V58, P688, DOI 10.1002/ana.20617; Baird AE, 2000, NEUROLOGY, V54, P674, DOI 10.1212/WNL.54.3.674; Bang OY, 2011, J CLIN NEUROL, V7, P53, DOI 10.3988/jcn.2011.7.2.53; Blom JW, 2004, J THROMB HAEMOST, V2, P1760, DOI 10.1111/j.1538-7836.2004.00928.x; Bura A, 2004, J THROMB HAEMOST, V2, P441, DOI 10.1111/j.1538-7933.2004.00619.x; Fujimoto S, 2011, CEREBROVASC DIS, V32, P148, DOI 10.1159/000328652; GORE JM, 1982, ANN INTERN MED, V96, P556, DOI 10.7326/0003-4819-96-5-556; GRAUS F, 1985, MEDICINE, V64, P16, DOI 10.1097/00005792-198501000-00002; GREENBERG E, 1964, AM J MED, V36, P106, DOI 10.1016/0002-9343(64)90153-6; Grisold W, 2009, ACTA NEUROL SCAND, V119, P1, DOI 10.1111/j.1600-0404.2008.01059.x; Guercini F, 2008, J THROMB HAEMOST, V6, P549, DOI 10.1111/j.1538-7836.2008.02903.x; Hong CT, 2009, CEREBROVASC DIS, V28, P411, DOI 10.1159/000235629; Kang DW, 2003, ARCH NEUROL-CHICAGO, V60, P1730, DOI 10.1001/archneur.60.12.1730; Kim SG, 2010, STROKE, V41, P798, DOI 10.1161/STROKEAHA.109.571356; Kono T, 2012, GERIATR GERONTOL INT, V12, P468, DOI 10.1111/j.1447-0594.2011.00796.x; Kwon HM, 2007, J NEUROL SCI, V258, P80, DOI 10.1016/j.jns.2007.02.035; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Lee AYY, 2003, CIRCULATION, V107, pI17, DOI 10.1161/01.CIR.0000078466.72504.AC; Monreal M, 2004, J THROMB HAEMOST, V2, P876, DOI 10.1111/j.1538-7836.2004.00721.x; MONREAL M, 1993, CHEST, V103, P816, DOI 10.1378/chest.103.3.816; PRANDONI P, 1992, NEW ENGL J MED, V327, P1128, DOI 10.1056/NEJM199210153271604; Seok JM, 2010, ANN NEUROL, V68, P213, DOI 10.1002/ana.22050; Sorensen HT, 2000, NEW ENGL J MED, V343, P1846, DOI 10.1056/NEJM200012213432504; Tesselaar MET, 2007, J THROMB HAEMOST, V5, P520, DOI 10.1111/j.1538-7836.2007.02369.x; Zwicker JI, 2009, CLIN CANCER RES, V15, P6830, DOI 10.1158/1078-0432.CCR-09-0371	25	75	85	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44959	10.1371/journal.pone.0044959	http://dx.doi.org/10.1371/journal.pone.0044959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984594	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500100
J	Sariyer, IK; Merabova, N; Patel, PK; Knezevic, T; Rosati, A; Turco, MC; Khalili, K				Sariyer, Ilker Kudret; Merabova, Nana; Patel, Prem Kumer; Knezevic, Tijana; Rosati, Alessandra; Turco, Maria C.; Khalili, Kamel			Bag3-Induced Autophagy Is Associated with Degradation of JCV Oncoprotein, T-Ag	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; HEAT-SHOCK-PROTEIN; BAG3 PROTEIN; FUNCTIONAL INTERACTION; NATALIZUMAB; ANTIGEN; CANCER; SIMIAN-VIRUS-40; POLYOMAVIRUSES; ACTIVATION	JC virus, JCV, is a human neurotropic polyomavirus whose replication in glial cells causes the fatal demyelinating disease progressive multifocal leukoencephalopathy (PML). In addition, JCV possesses oncogenic activity and expression of its transforming protein, large T-antigen (T-Ag), in several experimental animals induces tumors of neural origin. Further, the presence of JCV DNA and T-Ag have been repeatedly observed in several human malignant tissues including primitive neuroectodermal tumors and glioblastomas. Earlier studies have demonstrated that Bag3, a member of the Bcl-2-associated athanogene (Bag) family of proteins, which is implicated in autophagy and apoptosis, is downregulated upon JCV infection of glial cells and that JCV T-Ag is responsible for suppressing the activity of the BAG3 promoter. Here, we investigated the possible impact of Bag3 on T-Ag expression in JCV-infected human primary glial cells as well as in cells derived from T-Ag-induced medulloblastoma in transgenic animals. Results from these studies revealed that overexpression of Bag3 drastically decreases the level of T-Ag expression by inducing the autophagic degradation of the viral protein. Interestingly, this event leads to the inhibition of JCV infection of glial cells, suggesting that the reduced levels of T-antigen seen upon the overexpression of Bag3 has a biological impact on the viral lytic cycle. Results from protein-protein interaction studies showed that T-Ag and Bag3 physically interact with each other through the zinc-finger of T-Ag and the proline rich domains of Bag3, and this interaction is important for the autophagic degradation of T-Ag. Our observations open a new avenue of research for better understanding of virus-host interaction by investigating the interplay between T-Ag and Bag3, and their impact on the development of JCV-associated diseases.	[Sariyer, Ilker Kudret; Merabova, Nana; Patel, Prem Kumer; Knezevic, Tijana; Khalili, Kamel] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Sariyer, Ilker Kudret; Merabova, Nana; Patel, Prem Kumer; Knezevic, Tijana; Khalili, Kamel] Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19122 USA; [Rosati, Alessandra; Turco, Maria C.] Univ Salerno, Dept Pharmaceut & Biomed Sci FARMABIOMED, Fisciano, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Salerno	Sariyer, IK (corresponding author), Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA.	kamel.khalili@temple.edu	Sariyer, Ilker/AAE-7677-2020; TURCO, Maria Caterina/AAC-5282-2022	TURCO, Maria Caterina/0000-0002-7835-359X; Merabova, Nana/0000-0003-4832-1551; Rosati, Alessandra/0000-0001-6675-0857	National Institutes of Health [R01 MH086358 BAG3]; JCV in brain; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH092177, R01MH086358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JCV in brain; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant Number R01 MH086358 BAG3 mediates interplay of HIV-1 and JCV in brain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akan I, 2006, VIROLOGY, V349, P66, DOI 10.1016/j.virol.2006.01.025; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Basile A, 2009, J GEN VIROL, V90, P1629, DOI 10.1099/vir.0.008722-0; Beere HM, 2005, J CLIN INVEST, V115, P2633, DOI 10.1172/JCI26471; Behl C, 2011, AUTOPHAGY, V7, P795, DOI 10.4161/auto.7.7.15844; BERGER JR, 1995, J NEUROVIROL, V1, P5, DOI 10.3109/13550289509111006; Bonelli P, 2004, LEUKEMIA, V18, P358, DOI 10.1038/sj.leu.2403219; Carra S, 2008, AUTOPHAGY, V4, P237, DOI 10.4161/auto.5407; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Carra S, 2009, J BIOL CHEM, V284, P5523, DOI 10.1074/jbc.M807440200; Carson KR, 2009, LANCET ONCOL, V10, P816, DOI 10.1016/S1470-2045(09)70161-5; Chang CF, 1996, J VIROL, V70, P4150, DOI 10.1128/JVI.70.6.4150-4156.1996; Doong H, 2000, ONCOGENE, V19, P4385, DOI 10.1038/sj.onc.1203797; Festa M, 2011, AM J PATHOL, V178, P2504, DOI 10.1016/j.ajpath.2011.02.002; Franceschelli S, 2008, J CELL PHYSIOL, V215, P575, DOI 10.1002/jcp.21397; Gentilella A, 2008, ONCOGENE, V27, P5011, DOI 10.1038/onc.2008.142; Gentilella A, 2011, J BIOL CHEM, V286, P9205, DOI 10.1074/jbc.M110.175836; Kelley WL, 1997, P NATL ACAD SCI USA, V94, P3679, DOI 10.1073/pnas.94.8.3679; Khalili K, 2008, J CELL PHYSIOL, V215, P309, DOI 10.1002/jcp.21326; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Krynska B, 2000, VIROLOGY, V274, P65, DOI 10.1006/viro.2000.0450; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Lee JH, 1999, ONCOGENE, V18, P6183, DOI 10.1038/sj.onc.1203043; MILLER JR, 1982, NEW ENGL J MED, V307, P1436, DOI 10.1056/NEJM198212023072307; Moens U, 2008, J DTSCH DERMATOL GES, V6, P704, DOI 10.1111/j.1610-0387.2008.06810.x; Rosati A, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.24; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Rosati A, 2009, J CELL PHYSIOL, V218, P264, DOI 10.1002/jcp.21604; Safak M, 1999, J VIROL, V73, P10146, DOI 10.1128/JVI.73.12.10146-10157.1999; Safak M., 2005, The neurology of AIDS, P461; Sandborn WJ, 2005, NEW ENGL J MED, V353, P1912, DOI 10.1056/NEJMoa043335; Sariyer IK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014630; SAWAI ET, 1989, J VIROL, V63, P3961, DOI 10.1128/JVI.63.9.3961-3973.1989; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Weber T, 2008, NEUROL CLIN, V26, P833, DOI 10.1016/j.ncl.2008.03.007; White MK, 2006, ONCOGENE, V25, P5286, DOI 10.1038/sj.onc.1209618; White MK, 2005, EUR J CANCER, V41, P2537, DOI 10.1016/j.ejca.2005.08.019	37	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45000	10.1371/journal.pone.0045000	http://dx.doi.org/10.1371/journal.pone.0045000			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984599	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500105
J	Elze, T; Tanner, TG				Elze, Tobias; Tanner, Thomas G.			Temporal Properties of Liquid Crystal Displays: Implications for Vision Science Experiments	PLOS ONE			English	Article							COLOR MEASUREMENT METHODS; RESPONSE-TIME EVALUATION; MOTION-BLUR; LCD; RESOLUTION; FLICKER	Liquid crystal displays (LCD) are currently replacing the previously dominant cathode ray tubes (CRT) in most vision science applications. While the properties of the CRT technology are widely known among vision scientists, the photometric and temporal properties of LCDs are unfamiliar to many practitioners. We provide the essential theory, present measurements to assess the temporal properties of different LCD panel types, and identify the main determinants of the photometric output. Our measurements demonstrate that the specifications of the manufacturers are insufficient for proper display selection and control for most purposes. Furthermore, we show how several novel display technologies developed to improve fast transitions or the appearance of moving objects may be accompanied by side-effects in some areas of vision research. Finally, we unveil a number of surprising technical deficiencies. The use of LCDs may cause problems in several areas in vision science. Aside from the well-known issue of motion blur, the main problems are the lack of reliable and precise onsets and offsets of displayed stimuli, several undesirable and uncontrolled components of the photometric output, and input lags which make LCDs problematic for real-time applications. As a result, LCDs require extensive individual measurements prior to applications in vision science.	[Elze, Tobias] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA; [Elze, Tobias] Max Planck Inst Math Sci, Leipzig, Germany; [Tanner, Thomas G.] Max Planck Inst Biol Cybernet, Tubingen, Germany	Harvard University; Harvard Medical School; Schepens Eye Research Institute; Max Planck Society; Max Planck Society	Elze, T (corresponding author), Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA 02114 USA.	tobias.elze@schepens.harvard.edu		Elze, Tobias/0000-0002-2032-0496	Max Planck Society; National Institutes of Health [R01 EY018664]; NATIONAL EYE INSTITUTE [R01EY018664] Funding Source: NIH RePORTER	Max Planck Society(Max Planck Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	TE and TGT have been supported by Max Planck Society. TE has been supported by National Institutes of Health grant R01 EY018664. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach M, 1997, SPATIAL VISION, V10, P403, DOI 10.1163/156856897X00311; Badano A, 2003, ADV DIGITAL RADIOGRA, P91; Becker ME, 2008, SID INT SYMP DIG TEC, V39, P24, DOI 10.1889/1.3069637; Becker ME, 2008, J SOC INF DISPLAY, V16, P989, DOI 10.1889/JSID16.10.989; Brainard D.H., 2002, ENCY IMAGING SCI TEC, P172, DOI DOI 10.1002/0471443395.IMG011; Brown J.L., 1965, VISION VISUAL PERCEP, P251; Cowan WB, 1995, HDB OPTICS, V1, P2721; Cristaldi DJ, 2009, LIQUID CRYSTAL DISPL, P769; den Boer W., 2005, ACTIVE MATRIX LIQUID; ELZE T, 2009, J VIS, V9, P58; Elze T, 2010, J NEUROSCI METH, V191, P171, DOI 10.1016/j.jneumeth.2010.06.018; Elze T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012792; Elze T, 2009, MED PHYS, V36, P4984, DOI 10.1118/1.3238154; Feng XF, 2008, J SOC INF DISPLAY, V16, P981, DOI 10.1889/JSID16.10.981; Gallistel CR, 2009, PSYCHOL REV, V116, P439, DOI 10.1037/a0015251; HARRIS FJ, 1978, P IEEE, V66, P51, DOI 10.1109/PROC.1978.10837; Kihara K, 2010, BEHAV RES METHODS, V42, P1105, DOI 10.3758/BRM.42.4.1105; Kurita T., 1998, P IDW 98, V'98 3D3-4, P823; LaFontaine D, 2006, ELECTRON WORLD, V112, P15; Lagroix HEP, 2012, ATTEN PERCEPT PSYCHO, V74, P1033, DOI 10.3758/s13414-012-0281-4; Lee B-W., 2001, SOC INF DISP INT S, V32, P1260, DOI [10.1889/1.1831790, DOI 10.1889/1.1831790]; Lee JH, 2008, SID INT S, V35, p[1344, 21]; Lee SW, 2006, J SOC INF DISPLAY, V14, P387, DOI 10.1889/1.2196515; Liang HY, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2205152; Liang HY, 2007, MED PHYS, V34, P639, DOI 10.1118/1.2428403; Robson T, 1998, VISION RES PRACTICAL, P81; Saha A, 2006, J SOC INF DISPLAY, V14, P979, DOI 10.1889/1.2393035; Saha A, 2010, MED PHYS, V37, P74, DOI 10.1118/1.3265879; Schanda J, 2007, COLORIMETRY: UNDERSTANDING THE CIE SYSTEM, P25, DOI 10.1002/9780470175637.ch3; Sheather SJ, 2004, STAT SCI, V19, P588, DOI 10.1214/088342304000000297; Someya J, 2007, J SOC INF DISPLAY, V15, P79, DOI 10.1889/1.2451570; SPERLING G, 1971, BEHAV RES METH INSTR, V3, P151, DOI 10.3758/BF03209940; SPERLING G, 1971, BEHAV RES METH INSTR, V3, P148, DOI 10.3758/BF03209939; SRINIVASAN M, 1985, J COMP PHYSIOL A, V157, P579, DOI 10.1007/BF01351352; Suzuki S, 2002, P SOC PHOTO-OPT INS, V4657, P85, DOI 10.1117/12.463794; Theis D, 2003, OPTICS ENCY, P327; van Heesch FH, 2008, J SOC INF DISPLAY, V16, P1009, DOI 10.1889/JSID16.10.1009; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; Wang P, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00085; Watson A. B., 2010, SOC INFORM DISPLAY D, V41, P184; Watson A. B., 2006, SID S, V37, P1312; Watson AB, 2010, J SOC INF DISPLAY, V18, P179, DOI 10.1889/JSID18.2.179; Wiens S, 2004, PSYCHOL SCI, V15, P282, DOI 10.1111/j.0956-7976.2004.00667.x; Woods RL, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3292015; X Li, 2006, SID S, V37, P6, DOI DOI 10.1016/j.watres.2006.06.037; Yamamoto T, 2000, SID S, V31, P456	46	36	38	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44048	10.1371/journal.pone.0044048	http://dx.doi.org/10.1371/journal.pone.0044048			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984458	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700039
J	Maayan, I; Beenstock, J; Marbach, I; Tabachnick, S; Livnah, O; Engelberg, D				Maayan, Inbal; Beenstock, Jonah; Marbach, Irit; Tabachnick, Shira; Livnah, Oded; Engelberg, David			Osmostress Induces Autophosphorylation of Hog1 via a C-Terminal Regulatory Region That Is Conserved in p38 alpha	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; YEAST SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION PATHWAY; MAP KINASE; IN-VITRO; TYROSINE KINASES; DOCKING SITES; PHOSPHORYLATION; VARIANTS; MUTANTS	Many protein kinases require phosphorylation at their activation loop for induction of catalysis. Mitogen-activated protein kinases (MAPKs) are activated by a unique mode of phosphorylation, on neighboring Tyrosine and Threonine residues. Whereas many kinases obtain their activation via autophosphorylation, MAPKs are usually phosphorylated by specific, dedicated, MAPK kinases (MAP2Ks). Here we show however, that the yeast MAPK Hog1, known to be activated by the MAP2K Pbs2, is activated in pbs2 Delta cells via an autophosphorylation activity that is induced by osmotic pressure. We mapped a novel domain at the Hog1 C-terminal region that inhibits this activity. Removal of this domain provides a Hog1 protein that is partially independent of MAP2K, namely, partially rescues osmostress sensitivity of pbs2 Delta cells. We further mapped a short domain (7 amino acid residues long) that is critical for induction of autophosphorylation. Its removal abolishes autophosphorylation, but maintains Pbs2-mediated phosphorylation. This 7 amino acids stretch is conserved in the human p38 alpha. Similar to the case of Hog1, it's removal from p38 alpha abolishes p38 alpha's autophosphorylation capability, but maintains, although reduces, its activation by MKK6. This study joins a few recent reports to suggest that, like many protein kinases, MAPKs are also regulated via induced autoactivation.	[Maayan, Inbal; Beenstock, Jonah; Marbach, Irit; Tabachnick, Shira; Livnah, Oded; Engelberg, David] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Maayan, I (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	engelber@cc.huji.ac.il		Tabachnick Cherny, Shira/0000-0003-1595-4619	Israel Science Foundation [180/09]; U.S.-Israel Binational [2009116]; Singapore National Research Foundation under its HUJ-NUS partnership program in the Campus for Research Excellence And Technology Enterprise (CREATE)	Israel Science Foundation(Israel Science Foundation); U.S.-Israel Binational; Singapore National Research Foundation under its HUJ-NUS partnership program in the Campus for Research Excellence And Technology Enterprise (CREATE)	The study was supported by the Israel Science Foundation (http://www.isf.org.il/english/) grant 180/09 (Research Center); the U.S.-Israel Binational (http://www.bsf.org.il/BSFPublic/Default.aspx) grant 2009116 and by the Singapore National Research Foundation under its HUJ-NUS partnership program in the Campus for Research Excellence And Technology Enterprise (CREATE). The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	AHN NG, 1991, J BIOL CHEM, V266, P4220; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; Askari N, 2007, J BIOL CHEM, V282, P91, DOI 10.1074/jbc.M608012200; Askari N, 2009, BIOCHEMISTRY-US, V48, P2497, DOI 10.1021/bi900024v; Avitzour M, 2007, FEBS J, V274, P963, DOI 10.1111/j.1742-4658.2007.05644.x; Belham C, 1999, CURR BIOL, V9, pR93, DOI 10.1016/S0960-9822(99)80058-X; Bell M, 2003, J BIOL CHEM, V278, P14603, DOI 10.1074/jbc.C300006200; Bell M, 2001, J BIOL CHEM, V276, P25351, DOI 10.1074/jbc.M101818200; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Clotet J, 2007, METHOD ENZYMOL, V428, P63, DOI 10.1016/S0076-6879(07)28004-8; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; Diskin R, 2004, J BIOL CHEM, V279, P47040, DOI 10.1074/jbc.M404595200; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Friedmann Y, 2006, MOL PHARMACOL, V70, P1395, DOI 10.1124/mol.106.022962; GALCHEVAGARGOVA Z, 1994, SCIENCE, V265, P806, DOI 10.1126/science.8047888; GARTNER A, 1992, GENE DEV, V6, P1280, DOI 10.1101/gad.6.7.1280; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Knebel A, 1996, EMBO J, V15, P5314, DOI 10.1002/j.1460-2075.1996.tb00916.x; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Levin-Salomon V, 2009, BIOCHEM J, V417, P331, DOI 10.1042/BJ20081335; Levin-Salomon V, 2008, J BIOL CHEM, V283, P34500, DOI 10.1074/jbc.M806443200; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Lochhead PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pe4; Maayan I, 2009, FEBS LETT, V583, P2015, DOI 10.1016/j.febslet.2009.05.014; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Murakami Y, 2008, MOL CELL BIOL, V28, P2481, DOI 10.1128/MCB.01817-07; Nitta RT, 2008, J BIOL CHEM, V283, P34935, DOI 10.1074/jbc.M804970200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; ROBBINS DJ, 1993, J BIOL CHEM, V268, P5097; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Sclafani RA, 1996, CURR OPIN CELL BIOL, V8, P788, DOI 10.1016/S0955-0674(96)80079-2; SEGER R, 1991, P NATL ACAD SCI USA, V88, P6142, DOI 10.1073/pnas.88.14.6142; Westfall PJ, 2008, P NATL ACAD SCI USA, V105, P12212, DOI 10.1073/pnas.0805797105; Wilson C, 1997, J MOL EVOL, V44, P683; Yaakov G, 2003, MOL CELL BIOL, V23, P4826, DOI 10.1128/MCB.23.14.4826-4840.2003; Yao Z, 2000, FEBS LETT, V468, P37, DOI 10.1016/S0014-5793(00)01191-1; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200; Zhou B, 2002, J BIOL CHEM, V277, P13889, DOI 10.1074/jbc.M200377200	49	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44749	10.1371/journal.pone.0044749	http://dx.doi.org/10.1371/journal.pone.0044749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984552	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700081
J	Xu, L; He, X; Zhang, DM; Feng, FS; Wang, Z; Guan, LL; Wu, JH; Zhou, R; Zheng, BJ; Yuen, KY; Li, MF; Cao, KY				Xu, Lin; He, Xia; Zhang, Ding-mei; Feng, Fa-shen; Wang, Zhu; Guan, Lin-lin; Wu, Jue-heng; Zhou, Rong; Zheng, Bo-jian; Yuen, Kwok-yung; Li, Meng-feng; Cao, Kai-yuan			Surveillance and Genome Analysis of Human Bocavirus in Patients with Respiratory Infection in Guangzhou, China	PLOS ONE			English	Article							REAL-TIME PCR; ACUTE GASTROENTERITIS; TRACT INFECTION; YOUNG-CHILDREN; HOSPITALIZED CHILDREN; HONG-KONG; SAMPLES; PREVALENCE; PARVOVIRUS; PNEUMONIA	Human bocavirus (HBoV) is a novel parvovirus associated with respiratory tract diseases and gastrointestinal illness in adult and pediatric patients throughout the world. To investigate the epidemiological and genetic variation of HBoV in Guangzhou, South China, we screened 3460 throat swab samples from 1686 children and 1774 adults with acute respiratory infection symptoms for HBoV between March 2010 and February 2011, and analyzed the complete genome sequence of 2 HBoV strains. Specimens were screened for HBoV by real-time PCR and other 6 common respiratory viruses by RT-PCR or PCR. HBoV was detected in 58 (1.68%) out of 3460 samples, mostly from pediatric patients (52/58) and inpatient children (47/58). Six adult patients were detected as HBoV positive and 5 were emergency cases. Of these HBoV positive cases, 19 (32.76%) had co-pathogens including influenza virus (n = 5), RSV (n = 5), parainfluenza (n = 4), adenovirus (n = 1), coronavirus (n = 7). The complete genome sequences of 2 HBoVs strains (Genbank no. JN794565 and JN794566) were analyzed. Phylogenetic analysis showed that the 2 HBoV strains were HBoV1, and were most genetically close to ST2 (GenBank accession number DQ0000496). Recombination analysis confirmed that HBoV strain GZ9081 was an intra-genotype recombinant strain among HBoV1 variants.	[Xu, Lin; He, Xia; Zhang, Ding-mei; Feng, Fa-shen; Wang, Zhu; Guan, Lin-lin; Wu, Jue-heng; Li, Meng-feng; Cao, Kai-yuan] Sun Yat Sen Univ, Dept Microbiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Lin; He, Xia; Zhang, Ding-mei; Feng, Fa-shen; Wang, Zhu; Guan, Lin-lin; Wu, Jue-heng; Li, Meng-feng; Cao, Kai-yuan] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Xu, Lin; He, Xia; Zhang, Ding-mei; Feng, Fa-shen; Wang, Zhu; Guan, Lin-lin; Wu, Jue-heng; Zheng, Bo-jian; Yuen, Kwok-yung; Li, Meng-feng; Cao, Kai-yuan] Sun Yat Sen Univ, Univ Hong Kong, Joint Lab Infect Dis Surveillance, Guangzhou 510275, Guangdong, Peoples R China; [Zhou, Rong] Guangzhou Med Univ, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Zheng, Bo-jian; Yuen, Kwok-yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; University of Hong Kong; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; University of Hong Kong	Xu, L (corresponding author), Sun Yat Sen Univ, Dept Microbiol, Zhongshan Sch Med, Guangzhou 510275, Guangdong, Peoples R China.	caoky@mail.sysu.edu.cn	Zhang, Dingmei/ABC-7476-2020; meng, li/GVT-2063-2022	He, Xia/0000-0003-4319-4995; Yuen, Kwok-yung/0000-0002-2083-1552	National Major Projects of Major Infectious Disease Control and Prevention, the Ministry of Science and Technology of the People's Republic of China [2009ZX10004-213, 2012ZX10004213-001]	National Major Projects of Major Infectious Disease Control and Prevention, the Ministry of Science and Technology of the People's Republic of China	This research was supported by National Major Projects of Major Infectious Disease Control and Prevention, the Ministry of Science and Technology of the People's Republic of China (grant numbers 2009ZX10004-213 and 2012ZX10004213-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Arden KE, 2006, J MED VIROL, V78, P1232, DOI 10.1002/jmv.20689; Arnold JC, 2006, CLIN INFECT DIS, V43, P283, DOI 10.1086/505399; Cheng WX, 2008, CLIN INFECT DIS, V47, P161, DOI 10.1086/589244; Chieochansin T, 2008, JPN J INFECT DIS, V61, P479; Chung JY, 2006, EMERG INFECT DIS, V12, P1254, DOI 10.3201/eid1708.060261; Coiras MT, 2003, J MED VIROL, V69, P132, DOI 10.1002/jmv.10255; Foulongne V, 2006, EMERG INFECT DIS, V12, P1251, DOI 10.3201/eid1708.060213.; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Fu XL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-182; Kapoor A, 2010, J INFECT DIS, V201, P1633, DOI 10.1086/652416; Kesebir D, 2006, J INFECT DIS, V194, P1276, DOI 10.1086/508213; Kim JS, 2011, KOREAN J LAB MED, V31, P179, DOI 10.3343/kjlm.2011.31.3.179; Kleines M, 2007, J CLIN MICROBIOL, V45, P1032, DOI 10.1128/JCM.01884-06; Lau SKP, 2007, J INFECT DIS, V196, P986, DOI 10.1086/521310; Lin JH, 2009, J CLIN VIROL, V44, P219, DOI 10.1016/j.jcv.2008.12.018; Longtin J, 2008, EMERG INFECT DIS, V14, P217, DOI 10.3201/eid1402.070851; Lu XY, 2006, J CLIN MICROBIOL, V44, P3231, DOI 10.1128/JCM.00889-06; Maggi F, 2007, J CLIN VIROL, V38, P321, DOI 10.1016/j.jcv.2007.01.008; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Neske F, 2007, J CLIN MICROBIOL, V45, P2116, DOI 10.1128/JCM.00027-07; Ngan TKP, 2011, J MED VIROL, V83, P286, DOI 10.1002/jmv.21876; Peiris JSM, 2003, EMERG INFECT DIS, V9, P628; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Santos N, 2010, J CLIN VIROL, V48, P127, DOI 10.1016/j.jcv.2010.03.014; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Yu JM, 2008, J CLIN VIROL, V42, P280, DOI 10.1016/j.jcv.2008.03.032; Zheng LS, 2010, J MED VIROL, V82, P282, DOI 10.1002/jmv.21689	30	17	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44876	10.1371/journal.pone.0044876	http://dx.doi.org/10.1371/journal.pone.0044876			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984581	Green Published, gold			2022-12-25	WOS:000308638700096
J	Lesimple, C; Fureix, C; De Margerie, E; Seneque, E; Menguy, H; Hausberger, M				Lesimple, Clemence; Fureix, Carole; De Margerie, Emmanuel; Seneque, Emilie; Menguy, Herve; Hausberger, Martine			Towards a Postural Indicator of Back Pain in Horses (Equus caballus)	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; ELECTROMYOGRAPHIC RECORDINGS; SURFACE ELECTROMYOGRAPHY; DIFFERENT POSITIONS; BEHAVIOR; MANIPULATION; DISORDERS; TREADMILL; WORK; DYSFUNCTION	Postures have long been used and proved useful to describe animals' behaviours and emotional states, but remains difficult to assess objectively in field conditions. A recent study performed on horses using geometric morphometrics revealed important postural differences between 2 horse populations differing in management conditions (leisure horses living in social groups used for occasional "relaxed" riding/riding school horses living in individual boxes used in daily riding lessons with more constraining techniques). It was suggested that these postural differences may reflect chronic effects of riding techniques on the horses' kinematics and muscular development. In the present study, we tried to evaluate the interest of postural measures to assess welfare in horses. This study was separated into 2 parts. First, 18 horses coming from these 2 types of populations (leisure/riding school horses) were submitted to 2 back evaluations by 1) manual examination (experienced practitioner) and 2) sEMG measures along the spine. We then measured neck roundness on 16 of these 18 horses. The results highlighted high correlations between manual and sEMG examinations over the spine. sEMG measures at the different locations were strongly correlated all over the spine. Moreover, neck postures and muscular activities were strongly correlated, horses with concave necks having higher sEMG measures both at precise locations (i.e. cervical sites) but also when comparing neck postures to the whole spine muscular activity highlighting the functioning of horses' back as a whole. Lastly, strong differences appeared between the populations, leisure horses being evaluated as having sounder spines, exhibiting lower sEMG measures and rounder neck than the riding school horses. sEMG measures and neck "roundness" seemed therefore to be reliable indicators of back disorders, easy to evaluate in field conditions. This highlights the accuracy of using postural elements to evaluate the animals' general state and has important implications for animals' welfare evaluations.	[Lesimple, Clemence; Hausberger, Martine] Univ Rennes 1, Lab Ethol Anim & Humaine EthoS, CNRS, Biol Stn,UMR 6552, Paimpont, France; [Fureix, Carole; De Margerie, Emmanuel; Seneque, Emilie; Hausberger, Martine] Univ Rennes 1, Lab Ethol Anim & Humaine, CNRS, UMR 6552, Rennes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Lesimple, C (corresponding author), Univ Rennes 1, Lab Ethol Anim & Humaine EthoS, CNRS, Biol Stn,UMR 6552, Paimpont, France.	clemence.lesimple@univ-rennes1.fr		/0000-0003-0664-1151; de Margerie, Emmanuel/0000-0002-5380-3355	Caisse Centrale de la Mutualite Sociale Agricole; French Research Ministry	Caisse Centrale de la Mutualite Sociale Agricole; French Research Ministry(Ministry of Research, France)	This study was supported by the Caisse Centrale de la Mutualite Sociale Agricole and the French Research Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroz C, 2000, J OCCUP ENVIRON MED, V42, P660, DOI 10.1097/00043764-200006000-00018; ARENA JG, 1989, PAIN, V37, P57, DOI 10.1016/0304-3959(89)90153-X; ARENA JG, 1991, PAIN, V45, P23, DOI 10.1016/0304-3959(91)90160-Y; Aublet H, 1975, MANUEL HIPPOLOGIE, P4; Beerda B, 1999, PHYSIOL BEHAV, V66, P233, DOI 10.1016/S0031-9384(98)00289-3; Benhajali H, 2008, APPL ANIM BEHAV SCI, V112, P196, DOI 10.1016/j.applanim.2007.08.007; Biau S, 2004, PFERDEHEILKUNDE, V20, P135, DOI 10.21836/PEM20040204; Bugajska J, 2011, MED PR, V62, P153; Caneiro JP, 2010, MANUAL THER, V15, P54, DOI 10.1016/j.math.2009.06.002; Cauvin E, 1997, IN PRACTICE, V19, P522; Chiung-Yu C, 2007, J MANIP PHYSIOL THER, V31, P224; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cook WR, 1999, J EQUINE VET SCI, V19, P196, DOI 10.1016/S0737-0806(99)80067-7; Cooper JJ, 2005, APPL ANIM BEHAV SCI, V90, P351, DOI 10.1016/j.applanim.2004.08.005; CRAM JR, 1988, BIOFEEDBACK SELF-REG, V13, P123, DOI 10.1007/BF01001496; Darwin C., 1872, EXPRESS EMOT MAN, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Denoix JM, 1989, APPROCHE KINESITHERA, V18, p[23, 79]; Donaldson S, 2003, APPL PSYCHOPHYS BIOF, V28, P121, DOI 10.1023/A:1023858524879; Faber M, 2000, AM J VET RES, V61, P399, DOI 10.2460/ajvr.2000.61.399; Fonseca BPA, 2006, J EQUINE VET SCI, V26, P507, DOI 10.1016/j.jevs.2006.09.007; Fuller PO, 2011, ZOOLOGY, V114, P104, DOI 10.1016/j.zool.2010.11.003; Fureix C, 2011, NATURWISSENSCHAFTEN, V98, P583, DOI 10.1007/s00114-011-0803-2; Fureix C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012434; Geisser ME, 2005, J PAIN, V6, P711, DOI 10.1016/j.jpain.2005.06.008; Giacomini PG, 2004, EUR J PAIN, V8, P579, DOI 10.1016/j.ejpain.2004.02.004; Gillis C, 1999, VET CLIN N AM-EQUINE, V15, P97; Gomez Alvarez C B, 2006, Equine Vet J Suppl, P445; Hamaoui A, 2011, GAIT POSTURE, V34, P457, DOI 10.1016/j.gaitpost.2011.06.017; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; Hausberger M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014659; Hausberger M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007625; Haussler KK, 1996, J EQUINE VET SCI, V16, P279, DOI 10.1016/S0737-0806(96)80220-6; Haussler KK, 2006, EQUINE VET J, V38, P76, DOI 10.2746/042516406775374225; Heleski CR, 2002, APPL ANIM BEHAV SCI, V78, P291, DOI 10.1016/S0168-1591(02)00108-9; HOUTMAN ILD, 1994, SCAND J WORK ENV HEA, V20, P139, DOI 10.5271/sjweh.1419; Huzzey JM, 2005, J DAIRY SCI, V88, P2454, DOI 10.3168/jds.S0022-0302(05)72923-4; JEFFCOTT LB, 1980, EQUINE VET J, V12, P197, DOI 10.1111/j.2042-3306.1980.tb03427.x; Kierko A, 2011, ANN AGR ENV MED; KIRKALDYWILLIS WH, 1985, CAN FAM PHYSICIAN, V31, P535; KOWNACKI M, 1978, GENET POL, V19, P61; Krawczel PD, 2008, J DAIRY SCI, V91, P1903, DOI 10.3168/jds.2007-0520; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Lepicard EM, 2003, PSYCHIAT RES, V118, P273, DOI 10.1016/S0165-1781(03)00069-6; Lepicard EM, 2000, BEHAV BRAIN RES, V117, P185, DOI 10.1016/S0166-4328(00)00304-1; Lesimple C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010257; Licka T, 2009, VET J, V180, P71, DOI 10.1016/j.tvjl.2007.11.001; Licka T, 1998, EQUINE VET J, V30, P412, DOI 10.1111/j.2042-3306.1998.tb04511.x; Luttmann A, 2010, INT J IND ERGONOM, V40, P549, DOI 10.1016/j.ergon.2010.04.006; Mann S, 2004, BRIT J GUID COUNS, V32, P205, DOI 10.1080/0369880410001692247; Martin BB, 1999, VET CLIN N AM-EQUINE, V15, P61; Mortk PJ, 2008, CLIN BIOMECH, V24, P169; Murphy S, 2004, APPL ERGON, V35, P113, DOI 10.1016/j.apergo.2004.01.001; Odberg F O, 1999, Equine Vet J Suppl, P26; Reefmann N, 2009, APPL ANIM BEHAV SCI, V118, P199, DOI 10.1016/j.applanim.2009.02.013; Reeves NP, 2005, J ELECTROMYOGR KINES, V15, P53, DOI 10.1016/j.jelekin.2004.07.001; Ridgway K, 1999, VET CLIN N AM-EQUINE, V15, P263; Rosario JLP, 2010, INT J PSYCHOPHYSIOL, V77, P276, DOI 10.1016/j.ijpsycho.2010.06.126; SAINSBURY P, 1954, J NEUROL NEUROSUR PS, V17, P216, DOI 10.1136/jnnp.17.3.216; Schaubroeck J, 2000, J ORGAN BEHAV, V21, P163, DOI 10.1002/(SICI)1099-1379(200003)21:2<163::AID-JOB37>3.0.CO;2-L; Shearar KA, 2005, J MANIP PHYSIOL THER, V28, P493, DOI 10.1016/j.jmpt.2005.07.006; Sullivan KA, 2008, EQUINE VET J, V40, P14, DOI 10.2746/042516407X240456; Visser EK, 2008, APPL ANIM BEHAV SCI, V114, P521, DOI 10.1016/j.applanim.2008.03.003; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; WOLF SL, 1982, BEHAV THER, V13, P395, DOI 10.1016/S0005-7894(82)80003-8; Wood TG, 2001, J MANIP PHYSIOL THER, V24, P260, DOI 10.1067/mmt.2001.114365; Xin H, 1999, J ANIM SCI, V77, P1; Zsoldos RR, 2010, EQUINE VET J, V42, P455, DOI 10.1111/j.2042-3306.2010.00263.x	67	34	35	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44604	10.1371/journal.pone.0044604	http://dx.doi.org/10.1371/journal.pone.0044604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970261	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000035
J	Chaves-Campos, J; Coghill, LM; de Leon, FJG; Johnson, SG				Chaves-Campos, Johel; Coghill, Lyndon M.; Garcia de Leon, Francisco J.; Johnson, Steven G.			The Effect of Aquatic Plant Abundance on Shell Crushing Resistance in a Freshwater Snail	PLOS ONE			English	Article							PHOSPHORUS ENRICHMENT; PHENOTYPIC PLASTICITY; MULTIMODEL INFERENCE; BEHAVIORAL ECOLOGY; INDUCED DEFENSES; MODEL SELECTION; GRAZING SNAILS; PREDATOR; MORPHOLOGY; CALCIFICATION	Most of the shell material in snails is composed of calcium carbonate but the organic shell matrix determines the properties of calcium carbonate crystals. It has been shown that the deposition of calcium carbonate is affected by the ingestion of organic compounds. We hypothesize that organic compounds not synthesized by the snails are important for shell strength and must be obtained from the diet. We tested this idea indirectly by evaluating whether the abundance of the organic matter that snails eat is related to the strength of their shells. We measured shell crushing resistance in the snail Mexipyrgus churinceanus and the abundance of the most common aquatic macrophyte, the water lily Nymphaea ampla, in ten bodies of water in the valley of Cuatro Cienegas, Mexico. We used stable isotopes to test the assumption that these snails feed on water lily organic matter. We also measured other factors that can affect crushing resistance, such as the density of crushing predators, snail density, water pH, and the concentration of calcium and phosphorus in the water. The isotope analysis suggested that snails assimilate water lily organic matter that is metabolized by sediment bacteria. The variable that best explained the variation in crushing resistance found among sites was the local abundance of water lilies. We propose that the local amount of water lily organic matter provides organic compounds important in shell biomineralization, thus determining crushing resistance. Hence, we propose that a third trophic level could be important in the coevolution of snail defensive traits and predatory structures.	[Chaves-Campos, Johel; Coghill, Lyndon M.; Johnson, Steven G.] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [Garcia de Leon, Francisco J.] Ctr Invest Biol Noroeste, Lab Genet Conservac, La Paz, Baja California, Mexico	University of Louisiana System; University of New Orleans; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Telefonica SA	Chaves-Campos, J (corresponding author), Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA.	sgjohnso@uno.edu	León, Francisco García-De/AAH-9391-2019; Chaves-Campos, Johel/AAF-9147-2020	León, Francisco García-De/0000-0003-2323-2560; Chaves-Campos, Johel/0000-0001-8026-7626	University of New Orleans; CIBNOR	University of New Orleans; CIBNOR	The University of New Orleans provided support to SGJ, JC-C and LMC. The CIBNOR provided support to FJGL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLETON RD, 1988, P NATL ACAD SCI USA, V85, P4387, DOI 10.1073/pnas.85.12.4387; Arias JL, 2008, CHEM REV, V108, P4475, DOI 10.1021/cr078269p; Avery R, 2006, MAR ECOL PROG SER, V323, P159, DOI 10.3354/meps323159; BERENBAUM MR, 1995, P NATL ACAD SCI USA, V92, P2, DOI 10.1073/pnas.92.1.2; Bourdeau PE, 2011, FUNCT ECOL, V25, P177, DOI 10.1111/j.1365-2435.2010.01762.x; Bourdeau PE, 2010, OECOLOGIA, V162, P987, DOI 10.1007/s00442-009-1488-5; Bourdeau PE, 2010, P ROY SOC B-BIOL SCI, V277, P455, DOI 10.1098/rspb.2009.1295; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; Brookes JI, 2007, J EVOLUTION BIOL, V20, P1015, DOI 10.1111/j.1420-9101.2007.01299.x; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cairns A, 2009, ENVIRON REV, V17, P67, DOI 10.1139/A09-005; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Chaves-Campos J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022472; Chivers DP, 2008, EVOL ECOL, V22, P561, DOI 10.1007/s10682-007-9182-8; Dalziel B, 2005, J EXP MAR BIOL ECOL, V317, P25, DOI 10.1016/j.jembe.2004.11.015; DeWitt TJ, 2000, EVOL ECOL RES, V2, P129; Dinger E, 2001, AQUATIC INVERTEBRATE; Doi H, 2006, INT REV HYDROBIOL, V91, P501, DOI 10.1002/iroh.200610898; DUFFEY SS, 1980, ANNU REV ENTOMOL, V25, P447, DOI 10.1146/annurev.en.25.010180.002311; Elser JJ, 2005, FRESHWATER BIOL, V50, P1808, DOI 10.1111/j.1365-2427.2005.01451.x; Elser JJ, 2005, FRESHWATER BIOL, V50, P1826, DOI 10.1111/j.1365-2427.2005.01453.x; Evans S.B., 2005, USING CHEM DATA DEFI; Glass NH, 2009, AQUAT ECOL, V43, P1085, DOI 10.1007/s10452-008-9226-3; HARVELL CD, 1990, Q REV BIOL, V65, P323, DOI 10.1086/416841; Hershler R, 2002, SMITHSON CONTRIB EAR, P255; Hershler R, 1984, Journal of the Arizona-Nevada Academy of Science, V19, P61; Hood G.M., 2009, POPTOOLS VERSION 3 1; Hoverman JT, 2007, ECOLOGY, V88, P693, DOI 10.1890/05-1697; Hoverman JT, 2005, OECOLOGIA, V144, P481, DOI 10.1007/s00442-005-0082-8; Hulsey CD, 2006, J FISH BIOL, V68, P1399, DOI 10.1111/j.0022-1112.2006.01021.x; Hulsey CD, 2005, EVOL ECOL RES, V7, P303; Johnson SG, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-50; Kohzu A, 2004, AQUAT MICROB ECOL, V36, P189, DOI 10.3354/ame036189; Kurata K, 2001, MAR ECOL PROG SER, V223, P167, DOI 10.3354/meps223167; Kwong KL, 2010, BIOL INVASIONS, V12, P1153, DOI 10.1007/s10530-009-9537-x; Lysne SJ, 2007, J FRESHWATER ECOL, V22, P647, DOI 10.1080/02705060.2007.9664825; MADSEN H, 1992, HYDROBIOLOGIA, V228, P203, DOI 10.1007/BF00006587; Manly BFJ, 1997, RANDOMIZATION BOOTST; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marxen JC, 2003, BBA-PROTEINS PROTEOM, V1650, P92, DOI 10.1016/S1570-9639(03)00203-6; Mccoy MW, 2006, OECOLOGIA, V148, P547, DOI 10.1007/s00442-006-0403-6; McGoldrick DJ, 2008, CAN J FISH AQUAT SCI, V65, P1983, DOI 10.1139/F08-109; MONTGOMERY D. C., 2001, INTRO LINEAR REGRESS; MOSS B, 1972, J ECOL, V60, P917, DOI 10.2307/2258575; Nienhuis S, 2010, P ROY SOC B-BIOL SCI, V277, P2553, DOI 10.1098/rspb.2010.0206; Nishida R, 2002, ANNU REV ENTOMOL, V47, P57, DOI 10.1146/annurev.ento.47.091201.145121; PALMER AR, 1983, MAR BIOL, V75, P287, DOI 10.1007/BF00406014; PALMER AR, 1992, P NATL ACAD SCI USA, V89, P1379, DOI 10.1073/pnas.89.4.1379; PALMER AR, 1990, HYDROBIOLOGIA, V193, P155, DOI 10.1007/BF00028074; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.1890/0012-9658(2002)083[0703:USITET]2.0.CO;2; PRINGLE CM, 1993, LIMNOL OCEANOGR, V38, P753, DOI 10.4319/lo.1993.38.4.0753; R Core Team, 2022, R LANG ENV STAT COMP; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Rohlf FJ, 2009, TPS DIG 2 14; Rundle SD, 2004, P ROY SOC B-BIOL SCI, V271, pS67, DOI 10.1098/rsbl.2003.0106; Saporito RA, 2007, P NATL ACAD SCI USA, V104, P8885, DOI 10.1073/pnas.0702851104; SEELEY RH, 1986, P NATL ACAD SCI USA, V83, P6897, DOI 10.1073/pnas.83.18.6897; Stephens MJ, 2002, PHARYNGEAL MORPHOLOG; Stott LD, 2002, EARTH PLANET SC LETT, V195, P249, DOI 10.1016/S0012-821X(01)00585-4; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Trussell GC, 2000, EVOL ECOL RES, V2, P803; Trussell GC, 2000, P NATL ACAD SCI USA, V97, P2123, DOI 10.1073/pnas.040423397; Trussell GC, 1996, EVOLUTION, V50, P448, DOI 10.1111/j.1558-5646.1996.tb04507.x; Vermeij GJ, 1987, NATURAL HIST SHELLS; Wassen MJ, 2005, NATURE, V437, P547, DOI 10.1038/nature03950; Zar J. H., 2009, BIOSTATISTICAL ANAL; Zhang C, 2006, MAR BIOTECHNOL, V8, P572, DOI 10.1007/s10126-005-6029-6; Zhang WB, 2004, J SHELLFISH RES, V23, P1065	69	7	8	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44374	10.1371/journal.pone.0044374	http://dx.doi.org/10.1371/journal.pone.0044374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970206	Green Submitted, gold, Green Published			2022-12-25	WOS:000308458400063
J	Hoekstra, LA; Moroz, LL; Heyland, A				Hoekstra, Luke A.; Moroz, Leonid L.; Heyland, Andreas			Novel Insights into the Echinoderm Nervous System from Histaminergic and FMRFaminergic-Like Cells in the Sea Cucumber Leptosynapta clarki	PLOS ONE			English	Article							GIANT-NEURON SYSTEM; HOLOTHURIA-GLABERRIMA ECHINODERMATA; URCHIN HOLOPNEUSTES-PURPURASCENS; NITRIC-OXIDE PATHWAY; HEPTAPEPTIDE GFSKLYFAMIDE; CONNECTIVE-TISSUE; NEUROPEPTIDES; OPHIUROIDS; SETTLEMENT; BEHAVIOR	Understanding of the echinoderm nervous system is limited due to its distinct organization in comparison to other animal phyla and by the difficulty in accessing it. The transparent and accessible, apodid sea cucumber Leptosynapta clarki provides novel opportunities for detailed characterization of echinoderm neural systems. The present study used immunohistochemistry against FMRFamide and histamine to describe the neural organization in juvenile and adult sea cucumbers. Histaminergic-and FMRFaminergic-like immunoreactivity is reported in several distinct cell types throughout the body of L. clarki. FMRFamide-like immunoreactive cell bodies were found in the buccal tentacles, esophageal region and in proximity to the radial nerve cords. Sensory-like cells in the tentacles send processes toward the circumoral nerve ring, while unipolar and bipolar cells close to the radial nerve cords display extensive processes in close association with muscle and other cells of the body wall. Histamine-like immunoreactivity was identified in neuronal somatas located in the buccal tentacles, circumoral nerve ring and in papillae distributed across the body. The tentacular cells send processes into the nerve ring, while the processes of cells in the body wall papillae extend to the surface epithelium and radial nerve cords. Pharmacological application of histamine produced a strong coordinated, peristaltic response of the body wall suggesting the role of histamine in the feeding behavior. Our immunohistochemical data provide evidence for extensive connections between the hyponeural and ectoneural nervous system in the sea cucumber, challenging previously held views on a clear functional separation of the sub-components of the nervous system. Furthermore, our data indicate a potential function of histamine in coordinated, peristaltic movements; consistent with feeding patterns in this species. This study on L. clarki illustrates how using a broader range of neurotransmitter systems can provide better insight into the anatomy, function and evolution of echinoderm nervous sytems.	[Hoekstra, Luke A.; Moroz, Leonid L.; Heyland, Andreas] Univ Washington, Friday Harbor Labs, Seattle, WA 98195 USA; [Hoekstra, Luke A.] Indiana Univ, Dept Biol, Bloomington, IN USA; [Moroz, Leonid L.] Univ Florida, Whitney Lab Marine Biosci, Gainesville, FL USA; [Moroz, Leonid L.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Heyland, Andreas] Univ Guelph, Guelph, ON N1G 2W1, Canada	University of Washington; University of Washington Seattle; Indiana University System; Indiana University Bloomington; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Guelph	Hoekstra, LA (corresponding author), Univ Washington, Friday Harbor Labs, Seattle, WA 98195 USA.	aheyland@uoguelph.ca		Moroz, Leonid/0000-0002-1333-3176; Heyland, Andreas/0000-0002-7592-4473	Washington Research Foundation; NSERC [400230]; McKnight Brain Research Foundation; UF Opportunity Funds; United States National Institutes of Health [(NIH) 5R01GM097502, NIH 5R21RR025699, NIH 5R21DA030118];  [NSF IOS-1146575];  [NSF CNS-0821622]; Direct For Biological Sciences [1146575] Funding Source: National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030118] Funding Source: NIH RePORTER	Washington Research Foundation; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); McKnight Brain Research Foundation; UF Opportunity Funds; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors acknowledge funding from the Washington Research Foundation to LAH, the NSERC Discovery Grant (400230) and McKnight Brain Research Foundation Funds to AH, as well as UF Opportunity Funds, NSF IOS-1146575, NSF CNS-0821622, United States National Institutes of Health (NIH) 5R01GM097502, NIH 5R21RR025699 and NIH 5R21DA030118 to LLM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTIERI S M D L, 1986, Boletim de Fisiologia Animal (Sao Paulo), V10, P21; Angerer LM, 2011, DEVELOPMENT, V138, P3613, DOI 10.1242/dev.058172; Birenheide R, 1998, BIOL BULL-US, V194, P253, DOI 10.2307/1543095; Bourlat SJ, 2003, NATURE, V424, P925, DOI 10.1038/nature01851; Burke RD, 2006, DEV BIOL, V300, P434, DOI 10.1016/j.ydbio.2006.08.007; Burke RD, 2011, EVOL DEV, V13, P110, DOI 10.1111/j.1525-142X.2010.00460.x; COBB JLS, 1982, CELL TISSUE RES, V226, P675; COBB JLS, 1981, CELL TISSUE RES, V219, P197; COBB JLS, 1985, BIOL BULL, V168, P432, DOI 10.2307/1541523; COBB JLS, 1987, INVERTEBRATE NERVOUS, P483; Diaz-Balzac CA, 2007, BIOL BULL-US, V213, P28, DOI 10.2307/25066616; Diaz-Balzac CA, 2010, ZOOMORPHOLOGY, V129, P33, DOI 10.1007/s00435-009-0098-4; DIAZMIRANDA L, 1995, J COMP NEUROL, V352, P626, DOI 10.1002/cne.903520410; DIAZMIRANDA L, 1995, COMP BIOCHEM PHYS C, V110, P171, DOI 10.1016/0742-8413(94)00094-Q; DIAZMIRANDA L, 1992, BIOL BULL, V182, P241, DOI 10.2307/1542117; Elphick MR, 2001, J EXP BIOL, V204, P875; ELPHICK MR, 1995, J EXP BIOL, V198, P2519; Emanuel MB, 1999, CLIN EXP ALLERGY, V29, P1; Garcia-Arraras JE, 2001, J EXP BIOL, V204, P865; GARCIAARRARAS JE, 1991, NEUROSCI LETT, V132, P199, DOI 10.1016/0304-3940(91)90301-9; Heinzeller Thomas, 2001, P41; Hill RB, 1993, COMP PHYSL ECHINODER; Hyman LH, 1955, INVERTEBRATES ECHINO; Inoue M, 1999, P ROY SOC B-BIOL SCI, V266, P993, DOI 10.1098/rspb.1999.0735; Jacobs EH, 2000, TRENDS PHARMACOL SCI, V21, P293, DOI 10.1016/S0165-6147(00)01504-2; KOBZAR' G T, 1984, Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, V20, P419; LAI ZC, 1988, GENE DEV, V2, P173, DOI 10.1101/gad.2.2.173; Lambert P, 1997, SEA CUCUMBERS BRIT C; Leguia M, 2004, MOL BIOL CELL, V15, p431A; Leguia M, 2006, MOL REPROD DEV, V73, P1550, DOI 10.1002/mrd.20586; LORENZ W, 1973, GEN PHARMACOL, V4, P229; Mashanov VS, 2007, EVOL DEV, V9, P244, DOI 10.1111/j.1525-142X.2007.00157.x; Mashanov VS, 2010, GLIA, V58, P1581, DOI 10.1002/glia.21031; Mashanov VS, 2006, ZOOMORPHOLOGY, V125, P27, DOI 10.1007/s00435-005-0010-9; Mashanov VS, 2004, ACTA ZOOL-STOCKHOLM, V85, P29, DOI 10.1111/j.0001-7272.2004.00155.x; McCoole MD, 2011, J EXP BIOL, V214, P1773, DOI 10.1242/jeb.054486; MENDES E G, 1970, Comparative and General Pharmacology, V1, P11, DOI 10.1016/0010-4035(70)90003-0; METTRICK DF, 1965, COMP BIOCHEM PHYSIOL, V16, P547, DOI 10.1016/0010-406X(65)90318-X; MOTOKAWA T, 1984, BIOL REV, V59, P255, DOI 10.1111/j.1469-185X.1984.tb00409.x; Muneoka Y., 1995, Zoological Science (Tokyo), V12, P105; Muneoka Y, 2000, ACTA BIOL HUNG, V51, P111; PETERS BH, 1985, CELL TISSUE RES, V239, P219, DOI 10.1007/BF00214922; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; PROTAS LL, 1980, GEN PHARMACOL, V11, P113, DOI 10.1016/0306-3623(80)90019-1; Rasband W., 2006, IMAGEJ; REITE OB, 1972, PHYSIOL REV, V52, P778, DOI 10.1152/physrev.1972.52.3.778; SEWELL MA, 1994, MAR ECOL PROG SER, V114, P149, DOI 10.3354/meps114149; Smith SL, 1992, INVESTIGATION HISTAM, P89; STUBBS TR, 1981, CELL TISSUE RES, V220, P373; Sutherby J, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-14; Swanson RL, 2007, J EXP BIOL, V210, P3228, DOI 10.1242/jeb.004192; Swanson RL, 2006, MAR ECOL PROG SER, V314, P1, DOI 10.3354/meps314001; Swanson RL, 2012, MAR BIOL, V159, P915, DOI 10.1007/s00227-011-1869-2; Swanson RL, 2004, BIOL BULL-US, V206, P161, DOI 10.2307/1543640; Takahashi K, 1966, MUSCLE PHYSL, P513; VANDENSPIEGEL D, 1995, TISSUE CELL, V27, P457, DOI 10.1016/S0040-8166(95)80066-2; VON EULER U. S., 1952, ACTA PHYSIOL LATINOAMER, V2, P101; von Uexkull J, 1900, Z BIOL-MUNICH, V39, P73; Walker RJ, 2009, INVERTEBR NEUROSCI, V9, P111, DOI 10.1007/s10158-010-0097-7; WEISS KR, 1986, J NEUROSCI, V6, P2403; Witte I, 2002, J NEUROCHEM, V83, P504, DOI 10.1046/j.1471-4159.2002.01076.x; Wyman LC, 1930, J EXP ZOOL, V57, P441, DOI 10.1002/jez.1400570304	64	22	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44220	10.1371/journal.pone.0044220	http://dx.doi.org/10.1371/journal.pone.0044220			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970182	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400048
J	Miyasike-daSilva, V; McIlroy, WE				Miyasike-daSilva, Veronica; McIlroy, William E.			Does It Really Matter Where You Look When Walking on Stairs? Insights from a Dual-Task Study	PLOS ONE			English	Article							OBSTACLE AVOIDANCE; VISION; ADULTS; YOUNG; FALLS; GAIT; AGE	Although the visual system is known to provide relevant information to guide stair locomotion, there is less understanding of the specific contributions of foveal and peripheral visual field information. The present study investigated the specific role of foveal vision during stair locomotion and ground-stairs transitions by using a dual-task paradigm to influence the ability to rely on foveal vision. Fifteen healthy adults (26.9 +/- 3.3 years; 8 females) ascended a 7-step staircase under four conditions: no secondary tasks (CONTROL); gaze fixation on a fixed target located at the end of the pathway (TARGET); visual reaction time task (VRT); and auditory reaction time task (ART). Gaze fixations towards stair features were significantly reduced in TARGET and VRT compared to CONTROL and ART. Despite the reduced fixations, participants were able to successfully ascend stairs and rarely used the handrail. Step time was increased during VRT compared to CONTROL in most stair steps. Navigating on the transition steps did not require more gaze fixations than the middle steps. However, reaction time tended to increase during locomotion on transitions suggesting additional executive demands during this phase. These findings suggest that foveal vision may not be an essential source of visual information regarding stair features to guide stair walking, despite the unique control challenges at transition phases as highlighted by phase-specific challenges in dual-tasking. Instead, the tendency to look at the steps in usual conditions likely provides a stable reference frame for extraction of visual information regarding step features from the entire visual field.	[Miyasike-daSilva, Veronica; McIlroy, William E.] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; [McIlroy, William E.] Toronto Rehabil Inst, Mobil Team, Toronto, ON, Canada; [McIlroy, William E.] Heart & Stroke Fdn Ctr Stroke Recovery, Toronto, ON, Canada	University of Waterloo; University of Toronto; University Health Network Toronto; Toronto Rehabilitation Institute	Miyasike-daSilva, V (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.	wmcilroy@uwaterloo.ca		McIlroy, William/0000-0003-2319-1746	Natural Sciences and Engineering Research Council of Canada (NSERC); CAPES Foundation, Ministry of Education of Brazil	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CAPES Foundation, Ministry of Education of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the awards from the Natural Sciences and Engineering Research Council of Canada (NSERC) and CAPES Foundation, Ministry of Education of Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archea J., 1979, GUIDELINES STAIR SAF; BALL KK, 1988, J OPT SOC AM A, V5, P2210, DOI 10.1364/JOSAA.5.002210; Brabyn J, 2001, OPTOMETRY VISION SCI, V78, P264, DOI 10.1097/00006324-200105000-00008; Den Otter AR, 2011, GAIT POSTURE, V34, P169, DOI 10.1016/j.gaitpost.2011.04.004; Graci V, 2010, OPTOMETRY VISION SCI, V87, P21, DOI 10.1097/OPX.0b013e3181c1d547; King EC, 2010, EXP BRAIN RES, V207, P105, DOI 10.1007/s00221-010-2434-9; Marigold DS, 2007, EXP BRAIN RES, V176, P32, DOI 10.1007/s00221-006-0598-0; Miyasike-DaSilva V, 2011, EXP BRAIN RES, V209, P73, DOI 10.1007/s00221-010-2520-z; Ojha HA, 2009, PHYS THER, V89, P1080, DOI 10.2522/ptj.20080187; Patla AE, 1998, ECOL PSYCHOL, V10, P287, DOI 10.1207/s15326969eco103&4_7; SHELDON JH, 1960, BRIT MED J, V2, P1685, DOI 10.1136/bmj.2.5214.1685; SIMONEAU GG, 1991, J GERONTOL, V46, pM188, DOI 10.1093/geronj/46.6.M188; Siu KC, 2008, EXP BRAIN RES, V184, P115, DOI 10.1007/s00221-007-1087-9; Templer J.A., 1992, STAIRCASE STUDIES HA; WILD D, 1981, RHEUMATOL REHABIL, V20, P153, DOI 10.1093/rheumatology/20.3.153; Zietz D, 2009, J MOTOR BEHAV, V41, P357, DOI 10.3200/JMBR.41.4.357-366	16	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44722	10.1371/journal.pone.0044722	http://dx.doi.org/10.1371/journal.pone.0044722			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970297	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400112
J	Nakasujja, N; Allebeck, P; Agren, H; Musisi, S; Katabira, E				Nakasujja, Noeline; Allebeck, Peter; Agren, Hans; Musisi, Seggane; Katabira, Elly			Cognitive Dysfunction among HIV Positive and HIV Negative Patients with Psychosis in Uganda	PLOS ONE			English	Article							KYNURENIC ACID; SECONDARY MANIA; RISK-FACTORS; IMPAIRMENT; DEMENTIA; INFECTION; DISORDERS; DEPRESSION; VALIDITY; SCALE	Background: Cognitive impairment is an established phenomenon in HIV infected individuals and patients that have psychosis. However there is need to establish the severity of the impairment if patients are co morbid with both conditions. Aim: To compare cognitive function among HIV positive individuals and HIV negative individuals with psychosis. Methods: We recruited patients with psychosis at two national referral hospitals. A standardized demographics questionnaire and psychiatric, physical, and laboratory assessments were conducted. Types of psychosis were diagnosed using the Mini International Neuropsychiatric Inventory-PLUS while cognitive functioning was determined using the Mini mental state examination (MMSE) and a neuropsychological test battery. Follow-up assessments on cognitive function and severity of psychiatric illness were performed at 3 and 6 months. Pairwise comparison and multivariable logistic regression analysis were used to determine the differences between the HIV positive and HIV negative individuals. Results: There were 156 HIV positive and 322 HIV negative participants. The mean age was 33 years for the HIV positive group and 29 years for the HIV negative group (p<0.001). The HIV positive individuals were almost three times (OR = 2.62 CI 95% 1.69-4.06) more likely to be cognitively impaired on the MMSE as well as the following cognitive tests:- WHO-UCLA Auditory Verbal Learning Test (OR 1.79, 95% CI 1.09-2.92), Verbal Fluency (OR 3.42, 95% CI 2.24-5.24), Color Trails 1 (OR 2.03, 95% CI 1.29-3.02) and Color Trails 2 (OR 3.50 95% 2.00-6.10) all p = 0.01. There was improvement in cognitive function at follow up; however the impairment remained higher for the HIV positive group (p<0.001). Conclusion: Cognitive impairment in psychosis was worsened by HIV infection. Care plans to minimize the effect of this impairment should be structured for the management of individuals with HIV and psychosis.	[Nakasujja, Noeline; Musisi, Seggane] Makerere Univ, Coll Hlth Sci, Dept Psychiat, Kampala, Uganda; [Nakasujja, Noeline; Allebeck, Peter] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Agren, Hans] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden; [Katabira, Elly] Makerere Univ, Coll Hlth Sci, Dept Med, Kampala, Uganda	Makerere University; Karolinska Institutet; University of Gothenburg; Makerere University	Nakasujja, N (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Psychiat, Kampala, Uganda.	drnoeline@yahoo.com	Nakasujja, Noeline/GSI-4189-2022		Makerere University-Swedish International Development Cooperation Agency/Department for Research Cooperation cooperation grant	Makerere University-Swedish International Development Cooperation Agency/Department for Research Cooperation cooperation grant	Source of funding: Makerere University-Swedish International Development Cooperation Agency/Department for Research Cooperation cooperation grant. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Atlas A, 2007, BRAIN BEHAV IMMUN, V21, P86, DOI 10.1016/j.bbi.2006.02.005; Baran H, 2000, J NEURAL TRANSM, V107, P1127, DOI 10.1007/s007020070026; Bora E, 2010, SCHIZOPHRENIA BULL, V36, P36, DOI 10.1093/schbul/sbp094; De Ronchi D, 2000, INT J PSYCHIAT MED, V30, P173, DOI 10.2190/PLGX-N48F-RBHJ-UF8K; Dolder CR, 2004, AIDS, V18, pS35, DOI 10.1097/00002030-200401001-00006; Dube B, 2005, J PSYCHIATR NEUROSCI, V30, P237; ELMALLAKH RS, 1992, J CLIN PSYCHIAT, V53, P293; Fitzgerald D, 2004, AUST NZ J PSYCHIAT, V38, P501, DOI 10.1080/j.1440-1614.2004.01403.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GOLDBERG TE, 1995, CURR OPIN PSYCHIATR, V8, P34, DOI 10.1097/00001504-199501000-00009; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hill SK, 2009, SCHIZOPHR RES, V113, P167, DOI 10.1016/j.schres.2009.04.020; Hori H, 2006, SCHIZOPHR RES, V86, P138, DOI 10.1016/j.schres.2006.05.004; Horwah E, 2002, J INT ASS PHYS AIDS, V1, pS4; IACONO WG, 1992, AM J PSYCHIAT, V149, P1070; Kapiriri L, 2009, J AIDS HIV RES, V1, P034; Kipp W, 2010, AIDS CARE, V22, P271, DOI 10.1080/09540120903193625; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Maling S, 2011, AIDS CARE, V23, P171, DOI 10.1080/09540121.2010.498939; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; Nakimuli-Mpungu E, 2006, AM J PSYCHIAT, V163, P1349, DOI 10.1176/appi.ajp.163.8.1349; Nakimuli-Mpungu E, 2008, PSYCHOSOMATICS, V49, P530, DOI 10.1176/appi.psy.49.6.530; Nath A, 2008, INT REV PSYCHIATR, V20, P25, DOI 10.1080/09540260701861930; Nilsson LK, 2005, SCHIZOPHR RES, V80, P315, DOI 10.1016/j.schres.2005.07.013; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Robertson KR, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-8; Sacktor N, 2006, NEUROLOGY, V67, P311, DOI 10.1212/01.wnl.0000225183.74521.72; Sacktor NC, 2005, AIDS, V19, P1367; Sacktor NC, 2000, J NEUROVIROL, V6, P84, DOI 10.3109/13550280009006385; SCHMAND B, 1994, PSYCHOL MED, V24, P869, DOI 10.1017/S0033291700028968; SEWELL DD, 1994, AM J PSYCHIAT, V151, P237; Shapshak P, 2011, AIDS, V25, P123, DOI 10.1097/QAD.0b013e328340fd42; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Starace F, 2002, ACTA PSYCHIAT SCAND, V106, P20, DOI 10.1034/j.1600-0447.2002.02289.x; Wong MH, 2007, NEUROLOGY, V68, P350, DOI 10.1212/01.wnl.0000252811.48891.6d; YOUNG RC, 1978, BRIT J PSYCHIAT, V133, P429, DOI 10.1192/bjp.133.5.429	37	19	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44415	10.1371/journal.pone.0044415	http://dx.doi.org/10.1371/journal.pone.0044415			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970214	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400068
J	Sahni, J; Song, YM; Scharenberg, AM				Sahni, Jaya; Song, Yumei; Scharenberg, Andrew M.			The B. subtilis MgtE Magnesium Transporter Can Functionally Compensate TRPM7-Deficiency in Vertebrate B-Cells	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; HUMAN SOLUTE CARRIER; CORA MG2+ CHANNEL; SALMONELLA-ENTERICA; PLASMA-MEMBRANE; SLC41A1; TRPM7; VIRULENCE; PROTEIN; AGGREGATION	Recent studies have shown that the vertebrate magnesium transporters Solute carrier family 41, members 1 and 2 (SLC41A1, SLC41A2) and Magnesium transporter subtype 1 (MagT1) can endow vertebrate B-cells lacking the ion-channel kinase Transient receptor potential cation channel, subfamily M, member 7 (TRPM7) with a capacity to grow and proliferate. SLC41A1 and SLC41A2 display distant homology to the prokaryotic family of Mg2+ transporters, MgtE, first characterized in Bacillus subtilis. These sequence similarities prompted us to investigate whether MgtE could potentially compensate for the lack of TRPM7 in the vertebrate TRPM7-deficient DT40 B-cell model system. Here, we report that overexpression of MgtE is able to rescue the growth of TRPM7-KO DT40 B-cells. However, contrary to a previous report that describes regulation of MgtE channel gating by Mg2+ in a bacterial spheroplast model system, whole cell patch clamp analysis revealed no detectable current development in TRPM7-deficient cells expressing MgtE. In addition, we observed that MgtE expression is strongly downregulated at high magnesium concentrations, similar to what has been described for its vertebrate homolog, SLC41A1. We also show that the N-terminal cytoplasmic domain of MgtE is required for normal MgtE channel function, functionally confirming the predicted importance of this domain in regulation of MgtE-mediated Mg2+ entry. Overall, our findings show that consistent with its proposed function, Mg2+ uptake mediated by MgtE is able to restore cell growth and proliferation of TRPM7-deficient cells and supports the concept of functional homology between MgtE and its vertebrate homologs.	[Sahni, Jaya; Song, Yumei; Scharenberg, Andrew M.] Seattle Childrens Res Inst, Seattle, WA USA; [Scharenberg, Andrew M.] Univ Washington, Dept Pediat & Immunol, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle	Sahni, J (corresponding author), Seattle Childrens Res Inst, Seattle, WA USA.	slc41a2@gmail.com; andrewms@u.washington.edu			National Institutes of Health [P01GM078195, GM64316]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064316, P01GM078195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants P01GM078195 and GM64316 to AMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson GG, 2010, INFECT IMMUN, V78, P1239, DOI 10.1128/IAI.00865-09; Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Caldwell RA, 2011, AM J PHYSIOL-LUNG C, V301, pL346, DOI 10.1152/ajplung.00044.2011; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Deason-Towne F, 2011, FEBS LETT, V585, P2275, DOI 10.1016/j.febslet.2011.05.052; Goytain A, 2005, PHYSIOL GENOMICS, V21, P337, DOI 10.1152/physiolgenomics.00261.2004; Goytain A, 2005, BIOCHEM BIOPH RES CO, V330, P701, DOI 10.1016/j.bbrc.2005.03.037; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Hattori M, 2009, EMBO J, V28, P3602, DOI 10.1038/emboj.2009.288; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Kolisek M, 2008, J BIOL CHEM, V283, P16235, DOI 10.1074/jbc.M707276200; KOLLING R, 1994, EMBO J, V13, P3261, DOI 10.1002/j.1460-2075.1994.tb06627.x; Lejona S, 2003, J BACTERIOL, V185, P6287, DOI 10.1128/JB.185.21.6287-6294.2003; Li FY, 2011, NATURE, V475, P471, DOI 10.1038/nature10246; Maguire ME, 2006, FRONT BIOSCI-LANDMRK, V11, P3149, DOI 10.2741/2039; Mandt T, 2011, BIOCHEM J, V439, P129, DOI 10.1042/BJ20110807; McLane MW, 2007, SYNAPSE, V61, P875, DOI 10.1002/syn.20438; Merino S, 2001, FEMS MICROBIOL LETT, V198, P189, DOI 10.1111/j.1574-6968.2001.tb10641.x; Moomaw AS, 2008, PHYSIOLOGY, V23, P275, DOI 10.1152/physiol.00019.2008; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; O'Connor K, 2009, P NATL ACAD SCI USA, V106, P17522, DOI 10.1073/pnas.0906160106; Papp-Wallace KM, 2008, J BACTERIOL, V190, P6517, DOI 10.1128/JB.00772-08; Papp-Wallace KM, 2008, J BACTERIOL, V190, P6509, DOI 10.1128/JB.00144-08; Retamal P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005551; Runnels LW, 2011, CURR PHARM BIOTECHNO, V12, P42; Sagne C, 1996, BIOCHEM J, V316, P825, DOI 10.1042/bj3160825; Sahni J, 2007, BIOCHEM J, V401, P505, DOI 10.1042/BJ20060673; Sahni J, 2010, CELL CYCLE, V9, P3565, DOI 10.4161/cc.9.17.12798; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Smith RL, 1998, J BACTERIOL, V180, P2788, DOI 10.1128/JB.180.10.2788-2791.1998; Sponder G, 2010, MAGNESIUM RES, V23, P105, DOI 10.1684/mrh.2010.0206; Stankewich MC, 1998, P NATL ACAD SCI USA, V95, P14158, DOI 10.1073/pnas.95.24.14158; TOWNSEND DE, 1995, J BACTERIOL, V177, P5350, DOI 10.1128/jb.177.18.5350-5354.1995; Vilas GL, 2011, BIOCHEMISTRY-US, V50, P2157, DOI 10.1021/bi101887z; Wabakken T, 2003, BIOCHEM BIOPH RES CO, V306, P718, DOI 10.1016/S0006-291X(03)01030-1; Wolf Federica I, 2011, Magnes Res, V24, pS86, DOI 10.1684/mrh.2011.0288; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106; Zsurka G, 2001, GENOMICS, V72, P158, DOI 10.1006/geno.2000.6407	38	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44452	10.1371/journal.pone.0044452	http://dx.doi.org/10.1371/journal.pone.0044452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970223	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400074
J	Hitt, B; Riordan, SM; Kukreja, L; Eimer, WA; Rajapaksha, TW; Vassar, R				Hitt, Brian; Riordan, Sean M.; Kukreja, Lokesh; Eimer, William A.; Rajapaksha, Tharinda W.; Vassar, Robert			beta-Site Amyloid Precursor Protein (APP)-cleaving Enzyme 1 (BACE1)-deficient Mice Exhibit a Close Homolog of L1 (CHL1) Loss-of-function Phenotype Involving Axon Guidance Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURAL-CELL-ADHESION; OLFACTORY SENSORY NEURONS; ALZHEIMERS-DISEASE; MEMORY DEFICITS; KNOCKOUT MICE; A-BETA; SECRETASE; BACE1; MOLECULES; CLEAVAGE	BACE1 is the beta-secretase enzyme that initiates production of the beta-amyloid peptide involved in Alzheimer disease. However, little is known about the functions of BACE1. BACE1-deficient mice exhibit mild but complex neurological phenotypes suggesting therapeutic BACE1 inhibition may not be completely free of mechanism-based side effects. Recently, we have reported that BACE1 null mice have axon guidance defects in olfactory sensory neuron projections to glomeruli in the olfactory bulb. Here, we show that BACE1 deficiency also causes an axon guidance defect in the hippocampus, a shortened and disorganized infrapyramidal bundle of the mossy fiber projection from the dentate gyrus to CA3. Although we observed that a classical axon guidance molecule, EphA4, was cleaved by BACE1 when co-expressed with BACE1 in HEK293 cells, we could find no evidence of BACE1 processing of EphA4 in the brain. Remarkably, we discovered that the axon guidance defects of BACE1(-/-) mice were strikingly similar to those of mice deficient in a recently identified BACE1 substrate, the neural cell adhesion molecule close homolog of L1 (CHL1) that is involved in neurite outgrowth. CHL1 undergoes BACE1-dependent processing in BACE1(-/-), but not BACE1(-/-), hippocampus, and olfactory bulb, indicating that CHL1 is a BACE1 substrate in vivo. Finally, BACE1 and CHL1 co-localize in the terminals of hippocampal mossy fibers, olfactory sensory neuron axons, and growth cones of primary hippocampal neurons. We conclude that BACE1(-/-) axon guidance defects are likely the result of abrogated BACE1 processing of CHL1 and that BACE1 deficiency produces a CHL1 loss-of-function phenotype. Our results imply the possibility that axon mis-targeting may occur in adult neurogenic and/or regenerating neurons as a result of chronic BACE1 inhibition and add a note of caution to BACE1 inhibitor development.	[Hitt, Brian; Riordan, Sean M.; Kukreja, Lokesh; Eimer, William A.; Rajapaksha, Tharinda W.; Vassar, Robert] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Vassar, R (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	r-vassar@northwestern.edu	Riordan, Sean Michael/A-9053-2012	Riordan, Sean Michael/0000-0001-5727-1221; Eimer, William/0000-0003-1067-9339; Hitt, Brian/0000-0001-8720-6762	National Institutes of Health [R01AG022560]; Northwestern University Mechanisms of Aging and Dementia Training Grant [T32 AG20506]; Drug Discovery in Age-related Disorders Training Grant [T32 AG260-12]; Medical Scientist Training Program Training Grant [T32 GM08152-19]; Cellular and Molecular Basis of Disease Training Grant [T32 GM08061]; American Health Assistance Foundation Grant [A2012063]; National Institutes of Health from NCI [CCSG P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008061, T32GM008152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022560, T32AG020506, R01AG026012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Mechanisms of Aging and Dementia Training Grant; Drug Discovery in Age-related Disorders Training Grant; Medical Scientist Training Program Training Grant; Cellular and Molecular Basis of Disease Training Grant; American Health Assistance Foundation Grant; National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AG022560 (to R. V.), Northwestern University Mechanisms of Aging and Dementia Training Grant T32 AG20506 (to L. K.), Drug Discovery in Age-related Disorders Training Grant T32 AG260-12 (to S. R.), Medical Scientist Training Program Training Grant T32 GM08152-19, and Cellular and Molecular Basis of Disease Training Grant T32 GM08061 (to B. H.). This work was also supported by American Health Assistance Foundation Grant A2012063 (to R. V.).; We acknowledge the Getsios (Northwestern University) and the Sakaguchi (Wakayama Medical University) laboratories for providing the EphA4 plasmids used in this work. We thank Drs. Aryeh Routtenberg, Adriana Ferreira, and Thomas Bozza (Northwestern University) for helpful discussions. Confocal imaging work was performed at the Northwestern University Cell Imaging Facility generously supported by National Institutes of Health Grants CCSG P30 CA060553 from NCI awarded to the Robert H. Lurie Comprehensive Cancer Center. Growth cone collapse imaging and axon length measurement was accomplished through the generosity of Keyence Corp. (Japan).	Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cao LX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00231; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Crusio WE, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-3; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Galimberti I, 2010, NEURON, V65, P627, DOI 10.1016/j.neuron.2010.02.016; Giaccone G, 2010, ACTA NEUROPATHOL, V120, P803, DOI 10.1007/s00401-010-0747-1; Guaiquil V, 2009, MOL CELL BIOL, V29, P2694, DOI 10.1128/MCB.01460-08; Guaiquil VH, 2010, J MOL MED, V88, P497, DOI 10.1007/s00109-010-0591-8; Hemming ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008477; Heyden A, 2008, NEUROSCIENCE, V155, P221, DOI 10.1016/j.neuroscience.2008.04.080; Hitt BD, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-31; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hu XY, 2010, J NEUROSCI, V30, P8819, DOI 10.1523/JNEUROSCI.1334-10.2010; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Inoue E, 2009, J CELL BIOL, V185, P551, DOI 10.1083/jcb.200809151; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kuhn PH, 2012, EMBO J, V31, P3157, DOI 10.1038/emboj.2012.173; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Maretzky T, 2005, MOL CELL BIOL, V25, P9040, DOI 10.1128/MCB.25.20.9040-9053.2005; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Naus S, 2004, J BIOL CHEM, V279, P16083, DOI 10.1074/jbc.M400560200; O'Leary DDM, 2005, PROG BRAIN RES, V147, P43, DOI 10.1016/S0079-6123(04)47005-8; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Rajapaksha TW, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-88; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Schlatter MC, 2008, J NEUROCHEM, V104, P731, DOI 10.1111/j.1471-4159.2007.05013.x; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wright AG, 2007, J NEUROSCI, V27, P13667, DOI 10.1523/JNEUROSCI.2888-07.2007; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan XX, 2007, J COMP NEUROL, V501, P52, DOI 10.1002/cne.21239; Zhao J, 2007, J NEUROSCI, V27, P3639, DOI 10.1523/JNEUROSCI.4396-06.2007; Zhou LJ, 2012, J BIOL CHEM, V287, P25927, DOI 10.1074/jbc.M112.377465	57	111	113	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38408	38425		10.1074/jbc.M112.415505	http://dx.doi.org/10.1074/jbc.M112.415505			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22988240	Green Published, hybrid			2022-12-25	WOS:000310982800001
J	Lee, CF; Bird, S; Shaw, M; Jean, L; Vaux, DJ				Lee, Chiu Fan; Bird, Sarah; Shaw, Michael; Jean, Letitia; Vaux, David J.			Combined Effects of Agitation, Macromolecular Crowding, and Interfaces on Amyloidogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AIR-WATER-INTERFACE; BETA-AMYLOID PEPTIDE; ALPHA-SYNUCLEIN; SURFACE-TENSION; PHYSIOLOGICAL CONSEQUENCES; EXPERIMENTAL CONSTRAINTS; ADSORPTION-KINETICS; PROTEIN AGGREGATION; PARKINSONS-DISEASE; GLOBULAR-PROTEINS	Amyloid formation and accumulation is a hallmark of protein misfolding diseases and is associated with diverse pathologies including type II diabetes and Alzheimer's disease (AD). In vitro, amyloidogenesis is widely studied in conditions that do not simulate the crowded and viscous in vivo environment. A high volume fraction of most biological fluids is occupied by various macromolecules, a phenomenon known as macromolecular crowding. For some amyloid systems (e.g. alpha-synuclein) and under shaking condition, the excluded volume effect of macromolecular crowding favors aggregation, whereas increased viscosity reduces the kinetics of these reactions. Amyloidogenesis can also be catalyzed by hydrophobic-hydrophilic interfaces, represented by the air-water interface in vitro and diverse heterogeneous interfaces in vivo (e.g. membranes). In this study, we investigated the effects of two different crowding polymers (dextran and Ficoll) and two different experimental conditions (with and without shaking) on the fibrilization of amyloid-beta peptide, a major player in AD pathogenesis. Specifically, we demonstrate that, during macromolecular crowding, viscosity dominates over the excluded volume effect only when the system is spatially non homogeneous (i.e. an air-water interface is present). We also show that the surfactant activity of the crowding agents can critically influence the outcome of macromolecular crowding and that the structure of the amyloid species formed may depend on the polymer used. This suggests that, in vivo, the outcome of amyloidogenesis may be affected by both macromolecular crowding and spatial heterogeneity (e.g. membrane turn-over). More generally, our work suggests that any factors causing changes in crowding may be susceptibility factors in AD.	[Shaw, Michael; Jean, Letitia; Vaux, David J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Lee, Chiu Fan] Max Planck Inst Phys Komplexer Syst, D-01187 Dresden, Germany; [Bird, Sarah] Univ Oxford, Sch Clin, John Radcliffe Hosp, Med Sch,Med Sci Off, Oxford OX3 9DU, England	University of Oxford; Max Planck Society; University of Oxford	Vaux, DJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	david.vaux@path.ox.ac.uk		Vaux, David/0000-0002-4901-9795; Lee, Chiu Fan/0000-0003-4363-9050	Synaptica Ltd	Synaptica Ltd	This work was supported by a research grant from Synaptica Ltd (to L. J.).	Alvarez-Martinez MT, 2011, BBA-PROTEINS PROTEOM, V1814, P1305, DOI 10.1016/j.bbapap.2011.05.016; Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; BARBER BJ, 1995, J GERONTOL A-BIOL, V50, pB282, DOI 10.1093/gerona/50A.5.B282; Bokvist M, 2007, J AM CHEM SOC, V129, P14848, DOI 10.1021/ja076059o; Chi EY, 2010, BIOPHYS J, V98, P2299, DOI 10.1016/j.bpj.2010.01.056; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cottingham MG, 2004, LAB INVEST, V84, P523, DOI 10.1038/labinvest.3700054; Dupuis NF, 2009, J AM CHEM SOC, V131, P18283, DOI 10.1021/ja903814q; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hatters DM, 2002, J BIOL CHEM, V277, P7824, DOI 10.1074/jbc.M110429200; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; Jean L, 2012, BIOPHYS J, V102, P1154, DOI 10.1016/j.bpj.2012.01.041; Jean L, 2010, FASEB J, V24, P309, DOI 10.1096/fj.09-137653; Jiang DL, 2009, J PHYS CHEM B, V113, P3160, DOI 10.1021/jp8085792; Krishnan A, 2003, LANGMUIR, V19, P10342, DOI 10.1021/la035308t; Lee CF, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031922; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LIN SY, 1995, LANGMUIR, V11, P555, DOI 10.1021/la00002a033; Lopes DHJ, 2007, BIOPHYS J, V93, P3132, DOI 10.1529/biophysj.107.110635; LUBYPHELPS K, 1987, P NATL ACAD SCI USA, V84, P4910, DOI 10.1073/pnas.84.14.4910; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2000, BIOPHYS J, V78, P101, DOI 10.1016/S0006-3495(00)76576-3; Morinaga A, 2010, BBA-PROTEINS PROTEOM, V1804, P986, DOI 10.1016/j.bbapap.2010.01.012; Morris VK, 2011, J BIOL CHEM, V286, P15955, DOI 10.1074/jbc.M110.214197; Mukherjee S, 2009, J MOL BIOL, V393, P227, DOI 10.1016/j.jmb.2009.08.016; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; NABER D, 1979, EXP GERONTOL, V14, P59, DOI 10.1016/0531-5565(79)90010-X; Nagy I Z, 1982, Exp Brain Res, VSuppl 5, P118; Parhi P, 2009, BIOMATERIALS, V30, P6814, DOI 10.1016/j.biomaterials.2009.09.005; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Pronchik J, 2010, J AM CHEM SOC, V132, P9797, DOI 10.1021/ja102896h; ROTENBERG Y, 1983, J COLLOID INTERF SCI, V93, P169, DOI 10.1016/0021-9797(83)90396-X; SEGUR JB, 1951, IND ENG CHEM, V43, P2117, DOI 10.1021/ie50501a040; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; SNYDER SW, 1994, BIOPHYS J, V67, P1216, DOI 10.1016/S0006-3495(94)80591-0; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sukenik S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015608; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; TRIPP BC, 1995, J COLLOID INTERF SCI, V173, P16, DOI 10.1006/jcis.1995.1291; Uversky VN, 2002, FEBS LETT, V515, P99, DOI 10.1016/S0014-5793(02)02446-8; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Wenner JR, 1999, BIOPHYS J, V77, P3234, DOI 10.1016/S0006-3495(99)77154-7; Zhou BR, 2008, BBA-PROTEINS PROTEOM, V1784, P472, DOI 10.1016/j.bbapap.2008.01.004; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; Zhou Z, 2009, J BIOL CHEM, V284, P30148, DOI 10.1074/jbc.M109.002832	59	54	54	0	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.400580	http://dx.doi.org/10.1074/jbc.M112.400580			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988239	Green Published, hybrid			2022-12-25	WOS:000310642200035
J	Wawra, S; Agacan, M; Boddey, JA; Davidson, I; Gachon, CMM; Zanda, M; Grouffaud, S; Whisson, SC; Birch, PRJ; Porter, AJ; van West, P				Wawra, Stephan; Agacan, Mark; Boddey, Justin A.; Davidson, Ian; Gachon, Claire M. M.; Zanda, Matteo; Grouffaud, Severine; Whisson, Stephen C.; Birch, Paul R. J.; Porter, Andy J.; van West, Pieter			Avirulence Protein 3a (AVR3a) from the Potato Pathogen Phytophthora infestans Forms Homodimers through Its Predicted Translocation Region and Does Not Specifically Bind Phospholipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RXLR EFFECTOR AVR3A; ANIMAL HOST-CELLS; MOLECULAR CHAPERONE; PLANT IMMUNITY; CROSS-LINKING; OOMYCETE; DNAK; DIMERIZATION; MECHANISM; HSP70	The mechanism of translocation of RxLR effectors from plant pathogenic oomycetes into the cytoplasm of their host is currently the object of intense research activity and debate. Here, we report the biochemical and thermodynamic characterization of the Phytophthora infestans effector AVR3a in vitro. We show that the amino acids surrounding the RxLR leader mediate homodimerization of the protein. Dimerization was considerably attenuated by a localized mutation within the RxLR motif that was previously described to prevent translocation of the protein into host. Importantly, we confirm that the reported phospholipid-binding properties of AVR3a are mediated by its C-terminal effector domain, not its RxLR leader. However, we show that the observed phospholipid interaction is attributable to a weak association with denatured protein molecules and is therefore most likely physiologically irrelevant.	[Wawra, Stephan; Grouffaud, Severine; van West, Pieter] Univ Aberdeen, Aberdeen Oomycete Lab, Coll Life Sci & Med, Aberdeen AB25 2ZD, Scotland; [Davidson, Ian] Univ Aberdeen, Prote Facil, Aberdeen AB25 2ZD, Scotland; [Zanda, Matteo] Univ Aberdeen, Kosterlitz Ctr Therapeut, Aberdeen AB25 2ZD, Scotland; [Porter, Andy J.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Agacan, Mark] Univ Dundee, Prote Facil, Coll Life Sci, Dundee DD1 5EH, Scotland; [Boddey, Justin A.] Univ Melbourne, Walter & Eliza Hall Inst, Div Infect & Immun, Parkville, Vic 3052, Australia; [Boddey, Justin A.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Gachon, Claire M. M.] Scottish Marine Inst, Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland; [Zanda, Matteo] CNR, Ist Chim Riconoscimento Mol, I-20131 Milan, Italy; [Birch, Paul R. J.] Univ Dundee JHI, Coll Life Sci, Div Plant Sci, Dundee DD2 5DA, Scotland; [Grouffaud, Severine; Whisson, Stephen C.; Birch, Paul R. J.] Univ Dundee JHI, James Hutton Inst, Dundee DD2 5DA, Scotland	University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Aberdeen; University of Dundee; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; UHI Millennium Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); University of Dundee; James Hutton Institute; University of Dundee	Wawra, S (corresponding author), Univ Aberdeen, Aberdeen Oomycete Lab, Coll Life Sci & Med, Foresterhill, Aberdeen AB25 2ZD, Scotland.	s.wawra@abdn.ac.uk; p.vanwest@abdn.ac.uk	Wawra, Stephan/D-2781-2013; Zanda, Matteo/AAC-2391-2022	Wawra, Stephan/0000-0001-8555-1618; Gachon, Claire/0000-0002-3702-7472; Boddey, Justin/0000-0001-7322-2040; van West, Pieter/0000-0002-0767-6017; Birch, Paul/0000-0002-6559-3746	Biotechnology and Biological Sciences Research Council (BBSRC); Natural Environmental Research Council (NERC); University of Aberdeen; University of Dundee; Scottish Government Rural and Environmental Science Analytical Services Division (RESAS); Royal Society; BBSRC [BB/E007120/1, BB/G015244/1] Funding Source: UKRI; NERC [NE/J00460X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E007120/1, BB/G015244/1] Funding Source: researchfish; Natural Environment Research Council [NE/J00460X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Aberdeen; University of Dundee; Scottish Government Rural and Environmental Science Analytical Services Division (RESAS); Royal Society(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC; to S. W., P. R. J. B., A. J. P., and P. v. W.), the Natural Environmental Research Council (NERC; to S. W., C. M. M. G., and P. v. W.), the University of Aberdeen (to S. G., I. D., A. J. P., M. Z., and P. v. W.), the University of Dundee (to M. A. and P. R. J. B.), the Scottish Government Rural and Environmental Science Analytical Services Division (RESAS; to S. C. W.), and The Royal Society (to P. v. W.).	Armstrong MR, 2005, P NATL ACAD SCI USA, V102, P7766, DOI 10.1073/pnas.0500113102; Birch PRJ, 2006, TRENDS MICROBIOL, V14, P8, DOI 10.1016/j.tim.2005.11.007; Bos JIB, 2006, PLANT J, V48, P165, DOI 10.1111/j.1365-313X.2006.02866.x; Bos JIB, 2010, P NATL ACAD SCI USA, V107, P9909, DOI 10.1073/pnas.0914408107; Boutemy LS, 2011, J BIOL CHEM, V286, P35834, DOI 10.1074/jbc.M111.262303; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; BURROWS SD, 1994, BIOCHEMISTRY-US, V33, P12741, DOI 10.1021/bi00209a002; Ellis JG, 2011, P NATL ACAD SCI USA, V108, P14381, DOI 10.1073/pnas.1111668108; Ellis R. John, 1999, Current Opinion in Structural Biology, V9, P102, DOI 10.1016/S0959-440X(99)80013-X; Fidzinski P, 2012, BRAIN RES, V1430, P1, DOI 10.1016/j.brainres.2011.10.040; Gan PHP, 2010, PLANT SIGNAL BEHAV, V5, P1272, DOI 10.4161/psb.5.10.13013; Gu BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027217; Kale SD, 2011, CELL MICROBIOL, V13, P1839, DOI 10.1111/j.1462-5822.2011.01659.x; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Matulis D, 2000, J MOL BIOL, V296, P1053, DOI 10.1006/jmbi.1999.3470; Nickerson DP, 1997, PROTEIN ENG, V10, P1357, DOI 10.1093/protein/10.12.1357; Packschies L, 1997, BIOCHEMISTRY-US, V36, P3417, DOI 10.1021/bi962835l; Phillips AJ, 2008, TRENDS MICROBIOL, V16, P13, DOI 10.1016/j.tim.2007.10.013; PHIZICKY EM, 1995, MICROBIOL REV, V59, P94, DOI 10.1128/MMBR.59.1.94-123.1995; Plett JM, 2011, CURR BIOL, V21, P1197, DOI 10.1016/j.cub.2011.05.033; Rehmany AP, 2005, PLANT CELL, V17, P1839, DOI 10.1105/tpc.105.031807; Russell R, 1998, BIOCHEMISTRY-US, V37, P596, DOI 10.1021/bi972025p; Slepenkov SV, 2002, MOL MICROBIOL, V45, P1197, DOI 10.1046/j.1365-2958.2002.03093.x; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; Toews J, 2008, ANAL CHIM ACTA, V618, P168, DOI 10.1016/j.aca.2008.04.049; Wawra S, 2012, P NATL ACAD SCI USA, V109, P2096, DOI 10.1073/pnas.1113775109; Whisson SC, 2007, NATURE, V450, P115, DOI 10.1038/nature06203; Yaeno T, 2011, P NATL ACAD SCI USA, V108, P14682, DOI 10.1073/pnas.1106002108	29	25	29	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.395129	http://dx.doi.org/10.1074/jbc.M112.395129			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977236	Green Published, hybrid			2022-12-25	WOS:000310642200044
J	Ben-Lulu, S; Pollak, Y; Mogilner, J; Bejar, J; Coran, AG; Sukhotnik, I				Ben-Lulu, Shani; Pollak, Yulia; Mogilner, Jorge; Bejar, Jacob; Coran, Arnold G.; Sukhotnik, Igor			Dietary Transforming Growth Factor-Beta 2 (TGF-beta 2) Supplementation Reduces Methotrexate-Induced Intestinal Mucosal Injury in a Rat	PLOS ONE			English	Article							APOPTOSIS; CELLS; PROLIFERATION; CHEMOTHERAPY; EXPRESSION; MUCOSITIS	Background/Aims: Dietary supplementation with transforming growth factor-beta (TGF-beta) has been proven to minimize intestinal damage and facilitate regeneration after mucosal injury. In the present study, we evaluated the effects of oral TGF-beta 2 supplementation on intestinal structural changes, enterocyte proliferation and apoptosis following methotrexate (MTX)-induced intestinal damage in a rat and in a cell culture model. Methods: Caco-2 cells were treated with MTX and were incubated with increasing concentrations of TGF-beta 2. Cell apoptosis was assessed using FACS analysis by annexin staining and cell viability was monitored using Trypan Blue assay. Male rats were divided into four experimental groups: Control rats, CONTR-TGF-beta rats were treated with diet enriched with TGF-beta 2, MTX rats were treated with a single dose of methotrexate, and MTX-TGF-beta rats were treated with diet enriched with TGF-b beta 2. Intestinal mucosal damage, mucosal structural changes, enterocyte proliferation and enterocyte apoptosis were determined at sacrifice. Real Time PCR and Western blot were used to determine bax and bcl-2 mRNA, p-ERK, beta-catenin, IL-1B and bax protein expression. Results: Treatment of MTX-pretreated Caco-2 cells with TGF-B2 resulted in increased cell viability and decreased cell apoptosis. Treatment of MTX-rats with TGF-beta 2 resulted in a significant increase in bowel and mucosal weight, DNA and protein content, villus-height (ileum), crypt-depth (jejunum), decreased intestinal-injury score, decreased level of apoptosis and increased cell proliferation in jejunum and ileum compared to the untreated MTX group. MTX-TGF-beta 2 rats demonstrated a lower bax mRNA and protein levels as well as increased bcl-2 mRNA levels in jejunum and ileum compared to MTX group. Treatment with TGF-beta 2 also led to increased pERK, IL-1B and beta-catenin protein levels in intestinal mucosa. Conclusions: Treatment with TGF-beta 2 prevents mucosal-injury, enhances p-ERK and beta-catenin induced enterocyte proliferation, inhibits enterocyte apoptosis and improves intestinal recovery following MTX-induced intestinal-mucositis in rats.	[Ben-Lulu, Shani; Pollak, Yulia; Sukhotnik, Igor] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Lab Intestinal Adaptat & Recovery, IL-31096 Haifa, Israel; [Mogilner, Jorge; Sukhotnik, Igor] Bnai Zion Med Ctr, Dept Pediat Surg, Haifa, Israel; [Bejar, Jacob] Bnai Zion Med Ctr, Dept Pathol, Haifa, Israel; [Coran, Arnold G.] Univ Michigan, CS Mott Childrens Hosp, Pediat Surg Sect, Ann Arbor, MI 48109 USA; [Coran, Arnold G.] Univ Michigan, Sch Med, Ann Arbor, MI USA	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Bnai Zion Medical Center; Bnai Zion Medical Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ben-Lulu, S (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Lab Intestinal Adaptat & Recovery, POB 9649, IL-31096 Haifa, Israel.	igor-dr@internet-zahav.net			Israeli Ministry of Health [3/6164]	Israeli Ministry of Health	This work was supported by a research grant from Israeli Ministry of Health No 3/6164 from 01/06/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALISON MR, 1994, CELL BIOL INT, V18, P1, DOI 10.1006/cbir.1994.1001; Biasi F, 2006, FREE RADICAL BIO MED, V41, P443, DOI 10.1016/j.freeradbiomed.2006.04.005; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Dignass AU, 2001, EUR J GASTROEN HEPAT, V13, P763, DOI 10.1097/00042737-200107000-00002; Dufour C, 2008, AM J PHYSIOL-ENDOC M, V294, pE794, DOI 10.1152/ajpendo.00791.2007; Elvers M, 2005, MECH DEVELOP, V122, P587, DOI 10.1016/j.mod.2004.10.012; Genestier L, 1998, J CLIN INVEST, V102, P322, DOI 10.1172/JCI2676; GOLDMAN ID, 1985, PHARMACOL THERAPEUT, V28, P77, DOI 10.1016/0163-7258(85)90083-X; GORDON JI, 1994, CURR OPIN CELL BIOL, V6, P795, DOI 10.1016/0955-0674(94)90047-7; Harsha WTF, 2006, J PEDIATR GASTR NUTR, V42, P53, DOI 10.1097/01.mpg.0000189136.06151.7a; Huang X, 2011, J DENT RES, V90, P981, DOI 10.1177/0022034511408613; Keefe DMK, 2004, SUPPORT CARE CANCER, V12, P6, DOI 10.1007/s00520-003-0550-9; Keefe DMK, 2000, GUT, V47, P632, DOI 10.1136/gut.47.5.632; Kim YJ, 2009, EXPERT OPIN DRUG SAF, V8, P451, DOI 10.1517/14740330903066734; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kol TC, 1998, ONCOGENE, V16, P3445; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Mei J, 2005, BRIT J NUTR, V93, P37, DOI 10.1079/BJN20041302; Naidu MUR, 2004, NEOPLASIA, V6, P423, DOI 10.1593/neo.04169; Nakayama GR, 1997, J IMMUNOL METHODS, V204, P205, DOI 10.1016/S0022-1759(97)00043-4; PARK PO, 1990, SURGERY, V107, P574; Pritchard DM, 1998, CANCER RES, V58, P5453; Sancho P, 2004, WASTE MANAGE, V24, P919, DOI 10.1016/j.wasman.2004.04.003; Savion S, 2009, TOXICOL IN VITRO, V23, P1062, DOI 10.1016/j.tiv.2009.06.004; Singla DK, 2011, AM J PHYSIOL-HEART C, V300, pH1442, DOI 10.1152/ajpheart.00917.2010; Sonis ST, 2004, CANCER-AM CANCER SOC, V100, P1995, DOI 10.1002/cncr.20162; Sonis ST, 2004, NAT REV CANCER, V4, P277, DOI 10.1038/nrc1318; Sonis Stephen T., 1993, P2381; van de Wetering M, 2002, CELL, V109, pS13, DOI 10.1016/S0092-8674(02)00709-2; Verburg M, 2000, AM J PHYSIOL-GASTR L, V279, pG1037, DOI 10.1152/ajpgi.2000.279.5.G1037; Vizio B, 2005, BIOFACTORS, V24, P237, DOI 10.1002/biof.5520240128; Walia B, 2003, FASEB J, V17, P2130, DOI 10.1096/fj.02-1211fje; Winesett MP, 1996, CARCINOGENESIS, V17, P989, DOI 10.1093/carcin/17.5.989; Zanetti D., 2003, Molecular Aspects of Medicine, V24, P273, DOI 10.1016/S0098-2997(03)00022-0; Zhang MF, 1999, PEDIATR RES, V46, P657, DOI 10.1203/00006450-199912000-00017	35	27	27	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45221	10.1371/journal.pone.0045221	http://dx.doi.org/10.1371/journal.pone.0045221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984629	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500127
J	Blajecka, K; Marinov, M; Leitner, L; Uth, K; Posern, G; Arcaro, A				Blajecka, Karolina; Marinov, Marin; Leitner, Laura; Uth, Kristin; Posern, Guido; Arcaro, Alexandre			Phosphoinositide 3-Kinase C2 beta Regulates RhoA and the Actin Cytoskeleton through an Interaction with Dbl	PLOS ONE			English	Article							CELL-MIGRATION; DOWN-REGULATION; ALPHA-ISOFORM; C2 DOMAIN; ACTIVATION; GTPASES; GROWTH; FAMILY; RAS; TRANSCRIPTION	The regulation of cell morphology is a dynamic process under the control of multiple protein complexes acting in a coordinated manner. Phosphoinositide 3-kinases (PI3K) and their lipid products are widely involved in cytoskeletal regulation by interacting with proteins regulating RhoGTPases. Class II PI3K isoforms have been implicated in the regulation of the actin cytoskeleton, although their exact role and mechanism of action remain to be established. In this report, we have identified Dbl, a Rho family guanine nucleotide exchange factor (RhoGEF) as an interaction partner of PI3KC2 beta. Dbl was co-immunoprecipitated with PI3KC2 beta in NIH3T3 cells and cancer cell lines. Over-expression of Class II phosphoinositide 3-kinase PI3KC2 beta in NIH3T3 fibroblasts led to increased stress fibres formation and cell spreading. Accordingly, we found high basal RhoA activity and increased serum response factor (SRF) activation downstream of RhoA upon serum stimulation. In contrast, the dominant-negative form of PI3KC2 beta strongly reduced cell spreading and stress fibres formation, as well as SRF response. Platelet-derived growth factor (PDGF) stimulation of wild-type PI3KC2 beta over-expressing NIH3T3 cells strongly increased Rac and c-Jun N-terminal kinase (JNK) activation, but failed to show similar effect in the cells with the dominant-negative enzyme. Interestingly, epidermal growth factor (EGF) and PDGF stimulation led to increased extracellular signal-regulated kinase (Erk) and Akt pathway activation in cells with elevated wild-type PI3KC2 beta expression. Furthermore, increased expression of PI3KC2 beta protected NIH3T3 from detachment-dependent death (anoikis) in a RhoA-dependent manner. Taken together, these findings suggest that PI3KC2 beta modulates the cell morphology and survival through a specific interaction with Dbl and the activation of RhoA.	[Blajecka, Karolina; Uth, Kristin; Arcaro, Alexandre] Univ Bern, Dept Clin Res, Bern, Switzerland; [Marinov, Marin] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland; [Leitner, Laura; Posern, Guido] Max Planck Inst Biochem, Dept Mol Biol, AG Regulat Gene Express, D-82152 Martinsried, Germany	University of Bern; University Children's Hospital Zurich; Max Planck Society	Blajecka, K (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.	alexandre.arcaro@dkf.unibe.ch	Arcaro, Alexandre/G-1711-2010	Arcaro, Alexandre/0000-0001-9107-2947	Swiss National Science Foundation [3100A0-105321, 31003A-120294]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was funded by the Swiss National Science Foundation (grants 3100A0-105321 and 31003A-120294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcaro A, 2002, EMBO J, V21, P5097, DOI 10.1093/emboj/cdf512; Arcaro A, 2000, MOL CELL BIOL, V20, P3817, DOI 10.1128/MCB.20.11.3817-3830.2000; Arcaro A, 1998, J BIOL CHEM, V273, P33082, DOI 10.1074/jbc.273.49.33082; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Bi F, 2001, MOL CELL BIOL, V21, P1463, DOI 10.1128/MCB.21.5.1463-1474.2001; Broome MA, 1996, J BIOL CHEM, V271, P16798, DOI 10.1074/jbc.271.28.16798; Brown RA, 1999, J BIOL CHEM, V274, P14529, DOI 10.1074/jbc.274.21.14529; Buchsbaum RJ, 2007, J CELL SCI, V120, P1149, DOI 10.1242/jcs.03428; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Coleman ML, 2002, CELL DEATH DIFFER, V9, P493, DOI 10.1038/sj.cdd.4400987; Das M, 2007, MOL CELL BIOL, V27, P7906, DOI 10.1128/MCB.01369-07; DiNitto Jonathan P, 2003, Sci STKE, V2003, pre16, DOI 10.1126/stke.2132003re16; Domin J, 2005, J CELL PHYSIOL, V205, P452, DOI 10.1002/jcp.20478; Domin J, 1997, BIOCHEM J, V326, P139, DOI 10.1042/bj3260139; Engelman JA, 1998, AM J HUM GENET, V63, P1578, DOI 10.1086/302172; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; EVA A, 1987, ONCOGENE, V1, P355; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Gaidarov I, 2005, J BIOL CHEM, V280, P40766, DOI 10.1074/jbc.M507731200; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; Galbiati F, 1998, EMBO J, V17, P6633, DOI 10.1093/emboj/17.22.6633; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; GRAZIANI G, 1989, ONCOGENE, V4, P823; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jiang K, 2004, MOL CELL BIOL, V24, P5565, DOI 10.1128/MCB.24.12.5565-5576.2004; Kamynina E, 2007, MOL CELL BIOL, V27, P1809, DOI 10.1128/MCB.01051-06; Kato J, 2000, BIOCHEM BIOPH RES CO, V268, P141, DOI 10.1006/bbrc.2000.2106; Kato-Stankiewicz J, 2001, BIOCHEM BIOPH RES CO, V284, P470, DOI 10.1006/bbrc.2001.5004; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Katso RM, 2006, MOL BIOL CELL, V17, P3729, DOI 10.1091/mbc.E05-11-1083; Kauppinen KP, 2005, J BIOL CHEM, V280, P21638, DOI 10.1074/jbc.M413984200; Liu Z, 2011, J INT MED RES, V39, P1319, DOI 10.1177/147323001103900419; Maffucci T, 2005, J CELL BIOL, V169, P789, DOI 10.1083/jcb.200408005; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; MOOLENAAR WH, 1995, J BIOL CHEM, V270, P12949, DOI 10.1074/jbc.270.22.12949; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; PERONA R, 1993, ONCOGENE, V8, P1285; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; QIU RG, 1995, NATURE, V374, P457, DOI 10.1038/374457a0; QIU RG, 1995, P NATL ACAD SCI USA, V92, P11781, DOI 10.1073/pnas.92.25.11781; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RON D, 1988, EMBO J, V7, P2465, DOI 10.1002/j.1460-2075.1988.tb03093.x; RON D, 1989, ONCOGENE, V4, P1067; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Russo C, 2001, J BIOL CHEM, V276, P19524, DOI 10.1074/jbc.M009742200; Sasaki T, 2002, J BIOCHEM, V131, P495, DOI 10.1093/oxfordjournals.jbchem.a003126; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; Seok YM, 2010, HYPERTENSION, V56, P934, DOI 10.1161/HYPERTENSIONAHA.110.160853; van den Heuvel APJ, 2005, BIOCHEM J, V385, P795, DOI 10.1042/BJ20041449; Velichkova M, 2010, J CELL BIOL, V190, P407, DOI 10.1083/jcb.200911020; Wheeler M, 2001, MOL CELL BIOL, V21, P6660, DOI 10.1128/MCB.21.19.6660-6667.2001; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	63	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44945	10.1371/journal.pone.0044945	http://dx.doi.org/10.1371/journal.pone.0044945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984590	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500097
J	Hirsch, G; Lavoie-Lamoureux, A; Beauchamp, G; Lavoie, JP				Hirsch, Gaelle; Lavoie-Lamoureux, Anouk; Beauchamp, Guy; Lavoie, Jean-Pierre			Neutrophils Are Not Less Sensitive Than Other Blood Leukocytes to the Genomic Effects of Glucocorticoids	PLOS ONE			English	Article							RECURRENT AIRWAY-OBSTRUCTION; SEVERE ASTHMA; GLUTAMINE-SYNTHETASE; RECEPTOR ANTAGONIST; EQUINE NEUTROPHILS; CELL-DEATH; L-SELECTIN; DEXAMETHASONE; EXPRESSION; HORSES	Background: Neutrophils are generally considered less responsive to glucocorticoids compared to other inflammatory cells. The reported increase in human neutrophil survival mediated by these drugs partly supports this assertion. However, it was recently shown that dexamethasone exerts potent anti-inflammatory effects in equine peripheral blood neutrophils. Few comparative studies of glucocorticoid effects in neutrophils and other leukocytes have been reported and a relative insensitivity of neutrophils to these drugs could not be ruled out. Objective: We assessed glucocorticoid-responsiveness in equine and human peripheral blood neutrophils and neutrophil-depleted leukocytes. Methods: Blood neutrophils and neutrophil-depleted leukocytes were isolated from 6 healthy horses and 4 human healthy subjects. Cells were incubated for 5 h with or without LPS (100 ng/mL) alone or combined with hydrocortisone, prednisolone or dexamethasone (10(-8) M and 10(-6) M). IL-1 beta, TNF-alpha, IL-8, glutamine synthetase and GR-alpha mRNA expression was quantified by qPCR. Equine neutrophils were also incubated for 20 h with or without the three glucocorticoids and cell survival was assessed by flow cytometry and light microscopy on cytospin preparations. Results: We found that glucocorticoids down-regulated LPS-induced pro-inflammatory mRNA expression in both cell populations and species. These drugs also significantly increased glutamine synthetase gene expression in both equine cell populations. The magnitude of glucocorticoid response between cell populations was generally similar in both species. We also showed that dexamethasone had a comparable inhibitory effect on pro-inflammatory gene expression in both human and equine neutrophils. As reported in other species, glucocorticoids significantly increase the survival in equine neutrophils. Conclusions: Glucocorticoids exert genomic effects of similar magnitude on neutrophils and on other blood leukocytes. We speculate that the poor response to glucocorticoids observed in some chronic neutrophilic diseases such as severe asthma or COPD is not explained by a relative lack of inhibition of these drugs on pro-inflammatory cytokines expression in neutrophils.	[Hirsch, Gaelle; Lavoie-Lamoureux, Anouk; Beauchamp, Guy; Lavoie, Jean-Pierre] Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada	Universite de Montreal	Hirsch, G (corresponding author), Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada.	jean-pierre.lavoie@umontreal.ca			Natural Sciences and Engineering Research Council of Canada [MOP-94848]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided by the Natural Sciences and Engineering Research Council of Canada (grant # MOP-94848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mokdad M, 1998, INFLAMMATION, V22, P145, DOI 10.1023/A:1022383922039; Barnes PJ, 2007, J ALLERGY CLIN IMMUN, V119, P1055, DOI 10.1016/j.jaci.2007.01.015; Barnes PJ, 2011, BRIT J PHARMACOL, V163, P29, DOI 10.1111/j.1476-5381.2010.01199.x; Barnes PJ, 2010, J STEROID BIOCHEM, V120, P76, DOI 10.1016/j.jsbmb.2010.02.018; Barnes PJ, 2009, LANCET, V373, P1905, DOI 10.1016/S0140-6736(09)60326-3; BERCZI I, 1966, CAN J MICROBIOL, V12, P1070, DOI 10.1139/m66-143; BURROWS GE, 1981, CAN J COMP MED, V45, P207; BURTON JL, 1995, J LEUKOCYTE BIOL, V57, P317, DOI 10.1002/jlb.57.2.317; Buttgereit F, 1999, BIOCHEM PHARMACOL, V58, P363, DOI 10.1016/S0006-2952(99)00090-8; CASSATELLA MA, 1995, IMMUNOL TODAY, V16, P21, DOI 10.1016/0167-5699(95)80066-2; Cassatella MA, 1999, ADV IMMUNOL, V73, P369, DOI 10.1016/S0065-2776(08)60791-9; Chandrasekhar S, 1999, AM J PHYSIOL-LUNG C, V276, pL319, DOI 10.1152/ajplung.1999.276.2.L319; Cohen, 2007, ORPHANET J RARE DIS; COLOTTA F, 1992, BLOOD, V80, P2012; COX G, 1995, J IMMUNOL, V154, P4719; Czock D, 2005, CLIN PHARMACOKINET, V44, P61, DOI 10.2165/00003088-200544010-00003; Dandona P, 1999, CLIN PHARMACOL THER, V66, P58, DOI 10.1016/S0009-9236(99)70054-8; Fialkow L, 2006, CRIT CARE, V10, DOI 10.1186/cc5090; Filep JG, 2009, J CELL BIOCHEM, V108, P1039, DOI 10.1002/jcb.22351; Gaunitz F, 2002, BIOCHEM BIOPH RES CO, V296, P1026, DOI 10.1016/S0006-291X(02)02044-2; Grady JA, 2010, AM J VET RES, V71, P831, DOI 10.2460/ajvr.71.7.831; Grossmann C, 2004, EUR J ENDOCRINOL, V151, P397, DOI 10.1530/eje.0.1510397; HASLETT C, 1985, AM J PATHOL, V119, P101; Joubert P, 2001, EQUINE VET J, V33, P730, DOI 10.2746/042516401776249246; Langereis JD, 2011, EUR RESPIR J, V37, P406, DOI 10.1183/09031936.00170409; Lavoie JP, 2006, J VET INTERN MED, V20, P175, DOI 10.1892/0891-6640(2006)20[175:LOCEOA]2.0.CO;2; Lavoie JP, 2002, AM J VET RES, V63, P579, DOI 10.2460/ajvr.2002.63.579; Lavoie-Lamoureux A, 2012, VET IMMUNOL IMMUNOP, V146, P35, DOI 10.1016/j.vetimm.2012.01.020; Lavoie-Lamoureux A, 2010, AM J PHYSIOL-LUNG C, V299, pL472, DOI 10.1152/ajplung.00135.2009; Leclere M, 2010, EQUINE VET J, V42, P316, DOI 10.1111/j.2042-3306.2009.00022.x; Leclere M, 2011, RESPIROLOGY, V16, P1027, DOI 10.1111/j.1440-1843.2011.02033.x; Lecoq L, 2009, VET IMMUNOL IMMUNOP, V128, P126, DOI 10.1016/j.vetimm.2008.10.303; Meagher LC, 1996, J IMMUNOL, V156, P4422; Nicolaides NC, 2010, STEROIDS, V75, P1, DOI 10.1016/j.steroids.2009.09.002; Nupponen I, 2002, ACTA PAEDIATR, V91, P1200, DOI 10.1080/080352502320777432; Ordonez CL, 2000, AM J RESP CRIT CARE, V161, P1185, DOI 10.1164/ajrccm.161.4.9812061; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Pujols L, 2007, CURR ALLERGY ASTHM R, V7, P93, DOI 10.1007/s11882-007-0005-3; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Saffar AS, 2008, J ALLERGY CLIN IMMUN, V121, P492, DOI 10.1016/j.jaci.2007.10.003; Saffar AS, 2011, CURR DRUG TARGETS, V12, P556; Schleimer Robert P, 2004, Proc Am Thorac Soc, V1, P222, DOI 10.1513/pats.200402-018MS; SCHLEIMER RP, 1990, AM REV RESPIR DIS, V141, pS59; SCHLEIMER RP, 1989, J PHARMACOL EXP THER, V250, P598; Strandberg K, 2010, PULM PHARMACOL THER, V23, P316, DOI 10.1016/j.pupt.2010.03.004; Strickland I, 2001, J EXP MED, V193, P585, DOI 10.1084/jem.193.5.585; Vazquez-Tello A, 2010, CLIN EXP ALLERGY, V40, P1312, DOI 10.1111/j.1365-2222.2010.03544.x; WAKAJTYSRODE E, 1988, INT J IMMUNOPHARMACO, V10, P925, DOI 10.1016/0192-0561(88)90038-0; Weber PSD, 2004, J LEUKOCYTE BIOL, V75, P815, DOI 10.1189/jlb.1003505; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Wenzel SE, 1997, AM J RESP CRIT CARE, V156, P737, DOI 10.1164/ajrccm.156.3.9610046; WERTHEIM WA, 1993, J IMMUNOL, V151, P2166; Wang XQ, 2008, RESPIROLOGY, V13, P772, DOI 10.1111/j.1440-1843.2008.01344.x; Xu J, 2007, J PHARMACOKINET PHAR, V34, P355, DOI 10.1007/s10928-007-9050-8; Yang IA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002991.pub2	55	40	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44606	10.1371/journal.pone.0044606	http://dx.doi.org/10.1371/journal.pone.0044606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984532	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500069
J	Kaur, R; Gonzales, WL; Llambi, LD; Soriano, PJ; Callaway, RM; Rout, ME; Gallaher, TJ; Inderjit				Kaur, Rajwant; Gonzales, Wilfredo L.; Daniel Llambi, Luis; Soriano, Pascual J.; Callaway, Ragan M.; Rout, Marnie E.; Gallaher, Timothy J.; Inderjit			Community Impacts of Prosopis juliflora Invasion: Biogeographic and Congeneric Comparisons	PLOS ONE			English	Article							EXOTIC PLANT INVASIONS; SEEDLING GROWTH; SOIL PROPERTIES; WEAPONS; VEGETATION; MONOGRAPH; GRASSLAND; MECHANISM; SAVANNA; FOLIAGE	We coordinated biogeographical comparisons of the impacts of an exotic invasive tree in its native and non-native ranges with a congeneric comparison in the non-native range. Prosopis juliflora is taxonomically complicated and with P. pallida forms the P. juliflora complex. Thus we sampled P. juliflora in its native Venezuela, and also located two field sites in Peru, the native range of Prosopis pallida. Canopies of Prosopis juliflora, a native of the New World but an invader in many other regions, had facilitative effects on the diversity of other species in its native Venezuela, and P. pallida had both negative and positive effects depending on the year, (overall neutral effects) in its native Peru. However, in India and Hawaii, USA, where P. juliflora is an aggressive invader, canopy effects were consistently and strongly negative on species richness. Prosopis cineraria, a native to India, had much weaker effects on species richness in India than P. juliflora. We carried out multiple congeneric comparisons between P. juliflora and P. cineraria, and found that soil from the rhizosphere of P. juliflora had higher extractable phosphorus, soluble salts and total phenolics than P. cineraria rhizosphere soils. Experimentally applied P. juliflora litter caused far greater mortality of native Indian species than litter from P. cineraria. Prosopis juliflora leaf leachate had neutral to negative effects on root growth of three common crop species of north-west India whereas P. cineraria leaf leachate had positive effects. Prosopis juliflora leaf leachate also had higher concentrations of total phenolics and L-tryptophan than P. cineraria, suggesting a potential allelopathic mechanism for the congeneric differences. Our results also suggest the possibility of regional evolutionary trajectories among competitors and that recent mixing of species from different trajectories has the potential to disrupt evolved interactions among native species.	[Kaur, Rajwant; Inderjit] Univ Delhi, CEMDE, Dept Environm Studies, Delhi 110007, India; [Gonzales, Wilfredo L.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, LID, Lab Ecol Evolut, Lima, Peru; [Daniel Llambi, Luis; Soriano, Pascual J.] Univ Los Andes, Inst Ciencias Ambientales & Ecol, Merida, Venezuela; [Callaway, Ragan M.; Rout, Marnie E.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Gallaher, Timothy J.] Univ Hawaii Manoa, Dept Bot, Honolulu, HI 96822 USA	University of Delhi; Universidad Peruana Cayetano Heredia; University of Los Andes Venezuela; University of Montana System; University of Montana; University of Hawaii System; University of Hawaii Manoa	Kaur, R (corresponding author), Univ Delhi, CEMDE, Dept Environm Studies, Delhi 110007, India.	inderjitdu@gmail.com		GONZALES, WILFREDO/0000-0002-8885-5972; Gallaher, Timothy/0000-0002-5781-6874	University of Delhi; National Science Foundation [DEB 0614406]; Rocky Mountain Research Station, United States Department of Agriculture Forest Service; Programa de Ciencia y Tecnologia (FINCyT) [011-FINCyT-PIBAP-2007]	University of Delhi(University of Delhi); National Science Foundation(National Science Foundation (NSF)); Rocky Mountain Research Station, United States Department of Agriculture Forest Service; Programa de Ciencia y Tecnologia (FINCyT)	The research was funded by the University of Delhi. RMC gratefully acknowledges funding from the National Science Foundation, DEB 0614406, and the Rocky Mountain Research Station, United States Department of Agriculture Forest Service. WGL gratefully acknowledges funding from the Programa de Ciencia y Tecnologia (FINCyT), Contrato No011-FINCyT-PIBAP-2007. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R. K., 1976, Indian Forester, V102, P863; Aggarwal R. K., 1993, Indian Forester, V119, P321; Al-Humaid AI, 1998, J ARID ENVIRON, V38, P237, DOI 10.1006/jare.1997.0312; Allen SE, 1989, CHEM ANAL ECOLOGICAL; Allison SD, 2004, OECOLOGIA, V141, P612, DOI 10.1007/s00442-004-1679-z; ARCHER S, 1988, ECOL MONOGR, V58, P111, DOI 10.2307/1942463; Atlas RM., 2004, HDB MICROBIOLOGICAL; Brooker RW, 2009, AM NAT, V174, P919, DOI 10.1086/648058; BURKART A, 1976, J ARNOLD ARBORETUM, V57, P219; Burkart A, 1976, J ARNOLD ARBORAT, P450; Callaway RM, 2008, ECOLOGY, V89, P1043, DOI 10.1890/07-0370.1; Callaway RM, 2006, TRENDS ECOL EVOL, V21, P369, DOI 10.1016/j.tree.2006.04.008; Callaway RM, 2012, BIOL INVASIONS, V14, P1143, DOI 10.1007/s10530-011-0145-1; Callaway RM, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P341; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.2307/3868432; Carrillo-Garcia A, 2000, PLANT SOIL, V218, P207, DOI 10.1023/A:1014953028163; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; El-Keblawy A, 2007, PLANT ECOL, V190, P23, DOI 10.1007/s11258-006-9188-2; FRANCOPIZANA J, 1995, J VEG SCI, V6, P73, DOI 10.2307/3236258; FrancoPizana JG, 1996, J VEG SCI, V7, P257, DOI 10.2307/3236326; GOEL U, 1989, J CHEM ECOL, V15, P591, DOI 10.1007/BF01014703; IBM SPSS, 2010, IBM SPSS STAT 19 BRI; Inderjit, 2011, TRENDS ECOL EVOL, V26, P655, DOI 10.1016/j.tree.2011.08.003; Inderjit, 2011, ECOLOGY, V92, P316, DOI 10.1890/10-0400.1; Inderjit, 2010, TRENDS ECOL EVOL, V25, P512, DOI 10.1016/j.tree.2010.06.006; Jha P, 2010, PLANT SOIL, V326, P481, DOI 10.1007/s11104-009-0027-9; Kaushik N, 2003, J ARID ENVIRON, V55, P433, DOI 10.1016/S0140-1963(02)00289-6; Larrea-Alcazar DM, 2008, PLANT ECOL, V196, P153, DOI 10.1007/s11258-007-9344-3; Lortie CJ, 2004, OIKOS, V107, P433, DOI 10.1111/j.0030-1299.2004.13250.x; MacDougall AS, 2005, ECOLOGY, V86, P42, DOI 10.1890/04-0669; Nakano H, 2003, PLANT GROWTH REGUL, V40, P49, DOI 10.1023/A:1023049026335; NOOR M, 1995, J ARID ENVIRON, V31, P83, DOI 10.1006/jare.1995.0051; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Palacios RA, 2012, PLANT SYST EVOL, V298, P165, DOI 10.1007/s00606-011-0535-y; Pandit MK, 2011, J ECOL, V99, P1108, DOI 10.1111/j.1365-2745.2011.01838.x; Pasiecznik NM, 2001, PROSOPIS JULIFLORA P; Piper C.S., 1966, SOIL PLANT ANAL; Pollock JL, 2008, BIOL INVASIONS, V10, P875, DOI 10.1007/s10530-008-9239-9; REASONER DJ, 1979, APPL ENVIRON MICROB, V38, P229, DOI 10.1128/AEM.38.2.229-236.1979; Rossi BE, 2003, J VEG SCI, V14, P543, DOI 10.1658/1100-9233(2003)014[0543:EOPFOS]2.0.CO;2; Rothstein DE, 2004, ECOSYSTEMS, V7, P805, DOI 10.1007/s10021-004-0009-y; Rout ME, 2009, SCIENCE, V324, P734, DOI 10.1126/science.1173651; Schade JD, 2003, J VEG SCI, V14, P743, DOI 10.1658/1100-9233(2003)014[0743:TIOPCO]2.0.CO;2; Schaffner U, 2011, ECOLOGY, V92, P829, DOI 10.1890/10-1230.1; Simberloff D, 2012, ECOLOGY, V93, P598, DOI 10.1890/11-1232.1; SPSS Inc, 2008, SPSS VERS 16 0 2; SWAIN T., 1959, Journal of the Science of Food and Agriculture, V10, P63, DOI 10.1002/jsfa.2740100110; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Thorpe AS, 2009, J ECOL, V97, P641, DOI 10.1111/j.1365-2745.2009.01520.x; TIEDEMANN AR, 1986, SOIL SCI SOC AM J, V50, P472, DOI 10.2136/sssaj1986.03615995005000020044x; TIEDEMANN AR, 1977, J RANGE MANAGE, V30, P361, DOI 10.2307/3897722; TIEDEMANN AR, 1973, SOIL SCI SOC AM J, V37, P107, DOI 10.2136/sssaj1973.03615995003700010033x; Treier UA, 2009, ECOLOGY, V90, P1366, DOI 10.1890/08-0420.1; Trenchard LJ, 2008, BOT J LINN SOC, V156, P425, DOI 10.1111/j.1095-8339.2007.00712.x; VIRGINIA RA, 1983, SOIL SCI SOC AM J, V47, P138, DOI 10.2136/sssaj1983.03615995004700010028x; Wardle DA, 2011, SCIENCE, V332, P1273, DOI 10.1126/science.1197479; Zou CB, 2005, OECOLOGIA, V145, P32, DOI 10.1007/s00442-005-0110-8	58	76	81	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44966	10.1371/journal.pone.0044966	http://dx.doi.org/10.1371/journal.pone.0044966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984595	Green Published, gold			2022-12-25	WOS:000308738500101
J	Li, XY; Kong, XN; Chen, X; Zhang, N; Jiang, LY; Ma, TT; Yang, QF				Li, Xiaoyan; Kong, Xiangnan; Chen, Xi; Zhang, Ning; Jiang, Liyu; Ma, Tingting; Yang, Qifeng			LAPTM4B Allele*2 Is Associated with Breast Cancer Susceptibility and Prognosis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; GENETIC SUSCEPTIBILITY; OVEREXPRESSION; POLYMORPHISM; PROGRESSION; MARKER; RESISTANCE; EXPRESSION; PROTEIN; TUMORS	Background: Lysosome-associated protein transmembrane 4 beta (LAPTM4B) has two alleles named LAPTM4B*1 and LAPTM4B*2. Allele *1 contains only one copy of a 19-bp sequence at the 5'UTR in the first exon, whereas this sequence of allele*2 is duplicated and arrayed as a tandem repeat. Previous studies revealed that LAPTM4B polymorphisms contribute to the risk of certain types of cancers. This study aimed to investigate the polymorphism of LAPTM4B in breast cancer by analysis the correlation of LAPTM4B genotype with breast cancer susceptibility, clinicopathologic features and prognosis. Methods: Genotyping of the LAPTM4B polymorphism was determined by PCR method. The expression levels of LAPTM4B in breast cancer tissues and breast cancer cell lines were determined by quantitative reverse-transcription PCR (qRT-PCR) analysis. The correlation of LAPTM4B genotype with clinicopathologic parameters and prognosis were assessed statistically. Results: The results of qRT-PCR analysis indicated that LAPTM4B*2 was associated with the higher level of LAPTM4B expression compared with the LAPTM4B*1 in both breast cancer cell lines and breast cancer tissues. We found that LAPTM4B*2 was associated with an increased risk for breast cancer. LAPTM4B*2 was significantly associated with higher histopathologic grade, lymph node metastasis and poor prognosis. Conclusion: LAPTM4B*2 is a risk factor associated with breast cancer susceptibility and poor prognosis. LAPTM4B*2 may be a potential predicative marker for the susceptibility, progression and metastasis of breast cancer.	[Li, Xiaoyan; Kong, Xiangnan; Chen, Xi; Zhang, Ning; Jiang, Liyu; Ma, Tingting; Yang, Qifeng] Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China; [Yang, Qifeng] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250100, Shandong, Peoples R China; [Yang, Qifeng] Shandong Univ, Sch Med, Inst Mol Med & Genet, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Li, XY (corresponding author), Shandong Univ, Qilu Hosp, Dept Breast Surg, Jinan 250100, Shandong, Peoples R China.	qifengy@gmail.com	Zhang, Ning/GNP-1966-2022; Zhang, Ning/GOJ-8058-2022; yang, qiang/GYJ-0971-2022	Zhang, Ning/0000-0002-6430-4236; Yang, Qifeng/0000-0003-0576-8513	National Natural Science Foundation of China [81072150, 81172529]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (No. 81072150; No. 81172529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng XJ, 2008, ANN ONCOL, V19, P527, DOI 10.1093/annonc/mdm469; Fan MR, 2012, CANCER EPIDEMIOL, V36, P364, DOI 10.1016/j.canep.2011.12.004; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Kasper G, 2005, CANCER LETT, V224, P93, DOI 10.1016/j.canlet.2004.10.004; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Liu Xinrong, 2003, Beijing Da Xue Xue Bao Yi Xue Ban, V35, P340; Liu XR, 2009, CANCER SCI, V100, P2335, DOI 10.1111/j.1349-7006.2009.01346.x; Liu Y, 2007, ANN ONCOL, V18, P311, DOI 10.1093/annonc/mdl394; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Meng FL, 2010, INT J GYNECOL CANCER, V20, P745, DOI 10.1111/IGC.0b013e3181e02f90; Meng FL, 2011, CANCER-AM CANCER SOC, V117, P2652, DOI 10.1002/cncr.25833; Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Su P, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-38; Xu Y, 2012, JPN J CLIN ONCOL, V42, P413, DOI 10.1093/jjco/hys026; Yang H, 2011, SURG TODAY, V41, P810, DOI 10.1007/s00595-010-4338-5; Yang H, 2010, J SURG ONCOL, V101, P363, DOI 10.1002/jso.21489; Yin MZ, 2012, INT J GYNECOL CANCER, V22, P54, DOI 10.1097/IGC.0b013e318234f9ac; Yin MZ, 2011, INT J CANCER, V129, P629, DOI 10.1002/ijc.25689; Yu JC, 2009, CARCINOGENESIS, V30, P1562, DOI 10.1093/carcin/bgp173; Zhai GJ, 2012, MED ONCOL, V29, P2744, DOI 10.1007/s12032-011-0139-y; Zhang N, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-48; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025; Zinzani PL, 2011, ANN ONCOL, V22, P186	28	18	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44916	10.1371/journal.pone.0044916	http://dx.doi.org/10.1371/journal.pone.0044916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984585	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500094
J	Defour, A; Dessalle, K; Perez, AC; Poyot, T; Castells, J; Gallot, YS; Durand, C; Euthine, V; Gu, YS; Bechet, D; Peinnequin, A; Lefai, E; Freyssenet, D				Defour, Aurelia; Dessalle, Kevin; Perez, Andrea Castro; Poyot, Thomas; Castells, Josiane; Gallot, Yann Simon; Durand, Christine; Euthine, Vanessa; Gu, Yansong; Bechet, Daniel; Peinnequin, Andre; Lefai, Etienne; Freyssenet, Damien			Sirtuin 1 Regulates SREBP-1c Expression in a LXR-Dependent Manner in Skeletal Muscle	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; LIVER-X-RECEPTORS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; LIPID-METABOLISM; RELATIVE QUANTIFICATION; INSULIN; HOMEOSTASIS; GLUCOSE; ELECTROTRANSFER	Sirtuin 1 (SIRT1), a NAD(+)-dependent protein deacetylase, has emerged as a main determinant of whole body homeostasis in mammals by regulating a large spectrum of transcriptional regulators in metabolically relevant tissue such as liver, adipose tissue and skeletal muscle. Sterol regulatory element binding protein (SREBP)-1c is a transcription factor that controls the expression of genes related to fatty acid and triglyceride synthesis in tissues with high lipid synthesis rates such as adipose tissue and liver. Previous studies indicate that SIRT1 can regulate the expression and function of SREBP-1c in liver. In the present study, we determined whether SIRT1 regulates SREBP-1c expression in skeletal muscle. SREBP-1c mRNA and protein levels were decreased in the gastrocnemius muscle of mice harboring deletion of the catalytic domain of SIRT1 (SIRT1(Delta ex4/Delta ex4) mice). By contrast, adenoviral expression of SIRT1 in human myotubes increased SREBP-1c mRNA and protein levels. Importantly, SREBP-1c promoter transactivation, which was significantly increased in response to SIRT1 overexpression by gene electrotransfer in skeletalmuscle, was completely abolished when liver X receptor (LXR) response elements were deleted. Finally, our in vivo data fromSIRT1(Delta ex4/Delta ex4) mice and in vitro data from human myotubes overexpressing SIRT1 show that SIRT1 regulates LXR acetylation in skeletal muscle cells. This suggests a possible mechanism by which the regulation of SREBP-1c gene expression by SIRT1 may require the deacetylation of LXR transcription factors.	[Defour, Aurelia; Perez, Andrea Castro; Castells, Josiane; Gallot, Yann Simon; Freyssenet, Damien] Univ Lyon, Lab Physiol Exercice, St Etienne, France; [Dessalle, Kevin; Durand, Christine; Euthine, Vanessa; Lefai, Etienne] Univ Lyon, INRA 1235, INSERM, U1060,Lab CarMeN, Oullins, France; [Poyot, Thomas; Peinnequin, Andre] Ctr Rech, Inst Rech Biomed Armees, Serv Sante Armees, La Tronche, France; [Gu, Yansong] Obenomics Inc, Bellevue, WA USA; [Bechet, Daniel] INRA UMR 1019, Unite Nutr Humaine, St Genes Champanelle, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE	Defour, A (corresponding author), Univ Lyon, Lab Physiol Exercice, St Etienne, France.	damien.freyssenet@univ-st-etienne.fr	Gallot, Yann Simon/GNO-9167-2022; Lefai, Etienne/E-9615-2019; Lefai, Etienne/L-7961-2019; Gallot, Yann Simon/ABC-1826-2021; Gallot, Yann Simon/GQI-2372-2022; Bechet, Daniel/AAU-2874-2020	Gallot, Yann Simon/0000-0003-4447-1448; Lefai, Etienne/0000-0002-3042-7801; Lefai, Etienne/0000-0002-3042-7801; Gallot, Yann Simon/0000-0003-4447-1448; Gallot, Yann Simon/0000-0003-4447-1448; Bechet, Daniel/0000-0002-3812-8099; defour, aurelia/0000-0002-9114-0054	Caisse d'Epargne Rhone-Alpes	Caisse d'Epargne Rhone-Alpes(Region Auvergne-Rhone-Alpes)	AD was financially supported by a grant from the Caisse d'Epargne Rhone-Alpes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Canto C, 2010, CELL METAB, V11, P213, DOI 10.1016/j.cmet.2010.02.006; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cozzone D, 2006, DIABETOLOGIA, V49, P990, DOI 10.1007/s00125-006-0140-8; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; Ducluzeau PH, 2001, DIABETES, V50, P1134, DOI 10.2337/diabetes.50.5.1134; Durieux AC, 2005, BBA-GEN SUBJECTS, V1725, P403, DOI 10.1016/j.bbagen.2005.06.016; Durieux AC, 2002, BIOCHEM BIOPH RES CO, V296, P443, DOI 10.1016/S0006-291X(02)00901-4; Durieux AC, 2004, J GENE MED, V6, P809, DOI 10.1002/jgm.534; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Frojdo S, 2011, MOL CELL ENDOCRINOL, V335, P166, DOI 10.1016/j.mce.2011.01.008; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Gosmain Y, 2005, J LIPID RES, V46, P697, DOI 10.1194/jlr.M400261-JLR200; Gosmain Y, 2004, DIABETES, V53, P321, DOI 10.2337/diabetes.53.2.321; Guillet-Deniau I, 2002, DIABETES, V51, P1722, DOI 10.2337/diabetes.51.6.1722; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Lecomte V, 2010, MOL CELL BIOL, V30, P1182, DOI 10.1128/MCB.00690-09; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Muscat GEO, 2002, J BIOL CHEM, V277, P40722, DOI 10.1074/jbc.M206681200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rome S, 2008, PHYSIOL GENOMICS, V34, P327, DOI 10.1152/physiolgenomics.90211.2008; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001; Yu JJ, 2010, PHARMACOL RES, V62, P35, DOI 10.1016/j.phrs.2009.12.006; Yu JJ, 2009, ANN NY ACAD SCI, V1173, pE10, DOI 10.1111/j.1749-6632.2009.04952.x	46	21	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43490	10.1371/journal.pone.0043490	http://dx.doi.org/10.1371/journal.pone.0043490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984430	gold, Green Submitted, Green Published			2022-12-25	WOS:000308638700023
J	Halvorsen, K; Wong, WP				Halvorsen, Ken; Wong, Wesley P.			Binary DNA Nanostructures for Data Encryption	PLOS ONE			English	Article							NUCLEIC-ACIDS; COMPUTATION; OLIGONUCLEOTIDES; SHAPES	We present a simple and secure system for encrypting and decrypting information using DNA self-assembly. Binary data is encoded in the geometry of DNA nanostructures with two distinct conformations. Removing or leaving out a single component reduces these structures to an encrypted solution of ssDNA, whereas adding back this missing "decryption key" causes the spontaneous formation of the message through self-assembly, enabling rapid read out via gel electrophoresis. Applications include authentication, secure messaging, and barcoding.	[Halvorsen, Ken; Wong, Wesley P.] Harvard Univ, Sch Med, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02114 USA; [Halvorsen, Ken; Wong, Wesley P.] Childrens Hosp, Boston, MA 02115 USA; [Halvorsen, Ken; Wong, Wesley P.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Halvorsen, K (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02114 USA.	wong@idi.harvard.edu		Wong, Wesley/0000-0001-7398-546X	IDI startup funds	IDI startup funds	This work was supported by IDI startup funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. URL of IDI: http://www.idi.harvard.edu/.	ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Braich RS, 2002, SCIENCE, V296, P499, DOI 10.1126/science.1069528; Clelland CT, 1999, NATURE, V399, P533, DOI 10.1038/21092; Cui GZ, 2008, 2008 THIRD INTERNATIONAL CONFERENCE ON BIO-INSPIRED COMPUTING: THEORIES AND APPLICATIONS, P37, DOI 10.1109/BICTA.2008.4656701; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Farand J, 2009, ANAL CHEM, V81, P3723, DOI 10.1021/ac802452p; Franca LTC, 2002, Q REV BIOPHYS, V35, P169, DOI 10.1017/S0033583502003797; Gehani A., 2004, ASPECTS MOL COMPUTIN, P34; Guarnieri F, 1996, SCIENCE, V273, P220, DOI 10.1126/science.273.5272.220; Halvorsen K, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494005; Hashiyada M, 2004, TOHOKU J EXP MED, V204, P109, DOI 10.1620/tjem.204.109; Kawai J, 2003, GENOME RES, V13, P1488, DOI 10.1101/gr.914203; Lee I, 2004, NUCLEIC ACIDS RES, V32, P681, DOI 10.1093/nar/gkh196; Leier A, 2000, BIOSYSTEMS, V57, P13, DOI 10.1016/S0303-2647(00)00083-6; LIPTON RJ, 1995, SCIENCE, V268, P542, DOI 10.1126/science.7725098; Oberacher H, 2004, J AM SOC MASS SPECTR, V15, P32, DOI 10.1016/j.jasms.2003.09.005; Oberacher H, 2009, BIOPOLYMERS, V91, P401, DOI 10.1002/bip.21156; Ouyang Q, 1997, SCIENCE, V278, P446, DOI 10.1126/science.278.5337.446; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Quek SY, 2009, NAT NANOTECHNOL, V4, P230, DOI [10.1038/nnano.2009.10, 10.1038/NNANO.2009.10]; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Roweis S, 1998, J COMPUT BIOL, V5, P615, DOI 10.1089/cmb.1998.5.615; Schafer C, 2007, J AM CHEM SOC, V129, P1488, DOI 10.1021/ja067734h; Seeman NC, 2007, MOL BIOTECHNOL, V37, P246, DOI 10.1007/s12033-007-0059-4; Tanaka K, 2005, BIOSYSTEMS, V81, P25, DOI 10.1016/j.biosystems.2005.01.004; Yan H, 2003, P NATL ACAD SCI USA, V100, P8103, DOI 10.1073/pnas.1032954100; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312	29	30	33	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44212	10.1371/journal.pone.0044212	http://dx.doi.org/10.1371/journal.pone.0044212			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984477	Green Published, gold			2022-12-25	WOS:000308638700049
J	Rachel, RA; Nagashima, K; O'Sullivan, TN; Frost, LS; Stefano, FP; Marigo, V; Boesze-Battaglia, K				Rachel, Rivka A.; Nagashima, Kunio; O'Sullivan, T. Norene; Frost, Laura S.; Stefano, Frank P.; Marigo, Valeria; Boesze-Battaglia, Kathleen			Melanoregulin, Product of the dsu Locus, Links the BLOC-Pathway and Oa1 in Organelle Biogenesis	PLOS ONE			English	Article							HERMANSKY-PUDLAK-SYNDROME; OCULAR ALBINISM TYPE-1; PROTEIN-COUPLED RECEPTOR; COAT-COLOR PHENOTYPE; DILUTE SUPPRESSOR; GENE-PRODUCT; MELANOSOME TRANSPORT; MYOSIN-VA; MOUSE; HOMOLOG	Humans with Hermansky-Pudlak Syndrome (HPS) or ocular albinism (OA1) display abnormal aspects of organelle biogenesis. The multigenic disorder HPS displays broad defects in biogenesis of lysosome-related organelles including melanosomes, platelet dense granules, and lysosomes. A phenotype of ocular pigmentation in OA1 is a smaller number of macromelanosomes, in contrast to HPS, where in many cases the melanosomes are smaller than normal. In these studies we define the role of the Mreg(dsu) gene, which suppresses the coat color dilution of Myo5a, melanophilin, and Rab27a mutant mice in maintaining melanosome size and distribution. We show that the product of the Mreg(dsu) locus, melanoregulin (MREG), interacts both with members of the HPS BLOC-2 complex and with Oa1 in regulating melanosome size. Loss of MREG function facilitates increase in the size of micromelanosomes in the choroid of the HPS BLOC-2 mutants ruby, ruby2, and cocoa, while a transgenic mouse overexpressing melanoregulin corrects the size of retinal pigment epithelium (RPE) macromelanosomes in Oa1(ko/ko) mice. Collectively, these results suggest that MREG levels regulate pigment incorporation into melanosomes. Immunohistochemical analysis localizes melanoregulin not to melanosomes, but to small vesicles in the cytoplasm of the RPE, consistent with a role for this protein in regulating membrane interactions during melanosome biogenesis. These results provide the first link between the BLOC pathway and Oa1 in melanosome biogenesis, thus supporting the hypothesis that intracellular G-protein coupled receptors may be involved in the biogenesis of other organelles. Furthermore these studies provide the foundation for therapeutic approaches to correct the pigment defects in the RPE of HPS and OA1.	[Rachel, Rivka A.] NEI, Neurobiol Neurodegenerat & Repair Lab, Bethesda, MD 20892 USA; [Nagashima, Kunio] SAIC Frederick, Frederick Natl Lab Canc Res, Frederick, MD USA; [O'Sullivan, T. Norene] NCI, Frederick, MD 21701 USA; [Frost, Laura S.; Stefano, Frank P.; Boesze-Battaglia, Kathleen] Univ Penn, Dept Biochem, Philadelphia, PA 19104 USA; [Stefano, Frank P.] Univ Penn, Sch Dent Med, Live Cell Imaging Core, Philadelphia, PA 19104 USA; [Marigo, Valeria] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; University of Pennsylvania; Universita di Modena e Reggio Emilia	Rachel, RA (corresponding author), NEI, Neurobiol Neurodegenerat & Repair Lab, Bethesda, MD 20892 USA.	battagli@dental.upenn.edu	Marigo, Valeria/B-7947-2015	Marigo, Valeria/0000-0002-4428-2084	Vision of Children; National Institutes of Health, National Cancer Institute, Center for Cancer Research; National Eye Institute [EY-10420, EY018705]; National Cancer Institute [HHSN26120080001E]; Vision of Children Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026365] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010420, R29EY010420, R21EY018705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022465] Funding Source: NIH RePORTER	Vision of Children; National Institutes of Health, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vision of Children Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank the following individuals for expert technical assistance, with animals: Deborah Swing, Erika Truffer, Stephanie Springer, Holly Morris and Rob Koogle; with genotyping: Deborah Householder and Anna Trivett; with electron microscopy: Michelle Gignac; Alvina Bragin for expert technical assistance. We thank the Vision of Children for facilitating this collaboration and for funding productive meetings, and Drs. Nancy Jenkins and Neal Copeland for supporting the majority of the work in their laboratory at the National Cancer Institute.; This project was funded by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, extramural grants from the National Eye Institute, EY-10420 and EY018705 (KBB), federal funds from the National Cancer Institute under contract HHSN26120080001E (KN), and by the Vision of Children Foundation (VM). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anikster Y, 2001, NAT GENET, V28, P376, DOI 10.1038/ng576; BALKEMA GW, 1990, VISUAL NEUROSCI, V4, P595, DOI 10.1017/S0952523800005794; Bassi MT, 1996, GENOME RES, V6, P880, DOI 10.1101/gr.6.9.880; Cortese K, 2005, INVEST OPHTH VIS SCI, V46, P4358, DOI 10.1167/iovs.05-0834; Damek-Poprawa M, 2009, J BIOL CHEM, V284, P10877, DOI 10.1074/jbc.M808857200; Di Pietro SM, 2005, TRAFFIC, V6, P525, DOI 10.1111/j.1600-0854.2005.00299.x; Di Pietro SM, 2004, TRAFFIC, V5, P276, DOI 10.1111/j.1600-0854.2004.0171.x; Gardner JM, 1997, P NATL ACAD SCI USA, V94, P9238, DOI 10.1073/pnas.94.17.9238; Gautam R, 2004, J BIOL CHEM, V279, P12935, DOI 10.1074/jbc.M311311200; Giordano F, 2009, HUM MOL GENET, V18, P4530, DOI 10.1093/hmg/ddp415; Gunay-Aygun M, 2004, SEMIN THROMB HEMOST, V30, P537, DOI 10.1055/s-2004-835674; Gwynn B, 2004, BLOOD, V104, P3181, DOI 10.1182/blood-2004-04-1538; Gwynn B, 2000, BLOOD, V96, P4227; Hearing VJ, 2005, J DERMATOL SCI, V37, P3, DOI 10.1016/j.jdermsci.2004.08.014; Helip-Wooley A, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-33; Incerti B, 2000, HUM MOL GENET, V9, P2781, DOI 10.1093/hmg/9.19.2781; Innamorati G, 2006, PIGM CELL RES, V19, P125, DOI 10.1111/j.1600-0749.2006.00292.x; LAVAIL JH, 1978, J COMP NEUROL, V182, P399, DOI 10.1002/cne.901820304; Lopez VM, 2008, PLOS BIOL, V6, P1861, DOI 10.1371/journal.pbio.0060236; Matesic LE, 2001, P NATL ACAD SCI USA, V98, P10238, DOI 10.1073/pnas.181336698; MCGINNESS J, 1974, SCIENCE, V183, P853, DOI 10.1126/science.183.4127.853; MOORE KJ, 1988, P NATL ACAD SCI USA, V85, P8131, DOI 10.1073/pnas.85.21.8131; MOORE KJ, 1988, GENETICS, V119, P933; Newton JM, 1996, GENOMICS, V37, P219, DOI 10.1006/geno.1996.0545; Nguyen T, 2004, J INVEST DERMATOL, V122, P452, DOI 10.1046/j.0022-202X.2004.22117.x; Nguyen T, 2002, J INVEST DERMATOL, V119, P1156, DOI 10.1046/j.1523-1747.2002.19535.x; O'Sullivan TN, 2004, P NATL ACAD SCI USA, V101, P16831, DOI 10.1073/pnas.0407339101; Oetting WS, 1999, HUM MUTAT, V13, P99, DOI 10.1002/(SICI)1098-1004(1999)13:2<99::AID-HUMU2>3.3.CO;2-3; Ohbayashi N, 2012, J CELL SCI, V125, P1508, DOI 10.1242/jcs.094185; Rachel RA, 2002, J NEUROSCI, V22, P4249, DOI 10.1523/JNEUROSCI.22-11-04249.2002; Samaraweera P, 2001, EXP EYE RES, V72, P319, DOI 10.1006/exer.2000.0962; Schiaffino MV, 1999, NAT GENET, V23, P108, DOI 10.1038/12715; Schiaffino MV, 1996, P NATL ACAD SCI USA, V93, P9055, DOI 10.1073/pnas.93.17.9055; SCHNUR RE, 1994, AM J HUM GENET, V55, P484; Shen B, 2001, PIGM CELL RES, V14, P243, DOI 10.1034/j.1600-0749.2001.140403.x; Shen B, 2001, TRAFFIC, V2, P202, DOI 10.1034/j.1600-0854.2001.020306.x; Staleva L, 2006, EXP EYE RES, V82, P311, DOI 10.1016/j.exer.2005.07.003; Suzuki T, 2003, P NATL ACAD SCI USA, V100, P1146, DOI 10.1073/pnas.0237292100; Suzuki T, 2002, NAT GENET, V30, P321, DOI 10.1038/ng835; Suzuki T, 2001, GENOMICS, V78, P30, DOI 10.1006/geno.2001.6644; SWEET HO, 1983, J HERED, V74, P305, DOI 10.1093/oxfordjournals.jhered.a109794; Theos AC, 2005, MOL BIOL CELL, V16, P5356, DOI 10.1091/mbc.E05-07-0626; Tobin Gregory J., 1996, Methods (Orlando), V10, P208, DOI 10.1006/meth.1996.0096; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wu XF, 2002, MOL BIOL CELL, V13, P1735, DOI 10.1091/mbc.01-12-0595; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Young A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024376; Zhang Q, 2003, NAT GENET, V33, P145, DOI 10.1038/ng1087; Zhang Q, 2002, HUM MOL GENET, V11, P697, DOI 10.1093/hmg/11.6.697; Zhen LJ, 1999, BLOOD, V94, P146, DOI 10.1182/blood.V94.1.146.413k39_146_155	50	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e42446	10.1371/journal.pone.0042446	http://dx.doi.org/10.1371/journal.pone.0042446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984402	Green Submitted, Green Published, gold			2022-12-25	WOS:000308638700005
J	Sample, SJ; Racette, MA; Hao, ZL; Thomas, CF; Behan, M; Muir, P				Sample, Susannah J.; Racette, Molly A.; Hao, Zhengling; Thomas, Cathy F.; Behan, Mary; Muir, Peter			Functional Adaptation in Female Rats: The Role of Estrogen Signaling	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RECEPTOR-ALPHA; SENSORY NEURONS; ADAPTIVE RESPONSE; BONE-FORMATION; MICE LACKING; GROWTH; EXPRESSION; GPR30; BETA	Background: Sex steroids have direct effects on the skeleton. Estrogen acts on the skeleton via the classical genomic estrogen receptors alpha and beta (ER alpha and ER beta), a membrane ER, and the non-genomic G-protein coupled estrogen receptor (GPER). GPER is distributed throughout the nervous system, but little is known about its effects on bone. In male rats, adaptation to loading is neuronally regulated, but this has not been studied in females. Methodology/Principal Findings: We used the rat ulna end-loading model to induce an adaptive modeling response in ovariectomized (OVX) female Sprague-Dawley rats. Rats were treated with a placebo, estrogen (17 beta-estradiol), or G-1, a GPER-specific agonist. Fourteen days after OVX, rats underwent unilateral cyclic loading of the right ulna; half of the rats in each group had brachial plexus anesthesia (BPA) of the loaded limb before loading. Ten days after loading, serum estrogen concentrations, dorsal root ganglion (DRG) gene expression of ER alpha, ER beta, GPER, CGRP alpha, TRPV1, TRPV4 and TRPA1, and load-induced skeletal responses were quantified. We hypothesized that estrogen and G-1 treatment would influence skeletal responses to cyclic loading through a neuronal mechanism. We found that estrogen suppresses periosteal bone formation in female rats. This physiological effect is not GPER-mediated. We also found that absolute mechanosensitivity in female rats was decreased, when compared with male rats. Blocking of adaptive bone formation by BPA in Placebo OVX females was reduced. Conclusions: Estrogen acts to decrease periosteal bone formation in female rats in vivo. This effect is not GPER-mediated. Gender differences in absolute bone mechanosensitivity exist in young Sprague-Dawley rats with reduced mechanosensitivity in females, although underlying bone formation rate associated with growth likely influences this observation. In contrast to female and male rats, central neuronal signals had a diminished effect on adaptive bone formation in estrogen-deficient female rats.	[Sample, Susannah J.; Racette, Molly A.; Hao, Zhengling; Muir, Peter] Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA; [Thomas, Cathy F.; Behan, Mary] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sample, SJ (corresponding author), Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	muirp@vetmed.wisc.edu	Muir, Peter/AAH-8057-2021	Muir, Peter/0000-0003-0028-6005	Clinical and Translational Science Award (CTSA) program; National Center for Research Resources (NCRR) [1UL1RR025011]; National Center for Advancing Translational Sciences (NCATS) [9U54TR000021]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR023916, UL1RR025011] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010423] Funding Source: NIH RePORTER	Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The project described was supported by the Clinical and Translational Science Award (CTSA) program, previously through the National Center for Research Resources (NCRR) grant 1UL1RR025011, and now by the National Center for Advancing Translational Sciences (NCATS), grant 9U54TR000021. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brailoiu E, 2007, J ENDOCRINOL, V193, P311, DOI 10.1677/JOE-07-0017; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Burt-Pichat B, 2005, ENDOCRINOLOGY, V146, P503, DOI 10.1210/en.2004-0884; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chagin AS, 2007, J CLIN ENDOCR METAB, V92, P4873, DOI 10.1210/jc.2007-0814; Cohen J., ANAL BEHAV SCI, V1988, P531; Dun SL, 2009, J NEUROSCI RES, V87, P1610, DOI 10.1002/jnr.21980; Fitts JM, 2011, J PHARMACOL EXP THER, V338, P246, DOI 10.1124/jpet.110.173955; Ford J, 2011, J BONE MINER RES, V26, P298, DOI 10.1002/jbmr.209; Heino TJ, 2008, J ENDOCRINOL, V197, pR1, DOI 10.1677/JOE-07-0629; HILL EL, 1991, CELL TISSUE RES, V264, P469, DOI 10.1007/BF00319037; Hou YX, 2010, ARCH ORAL BIOL, V55, P309, DOI 10.1016/j.archoralbio.2010.02.002; Hsieh YF, 1999, BONE, V25, P379, DOI 10.1016/S8756-3282(99)00181-7; Imai S, 1997, J BONE MINER RES, V12, P1018, DOI 10.1359/jbmr.1997.12.7.1018; Jagger CJ, 1996, J CLIN INVEST, V98, P2351, DOI 10.1172/JCI119047; Jarvinen TLN, 2003, BONE, V32, P642, DOI 10.1016/S8756-3282(03)00100-5; Jimenez-Andrade JM, 2010, BONE, V46, P306, DOI 10.1016/j.bone.2009.09.013; Kotha SP, 2004, J BIOMECH, V37, P541, DOI 10.1016/j.jbiomech.2003.08.009; Kuhn J, 2008, EUR J NEUROSCI, V27, P1700, DOI 10.1111/j.1460-9568.2008.06131.x; Kwan KY, 2009, J NEUROSCI, V29, P4808, DOI 10.1523/JNEUROSCI.5380-08.2009; Lanyon L, 2001, J BONE MINER RES, V16, P1937, DOI 10.1359/jbmr.2001.16.11.1937; LANYON LE, 1984, J BIOMECH, V17, P897, DOI 10.1016/0021-9290(84)90003-4; Lee K, 2003, NATURE, V424, P389, DOI 10.1038/424389a; Lee KCL, 2004, J ENDOCRINOL, V182, P193, DOI 10.1677/joe.0.1820193; Li L, 2007, J ORTHOP RES, V25, P1204, DOI 10.1002/jor.20406; Martensson UEA, 2009, ENDOCRINOLOGY, V150, P687, DOI 10.1210/en.2008-0623; Martin CD, 2007, NEUROSCI LETT, V427, P148, DOI 10.1016/j.neulet.2007.08.055; Mosley JR, 2002, BONE, V30, P314, DOI 10.1016/S8756-3282(01)00626-3; Ohlsson C, 2012, P NATL ACAD SCI USA, V109, P983, DOI 10.1073/pnas.1111436109; Papka RE, 2002, NEUROSCI LETT, V319, P71, DOI 10.1016/S0304-3940(01)02562-9; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Reed WR, 2009, J NEUROPHYSIOL, V102, P1062, DOI 10.1152/jn.00165.2009; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Roepke TA, 2010, ENDOCRINOLOGY, V151, P4926, DOI 10.1210/en.2010-0573; Sample SJ, 2008, J BONE MINER RES, V23, P1372, DOI [10.1359/jbmr.080407, 10.1359/JBMR.080407]; Sample SJ, 2010, J BONE MINER RES, V25, P2016, DOI 10.1002/jbmr.101; Saxon LK, 2007, AM J PHYSIOL-ENDOC M, V293, pE484, DOI 10.1152/ajpendo.00189.2007; Saxon LK, 2006, BONE, V39, P1261, DOI 10.1016/j.bone.2006.06.030; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Serre CM, 1999, BONE, V25, P623, DOI 10.1016/S8756-3282(99)00215-X; SOHRABJI F, 1994, J NEUROSCI, V14, P459; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; Wang C, 2009, J IMMUNOL, V182, P3294, DOI 10.4049/jimmunol.0803205; Windahl SH, 2009, AM J PHYSIOL-ENDOC M, V296, pE490, DOI 10.1152/ajpendo.90691.2008; Wu Q, 2009, NEUROSCI LETT, V463, P254, DOI 10.1016/j.neulet.2009.07.078; Yang XR, 2006, AM J PHYSIOL-LUNG C, V290, pL1267, DOI 10.1152/ajplung.00515.2005; Zhao H, 2010, AM J PHYSIOL-GASTR L, V298, pG212, DOI 10.1152/ajpgi.00396.2009	48	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43215	10.1371/journal.pone.0043215	http://dx.doi.org/10.1371/journal.pone.0043215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984413	gold, Green Published, Green Submitted			2022-12-25	WOS:000308638700015
J	Siegel, D; Kepa, JK; Ross, D				Siegel, David; Kepa, Jadwiga K.; Ross, David			NAD(P)H: Quinone Oxidoreductase 1 (NQO1) Localizes to the Mitotic Spindle in Human Cells	PLOS ONE			English	Article							20S PROTEASOMAL DEGRADATION; NAD(P)H-QUINONE OXIDOREDUCTASE-1; IN-VITRO; ANTITUMOR QUINONES; DT-DIAPHORASE; P53; EXPRESSION; STABILITY; GENE; PROTEINS	NAD(P)H: quinone oxidoreductase 1 (NQO1) is an FAD containing quinone reductase that catalyzes the 2-electron reduction of a broad range of quinones. The 2-electron reduction of quinones to hydroquinones by NQO1 is believed to be a detoxification process since this reaction bypasses the formation of the highly reactive semiquinone. NQO1 is expressed at high levels in normal epithelium, endothelium and adipocytes as well as in many human solid tumors. In addition to its function as a quinone reductase NQO1 has been shown to reduce superoxide and regulate the 20 S proteasomal degradation of proteins including p53. Biochemical studies have indicated that NQO1 is primarily located in the cytosol, however, lower levels of NQO1 have also been found in the nucleus. In these studies we demonstrate using immunocytochemistry and confocal imaging that NQO1 was found associated with mitotic spindles in cells undergoing division. The association of NQO1 with the mitotic spindles was observed in many different human cell lines including nontransformed cells (astrocytes, HUVEC) immortalized cell lines (HBMEC, 16HBE) and cancer (pancreatic adenocarcinoma, BXPC3). Confocal analysis of double-labeling experiments demonstrated co-localization of NQO1 with alpha-tubulin in mitotic spindles. In studies with BxPc-3 human pancreatic cancer cells the association of NQO1 with mitotic spindles appeared to be unchanged in the presence of NQO1 inhibitors ES936 or dicoumarol suggesting that NQO1 can associate with the mitotic spindle and still retain catalytic activity. Analysis of archival human squamous lung carcinoma tissue immunostained for NQO1 demonstrated positive staining for NQO1 in the spindles of mitotic cells. The purpose of this study is to demonstrate for the first time the association of the quinone reductase NQO1 with the mitotic spindle in human cells.	[Siegel, David; Kepa, Jadwiga K.; Ross, David] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Siegel, D (corresponding author), Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO 80045 USA.	david.siegel@ucdenver.edu		Ross, David/0000-0002-8307-5942	National Institutes of Health [R01ES108943]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grant R01ES108943. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade N, 2009, TOXICOL SCI, V107, P451, DOI 10.1093/toxsci/kfn243; AIZAWA H, 1990, J BIOL CHEM, V265, P13849; Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Beall HD, 1998, J MED CHEM, V41, P4755, DOI 10.1021/jm980328r; Bui CB, 2011, BIOCHEM BIOPH RES CO, V412, P347, DOI 10.1016/j.bbrc.2011.07.101; Cao JN, 2010, CANCER RES, V70, P6004, DOI 10.1158/0008-5472.CAN-09-4490; Chan TS, 2002, FREE RADICAL RES, V36, P421, DOI 10.1080/10715760290021270; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; DURKACZ BW, 1980, NATURE, V283, P593, DOI 10.1038/283593a0; Khutornenko AA, 2010, P NATL ACAD SCI USA, V107, P12828, DOI 10.1073/pnas.0910885107; Lafarga M, 2002, GLIA, V38, P313, DOI 10.1002/glia.10075; LIND C, 1990, METHOD ENZYMOL, V186, P287; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Morris VB, 2000, EXP CELL RES, V256, P122, DOI 10.1006/excr.2000.4800; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; Patrick BA, 2011, ONCOGENE, V30, P1098, DOI 10.1038/onc.2010.491; Pfeiffer E, 1996, CHEM-BIOL INTERACT, V102, P37, DOI 10.1016/0009-2797(96)03730-1; Rokah OH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011401; SCHLAGER JJ, 1990, INT J CANCER, V45, P403, DOI 10.1002/ijc.2910450304; Schweitzer KM, 1997, LAB INVEST, V76, P25; Sharp SY, 2000, MOL PHARMACOL, V58, P1146, DOI 10.1124/mol.58.5.1146; Siegel D, 1998, CLIN CANCER RES, V4, P2065; Siegel D, 1999, PHARMACOGENETICS, V9, P113, DOI 10.1097/00008571-199902000-00015; Siegel D, 2001, MOL PHARMACOL, V59, P263, DOI 10.1124/mol.59.2.263; Siegel D, 1997, MOL PHARMACOL, V52, P300, DOI 10.1124/mol.52.2.300; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Siegel D, 2012, BIOCHEM PHARMACOL, V83, P1033, DOI 10.1016/j.bcp.2011.12.017; Siegel D, 2011, J PHARMACOL EXP THER, V336, P874, DOI 10.1124/jpet.110.176438; Sieger D, 2000, FREE RADICAL BIO MED, V29, P246, DOI 10.1016/S0891-5849(00)00310-5; Sollner S, 2009, FEBS J, V276, P4313, DOI 10.1111/j.1742-4658.2009.07143.x; Tsvetkov P, 2011, J BIOL CHEM, V286, P8839, DOI 10.1074/jbc.M110.193276; Wignall SM, 2004, CHEM BIOL, V11, P135, DOI 10.1016/j.chembiol.2003.12.019; Winski SL, 2002, CANCER RES, V62, P1420; Winski SL, 2001, BIOCHEM PHARMACOL, V61, P1509, DOI 10.1016/S0006-2952(01)00631-1; Wu N, 2006, J MOL BIOL, V364, P955, DOI 10.1016/j.jmb.2006.09.075	37	29	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44861	10.1371/journal.pone.0044861	http://dx.doi.org/10.1371/journal.pone.0044861			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984577	Green Submitted, Green Published, gold			2022-12-25	WOS:000308638700093
J	Gao, XH; Wu, Y; Zhang, Y; Zhang, NX; Tang, J; Qiu, J; Lin, XF; Du, YK				Gao, Xiaohui; Wu, Yu; Zhang, Yu; Zhang, Naixing; Tang, Jie; Qiu, Jun; Lin, Xiaofang; Du, Yukai			Effectiveness of School-based Education on HIV/AIDS Knowledge, Attitude, and Behavior among Secondary School Students in Wuhan, China	PLOS ONE			English	Article							PEER EDUCATION; UNIVERSITY-STUDENTS; AIDS KNOWLEDGE; RURAL STUDENTS; HIV PREVENTION; CONDOM USE; PROGRAM; STATE	Background: Human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) are among the most complex health problems in the world. Young people are at high risk of HIV and AIDS infections and are, therefore, in need of targeted prevention. School-based HIV/AIDS health education may be an effective way to prevent the spread of AIDS among adolescents. Methods: The study was a school-based intervention conducted in three middle schools and two high schools in Wuhan, China, which included 702 boys and 766 girls, with ages from 11 to 18 years old. The intervention was a one-class education program about HIV/AIDS for participants. HIV/AIDS knowledge, attitude, and high-risk behaviors were investigated using an anonymous self-administered questionnaire before and after the education intervention. Chi-square test was used to compare differences before and after the intervention. Non-conditional logistic regression analysis was used to identify the factors that affect HIV/AIDS knowledge. Results: Misconceptions about basic medical knowledge and non-transmission modes of HIV/AIDS among all the students prevail. Approximately 10% to 40% of students had negative attitudes about HIV/AIDS before the intervention. After the intervention, all of the students had significant improvements in knowledge and attitude about HIV/AIDS (P,. 05), indicating that educational intervention increased the students' knowledge significantly and changed their attitudes positively. Logistic regression analyses indicated that before the intervention the students' level of knowledge about HIV/AIDS was significantly associated with grade, economic status of the family, and attitudes toward participation in HIV/AIDS health information campaigns. Conclusions: HIV/AIDS education programs were welcomed by secondary students and positively influenced HIV/AIDS-related knowledge and attitudes. A systematic and long-term intervention among secondary school students must be conducted for the prevention of HIV.	[Gao, Xiaohui; Wu, Yu; Zhang, Yu; Tang, Jie; Qiu, Jun; Lin, Xiaofang; Du, Yukai] Huazhong Univ Sci & Technol, Dept Child & Maternal Hlth Care, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Zhang, Naixing] Huazhong Univ Sci & Technol, Dept Social Med & Hlth Management, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Tang, Jie] Guangzhou Med Univ, Guangzhou, Guangdong, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Guangzhou Medical University	Gao, XH (corresponding author), Huazhong Univ Sci & Technol, Dept Child & Maternal Hlth Care, Sch Publ Hlth, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China.	duyukai100@163.com	Jie, Tang/AAS-7192-2021	Tang, Jie/0000-0002-0568-8444	Joint School on Education, Sociology, Technology and Medicine Research Paper Award in China, Medical Planning Project [YX10001]; Yuanxuan College Foundation in Hong Kong	Joint School on Education, Sociology, Technology and Medicine Research Paper Award in China, Medical Planning Project; Yuanxuan College Foundation in Hong Kong	This research was supported by Joint School on Education, Sociology, Technology and Medicine Research Paper Award in China, Medical Planning Project No. YX10001 (URL: http://www.compe.cn/). We thank the support of Yuanxuan College Foundation in Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpabio II, 2009, J ADOLESCENT HEALTH, V44, P118, DOI 10.1016/j.jadohealth.2008.05.005; Albrektsson Madelene, 2009, Open AIDS J, V3, P55, DOI 10.2174/1874613600903010055; [Anonymous], WUHAN STAT YB 2011; Babikian T, 2004, AIDS BEHAV, V8, P47, DOI 10.1023/B:AIBE.0000017525.92015.5d; Berten H, 2009, J ADOLESCENCE, V32, P1303, DOI 10.1016/j.adolescence.2008.12.004; Blake SM, 2005, PREV MED, V40, P239, DOI 10.1016/j.ypmed.2004.05.028; Borgia P, 2005, J ADOLESCENT HEALTH, V36, P508, DOI 10.1016/j.jadohealth.2004.03.005; Caron F, 2004, HEALTH EDUC RES, V19, P185, DOI 10.1093/her/cyg017; Cartagena RG, 2006, J ADOLESCENT HEALTH, V39, P925; Cheng Y, 2008, J ADOLESCENT HEALTH, V42, P184, DOI 10.1016/j.jadohealth.2007.07.016; Citak GG, 2009, PROCD SOC BEHV, V1, P2086, DOI 10.1016/j.sbspro.2009.01.367; Ergene T, 2005, AIDS EDUC PREV, V17, P268, DOI 10.1521/aeap.17.4.268.66533; Francis DA, 2009, INT J EDUC DEV, P314; Ganczak M, 2007, J ADOLESCENT HEALTH, V40, pCOVER1, DOI 10.1016/j.jadohealth.2007.01.011; Halpern CT, 2008, SOC SCI MED, V67, P628, DOI 10.1016/j.socscimed.2008.05.001; Kyrychenko P, 2006, J ADOLESCENT HEALTH, V39, P900, DOI 10.1016/j.jadohealth.2006.06.006; Liao W, 2010, BIOMED ENVIRON SCI, V23, P409, DOI 10.1016/S0895-3988(10)60083-9; Lowe J, 2008, J SCH NURS, V24, P229, DOI 10.1177/1059840508319866; MOH, 2010, CHIN 2010 UNGASS COU; Nwokocha Ada R C, 2002, J Pediatr Adolesc Gynecol, V15, P93, DOI 10.1016/S1083-3188(01)00150-4; Oni AA, 2005, J ASSOC NURSE AIDS C, V16, P40, DOI 10.1016/j.jana.2005.01.003; Oshi DC, 2005, J BIOSOC SCI, V37, P175, DOI 10.1017/S0021932004006820; SCAWC, 2007, JOINT ASS HIV AIDS P; Tapia-Aguirre V, 2004, ARCH MED RES, V35, P334, DOI 10.1016/j.arcmed.2004.05.002; UN, 2011, UN UN ACC ZER NEW HI; UNAIDS, 2010, REP GLOB AIDS EP; Ungan M, 2003, PATIENT EDUC COUNS, V51, P163, DOI 10.1016/S0738-3991(02)00190-8; UNGASS, 2009, GUID CONSTR COR IND; Van Rossem R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-30; Wu Q, 2010, INT J STD AIDS, V21, P87, DOI 10.1258/ijsa.2009.008508; Zimet GD, 1998, HDB SEXUALITY RELATE, P365	31	32	37	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44881	10.1371/journal.pone.0044881	http://dx.doi.org/10.1371/journal.pone.0044881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001LK	22970322	Green Published, gold, Green Submitted			2022-12-25	WOS:000308462000054
J	Lei, L; Li, ZY; Zhong, GM				Lei, Lei; Li, Zhongyu; Zhong, Guangming			Rottlerin-Mediated Inhibition of Chlamydia trachomatis Growth and Uptake of Sphingolipids Is Independent of p38-Regulated/Activated Protein Kinase (PRAK)	PLOS ONE			English	Article							F-ACTIN REARRANGEMENT; INFECTED CELLS; PATHWAY; ACQUISITION; ACTIVATION; APOPTOSIS; MK5	We previously found that rottlerin, a plant-derived small molecule compound, profoundly inhibited Chlamydia trachomatis growth and blocked sphingolipid trafficking from host cell Golgi into chlamydial inclusions. Since the p38-regulated/activated protein kinase (PRAK) is a known target of rottlerin and is activated in Chlamydia trachomatis-infected cells, we investigated the potential role of this kinase in rottlerin-mediated anti-chlamydial activity. However, we found that a PRAK-specific inhibitor failed to inhibit chlamydial growth, suggesting that the kinase activity of PRAK may not be required for chlamydial intracellular replication. This conclusion was supported by the observation that chlamydial organisms replicated equally well in mouse embryonic fibroblast cells with or without PRAK. Moreover, neither the PRAK inhibitor nor PRAK deficiency altered host sphingolipid trafficking into chlamydial inclusions. Finally, rottlerin maintained its anti-chlamydial activity in PRAK-deficient cells. Together, these observations have demonstrated that PRAK is not required for either the rottlerin-mediated anti-chlamydial activity or rottlerin inhibition of sphingolipid trafficking, suggesting that rottlerin may achieve its inhibitory role by targeting other host factors.	[Lei, Lei; Zhong, Guangming] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Li, Zhongyu] Univ S China, Hengyang, Hunan, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of South China	Lei, L (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	zhongg@uthscsa.edu	Lei, Lei/I-3002-2013		National Institutes of Health [R01AI64537]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health R01AI64537. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BK, 2006, J INVEST DERMATOL, V126, P1348, DOI 10.1038/sj.jid.5700244; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; BRUNHAM RC, 1988, J INFECT DIS, V158, P510, DOI 10.1093/infdis/158.3.510; Chen G, 2000, J BIOL CHEM, V275, P38973, DOI 10.1074/jbc.M002856200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Elwell CA, PLOS PATHOG, V7; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Gerits N, 2007, J BIOL CHEM, V282, P37232, DOI 10.1074/jbc.M704873200; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Kostenko Sergiy, 2011, World J Biol Chem, V2, P73, DOI 10.4331/wjbc.v2.i5.73; Kostenko S, 2009, CELL SIGNAL, V21, P712, DOI 10.1016/j.cellsig.2009.01.009; Lei L, MICROB PATHOG, V51, P101; Li ZY, 2008, INFECT IMMUN, V76, P3415, DOI 10.1128/IAI.01377-07; Maioli E, 2012, SCI WORLD J, DOI 10.1100/2012/350826; Miller KE, 2006, AM FAM PHYSICIAN, V73, P1411; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Ni H, 1998, BIOCHEM BIOPH RES CO, V243, P492, DOI 10.1006/bbrc.1998.8135; Sharma J, 2006, INFECT IMMUN, V74, P1490, DOI 10.1128/IAI.74.3.1490-1499.2006; Sharma J, 2005, INFECT IMMUN, V73, P4414, DOI 10.1128/IAI.73.7.4414-4419.2005; Shivshankar P, 2008, APPL ENVIRON MICROB, V74, P1243, DOI 10.1128/AEM.02151-07; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Tillman DM, 2003, CANCER RES, V63, P5118	25	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44733	10.1371/journal.pone.0044733	http://dx.doi.org/10.1371/journal.pone.0044733			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970301	gold, Green Published, Green Submitted			2022-12-25	WOS:000308462000048
J	Feinkohl, I; Sattar, N; Welsh, P; Reynolds, RM; Deary, IJ; Strachan, MWJ; Price, JF				Feinkohl, Insa; Sattar, Naveed; Welsh, Paul; Reynolds, Rebecca M.; Deary, Ian J.; Strachan, Mark W. J.; Price, Jackie F.		Edinburgh Type 2 Diabet Study Inve	Association of N-Terminal Pro-Brain Natriuretic Peptide with Cognitive Function and Depression in Elderly People with Type 2 Diabetes	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LEFT-VENTRICULAR DYSFUNCTION; CONGESTIVE-HEART-FAILURE; MINI-MENTAL-STATE; HOSPITAL ANXIETY; ARTERY-DISEASE; PLASMA-LEVELS; RISK-FACTORS; IMPAIRMENT; ADULTS	Background: Type 2 diabetes mellitus is associated with risk of congestive heart failure (CHF), cognitive dysfunction and depression. CHF itself is linked both to poor cognition and depression. The ventricular N-terminal pro-brain natriuretic peptide (NT-proBNP) is a marker of CHF, suggesting potential as a marker for cognitive impairment and/or depression. This was tested in the Edinburgh Type 2 Diabetes Study (ET2DS). Methodology and Principal Findings: Cross-sectional analysis of 1066 men and women aged 60-75 with type 2 diabetes. Results from seven neuropsychological tests were combined in a standardised general cognitive ability factor, 'g'. A vocabulary-based test estimated pre-morbid cognitive ability. The Hospital Anxiety and Depression Scale (HADS) assessed possible depression. After adjustment for age and sex, raised plasma NT-proBNP was weakly associated with lower 'g' and higher depression scores (beta -0.09, 95% CI -0.13 to -0.03, p = 0.004 and beta 0.08, 95% CI 0.04 to 0.12, p < 0.001, respectively). Comparing extreme quintiles of NT-proBNP, subjects in the highest quintile were more likely to have reduced cognitive ability (within the lowest tertile of 'g') and 'possible' depression (HADS depression >= 8) (OR 1.80; 95% CI: 1.20, 2.70; p = 0.005 and OR 2.18; 95% CI: 1.28, 3.71; p = 0.004, respectively). Associations persisted when pre-morbid ability was adjusted for, but as expected were no longer statistically significant following the adjustment for diabetes-related and vascular co-variates (beta -0.02, 95% CI 20.07 to 0.03, p > 0.05 for 'g'; beta 0.03, 95% CI 20.02 to 0.07, p. 0.05 for depression scores). Conclusion: Raised plasma NT-proBNP was weakly but statistically significantly associated with poorer cognitive function and depression. The prospective phases of the ET2DS will help determine whether or not NT-proBNP can be considered a risk marker for subsequent cognitive impairment and incident depression and whether it provides additional information over and above traditional risk factors for these conditions.	[Feinkohl, Insa; Price, Jackie F.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Sattar, Naveed; Welsh, Paul] Univ Glasgow, Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Reynolds, Rebecca M.] Univ Edinburgh, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Deary, Ian J.] Univ Edinburgh, Psychol Sch Philosophy Psychol & Language Sci, Edinburgh, Midlothian, Scotland; [Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Strachan, Mark W. J.] Western Gen Hosp, Metab Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Glasgow; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Feinkohl, I (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland.	I.Feinkohl@sms.ed.ac.uk; Jackie.Price@ed.ac.uk	Reynolds, Rebecca M/C-3044-2008; Deary, Ian J/C-6297-2009; Welsh, Paul/H-5249-2019	Reynolds, Rebecca M/0000-0001-6226-8270; Deary, Ian J/0000-0002-1733-263X; Welsh, Paul/0000-0002-7970-3643; Price, Jackie/0000-0003-3251-3970	Medical Research Council; Chief Scientist Office of the Scottish Executive; Pfizer plc; British Heart Foundation [FS/10/005/28147] Funding Source: researchfish; Medical Research Council [G0500877, G0700704B] Funding Source: researchfish; The Sir Jules Thorn Charitable Trust [09/01PhD] Funding Source: researchfish; Chief Scientist Office [CZG/2/478, CZB/4/582] Funding Source: researchfish; MRC [G0500877] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office of the Scottish Executive; Pfizer plc(Pfizer); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Sir Jules Thorn Charitable Trust; Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The ET2DS is funded by the Medical Research Council, the Chief Scientist Office of the Scottish Executive and Pfizer plc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Almeida OP, 2011, ARQ NEURO-PSIQUIAT, V59, P324; Andersen NH, 2005, DIABETIC MED, V22, P188, DOI 10.1111/j.1464-5491.2004.01396.x; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Bankier B, 2008, EUR HEART J, V29, P2212, DOI 10.1093/eurheartj/ehn326; Bankier B, 2009, J PSYCHOSOM RES, V66, P189, DOI 10.1016/j.jpsychores.2008.09.010; Bekelman DB, 2007, J CARD FAIL, V13, P643, DOI 10.1016/j.cardfail.2007.05.005; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bourdel-Marchasson I, 2010, DIABETES METAB, V36, P173, DOI 10.1016/j.diabet.2010.03.001; Bunevicius R, 2006, CLIN CARDIOL, V29, P170, DOI 10.1002/clc.4960290409; Carney RM, 2002, J PSYCHOSOM RES, V53, P897, DOI 10.1016/S0022-3999(02)00311-2; Castleberry C, 2010, J AM COLL CARDIOL, V55; Crawford JR, 2001, PSYCHOL MED, V31, P451, DOI 10.1017/S0033291701003634; Cukierman T, 2005, DIABETOLOGIA, V48, P2460, DOI 10.1007/s00125-005-0023-4; Curb JD, 1996, ARTERIOSCL THROM VAS, V16, P1495, DOI 10.1161/01.ATV.16.12.1495; Daniels LB, 2009, CIRCULATION, V120, pS542; Deary IJ, 2005, PSYCHOL SCI, V16, P64, DOI 10.1111/j.0956-7976.2005.00781.x; Deary IJ, 2004, INTELLIGENCE, V32, P113, DOI 10.1016/j.intell.2003.06.001; Di Angelantonio E, 2009, CIRCULATION, V120, P2177, DOI 10.1161/CIRCULATIONAHA.109.884866; Doust JA, 2004, ARCH INTERN MED, V164, P1978, DOI 10.1001/archinte.164.18.1978; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gunstad J, 2006, AM J CARDIOL, V98, P538, DOI 10.1016/j.amjcard.2006.02.062; Hayashi C, 2004, DIABETES RES CLIN PR, V66, P269, DOI 10.1016/j.diabres.2004.03.013; He J, 2001, ARCH INTERN MED, V161, P996, DOI 10.1001/archinte.161.7.996; Jankowska EA, 2010, EUR J HEART FAIL, V12, P966, DOI 10.1093/eurjhf/hfq108; Kerola T, 2010, ANN MED, V42, P207, DOI 10.3109/07853891003652542; Kondziella D, 2009, NEUROREPORT, V20, P825, DOI 10.1097/WNR.0b013e328326f82f; Luciano M, 2009, PSYCHOSOM MED, V71, P404, DOI 10.1097/PSY.0b013e3181a24fb9; Magnusson M, 2004, DIABETES CARE, V27, P1929, DOI 10.2337/diacare.27.8.1929; Marioni RE, 2010, DIABETES, V59, P710, DOI 10.2337/db09-1163; Mauro F, 2007, ARCH MED RES, V38, P234, DOI 10.1016/j.arcmed.2006.10.004; Muller-Tasch T, 2007, J CARD FAIL, V13, P818, DOI 10.1016/j.cardfail.2007.07.008; Naito J, 2009, GERIATR GERONTOL INT, V9, P242, DOI 10.1111/j.1447-0594.2009.00526.x; Nichols GA, 2004, DIABETES CARE, V27, P1879, DOI 10.2337/diacare.27.8.1879; Nilsson K, 2010, CLIN BIOCHEM, V43, P1282, DOI 10.1016/j.clinbiochem.2010.08.011; Olsson I, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-46; Politi P, 2007, NEUROSCI LETT, V417, P322, DOI 10.1016/j.neulet.2007.02.056; Price Jackie F, 2008, BMC Endocr Disord, V8, P18, DOI 10.1186/1472-6823-8-18; Reijmer YD, 2010, DIABETES-METAB RES, V26, P507, DOI 10.1002/dmrr.1112; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Suwa M, 2009, INT J CARDIOL, V136, P351, DOI 10.1016/j.ijcard.2008.04.099; Thomas SA, 2008, CRIT CARE NURSE, V28, P40; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922, DOI 10.1111/j.1532-5415.1992.tb01992.x; Vaes B, 2009, J AM GERIATR SOC, V57, P823, DOI 10.1111/j.1532-5415.2009.02218.x; van den Broek KC, 2011, AM J CARDIOL, V107, P723, DOI 10.1016/j.amjcard.2010.10.055; van Melle JP, 2005, EUR HEART J, V26, P2650, DOI 10.1093/eurheartj/ehi480; Wannamethee SG, 2011, J AM COLL CARDIOL, V58, P56, DOI 10.1016/j.jacc.2011.02.041; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zuccala G, 1997, J NEUROL NEUROSUR PS, V63, P509, DOI 10.1136/jnnp.63.4.509	50	19	19	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44569	10.1371/journal.pone.0044569	http://dx.doi.org/10.1371/journal.pone.0044569			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	002ZJ	22973461	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000308577600069
J	Boreddy, SR; Srivastava, SK				Boreddy, S. R.; Srivastava, S. K.			Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic model	ONCOGENE			English	Article						NF kappa B; TGF-beta; RKIP; Snail; metastasis; apoptosis	NF-KAPPA-B; CANCER-CELLS; E-CADHERIN; TGF-BETA; SMAD PATHWAYS; AKT INHIBITOR; EXPRESSION; APOPTOSIS; KINASE; ACTIVATION	Deguelin is known to suppress the growth of cancer cells; however, its anti-metastatic effects have not been studied so far in any cancer model. In the present study, we aimed to evaluate the anti-metastatic potential of deguelin in vivo and in tumor growth factor-beta 1 (TGF beta 1)-stimulated cells. Our results demonstrate that tumor growth, peritoneal dissemination and liver/lung metastasis of orthotopically implanted PanC-1-luc cells were significantly reduced in deguelin-treated mice along with the induction of apoptosis. Furthermore, deguelin-treated tumors showed increased epithelial signature such as increased expression of E-Cadherin and cytokeratin-18 and decreased expression of Snail. Similar observations were made when PanC-1, COLO-357 and L3.6pl cells were treated in vitro with deguelin. Moreover, E-cadherin was transcriptionally upregulated and accumulated in the membrane fraction of deguelin-treated cells, as indicated by increased interaction of E-Cadherin with beta-catenin. TGF beta 1-induced downregulation of E-Cadherin and upregulation of Snail were abrogated by deguelin treatment. In addition, deguelin inhibited TGF beta 1-induced Smad3 phosphorylation and Smad4 nuclear translocation in PanC-1 cells. Furthermore, when TGF beta 1-induced nuclear factor kappa B (NF kappa B) activation was inhibited, TGF beta 1-induced Snail upregulation or E-Cadherin downregulation was blocked. Deguelin also significantly downregulated the constitutive phosphorylation and DNA binding of NF kappa B in a dose-dependent manner. Interestingly, overexpression of either NF kappa B or Snail completely abrogated deguelin-mediated epithelial-to-mesenchymal transition (EMT) inhibition, whereas overexpression of NF kappa B but not Snail rescued cells from deguelin-induced apoptosis. Hence, deguelin targets NF kappa B to induce reversal of EMT and apoptosis but downstream effectors might be different for both processes. Taken together, our results suggest that deguelin suppresses both pancreatic tumor growth and metastasis by inducing apoptosis and inhibiting EMT.	Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Amarillo, TX 79106 USA; [Srivastava, S. K.] Texas Tech Univ, Hlth Sci Ctr, Canc Biol Ctr, Amarillo, TX 79106 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University Health Sciences Center Amarillo	Srivastava, SK (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, ARB, 1406 Coulter,Suite 1103, Amarillo, TX 79106 USA.	Sanjay.Srivastava@ttuhsc.edu	Srivastava, Sanjay K./AAE-7635-2020		National Cancer Institute [CA106953, CA129038]; NATIONAL CANCER INSTITUTE [R01CA106953, R01CA129038] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to acknowledge National Cancer Institute for supporting the present study in part by R01 grants CA106953 and CA129038 (to SKS). The technical assistance of Kartick C Pramanik, Prabodh K Kandala and Parul Gupta in the in vivo experiment is greatly appreciated. We would also like to thank Dr Thomas L Brown (Wright State University, Dayton, OH, USA), Dr Ming H Wang (Texas Tech Health Sciences Center, Amarillo, TX, USA), Dr Fazlul H Sarkar (Wayne State University, Detroit, MI, USA), Dr Paul Chiao (MD Anderson Cancer Center, Houston, TX, USA), Dr Frank C Marini (MD Anderson Cancer Center, Houston, TX, USA) and Dr Ming-Sound Tsao (University of Toronto, Toronto, Ontario, Canada) for providing the cell lines.	Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Baritaki S, 2009, ONCOGENE, V28, P3573, DOI 10.1038/onc.2009.214; Batra S, 2010, MOL CANCER THER, V9, P1596, DOI 10.1158/1535-7163.MCT-09-1146; Beavon IRG, 2000, EUR J CANCER, V36, P1607, DOI 10.1016/S0959-8049(00)00158-1; Besmer DM, 2011, CANCER RES, V71, P4432, DOI 10.1158/0008-5472.CAN-10-4439; Boreddy SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025799; Boreddy SR, 2011, CLIN CANCER RES, V17, P1784, DOI 10.1158/1078-0432.CCR-10-1891; Brinck U, 2004, ANTICANCER RES, V24, P2237; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cates JMM, 2009, PANCREAS, V38, pE1, DOI 10.1097/MPA.0b013e3181878b7f; Chen Y, 2009, INT J HEMATOL, V89, P618, DOI 10.1007/s12185-009-0307-4; Dell'Eva R, 2007, CARCINOGENESIS, V28, P404, DOI 10.1093/carcin/bgl162; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Gingery A, 2008, EXP CELL RES, V314, P2725, DOI 10.1016/j.yexcr.2008.06.006; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ito S, 2010, LEUKEMIA RES, V34, P352, DOI 10.1016/j.leukres.2009.09.003; Javle MM, 2007, ANN SURG ONCOL, V14, P3527, DOI 10.1245/s10434-007-9540-3; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kandala PK, 2012, J BIOL CHEM, V287, P28745, DOI 10.1074/jbc.M112.351379; Kang HW, DIG DIS SCI; Lee HY, 2005, J NATL CANCER I, V97, P1695, DOI 10.1093/jnci/dji377; Lee H, 2010, ONCOL REP, V24, P957, DOI 10.3892/or_00000942; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Murillo G, 2002, EUR J CANCER, V38, P2446, DOI 10.1016/S0959-8049(02)00192-2; Murillo G, 2009, CANCER PREV RES, V2, P942, DOI 10.1158/1940-6207.CAPR-08-0232; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Oh SH, 2007, J NATL CANCER I, V99, P949, DOI 10.1093/jnci/djm007; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pramanik KC, ANTIOXID REDOX SIGNA; Sahu RP, 2009, JNCI-J NATL CANCER I, V101, P176, DOI 10.1093/jnci/djn470; Salahshor S, 2008, MODERN PATHOL, V21, P271, DOI 10.1038/modpathol.3800990; Shah AN, 2007, ANN SURG ONCOL, V14, P3629, DOI 10.1245/s10434-007-9583-5; Takekawa M, 2002, EMBO J, V21, P6473, DOI 10.1093/emboj/cdf643; Tang HH, 2010, FEBS LETT, V584, P662, DOI 10.1016/j.febslet.2009.12.051; Udeani GO, 2001, CANCER CHEMOTH PHARM, V47, P263, DOI 10.1007/s002800000187; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Weinel RJ, 1996, INT J PANCREATOL, V19, P25; Wu K, 2009, CRIT REV IMMUNOL, V29, P241, DOI 10.1615/CritRevImmunol.v29.i3.40; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yan Y, 2005, NEOPLASIA, V7, P1053, DOI 10.1593/neo.05532; Yeung KC, 2001, MOL CELL BIOL, V21, P7207, DOI 10.1128/MCB.21.21.7207-7217.2001; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	47	55	60	0	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 22	2013	32	34					3980	3991		10.1038/onc.2012.413	http://dx.doi.org/10.1038/onc.2012.413			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IC	22986522	Green Accepted			2022-12-25	WOS:000323748100006
J	Velisetty, P; Chalamalasetti, SV; Chakrapani, S				Velisetty, Phanindra; Chalamalasetti, Sreevatsa V.; Chakrapani, Sudha			Conformational Transitions Underlying Pore Opening and Desensitization in Membrane-embedded Gloeobacter violaceus Ligand-gated Ion Channel (GLIC)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; 2ND TRANSMEMBRANE SEGMENT; FRONTAL-LOBE EPILEPSY; CYS-LOOP RECEPTOR; X-RAY-STRUCTURE; SIDE-CHAINS; THERAPEUTIC TARGETS; EMERGING FRONTIERS; PROTEIN-STRUCTURE; CLINICAL SCIENCE	Direct structural insight into the mechanisms underlying activation and desensitization remain unavailable for the pentameric ligand-gated channel family. Here, we report the structural rearrangements underlying gating transitions in membrane-embedded GLIC, a prokaryotic homologue, using site-directed spin labeling and electron paramagnetic resonance (EPR) spectroscopy. We particularly probed the conformation of pore-lining second transmembrane segment (M2) under conditions that favor the closed and the ligand-bound desensitized states. The spin label mobility, intersubunit spin-spin proximity, and the solvent-accessibility parameters in the two states clearly delineate the underlying protein motions within M2. Our results show that during activation the extracellular hydrophobic region undergoes major changes involving an outward translational movement, away from the pore axis, leading to an increase in the pore diameter, whereas the lower end of M2 remains relatively immobile. Most notably, during desensitization, the intervening polar residues in the middle of M2 move closer to form a solvent-occluded barrier and thereby reveal the location of a distinct desensitization gate. In comparison with the crystal structure of GLIC, the structural dynamics of the channel in a membrane environment suggest a more loosely packed conformation with water-accessible intrasubunit vestibules penetrating from the extracellular end all the way to the middle of M2 in the closed state. These regions have been implicated to play a major role in alcohol and drug modulation. Overall, these findings represent a key step toward understanding the fundamentals of gating mechanisms in this class of channels.	[Velisetty, Phanindra; Chalamalasetti, Sreevatsa V.; Chakrapani, Sudha] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Chakrapani, S (corresponding author), 10900 Euclid Ave,Robbins Bldg,E620, Cleveland, OH 44106 USA.	sudha.chakrapani@case.edu		chakrapani, sudha/0000-0003-0722-2338				Altenbach C, 2005, BIOPHYS J, V89, P2103, DOI 10.1529/biophysj.105.059063; ALTENBACH C, 1994, P NATL ACAD SCI USA, V91, P1667, DOI 10.1073/pnas.91.5.1667; ALTENBACH C, 1990, SCIENCE, V248, P1088, DOI 10.1126/science.2160734; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; Barrantes FJ, 2002, MOL MEMBR BIOL, V19, P277, DOI 10.1080/09687680210166226; Bertrand S, 1998, BRIT J PHARMACOL, V125, P751, DOI 10.1038/sj.bjp.0702154; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; Chang YC, 1998, MOL PHARMACOL, V53, P511, DOI 10.1124/mol.53.3.511; Colon-Saez JO, 2011, J PHYSIOL-LONDON, V589, P3163, DOI 10.1113/jphysiol.2011.209494; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293; Cymes GD, 2002, BIOCHEMISTRY-US, V41, P5548, DOI 10.1021/bi011864f; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; Donnelly-Roberts D, 2011, BIOCHEM PHARMACOL, V82, P797, DOI 10.1016/j.bcp.2011.05.002; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; FARAHBAKHSH ZT, 1992, PHOTOCHEM PHOTOBIOL, V56, P1019, DOI 10.1111/j.1751-1097.1992.tb09725.x; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Gonzalez-Gutierrez G, 2012, P NATL ACAD SCI USA, V109, P6331, DOI 10.1073/pnas.1119268109; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; Gopalakrishnan M, 2007, BIOCHEM PHARMACOL, V74, P1091, DOI 10.1016/j.bcp.2007.09.007; Goyal R, 2011, J BIOL CHEM, V286, P34635, DOI 10.1074/jbc.M111.269647; Gross A, 2002, BIOCHEMISTRY-US, V41, P1123, DOI 10.1021/bi015828s; Gross A, 1999, BIOCHEMISTRY-US, V38, P10324, DOI 10.1021/bi990856k; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Hubbell WL, 2000, NAT STRUCT BIOL, V7, P735, DOI 10.1038/78956; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Koteiche HA, 2003, BIOCHEMISTRY-US, V42, P6099, DOI 10.1021/bi0342867; Kuryatov A, 1997, J NEUROSCI, V17, P9035; LABARCA C, 1995, NATURE, V376, P514, DOI 10.1038/376514a0; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; Milone M, 1997, J NEUROSCI, V17, P5651; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; OCHOA ELM, 1989, CELL MOL NEUROBIOL, V9, P141, DOI 10.1007/BF00713026; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Purohit Y, 2006, J GEN PHYSIOL, V127, P703, DOI 10.1085/jgp.200509437; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; SCUKA M, 1992, PROG NEUROBIOL, V38, P19, DOI 10.1016/0301-0082(92)90033-B; SUNSHINE C, 1992, BIOCHIM BIOPHYS ACTA, V1108, P240, DOI 10.1016/0005-2736(92)90031-G; Tasneem A, 2005, GENOME BIOL, V6; Velisetty P, 2012, J BIOL CHEM, V287, P18467, DOI 10.1074/jbc.M112.348045; Wang HL, 2012, J BIOL CHEM, V287, P6482, DOI 10.1074/jbc.M111.305839; Weiland S, 1996, FEBS LETT, V398, P91, DOI 10.1016/S0014-5793(96)01215-X; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Williams DB, 1999, BIOPHYS J, V77, P2563, DOI 10.1016/S0006-3495(99)77091-8; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; YAKEL JL, 1993, P NATL ACAD SCI USA, V90, P5030, DOI 10.1073/pnas.90.11.5030; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	63	37	37	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36864	36872		10.1074/jbc.M112.401067	http://dx.doi.org/10.1074/jbc.M112.401067			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977232	hybrid, Green Published			2022-12-25	WOS:000310588500023
J	Aldini, R; Budriesi, R; Roda, G; Micucci, M; Ioan, P; D'Errico-Grigioni, A; Sartini, A; Guidetti, E; Marocchi, M; Cevenini, M; Rosini, F; Montagnani, M; Chiarini, A; Mazzella, G				Aldini, Rita; Budriesi, Roberta; Roda, Giulia; Micucci, Matteo; Ioan, Pierfranco; D'Errico-Grigioni, Antonia; Sartini, Alessandro; Guidetti, Elena; Marocchi, Margherita; Cevenini, Monica; Rosini, Francesca; Montagnani, Marco; Chiarini, Alberto; Mazzella, Giuseppe			Curcuma longa Extract Exerts a Myorelaxant Effect on the Ileum and Colon in a Mouse Experimental Colitis Model, Independent of the Anti-Inflammatory Effect	PLOS ONE			English	Article							NF-KAPPA-B; TRINITROBENZENE SULFONIC-ACID; INFLAMMATORY-BOWEL-DISEASE; ENTERIC NERVOUS-SYSTEM; DEXTRAN SULFATE SODIUM; ULCERATIVE-COLITIS; SMOOTH-MUSCLE; INTESTINAL INFLAMMATION; MAINTENANCE THERAPY; CELLS	Background: Curcuma has long been used as an anti-inflammatory agent in inflammatory bowel disease. Since gastrointestinal motility is impaired in inflammatory states, the aim of this work was to evaluate if Curcuma Longa had any effect on intestinal mortality Methods: The biological activity of Curcuma extract was evaluated against Carbachol induced contraction in isolated mice intestine. Acute and chronic colitis were induced in Balb/c mice by Dextran Sulphate Sodium administration (5% and 2.5% respectively) and either Curcuma extract (200 mg/kg/day) or placebo was thereafter administered for 7 and 21 days respectively. Spontaneous contractions and the response to Carbachol and Atropine of ileum and colon were studied after colitis induction and Curcuma administration. Results: Curcuma extract reduced the spontaneous contractions in the ileum and colon; the maximal response to Carbachol was inhibited in a non-competitive and reversible manner. Similar results were obtained in ileum and colon from Curcuma fed mice. DSS administration decreased the motility, mainly in the colon and Curcuma almost restored both the spontaneous contractions and the response to Carbachol after 14 days assumption, compared to standard diet, but a prolonged assumption of Curcuma decreased the spontaneous and Carbachol-induced contractions. Conclusions: Curcuma extract has a direct and indirect myorelaxant effect on mouse ileum and colon, independent of the anti-inflammatory effect. The indirect effect is reversible and non-competitive with the cholinergic agent. These results suggest the use of curcuma extract as a spasmolytic agent.	[Aldini, Rita; Roda, Giulia; Sartini, Alessandro; Guidetti, Elena; Marocchi, Margherita; Cevenini, Monica; Montagnani, Marco; Mazzella, Giuseppe] Univ Bologna, Dipartimento Med Clin, Osped Policlin S Orsola, Bologna, Italy; [Aldini, Rita] Univ Bologna, Dipartimento Sci Metalli Elettrochim & Tecn Chim, Bologna, Italy; [Budriesi, Roberta; Micucci, Matteo; Ioan, Pierfranco; Chiarini, Alberto] Univ Bologna, Dipartimento Sci Farmaceut, I-40126 Bologna, Italy; [D'Errico-Grigioni, Antonia; Rosini, Francesca] Univ Bologna, Dipartimento Med Interna Invecchiamento & Malatt, Osped Policlin S Orsola, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Aldini, R (corresponding author), Univ Bologna, Dipartimento Med Clin, Osped Policlin S Orsola, Bologna, Italy.	rita.aldini@unibo.it; roberta.budriesi@unibo.it	Roda, Giulia/E-5521-2011; Sartini, Alessandro/AAN-3396-2020; Micucci, Matteo/AAM-6126-2020; mazzella, giuseppe/A-1865-2016	Sartini, Alessandro/0000-0003-1573-6451; MICUCCI, MATTEO/0000-0003-3525-1531; D'ERRICO, ANTONIETTA/0000-0003-2747-3732; Mazzella, Giuseppe/0000-0001-8656-8112; MONTAGNANI, MARCO/0000-0003-0103-0327	Fondazione del Monte di Bologna e Ravenna; Alisal [Mazz100136- 2010]; MINISTERO DELLE POLITICHE AGRICOLE, ALIMENTARI E FORESTALI [D.M. 11008/7303/10]	Fondazione del Monte di Bologna e Ravenna(Fondazione del Monte di Bologna e Ravenna); Alisal; MINISTERO DELLE POLITICHE AGRICOLE, ALIMENTARI E FORESTALI	This work was supported by grants from Fondazione del Monte di Bologna e Ravenna and from Alisal (Mazz100136- 2010). ALISAL is a project supported by the MINISTERO DELLE POLITICHE AGRICOLE, ALIMENTARI E FORESTALI, with D.M. 11008/7303/10, dated 17/05/2010. The title of the project is: Miglioramento delle proprieta igienico-sanitarie, salutistiche e funzionali di commodity per l'alimentazione dell'uomo e/o degli animali (Improvement of sanitary properties, healthy and functional food commodities for human and/or animals). Prof. Mazzella was supported with materials, reagents, animals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED T, 2008, PHARM BIOCH BEHAV, V91, P554; Akiho Hirotada, 2011, World J Gastrointest Pathophysiol, V2, P72; AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; [Anonymous], VERS 3 0 GRAPHPAD SO; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Aube AC, 1999, NEUROGASTROENT MOTIL, V11, P55; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Blandizzi C, 2003, BRIT J PHARMACOL, V139, P309, DOI 10.1038/sj.bjp.0705249; Camacho-Barquero L, 2007, INT IMMUNOPHARMACOL, V7, P333, DOI 10.1016/j.intimp.2006.11.006; Claramunt RM, 2009, BIOORGAN MED CHEM, V17, P1290, DOI 10.1016/j.bmc.2008.12.029; Deguchi Y, 2007, DIGEST DIS SCI, V52, P2993, DOI 10.1007/s10620-006-9138-9; Fitzpatrick LR, 2000, DIGEST DIS SCI, V45, P2327, DOI 10.1023/A:1005630723111; Furness JB, 2008, NEUROGASTROENT MOTIL, V20, P32, DOI 10.1111/j.1365-2982.2008.01094.x; Grundy D, 2005, CURR OPIN GASTROEN, V21, P176, DOI 10.1097/01.mog.0000153315.28327.6e; Han SS, 2002, J BIOCHEM MOL BIOL, V35, P337; Hanai H, 2006, CLIN GASTROENTEROL H, V4, P1502, DOI 10.1016/j.cgh.2006.08.008; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; Ihara E, 2009, MOL PHARMACOL, V75, P1031, DOI 10.1124/mol.108.049858; Itthipanichpong C, 2006, J MED ASS THAI S2, V86, pS2999; JACOBSON K, 1995, GASTROENTEROLOGY, V109, P718, DOI 10.1016/0016-5085(95)90378-X; JAIN SK, 1994, CIBA F SYMP, V185, P153; Jian YT, 2005, WORLD J GASTROENTERO, V11, P1747, DOI 10.3748/wjg.v11.i12.1747; Kim GY, 2005, J IMMUNOL, V174, P8116, DOI 10.4049/jimmunol.174.12.8116; Kinoshita K, 2003, AM J PHYSIOL-GASTR L, V285, pG483, DOI 10.1152/ajpgi.00038.2003; Kohno N, 2006, J MED INVESTIG, V53, P277, DOI 10.2152/jmi.53.277; Kondo T, 2011, EUR J PHARMACOL, V670, P236, DOI 10.1016/j.ejphar.2011.08.034; Kumar Anil, 2010, Indian J Physiol Pharmacol, V54, P284; Larmonier CB, 2011, INFLAMM BOWEL DIS, V17, P503, DOI 10.1002/ibd.21391; Lim Allen W, 2011, Therap Adv Gastroenterol, V4, P145, DOI 10.1177/1756283X10382816; Linden D, 2003, BRIT J PHARMACOL, V139, P185, DOI 10.1038/sj.bjp.0705250; Linden DR, 2004, J PHYSIOL-LONDON, V557, P191, DOI 10.1113/jphysiol.2004.062174; Lomax AE, 2005, NEUROGASTROENT MOTIL, V17, P4, DOI 10.1111/j.1365-2982.2004.00607.x; Mattar Mark C, 2011, Gastrointest Cancer Res, V4, P53; Mizuta Y, 2000, GASTROENTEROLOGY, V118, P714, DOI 10.1016/S0016-5085(00)70141-7; Motagally MA, 2009, AM J PHYSIOL-GASTR L, V296, pG1077, DOI 10.1152/ajpgi.00006.2009; Motulsky H, 2003, PRACTICAL GUIDE CURV; Myers BS, 1997, AM J PHYSIOL-GASTR L, V273, pG928, DOI 10.1152/ajpgi.1997.273.4.G928; Negi PS, 1999, J AGR FOOD CHEM, V47, P4297, DOI 10.1021/jf990308d; Papadakis KA, 2000, INFLAMM BOWEL DIS, V6, P303, DOI 10.1002/ibd.3780060408; Pazdrak K, 2004, GASTROENTEROLOGY, V127, P1096, DOI 10.1053/j.gastro.2004.07.008; Qureshi S, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01406.x; Qureshi S, 2010, NEUROGASTROENT MOTIL, V22, pe64; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; REDDY SN, 1991, GASTROENTEROLOGY, V101, P1289, DOI 10.1016/0016-5085(91)90079-Z; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Salh B, 2003, AM J PHYSIOL-GASTR L, V285, pG235, DOI 10.1152/ajpgi.00449.2002; Sato K, 2006, BRIT J PHARMACOL, V148, P200, DOI 10.1038/sj.bjp.0706717; Shimouchi A, 2009, DIGEST DIS SCI, V54, P1725, DOI 10.1007/s10620-008-0550-1; Singh AK, 1996, CANCER LETT, V107, P109, DOI 10.1016/0304-3835(96)04357-1; Singh G, 2010, FOOD CHEM TOXICOL, V48, P1026, DOI 10.1016/j.fct.2010.01.015; SINGH S, 1995, J BIOL CHEM, V270, P24995, DOI 10.1074/jbc.270.42.24995; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sugimoto K, 2002, GASTROENTEROLOGY, V123, P1912, DOI 10.1053/gast.2002.37050; TAKEMASA KENJIRO, 1957, JOUR PHYSIOL SOC JAPAN, V19, P1217; Tallarida RJ, 1987, MANUAL PHARM CALCULA; Tomita R, 1998, J GASTROENTEROL, V33, P48, DOI 10.1007/PL00009965; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Ukil A, 2003, BRIT J PHARMACOL, V139, P209, DOI 10.1038/sj.bjp.0705241; Vasina V, 2006, AUTON NEUROSCI-BASIC, V126, P264, DOI 10.1016/j.autneu.2006.02.025; Vrees MD, 2002, ARCH SURG-CHICAGO, V137, P439, DOI 10.1001/archsurg.137.4.439; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xu YX, 1997, EXP HEMATOL, V25, P413; Xu YX, 1998, HEMATOPATHOL MOL HEM, V11, P49	64	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44650	10.1371/journal.pone.0044650	http://dx.doi.org/10.1371/journal.pone.0044650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984538	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500071
J	Guasch, L; Ojeda, MJ; Gonzalez-Abuin, N; Sala, E; Cereto-Massague, A; Mulero, M; Valls, C; Pinent, M; Ardevol, A; Garcia-Vallve, S; Pujadas, G				Guasch, Laura; Jose Ojeda, Maria; Gonzalez-Abuin, Noemi; Sala, Esther; Cereto-Massague, Adria; Mulero, Miquel; Valls, Cristina; Pinent, Montserrat; Ardevol, Anna; Garcia-Vallve, Santiago; Pujadas, Gerard			Identification of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin (Part I): Virtual Screening and Activity Assays	PLOS ONE			English	Article							MEDICINAL CHEMISTRY; DPP-4 INHIBITOR; DRUG DISCOVERY; HIGHLY POTENT; DATABASE; POLYPEPTIDE; DESIGN; SYSTEM; MODEL	Background: There has been great interest in determining whether natural products show biological activity toward protein targets of pharmacological relevance. One target of particular interest is DPP-IV whose most important substrates are incretins that, among other beneficial effects, stimulates insulin biosynthesis and secretion. Incretins have very short half-lives because of their rapid degradation by DPP-IV and, therefore, inhibiting this enzyme improves glucose homeostasis. As a result, DPP-IV inhibitors are of considerable interest to the pharmaceutical industry. The main goals of this study were (a) to develop a virtual screening process to identify potential DPP-IV inhibitors of natural origin; (b) to evaluate the reliability of our virtual-screening protocol by experimentally testing the in vitro activity of selected natural-product hits; and (c) to use the most active hit for predicting derivatives with higher binding affinities for the DPP-IV binding site. Methodology/Principal Findings: We predicted that 446 out of the 89,165 molecules present in the natural products subset of the ZINC database would inhibit DPP-IV with good ADMET properties. Notably, when these 446 molecules were merged with 2,342 known DPP-IV inhibitors and the resulting set was classified into 50 clusters according to chemical similarity, there were 12 clusters that contained only natural products for which no DPP-IV inhibitory activity has been previously reported. Nine molecules from 7 of these 12 clusters were then selected for in vitro activity testing and 7 out of the 9 molecules were shown to inhibit DPP-IV (where the remaining two molecules could not be solubilized, preventing the evaluation of their DPP-IV inhibitory activity). Then, the hit with the highest activity was used as a lead compound in the prediction of more potent derivatives. Conclusions/Significance: We have demonstrated that our virtual-screening protocol was successful in identifying novel lead compounds for developing more potent DPP-IV inhibitors.	[Guasch, Laura; Jose Ojeda, Maria; Gonzalez-Abuin, Noemi; Sala, Esther; Cereto-Massague, Adria; Mulero, Miquel; Valls, Cristina; Pinent, Montserrat; Ardevol, Anna; Garcia-Vallve, Santiago; Pujadas, Gerard] Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Grp Recerca Nutrigen, Tarragona, Catalonia, Spain; [Garcia-Vallve, Santiago; Pujadas, Gerard] Avinguda Univ, TECNIO, Ctr Tecnol Nutr & Salut, Catalonia, Spain	Universitat Rovira i Virgili	Guasch, L (corresponding author), Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Grp Recerca Nutrigen, Campus Sescelades, Tarragona, Catalonia, Spain.	gerard.pujadas@urv.cat	Pinent, Montserrat/C-7109-2011; Ardévol, Anna/AAO-6194-2021; Valls-Bautista, Cristina/K-8769-2014; Cereto-Massagué, Adrià/I-1643-2015; MJosé, Ojeda/ABB-5745-2020; Pujadas, Gerard/B-1457-2010; Massagué, Adrià Cereto i/AAC-2630-2021; PUJADAS, GERARD/W-9348-2019; Mulero, Miquel/L-4672-2014; Garcia-Vallve, Santi/A-4226-2008; Pinent, Montserrat/ABE-6178-2021; Sala, Esther/AAB-4997-2022	Pinent, Montserrat/0000-0003-3550-5378; Ardévol, Anna/0000-0003-0156-7538; Valls-Bautista, Cristina/0000-0001-5583-5695; Cereto-Massagué, Adrià/0000-0002-9319-6377; Pujadas, Gerard/0000-0003-2598-8089; PUJADAS, GERARD/0000-0003-2598-8089; Mulero, Miquel/0000-0003-2545-2065; Garcia-Vallve, Santi/0000-0002-0348-7497; Pinent, Montserrat/0000-0003-3550-5378; Guasch, Laura/0000-0003-4990-7765; Sala, Esther/0000-0002-5149-1992; Gonzalez-Abuin, Noemi/0000-0001-5484-1604; Ojeda Montes, Maria Jose/0000-0002-9290-1935	Ministerio de Educacion y Ciencia of the Spanish Government [AGL2011-25831/ALI, AGL2011-23879/ALI]; ACC1O [TECCT11-1-0012]	Ministerio de Educacion y Ciencia of the Spanish Government(Spanish Government); ACC1O	This research was supported by grants from the Ministerio de Educacion y Ciencia of the Spanish Government (AGL2011-25831/ALI and AGL2011-23879/ALI) and the ACC1O(TECCT11-1-0012) program (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertgeerts K, 2004, PROTEIN SCI, V13, P412, DOI 10.1110/ps.03460604; Akiyama T, 2001, J ANTIBIOT, V54, P744, DOI 10.7164/antibiotics.54.744; Al-masri IM, 2009, J ENZYM INHIB MED CH, V24, P1061, DOI 10.1080/14756360802610761; Andrews KM, 2011, BIOORG MED CHEM LETT, V21, P1810, DOI 10.1016/j.bmcl.2011.01.055; Backes BJ, 2007, BIOORG MED CHEM LETT, V17, P2005, DOI 10.1016/j.bmcl.2007.01.026; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biftu T, 2007, BIOORG MED CHEM LETT, V17, P3384, DOI 10.1016/j.bmcl.2007.03.095; Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Demuth HU, 2005, BBA-PROTEINS PROTEOM, V1751, P33, DOI 10.1016/j.bbapap.2005.05.010; Dixon SL, 2006, J COMPUT AID MOL DES, V20, P647, DOI 10.1007/s10822-006-9087-6; Duan JX, 2010, J MOL GRAPH MODEL, V29, P157, DOI 10.1016/j.jmgm.2010.05.008; Eckhardt M, 2007, J MED CHEM, V50, P6450, DOI 10.1021/jm701280z; Edmondson SD, 2008, BIOORG MED CHEM LETT, V18, P2409, DOI 10.1016/j.bmcl.2008.02.050; Edmondson SD, 2006, J MED CHEM, V49, P3614, DOI 10.1021/jm060015t; Edmondson SD, 2009, BIOORG MED CHEM LETT, V19, P4097, DOI 10.1016/j.bmcl.2009.06.011; Green Brian D, 2006, Diab Vasc Dis Res, V3, P159, DOI 10.3132/dvdr.2006.024; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Havale SH, 2009, BIOORGAN MED CHEM, V17, P1783, DOI 10.1016/j.bmc.2009.01.061; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kaelin DE, 2007, BIOORG MED CHEM LETT, V17, P5806, DOI 10.1016/j.bmcl.2007.08.049; Kim D, 2005, J MED CHEM, V48, P141, DOI 10.1021/jm0493156; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Kuhn B, 2007, CURR TOP MED CHEM, V7, P609, DOI 10.2174/156802607780091064; Lagorce D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-396; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Meier JJ, 2002, REGUL PEPTIDES, V107, P1, DOI 10.1016/S0167-0115(02)00039-3; Mendieta L, 2011, EXPERT OPIN THER PAT, V21, P1693, DOI 10.1517/13543776.2011.627325; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; Nordhoff S, 2009, BIOORG MED CHEM LETT, V19, P4201, DOI 10.1016/j.bmcl.2009.05.109; Pascual I, 2007, ENZYME MICROB TECH, V40, P414, DOI 10.1016/j.enzmictec.2006.07.012; Qiao L, 2006, BIOORG MED CHEM LETT, V16, P123, DOI 10.1016/j.bmcl.2005.09.037; Rush TS, 2005, J MED CHEM, V48, P1489, DOI 10.1021/jm040163o; Salam NK, 2009, J CHEM INF MODEL, V49, P2356, DOI 10.1021/ci900212v; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wallace MB, 2008, BIOORG MED CHEM LETT, V18, P2362, DOI 10.1016/j.bmcl.2008.02.071; Ward RA, 2005, J MED CHEM, V48, P6991, DOI 10.1021/jm0505866; Yazbeck R, 2009, TRENDS PHARMACOL SCI, V30, P600, DOI 10.1016/j.tips.2009.08.003; Zettl H, 2010, CHEMMEDCHEM, V5, P179, DOI 10.1002/cmdc.200900448; Zhang SD, 2011, MEDCHEMCOMM, V2, P471, DOI 10.1039/c0md00245c; Zsoldos Z, 2007, J MOL GRAPH MODEL, V26, P198, DOI 10.1016/j.jmgm.2006.06.002	42	31	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44971	10.1371/journal.pone.0044971	http://dx.doi.org/10.1371/journal.pone.0044971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984596	Green Submitted, gold, Green Published			2022-12-25	WOS:000308738500102
J	Hoxha, E; Lambers, E; Wasserstrom, JA; Mackie, A; Ramirez, V; Abramova, T; Verma, SK; Krishnamurthy, P; Kishore, R				Hoxha, Eneda; Lambers, Erin; Wasserstrom, John A.; Mackie, Alexander; Ramirez, Veronica; Abramova, Tatiana; Verma, Suresh K.; Krishnamurthy, Prasanna; Kishore, Raj			Elucidation of a Novel Pathway through Which HDAC1 Controls Cardiomyocyte Differentiation through Expression of SOX-17 and BMP2	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HISTONE DEACETYLASE 1; DEVELOPMENTAL REGULATORS; PLURIPOTENT; OCT4; POLYCOMB; THERAPY; NETWORK; REPAIR; HEART	Embryonic Stem Cells not only hold a lot of potential for use in regenerative medicine, but also provide an elegant and efficient way to study specific developmental processes and pathways in mammals when whole animal gene knock out experiments fail. We have investigated a pathway through which HDAC1 affects cardiovascular and more specifically cardiomyocyte differentiation in ES cells by controlling expression of SOX17 and BMP2 during early differentiation. This data explains current discrepancies in the role of HDAC1 in cardiovascular differentiation and sheds light into a new pathway through which ES cells determine cardiovascular cell fate.	[Hoxha, Eneda; Lambers, Erin; Wasserstrom, John A.; Mackie, Alexander; Ramirez, Veronica; Abramova, Tatiana; Verma, Suresh K.; Krishnamurthy, Prasanna; Kishore, Raj] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hoxha, E (corresponding author), Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA.	r-kishore@northwestern.edu	Verma, Suresh/AAU-9979-2020	Verma, Suresh Kumar/0000-0002-0739-1302; KRISHNAMURTHY, PRASANNA/0000-0002-4842-6364	National Institute of Health [HL091983, HL105597, HL095874, HL053354, HL108795]; American Heart Association's pre-doctoral fellowship grant [11PRE7360065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105597, R01HL053354, R37HL053354, R01HL095874, R01HL091983, P01HL108795] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association's pre-doctoral fellowship grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Work described in this manuscript was supported in part by National Institute of Health grants HL091983, HL105597, HL095874, HL053354 and HL108795 to RK and American Heart Association's pre-doctoral fellowship grant 11PRE7360065 to EH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-David U, 2012, CELL STEM CELL, V10, P10, DOI 10.1016/j.stem.2011.12.007; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Campbell PA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000553; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Hinkel R, 2011, EXPERT OPIN BIOL TH, V11, P723, DOI 10.1517/14712598.2011.570749; Joggerst SJ, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001124; Karantzali E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r65; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lagger S, 2010, EMBO J, V29, P3992, DOI 10.1038/emboj.2010.264; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Ma PP, 2008, DEV BIOL, V319, P110, DOI 10.1016/j.ydbio.2008.04.011; Marmorstein R, 2001, NAT REV MOL CELL BIO, V2, P422, DOI 10.1038/35073047; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Rajasingh J, 2008, CIRC RES, V102, pE107, DOI 10.1161/CIRCRESAHA.108.176115; Ren XF, 2006, MED HYPOTHESES, V67, P1469, DOI 10.1016/j.mehy.2006.06.021; Rolletschek A, 2009, BIOL CHEM, V390, P845, DOI 10.1515/BC.2009.103; Stefanovic S, 2009, J CELL BIOL, V186, P665, DOI 10.1083/jcb.200901040; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wasserstrom JA, 2009, CIRC-HEART FAIL, V2, P223, DOI 10.1161/CIRCHEARTFAILURE.108.811539	27	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45046	10.1371/journal.pone.0045046	http://dx.doi.org/10.1371/journal.pone.0045046			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984607	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500109
J	Kulhankova, K; Rouse, T; Nasr, ME; Field, EH				Kulhankova, Katarina; Rouse, Todd; Nasr, Mohamed E.; Field, Elizabeth H.			Dendritic Cells Control CD4(+)CD25(+) Treg Cell Suppressor Function In Vitro through Juxtacrine Delivery of IL-2	PLOS ONE			English	Article							REGULATORY T-CELLS; RECEPTOR-ALPHA-CHAIN; AUTOIMMUNE-DISEASE; SELF-TOLERANCE; CUTTING EDGE; INTERLEUKIN-2; ACTIVATION; EXPRESSION; EXPANSION; ANTIGEN	CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) restrict inflammatory responses to self and nonself. Aberrant Treg activity is pathologic: Insufficient Treg activity is implicated in autoimmunity, allergy, and graft-versus-host-disease; overabundant activity is implicated in chronic infection and cancer. Tregs require IL-2 for their expansion and acquisition/execution of suppressor function; however, because Tregs cannot produce IL-2, they depend on IL-2 from an exogenous source. Until now, that IL-2 source had not been established. We asked whether dendritic cells (DCs) could supply IL-2 to Tregs and, if so, what was required for that delivery. We used flow cytometry, IL-2 ELISPOT, RT-qPCR, and IL-2 promoter-driven reporter assays to measure intracytoplasmic IL-2, secreted protein, IL-2 message and IL-2 promoter activity in bone marrow-derived (BMDC) and splenic DCs. We examined conjugate formation between Tregs, conventional CD4(+) cells, and IL-2-expressing DCs. We measured Treg levels of CD25, Foxp3, and suppressor function after co-culture with IL-2 sufficient and IL-2(-/-) DCs. We generated IL-2-mCherry-expressing DCs and used epifluorescence microscopy and flow cytometry to track IL-2 transfer to Tregs and test requirements for transfer. Between 0.7 to 2.4% of DCs constitutively produced IL-2 and diverted IL-2 secretion to Tregs by preferentially forming conjugates with them. Uptake of DC IL-2 by Tregs required cell-cell contact and CD25. Tregs increased levels of CD25 and Foxp3 from baseline and showed greater suppressor function when co-cultured with IL-2-sufficient DCs, but not when co-cultured with IL-2(-/-) DCs. Exogenous IL-2, added in excess of 500 U/ml to co-cultures with IL-2(-/-) DCs, restored Treg suppressor function. These data support a model of juxtacrine delivery of IL-2 from DCs to Tregs and suggest that a subset of DCs modulates Treg function through controlled, spatial delivery of IL-2. Knowledge of how DCs regulate Tregs should be integrated into the design of interventions intended to alter Treg function.	[Kulhankova, Katarina; Field, Elizabeth H.] Univ Iowa, Dept Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Rouse, Todd; Nasr, Mohamed E.; Field, Elizabeth H.] Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Kulhankova, K (corresponding author), Univ Iowa, Dept Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	elizabeth-field@uiowa.edu		Field, Elizabeth/0000-0003-4043-7461	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; VA Merit Review Grant; VA MREP Grant; NIH [R21 DE19609-01, NIH T32 AI007260-22]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007260] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE019609] Funding Source: NIH RePORTER	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); VA Merit Review Grant(US Department of Veterans Affairs); VA MREP Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This material is based upon work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development with VA Merit Review Grant (EHF) and VA MREP Grant (MEN), and also NIH R21 DE19609-01(EHF), NIH T32 AI007260-22 (KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Barron L, 2010, J IMMUNOL, V185, P6426, DOI 10.4049/jimmunol.0903940; Battaglia M, 2011, SEMIN IMMUNOL, V23, P182, DOI 10.1016/j.smim.2011.07.007; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Berntsen A, 2010, J IMMUNOTHER, V33, P425, DOI 10.1097/CJI.0b013e3181cd870f; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030422; Brinster C, 2005, J IMMUNOL, V175, P7332, DOI 10.4049/jimmunol.175.11.7332; Bruno L, 2008, CELL CYCLE, V7, P2296, DOI 10.4161/cc.6444; Brusko T, 2008, EUR J IMMUNOL, V38, P931, DOI 10.1002/eji.200738108; Brusko TM, 2008, IMMUNOL REV, V223, P371, DOI 10.1111/j.1600-065X.2008.00637.x; Chen YL, 2001, J IMMUNOASS IMMUNOCH, V22, P353, DOI 10.1081/IAS-100107400; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; Curiel TJ, 2008, CURR OPIN IMMUNOL, V20, P241, DOI 10.1016/j.coi.2008.04.008; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; Edinger M, 2011, CURR OPIN IMMUNOL, V23, P679, DOI 10.1016/j.coi.2011.06.006; Ekerfelt C, 2002, J IMMUNOL METHODS, V260, P55, DOI 10.1016/S0022-1759(01)00520-8; Fehervari Z, 2006, TRENDS IMMUNOL, V27, P109, DOI 10.1016/j.it.2006.01.005; Fehervari Z, 2004, INT IMMUNOL, V16, P1769, DOI 10.1093/intimm/dxh178; Feng G, 2008, TRANSPLANTATION, V86, P578, DOI 10.1097/TP.0b013e3181806a60; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Granucci F, 2003, J IMMUNOL, V170, P5075, DOI 10.4049/jimmunol.170.10.5075; Guiducci C, 2005, EUR J IMMUNOL, V35, P557, DOI 10.1002/eji.200425810; HEMAR A, 1995, J CELL BIOL, V129, P55, DOI 10.1083/jcb.129.1.55; Kalantari T, 2011, IMMUNOL RES, V51, P153, DOI 10.1007/s12026-011-8255-5; Kim HP, 2002, EMBO J, V21, P3051, DOI 10.1093/emboj/cdf321; Koenen HJPM, 2003, J IMMUNOL, V171, P6431, DOI 10.4049/jimmunol.171.12.6431; Liu CP, 1996, J EXP MED, V184, P1619, DOI 10.1084/jem.184.5.1619; Malek TR, 2003, J LEUKOCYTE BIOL, V74, P961, DOI 10.1189/jlb.0603272; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; Marguti I, 2009, IMMUNOLOGY, V127, P50, DOI 10.1111/j.1365-2567.2008.02927.x; Murawski MR, 2006, ANN NY ACAD SCI, V1079, P198, DOI 10.1196/annals.1375.031; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Muthuswamy R, 2008, CANCER RES, V68, P5972, DOI 10.1158/0008-5472.CAN-07-6818; Ohkura N, 2010, SEMIN IMMUNOPATHOL, V32, P95, DOI 10.1007/s00281-010-0200-5; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Papiernik M, 1998, INT IMMUNOL, V10, P371, DOI 10.1093/intimm/10.4.371; Piccirillo CA, 2004, TRENDS IMMUNOL, V25, P374, DOI 10.1016/j.it.2004.04.009; Putnam AL, 2009, DIABETES, V58, P652, DOI 10.2337/db08-1168; Rigby SM, 2003, BLOOD, V101, P2024, DOI 10.1182/blood-2002-05-1513; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Ruter J, 2009, FRONT BIOSCI-LANDMRK, V14, P1761, DOI 10.2741/3338; SADLACK B, 1995, EUR J IMMUNOL, V25, P3053, DOI 10.1002/eji.1830251111; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sauma D, 2004, SCAND J IMMUNOL, V59, P183, DOI 10.1111/j.0300-9475.2004.01380.x; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sgouroudis E, 2011, AUTOIMMUNITY, V44, P406, DOI 10.3109/08916934.2010.536795; Smith KA, 2006, MED IMMUNOL, V5, P3; Sojka DK, 2005, J IMMUNOL, V175, P7274, DOI 10.4049/jimmunol.175.11.7274; Soper DM, 2007, EUR J IMMUNOL, V37, P1817, DOI 10.1002/eji.200737101; Stauber DJ, 2006, P NATL ACAD SCI USA, V103, P2788, DOI 10.1073/pnas.0511161103; Suffner J, 2010, J IMMUNOL, V184, P1810, DOI 10.4049/jimmunol.0902420; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; SUZUKI H, 1995, SCIENCE, V268, P1472, DOI 10.1126/science.7770771; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Wei S, 2007, CANCER RES, V67, P7487, DOI 10.1158/0008-5472.CAN-07-0565; Welters MJP, 2008, EXPERT OPIN BIOL TH, V8, P1365, DOI 10.1517/14712598.8.9.1365 ; Welters MJP, 2010, P NATL ACAD SCI USA, V107, P11895, DOI 10.1073/pnas.1006500107; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wolf M, 2001, EUR J IMMUNOL, V31, P1637, DOI 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Wuest TY, 2008, J LEUKOCYTE BIOL, V84, P973, DOI 10.1189/jlb.1107778; Yamazaki S, 2003, J EXP MED, V198, P235, DOI 10.1084/jem.20030422; Yu AX, 2006, J IMMUNOL, V177, P5115, DOI 10.4049/jimmunol.177.8.5115; Yu AX, 2001, J BIOL CHEM, V276, P381, DOI 10.1074/jbc.M007991200; Yui MA, 2001, J IMMUNOL, V166, P1730, DOI 10.4049/jimmunol.166.3.1730; Yui MA, 2004, J IMMUNOL, V172, P4691, DOI 10.4049/jimmunol.172.8.4691; Zanoni I, 2005, J IMMUNOL, V175, P286, DOI 10.4049/jimmunol.175.1.286; zur Wiesch JS, 2011, J VIROL, V85, P1287, DOI 10.1128/JVI.01758-10	78	15	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43609	10.1371/journal.pone.0043609	http://dx.doi.org/10.1371/journal.pone.0043609			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984435	Green Submitted, gold, Green Published			2022-12-25	WOS:000308738500018
J	Ren, J; Yan, XM; Ai, HS; Zhang, ZY; Huang, X; Ouyang, J; Yang, M; Yang, HG; Han, PF; Zeng, WH; Chen, YJ; Guo, YM; Xiao, SJ; Ding, NS; Huang, LS				Ren, Jun; Yan, Xueming; Ai, Huashui; Zhang, Zhiyan; Huang, Xiang; Ouyang, Jing; Yang, Ming; Yang, Huaigu; Han, Pengfei; Zeng, Weihong; Chen, Yijie; Guo, Yuanmei; Xiao, Shijun; Ding, Nengshui; Huang, Lusheng			Susceptibility towards Enterotoxigenic Escherichia coli F4ac Diarrhea Is Governed by the MUC13 Gene in Pigs	PLOS ONE			English	Article							K88AC FIMBRIAL ADHESIN; ASSOCIATION ANALYSIS; RECEPTOR LOCUS; ETEC F4AB/AC; BAC LIBRARY; MUCIN; GENOME; EXPRESSION; RESOURCE; SWINE	Enterotoxigenic Escherichia coli (ETEC) F4ac is a major determinant of diarrhea and mortality in neonatal and young pigs. Susceptibility to ETEC F4ac is governed by the intestinal receptor specific for the bacterium and is inherited as a monogenic dominant trait. To identify the receptor gene (F4acR), we first mapped the locus to a 7.8-cM region on pig chromosome 13 using a genome scan with 194 microsatellite markers. A further scan with high density markers on chromosome 13 refined the locus to a 5.7-cM interval. Recombination breakpoint analysis defined the locus within a 2.3-Mb region. Further genome-wide mapping using 39,720 informative SNPs revealed that the most significant markers were proximal to the MUC13 gene in the 2.3-Mb region. Association studies in a collection of diverse outbred populations strongly supported that MUC13 is the most likely responsible gene. We characterized the porcine MUC13 gene that encodes two transcripts: MUC13A and MUC13B. Both transcripts have the characteristic PTS regions of mucins that are enriched in distinct tandem repeats. MUC13B is predicated to be heavily O-glycosylated, forming the binding site of the bacterium; while MUC13A does not have the O-glycosylation binding site. Concordantly, 127 independent pigs homozygous for MUC13A across diverse breeds are all resistant to ETEC F4ac, and all 718 susceptible animals from the broad breed panel carry at least one MUC13B allele. Altogether, we conclude that susceptibility towards ETEC F4ac is governed by the MUC13 gene in pigs. The finding has an immediate translation into breeding practice, as it allows us to establish an efficient and accurate diagnostic test for selecting against susceptible animals. Moreover, the finding improves our understanding of mucins that play crucial roles in defense against enteric pathogens. It revealed, for the first time, the direct interaction between MUC13 and enteric bacteria, which is poorly understood in mammals.	[Ren, Jun; Yan, Xueming; Ai, Huashui; Zhang, Zhiyan; Huang, Xiang; Ouyang, Jing; Yang, Ming; Yang, Huaigu; Han, Pengfei; Zeng, Weihong; Chen, Yijie; Guo, Yuanmei; Xiao, Shijun; Ding, Nengshui; Huang, Lusheng] Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China; [Ren, Jun; Yan, Xueming; Ai, Huashui; Zhang, Zhiyan; Huang, Xiang; Ouyang, Jing; Yang, Ming; Yang, Huaigu; Han, Pengfei; Zeng, Weihong; Chen, Yijie; Guo, Yuanmei; Xiao, Shijun; Ding, Nengshui; Huang, Lusheng] Jiangxi Agr Univ, Minist Agr China, Nanchang, Peoples R China; [Yan, Xueming] Jiangxi Sci & Technol Normal Univ, Coll Life Sci, Nanchang, Peoples R China	Jiangxi Agricultural University; Jiangxi Agricultural University; Ministry of Agriculture & Rural Affairs; Jiangxi Science & Technology Normal University	Ren, J (corresponding author), Jiangxi Agr Univ, Key Lab Anim Biotechnol Jiangxi Prov, Nanchang, Peoples R China.	renjunjxau@hotmail.com; Lushenghuang@hotmail.com	Chen, Yijie/AAE-8964-2019; Ren, Jun/H-9793-2019		National 863 Program of China [2011AA100304-4]; National Swine Industry and Technology System of China [nycytx-009]; National Natural Science Foundation of China [30960248]	National 863 Program of China(National High Technology Research and Development Program of China); National Swine Industry and Technology System of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National 863 Program of China (2011AA100304-4), National Swine Industry and Technology System of China (nycytx-009), and National Natural Science Foundation of China (30960248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bayati HK, 1999, MAMM GENOME, V10, P569, DOI 10.1007/s003359901046; Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Baker DR, 1997, VET MICROBIOL, V54, P123, DOI 10.1016/S0378-1135(96)01277-1; Browning BL, 2007, GENET EPIDEMIOL, V31, P365, DOI 10.1002/gepi.20216; Dekker J, 2002, TRENDS BIOCHEM SCI, V27, P126, DOI 10.1016/S0968-0004(01)02052-7; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; ERICKSON AK, 1994, INFECT IMMUN, V62, P5404, DOI 10.1128/IAI.62.12.5404-5410.1994; Fahrenkrug SC, 2001, MAMM GENOME, V12, P472, DOI 10.1007/s003350020015; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Francis DH, 1998, INFECT IMMUN, V66, P4050; GIBBONS RA, 1977, THEOR APPL GENET, V51, P65, DOI 10.1007/BF00299479; Grange PA, 1998, INFECT IMMUN, V66, P1613, DOI 10.1128/IAI.66.4.1613-1621.1998; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; GUINEE PAM, 1979, INFECT IMMUN, V23, P700; Guo Y, 2009, ANIM GENET, V40, P47, DOI 10.1111/j.1365-2052.2008.01802.x; Gupta R, 1999, GLYCOBIOLOGY, V9, P1009, DOI 10.1093/glycob/9.10.1009; Hoorens PR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-140; Jacobsen M, 2010, ANIM GENET, V41, P21, DOI 10.1111/j.1365-2052.2009.01952.x; Jacobsen Mette, 2011, BMC Res Notes, V4, P225, DOI 10.1186/1756-0500-4-225; Ji HY, 2011, MOL BIOL REP, V38, P1593, DOI 10.1007/s11033-010-0268-y; Joller D, 2009, ANIM GENET, V40, P749, DOI 10.1111/j.1365-2052.2009.01881.x; Jorgensen C.B., 2004, International application published under the patent cooperation treaty (PCT), Patent No. [PCT/DK2003/000807, 2003000807]; Jorgensen CB, 2003, CYTOGENET GENOME RES, V102, P157, DOI 10.1159/000075742; Jorgensen CB, 2004, International application published under the patent cooperation treaty (PCT), Patent No. [WO2004/048606-A2, 2004048606]; Liu W, 2006, PROG NAT SCI-MATER, V16, P889; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036949, 10.1371/journal.pone.0032127, 10.1371/journal.pone.0040003, 10.1186/1746-1596-7-49]; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maher DM, 2011, MOL CANCER RES, V9, P531, DOI 10.1158/1541-7786.MCR-10-0443; Moncada DM, 2003, TRENDS PARASITOL, V19, P305, DOI 10.1016/S1471-4922(03)00122-3; Moon HW, 1999, J VET DIAGN INVEST, V11, P557, DOI 10.1177/104063879901100617; Peng QL, 2007, ANIM GENET, V38, P397, DOI 10.1111/j.1365-2052.2007.01608.x; Python P, 2005, J ANIM BREED GENET, V122, P5, DOI 10.1111/j.1439-0388.2005.00490.x; Python P, 2002, ANIM GENET, V33, P441, DOI 10.1046/j.1365-2052.2002.00915.x; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rampoldi A, 2011, MAMM GENOME, V22, P122, DOI 10.1007/s00335-010-9305-3; Rogel-Gaillard C, 1999, CYTOGENET CELL GENET, V85, P205, DOI 10.1159/000015294; Schroyen M, 2012, ANIM GENET, V43, P324, DOI 10.1111/j.1365-2052.2011.02241.x; Sheng YH, 2011, GUT, V60, P1661, DOI 10.1136/gut.2011.239194; Sobel E, 2001, HUM HERED, V52, P121, DOI 10.1159/000053366; Sobel E, 1996, AM J HUM GENET, V58, P1323; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; Wang Y, 2007, J ANIM BREED GENET, V124, P225, DOI 10.1111/j.1439-0388.2007.00664.x; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Yan XM, 2009, J MED MICROBIOL, V58, P1112, DOI 10.1099/jmm.0.009803-0; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Zhang B, 2008, ANIM GENET, V39, P258, DOI 10.1111/j.1365-2052.2008.01721.x	48	40	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44573	10.1371/journal.pone.0044573	http://dx.doi.org/10.1371/journal.pone.0044573			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984528	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500066
J	Stella, SL; Vila, A; Hung, AY; Rome, ME; Huynh, U; Sheng, M; Kreienkamp, HJ; Brecha, NC				Stella, Salvatore L., Jr.; Vila, Alejandro; Hung, Albert Y.; Rome, Michael E.; Huynh, Uyenchi; Sheng, Morgan; Kreienkamp, Hans-Juergen; Brecha, Nicholas C.			Association of Shank 1A Scaffolding Protein with Cone Photoreceptor Terminals in the Mammalian Retina	PLOS ONE			English	Article							90/POSTSYNAPTIC DENSITY-95-ASSOCIATED PROTEIN; POSTSYNAPTIC DENSITY PROTEINS; SYNAPSE-ASSOCIATED PROTEIN; SENSITIVE CALCIUM-CHANNEL; DENDRITIC SPINES; MOUSE RETINA; RAT RETINA; IMMUNOCYTOCHEMICAL LOCALIZATION; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES	Photoreceptor terminals contain post-synaptic density (PSD) proteins e. g., PSD-95/PSD-93, but their role at photoreceptor synapses is not known. PSDs are generally restricted to post-synaptic boutons in central neurons and form scaffolding with multiple proteins that have structural and functional roles in neuronal signaling. The Shank family of proteins (Shank 1-3) functions as putative anchoring proteins for PSDs and is involved in the organization of cytoskeletal/signaling complexes in neurons. Specifically, Shank 1 is restricted to neurons and interacts with both receptors and signaling molecules at central neurons to regulate plasticity. However, it is not known whether Shank 1 is expressed at photoreceptor terminals. In this study we have investigated Shank 1A localization in the outer retina at photoreceptor terminals. We find that Shank 1A is expressed presynaptically in cone pedicles, but not rod spherules, and it is absent from mice in which the Shank 1 gene is deleted. Shank 1A co-localizes with PSD-95, peanut agglutinin, a marker of cone terminals, and glycogen phosphorylase, a cone specific marker. These findings provide convincing evidence for Shank 1A expression in both the inner and outer plexiform layers, and indicate a potential role for PSD-95/Shank 1 complexes at cone synapses in the outer retina.	[Stella, Salvatore L., Jr.] Univ Missouri, Sch Med, Dept Ophthalmol, Kansas City, MO 64108 USA; [Stella, Salvatore L., Jr.] Univ Missouri, Sch Med, Dept Basic Med Sci, Kansas City, MO 64108 USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Stella, Salvatore L., Jr.; Vila, Alejandro; Rome, Michael E.; Huynh, Uyenchi; Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Brecha, Nicholas C.] VAGLAHS, CURE Digest Dis Res Ctr, Los Angeles, CA USA; [Brecha, Nicholas C.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA; [Kreienkamp, Hans-Juergen] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, Hamburg, Germany; [Hung, Albert Y.; Sheng, Morgan] MIT, Picower Inst Learning & Memory, Inst Phys & Chem Res RIKEN, Neurosci Res Ctr,Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Hung, Albert Y.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Hamburg; University Medical Center Hamburg-Eppendorf; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; RIKEN; Harvard University; Massachusetts General Hospital	Stella, SL (corresponding author), Univ Missouri, Sch Med, Dept Ophthalmol, Kansas City, MO 64108 USA.	stellas@umkc.edu		Stella Jr., Salvatore/0000-0003-1971-2537	National Institutes of Health [EY 04067, DK 41301, NS41411]; Department of Veterans Affairs; Fight for Sight [GA05039]; Deutsche Forschungsgemeinschaft [Kr 1321/3-1, Kr 1321/4-1]; NATIONAL EYE INSTITUTE [R01EY004067, R56EY004067, R01EY015573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK041301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS041411] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Fight for Sight; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Institutes of Health, grants EY 04067 (NCB) and DK 41301 (NCB). A Senior Career Scientist Award from the Department of Veterans Affairs to NCB. A Fight for Sight Grant-in-Aid (GA05039) to SLS, Jr., and the Deutsche Forschungsgemeinschaft (Kr 1321/3-1 and Kr 1321/4-1) to HJK. AYH was a recipient of National Institutes of Health K08 Award NS41411. MS is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SL, 2003, VISUAL NEUROSCI, V20, P267, DOI 10.1017/S0952523803203059; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; Blackmon SM, 2000, BRAIN RES, V885, P53, DOI 10.1016/S0006-8993(00)02928-0; BLANKS JC, 1984, INVEST OPHTH VIS SCI, V25, P546; Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Brandstatter JH, 2004, J COMP NEUROL, V475, P551, DOI 10.1002/cne.20194; Calin-Jageman I, 2007, J NEUROSCI, V27, P1374, DOI 10.1523/JNEUROSCI.5191-06.2007; Chetkovich DM, 2002, J NEUROSCI, V22, P6415; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; El-Hussein AE, 2000, SCIENCE, V290, P1364; FARISS RN, 1990, EXP EYE RES, V51, P473, DOI 10.1016/0014-4835(90)90160-V; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gessert S, 2011, DEV DYNAM, V240, P1528, DOI 10.1002/dvdy.22613; Haverkamp S, 2005, J NEUROSCI, V25, P5438, DOI 10.1523/JNEUROSCI.1117-05.2005; Heidelberger R, 2005, PROG RETIN EYE RES, V24, P682, DOI 10.1016/j.preteyeres.2005.04.002; Hirano AA, 2005, J COMP NEUROL, V488, P70, DOI 10.1002/cne.20577; Hirao K, 2000, GENES CELLS, V5, P203, DOI 10.1046/j.1365-2443.2000.00318.x; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; IWASAKI M, 1992, J COMP NEUROL, V319, P277, DOI 10.1002/cne.903190207; Johnson J, 2003, J NEUROSCI, V23, P518, DOI 10.1523/JNEUROSCI.23-02-00518.2003; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kim JH, 2009, EXP MOL MED, V41, P236, DOI 10.3858/emm.2009.41.4.026; Koulen P, 1998, J NEUROSCI, V18, P10136; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Mehta S, 2001, J BIOL CHEM, V276, P16092, DOI 10.1074/jbc.M100643200; Morgans CW, 2005, VISUAL NEUROSCI, V22, P561, DOI 10.1017/S0952523805225038; Morgans CW, 2001, MOL VIS, V7, P202; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; Pfeiffer-Guglielmi B, 2003, J NEUROCHEM, V85, P73, DOI 10.1046/j.1471-4159.2003.01644.x; Pham E, 2010, FEBS J, V277, P3051, DOI 10.1111/j.1742-4658.2010.07719.x; Quitsch A, 2005, J NEUROSCI, V25, P479, DOI 10.1523/JNEUROSCI.2699-04.2005; ROSTAS JAP, 1991, MOL NEUROBIOL, V5, P203, DOI 10.1007/BF02935546; Sala C, 2005, J NEUROSCI, V25, P4587, DOI 10.1523/JNEUROSCI.4822-04.2005; Sala C, 2003, J NEUROSCI, V23, P6327; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Schmitz F, 2000, NEURON, V28, P857, DOI 10.1016/S0896-6273(00)00159-8; Schmitz Y, 1997, NEUROSCIENCE, V78, P1209, DOI 10.1016/S0306-4522(96)00678-1; Schutt J, 2009, J BIOL CHEM, V284, P25479, DOI 10.1074/jbc.M109.042663; Sharma K, 2006, MOL CELL NEUROSCI, V31, P702, DOI 10.1016/j.mcn.2006.01.010; Sheng M, 2000, J CELL SCI, V113, P1851; Sheng M, 2001, J CELL SCI, V114, P1251; Sherry DM, 2003, J COMP NEUROL, V465, P480, DOI 10.1002/cne.10838; Stella SL, 2007, J NEUROSCI RES, V85, P1126, DOI 10.1002/jnr.21210; Stella SL, 2002, J NEUROPHYSIOL, V87, P351, DOI 10.1152/jn.00010.2001; Taylor WR, 1998, VISUAL NEUROSCI, V15, P541; Thomas U, 1997, MECH DEVELOP, V62, P161, DOI 10.1016/S0925-4773(97)00658-8; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Wassle H, 2006, J COMP NEUROL, V496, P544, DOI 10.1002/cne.20942; Wilkinson MF, 1996, J GEN PHYSIOL, V107, P621, DOI 10.1085/jgp.107.5.621; Wyneken U, 2004, BRAIN RES REV, V47, P54, DOI 10.1016/j.brainresrev.2004.06.005; Yao I, 1999, J BIOL CHEM, V274, P27463, DOI 10.1074/jbc.274.39.27463; Yao I, 2002, J NEUROSCI, V22, P5354; ZHANG DR, 1991, VISUAL NEUROSCI, V6, P429, DOI 10.1017/S0952523800001292; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005; Zhang H, 2006, EUR J NEUROSCI, V23, P2297, DOI 10.1111/j.1460-9568.2006.04734.x; Zitzer H, 1999, J BIOL CHEM, V274, P32997, DOI 10.1074/jbc.274.46.32997	66	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43463	10.1371/journal.pone.0043463	http://dx.doi.org/10.1371/journal.pone.0043463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984429	gold, Green Submitted, Green Published			2022-12-25	WOS:000308738500015
J	Wu, YN; Zhang, YA; Xie, GX; Zhao, AH; Pan, XL; Chen, TL; Hu, YX; Liu, YM; Cheng, Y; Chi, Y; Yao, L; Jia, W				Wu, Yani; Zhang, Yinan; Xie, Guoxiang; Zhao, Aihua; Pan, Xiaolan; Chen, Tianlu; Hu, Yixue; Liu, Yumin; Cheng, Yu; Chi, Yi; Yao, Lei; Jia, Wei			The Metabolic Responses to Aerial Diffusion of Essential Oils	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; GENERALIZED ANXIETY DISORDER; IDENTIFYING DIFFERENCES; PSYCHIATRIC-DISORDERS; INOSITOL TREATMENT; OXIDATIVE STRESS; GUT MICROBIOTA; PANIC DISORDER; ANIMAL-MODELS; DOUBLE-BLIND	Anxiety disorders are the most prevalent psychiatric disorders and affect a great number of people worldwide. Essential oils, take effects through inhalation or topical application, are believed to enhance physical, emotional, and spiritual well-being. Although clinical studies suggest that the use of essential oils may have therapeutic potential, evidence for the efficacy of essential oils in treating medical conditions remains poor, with a particular lack of studies employing rigorous analytical methods that capture its identifiable impact on human biology. Here, we report a comprehensive gas chromatography time-of-flight mass spectrometry (GC-TOFMS) based metabonomics study that reveals the aromas-induced metabolic changes and the anxiolytic effect of aromas in elevated plus maze (EPM) induced anxiety model rats. The significant alteration of metabolites in the EPM group was attenuated by aromas treatment, concurrent with the behavioral improvement with significantly increased open arms time and open arms entries. Brain tissue and urinary metabonomic analysis identified a number of altered metabolites in response to aromas intervention. These metabolic changes included the increased carbohydrates and lowered levels of neurotransmitters (tryptophan, serine, glycine, aspartate, tyrosine, cysteine, phenylalanine, hypotaurine, histidine, and asparagine), amino acids, and fatty acids in the brain. Elevated aspartate, carbohydrates (sucrose, maltose, fructose, and glucose), nucleosides and organic acids such as lactate and pyruvate were also observed in the urine. The EPM induced metabolic differences observed in urine or brain tissue was significantly reduced after 10 days of aroma inhalation, as noted with the loss of statistical significance on many of the metabolites in the aroma-EPM group. This study demonstrates, for the first time, that the metabonomics approach can capture the subtle metabolic changes resulting from exposure to essential oils and provide the basis for pinpointing affected pathways in anxiety-related behavior, which will lead to an improved mechanistic understanding of anxiolytic effect of essential oils.	[Wu, Yani; Zhao, Aihua; Cheng, Yu; Chi, Yi] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Wu, Yani; Pan, Xiaolan; Hu, Yixue; Yao, Lei] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China; [Zhang, Yinan; Chen, Tianlu] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Xom Res Ctr Metab Dis, Shanghai 200030, Peoples R China; [Xie, Guoxiang; Jia, Wei] Univ N Carolina Greensboro, Ctr Translat Biomed Res, Kannapolis, NC USA; [Liu, Yumin] Shanghai Jiao Tong Univ, Ctr Instrumental Anal, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of North Carolina; University of North Carolina Greensboro; Shanghai Jiao Tong University	Wu, YN (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China.	g_xie@uncg.edu; w_jia@uncg.edu	Jia, Wei/AAN-5102-2020; Xie, Guoxiang/F-3022-2016	Jia, Wei/0000-0002-3739-8994; Xie, Guoxiang/0000-0002-0951-4150				Aoshima H, 1999, BIOSCI BIOTECH BIOCH, V63, P743, DOI 10.1271/bbb.63.743; Bagetta G, 2010, FITOTERAPIA, V81, P453, DOI 10.1016/j.fitote.2010.01.013; BELIVEAU GP, 1987, J NUTR, V117, P36, DOI 10.1093/jn/117.1.36; BENJAMIN J, 1995, AM J PSYCHIAT, V152, P1084; Beyoglu D, 2012, BIOCHEM PHARMACOL, V83, P1331, DOI 10.1016/j.bcp.2011.12.031; Bouayed J, 2009, OXID MED CELL LONGEV, V2, P63, DOI 10.4161/oxim.2.2.7944; Bradley BF, 2007, PHYSIOL BEHAV, V92, P931, DOI 10.1016/j.physbeh.2007.06.023; Bradley BF, 2007, J ETHNOPHARMACOL, V111, P517, DOI 10.1016/j.jep.2006.12.021; BUCHBAUER G, 1993, J PHARM SCI-US, V82, P660, DOI 10.1002/jps.2600820623; Cheng Y, 2012, J PROTEOME RES, V11, P1354, DOI 10.1021/pr201001a; Chepulis LM, 2009, PHYSIOL BEHAV, V97, P359, DOI 10.1016/j.physbeh.2009.03.001; Davis P., 2005, IEE Seminar on Security of Distributed Control Systems, P1, DOI 10.1049/ic:20050251; de Almeida RN, 2004, PHARMACOL BIOCHEM BE, V77, P361, DOI 10.1016/j.pbb.2003.11.004; Edris AE, 2007, PHYTOTHER RES, V21, P308, DOI 10.1002/ptr.2072; Einat H, 2001, J AFFECT DISORDERS, V62, P113, DOI 10.1016/S0165-0327(00)00355-4; Ersan S, 2006, PROG NEURO-PSYCHOPH, V30, P1039, DOI 10.1016/j.pnpbp.2006.03.034; Gormanns P, 2011, J PSYCHIATR RES, V45, P973, DOI 10.1016/j.jpsychires.2010.12.010; Haug TT, 2002, SCAND J GASTROENTERO, V37, P294, DOI 10.1080/003655202317284192; Jonsson P, 2004, ANAL CHEM, V76, P1738, DOI 10.1021/ac0352427; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Kasper S, 2010, INT CLIN PSYCHOPHARM, V25, P277, DOI 10.1097/YIC.0b013e32833b3242; Komiya M, 2006, BEHAV BRAIN RES, V172, P240, DOI 10.1016/j.bbr.2006.05.006; Kuloglu M, 2002, NEUROPSYCHOBIOLOGY, V46, P186, DOI 10.1159/000067810; LAPIN IP, 1993, PHARMACOL BIOCHEM BE, V44, P241, DOI 10.1016/0091-3057(93)90305-D; Lee MS, 2012, MATURITAS, V71, P257, DOI 10.1016/j.maturitas.2011.12.018; Lehrner J, 2005, PHYSIOL BEHAV, V86, P92, DOI 10.1016/j.physbeh.2005.06.031; Lis-Balchin M, 1997, J ROY SOC HEALTH, V117, P324, DOI 10.1177/146642409711700511; LOWRY OH, 1964, J BIOL CHEM, V239, P18; National Cancer Institute USNIoH, 2010, AR ESS OILS PDQS; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; Nutt DJ, 2001, J CLIN PSYCHIAT, V62, P22; Oroszi G, 2005, ALCOHOL CLIN EXP RES, V29, P303, DOI 10.1097/01.ALC.0000156128.28257.2E; Pan L, 2010, J PHARMACEUT BIOMED, V52, P589, DOI 10.1016/j.jpba.2010.01.046; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Quide Y, 2012, NEUROSCI BIOBEHAV R, V36, P626, DOI 10.1016/j.neubiorev.2011.09.004; Setzer WN, 2009, NAT PROD COMMUN, V4, P1305; SMIRNOVA A V, 1957, Farmakol Toksikol, V20, P62; Stein MB, 2004, J CLIN PSYCHIAT, V65, P3; Tannock GW, 2005, GASTROENTEROL CLIN N, V34, P361, DOI 10.1016/j.gtc.2005.05.006; THURSTON JH, 1989, METAB BRAIN DIS, V4, P177, DOI 10.1007/BF01000294; Tsang HWH, 2010, REV NEUROSCIENCE, V21, P141; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Umezu T, 2010, PHARMACOL BIOCHEM BE, V94, P497, DOI 10.1016/j.pbb.2009.11.001; van der Watt G, 2008, CONTEMP NURSE, V30, P69, DOI 10.5172/conu.673.30.1.69; Wildwood C, 1996, ENCY AROMATHERAPY, P1; Yap IKS, 2008, J PROTEOME RES, V7, P3718, DOI 10.1021/pr700864x; Zheng XJ, 2011, J PROTEOME RES, V10, P5512, DOI 10.1021/pr2007945	48	11	12	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44830	10.1371/journal.pone.0044830	http://dx.doi.org/10.1371/journal.pone.0044830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984571	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500090
J	Chaikind, B; Kilambi, KP; Gray, JJ; Ostermeier, M				Chaikind, Brian; Kilambi, Krishna Praneeth; Gray, Jeffrey J.; Ostermeier, Marc			Targeted DNA Methylation Using an Artificially Bisected M. HhaI Fused to Zinc Fingers	PLOS ONE			English	Article							PROTEIN-FRAGMENT COMPLEMENTATION; GENE-EXPRESSION; PROMOTER; SITE; METHYLTRANSFERASE; SEQUENCES; ANGSTROM	Little is known about the effects of single DNA methylation events on gene transcription. The ability to direct the methylation toward a single unique site within a genome would have broad use as a tool to study the effects of specific epigenetic changes on transcription. A targeted enzyme might also be useful in a therapy for diseases with an epigenetic component or as a means to site-specifically label DNA. Previous studies have sought to target methyltransferase activity by fusing DNA binding proteins to methyltransferases. However, the methyltransferase domain remains active even when the DNA binding protein is unbound, resulting in significant off-target methylation. A better strategy would make methyltransferase activity contingent upon the DNA binding protein's association with its DNA binding site. We have designed targeted methyltransferases by fusing zinc fingers to the fragments of artificially-bisected, assembly-compromised methyltransferases. The zinc fingers' binding sites flank the desired target site for methylation. Zinc finger binding localizes the two fragments near each other encouraging their assembly only over the desired site. Through a combination of molecular modeling and experimental optimization in E. coli, we created an engineered methyltransferase derived from M. HhaI with 50-60% methylation at a target site and nearly undetectable levels of methylation at a non-target M. HhaI site (1.462.4%). Using a restriction digestion assay, we demonstrate that localization of both fragments synergistically increases methylation at the target site, illustrating the promise of our approach.	[Chaikind, Brian] Johns Hopkins Univ, Chem Biol Interface Grad Program, Baltimore, MD 21218 USA; [Kilambi, Krishna Praneeth; Gray, Jeffrey J.; Ostermeier, Marc] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University	Chaikind, B (corresponding author), Johns Hopkins Univ, Chem Biol Interface Grad Program, Baltimore, MD 21218 USA.	oster@jhu.edu	Ostermeier, Marc/A-2697-2010; Gray, Jeffrey J./B-5682-2008	Ostermeier, Marc/0000-0003-0900-3665; Gray, Jeffrey J./0000-0001-6380-2324; Kilambi, Krishna Praneeth/0000-0003-4848-2611	National Institute of General Medicine at the National Institutes of Health [R01 GM066972, GM078221]; Chemistry-Biology Interface program training grant from the National Institute of General Medical Sciences at the National Institutes of Health [T32 GM080189]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078221, T32GM080189, R01GM066972] Funding Source: NIH RePORTER	National Institute of General Medicine at the National Institutes of Health; Chemistry-Biology Interface program training grant from the National Institute of General Medical Sciences at the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by funding from the National Institute of General Medicine at the National Institutes of Health [R01 GM066972 to M.O., GM078221 to J.J.G.]. Brian Chaikind was supported in part by the Chemistry-Biology Interface program training grant from the National Institute of General Medical Sciences at the National Institutes of Health [T32 GM080189]. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beerli RR, 1998, P NATL ACAD SCI USA, V95, P14628, DOI 10.1073/pnas.95.25.14628; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Bujnicki JM, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-3; Carvin CD, 2003, NUCLEIC ACIDS RES, V31, P6493, DOI 10.1093/nar/gkg853; Chen T, 2006, GENE EXPRESSION REGU, P377, DOI DOI 10.1007/978-0-387-40049-5_23; CHENG XD, 1993, CELL, V74, P299, DOI 10.1016/0092-8674(93)90421-L; Choe W, 2005, BIOCHEM BIOPH RES CO, V334, P1233, DOI 10.1016/j.bbrc.2005.07.017; Darii MV, 2009, BBA-PROTEINS PROTEOM, V1794, P1654, DOI 10.1016/j.bbapap.2009.07.016; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Horsthemke B, 2008, ADV GENET, V61, P225, DOI 10.1016/S0065-2660(07)00008-9; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kitazawa R, 2007, MOL ENDOCRINOL, V21, P148, DOI 10.1210/me.2006-0205; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li FY, 2007, NUCLEIC ACIDS RES, V35, P100, DOI 10.1093/nar/gkl1035; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; MCCLELLAND M, 1994, NUCLEIC ACIDS RES, V22, P3640, DOI 10.1093/nar/22.17.3640; McNamara AR, 2002, NUCLEIC ACIDS RES, V30, P3818, DOI 10.1093/nar/gkf501; Meister GE, 2008, BIOCHEM BIOPH RES CO, V377, P226, DOI 10.1016/j.bbrc.2008.09.099; Meister GE, 2010, NUCLEIC ACIDS RES, V38, P1749, DOI 10.1093/nar/gkp1126; Michnick SW, 2000, METHOD ENZYMOL, V328, P208, DOI 10.1016/S0076-6879(00)28399-7; Minczuk M, 2006, P NATL ACAD SCI USA, V103, P19689, DOI 10.1073/pnas.0609502103; Nile CJ, 2008, ARTHRITIS RHEUM, V58, P2686, DOI 10.1002/art.23758; Nomura W, 2007, J AM CHEM SOC, V129, P8676, DOI 10.1021/ja0705588; Pogribny IP, 2000, CANCER RES, V60, P588; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sambrook J, 2001, MOL CLONING LAB MANU; Shieh FK, 2006, J MOL BIOL, V362, P516, DOI 10.1016/j.jmb.2006.07.030; Slaska-Kiss K, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-17; Smith AE, 2008, J BIOL CHEM, V283, P9878, DOI 10.1074/jbc.M710393200; van der Gun BTF, 2010, BIOCONJUGATE CHEM, V21, P1239, DOI 10.1021/bc1000388; van Vlodrop IJH, 2011, CLIN CANCER RES, V17, P4225, DOI 10.1158/1078-0432.CCR-10-3394; Vlahovicek K, 2000, BIOINFORMATICS, V16, P1044, DOI 10.1093/bioinformatics/16.11.1044; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Xu GL, 1997, NAT GENET, V17, P376, DOI 10.1038/ng1297-376; Zhang X, 2010, PROSTATE, V70, P765, DOI 10.1002/pros.21109; Zohar H, 2011, NANOSCALE, V3, P3027, DOI 10.1039/c1nr10280j	39	24	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44852	10.1371/journal.pone.0044852	http://dx.doi.org/10.1371/journal.pone.0044852			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984575	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700092
J	Lavin, KM; Straub, AM; Uhranowsky, KA; Smoliga, JM; Zavorsky, GS				Lavin, Kaleen M.; Straub, Allison M.; Uhranowsky, Kathleen A.; Smoliga, James M.; Zavorsky, Gerald S.			Alveolar-Membrane Diffusing Capacity Limits Performance in Boston Marathon Qualifiers	PLOS ONE			English	Article							INDUCED ARTERIAL HYPOXEMIA; CHRONIC HEART-FAILURE; NITRIC-OXIDE; CARBON-MONOXIDE; EXERCISE PERFORMANCE; PULMONARY DIFFUSION; AEROBIC CAPACITY; REFERENCE VALUES; LUNG DIFFUSION; SEA-LEVEL	Purpose: (1) to examine the relation between pulmonary diffusing capacity and marathon finishing time, and (2), to evaluate the accuracy of pulmonary diffusing capacity for nitric oxide (DLNO) in predicting marathon finishing time relative to that of pulmonary diffusing capacity for carbon monoxide (DLCO). Methods: 28 runners [18 males, age = 37 (SD 9) years, body mass = 70 (13) kg, height = 173 (9) cm, percent body fat = 17 (7) %] completed a test battery consisting of measurement of DLNO and DLCO at rest, and a graded exercise test to determine running economy and aerobic capacity prior to the 2011 Steamtown Marathon (Scranton, PA). One to three weeks later, all runners completed the marathon (range: 2: 22: 38 to 4: 48: 55). Linear regressions determined the relation between finishing time and a variety of anthropometric characteristics, resting lung function variables, and exercise parameters. Results: In runners meeting Boston Marathon qualification standards, 74% of the variance in marathon finishing time was accounted for by differences in DLNO relative to body surface area (BSA) (SEE = 11.8 min, p<0.01); however, the relation between DLNO or DLCO to finishing time was non-significant in the non-qualifiers (p = 0.14 to 0.46). Whereas both DLCO and DLNO were predictive of finishing time for all finishers, DLNO showed a stronger relation (r(2) = 0.30, SEE = 33.4 min, p<0.01) compared to DLCO when considering BSA. Conclusion: DLNO is a performance-limiting factor in only Boston qualifiers. This suggests that alveolar-capillary membrane conductance is a limitation to performance in faster marathoners. Additionally, DLNO/BSA predicts marathon finishing time and aerobic capacity more accurately than DLCO.	[Lavin, Kaleen M.; Straub, Allison M.; Uhranowsky, Kathleen A.; Zavorsky, Gerald S.] Marywood Univ, Human Physiol Lab, Scranton, PA 18509 USA; [Zavorsky, Gerald S.] Commonwealth Med Coll, Scranton, PA USA; [Smoliga, James M.] High Point Univ, Dept Phys Therapy, High Point, NC USA	Geisinger Commonwealth School of Medicine	Lavin, KM (corresponding author), Marywood Univ, Human Physiol Lab, Scranton, PA 18509 USA.	zavorsky@marywood.edu	Zavorsky, Gerald S./AAI-1422-2021; Zavorsky, Gerald S./I-7753-2013	Zavorsky, Gerald S./0000-0002-4473-1601; Zavorsky, Gerald S./0000-0002-4473-1601; Smoliga, James/0000-0002-1895-5687; Lavin, Kaleen/0000-0003-1426-8174				Aguilaniu B, 2008, EUR RESPIR J, V31, P1091, DOI 10.1183/09031936.00063207; Amann M, 2012, EXP PHYSIOL, V97, P311, DOI 10.1113/expphysiol.2011.058800; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Billat VL, 2001, MED SCI SPORT EXER, V33, P2089, DOI 10.1097/00005768-200112000-00018; BORLAND CDR, 1989, EUR RESPIR J, V2, P56; Ceridon ML, 2010, J APPL PHYSIOL, V109, P643, DOI 10.1152/japplphysiol.01411.2009; Coyle EF, 2007, SPORTS MED, V37, P306, DOI 10.2165/00007256-200737040-00009; de Bisschop C, 2012, J APPL PHYSIOL, V112, P20, DOI 10.1152/japplphysiol.00670.2011; DEMPSEY JA, 1984, J PHYSIOL-LONDON, V355, P161, DOI 10.1113/jphysiol.1984.sp015412; DEMPSEY JA, 1985, AM J CARDIOL, V55, pD59, DOI 10.1016/0002-9149(85)91056-2; Dennis SC, 1999, EUR J APPL PHYSIOL, V79, P280, DOI 10.1007/s004210050507; Florence SL, 1997, EUR J APPL PHYSIOL O, V75, P274, DOI 10.1007/s004210050160; Guazzi M, 2002, EUR HEART J, V23, P467, DOI 10.1053/euhj.2001.2803; Hagan R D, 1987, Br J Sports Med, V21, P3; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HANSON P, 1982, J APPL PHYSIOL, V52, P615, DOI 10.1152/jappl.1982.52.3.615; Harms CA, 2000, MED SCI SPORT EXER, V32, P1101, DOI 10.1097/00005768-200006000-00010; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Joyner MJ, 2011, J APPL PHYSIOL, V110, P275, DOI 10.1152/japplphysiol.00563.2010; KOSKOLOU MD, 1994, EUR J APPL PHYSIOL, V68, P80, DOI 10.1007/BF00599246; La Torre A, 2011, J STRENGTH COND RES, V25, P3242, DOI 10.1519/JSC.0b013e31821bf2bd; Loftin M, 2007, J STRENGTH COND RES, V21, P1188; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; MANIER G, 1991, RESP PHYSIOL, V83, P143, DOI 10.1016/0034-5687(91)90024-D; MARON MB, 1976, J APPL PHYSIOL, V40, P836, DOI 10.1152/jappl.1976.40.5.836; MAUGHAN RJ, 1983, EUR J APPL PHYSIOL O, V52, P80, DOI 10.1007/BF00429030; MILES DS, 1983, RESP PHYSIOL, V52, P349, DOI 10.1016/0034-5687(83)90090-7; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Millet GY, 2011, SCAND J MED SCI SPOR, V21, P54, DOI 10.1111/j.1600-0838.2009.01001.x; POWERS SK, 1988, EUR J APPL PHYSIOL O, V58, P298, DOI 10.1007/BF00417266; PURI S, 1995, CIRCULATION, V91, P2769, DOI 10.1161/01.CIR.91.11.2769; Rapoport BI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000960; Romer LM, 2006, AM J PHYSIOL-REG I, V290, pR365, DOI 10.1152/ajpregu.00332.2005; ROUGHTON FJW, 1957, J APPL PHYSIOL, V11, P290, DOI 10.1152/jappl.1957.11.2.290; SJODIN B, 1985, SPORTS MED, V2, P83; Stellingwerff T, 2011, J APPL PHYSIOL, V110, P278, DOI 10.1152/japplphysiol.01259.2010; Tamhane RM, 2001, CHEST, V120, P1850, DOI 10.1378/chest.120.6.1850; Wagner PD, 2005, EXERC SPORT SCI REV, V33, P3; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037/0003-066X.54.8.594; Zavorsky GS, 2010, ACTA PHYSIOL, V198, P499, DOI 10.1111/j.1748-1716.2009.02059.x; Zavorsky GS, 2008, NITRIC OXIDE-BIOL CH, V18, P70, DOI 10.1016/j.niox.2007.10.002; Zavorsky GS, 2005, NITRIC OXIDE-BIOL CH, V12, P31, DOI 10.1016/j.niox.2004.11.002	42	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44513	10.1371/journal.pone.0044513	http://dx.doi.org/10.1371/journal.pone.0044513			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984520	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700067
J	Meloni, D; Davidse, A; Langeveld, JPM; Varello, K; Casalone, C; Corona, C; Balkema-Buschmann, A; Groschup, MH; Ingravalle, F; Bozzetta, E				Meloni, Daniela; Davidse, Aart; Langeveld, Jan P. M.; Varello, Katia; Casalone, Cristina; Corona, Cristiano; Balkema-Buschmann, Anne; Groschup, Martin H.; Ingravalle, Francesco; Bozzetta, Elena			EU-Approved Rapid Tests for Bovine Spongiform Encephalopathy Detect Atypical Forms: A Study for Their Sensitivities	PLOS ONE			English	Article							BSE-AFFECTED CATTLE; PRION PROTEIN; TRANSMISSION; PRP	Since 2004 it become clear that atypical bovine spongiform encephalopthies (BSEs) exist in cattle. Whenever their detection has relied on active surveillance plans implemented in Europe since 2001 by rapid tests, the overall and inter-laboratory performance of these diagnostic systems in the detection of the atypical strains has not been studied thoroughly to date. To fill this gap, the present study reports on the analytical sensitivity of the EU-approved rapid tests for atypical L-and H-type and classical BSE in parallel. Each test was challenged with two dilution series, one created from a positive pool of the three BSE forms according to the EURL standard method of homogenate preparation (50% w/v) and the other as per the test kit manufacturer's instructions. Multilevel logistic models and simple logistic models with the rapid test as the only covariate were fitted for each BSE form analyzed as directed by the test manufacturer's dilution protocol. The same schemes, but excluding the BSE type, were then applied to compare test performance under the manufacturer's versus the water protocol. The IDEXX HerdChek (R) BSE-scrapie short protocol test showed the highest sensitivity for all BSE forms. The IDEXX (R) HerdChek BSE-scrapie ultra short protocol, the Prionics (R) - Check WESTERN and the AJ Roboscreen (R) BetaPrion tests showed similar sensitivities, followed by the Roche (R) PrionScreen, the Bio-Rad (R) TeSeE (TM) SAP and the Prionics (R) - Check PrioSTRIP in descending order of analytical sensitivity. Despite these differences, the limit of detection of all seven rapid tests against the different classes of material set within a 2 log(10) range of the best-performing test, thus meeting the European Food Safety Authority requirement for BSE surveillance purposes. These findings indicate that not many atypical cases would have been missed surveillance since 2001 which is important for further epidemiological interpretations of the sporadic character of atypical forms.	[Meloni, Daniela; Varello, Katia; Casalone, Cristina; Corona, Cristiano; Ingravalle, Francesco; Bozzetta, Elena] Ctr Referenza Nazl Encefalopatie Anim, Ist Zooprofilatt Sperimentale Piemonte Liguria &, Turin, Italy; [Davidse, Aart; Langeveld, Jan P. M.] Cent Vet Inst Wageningen UR, Lelystad, Netherlands; [Balkema-Buschmann, Anne; Groschup, Martin H.] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Insel Riems, Germany	IZS Piemonte Liguria e Valle D'aosta; Wageningen University & Research; Friedrich Loeffler Institute	Meloni, D (corresponding author), Ctr Referenza Nazl Encefalopatie Anim, Ist Zooprofilatt Sperimentale Piemonte Liguria &, Turin, Italy.	elena.bozzetta@izsto.it	Bozzetta, Elena Maria/K-7580-2016; Casalone, Cristina/J-6763-2018	Casalone, Cristina/0000-0001-5271-832X; Varello, Katia/0000-0002-0486-2121				Altman D.G., 1991, PRACTICAL STATISTIC; [Anonymous], 1998, OFFICIAL J EUROPEA L, VL 122, P59; [Anonymous], 1999, OFFICIAL J EUROPEA L, VL 147, P1; [Anonymous], PRION CHECK WESTERN; [Anonymous], PRION CHECK LIA BSE; [Anonymous], BETAPRION BSE EIA TE; [Anonymous], PRIONSCREEN TEST; [Anonymous], PRION CHECK PRIOSTRI; [Anonymous], 2005, EFSA J, V48, P1; [Anonymous], IDEXX HERDCHECK BOV; [Anonymous], 2003, OPINION SCI STEERING; [Anonymous], 2010, EFSA J, V8, P1591; [Anonymous], 2010, OFFICIAL J EUROPEA L, VL 279, P10; [Anonymous], TESEE PUR DET SAP TE; [Anonymous], 2009, EFSA J, V7, P1436; [Anonymous], ENF SCI; Armstrong BK, 2001, PRINCIPLE EXPOSURE M; Balkema-Buschmann A, 2011, J TOXICOL ENV HEAL A, V74, P103, DOI 10.1080/15287394.2011.529060; Baron T, 2006, LANCET, V367, P297, DOI 10.1016/S0140-6736(06)68060-4; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Biacabe AG, 2008, EMERG INFECT DIS, V14, P298, DOI 10.3201/eid1402.071141; Breyer J, 2012, VET MICROBIOL, DOI [10.1016/j.vet-mic.2011.12.008, DOI 10.1016/J.VET-MIC.2011.12.008]; Brown P, 2006, EMERG INFECT DIS, V12, P1816; Buschmann A, 2006, VET MICROBIOL, V117, P103, DOI 10.1016/j.vetmic.2006.06.016; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Comoy EE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003017; Dobly A, 2010, BMC VET RES, V6, DOI 10.1186/1746-6148-6-26; Dudas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010638; EFSA (European Food Safety Authority), 2007, EFSA J, V208, P1; Everest SJ, 2006, J GEN VIROL, V87, P471, DOI 10.1099/vir.0.81539-0; Fleiss JL, 2013, STAT METHODS RATES P; Grassi J, 2008, VET RES, V39, DOI 10.1051/vetres:2008009; Gretzschel A, 2006, J GEN VIROL, V87, P3715, DOI 10.1099/vir.0.81816-0; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Kittelberger R, 2012, EMERG INFECT DIS, V18, P890, DOI 10.3201/eid1805.111824; Klingeborn M, 2006, J GEN VIROL, V87, P1751, DOI 10.1099/vir.0.81618-0; Kong QZ, 2008, J VIROL, V82, P3697, DOI 10.1128/JVI.02561-07; Langeveld JPM, 2011, J CLIN MICROBIOL, V49, P3026, DOI 10.1128/JCM.01102-11; Moynagh J, 1999, NATURE, V400, P105, DOI 10.1038/21981; Ono F, 2011, JPN J INFECT DIS, V64, P81; Pirisinu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012723; Polak MP, 2012, VET J, V191, P128, DOI 10.1016/j.tvjl.2010.12.019; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; Seuberlich T, 2012, EMERG INFECT DIS, V18, P158, DOI 10.3201/eid1801.111225; Szklo M, 2006, EPIDEMIOLOGY BASICS; Webster K, 2009, DETERMINATION ANAL S; WILESMITH JW, 1988, VET REC, V123, P638; Wolfang P, 2004, FIELD TRIAL 7 NEW RA	50	11	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43133	10.1371/journal.pone.0043133	http://dx.doi.org/10.1371/journal.pone.0043133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984410	Green Published, gold			2022-12-25	WOS:000308638700012
J	Schwartz, CL; Heumann, JM; Dawson, SC; Hoenger, A				Schwartz, Cindi L.; Heumann, John M.; Dawson, Scott C.; Hoenger, Andreas			A Detailed, Hierarchical Study of Giardia lamblia's Ventral Disc Reveals Novel Microtubule-Associated Protein Complexes	PLOS ONE			English	Article							ELECTRON-MICROSCOPE TOMOGRAPHY; CRYOELECTRON TOMOGRAPHY; MOLECULAR ARCHITECTURE; BINUCLEATE PARASITE; ATTACHMENT; INTESTINALIS; CYTOSKELETON; FLAGELLA; ANNEXIN; MODEL	Giardia lamblia is a flagellated, unicellular parasite of mammals infecting over one billion people worldwide. Giardia's two-stage life cycle includes a motile trophozoite stage that colonizes the host small intestine and an infectious cyst form that can persist in the environment. Similar to many eukaryotic cells, Giardia contains several complex microtubule arrays that are involved in motility, chromosome segregation, organelle transport, maintenance of cell shape and transformation between the two life cycle stages. Giardia trophozoites also possess a unique spiral microtubule array, the ventral disc, made of approximately 50 parallel microtubules and associated microribbons, as well as a variety of associated proteins. The ventral disc maintains trophozoite attachment to the host intestinal epithelium. With the help of a combined SEM/microtome based slice and view method called 3View (R) (Gatan Inc., Pleasanton, CA), we present an entire trophozoite cell reconstruction and describe the arrangement of the major cytoskeletal elements. To aid in future analyses of disc-mediated attachment, we used electron-tomography of freeze-substituted, plastic-embedded trophozoites to explore the detailed architecture of ventral disc microtubules and their associated components. Lastly, we examined the disc microtubule array in three dimensions in unprecedented detail using cryo-electron tomography combined with internal sub-tomogram volume averaging of repetitive domains. We discovered details of protein complexes stabilizing microtubules by attachment to their inner and outer wall. A unique tri-laminar microribbon structure is attached vertically to the disc microtubules and is connected to neighboring microribbons via crossbridges. This work provides novel insight into the structure of the ventral disc microtubules, microribbons and associated proteins. Knowledge of the components comprising these structures and their three-dimensional organization is crucial toward understanding how attachment via the ventral disc occurs in vivo.	[Schwartz, Cindi L.; Heumann, John M.; Hoenger, Andreas] Univ Colorado, Dept MCD Biol, Boulder Lab Electron Microscopy Cells 3D, Boulder, CO 80309 USA; [Dawson, Scott C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA	University of Colorado System; University of Colorado Boulder; University of California System; University of California Davis	Schwartz, CL (corresponding author), Univ Colorado, Dept MCD Biol, Boulder Lab Electron Microscopy Cells 3D, Boulder, CO 80309 USA.	andreas.hoenger@colorado.edu		Hoenger, Andreas/0000-0001-9176-6658; Dawson, Scott/0000-0002-0843-1759	National Institutes of Health-National Center for Research Resources [RR000592]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER	National Institutes of Health-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work has been supported by a National Institutes of Health-National Center for Research Resources grant (RR000592) to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam RD, 2001, CLIN MICROBIOL REV, V14, P447, DOI 10.1128/CMR.14.3.447-475.2001; AMOS LA, 1974, J CELL SCI, V14, P523; Bauer B, 1999, FEMS MICROBIOL LETT, V173, P147, DOI 10.1111/j.1574-6968.1999.tb13496.x; Bouchet-Marquis C, 2012, J STRUCT BIOL, V177, P119, DOI 10.1016/j.jsb.2011.10.007; Bouchet-Marquis C, 2011, MICRON, V42, P152, DOI 10.1016/j.micron.2010.07.003; CHRETIEN D, 1991, ORGANIZATION, V71, P161; Cope J, 2010, J STRUCT BIOL, V170, P257, DOI 10.1016/j.jsb.2009.12.004; Cotton JA, 2011, INT J PARASITOL, V41, P925, DOI 10.1016/j.ijpara.2011.05.002; CROSSLEY R, 1983, J CELL SCI, V59, P81; CROSSLEY R, 1983, J CELL SCI, V62, P419; Cyrklaff M, 2007, J EXP MED, V204, P1281, DOI 10.1084/jem.20062405; Davids BJ, 2008, INT J PARASITOL, V38, P353, DOI 10.1016/j.ijpara.2007.08.012; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Garvalov BK, 2006, J CELL BIOL, V174, P759, DOI 10.1083/jcb.200606074; Gilbert P.F.C., 1972, ELECT TOMOGRAPHY MET, V182, P89; Hagen KD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001442; Hansen WR, 2006, EUKARYOT CELL, V5, P781, DOI 10.1128/EC.5.4.781-783.2006; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; HOLBERTON DV, 1981, J CELL SCI, V47, P139; HOLBERTON DV, 1981, J CELL SCI, V47, P167; HOLBERTON DV, 1974, J EXP BIOL, V60, P207; HOLBERTON DV, 1973, J CELL SCI, V13, P11; HOOPS HJ, 1983, J CELL BIOL, V97, P902, DOI 10.1083/jcb.97.3.902; House SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002167; Hu K, 2002, J CELL BIOL, V156, P1039, DOI 10.1083/jcb.200112086; KEISTER DB, 1983, T ROY SOC TROP MED H, V77, P487, DOI 10.1016/0035-9203(83)90120-7; Koning RI, 2008, J STRUCT BIOL, V161, P459, DOI 10.1016/j.jsb.2007.08.011; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Land KM, 1999, DRUG RESIST UPDATE, V2, P289, DOI 10.1054/drup.1999.0104; Lechtreck KF, 2002, J CELL SCI, V115, P1511; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McDonald K, 2010, METHOD CELL BIOL, V96, P671, DOI 10.1016/S0091-679X(10)96028-7; McIntosh JR, 2009, J MOL BIOL, V394, P177, DOI 10.1016/j.jmb.2009.09.033; Mercogliano CP, 2006, J MOL BIOL, V355, P211, DOI 10.1016/j.jmb.2005.10.026; Mueller JC, 1974, SCANNING ELECT MICRO; NARCISI EM, 1994, J PARASITOL, V80, P468, DOI 10.2307/3283419; Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618; Nicastro D, 2011, P NATL ACAD SCI USA, V108, pE845, DOI 10.1073/pnas.1106178108; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; NOHRIA A, 1992, MOL BIOCHEM PARASIT, V56, P27, DOI 10.1016/0166-6851(92)90151-9; Nohynkova E, 2006, EUKARYOT CELL, V5, P753, DOI 10.1128/EC.5.4.753-761.2006; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Palm D, 2005, MOL BIOCHEM PARASIT, V141, P199, DOI 10.1016/j.molbiopara.2005.03.005; PEATTIE DA, 1990, PARASITOL TODAY, V6, P52, DOI 10.1016/0169-4758(90)90070-K; Sagolla MS, 2006, J CELL SCI, V119, P4889, DOI 10.1242/jcs.03276; Sanchez T, 2011, SCIENCE, V333, P456, DOI 10.1126/science.1203963; Sandberg K, 2003, J STRUCT BIOL, V144, P61, DOI 10.1016/j.jsb.2003.09.013; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Savioli L, 2006, TRENDS PARASITOL, V22, P203, DOI 10.1016/j.pt.2006.02.015; SHERWIN T, 1989, CELL, V57, P211, DOI 10.1016/0092-8674(89)90959-8; Slocik JM, 2005, SMALL, V1, P1048, DOI 10.1002/smll.200500172; Sui HX, 2006, NATURE, V442, P475, DOI 10.1038/nature04816; TAYLOR KA, 1974, SCIENCE, V186, P1036, DOI 10.1126/science.186.4168.1036; Thompson RCA, 2000, INT J PARASITOL, V30, P1259, DOI 10.1016/S0020-7519(00)00127-2; Vickerman K, 1976, COMP CELL BIOL KINET, V1; Weiland MEL, 2005, INT J PARASITOL, V35, P617, DOI 10.1016/j.ijpara.2004.12.009; Weiland MEL, 2003, INT J PARASITOL, V33, P1341, DOI 10.1016/S0020-7519(03)00201-7; West JB, 2010, RESP PHYSIOL NEUROBI, V170, P202, DOI 10.1016/j.resp.2009.12.010; Woessner DJ, 2012, EUKARYOT CELL, V11, P292, DOI 10.1128/EC.05262-11; Xiong QR, 2009, J STRUCT BIOL, V168, P378, DOI 10.1016/j.jsb.2009.08.016	61	34	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43783	10.1371/journal.pone.0043783	http://dx.doi.org/10.1371/journal.pone.0043783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984443	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700030
J	Sharp, SY; Roe, SM; Kazlauskas, E; Cikotiene, I; Workman, P; Matulis, D; Prodromou, C				Sharp, Swee Y.; Roe, S. Mark; Kazlauskas, Egidijus; Cikotiene, Inga; Workman, Paul; Matulis, Daumantas; Prodromou, Chrisostomos			Co-Crystalization and In Vitro Biological Characterization of 5-Aryl-4-(5-Substituted-2-4-Dihydroxyphenyl)-1,2,3-Thiadiazole Hsp90 Inhibitors	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; BREAST-CANCER; CHAPERONE; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; POTENT; PHARMACOKINETICS; EXPLOITATION; HYDROQUINONE; DEGRADATION; METABOLISM	A potential therapeutic strategy for targeting cancer that has gained much interest is the inhibition of the ATP binding and ATPase activity of the molecular chaperone Hsp90. We have determined the structure of the human Hsp90 alpha N-terminal domain in complex with a series of 5-aryl-4-(5-substituted-2-4-dihydroxyphenyl)-1,2,3-thiadiazoles. The structures provide the molecular details for the activity of these inhibitors. One of these inhibitors, ICPD 34, causes a structural change that affects a mobile loop, which adopts a conformation similar to that seen in complexes with ADP, rather than the conformation generally seen with the pyrazole/isoxazole-resorcinol class of inhibitors. Competitive binding to the Hsp90 N-terminal domain was observed in a biochemical assay, and these compounds showed antiproliferative activity and induced apoptosis in the HCT116 human colon cancer cell line. These inhibitors also caused induction of the heat shock response with the upregulation of Hsp72 and Hsp27 protein expression and the depletion of Hsp90 clients, CRAF, ERBB2 and CDK4, thus confirming that antiproliferative activity was through the inhibition of Hsp90. The presence of increased levels of the cleavage product of PARP indicated apoptosis in response to Hsp90 inhibitors. This work provides a framework for the further optimization of thiadiazole inhibitors of Hsp90. Importantly, we demonstrate that the thiadiazole inhibitors display a more limited core set of interactions relative to the clinical trial candidate NVP-AUY922, and consequently may be less susceptible to resistance derived through mutations in Hsp90.	[Sharp, Swee Y.; Workman, Paul] Inst Canc Res, Haddow Labs, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, Sutton, Surrey, England; [Roe, S. Mark] Univ Sussex, Brighton, Falmer, England; [Kazlauskas, Egidijus; Matulis, Daumantas] Vilnius State Univ, Lab Biothermodynam & Drug Design, Inst Biotechnol, Vilnius, Lithuania; [Cikotiene, Inga] Vilnius State Univ, Fac Chem, Dept Organ Chem, Vilnius, Lithuania; [Prodromou, Chrisostomos] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, Falmer, England	Cancer Research UK; University of London; Institute of Cancer Research - UK; University of Sussex; Vilnius University; Vilnius University; University of Sussex	Sharp, SY (corresponding author), Inst Canc Res, Haddow Labs, Div Canc Therapeut, Canc Res UK Canc Therapeut Unit, Sutton, Surrey, England.	chris.prodromou@sussex.ac.uk	Matulis, Daumantas/F-9367-2010; Prodromou, Chrisostomos/ABA-9133-2021; Cikotiene, Inga/F-1658-2010	Matulis, Daumantas/0000-0002-6178-6276; Prodromou, Chrisostomos/0000-0003-4320-1147; Cikotiene, Inga/0000-0002-8062-3907; Roe, Mark/0000-0002-7371-9855; Kazlauskas, Egidijus/0000-0001-8430-7349	Diamond Light Source; Wellcome Trust senior investigator award [095605/Z11/Z]; Cancer Research UK program [C309/A8274]; NHS; Royal Marsden Hospital;  [FP7-REGPOT-2009-1];  [245721];  [TD0905];  [CM0804]; Cancer Research UK [11566] Funding Source: researchfish; Medical Research Council [G0801130B] Funding Source: researchfish	Diamond Light Source; Wellcome Trust senior investigator award(Wellcome Trust); Cancer Research UK program(Cancer Research UK); NHS; Royal Marsden Hospital(Royal Society of New ZealandMarsden Fund (NZ)); ; ; ; ; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors acknowledge support from the Diamond Light Source and the Wellcome Trust senior investigator award (LHP), 095605/Z11/Z. This study was also supported by Cancer Research UK program grant number C309/A8274 to PW. PW is a Cancer Research UK Life Fellow. They also acknowledge NHS funding to the NIHR Biomedical Research Centre at The Institute of Cancer Research and Royal Marsden Hospital. DM acknowledges FP7-REGPOT-2009-1 grant "MoBiLi", agreement no.: 245721, and the COST projects TD0905 and CM0804. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerji U, 2005, J CLIN ONCOL, V23, P4152, DOI 10.1200/JCO.2005.00.612; Brough PA, 2008, J MED CHEM, V51, P196, DOI 10.1021/jm701018h; Cheung KMJ, 2005, BIOORG MED CHEM LETT, V15, P3338, DOI 10.1016/j.bmcl.2005.05.046; Chiosis G, 2006, EXPERT OPIN THER TAR, V10, P37, DOI 10.1517/14728222.10.1.37; Chiosis G, 2001, CHEM BIOL, V8, P289, DOI 10.1016/S1074-5521(01)00015-1; Chiosis G, 2006, CURR TOP MED CHEM, V6, P1183, DOI 10.2174/156802606777812013; Cikotiene I, 2009, BIOORG MED CHEM LETT, V19, P1089, DOI 10.1016/j.bmcl.2009.01.003; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dymock BW, 2005, J MED CHEM, V48, P4212, DOI 10.1021/jm050355z; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; Egorin MJ, 2001, CANCER CHEMOTH PHARM, V47, P291, DOI 10.1007/s002800000242; Egorin MJ, 1998, CANCER RES, V58, P2385; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ge J, 2006, J MED CHEM, V49, P4606, DOI 10.1021/jm0603116; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Hostein I, 2001, CANCER RES, V61, P4003; Howes R, 2006, ANAL BIOCHEM, V350, P202, DOI 10.1016/j.ab.2005.12.023; Jensen MR, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1996; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kaur G, 2004, CLIN CANCER RES, V10, P4813, DOI 10.1158/1078-0432.CCR-03-0795; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Maloney A, 2002, EXPERT OPIN BIOL TH, V2, P3, DOI 10.1517/14712598.2.1.3; Millson SH, 2011, FASEB J; Modi S, 2011, CLIN CANCER RES, V17, P5132, DOI 10.1158/1078-0432.CCR-11-0072; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Pacey S, 2006, HANDB EXP PHARM, V172, P331; Pacey S, 2011, CLIN CANCER RES, V17, P1561, DOI 10.1158/1078-0432.CCR-10-1927; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Prodromou C, 1996, PROTEINS, V25, P517, DOI 10.1002/prot.13; Prodromou C, 2009, ACS CHEM BIOL, V4, P289, DOI 10.1021/cb9000316; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Sharp SY, 2007, MOL CANCER THER, V6, P1198, DOI 10.1158/1535-7163.MCT-07-0149; Sharp SY, 2007, CANCER RES, V67, P2206, DOI 10.1158/0008-5472.CAN-06-3473; Smith NF, 2006, MOL CANCER THER, V5, P1628, DOI 10.1158/1535-7163.MCT-06-0041; Travers J, 2012, DRUG DISCOV TODAY, V17, P242, DOI 10.1016/j.drudis.2011.12.021; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Wright L, 2004, CHEM BIOL, V11, P775, DOI 10.1016/j.chembiol.2004.03.033; Xu WP, 2007, CLIN CANCER RES, V13, P1625, DOI 10.1158/1078-0432.CCR-06-2966	48	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44642	10.1371/journal.pone.0044642	http://dx.doi.org/10.1371/journal.pone.0044642			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984537	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000308638700075
J	Velyvis, A; Ruschak, AM; Kay, LE				Velyvis, Algirdas; Ruschak, Amy M.; Kay, Lewis E.			An Economical Method for Production of H-2, (CH3)-C-13-Threonine for Solution NMR Studies of Large Protein Complexes: Application to the 670 kDa Proteasome	PLOS ONE			English	Article							MOLECULAR-WEIGHT PROTEINS; ESCHERICHIA-COLI; 2-KETO-4-HYDROXYGLUTARATE ALDOLASE; THREONINE DEHYDROGENASE; LABELING STRATEGIES; 20S PROTEASOME; SPECTROSCOPY; C-13; RELAXATION; TROSY	NMR studies of very high molecular weight protein complexes have been greatly facilitated through the development of labeling strategies whereby (CH3)-C-13 methyl groups are introduced into highly deuterated proteins. Robust and cost-effective labeling methods are well established for all methyl containing amino acids with the exception of Thr. Here we describe an inexpensive biosynthetic strategy for the production of L-[alpha-H-2; beta-H-2; gamma-C-13]-Thr that can then be directly added during protein expression to produce highly deuterated proteins with Thr methyl group probes of structure and dynamics. These reporters are particularly valuable, because unlike other methyl containing amino acids, Thr residues are localized predominantly to the surfaces of proteins, have unique hydrogen bonding capabilities, have a higher propensity to be found at protein nucleic acid interfaces and can play important roles in signaling pathways through phosphorylation. The utility of the labeling methodology is demonstrated with an application to the 670 kDa proteasome core particle, where high quality Thr C-13,H-1 correlation spectra are obtained that could not be generated from samples prepared with commercially available U-[C-13,H-1]-Thr.	[Velyvis, Algirdas; Ruschak, Amy M.; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Velyvis, Algirdas; Ruschak, Amy M.; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Velyvis, Algirdas; Ruschak, Amy M.; Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S 1A1, Canada; [Kay, Lewis E.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Velyvis, A (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	algirdas.velyvis@utoronto.ca; kay@pound.med.utoronto.ca			Canadian Institutes of Health Research (CIHR); CIHR; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Salary support for A.M.R. was obtained in the form of a Canadian Institutes of Health Research (CIHR) post-doctoral fellowship. This work was supported by grants from the CIHR and the Natural Sciences and Engineering Research Council of Canada (L.E.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amero C, 2009, J AM CHEM SOC, V131, P3448, DOI 10.1021/ja809880p; Ayala I, 2009, J BIOMOL NMR, V43, P111, DOI 10.1007/s10858-008-9294-7; Baldwin AJ, 2011, J MOL BIOL, V413, P310, DOI 10.1016/j.jmb.2011.07.017; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Clapes P, 2010, CURR OPIN CHEM BIOL, V14, P154, DOI 10.1016/j.cbpa.2009.11.029; CLORE GM, 1991, SCIENCE, V252, P1390, DOI 10.1126/science.2047852; Fesko K, 2008, J MOL CATAL B-ENZYM, V52-53, P19, DOI 10.1016/j.molcatb.2007.10.010; Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860; Fischer M, 2007, CHEMBIOCHEM, V8, P610, DOI 10.1002/cbic.200600551; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Freeman AK, 2011, SEMIN CELL DEV BIOL, V22, P681, DOI 10.1016/j.semcdb.2011.08.009; Gans P, 2010, ANGEW CHEM INT EDIT, V49, P1958, DOI 10.1002/anie.200905660; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Gardner KH, 1997, J AM CHEM SOC, V119, P7599, DOI 10.1021/ja9706514; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Gerstein M, 1997, J MOL BIOL, V274, P562, DOI 10.1006/jmbi.1997.1412; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goto NK, 2000, CURR OPIN STRUC BIOL, V10, P585, DOI 10.1016/S0959-440X(00)00135-4; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; GRZESIEK S, 1993, J AM CHEM SOC, V115, P4369, DOI 10.1021/ja00063a068; Haines DC, 2001, BIOCHEMISTRY-US, V40, P13456, DOI 10.1021/bi011197q; Hamel DJ, 2005, J AM CHEM SOC, V127, P9676, DOI 10.1021/ja052517m; Huo XW, 1996, BIOCHEMISTRY-US, V35, P16180, DOI 10.1021/bi962203z; Isaacson RL, 2007, J AM CHEM SOC, V129, P15428, DOI 10.1021/ja0761784; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Karagoz GE, 2011, P NATL ACAD SCI USA, V108, P580, DOI 10.1073/pnas.1011867108; Kato H, 2011, P NATL ACAD SCI USA, V108, P12283, DOI 10.1073/pnas.1105848108; Kim D, 2009, BIOTECHNOL LETT, V31, P1427, DOI 10.1007/s10529-009-0016-3; Kreishman-Deitrick M, 2005, BIOCHEMISTRY-US, V44, P15247, DOI 10.1021/bi051065n; Kupce E, 1996, J MAGN RESON SER B, V110, P309, DOI 10.1006/jmrb.1996.0048; LABER B, 1994, BIOCHEMISTRY-US, V33, P3413, DOI 10.1021/bi00177a035; LANE RS, 1971, BIOCHEMISTRY-US, V10, P1353; Laver WG, 1959, J CHEM SOC, P1483; LeMaster DM, 1996, J AM CHEM SOC, V118, P9255, DOI 10.1021/ja960877r; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; MARCUS JP, 1993, J BACTERIOL, V175, P6505, DOI 10.1128/jb.175.20.6505-6511.1993; MARCUS JP, 1993, BIOCHEM BIOPH RES CO, V190, P1066, DOI 10.1006/bbrc.1993.1157; MARCUS JP, 1993, BIOCHIM BIOPHYS ACTA, V1164, P299, DOI 10.1016/0167-4838(93)90262-P; McCourt JA, 2006, AMINO ACIDS, V31, P173, DOI 10.1007/s00726-005-0297-3; MILLER S, 1987, J MOL BIOL, V196, P641, DOI 10.1016/0022-2836(87)90038-6; Ollerenshaw JE, 2005, J BIOMOL NMR, V33, P25, DOI 10.1007/s10858-005-2614-2; Ollerenshaw JE, 2003, MAGN RESON CHEM, V41, P843, DOI 10.1002/mrc.1256; Ost TWB, 2000, FEBS LETT, V486, P173, DOI 10.1016/S0014-5793(00)02267-5; PATIL RV, 1992, J BACTERIOL, V174, P102, DOI 10.1128/jb.174.1.102-107.1992; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Religa TL, 2011, J AM CHEM SOC, V133, P9063, DOI 10.1021/ja202259a; Religa TL, 2010, J BIOMOL NMR, V47, P163, DOI 10.1007/s10858-010-9419-7; Religa TL, 2010, SCIENCE, V328, P98, DOI 10.1126/science.1184991; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Ruschak AM, 2010, J BIOMOL NMR, V48, P129, DOI 10.1007/s10858-010-9449-1; Ruschak AM, 2010, NATURE, V467, P868, DOI 10.1038/nature09444; SANTORO J, 1992, J MAGN RESON, V97, P202, DOI 10.1016/0022-2364(92)90250-B; SEEMULLER E, 1995, SCIENCE, V268, P579, DOI 10.1126/science.7725107; Sinha K, 2011, BIOCHEMISTRY-US, V50, P10189, DOI 10.1021/bi201496d; Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512; Steinreiber J, 2007, TETRAHEDRON, V63, P918, DOI 10.1016/j.tet.2006.11.035; Stoffregen MC, 2012, STRUCTURE, V20, P573, DOI 10.1016/j.str.2012.02.012; Takeda M, 2011, J AM CHEM SOC, V133, P17420, DOI 10.1021/ja206799v; Tugarinov V, 2004, ANNU REV BIOCHEM, V73, P107, DOI 10.1146/annurev.biochem.73.011303.074004; Tugarinov V, 2004, J BIOMOL NMR, V28, P165, DOI 10.1023/B:JNMR.0000013824.93994.1f; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Velyvis A, 2007, P NATL ACAD SCI USA, V104, P8815, DOI 10.1073/pnas.0703347104; VUISTER GW, 1992, J MAGN RESON, V98, P428, DOI 10.1016/0022-2364(92)90144-V; Zhang KC, 2010, P NATL ACAD SCI USA, V107, P6234, DOI 10.1073/pnas.0912903107	65	68	68	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43725	10.1371/journal.pone.0043725	http://dx.doi.org/10.1371/journal.pone.0043725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984438	Green Submitted, gold, Green Published			2022-12-25	WOS:000308638700027
J	Voss-Bohme, A				Voss-Boehme, Anja			Multi-Scale Modeling in Morphogenesis: A Critical Analysis of the Cellular Potts Model	PLOS ONE			English	Article							DIFFERENTIAL ADHESION; REARRANGEMENT; CELLS	Cellular Potts models (CPMs) are used as a modeling framework to elucidate mechanisms of biological development. They allow a spatial resolution below the cellular scale and are applied particularly when problems are studied where multiple spatial and temporal scales are involved. Despite the increasing usage of CPMs in theoretical biology, this model class has received little attention from mathematical theory. To narrow this gap, the CPMs are subjected to a theoretical study here. It is asked to which extent the updating rules establish an appropriate dynamical model of intercellular interactions and what the principal behavior at different time scales characterizes. It is shown that the longtime behavior of a CPM is degenerate in the sense that the cells consecutively die out, independent of the specific interdependence structure that characterizes the model. While CPMs are naturally defined on finite, spatially bounded lattices, possible extensions to spatially unbounded systems are explored to assess to which extent spatio-temporal limit procedures can be applied to describe the emergent behavior at the tissue scale. To elucidate the mechanistic structure of CPMs, the model class is integrated into a general multiscale framework. It is shown that the central role of the surface fluctuations, which subsume several cellular and intercellular factors, entails substantial limitations for a CPM's exploitation both as a mechanistic and as a phenomenological model.	Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, D-01062 Dresden, Germany	Technische Universitat Dresden	Voss-Bohme, A (corresponding author), Tech Univ Dresden, Ctr Informat Serv & High Performance Comp, D-01062 Dresden, Germany.	anja.voss-boehme@tu-dresden.de	Voss-Böhme, Anja/O-6869-2017	Voss-Böhme, Anja/0000-0001-6510-8694	German Federal Ministry of Education and Research (Virtual Liver Network)	German Federal Ministry of Education and Research (Virtual Liver Network)	This study was supported by the German Federal Ministry of Education and Research (Virtual Liver Network). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.168102; [Anonymous], 2000, INTRO MARKOV CHAINS, DOI DOI 10.1007/978-1-4612-1590-5_8; Balter A, 2007, SINGLE CELL BASED MO, P151, DOI [DOI 10.1007/978-3-7643-8123-3_7, 10.1007/978-3-7643-8123-3_7]; Bremaud P., 1975, MARKOV CHAINS GIBBS, V19, P91, DOI DOI 10.1007/978-1-4757-3124-8; COX JT, 1990, PROBAB THEORY REL, V85, P195, DOI 10.1007/BF01277982; De Masi A., 1991, MATH METHODS HYDRODY; Deroulers C, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031917; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Glazier JA, 2007, SINGLE CELL BASED MO, P79, DOI [10.1007/978-3-7643-8123-3_4, DOI 10.1007/978-3-7643-8123-3_4]; Harrison NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022700; Hogeweg P, 2000, J THEOR BIOL, V203, P317, DOI 10.1006/jtbi.2000.1087; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Kafer J, 2006, PLOS COMPUT BIOL, V2, P518, DOI 10.1371/journal.pcbi.0020056; Kohn-Luque A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024175; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; LIGGETT TM, 1999, STOCHASTIC INTERACTI; Madras N., 2002, FIELDS I MONOGRAPHS; Maree AFM, 2007, SINGLE CELL BASED MO, P107, DOI DOI 10.1007/978-3-7643-8123-3_5; Maree AFM, 2006, B MATH BIOL, V68, P1169, DOI 10.1007/s11538-006-9131-7; MARTINS ML, 1991, PHYS REV LETT, V66, P2045, DOI 10.1103/PhysRevLett.66.2045; Merks RMH, 2009, MATH MODEL NAT PHENO, V4, P149, DOI 10.1051/mmnp/20094406; Merks RMH, 2005, PHYSICA A, V352, P113, DOI 10.1016/j.physa.2004.12.028; Merks RMH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000163; NAGAI T, 1988, J PHYS SOC JPN, V57, P2221, DOI 10.1143/JPSJ.57.2221; Nakajima A, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/3/033035; Newman TJ, 2005, MATH BIOSCI ENG, V2, P613, DOI 10.3934/mbe.2005.2.613; Ouchi NB, 2003, PHYSICA A, V329, P451, DOI 10.1016/S0378-4371(03)00574-0; Sandersius SA, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/4/045007; Savill NJ, 2003, DEV BIOL, V258, P141, DOI 10.1016/S0012-1606(03)00107-6; Savill NJ, 1997, J THEOR BIOL, V184, P229, DOI 10.1006/jtbi.1996.0237; Simpson MJ, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.041901; Sottoriva A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001132; Starruss J, 2007, J STAT PHYS, V128, P269, DOI 10.1007/s10955-007-9298-9; Starruss J, COMMUNICATION; Suzuki Y, 1991, TOKYO J MATH, V14, P61; Szabo A, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/046007; Turner S, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.021910; Varadhan SRS, 1997, ASIAN J MATH, V1, P623; Voss-Bohme A, 2010, J THEOR BIOL, V263, P419, DOI 10.1016/j.jtbi.2009.12.011; Voss-Bohme A, 2009, MARK P REL FIELDS, V15, P441; WELIKY M, 1990, DEVELOPMENT, V109, P373; Zajac M, 2003, J THEOR BIOL, V222, P247, DOI 10.1016/S0022-5193(03)00033-X; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024999	44	43	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e42852	10.1371/journal.pone.0042852	http://dx.doi.org/10.1371/journal.pone.0042852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984409	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700011
J	Walter, J; Hausmann, S; Drepper, T; Puls, M; Eggert, T; Dihne, M				Walter, Janine; Hausmann, Sascha; Drepper, Thomas; Puls, Michael; Eggert, Thorsten; Dihne, Marcel			Flavin Mononucleotide-Based Fluorescent Proteins Function in Mammalian Cells without Oxygen Requirement	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PREDICTS RADIATION RESPONSE; REPORTER PROTEINS; HYPOXIA PROMOTES; TUMOR HYPOXIA; TRANSPLANTATION; SURVIVAL; BACTERIA; CULTURE; GROWTH	Usage of the enhanced green fluorescent protein (eGFP) in living mammalian cells is limited to aerobic conditions due to requirement of oxygen during chromophore formation. Since many diseases or disease models are associated with acute or chronic hypoxia, eGFP-labeling of structures of interest in experimental studies might be unreliable leading to biased results. Thus, a chromophore yielding a stable fluorescence under hypoxic conditions is desirable. The fluorescence of flavin mononucleotide (FMN)-based fluorescent proteins (FbFPs) does not require molecular oxygen. Recently, the advantages of FbFPs for several bacterial strains and yeasts were described, specifically, their usage as a real time fluorescence marker in bacterial expression studies and their ability of chromophore formation under anaerobic conditions. Our objective was to verify if FbFPs also function in mammalian cells in order to potentially broaden the repertoire of chromophores with ones that can reliably be used in mammalian studies under hypoxic conditions. In the present study, we demonstrate for the first time, that FbFPs can be expressed in different mammalian cells, among them murine neural stem cells during proliferative and differentiated stages. Fluorescence intensities were comparable to eGFP. In contrast to eGFP, the FbFP fluorescence did not decrease when cells were exposed to defined hypoxic conditions neither in proliferating nor in differentiated cells. Thus, FbFPs can be regarded as an alternative to eGFP in studies that target cellular structures which are exposed to hypoxic conditions.	[Walter, Janine; Dihne, Marcel] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Baden Baden, Germany; [Hausmann, Sascha; Puls, Michael; Eggert, Thorsten] Evocatal GmbH, Dusseldorf, North Rhine Wes, Germany; [Walter, Janine] Univ Dusseldorf, Dept Neurol, Dusseldorf, North Rhine Wes, Germany; [Drepper, Thomas] Univ Dusseldorf, Inst Mol Enzyme Technol, Dusseldorf, North Rhine Wes, Germany; [Drepper, Thomas] Forschungszentrum Julich, D-52425 Julich, North Rhine Wes, Germany	Eberhard Karls University of Tubingen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich	Walter, J (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurol & Epileptol, Baden Baden, Germany.	Janine.Walter@googlemail.com	drepper, thomas/ABB-4717-2020; Drepper, Thomas/ABA-8291-2020	drepper, thomas/0000-0002-0096-8084; Drepper, Thomas/0000-0002-0096-8084				Ambros JT, 2007, TRANSPL INT, V20, P219, DOI 10.1111/j.1432-2277.2006.00418.x; BALIN AK, 1984, J EXP MED, V160, P152, DOI 10.1084/jem.160.1.152; Basciano L, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-12; Boyle Robert George, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P281; Brahimi-Horn MC, 2007, J MOL MED-JMM, V85, P1301, DOI 10.1007/s00109-007-0281-3; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Celaya RB, 2005, PHOTOCHEM PHOTOBIOL, V81, P73, DOI 10.1562/2004-08-22-IR-282.1; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Charlier N, 2002, MOL BRAIN RES, V104, P21, DOI 10.1016/S0169-328X(02)00198-5; Choi CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018499; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Daadi MM, 2009, MOL THER, V17, P1282, DOI 10.1038/mt.2009.104; Danovaro R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-30; Dougherty CJ, 2008, MOL VIS, V14, P471; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Drepper T, 2010, APPL ENVIRON MICROB, V76, P5990, DOI 10.1128/AEM.00701-10; Fyles AW, 1998, RADIOTHER ONCOL, V48, P149, DOI 10.1016/S0167-8140(98)00044-9; Grahl N, 2010, MED MYCOL, V48, P1, DOI 10.3109/13693780902947342; Hockel M, 1996, CANCER RES, V56, P4509; Howard RS, PRACT NEUROL, V11, P4; Huala E, 1997, SCIENCE, V278, P2120, DOI 10.1126/science.278.5346.2120; Kain SR, 1999, DRUG DISCOV TODAY, V4, P304, DOI 10.1016/S1359-6446(99)01330-6; Kanichai M, 2008, J CELL PHYSIOL, V216, P708, DOI 10.1002/jcp.21446; Krauss U, 2005, PHYS CHEM CHEM PHYS, V7, P2804, DOI 10.1039/b504554a; Krohn KA, 2008, J NUCL MED, V49, p129S, DOI 10.2967/jnumed.107.045914; Kuchimaru T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015736; Laitinen A, 2011, METHODS MOL BIOL, V698, P63, DOI 10.1007/978-1-60761-999-4_6; Lamm K, 1996, Audiol Neurootol, V1, P148; Lobo LA, 2011, FEMS MICROBIOL LETT, V317, P67, DOI 10.1111/j.1574-6968.2011.02212.x; Losi A, 2002, BIOPHYS J, V82, P2627, DOI 10.1016/S0006-3495(02)75604-X; Losi A, 2012, ANNU REV PLANT BIOL, V63, P49, DOI 10.1146/annurev-arplant-042811-105538; Mengesha A, 2010, CURR GENE THER, V10, P15; Nagayama T, 1999, J NEUROSCI, V19, P2987; Nordsmark M, 1996, RADIOTHER ONCOL, V41, P31, DOI 10.1016/S0167-8140(96)91811-3; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Piekarski T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-265; Potzkei J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-28; Prado-Lopez S, 2010, STEM CELLS, V28, P407, DOI 10.1002/stem.295; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; ROSENBAUM DM, 1994, ANN NEUROL, V36, P864, DOI 10.1002/ana.410360610; Ryan RM, 2006, BIOESSAYS, V28, P84, DOI 10.1002/bies.20336; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Sun XL, 2011, MOL IMAGING BIOL, V13, P399, DOI 10.1007/s11307-010-0420-z; TANNOCK I, 1981, BRIT J CANCER, V43, P245, DOI 10.1038/bjc.1981.37; Theus MH, 2008, EXP NEUROL, V210, P656, DOI 10.1016/j.expneurol.2007.12.020; Tielker D, 2009, EUKARYOT CELL, V8, P913, DOI 10.1128/EC.00394-08; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Vordermark D, 2001, NEOPLASIA, V3, P527, DOI 10.1038/sj.neo.7900192; Wei Ming Q, 2008, Genet Vaccines Ther, V6, P8, DOI 10.1186/1479-0556-6-8; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	51	32	33	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43921	10.1371/journal.pone.0043921	http://dx.doi.org/10.1371/journal.pone.0043921			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984451	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700032
J	Walter, WD; Anderson, CW; VerCauteren, KC				Walter, W. David; Anderson, Charles W.; VerCauteren, Kurt C.			Evaluation of Remote Delivery of Passive Integrated Transponder (PIT) Technology to Mark Large Mammals	PLOS ONE			English	Article							WHITE-TAILED DEER; TOPICAL TREATMENT; CAPTURE; SYSTEM; WILD; IMMUNOCONTRACEPTION; IDENTIFICATION; ACARICIDE; MIGRATION; IXODIDAE	Methods to individually mark and identify free-ranging wildlife without trapping and handling would be useful for a variety of research and management purposes. The use of Passive Integrated Transponder technology could be an efficient method for collecting data for mark-recapture analysis and other strategies for assessing characteristics about populations of various wildlife species. Passive Integrated Transponder tags (PIT) have unique numbered frequencies and have been used to successfully mark and identify mammals. We tested for successful injection of PIT and subsequent functioning of PIT into gelatin blocks using 4 variations of a prototype dart. We then selected the prototype dart that resulted in the least depth of penetration in the gelatin block to assess the ability of PIT to be successfully implanted into muscle tissue of white-tailed deer (Odocoileus virginianus) post-mortem and long-term in live, captive Rocky Mountain elk (Cervus elaphus). The prototype dart with a 12.7 mm (0.5 inch) needle length and no powder charge resulted in the shallowest mean (+/- SD) penetration depth into gelatin blocks of 27.0 mm (+/-5.6 mm) with 2.0 psi setting on the Dan-Inject CO2-pressured rifle. Eighty percent of PIT were successfully injected in the muscle mass of white-tailed deer post-mortem with a mean (+/- SD) penetration depth of 22.2 mm (+/-3.8 mm; n = 6). We injected PIT successfully into 13 live, captive elk by remote delivery at about 20 m that remained functional for 7 months. We successfully demonstrated that PIT could be remotely delivered in darts into muscle mass of large mammals and remain functional for >6 months. Although further research is warranted to fully develop the technique, remote delivery of PIT technology to large mammals is possible using prototype implant darts.	[Walter, W. David; Anderson, Charles W.; VerCauteren, Kurt C.] US Fish & Wildlife Serv, USDA, Anim & Plant Hlth Inspect Serv, Natl Wildlife Res Ctr, Ft Collins, CO USA	United States Department of Agriculture (USDA); United States Department of the Interior; US Fish & Wildlife Service	Walter, WD (corresponding author), US Geol Survey, Cooperat Fish & Wildlife Res Unit, University Pk, PA USA.	wdwalter@psu.edu			National Wildlife Research Center of the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services	National Wildlife Research Center of the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services	Funding for this research was provided by the National Wildlife Research Center of the United States Department of Agriculture, Animal and Plant Health Inspection Service, Wildlife Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RA, 2008, J ANIM ECOL, V77, P1115, DOI 10.1111/j.1365-2656.2008.01447.x; [Anonymous], 2007, HDB WILDLIFE CHEM IM; Bishop CJ, 2011, DEV AUTOMATED DEVICE; Boarman WI, 1998, WILDLIFE SOC B, V26, P886; Bubb DH, 2002, HYDROBIOLOGIA, V483, P225, DOI 10.1023/A:1021352217332; Carling MD, 2003, J MAMMAL, V84, P1237, DOI 10.1644/BRB-116; Cattet MRL, 2006, WILDLIFE SOC B, V34, P741, DOI 10.2193/0091-7648(2006)34[741:EOTPFI]2.0.CO;2; Delsink AK, 2007, J S AFR VET ASSOC, V78, P25; DeNicola AJ, 1996, WILDLIFE SOC B, V24, P301; ELBIN SB, 1994, WILDLIFE SOC B, V22, P677; FAGERSTONE KA, 1987, J WILDLIFE MANAGE, V51, P294, DOI 10.2307/3801005; Freitag A, 2001, BIRD STUDY, V48, P102, DOI 10.1080/00063650109461207; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; GEORGIADIS N, 1994, J HERED, V85, P100, DOI 10.1093/oxfordjournals.jhered.a111405; Gibbons JW, 2004, BIOSCIENCE, V54, P447, DOI 10.1641/0006-3568(2004)054[0447:PTSTAI]2.0.CO;2; Gionfriddo JP, 2011, WILDLIFE SOC B, V35, P149, DOI 10.1002/wsb.17; Haulton SM, 2001, WILDLIFE SOC B, V29, P255; Jacobson HA, 1997, WILDLIFE SOC B, V25, P547; Karesh WB, 2007, CONSERV BIOL, V1, P261; Kerry Knowles, 1993, Proceedings of the NIPR Symposium on Polar Biology, V6, P62; Kilpatrick HJ, 1996, WILDLIFE SOC B, V24, P306; Kreeger TJ, 2002, WILDLIFE SOC B, V30, P968; MACE RD, 1994, WILDLIFE SOC B, V22, P74; Morgan JB, 2004, J ANIM SCI, V82, P3308; Morley CG, 2002, NEW ZEAL J ZOOL, V29, P143, DOI 10.1080/03014223.2002.9518297; Newey S, 2009, WILDLIFE BIOL, V15, P405, DOI 10.2981/08-083; PENGILLY D, 1994, FISH RES, V19, P293, DOI 10.1016/0165-7836(94)90045-0; Pound JM, 2000, J MED ENTOMOL, V37, P588, DOI 10.1603/0022-2585-37.4.588; RICE WR, 1977, J WILDLIFE MANAGE, V41, P197, DOI 10.2307/3800595; Rogers LM, 2002, MAMMAL REV, V32, P63, DOI 10.1046/j.1365-2907.2002.00096.x; Rutberg AT, 2004, WILDLIFE RES, V35, P494; Ryser A, 2005, WILDLIFE SOC B, V33, P721, DOI 10.2193/0091-7648(2005)33[721:ARTSFT]2.0.CO;2; SCHOOLEY RL, 1993, J MAMMAL, V74, P480, DOI 10.2307/1382406; Silvy Nova J., 2005, P339; Stafford KC, 2009, VECTOR-BORNE ZOONOT, V9, P371, DOI 10.1089/vbz.2008.0161; Stein FJ, 2003, J AM VET MED ASSOC, V223, P1316, DOI 10.2460/javma.2003.223.1316; Walter WD, 2002, WILDLIFE SOC B, V30, P908; Wyneken Jeanette, 2010, Herpetological Review, V41, P448; Zimmerman J. L., 2008, P W VIRGINIA ACAD SC, V79, P1	39	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44838	10.1371/journal.pone.0044838	http://dx.doi.org/10.1371/journal.pone.0044838			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984572	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700090
J	Grimston, SK; Watkins, MP; Brodt, MD; Silva, MJ; Civitelli, R				Grimston, Susan K.; Watkins, Marcus P.; Brodt, Michael D.; Silva, Matthew J.; Civitelli, Roberto			Enhanced Periosteal and Endocortical Responses to Axial Tibial Compression Loading in Conditional Connexin43 Deficient Mice	PLOS ONE			English	Article							BONE-FORMATION; MOUSE TIBIA; INTERCELLULAR COMMUNICATION; OSTEOBLAST DIFFERENTIATION; PARATHYROID-HORMONE; CORTICAL BONE; BETA-CATENIN; IN-VIVO; INCREASES; NETWORKS	The gap junction protein, connexin43 (Cx43) is involved in mechanotransduction in bone. Recent studies using in vivo models of conditional Cx43 gene (Gja1) deletion in the osteogenic linage have generated inconsistent results, with Gja1 ablation resulting in either attenuated or enhanced response to mechanical load, depending upon the skeletal site examined or the type of load applied. To gain further insights on Cx43 and mechanotransduction, we examined bone formation response at both endocortical and periosteal surfaces in 2-month-old mice with conditional Gja1 ablation driven by the Dermo1 promoter (cKO). Relative to wild type (WT) littermates, it requires a larger amount of compressive force to generate the same periosteal strain in cKO mice. Importantly, cKO mice activate periosteal bone formation at a lower strain level than do WT mice, suggesting an increased sensitivity to mechanical load in Cx43 deficiency. Consistently, trabecular bone mass also increases in mutant mice upon load, while it decreases in WT. On the other hand, bone formation actually decreases on the endocortical surface in WT mice upon application of axial mechanical load, and this response is also accentuated in cKO mice. These changes are associated with increase of Cox-2 in both genotypes and further decrease of Sost mRNA in cKO relative to WT bones. Thus, the response of bone forming cells to mechanical load differs between trabecular and cortical components, and remarkably between endocortical and periosteal envelopes. Cx43 deficiency enhances both the periosteal and endocortical response to mechanical load applied as axial compression in growing mice.	[Grimston, Susan K.; Watkins, Marcus P.; Civitelli, Roberto] Washington Univ St Louis, Dept Internal Med, Div Bone & Mineral Dis, St Louis, MO USA; [Brodt, Michael D.; Silva, Matthew J.] Washington Univ St Louis, Dept Orthoped Surg, St Louis, MO USA; [Grimston, Susan K.; Watkins, Marcus P.; Brodt, Michael D.; Silva, Matthew J.; Civitelli, Roberto] Washington Univ St Louis, Musculoskeletal Res Ctr, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Grimston, SK (corresponding author), Washington Univ St Louis, Dept Internal Med, Div Bone & Mineral Dis, St Louis, MO USA.	Sgrimsto@dom.wustl.edu	Civitelli, Roberto/AAA-8260-2019; Watkins, Marcus/V-8817-2019	Civitelli, Roberto/0000-0003-4076-4315; Watkins, Marcus/0000-0002-1224-3478; Silva, Matthew/0000-0001-7375-4522	National Institutes of Health/National Institute of Arthritis and Musculoskeletal Skin Diseases [AR041255, AR047867, P30AR057235]; Barnes Jewish Hospital Foundation; Zealand; Novartis; Amgen; Eli-Lilly; Pfizer; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047867, R01AR041255, R29AR041255, P30AR057235] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Arthritis and Musculoskeletal Skin Diseases; Barnes Jewish Hospital Foundation; Zealand; Novartis(Novartis); Amgen(Amgen); Eli-Lilly(Eli Lilly); Pfizer(Pfizer); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health/National Institute of Arthritis and Musculoskeletal Skin Diseases grants AR041255 (RC), AR047867 (MJS), P30AR057235 (Washington University Core Center for Musculoskeletal Biology and Medicine) and funds from the Barnes Jewish Hospital Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Roberto Civitelli has a material transfer agreement with Zealand Pharma (Glostrup, Denmark) for the use of gap junction-modifying peptides but receives no honoraria or research funds from Zealand. He receives consultant fees from Novartis and Amgen, grant support from Eli-Lilly and Pfizer, and owns stock of Eli-Lilly, Merck, and Amgen. All other authors state they have no conflict of interest. This does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials.	Bivi N, 2012, J BONE MINER RES, V27, P374, DOI 10.1002/jbmr.548; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Brodt MD, 2010, J BONE MINER RES, V25, P2006, DOI 10.1002/jbmr.96; Christiansen BA, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2917435; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; CIVITELLI R, 1993, J CLIN INVEST, V91, P1888, DOI 10.1172/JCI116406; Civitelli R, 2008, ARCH BIOCHEM BIOPHYS, V473, P188, DOI 10.1016/j.abb.2008.04.005; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; FOLDES J, 1990, J BONE MINER RES, V5, P1063; Forwood MR, 1996, J BONE MINER RES, V11, P1688; Fritton JC, 2008, J BONE MINER RES, V23, P663, DOI [10.1359/jbmr.080104, 10.1359/JBMR.080104]; Fritton JC, 2005, BONE, V36, P1030, DOI 10.1016/j.bone.2005.02.013; Gluhak-Heinrich J, 2006, CELL COMMUN ADHES, V13, P115, DOI 10.1080/15419060600634619; Grimston SK, 2011, J BONE MINER RES; Grimston SK, 2008, J BONE MINER RES, V23, P879, DOI [10.1359/jbmr.080222, 10.1359/JBMR.080222]; Hens JR, 2005, J BONE MINER RES, V20, P1103, DOI 10.1359/JBMR.050210; Kjaer AW, 2004, AM J MED GENET A, V127A, P152, DOI 10.1002/ajmg.a.20614; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Lin CW, 2009, J BONE MINER RES, V24, P1651, DOI [10.1359/JBMR.090411, 10.1359/jbmr.090411]; Mahajan G, 2011, AUST NZ J OBSTET GYN, V51, P403, DOI 10.1111/j.1479-828X.2011.01337.x; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Mbalaviele G, 2005, J CELL BIOCHEM, V94, P403, DOI 10.1002/jcb.20253; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Paznekas WA, 2003, AM J HUM GENET, V72, P408, DOI 10.1086/346090; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Salazar V, 2011, 33 ANN M AM SOC BON; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Silva MJ, 2005, ANAT REC PART A, V283A, P380, DOI 10.1002/ar.a.20171; Stains JP, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-222; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; VanderMolen MA, 1996, J BIOL CHEM, V271, P12165, DOI 10.1074/jbc.271.21.12165; Wyatt S S, 2001, Australas Radiol, V45, P369, DOI 10.1046/j.1440-1673.2001.00941.x; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023516	35	52	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44222	10.1371/journal.pone.0044222	http://dx.doi.org/10.1371/journal.pone.0044222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970183	gold, Green Submitted, Green Published			2022-12-25	WOS:000308748400012
J	Lin, CM; Lin, SM; Chung, FT; Lin, HC; Lee, KY; Huang, CD; Kuo, CH; Liu, CY; Wang, CH; Kuo, HP				Lin, Chieh-Mo; Lin, Shu-Min; Chung, Fu-Tsai; Lin, Horng-Chyuan; Lee, Kang-Yun; Huang, Chien-Da; Kuo, Chih-Hsi; Liu, Chien-Ying; Wang, Chun-Hua; Kuo, Han-Pin			Amplified Mycobacterium Tuberculosis Direct Test for Diagnosing Tuberculous Pleurisy-A Diagnostic Accuracy Study	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ACID AMPLIFICATION TESTS; PULMONARY TUBERCULOSIS; BIOPSY SPECIMENS; EFFUSION; PCR	Background: The study was designed to investigate the clinical usefulness of Amplified Mycobacterium Tuberculosis Direct (AMTD) tests for diagnosing TB pleurisy. Methods: One hundred and fifty-two patients for whom the exclusion of tuberculous pleural effusion was necessary were retrospectively analyzed. Results: The sensitivity of AMTD in diagnosing pleural TB was 36.4% (20 of 55). Combining sputum and pleural effusion AFB smear, pleural biopsy, and AMTD test of pleural effusion increased sensitivity to 82.5% (33/40). There were significantly higher percentages of neutrophils in the pleural effusion in the positive than in the negative AMTD group (38.0 +/- 6.7% vs. 11.1 +/- 3.7%, p<0.001). Patients with symptom duration <18 days prior to pleural effusion studies had more positive AMTD tests than those with symptom >18 days (70% vs. 31.4%; OR 5.09; 95% CI 1.54-16.79; p = 0.011). Conclusions: Combining AMTD tests with conventional diagnostic methods offer good sensitivity for pleural TB diagnosis. Patients in the early course of the disease are better candidates for AMTD tests.	[Lin, Chieh-Mo] Chang Gung Mem Hosp, Chiayi Branch, Div Pulm & Crit Care Med, Chiayi, Taiwan; [Lin, Shu-Min; Chung, Fu-Tsai; Lin, Horng-Chyuan; Lee, Kang-Yun; Huang, Chien-Da; Kuo, Chih-Hsi; Liu, Chien-Ying; Wang, Chun-Hua; Kuo, Han-Pin] Chang Gung Univ, Sch Med, Chang Gung Mem Hosp, Pulm Dis Res Ctr,Dept Thorac Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Lin, CM (corresponding author), Chang Gung Mem Hosp, Chiayi Branch, Div Pulm & Crit Care Med, Chiayi, Taiwan.	smlin100@gmail.com	Wang, Chun-Hua/V-9861-2019; Huang, Chien-Da/AAY-3771-2021; Wang, Chun-Hua/C-1488-2016	Wang, Chun-Hua/0000-0002-3514-9353; Huang, Chien-Da/0000-0002-4999-6019	Chang Gung Medical Research Fund, Chang Gung Memorial Hospital, Linkou, Taiwan [CMRPG 391291]	Chang Gung Medical Research Fund, Chang Gung Memorial Hospital, Linkou, Taiwan	This project is supported by the Chang Gung Medical Research Fund, Chang Gung Memorial Hospital, Linkou, Taiwan (grant no. CMRPG 391291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES PF, 1989, J IMMUNOL, V142, P1114; Baumann MH, 2007, CHEST, V131, P1125, DOI 10.1378/chest.06-2352; Bradley SP, 1996, AM J RESP CRIT CARE, V153, P1606, DOI 10.1164/ajrccm.153.5.8630609; BUENO CE, 1990, ARCH INTERN MED, V150, P1190, DOI 10.1001/archinte.1990.00390180034005; Burgess LJ, 1996, CHEST, V109, P414, DOI 10.1378/chest.109.2.414; Catanzaro A, 1997, AM J RESP CRIT CARE, V155, P1804, DOI 10.1164/ajrccm.155.5.9154896; Cheng VCC, 2005, EUR J CLIN MICROBIOL, V24, P711, DOI 10.1007/s10096-005-0039-1; Cohen RA, 1998, AM J RESP CRIT CARE, V157, P156, DOI 10.1164/ajrccm.157.1.97-06043; Conaty SJ, 2005, J INFECTION, V50, P187, DOI 10.1016/j.jinf.2004.03.010; DEWIT D, 1992, TUBERCLE LUNG DIS, V73, P262, DOI 10.1016/0962-8479(92)90130-C; Johansen IS, 2002, EUR J CLIN MICROBIOL, V21, P455, DOI 10.1007/s10096-002-0737-x; Liam C K, 2000, Respirology, V5, P33, DOI 10.1046/j.1440-1843.2000.00223.x; Light R W, 1999, Curr Opin Pulm Med, V5, P245, DOI 10.1097/00063198-199907000-00012; Lin MT, 2009, RESP MED, V103, P820, DOI 10.1016/j.rmed.2008.12.023; Lin SM, 2010, J THORAC CARDIOV SUR, V139, P1554, DOI 10.1016/j.jtcvs.2010.02.019; MILLER N, 1994, J CLIN MICROBIOL, V32, P393, DOI 10.1128/JCM.32.2.393-397.1994; Mitarai S, 2000, INT J TUBERC LUNG D, V4, P871; Moon JW, 2005, CLIN INFECT DIS, V41, P660, DOI 10.1086/432474; Neves DD, 2007, BRAZ J INFECT DIS, V11, P83, DOI 10.1590/S1413-86702007000100019; Pai M, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-6; Ruiz-Manzano J, 2000, CHEST, V118, P648, DOI 10.1378/chest.118.3.648; SEIBERT AF, 1991, CHEST, V99, P883, DOI 10.1378/chest.99.4.883; Valdes L, 1996, CHEST, V109, P158, DOI 10.1378/chest.109.1.158; Valdes Luis, 2003, Eur J Intern Med, V14, P77, DOI 10.1016/S0953-6205(03)00018-9; 1996, MMWR MORB MORTAL WKL, V45, P950	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44842	10.1371/journal.pone.0044842	http://dx.doi.org/10.1371/journal.pone.0044842			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970318	gold, Green Submitted, Green Published			2022-12-25	WOS:000308748400033
J	Huang, RZ; Gao, HC; Zhang, L; Jia, JM; Liu, X; Zheng, P; Ma, LH; Li, WJ; Deng, J; Wang, X; Yang, L; Wang, MJ; Xie, P				Huang, Rongzhong; Gao, Hongchang; Zhang, Liang; Jia, Jianmin; Liu, Xia; Zheng, Peng; Ma, Lihua; Li, Wenjuan; Deng, Jing; Wang, Xiao; Yang, Liu; Wang, Mingju; Xie, Peng			Borna Disease Virus Infection Perturbs Energy Metabolites and Amino Acids in Cultured Human Oligodendroglia Cells	PLOS ONE			English	Article							KETOGLUTARATE GLUTAMATE EXCHANGE; CENTRAL-NERVOUS-SYSTEM; TCA CYCLE; NMR; GLYCOLYSIS; PYRUVATE; LACTATE; BRAIN; RATS; DISORDERS	Background: Borna disease virus is a neurotropic, non-cytolytic virus that has been widely employed in neuroscientific research. Previous studies have revealed that metabolic perturbations are associated with Borna disease viral infection. However, the pathophysiological mechanism underlying its mode of action remains unclear. Methodology: Human oligodendroglia cells infected with the human strain Borna disease virus Hu-H1 and non-infected matched control cells were cultured in vitro. At day 14 post-infection, a proton nuclear magnetic resonance-based metabonomic approach was used to differentiate the metabonomic profiles of 28 independent intracellular samples from Borna disease virus-infected cells (n = 14) and matched control cells (n = 14). Partial least squares discriminant analysis was performed to demonstrate that the whole metabonomic patterns enabled discrimination between the two groups, and further statistical testing was applied to determine which individual metabolites displayed significant differences between the two groups. Findings: Metabonomic profiling revealed perturbations in 23 metabolites, 19 of which were deemed individually significant: nine energy metabolites (a-glucose, acetate, choline, creatine, formate, myo-inositol, nicotinamide adenine dinucleotide, pyruvate, succinate) and ten amino acids (aspartate, glutamate, glutamine, glycine, histidine, isoleucine, phenylalanine, threonine, tyrosine, valine). Partial least squares discriminant analysis demonstrated that the whole metabolic patterns enabled statistical discrimination between the two groups. Conclusion: Borna disease viral infection perturbs the metabonomic profiles of several metabolites in human oligodendroglia cells cultured in vitro. The findings suggest that Borna disease virus manipulates the host cell's metabolic network to support viral replication and proliferation.	[Huang, Rongzhong; Zhang, Liang; Liu, Xia; Zheng, Peng; Ma, Lihua; Deng, Jing; Wang, Mingju; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Gao, Hongchang; Jia, Jianmin] Wenzhou Med Coll, Dept Pharm, Wenzhou, Zhejiang, Peoples R China; [Huang, Rongzhong; Zhang, Liang; Liu, Xia; Zheng, Peng; Ma, Lihua; Li, Wenjuan; Deng, Jing; Wang, Xiao; Yang, Liu; Wang, Mingju; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Huang, Rongzhong; Zhang, Liang; Liu, Xia; Zheng, Peng; Ma, Lihua; Li, Wenjuan; Deng, Jing; Wang, Xiao; Yang, Liu; Wang, Mingju; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China	Chongqing Medical University; Wenzhou Medical University; Chongqing Medical University	Huang, RZ (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.	xiepeng@cqmu.edu.cn			National Basic Research Program of China (973 Program) [2009CB918300]; National Natural Science Foundation of China [30900456, 21175099]; Natural Science Foundation Project of Chongqing (CSTC) [2008BB5238, 2010BB5393]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC)	This work was supported by the National Basic Research Program of China (973 Program) (Grant No. 2009CB918300), the National Natural Science Foundation of China (Grant No. 30900456 and 21175099), and the Natural Science Foundation Project of Chongqing (CSTC, 2008BB5238 and 2010BB5393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar E, 2005, ENDOCRINE, V28, P295, DOI 10.1385/ENDO:28:3:295; Akhtar SN, 2007, NMR BIOMED, V20, P422, DOI 10.1002/nbm.1099; BACZKO K, 1988, J INFECT DIS, V158, P144, DOI 10.1093/infdis/158.1.144; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Benjamini Y, 2001, ANN STAT, V29, P1165; Bode L, 2003, CLIN MICROBIOL REV, V16, P534, DOI 10.1128/CMR.16.3.534-545.2003; Bode L, 1996, MOL PSYCHIATR, V1, P200; Clemente R, 2009, J VIROL, V83, P2655, DOI 10.1128/JVI.02206-08; de la Torre JC, 2000, VIRUS TAXONOMY, V10, P531; delaTorre JC, 1996, VIRUS RES, V44, P33, DOI 10.1016/0168-1702(96)01338-X; DITTRICH W, 1989, BIOL PSYCHIAT, V26, P818, DOI 10.1016/0006-3223(89)90122-4; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Feron O, 2009, RADIOTHER ONCOL, V92, P329, DOI 10.1016/j.radonc.2009.06.025; Feschotte C, 2010, NATURE, V463, P39, DOI 10.1038/463039a; FLECK MW, 1993, J NEUROSCI, V13, P3944; Gosztonyi G, 2001, CURR TOP MICROBIOL, V253, P121; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Hornig M, 2012, MOL PSYCHIATR, V17, P486, DOI 10.1038/mp.2011.179; Hornig M, 2001, CURR TOP MICROBIOL, V253, P157; Ibrahim MS, 2002, J VIROL, V76, P3873, DOI 10.1128/JVI.76.8.3873-3880.2002; Kohno T, 1999, J VIROL, V73, P760, DOI 10.1128/JVI.73.1.760-766.1999; Legendre P, 2001, CELL MOL LIFE SCI, V58, P760, DOI 10.1007/PL00000899; Li Q, 2009, EUR J NEUROL, V16, P399, DOI 10.1111/j.1468-1331.2008.02516.x; Li YH, 2008, BRAIN RES, V1190, P49, DOI 10.1016/j.brainres.2007.11.006; Liu STH, 2011, P NATL ACAD SCI USA, V108, P12869, DOI 10.1073/pnas.1109796108; LOU HC, 1994, ACTA PAEDIATR, V83, P86, DOI 10.1111/j.1651-2227.1994.tb13461.x; Ludwig H, 1993, Arch Virol Suppl, V7, P111; LUDWIG H, 1988, PROG MED VIROL, V35, P107; Mashego MR, 2007, BIOTECHNOL LETT, V29, P1, DOI 10.1007/s10529-006-9218-0; MASON GF, 1995, J CEREBR BLOOD F MET, V15, P12, DOI 10.1038/jcbfm.1995.2; MASON GF, 1992, J CEREBR BLOOD F MET, V12, P434, DOI 10.1038/jcbfm.1992.61; MULLER CE, 1995, ACTA NEUROPATHOL, V89, P438, DOI 10.1007/BF00307649; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Ovanesov MV, 2007, J NEUROVIROL, V13, P185, DOI 10.1080/13550280701258415; PAULI G, 1985, VIRUS RES, V2, P29, DOI 10.1016/0168-1702(85)90057-7; Pletnikov MV, 2000, DEV BRAIN RES, V119, P179, DOI 10.1016/S0165-3806(99)00168-6; Qian J, 2010, ANTIVIR RES, V87, P249, DOI 10.1016/j.antiviral.2010.05.011; Rich PR, 2003, BIOCHEM SOC T, V31, P1095; Ritter JB, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-61; Schurr A, 2007, NEUROSCIENCE, V147, P613, DOI 10.1016/j.neuroscience.2007.05.002; Solbrig MV, 2003, PHARMACOL BIOCHEM BE, V74, P777, DOI 10.1016/S0091-3057(03)00019-4; Sripadi P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012590; TILTON WM, 1991, J LAB CLIN MED, V118, P146; Utrilla J, 2009, J IND MICROBIOL BIOT, V36, P1057, DOI 10.1007/s10295-009-0589-9; Zhang CX, 2005, J NEUROVIROL, V11, P256, DOI 10.1080/13550280590952781	46	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44665	10.1371/journal.pone.0044665	http://dx.doi.org/10.1371/journal.pone.0044665			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970281	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000042
J	Zhang, LJ; Tao, BB; Wang, MJ; Jin, HM; Zhu, YC				Zhang, Li-Jia; Tao, Bei-Bei; Wang, Ming-Jie; Jin, Hui-Ming; Zhu, Yi-Chun			PI3K p110 alpha Isoform-Dependent Rho GTPase Rac1 Activation Mediates H2S-Promoted Endothelial Cell Migration via Actin Cytoskeleton Reorganization	PLOS ONE			English	Article							FOCAL ADHESION KINASE; HYDROGEN-SULFIDE; ADHERENS JUNCTIONS; PROTEIN-KINASE; PHOSPHORYLATION; H2S; ANGIOGENESIS; MOTILITY; VASORELAXANT; INFLAMMATION	Hydrogen sulfide (H2S) is now considered as the third gaseotransmitter, however, the signaling pathways that modulate the biomedical effect of H2S on endothelial cells are poorly defined. In the present study, we found in human endothelial cells that H2S increased cell migration rates and induced a marked reorganization of the actin cytoskeleton, which was prevented by depletion of Rac1. Pharmacologic inhibiting vascular endothelial growth factor receptor (VEGFR) and phosphoinositide 3-kinase (PI3K) both blunted the activation of Rac1 and the promotion of cell migration induced by H2S. Moreover, H2S-induced Rac1 activation was selectively dependent on the presence of the PI3K p110 alpha isoform. Activated Rac1 by H2S thus in turn resulted in the phosphorylation of the F-actin polymerization modulator, cofilin. Additionally, inhibiting of extracellular signal-regulated kinase (ERK) decreased the augmented cell migration rate by H2S, but had no effect on Rac1 activation. These results indicate that Rac1 conveys the H2S signal to microfilaments inducing rearrangements of actin cytoskeleton that regulates cell migration. VEGFR-PI3K was found to be upstream pathway of Rac1, while cofilin acted as a downstream effector of Rac1. ERK was also shown to be involved in the action of H2S on endothelial cell migration, but independently of Rac1.	[Zhang, Li-Jia; Tao, Bei-Bei; Wang, Ming-Jie; Jin, Hui-Ming; Zhu, Yi-Chun] Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai 200433, Peoples R China	Fudan University	Zhang, LJ (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Physiol & Pathophysiol, Shanghai 200433, Peoples R China.	yczhu@shmu.edu.cn		Zhu, Yichun/0000-0002-0873-2957	Ministry of Science and Technology of China [2010CB912601, 2009ZX09303-006]; National Natural Science Foundation of China [30825016, 30971064, 81000045]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Ministry of Science and Technology (2010CB912601 and 2009ZX09303-006) of China and the National Natural Science Foundation of China (30825016, 30971064, 81000045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Cai WJ, 2007, CARDIOVASC RES, V76, P29, DOI 10.1016/j.cardiores.2007.05.026; Cain RJ, 2010, J CELL BIOL, V188, P863, DOI 10.1083/jcb.200907135; Cheng CM, 2009, J BIOL CHEM, V284, P8786, DOI 10.1074/jbc.M806144200; Delorme V, 2007, DEV CELL, V13, P646, DOI 10.1016/j.devcel.2007.08.011; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gadalla MM, 2010, J NEUROCHEM, V113, P14, DOI 10.1111/j.1471-4159.2010.06580.x; Graupera M, 2008, NATURE, V453, P662, DOI 10.1038/nature06892; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hedges JC, 1999, J BIOL CHEM, V274, P24211, DOI 10.1074/jbc.274.34.24211; Hegde Akhil, 2011, Inflammation & Allergy Drug Targets, V10, P118; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Jimenez C, 2000, J CELL BIOL, V151, P249, DOI 10.1083/jcb.151.2.249; Kimura H, 2010, AMINO ACIDS; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Lefer DJ, 2007, P NATL ACAD SCI USA, V104, P17907, DOI 10.1073/pnas.0709010104; Liu ZX, 2002, J BIOL CHEM, V277, P10452, DOI 10.1074/jbc.M107551200; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Nguyen DHD, 1999, J CELL BIOL, V146, P149, DOI 10.1083/jcb.146.1.149; Pan J, 2005, J NEUROCHEM, V93, P571, DOI 10.1111/j.1471-4159.2005.03106.x; Papapetropoulos A, 2009, P NATL ACAD SCI USA, V106, P21972, DOI 10.1073/pnas.0908047106; Ray RM, 2007, CELL MOTIL CYTOSKEL, V64, P143, DOI 10.1002/cm.20172; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; Vial E, 2004, ANN NY ACAD SCI, V1030, P208, DOI 10.1196/annals.1329.027; Vicente-Manzanares M, 2005, J CELL SCI, V118, DOI 10.1242/jcs.02662; Wagner F, 2009, CRIT CARE, V13, DOI 10.1186/cc7700; Wang MJ, 2010, ANTIOXID REDOX SIGN, V12, P1065, DOI 10.1089/ars.2009.2945; Wang R, 2010, ANTIOXID REDOX SIGN, V12, P1061, DOI 10.1089/ars.2009.2938; Yang G, 2011, AM J PATHOL; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667; Yang W, 2005, J PHYSIOL-LONDON, V569, P519, DOI 10.1113/jphysiol.2005.097642; Yao LL, 2010, AM J PHYSIOL-HEART C, V298, pH1310, DOI 10.1152/ajpheart.00339.2009; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhao WM, 2002, AM J PHYSIOL-HEART C, V283, pH474, DOI 10.1152/ajpheart.00013.2002; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	47	26	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44590	10.1371/journal.pone.0044590	http://dx.doi.org/10.1371/journal.pone.0044590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970259	Green Submitted, Green Published, gold			2022-12-25	WOS:000308462000033
J	Maling, N; Hashemiyoon, R; Foote, KD; Okun, MS; Sanchez, JC				Maling, Nicholas; Hashemiyoon, Rowshanak; Foote, Kelly D.; Okun, Michael S.; Sanchez, Justin C.			Increased Thalamic Gamma Band Activity Correlates with Symptom Relief following Deep Brain Stimulation in Humans with Tourette's Syndrome	PLOS ONE			English	Article							CM-PF COMPLEX; RESPONSIVE CORTICAL STIMULATION; BEHAVIORAL SPECTRUM; VISUAL-CORTEX; OSCILLATIONS; SYNCHRONIZATION; INFORMATION; DISORDERS; MECHANISM; NEURONS	Tourette syndrome (TS) is an idiopathic, childhood-onset neuropsychiatric disorder, which is marked by persistent multiple motor and phonic tics. The disorder is highly disruptive and in some cases completely debilitating. For those with severe, treatment-refractory TS, deep brain stimulation (DBS) has emerged as a possible option, although its mechanism of action is not fully understood. We performed a longitudinal study of the effects of DBS on TS symptomatology while concomitantly examining neurophysiological dynamics. We present the first report of the clinical correlation between the presence of gamma band activity and decreased tic severity. Local field potential recordings from five subjects implanted in the centromedian nucleus (CM) of the thalamus revealed a temporal correlation between the power of gamma band activity and the clinical metrics of symptomatology as measured by the Yale Global Tic Severity Scale and the Modified Rush Tic Rating Scale. Additional studies utilizing short-term stimulation also produced increases in gamma power. Our results suggest that modulation of gamma band activity in both long-term and short-term DBS of the CM is a key factor in mitigating the pathophysiology associated with TS.	[Maling, Nicholas] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Hashemiyoon, Rowshanak; Sanchez, Justin C.] Univ Miami, Dept Biomed Engn, Coral Gables, FL 33124 USA; [Foote, Kelly D.] Univ Florida, Dept Neurosurg, Gainesville, FL 32610 USA; [Foote, Kelly D.; Okun, Michael S.] Univ Florida, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Okun, Michael S.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Sanchez, Justin C.] Univ Miami, Neurosci Program, Miami, FL USA; [Sanchez, Justin C.] Univ Miami, Miami Project Cure Paralysis, Miami, FL USA	State University System of Florida; University of Florida; University of Miami; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Miami; University of Miami	Maling, N (corresponding author), Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA.	jcsanchez@miami.edu		Foote, Kelly/0000-0002-2436-4138; Okun, Michael/0000-0002-6247-9358; Maling, Nicholas/0000-0001-6204-375X	United States National Institutes of Health [5R21NS072897, R34MH080764]; University of Florida; Neuropace, Mountainview, CA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH080764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS072897] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida(University of Florida); Neuropace, Mountainview, CA; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by United States National Institutes of Health grants 5R21NS072897 (Multi-PI Sanchez and Okun) and R34MH080764 (PI: Okun). Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would also like to acknowledge the donation of devices to the NIH sponsored study by Neuropace, Mountainview, CA. We would like to recognize the important feedback given on this project by Dana Mason, Stacy Merritt, Kyle Rizer, David Greene, Martha Morrell, Brent Wingeier, and Rosana Estellar.	Babiloni C, 2006, CLIN NEUROPHYSIOL, V117, P1000, DOI 10.1016/j.clinph.2005.12.028; BERENDSE HW, 1991, NEUROSCIENCE, V42, P73, DOI 10.1016/0306-4522(91)90151-D; Bloch MH, 2006, ARCH PEDIAT ADOL MED, V160, P63; Bront-Stewart H, 2011, DYNAMICAL NEUROSCIEN; Cavanna AE, 2009, J NEUROPSYCH CLIN N, V21, P13, DOI 10.1176/appi.neuropsych.21.1.13; Cheung MYC, 2007, MOVEMENT DISORD, V22, P1743, DOI 10.1002/mds.21599; DeCoteau WE, 2007, J NEUROPHYSIOL, V97, P3800, DOI 10.1152/jn.00108.2007; Donoghue JP, 1998, J NEUROPHYSIOL, V79, P159, DOI 10.1152/jn.1998.79.1.159; Eapen Valsamma, 2008, Prim Care Companion J Clin Psychiatry, V10, P103; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; Frank MC, 2011, J NEUROL SCI, V310, P276, DOI 10.1016/j.jns.2011.06.032; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Goetz CG, 1999, MOVEMENT DISORD, V14, P502, DOI 10.1002/1531-8257(199905)14:3<502::AID-MDS1020>3.0.CO;2-G; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Haber SN, 2009, BRAIN RES BULL, V78, P69, DOI 10.1016/j.brainresbull.2008.09.013; Hariz MI, 2010, EUR J NEUROSCI, V32, P1128, DOI 10.1111/j.1460-9568.2010.07415.x; Hashemiyoon R, 1996, COMPUTATIONAL NEUROS; HASSLER R, 1970, REV NEUROL, V123, P89; Houeto JL, 2005, J NEUROL NEUROSUR PS, V76, P992, DOI 10.1136/jnnp.2004.043273; Jankovic J, 2011, MOVEMENT DISORD, V26, P1149, DOI 10.1002/mds.23618; Kuhn J, 2007, J NEUROL, V254, P963, DOI 10.1007/s00415-006-0404-8; Kurlan R, 2002, NEUROLOGY, V59, P414, DOI 10.1212/WNL.59.3.414; Leckman JF, 2006, J CHILD PSYCHOL PSYC, V47, P537, DOI 10.1111/j.1469-7610.2006.01620.x; Leckman JF, 2010, J CHILD ADOL PSYCHOP, V20, P237, DOI 10.1089/cap.2009.0118; Leckman JF, 2002, LANCET, V360, P1577, DOI 10.1016/S0140-6736(02)11526-1; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Marceglia S, 2010, MOVEMENT DISORD, V25, P300, DOI 10.1002/mds.22982; Matsumoto N, 2001, J NEUROPHYSIOL, V85, P960, DOI 10.1152/jn.2001.85.2.960; McNaught KS, 2011, NAT REV NEUROL, V7, P667, DOI 10.1038/nrneurol.2011.167; Minamimoto T, 2002, J NEUROPHYSIOL, V87, P3090, DOI 10.1152/jn.2002.87.6.3090; Minamimoto T, 2009, BRAIN RES BULL, V78, P75, DOI 10.1016/j.brainresbull.2008.08.013; Mink JW, 2006, MOVEMENT DISORD, V21, P1831, DOI 10.1002/mds.21039; Mink JW, 2001, PEDIATR NEUROL, V25, P190, DOI 10.1016/S0887-8994(01)00262-4; Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Nadasdy Z, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.006.2009; Okun MS, 2012, TRIAL SCHEDULED DEEP; Piedad JCP, 2012, NEUROSURGERY, V71, P173, DOI 10.1227/NEU.0b013e3182535a00; Plessen KJ, 2009, J PSYCHOSOM RES, V67, P559, DOI 10.1016/j.jpsychores.2009.07.005; Porta M, 2009, EUR NEUROL, V62, P264, DOI 10.1159/000235595; Raeva S N, 2006, Neurosci Behav Physiol, V36, P287, DOI 10.1007/s11055-006-0015-y; Robertson MM, 2009, J PSYCHOSOM RES, V67, P475, DOI 10.1016/j.jpsychores.2009.07.010; Robertson MM, 2012, ARCH DIS CHILD ED PR; Sassi M, 2011, ACTA NEUROCHIR, V153, P639, DOI 10.1007/s00701-010-0803-6; Savica R, 2012, MAYO CLIN PROC, V87, P59, DOI 10.1016/j.mayocp.2011.08.005; Schroeder CE, 2009, BRAIN TOPOGR, V22, P24, DOI 10.1007/s10548-009-0080-y; Servello D, 2009, J NEUROL, V256, P1533, DOI 10.1007/s00415-009-5159-6; Steeves TDL, 2010, ANN NEUROL, V67, P170, DOI 10.1002/ana.21809; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Steriade M, 1996, J NEUROSCI, V16, P2788; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Sudhyadhom A, 2009, NEUROIMAGE, V47, pT44, DOI 10.1016/j.neuroimage.2009.04.018; Sun FT, 2008, NEUROTHERAPEUTICS, V5, P68, DOI 10.1016/j.nurt.2007.10.069; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Temel Y, 2004, MOVEMENT DISORD, V19, P3, DOI 10.1002/mds.10649; Uhhaas PJ, 2006, NEURON, V52, P155, DOI 10.1016/j.neuron.2006.09.020; Vandewalle V, 1999, LANCET, V353, P724, DOI 10.1016/S0140-6736(98)05964-9; Wanderer S, 2012, J DEV BEHAV PEDIATR, V33, P124, DOI 10.1097/DBP.0b013e31823f6933	63	77	77	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44215	10.1371/journal.pone.0044215	http://dx.doi.org/10.1371/journal.pone.0044215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970181	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400047
J	Norambuena, J; Flores, R; Cardenas, JP; Quatrini, R; Chavez, R; Levican, G				Norambuena, Javiera; Flores, Rodrigo; Cardenas, Juan P.; Quatrini, Raquel; Chavez, Renato; Levican, Gloria			Thiol/Disulfide System Plays a Crucial Role in Redox Protection in the Acidophilic Iron-Oxidizing Bacterium Leptospirillum ferriphilum	PLOS ONE			English	Article							DISULFIDE BOND FORMATION; ESCHERICHIA-COLI; THIOREDOXIN REDUCTASE; HELICOBACTER-PYLORI; CCMG PROTEIN; THIOL; MECHANISMS; FERROOXIDANS; RESISTANCE; EXPRESSION	Thiol/disulfide systems are involved in the maintenance of the redox status of proteins and other molecules that contain thiol/disulfide groups. Leptospirillum ferriphilum DSM14647, an acidophilic bacterium that uses Fe2+ as electron donor, and withstands very high concentrations of iron and other redox active metals, is a good model to study how acidophiles preserve the thiol/disulfide balance. We studied the composition of thiol/disulfide systems and their role in the oxidative stress response in this extremophile bacterium. Bioinformatic analysis using genomic data and enzymatic assays using protein extracts from cells grown under oxidative stress revealed that the major thiol/disulfide system from L. ferriphilum are a cytoplasmic thioredoxin system (composed by thioredoxins Trx and thioredoxin reductase TR), periplasmic thiol oxidation system (DsbA/DsbB) and a c-type cytochrome maturation system (DsbD/DsbE). Upon exposure of L. ferriphilum to reactive oxygen species (ROS)-generating compounds, transcriptional activation of the genes encoding Trxs and the TR enzyme, which results in an increase of the corresponding activity, was observed. Altogether these data suggest that the thioredoxin-based thiol/disulfide system plays an important role in redox protection of L. ferriphilum favoring the survival of this microorganism under extreme environmental oxidative conditions.	[Norambuena, Javiera; Flores, Rodrigo; Chavez, Renato; Levican, Gloria] Univ Santiago Chile, Dept Biol, Fac Quim & Biol, Lab Microbiol Basica & Aplicada, Santiago, Chile; [Cardenas, Juan P.; Quatrini, Raquel] Fdn Ciencia & Vida, Lab Ecofisiol Microbiana, Santiago, Chile	Universidad de Santiago de Chile	Levican, G (corresponding author), Univ Santiago Chile, Dept Biol, Fac Quim & Biol, Lab Microbiol Basica & Aplicada, Santiago, Chile.	gloria.levican@usach.cl	Quatrini, Raquel/S-4099-2019; Levican, Gloria/R-5191-2019; Quatrini, Raquel/GSD-7689-2022; Quatrini, Raquel/N-1801-2013; Cardenas, Juan Pablo/AAB-2469-2020	Quatrini, Raquel/0000-0003-2600-2605; Levican, Gloria/0000-0002-1275-7399; Quatrini, Raquel/0000-0003-2600-2605; Cardenas, Juan Pablo/0000-0001-6715-7270; Norambuena, Javiera/0000-0002-2992-4907; Chavez, Renato/0000-0003-1754-3610	Fondecyt [11085045, 1100887]; Innova [08CM01-03]; Dicyt-Usach from the Government of Chile	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Innova; Dicyt-Usach from the Government of Chile	This work was supported by Fondecyt grants No11085045 (GL) and 1100887 (RQ), Innova 08CM01-03 (RQ) and Dicyt-Usach (GL, RC) from the Government of Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arner ES, 2001, CURR PROTOC TOXICOL, V7, P41; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Baker LMS, 2001, J BACTERIOL, V183, P1961, DOI 10.1128/JB.183.6.1961-1973.2001; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Birch CS, 2009, FREE RADICAL BIO MED, V47, P184, DOI 10.1016/j.freeradbiomed.2009.04.023; BJELLQVIST B, 1994, ELECTROPHORESIS, V15, P529, DOI 10.1002/elps.1150150171; Boylan JA, 2006, MOL MICROBIOL, V59, P475, DOI 10.1111/j.1365-2958.2005.04963.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Cerda O, 2003, FEMS MICROBIOL LETT, V224, P175, DOI 10.1016/S0378-1097(03)00423-3; Cortes A, 2011, 19 INT BIOH S, P354; Di Matteo A, 2010, PROTEINS, V78, P2213, DOI 10.1002/prot.22733; Dressaire C, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S18; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Giles GI, 2002, BIOL CHEM, V383, P375, DOI 10.1515/BC.2002.042; Goltsman DSA, 2009, APPL ENVIRON MICROB, V75, P4599, DOI 10.1128/AEM.02943-08; Goulding CW, 2004, J BIOL CHEM, V279, P3516, DOI 10.1074/jbc.M311833200; Hishinuma S, 2008, FEMS MICROBIOL LETT, V289, P138, DOI 10.1111/j.1574-6968.2008.01374.x; Hochgrafe F, 2007, J BIOL CHEM, V282, P25981, DOI 10.1074/jbc.C700105200; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Horsburgh MJ, 2001, INFECT IMMUN, V69, P3744, DOI 10.1128/IAI.69.6.3744-3754.2001; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; INGLEDEW WJ, 1982, BIOCHIM BIOPHYS ACTA, V683, P89, DOI 10.1016/0304-4173(82)90007-6; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Kranz RG, 2009, MICROBIOL MOL BIOL R, V73, P510, DOI 10.1128/MMBR.00001-09; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Levican G, 2012, J MOL MICROB BIOTECH, V22, P94, DOI 10.1159/000338105; Levican G, 2007, P NATL ACAD SCI USA, V104, P3135, DOI 10.1073/pnas.0611611104; Li B, 2010, BIORESOURCE TECHNOL, V101, P9811, DOI 10.1016/j.biortech.2010.07.043; Li KY, 2003, ARCH MICROBIOL, V180, P484, DOI 10.1007/s00203-003-0620-x; Li Q, 2001, BIOL CHEM, V382, P1679, DOI 10.1515/BC.2001.203; Lim Hye Won, 1995, Journal of Biochemistry and Molecular Biology, V28, P17; Linke K, 2003, ANTIOXID REDOX SIGN, V5, P425, DOI 10.1089/152308603768295168; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Maaty WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006964; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Nieto PA, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-63; Osorio H, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-203; Pedone E, 2010, CELL MOL LIFE SCI, V67, P3797, DOI 10.1007/s00018-010-0449-9; Pillay CS, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-15; Potamitou A, 2002, J BIOL CHEM, V277, P18561, DOI 10.1074/jbc.M201225200; Prinz WA, 1997, J BIOL CHEM, V272, P15661, DOI 10.1074/jbc.272.25.15661; Ram RJ, 2005, SCIENCE, V308, P1915, DOI 10.1126/science. 1109070; Reid E, 2001, BIOCHEM J, V355, P51, DOI 10.1042/0264-6021:3550051; Rigobello MP, 2004, BIOCHEM PHARMACOL, V67, P689, DOI 10.1016/j.bcp.2003.09.038; Ritz D, 2001, ANNU REV MICROBIOL, V55, P21, DOI 10.1146/annurev.micro.55.1.21; Rodrigues VD, 2010, PROCESS BIOCHEM, V45, P914, DOI 10.1016/j.procbio.2010.02.018; Ruddock LW, 1999, CURR BIOL, V9, pR400, DOI 10.1016/S0960-9822(99)80253-X; Servant Florence, 2002, Brief Bioinform, V3, P246, DOI 10.1093/bib/3.3.246; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x; Yarzabal A, 2002, FEMS MICROBIOL LETT, V209, P189, DOI 10.1016/S0378-1097(02)00514-1; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1	63	17	17	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44576	10.1371/journal.pone.0044576	http://dx.doi.org/10.1371/journal.pone.0044576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970253	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400089
J	Sartoretto, JL; Hermann, K; Shiroto, T; Sartoretto, SM; Pluth, MD; Lippard, SJ; Michel, T				Sartoretto, Juliano L.; Kalwa, Hermann; Shiroto, Takashi; Sartoretto, Simone M.; Pluth, Michael D.; Lippard, Stephen J.; Michel, Thomas			Role of Ca2+ in the Control of H2O2-Modulated Phosphorylation Pathways Leading to eNOS Activation in Cardiac Myocytes	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; PROTEIN-KINASE-C; HYDROGEN-PEROXIDE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; HEART-FAILURE; CONTRACTION; MECHANISMS; EXPRESSION; ISOFORMS	Nitric oxide (NO) and hydrogen peroxide (H2O2) play key roles in physiological and pathological responses in cardiac myocytes. The mechanisms whereby H2O2-modulated phosphorylation pathways regulate the endothelial isoform of nitric oxide synthase (eNOS) in these cells are incompletely understood. We show here that H2O2 treatment of adult mouse cardiac myocytes leads to increases in intracellular Ca2+ ([Ca2+](i)), and document that activity of the L-type Ca2+ channel is necessary for the H2O2-promoted increase in sarcomere shortening and of [Ca2+](i). Using the chemical NO sensor Cu-2(FL2E), we discovered that the H2O2-promoted increase in cardiac myocyte NO synthesis requires activation of the L-type Ca2+ channel, as well as phosphorylation of the AMP-activated protein kinase (AMPK), and mitogen-activated protein kinase kinase 1/2 (MEK1/2). Moreover, H2O2-stimulated phosphorylations of eNOS, AMPK, MEK1/2, and ERK1/2 all depend on both an increase in [Ca2+](i) as well as the activation of protein kinase C (PKC). We also found that H2O2-promoted cardiac myocyte eNOS translocation from peripheral membranes to internal sites is abrogated by the L-type Ca2+ channel blocker nifedipine. We have previously shown that kinase Akt is also involved in H2O2-promoted eNOS phosphorylation. Here we present evidence documenting that H2O2-promoted Akt phosphorylation is dependent on activation of the L-type Ca2+ channel, but is independent of PKC. These studies establish key roles for Ca2+- and PKC-dependent signaling pathways in the modulation of cardiac myocyte eNOS activation by H2O2.	[Sartoretto, Juliano L.; Kalwa, Hermann; Shiroto, Takashi; Sartoretto, Simone M.; Michel, Thomas] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Cardiovasc Div, Boston, MA 02115 USA; [Pluth, Michael D.; Lippard, Stephen J.] MIT, Dept Chem, Cambridge, MA 02139 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Sartoretto, JL (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Cardiovasc Div, Boston, MA 02115 USA.	thomas_michel@harvard.edu	Sartoretto, Simone/F-5622-2014; Kalwa, Hermann/ABG-2323-2021; Pluth, Michael/A-7222-2012	Sartoretto, Simone/0000-0002-0771-233X; Pluth, Michael/0000-0003-3604-653X; sartoretto, juliano/0000-0002-0355-5541	National Institutes of Health [HL46457, HL48743, GM36259]; Uehara Memorial Foundation; American Diabetes Association/Takeda Cardiovascular Postdoctoral Fellowship Award; FAPESP [2009/54535-7]; Fonds National de Recherche, Luxembourg; National Science Foundation [NSF CHE-0907905];  [K99GM092970]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048743, R01HL046457, R29HL046457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036259, R37GM036259, K99GM092970] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0907905] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); American Diabetes Association/Takeda Cardiovascular Postdoctoral Fellowship Award(American Diabetes Association); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fonds National de Recherche, Luxembourg; National Science Foundation(National Science Foundation (NSF)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by National Institutes of Health Grants HL46457, HL48743, and GM36259 (to TM) and by K99GM092970 to MDP; by a fellowship grant from the Uehara Memorial Foundation (to TS); by an American Diabetes Association/Takeda Cardiovascular Postdoctoral Fellowship Award (to JLS); by a FAPESP award 2009/54535-7 (to SMS); and by a postdoctoral fellowship from the Fonds National de Recherche, Luxembourg (to HK). SJL thanks the National Science Foundation for support of this work under grant NSF CHE-0907905. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balligand JL, 2009, PHYSIOL REV, V89, P481, DOI 10.1152/physrev.00042.2007; Belhassen L, 1997, J BIOL CHEM, V272, P11198; BERESEWICZ A, 1991, J MOL CELL CARDIOL, V23, P899, DOI 10.1016/0022-2828(91)90133-7; Bowling N, 1999, CIRCULATION, V99, P384, DOI 10.1161/01.CIR.99.3.384; Cain BS, 1999, J SURG RES, V81, P249, DOI 10.1006/jsre.1998.5508; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Dai DF, 2012, CARDIOVASC RES, V93, P79, DOI 10.1093/cvr/cvr274; Dorn GW, 2002, ANNU REV PHYSIOL, V64, P407, DOI 10.1146/annurev.physiol.64.081501.155903; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Feron O, 1996, J BIOL CHEM, V271, P22810, DOI 10.1074/jbc.271.37.22810; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hambleton M, 2006, CIRCULATION, V114, P574, DOI 10.1161/CIRCULATIONAHA.105.592550; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; KIMURA M, 1992, BRIT J PHARMACOL, V107, P488, DOI 10.1111/j.1476-5381.1992.tb12772.x; Kuster GM, 2010, FREE RADICAL BIO MED, V48, P1182, DOI 10.1016/j.freeradbiomed.2010.01.038; Lenz JC, 2002, J CELL BIOL, V159, P291, DOI 10.1083/jcb.200203048; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; McQuade LE, 2010, P NATL ACAD SCI USA, V107, P8525, DOI 10.1073/pnas.0914794107; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Octavia Y, 2012, FREE RADICAL BIO MED, V52, P291, DOI 10.1016/j.freeradbiomed.2011.10.482; Partovian C, 2005, CIRC RES, V97, P482, DOI 10.1161/01.RES.0000179775.04114.45; SAKAI K, 1983, J PHARMACOL METHOD, V10, P263; Sartoretto JL, 2011, P NATL ACAD SCI USA, V108, P15792, DOI 10.1073/pnas.1111331108; Sartoretto JL, 2009, AM J PHYSIOL-HEART C, V297, pH1697, DOI 10.1152/ajpheart.00595.2009; SHEPHERD M, 1987, BIOCHEM MED METAB B, V38, P195, DOI 10.1016/0885-4505(87)90080-6; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; Tanaka M, 2011, INTERNAL MED, V50, P2877, DOI 10.2169/internalmedicine.50.5925; Thomas SR, 2002, J BIOL CHEM, V277, P6017, DOI 10.1074/jbc.M109107200; WARD CA, 1995, J MOL CELL CARDIOL, V27, P1089, DOI 10.1016/0022-2828(95)90077-2; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Yin LH, 2004, AM J PHYSIOL-HEART C, V287, pH1276, DOI 10.1152/ajpheart.01120.2003	31	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44627	10.1371/journal.pone.0044627	http://dx.doi.org/10.1371/journal.pone.0044627			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970272	Green Submitted, Green Published, gold			2022-12-25	WOS:000308458400097
J	Spoida, K; Distler, C; Trampe, AK; Hoffmann, KP				Spoida, Katharina; Distler, Claudia; Trampe, Anne-Kathrin; Hoffmann, Klaus-Peter			Blocking Retinal Chloride Co-Transporters KCC2 and NKCC: Impact on Direction Selective ON and OFF Responses in the Rat's Nucleus of the Optic Tract	PLOS ONE			English	Article							DORSAL TERMINAL NUCLEUS; STARBURST AMACRINE CELLS; GANGLION-CELLS; OPTOKINETIC NYSTAGMUS; CORTICAL PROJECTIONS; STRIATE CORTEX; MECHANISMS; COTRANSPORTERS; SYSTEM; UNITS	In the present study we investigated in vivo the effects of pharmacological manipulation of retinal processing on the response properties of direction selective retinal slip cells in the nucleus of the optic tract and dorsal terminal nucleus (NOT-DTN), the key visuomotor interface in the pathway underlying the optokinetic reflex. Employing a moving visual stimulus consisting of either a large dark or light edge we could differentiate direction selective ON and OFF responses in retinal slip cells. To disclose the origin of the retinal slip cells' unexpected OFF response we selectively blocked the retinal ON channels and inactivated the visual cortex by cooling. Cortical cooling had no effect on the direction selectivity of the ON or the OFF response in NOT-DTN retinal slip cells. Blockade of the retinal ON channel with APB led to a loss of the ON and, to a lesser degree, of the OFF response and a reduction in direction selectivity. Subsequent blocking of GABA receptors in the retina with picrotoxin unmasked a vigorous albeit direction unselective OFF response in the NOT-DTN. Disturbing the retinal chloride homeostasis by intraocular injections of bumetanide or furosemide led to a loss of direction selectivity in both the NOT-DTN's ON and the OFF response due to a reduced response in the neuron's preferred direction under bumetanide as well as under furosemide and a slightly increased response in the null direction under bumetanide. Our results indicate that the direction specificity of retinal slip cells in the NOT-DTN of the rat strongly depends on direction selective retinal input which depends on intraretinal chloride homeostasis. On top of the well established input from ON center direction selective ganglion cells we could demonstrate an equally effective input from the retinal OFF system to the NOT-DTN.	[Spoida, Katharina; Distler, Claudia; Trampe, Anne-Kathrin; Hoffmann, Klaus-Peter] Ruhr Univ Bochum, Bochum, Germany	Ruhr University Bochum	Spoida, K (corresponding author), Ruhr Univ Bochum, Univ Str 150, Bochum, Germany.	kphoffm@gmail.com		Spoida, Katharina/0000-0002-4132-0655	ZEN grant from Hertie Foundation	ZEN grant from Hertie Foundation	K.-P. Hoffmann was supported by a ZEN grant from the Hertie Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackert JM, 2009, J PHYSIOL-LONDON, V587, P4481, DOI 10.1113/jphysiol.2009.173344; Ackert JM, 2006, J NEUROSCI, V26, P4206, DOI 10.1523/JNEUROSCI.0496-06.2006; Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; ARIEL M, 1991, VISUAL NEUROSCI, V7, P431, DOI 10.1017/S095252380000972X; Bai X, 2009, NEUROSCIENCE, V162, P184, DOI 10.1016/j.neuroscience.2009.04.060; Billups D, 2002, J PHYSIOL-LONDON, V545, P183, DOI 10.1113/jphysiol.2002.024877; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; BONAVENTURE N, 1992, VISION RES, V32, P601, DOI 10.1016/0042-6989(92)90176-J; BUHL EH, 1986, J COMP NEUROL, V253, P163, DOI 10.1002/cne.902530204; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; COLLEWIJN H, 1975, BRAIN RES, V100, P489, DOI 10.1016/0006-8993(75)90154-7; DANN JF, 1987, J COMP NEUROL, V262, P141, DOI 10.1002/cne.902620111; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; Distler C, 2011, OXFORD HDB EYE MOVEM, P65; Emran F, 2007, P NATL ACAD SCI USA, V104, P19126, DOI 10.1073/pnas.0709337104; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Farajian R, 2011, J PHYSIOL-LONDON, V589, P4473, DOI 10.1113/jphysiol.2011.213371; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; Gavrikov KE, 2006, P NATL ACAD SCI USA, V103, P18793, DOI 10.1073/pnas.0604551103; Geffen MN, 2007, PLOS BIOL, V5, P640, DOI 10.1371/journal.pbio.0050065; GRASSE KL, 1990, VISUAL NEUROSCI, V4, P605, DOI 10.1017/S0952523800005800; GRASSE KL, 1984, EXP BRAIN RES, V55, P69; Harvey RJ, 1997, VISION RES, V37, P1615, DOI 10.1016/S0042-6989(96)00292-1; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; HOFFMANN KP, 1985, EXP BRAIN RES, V59, P395; HOFFMANN KP, 1991, J COMP NEUROL, V313, P707, DOI 10.1002/cne.903130413; HOLLANDER H, 1979, J COMP NEUROL, V184, P783, DOI 10.1002/cne.901840410; Hoshi H, 2011, J COMP NEUROL, V519, P2509, DOI 10.1002/cne.22678; Ibbotson MR, 2002, EXP BRAIN RES, V147, P80, DOI 10.1007/s00221-002-1215-5; Ibbotson MR, 2001, J NEUROPHYSIOL, V86, P997, DOI 10.1152/jn.2001.86.2.997; Kanjhan R, 2010, NEUROSCI LETT, V483, P105, DOI 10.1016/j.neulet.2010.07.071; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; KITTILA CA, 1995, J NEUROPHYSIOL, V73, P703, DOI 10.1152/jn.1995.73.2.703; KLAUER S, 1990, EXP BRAIN RES, V83, P178; KNAPP AG, 1988, J NEUROPHYSIOL, V60, P1010, DOI 10.1152/jn.1988.60.3.1010; Kogo N, 1998, J NEUROSCI, V18, P2673; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; LUI F, 1994, J COMP NEUROL, V344, P598, DOI 10.1002/cne.903440408; Miller RF, 2008, INVEST OPHTH VIS SCI, V49, P5184, DOI 10.1167/iovs.08-2456; Moore BD, 2011, NEURON, V71, P812, DOI 10.1016/j.neuron.2011.06.025; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; OYSTER CW, 1980, J COMP NEUROL, V190, P49, DOI 10.1002/cne.901900105; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; Renteria RC, 2006, J NEUROSCI, V26, P11857, DOI 10.1523/JNEUROSCI.1718-06.2006; Reymond E, 1990, P AUST NEUROSCI ASS, V1, P122; ROSENBERG AF, 1991, J NEUROPHYSIOL, V65, P1022, DOI 10.1152/jn.1991.65.5.1022; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; SCHMIDT M, 1993, J COMP NEUROL, V330, P147, DOI 10.1002/cne.903300202; Sha O., 2006, Neuroembryology and Aging, V4, P183, DOI 10.1159/000118928; SIMPSON JI, 1984, ANNU REV NEUROSCI, V7, P13, DOI 10.1146/annurev.ne.07.030184.000305; Taylor WR, 2002, J NEUROSCI, V22, P7712; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; VOLCHAN E, 1989, EXP BRAIN RES, V78, P380; Yang G, 1990, P AUST NEUROSCI ASS, V1, P142; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; YUCEL YH, 1989, VISUAL NEUROSCI, V2, P357, DOI 10.1017/S0952523800002169; Zhou ZJ, 2008, J PHYSIOL-LONDON, V586, P4371, DOI 10.1113/jphysiol.2008.159020	61	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44724	10.1371/journal.pone.0044724	http://dx.doi.org/10.1371/journal.pone.0044724			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970298	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400113
J	Sun, LG; Zhou, X; Wang, YH; Cheng, WH; Jia, N				Sun, Liguang; Zhou, Xin; Wang, Yuhong; Cheng, Wenhan; Jia, Nan			Identification of Paleo-Events Recorded in the Yellow Sea Sediments by Sorting Coefficient of Grain Size	PLOS ONE			English	Article							CHINESE LOESS; RIVER; MUD	Identification of natural and anthropogenic events in the past is important for studying their patterns and mechanisms; and sensitive proxies in marine sediments are more reliable for identifying these events than those in terrestrial sediments, which are usually disturbed by human activities. Since the main source materials for the sediments in the Northern Yellow Sea Mud are transported by the Yellow River, sedimentary characteristics can be used to reconstruct the historical events that occurred in the Yellow River Valley. In the present study, by analyzing sorting coefficient of grain size in a 250-year sediment core from the Northern Yellow Sea Mud, we identified several major historical events: the Haiyuan Earthquake in AD 1920 and several times of relocation of the Yellow River estuary. The proxy has the potential of detecting and reconstructing historical events; in combination with historical archives, they also provide an accurate dating method.	[Sun, Liguang; Zhou, Xin; Cheng, Wenhan; Jia, Nan] Univ Sci & Technol China, Inst Polar Environm, Hefei 230026, Peoples R China; [Sun, Liguang; Zhou, Xin; Cheng, Wenhan; Jia, Nan] Univ Sci & Technol China, Sch Earth & Space Sci, Hefei 230026, Peoples R China; [Wang, Yuhong] Ningbo Univ, Adv Management Res Ctr, Ningbo 315211, Zhejiang, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Ningbo University	Sun, LG (corresponding author), Univ Sci & Technol China, Inst Polar Environm, Hefei 230026, Peoples R China.	slg@ustc.edu.cn		Zhou, Xin/0000-0003-2640-6431	National Basic Research Program of China [2010CB428902]	National Basic Research Program of China(National Basic Research Program of China)	This study is supported by the National Basic Research Program of China (2010CB428902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleby P.C., 2002, TRACKING ENV CHANGE, P171, DOI [DOI 10.1007/0-306-47669-X_9, 10.1007/0-306-47669-X_9]; Central Meteorological Bureau of China, 1981, YEARL CHARTS DRYN WE; Close U., 1922, NATL GEOGR MAG, V41, P445; D'Arrigo R, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022271; Folk R.L., 1957, J SEDIMENT RES, V27, P3, DOI [10.1306/74D70646-2B21-11D7-8648000102C1865D, DOI 10.1306/74D70646-2B21-11D7-8648000102C1865D, 10.1306/74d70646-2b21-11d7-8648000102c1865]; Gao W, 1997, J SEDIMENT RES, P1; [郭其蕴 Guo Qiyun], 2004, [大气科学, Chinese Journal of Atmospheric Sciences], V28, P206; KUKLA G, 1987, QUATERNARY SCI REV, V6, P191, DOI 10.1016/0277-3791(87)90004-7; [李凤业 Li Fengye], 2002, [海洋与湖沼, Oceanolgia et Limnologia Sinica], V33, P364; [刘健 Liu Jian], 2007, [第四纪研究, Quaternary Sciences], V27, P1031; Liu TS, 1998, ANNU REV EARTH PL SC, V26, P111, DOI 10.1146/annurev.earth.26.1.111; Luo C.Z., 1996, FLOODS CHINA; Peng SZ, 2001, SCI CHINA SER D, V44, P261, DOI 10.1007/BF02911995; [齐君 Qi Jun], 2004, [海洋地质与第四纪地质, Marine Geology & Quaternary Geology], V24, P9; Qiao SQ, 2011, CONT SHELF RES, V31, P1336, DOI 10.1016/j.csr.2011.05.007; Shen S.X., 1996, OCEANLOLGIA LIMNOLOG, V27, P518; Shi CX, 2005, GEOGR ANN A, V87A, P461, DOI 10.1111/j.0435-3676.2005.00271.x; Sun Y, 2006, PALAEOGEOGR PALAEOCL, V241, P129, DOI 10.1016/j.palaeo.2006.06.018; Tang K, 1994, YELLOW RIVER, P13; The Ministry of Water Resources of the People's Republic of China, 2010, SPEC RIV SED B 2009; Trask P. D., 1932, ORIGIN ENV SOURCE SE; Xiang R, 2006, SCI CHINA SER D, V49, P604, DOI 10.1007/s11430-006-0604-1; Xiao SB, 2005, CHINESE SCI BULL, V50, P466, DOI 10.1360/03wd0571; Xie Z, 2011, J HOHAI U PHILOS SOC, V13, P15; Yang WF, 2009, MAR POLLUT BULL, V58, P923, DOI 10.1016/j.marpolbul.2009.03.019; Yang ZS, 2007, MAR GEOL, V240, P169, DOI 10.1016/j.margeo.2007.02.008; ZHANG J, 1990, J HYDROL, V120, P203, DOI 10.1016/0022-1694(90)90150-V; Zhang Z., 1995, GEO J, V36, P269, DOI DOI 10.1007/BF00813183	28	8	8	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44725	10.1371/journal.pone.0044725	http://dx.doi.org/10.1371/journal.pone.0044725			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970299	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400114
J	Hause, RJ; Leung, KK; Barkinge, JL; Ciaccio, MF; Chuu, CP; Jones, RB				Hause, Ronald J., Jr.; Leung, Kin K.; Barkinge, John L.; Ciaccio, Mark F.; Chuu, Chih-pin; Jones, Richard B.			Comprehensive Binary Interaction Mapping of SH2 Domains via Fluorescence Polarization Reveals Novel Functional Diversification of ErbB Receptors	PLOS ONE			English	Article							TYROSINE PHOSPHORYLATION; BINDING; SRC; GENE; RECRUITMENT; EXPRESSION; SITES; PHOSPHOPEPTIDES; OVEREXPRESSION; SELECTIVITY	First-generation interaction maps of Src homology 2 (SH2) domains with receptor tyrosine kinase (RTK) phosphosites have previously been generated using protein microarray (PM) technologies. Here, we developed a large-scale fluorescence polarization (FP) methodology that was able to characterize interactions between SH2 domains and ErbB receptor phosphosites with higher fidelity and sensitivity than was previously achieved with PMs. We used the FP assay to query the interaction of synthetic phosphopeptides corresponding to 89 ErbB receptor intracellular tyrosine sites against 93 human SH2 domains and 2 phosphotyrosine binding (PTB) domains. From 358,944 polarization measurements, the affinities for 1,405 unique biological interactions were determined, 83% of which are novel. In contrast to data from previous reports, our analyses suggested that ErbB2 was not more promiscuous than the other ErbB receptors. Our results showed that each receptor displays unique preferences in the affinity and location of recruited SH2 domains that may contribute to differences in downstream signaling potential. ErbB1 was enriched versus the other receptors for recruitment of domains from RAS GEFs whereas ErbB2 was enriched for recruitment of domains from tyrosine and phosphatidyl inositol phosphatases. ErbB3, the kinase inactive ErbB receptor family member, was predictably enriched for recruitment of domains from phosphatidyl inositol kinases and surprisingly, was enriched for recruitment of domains from tyrosine kinases, cytoskeletal regulatory proteins, and RHO GEFs but depleted for recruitment of domains from phosphatidyl inositol phosphatases. Many novel interactions were also observed with phosphopeptides corresponding to ErbB receptor tyrosines not previously reported to be phosphorylated by mass spectrometry, suggesting the existence of many biologically relevant RTK sites that may be phosphorylated but below the detection threshold of standard mass spectrometry procedures. This dataset represents a rich source of testable hypotheses regarding the biological mechanisms of ErbB receptors.	[Hause, Ronald J., Jr.; Barkinge, John L.; Jones, Richard B.] Univ Chicago, Comm Genet Gen & Syst Biol, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Hause, Ronald J., Jr.; Leung, Kin K.; Barkinge, John L.; Ciaccio, Mark F.; Jones, Richard B.] Univ Chicago, Inst Genom & Syst Biol, Gwen & Jules Knapp Ctr Biomed Discovery, Chicago, IL 60637 USA; [Leung, Kin K.; Jones, Richard B.] Univ Chicago, Comm Canc Biol, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Ciaccio, Mark F.; Jones, Richard B.] Univ Chicago, Comm Cellular & Mol Physiol, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Chuu, Chih-pin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan; [Chuu, Chih-pin] Natl Hlth Res Inst, Translat Ctr Glandular Malignancies, Miaoli, Taiwan	University of Chicago; University of Chicago; University of Chicago; University of Chicago; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Hause, RJ (corresponding author), Univ Chicago, Comm Genet Gen & Syst Biol, Ben May Dept Canc Res, Chicago, IL 60637 USA.	rbjones@uchicago.edu	Chuu, Chih-Pin/B-1086-2010; Chuu, Chih-Pin/N-6697-2019	Hause, Ronald/0000-0002-5229-7366	Cancer Research Foundation; Illinois Department of Health; National Institutes of Health Postdoctoral Cardiovascular Training Grant; NIH Cancer Biology Postdoctoral Training Grant; NIH Cancer Biology Predoctoral Training grant; NIH Genetics and Regulation Predoctoral Training Grant; NIH Systems Biology of Oxygen Predoctoral Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197] Funding Source: NIH RePORTER	Cancer Research Foundation; Illinois Department of Health; National Institutes of Health Postdoctoral Cardiovascular Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Cancer Biology Postdoctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Cancer Biology Predoctoral Training grant; NIH Genetics and Regulation Predoctoral Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Systems Biology of Oxygen Predoctoral Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by awards from the Cancer Research Foundation and The Illinois Department of Health. Additional support was provided by National Institutes of Health Postdoctoral Cardiovascular Training Grant (JB), NIH Cancer Biology Postdoctoral Training Grant (CPC), NIH Cancer Biology Predoctoral Training grant (KKL), NIH Genetics and Regulation Predoctoral Training Grant (RJH), and NIH Systems Biology of Oxygen Predoctoral Training Grant (MFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1986, SCIENCE, V232, P1644, DOI 10.1126/science.3012781; ALIMANDI M, 1995, ONCOGENE, V10, P1813; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BIBBINS KB, 1993, MOL CELL BIOL, V13, P7278, DOI 10.1128/MCB.13.12.7278; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Ciaccio MF, 2010, NAT METHODS, V7, P148, DOI [10.1038/nmeth.1418, 10.1038/NMETH.1418]; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; FELDER S, 1993, MOL CELL BIOL, V13, P1449, DOI 10.1128/MCB.13.3.1449; Fiddes RJ, 1998, J BIOL CHEM, V273, P7717, DOI 10.1074/jbc.273.13.7717; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hsieh MY, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-57; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ji QS, 1999, MOL CELL BIOL, V19, P4961; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kaimachnikov NP, 2009, FEBS J, V276, P4102, DOI 10.1111/j.1742-4658.2009.07117.x; Kaushansky A, 2008, CHEM BIOL, V15, P808, DOI 10.1016/j.chembiol.2008.07.006; Kaushansky A, 2008, MOL BIOSYST, V4, P643, DOI 10.1039/b801018h; Kaushansky A, 2010, NAT PROTOC, V5, P773, DOI 10.1038/nprot.2010.36; KAVANAUGH WM, 1994, SCIENCE, V266, P1862, DOI 10.1126/science.7527937; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KRAUS MH, 1989, P NATL ACAD SCI USA, V86, P9193, DOI 10.1073/pnas.86.23.9193; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; LEMMON MA, 1994, BIOCHEMISTRY-US, V33, P5070, DOI 10.1021/bi00183a010; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Liu BA, 2010, MOL CELL PROTEOMICS, V9, P2391, DOI 10.1074/mcp.M110.001586; Lubman OY, 2003, J MOL BIOL, V328, P655, DOI 10.1016/S0022-2836(03)00344-9; Lynch BA, 1997, ANAL BIOCHEM, V247, P77, DOI 10.1006/abio.1997.2042; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; PANAYOTOU G, 1993, MOL CELL BIOL, V13, P3567, DOI 10.1128/MCB.13.6.3567; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; PLOWMAN GD, 1993, NATURE, V366, P473, DOI 10.1038/366473a0; PLOWMAN GD, 1990, P NATL ACAD SCI USA, V87, P4905, DOI 10.1073/pnas.87.13.4905; Ritz C, 2005, J STAT SOFTW, V12, P1; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12; Shalloway D, 1997, TRENDS CELL BIOL, V7, P215; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Stiffler MA, 2006, J AM CHEM SOC, V128, P5913, DOI 10.1021/ja060943h; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Sundvall M, 2010, MOL BIOL CELL, V21, P4275, DOI 10.1091/mbc.E10-04-0332; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; YAMAMOTO T, 1986, NATURE, V319, P230, DOI 10.1038/319230a0; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	55	42	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44471	10.1371/journal.pone.0044471	http://dx.doi.org/10.1371/journal.pone.0044471			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973453	Green Submitted, Green Published, gold			2022-12-25	WOS:000308577600059
J	Bhandari, RK; Haque, MM; Skinner, MK				Bhandari, Ramji K.; Haque, Md. M.; Skinner, Michael K.			Global Genome Analysis of the Downstream Binding Targets of Testis Determining Factor SRY and SOX9	PLOS ONE			English	Article							SEX-DETERMINING REGION; GONADAL DEVELOPMENT; EMBRYONIC TESTIS; Y-CHROMOSOME; IN-VIVO; GENE; MICE; DIFFERENTIATION; TRANSCRIPTION; PROTEIN	A major event in mammalian male sex determination is the induction of the testis determining factor Sry and its downstream gene Sox9. The current study provides one of the first genome wide analyses of the downstream gene binding targets for SRY and SOX9 to help elucidate the molecular control of Sertoli cell differentiation and testis development. A modified ChIP-Chip analysis using a comparative hybridization was used to identify 71 direct downstream binding targets for SRY and 109 binding targets for SOX9. Interestingly, only 5 gene targets overlapped between SRY and SOX9. In addition to the direct response element binding gene targets, a large number of atypical binding gene targets were identified for both SRY and SOX9. Bioinformatic analysis of the downstream binding targets identified gene networks and cellular pathways potentially involved in the induction of Sertoli cell differentiation and testis development. The specific DNA sequence binding site motifs for both SRY and SOX9 were identified. Observations provide insights into the molecular control of male gonadal sex determination.	[Bhandari, Ramji K.; Haque, Md. M.; Skinner, Michael K.] Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University	Bhandari, RK (corresponding author), Washington State Univ, Sch Biol Sci, Ctr Reprod Biol, Pullman, WA 99164 USA.	skinner@wsu.edu		Bhandari, Ramji/0000-0001-5608-7254	United States National Institutes of Health	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a United States National Institutes of Health grant to MKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Bhandari RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019935; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bowles J, 2010, DEV CELL, V19, P440, DOI 10.1016/j.devcel.2010.08.010; Bradford ST, 2009, BIOL REPROD, V80, P1178, DOI 10.1095/biolreprod.108.071480; Clement TM, 2007, REPRODUCTION, V134, P455, DOI 10.1530/REP-06-0341; Clement TM, 2011, BIOL REPROD, V85, P277, DOI 10.1095/biolreprod.110.090282; Cui SY, 2004, DEVELOPMENT, V131, P4095, DOI 10.1242/dev.01266; Cupp AS, 2003, BIOL REPROD, V68, P2033, DOI 10.1095/biolreprod.102.012617; daSilva SM, 1996, NAT GENET, V14, P62, DOI 10.1038/ng0996-62; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; DiNapoli L, 2008, MOL ENDOCRINOL, V22, P1, DOI 10.1210/me.2007-0250; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Guerrero-Bosagna C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013100; Hardle W, 1977, APPL STAT, V44, P258; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; JOST A, 1970, PHILOS T ROY SOC B, V259, P119, DOI 10.1098/rstb.1970.0052; JOST A, 1953, RECENT PROG HORM RES, V8, P379; JOST A, 1947, ARCH ANAT MICROSC MO, V36, P244; Kashimada K, 2011, FASEB J, V25, P3561, DOI 10.1096/fj.11-184333; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kim Y, 2007, P NATL ACAD SCI USA, V104, P16558, DOI 10.1073/pnas.0702581104; Kim Y, 2006, DEV DYNAM, V235, P2292, DOI 10.1002/dvdy.20894; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Levine E, 2000, BIOL REPROD, V62, P132, DOI 10.1095/biolreprod62.1.132; Levine E, 2000, BIOL REPROD, V62, P477, DOI 10.1095/biolreprod62.3.477; MCELREAVEY K, 1993, P NATL ACAD SCI USA, V90, P3368, DOI 10.1073/pnas.90.8.3368; Murphy M, 2010, AUK, V127, P1, DOI 10.1525/auk.2010.127.1.1; Nef Serge, 2009, Journal of Biology (London), V8, P74, DOI 10.1186/jbiol173; Nilsson EE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011637; O'Neill LP, 2006, NAT GENET, V38, P835, DOI 10.1038/ng1820; Ohe K, 2002, P NATL ACAD SCI USA, V99, P1146, DOI 10.1073/pnas.022645899; Ohno S, 1979, Recent Prog Horm Res, V35, P449; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PAGE DC, 1987, NATURE, V328, P437, DOI 10.1038/328437a0; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Schmahl J, 2004, DEVELOPMENT, V131, P3627, DOI 10.1242/dev.01239; Sekido R, 2004, DEV BIOL, V274, P271, DOI 10.1016/j.ydbio.2004.07.011; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Small CL, 2005, BIOL REPROD, V72, P492, DOI 10.1095/biolreprod.104.033696; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Thevenet L, 2005, J BIOL CHEM, V280, P38625, DOI 10.1074/jbc.M504127200; Toedling J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-221; Tukey JW, 1977, EXPLORATORY DATA ANA; WACHTEL SS, 1975, NATURE, V257, P235, DOI 10.1038/257235a0; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006	51	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43380	10.1371/journal.pone.0043380	http://dx.doi.org/10.1371/journal.pone.0043380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984422	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500012
J	Caliman, A; Carneiro, LS; Leal, JJF; Farjalla, VF; Bozelli, RL; Esteves, FA				Caliman, Adriano; Carneiro, Luciana S.; Leal, Joao J. F.; Farjalla, Vinicius F.; Bozelli, Reinaldo L.; Esteves, Francisco A.			Community Biomass and Bottom up Multivariate Nutrient Complementarity Mediate the Effects of Bioturbator Diversity on Pelagic Production	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; SPECIES-RICHNESS; FRESH-WATER; BIOGEOCHEMICAL PROCESSES; HABITAT STRUCTURE; BIODIVERSITY LOSS; MARINE-SEDIMENTS; PLANT DIVERSITY; COASTAL LAGOONS; DENSITY	Tests of the biodiversity and ecosystem functioning (BEF) relationship have focused little attention on the importance of interactions between species diversity and other attributes of ecological communities such as community biomass. Moreover, BEF research has been mainly derived from studies measuring a single ecosystem process that often represents resource consumption within a given habitat. Focus on single processes has prevented us from exploring the characteristics of ecosystem processes that can be critical in helping us to identify how novel pathways throughout BEF mechanisms may operate. Here, we investigated whether and how the effects of biodiversity mediated by non-trophic interactions among benthic bioturbator species vary according to community biomass and ecosystem processes. We hypothesized that (1) bioturbator biomass and species richness interact to affect the rates of benthic nutrient regeneration [dissolved inorganic nitrogen (DIN) and total dissolved phosphorus (TDP)] and consequently bacterioplankton production (BP) and that (2) the complementarity effects of diversity will be stronger on BP than on nutrient regeneration because the former represents a more integrative process that can be mediated by multivariate nutrient complementarity. We show that the effects of bioturbator diversity on nutrient regeneration increased BP via multivariate nutrient complementarity. Consistent with our prediction, the complementarity effects were significantly stronger on BP than on DIN and TDP. The effects of the biomass-species richness interaction on complementarity varied among the individual processes, but the aggregated measures of complementarity over all ecosystem processes were significantly higher at the highest community biomass level. Our results suggest that the complementarity effects of biodiversity can be stronger on more integrative ecosystem processes, which integrate subsidiary "simpler" processes, via multivariate complementarity. In addition, reductions in community biomass may decrease the strength of interspecific interactions so that the enhanced effects of biodiversity on ecosystem processes can disappear well before species become extinct.	[Caliman, Adriano; Carneiro, Luciana S.; Leal, Joao J. F.; Farjalla, Vinicius F.; Bozelli, Reinaldo L.; Esteves, Francisco A.] Univ Fed Rio de Janeiro, CCS, Inst Biol, Dept Ecol, Rio De Janeiro, Brazil; [Leal, Joao J. F.] Ctr Fed Educ Tecnol Quim, Rio De Janeiro, Brazil; [Esteves, Francisco A.] Nucleo Pesquisas Ecol & Desenvolvimento Socio Amb, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Caliman, A (corresponding author), Univ Fed Rio Grande do Norte, Ctr Biociencias, Dept Bot Ecol & Zool, BR-59072970 Natal, RN, Brazil.	caliman@cb.ufrn.br	Caliman, Adriano/A-8668-2008; Bozelli, Reinaldo/S-6414-2019; Bozelli, Reinaldo L/G-1805-2012; Farjalla, Vinicius F/V-4351-2019; Farjalla, Vinicius/G-4945-2010	Caliman, Adriano/0000-0001-9218-5601; Bozelli, Reinaldo L/0000-0001-9916-1629; Farjalla, Vinicius F/0000-0003-4084-5983; Farjalla, Vinicius/0000-0003-4084-5983	Brazilian Council of Research and Technology (CNPq); Coordination for the Improvement of Higher Level Education (CAPES)	Brazilian Council of Research and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Level Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants and scholarships provided by Brazilian Council of Research and Technology (CNPq-www.cnpq.br) and Coordination for the Improvement of Higher Level Education (CAPES-www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DC, 2011, ECOLOGY, V92, P1013, DOI 10.1890/i0012-9658-92-5-1013; Aller RC, 1998, DEEP-SEA RES PT I, V45, P133, DOI 10.1016/S0967-0637(97)00049-6; Alves JM, 2010, AQUAT ECOL, V44, P421, DOI 10.1007/s10452-009-9302-3; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bengtsson J, 1998, APPL SOIL ECOL, V10, P191, DOI 10.1016/S0929-1393(98)00120-6; Biles CL, 2003, J EXP MAR BIOL ECOL, V285, P165, DOI 10.1016/S0022-0981(02)00525-7; Biles CL, 2002, HYDROL EARTH SYST SC, V6, P999, DOI 10.5194/hess-6-999-2002; Bozelli RL, 2009, LIMNOLOGICA, V39, P306, DOI 10.1016/j.limno.2009.06.004; Bracken MES, 2006, ECOLOGY, V87, P2397, DOI 10.1890/0012-9658(2006)87[2397:SDENUV]2.0.CO;2; Bulling MT, 2010, PHILOS T R SOC B, V365, P2107, DOI 10.1098/rstb.2010.0022; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Caliman A, 2010, BRAZ J BIOL, V70, P803, DOI 10.1590/S1519-69842010000400011; Caliman A, 2009, THESIS U FEDERAL RIO; Caliman A, 2007, J N AM BENTHOL SOC, V26, P450, DOI 10.1899/06-050.1; Caliman A, 2011, OIKOS, V120, P1639, DOI 10.1111/j.1600-0706.2011.19362.x; Caliman A, 2010, BIODIVERS CONSERV, V19, P651, DOI 10.1007/s10531-009-9725-0; CALLISTO M, 1998, ECOLOGIA LAGOAS COST, P479; Cardinale BJ, 2004, OIKOS, V104, P437, DOI 10.1111/j.0030-1299.2004.13254.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Cottingham KL, 2005, FRONT ECOL ENVIRON, V3, P145, DOI 10.1890/1540-9295(2005)003[0145:KWTDTL]2.0.CO;2; Covich AP, 2004, BIOSCIENCE, V54, P767, DOI 10.1641/0006-3568(2004)054[0767:TROBIT]2.0.CO;2; De Haas EM, 2005, FRESHWATER BIOL, V50, P770, DOI 10.1111/j.1365-2427.2005.01356.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Duffy JE, 2009, FRONT ECOL ENVIRON, V7, P437, DOI 10.1890/070195; Duffy JE, 2003, ECOL LETT, V6, P637; Emmerson MC, 2001, NATURE, V411, P73, DOI 10.1038/35075055; Esteves FA, 2008, BRAZ J BIOL, V68, P967, DOI 10.1590/S1519-69842008000500006; Farjalla V. F., 2006, Braz. J. Biol., V66, P383, DOI 10.1590/S1519-69842006000300002; Figueiredo-Barros MP, 2006, ESTUAR COAST SHELF S, V69, P87, DOI 10.1016/j.ecss.2006.03.023; Figueiredo-Barros MP, 2009, CAN J FISH AQUAT SCI, V66, P1649, DOI 10.1139/F09-111; Flecker AS, 1999, COPEIA, P495, DOI 10.2307/1447498; Gamfeldt L, 2008, INT REV HYDROBIOL, V93, P550, DOI 10.1002/iroh.200711022; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Gilbertson WW, 2012, FEMS MICROBIOL ECOL; Giller PS, 2004, OIKOS, V104, P423, DOI 10.1111/j.0030-1299.2004.13253.x; Godbold JA, 2011, P ROY SOC B-BIOL SCI, V278, P2510, DOI 10.1098/rspb.2010.2414; Godbold JA, 2009, MAR ECOL PROG SER, V396, P273, DOI 10.3354/meps08401; Golterman HL, 1978, METHODS PHYS CHEM AN; Gotelli NJ, 2013, ECOSIMR 1 00; GRANELI W, 1979, HYDROBIOLOGIA, V66, P149, DOI 10.1007/BF00032045; Griffin JN, 2008, ECOLOGY, V89, P298, DOI 10.1890/07-1220.1; Griffiths GJK, 2008, ECOLOGY, V89, P2986, DOI 10.1890/08-0685.1; GUREVITCH J, 1992, AM NAT, V140, P539, DOI 10.1086/285428; He JS, 2005, BASIC APPL ECOL, V6, P505, DOI 10.1016/j.baae.2005.04.002; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; Hiddink JG, 2009, OIKOS, V118, P1892, DOI 10.1111/j.1600-0706.2009.17556.x; Hillebrand H, 2009, ECOL LETT, V12, P1405, DOI 10.1111/j.1461-0248.2009.01388.x; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Ieno EN, 2006, MAR ECOL PROG SER, V311, P263, DOI 10.3354/meps311263; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Jolliffe PA, 2000, J ECOL, V88, P371, DOI 10.1046/j.1365-2745.2000.00470.x; Kristensen E, 2000, HYDROBIOLOGIA, V426, P1, DOI 10.1023/A:1003980226194; Kristensen E, 2012, MAR ECOL PROG SER, V446, P285, DOI 10.3354/meps09506; Leal JJF, 2003, INT REV HYDROBIOL, V88, P167, DOI 10.1002/iroh.200390012; Lohrer AM, 2004, NATURE, V431, P1092, DOI 10.1038/nature03042; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Maestre FT, 2012, J ECOL, V100, P317, DOI 10.1111/j.1365-2745.2011.01918.x; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Marinelli RL, 2003, ESTUAR COAST SHELF S, V57, P179, DOI 10.1016/S0272-7714(02)00342-6; Marquard E, 2009, J ECOL, V97, P696, DOI 10.1111/j.1365-2745.2009.01521.x; Massol F, 2011, ECOL LETT, V14, P313, DOI 10.1111/j.1461-0248.2011.01588.x; Mermillod-Blondin F, 2005, J EXP MAR BIOL ECOL, V315, P187, DOI 10.1016/j.jembe.2004.09.013; Mermillod-Blondin F, 2006, AQUAT SCI, V68, P434, DOI 10.1007/s00027-006-0858-x; Mermillod-Blondin F, 2011, J N AM BENTHOL SOC, V30, P770, DOI 10.1899/10-121.1; Meysman FJR, 2006, TRENDS ECOL EVOL, V21, P688, DOI 10.1016/j.tree.2006.08.002; Moore JW, 2006, BIOSCIENCE, V56, P237, DOI 10.1641/0006-3568(2006)056[0237:AEEIS]2.0.CO;2; Mouillot D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017476; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Palmer MA, 2000, BIOSCIENCE, V50, P1062, DOI 10.1641/0006-3568(2000)050[1062:LBASBA]2.0.CO;2; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Peter H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023225; Peter H, 2011, ISME J, V5, P351, DOI 10.1038/ismej.2010.119; Raffaelli DG, 2006, MAR ECOL PROG SER, V311, P285, DOI 10.3354/meps311285; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Reiss J, 2009, TRENDS ECOL EVOL, V24, P505, DOI 10.1016/j.tree.2009.03.018; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Rosenfeld JS, 2002, CONSERV BIOL, V16, P837, DOI 10.1046/j.1523-1739.2002.01080.x; Schindler DE, 2002, OIKOS, V98, P177, DOI 10.1034/j.1600-0706.2002.980201.x; Schmid B, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P61; Schmitz OJ, 2008, ECOLOGY, V89, P2436, DOI 10.1890/07-1030.1; SIMON M, 1989, MAR ECOL PROG SER, V51, P201, DOI 10.3354/meps051201; Smith David C., 1992, Marine Microbial Food Webs, V6, P107; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Stief P, 2006, ECOLOGY, V87, P3152, DOI 10.1890/0012-9658(2006)87[3152:TIEOPF]2.0.CO;2; Sundareshwar PV, 2003, SCIENCE, V299, P563, DOI 10.1126/science.1079100; Sundback K, 2003, MAR ECOL PROG SER, V246, P115, DOI 10.3354/meps246115; Teal LR, 2008, AQUAT BIOL, V2, P207, DOI 10.3354/ab00052; Teal LR, 2010, MAR ECOL PROG SER, V414, P27, DOI 10.3354/meps08736; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Vaughn CC, 2010, BIOSCIENCE, V60, P25, DOI 10.1525/bio.2010.60.1.7; Waldbusser GG, 2004, LIMNOL OCEANOGR, V49, P1482, DOI 10.4319/lo.2004.49.5.1482; WHITING GJ, 1993, NATURE, V364, P794, DOI 10.1038/364794a0; Wootton JT, 2005, ANNU REV ECOL EVOL S, V36, P419, DOI 10.1146/annurev.ecolsys.36.091704.175535; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	101	4	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44925	10.1371/journal.pone.0044925	http://dx.doi.org/10.1371/journal.pone.0044925			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984586	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500095
J	Josse, AR; Garcia-Bailo, B; Fischer, K; El-Sohemy, A				Josse, Andrea R.; Garcia-Bailo, Bibiana; Fischer, Karina; El-Sohemy, Ahmed			Novel Effects of Hormonal Contraceptive Use on the Plasma Proteome	PLOS ONE			English	Article							DOSE ORAL-CONTRACEPTIVES; RISK-FACTORS; CARDIOVASCULAR-DISEASE; CLINICAL PROTEOMICS; VITAMIN-C; HEALTH; POPULATION; BENEFITS; METAANALYSIS; ASSOCIATION	Background: Hormonal contraceptive (HC) use may increase cardiometabolic risk; however, the effect of HC on emerging cardiometabolic and other disease risk factors is not clear. Objectives: To determine the association between HC use and plasma proteins involved in established and emerging disease risk pathways. Method: Concentrations of 54 high-abundance plasma proteins were measured simultaneously by LC-MRM/MS in 783 women from the Toronto Nutrigenomics and Health Study. C-reactive protein (CRP) was measured separately. ANCOVA was used to test differences in protein concentrations between users and non-users, and among HC users depending on total hormone dose. Linear regression was used to test the association between duration (years) of HC use and plasma protein concentrations. Principal components analysis (PCA) was used to identify plasma proteomic profiles in users and non-users. Results: After Bonferroni correction, 19 proteins involved in inflammation, innate immunity, coagulation and blood pressure regulation were significantly different between users and non-users (P<0.0009). These differences were replicated across three distinct ethnocultural groups. Traditional markers of glucose and lipid metabolism were also significantly higher among HC users. Neither hormone dose nor duration of use affected protein concentrations. PCA identified 4 distinct proteomic profiles in users and 3 in non-users. Conclusion: HC use was associated with different concentrations of plasma proteins along various disease-related pathways, and these differences were present across different ethnicities. Aside from the known effect of HC on traditional biomarkers of cardiometabolic risk, HC use also affects numerous proteins that may be biomarkers of dysregulation in inflammation, coagulation and blood pressure.	[Josse, Andrea R.; Garcia-Bailo, Bibiana; Fischer, Karina; El-Sohemy, Ahmed] Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada; [Fischer, Karina] ETH, Dept Agr & Food Sci, Inst Food Nutr & Hlth, Zurich, Switzerland	University of Toronto; Swiss Federal Institutes of Technology Domain; ETH Zurich	Josse, AR (corresponding author), Univ Toronto, Fac Med, Dept Nutr Sci, Toronto, ON, Canada.	a.el.sohemy@utoronto.ca		Josse, Andrea/0000-0002-7247-9466; El-Sohemy, Ahmed/0000-0002-8877-6414	Advanced Food and Materials Network (AFMNet); Canadian Institutes of Health Research (CIHR); Canadian Diabetes Association (CDA) Post-Doctoral fellowships; Ontario Graduate Scholarship; Canada Research Chair in Nutrigenomics	Advanced Food and Materials Network (AFMNet); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association (CDA) Post-Doctoral fellowships; Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canada Research Chair in Nutrigenomics	Funding for the research was obtained from the Advanced Food and Materials Network (AFMNet). ARJ is funded by Canadian Institutes of Health Research (CIHR) and Canadian Diabetes Association (CDA) Post-Doctoral fellowships; BGB is funded by an Ontario Graduate Scholarship; AES is supported by a Canada Research Chair in Nutrigenomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2005, J PHYSIOL-LONDON, V563, P23, DOI 10.1113/jphysiol.2004.080473; Apweiler R, 2009, CLIN CHEM LAB MED, V47, P724, DOI 10.1515/CCLM.2009.167; Asleh R, 2005, VASC HEALTH RISK MAN, V1, P19, DOI 10.2147/vhrm.1.1.19.58930; Baillargeon JP, 2005, J CLIN ENDOCR METAB, V90, P3863, DOI 10.1210/jc.2004-1958; Baird DT, 2005, HUM REPROD UPDATE, V11, P513, DOI 10.1093/humupd/dmi019; Cahill L, 2009, AM J EPIDEMIOL, V170, P464, DOI 10.1093/aje/kwp156; DeClercq Vanessa, 2008, Cardiovascular & Hematological Disorders - Drug Targets, V8, P228, DOI 10.2174/187152908785849080; DELECINANA MA, 2006, CEREBROVASC DIS, V21, P48; Du Y, 2011, J ADOLESCENT HEALTH, V48, P331, DOI 10.1016/j.jadohealth.2011.01.004; Ekmekci OB, 2006, CLIN CHIM ACTA, V368, P77, DOI 10.1016/j.cca.2005.12.015; Fan NJ, 2012, CAN J GASTROENTEROL, V26, P41, DOI 10.1155/2012/645218; Folsom AR, 2001, THROMB HAEMOSTASIS, V86, P366; Foulds HJA, 2012, J HYPERTENS, V30, P359, DOI 10.1097/HJH.0b013e32834f0b86; Frempong BA, 2008, J CLIN ENDOCR METAB, V93, P2097, DOI 10.1210/jc.2007-2599; Garcia-Bailo B, 2012, AM J CLIN NUTR, V95, P352, DOI 10.3945/ajcn.111.022657; Gerszten RE, 2008, AM J PHYSIOL-LUNG C, V295, pL16, DOI 10.1152/ajplung.00044.2008; Gronich N, 2011, CAN MED ASSOC J, V183, pE1319, DOI 10.1503/cmaj.110463; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Haider Z, 2009, BEST PRACT RES CL OB, V23, P249, DOI 10.1016/j.bpobgyn.2008.12.003; Hemingway H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000286; Hortin GL, 2008, CLIN CHEM, V54, P1608, DOI 10.1373/clinchem.2008.108175; Huber JC, 2008, EXPERT OPIN PHARMACO, V9, P2317, DOI 10.1517/14656566.9.13.2317 ; Hurwitz BE, 2009, GYNECOL ENDOCRINOL, V25, P441, DOI 10.1080/09513590902770149; Katayama H, 2009, GENOME MED, V1, DOI 10.1186/gm47; Khader YS, 2003, CONTRACEPTION, V68, P11, DOI 10.1016/S0010-7824(03)00073-8; Kim J.-O., 1978, FACTOR ANAL STAT MET; Kluft C, 2007, CLIMACTERIC, V10, P32, DOI 10.1080/13697130701598548; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Kwok S, 2009, CLIN ENDOCRINOL, V71, P727, DOI 10.1111/j.1365-2265.2009.03580.x; Lear SA, 2012, OBESITY SILVER SPRIN; Levy AP, 2010, ANTIOXID REDOX SIGN, V12, P293, DOI 10.1089/ars.2009.2793; Li GH, 2010, MED RES REV, DOI 31:n/a; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Obisesan K A, 2002, West Afr J Med, V21, P197; Pitteri SJ, 2009, GENOME MED, V1, DOI 10.1186/gm121; Salgado FJ, 2011, ACUTE PHASE PROTEINS AS EARLY NON-SPECIFIC BIOMARKERS OF HUMAN AND VETERINARY DISEASES, P127; Shen YF, 2005, PROTEOMICS, V5, P4034, DOI 10.1002/pmic.200401246; Soska V, 2011, SCAND J CLIN LAB INV, V71, P94, DOI 10.3109/00365513.2011.553240; Williams JK, 2004, INT J FERTIL WOMEN M, V49, P30	41	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45162	10.1371/journal.pone.0045162	http://dx.doi.org/10.1371/journal.pone.0045162			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984625	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500123
J	Lio, P; Angelini, C; De Feis, I; Nguyen, VA				Lio, Pietro; Angelini, Claudia; De Feis, Italia; Viet-Anh Nguyen			Statistical Approaches to Use a Model Organism for Regulatory Sequences Annotation of Newly Sequenced Species	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; SCHIZOSACCHAROMYCES-POMBE; CANDIDA-ALBICANS; CELL-CYCLE; HUMAN GENOME; SITES; YEAST; GENE; EXPRESSION; IDENTIFICATION	A major goal of bioinformatics is the characterization of transcription factors and the transcriptional programs they regulate. Given the speed of genome sequencing, we would like to quickly annotate regulatory sequences in newly-sequenced genomes. In such cases, it would be helpful to predict sequence motifs by using experimental data from closely related model organism. Here we present a general algorithm that allow to identify transcription factor binding sites in one newly sequenced species by performing Bayesian regression on the annotated species. First we set the rationale of our method by applying it within the same species, then we extend it to use data available in closely related species. Finally, we generalise the method to handle the case when a certain number of experiments, from several species close to the species on which to make inference, are available. In order to show the performance of the method, we analyse three functionally related networks in the Ascomycota. Two gene network case studies are related to the G2/M phase of the Ascomycota cell cycle; the third is related to morphogenesis. We also compared the method with MatrixReduce and discuss other types of validation and tests. The first network is well known and provides a biological validation test of the method. The two cell cycle case studies, where the gene network size is conserved, demonstrate an effective utility in annotating new species sequences using all the available replicas from model species. The third case, where the gene network size varies among species, shows that the combination of information is less powerful but is still informative. Our methodology is quite general and could be extended to integrate other high-throughput data from model organisms.	[Lio, Pietro; Viet-Anh Nguyen] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England; [Angelini, Claudia; De Feis, Italia] CNR, Ist Applicaz Calcolo Mauro Picone, I-80125 Naples, Italy	University of Cambridge; Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR)	Lio, P (corresponding author), Univ Cambridge, Comp Lab, Pembroke St, Cambridge CB2 3QG, England.	pl219@cam.ac.uk	DEFEIS, ITALIA/N-7506-2015; Angelini, Claudia/J-4106-2012; Angelini, Claudia/AAL-2555-2020; P. Lió, Pietro Lio/AAV-3358-2021	DEFEIS, ITALIA/0000-0002-3694-8202; Angelini, Claudia/0000-0001-8350-8464; P. Lió, Pietro Lio/0000-0002-0540-5053	Italian Flagships Project "Epigenomics"	Italian Flagships Project "Epigenomics"	We acknowledge the Schizosaccharomyces Japonicus Sequencing Project at Broad Institute of Harvard and MIT (http://www.broad.mit.edu). Claudia Angelini and Italia De Feis acknowledge the Italian Flagships Project "Epigenomics", that partially supported the research.	Angelini C, 2010, LECT NOTES COMPUTER, V6160, P367; Angelini C, 2008, AIP CONF PROC, V1028, P277, DOI 10.1063/1.2965094; Angelini C, 2007, LECT NOTES COMPUT SC, V4447, P1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blanco E, 2006, NUCLEIC ACIDS RES, V34, pD63, DOI 10.1093/nar/gkj116; Brown CT, 2008, METHOD CELL BIOL, V87, P337, DOI 10.1016/S0091-679X(08)00218-5; Conlon EM, 2003, P NATL ACAD SCI USA, V100, P3339, DOI 10.1073/pnas.0630591100; Conlon EM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-247; Cote P, 2009, MOL BIOL CELL, V20, P3363, DOI 10.1091/mbc.E09-03-0210; Dekker N, 2004, MOL BIOL CELL, V15, P3903, DOI 10.1091/mbc.E04-04-0319; Eddy SR, 2005, PLOS BIOL, V3, P95, DOI 10.1371/journal.pbio.0030010; Foat BC, 2005, P NATL ACAD SCI USA, V102, P17675, DOI 10.1073/pnas.0503803102; Geuten K, 2007, SYSTEMATIC BIOL, V56, P609, DOI 10.1080/10635150701499563; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P4795, DOI 10.1073/pnas.0409882102; Martin-Cuadrado AB, 2003, J CELL SCI, V116, P1689, DOI 10.1242/jcs.00377; Martin-Cuadrado AB, 2008, MOL MICROBIOL, V69, P188, DOI 10.1111/j.1365-2958.2008.06275.x; McAuliffe JD, 2005, P NATL ACAD SCI USA, V102, P7900, DOI 10.1073/pnas.0502790102; MINEHART PL, 1992, J BACTERIOL, V174, P1828, DOI 10.1128/jb.174.6.1828-1836.1992; Mulhern SM, 2006, EUKARYOT CELL, V5, P2001, DOI 10.1128/EC.00155-06; Ndamukong I, 2006, THESIS GOTTINGEN; Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018; Nguyen VA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S14; Nye TMW, 2006, BIOINFORMATICS, V22, P117, DOI 10.1093/bioinformatics/bti720; Oliva A, 2005, PLOS BIOL, V3, P1239, DOI 10.1371/journal.pbio.0030225; Pardi F, 2005, PLOS GENET, V1, P672, DOI 10.1371/journal.pgen.0010071; Piazza F, 2005, PHYSICA A, V347, P472, DOI 10.1016/j.physa.2004.08.038; Rajewsky N, 2002, GENOME RES, V12, P298, DOI 10.1101/gr.207502. Article published online before print in January 2002; Robertson AG, 2005, NUCLEIC ACIDS RES, V1, pD68; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Song Y, 2008, MOL BIOL CELL, V19, P5456, DOI 10.1091/mbc.E08-03-0272; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Tadesse MG, 2004, BIOINFORMATICS, V20, P2553, DOI 10.1093/bioinformatics/bth282; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; WEEMS JJ, 1992, CLIN INFECT DIS, V14, P756, DOI 10.1093/clinids/14.3.756; Weirauch MT, 2010, TRENDS GENET, V26, P66, DOI 10.1016/j.tig.2009.12.002; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934	43	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e42489	10.1371/journal.pone.0042489	http://dx.doi.org/10.1371/journal.pone.0042489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984403	gold, Green Submitted, Green Published			2022-12-25	WOS:000308638700006
J	Siddique, MM; Bikman, BT; Wang, LP; Ying, L; Reinhardt, E; Shui, GH; Wenk, MR; Summers, SA				Siddique, Monowarul M.; Bikman, Benjamin T.; Wang, Liping; Ying, Li; Reinhardt, Erin; Shui, Guanghou; Wenk, Markus R.; Summers, Scott A.			Ablation of Dihydroceramide Desaturase Confers Resistance to Etoposide-Induced Apoptosis In Vitro	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; HUMAN GLIOMA-CELLS; CERAMIDE ACCUMULATION; CASPASE-3 ACTIVATION; BIOSYNTHESIS; PROTEIN; PHOSPHATASE; CANCER; STRESS; GROWTH	Sphingolipid biosynthesis is potently upregulated by factors associated with cellular stress, including numerous chemotherapeutics, inflammatory cytokines, and glucocorticoids. Dihydroceramide desaturase 1 (Des1), the third enzyme in the highly conserved pathway driving sphingolipid biosynthesis, introduces the 4,5-trans-double bond that typifies most higher-order sphingolipids. Surprisingly, recent studies have shown that certain chemotherapeutics and other drugs inhibit Des1, giving rise to a number of sphingolipids that lack the characteristic double bond. In order to assess the effect of an altered sphingolipid profile (via Des1 inhibition) on cell function, we generated isogenic mouse embryonic fibroblasts lacking both Des1 alleles. Lipidomic profiling revealed that these cells contained higher levels of dihydroceramide than wildtype fibroblasts and that complex sphingolipids were comprised predominantly of the saturated backbone (e. g. sphinganine vs. sphingosine, dihydrosphingomyelin vs. sphingomyelin, etc.). Des1 ablation activated pro-survival and anabolic signaling intermediates (e.g. Akt/PKB, mTOR, MAPK, etc.) and provided protection from apoptosis caused by etoposide, a chemotherapeutic that induces sphingolipid synthesis by upregulating several sphingolipid biosynthesizing enzymes. These data reveal that the double bond present in most sphingolipids has a profound impact on cell survival pathways, and that the manipulation of Des1 could have important effects on apoptosis.	[Siddique, Monowarul M.; Bikman, Benjamin T.; Ying, Li; Reinhardt, Erin; Summers, Scott A.] Duke Natl Univ Singapore, Program Cardiovasc & Metab Dis, Grad Sch Med, Singapore, Singapore; [Bikman, Benjamin T.] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA; [Wang, Liping; Summers, Scott A.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore	National University of Singapore; Brigham Young University; Duke University; National University of Singapore	Siddique, MM (corresponding author), Duke Natl Univ Singapore, Program Cardiovasc & Metab Dis, Grad Sch Med, Singapore, Singapore.	mobin.siddique@duke-nus.edu.sg; scott.summers@duke-nus.edu.sg	/AAE-5384-2020; Wenk, Markus Rene/D-1441-2014; Bikman, Benjamin/AAT-9606-2021	Li, Ying/0000-0002-6859-7208; Shui, Guanghou/0000-0002-1621-9643	National Medical Research Council [IRG09may004]; National Institutes of Health [R01DK081456-01]; Singapore Ministry of Education Academic Research Fund -NUS Signature Research Program; Agency for Science, Technology and Research, Singapore; Ministry of Health, Singapore; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081456] Funding Source: NIH RePORTER	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore Ministry of Education Academic Research Fund -NUS Signature Research Program(Ministry of Education, SingaporeNational University of Singapore); Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Medical Research Council (IRG09may004); the National Institutes of Health grant R01DK081456-01 (SAS); the Singapore Ministry of Education Academic Research Fund -NUS Signature Research Program funded by the Agency for Science, Technology and Research, Singapore, and the Ministry of Health, Singapore (SAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery K, 2008, STEM CELLS DEV, V17, P1195, DOI 10.1089/scd.2008.0063; Bikman BT, 2012, J BIOL CHEM, V287, P17426, DOI 10.1074/jbc.M112.359950; Cadena DL, 1997, BIOCHEMISTRY-US, V36, P6960, DOI 10.1021/bi970091l; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; Dbaibo GS, 1998, J CLIN INVEST, V102, P329, DOI 10.1172/JCI1180; deChaves EIP, 1997, J BIOL CHEM, V272, P3028, DOI 10.1074/jbc.272.5.3028; Devlin CM, 2011, J BIOL CHEM, V286, P38069, DOI 10.1074/jbc.M111.297994; Dimanche-Boitrel MT, 2011, RECENT PAT ANTI-CANC, V6, P284, DOI 10.2174/157489211796957838; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Fabrias G, 2012, PROG LIPID RES, V51, P82, DOI 10.1016/j.plipres.2011.12.002; Furuya H, 2011, CANCER METAST REV, V30, P567, DOI 10.1007/s10555-011-9304-1; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gomez-Munoz A, 2010, ADV EXP MED BIOL, V688, P118; Gonzalez-Pertusa JA, 2010, ENDOCRINOLOGY, V151, P1487, DOI 10.1210/en.2009-0975; Grandela C, 2008, STEM CELL RES, V1, P116, DOI 10.1016/j.scr.2007.10.003; Hannun YA, 2000, TRENDS CELL BIOL, V10, P73, DOI 10.1016/S0962-8924(99)01694-3; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Hayashi H, 2006, J BIOL CHEM, V281, P1332, DOI 10.1074/jbc.M505905200; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hu W, 2011, J BIOL CHEM, V286, P16596, DOI 10.1074/jbc.M110.186916; Huwiler A, 2006, CURR PHARM DESIGN, V12, P4625, DOI 10.2174/138161206779010422; Idkowiak-Baldys J, 2010, BIOCHEM J, V427, P265, DOI 10.1042/BJ20091589; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1074/jbc.M110629200; Kraveka JM, 2007, J BIOL CHEM, V282, P16718, DOI 10.1074/jbc.M700647200; Levkau B, 1998, MOL CELL, V1, P553, DOI 10.1016/S1097-2765(00)80055-6; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mizutani Y, 2004, FEBS LETT, V563, P93, DOI 10.1016/S0014-5793(04)00274-1; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Omae F, 2004, BIOCHEM J, V379, P687, DOI 10.1042/BJ20031425; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Perry DK, 2000, J BIOL CHEM, V275, P9078, DOI 10.1074/jbc.275.12.9078; Ravid T, 2003, AM J PHYSIOL-LUNG C, V284, pL1082, DOI 10.1152/ajplung.00172.2002; Renert AF, 2009, J PROTEOME RES, V8, P4810, DOI 10.1021/pr9005316; Sawada M, 2001, ONCOGENE, V20, P1368, DOI 10.1038/sj.onc.1204207; Sawada N, 2000, CELL DEATH DIFFER, V7, P761, DOI 10.1038/sj.cdd.4400711; Seumois G, 2007, J LEUKOCYTE BIOL, V81, P1477, DOI 10.1189/jlb.0806529; Signorelli P, 2009, CANCER LETT, V282, P238, DOI 10.1016/j.canlet.2009.03.020; SPIEGEL S, 1993, ADV LIPID RES, V25, P105; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Summers SA, 2005, DIABETES, V54, P591, DOI 10.2337/diabetes.54.3.591; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Thomas RL, 1999, J BIOL CHEM, V274, P30580, DOI 10.1074/jbc.274.43.30580; Vieira CR, 2010, CHEM BIOL, V17, P766, DOI 10.1016/j.chembiol.2010.05.023; von Haefen C, 2002, ONCOGENE, V21, P4009, DOI 10.1038/sj.onc.1205497; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Yart A, 2001, J BIOL CHEM, V276, P8856, DOI 10.1074/jbc.M006966200; Yin D, 2000, J NEUROSURG, V93, P289, DOI 10.3171/jns.2000.93.2.0289; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	53	27	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44042	10.1371/journal.pone.0044042	http://dx.doi.org/10.1371/journal.pone.0044042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984457	gold, Green Submitted, Green Published			2022-12-25	WOS:000308638700038
J	Strange, RW; Hough, MA; Antonyuk, SV; Hasnain, SS				Strange, Richard W.; Hough, Michael A.; Antonyuk, Svetlana V.; Hasnain, S. Samar			Structural Evidence for a Copper-Bound Carbonate Intermediate in the Peroxidase and Dismutase Activities of Superoxide Dismutase	PLOS ONE			English	Article							HYDROXYL RADICAL PRODUCTION; CU,ZN-SUPEROXIDE DISMUTASE; HYDROGEN-PEROXIDE; ACTIVE-SITE; ANION-BINDING; INORGANIC-PHOSPHATE; BICARBONATE; BOVINE; CU,ZN; MECHANISM	Copper-zinc superoxide dismutase (SOD) is of fundamental importance to our understanding of oxidative damage. Its primary function is catalysing the dismutation of superoxide to O-2 and H2O2. SOD also reacts with H2O2, leading to the formation of a strong copper-bound oxidant species that can either inactivate the enzyme or oxidise other substrates. In the presence of bicarbonate (or CO2) and H2O2, this peroxidase activity is enhanced and produces the carbonate radical. This freely diffusible reactive oxygen species is proposed as the agent for oxidation of large substrates that are too bulky to enter the active site. Here, we provide direct structural evidence, from a 2.15 angstrom resolution crystal structure, of (bi) carbonate captured at the active site of reduced SOD, consistent with the view that a bound carbonate intermediate could be formed, producing a diffusible carbonate radical upon reoxidation of copper. The bound carbonate blocks direct access of substrates to Cu(I), suggesting that an adjunct to the accepted mechanism of SOD catalysed dismutation of superoxide operates, with Cu(I) oxidation by superoxide being driven via a proton-coupled electron transfer mechanism involving the bound carbonate rather than the solvent. Carbonate is captured in a different site when SOD is oxidised, being located in the active site channel adjacent to the catalytically important Arg143. This is the probable route of diffusion from the active site following reoxidation of the copper. In this position, the carbonate is poised for re-entry into the active site and binding to the reduced copper.	[Strange, Richard W.; Hough, Michael A.; Antonyuk, Svetlana V.; Hasnain, S. Samar] Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Mol Biophys Grp, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Strange, RW (corresponding author), Univ Liverpool, Fac Hlth & Life Sci, Inst Integrat Biol, Mol Biophys Grp, Liverpool L69 3BX, Merseyside, England.	r.strange@liv.ac.uk; s.s.hasnain@liv.ac.uk	Hough, Michael/H-4409-2013; Antonyuk, Svetlana V/B-6002-2013; Antonyuk, Svetlana/W-5159-2019	Antonyuk, Svetlana/0000-0002-2779-9946; Hough, Michael/0000-0001-7377-6713	Motor Neuron Disease Association U.K. [6055]	Motor Neuron Disease Association U.K.	This work was supported by the Motor Neuron Disease Association U.K., grant number 6055 (R. W. S., S. S. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERBOOM TPM, 1978, EUR J BIOCHEM, V84, P413, DOI 10.1111/j.1432-1033.1978.tb12182.x; Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bonini MG, 2009, J BIOL CHEM, V284, P14618, DOI 10.1074/jbc.M804644200; BRAY RC, 1974, BIOCHEM J, V139, P43, DOI 10.1042/bj1390043; CABELLI DE, 1989, J BIOL CHEM, V264, P9967; CARUGO KD, 1994, FEBS LETT, V349, P93, DOI 10.1016/0014-5793(94)00651-2; Chandran K, 2010, BIOCHEMISTRY-US, V49, P10616, DOI 10.1021/bi1010305; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DEFREITAS DM, 1987, INORG CHEM, V26, P2788; DESIDERI A, 1988, J INORG BIOCHEM, V33, P91, DOI 10.1016/0162-0134(88)80037-0; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Elam JS, 2003, J BIOL CHEM, V278, P21032, DOI 10.1074/jbc.M300484200; Ellerby LM, 1996, J AM CHEM SOC, V118, P6556, DOI 10.1021/ja953845x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferraroni M, 1998, J BIOL INORG CHEM, V3, P411, DOI 10.1007/s007750050251; Geers C, 2000, PHYSIOL REV, V80, P681, DOI 10.1152/physrev.2000.80.2.681; GETZOFF ED, 1983, NATURE, V306, P287, DOI 10.1038/306287a0; Goss SPA, 1999, J BIOL CHEM, V274, P28233, DOI 10.1074/jbc.274.40.28233; Hart PJ, 1999, BIOCHEMISTRY-US, V38, P2167, DOI 10.1021/bi982284u; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5299, DOI 10.1021/bi00695a011; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5294, DOI 10.1021/bi00695a010; Jewett SL, 1999, FREE RADICAL BIO MED, V26, P905, DOI 10.1016/S0891-5849(98)00274-3; Jewett SL, 2000, BIOCHEM BIOPH RES CO, V274, P57, DOI 10.1006/bbrc.2000.3092; Karunakaran C, 2004, J BIOL CHEM, V279, P32534, DOI 10.1074/jbc.M314272200; Kurahashi T, 2001, J AM CHEM SOC, V123, P9268, DOI 10.1021/ja015953r; Lambert LA, 2005, COMP BIOCHEM PHYS B, V142, P129, DOI 10.1016/j.cbpb.2005.07.007; Leone M, 1998, BIOCHEMISTRY-US, V37, P4459, DOI 10.1021/bi971878e; Liochev SI, 2004, P NATL ACAD SCI USA, V101, P743, DOI 10.1073/pnas.0307635100; Liochev SI, 1999, FREE RADICAL BIO MED, V27, P1444, DOI 10.1016/S0891-5849(99)00190-2; Liochev SI, 2004, ARCH BIOCHEM BIOPHYS, V421, P255, DOI 10.1016/j.abb.2003.11.015; Liochev SI, 2010, FREE RADICAL BIO MED, V48, P1565, DOI 10.1016/j.freeradbiomed.2010.02.036; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Medinas DB, 2007, IUBMB LIFE, V59, P255, DOI 10.1080/15216540701230511; Medinas DB, 2010, FREE RADICAL BIO MED, V49, P682, DOI 10.1016/j.freeradbiomed.2010.04.040; Medinas DB, 2009, CHEM RES TOXICOL, V22, P639, DOI 10.1021/tx800287m; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramirez DC, 2005, FREE RADICAL BIO MED, V38, P201, DOI 10.1016/j.freeradbiomed.2004.10.008; Sankarapandi S, 1999, J BIOL CHEM, V274, P1226, DOI 10.1074/jbc.274.3.1226; SATO K, 1992, J BIOL CHEM, V267, P25371; SETTE M, 1992, BIOCHEMISTRY-US, V31, P12410, DOI 10.1021/bi00164a016; Smirnov VV, 2006, J AM CHEM SOC, V128, P16424, DOI 10.1021/ja066369r; Strange RW, 2006, J MOL BIOL, V356, P1152, DOI 10.1016/j.jmb.2005.11.081; Strater N, 1999, P NATL ACAD SCI USA, V96, P11151, DOI 10.1073/pnas.96.20.11151; TAINER JA, 1982, J MOL BIOL, V160, P181, DOI 10.1016/0022-2836(82)90174-7; UCHIDA K, 1994, J BIOL CHEM, V269, P2405; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; YIM MB, 1990, P NATL ACAD SCI USA, V87, P5006, DOI 10.1073/pnas.87.13.5006; Zhang H, 2000, J BIOL CHEM, V275, P14038, DOI 10.1074/jbc.275.19.14038; Zhang H, 2003, J BIOL CHEM, V278, P24078, DOI 10.1074/jbc.M302051200; Zhang HB, 2002, J BIOL CHEM, V277, P49767, DOI 10.1074/jbc.M204005200	53	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44811	10.1371/journal.pone.0044811	http://dx.doi.org/10.1371/journal.pone.0044811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984565	gold, Green Published, Green Accepted			2022-12-25	WOS:000308638700086
J	Porretta, D; Mastrantonio, V; Bellini, R; Somboon, P; Urbanelli, S				Porretta, Daniele; Mastrantonio, Valentina; Bellini, Romeo; Somboon, Pradya; Urbanelli, Sandra			Glacial History of a Modern Invader: Phylogeography and Species Distribution Modelling of the Asian Tiger Mosquito Aedes albopictus	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; GENETIC DIVERSITY; PENINSULAR MALAYSIA; DIPTERA-CULICIDAE; SOUTHEAST-ASIA; PLEISTOCENE; REFUGIA; TEMPERATE; INSIGHTS	Background: The tiger mosquito, Aedes albopictus, is one of the 100 most invasive species in the world and a vector of human diseases. In the last 30 years, it has spread from its native range in East Asia to Africa, Europe, and the Americas. Although this modern invasion has been the focus of many studies, the history of the species' native populations remains poorly understood. Here, we aimed to assess the role of Pleistocene climatic changes in shaping the current distribution of the species in its native range. Methodology/Principal Findings: We investigated the phylogeography, historical demography, and species distribution of Ae. albopictus native populations at the Last Glacial Maximum (LGM). Individuals from 16 localities from East Asia were analyzed for sequence variation at two mitochondrial genes. No phylogeographic structure was observed across the study area. Demographic analyses showed a signature of population expansion that started roughly 70,000 years BP. The occurrence of a continuous and climatically suitable area comprising Southeast China, Indochinese Peninsula, and Sundaland during LGM was indicated by species distribution modelling. Conclusions/Significance: Our results suggest an evolutionary scenario in which, during the last glacial phase, Ae. albopictus did not experience a fragmentation phase but rather persisted in interconnected populations and experienced demographic growth. The wide ecological flexibility of the species probably played a crucial role in its response to glacial-induced environmental changes. Currently, there is little information on the impact of Pleistocene climatic changes on animal species in East Asia. Most of the studies focused on forest-associated species and suggested cycles of glacial fragmentation and post-glacial expansion. The case of Ae. albopictus, which exhibits a pattern not previously observed in the study area, adds an important piece to our understanding of the Pleistocene history of East Asian biota.	[Porretta, Daniele] Univ Tuscia, Dept Ecol & Biol Sci, Viterbo, Italy; [Mastrantonio, Valentina; Urbanelli, Sandra] Univ Roma La Sapienza, Dept Environm Biol, Rome, Italy; [Bellini, Romeo] Agr & Environm Ctr G Nicoli, Crevalcore, Italy; [Somboon, Pradya] Chiang Mai Univ, Dept Parasitol, Chiang Mai, Thailand	Tuscia University; Sapienza University Rome; Chiang Mai University	Porretta, D (corresponding author), Univ Tuscia, Dept Ecol & Biol Sci, Viterbo, Italy.	daniele.porretta@uniroma1.it	Somboon, Pradya/AAL-3458-2020; URBANELLI, Sandra/N-8821-2016	Somboon, Pradya/0000-0002-0760-4363; MASTRANTONIO, VALENTINA/0000-0001-7701-4716; URBANELLI, Sandra/0000-0003-1183-0344	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work was funded by the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbruster P, 2003, J MED ENTOMOL, V40, P356, DOI 10.1603/0022-2585-40.3.356; Armistead JS, 2008, J MED ENTOMOL, V45, P629, DOI 10.1603/0022-2585(2008)45[629:ILCBAA]2.0.CO;2; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Beheregaray LB, 2008, MOL ECOL, V17, P3754, DOI 10.1111/j.1365-294X.2008.03857.x; Bellwood P, 1999, CAMBRIDGE HIST SE AS, V1, P61; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2; Bisconti R, 2011, MOL ECOL, V20, P5313, DOI 10.1111/j.1365-294X.2011.05363.x; BLACK WC, 1988, HEREDITY, V61, P439, DOI 10.1038/hdy.1988.136; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Burns EL, 2007, CONSERV GENET, V8, P17, DOI 10.1007/s10592-006-9143-8; Campbell P, 2006, MOL ECOL, V15, P29, DOI 10.1111/j.1365-294X.2005.02769.x; Canestrelli D, 2010, MOL ECOL, V19, P5432, DOI 10.1111/j.1365-294X.2010.04900.x; Carrieri M, 2003, ENVIRON ENTOMOL, V32, P1313, DOI 10.1603/0046-225X-32.6.1313; Chen B, 2011, HEREDITY, V106, P241, DOI 10.1038/hdy.2010.58; Chen Hong, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P491; de la Roque S, 2008, REV SCI TECH OIE, V27, P339, DOI 10.20506/rst.27.2.1807; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fu YX, 1997, GENETICS, V147, P915; Fuchs J, 2008, J BIOGEOGR, V35, P565, DOI 10.1111/j.1365-2699.2007.01811.x; Gray J S, 2009, Interdiscip Perspect Infect Dis, V2009, P593232, DOI 10.1155/2009/593232; Hasumi H., 2004, K 1 COUPLED MODEL MI; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hickerson MJ, 2010, MOL PHYLOGENET EVOL, V54, P291, DOI 10.1016/j.ympev.2009.09.016; Hofreiter M, 2009, CURR BIOL, V19, pR584, DOI 10.1016/j.cub.2009.06.030; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Innes JB, 2009, QUATERNARY SCI REV, V28, P2277, DOI 10.1016/j.quascirev.2009.04.010; Iyengar A, 2005, MOL ECOL, V14, P2281, DOI 10.1111/j.1365-294X.2005.02582.x; Jackson ST, 2004, ANNU REV EARTH PL SC, V32, P495, DOI 10.1146/annurev.earth.32.101802.120435; Jones MK, 2009, SCIENCE, V324, P730, DOI 10.1126/science.1172082; KAMBHAMPATI S, 1991, HEREDITY, V67, P85, DOI 10.1038/hdy.1991.67; Kamgang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020257; Knowles LL, 2009, ANNU REV ECOL EVOL S, V40, P593, DOI 10.1146/annurev.ecolsys.38.091206.095702; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; Lawing AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028554; Lounibos LP, 2003, ANN ENTOMOL SOC AM, V96, P512, DOI 10.1603/0013-8746(2003)096[0512:AEOPDI]2.0.CO;2; Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206; Maia RT, 2009, GENET MOL RES, V8, P998, DOI 10.4238/vol8-3gmr624; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Morgan K, 2011, MOL ECOL, V20, P4533, DOI 10.1111/j.1365-294X.2011.05268.x; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; NEI M, 1978, GENETICS, V89, P583; Otto-Bliesner BL, 2006, J CLIMATE, V19, P2526, DOI 10.1175/JCLI3748.1; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; Pfenninger M, 2002, EVOLUTION, V56, P1776, DOI 10.1111/j.0014-3820.2002.tb00191.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pope KO, 2008, J BIOGEOGR, V35, P1, DOI 10.1111/j.1365-2699.2007.01797.x; Porretta D, 2007, J APPL ECOL, V44, P682, DOI 10.1111/j.1365-2664.2007.01301.x; Porretta D, 2011, J BIOGEOGR, V38, P20, DOI 10.1111/j.1365-2699.2010.02385.x; Porretta D, 2011, 59 ANN M ENT SOC AM; Porretta D, 2010, 20 ANN M IT SOC EC R; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Quante M, 2010, RELICT SPECIES: PHYLOGEOGRAPHY AND CONSERVATION BIOLOGY, P9, DOI 10.1007/978-3-540-92160-8_2; Rai N, 2001, INTERNET ARCHEOLOGY; Rambaut A., 2007, TRACER V1 4; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Sakka H, 2010, BIOL J LINN SOC, V100, P797, DOI 10.1111/j.1095-8312.2010.01477.x; Salzburger W, 2011, MOL ECOL, V20, P1952, DOI 10.1111/j.1365-294X.2011.05066.x; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Su YC, 2007, J BIOGEOGR, V34, P177, DOI 10.1111/j.1365-2699.2006.01617.x; Svenning JC, 2008, J ECOL, V96, P1117, DOI 10.1111/j.1365-2745.2008.01422.x; Svenning JC, 2011, QUATERNARY SCI REV, V30, P2930, DOI 10.1016/j.quascirev.2011.06.012; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Taberlet P, 2002, SCIENCE, V297, P2009, DOI 10.1126/science.297.5589.2009; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teacher AGF, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-214; TEMPLETON AR, 1992, GENETICS, V132, P619; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x; Urbanelli S, 2005, 14 ANN M IT SOC EC T; Usmani-Brown S, 2009, ANN ENTOMOL SOC AM, V102, P144, DOI 10.1603/008.102.0116; Valdiosera CE, 2007, MOL ECOL, V16, P5140, DOI 10.1111/j.1365-294X.2007.03590.x; Vidya TNC, 2009, P ROY SOC B-BIOL SCI, V276, P893, DOI 10.1098/rspb.2008.1494; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Yu G, 2007, PALAEOGEOGR PALAEOCL, V250, P167, DOI 10.1016/j.palaeo.2007.03.010; Zarowiecki M, 2011, J BIOGEOGR, V38, P1422, DOI 10.1111/j.1365-2699.2011.02477.x	90	65	70	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44515	10.1371/journal.pone.0044515	http://dx.doi.org/10.1371/journal.pone.0044515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970238	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400082
J	Shen, J; Terry, MB; Liao, YY; Gurvich, I; Wang, Q; Senie, RT; Santella, RM				Shen, Jing; Terry, Mary Beth; Liao, Yuyan; Gurvich, Irina; Wang, Qiao; Senie, Ruby T.; Santella, Regina M.			Genetic Variation in Telomere Maintenance Genes, Telomere Length and Breast Cancer Risk	PLOS ONE			English	Article							LYMPHOBLASTOID CELL-LINES; NEW-YORK SITE; SISTERS DISCORDANT; BLOOD-CELLS; ASSOCIATION; WOMEN; STRESS; VARIANTS; OBESITY; LOCUS	Background: Telomeres at the ends of eukaryotic chromosomes play a critical role in maintaining the integrity and stability of the genome and participate in the initiation of DNA damage/repair responses. Methods: We performed a case-control study to evaluate the role of three SNPs (TERT-07, TERT-54 and POT1-03) in telomere maintenance genes previously found to be significantly associated with breast cancer risk. We used sister-sets obtained from the New York site of the Breast Cancer Family Registry (BCFR). Among the 313 sister-sets, there were 333 breast cancer cases and 409 unaffected sisters who were evaluated in the current study. We separately applied conditional logistic regression and generalized estimating equations (GEE) models to evaluate associations between the three SNPs and breast cancer risk within sister-sets. We examined the associations between genotype, covariates and telomere length among unaffected sisters using a GEE model. Results: We found no significant associations between the three SNPs in telomere maintenance genes and breast cancer risk by both conditional logistic regression and GEE models, nor were these SNPs significantly related to telomere length. Among unaffected sisters, shortened telomeres were statistically significantly correlated with never hormone replacement therapy (HRT) use. Increased duration of HRT use was significantly associated with reduced telomere length. The means of telomere length were 0.77 (SD = 0.35) for never HRT use, 0.67 (SD = 0.29) for HRT use <5yrs and 0.59 (SD = 0.24) for HRT use >= 5yrs after adjusting for age of blood donation and race and ethnicity. Conclusions: We found that exogenous hormonal exposure was inversely associated with telomere length. No significant associations between genetic variants and telomere length or breast cancer risk were observed. These findings provide initial evidence to understand hormonal exposure in the regulation of telomere length and breast cancer risk but need replication in prospective studies.	[Shen, Jing; Gurvich, Irina; Wang, Qiao; Santella, Regina M.] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA; [Terry, Mary Beth; Liao, Yuyan; Senie, Ruby T.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Columbia University; Columbia University	Shen, J (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10027 USA.	js2182@columbia.edu		Terry, Mary Beth/0000-0002-4106-5033	Breast Cancer Research Foundation; Women At Risk (WAR); National Institutes of Health [R03 CA125768, U01 CA69398, P30 CA13696, P30 ES009089]; National Cancer Institute, National Institutes of Health under RFA through Columbia University [U01 CA69398, CA-06-503]; NATIONAL CANCER INSTITUTE [P30CA013696, R03CA125768, U01CA069398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER	Breast Cancer Research Foundation; Women At Risk (WAR); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, National Institutes of Health under RFA through Columbia University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by awards from the Breast Cancer Research Foundation, Women At Risk (WAR) and National Institutes of Health grants R03 CA125768, U01 CA69398, P30 CA13696 and P30 ES009089. This work was also supported by the National Cancer Institute, National Institutes of Health under RFA # CA-06-503 and through cooperative agreements with members of the Breast Cancer Family Registry (BCFR) and Principal Investigators, including Columbia University (U01 CA69398). The content of this manuscript does not necessarily reflect the views or policies of the National Cancer Institute or any of the collaborating centers in the BCFR, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government or the BCFR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Browner WS, 2004, AM J MED, V117, P851, DOI 10.1016/j.amjmed.2004.06.033; Cardon LR, 2003, LANCET, V361, P598, DOI 10.1016/S0140-6736(03)12520-2; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Choi JE, 2009, CANCER EPIDEM BIOMAR, V18, P2773, DOI 10.1158/1055-9965.EPI-09-0323; Cox DG, 2001, BIOINFORMATICS, V17, P738, DOI 10.1093/bioinformatics/17.8.738; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Entringer S, 2011, P NATL ACAD SCI USA, V108, pE513, DOI 10.1073/pnas.1107759108; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Gramatges MM, 2010, CANCER EPIDEM BIOMAR, V19, P605, DOI 10.1158/1055-9965.EPI-09-0896; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Gu JA, 2011, CANCER PREV RES, V4, P514, DOI 10.1158/1940-6207.CAPR-11-0063; Heaphy CM, 2011, MODERN PATHOL, V24, P194, DOI 10.1038/modpathol.2010.198; Hoxha M, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-41; Iwano T, 2004, J BIOL CHEM, V279, P1442, DOI 10.1074/jbc.M309138200; Karlseder J, 2003, MOL CELL BIOL, V23, P6533, DOI 10.1128/MCB.23.18.6533-6541.2003; Kennedy DO, 2005, JNCI-J NATL CANCER I, V97, P127, DOI 10.1093/jnci/dji013; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Lee DC, 2005, YONSEI MED J, V46, P471, DOI 10.3349/ymj.2005.46.4.471; Lin J, 2011, BRAIN RES, V1379, P224, DOI 10.1016/j.brainres.2010.10.033; Liu LF, 2009, J BIOL CHEM, V284, P5165, DOI 10.1074/jbc.M807098200; Machella N, 2008, CARCINOGENESIS, V29, P1367, DOI 10.1093/carcin/bgn140; Meeker AK, 2004, J MAMMARY GLAND BIOL, V9, P285, DOI 10.1023/B:JOMG.0000048775.04140.92; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; Njajou OT, 2007, P NATL ACAD SCI USA, V104, P12135, DOI 10.1073/pnas.0702703104; Njajou OT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013048; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Donnell CJ, 2008, ARTERIOSCL THROM VAS, V28, P1165, DOI 10.1161/ATVBAHA.107.154849; Parks CG, 2009, CANCER EPIDEM BIOMAR, V18, P551, DOI 10.1158/1055-9965.EPI-08-0614; Pavanello S, 2010, CARCINOGENESIS, V31, P216, DOI 10.1093/carcin/bgp278; Pooley KA, 2010, CANCER EPIDEM BIOMAR, V19, P1862, DOI 10.1158/1055-9965.EPI-10-0281; Pooley KA, 2010, CANCER RES, V70, P3170, DOI 10.1158/0008-5472.CAN-09-4595; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Savage SA, 2007, BRIT J CANCER, V97, P832, DOI 10.1038/sj.bjc.6603934; Shen J, 2007, CANCER RES, V67, P5538, DOI 10.1158/0008-5472.CAN-06-3490; Shen J, 2010, CANCER EPIDEM BIOMAR, V19, P219, DOI 10.1158/1055-9965.EPI-09-0771; Shen J, 2009, INT J CANCER, V124, P1637, DOI 10.1002/ijc.24105; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Svenson U, 2009, BBA-MOL BASIS DIS, V1792, P317, DOI 10.1016/j.bbadis.2009.01.017; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Varadi V, 2009, EUR J CANCER, V45, P3008, DOI 10.1016/j.ejca.2009.08.012; Varadi V, 2009, CANCER GENET CYTOGEN, V190, P71, DOI 10.1016/j.cancergencyto.2008.12.006; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; Von Zglinicki T, 2000, ANN NY ACAD SCI, V908, P99, DOI 10.1111/j.1749-6632.2000.tb06639.x; WILKIE AOM, 1990, NATURE, V346, P868, DOI 10.1038/346868a0; Wolkowitz OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017837; Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734; Zheng YL, 2010, BREAST CANCER RES TR, V120, P769, DOI 10.1007/s10549-009-0440-z; Zipprich J, 2009, CANCER RES, V69, P2966, DOI 10.1158/0008-5472.CAN-08-3418	54	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44308	10.1371/journal.pone.0044308	http://dx.doi.org/10.1371/journal.pone.0044308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970196	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400055
J	Scales, TME; Jayo, A; Obara, B; Holt, MR; Hotchin, NA; Berditchevski, F; Parsons, M				Scales, T. M. E.; Jayo, A.; Obara, B.; Holt, M. R.; Hotchin, N. A.; Berditchevski, F.; Parsons, M.			alpha 3 beta 1 integrins regulate CD151 complex assembly and membrane dynamics in carcinoma cells within 3D environments	ONCOGENE			English	Article						alpha 3 integrin; CD151; migration; protrusion; actin cytoskeleton; 3D ECM	LAMININ-BINDING INTEGRINS; TETRASPANIN CD151; TRANSMEMBRANE-4 SUPERFAMILY; CLINICAL-SIGNIFICANCE; ADHESION DYNAMICS; PROTEIN COMPLEXES; GENE-EXPRESSION; RAC ACTIVATION; BREAST-CANCER; IN-VIVO	Integrins are extracellular matrix (ECM) receptors that are key players in the regulation of tumour cell invasion. The laminin-binding integrin alpha 3 beta 1 has previously been shown to regulate adhesion and migration of carcinoma cells in part through co-operative signalling with the tetraspanin family of transmembrane proteins. However, the spatial and temporal regulation of crosstalk between these families of transmembrane proteins in intact cells remains poorly understood. Here we have used fluorescence resonance energy transfer (FRET) to demonstrate for the first time that alpha 3 beta 1 and the tetraspanin CD151 directly associate at the front and retracting rear of polarised migrating breast carcinoma cells in both two-dimentional (2D) and three-dimentional (3D) matrices. Furthermore, localised alpha 3 beta 1-CD151 binding correlates with lower CD151 homodimerisation in cells migrating on laminin or within matrigel. Loss of alpha 3 beta 1 integrin leads to increased CD151 homodimer formation, increased activation of Rho GTPase, loss of cell polarity and decreased invasion in 3D ECM. As a result, alpha 3-silenced cells show decreased actin-based membrane protrusion and retraction in both 2D and 3D environments. These data demonstrate that associations between alpha 3 beta 1 and CD151 occur dynamically within discrete subcellular compartments and act to establish local GTPase signalling to promote tumour cell invasion. These novel findings shed light on the complex crosstalk and switching between receptor complexes in response to different extracellular cues during cell invasion in 3D environments.	[Scales, T. M. E.; Jayo, A.; Holt, M. R.; Parsons, M.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Obara, B.] Univ Oxford, Oxford E Res Ctr, Oxford, England; [Obara, B.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford, England; [Hotchin, N. A.] Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham, W Midlands, England; [Berditchevski, F.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	University of London; King's College London; University of Oxford; University of Oxford; Cancer Research UK; University of Birmingham; University of Birmingham	Parsons, M (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, Room 3-22B,New Hunts House,Guys Campus, London SE1 1UL, England.	maddy.parsons@kcl.ac.uk	Jayo, Asier/A-8419-2015; Jayo, Asier/A-2359-2010; Jayo, Asier/AAE-5895-2021; Parsons, Maddy/B-2203-2013	Jayo, Asier/0000-0002-9899-8723; Jayo, Asier/0000-0002-9899-8723; Jayo, Asier/0000-0002-9899-8723; Parsons, Maddy/0000-0002-2021-8379; Holt, Mark/0000-0001-7775-8539; Obara, Boguslaw/0000-0003-4084-7778; Hotchin, Neil/0000-0002-1844-7607	Cancer Research UK; Wellcome Trust; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Royal Society University Research Fellowship; MRC [MR/J000647/1] Funding Source: UKRI; Medical Research Council [MR/J000647/1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society University Research Fellowship(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank Simon Ameer-Beg and Daniel Matthews for technical assistance and support with the multiphoton FLIM. This research was funded by grants from Cancer Research UK (to MP, FB and NH), the Wellcome Trust (to NH), the Biotechnology and Biological Sciences Research Council and Engineering and Physical Sciences Research Council (to BO) and a Royal Society University Research Fellowship (to MP).	Ang J, 2004, CANCER EPIDEM BIOMAR, V13, P1717; Arthur WT, 2001, MOL BIOL CELL, V12, P2711, DOI 10.1091/mbc.12.9.2711; Baldwin G, 2008, J BIOL CHEM, V283, P35445, DOI 10.1074/jbc.M806394200; Berditchevski F, 2001, J BIOL CHEM, V276, P41165, DOI 10.1074/jbc.M104041200; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Claas C, 2001, J BIOL CHEM, V276, P7974, DOI 10.1074/jbc.M008650200; Egeblad M, 2010, CURR OPIN CELL BIOL, V22, P697, DOI 10.1016/j.ceb.2010.08.015; Frank DE, 2004, J CELL SCI, V117, P1351, DOI 10.1242/jcs.01003; Fukushima Y, 1998, INT J CANCER, V76, P63, DOI 10.1002/(SICI)1097-0215(19980330)76:1<63::AID-IJC11>3.0.CO;2-H; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Hashida H, 2003, BRIT J CANCER, V89, P158, DOI 10.1038/sj.bjc.6601015; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Latysheva N, 2006, MOL CELL BIOL, V26, P7707, DOI 10.1128/MCB.00849-06; Lichtner RB, 1998, EXP CELL RES, V240, P368, DOI 10.1006/excr.1998.4012; Liu L, 2007, J BIOL CHEM, V282, P31631, DOI 10.1074/jbc.M701165200; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; MELCHIORI A, 1995, EXP CELL RES, V219, P233, DOI 10.1006/excr.1995.1223; Mitchell K, 2010, CANCER RES, V70, P6359, DOI 10.1158/0008-5472.CAN-09-4283; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Morton PE, 2011, METHODS MOL BIOL, V769, P403, DOI 10.1007/978-1-61779-207-6_27; Nakamura T, 2006, METHOD ENZYMOL, V406, P315, DOI 10.1016/S0076-6879(06)06023-X; Nguyen BP, 2000, J BIOL CHEM, V275, P31896, DOI 10.1074/jbc.M006379200; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; OKADA T, 1994, CLIN EXP METASTAS, V12, P305, DOI 10.1007/BF01753837; Parsons M, 2005, MOL CELL BIOL, V25, P1680, DOI 10.1128/MCB.25.5.1680-1695.2005; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Ramirez NE, 2011, J CLIN INVEST, V121, P226, DOI 10.1172/JCI42328; Reynolds LE, 2008, J CLIN INVEST, V118, P965, DOI 10.1172/JCI33538; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Sadej R, 2009, MOL CANCER RES, V7, P787, DOI 10.1158/1541-7786.MCR-08-0574; Sah VP, 2000, ANNU REV PHARMACOL, V40, P459, DOI 10.1146/annurev.pharmtox.40.1.459; Sarmiento C, 2008, J CELL BIOL, V180, P1245, DOI 10.1083/jcb.200708123; Sterk LMT, 2002, J CELL SCI, V115, P1161; Stipp CS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001355; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Sugiura T, 1999, J CELL BIOL, V146, P1375, DOI 10.1083/jcb.146.6.1375; Takeda Y, 2011, BLOOD, V118, P464, DOI 10.1182/blood-2010-08-302240; Tokuhara T, 2001, CLIN CANCER RES, V7, P4109; Turner FE, 2006, J BIOL CHEM, V281, P21321, DOI 10.1074/jbc.M509731200; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang ZM, 1999, J CELL SCI, V112, P2925; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Worth DC, 2008, INT J BIOCHEM CELL B, V40, P2397, DOI 10.1016/j.biocel.2008.04.008; Worth DC, 2010, J CELL BIOL, V189, P369, DOI 10.1083/jcb.200912014; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Yauch RL, 2000, J BIOL CHEM, V275, P9230, DOI 10.1074/jbc.275.13.9230; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200; Zhou H, 2005, J BIOL CHEM, V280, P10624, DOI 10.1074/jbc.M411900200; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031	57	15	16	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 22	2013	32	34					3965	3979		10.1038/onc.2012.415	http://dx.doi.org/10.1038/onc.2012.415			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IC	22986527				2022-12-25	WOS:000323748100005
J	Reid, AT; Lord, T; Stanger, SJ; Roman, SD; McCluskey, A; Robinson, PJ; Aitken, RJ; Nixon, B				Reid, Andrew T.; Lord, Tessa; Stanger, Simone J.; Roman, Shaun D.; McCluskey, Adam; Robinson, Phillip J.; Aitken, R. John; Nixon, Brett			Dynamin Regulates Specific Membrane Fusion Events Necessary for Acrosomal Exocytosis in Mouse Spermatozoa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-TESTIS BARRIER; ZONA-PELLUCIDA; SPERM; PROTEIN; ENDOCYTOSIS; SERTOLI; PHOSPHORYLATION; EXPRESSION; COMPLEXES; GTPASE	Mammalian spermatozoa must complete an acrosome reaction prior to fertilizing an oocyte. The acrosome reaction is a unique exocytotic event involving a series of prolonged membrane fusions that ultimately result in the production of membrane vesicles and release of the acrosomal contents. This event requires the concerted action of a large number of fusion-competent signaling and scaffolding proteins. Here we show that two different members of the dynamin GTPase family localize to the developing acrosome of maturing mouse germ cells. Both dynamin 1 and 2 also remain within the periacrosomal region of mature mouse spermatozoa and are thus well positioned to regulate the acrosome reaction. Two pharmacological inhibitors of dynamin, dynasore and Dyngo-4a, blocked the in vitro induction of acrosomal exocytosis by progesterone, but not by the calcium ionophore A23187, and elicited a concomitant reduction of in vitro fertilization. In vivo treatment with these inhibitors also resulted in spermatozoa displaying reduced acrosome reaction potential. Dynamin 1 and 2 phosphorylation increased on progesterone treatment, and this was also selectively blocked by dynasore. On the basis of our collective data, we propose that dynamin could regulate specific membrane fusion events necessary for acrosomal exocytosis in mouse spermatozoa.	[Reid, Andrew T.; Lord, Tessa; Stanger, Simone J.; Roman, Shaun D.; Aitken, R. John; Nixon, Brett] Univ Newcastle, Sch Environm & Life Sci, Discipline Biol Sci, Callaghan, NSW 2308, Australia; [McCluskey, Adam] Univ Newcastle, Sch Environm & Life Sci, Discipline Chem, Callaghan, NSW 2308, Australia; [Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia	University of Newcastle; University of Newcastle; Children's Medical Research Institute - Australia; University of Sydney	Nixon, B (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Discipline Biol Sci, Univ Dr, Callaghan, NSW 2308, Australia.	Brett.Nixon@newcastle.edu.au	Roman, Shaun/AFR-5087-2022; Aitken, Robert John/AAY-8238-2020; Robinson, Phillip J/G-4008-2011; McCluskey, Adam/F-1894-2011; Nixon, Brett/B-5121-2012; ROMAN, SHAUN/G-7047-2013	Aitken, Robert John/0000-0002-9152-156X; Robinson, Phillip J/0000-0002-7878-0313; McCluskey, Adam/0000-0001-7125-863X; Nixon, Brett/0000-0003-2745-8188; ROMAN, SHAUN/0000-0002-7758-7757; Reid, Andrew/0000-0001-5751-7025; Lord, Tessa/0000-0002-1199-0375				Abou-Haila A, 2000, ARCH BIOCHEM BIOPHYS, V379, P173, DOI 10.1006/abbi.2000.1880; Abou-Haila A, 2003, HISTOCHEM CELL BIOL, V119, P179, DOI 10.1007/s00418-003-0504-9; AITKEN RJ, 1993, J ANDROL, V14, P132; Altschuler Y, 1998, J CELL BIOL, V143, P1871, DOI 10.1083/jcb.143.7.1871; Anantharam A, 2011, MOL BIOL CELL, V22, P1907, DOI 10.1091/mbc.E11-02-0101; Arnoult C, 1996, P NATL ACAD SCI USA, V93, P13004, DOI 10.1073/pnas.93.23.13004; Asquith KL, 2004, J CELL SCI, V117, P3645, DOI 10.1242/jcs.01214; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; Baleato RM, 2005, DEV BIOL, V286, P78, DOI 10.1016/j.ydbio.2005.07.009; BARROS C, 1967, J CELL BIOL, V34, pC1, DOI 10.1083/jcb.34.3.C1; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; Burmann F, 2011, MOL MICROBIOL, V79, P1294, DOI 10.1111/j.1365-2958.2011.07523.x; Buffone MG, 2008, INT J DEV BIOL, V52, P511, DOI 10.1387/ijdb.072532mb; Cao H, 2000, J CELL SCI, V113, P1993; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Chircop M, 2011, BBA-MOL CELL RES, V1813, P1689, DOI 10.1016/j.bbamcr.2010.12.018; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; DJAKIEW D, 1988, BIOL REPROD, V39, P1193, DOI 10.1095/biolreprod39.5.1193; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; FAWCETT DW, 1963, Z ZELLFORSCH MIK ANA, V60, P276, DOI 10.1007/BF00350481; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Gilleron J, 2011, INT J BIOCHEM CELL B, V43, P1208, DOI 10.1016/j.biocel.2011.04.014; Gorini G, 2010, FEBS LETT, V584, P845, DOI 10.1016/j.febslet.2009.12.061; Grimmer S, 2005, TRAFFIC, V6, P144, DOI 10.1111/j.1600-0854.2005.00258.x; Guttman JA, 2004, BIOL REPROD, V71, P548, DOI 10.1095/biolreprod.104.028803; Harper CB, 2011, J BIOL CHEM, V286, P35966, DOI 10.1074/jbc.M111.283879; Harper CV, 2008, J CELL SCI, V121, P2130, DOI 10.1242/jcs.030379; Hill TA, 2010, J MED CHEM, V53, P4094, DOI 10.1021/jm100119c; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Jaiswal JK, 2009, CELL, V137, P1308, DOI 10.1016/j.cell.2009.04.064; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Kessels MM, 2006, J CELL SCI, V119, P1504, DOI 10.1242/jcs.02877; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Kusumi N, 2007, CELL STRUCT FUNCT, V32, P101, DOI 10.1247/csf.07024; Larsen MR, 2004, MOL CELL PROTEOMICS, V3, P456, DOI 10.1074/mcp.M300105-MCP200; LEBLOND CP, 1952, ANN NY ACAD SCI, V55, P548, DOI 10.1111/j.1749-6632.1952.tb26576.x; Lie PPY, 2006, J ENDOCRINOL, V191, P571, DOI 10.1677/joe.1.06996; Lin YN, 2007, MOL CELL BIOL, V27, P6794, DOI 10.1128/MCB.01029-07; Liu DY, 2003, FERTIL STERIL, V79, P74, DOI 10.1016/S0015-0282(02)04555-7; LIU JP, 1994, J BIOL CHEM, V269, P21043; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; Moreno RD, 2000, BIOL REPROD, V63, P89, DOI 10.1095/biolreprod63.1.89; Morita M, 2010, J BIOCHEM, V148, P533, DOI 10.1093/jb/mvq116; Nakanishi A, 2008, ACTA MED OKAYAMA, V62, P385; Nixon B, 2006, BIOL REPROD, V74, P275, DOI 10.1095/biolreprod.105.044644; Nixon B, 2009, J CELL PHYSIOL, V218, P122, DOI 10.1002/jcp.21575; Odell LR, 2009, CHEMMEDCHEM, V4, P1182, DOI 10.1002/cmdc.200900054; Otsuka A, 2009, BIOCHEM BIOPH RES CO, V378, P478, DOI 10.1016/j.bbrc.2008.11.066; PAGE KC, 1992, BIOCHEM CELL BIOL, V70, P496, DOI 10.1139/o92-077; Peters C, 2004, CELL, V119, P667, DOI 10.1016/j.cell.2004.11.023; Pietrobon EO, 2005, MOL REPROD DEV, V70, P58, DOI 10.1002/mrd.20190; QUINN P, 1985, FERTIL STERIL, V44, P493; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Reid AT, 2011, ASIAN J ANDROL, V13, P88, DOI 10.1038/aja.2010.74; ROBINSON PJ, 1993, NATURE, V365, P163, DOI 10.1038/365163a0; ROLDAN ERS, 1994, SCIENCE, V266, P1578, DOI 10.1126/science.7985030; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Ryan TA, 2003, P NATL ACAD SCI USA, V100, P2171, DOI 10.1073/pnas.0530260100; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; SONTAG JM, 1994, J BIOL CHEM, V269, P4547; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Vaid KS, 2007, J CELL PHYSIOL, V210, P644, DOI 10.1002/jcp.20855; Viggiano JM, 1996, J ANDROL, V17, P692; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; YANAGIMACHI R, 1970, AM J ANAT, V128, P429, DOI 10.1002/aja.1001280404; Zhao LM, 2007, MOL REPROD DEV, V74, P750, DOI 10.1002/mrd.20660	81	40	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.392803	http://dx.doi.org/10.1074/jbc.M112.392803			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977254	hybrid, Green Published			2022-12-25	WOS:000310642200007
J	Kawano, M; Kawaji, H; Grandjean, V; Kiani, J; Rassoulzadegan, M				Kawano, Mitsuoki; Kawaji, Hideya; Grandjean, Valerie; Kiani, Jafar; Rassoulzadegan, Minoo			Novel Small Noncoding RNAs in Mouse Spermatozoa, Zygotes and Early Embryos	PLOS ONE			English	Article							PIWI-INTERACTING RNAS; SPERM; INHERITANCE; MICRORNAS; OOCYTES; SIRNAS; SERVER	The recent discovery of a significant amount of RNA in spermatozoa contradicted the previously held belief that paternal contribution was limited to one copy of the genome. Furthermore, detection of RNA in sperm raised the intriguing question of its possible role in embryonic development. The possibility that RNAs may serve as epigenetic determinants was supported by experiments showing inheritance of epigenetic traits in mice mediated by RNA. We used high-throughput, large-scale sequencing technology to analyze sperm RNA. The RNA sequences generated were diverse in terms of length and included mRNAs, rRNAs, piRNAs, and miRNAs. We studied two small noncoding RNAs enriched in mature sperm, designated sperm RNAs (spR) -12 and -13. They are both encoded in a piRNA locus on chromosome 17, but neither their length (20-21 nt), nor their sequences correspond to known piRNAs or miRNAs. They are resistant to periodate-oxidation-mediated reaction, implying that they undergo terminal post-transcriptional modification. Both were detected in sperm and ovulated unfertilized oocytes, present in one-cell embryos and maintained in preimplantation stages, but not at later differentiation stages. These findings offer a new perspective regarding a possibly important role for gamete-specific small RNAs in early embryogenesis.	[Kawano, Mitsuoki; Kawaji, Hideya] RIKEN Om Sci Ctr, Yokohama, Kanagawa, Japan; [Kawano, Mitsuoki] Hokkaido Univ, Grad Sch Dent Med, Sapporo, Hokkaido, Japan; [Grandjean, Valerie; Kiani, Jafar; Rassoulzadegan, Minoo] Fac Med Nice, INSERM, U636, F-06034 Nice, France; [Grandjean, Valerie; Kiani, Jafar; Rassoulzadegan, Minoo] Univ Nice Sophia Antipolis, Lab Genet Dev Normal & Pathol, Nice, France	RIKEN; Hokkaido University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur	Kawano, M (corresponding author), Niigata Univ Pharm & Appl Life Sci, Dept Appl Life Sci, Niigata, Japan.	mkawano@nupals.ac.jp	Grandjean, Valerie/O-3935-2016; Kawano, Mitsuoki/GLS-2569-2022; Rassoulzadegan, Minoo/O-7939-2016; Kawaji, Hideya/N-5116-2015; Kawano, Mitsuoki/AAT-7600-2020	Kawano, Mitsuoki/0000-0003-1570-0491; Kawaji, Hideya/0000-0002-0575-0308; Kiani, Jafar/0000-0002-5907-5846; Valerie, GRANDJEAN/0000-0003-1661-7411	RIKEN OSC research grant from MEXT (YH); Ligue Nationale Contre le Cancer; Agence Nationale de la Recherche;  [20770145]	RIKEN OSC research grant from MEXT (YH); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Agence Nationale de la Recherche(French National Research Agency (ANR)); 	The study was supported in part by grants from the RIKEN OSC research grant from MEXT (YH), the Grant-in-Aid for Young Scientists (B) (MK, 20770145), and by grants from Ligue Nationale Contre le Cancer and Agence Nationale de la Recherche (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanai M, 2006, BIOL REPROD, V75, P877, DOI 10.1095/biolreprod.106.056499; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Cheng AG, 2009, OLIGONUCLEOTIDES, V19, P203, DOI 10.1089/oli.2008.0176; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Houwing S, 2007, CELL, V129, P69, DOI 10.1016/j.cell.2007.03.026; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kramer JA, 1997, MOL HUM REPROD, V3, P473, DOI 10.1093/molehr/3.6.473; Krawetz SA, 2005, NAT REV GENET, V6, P633, DOI 10.1038/nrg1654; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Perry ACF, 1999, SCIENCE, V284, P1180, DOI 10.1126/science.284.5417.1180; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Saito K, 2007, GENE DEV, V21, P1603, DOI 10.1101/gad.1563607; Suh N, 2011, DEVELOPMENT, V138, P1653, DOI 10.1242/dev.056234; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333; Wagner KD, 2008, DEV CELL, V14, P962, DOI 10.1016/j.devcel.2008.03.009; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	22	81	86	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44542	10.1371/journal.pone.0044542	http://dx.doi.org/10.1371/journal.pone.0044542			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984523	Green Published, gold			2022-12-25	WOS:000308738500063
J	Klassen, K; Martineau, AR; Wilkinson, RJ; Cooke, G; Courtney, AP; Hickson, M				Klassen, Karen; Martineau, Adrian R.; Wilkinson, Robert J.; Cooke, Graham; Courtney, Alan P.; Hickson, Mary			The Effect of Tenofovir on Vitamin D Metabolism in HIV-Infected Adults Is Dependent on Sex and Ethnicity	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; PARATHYROID-HORMONE; D DEFICIENCY; TUBULAR DYSFUNCTION; HYPERPARATHYROIDISM; OSTEOPOROSIS; PREVALENCE; PREDICTORS; DIETARY; WOMEN	Background: Tenofovir has been associated with renal phosphate wasting, reduced bone mineral density, and higher parathyroid hormone levels. The aim of this study was to carry out a detailed comparison of the effects of tenofovir versus non-tenofovir use on calcium, phosphate and, vitamin D, parathyroid hormone (PTH), and bone mineral density. Methods: A cohort study of 56 HIV-1 infected adults at a single centre in the UK on stable antiretroviral regimes comparing biochemical and bone mineral density parameters between patients receiving either tenofovir or another nucleoside reverse transcriptase inhibitor. Principal Findings: In the unadjusted analysis, there was no significant difference between the two groups in PTH levels (tenofovir mean 5.9 pmol/L, 95% confidence intervals 5.0 to 6.8, versus non-tenofovir; 5.9, 4.9 to 6.9; p = 0.98). Patients on tenofovir had significantly reduced urinary calcium excretion (median 3.01 mmol/24 hours) compared to non-tenofovir users (4.56; p < 0.0001). Stratification of the analysis by age and ethnicity revealed that non-white men but not women, on tenofovir had higher PTH levels than non-white men not on tenofovir (mean difference 3.1 pmol/L, 95% CI 5.3 to 0.9; p = 0.007). Those patients with optimal 25-hydroxyvitamin D (>75 nmol/L) on tenofovir had higher 1,25-dihydroxyvitamin D [1,25(OH)(2)D] (median 48 pg/mL versus 31; p = 0.012), fractional excretion of phosphate (median 26.1%, versus 14.6; p = 0.025) and lower serum phosphate (median 0.79 mmol/L versus 1.02; p = 0.040) than those not taking tenofovir. Conclusions: The effects of tenofovir on PTH levels were modified by sex and ethnicity in this cohort. Vitamin D status also modified the effects of tenofovir on serum concentrations of 1,25(OH)(2)D and phosphate.	[Klassen, Karen] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Klassen, Karen; Courtney, Alan P.; Hickson, Mary] Imperial Coll Healthcare NHS Trust, London, England; [Martineau, Adrian R.; Wilkinson, Robert J.; Cooke, Graham] Univ London Imperial Coll Sci Technol & Med, Dept Med, London SW7 2AZ, England; [Martineau, Adrian R.] Univ London, Barts & London Med Sch Med & Dent, London, England; [Wilkinson, Robert J.] MRC Natl Inst Med Res, London, England	Queensland University of Technology (QUT); Imperial College London; Imperial College London; University of London; MRC National Institute for Medical Research	Klassen, K (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.	k.klassen@qut.edu.au	Hickson, Mary/D-3672-2011; Martineau, Adrian R/A-3083-2010; Klassen, Karen/I-3812-2012	Hickson, Mary/0000-0001-7996-0095; Klassen, Karen/0000-0001-6739-7610; Cooke, Graham/0000-0001-6475-5056; Wilkinson, Robert/0000-0002-2753-1800	Wellcome Trust [088316]; Medical Research Council [U.1175.02.002.00014.01]; Medical Research Council [MC_U117588499] Funding Source: researchfish; MRC [MC_U117588499] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Imperial College Healthcare Charity, RJW is supported by the Wellcome Trust (088316) and Medical Research Council U.1175.02.002.00014.01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspray TJ, 2005, BONE, V36, P710, DOI 10.1016/j.bone.2005.01.002; Bech A, 2012, HIV MED; Berndt T, 2009, PHYSIOLOGY, V24, P17, DOI 10.1152/physiol.00034.2008; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Burnett SAM, 2006, J BONE MINER RES, V21, P1187, DOI 10.1359/JBMR.060507; Childs KE, 2010, AIDS RES HUM RETROV, V26, P855, DOI 10.1089/aid.2009.0308; Daria P, 2011, AIDS, V25, P1430, DOI 10.1097/QAD.0b013e328349060e; Fausto A, 2006, BONE, V38, P893, DOI 10.1016/j.bone.2005.11.001; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Health Do, 1991, DIETARY REFERENCE VA; Heaney RP, 2003, J AM COLL NUTR, V22, P142, DOI 10.1080/07315724.2003.10719287; Hoare J, 2004, NATL DIET NUTR SURVE; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Izzedine H, 2009, NAT REV NEPHROL, V5, P564, DOI 10.1038/nrneph.2009.142; Masia M, 2012, AIDS RES HUM RETROV, V28, P242, DOI [10.1089/aid.2011.0052, 10.1089/AID.2011.0052]; Maunsell Z, 2005, CLIN CHEM, V51, P1683, DOI 10.1373/clinchem.2005.052936; MAWER EB, 1990, CLIN CHIM ACTA, V190, P199, DOI 10.1016/0009-8981(90)90174-Q; Mueller NJ, 2010, AIDS, V24, P1127, DOI 10.1097/QAD.0b013e328337b161; NELSON M, 1988, Journal of Human Nutrition and Dietetics, V1, P115, DOI 10.1111/j.1365-277X.1988.tb00443.x; Perrot S, 2009, JCR-J CLIN RHEUMATOL, V15, P72, DOI 10.1097/RHU.0b013e31819c20d8; Prentice A, 2008, BONE, V42, P788, DOI 10.1016/j.bone.2007.11.014; Rodriguez-Novoa S, 2009, CLIN INFECT DIS, V48, pE108, DOI 10.1086/598507; Rosenvinge MM, 2010, JAIDS-J ACQ IMM DEF, V54, P496, DOI 10.1097/QAI.0b013e3181caebaa; Saidenberg-Kermanac'h N, 2011, JOINT BONE SPINE, V78, P306, DOI 10.1016/j.jbspin.2010.11.007; Stellbrink HJ, 2010, CLIN INFECT DIS, V51, P963, DOI 10.1086/656417; van Vonderen MGA, 2009, AIDS, V23, P1367, DOI 10.1097/QAD.0b013e32832c4947; Williams John, 2006, J Infect, V52, pe107, DOI 10.1016/j.jinf.2005.07.014; Woodward CLN, 2009, HIV MED, V10, P482, DOI 10.1111/j.1468-1293.2009.00716.x	29	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44845	10.1371/journal.pone.0044845	http://dx.doi.org/10.1371/journal.pone.0044845			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984574	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500091
J	Shimura, H; Itoh, K; Sugiyama, A; Ichijo, S; Ichijo, M; Furuya, F; Nakamura, Y; Kitahara, K; Kobayashi, K; Yukawa, Y; Kobayashi, T				Shimura, Hiroki; Itoh, Katsuhiko; Sugiyama, Atsushi; Ichijo, Sayaka; Ichijo, Masashi; Furuya, Fumihiko; Nakamura, Yuji; Kitahara, Ken; Kobayashi, Kazuhiko; Yukawa, Yasuhiro; Kobayashi, Tetsuro			Absorption of Radionuclides from the Fukushima Nuclear Accident by a Novel Algal Strain	PLOS ONE			English	Article							CELL-WALL; CONTAMINATION; STRONTIUM; KELP	Large quantities of radionuclides have leaked from the Fukushima Daiichi Nuclear Power Plant into the surrounding environment. Effective prevention of health hazards resulting from radiation exposure will require the development of efficient and economical methods for decontaminating radioactive wastewater and aquatic ecosystems. Here we describe the accumulation of water-soluble radionuclides released by nuclear reactors by a novel strain of alga. The newly discovered green microalgae, Parachlorella sp. binos (Binos) has a thick alginate-containing extracellular matrix and abundant chloroplasts. When this strain was cultured with radioiodine, a light-dependent uptake of radioiodine was observed. In dark conditions, radioiodine uptake was induced by addition of hydrogen superoxide. High-resolution secondary ion mass spectrometry (SIMS) showed a localization of accumulated iodine in the cytosol. This alga also exhibited highly efficient incorporation of the radioactive isotopes strontium and cesium in a light-independent manner. SIMS analysis showed that strontium was distributed in the extracellular matrix of Binos. Finally we also showed the ability of this strain to accumulate radioactive nuclides from water and soil samples collected from a heavily contaminated area in Fukushima. Our results demonstrate that Binos could be applied to the decontamination of iodine, strontium and cesium radioisotopes, which are most commonly encountered after nuclear reactor accidents.	[Shimura, Hiroki; Yukawa, Yasuhiro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Environm Med, Chuo Ku, Yamanashi, Japan; [Shimura, Hiroki; Ichijo, Sayaka; Ichijo, Masashi; Furuya, Fumihiko; Kobayashi, Tetsuro] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Internal Med 3, Chuo Ku, Yamanashi, Japan; [Itoh, Katsuhiko] Kitasato Inst, Kitasato Acad Res Org, Dept Business Dev, Sagamihara, Kanagawa, Japan; [Sugiyama, Atsushi; Nakamura, Yuji; Kitahara, Ken] Toho Univ, Sch Med, Dept Pharmacol, Ota Ku, Tokyo, Japan; [Kobayashi, Kazuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Global Agr Sci, Bunkyo Ku, Tokyo, Japan; [Yukawa, Yasuhiro] Japan Biomass Corp, Kashiwa, Chiba, Japan	University of Yamanashi; University of Yamanashi; Kitasato University; University of Tokyo	Shimura, H (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Environm Med, Chuo Ku, Yamanashi, Japan.	tetsurou@yamanashi.ac.jp	Kobayashi, Kazuhiko/AAN-7096-2020		Grants-in-Aid for Scientific Research [24651074] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bolsunovsky A, 2011, J ENV RADIOACT; Brumfiel G, 2011, NATURE, V474, P135, DOI 10.1038/474135a; Colin C, 2003, J BIOL CHEM, V278, P23545, DOI 10.1074/jbc.M300247200; Davis TA, 2003, WATER RES, V37, P4311, DOI 10.1016/S0043-1354(03)00293-8; Endo S, 2012, J ENVIRON RADIOACTIV, V111, P18, DOI 10.1016/j.jenvrad.2011.11.006; Guerquin-Kern JL, 2005, BBA-GEN SUBJECTS, V1724, P228, DOI 10.1016/j.bbagen.2005.05.013; Japan Biomass Corporation, 2011, Japan patent, Patent No. [PCT/JP2009/65025, PCTJP200965025]; Krejci MR, 2011, CHEMSUSCHEM, V4, P470, DOI 10.1002/cssc.201000448; Kupper FC, 2008, P NATL ACAD SCI USA, V105, P6954, DOI 10.1073/pnas.0709959105; Moysich KB, 2002, LANCET ONCOL, V3, P269, DOI 10.1016/S1470-2045(02)00727-1; Nuclear and Industrial Safety Agency, REG EV COND REACT CO; PATTERSON CO, 1973, PLANT PHYSIOL, V51, P104, DOI 10.1104/pp.51.1.104; Peplow M, 2011, NATURE, V471, P562, DOI 10.1038/471562a; Sato I, 2011, J TOXICOL SCI, V36, P829, DOI 10.2131/jts.36.829; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vinichuk MM, 2005, J ENVIRON RADIOACTIV, V78, P77, DOI 10.1016/j.jenvrad.2004.02.008; Yablokov AV, 2009, ANN NY ACAD SCI, V1181, P5, DOI [10.1111/j.1749-6632.2009.04821.x, 10.1111/j.1749-6632.2009.04820.x]; Yamamoto M, 2005, PLANTA, V221, P766, DOI 10.1007/s00425-005-1486-8; Yamamoto M, 2003, J PHYCOL, V39, P172, DOI 10.1046/j.1529-8817.2003.02052.x	19	41	42	4	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44200	10.1371/journal.pone.0044200	http://dx.doi.org/10.1371/journal.pone.0044200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984475	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500036
J	Basavaraj, S; Yan, J				Basavaraj, Sidhesh; Yan, Jun			Prepulse Inhibition of Acoustic Startle Reflex as a Function of the Frequency Difference between Prepulse and Background Sounds in Mice	PLOS ONE			English	Article							AUDITORY-CORTEX; RATS; STIMULATION; MODULATION; SYSTEM; BRAIN; DISCRIMINATION; ENVIRONMENTS; INTENSITY; EVOCATION	Background: Prepulse inhibition (PPI) depicts the effects of a weak sound preceding strong acoustic stimulus on acoustic startle response (ASR). Previous studies suggest that PPI is influenced by physical parameters of prepulse sound such as intensity and preceding time. The present study characterizes the impact of prepulse tone frequency on PPI. Methods: Seven female C57BL mice were used in the present study. ASR was induced by a 100 dB SPL white noise burst. After assessing the effect of background sounds (white noise and pure tones) on ASR, PPI was tested by using prepulse pure tones with the background tone of either 10 or 18 kHz. The inhibitory effect was assessed by measuring and analyzing the changes in the first peak-to-peak magnitude, root mean square value, duration and latency of the ASR as the function of frequency difference between prepulse and background tones. Results: Our data showed that ASR magnitude with pure tone background varied with tone frequency and was smaller than that with white noise background. Prepulse tone systematically reduced ASR as the function of the difference in frequency between prepulse and background tone. The 0.5 kHz difference appeared to be a prerequisite for inducing substantial ASR inhibition. The frequency dependence of PPI was similar under either a 10 or 18 kHz background tone. Conclusion: PPI is sensitive to frequency information of the prepulse sound. However, the critical factor is not tone frequency itself, but the frequency difference between the prepulse and background tones.	[Basavaraj, Sidhesh; Yan, Jun] Univ Calgary, Fac Med, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Calgary	Basavaraj, S (corresponding author), Univ Calgary, Fac Med, Hotchkiss Brain Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.	juyan@ucalgary.ca			Canadian Institute of Health Research; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates - Health Solutions	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates - Health Solutions	Funding: 1. The Canadian Institute of Health Research (http://www.cihr.ca/e/193.html), 2. The Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), 3. The Alberta Innovates - Health Solutions (http://www.aihealthsolutions.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey PJ, 2002, BRIT MED BULL, V63, P135, DOI 10.1093/bmb/63.1.135; BLUMENTHAL TD, 1987, PSYCHOPHYSIOLOGY, V24, P320, DOI 10.1111/j.1469-8986.1987.tb00302.x; BLUMENTHAL TD, 1989, PSYCHOPHYSIOLOGY, V26, P158, DOI 10.1111/j.1469-8986.1989.tb03148.x; Blumenthal TD, 1996, BIOL PSYCHOL, V44, P85, DOI 10.1016/0301-0511(96)05214-3; BLUMENTHAL TD, 1995, PERCEPT PSYCHOPHYS, V57, P487, DOI 10.3758/BF03213074; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; BROWN P, 1991, BRAIN, V114, P1891, DOI 10.1093/brain/114.4.1891; BUCKLAND G, 1969, J COMP PHYSIOL PSYCH, V67, P493, DOI 10.1037/h0027307; Carlson S, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P83; Clause A, 2011, J NEUROSCI METH, V200, P63, DOI 10.1016/j.jneumeth.2011.05.027; Crippa Alessandro, 2010, Open Neuroimag J, V4, P16, DOI 10.2174/1874440001004010016; DAVIS M, 1982, J NEUROSCI, V2, P791; DAWSON ME, 1993, J ABNORM PSYCHOL, V102, P633, DOI 10.1037/0021-843X.102.4.633; Du Y, 2011, J NEUROSCI, V31, P13644, DOI 10.1523/JNEUROSCI.1292-11.2011; Fendt M, 2001, PSYCHOPHARMACOLOGY, V156, P216, DOI 10.1007/s002130100794; GERRARD RL, 1990, J EXP PSYCHOL-ANIM B, V16, P106, DOI 10.1037/0097-7403.16.1.106; HOFFMAN HS, 1963, SCIENCE, V141, P928, DOI 10.1126/science.141.3584.928; HOFFMAN HS, 1964, J COMP PHYSIOL PSYCH, V58, P132, DOI 10.1037/h0045324; HOFFMAN HS, 1980, PSYCHOL REV, V87, P175, DOI 10.1037/0033-295X.87.2.175; HOFFMAN HS, 1968, J ACOUST SOC AM, V43, P269, DOI 10.1121/1.1910776; HOFFMAN HS, 1965, J COMP PHYSIOL PSYCH, V60, P53, DOI 10.1037/h0022325; ISON JR, 1971, J COMP PHYSIOL PSYCH, V75, P435, DOI 10.1037/h0030934; Jennings PD, 1996, PSYCHOPHYSIOLOGY, V33, P148, DOI 10.1111/j.1469-8986.1996.tb02118.x; Koch M, 1997, BEHAV BRAIN RES, V89, P35, DOI 10.1016/S0166-4328(97)02296-1; LANE SJ, 1991, PSYCHOPHYSIOLOGY, V28, P579, DOI 10.1111/j.1469-8986.1991.tb01997.x; Larrauri Jose, 2006, EXS, V98, P245; Lee YL, 1996, J NEUROSCI, V16, P3775; Li L, 2009, NEUROSCI BIOBEHAV R, V33, P1157, DOI 10.1016/j.neubiorev.2009.02.001; Morgane PJ, 2006, NEUROSCI BIOBEHAV R, V30, P119, DOI 10.1016/j.neubiorev.2005.04.020; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; PINCKNEY LA, 1976, ANIM LEARN BEHAV, V4, P467, DOI 10.3758/BF03214441; Plappert CF, 2004, BEHAV BRAIN RES, V152, P403, DOI 10.1016/j.bbr.2003.10.025; POWELL EW, 1974, BEHAV BIOL, V12, P149, DOI 10.1016/S0091-6773(74)91162-6; REIJMERS LGJE, 1994, BRAIN RES, V667, P144, DOI 10.1016/0006-8993(94)91727-2; SCHWARTZ GM, 1976, J EXP PSYCHOL ANIM B, V2, P28, DOI 10.1037/0097-7403.2.1.28; Sloan AM, 2009, HEARING RES, V251, P60, DOI 10.1016/j.heares.2009.02.009; STITT CL, 1973, J COMP PHYSIOL PSYCH, V84, P207, DOI 10.1037/h0035056; STITT CL, 1974, J COMP PHYSIOL PSYCH, V86, P826, DOI 10.1037/h0036419; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; VALLSSOLE J, 1995, NEUROSCI LETT, V195, P97, DOI 10.1016/0304-3940(94)11790-P; Willott JF, 2008, HEARING RES, V235, P60, DOI 10.1016/j.heares.2007.10.006; WILLOTT JF, 1994, BEHAV NEUROSCI, V108, P703, DOI 10.1037/0735-7044.108.4.703; Wright BA, 2009, PHILOS T R SOC B, V364, P301, DOI 10.1098/rstb.2008.0262; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Yee BK, 2005, BEHAV BRAIN RES, V163, P265, DOI 10.1016/j.bbr.2005.05.013; Yeomans JS, 1995, BRAIN RES REV, V21, P301, DOI 10.1016/0165-0173(96)00004-5; Zhang YF, 2005, HEARING RES, V201, P145, DOI 10.1016/j.heares.2004.10.003	47	11	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e45123	10.1371/journal.pone.0045123	http://dx.doi.org/10.1371/journal.pone.0045123			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984620	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700110
J	Norden, J; Grieskamp, T; Christoffels, VM; Moorman, AFM; Kispert, A				Norden, Julia; Grieskamp, Thomas; Christoffels, Vincent M.; Moorman, Antoon F. M.; Kispert, Andreas			Partial Absence of Pleuropericardial Membranes in Tbx18- and Wt1-Deficient Mice	PLOS ONE			English	Article							PERICARDIAL DEFECTS; CONGENITAL ABSENCE; GENE	The pleuropericardial membranes are fibro-serous walls that separate the pericardial and pleural cavities and anchor the heart inside the mediastinum. Partial or complete absence of pleuropericardial membranes is a rare human disease, the etiology of which is poorly understood. As an attempt to better understand these defects, we wished to analyze the cellular and molecular mechanisms directing the separation of pericardial and pleural cavities by pleuropericardial membranes in the mouse. We found by histological analyses that both in Tbx18- and Wt1-deficient mice the pleural and pericardial cavities communicate due to a partial absence of the pleuropericardial membranes in the hilus region. We trace these defects to a persisting embryonic connection between these cavities, the pericardioperitoneal canals. Furthermore, we identify mesenchymal ridges in the sinus venosus region that tether the growing pleuropericardial membranes to the hilus of the lung, and thus, close the pericardioperitoneal canals. In Tbx18-deficient embryos these mesenchymal ridges are not established, whereas in Wt1-deficient embryos the final fusion process between these tissues and the body wall does not occur. We suggest that this fusion is an active rather than a passive process, and discuss the interrelation between closure of the pericardioperitoneal canals, lateral release of the pleuropericardial membranes from the lateral body wall, and sinus horn development.	[Norden, Julia; Grieskamp, Thomas; Kispert, Andreas] Hannover Med Sch, Inst Mol Biol, OE5250, D-30623 Hannover, Germany; [Christoffels, Vincent M.; Moorman, Antoon F. M.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands	Hannover Medical School; University of Amsterdam; Academic Medical Center Amsterdam	Norden, J (corresponding author), Hannover Med Sch, Inst Mol Biol, OE5250, D-30623 Hannover, Germany.	kispert.andreas@mh-hannover.de			European Community [LSHM-CT-2005-018630]; German Research Foundation (DFG) [KFO136]	European Community(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the European Community's Sixth Framework Programme contract ('HeartRepair' LSHM-CT-2005-018630), the German Research Foundation (DFG) for the Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) and for the Clinical Research Group KFO136 at Hannover Medical School to A. K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussen M, 2004, GENE DEV, V18, P1209, DOI 10.1101/gad.300104; Christoffels VM, 2006, CIRC RES, V98, P1555, DOI 10.1161/01.RES.0000227571.84189.65; Faridah Y, 2002, INT J CARDIOVAS IMAG, V18, P67, DOI 10.1023/A:1014350814067; Frick H, 1949, Z ANAT ENTWICKLUNGS, V114, P230; Kraus F, 2001, MECH DEVELOP, V100, P83, DOI 10.1016/S0925-4773(00)00494-9; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Norden J, 2010, CIRC RES, V106, P1212, DOI 10.1161/CIRCRESAHA.110.217455; OYAMADA A, 1953, AMA AM J DIS CHILD, V85, P182, DOI 10.1001/archpedi.1953.02050070191007; Perna G., 1909, ANAT ANZEIGER, V35, P323; Sadler T.W., 2003, MED EMBRYOLOGIE NORM; Saffirio C, 2007, ANN THORAC SURG, V84, P2137, DOI 10.1016/j.athoracsur.2007.06.103; Salzer GM, 1959, ANAT EMBRYOL BERL, V121, P54; Salzer GM, 1960, ANAT EMBRYOL BERL, V122, P232; Sunderland S, 1944, BRIT HEART J, V6, P167; USKOW N, 1883, ARCH MIKROSK ANAT, V22, P143; VESELY T, 1989, SURG RADIOL ANAT, V11, P171, DOI 10.1007/BF02096477; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062	18	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e45100	10.1371/journal.pone.0045100	http://dx.doi.org/10.1371/journal.pone.0045100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984617	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700109
J	Opazo, R; Ortuzar, F; Navarrete, P; Espejo, R; Romero, J				Opazo, Rafael; Ortuzar, Felipe; Navarrete, Paola; Espejo, Romilio; Romero, Jaime			Reduction of Soybean Meal Non-Starch Polysaccharides and alpha-Galactosides by Solid-State Fermentation Using Cellulolytic Bacteria Obtained from Different Environments	PLOS ONE			English	Article							ANTINUTRITIONAL FACTORS; PROTEIN ENRICHMENT; TEMPERATURE; OLIGOSACCHARIDES; AMPLIFICATION; STREPTOMYCES; POPULATIONS; DIVERSITY; AQUAFEEDS; DIGESTION	Soybean meal (SBM) is an important protein source in animal feed. However, the levels of SBM inclusion are restricted in some animal species by the presence of antinutritional factors (ANFs), including non-starch polysaccharides (NSPs) and alpha-galactosides (GOSs). The aim of this study was to reduce the soybean meal NSPs and GOSs by solid-state fermentation (SSF) using a combination of cellulolytic bacteria isolated from different environments (termites, earthworms, corn silage and bovine ruminal content). To analyse the key enzymatic activities, the isolates were grown in minimal media containing NSPs extracted from SBM. The selected bacterial strains belonged to the genera Streptomyces, Cohnella and Cellulosimicrobium. SSF resulted in a reduction of nearly 24% in the total NSPs, 83% of stachyose and 69% of raffinose and an increase in the protein content. These results suggest that cellulolytic bacteria-based SSF processing facilitates SBM nutritional improvement. In addition, the use of fermented SBM in animal diets can be recommended.	[Opazo, Rafael; Ortuzar, Felipe; Navarrete, Paola; Espejo, Romilio; Romero, Jaime] Univ Chile, INTA, Lab Biotecnol, Santiago, Chile	Universidad de Chile	Opazo, R (corresponding author), Univ Chile, INTA, Lab Biotecnol, Santiago, Chile.	jromero@inta.uchile.cl	navarrete, paola/B-5371-2014; Romero, Jaime/I-2816-2013; Espejo, Romilio T/J-3183-2015	navarrete, paola/0000-0003-0692-2324; Romero, Jaime/0000-0001-9614-2393; Espejo, Romilio T/0000-0003-0495-4576	CONICYT-Chile [FONDECYT 1080480/110253]; CORFO [INNOVA CHILE 05CT6PPT-09]; CONICYT	CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); CORFO; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This investigation was supported by grants FONDECYT 1080480/110253 from CONICYT-Chile and INNOVA CHILE 05CT6PPT-09 from CORFO. R. Opazo was supported by fellowships from CONICYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039331; AOAC, 2002, OFFICIAL METHODS ANA, V15th, DOI DOI 10.1007/978-3-642-31241-0; Bhat MK, 2000, BIOTECHNOL ADV, V18, P355, DOI 10.1016/S0734-9750(00)00041-0; Carrico JA, 2005, J CLIN MICROBIOL, V43, P5483, DOI 10.1128/JCM.43.11.5483-5490.2005; Carter C. G., 1994, Aquaculture and Fisheries Management, V25, P37, DOI 10.1111/j.1365-2109.1994.tb00664.x; Choct M, 2010, ASIAN AUSTRAL J ANIM, V23, P1386, DOI 10.5713/ajas.2010.90222; CHURCH FC, 1980, MYCOLOGIA, V72, P279, DOI 10.2307/3759251; Dharmaraj S, 2010, AFR J MICROBIOL RES, V4, P240; Dunn O. J., 2009, NONPARAMETRIC STAT, P189; El-Naggar MY, 2009, J MICROBIOL BIOTECHN, V19, P468, DOI 10.4014/jmb.0807.457; ENGLYST HN, 1994, ANALYST, V119, P1497, DOI 10.1039/an9941901497; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; GHOSE TK, 1987, PURE APPL CHEM, V59, P257, DOI 10.1351/pac198759020257; Giannoccaro E, 2006, J FOOD SCI, V71, pC59, DOI 10.1111/j.1365-2621.2006.tb12389.x; Gonzalez N, 2003, J MICROBIOL METH, V55, P91, DOI 10.1016/S0167-7012(03)00110-6; Graminha EBN, 2008, ANIM FEED SCI TECH, V144, P1, DOI 10.1016/j.anifeedsci.2007.09.029; HENDRICKS CW, 1995, APPL ENVIRON MICROB, V61, P2016, DOI 10.1128/AEM.61.5.2016-2019.1995; Huisman MMH, 1998, CARBOHYD POLYM, V37, P87, DOI 10.1016/S0144-8617(97)00111-2; Jezierny D, 2010, ANIM FEED SCI TECH, V157, P111, DOI 10.1016/j.anifeedsci.2010.03.001; Karr-Lilienthal LK, 2005, LIVEST PROD SCI, V97, P1, DOI 10.1016/j.livprodsci.2005.01.015; Kaufman L, 2008, INTRODUCTION, P1; Killham K., 2007, SOIL MICROBIOLOGY EC, P120; Kim SW, 2010, J ANIM SCI, V88, P214, DOI 10.2527/jas.2009-1993; Knudsen KEB, 1997, ANIM FEED SCI TECH, V67, P319, DOI 10.1016/S0377-8401(97)00009-6; LeBlanc JG, 2004, APPL MICROBIOL BIOT, V65, P119, DOI 10.1007/s00253-003-1532-z; LONSANE BK, 1985, ENZYME MICROB TECH, V7, P258, DOI 10.1016/0141-0229(85)90083-3; LOQUET M, 1984, APPL BIOCHEM BIOTECH, V9, P377, DOI 10.1007/BF02798984; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Magne F, 2006, FEMS MICROBIOL ECOL, V57, P128, DOI 10.1111/j.1574-6941.2006.00097.x; McCracken VJ, 2001, J NUTR, V131, P1862, DOI 10.1093/jn/131.6.1862; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NIGAM P, 1994, J BASIC MICROB, V34, P405, DOI 10.1002/jobm.3620340607; NITISINPRASERT S, 1991, J APPL BACTERIOL, V71, P154, DOI 10.1111/j.1365-2672.1991.tb02972.x; Oh HW, 2008, ANTON LEEUW INT J G, V93, P437, DOI 10.1007/s10482-007-9210-2; OLLI JJ, 1994, ACTA AGR SCAND A-AN, V44, P50, DOI 10.1080/09064709409410181; Pandey A, 2003, BIOCHEM ENG J, V13, P81, DOI 10.1016/S1369-703X(02)00121-3; Perez J., 2002, International Microbiology, V5, P53, DOI 10.1007/s10123-002-0062-3; Poulsen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016763; Prajapati JB, 2008, FUNCT FOOD NUTRA SER, P1; Refstie S, 2005, AQUACULTURE, V246, P331, DOI 10.1016/j.aquaculture.2005.01.001; Brasil APR, 2010, FOOD CHEM, V118, P251, DOI 10.1016/j.foodchem.2009.04.124; ROUSSOS S, 1994, OLEAGINEUX, V49, P235; Ruijssenaars HJ, 2001, APPL MICROBIOL BIOT, V55, P143, DOI 10.1007/s002530000477; Russell JB, 2009, FEMS MICROBIOL ECOL, V67, P183, DOI 10.1111/j.1574-6941.2008.00633.x; Smits JP, 1998, ENZYME MICROB TECH, V22, P50, DOI 10.1016/S0141-0229(97)00103-8; Soccol CR, 2003, BIOCHEM ENG J, V13, P205, DOI 10.1016/S1369-703X(02)00133-X; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tirado O, 2005, J MAR BIOL ASSOC UK, V85, P269, DOI 10.1017/S002531540501115Xh; Ugwuanyi JO, 2008, BIORESOURCE TECHNOL, V99, P6974, DOI 10.1016/j.biortech.2008.01.025; Vargas-Garcia MC, 2010, WASTE MANAGE, V30, P771, DOI 10.1016/j.wasman.2009.12.019; Villas-Boas SG, 2002, ANIM FEED SCI TECH, V98, P1, DOI 10.1016/S0377-8401(02)00017-2; Wei H, 2009, CURR OPIN BIOTECH, V20, P330, DOI 10.1016/j.copbio.2009.05.008; Wenzel M, 2002, J APPL MICROBIOL, V92, P32, DOI 10.1046/j.1365-2672.2002.01502.x; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Wilson Robert P., 2002, P143; Zhou Z, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S8; Zubkov MV, 1999, APPL ENVIRON MICROB, V65, P3251	59	20	24	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44783	10.1371/journal.pone.0044783	http://dx.doi.org/10.1371/journal.pone.0044783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984557	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700082
J	Duprez, DA; Neuhaus, J; Kuller, LH; Tracy, R; Belloso, W; De Wit, S; Drummond, F; Lane, HC; Ledergerber, B; Lundgren, J; Nixon, D; Paton, NI; Prineas, RJ; Neaton, JD				Duprez, Daniel A.; Neuhaus, Jacqueline; Kuller, Lewis H.; Tracy, Russell; Belloso, Waldo; De Wit, Stephane; Drummond, Fraser; Lane, H. Clifford; Ledergerber, Bruno; Lundgren, Jens; Nixon, Daniel; Paton, Nicholas I.; Prineas, Ronald J.; Neaton, James D.		INSIGHT SMART Study Grp	Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; D-DIMER; ANTIRETROVIRAL THERAPY; OPPORTUNISTIC DISEASE; RISK; BIOMARKERS; DEATH; INTERLEUKIN-6; THROMBOSIS; EVENTS	Background: The SMART study was a trial of intermittent use of antiretroviral therapy (ART) (drug conservation [DC]) versus continuous use of ART (viral suppression [VS]) as a strategy to reduce toxicities, including cardiovascular disease (CVD) risk. We studied the predictive value of high sensitivity C-reactive protein (hsCRP), interleukin-6 (IL-6) and D-dimer with CVD morbidity and mortality in HIV-infected patients who were enrolled in SMART beyond other measured CVD risk factors. Methods: A blood sample was available in 5098 participants who were enrolled in the SMART study for the measurement of IL-6, hsCRP and D-dimer. Hazard ratios (HR) with 95% CI for CVD events were estimated for each quartile (Q) for each biomarker vs the 1st quartile and for 1 SD higher levels. For both treatment groups combined, unadjusted and adjusted HRs were determined using Cox regression models. Results: There were 252 participants who had a CVD event over a median follow-up of 29 months. Adjusted HRs (95% CI) for CVD for Q4 vs Q1 were 4.65 (2.61, 8.29), 2.10 (1.40, 3.16), and 2.14 (1.38, 3.33) for IL-6, hsCRP and D-dimer, respectively. Associations were similar for the DC and VS treatment groups (interaction p-values were >0.30). The addition of the three biomarkers to a model that included baseline covariates significantly improved model fit (p<0.001). Area under the curve (AUC) estimates improved with inclusion of the three biomarkers in a model that included baseline covariates corresponding to other CVD risk factors and HIV factors (0.741 to 0.771; p<0.001 for difference). Conclusions: In HIV-infected individuals, IL-6, hsCRP and D-dimer are associated with an increased risk of CVD independent of other CVD risk factors. Further research is needed to determine whether these biomarkers can be used to improve CVD risk prediction among HIV positive individuals.	[Duprez, Daniel A.; Neuhaus, Jacqueline; Neaton, James D.] Univ Minnesota, Minneapolis, MN 55455 USA; [Kuller, Lewis H.] Univ Pittsburgh, Pittsburgh, PA USA; [Tracy, Russell] Univ Vermont, Burlington, VT USA; [Belloso, Waldo] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [De Wit, Stephane] St Pierre Hosp, Brussels, Belgium; [Drummond, Fraser] Univ New S Wales, Fac Med, Kirby Inst, Sydney, NSW, Australia; [Lane, H. Clifford] NIAID, NIH, Bethesda, MD 20892 USA; [Ledergerber, Bruno] Univ Zurich, Univ Zurich Hosp, Zurich, Switzerland; [Lundgren, Jens] Univ Copenhagen, Copenhagen, Denmark; [Nixon, Daniel] Virginia Commonwealth Univ, Richmond, VA USA; [Paton, Nicholas I.] MRC, Clin Trials Unit, London, England; [Prineas, Ronald J.] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA	University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Vermont; Hospital Italiano de Buenos Aires; University of Buenos Aires; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of New South Wales Sydney; Kirby Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Zurich; University Zurich Hospital; University of Copenhagen; Virginia Commonwealth University; Medical Research Council Clinical Trials Unit; Wake Forest University; Wake Forest Baptist Medical Center	Duprez, DA (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.	dupre007@umn.edu	Ledergerber, Bruno/B-5656-2009; Emery, Sean/J-3825-2017; Emery, Sean/O-9122-2019; Lundgren, Jens/AAE-6876-2019	Ledergerber, Bruno/0000-0002-6881-4401; Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Lundgren, Jens/0000-0001-8901-7850	NIAD, United States National Institutes of Health [UO1AI068641, U01AI042170, U01AI046362]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI042170, U01AI068641, ZIAAI000585, U01AI046362] Funding Source: NIH RePORTER; MRC [MC_U122886352] Funding Source: UKRI; Medical Research Council [MC_U122886352] Funding Source: researchfish	NIAD, United States National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Support for this work was provided by NIAD, United States National Institutes of Health grants UO1AI068641, U01AI042170, and U01AI046362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker J, 2010, HIV MED, V11, P608, DOI 10.1111/j.1468-1293.2010.00835.x; Baker JV, 2011, EUR HEART J, V32, P945, DOI 10.1093/eurheartj/ehq483; Baker JV, 2011, JAIDS-J ACQ IMM DEF, V56, P36, DOI 10.1097/QAI.0b013e3181f7f61a; Baker JV, 2010, CURR OPIN HIV AIDS, V5, P511, DOI 10.1097/COH.0b013e32833ed7ec; Blum A, 2005, CLIN CARDIOL, V28, P149, DOI 10.1002/clc.4960280311; Calmy A, 2009, ANTIVIR THER, V14, P165; Chambless LE, 2006, STAT MED, V25, P3474, DOI 10.1002/sim.2299; Croce K, 2007, CURR OPIN HEMATOL, V14, P55, DOI 10.1097/00062752-200701000-00011; Currier Judith S, 2008, Circulation, V118, pe29, DOI 10.1161/CIRCULATIONAHA.107.189624; Danesh J, 2001, CIRCULATION, V103, P2323; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; El-Sadr WM, 2008, ANN INTERN MED, V149, P289, DOI 10.7326/0003-4819-149-5-200809020-00003; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Folsom AR, 2009, AM J HEMATOL, V84, P349, DOI 10.1002/ajh.21429; Ford ES, 2010, AIDS, V24, P1509, DOI 10.1097/QAD.0b013e32833ad914; Friis-Moller N, 2003, NEW ENGL J MED, V349, P1993, DOI 10.1056/NEJMoa030218; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Grinspoon S. K., 2008, Circulation, V118, P198, DOI 10.1161/CIRCULATIONAHA.107.189622; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Ho JE, 2009, HEART, V95, P1193, DOI 10.1136/hrt.2008.161463; Hogg RS, 1998, JAMA-J AM MED ASSOC, V279, P450, DOI 10.1001/jama.279.6.450; Hsue PY, 2009, AIDS, V23, P2021, DOI 10.1097/QAD.0b013e32832e7140; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Karpatkin S, 2002, THROMB HAEMOSTASIS, V88, P389; Kowalska JD, 2011, EPIDEMIOLOGY, V22, P516, DOI 10.1097/EDE.0b013e31821b5332; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Lifson AR, 2010, HIV CLIN TRIALS, V11, P205, DOI 10.1310/hct1104-205; Mocroft A, 2003, LANCET, V362, P22, DOI 10.1016/S0140-6736(03)13802-0; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Palella FJ, 2011, CURR OPIN HIV AIDS, V6, P266, DOI 10.1097/COH.0b013e328347876c; Phillips AN, 2008, ANTIVIR THER, V13, P177; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Shen YMP, 2004, CLIN APPL THROMB-HEM, V10, P277, DOI 10.1177/107602960401000311; Shorr AF, 2002, CHEST, V121, P1262, DOI 10.1378/chest.121.4.1262; Soliman EZ, 2011, J ELECTROCARDIOL, V44, P779, DOI 10.1016/j.jelectrocard.2010.10.027; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084	38	386	388	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44454	10.1371/journal.pone.0044454	http://dx.doi.org/10.1371/journal.pone.0044454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970224	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000308748400019
J	McLeish, MJ; Beukman, G; van Noort, S; Wossler, TC				McLeish, Michael J.; Beukman, Gary; van Noort, Simon; Wossler, Theresa C.			Host-Plant Species Conservatism and Ecology of a Parasitoid Fig Wasp Genus (Chalcidoidea; Sycoryctinae; Arachonia)	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; APPARENT COMPETITION; GLOBAL PATTERNS; TROPHIC LEVELS; SPECIATION; COMMUNITY; DIVERSIFICATION; POLLINATORS; HYMENOPTERA; EVOLUTION	Parasitoid diversity in terrestrial ecosystems is enormous. However, ecological processes underpinning their evolutionary diversification in association with other trophic groups are still unclear. Specialisation and interdependencies among chalcid wasps that reproduce on Ficus presents an opportunity to investigate the ecology of a multi-trophic system that includes parasitoids. Here we estimate the host-plant species specificity of a parasitoid fig wasp genus that attacks the galls of non-pollinating pteromalid and pollinating agaonid fig wasps. We discuss the interactions between parasitoids and the Ficus species present in a forest patch of Uganda in context with populations in Southern Africa. Haplotype networks are inferred to examine intraspecific mitochondrial DNA divergences and phylogenetic approaches used to infer putative species relationships. Taxonomic appraisal and putative species delimitation by molecular and morphological techniques are compared. Results demonstrate that a parasitoid fig wasp population is able to reproduce on at least four Ficus species present in a patch. This suggests that parasitoid fig wasps have relatively broad host-Ficus species ranges compared to fig wasps that oviposit internally. Parasitoid fig wasps did not recruit on all available host plants present in the forest census area and suggests an important ecological consequence in mitigating fitness trade-offs between pollinator and Ficus reproduction. The extent to which parasitoid fig wasps exert influence on the pollination mutualism must consider the fitness consequences imposed by the ability to interact with phenotypes of multiple Ficus and fig wasps species, but not equally across space and time.	[McLeish, Michael J.] Chinese Acad & Sci, Plant Geog Lab, Xishuangbanna Trop Bot Gardens, Mengla, Yunnan, Peoples R China; [Beukman, Gary; Wossler, Theresa C.] Univ Stellenbosch, Dept Bot & Zool, DST NRF Ctr Excellence Invas Biol, Matieland, South Africa; [van Noort, Simon] Iziko S African Museum, Nat Hist Dept, Cape Town, South Africa; [van Noort, Simon] Univ Cape Town, Dept Zool, ZA-7925 Cape Town, South Africa	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; National Research Foundation - South Africa; Stellenbosch University; University of Cape Town	McLeish, MJ (corresponding author), Chinese Acad & Sci, Plant Geog Lab, Xishuangbanna Trop Bot Gardens, Mengla, Yunnan, Peoples R China.	michaelm@xtbg.org.cn	van Noort, Simon/C-4006-2017	van Noort, Simon/0000-0001-6930-9741; Wossler, Theresa/0000-0003-3725-6133	Claude Leon Foundation; START secretariat; South African National Research Foundation [GUN 61497]; National Research Foundation [IFR2009090800013]; Centre for Invasion Biology	Claude Leon Foundation; START secretariat; South African National Research Foundation(National Research Foundation - South Africa); National Research Foundation; Centre for Invasion Biology	This work supported by the Claude Leon Foundation and START secretariat and by a South African National Research Foundation grant GUN 61497. This material is partially supported financially by the National Research Foundation, Ref. no. IFR2009090800013 and the Centre for Invasion Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDURAHIMAN UC, 1978, ENTOMON, V3, P181; AVISE JC, 1990, OXFORD SURVEYS EVOLU, V7, P43; Berg C.C., 1992, AFRICAN FIG TREES FI; BOUCEK Z, 1981, Tijdschrift voor Entomologie, V124, P149; Bronstein JL, 2003, AM NAT, V162, pS24, DOI 10.1086/378645; Buffington M. L., 2005, American Entomologist, V51, P50; Buffington Matthew, 2008, American Entomologist, V54, P222; Burrows J., 2003, FIGS SO S CENTRAL AF; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Compton S., 1988, Antenna, V12, P102; COMPTON SG, 1988, ECOLOGY, V69, P1302, DOI 10.2307/1941288; COMPTON SG, 1992, P K NED AKAD WETENSC, V95, P423; Compton Stephen G., 2005, Acta Societatis Zoologicae Bohemicae, V69, P37; Compton SG, 2009, AFR NAT HIST, V5, P9; Compton Stephen G., 1994, P343; CONNOR EF, 2001, ENCY BIODIVERSITY, V5, P297; Cook JM, 2010, ECOL ENTOMOL, V35, P54, DOI 10.1111/j.1365-2311.2009.01148.x; Cornille A, 2012, P ROY SOC B-BIOL SCI, V279, P1731, DOI 10.1098/rspb.2011.1972; Cronin JT, 2007, ECOLOGY, V88, P2966, DOI 10.1890/07-0070.1; Cronin JT, 2005, P ROY SOC B-BIOL SCI, V272, P2225, DOI 10.1098/rspb.2005.3286; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DRUMMOND AJ, 2003, BEAST VERSION 1 4 8; Dunn DW, 2008, PLOS BIOL, V6, P490, DOI 10.1371/journal.pbio.0060059; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fatouros NE, 2008, BEHAV ECOL, V19, P677, DOI 10.1093/beheco/arn011; Feder JL, 2010, ECOL ENTOMOL, V35, P67, DOI 10.1111/j.1365-2311.2009.01144.x; Fellowes MDE, 1999, BEHAV ECOL SOCIOBIOL, V46, P95, DOI 10.1007/s002650050597; Fenoglio MS, 2010, ECOL ENTOMOL, V35, P594, DOI 10.1111/j.1365-2311.2010.01218.x; Fill A, 2012, ECOL ENTOMOL, V37, P43, DOI 10.1111/j.1365-2311.2011.01333.x; Forister ML, 2011, BIOTROPICA, V43, P270, DOI 10.1111/j.1744-7429.2010.00702.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Ghara M, 2010, ECOL ENTOMOL, V35, P139, DOI 10.1111/j.1365-2311.2010.01176.x; Gripenberg S, 2007, OIKOS, V116, P181, DOI [10.1111/j.2006.0030-1299.15266.x, 10.1111/j.0030-1299.2007.15266.x]; Grison-Pige L, 2002, J CHEM ECOL, V28, P283, DOI 10.1023/A:1017930023741; Grover JP, 1998, J THEOR BIOL, V191, P353, DOI 10.1006/jtbi.1997.0562; HAWKINS BA, 1990, J ANIM ECOL, V59, P57, DOI 10.2307/5158; HAWKINS BA, 1992, J ANIM ECOL, V61, P361, DOI 10.2307/5328; Hayward A, 2006, MOL ECOL, V15, P479, DOI 10.1111/j.1365-294X.2005.02811.x; Herre EA, 1997, P ROY SOC B-BIOL SCI, V264, P1501, DOI 10.1098/rspb.1997.0208; Herre EA, 1996, J BIOGEOGR, V23, P593, DOI 10.1111/j.1365-2699.1996.tb00020.x; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; HOLT RD, 1993, AM NAT, V142, P623, DOI 10.1086/285561; Holt RD, 1999, ECOLOGY, V80, P1495, DOI 10.2307/176542; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ideo S, 2008, ENTOMOL SCI, V11, P1, DOI 10.1111/j.1479-8298.2007.00244.x; Jackson AP, 2008, SYMBIOSIS, V45, P57; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Jousselin E, 2008, EVOLUTION, V62, P1777, DOI 10.1111/j.1558-5646.2008.00406.x; Kerr Peter H., 2008, American Entomologist, V54, P198; Kessler A, 2011, FUNCT ECOL, V25, P348, DOI 10.1111/j.1365-2435.2010.01818.x; Laing J, 1937, J ANIM ECOL, V6, P298, DOI 10.2307/1186; LASALLE J, 1991, REDIA, V74, P313; Marussich WA, 2007, MOL ECOL, V16, P1925, DOI 10.1111/j.1365-294X.2007.03278.x; McLeish MJ, 2010, MOL ECOL, V19, P1483, DOI 10.1111/j.1365-294X.2010.04583.x; McLeish M, 2011, NEW PHYTOL, V191, P210, DOI 10.1111/j.1469-8137.2011.03683.x; McLeish MJ, 2010, MOL PHYLOGENET EVOL, V57, P122, DOI 10.1016/j.ympev.2010.05.025; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Niogret J, 2009, ECOL ENTOMOL, V34, P763, DOI 10.1111/j.1365-2311.2009.01131.x; PATINO S, 1995, NEW PHYTOL, V129, P125, DOI 10.1111/j.1469-8137.1995.tb03016.x; Peng YQ, 2005, ECOL ENTOMOL, V30, P70, DOI 10.1111/j.0307-6946.2005.00650.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Proffit M, 2007, J ANIM ECOL, V76, P296, DOI 10.1111/j.1365-2656.2007.01213.x; R Development Core Team, 2009, R FDN STAT COMP; Rambaut A, 2014, TRACER V1 6; Royer PD, 2011, J ECOL, V99, P714, DOI 10.1111/j.1365-2745.2011.01804.x; Silvieus SI, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P225; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Stireman JO, 2006, P ROY SOC B-BIOL SCI, V273, P523, DOI 10.1098/rspb.2005.3363; TAJIMA F, 1983, GENETICS, V105, P437; Tzeng HY, 2008, SYMBIOSIS, V45, P129; Vamosi SM, 2005, CAN J ZOOL, V83, P894, DOI 10.1139/Z05-063; van Noort S., 2003, FIGS S SOUTH CENTRAL, P12; van Noort Simon, 1999, P299; vanNoort S, 1996, J BIOGEOGR, V23, P415, DOI 10.1111/j.1365-2699.1996.tb00003.x; WARE AB, 1994, J CHEM ECOL, V20, P785, DOI 10.1007/BF02059613; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weiblen GD, 2002, MOL ECOL, V11, P1573, DOI 10.1046/j.1365-294X.2002.01529.x; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; West SA, 1996, J BIOGEOGR, V23, P447, DOI 10.1111/j.1365-2699.1996.tb00006.x; Wiebes J. T., 1966, Zoologische Mededeelingen Leiden, V41, P151	84	13	13	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44804	10.1371/journal.pone.0044804	http://dx.doi.org/10.1371/journal.pone.0044804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970309	Green Submitted, Green Published, gold			2022-12-25	WOS:000308748400030
J	Su, YF; Shyu, YC; Shen, CKJ; Hwang, J				Su, Yee-Fun; Shyu, Yu-Chiau; Shen, Che-Kun James; Hwang, Jaulang			Phosphorylation-Dependent SUMOylation of the Transcription Factor NF-E2	PLOS ONE			English	Article							ERYTHROLEUKEMIA CELL-DIFFERENTIATION; LEUCINE-ZIPPER PROTEIN; SUMO MODIFICATION; GENE-EXPRESSION; TOPOISOMERASE-I; REPRESSION; PATHWAYS; KINASE; JUN	Nuclear factor erythroid-derived 2 (NF-E2), a heterodimer composed of p45 and p18, is a transcriptional activator in hematopoietic progenitors. The transcriptional activity of NF-E2 is not only upregulated by SUMOylation but also stimulated by the cAMP-dependent protein kinase A (PKA). However, the relationship between SUMOylation and phosphorylation in the activation of NF-E2 is unclear. In the present studies, we have demonstrated that PKA enhances NF-E2 SUMOylation in an in vitro system using purified proteins, suggesting a possible mechanism for PKA-dependent activation of the NF-E2 transcription factor through SUMOylation.	[Su, Yee-Fun; Shen, Che-Kun James; Hwang, Jaulang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Hwang, Jaulang] Taipei Med Univ, Sch Med, Dept Biochem, Taipei, Taiwan; [Shyu, Yu-Chiau] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Shyu, Yu-Chiau] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	Academia Sinica - Taiwan; Taipei Medical University; National Yang Ming Chiao Tung University; Taipei City Hospital	Su, YF (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	jaulang@tmu.edu.tw		Shyu, Yu-Chiau/0000-0003-1747-2226	National Science Council in Taiwan [NSC98-2311-B-001-008-MY3]; Institute of Molecular Biology; Academia Sinica, National Science Council	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Institute of Molecular Biology; Academia Sinica, National Science Council(Ministry of Science and Technology, TaiwanAcademia Sinica - Taiwan)	This work was supported by grants from the National Science Council in Taiwan (NSC98-2311-B-001-008-MY3) and Institute of Molecular Biology (to JH), Academia Sinica, National Science Council (http://web1.nsc.gov.tw/mp.aspx?mp=7), and Institute of Molecular Biology (http://www.imb.sinica.edu.tw/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; ANDREWS NC, 1993, P NATL ACAD SCI USA, V90, P11488, DOI 10.1073/pnas.90.24.11488; Andrews NC, 1998, INT J BIOCHEM CELL B, V30, P429, DOI 10.1016/S1357-2725(97)00135-0; Arito M, 2008, J BIOL CHEM, V283, P15224, DOI 10.1074/jbc.M800910200; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bossis G, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-13; Chen TY, 2000, APPL MICROBIOL BIOT, V53, P558, DOI 10.1007/s002530051657; GARINGO AD, 1995, J BIOL CHEM, V270, P9169, DOI 10.1074/jbc.270.16.9169; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Goerttler PS, 2005, BRIT J HAEMATOL, V129, P138, DOI 10.1111/j.1365-2141.2005.05416.x; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hilgarth RS, 2004, J BIOL CHEM, V279, P53899, DOI 10.1074/jbc.R400021200; Kang Jungseog, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-5; KOTKOW KJ, 1995, MOL CELL BIOL, V15, P4640; Levin J, 1999, BLOOD, V94, P3037, DOI 10.1182/blood.V94.9.3037.421k42_3037_3047; Motohashi H, 2006, MOL CELL BIOL, V26, P4652, DOI 10.1128/MCB.02193-05; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Nagai T, 1998, J BIOL CHEM, V273, P5358, DOI 10.1074/jbc.273.9.5358; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Shyu YC, 2005, MOL CELL BIOL, V25, P10365, DOI 10.1128/MCB.25.23.10365-10378.2005; Vanhatupa S, 2008, BIOCHEM J, V409, P179, DOI 10.1042/BJ20070620; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yang ML, 2006, J BIOL CHEM, V281, P8264, DOI 10.1074/jbc.M510364200; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X	29	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44608	10.1371/journal.pone.0044608	http://dx.doi.org/10.1371/journal.pone.0044608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970264	Green Submitted, gold, Green Published			2022-12-25	WOS:000308748400025
J	Acharya, P; Chaubey, S; Grover, M; Tatu, U				Acharya, Pragyan; Chaubey, Shweta; Grover, Manish; Tatu, Utpal			An Exported Heat Shock Protein 40 Associates with Pathogenesis-Related Knobs in Plasmodium falciparum Infected Erythrocytes	PLOS ONE			English	Article							MEMBRANE PROTEIN-1; MAURERS CLEFTS; MALARIA; CYTOADHERENCE; TRAFFICKING; VIRULENCE; REVEALS; DOMAINS; SURFACE; FAMILY	Cell surface structures termed knobs are one of the most important pathogenesis related protein complexes deployed by the malaria parasite Plasmodium falciparum at the surface of the infected erythrocyte. Despite their relevance to the disease, their structure, mechanisms of traffic and their process of assembly remain poorly understood. In this study, we have explored the possible role of a parasite-encoded Hsp40 class of chaperone, namely PFB0090c/PF3D7_0201800 (KAHsp40) in protein trafficking in the infected erythrocyte. We found the gene coding for PF3D7_0201800 to be located in a chromosomal cluster together with knob components KAHRP and PfEMP3. Like the knob components, KAHsp40 too showed the presence of PEXEL motif required for transport to the erythrocyte compartment. Indeed, sub-cellular fractionation and immunofluorescence analysis (IFA) showed KAHsp40 to be exported in the erythrocyte cytoplasm in a stage dependent manner localizing as punctuate spots in the erythrocyte periphery, distinctly from Maurer's cleft, in structures which could be the reminiscent of knobs. Double IFA analysis revealed co-localization of PF3D7_0201800 with the markers of knobs (KAHRP, PfEMP1 and PfEMP3) and components of the PEXEL translocon (Hsp101, PTEX150). KAHsp40 was also found to be in a complex with KAHRP, PfEMP3 and Hsp101 as confirmed by co-immunoprecipitation assay. Our results suggest potential involvement of a parasite encoded Hsp40 in chaperoning knob assembly in the erythrocyte compartment.	[Acharya, Pragyan; Chaubey, Shweta; Grover, Manish; Tatu, Utpal] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Acharya, P (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	tatu@biochem.iisc.ernet.in		Tatu, Utpal/0000-0003-0404-8872; GROVER, MANISH/0000-0002-1625-7930	European Union MALSIG Grant [223044]	European Union MALSIG Grant	European Union MALSIG Grant;223044,http://ec.europa.eu/research/health/infectious-diseases/poverty-diseases/projects/178_en.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2007, MOL BIOCHEM PARASIT, V153, P85, DOI 10.1016/j.molbiopara.2007.01.009; Aikawa M, 1996, EXP PARASITOL, V84, P339, DOI 10.1006/expr.1996.0122; BIGGS BA, 1989, P NATL ACAD SCI USA, V86, P2428, DOI 10.1073/pnas.86.7.2428; Botha M, 2007, INT J BIOCHEM CELL B, V39, P1781, DOI 10.1016/j.biocel.2007.02.011; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Gehde N, 2009, MOL MICROBIOL, V71, P613, DOI 10.1111/j.1365-2958.2008.06552.x; Genevaux P, 2007, MOL MICROBIOL, V66, P840, DOI 10.1111/j.1365-2958.2007.05961.x; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Khattab A, 2006, TRAFFIC, V7, P1654, DOI 10.1111/j.1600-0854.2006.00494.x; Knuepfer E, 2005, MOL MICROBIOL, V58, P1039, DOI 10.1111/j.1365-2958.2005.04895.x; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; Lanzer M, 2006, INT J PARASITOL, V36, P23, DOI 10.1016/j.ijpara.2005.10.001; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mayer C, 2012, J BIOL CHEM, V287, P7182, DOI 10.1074/jbc.M111.330779; Newbold C, 1999, INT J PARASITOL, V29, P927, DOI 10.1016/S0020-7519(99)00049-1; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Saridaki T, 2008, CELL MICROBIOL, V10, P2483, DOI 10.1111/j.1462-5822.2008.01223.x; Shonhai A, 2007, PROTEIN SCI, V16, P1803, DOI 10.1110/ps.072918107; Singh GP, 2004, MOL BIOCHEM PARASIT, V137, P307, DOI 10.1016/j.molbiopara.2004.05.016; Spycher C, 2006, MOL CELL BIOL, V26, P4074, DOI 10.1128/MCB.00095-06; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Tilley L, 2008, TRAFFIC, V9, P187, DOI 10.1111/j.1600-0854.2007.00684.x; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172	28	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44605	10.1371/journal.pone.0044605	http://dx.doi.org/10.1371/journal.pone.0044605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970262	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000308462000036
J	Zhang, Y; Zhao, ZH; Chen, CTA; Tang, K; Su, JQ; Jiao, NZ				Zhang, Yao; Zhao, Zihao; Chen, Chen-Tung Arthur; Tang, Kai; Su, Jianqiang; Jiao, Nianzhi			Sulfur Metabolizing Microbes Dominate Microbial Communities in Andesite-Hosted Shallow-Sea Hydrothermal Systems	PLOS ONE			English	Article							DEEP-SEA; EPSILON-PROTEOBACTERIA; DIVERSITY; QUALITY; VENTS; WATER; RNA; DNA	To determine microbial community composition, community spatial structure and possible key microbial processes in the shallow-sea hydrothermal vent systems off NE Taiwan's coast, we examined the bacterial and archaeal communities of four samples collected from the water column extending over a redoxocline gradient of a yellow and four from a white hydrothermal vent. Ribosomal tag pyrosequencing based on DNA and RNA showed statistically significant differences between the bacterial and archaeal communities of the different hydrothermal plumes. The bacterial and archaeal communities from the white hydrothermal plume were dominated by sulfur-reducing Nautilia and Thermococcus, whereas the yellow hydrothermal plume and the surface water were dominated by sulfide-oxidizing Thiomicrospira and Euryarchaeota Marine Group II, respectively. Canonical correspondence analyses indicate that methane (CH4) concentration was the only statistically significant variable that explains all community cluster patterns. However, the results of pyrosequencing showed an essential absence of methanogens and methanotrophs at the two vent fields, suggesting that CH4 was less tied to microbial processes in this shallow-sea hydrothermal system. We speculated that mixing between hydrothermal fluids and the sea or meteoric water leads to distinctly different CH4 concentrations and redox niches between the yellow and white vents, consequently influencing the distribution patterns of the free-living Bacteria and Archaea. We concluded that sulfur-reducing and sulfide-oxidizing chemolithoautotrophs accounted for most of the primary biomass synthesis and that microbial sulfur metabolism fueled microbial energy flow and element cycling in the shallow hydrothermal systems off the coast of NE Taiwan.	[Zhang, Yao; Zhao, Zihao; Tang, Kai; Jiao, Nianzhi] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Chen, Chen-Tung Arthur] Natl Sun Yat Sen Univ, Inst Marine Geol & Chem, Kaohsiung, Taiwan; [Su, Jianqiang] Chinese Acad Sci, Key Lab Urban Environm & Hlth, Inst Urban Environm, Xiamen, Peoples R China	Xiamen University; National Sun Yat Sen University; Chinese Academy of Sciences; Institute of Urban Environment, CAS	Zhang, Y (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	yaozhang@xmu.edu.cn; jiao@xmu.edu.cn	CAS, KLUEH-Cooperation/E-1148-2017; chen, chen/GRY-7085-2022; Chen, Chen-Tung Arthur/C-8901-2011; Su, Jian-Qiang/C-2388-2009; CHEN, CHEN/HDM-6657-2022; CAS, KLUEH/T-5743-2019	Chen, Chen-Tung Arthur/0000-0002-5170-6471; Su, Jian-Qiang/0000-0003-1875-249X; 	National Natural Science Foundation of China (NSFC) Projects [41176095, 91028001, 41023007]; New Century Excellent Talents (NCET) Plan	National Natural Science Foundation of China (NSFC) Projects(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents (NCET) Plan(Program for New Century Excellent Talents in University (NCET))	This research was supported by the National Natural Science Foundation of China (NSFC) Projects 41176095, 91028001 and 41023007, and the New Century Excellent Talents (NCET) Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Campbell BJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000362; Chen CTA, 2005, CHEM GEOL, V224, P69, DOI 10.1016/j.chemgeo.2005.07.022; Clarke K., 2001, PRIMER V5 USER MANUA; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; DeLong EF, 2006, P NATL ACAD SCI USA, V103, P6417, DOI 10.1073/pnas.0602079103; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Flores GE, 2011, ENVIRON MICROBIOL, V13, P2158, DOI 10.1111/j.1462-2920.2011.02463.x; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gaidos E, 2011, ENVIRON MICROBIOL, V13, P1138, DOI 10.1111/j.1462-2920.2010.02392.x; Grasshoff K., 1999, METHODS SEAWATER ANA; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huber JA, 2010, FEMS MICROBIOL ECOL, V73, P538, DOI 10.1111/j.1574-6941.2010.00910.x; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Leps J, 2003, MULTIVARIATE ANAL EC; Li Z-X, 2009, SCI DEV, V437, P40; [刘长华 LIU Chang-hua], 2010, [海洋科学, Marine Sciences], V34, P61; [刘长华 LIU Changhua], 2007, [海洋科学, Marine Sciences], V31, P61; Longnecker K, 2001, FEMS MICROBIOL ECOL, V35, P287, DOI 10.1111/j.1574-6941.2001.tb00814.x; Maugeri TL, 2010, CHEM ECOL, V26, P285, DOI 10.1080/02757541003693250; MUYZER G, 1995, ARCH MICROBIOL, V164, P165, DOI 10.1007/BF02529967; Nakagawa S, 2005, ENVIRON MICROBIOL, V7, P1619, DOI 10.1111/j.1462-2920.2005.00856.x; NOVITSKY JA, 1986, APPL ENVIRON MICROB, V52, P504, DOI 10.1128/AEM.52.3.504-509.1986; Opatkiewicz AD, 2009, FEMS MICROBIOL ECOL, V70, P413, DOI 10.1111/j.1574-6941.2009.00747.x; PAI SC, 1990, ANAL CHIM ACTA, V232, P345, DOI 10.1016/S0003-2670(00)81252-0; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith JL, 2008, INT J SYST EVOL MICR, V58, P1598, DOI 10.1099/ijs.0.65435-0; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; SWINNERTON JW, 1967, J GAS CHROMATOGR, V5, P570, DOI 10.1093/chromsci/5.11.570; Takail K, 2006, GEOPHYS MONOGR SER, V166, P185; Tarasov VG, 2005, CHEM GEOL, V224, P5, DOI 10.1016/j.chemgeo.2005.07.021; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERBRAAK CJF, 1989, HYDROBIOLOGIA, V184, P169, DOI 10.1007/BF02392953; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Yang LY, 2012, MAR CHEM, V128, P64, DOI 10.1016/j.marchem.2011.10.003; Yildirim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013963; Zeng Z-G, 2007, SCI CHINA SER D, V37, P1134	43	107	110	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44593	10.1371/journal.pone.0044593	http://dx.doi.org/10.1371/journal.pone.0044593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970260	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000034
J	Kim, KT; Carroll, AP; Mashkani, B; Cairns, MJ; Small, D; Scott, RJ				Kim, Kyu-Tae; Carroll, Adam P.; Mashkani, Baratali; Cairns, Murray J.; Small, Donald; Scott, Rodney J.			MicroRNA-16 Is Down-Regulated in Mutated FLT3 Expressing Murine Myeloid FDC-P1 Cells and Interacts with Pim-1	PLOS ONE			English	Article							INTERNAL TANDEM DUPLICATION; CONSTITUTIVELY ACTIVATED FLT3; KINASE INHIBITOR; TYROSINE KINASE; MIR-16 TARGETS; IN-VITRO; LEUKEMIA; GENE; CANCER; MECHANISMS	Activating mutations in the receptor tyrosine kinase FLT3 are one of the most frequent somatic mutations in acute myeloid leukemia (AML). Internal tandem duplications of the juxtamembrane region of FLT3 (FLT3/ITD) constitutively activate survival and proliferation pathways, and are associated with a poor prognosis in AML. We suspected that alteration of small non-coding microRNA ( miRNA) expression in these leukemia cells is involved in the transformation process and used miRNA microarrays to determine the miRNA signature from total RNA harvested from FLT3/ITD expressing FDC-P1 cells (FD-FLT3/ITD). This revealed that a limited set of miRNAs appeared to be affected by expression of FLT3/ITD compared to the control group consisting of FDC-P1 parental cells transfected with an empty vector (FD-EV). Among differentially expressed miRNAs, we selected miR-16, miR-21 and miR-223 to validate the microarray data by quantitative real-time RT-PCR showing a high degree of correlation. We further analyzed miR-16 expression with FLT3 inhibitors in FLT3/ITD expressing cells. MiR-16 was found to be one of most significantly down-regulated miRNAs in FLT3/ITD expressing cells and was up-regulated upon FLT3 inhibition. The data suggests that miR-16 is acting as a tumour suppressor gene in FLT3/ITD-mediated leukemic transformation. Whilst miR-16 has been reported to target multiple mRNAs, computer models from public bioinformatic resources predicted a potential regulatory mechanism between miR-16 and Pim-1 mRNA. In support of this interaction, miR-16 was shown to suppress Pim-1 reporter gene expression. Further, our data demonstrated that over-expression of miR-16 mimics suppressed Pim-1 expression in FD-FLT3/ITD cells suggesting that increased miR-16 expression contributes to depletion of Pim-1 after FLT3 inhibition and that miR-16 repression may be associated with up-regulated Pim-1 in FLT3/ITD expressing cells.	[Kim, Kyu-Tae; Carroll, Adam P.; Mashkani, Baratali; Cairns, Murray J.; Scott, Rodney J.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Small, Donald] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Small, Donald] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	University of Newcastle; Johns Hopkins University; Johns Hopkins University	Kim, KT (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia.	kyutae.kim@gmail.com	, Ali/R-6528-2019; Scott, Rodney J/B-2827-2013	, Ali/0000-0002-7606-5455; Scott, Rodney J/0000-0001-7724-3404; Cairns, Murray/0000-0003-2490-2538	University of Newcastle [10.21001]; Hunter Medical Research Institute [10.81531]	University of Newcastle; Hunter Medical Research Institute	This study was supported by funds from the University of Newcastle (grant number: 10.21001) and the Hunter Medical Research Institute (grant number: 10.81531). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 2006, CANCER RES, V66, P3828, DOI 10.1158/0008-5472.CAN-05-2309; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baudry A, 2010, SCIENCE, V329, P1537, DOI 10.1126/science.1193692; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Beveridge NJ, 2009, CELL SIGNAL, V21, P1837, DOI 10.1016/j.cellsig.2009.07.019; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; BIRG F, 1992, BLOOD, V80, P2584; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boominathan L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010615; Calin GA, 2006, LEUKEMIA RES, V30, P653, DOI 10.1016/j.leukres.2005.10.017; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Carow CE, 1996, BLOOD, V87, P1089, DOI 10.1182/blood.V87.3.1089.bloodjournal8731089; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen LS, 2011, BLOOD, V118, P693, DOI 10.1182/blood-2010-12-323022; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Chu SH, 2009, DRUG RESIST UPDATE, V12, P8, DOI 10.1016/j.drup.2008.12.001; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enjeti Anoop Kumar, 2004, Hematol J, V5, P419, DOI 10.1038/sj.thj.6200544; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Eyholzer M, 2010, LEUKEMIA RES, V34, P672, DOI 10.1016/j.leukres.2009.11.019; Fathi AT, 2012, LEUKEMIA RES, V36, P224, DOI 10.1016/j.leukres.2011.07.011; Fazi F, 2007, CANCER CELL, V12, P457, DOI 10.1016/j.ccr.2007.09.020; Felli N, 2009, HAEMATOL-HEMATOL J, V94, P479, DOI 10.3324/haematol.2008.002345; Flamant S, 2010, HAEMATOL-HEMATOL J, V95, P1325, DOI 10.3324/haematol.2009.020636; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Frost MJ, 2002, MOL CANCER THER, V1, P1115; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Grundler R, 2009, J EXP MED, V206, P1957, DOI 10.1084/jem.20082074; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kaddar T, 2009, BIOL CELL, V101, P511, DOI 10.1042/BC20080213; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Kim KT, 2007, BRIT J HAEMATOL, V138, P603, DOI 10.1111/j.1365-2141.2007.06696.x; Kim KT, 2006, BRIT J HAEMATOL, V134, P500, DOI 10.1111/j.1365-2141.2006.06225.x; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lawrie CH, 2007, BRIT J HAEMATOL, V137, P503, DOI 10.1111/j.1365-2141.2007.06611.x; Levis M, 2004, BLOOD, V104, P1145, DOI 10.1182/blood-2004-01-0388; Levis M, 2003, LEUKEMIA, V17, P1738, DOI 10.1038/sj.leu.2403099; Li L, 2007, BRIT J HAEMATOL, V137, P64, DOI 10.1111/j.1365-2141.2007.06525.x; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lynam-Lennon N, 2009, BIOL REV, V84, P55, DOI 10.1111/j.1469-185X.2008.00061.x; Marton S, 2008, LEUKEMIA, V22, P330, DOI 10.1038/sj.leu.2405022; Mashkani B, 2010, BIOORGAN MED CHEM, V18, P1789, DOI 10.1016/j.bmc.2010.01.056; Mi SL, 2007, P NATL ACAD SCI USA, V104, P19971, DOI 10.1073/pnas.0709313104; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; Mizuki M, 2003, BLOOD, V101, P3164, DOI 10.1182/blood-2002-06-1677; Nakao M, 1996, LEUKEMIA, V10, P1911; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Peltola KJ, 2004, BLOOD, V103, P3744, DOI 10.1182/blood-2003-09-3126; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Qi LQ, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-163; Radomska HS, 2006, J EXP MED, V203, P371, DOI 10.1084/jem.20052242; Roberts KG, 2007, MOL CANCER THER, V6, P1159, DOI 10.1158/1535-7163.MCT-06-0641; Rosnet O, 1996, LEUKEMIA, V10, P238; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shin VY, 2011, CARCINOGENESIS, V32, P240, DOI 10.1093/carcin/bgq240; SHOUNAN Y, 1995, EXP HEMATOL, V23, P492; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Smith BD, 2004, BLOOD, V103, P3669, DOI 10.1182/blood-2003-11-3775; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Thomas M, 2011, ONCOGENE; Tse KF, 2002, LEUKEMIA, V16, P2027, DOI 10.1038/sj.leu.2402674; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Vu HA, 2009, BIOCHEM BIOPH RES CO, V383, P308, DOI 10.1016/j.bbrc.2009.03.157; Weisberg E, 2009, DRUG RESIST UPDATE, V12, P81, DOI 10.1016/j.drup.2009.04.001; Yendamuri S, 2009, LEUKEMIA, V23, P1257, DOI 10.1038/leu.2008.382; Yokota S, 1997, LEUKEMIA, V11, P1605, DOI 10.1038/sj.leu.2400812; Young SM, 2006, CELL SIGNAL, V18, P608, DOI 10.1016/j.cellsig.2005.06.005; Zhang X, 2011, ONCOGENE; Zhang XN, 2010, CANCER RES, V70, P7176, DOI 10.1158/0008-5472.CAN-10-0697; Zheng R, 2004, BLOOD, V103, P1883, DOI 10.1182/blood-2003-06-1978	81	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44546	10.1371/journal.pone.0044546	http://dx.doi.org/10.1371/journal.pone.0044546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970245	Green Published, gold			2022-12-25	WOS:000308458400087
J	Latreille, J; Kesse-Guyot, E; Malvy, D; Andreeva, V; Galan, P; Tschachler, E; Hercberg, S; Guinot, C; Ezzedine, K				Latreille, Julie; Kesse-Guyot, Emmanuelle; Malvy, Denis; Andreeva, Valentina; Galan, Pilar; Tschachler, Erwin; Hercberg, Serge; Guinot, Christiane; Ezzedine, Khaled			Dietary Monounsaturated Fatty Acids Intake and Risk of Skin Photoaging	PLOS ONE			English	Article							ANTIOXIDANT VITAMINS; METABOLIC SYNDROME; OLIVE OIL; MECHANISMS; SU.VI.MAX; WOMEN; PREVENTION; MINERALS; TRIAL; FOOD	Background: Intake of monounsaturated fatty acids has been reported to reduce oxidative stress, insulin resistance and related inflammatory processes and may thus protect from skin photoaging. The objective of this study was to investigate the association between the risk of photoaging, monounsaturated fatty acids intake and the sources of monounsaturated fatty acids. Methodology/Principal Findings: A cross sectional study was conducted within the framework of the SUVIMAX cohort. The survey included 1264 women and 1655 men aged between 45 and 60 years old. Dietary monounsaturated fatty acids intakes were estimated by dietary source through at least ten 24-h diet records completed during the first 2.5 years of the follow-up period. Severity of facial skin photoaging was graded by trained investigators at baseline during a clinical examination using a 6-grade scale illustrated by photographs. A lower risk of severe photoaging was associated with higher intakes of monounsaturated fatty acids from olive oil in both sexes. Strikingly, no association was found with intake of monounsaturated fatty acids from animal sources whether from dairy products, meat or processed meat. Conclusion/Significance: These findings support the beneficial effect of dietary olive oil or healthy diet habits associated with olive oil consumption on the severity of facial photoaging.	[Latreille, Julie; Tschachler, Erwin; Guinot, Christiane] CERIES Res Ctr Human Skin Founded CHANEL, Neuilly Sur Seine, France; [Latreille, Julie; Kesse-Guyot, Emmanuelle; Malvy, Denis; Andreeva, Valentina; Galan, Pilar; Hercberg, Serge; Ezzedine, Khaled] Univ Paris 13, Ctr Res Human Nutr Ile France, INRA, INSERM,U1125,CNAM,UMR U557, Paris, France; [Malvy, Denis] Hop St Andre, Dept Internal Med & Trop Dis, Bordeaux, France; [Tschachler, Erwin] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Hercberg, Serge] Hop Avicenne, Dept Publ Hlth, F-93009 Bobigny, France; [Guinot, Christiane] Univ Tours, Comp Sci Lab, Tours, France; [Ezzedine, Khaled] Hop St Andre, Dept Dermatol, Bordeaux, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; CHU Bordeaux; Medical University of Vienna; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Universite de Tours; CHU Bordeaux	Latreille, J (corresponding author), CERIES Res Ctr Human Skin Founded CHANEL, Neuilly Sur Seine, France.	julie.latreille@ceries-lab.com	Andreeva, Valentina/F-2680-2017; MALVY, Denis/T-7930-2019; HERCBERG, Serge/B-4429-2008; Serge, Hercberg/F-3038-2017; Kesse-Guyot, Emmanuelle/F-2692-2017; Ezzedine, Khaled/F-2716-2017; Pilar, Galan/F-2908-2017; Kesse-Guyot, Emmanuelle/K-4689-2012; Kesse-Guyot, Emmanuelle/ABH-7347-2020	Andreeva, Valentina/0000-0001-9480-5210; HERCBERG, Serge/0000-0002-3168-1350; Serge, Hercberg/0000-0002-3168-1350; Kesse-Guyot, Emmanuelle/0000-0002-9715-3534; Ezzedine, Khaled/0000-0002-5468-4589; Pilar, Galan/0000-0003-1706-3107; Tschachler, Erwin/0000-0002-0248-1798				ARNAULT N, 2006, TABLE COMPOSITION AL; Astorg P, 2004, LIPIDS, V39, P527, DOI 10.1007/s11745-004-1259-6; Bergouignan A, 2009, PROG LIPID RES, V48, P128, DOI 10.1016/j.plipres.2009.02.004; Black HS, 1998, MUTAT RES-FUND MOL M, V422, P185, DOI 10.1016/S0027-5107(98)00191-2; CESARINI JP, 1988, PIGM CELL RES, V1, P223, DOI 10.1111/j.1600-0749.1988.tb00420.x; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cosgrove MC, 2007, AM J CLIN NUTR, V86, P1225, DOI 10.1093/ajcn/86.4.1225; Ezzedine K, 2008, J EUR ACAD DERMATOL, V22, P186, DOI 10.1111/j.1468-3083.2007.02367.x; Farage M.A., 2010, TXB AGING SKIN, V1st ed., P949; Favier JC, 1995, REPERTOIRE GEN ALIME; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Galland L, 2010, NUTR CLIN PRACT, V25, P634, DOI 10.1177/0884533610385703; Gillingham LG, 2011, LIPIDS, V46, P209, DOI 10.1007/s11745-010-3524-y; Guinot C, 2001, SKIN AND ENVIRONMENT - PERCEPTION AND PROTECTION, VOLS 1 AND 2, P1099; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hercberg S, 1998, CONTROL CLIN TRIALS, V19, P336, DOI 10.1016/S0197-2456(98)00015-4; IRELAND J, 2002, REPERTOIRE GEN ALIME, V2; LARNIER C, 1994, BRIT J DERMATOL, V130, P167, DOI 10.1111/j.1365-2133.1994.tb02895.x; Makrantonaki E, 2007, ANN NY ACAD SCI, V1119, P40, DOI 10.1196/annals.1404.027; Malvy DJM, 2000, J AM ACAD DERMATOL, V42, P47, DOI 10.1016/S0190-9622(00)90008-2; Mennen LI, 2002, EUR J CLIN NUTR, V56, P659, DOI 10.1038/sj.ejcn.1601374; Ministry of Agriculture FaF, 2004, FATT AC SUPPL MCCANC; Moullec N. le, 1996, Cahiers de Nutrition et de Dietetique, V31, P158; Nagata C, 2010, BRIT J NUTR, V103, P1493, DOI 10.1017/S0007114509993461; Owen R W, 2000, Lancet Oncol, V1, P107, DOI 10.1016/S1470-2045(00)00015-2; PETERSON B, 1990, J R STAT SOC C-APPL, V39, P205; Puizina-Ivic N, 2008, ACTA DERMATOVEN ALP, V17, P47; Purba MB, 2001, J AM COLL NUTR, V20, P71, DOI 10.1080/07315724.2001.10719017; Quiles JL, 2006, NUTR REV, V64, pS31, DOI 10.1111/j.1753-4887.2006.tb00261.x; Rabe JH, 2006, J AM ACAD DERMATOL, V55, P1, DOI 10.1016/j.jaad.2005.05.010; Riccardi G, 2004, CLIN NUTR, V23, P447, DOI 10.1016/j.clnu.2004.02.006; Sies H, 2004, ANNU REV NUTR, V24, P173, DOI 10.1146/annurev.nutr.24.012003.132320; USDA, 2003, NAT NUTR DAT STAND R; Viola P, 2009, CLIN DERMATOL, V27, P159, DOI 10.1016/j.clindermatol.2008.01.008; WILLETT W, 1986, AM J EPIDEMIOL, V124, P17, DOI 10.1093/oxfordjournals.aje.a114366; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; Yaar M, 2007, BRIT J DERMATOL, V157, P874, DOI 10.1111/j.1365-2133.2007.08108.x; Zouboulis CC, 2011, CLIN DERMATOL, V29, P3, DOI 10.1016/j.clindermatol.2010.07.001	38	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44490	10.1371/journal.pone.0044490	http://dx.doi.org/10.1371/journal.pone.0044490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970231	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400077
J	Lee, CK; Herbold, CW; Polson, SW; Wommack, KE; Williamson, SJ; McDonald, IR; Cary, SC				Lee, Charles K.; Herbold, Craig W.; Polson, Shawn W.; Wommack, K. Eric; Williamson, Shannon J.; McDonald, Ian R.; Cary, S. Craig			Groundtruthing Next-Gen Sequencing for Microbial Ecology-Biases and Errors in Community Structure Estimates from PCR Amplicon Pyrosequencing	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; RARE BIOSPHERE; BACTERIAL DIVERSITY; SPECIES RICHNESS; ARCTIC-OCEAN; AMPLIFICATION; PRIMERS; HETERODUPLEXES; DIVERGENCE; ALIGNMENT	Analysis of microbial communities by high-throughput pyrosequencing of SSU rRNA gene PCR amplicons has transformed microbial ecology research and led to the observation that many communities contain a diverse assortment of rare taxa-a phenomenon termed the Rare Biosphere. Multiple studies have investigated the effect of pyrosequencing read quality on operational taxonomic unit (OTU) richness for contrived communities, yet there is limited information on the fidelity of community structure estimates obtained through this approach. Given that PCR biases are widely recognized, and further unknown biases may arise from the sequencing process itself, a priori assumptions about the neutrality of the data generation process are at best unvalidated. Furthermore, post-sequencing quality control algorithms have not been explicitly evaluated for the accuracy of recovered representative sequences and its impact on downstream analyses, reducing useful discussion on pyrosequencing reads to their diversity and abundances. Here we report on community structures and sequences recovered for in vitro-simulated communities consisting of twenty 16S rRNA gene clones tiered at known proportions. PCR amplicon libraries of the V3-V4 and V6 hypervariable regions from the in vitro-simulated communities were sequenced using the Roche 454 GS FLX Titanium platform. Commonly used quality control protocols resulted in the formation of OTUs with >1% abundance composed entirely of erroneous sequences, while over-aggressive clustering approaches obfuscated real, expected OTUs. The pyrosequencing process itself did not appear to impose significant biases on overall community structure estimates, although the detection limit for rare taxa may be affected by PCR amplicon size and quality control approach employed. Meanwhile, PCR biases associated with the initial amplicon generation may impose greater distortions in the observed community structure.	[Lee, Charles K.; Herbold, Craig W.; McDonald, Ian R.; Cary, S. Craig] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand; [Polson, Shawn W.] Univ Delaware, Ctr Bioinformat & Computat Biol, Delaware Biotechnol Inst, Newark, DE USA; [Polson, Shawn W.] Univ Delaware, Dept Comp & Informat Sci, Newark, DE 19716 USA; [Wommack, K. Eric] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA; [Polson, Shawn W.; Wommack, K. Eric] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Wommack, K. Eric; Cary, S. Craig] Univ Delaware, Coll Earth Ocean & Environm, Lewes, DE 19958 USA; [Williamson, Shannon J.] J Craig Venter Inst, San Diego, CA USA	University of Waikato; University of Delaware; University of Delaware; University of Delaware; University of Delaware; University of Delaware; J. Craig Venter Institute	Lee, CK (corresponding author), Univ Waikato, Dept Biol Sci, Private Bag 3105, Hamilton, New Zealand.	caryc@waikato.ac.nz	McDonald, Ian R/A-4851-2008; Herbold, Craig W./S-4397-2018; Polson, Shawn W./B-7696-2011; Lee, Charles/AAC-9417-2019	McDonald, Ian R/0000-0002-4847-6492; Herbold, Craig W./0000-0003-3479-0197; Polson, Shawn W./0000-0002-3398-6932; Lee, Charles/0000-0002-6562-4733; Cary, Stephen/0000-0002-2876-2387	Office of Science (BER); U.S. Department of Energy [De-FC02-02ER63453]; National Science Foundation [MCB-0731916, ANT-0739648, ANT-0229836]; New Zealand Marsden Fund [UOW0802, UOW1003]	Office of Science (BER)(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This research was supported by grants from the Office of Science (BER), U.S. Department of Energy (Cooperative Agreement No. De-FC02-02ER63453) and the National Science Foundation to KEW, SJW, and SCC (MCB-0731916) and SCC (ANT-0739648 and ANT-0229836). The New Zealand Marsden Fund provided financial support for CWH, IRM, SCC (UOW0802), and CKL (UOW1003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Ashby MN, 2007, APPL ENVIRON MICROB, V73, P4532, DOI 10.1128/AEM.02956-06; Bahl J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1167; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Banks JC, 2009, ENVIRON MICROBIOL, V11, P577, DOI 10.1111/j.1462-2920.2008.01816.x; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bragg L, 2012, FAST HIGH SPECIFICIT, P1; Bru D, 2008, APPL ENVIRON MICROB, V74, P1660, DOI 10.1128/AEM.02403-07; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Contreras M, 2010, MICROBIOL-SGM, V156, P3282, DOI 10.1099/mic.0.043174-0; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; Elshahed MS, 2008, APPL ENVIRON MICROB, V74, P5422, DOI 10.1128/AEM.00410-08; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Fonseca VG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1095; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Galand PE, 2009, ISME J, V3, P860, DOI 10.1038/ismej.2009.23; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Hoffmann C, 2009, INFECT IMMUN, V77, P4668, DOI 10.1128/IAI.00493-09; Hollister EB, 2010, ISME J, V4, P829, DOI 10.1038/ismej.2010.3; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huber JA, 2009, ENVIRON MICROBIOL, V11, P1292, DOI 10.1111/j.1462-2920.2008.01857.x; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Hugenholtz P, 2001, ENV MOL MICROBIOLOGY; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huws SA, 2007, J MICROBIOL METH, V70, P565, DOI 10.1016/j.mimet.2007.06.013; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kirchman DL, 2010, ENVIRON MICROBIOL, V12, P1132, DOI 10.1111/j.1462-2920.2010.02154.x; Kunin V, 2010, OPEN J, V1, P1; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Kurata S, 2004, APPL ENVIRON MICROB, V70, P7545, DOI 10.1128/AEM.70.12.7545-7549.2004; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lauro FM, 2011, ISME J, V5, P879, DOI 10.1038/ismej.2010.185; Lueders T, 2003, APPL ENVIRON MICROB, V69, P320, DOI 10.1128/AEM.69.1.320-326.2003; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Qiu XY, 2001, APPL ENVIRON MICROB, V67, P880, DOI 10.1128/AEM.67.2.880-887.2001; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Rueckert A, 2007, LIMNOL OCEANOGR-METH, V5, P474, DOI 10.4319/lom.2007.5.474; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; Suzuki M, 1998, APPL ENVIRON MICROB, V64, P4522; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Thompson JR, 2002, NUCLEIC ACIDS RES, V30, P2083, DOI 10.1093/nar/30.9.2083; Tiao G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1645; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Youssef NH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012414; Zinger L, 2009, ISME J, V3, P850, DOI 10.1038/ismej.2009.20	62	115	118	0	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44224	10.1371/journal.pone.0044224	http://dx.doi.org/10.1371/journal.pone.0044224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970184	gold, Green Published			2022-12-25	WOS:000308458400049
J	Han, T; Abdel-Motal, UM; Chang, DK; Sui, JH; Muvaffak, A; Campbell, J; Zhu, Q; Kupper, TS; Marasco, WA				Han, Thomas; Abdel-Motal, Ussama M.; Chang, De-Kuan; Sui, Jianhua; Muvaffak, Asli; Campbell, James; Zhu, Quan; Kupper, Thomas S.; Marasco, Wayne A.			Human Anti-CCR4 Minibody Gene Transfer for the Treatment of Cutaneous T-Cell Lymphoma	PLOS ONE			English	Article							CHEMOKINE RECEPTORS CCR4; SEZARY-SYNDROME; ANTITUMOR-ACTIVITY; MYCOSIS-FUNGOIDES; ANTIBODY; EXPRESSION; ALEMTUZUMAB; THERAPY; LYMPHOCYTES; MICE	Background: Although several therapeutic options have become available for patients with Cutaneous T-cell Lymphoma (CTCL), no therapy has been curative. Recent studies have demonstrated that CTCL cells overexpress the CC chemokine receptor 4 (CCR4). Methodology/Principal Findings: In this study, a xenograft model of CTCL was established and a recombinant adenoassociated viral serotype 8 (AAV8) vector expressing a humanized single-chain variable fragment (scFv)-Fc fusion (scFvFc or "minibody'') of anti-CCR4 monoclonal antibody (mAb) h1567 was evaluated for curative treatment. Human CCR4(+) tumor-bearing mice treated once with intravenous infusion of AAV8 virions encoding the h1567 (AAV8-h1567) minibody showed anti-tumor activity in vivo and increased survival. The AAV8-h1567 minibody notably increased the number of tumor-infiltrating Ly-6G(+) Fc gamma RIIIa(CD16A)(+) murine neutrophils in the tumor xenografts over that of AAV8-control minibody treated mice. Furthermore, in CCR4(+) tumor-bearing mice co-treated with AAV8-h1567 minibody and infused with human peripheral blood mononuclear cells (PBMCs), marked tumor infiltration of human CD16A(+) CD56(+) NK cells was observed. The h1567 minibody also induced in vitro ADCC activity through both mouse neutrophils and human NK cells. Conclusions/Significance: Overall, our data demonstrate that the in vivo anti-tumor activity of h1567 minibody is mediated, at least in part, through CD16A(+) immune effector cell ADCC mechanisms. These data further demonstrate the utility of the AAV-minibody gene transfer system in the rapid evaluation of candidate anti-tumor mAbs and the potency of h1567 as a potential novel therapy for CTCL.	[Han, Thomas; Abdel-Motal, Ussama M.; Chang, De-Kuan; Sui, Jianhua; Muvaffak, Asli; Zhu, Quan; Marasco, Wayne A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Han, Thomas; Abdel-Motal, Ussama M.; Chang, De-Kuan; Sui, Jianhua; Zhu, Quan; Marasco, Wayne A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Campbell, James; Kupper, Thomas S.] Harvard Univ, Brigham & Womens Hosp, Harvard Skin Dis Res Ctr, Dept Dermatol,Med Sch, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Han, T (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	tkupper@partners.org; wayne_marasco@dfci.harvard.edu	Kupper, Thomas/O-4962-2019	Marasco, Wayne/0000-0003-3764-4611; SUI, JIANHUA/0000-0002-1272-9662	Skin Cancer Score project [2P50CA093683]; National Institutes of Health (NIH) [1K01AI073861]; NIH [AI058804]; NATIONAL CANCER INSTITUTE [P50CA093683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI058804, K01AI073861] Funding Source: NIH RePORTER	Skin Cancer Score project; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by Skin Cancer Score project 2P50CA093683 to TSK, JC and WAM; by National Institutes of Health (NIH) grant 1K01AI073861 to TH; and by NIH grant AI058804 to QZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinari L, 2008, LEUKEMIA RES, V32, P1299, DOI 10.1016/j.leukres.2007.11.009; Baekkevold ES, 2005, J EXP MED, V201, P1045, DOI 10.1084/jem.20041059; Beissert S, 2006, J INVEST DERMATOL, V126, P15, DOI 10.1038/sj.jid.5700004; Berney T, 2001, TRANSPLANTATION, V72, P133, DOI 10.1097/00007890-200107150-00026; Campbell JJ, 2010, BLOOD, V116, P767, DOI 10.1182/blood-2009-11-251926; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Clark RA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003008; Collaco RF, 1999, GENE, V238, P397, DOI 10.1016/S0378-1119(99)00347-9; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Deckert PM, 2009, CURR DRUG TARGETS, V10, P158, DOI 10.2174/138945009787354502; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Ferenczi K, 2002, J INVEST DERMATOL, V119, P1405, DOI 10.1046/j.1523-1747.2002.19610.x; Ferris RL, 2010, J CLIN ONCOL, V28, P4390, DOI 10.1200/JCO.2009.27.6360; FLEMING TJ, 1993, J IMMUNOL, V150, P5379; FLEMING TJ, 1993, J IMMUNOL, V151, P2399; Girardi M, 2004, NEW ENGL J MED, V350, P1978, DOI 10.1056/NEJMra032810; Gupta P, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-72; HADLEY AG, 1992, IMMUNOLOGY, V76, P446; Ishida T, 2012, J CLIN ONCOL; Ito A, 2009, CANCER IMMUNOL IMMUN, V58, P1195, DOI 10.1007/s00262-008-0632-0; Kim EJ, 2005, J CLIN INVEST, V115, P798, DOI 10.1172/JCI200524826; Kim YH, 2007, BLOOD, V109, P4655, DOI 10.1182/blood-2006-12-062877; Kunkel EJ, 2002, AM J PATHOL, V160, P347, DOI 10.1016/S0002-9440(10)64378-7; Li BH, 2010, CANCER RES, V70, P6293, DOI 10.1158/0008-5472.CAN-10-0009; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; Luo Yi, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0320s22; Marasco WA, 2005, NAT BIOTECHNOL, V23, P551, DOI 10.1038/nbt0505-551; Martin SI, 2006, CLIN INFECT DIS, V43, P16, DOI 10.1086/504811; Michelfelder S, 2007, EXP HEMATOL, V35, P1766, DOI 10.1016/j.exphem.2007.07.018; Olkhanud PB, 2009, CANCER RES, V69, P5996, DOI 10.1158/0008-5472.CAN-08-4619; Presta Leonard G., 2002, Current Pharmaceutical Biotechnology, V3, P237, DOI 10.2174/1389201023378256; Querfeld C, 2009, LEUKEMIA LYMPHOMA, V50, P1969, DOI 10.3109/10428190903216770; Repp R, 2011, J IMMUNOL METHODS; Selvaraj P, 2004, IMMUNOL RES, V29, P219, DOI 10.1385/IR:29:1-3:219; Siders WM, 2010, LEUKEMIA LYMPHOMA, V51, P1293, DOI 10.3109/10428191003777963; Sokolowska-Wojdyo M, 2005, BRIT J DERMATOL, V152, P258, DOI 10.1111/J.1365-2133.2004.06325.X; Sui JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000197; Ure UB, 2007, EUR J DERMATOL, V17, P525; Veldwijk MR, 2002, MOL THER, V6, P272, DOI 10.1006/mthe.2002.0569; Vermeer MH, 2002, MODERN PATHOL, V15, P838, DOI 10.1097/01.MP.0000021006.53593.B0; Wang J, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-50; WASIK MA, 1994, AM J PATHOL, V144, P1089; Watanabe Y, 2010, ORAL SURG ORAL MED O, V109, P744, DOI 10.1016/j.tripleo.2009.12.015; Willemze R, 2005, BLOOD, V105, P3768, DOI 10.1182/blood-2004-09-3502; Wu CS, 2008, KAOHSIUNG J MED SCI, V24, P577, DOI 10.1016/S1607-551X(09)70019-1; Wu XS, 2009, J INVEST DERMATOL, V129, P1115, DOI 10.1038/jid.2009.45; Xu XC, 2000, CANCER RES, V60, P4475; Yamamoto K, 2010, J CLIN ONCOL, V28, P1591, DOI 10.1200/JCO.2009.25.3575; Yamanaka K, 2005, CLIN CANCER RES, V11, P5748, DOI 10.1158/1078-0432.CCR-04-2514; Yawalkar N, 2003, BLOOD, V102, P4059, DOI 10.1182/blood-2003-04-1044	50	27	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44455	10.1371/journal.pone.0044455	http://dx.doi.org/10.1371/journal.pone.0044455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973452	Green Submitted, Green Published, gold			2022-12-25	WOS:000308577600057
J	Brock, SE; Rendon, BE; Yaddanapudi, K; Mitchell, RA				Brock, Stephanie E.; Rendon, Beatriz E.; Yaddanapudi, Kavitha; Mitchell, Robert A.			Negative Regulation of AMP-activated Protein Kinase (AMPK) Activity by Macrophage Migration Inhibitory Factor (MIF) Family Members in Non-small Cell Lung Carcinomas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-DOPACHROME TAUTOMERASE; ACETYL-COA CARBOXYLASE; ENERGY STRESS; CANCER; EXPRESSION; GROWTH; LKB1; GENE; PHOSPHORYLATION; BETA	AMP-activated protein kinase (AMPK) is a nutrient-and metabolic stress-sensing enzyme activated by the tumor suppressor kinase, LKB1. Because macrophage migration inhibitory factor (MIF) and its functional homolog, D-dopachrome tautomerase (D-DT), have protumorigenic functions in non-small cell lung carcinomas (NSCLCs) but have AMPK-activating properties in nonmalignant cell types, we set out to investigate this apparent paradox. Our data now suggest that, in contrast to MIF and D-DTs AMPK-activating properties in nontransformed cells, MIF and D-DT act cooperatively to inhibit steady-state phosphorylation and activation of AMPK in LKB1 wild type and LKB1 mutant human NSCLC cell lines. Our data further indicate that MIF and D-DT, acting through their shared cell surface receptor, CD74, antagonize NSCLC AMPK activation by maintaining glucose uptake, ATP production, and redox balance, resulting in reduced Ca2+/calmodulin-dependent kinase kinase beta-dependent AMPK activation. Combined, these studies indicate that MIF and D-DT cooperate to inhibit AMPK activation in an LKB1-independent manner.	[Brock, Stephanie E.; Rendon, Beatriz E.; Yaddanapudi, Kavitha; Mitchell, Robert A.] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA; [Mitchell, Robert A.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40202 USA	University of Louisville; University of Louisville	Mitchell, RA (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Clin & Translat Res Bldg,Suite 404,505 S Hancock, Louisville, KY 40202 USA.	robert.mitchell@louisville.edu			National Institutes of Health [CA129967]; NATIONAL CANCER INSTITUTE [R01CA129967] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA129967 (to R. A. M).	Bacher M, 2003, AM J PATHOL, V162, P11, DOI 10.1016/S0002-9440(10)63793-5; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Benigni F, 2000, J CLIN INVEST, V106, P1291, DOI 10.1172/JCI9900; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Carretero J, 2004, ONCOGENE, V23, P4037, DOI 10.1038/sj.onc.1207502; Coleman AM, 2008, J IMMUNOL, V181, P2330, DOI 10.4049/jimmunol.181.4.2330; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Gusarova GA, 2011, MOL CELL BIOL, V31, P3546, DOI 10.1128/MCB.05114-11; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Heinrichs D, 2011, P NATL ACAD SCI USA, V108, P17444, DOI 10.1073/pnas.1107023108; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Iwata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033402; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Luo ZJ, 2010, FUTURE ONCOL, V6, P457, DOI 10.2217/FON.09.174; Makowski L, 2008, BRIT J CANCER, V99, P683, DOI 10.1038/sj.bjc.6604515; MARSH BJ, 1995, J CELL BIOL, V130, P1081, DOI 10.1083/jcb.130.5.1081; Martin J, 2009, FASEB J, V23, P720, DOI 10.1096/fj.08-119628; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; McClelland M, 2009, AM J PATHOL, V174, P638, DOI 10.2353/ajpath.2009.080463; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Miller EJ, 2008, NATURE, V451, P578, DOI 10.1038/nature06504; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Rendon BE, 2007, J BIOL CHEM, V282, P29910, DOI 10.1074/jbc.M704898200; Rocha GZ, 2011, CLIN CANCER RES, V17, P3993, DOI 10.1158/1078-0432.CCR-10-2243; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; SIM ATR, 1988, FEBS LETT, V233, P294, DOI 10.1016/0014-5793(88)80445-9; Swinnen JV, 2005, CANCER RES, V65, P2441, DOI 10.1158/0008-5472.CAN-04-3025; Tarnowski M, 2010, MOL CANCER RES, V8, P1328, DOI 10.1158/1541-7786.MCR-10-0288; Waeber G, 1997, P NATL ACAD SCI USA, V94, P4782, DOI 10.1073/pnas.94.9.4782; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; White ES, 2003, CLIN CANCER RES, V9, P853; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; Winner M, 2007, CANCER RES, V67, P186, DOI 10.1158/0008-5472.CAN-06-3292; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Xin D, 2010, MOL CANCER RES, V8, P1601, DOI 10.1158/1541-7786.MCR-10-0101	47	29	30	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.378299	http://dx.doi.org/10.1074/jbc.M112.378299			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988252	hybrid, Green Published			2022-12-25	WOS:000310642200027
J	Lu, CF; Mi, LZ; Schurpf, T; Walz, T; Springer, TA				Lu, Chafen; Mi, Li-Zhi; Schuerpf, Thomas; Walz, Thomas; Springer, Timothy A.			Mechanisms for Kinase-mediated Dimerization of the Epidermal Growth Factor Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ACTIVATION; DOMAIN; EGFR; REGION; VISUALIZATION; COMPLEXES; AFFINITY; BINDING; CANCER	We study a mechanism by which dimerization of the EGF receptor (EGFR) cytoplasmic domain is transmitted to the ectodomain. Therapeutic and other small molecule antagonists to the kinase domain that stabilize its active conformation, but not those that stabilize an inactive conformation, stabilize ectodomain dimerization. Inhibitor-induced dimerization requires an asymmetric kinase domain interface associated with activation. EGF and kinase inhibitors stimulate formation of identical dimer interfaces in the EGFR transmembrane domain, as shown by disulfide cross-linking. Disulfide cross-linking at an interface in domain IV in the ectodomain was also stimulated similarly; however, EGF but not inhibitors stimulated cross-linking in domain II. Inhibitors similarly induced noncovalent dimerization in nearly full-length, detergent-solubilized EGFR as shown by gel filtration. EGFR ectodomain deletion resulted in spontaneous dimerization, whereas deletion of exons 2-7, in which extracellular domains III and IV are retained, did not. In EM, kinase inhibitor-induced dimers lacked any well defined orientation between the ectodomain monomers. Fab of the therapeutic antibody cetuximab to domain III confirmed a variable position and orientation of this domain in inhibitor-induced dimers but suggested that the C termini of domain IV of the two monomers were in close proximity, consistent with dimerization in the transmembrane domains. The results provide insights into the relative energetics of intracellular and extracellular dimerization in EGFR and have significance for physiologic dimerization through the asymmetric kinase interface, bidirectional signal transmission in EGFR, and mechanism of action of therapeutics.	[Lu, Chafen; Mi, Li-Zhi; Schuerpf, Thomas; Springer, Timothy A.] Harvard Univ, Sch Med, Childrens Hosp Boston, Immune Dis Inst, Boston, MA 02115 USA; [Lu, Chafen; Mi, Li-Zhi; Schuerpf, Thomas; Springer, Timothy A.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Walz, Thomas] Howard Hughes Med Inst, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Immune Dis Inst, 3 Blackfan Circle, Boston, MA 02115 USA.	springer@idi.harvard.edu	Mi, Li-Zhi/B-1371-2016; Schürpf, Thomas/E-7380-2012	Mi, Li-Zhi/0000-0001-9907-5245; Schurpf, Thomas/0000-0003-3023-1136; Walz, Thomas/0000-0003-2606-2835	National Institutes of Health [HL-103526]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL103526] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-103526. This work was also supported by the Howard Hughes Medical Institute (to T. W.).	Alvarado D, 2009, NATURE, V461, P287, DOI 10.1038/nature08297; Arteaga CL, 1997, J BIOL CHEM, V272, P23247, DOI 10.1074/jbc.272.37.23247; Arteaga CL, 2003, EXP CELL RES, V284, P122, DOI 10.1016/S0014-4827(02)00104-0; Blair JA, 2007, NAT CHEM BIOL, V3, P229, DOI 10.1038/nchembio866; CHANTRY A, 1995, J BIOL CHEM, V270, P3068; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; Eck MJ, 2010, BBA-PROTEINS PROTEOM, V1804, P559, DOI 10.1016/j.bbapap.2009.12.010; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Garrett TPJ, 2009, P NATL ACAD SCI USA, V106, P5082, DOI 10.1073/pnas.0811559106; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Lichtner RB, 2001, CANCER RES, V61, P5790; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Mi LZ, 2008, BIOCHEMISTRY-US, V47, P10314, DOI 10.1021/bi801006s; Mi LZ, 2011, NAT STRUCT MOL BIOL, V18, P984, DOI 10.1038/nsmb.2092; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034; Yu XC, 2002, MOL BIOL CELL, V13, P2547, DOI 10.1091/mbc.01-08-0411; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	32	53	54	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.414391	http://dx.doi.org/10.1074/jbc.M112.414391			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988250	Green Published, hybrid			2022-12-25	WOS:000310642200057
J	Ruecker, A; Shea, M; Hackett, F; Suarez, C; Hirst, EMA; Milutinovic, K; Withers-Martinez, C; Blackman, MJ				Ruecker, Andrea; Shea, Michael; Hackett, Fiona; Suarez, Catherine; Hirst, Elizabeth M. A.; Milutinovic, Katarina; Withers-Martinez, Chrislaine; Blackman, Michael J.			Proteolytic Activation of the Essential Parasitophorous Vacuole Cysteine Protease SERA6 Accompanies Malaria Parasite Egress from Its Host Erythrocyte	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM MEROZOITES; SUBTILISIN-LIKE PROTEASE-1; AUTOPROTEOLYTIC CLEAVAGE SITES; HUMAN PROCATHEPSIN L; RED-BLOOD-CELL; INFECTED ERYTHROCYTES; SURFACE PROTEIN-1; STREPTOLYSIN-O; SERINE; ANTIGEN	The malaria parasite replicates within an intraerythrocytic parasitophorous vacuole (PV). The PV and host cell membranes eventually rupture, releasing merozoites in a process called egress. Certain inhibitors of serine and cysteine proteases block egress, indicating a crucial role for proteases. The Plasmodium falciparum genome encodes nine serine-repeat antigens (SERAs), each of which contains a central domain homologous to the papain-like (clan CA, family C1) protease family. SERA5 and SERA6 are indispensable in blood-stage parasites, but the function of neither is known. Here we show that SERA6 localizes to the PV where it is precisely cleaved just prior to egress by an essential serine protease called PfSUB1. Mutations that replace the predicted catalytic Cys of SERA6, or that block SERA6 processing by PfSUB1, could not be stably introduced into the parasite genomic sera6 locus, indicating that SERA6 is an essential enzyme and that processing is important for its function. We demonstrate that cleavage of SERA6 by PfSUB1 converts it to an active cysteine protease. Our observations reveal a proteolytic activation step in the malarial PV that may be required for release of the parasite from its host erythrocyte.	[Ruecker, Andrea; Shea, Michael; Hackett, Fiona; Suarez, Catherine; Hirst, Elizabeth M. A.; Milutinovic, Katarina; Withers-Martinez, Chrislaine; Blackman, Michael J.] Natl Inst Med Res, MRC, Div Parasitol, London NW7 1AA, England	MRC National Institute for Medical Research	Blackman, MJ (corresponding author), Natl Inst Med Res, MRC, Div Parasitol, Mill Hill, London NW7 1AA, England.	mblackm@nimr.mrc.ac.uk		Suarez, Catherine/0000-0003-2984-7881; Ruecker, Andrea/0000-0003-3804-9670	United Kingdom Medical Research Council [U117532063]; Medical Research Council; Swiss National Science Foundation; European Union [PITN-GA-2008-215281]; MRC [MC_U117532063] Funding Source: UKRI; Medical Research Council [MC_U117532063] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by United Kingdom Medical Research Council Grant U117532063.; Recipient of a Medical Research Council Ph.D. studentship.; Supported by a Swiss National Science Foundation Postdoctoral Fellowship.; Supported by European Union Framework Programme 7-funded Marie Curie Initial Training Network InterMalTraining Contract PITN-GA-2008-215281 and by a Swiss National Science Foundation Fellowship for Prospective Researchers.	Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Ansorge I, 1997, MOL BIOCHEM PARASIT, V84, P259, DOI 10.1016/S0166-6851(96)02806-X; Ansorge I, 1996, BIOCHEM J, V315, P307, DOI 10.1042/bj3150307; Aoki S, 2002, J BIOL CHEM, V277, P47533, DOI 10.1074/jbc.M207145200; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Arisue N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017775; Blackman MJ, 2008, CELL MICROBIOL, V10, P1925, DOI 10.1111/j.1462-5822.2008.01176.x; Blackman MJ, 2002, BIOCHEMISTRY-US, V41, P12244, DOI 10.1021/bi0263661; BLACKMAN MJ, 1994, METHOD CELL BIOL, V45, P213; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P35, DOI 10.1016/0166-6851(91)90128-S; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Burghaus PA, 2001, J BIOL CHEM, V276, P26838, DOI 10.1074/jbc.M100111200; Chandramohanadas R, 2009, SCIENCE, V324, P794, DOI 10.1126/science.1171085; Child MA, 2010, MOL MICROBIOL, V78, P187, DOI 10.1111/j.1365-2958.2010.07324.x; CLARK PI, 1978, EUR J BIOCHEM, V84, P293, DOI 10.1111/j.1432-1033.1978.tb12168.x; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Crabb BS, 2004, METH MOL B, V270, P263; de Monerri NCS, 2011, INFECT IMMUN, V79, P1086, DOI 10.1128/IAI.00902-10; DEBRABANT A, 1992, MOL BIOCHEM PARASIT, V53, P89, DOI 10.1016/0166-6851(92)90010-H; DELPLACE P, 1988, BIOL CELL, V64, P215, DOI 10.1016/0248-4900(88)90080-9; DELPLACE P, 1985, MOL BIOCHEM PARASIT, V17, P239, DOI 10.1016/0166-6851(85)90021-0; DELPLACE P, 1987, MOL BIOCHEM PARASIT, V23, P193, DOI 10.1016/0166-6851(87)90026-0; Doran JD, 1999, EUR J BIOCHEM, V263, P145, DOI 10.1046/j.1432-1327.1999.00473.x; Glushakova S, 2009, CELL MICROBIOL, V11, P95, DOI 10.1111/j.1462-5822.2008.01242.x; Harris PK, 2005, PLOS PATHOG, V1, P241, DOI 10.1371/journal.ppat.0010029; Hodder AN, 2003, J BIOL CHEM, V278, P48169, DOI 10.1074/jbc.M306755200; Hodder AN, 2009, J MOL BIOL, V392, P154, DOI 10.1016/j.jmb.2009.07.007; Jean L, 2003, J BIOL CHEM, V278, P28572, DOI 10.1074/jbc.M303827200; KNAPP B, 1991, MOL BIOCHEM PARASIT, V44, P1, DOI 10.1016/0166-6851(91)90215-R; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Li H, 2002, PARASITOL INT, V51, P343, DOI 10.1016/S1383-5769(02)00042-9; McCoubrie JE, 2007, INFECT IMMUN, V75, P5565, DOI 10.1128/IAI.00405-07; Menard R, 1998, J BIOL CHEM, V273, P4478, DOI 10.1074/jbc.273.8.4478; Miller SK, 2002, J BIOL CHEM, V277, P47524, DOI 10.1074/jbc.M206974200; Nyalwidhe J, 2006, PROTEOMICS, V6, P1563, DOI 10.1002/pmic.200500379; Olivieri A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002448; Pungercar JR, 2009, FEBS J, V276, P660, DOI 10.1111/j.1742-4658.2008.06815.x; Putrianti ED, 2010, CELL MICROBIOL, V12, P725, DOI 10.1111/j.1462-5822.2009.01419.x; Quraishi O, 2001, J BIOL CHEM, V276, P8118, DOI 10.1074/jbc.M005851200; Sajid M, 2003, MOL BIOCHEM PARASIT, V131, P65, DOI 10.1016/S0166-6851(03)00194-4; Salmon BL, 2001, P NATL ACAD SCI USA, V98, P271, DOI 10.1073/pnas.011413198; Schmidt-Christensen A, 2008, CELL MICROBIOL, V10, P1723, DOI 10.1111/j.1462-5822.2008.01162.x; Soni S, 2005, BLOOD CELL MOL DIS, V35, P201, DOI 10.1016/j.bcmd.2005.05.006; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Withers-Martinez C, 2002, J BIOL CHEM, V277, P29698, DOI 10.1074/jbc.M203088200; Withers-Martinez C, 2012, INT J PARASITOL, V42, P597, DOI 10.1016/j.ijpara.2012.04.005; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	47	44	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.400820	http://dx.doi.org/10.1074/jbc.M112.400820			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22984267	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000310642200030
J	Phuan, PW; Anderson, MO; Tradtrantip, L; Zhang, H; Tan, J; Lam, C; Bennett, JL; Verkman, AS				Phuan, Puay-Wah; Anderson, Marc O.; Tradtrantip, Lukmanee; Zhang, Hua; Tan, Joseph; Lam, Chiwah; Bennett, Jeffrey L.; Verkman, A. S.			A Small-molecule Screen Yields Idiotype-specific Blockers of Neuromyelitis Optica Immunoglobulin G Binding to Aquaporin-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WATER CHANNEL AQUAPORIN-4; ORTHOGONAL ARRAYS; IGG BINDING; ANTIBODIES; CELLS; AUTOANTIBODIES; CYTOTOXICITY; NATALIZUMAB; PREDICTION; INHIBITORS	Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system caused by binding of anti-aquaporin-4 (AQP4) autoantibodies (NMO-IgG) to AQP4 on astrocytes. A screen was developed to identify inhibitors of NMO-IgG-dependent, complement-dependent cytotoxicity. Screening of 50,000 synthetic small molecules was done using CHO cells expressing human AQP4 and a human NMO recombinant monoclonal antibody (rAb-53). The screen yielded pyrano[2,3-c]pyrazoles that blocked rAb-53 binding to AQP4 and prevented cytotoxicity in cell culture and spinal cord slice models of NMO. Structure-activity analysis of 82 analogs yielded a blocker with IC50 similar to 6 mu M. Analysis of the blocker mechanism indicated idiotype specificity, as (i) pyrano[2,3-c] pyrazoles did not prevent AQP4 binding or cytotoxicity of other NMO-IgGs, and (ii) surface plasmon resonance showed specific rAb-53 binding. Antibody structure modeling and docking suggested a putative binding site near the complementarity-determining regions. Small molecules with idiotype-specific antibody targeting may be useful as research tools and therapeutics.	[Phuan, Puay-Wah; Tradtrantip, Lukmanee; Zhang, Hua; Tan, Joseph; Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Phuan, Puay-Wah; Tradtrantip, Lukmanee; Zhang, Hua; Tan, Joseph; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Anderson, Marc O.] San Francisco State Univ, Dept Chem & Biochem, San Francisco, CA 94132 USA; [Lam, Chiwah; Bennett, Jeffrey L.] Univ Colorado Denver, Dept Neurol, Aurora, CO 80045 USA; [Lam, Chiwah; Bennett, Jeffrey L.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO 80045 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; California State University System; San Francisco State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, 1246 Hlth Sci E Tower, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu			National Institutes of Health Grants [EY13574, EB00415, DK35124, HL73856, DK86125, DK72517]; Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society [RG4320]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035124, R37DK035124, P30DK072517, RC1DK086125] Funding Source: NIH RePORTER	National Institutes of Health Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY13574, EB00415, DK35124, HL73856, DK86125, and DK72517 (to A. S. V.). This work was also supported by grants from the Guthy-Jackson Charitable Foundation (to A. S. V. and J. L. B.) and Grant RG4320 from the National Multiple Sclerosis Society (to J. L. B.).	Abdelrazek FM, 2006, ARCH PHARM, V339, P456, DOI 10.1002/ardp.200600057; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Crane JM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227298; Cree B, 2008, CURR NEUROL NEUROSCI, V8, P427, DOI 10.1007/s11910-008-0066-2; Foloppe N, 2006, BIOORGAN MED CHEM, V14, P4792, DOI 10.1016/j.bmc.2006.03.021; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Irani SR, 2011, CURR NEUROL NEUROSCI, V11, P298, DOI 10.1007/s11910-011-0186-y; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; Khatri BO, 2009, NEUROLOGY, V72, P402, DOI 10.1212/01.wnl.0000341766.59028.9d; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Litvinov YM, 2009, J COMB CHEM, V11, P914, DOI 10.1021/cc900076j; Lozeron P, 2007, CURR OPIN NEUROL, V20, P536; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341; Marignier R, 2010, BRAIN, V133, P2578, DOI 10.1093/brain/awq177; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Nielsen S, 1997, J NEUROSCI, V17, P171; Papadopoulos MC, 2012, LANCET NEUROL, V11, P535, DOI 10.1016/S1474-4422(12)70133-3; Parratt JDE, 2010, MULT SCLER J, V16, P1156, DOI 10.1177/1352458510382324; Phuan PW, 2012, J BIOL CHEM, V287, P13829, DOI 10.1074/jbc.M112.344325; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Tradtrantip L, 2012, FASEB J, V26, P2197, DOI 10.1096/fj.11-201608; Tradtrantip L, 2012, ANN NEUROL, V71, P314, DOI 10.1002/ana.22657; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Verkman AS, 2011, J CELL SCI, V124, P2107, DOI 10.1242/jcs.079467; Vincent A, 2011, LANCET NEUROL, V10, P759, DOI 10.1016/S1474-4422(11)70096-5; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Wang Q, 2008, NAT PROTOC, V3, P1832, DOI 10.1038/nprot.2008.184; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Yang BX, 1996, J BIOL CHEM, V271, P4577; Zaki MEA, 2006, Z NATURFORSCH C, V61, P1; Zhang H, 2011, ANN NEUROL, V70, P943, DOI 10.1002/ana.22551	33	11	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36837	36844		10.1074/jbc.M112.408716	http://dx.doi.org/10.1074/jbc.M112.408716			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22989877	Green Published, hybrid			2022-12-25	WOS:000310588500020
J	Kallberg, Y; Segerstolpe, A; Lackmann, F; Persson, B; Wieslander, L				Kallberg, Yvonne; Segerstolpe, Asa; Lackmann, Fredrik; Persson, Bengt; Wieslander, Lars			Evolutionary Conservation of the Ribosomal Biogenesis Factor Rbm19/Mrd1: Implications for Function	PLOS ONE			English	Article							RNA-RECOGNITION MOTIF; ENCEPHALITOZOON-CUNICULI; SECONDARY STRUCTURE; BINDING PROTEINS; SPLICING FACTORS; MOLECULAR-BASIS; SEQUENCE; SUBUNIT; DOMAINS; SPECIFICITY	Ribosome biogenesis in eukaryotes requires coordinated folding and assembly of a pre-rRNA into sequential pre-rRNA-protein complexes in which chemical modifications and RNA cleavages occur. These processes require many small nucleolar RNAs (snoRNAs) and proteins. Rbm19/Mrd1 is one such protein that is built from multiple RNA-binding domains (RBDs). We find that Rbm19/Mrd1 with five RBDs is present in all branches of the eukaryotic phylogenetic tree, except in animals and Choanoflagellates, that instead have a version with six RBDs and Microsporidia which have a minimal Rbm19/Mrd1 protein with four RBDs. Rbm19/Mrd1 therefore evolved as a multi-RBD protein very early in eukaryotes. The linkers between the RBDs have conserved properties; they are disordered, except for linker 3, and position the RBDs at conserved relative distances from each other. All but one of the RBDs have conserved properties for RNA-binding and each RBD has a specific consensus sequence and a conserved position in the protein, suggesting a functionally important modular design. The patterns of evolutionary conservation provide information for experimental analyses of the function of Rbm19/Mrd1. In vivo mutational analysis confirmed that a highly conserved loop 5-beta 4-strand in RBD6 is essential for function.	[Kallberg, Yvonne] Karolinska Inst, Ctr Mol Med, Sci Life Lab, Stockholm, Sweden; [Segerstolpe, Asa; Lackmann, Fredrik; Wieslander, Lars] Stockholm Univ, Dept Mol Biol & Funct Genom, S-10691 Stockholm, Sweden; [Persson, Bengt] Linkoping Univ, Swedish eSci Res Ctr, IFM Bioinformat, Linkoping, Sweden; [Persson, Bengt] Karolinska Inst, Sci Life Lab, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet; Stockholm University; Linkoping University; Swedish e-Science Research Centre (SeRC); Karolinska Institutet	Kallberg, Y (corresponding author), Karolinska Inst, Ctr Mol Med, Sci Life Lab, Stockholm, Sweden.	Lars.Wieslander@molbio.su.se	Wieslander, Lars/B-4670-2016	Wieslander, Lars/0000-0003-3271-6946; Persson, Bengt/0000-0003-3165-5344	Swedish Research Council; Carl Tryggers Stiftelse; Linkoping University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Tryggers Stiftelse; Linkoping University	This work was supported by the Swedish Research Council, Carl Tryggers Stiftelse, and Linkoping University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Auweter SD, 2006, NUCLEIC ACIDS RES, V34, P4943, DOI 10.1093/nar/gkl620; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Biderre C, 1997, J EUKARYOT MICROBIOL, V44, p76S, DOI 10.1111/j.1550-7408.1997.tb05790.x; Bingham J, 2000, BIOINFORMATICS, V16, P660, DOI 10.1093/bioinformatics/16.7.660; BIRNEY E, 1993, NUCLEIC ACIDS RES, V21, P5803, DOI 10.1093/nar/21.25.5803; Bjork P, 2002, MOL BIOL CELL, V13, P3683, DOI 10.1091/mbc.E02-03-0138; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Califice S, 2012, PLANT PHYSIOL, V158, P546, DOI 10.1104/pp.111.189019; Cao YQ, 2011, RES MICROBIOL, V162, P729, DOI 10.1016/j.resmic.2011.05.004; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Datta PP, 2007, MOL CELL, V28, P434, DOI 10.1016/j.molcel.2007.08.026; De Gaudenzi J, 2005, EUKARYOT CELL, V4, P2106, DOI 10.1128/EC.4.12.2106-2114.2005; Dominguez C, 2006, NUCLEIC ACIDS RES, V34, P3634, DOI 10.1093/nar/gkl488; ElAntak L, 2007, J BIOL CHEM, V282, P8165, DOI 10.1074/jbc.M610860200; Gatehouse HS, 1998, J INVERTEBR PATHOL, V71, P97, DOI 10.1006/jipa.1997.4737; Ginisty H, 2001, J BIOL CHEM, V276, P14338, DOI 10.1074/jbc.M011120200; Hage Aziz El, 2004, RNA Biol, V1, P10; HARTSKEERL RA, 1993, NUCLEIC ACIDS RES, V21, P1489, DOI 10.1093/nar/21.6.1489; Jin SB, 2002, J BIOL CHEM, V277, P18431, DOI 10.1074/jbc.M112395200; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorenzen JA, 2005, GENE EXPR PATTERNS, V6, P45, DOI 10.1016/j.modgep.2005.05.001; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Lundkvist P, 2009, MOL CELL BIOL, V29, P5763, DOI 10.1128/MCB.00428-09; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Maruyama K, 1999, NUCLEIC ACIDS RES, V27, P2029, DOI 10.1093/nar/27.9.2029; Mayer AN, 2003, DEVELOPMENT, V130, P3917, DOI 10.1242/dev.00600; Mullineux ST, 2012, BIOCHIMIE, DOI j.biochi.2012.02.001; Nagai K, 1995, Nucleic Acids Symp Ser, P1; Pancevac C, 2010, NUCLEIC ACIDS RES, V38, P3119, DOI 10.1093/nar/gkq002; Peyretaillade E, 1998, NUCLEIC ACIDS RES, V26, P3513, DOI 10.1093/nar/26.15.3513; Peyretaillade E, 2011, RES MICROBIOL, V162, P598, DOI 10.1016/j.resmic.2011.03.004; Saijou E, 2004, NUCLEIC ACIDS RES, V32, P1028, DOI 10.1093/nar/gkh264; Segerstolpe A, 2008, NUCLEIC ACIDS RES, V36, P4364, DOI 10.1093/nar/gkn384; SHAMOO Y, 1995, NUCLEIC ACIDS RES, V23, P725, DOI 10.1093/nar/23.5.725; Sharma MR, 2005, MOL CELL, V18, P319, DOI 10.1016/j.molcel.2005.03.028; Tintaru AM, 2007, EMBO REP, V8, P756, DOI 10.1038/sj.embor.7401031; Varani G, 1998, ANNU REV BIOPH BIOM, V27, P407, DOI 10.1146/annurev.biophys.27.1.407; Wang LX, 2008, BIOINFORMATICS, V24, P1401, DOI 10.1093/bioinformatics/btn132; WISE JA, 1991, METHODS ENZYMOL, V194, P405; Zhang J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-115	44	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43786	10.1371/journal.pone.0043786	http://dx.doi.org/10.1371/journal.pone.0043786			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984444	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500022
J	Park, CH; Kim, KT				Park, Choon-Ho; Kim, Kyong-Tai			Apoptotic Phosphorylation of Histone H3 on Ser-10 by Protein Kinase C delta	PLOS ONE			English	Article							PKC-DELTA; ACTIVATION; CHROMATIN; IDENTIFICATION; SENSITIVITY; SURVIVAL	Phosphorylation of histone H3 on Ser-10 is regarded as an epigenetic mitotic marker and is tightly correlated with chromosome condensation during both mitosis and meiosis. However, it was also reported that histone H3 Ser-10 phosphorylation occurs when cells are exposed to various death stimuli, suggesting a potential role in the regulation of apoptosis. Here we report that histone H3 Ser-10 phosphorylation is mediated by the pro-apoptotic kinase protein kinase C (PKC) delta during apoptosis. We observed that PKC delta robustly phosphorylates histone H3 on Ser-10 both in vitro and in vivo. Ectopic expression of catalytically active PKC delta efficiently induces condensed chromatin structure in the nucleus. We also discovered that activation of PKC delta is required for histone H3 Ser-10 phosphorylation after treatment with DNA damaging agents during apoptosis. Collectively, these findings suggest that PKC delta is the kinase responsible for histone H3 Ser-10 phosphoryation during apoptosis and thus contributes to chromatin condensation together with other apoptosis-related histone modifications. As a result, histone H3 Ser-10 phosphorylation can be designated a new 'apoptotic histone code' mediated by PKC delta.	[Park, Choon-Ho; Kim, Kyong-Tai] Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea; [Kim, Kyong-Tai] Pohang Univ Sci & Technol, Div Integrat Biosci & Biotechnol, Pohang, South Korea	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Park, CH (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Div Mol & Life Sci, Pohang, South Korea.	ktk@postech.ac.kr		KIM, KYONG-TAI/0000-0001-7292-2627	National Research Foundation of Korea (NRF) [20110027957, 20110031234, 20120005830]; National Research Foundation of Korea (NRF) (WCU program) [R31-10105]; Brain Korea 21 program; National Frontier Research Program of the Korean Ministry of Education, Science and Technology [20110031517]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); National Research Foundation of Korea (NRF) (WCU program); Brain Korea 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Frontier Research Program of the Korean Ministry of Education, Science and Technology	This work was supported by the National Research Foundation of Korea (NRF) (No. 20110027957, 20110031234, 20120005830, and WCU program R31-10105). This work was also supported by the Brain Korea 21 program and the National Frontier Research Program (20110031517) of the Korean Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Bharti A, 1998, MOL CELL BIOL, V18, P6719, DOI 10.1128/MCB.18.11.6719; Bode Ann M, 2005, Sci STKE, V2005, pre4, DOI 10.1126/stke.2812005re4; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Crosio C, 2002, MOL CELL BIOL, V22, P874, DOI 10.1128/MCB.22.3.874-885.2002; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Fullgrabe J, 2010, CELL DEATH DIFFER, V17, P1238, DOI 10.1038/cdd.2010.58; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Grant PA, 2001, GENOME BIOL, V2; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hu Y, 2007, CELL DEATH DIFFER, V14, P2035, DOI 10.1038/sj.cdd.4402214; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Hurd PJ, 2009, J BIOL CHEM, V284, P16575, DOI 10.1074/jbc.M109.005421; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee YJ, 2002, CELL GROWTH DIFFER, V13, P237; Leitges M, 2001, J CLIN INVEST, V108, P1505; Mecklenbrauker I, 2004, NATURE, V431, P456, DOI 10.1038/nature02955; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Park CH, 2011, MOL BIOL CELL, V22, P1398, DOI 10.1091/mbc.E10-08-0717; Perez-Cadahia B, 2010, CURR OPIN DRUG DISC, V13, P613; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wang D, 2004, J BIOL CHEM, V279, P20622, DOI 10.1074/jbc.M402547200; Waring P, 1997, J BIOL CHEM, V272, P17929, DOI 10.1074/jbc.272.29.17929; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yoshida K, 2003, EMBO J, V22, P1431, DOI 10.1093/emboj/cdg134; Yoshida K, 2002, J BIOL CHEM, V277, P48372, DOI 10.1074/jbc.M205485200	36	28	28	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44307	10.1371/journal.pone.0044307	http://dx.doi.org/10.1371/journal.pone.0044307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984491	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500046
J	Pires, RH; Karsai, A; Saraiva, MJ; Damas, AM; Kellermayer, MSZ				Pires, Ricardo H.; Karsai, Arpad; Saraiva, Maria J.; Damas, Ana M.; Kellermayer, Miklos S. Z.			Distinct Annular Oligomers Captured along the Assembly and Disassembly Pathways of Transthyretin Amyloid Protofibrils	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; IN-VITRO; PROTEIN AGGREGATION; ALZHEIMERS-DISEASE; FIBRIL FORMATION; PRION PROTEIN; WILD-TYPE; PH; INTERMEDIATE; DENATURATION	Background: Defects in protein folding may lead to severe degenerative diseases characterized by the appearance of amyloid fibril deposits. Cytotoxicity in amyloidoses has been linked to poration of the cell membrane that may involve interactions with amyloid intermediates of annular shape. Although annular oligomers have been detected in many amyloidogenic systems, their universality, function and molecular mechanisms of appearance are debated. Methodology/Principal Findings: We investigated with high-resolution in situ atomic force microscopy the assembly and disassembly of transthyretin (TTR) amyloid protofibrils formed of the native protein by pH shift. Annular oligomers were the first morphologically distinct intermediates observed in the TTR aggregation pathway. Morphological analysis suggests that they can assemble into a double-stack of octameric rings with a 16 +/- 2 nm diameter, and displaying the tendency to form linear structures. According to light scattering data coupled to AFM imaging, annular oligomers appeared to undergo a collapse type of structural transition into spheroid oligomers containing 8-16 monomers. Disassembly of TTR amyloid protofibrils also resulted in the rapid appearance of annular oligomers but with a morphology quite distinct from that observed in the assembly pathway. Conclusions/Significance: Our observations indicate that annular oligomers are key dynamic intermediates not only in the assembly but also in the disassembly of TTR protofibrils. The balance between annular and more compact forms of aggregation could be relevant for cytotoxicity in amyloidogenic disorders.	[Pires, Ricardo H.; Kellermayer, Miklos S. Z.] Semmelweis Univ, Fac Med, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary; [Pires, Ricardo H.; Saraiva, Maria J.; Damas, Ana M.] Univ Porto, Inst Mol & Cell Biol, P-4100 Oporto, Portugal; [Karsai, Arpad] Univ Pecs, Dept Biophys, Pecs, Hungary; [Saraiva, Maria J.; Damas, Ana M.] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4100 Oporto, Portugal	Semmelweis University; Universidade do Porto; University of Pecs; Universidade do Porto	Pires, RH (corresponding author), Semmelweis Univ, Fac Med, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary.	pires.ricardo@med.semmelweis-univ.hu; amdamas@ibmc.up.pt; kellermayer.miklos@med.semmelweis-univ.hu	Saraiva, Maria João/K-3907-2013	Saraiva, Maria João/0000-0002-3360-6899; Kellermayer, Miklos/0000-0002-5553-6553	Hungarian Science Foundation [OTKA K73256, K84133]; Hungarian National Office of Research and Technology [NANOAMI KFKT-1-2006-0021, OMFB-380/2006]; Hungarian Medical Research Council [ETT-229/09]; Hungarian National Development Agency [TAMOP-4.2.1.B-09/1/KMR-2010-0001]; EU [037525]; Calouste Gulbenkian Foundation (Portugal)	Hungarian Science Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Office of Research and Technology(National Office for Research and Technology); Hungarian Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Hungarian National Development Agency; EU(European Commission); Calouste Gulbenkian Foundation (Portugal)	This work was supported by grants from the Hungarian Science Foundation (OTKA K73256 and K84133, http://www.otka.hu), the Hungarian National Office of Research and Technology (NANOAMI KFKT-1-2006-0021, OMFB-380/2006), the Hungarian Medical Research Council (ETT-229/09, http://www.ett.hu), Hungarian National Development Agency (TAMOP-4.2.1.B-09/1/KMR-2010-0001, http://www.nfu.hu) to MSK and Project no. 037525 EURAMY (FP6-LIFESCIHEALTH-6, http://cordis.europa.eu) from EU to AMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RHP acknowledges the award of a travel grant from the Calouste Gulbenkian Foundation (Portugal). We are thankful to Dr. Karoly Modos for useful discussions regarding the DLS measurements and data analysis.	Agocs G, 2010, FEBS LETT, V584, P1139, DOI 10.1016/j.febslet.2010.01.058; Ahmed M, 1942, NAT STRUCT MOL BIOL, V17, P561; Almeida MR, 1997, ENDOCRINE, V6, P309, DOI 10.1007/BF02820508; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Blake C, 1996, STRUCTURE, V4, P989, DOI 10.1016/S0969-2126(96)00104-9; BLAKE CCF, 1978, J MOL BIOL, V121, P339, DOI 10.1016/0022-2836(78)90368-6; BRYAN RK, 1990, FUND THEOR, V39, P221; Capone R, 2009, NEUROTOX RES, V16, P1, DOI 10.1007/s12640-009-9033-1; Cardoso I, 2002, J MOL BIOL, V317, P683, DOI 10.1006/jmbi.2002.5441; Carnally SM, 2008, BIOCHEM BIOPH RES CO, V372, P752, DOI 10.1016/j.bbrc.2008.05.100; Carrotta R, 2005, J BIOL CHEM, V280, P30001, DOI 10.1074/jbc.M500052200; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Damas AM, 2000, J STRUCT BIOL, V130, P290, DOI 10.1006/jsbi.2000.4273; Demuro A, 2011, J CELL BIOL, V195, P515, DOI 10.1083/jcb.201104133; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Diociaiuti M, 2006, BIOPHYS J, V91, P2275, DOI 10.1529/biophysj.105.079475; Hill SE, 2009, BIOPHYS J, V96, P3781, DOI 10.1016/j.bpj.2009.01.044; Ishimaru D, 2003, BIOCHEMISTRY-US, V42, P9022, DOI 10.1021/bi034218k; Jack CR, 2009, BRAIN, V132, P1355, DOI 10.1093/brain/awp062; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kelly JW, 1997, ADV PROTEIN CHEM, V50, P161, DOI 10.1016/S0065-3233(08)60321-6; Kobori T, 2009, J BIOL CHEM, V284, P35507, DOI 10.1074/jbc.M109.060228; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Kumar S, 2009, J MOL BIOL, V385, P1266, DOI 10.1016/j.jmb.2008.11.033; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lasagna-Reeves CA, 2011, J BIOL CHEM, V286, P22122, DOI 10.1074/jbc.M111.236257; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Last NB, 2011, P NATL ACAD SCI USA, V108, P9460, DOI 10.1073/pnas.1102356108; Liu K, 2000, NAT STRUCT BIOL, V7, P754; Malisauskas M, 2003, J MOL BIOL, V330, P879, DOI 10.1016/S0022-2836(03)00551-5; Modler AJ, 2004, AMYLOID, V11, P215, DOI 10.1080/13506120400014831; Modler AJ, 2003, J MOL BIOL, V325, P135, DOI 10.1016/S0022-2836(02)01175-0; Mukhopadhyay S, 2006, J MOL BIOL, V358, P935, DOI 10.1016/j.jmb.2006.02.006; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; Pires RH, 2011, J MOL RECOGNIT, V24, P467, DOI 10.1002/jmr.1112; Pountney DL, 2004, J NEUROCHEM, V90, P502, DOI 10.1111/j.1471-4159.2004.02533.x; Quintas A, 1997, FEBS LETT, V418, P297, DOI 10.1016/S0014-5793(97)01398-7; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Saraiva Maria Joao Mascarenhas, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402004647; SARAIVA MJM, 1995, HUM MUTAT, V5, P191; Saraiva MJM, 2001, HUM MUTAT, V17, P493, DOI 10.1002/humu.1132; Sbrana F, 2007, EUR BIOPHYS J BIOPHY, V36, P727, DOI 10.1007/s00249-007-0159-x; Shahi P, 2007, BIOCHEMISTRY-US, V46, P7365, DOI 10.1021/bi7001136; Sokolowski F, 2003, J BIOL CHEM, V278, P40481, DOI 10.1074/jbc.M304391200; Srinivasan R, 2004, AMYLOID, V11, P10, DOI 10.1080/13506120410001667872; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Stefani M, 2012, PROG NEUROBIOL, DOI [10.1016/j.pneurobio.2012.1003.1002, DOI 10.1016/J.PNEUROBIO.2012.1003.1002]; Vendrely C, 2005, BBA-GEN SUBJECTS, V1724, P355, DOI 10.1016/j.bbagen.2005.05.017; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Yamaguchi I, 2001, BIOCHEMISTRY-US, V40, P8499, DOI 10.1021/bi0027128; Zheng J, 2008, J PHYS CHEM B, V112, P6856, DOI 10.1021/jp711335b; Zhu M, 2004, J BIOL CHEM, V279, P24452, DOI 10.1074/jbc.M400004200	54	37	37	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44992	10.1371/journal.pone.0044992	http://dx.doi.org/10.1371/journal.pone.0044992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984597	Green Submitted, Green Published, gold			2022-12-25	WOS:000308738500103
J	Rapoport, BI; Turicchia, L; Wattanapanitch, W; Davidson, TJ; Sarpeshkar, R				Rapoport, Benjamin I.; Turicchia, Lorenzo; Wattanapanitch, Woradorn; Davidson, Thomas J.; Sarpeshkar, Rahul			Efficient Universal Computing Architectures for Decoding Neural Activity	PLOS ONE			English	Article							BRAIN-MACHINE INTERFACES; HIPPOCAMPAL PLACE CELLS; KALMAN FILTER; PROSTHETIC DEVICES; ENERGY-EFFICIENT; CONTROL SIGNALS; POPULATION; STIMULATOR; MOVEMENT; ALGORITHMS	The ability to decode neural activity into meaningful control signals for prosthetic devices is critical to the development of clinically useful brain-machine interfaces (BMIs). Such systems require input from tens to hundreds of brain-implanted recording electrodes in order to deliver robust and accurate performance; in serving that primary function they should also minimize power dissipation in order to avoid damaging neural tissue; and they should transmit data wirelessly in order to minimize the risk of infection associated with chronic, transcutaneous implants. Electronic architectures for brain-machine interfaces must therefore minimize size and power consumption, while maximizing the ability to compress data to be transmitted over limited-bandwidth wireless channels. Here we present a system of extremely low computational complexity, designed for real-time decoding of neural signals, and suited for highly scalable implantable systems. Our programmable architecture is an explicit implementation of a universal computing machine emulating the dynamics of a network of integrate-and-fire neurons; it requires no arithmetic operations except for counting, and decodes neural signals using only computationally inexpensive logic operations. The simplicity of this architecture does not compromise its ability to compress raw neural data by factors greater than 10(5). We describe a set of decoding algorithms based on this computational architecture, one designed to operate within an implanted system, minimizing its power consumption and data transmission bandwidth; and a complementary set of algorithms for learning, programming the decoder, and postprocessing the decoded output, designed to operate in an external, nonimplanted unit. The implementation of the implantable portion is estimated to require fewer than 5000 operations per second. A proof-of-concept, 32-channel field-programmable gate array (FPGA) implementation of this portion is consequently energy efficient. We validate the performance of our overall system by decoding electrophysiologic data from a behaving rodent.	[Rapoport, Benjamin I.] Harvard Univ, Sch Med, MD Ph D Program, Boston, MA 02115 USA; [Rapoport, Benjamin I.; Turicchia, Lorenzo; Wattanapanitch, Woradorn; Sarpeshkar, Rahul] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Rapoport, Benjamin I.] Harvard Univ, Div Hlth Sci & Technol, Cambridge, MA 02138 USA; [Davidson, Thomas J.] Stanford Univ, Sch Med, Dept Bioengn, Stanford, CA 94305 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Stanford University	Rapoport, BI (corresponding author), Harvard Univ, Sch Med, MD Ph D Program, Boston, MA 02115 USA.	rahuls@mit.edu	Rapoport, Benjamin/ABF-2332-2021	Davidson, Thomas/0000-0003-0836-6333	National Institutes of Health [NS056140]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056140] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grant NS056140 from the National Institutes of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Actel Corporation, 2009, IGLOO LOW POW FLASH; Arfin SK, 2012, IEEE T BIOMED CIRC S, V6, P1, DOI 10.1109/TBCAS.2011.2166072; Baker MW, 2007, IEEE T BIOMED CIRC S, V1, P28, DOI 10.1109/TBCAS.2007.893180; Bengio Y, 2007, PROG BRAIN RES, V165, P521, DOI 10.1016/S0079-6123(06)65033-4; Best PJ, 2001, ANNU REV NEUROSCI, V24, P459, DOI 10.1146/annurev.neuro.24.1.459; Brockwell AE, 2004, J NEUROPHYSIOL, V91, P1899, DOI 10.1152/jn.00438.2003; Brown EN, 1998, J NEUROSCI, V18, P7411; Chader GJ, 2009, PROG BRAIN RES, V175, P317, DOI 10.1016/S0079-6123(09)17522-2; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; Eliasmith C, 2003, NEURAL ENG, P112; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; Ghovanloo M, 2007, IEEE T CIRCUITS SYST, V54, P71; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Holleman J, 2007, P ANN INT IEEE EMBS, P3930, DOI 10.1109/IEMBS.2007.4353193; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Japkowicz N., 2011, EVALUATING LEARNING, DOI 10.1017/CBO9780511921803; Kelly SK, 2011, IEEE T BIOMED CIRC S, V5, P20, DOI 10.1109/TBCAS.2010.2076384; Koyama S, 2010, J COMPUT NEUROSCI, V29, P73, DOI 10.1007/s10827-009-0196-9; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Madisetti V., 2009, DIGITAL SIGNAL PROCE; Mandal S, 2008, IEEE T BIOMED CIRC S, V2, P301, DOI 10.1109/TBCAS.2008.2005295; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mohseni P, 2005, IEEE T NEUR SYS REH, V13, P263, DOI 10.1109/TNSRE.2005.853625; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Narasimhan K, 2004, NAT NEUROSCI, V7, P425, DOI 10.1038/nn0504-425; Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Olsson RH, 2005, IEEE J SOLID-ST CIRC, V40, P2796, DOI 10.1109/JSSC.2005.858479; Panasonic Industry, 2022, ULTRA LOW POWER BIOE, DOI 10.1017/CBO9780511841446; Paninski L, 2004, J NEUROPHYSIOL, V91, P515, DOI 10.1152/jn.00587.2002; Patil PG, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.5.FOCUS.JULY09.INTRO; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Rapoport B, 2011, SYSTEM CIRCUIT DESIG, P216; RAPOPORT BI, 2009, EMBC 2009 ANN INT C, P4214; Rizk M, 2009, MED BIOL ENG COMPUT, V47, P955, DOI 10.1007/s11517-009-0451-2; Salanova V, 2007, CURR NEUROL NEUROSCI, V7, P315, DOI 10.1007/s11910-007-0048-9; Sanchez JC, 2005, IEEE T NEUR SYS REH, V13, P213, DOI 10.1109/TNSRE.2005.847382; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Sarma SV, 2010, IEEE T BIO-MED ENG, V57, P1297, DOI 10.1109/TBME.2009.2039213; Sarpeshkar R, 2008, IEEE T BIOMED CIRC S, V2, P173, DOI 10.1109/TBCAS.2008.2003198; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Serruya M, 2003, BIOL CYBERN, V88, P219, DOI 10.1007/s00422-002-0374-6; Shenoy KV, 2003, NEUROREPORT, V14, P591, DOI 10.1097/00001756-200303240-00013; Shire DB, 2009, IEEE T BIO-MED ENG, V56, P2502, DOI 10.1109/TBME.2009.2021401; Srinivasan L, 2007, J NEUROPHYSIOL, V98, P2456, DOI 10.1152/jn.01118.2006; Stark E, 2007, J NEUROSCI, V27, P8387, DOI 10.1523/JNEUROSCI.1321-07.2007; Tarsy MD, 2008, CURR CLIN NEUROL, P1, DOI 10.1007/978-1-59745-360-8; Theogarajan LS, 2008, IEEE J SOLID-ST CIRC, V43, P2322, DOI 10.1109/JSSC.2008.2004331; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Wattanapanitch W, 2011, IEEE T BIOMED CIRC S, V5, P592, DOI 10.1109/TBCAS.2011.2163404; Wattanapanitch W, 2007, IEEE T BIOMED CIRC S, V1, P136, DOI 10.1109/TBCAS.2007.907868; Wolfram S., 2002, NEW KIND SCI; Wu W, 2004, P ANN INT IEEE EMBS, V26, P4126; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Wu W, 2004, IEEE T BIO-MED ENG, V51, P933, DOI 10.1109/TBME.2004.826666; Wu W, 2008, IEEE T NEUR SYS REH, V16, P213, DOI 10.1109/TNSRE.2008.922679	59	11	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e42492	10.1371/journal.pone.0042492	http://dx.doi.org/10.1371/journal.pone.0042492			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984404	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500006
J	Shao, CR; Sun, B; DeVoe, DL; Colombini, M				Shao, Chenren; Sun, Bing; DeVoe, Don L.; Colombini, Marco			Dynamics of Ceramide Channels Detected Using a Microfluidic System	PLOS ONE			English	Article							FORMS CHANNELS; ION CHANNELS; MEMBRANES; C-2-CERAMIDE; APOPTOSIS; PRESSURE; PROTEINS; LIPIDS	Ceramide, a proapoptotic sphingolipid, has been shown to form channels, in mitochondrial outer membranes, large enough to translocate proteins. In phospholipid membranes, electrophysiological studies and electron microscopic visualization both report that these channels form in a range of sizes with a modal value of 10 nm in diameter. A hydrogen bonded barrel-like structure consisting of hundreds of ceramide molecules has been proposed for the structure of the channel and this is supported by electrophysiological studies and molecular dynamic simulations. To our knowledge, the mechanical strength and deformability of such a large diameter but extremely thin cylindrical structure has never been reported. Here we present evidence for a reversible mechanical distortion of the cylinder following the addition of La3+. A microfluidic system was used to repeatedly lower and then restore the conductance by alternatively perfusing La3+ and EDTA. Although aspects of the kinetics of conductance drop and recovery are consistent with a disassembly/diffusion/reassembly model, others are inconsistent with the expected time scale of lateral diffusion of disassembled channel fragments in the membrane. The presence of a residual conductance following La3+ treatment and the relationship between the residual conductance and the initial conductance were both indicative of a distortion/recovery process in analogy with a pressure-induced distortion of a flexible cylinder.	[Shao, Chenren; DeVoe, Don L.] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA; [Sun, Bing; Colombini, Marco] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Shao, CR (corresponding author), Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA.	colombini@umd.edu	DeVoe, Don L/A-2891-2011; Colombini, Marco/A-1540-2014	DeVoe, Don L/0000-0002-7740-9993; 	National Science Foundation [MCB-1023008, CBET0966407]; National Institutes of Health of the United States of America [R21EB009485, R21EB011750]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB011750, R21EB009485] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1023008] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Science Foundation [MCB-1023008] and [CBET0966407] and by the National Institutes of Health [R21EB009485] and [R21EB011750] of the United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anishkin A, 2006, BIOPHYS J, V90, P2414, DOI 10.1529/biophysj.105.071977; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Cantor RS, 1999, CHEM PHYS LIPIDS, V101, P45, DOI 10.1016/S0009-3084(99)00054-7; Colombini M, 2010, BBA-BIOENERGETICS, V1797, P1239, DOI 10.1016/j.bbabio.2010.01.021; Ermakov YA, 2010, BIOPHYS J, V98, P1018, DOI 10.1016/j.bpj.2009.11.044; Ganesan V, 2010, FEBS LETT, V584, P2128, DOI 10.1016/j.febslet.2010.02.032; Ganesan V, 2010, APOPTOSIS, V15, P553, DOI 10.1007/s10495-009-0449-0; Gullingsrud J, 2004, BIOPHYS J, V86, P3496, DOI 10.1529/biophysj.103.034322; Heimburg T, 2010, BIOPHYS CHEM, V150, P2, DOI 10.1016/j.bpc.2010.02.018; Heimburg T, 2007, BIOPHYS J, V92, P3159, DOI 10.1529/biophysj.106.099754; Hromada LP, 2008, LAB CHIP, V8, P602, DOI 10.1039/b716388f; KAGAWA Y, 1971, J BIOL CHEM, V246, P5477; Linke WA, 2000, HISTOL HISTOPATHOL, V15, P799, DOI 10.14670/HH-15.799; Samanta S, 2011, BBA-BIOMEMBRANES, V1808, P1196, DOI 10.1016/j.bbamem.2011.01.007; Shao CR, 2011, ANN BIOMED ENG, V39, P2242, DOI 10.1007/s10439-011-0323-4; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P227, DOI 10.1007/s10863-005-6632-2; Siskind LJ, 2003, BIOPHYS J, V85, P1560, DOI 10.1016/S0006-3495(03)74588-3; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200	21	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43513	10.1371/journal.pone.0043513	http://dx.doi.org/10.1371/journal.pone.0043513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984432	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500016
J	Yao, B; Zhang, L; Liang, SD; Zhang, C				Yao, Bo; Zhang, Lin; Liang, Shide; Zhang, Chi			SVMTriP: A Method to Predict Antigenic Epitopes Using Support Vector Machine to Integrate Tri-Peptide Similarity and Propensity	PLOS ONE			English	Article							B-CELL EPITOPES; PROTEINS; DETERMINANTS; SEQUENCES; DATABASE; LOCATION; PROGRAM; CURVES; SITES; SCALE	Identifying protein surface regions preferentially recognizable by antibodies (antigenic epitopes) is at the heart of new immuno-diagnostic reagent discovery and vaccine design, and computational methods for antigenic epitope prediction provide crucial means to serve this purpose. Many linear B-cell epitope prediction methods were developed, such as BepiPred, ABCPred, AAP, BCPred, BayesB, BEOracle/BROracle, and BEST, towards this goal. However, effective immunological research demands more robust performance of the prediction method than what the current algorithms could provide. In this work, a new method to predict linear antigenic epitopes is developed; Support Vector Machine has been utilized by combining the Tri-peptide similarity and Propensity scores (SVMTriP). Applied to non-redundant B-cell linear epitopes extracted from IEDB, SVMTriP achieves a sensitivity of 80.1% and a precision of 55.2% with a five-fold cross-validation. The AUC value is 0.702. The combination of similarity and propensity of tri-peptide subsequences can improve the prediction performance for linear B-cell epitopes. Moreover, SVMTriP is capable of recognizing viral peptides from a human protein sequence background. A web server based on our method is constructed for public use. The server and all datasets used in the current study are available at http://sysbio.unl.edu/SVMTriP.	[Yao, Bo; Zhang, Chi] Univ Nebraska, Sch Biol Sci, Ctr Plant Sci & Innovat, Lincoln, NE 68583 USA; [Zhang, Lin] Univ Nebraska, Dept Stat, Lincoln, NE USA; [Liang, Shide] Osaka Univ, Immunol Frontier Res Ctr, Syst Immunol Lab, Suita, Osaka, Japan	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Osaka University	Yao, B (corresponding author), Univ Nebraska, Sch Biol Sci, Ctr Plant Sci & Innovat, Lincoln, NE 68583 USA.	shideliang@hotmail.com; czhang5@unl.edu	Liang, Shide/AAO-7663-2021; Zhang, Chi/C-4996-2009	Liang, Shide/0000-0003-2255-9887; Zhang, Chi/0000-0002-1827-8137	University of Nebraska, Lincoln, NE	University of Nebraska, Lincoln, NE	The work was supported by funding under Chi Zhang's startup funds from University of Nebraska, Lincoln, NE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix AJP, 1999, VACCINE, V18, P311, DOI 10.1016/S0264-410X(99)00329-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Chen J, 2007, AMINO ACIDS, V33, P423, DOI 10.1007/s00726-006-0485-9; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Gao JZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040104; GETZOFF ED, 1988, ADV IMMUNOL, V43, P1; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; JOACHIMS T, 1999, MAKING LARGE SCALE S; KARPLUS PA, 1985, NATURWISSENSCHAFTEN, V72, P212, DOI 10.1007/BF01195768; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Lei ZD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-291; MILICH DR, 1989, ADV IMMUNOL, V45, P195, DOI 10.1016/S0065-2776(08)60694-X; Odorico M, 2003, J MOL RECOGNIT, V16, P20, DOI 10.1002/jmr.602; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; PELLEQUER JL, 1993, IMMUNOL LETT, V36, P83, DOI 10.1016/0165-2478(93)90072-A; PELLEQUER JL, 1993, J MOL GRAPH MODEL, V11, P204, DOI 10.1016/0263-7855(93)80074-2; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79; Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078; Schonbach C, 2000, NUCLEIC ACIDS RES, V28, P222, DOI 10.1093/nar/28.1.222; Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang YL, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-251; Wee LJK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S4-S21	28	186	190	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45152	10.1371/journal.pone.0045152	http://dx.doi.org/10.1371/journal.pone.0045152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984622	Green Published, gold			2022-12-25	WOS:000308738500120
J	Jun, G; Moncaster, JA; Koutras, C; Seshadri, S; Buros, J; McKee, AC; Levesque, G; Wolf, PA; St George-Hyslop, P; Goldstein, LE; Farrer, LA				Jun, Gyungah; Moncaster, Juliet A.; Koutras, Carolina; Seshadri, Sudha; Buros, Jacqueline; McKee, Ann C.; Levesque, Georges; Wolf, Philip A.; St George-Hyslop, Peter; Goldstein, Lee E.; Farrer, Lindsay A.			delta-Catenin Is Genetically and Biologically Associated with Cortical Cataract and Future Alzheimer-Related Structural and Functional Brain Changes	PLOS ONE			English	Article							SUSCEPTIBILITY VARIANTS; COMMON VARIANTS; FRAMINGHAM; DISEASE; PROTEIN; HERITABILITY; GENE; AGE; PRESENILIN-1; LINKAGE	Multiple lines of evidence suggest that specific subtypes of age-related cataract (ARC) and Alzheimer disease (AD) are related etiologically. To identify shared genetic factors for ARC and AD, we estimated co-heritability of quantitative measures of cataract subtypes with AD-related brain MRI traits among 1,249 members of the Framingham Eye Study who had a brain MRI scan approximately ten years after the eye exam. Cortical cataract (CC) was found to be co-heritable with future development of AD and with several MRI traits, especially temporal horn volume (THV, rho = 0.24, P<10(-4)). A genome-wide association study using 187,657 single nucleotide polymorphisms (SNPs) for the bivariate outcome of CC and THV identified genome-wide significant association with CTNND2 SNPs rs17183619, rs13155993 and rs13170756 (P<2.6x10(-7))(.) These SNPs were also significantly associated with bivariate outcomes of CC and scores on several highly heritable neuropsychological tests (5.7x10(-9) <= P<3.7x10(-6)). Statistical interaction was demonstrated between rs17183619 and APP SNP rs2096488 on CC (P = 0.0015) and CC-THV (P = 0.038). A rare CTNND2 missense mutation (G810R) 249 base pairs from rs17183619 altered delta-catenin localization and increased secreted amyloid-beta(1-42) in neuronal cell culture. Immunohistopathological analysis of lens tissue obtained from two autopsy-confirmed AD subjects and two non-AD controls revealed elevated expression of delta-catenin in epithelial and cortical regions of lenses from AD subjects compared to controls. Our findings suggest that genetic variation in delta catenin may underlie both cortical lens opacities in mid-life and subsequent MRI and cognitive changes that presage the development of AD.	[Jun, Gyungah; Buros, Jacqueline; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med Biomed Genet, Boston, MA 02118 USA; [Jun, Gyungah; Buros, Jacqueline; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Med Biomed Genet, Boston, MA USA; [Jun, Gyungah; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Jun, Gyungah; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Ophthalmol, Boston, MA USA; [Jun, Gyungah; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Biostat, Boston, MA 02118 USA; [Jun, Gyungah; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Moncaster, Juliet A.; Goldstein, Lee E.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Moncaster, Juliet A.; Goldstein, Lee E.] Boston Univ, Sch Publ Hlth, Dept Psychiat, Boston, MA USA; [Seshadri, Sudha; McKee, Ann C.; Wolf, Philip A.; Goldstein, Lee E.; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Seshadri, Sudha; McKee, Ann C.; Wolf, Philip A.; Goldstein, Lee E.; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Neurol, Boston, MA USA; [McKee, Ann C.; Goldstein, Lee E.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [McKee, Ann C.; Goldstein, Lee E.] Boston Univ, Sch Publ Hlth, Dept Pathol & Lab Med, Boston, MA USA; [Wolf, Philip A.; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Epidemiol, Boston, MA 02118 USA; [Wolf, Philip A.; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Seshadri, Sudha; Wolf, Philip A.] Boston Univ, Sch Med, Framingham Heart Study, Boston, MA 02118 USA; [Seshadri, Sudha; Wolf, Philip A.] Boston Univ, Sch Publ Hlth, Framingham Heart Study, Boston, MA USA; [McKee, Ann C.; Goldstein, Lee E.; Farrer, Lindsay A.] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [McKee, Ann C.; Goldstein, Lee E.; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Alzheimers Dis Ctr, Boston, MA USA; [Koutras, Carolina; St George-Hyslop, Peter] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [McKee, Ann C.] Bedford Vet Adm Hosp, Geriatr Res Educ Clin Ctr, Bedford, MA USA; [Levesque, Georges] Univ Laval, CHUL, Neurosci Res Ctr, Quebec City, PQ, Canada; [St George-Hyslop, Peter] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England	Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; Framingham Heart Study; Boston University; Framingham Heart Study; Boston University; Boston University; University of Toronto; Geriatric Research Education & Clinical Center; Laval University; University of Cambridge	Jun, G (corresponding author), Boston Univ, Sch Med, Dept Med Biomed Genet, Boston, MA 02118 USA.	gyungah@bu.edu; farrer@bu.edu	Farrer, Lindsay/AAS-1035-2020	Farrer, Lindsay/0000-0001-5533-4225; Buros, Jacqueline/0000-0001-9588-4889; Wolf, Philip/0000-0002-3628-301X; Moncaster, Juliet/0000-0002-7849-4325; Jun, Gyungah/0000-0002-3230-8697; Koutras, Carolina/0000-0002-9854-8458; Goldstein, Lee/0000-0001-8419-9800; Seshadri, Sudha/0000-0001-6135-2622	National Institute on Aging [R01-AG025259, R01-AG33193, R01-AG081220, R01-AG16495, R01-AG033040, P30-AG13846]; National Institute of General Medical Science [R01-GM75986]; Wellcome Trust; Medical Research Council; Canadian Institutes of Health Research; Alzheimer Society of Ontario; Ontario Research Fund; National Heart, Lung, and Blood Institute's Framingham Heart Study [N01-HC-25195]; Affymetrix, Inc [N02-HL-64278]; United States Public Health Service Resource grants from National Center for Research Resources [RR03655, RR163736]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033193, P30AG013846, R01AG025259, R01AG033040, R01AG008122, R01AG016495] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Ontario; Ontario Research Fund; National Heart, Lung, and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix, Inc; United States Public Health Service Resource grants from National Center for Research Resources; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the National Institute on Aging (R01-AG025259, R01-AG33193, R01-AG081220, R01-AG16495, R01-AG033040, and P30-AG13846), National Institute of General Medical Science (R01-GM75986), Wellcome Trust, Medical Research Council, Canadian Institutes of Health Research, Alzheimer Society of Ontario, and Ontario Research Fund. This work was also supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (contract N01-HC-25195) and its contract with Affymetrix, Inc, for genotyping services (contract N02-HL-64278). The results of this study were obtained by using the software package S. A. G. E. and the Boston University Linux Cluster for Genetic Analysis (LinGA) which are supported by United States Public Health Service Resource grants RR03655 and RR163736, respectively, from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Andersson ME, 2007, MOL VIS, V13, P993; [Anonymous], 2011, ALZHEIMERS DIS FACTS; Au R, 2004, EXP AGING RES, V30, P333, DOI 10.1080/03610730490484380; Blacker D, 2007, ARCH NEUROL-CHICAGO, V64, P862, DOI 10.1001/archneur.64.6.862; Choi Seung-Hoan, 2011, BMC Proc, V5 Suppl 9, pS79, DOI 10.1186/1753-6561-5-S9-S79; Cooper MA, 2009, J COMP NEUROL, V514, P310, DOI 10.1002/cne.22030; DAWBER TR, 1966, CIRCULATION, V34, P553, DOI 10.1161/01.CIR.34.4.553; De Jager PL, 2011, NEUROBIOL A IN PRESS; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; Dhaenens CM, 2004, NEUROSCI LETT, V368, P290, DOI 10.1016/j.neulet.2004.07.040; Duparc RH, 2006, DEV BIOL, V300, P647, DOI 10.1016/j.ydbio.2006.07.045; Elias MF, 2000, ARCH NEUROL-CHICAGO, V57, P808, DOI 10.1001/archneur.57.6.808; Elston Robert C, 2004, Hum Genomics, V1, P456; FARMER ME, 1987, PSYCHOL REP, V60, P1023, DOI 10.2466/pr0.1987.60.3c.1023; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Farrer LA, 1997, NEUROLOGIST, V3, P13, DOI 10.1097/00127893-199701000-00003; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Frederikse PH, 2002, AM J PATHOL, V161, P1985, DOI 10.1016/S0002-9440(10)64475-6; Frederikse PH, 1998, CURR EYE RES, V17, P947, DOI 10.1076/ceyr.17.9.947.5135; Frederikse PH, 2000, CURR EYE RES, V20, P462, DOI 10.1076/0271-3683(200006)20:6;1-Y;FT462; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Hatzfeld M, 1996, J CELL SCI, V109, P2767; Hiller R, 2003, OPHTHALMOLOGY, V110, P578, DOI 10.1016/S0161-6420(02)01762-1; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Jack CR, 2003, NEUROLOGY, V60, P253, DOI 10.1212/01.WNL.0000042480.86872.03; JACOBS DM, 1995, NEUROLOGY, V45, P957, DOI 10.1212/WNL.45.5.957; JANSSENS MJJ, 1979, EUPHYTICA, V28, P601, DOI 10.1007/BF00038926; Jun G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000584; Keen KJ, 2003, STAT MED, V22, P3229, DOI 10.1002/sim.1559; Kouchi Z, 2009, J BIOL CHEM, V284, P1954, DOI 10.1074/jbc.M806250200; Levesque G, 1999, J NEUROCHEM, V72, P999, DOI 10.1046/j.1471-4159.1999.0720999.x; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Liauw J, 2002, MOL BRAIN RES, V109, P56, DOI 10.1016/S0169-328X(02)00491-6; Matter C, 2009, NEURON, V64, P320, DOI 10.1016/j.neuron.2009.09.026; Melov S, 2005, FREE RADICAL BIO MED, V38, P258, DOI 10.1016/j.freeradbiomed.2004.10.023; Moncaster JA, NONINVASIVE OC UNPUB; Moncaster JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010659; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; National Eye Institute, 2009, NAT PLAN EYE VIS RES; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Restituito S, 2011, J NEUROSCI, V31, P12083, DOI 10.1523/JNEUROSCI.2513-11.2011; Sanfilippo PG, 2010, SURV OPHTHALMOL, V55, P561, DOI 10.1016/j.survophthal.2010.07.003; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Sherva R, 2011, CURR PSYCHIAT REP, V13, P138, DOI 10.1007/s11920-011-0184-4; Shiels A, 2010, MOL VIS, V16, P2007; So HC, 2011, GENET EPIDEMIOL, V35, P447, DOI 10.1002/gepi.20593; So HC, 2011, GENET EPIDEMIOL, V35, P310, DOI 10.1002/gepi.20579; Stahl B, 1999, J BIOL CHEM, V274, P9141, DOI 10.1074/jbc.274.14.9141; TAYLOR HR, 1989, AUST NZ J OPHTHALMOL, V17, P81, DOI 10.1111/j.1442-9071.1989.tb00492.x; von Otter M, 2010, NEUROMOL MED, V12, P229, DOI 10.1007/s12017-009-8103-0; Wang T, 2007, ANN HUM GENET, V71, P96, DOI 10.1111/j.1469-1809.2006.00303.x; Wang T, 2005, GENET EPIDEMIOL, V29, P12, DOI 10.1002/gepi.20075; WEST SK, 1988, INVEST OPHTH VIS SCI, V29, P73; Zhou JH, 1997, NEUROREPORT, V8, P1489, DOI 10.1097/00001756-199704140-00033	59	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43728	10.1371/journal.pone.0043728	http://dx.doi.org/10.1371/journal.pone.0043728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984439	Green Submitted, Green Published, gold			2022-12-25	WOS:000308638700028
J	Kling, D; Egeland, T; Mostad, P				Kling, Daniel; Egeland, Thore; Mostad, Petter			Using Object Oriented Bayesian Networks to Model Linkage, Linkage Disequilibrium and Mutations between STR Markers	PLOS ONE			English	Article							IDENTIFICATION; PATERNITY	In a number of applications there is a need to determine the most likely pedigree for a group of persons based on genetic markers. Adequate models are needed to reach this goal. The markers used to perform the statistical calculations can be linked and there may also be linkage disequilibrium (LD) in the population. The purpose of this paper is to present a graphical Bayesian Network framework to deal with such data. Potential LD is normally ignored and it is important to verify that the resulting calculations are not biased. Even if linkage does not influence results for regular paternity cases, it may have substantial impact on likelihood ratios involving other, more extended pedigrees. Models for LD influence likelihoods for all pedigrees to some degree and an initial estimate of the impact of ignoring LD and/or linkage is desirable, going beyond mere rules of thumb based on marker distance. Furthermore, we show how one can readily include a mutation model in the Bayesian Network; extending other programs or formulas to include such models may require considerable amounts of work and will in many case not be practical. As an example, we consider the two STR markers vWa and D12S391. We estimate probabilities for population haplotypes to account for LD using a method based on data from trios, while an estimate for the degree of linkage is taken from the literature. The results show that accounting for haplotype frequencies is unnecessary in most cases for this specific pair of markers. When doing calculations on regular paternity cases, the markers can be considered statistically independent. In more complex cases of disputed relatedness, for instance cases involving siblings or so-called deficient cases, or when small differences in the LR matter, independence should not be assumed. (The networks are freely available at http://arken.umb.no/similar to dakl/BayesianNetworks.)	[Kling, Daniel; Egeland, Thore] Norwegian Inst Publ Hlth, Dept Family Genet, Oslo, Norway; [Kling, Daniel; Egeland, Thore] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Mostad, Petter] Chalmers Univ Technol & Math Sci, Gothenburg, Sweden	Norwegian Institute of Public Health (NIPH); Norwegian University of Life Sciences; Chalmers University of Technology	Kling, D (corresponding author), Norwegian Inst Publ Hlth, Dept Family Genet, Oslo, Norway.	daniel.kling@fhi.no	Mostad, Petter/AAB-9960-2021	Mostad, Petter/0000-0002-2569-6070	Norwegian Institute of Public Health	Norwegian Institute of Public Health	The work was funded by the Norwegian Institute of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2005, AM J HUM GENET, V77, P754, DOI 10.1086/497345; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Biedermann A, 2006, FORENSIC SCI INT, V163, P18, DOI 10.1016/j.forsciint.2005.11.001; Brenner CH, 1997, GENETICS, V145, P535; Buckleton J.S., 2004, FORENSIC DNA EVIDENC; Budowle B, 2011, INT J LEGAL MED, V125, P101, DOI 10.1007/s00414-010-0516-7; Dawid AP, 2007, FORENSIC SCI INT, V169, P195, DOI 10.1016/j.forsciint.2006.08.028; Egeland T, 2000, FORENSIC SCI INT, V110, P47, DOI 10.1016/S0379-0738(00)00147-X; Egeland T, 2008, FORENSIC SCI INT-GEN, V2, P219, DOI 10.1016/j.fsigen.2008.02.006; Gill P, 2011, FORENSIC SCI INT-GEN, V6, P477; Gill P, 2006, FORENSIC SCI INT, V163, P155, DOI 10.1016/j.forsciint.2005.11.025; Gomes RR, 2009, GENET MOL RES, V8, P273, DOI 10.4238/vol8-1gmr555; Hepler AB, 2008, FORENSIC SCI INT-GEN, V2, P166, DOI 10.1016/j.fsigen.2007.12.003; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kling D, 2012, FORENSIC SCI INT-GEN, V6, P616, DOI 10.1016/j.fsigen.2012.01.012; Kling D, 2012, FORENSIC SCI INT-GEN, V6, P322, DOI 10.1016/j.fsigen.2011.07.007; Koller D., 1997, P 13 C UNC ART INT U, P302; Lauritzen SL, 2003, STAT SCI, V18, P489, DOI 10.1214/ss/1081443232; O'Connor KL, 2011, FORENSIC SCI INT-GEN, V5, P538, DOI 10.1016/j.fsigen.2010.09.003; Phillips C, 2011, FORENSIC SCI INT-GEN, V5, P155, DOI 10.1016/j.fsigen.2010.02.003; Skare O, 2009, BIOINFORMATICS, V25, P2376, DOI 10.1093/bioinformatics/btp418; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Taroni F., 2014, BAYESIAN NETWORKS PR, VSecond, DOI 10.1002/0470091754; Tillmar AO, 2011, FORENSIC SCI INT-GEN, V5, P506, DOI 10.1016/j.fsigen.2010.11.004	24	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43873	10.1371/journal.pone.0043873	http://dx.doi.org/10.1371/journal.pone.0043873			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984448	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700031
J	Porazinska, DL; Giblin-Davis, RM; Powers, TO; Thomas, WK				Porazinska, Dorota L.; Giblin-Davis, Robin M.; Powers, Thomas O.; Thomas, W. Kelley			Nematode Spatial and Ecological Patterns from Tropical and Temperate Rainforests	PLOS ONE			English	Article							CRYPTIC DIVERSITY; BIODIVERSITY; COMMUNITIES; GENERATION; NUMBER; PLANT	Large scale diversity patterns are well established for terrestrial macrobiota (e.g. plants and vertebrates), but not for microscopic organisms (e.g. nematodes). Due to small size, high abundance, and extensive dispersal, microbiota are assumed to exhibit cosmopolitan distributions with no biogeographical patterns. This assumption has been extrapolated from local spatial scale studies of a few taxonomic groups utilizing morphological approaches. Recent molecularly-based studies, however, suggest something quite opposite. Nematodes are the most abundant metazoans on earth, but their diversity patterns are largely unknown. We conducted a survey of nematode diversity within three vertical strata (soil, litter, and canopy) of rainforests at two contrasting latitudes in the North American meridian (temperate: the Olympic National Forest, WA, U.S.A and tropical: La Selva Biological Station, Costa Rica) using standardized sampling designs and sample processing protocols. To describe nematode diversity, we applied an ecometagenetic approach using 454 pyrosequencing. We observed that: 1) nematode communities were unique without even a single common species between the two rainforests, 2) nematode communities were unique among habitats in both rainforests, 3) total species richness was 300% more in the tropical than in the temperate rainforest, 4) 80% of the species in the temperate rainforest resided in the soil, whereas only 20% in the tropics, 5) more than 90% of identified species were novel. Overall, our data provided no support for cosmopolitanism at both local (habitats) and large (rainforests) spatial scales. In addition, our data indicated that biogeographical patterns typical of macrobiota also exist for microbiota.	[Porazinska, Dorota L.; Giblin-Davis, Robin M.] Univ Florida, Inst Food & Agr Sci, Ft Lauderdale Res & Educ Ctr, Ft Lauderdale, FL 33314 USA; [Powers, Thomas O.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA; [Thomas, W. Kelley] Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA	State University System of Florida; University of Florida; University of Nebraska System; University of Nebraska Lincoln; University System Of New Hampshire; University of New Hampshire	Porazinska, DL (corresponding author), Univ Florida, Inst Food & Agr Sci, Ft Lauderdale Res & Educ Ctr, Ft Lauderdale, FL 33314 USA.	dorotalp@ufl.edu		Giblin-Davis, Robin/0000-0002-8861-8678	United States Department of Agriculture/Cooperative State Research, Education, and Extension Service - Tropical and Subtropical Agricultural Research [2006-04347, 2008-34135 -19505]; National Science Foundation - Biodiversity Surveys and Inventories [DEB-0450537]; University of Florida Open-Access Publishing Fund	United States Department of Agriculture/Cooperative State Research, Education, and Extension Service - Tropical and Subtropical Agricultural Research; National Science Foundation - Biodiversity Surveys and Inventories(National Science Foundation (NSF)); University of Florida Open-Access Publishing Fund	This work has been supported by the United States Department of Agriculture/Cooperative State Research, Education, and Extension Service - Tropical and Subtropical Agricultural Research (grants 2006-04347 and 2008-34135 -19505), the National Science Foundation (DEB-0450537) - Biodiversity Surveys and Inventories. Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral-Zettler Linda, 2010, P223; Basset Y, 2001, PLANT ECOL, V153, P87, DOI 10.1023/A:1017581406101; Becking L.G.M.B, 1934, GEOBIOLOGIE INLEIDIN; Beijerinck M, 1918, JB KONINKLIJKE AKAD; Bik HM, 2012, MOL ECOL, V21, P1048, DOI 10.1111/j.1365-294X.2011.05297.x; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Boag B, 1998, BIODIVERS CONSERV, V7, P617, DOI 10.1023/A:1008852301349; Chao A, 2000, STAT SINICA, V10, P227; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; COLWELL R. K, 2009, ESTIMATES STAT ESTIM; Creer S, 2010, MOL ECOL, V19, P4, DOI 10.1111/j.1365-294X.2009.04473.x; DELEY P, 2006, WORMBOOK, DOI DOI 10.1895/WORMBOOK.1.41.1; Derycke S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013716; Derycke S, 2010, ZOOL SCR, V39, P276, DOI 10.1111/j.1463-6409.2009.00420.x; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Fenchel T, 1997, OIKOS, V80, P220, DOI 10.2307/3546589; Finlay BJ, 1996, Q REV BIOL, V71, P221, DOI 10.1086/419370; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fonseca VG, 2010, CARBON NANOTUBES LON, V1, DOI [10.1038/ncomms1095, DOI 10.1038/NCOMMS1095]; Fontaneto D, 2006, GLOBAL ECOL BIOGEOGR, V15, P153, DOI 10.1111/j.1466-822X.2006.00193.x; Fulthorpe RR, 2008, ISME J, V2, P901, DOI 10.1038/ismej.2008.55; Guil N, 2009, SYST BIODIVERS, V7, P259, DOI 10.1017/S1477200009003016; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; JENKINS W. R., 1964, PLANT DIS REP, V48, P692; Kiontke KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-339; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Medinger R, 2010, MOL ECOL, V19, P32, DOI 10.1111/j.1365-294X.2009.04478.x; Neher DA, 2010, ANNU REV PHYTOPATHOL, V48, P371, DOI 10.1146/annurev-phyto-073009-114439; Nolte V, 2010, MOL ECOL, V19, P2908, DOI 10.1111/j.1365-294X.2010.04669.x; Porazinska DL, 2012, J NEMATOL IN PRESS, V44; Porazinska DL, 2010, ZOOTAXA, P55, DOI 10.11646/zootaxa.2427.1.6; Porazinska DL, 2010, MOL ECOL, V19, P5521, DOI 10.1111/j.1365-294X.2010.04891.x; Porazinska DL, 2010, MOL ECOL RESOUR, V10, P666, DOI 10.1111/j.1755-0998.2009.02819.x; Porazinska DL, 2009, MOL ECOL RESOUR, V9, P1439, DOI 10.1111/j.1755-0998.2009.02611.x; Powers TO, 2009, MOL ECOL, V18, P985, DOI 10.1111/j.1365-294X.2008.04075.x; Robeson MS, 2011, P NATL ACAD SCI USA, V108, P4406, DOI 10.1073/pnas.1012678108; Sollins Phillip, 1994, P34; Sudhaus W, 2007, ZOOTAXA, P45, DOI 10.11646/zootaxa.1456.1.2; Taylor JW, 2006, PHILOS T R SOC B, V361, P1947, DOI 10.1098/rstb.2006.1923; VIGLIERCHIO DR, 1983, J NEMATOL, V15, P438; Wardle DA, 2002, COMMUNITIES ECOSYSTE; Wu TH, 2011, P NATL ACAD SCI USA, V108, P17720, DOI 10.1073/pnas.1103824108; YEATES GW, 1993, J NEMATOL, V25, P315; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	46	49	52	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44641	10.1371/journal.pone.0044641	http://dx.doi.org/10.1371/journal.pone.0044641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984536	Green Published, gold			2022-12-25	WOS:000308638700074
J	Shi, Y; Luo, GJ; Zhang, L; Shi, J; Zhang, DQ; Chen, JM; Chen, XB; Li, ZD; Zhao, Q				Shi, Yun; Luo, Guo-jun; Zhang, Li; Shi, Ji; Zhang, Dao-quan; Chen, Jian-min; Chen, Xiao-bo; Li, Zhuo-dong; Zhao, Qing			Interaction between Alcohol Consumption and CYP 2C19 Gene Polymorphism in Relation to Oesophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; NORTHWESTERN CHINA; POOR METABOLIZERS; CANCER; POPULATION; RISK; SUSCEPTIBILITY; FREQUENCIES; SMOKING; ENZYMES	Objectives: The purpose of this study is to explore the relationship between the interactions of CYP2C19 gene polymorphisms and several environmental factors and oesophageal squamous cell carcinoma (OSCC). Methods: In a case-control study of OSCC patients (n = 350) and healthy controls (n = 350), we investigated the roles of polymorphism in the CYP2C19 gene by the use of polymerase chain reaction - restriction fragment length polymorphism (PCR - RFLP) analysis. Results: The CYP2C19*3 AG+AA genotype was significantly more prevalent in OSCC patients (10.0% versus 3.43%; P<0.01). Multiple logistic regression analysis showed drinking (OR: 5.603, 95% CI: 3.431-11.112; P = 0.005) and smoking (OR: 4.341, 95% CI: 3.425-10.241; P = 0.001) was the independent risk factor of OSCC respectively, and there were significant interaction between CYP2C19*3 and drinking (OR: 8.747, 95% CI: 6.321-18.122; P = 0.009). Conclusions: The CYP2C19*3 polymorphism and OSCC were synergistically and significantly associated in Chinese Han patients.	[Shi, Yun; Luo, Guo-jun; Zhang, Li; Shi, Ji; Chen, Xiao-bo; Li, Zhuo-dong; Zhao, Qing] Kunming Gen Hosp Chengdu Mil Reg, Dept Chest Surg, Kunming, Yunnan Province, Peoples R China; [Zhang, Dao-quan] Sixtieth Cent Hosp Peoples Liberat Army, Dept Chest Surg, Dali, Yunnan Province, Peoples R China; [Chen, Jian-min] Fifty Ninth Cent Hosp Peoples Liberat Army, Dept Chest Surg, Kaiyuan, Yunnan Province, Peoples R China	Kunming General Hospital	Shi, Y (corresponding author), Kunming Gen Hosp Chengdu Mil Reg, Dept Chest Surg, Kunming, Yunnan Province, Peoples R China.	kmzyylgj@126.com						Afsar NA, 2010, BASIC CLIN PHARMACOL, V107, P570, DOI 10.1111/j.1742-7843.2009.00531.x; Ashfield-Watt PAL, 2004, PUBLIC HEALTH NUTR, V7, P257, DOI 10.1079/PHN2003524; Bozina N, 2009, ARH HIG RADA TOKSIKO, V60, P217, DOI 10.2478/10004-1254-60-2009-1885; Bye H, 2011, CARCINOGENESIS, V32, P1855, DOI 10.1093/carcin/bgr211; CHEN KL, 1995, B CHIN CANC, V4, P7; CHEN W, 2003, CANC RES CLIN, V15, P5; Ercan B, 2008, CELL BIOCHEM FUNCT, V26, P309, DOI 10.1002/cbf.1437; Fava C, 2008, HYPERTENSION, V52, P373, DOI 10.1161/HYPERTENSIONAHA.108.114199; Fichtlscherer S, 2004, CIRCULATION, V109, P178, DOI 10.1161/01.CIR.0000105763.51286.7F; Imig JD, 2000, MOL BIOTECHNOL, V16, P233, DOI 10.1385/MB:16:3:233; Isomura Y, 2010, J GASTROENTEROL, V45, P1045, DOI 10.1007/s00535-010-0246-0; Lundell K, 2008, CURR DRUG METAB, V9, P323, DOI 10.2174/138920008784220574; Matejcic M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029366; Node K, 2001, J BIOL CHEM, V276, P15983, DOI 10.1074/jbc.M100439200; Shi WX, 2004, WORLD J GASTROENTERO, V10, P1961, DOI 10.3748/wjg.v10.i13.463; Tanaka F, 2010, GUT, V59, P1457, DOI 10.1136/gut.2009.205724; Xie HG, 2001, ANNU REV PHARMACOL, V41, P815, DOI 10.1146/annurev.pharmtox.41.1.815; Xie XA, 2011, CLIN CHEM LAB MED, V49, P55, DOI 10.1515/CCLM.2011.024; Yadav SS, 2010, MUTAT RES-FUND MOL M, V684, P49, DOI 10.1016/j.mrfmmm.2009.11.010; Yang YN, 2010, CLIN APPL THROMB-HEM, V16, P579, DOI 10.1177/1076029610364522; Zheng ST, 2011, EUR J GASTROEN HEPAT, V23, P1087, DOI 10.1097/MEG.0b013e32834a14d9; Zheng ST, 2010, EUR J GASTROEN HEPAT, V22, P917, DOI 10.1097/MEG.0b013e3283313d8b	22	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43412	10.1371/journal.pone.0043412	http://dx.doi.org/10.1371/journal.pone.0043412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984423	Green Submitted, Green Published, gold			2022-12-25	WOS:000308638700019
J	Staff, L; Hurd, P; Reale, L; Seoighe, C; Rockwood, A; Gehring, C				Staff, Lee; Hurd, Patricia; Reale, Lara; Seoighe, Cathal; Rockwood, Alyn; Gehring, Chris			The Hidden Geometries of the Arabidopsis thaliana Epidermis	PLOS ONE			English	Article							CELL FATE; MESOPHYLL; SHAPE	The quest for the discovery of mathematical principles that underlie biological phenomena is ancient and ongoing. We present a geometric analysis of the complex interdigitated pavement cells in the Arabidopsis thaliana (Col.) adaxial epidermis with a view to discovering some geometric characteristics that may govern the formation of this tissue. More than 2,400 pavement cells from 10, 17 and 24 day old leaves were analyzed. These interdigitated cells revealed a number of geometric properties that remained constant across the three age groups. In particular, the number of digits per cell rarely exceeded 15, irrespective of cell area. Digit numbers per 100 mu m(2) cell area reduce with age and as cell area increases, suggesting early developmental programming of digits. Cell shape proportions as defined by length: width ratios were highly conserved over time independent of the size and, interestingly, both the mean and the medians were close to the golden ratio 1.618034. With maturity, the cell area: perimeter ratios increased from a mean of 2.0 to 2.4. Shape properties as defined by the medial axis transform (MAT) were calculated and revealed that branch points along the MAT typically comprise one large and two small angles. These showed consistency across the developmental stages considered here at 140 degrees (+/- 5 degrees) for the largest angles and 110 degrees (+/- 5 degrees) for the smaller angles. Voronoi diagram analyses of stomatal center coordinates revealed that giant pavement cells (>= 500 mu m(2)) tend to be arranged along Voronoi boundaries suggesting that they could function as a scaffold of the epidermis. In addition, we propose that pavement cells have a role in spacing and positioning of the stomata in the growing leaf and that they do so by growing within the limits of a set of 'geometrical rules'.	[Staff, Lee; Hurd, Patricia; Rockwood, Alyn] King Abdullah Univ Sci & Technol, Geometr Modeling & Sci Visualizat Ctr, Thuwal, Saudi Arabia; [Reale, Lara] Univ Perugia, Dept Appl Biol, I-06100 Perugia, Italy; [Seoighe, Cathal] Natl Univ Ireland, Sch Math Stat & Appl Math, Galway, Ireland; [Gehring, Chris] King Abdullah Univ Sci & Technol, Div Chem Life Sci & Engn, Thuwal, Saudi Arabia	King Abdullah University of Science & Technology; University of Perugia; Ollscoil na Gaillimhe-University of Galway; King Abdullah University of Science & Technology	Staff, L (corresponding author), King Abdullah Univ Sci & Technol, Geometr Modeling & Sci Visualizat Ctr, Thuwal, Saudi Arabia.	christoph.gehring@KAUST.edu.sa		REALE, Lara/0000-0001-7570-3972; Gehring, Christoph/0000-0003-4355-4591	KAUST	KAUST(King Abdullah University of Science & Technology)	The project was funded by KAUST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atela P, 2011, MATH MODEL NAT PHENO, V6, P173, DOI 10.1051/mmnp/20116207; BIERHORST DW, 1977, AM J BOT, V64, P125, DOI 10.2307/2442101; Bird SM, 2003, NEW PHYTOL, V157, P9, DOI 10.1046/j.1469-8137.2003.00543.x; BLUM H, 1973, J THEOR BIOL, V38, P205, DOI 10.1016/0022-5193(73)90175-6; Chandra P, 2012, FIBONACCI NUMBER; Delaunay B, 1934, B ACAD SCI URSS, V6, P793; Dong JA, 2010, CURR TOP DEV BIOL, V91, P267, DOI 10.1016/S0070-2153(10)91009-0; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Glover BJ, 2010, ENCY LIFE SCI ELS; Hussey PJ, 2006, ANNU REV PLANT BIOL, V57, P109, DOI 10.1146/annurev.arplant.57.032905.105206; Kuhlemeier C, 2007, TRENDS PLANT SCI, V12, P143, DOI 10.1016/j.tplants.2007.03.004; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; Larkin JC, 1997, PLANT CELL, V9, P1109, DOI 10.1105/tpc.9.7.1109; MELARAGNO JE, 1993, PLANT CELL, V5, P1661, DOI 10.1105/tpc.5.11.1661; Nadeau JA, 2009, CURR OPIN PLANT BIOL, V12, P29, DOI 10.1016/j.pbi.2008.10.006; Newell AC, 2008, PLANT SIGNAL BEHAV, V3, P586, DOI 10.4161/psb.3.8.6223; Panteris E, 2005, NEW PHYTOL, V167, P721, DOI 10.1111/j.1469-8137.2005.01464.x; Peterson KM, 2010, PLANT CELL, V22, P296, DOI 10.1105/tpc.109.072777; PYKE KA, 1991, PLANT PHYSIOL, V96, P1193, DOI 10.1104/pp.96.4.1193; Qian PP, 2009, PLANT CELL REP, V28, P1147, DOI 10.1007/s00299-009-0729-8; Roeder AHK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000367; Sachs T, 1991, PATTERN FORMATION PL; Saglamyurek E, 2011, NATURE, V469, P512, DOI 10.1038/nature09719; Serna L, 2002, DEV BIOL, V241, P24, DOI 10.1006/dbio.2001.0506; Serna L, 2009, BIOESSAYS, V31, P865, DOI 10.1002/bies.200800231; Shimada T, 2011, CELL MOL LIFE SCI, V68, P2081, DOI 10.1007/s00018-011-0685-7; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Van Volkenburgh E, 1999, PLANT CELL ENVIRON, V22, P1463, DOI 10.1046/j.1365-3040.1999.00514.x; Zhang CH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-27	29	21	21	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43546	10.1371/journal.pone.0043546	http://dx.doi.org/10.1371/journal.pone.0043546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984433	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700025
J	Yu, PL; Shen, FC; Zhang, XF; Cao, RS; Zhao, XD; Liu, PF; Tu, HM; Yang, XZ; Shi, RH; Zhang, HJ				Yu, Pengli; Shen, Fangcheng; Zhang, Xiaofei; Cao, Risheng; Zhao, Xiaodan; Liu, Pengfei; Tu, Huiming; Yang, Xiaozhong; Shi, Ruihua; Zhang, Hongjie			Association of Single Nucleotide Polymorphisms of IL23R and IL17 with Ulcerative Colitis Risk in a Chinese Han Population	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; TH17 CELLS; SUSCEPTIBILITY; GENE; IL-23; HUNGARIAN; VARIANT; IL-17	Background: Previous studies implicated that IL23R and IL17 genes play an important role in autoimmune inflammation. Genome-wide association studies have also identified multiple single nucleotide polymorphisms (SNPs) in the IL23R gene region associated with inflammatory bowel diseases. This study examined the association of IL23R and IL17A gene SNPs with ulcerative colitis susceptibility in a population in China. Methodology: A total of 270 ulcerative colitis and 268 healthy controls were recruited for the analyses of 23 SNPs in the IL23R and IL17A regions. Genomic DNA was extracted and analysis of these 23 SNPs using ligase detection reaction allelic (LDR) technology. Genotype and allele associations were calculated using SPSS 13.0 software package. Principal Findings: Compared to the healthy controls, the variant alleles IL23R rs7530511, and rs11805303 showed a statistically significant difference for ulcerative colitis susceptibility (0.7% vs 3.3%, P = 0.002; 60.4% vs 53.2%, P = 0.0017, respectively). The linkage disequilibrium (LD) patterns of these SNPs were measured and three LD blocks from the SNPs of IL23R and one block from those of IL17A were identified. A novel association with ulcerative colitis susceptibility occurred in haplotypes of IL23R (Block1 H3 P = 0.02; Block2 H2 P = 0.019; Block3 H4 P = 0.029) and IL17A (H4 P = 0.034). Pair-wise analyses showed an interaction between the risk haplotypes in IL23R and IL17A (P = 0.014). Conclusions: Our study demonstrated that rs7530511, and rs11805303 of IL23R were significantly associated with ulcerative colitis susceptibility in the Chinese population. The most noticeable finding was the linkage of IL23R and IL17A gene region to ulcerative colitis risk due to the gene-gene interaction.	[Yu, Pengli; Shen, Fangcheng; Zhang, Xiaofei; Cao, Risheng; Zhao, Xiaodan; Shi, Ruihua; Zhang, Hongjie] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Liu, Pengfei] Peoples Hosp Jiangyin, Dept Gastroenterol, Jiangyin, Peoples R China; [Tu, Huiming] Fourth Peoples Hosp Wuxi, Dept Gastroenterol, Wuxi, Peoples R China; [Yang, Xiaozhong] First Hosp Huaian, Dept Gastroenterol, Huaian, Peoples R China	Nanjing Medical University; Jiangnan University	Yu, PL (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China.	ruihuashi@126.com; hjzhang06@163.com			National Natural Science Foundation of China [30771039]; Key Medical Personnel of Jiangsu Province [RC2011063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Medical Personnel of Jiangsu Province	This work was supported by the National Natural Science Foundation of China (no. 30771039) (http://www.nsfc.gov.cn/Portal0/default152.htm) and the Key Medical Personnel of Jiangsu Province (no. RC2011063) (http://www.jswst.gov.cn/gb/jsswst/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, INFLAMM BOWEL DIS, V15, P1090, DOI 10.1002/ibd.20894; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Arisawa T, 2008, J CLIN IMMUNOL, V28, P44, DOI 10.1007/s10875-007-9125-8; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Buning C, 2007, ALIMENT PHARM THERAP, V26, P1025, DOI 10.1111/j.1365-2036.2007.03446.x; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Dambacher J, 2009, GUT, V58, P1207, DOI 10.1136/gut.2007.130112; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Duvallet E, 2011, ANN MED, V43, P503, DOI 10.3109/07853890.2011.577093; Einarsdottir E, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-8; Ferguson LR, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/539461; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Furuya T, 2007, CLIN RHEUMATOL, V26, P2137, DOI 10.1007/s10067-007-0745-4; Glas J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000819; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hazlett J, 2011, GENES IMMUN; Head Kathleen A, 2003, Altern Med Rev, V8, P247; Huber AK, 2008, J CLIN ENDOCR METAB, V93, P1077, DOI 10.1210/jc.2007-2190; Hundorfean G, 2012, INFLAMM BOWEL DIS, V18, P180, DOI 10.1002/ibd.21677; Jurgens M, 2010, AM J GASTROENTEROL, V105, P1811, DOI 10.1038/ajg.2010.95; Kim SW, 2011, GUT, V60, P1527, DOI 10.1136/gut.2011.238477; Lacher M, 2010, ACTA PAEDIATR, V99, P727, DOI 10.1111/j.1651-2227.2009.01680.x; Lakatos PL, 2008, DIGEST LIVER DIS, V40, P867, DOI 10.1016/j.dld.2008.03.022; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lappalainen M, 2008, INFLAMM BOWEL DIS, V14, P1118, DOI 10.1002/ibd.20431; Lees CW, 2011, GUT, V60, P1739, DOI 10.1136/gut.2009.199679; Lewis JD, 2008, INFLAMM BOWEL DIS, V14, P1660, DOI 10.1002/ibd.20520; Liu ZJ, 2009, WORLD J GASTROENTERO, V15, P5784, DOI 10.3748/wjg.15.5784; Magyari Lili, 2009, Orvosi Hetilap, V150, P81, DOI 10.1556/OH.2009.28445; McGovern DPB, 2009, INFLAMM BOWEL DIS, V15, P883, DOI 10.1002/ibd.20855; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nordang GBN, 2009, RHEUMATOLOGY, V48, P367, DOI 10.1093/rheumatology/ken512; Oliver J, 2007, CLIN GASTROENTEROL H, V5, P977, DOI 10.1016/j.cgh.2007.05.002; Pidasheva S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025038; Ramsey CD, 2005, GENES IMMUN, V6, P236, DOI 10.1038/sj.gene.6364170; Roberts RL, 2007, AM J GASTROENTEROL, V102, P2754, DOI 10.1111/j.1572-0241.2007.01525.x; Sakamoto Juichi, 2005, Nihon Rinsho, V63, P744; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1808, DOI 10.1002/ibd.21248; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Schmechel S, 2008, INFLAMM BOWEL DIS, V14, P204, DOI 10.1002/ibd.20315; Schmidt-Weber CB, 2007, J ALLERGY CLIN IMMUN, V120, P247, DOI 10.1016/j.jaci.2007.06.039; Shen W, 2010, NEUROCHEM RES, V35, P940, DOI 10.1007/s11064-009-0091-9; Silverberg MS, 2009, NAT GENET, V41, P216, DOI 10.1038/ng.275; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JCI33194, 10.1172/JC133194]; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051; Wang JY, 2009, ALLERGY, V64, P1056, DOI 10.1111/j.1398-9995.2009.01950.x; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zelante T, 2007, EUR J IMMUNOL, V37, P2695, DOI 10.1002/eji.200737409	50	22	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44380	10.1371/journal.pone.0044380	http://dx.doi.org/10.1371/journal.pone.0044380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984500	gold, Green Published, Green Submitted			2022-12-25	WOS:000308638700056
J	Van Colen, C; Debusschere, E; Braeckman, U; Van Gansbeke, D; Vincx, M				Van Colen, Carl; Debusschere, Elisabeth; Braeckman, Ulrike; Van Gansbeke, Dirk; Vincx, Magda			The Early Life History of the Clam Macoma balthica in a High CO2 World	PLOS ONE			English	Article							CARBON-DIOXIDE CONCENTRATIONS; AMORPHOUS CALCIUM-CARBONATE; NEAR-FUTURE LEVELS; OCEAN ACIDIFICATION; LARVAL DEVELOPMENT; ELEVATED PCO(2); BIVALVE; FERTILIZATION; SEDIMENT; PH	This study investigated the effects of experimentally manipulated seawater carbonate chemistry on several early life history processes of the Baltic tellin (Macoma balthica), a widely distributed bivalve that plays a critical role in the functioning of many coastal habitats. We demonstrate that ocean acidification significantly depresses fertilization, embryogenesis, larval development and survival during the pelagic phase. Fertilization and the formation of a D-shaped shell during embryogenesis were severely diminished: successful fertilization was reduced by 11% at a 0.6 pH unit decrease from present (pH 8.1) conditions, while hatching success was depressed by 34 and 87%, respectively at a 0.3 and 0.6 pH unit decrease. Under acidified conditions, larvae were still able to develop a shell during the post-embryonic phase, but higher larval mortality rates indicate that fewer larvae may metamorphose and settle in an acidified ocean. The cumulative impact of decreasing seawater pH on fertilization, embryogenesis and survival to the benthic stage is estimated to reduce the number of competent settlers by 38% for a 0.3 pH unit decrease, and by 89% for a 0.6 pH unit decrease from present conditions. Additionally, slower growth rates and a delayed metamorphosis at a smaller size were indicative for larvae developed under acidified conditions. This may further decline the recruit population size due to a longer subjection to perturbations, such as predation, during the pelagic phase. In general, early life history processes were most severely compromised at similar to pH 7.5, which corresponds to seawater undersaturated with respect to aragonite. Since recent models predict a comparable decrease in pH in coastal waters in the near future, this study indicates that future populations of Macoma balthica are likely to decline as a consequence of ongoing ocean acidification.	[Van Colen, Carl; Debusschere, Elisabeth; Braeckman, Ulrike; Van Gansbeke, Dirk; Vincx, Magda] Univ Ghent, Dept Biol, Marine Biol Sect, B-9000 Ghent, Belgium	Ghent University	Van Colen, C (corresponding author), Univ Ghent, Dept Biol, Marine Biol Sect, B-9000 Ghent, Belgium.	carl.vancolen@ugent.be	Braeckman, Ulrike/AAJ-4801-2021	Braeckman, Ulrike/0000-0002-7558-6363; Debusschere, Elisabeth/0000-0002-5595-0295	Flemish Fund for Scientific Research FWO [1.2.380.11.N]; Ghent University [BOF-GOA 01GA1911W]	Flemish Fund for Scientific Research FWO(FWO); Ghent University(Ghent University)	CVC is a postdoctoral fellow of the Flemish Fund for Scientific Research FWO (1.2.380.11.N). Additional financial support for this study came from the special research fund of Ghent University through project BOF-GOA 01GA1911W. The funder had no role in study design, data collection and analysis.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; [Anonymous], 2007, CO2SYS XLS CALCULATO; Bos OG, 2007, MAR ECOL PROG SER, V330, P155, DOI 10.3354/meps330155; Bos OG, 2006, MAR ECOL PROG SER, V320, P207, DOI 10.3354/meps320207; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Comeau S, 2010, MAR BIOL, V157, P2341, DOI 10.1007/s00227-010-1493-6; CONOVER W. J, 1980, PRACTICAL NONPARAMET; Dickson A., 2007, PICES SPECIAL PUBLIC, V3, DOI 10.25607/OBP-1342; Dupont S, 2010, ESTUAR COAST SHELF S, V89, P182, DOI 10.1016/j.ecss.2010.06.013; Dupont S, 2010, J EXP ZOOL PART B, V314B, P382, DOI [10.1002/jezmde.21342, 10.1002/jez.b.21342]; Ellis RP, 2009, AQUAT BIOL, V5, P41, DOI 10.3354/ab00118; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Gattuso J.P., 2010, GUIDE BEST PRACTICES; Gazeau F, 2010, BIOGEOSCIENCES, V7, P2051, DOI 10.5194/bg-7-2051-2010; Gazeau F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023010; Gould MC, 2003, MICROSC RES TECHNIQ, V61, P379, DOI 10.1002/jemt.10351; Gutowska MA, 2008, MAR ECOL PROG SER, V373, P303, DOI 10.3354/meps07782; Havenhand JN, 2009, BIOGEOSCIENCES, V6, P3009, DOI 10.5194/bg-6-3009-2009; Havenhand JN, 2008, CURR BIOL, V18, pR651, DOI 10.1016/j.cub.2008.06.015; Hendriks IE, 2010, ESTUAR COAST SHELF S, V89, P186, DOI 10.1016/j.ecss.2010.06.007; Hendriks IE, 2010, ESTUAR COAST SHELF S, V86, P157, DOI 10.1016/j.ecss.2009.11.022; Herman PMJ, 2000, MAR ECOL PROG SER, V204, P79, DOI 10.3354/meps204079; Hiddink JG, 2002, J EXP MAR BIOL ECOL, V269, P223, DOI 10.1016/S0022-0981(02)00002-3; His E, 1997, WATER RES, V31, P351, DOI 10.1016/S0043-1354(96)00244-8; HOLLAND AF, 1987, ESTUARIES, V10, P227, DOI 10.2307/1351851; Honkoop PJC, 1999, MAR ECOL PROG SER, V180, P297, DOI 10.3354/meps180297; JOHNSON CH, 1981, J CELL BIOL, V89, P284, DOI 10.1083/jcb.89.2.284; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Lischka S, 2010, BIOGEOSCIENCES, V7, P8177, DOI DOI 10.5194/BGD-7-8177-2010; Marinelli RL, 2003, ESTUAR COAST SHELF S, V57, P179, DOI 10.1016/S0272-7714(02)00342-6; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Michaud E, 2006, J EXP MAR BIOL ECOL, V337, P178, DOI 10.1016/j.jembe.2006.06.025; Morita M, 2010, ZYGOTE, V18, P103, DOI 10.1017/S0967199409990177; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Parker LM, 2010, MAR BIOL, V157, P2435, DOI 10.1007/s00227-010-1508-3; Pineda J, 2009, POPUL ECOL, V51, P17, DOI 10.1007/s10144-008-0118-0; Provoost P, 2010, BIOGEOSCIENCES, V7, P3869, DOI 10.5194/bg-7-3869-2010; REISE K, 1983, MAR ECOL PROG SER, V12, P229, DOI 10.3354/meps012229; Reuter KE, 2011, GLOBAL CHANGE BIOL, V17, P163, DOI 10.1111/j.1365-2486.2010.02216.x; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Solomon S., 2007, CONTRIBUTION WORKING, P996; Struyf E, 1995, HYDROBIOLOGIA, V540, P26; Talmage SC, 2010, P NATL ACAD SCI USA, V107, P17246, DOI 10.1073/pnas.0913804107; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; Van Colen C, 2010, MAR POLLUT BULL, V60, P178, DOI 10.1016/j.marpolbul.2009.09.028; Watson SA, 2009, J SHELLFISH RES, V28, P431, DOI 10.2983/035.028.0302; Weiss IM, 2002, J EXP ZOOL, V293, P478, DOI 10.1002/jez.90004; Willows RI, 1998, LIMNOL OCEANOGR, V43, P1332, DOI 10.4319/lo.1998.43.6.1332; Wootton JT, 2008, P NATL ACAD SCI USA, V105, P18848, DOI 10.1073/pnas.0810079105; ZWARTS L, 1992, MAR ECOL PROG SER, V83, P113, DOI 10.3354/meps083113	54	32	33	0	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44655	10.1371/journal.pone.0044655	http://dx.doi.org/10.1371/journal.pone.0044655			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970279	Green Published, gold			2022-12-25	WOS:000308748400027
J	Bosman, AB; Wagenaar, J; Stegeman, A; Vernooij, H; Mevius, D				Bosman, Angela B.; Wagenaar, Jaap; Stegeman, Arjan; Vernooij, Hans; Mevius, Dik			Quantifying Antimicrobial Resistance at Veal Calf Farms	PLOS ONE			English	Article							FECAL ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; FOOD ANIMALS; DAIRY-COWS; PIGS; SAMPLES; SUSCEPTIBILITY; HARMONIZATION; SURVEILLANCE; PRODUCTS	This study was performed to determine a sampling strategy to quantify the prevalence of antimicrobial resistance on veal calf farms, based on the variation in antimicrobial resistance within and between calves on five farms. Faecal samples from 50 healthy calves (10 calves/farm) were collected. From each individual sample and one pooled faecal sample per farm, 90 selected Escherichia coli isolates were tested for their resistance against 25 mg/L amoxicillin, 25 mg/L tetracycline, 0.5 mg/L cefotaxime, 0.125 mg/L ciprofloxacin and 8/152 mg/L trimethoprim/sulfamethoxazole (tmp/s) by replica plating. From each faecal sample another 10 selected E. coli isolates were tested for their resistance by broth microdilution as a reference. Logistic regression analysis was performed to compare the odds of testing an isolate resistant between both test methods (replica plating vs. broth microdilution) and to evaluate the effect of pooling faecal samples. Bootstrap analysis was used to investigate the precision of the estimated prevalence of resistance to each antimicrobial obtained by several simulated sampling strategies. Replica plating showed similar odds of E. coli isolates tested resistant compared to broth microdilution, except for ciprofloxacin (OR 0.29, p <= 0.05). Pooled samples showed in general lower odds of an isolate being resistant compared to individual samples, although these differences were not significant. Bootstrap analysis showed that within each antimicrobial the various compositions of a pooled sample provided consistent estimates for the mean proportion of resistant isolates. Sampling strategies should be based on the variation in resistance among isolates within faecal samples and between faecal samples, which may vary by antimicrobial. In our study, the optimal sampling strategy from the perspective of precision of the estimated levels of resistance and practicality consists of a pooled faecal sample from 20 individual animals, of which 90 isolates are tested for their susceptibility by replica plating.	[Bosman, Angela B.; Wagenaar, Jaap; Mevius, Dik] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Wagenaar, Jaap; Mevius, Dik] Wageningen UR, Cent Vet Inst, Lelystad, Netherlands; [Stegeman, Arjan; Vernooij, Hans] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands	Utrecht University; Wageningen University & Research; Utrecht University	Bosman, AB (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.	A.B.Bosman@uu.nl	Vernooij, Johannes/J-3991-2019	Vernooij, Johannes/0000-0002-2646-9216	Ministry of Agriculture, Nature and Food Quality [3201949]; Product Board Meat and Livestock [08.30.002]	Ministry of Agriculture, Nature and Food Quality; Product Board Meat and Livestock	This study was funded by the Ministry of Agriculture, Nature and Food Quality (project nr. 3201949), and the Product Board Meat and Livestock (project nr. 08.30.002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup FM, 1999, INT J ANTIMICROB AG, V12, P279, DOI 10.1016/S0924-8579(99)90059-6; Aarestrup FM, 2004, J VET MED B, V51, P380, DOI 10.1111/j.1439-0450.2004.00775.x; Akwar HT, 2008, CAN J VET RES, V72, P202; [Anonymous], 2010, EFSA J; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Boerlin P, 2006, ANTIMICROBIAL RESIST, VFour, P27; Davison HC, 2000, TRENDS MICROBIOL, V8, P554, DOI 10.1016/S0966-842X(00)01873-4; Dewulf J, 2007, PREV VET MED, V78, P339, DOI 10.1016/j.prevetmed.2006.11.001; Dohoo I. R., 2009, VET EPIDEMIOLOGIC RE, V2, P584; Dunlop RH, 1998, APPL ENVIRON MICROB, V64, P366; Dunlop RH, 1999, EPIDEMIOL INFECT, V122, P485, DOI 10.1017/S0950268899002411; Efron B., 1994, INTRO BOOTSTRAP; Franklin A, 2001, REV SCI TECH OIE, V20, P859, DOI 10.20506/rst.20.3.1315; GOLDSTEIN EJC, 1991, ANTIMICROB AGENTS CH, V35, P560, DOI 10.1128/AAC.35.3.560; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Jakobsen L, 2010, INT J FOOD MICROBIOL, V142, P264, DOI 10.1016/j.ijfoodmicro.2010.06.025; Johnson JR, 2007, EMERG INFECT DIS, V13, P838, DOI 10.3201/eid1306.061576; Jordan D, 2005, AUST VET J, V83, P688, DOI 10.1111/j.1751-0813.2005.tb13051.x; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V52, P145, DOI 10.1093/jac/dkg312; Leverstein-van Hall MA, 2011, CLIN MICROBIOL INFEC, V17, P873, DOI 10.1111/j.1469-0691.2011.03497.x; MARAN, 2009, MARAN 2009 MON ANT R; Nijsten R, 1996, J ANTIMICROB CHEMOTH, V37, P1131, DOI 10.1093/jac/37.6.1131; NIJSTEN R, 1994, EPIDEMIOL INFECT, V113, P45, DOI 10.1017/S0950268800051451; OSTERBLAD M, 1995, J CLIN MICROBIOL, V33, P3146, DOI 10.1128/JCM.33.12.3146-3149.1995; Persoons D, 2011, MICROB DRUG RESIST, V17, P513, DOI 10.1089/mdr.2011.0048; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; van den Bogaard AE, 2001, J ANTIMICROB CHEMOTH, V47, P763, DOI 10.1093/jac/47.6.763; van den Bogaard AEJM, 2000, J ANTIMICROB CHEMOTH, V45, P663, DOI 10.1093/jac/45.5.663; Vieira AR, 2008, J ANTIMICROB CHEMOTH, V62, P535, DOI 10.1093/jac/dkn210; Villarroel A, 2006, AM J VET RES, V67, P951, DOI 10.2460/ajvr.67.6.951; Wagner BA, 2002, AM J VET RES, V63, P1662, DOI 10.2460/ajvr.2002.63.1662; Weese JS, 2010, LETT APPL MICROBIOL, V51, P338, DOI 10.1111/j.1472-765X.2010.02901.x	32	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44831	10.1371/journal.pone.0044831	http://dx.doi.org/10.1371/journal.pone.0044831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970313	Green Published, gold, Green Submitted			2022-12-25	WOS:000308462000050
J	Nackaerts, E; Wagemans, J; Helsen, W; Swinnen, SP; Wenderoth, N; Alaerts, K				Nackaerts, Evelien; Wagemans, Johan; Helsen, Werner; Swinnen, Stephan P.; Wenderoth, Nicole; Alaerts, Kaat			Recognizing Biological Motion and Emotions from Point-Light Displays in Autism Spectrum Disorders	PLOS ONE			English	Article							EYE-MOVEMENTS; VISUAL-PERCEPTION; MIRROR NEURONS; SHORT FORMS; RECOGNITION; CHILDREN; PATTERNS; SCALE; INDIVIDUALS; SUPERIOR	One of the main characteristics of Autism Spectrum Disorder (ASD) are problems with social interaction and communication. Here, we explored ASD-related alterations in 'reading' body language of other humans. Accuracy and reaction times were assessed from two observational tasks involving the recognition of 'biological motion' and 'emotions' from point-light displays (PLDs). Eye movements were recorded during the completion of the tests. Results indicated that typically developed-participants were more accurate than ASD-subjects in recognizing biological motion or emotions from PLDs. No accuracy differences were revealed on two control-tasks (involving the indication of color-changes in the moving point-lights). Group differences in reaction times existed on all tasks, but effect sizes were higher for the biological and emotion recognition tasks. Biological motion recognition abilities were related to a person's ability to recognize emotions from PLDs. However, ASD-related atypicalities in emotion recognition could not entirely be attributed to more basic deficits in biological motion recognition, suggesting an additional ASD-specific deficit in recognizing the emotional dimension of the point light displays. Eye movements were assessed during the completion of tasks and results indicated that ASD-participants generally produced more saccades and shorter fixation-durations compared to the control-group. However, especially for emotion recognition, these altered eye movements were associated with reductions in task-performance.	[Nackaerts, Evelien; Helsen, Werner; Swinnen, Stephan P.; Wenderoth, Nicole; Alaerts, Kaat] Katholieke Univ Leuven, Res Ctr Movement Control & Neuroplast, Grp Biomed Sci, Dept Biomed Kinesiol, Heverlee, Belgium; [Wagemans, Johan] Katholieke Univ Leuven, Expt Psychol Lab, Louvain, Belgium; [Wenderoth, Nicole] ETH, Dept Hlth Sci & Technol, Neural Control Movement Lab, Zurich, Switzerland	KU Leuven; KU Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich	Nackaerts, E (corresponding author), Katholieke Univ Leuven, Res Ctr Movement Control & Neuroplast, Grp Biomed Sci, Dept Biomed Kinesiol, Heverlee, Belgium.	Kaat.Alaerts@faber.kuleuven.be	Wagemans, Johan/M-3878-2019; Wenderoth, Nicole/D-7262-2015; Alaerts, Kaat/HGV-0661-2022	Wenderoth, Nicole/0000-0002-3246-9386; Nackaerts, Evelien/0000-0002-6580-4902; Alaerts, Kaat/0000-0001-8665-6374; Wagemans, Johan/0000-0002-7970-1541	Flanders Fund for Scientific Research (FWO) [G.0758.10]; FWO; Interuniversity Attraction Poles program of the Belgian federal government [P6/29]; Research Council of the University of Leuven [IDO/08/013]; Flemish government [METH/08/02]	Flanders Fund for Scientific Research (FWO)(FWO); FWO(FWO); Interuniversity Attraction Poles program of the Belgian federal government(Belgian Federal Science Policy Office); Research Council of the University of Leuven(KU Leuven); Flemish government(European Commission)	Support for this study was provided through grants from the Flanders Fund for Scientific Research (FWO projectsG.0758.10). KA is supported by a FWO postdoctoral Research fellowship grant. This work was also supported by Grant P6/29 from the Interuniversity Attraction Poles program of the Belgian federal government. This study has been conducted in collaboration with the Leuven Autism Research Consortium (LAuRes), funded by the Research Council of the University of Leuven (IDO/08/013). JW is supported by the Methusalem program of the Flemish government (METH/08/02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaerts K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020989; Annaz D, 2010, DEVELOPMENTAL SCI, V13, P826, DOI 10.1111/j.1467-7687.2009.00939.x; APA, 1994, DIAGN STAT MAN MENT; Atkinson AP, 2009, NEUROPSYCHOLOGIA, V47, P3023, DOI 10.1016/j.neuropsychologia.2009.05.019; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Boraston Z, 2007, J PHYSIOL-LONDON, V581, P893, DOI 10.1113/jphysiol.2007.133587; Brenner LA, 2007, J AUTISM DEV DISORD, V37, P1289, DOI 10.1007/s10803-006-0277-9; Brownlow S, 1997, PSYCHOL REC, V47, P411, DOI 10.1007/BF03395235; Catteeuw P, 2009, J SPORT EXERCISE PSY, V31, P786, DOI 10.1123/jsep.31.6.786; Chouchourelou A, 2006, SOC NEUROSCI-UK, V1, P63, DOI 10.1080/17470910600630599; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Constantino JN, 2003, J AUTISM DEV DISORD, V33, P427, DOI 10.1023/A:1025014929212; Corden B, 2008, NEUROPSYCHOLOGIA, V46, P137, DOI 10.1016/j.neuropsychologia.2007.08.005; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Evers K, 2011, RES AUTISM SPECT DIS, V5, P1327, DOI 10.1016/j.rasd.2011.01.004; Fan YT, 2010, J CHILD PSYCHOL PSYC, V51, P981, DOI 10.1111/j.1469-7610.2010.02269.x; Freitag CM, 2008, NEUROPSYCHOLOGIA, V46, P1480, DOI 10.1016/j.neuropsychologia.2007.12.025; FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8; Girard TA, 2010, ASSESSMENT, V17, P400, DOI 10.1177/1073191110369763; Goldberg MC, 2002, NEUROPSYCHOLOGIA, V40, P2039, DOI 10.1016/S0028-3932(02)00059-3; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Harms MB, 2010, NEUROPSYCHOL REV, V20, P290, DOI 10.1007/s11065-010-9138-6; Hubert B, 2007, J AUTISM DEV DISORD, V37, P1386, DOI 10.1007/s10803-006-0275-y; Ikeda H, 2009, PERCEPTION, V38, P1002, DOI 10.1068/p6250; Jastorff J, 2009, J NEUROSCI, V29, P7315, DOI 10.1523/JNEUROSCI.4870-08.2009; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Joseph RM, 2009, DEVELOPMENTAL SCI, V12, P1083, DOI 10.1111/j.1467-7687.2009.00855.x; Kaiser MD, 2009, PSYCHON B REV, V16, P761, DOI 10.3758/PBR.16.5.761; Keehn B, 2009, J AUTISM DEV DISORD, V39, P383, DOI 10.1007/s10803-008-0608-0; Kemner C, 1998, J AUTISM DEV DISORD, V28, P61, DOI 10.1023/A:1026015120128; Klin A, 2002, ARCH GEN PSYCHIAT, V59, P809, DOI 10.1001/archpsyc.59.9.809; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Koldewyn K, 2010, BRAIN, V133, P599, DOI 10.1093/brain/awp272; Moore DG, 1997, BRIT J DEV PSYCHOL, V15, P401, DOI 10.1111/j.2044-835X.1997.tb00738.x; Murphy P, 2009, NEUROPSYCHOLOGIA, V47, P3225, DOI 10.1016/j.neuropsychologia.2009.07.026; Neri P, 2006, NAT NEUROSCI, V9, P1186, DOI 10.1038/nn1759; Parron C, 2008, AUTISM, V12, P261, DOI 10.1177/1362361307089520; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Pelphrey KA, 2011, J CHILD PSYCHOL PSYC, V52, P631, DOI 10.1111/j.1469-7610.2010.02349.x; Perry A, 2010, SOC NEUROSCI-UK, V5, P272, DOI 10.1080/17470910903395767; Rommelse NNJ, 2008, BRAIN COGNITION, V68, P391, DOI 10.1016/j.bandc.2008.08.025; Ryan JJ, 1999, PSYCHOL ASSESSMENT, V11, P207, DOI 10.1037/1040-3590.11.2.207; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Saygin AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013491; Snow J, 2011, J INT NEUROPSYCH SOC, V17, P1021, DOI 10.1017/S1355617711000981; Ulloa ER, 2007, BEHAV BRAIN RES, V183, P188, DOI 10.1016/j.bbr.2007.06.007; van der Geest JN, 2001, BIOL PSYCHIAT, V50, P614, DOI 10.1016/S0006-3223(01)01070-8; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8	51	94	98	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44473	10.1371/journal.pone.0044473	http://dx.doi.org/10.1371/journal.pone.0044473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001KC	22970227	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400075
J	Stefanowicz, D; Hackett, TL; Garmaroudi, FS; Gunther, OP; Neumann, S; Sutanto, EN; Ling, KM; Kobor, MS; Kicic, A; Stick, SM; Pare, PD; Knight, DA				Stefanowicz, Dorota; Hackett, Tillie-Louise; Garmaroudi, Farshid S.; Guenther, Oliver P.; Neumann, Sarah; Sutanto, Erika N.; Ling, Kak-Ming; Kobor, Michael S.; Kicic, Anthony; Stick, Stephen M.; Pare, Peter D.; Knight, Darryl A.			DNA Methylation Profiles of Airway Epithelial Cells and PBMCs from Healthy, Atopic and Asthmatic Children	PLOS ONE			English	Article							LIM-DOMAIN; TRANSCRIPTIONAL REPRESSION; MICROARRAY ANALYSIS; INHALANT ALLERGEN; SIGNAL TRANSDUCER; PROSTATE-CANCER; GENE-EXPRESSION; STAT PATHWAY; ASSOCIATION; ACTIVATION	Background: Allergic inflammation is commonly observed in a number of conditions that are associated with atopy including asthma, eczema and rhinitis. However, the genetic, environmental or epigenetic factors involved in these conditions are likely to be different. Epigenetic modifications, such as DNA methylation, can be influenced by the environment and result in changes to gene expression. Objectives: To characterize the DNA methylation pattern of airway epithelial cells (AECs) compared to peripheral blood mononuclear cells (PBMCs) and to discern differences in methylation within each cell type amongst healthy, atopic and asthmatic subjects. Methods: PBMCs and AECs from bronchial brushings were obtained from children undergoing elective surgery for non-respiratory conditions. The children were categorized as atopic, atopic asthmatic, non-atopic asthmatic or healthy controls. Extracted DNA was bisulfite treated and 1505 CpG loci across 807 genes were analyzed using the Illumina GoldenGate Methylation Cancer Panel I. Gene expression for a subset of genes was performed using RT-PCR. Results: We demonstrate a signature set of CpG sites that are differentially methylated in AECs as compared to PBMCs regardless of disease phenotype. Of these, 13 CpG sites were specific to healthy controls, 8 sites were only found in atopics, and 6 CpGs were unique to asthmatics. We found no differences in the methylation status of PBMCs between disease phenotypes. In AECs derived from asthmatics compared to atopics, 8 differentially methylated sites were identified including CpGs in STAT5A and CRIP1. We demonstrate STAT5A gene expression is decreased whereas CRIP1 gene expression is elevated in the AECs from asthmatic compared to both healthy and atopic subjects. Discussion: We characterized a cell specific DNA methylation signature for AECs compared to PBMCs regardless of asthmatic or atopic status. Our data highlight the importance of understanding DNA methylation in the epithelium when studying the epithelial contribution to asthma.	[Stefanowicz, Dorota; Hackett, Tillie-Louise; Garmaroudi, Farshid S.; Pare, Peter D.; Knight, Darryl A.] Univ British Columbia, Heart & Lung Inst, James Hogg Res Ctr, Dept Med, Vancouver, BC, Canada; [Stefanowicz, Dorota; Hackett, Tillie-Louise; Garmaroudi, Farshid S.; Pare, Peter D.; Knight, Darryl A.] St Pauls Hosp, Vancouver, BC V6Z 1Y6, Canada; [Hackett, Tillie-Louise; Knight, Darryl A.] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC V5Z 1M9, Canada; [Guenther, Oliver P.] Prevent Organ Failure Ctr Excellence, Vancouver, BC, Canada; [Neumann, Sarah; Kobor, Michael S.] Univ British Columbia, Ctr Mol Med & Therapeut, Child & Family Res Inst, Dept Med Genet, Vancouver, BC, Canada; [Sutanto, Erika N.; Kicic, Anthony; Stick, Stephen M.] Princess Margaret Hosp Children, Dept Resp Med, Perth, WA, Australia; [Kicic, Anthony; Stick, Stephen M.] Univ Western Australia, Sch Paediat & Child Hlth, Nedlands, WA 6009, Australia; [Sutanto, Erika N.; Ling, Kak-Ming; Kicic, Anthony; Stick, Stephen M.] Univ Western Australia, Telethon Inst Child Hlth Res, Nedlands, WA 6009, Australia; [Sutanto, Erika N.; Ling, Kak-Ming; Kicic, Anthony; Stick, Stephen M.] Univ Western Australia, Ctr Child Hlth Res, Nedlands, WA 6009, Australia; [Pare, Peter D.] Univ British Columbia, Dept Med, Div Resp, Vancouver, BC, Canada	University of British Columbia; St. Paul's Hospital; University of Saskatchewan; University of British Columbia; Child & Family Research Institute; University of British Columbia; University of Western Australia; University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of British Columbia	Stefanowicz, D (corresponding author), Univ British Columbia, Heart & Lung Inst, James Hogg Res Ctr, Dept Med, Vancouver, BC, Canada.	Darryl.Knight@hli.ubc.ca	Stick, Stephen/GZG-7584-2022; Pare, Peter D/C-7425-2011; Stick, Stephen/O-5683-2014; Ling, Kak Ming/AAD-1167-2020; Stick, Stephen/AAA-5945-2021; Kicic, Anthony/ABA-1252-2021	Ling, Kak Ming/0000-0001-7743-3179; Stick, Stephen/0000-0002-5386-8482; Kicic, Anthony/0000-0002-0008-9733; Gunther, Oliver/0000-0003-1900-715X; Sutanto, Erika/0000-0002-4224-2839; Kobor, Michael/0000-0003-4140-1743	NSERC (Natural Sciences and Engineering Research Council of Canada); Canadian Institute for Health Research/Canadian Lung Association/GSK (GlaxoSmithKline); CIHR/IMPACT (Canadian Institutes of Health Research); Michael Smith Foundation; Tehran University of Medical Science (Iran); CIHR (Centre for Integrated Healthcare Research); NHMRC [303145, 458513]; Asthma Foundation of Western Australia; corporate office and Science and Technology at Johnson Johnson; CIHR; Canadian Lung Association; Canadian Thoracic Society; GlaxoSmithKline (GSK)	NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Health Research/Canadian Lung Association/GSK (GlaxoSmithKline)(Canadian Institutes of Health Research (CIHR)); CIHR/IMPACT (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation(Michael Smith Foundation for Health Research); Tehran University of Medical Science (Iran)(Tehran University of Medical Sciences); CIHR (Centre for Integrated Healthcare Research)(Canadian Institutes of Health Research (CIHR)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Asthma Foundation of Western Australia; corporate office and Science and Technology at Johnson Johnson; CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Lung Association; Canadian Thoracic Society; GlaxoSmithKline (GSK)(GlaxoSmithKline)	DS is the recipient of a NSERC (Natural Sciences and Engineering Research Council of Canada) Graduate Student Scholarship. TLH is the recipient of a Canadian Institute for Health Research/Canadian Lung Association/GSK (GlaxoSmithKline), CIHR/IMPACT (Canadian Institutes of Health Research) strategic training and Michael Smith Foundation post doctoral fellowships. FSG is the recipient of the Tehran University of Medical Science (Iran) Doctoral Award. DAK is the Canada Research Chair in Airway Disease and a Michael Smith Foundation for Health Research Career Investigator. SS is a NHMRC Practitioner Fellow (New Hanover Medical Research). This work is funded by CIHR (Centre for Integrated Healthcare Research), NHMRC (303145, 458513), and the Asthma Foundation of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DAK received an unrestricted educational grant from the corporate office and Science and Technology at Johnson & Johnson and TLH is the recipient of a Canadian Institute for Health Research/Canadian Lung Association/GSK (GlaxoSmithKline), CIHR/IMPACT (Canadian Institutes of Health Research) strategic training and Michael Smith Foundation post doctoral fellowships. The fellowship is fully paid from CIHR through partnership funding with the Canadian Lung Association, Canadian Thoracic Society and GlaxoSmithKline (GSK). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Allen ML, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-51; Amishima M, 1998, AM J RESP CRIT CARE, V157, P1907, DOI 10.1164/ajrccm.157.6.9609040; Anglim PP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-62; Angrisano T, 2006, NUCLEIC ACIDS RES, V34, P364, DOI 10.1093/nar/gkj400; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Barbato A, 2006, AM J RESP CRIT CARE, V174, P975, DOI 10.1164/rccm.200602-189OC; Bauerschlag DO, 2011, ONCOLOGY-BASEL, V80, P12, DOI 10.1159/000327746; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Bousquet J, 2005, B WORLD HEALTH ORGAN, V83, P548; Chang DF, 2003, DEV CELL, V4, P107, DOI 10.1016/S1534-5807(02)00396-9; Dallosso AR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000745; Dallosso AR, 2012, ONCOGENE; Davis S, 2010, METHYLUMI HANDLE ILL; de Boer WI, 2008, CAN J PHYSIOL PHARM, V86, P105, DOI [10.1139/Y08-004, 10.1139/y08-004]; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; DUNNILL MS, 1960, J CLIN PATHOL, V13, P27, DOI 10.1136/jcp.13.1.27; Esteller M, 2006, CARCINOGENESIS, V27, P1121, DOI 10.1093/carcin/bgl033; Fedorov IA, 2005, THORAX, V60, P389, DOI 10.1136/thx.2004.030262; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Hackett TL, 2008, STEM CELLS, V26, P2576, DOI 10.1634/stemcells.2008-0171; Hackett TL, 2011, AM J RESP CELL MOL, V45, P1090, DOI 10.1165/rcmb.2011-0031OC; Hackett TL, 2009, AM J RESP CRIT CARE, V180, P122, DOI 10.1164/rccm.200811-1730OC; Hallquist NA, 1996, J LEUKOCYTE BIOL, V59, P172, DOI 10.1002/jlb.59.2.172; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Holgate ST, 2000, AM J RESP CRIT CARE, V162, pS113, DOI 10.1164/ajrccm.162.supplement_2.ras-12; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Hollingsworth JW, 2008, J CLIN INVEST, V118, P3462, DOI 10.1172/JCI34378; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Javierre BM, 2011, MOL CANCER RES, V9, P1139, DOI 10.1158/1541-7786.MCR-10-0515; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kagami S, 2000, BLOOD, V95, P1370, DOI 10.1182/blood.V95.4.1370.004k29_1370_1377; Kicic A, 2006, AM J RESP CRIT CARE, V174, P1110, DOI 10.1164/rccm.200603-392OC; Kim KY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-160; Kobayashi Y, 2011, GENOME RES, V21, P1017, DOI 10.1101/gr.119487.110; Lane C, 2004, THORAX, V59, P757, DOI 10.1136/thx.2003.014894; Lanningham-Foster L, 2002, AM J PHYSIOL-ENDOC M, V282, pE1197, DOI 10.1152/ajpendo.00508.2001; Latonen L, 2008, EXP CELL RES, V314, P738, DOI 10.1016/j.yexcr.2007.11.024; Li GP, 2004, CELL MOL IMMUNOL, V1, P471; Liu JB, 2002, AM J RESP CELL MOL, V27, P306, DOI 10.1165/rcmb.4850; Lu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024590; Macaubas C, 1999, CLIN EXP ALLERGY, V29, P1223; Mayor R, 2009, BRIT J CANCER, V100, P1534, DOI 10.1038/sj.bjc.6605045; McNamara PS, 2008, EUR RESPIR J, V32, P763, DOI 10.1183/09031936.00162507; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Mullings RE, 2001, J ALLERGY CLIN IMMUN, V108, P832, DOI 10.1067/mai.2001.119554; Novak P, 2008, CANCER RES, V68, P8616, DOI 10.1158/0008-5472.CAN-08-1419; Robertson KD, 2000, NAT REV GENET, V1, P11, DOI 10.1038/35049533; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Ronneberg JA, 2011, MOL ONCOL, V5, P61, DOI 10.1016/j.molonc.2010.11.004; Sampath D, 1999, J CLIN INVEST, V103, P1353, DOI 10.1172/JCI6130; Shin SW, 2011, ALLERGY ASTHMA IMMUN, V3, P265, DOI 10.4168/aair.2011.3.4.265; Shin S, 2012, MOL GENET GENOMICS, V287, P361, DOI 10.1007/s00438-012-0685-9; Southam DS, 2005, J ALLERGY CLIN IMMUN, V115, P95, DOI 10.1016/j.jaci.2004.09.022; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017490; Team R. D. C, 2011, R LANG ENV STAT COMP; Trautmann A, 2005, INT ARCH ALLERGY IMM, V138, P142, DOI 10.1159/000088436; UPHAM JW, 1995, CLIN EXP ALLERGY, V25, P634, DOI 10.1111/j.1365-2222.1995.tb01111.x; Weiskirchen R, 2003, BIOESSAYS, V25, P152, DOI 10.1002/bies.10226; Xu R, 2009, J CELL BIOL, V184, P57, DOI 10.1083/jcb.200807021; Yang YW, 2008, J ALLERGY CLIN IMMUN, V121, P1393, DOI 10.1016/j.jaci.2008.02.031; Yao XL, 2011, J IMMUNOL, V186, P576, DOI 10.4049/jimmunol.1001534; Yuen RKC, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-7; Zheng SS, 2011, J NUTR BIOCHEM, V22, P567, DOI 10.1016/j.jnutbio.2010.04.013; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	71	85	85	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44213	10.1371/journal.pone.0044213	http://dx.doi.org/10.1371/journal.pone.0044213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970180	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400046
J	Wang, YL; Hu, XW; Greshock, J; Shen, L; Yang, XJ; Shao, ZJ; Liang, S; Tanyi, JL; Sood, AK; Zhang, L				Wang, Yanling; Hu, Xiaowen; Greshock, Joel; Shen, Liang; Yang, Xiaojun; Shao, Zhongjun; Liang, Shun; Tanyi, Janos L.; Sood, Anil K.; Zhang, Lin			Genomic DNA Copy-Number Alterations of the let-7 Family in Human Cancers	PLOS ONE			English	Article							HETEROCHRONIC GENES; MICRORNA BIOGENESIS; FEEDBACK LOOP; STEM-CELLS; LIN28; EXPRESSION; TARGET; GROWTH; SUPPRESSES; REPRESSES	In human cancer, expression of the let-7 family is significantly reduced, and this is associated with shorter survival times in patients. However, the mechanisms leading to let-7 downregulation in cancer are still largely unclear. Since an alteration in copy-number is one of the causes of gene deregulation in cancer, we examined copy number alterations of the let-7 family in 2,969 cancer specimens from a high-resolution SNP array dataset. We found that there was a reduction in the copy number of let-7 genes in a cancer-type specific manner. Importantly, focal deletion of four let-7 family members was found in three cancer types: medulloblastoma (let-7a-2 and let-7e), breast cancer (let-7a-2), and ovarian cancer (let-7a-3/let-7b). For example, the genomic locus harboring let-7a-3/let-7b was deleted in 44% of the specimens from ovarian cancer patients. We also found a positive correlation between the copy number of let-7b and mature let-7b expression in ovarian cancer. Finally, we showed that restoration of let-7b expression dramatically reduced ovarian tumor growth in vitro and in vivo. Our results indicate that copy number deletion is an important mechanism leading to the downregulation of expression of specific let-7 family members in medulloblastoma, breast, and ovarian cancers. Restoration of let-7 expression in tumor cells could provide a novel therapeutic strategy for the treatment of cancer.	[Wang, Yanling; Hu, Xiaowen; Shen, Liang; Yang, Xiaojun; Shao, Zhongjun; Liang, Shun; Tanyi, Janos L.; Zhang, Lin] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Greshock, Joel] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Div Surg, Houston, TX 77030 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; UTMD Anderson Cancer Center	Wang, YL (corresponding author), Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA.	linzhang@mail.med.upenn.edu	Zhang, Lin/K-8478-2012		National Institutes of Health [R01-CA142776, P50-CA83638-7951, 5K12HD000849]; Department of Defense [W81XWH-10-1-0082]; Ovarian Cancer Research Fund; China Scholarship Council; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA142776, P50CA083638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Ovarian Cancer Research Fund; China Scholarship Council(China Scholarship Council); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-CA142776 (LZ), P50-CA83638-7951 Project 3 (LZ), Department of Defense Grant W81XWH-10-1-0082 (LZ), and the Ovarian Cancer Research Fund (LZ). ZS was supported by the China Scholarship Council. JT was supported by National Institutes of Health Grant 5K12HD000849. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; AMBROS V, 1994, TRENDS GENET, V10, P123, DOI 10.1016/0168-9525(94)90213-5; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Deng S, 2008, CELL CYCLE, V7, P2643, DOI 10.4161/cc.7.17.6597; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; King CE, 2011, ONCOGENE; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; KUMAR MS, 2008, P NATL ACAD SCI US; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; MAINESBANDIERA SL, 1992, AM J OBSTET GYNECOL, V167, P729, DOI 10.1016/S0002-9378(11)91579-8; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meirelles K, 2012, P NATL ACAD SCI US; Meng FY, 2007, J BIOL CHEM, V282, P8256, DOI 10.1074/jbc.M607712200; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Moss EG, 2007, CURR BIOL, V17, pR425, DOI 10.1016/j.cub.2007.03.043; Nair VS, 2012, J NATL CANC I; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Peng Y, 2008, MOL CANCER RES, V6, P663, DOI 10.1158/1541-7786.MCR-07-0370; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Qian PX, 2011, CANCER RES, V71, P6463, DOI 10.1158/0008-5472.CAN-11-1322; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Slack F, 1997, ANNU REV GENET, V31, P611, DOI 10.1146/annurev.genet.31.1.611; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Trang P, 2010, ONCOGENE, V29, P1580, DOI 10.1038/onc.2009.445; Trang P, 2011, MOL THER, V19, P1116, DOI 10.1038/mt.2011.48; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wang YC, 2010, CARCINOGENESIS, V31, P1516, DOI 10.1093/carcin/bgq107; Yang XJ, 2010, CANCER RES, V70, P9463, DOI 10.1158/0008-5472.CAN-10-2388; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhang WC, 2012, CELL	65	39	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44399	10.1371/journal.pone.0044399	http://dx.doi.org/10.1371/journal.pone.0044399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970210	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400066
J	Krem, MM; Luo, P; Ing, BI; Horwitz, MS				Krem, Maxwell M.; Luo, Ping; Ing, Brandon I.; Horwitz, Marshall S.			The Kelch Protein KLHDC8B Guards against Mitotic Errors, Centrosomal Amplification, and Chromosomal Instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REED-STERNBERG CELLS; IMMUNOGLOBULIN GENE REARRANGEMENTS; PERIPHERAL-BLOOD LYMPHOCYTES; 3D NUCLEAR-ORGANIZATION; HODGKINS-LYMPHOMA; REPEAT SUPERFAMILY; BASE-LINE; B-CELLS; DISEASE; MUTATIONS	The malignant cell in classical Hodgkin lymphoma (HL) is the binucleated giant Reed-Sternberg cell. Chromosomal instability and mitotic errors may contribute to HL pathogenesis; one potential mitotic regulator is the kelch protein KLHDC8B, which localizes to the midbody, is expressed during mitosis, and is mutated in a subset of familial and sporadic HL. We report that disrupting KLHDC8B function in HeLa cells, B lymphoblasts, and fibroblasts leads to significant increases in multinucleation, multipolar mitoses, failed abscission, asymmetric segregation of daughter nuclei, formation of anucleated daughter cells, centrosomal amplification, and aneuploidy. We recapitulated the major pathologic features of the Reed-Sternberg cell and concluded that KLHDC8B is essential for mitotic integrity and maintenance of chromosomal stability. The significant impact of KLHDC8B implicates the central roles of mitotic regulation and chromosomal segregation in the pathogenesis of HL and provides a novel molecular mechanism for chromosomal instability in HL.	[Krem, Maxwell M.] Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98109 USA; Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Krem, MM (corresponding author), Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Campus Box 358056,850 Republican St, Seattle, WA 98109 USA.	mkrem@u.washington.edu		Horwitz, Marshall/0000-0002-1683-1680	Leukemia and Lymphoma Society; Conquer Cancer Foundation of the American Society of Clinical Oncology; St. Baldrick's Foundation	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Conquer Cancer Foundation of the American Society of Clinical Oncology; St. Baldrick's Foundation	Recipient of funding from the Leukemia and Lymphoma Society, the Conquer Cancer Foundation of the American Society of Clinical Oncology, and the St. Baldrick's Foundation. To whom correspondence should be addressed: Institute for Stem Cell and Regenerative Medicine, Campus Box 358056, University of Washington School of Medicine, 850 Republican St., Seattle, WA 98109. Tel.: 206-616-4567; Fax: 206-897-1775; E-mail: mkrem@u.washington.edu.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; BARRIOS L, 1988, HUM GENET, V78, P320, DOI 10.1007/BF00291727; Boveri T, 1929, FRAGE ENTSTEHUNG MAL; Conery AR, 2010, P NATL ACAD SCI USA, V107, P15455, DOI 10.1073/pnas.1010627107; Daniels MJ, 2004, SCIENCE, V306, P876, DOI 10.1126/science.1102574; DREXLER HG, 1989, INT J CANCER, V43, P1083, DOI 10.1002/ijc.2910430622; Falzetti D, 1999, HAEMATOLOGICA, V84, P298; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godinho S, 2009, CANCER METAST REV, V28, P85, DOI 10.1007/s10555-008-9163-6; Guffei A, 2010, HAEMATOL-HEMATOL J, V95, P2038, DOI 10.3324/haematol.2010.030171; Hanks S, 2004, NAT GENET, V36, P1159, DOI 10.1038/ng1449; Harvey EB, 1919, BIOL BULL-US, V37, P96, DOI 10.2307/1536351; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jonsdottir AB, 2009, CELL ONCOL, V31, P191, DOI 10.3233/CLO-2009-0465; Kanzler H, 1996, J EXP MED, V184, P1495, DOI 10.1084/jem.184.4.1495; Knecht H, 2009, LEUKEMIA, V23, P565, DOI 10.1038/leu.2008.314; Knecht H, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-99; Kramer A, 2003, LEUKEMIA, V17, P2207, DOI 10.1038/sj.leu.2403142; Krem MM, 2010, CELL CYCLE, V9, P670, DOI 10.4161/cc.9.4.10780; Kroll J, 2005, MOL CELL BIOL, V25, P8531, DOI 10.1128/MCB.25.19.8531-8540.2005; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; KUPPERS R, 1994, P NATL ACAD SCI USA, V91, P10962, DOI 10.1073/pnas.91.23.10962; Kuppers R, 2001, BLOOD, V97, P818, DOI 10.1182/blood.V97.3.818; Leoncini L, 1997, LEUKEMIA LYMPHOMA, V26, P307, DOI 10.3109/10428199709051780; Lingle WL, 2005, ADV EXP MED BIOL, V570, P393, DOI 10.1007/1-4020-3764-3_14; M'kacher R, 2003, INT J RADIAT ONCOL, V57, P321, DOI 10.1016/S0360-3016(03)00578-9; Maerki S, 2009, J CELL BIOL, V187, P791, DOI 10.1083/jcb.200906117; Marafioti T, 2000, BLOOD, V95, P1443, DOI 10.1182/blood.V95.4.1443.004k55_1443_1450; Martin-Subero JI, 2003, LEUKEMIA, V17, P2214, DOI 10.1038/sj.leu.2403129; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Matsuura S, 2006, AM J MED GENET A, V140A, P358, DOI 10.1002/ajmg.a.31069; NEWCOM SR, 1988, INT J CELL CLONING, V6, P417, DOI 10.1002/stem.5530060606; Norppa Hannu, 2004, IARC Sci Publ, P179; Pihan GA, 1998, CANCER RES, V58, P3974; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Re D, 2002, ANN ONCOL, V13, P19, DOI 10.1093/annonc/13.S1.19; Re D, 2005, J CLIN ONCOL, V23, P6379, DOI 10.1200/JCO.2005.55.013; RIEDER CL, 1994, J CELL BIOL, V127, P1301, DOI 10.1083/jcb.127.5.1301; Rieder CL, 2011, CHROMOSOME RES, V19, P291, DOI 10.1007/s10577-010-9178-z; Salipante SJ, 2009, P NATL ACAD SCI USA, V106, P14920, DOI 10.1073/pnas.0904231106; Sambuughin N, 2010, AM J HUM GENET, V87, P842, DOI 10.1016/j.ajhg.2010.10.020; Schwartz JL, 2004, MUTAGENESIS, V19, P477, DOI 10.1093/mutage/geh060; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; STORKUS WJ, 1989, P NATL ACAD SCI USA, V86, P2361, DOI 10.1073/pnas.86.7.2361; Taylor SM, 2010, BLOOD, V116, P3108, DOI 10.1182/blood-2010-01-266197; Watanabe A, 2004, CLIN LAB HAEMATOL, V26, P25, DOI 10.1111/j.0141-9854.2003.00574.x; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	49	12	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39083	39093		10.1074/jbc.M112.390088	http://dx.doi.org/10.1074/jbc.M112.390088			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22988245	Green Published, hybrid			2022-12-25	WOS:000310982800064
J	Benbow, JH; Mann, T; Keeler, C; Fan, CP; Hodsdon, ME; Lolis, E; DeGray, B; Ehrlich, BE				Benbow, Jennifer H.; Mann, Taylor; Keeler, Camille; Fan, Chengpeng; Hodsdon, Michael E.; Lolis, Elias; DeGray, Brenda; Ehrlich, Barbara E.			Inhibition of Paclitaxel-induced Decreases in Calcium Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; NEUROPATHIC PAIN; PERIPHERAL NEUROPATHY; CHEMICAL-SHIFT; RAT MODELS; SENSOR-1; LITHIUM; IBUDILAST; PROTEIN; OSCILLATIONS	Peripheral neuropathy is one of the most severe and irreversible side effects caused by treatment from several chemotherapeutic drugs, including paclitaxel (Taxol (R)) and vincristine. Strategies are needed that inhibit this unwanted side effect without altering the chemotherapeutic action of these drugs. We previously identified two proteins in the cellular pathway that lead to Taxol-induced peripheral neuropathy, neuronal calcium sensor-1 (NCS-1) and calpain. Prolonged treatment with Taxol induces activation of calpain, degradation of NCS-1, and loss of intracellular calcium signaling. This paper has focused on understanding the molecular basis for prevention of peripheral neuropathy by testing the effects of addition of two candidate compounds to the existing chemotherapeutic drug regime: lithium and ibudilast. We found that the co-administration of either lithium or ibudilast to neuroblastoma cells that were treated with Taxol or vincristine inhibited activation of calpain and the reductions in NCS-1 levels and calcium signaling associated with these chemotherapeutic drugs. The ability of Taxol to alter microtubule formation was unchanged by the addition of either candidate compound. These results allow us to suggest that it is possible to prevent the unnecessary and irreversible damage caused by chemotherapeutic drugs while still maintaining therapeutic efficacy. Specifically, the addition of either lithium or ibudilast to existing chemotherapy treatment protocols has the potential to prevent chemotherapy-induced peripheral neuropathy.	[Benbow, Jennifer H.; Mann, Taylor; Fan, Chengpeng; Lolis, Elias; DeGray, Brenda; Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Keeler, Camille; Hodsdon, Michael E.] Yale Univ, Dept Lab Med, New Haven, CT 06520 USA; [Ehrlich, Barbara E.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Ehrlich, BE (corresponding author), Yale Univ, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.	barbara.ehrlich@yale.edu	/AAX-8408-2021	/0000-0001-9657-9704; Lolis, Elias/0000-0002-7902-7868	National Institutes of Health [DK57751, DK61747, 5T32DK 007356-32]; Department of Defense for Breast Cancer Research Grant [J00181]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007356, R01DK061747, P01DK057751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense for Breast Cancer Research Grant(United States Department of Defense); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK57751 and DK61747 and National Institutes of Health Training Grant 5T32DK 007356-32 administered by the Department of Digestive Diseases at Yale University. This work was also supported by Department of Defense for Breast Cancer Research Grant J00181.	Aravind P, 2008, J MOL BIOL, V376, P1100, DOI 10.1016/j.jmb.2007.12.033; Benbow JH, 2011, J BIOL CHEM, V286, P34575, DOI 10.1074/jbc.M111.265751; Blachford C, 2009, CELL CALCIUM, V46, P257, DOI 10.1016/j.ceca.2009.08.002; Boehmerle W, 2007, P NATL ACAD SCI USA, V104, P11103, DOI 10.1073/pnas.0701546104; Boehmerle W, 2006, P NATL ACAD SCI USA, V103, P18356, DOI 10.1073/pnas.0607240103; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Cho Y, 2010, P NATL ACAD SCI USA, V107, P11313, DOI 10.1073/pnas.1002716107; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; EHRLICH BE, 1980, J MEMBRANE BIOL, V52, P187, DOI 10.1007/BF01869189; Estrada M, 2006, J CELL SCI, V119, P733, DOI 10.1242/jcs.02775; Hama AT, 2012, J NEUROTRAUM, V29, P600, DOI 10.1089/neu.2011.1863; HENNEQUIN C, 1995, BRIT J CANCER, V71, P1194, DOI 10.1038/bjc.1995.232; Hilkens P H, 1997, J Peripher Nerv Syst, V2, P350; Koh PO, 2003, P NATL ACAD SCI USA, V100, P313, DOI 10.1073/pnas.232693499; Ledeboer A, 2006, NEURON GLIA BIOL, V2, P279, DOI 10.1017/S1740925X0700035X; Ledeboer A, 2007, EXPERT OPIN INV DRUG, V16, P935, DOI 10.1517/13543784.16.7.935; Lyseng-Williamson KA, 2005, DRUGS, V65, P2513, DOI 10.2165/00003495-200565170-00007; Mielke S, 2006, EUR J CANCER, V42, P24, DOI 10.1016/j.ejca.2005.06.030; Mo M., 2012, FASEB J IN PRESS; Muthuraman A, 2011, FOOD CHEM TOXICOL, V49, P2557, DOI 10.1016/j.fct.2011.06.069; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Philippov PP, 2006, NEURONAL CALCIUM SEN; Pourmohammadi N, 2012, BASIC CLIN PHARMACOL, V110, P231, DOI 10.1111/j.1742-7843.2011.00795.x; Preston N J, 1996, Eur J Cancer Care (Engl), V5, P147, DOI 10.1111/j.1365-2354.1996.tb00226.x; Ramos-Franco J, 1998, BIOPHYS J, V75, P2783, DOI 10.1016/S0006-3495(98)77721-5; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Schlecker C, 2006, J CLIN INVEST, V116, P1668, DOI 10.1172/JCI22466; Shimizu T, 2000, PAIN, V85, P59, DOI 10.1016/S0304-3959(99)00249-3; SPENCER CM, 1994, DRUGS, V48, P794, DOI 10.2165/00003495-199448050-00009; Wang MS, 2004, BRAIN, V127, P671, DOI 10.1093/brain/awh078; WISHART DS, 1994, J BIOMOL NMR, V4, P171	32	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.385070	http://dx.doi.org/10.1074/jbc.M112.385070			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988235	Green Published, hybrid			2022-12-25	WOS:000310642200026
J	Pinto, JR; Gomes, AV; Jones, MA; Liang, JS; Nguyen, S; Miller, T; Parvatiyar, MS; Potter, JD				Pinto, Jose Renato; Gomes, Aldrin V.; Jones, Michelle A.; Liang, Jingsheng; Nguyen, Susan; Miller, Todd; Parvatiyar, Michelle S.; Potter, James D.			The Functional Properties of Human Slow Skeletal Troponin T Isoforms in Cardiac Muscle Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; MESSENGER-RNA; FORCE DEVELOPMENT; CA2+ SENSITIVITY; CONTRACTION; HEART; IDENTIFICATION; TROPOMYOSIN; EXPRESSION; BINDING	Human slow skeletal troponin T (HSSTnT) shares a high degree of homology with cardiac TnT (CTnT). Although the presence of HSSTnT has not been confirmed in the heart at the protein level, detectable levels of HSSTnT mRNA have been found. Whether HSSTnT isoforms are expressed transiently remains unknown. Because transient re- expression of HSSTnT may be a potential mechanism of regulating function, we explored the effect of HSSTnT on the regulation of cardiac muscle. At least three HSSTnT isoforms have been found to exist in slow skeletal muscle: HSSTnT1 (+exons 5 and 12), HSSTnT2 (+exon 5, -exon 12), and HSSTnT3 (-exons 5 and 12). Another isoform, HSSTnT hypothetical (Hyp) (-exon 5, +exon 12), has only been found at the mRNA level. Compared with HCTnT3 (adult isoform), Tn complexes containing HSSTnT1, -2, and -3 did not alter the actomyosin ATPase activation and inhibition in the presence and absence of Ca2+, respectively. HSSTnTHyp was not evaluated as it did not form a Tn complex under a variety of conditions. Porcine papillary skinned fibers displaced with HSSTnT1, -2, or -3 and reconstituted with human cardiac troponin I and troponin C (HCTnI.TnC) complex showed a decrease in the Ca2+ sensitivity of force development and an increase in maximal recovered force (HSSTnT1 and -3) compared with HCTnT3. In contrast, HSSTnTHyp showed an increase in the Ca2+ sensitivity of force development. This suggests that re- or overexpression of specific SSTnT isoforms might have therapeutic potential in the failing heart because they increase the maximal force of contraction. In addition, circular dichroism and proteolytic digestion experiments revealed structural differences between HSSTnT isoforms and HCTnT3 and that HSSTnT1 is more susceptible to calpain and trypsin proteolysis than the other HSSTnTs. Overall, HSSTnT isoforms despite being homologues of CTnT may display distinct functional properties in muscle regulation.	[Pinto, Jose Renato] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Pinto, Jose Renato; Jones, Michelle A.; Liang, Jingsheng; Miller, Todd; Parvatiyar, Michelle S.; Potter, James D.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Gomes, Aldrin V.; Nguyen, Susan] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Parvatiyar, Michelle S.] Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90095 USA	State University System of Florida; Florida State University; University of Miami; University of California System; University of California Davis; University of California System; University of California Los Angeles	Pinto, JR (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Rm 1350-H,1115 W Call St, Tallahassee, FL 32306 USA.	jose.pinto@med.fsu.edu	parvatiyar, michelle/ABH-7542-2020; Gomes, Aldrin V/I-6529-2018; Pinto, Jose Renato/H-2631-2017	Gomes, Aldrin V/0000-0002-9819-3036; Pinto, Jose Renato/0000-0001-9092-4976; Parvatiyar, Michelle/0000-0002-9416-0069	National Institutes of Health [HL096819, AR050199, HL042325]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL110632, R01HL096819, R37HL042325, R01HL042325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL096819 (to A. V. G.), AR050199, and HL042325 (to J. D. P.).	ANDERSON PAW, 1991, CIRC RES, V69, P1226, DOI 10.1161/01.RES.69.5.1226; Barton PJR, 2004, MOL CELL BIOCHEM, V263, P91, DOI 10.1023/B:MCBI.0000041851.53074.72; Bodor GS, 1997, CLIN CHEM, V43, P476; Chandra M, 2006, BIOPHYS J, V90, P2867, DOI 10.1529/biophysj.105.076950; Cullen ME, 2004, MOL CELL BIOCHEM, V263, P81, DOI 10.1023/B:MCBI.0000041850.37415.b8; Dweck D, 2005, ANAL BIOCHEM, V347, P303, DOI 10.1016/j.ab.2005.09.025; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Fiske CH, 1925, J BIOL CHEM, V66, P375; Fredericks S, 2007, CLIN BIOCHEM, V40, P423, DOI 10.1016/j.clinbiochem.2006.12.008; GAHLMANN R, 1987, J BIOL CHEM, V262, P16122; GOLL DE, 1992, BIOCHIMIE, V74, P225, DOI 10.1016/0300-9084(92)90121-T; Gomes AV, 2002, J BIOL CHEM, V277, P35341, DOI 10.1074/jbc.M204118200; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Huang QQ, 2008, AM J PHYSIOL-CELL PH, V294, pC213, DOI 10.1152/ajpcell.00146.2007; IZUMO S, 1987, J CLIN INVEST, V79, P970, DOI 10.1172/JCI112908; Krishan K, 2000, J MUSCLE RES CELL M, V21, P527, DOI 10.1023/A:1026541803317; Lang R, 2002, J BIOL CHEM, V277, P11670, DOI 10.1074/jbc.M108912200; Larsson L, 2008, AM J PHYSIOL-CELL PH, V295, pC722, DOI 10.1152/ajpcell.00110.2008; LOMPRE AM, 1979, NATURE, V282, P105, DOI 10.1038/282105a0; McCall SJ, 2006, PEDIATR RES, V60, P276, DOI 10.1203/01.pdr.0000233004.95404.1f; Nosek TM, 2004, ARCH BIOCHEM BIOPHYS, V430, P178, DOI 10.1016/j.abb.2004.07.014; Oliveira DM, 2000, J BIOL CHEM, V275, P27513; PEARLSTONE JR, 1981, FEBS LETT, V128, P119, DOI 10.1016/0014-5793(81)81095-2; Perry SV, 1998, J MUSCLE RES CELL M, V19, P575; Pinto JR, 2008, J BIOL CHEM, V283, P2156, DOI 10.1074/jbc.M707066200; Ricchiuti V, 1999, CLIN CHEM, V45, P2129; SABRY MA, 1991, J MUSCLE RES CELL M, V12, P262, DOI 10.1007/BF01745116; SAGGIN L, 1990, DEVELOPMENT, V110, P547; SAMSON F, 1994, BIOCHEM BIOPH RES CO, V199, P841, DOI 10.1006/bbrc.1994.1305; SCHACHAT FH, 1987, J MOL BIOL, V198, P551, DOI 10.1016/0022-2836(87)90300-7; Szczesna D, 2001, J BIOL CHEM, V276, P7086, DOI 10.1074/jbc.M009823200; Szczesna D, 2000, J BIOL CHEM, V275, P624, DOI 10.1074/jbc.275.1.624; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TOBACMAN LS, 1987, J BIOL CHEM, V262, P4059; Wang Q, 2001, ANAT RECORD, V263, P72, DOI 10.1002/ar.1078; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	36	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37362	37370		10.1074/jbc.M112.364927	http://dx.doi.org/10.1074/jbc.M112.364927			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977240	hybrid, Green Published			2022-12-25	WOS:000310588500067
J	Di Gaetano, C; Voglino, F; Guarrera, S; Fiorito, G; Rosa, F; Di Blasio, AM; Manzini, P; Dianzani, I; Betti, M; Cusi, D; Frau, F; Barlassina, C; Mirabelli, D; Magnani, C; Glorioso, N; Bonassi, S; Piazza, A; Matullo, G				Di Gaetano, Cornelia; Voglino, Floriana; Guarrera, Simonetta; Fiorito, Giovanni; Rosa, Fabio; Di Blasio, Anna Maria; Manzini, Paola; Dianzani, Irma; Betti, Marta; Cusi, Daniele; Frau, Francesca; Barlassina, Cristina; Mirabelli, Dario; Magnani, Corrado; Glorioso, Nicola; Bonassi, Stefano; Piazza, Alberto; Matullo, Giuseppe			An Overview of the Genetic Structure within the Italian Population from Genome-Wide Data	PLOS ONE			English	Article							MTDNA HAPLOGROUP-H; Y-CHROMOSOME; HIGH-RESOLUTION; PATTERNS; ORIGIN; SUBSTRUCTURE; DIVERSITY; ANCESTRY; ASSOCIATION; EUROPEANS	In spite of the common belief of Europe as reasonably homogeneous at genetic level, advances in high-throughput genotyping technology have resolved several gradients which define different geographical areas with good precision. When Northern and Southern European groups were considered separately, there were clear genetic distinctions. Intra-country genetic differences were also evident, especially in Finland and, to a lesser extent, within other European populations. Here, we present the first analysis using the 125,799 genome-wide Single Nucleotide Polymorphisms (SNPs) data of 1,014 Italians with wide geographical coverage. We showed by using Principal Component analysis and model-based individual ancestry analysis, that the current population of Sardinia can be clearly differentiated genetically from mainland Italy and Sicily, and that a certain degree of genetic differentiation is detectable within the current Italian peninsula population. Pair-wise F-ST statistics Northern and Southern Italy amounts approximately to 0.001 between, and around 0.002 between Northern Italy and Utah residents with Northern and Western European ancestry (CEU). The Italian population also revealed a fine genetic substructure underscoring by the genomic inflation (Sardinia vs. Northern Italy = 3.040 and Northern Italy vs. CEU = 1.427), warning against confounding effects of hidden relatedness and population substructure in association studies.	[Di Gaetano, Cornelia; Piazza, Alberto; Matullo, Giuseppe] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Di Gaetano, Cornelia; Voglino, Floriana; Guarrera, Simonetta; Fiorito, Giovanni; Rosa, Fabio; Piazza, Alberto; Matullo, Giuseppe] Human Genet Fdn HuGeF, Turin, Italy; [Di Blasio, Anna Maria] Ist Auxol Italiano, Cusano Milanino, Italy; [Manzini, Paola] San Giovanni Molinette Hosp, Banca Sangue, Turin, Italy; [Dianzani, Irma; Betti, Marta] Univ Piemonte Orientale, Dept Hlth Sci, Novara, Italy; [Cusi, Daniele; Frau, Francesca; Barlassina, Cristina] Univ Milan, Dept Med Surg & Dent, Milan, Italy; [Cusi, Daniele; Frau, Francesca; Barlassina, Cristina] Fdn Filarete, Genom & Bioinformat Unit, Milan, Italy; [Mirabelli, Dario] Univ Turin, Canc Epidemiol Unit, Turin, Italy; [Mirabelli, Dario] CPO Piemonte, Turin, Italy; [Magnani, Corrado] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy; [Glorioso, Nicola] Univ Sassari, AOU, Hypertens & Related Dis Ctr, I-07100 Sassari, Italy; [Bonassi, Stefano] IRCCS San Raffaele Pisana, Unit Clin & Mol Epidemiol, Rome, Italy	University of Turin; IRCCS Istituto Auxologico Italiano; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Eastern Piedmont Amedeo Avogadro; University of Milan; University of Turin; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; University of Eastern Piedmont Amedeo Avogadro; University of Sassari; IRCCS San Raffaele Pisana	Di Gaetano, C (corresponding author), Univ Turin, Dept Genet Biol & Biochem, Turin, Italy.	cornelia.digaetano@unito.it	Matullo, Giuseppe/K-6383-2016; Di Gaetano, Cornelia/AAA-5477-2019; Rosa, Fabio/AGI-6840-2022; Bonassi, Stefano/ABI-6281-2020; Guarrera, Simonetta/AAB-8482-2022; Betti, Marta/K-4395-2016	Matullo, Giuseppe/0000-0003-0674-7757; Di Gaetano, Cornelia/0000-0001-8938-7093; Rosa, Fabio/0000-0002-8335-4482; Bonassi, Stefano/0000-0003-3833-6717; Betti, Marta/0000-0002-1372-6666; Barlassina, Cristina/0000-0001-7407-2697; Betti, Marta/0000-0003-0846-4988; Fiorito, Giovanni/0000-0002-7651-5452; Piazza, Alberto/0000-0002-2355-4183	Human Genetic Foundation (HuGeF) of Turin; Associazione Italiana per la Ricerca sul Cancro (AIRC); non-profit Buzzi Unicem Foundation for mesothelioma research; HYPERGENES project [FP7 - HEALTH-2007-201550]; InterOmics an Italian Flagship project; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); Consiglio Nazionale delle Ricerche (CNR)	Human Genetic Foundation (HuGeF) of Turin; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); non-profit Buzzi Unicem Foundation for mesothelioma research; HYPERGENES project; InterOmics an Italian Flagship project; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Consiglio Nazionale delle Ricerche (CNR)(Consiglio Nazionale delle Ricerche (CNR))	The main supporter of this project was the Human Genetic Foundation (HuGeF) of Turin (to M.G.). This study used data from grants funded by Associazione Italiana per la Ricerca sul Cancro (AIRC) AIRC 2007, and the non-profit Buzzi Unicem Foundation for mesothelioma research (to B.S.), HYPERGENES project (funded by the Seventh Framework Programme FP7 - HEALTH-2007-201550) and InterOmics an Italian Flagship project (funded by Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) and Consiglio Nazionale delle Ricerche (CNR) (to C.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; AMMERMAN AJ, 1984, NEOLITHIC TRANSITION; Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; BARBUJANI G, 1995, P NATL ACAD SCI USA, V92, P9171, DOI 10.1073/pnas.92.20.9171; Betti M, 2009, INT J HYG ENVIR HEAL, V212, P322, DOI 10.1016/j.ijheh.2008.08.001; Bonifazi C., 2000, INT J POPULATION GEO, V6, P111, DOI DOI 10.1002/(SICI)1099-1220(200003/04)6:2<111::AID-IJPG172>3.0.CO;2-L; Bosch E, 2001, AM J HUM GENET, V68, P1019, DOI 10.1086/319521; Bosch N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008269; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cann HM, 2002, SCIENCE, V296, P261; Capelli C, 2003, CURR BIOL, V13, P979, DOI 10.1016/S0960-9822(03)00373-7; Capelli C, 2007, MOL PHYLOGENET EVOL, V44, P228, DOI 10.1016/j.ympev.2006.11.030; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2007, ANNU REV GENOM HUM G, V8, P1, DOI 10.1146/annurev.genom.8.080706.092403; CAVALLISFORZA LL, 1993, EUR J HUM GENET, V1, P3; Deng LB, 2008, HUM MUTAT, V29, P1209, DOI 10.1002/humu.20775; Development Core Team R, 2008, R LANG ENV STAT COMP; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Di Giacomo F, 2003, MOL PHYLOGENET EVOL, V28, P387, DOI 10.1016/S1055-7903(03)00016-2; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hao K, 2004, EUR J HUM GENET, V12, P1001, DOI 10.1038/sj.ejhg.5201273; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Humphreys K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022547; Huyghe JR, 2011, EUR J HUM GENET, V19, P347, DOI 10.1038/ejhg.2010.179; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Keller A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1701; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Loogvali EL, 2004, MOL BIOL EVOL, V21, P2012, DOI 10.1093/molbev/msh209; Maca-Meyer N, 2003, ANN HUM GENET, V67, P329, DOI 10.1046/j.1469-1809.2003.00045.x; Malyarchuk BA, 2002, ANN HUM GENET, V66, P261, DOI 10.1017/S0003480002001161; MANTEL N, 1967, CANCER RES, V27, P209; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Morelli L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010419; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Novembre J, 2008, NAT GENET, V40, P646, DOI 10.1038/ng.139; O'Dushlaine CT, 2010, EUR J HUM GENET, V18, P1248, DOI 10.1038/ejhg.2010.87; PIAZZA A, 1988, ANN HUM GENET, V52, P203, DOI 10.1111/j.1469-1809.1988.tb01098.x; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sajantila A, 1996, P NATL ACAD SCI USA, V93, P12035, DOI 10.1073/pnas.93.21.12035; Salm MPA, 2012, GENOME RES, V22, P1144, DOI 10.1101/gr.126037.111; Salmela E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016747; Salvi E, 2011, HYPERTENSION; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Tian C, 2009, MOL MED, V15, P371, DOI 10.2119/molmed.2009.00094; Torroni A, 1998, AM J HUM GENET, V62, P1137, DOI 10.1086/301822; Winney B, 2011, EUR J HUM GENET	61	46	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43759	10.1371/journal.pone.0043759	http://dx.doi.org/10.1371/journal.pone.0043759			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984441	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500021
J	Lai, XS; Wang, JY; Nabar, NR; Pan, SQ; Tang, CZ; Huang, Y; Hao, MF; Yang, ZH; Ma, CM; Zhang, J; Chew, H; He, ZQ; Yang, JJ; Su, BG; Zhang, J; Liang, J; Sneed, KB; Zhou, SF				Lai, Xinsheng; Wang, Jiayou; Nabar, Neel R.; Pan, Sanqiang; Tang, Chunzhi; Huang, Yong; Hao, Mufeng; Yang, Zhonghua; Ma, Chunmei; Zhang, Jin; Chew, Helen; He, Zhenquan; Yang, Junjun; Su, Baogui; Zhang, Jian; Liang, Jun; Sneed, Kevin B.; Zhou, Shu-Feng			Proteomic Response to Acupuncture Treatment in Spontaneously Hypertensive Rats	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; RESEARCH-PROGRAM SHARP; OXIDATIVE STRESS; STOP HYPERTENSION; NADPH OXIDASES; BLOOD-PRESSURE; HEART-DISEASE; DOUBLE-BLIND; MECHANISMS; UPDATE	Previous animal and clinical studies have shown that acupuncture is an effective alternative treatment in the management of hypertension, but the mechanism is unclear. This study investigated the proteomic response in the nervous system to treatment at the Taichong (LR3) acupoint in spontaneously hypertensive rats (SHRs). Unanesthetized rats were subject to 5-min daily acupuncture treatment for 7 days. Blood pressure was monitored over 7 days. After euthanasia on the 7th day, rat medullas were dissected, homogenized, and subject to 2D gel electrophoresis and MALDI-TOF analysis. The results indicate that blood pressure stabilized after the 5th day of acupuncture, and compared with non-acupoint treatment, Taichong-acupunctured rat's systolic pressure was reduced significantly (P<0.01), though not enough to bring blood pressure down to normal levels. The different treatment groups also showed differential protein expression: the 2D images revealed 571+/-15 proteins in normal SD rats' medulla, 576+/-31 proteins in SHR's medulla, 597644 proteins in medulla of SHR after acupuncturing Taichong, and 616+/-18 proteins in medulla of SHR after acupuncturing non-acupoint. In the medulla of Taichong group, compared with non-acupoint group, seven proteins were down-regulated: heat shock protein-90, synapsin-1, pyruvate kinase isozyme, NAD-dependent deacetylase sirtuin-2, protein kinase C inhibitor protein 1, ubiquitin hydrolase isozyme L1, and myelin basic protein. Six proteins were up-regulated: glutamate dehydrogenase 1, aldehyde dehydrogenase 2, glutathione S-transferase M5, Rho GDP dissociation inhibitor 1, DJ-1 protein and superoxide dismutase. The altered expression of several proteins by acupuncture has been confirmed by ELISA, Western blot and qRT-PCR assays. The results indicate an increase in antioxidant enzymes in the medulla of the SHRs subject to acupuncture, which may provide partial explanation for the antihypertensive effect of acupuncture. Further studies are warranted to investigate the role of oxidative stress modulation by acupuncture in the treatment of hypertension.	[Lai, Xinsheng; Tang, Chunzhi; Yang, Junjun] Guangzhou Univ Chinese Med, Sch Acupuncture & Moxibust, Dept Acupuncture & Moxibust, Guangzhou, Guangdong, Peoples R China; [Wang, Jiayou; Hao, Mufeng; Yang, Zhonghua; Ma, Chunmei; Zhang, Jin; He, Zhenquan] Guangzhou Univ Chinese Med, Sch Fundamental Med Sci, Dept Human Anat, Guangzhou, Guangdong, Peoples R China; [Nabar, Neel R.; Chew, Helen; Liang, Jun; Zhou, Shu-Feng] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL USA; [Pan, Sanqiang; Su, Baogui] Jinan Univ, Sch Med, Dept Human Anat, Guangzhou, Guangdong, Peoples R China; [Huang, Yong] So Med Univ, Sch Chinese Med, Dept Acupuncture & Moxibust, Guangzhou, Guangdong, Peoples R China; [Zhang, Jian] Third Hosp Nanchang, Dept Surg, Nanchang, Jiangxi, Peoples R China; [Sneed, Kevin B.] Univ S Florida, Coll Pharm, Dept Pharmacotherapeut & Clin Res, Tampa, FL USA	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; State University System of Florida; University of South Florida; Jinan University; Southern Medical University - China; State University System of Florida; University of South Florida	Lai, XS (corresponding author), Guangzhou Univ Chinese Med, Sch Acupuncture & Moxibust, Dept Acupuncture & Moxibust, Guangzhou, Guangdong, Peoples R China.	xmishu@126.com; szhou@health.usf.edu	Zhou, Shu-Feng/E-3166-2013; Wang, Jiayou/AAN-4760-2021	Zhou, Shu-Feng/0000-0002-5542-6119; Wang, Jiayou/0000-0001-9697-2004; Nabar, Neel/0000-0002-9704-3570	National 973 program of China [2006CB504505]; Natural Science Foundation of China [90709027]; University of South Florida College of Pharmacy Startup Fund	National 973 program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); University of South Florida College of Pharmacy Startup Fund	The authors appreciate the support by the National 973 program of China (Grant No. 2006CB504505), the Natural Science Foundation of China (Grant No. 90709027), and University of South Florida College of Pharmacy Startup Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKHMEDOV TI, 1993, TERAPEVT ARKH, V65, P22; ANSHELEVICH YV, 1985, TERAPEVT ARKH, V57, P42; Benter IF, 2011, J CARDIOVASC PHARM, V57, P559, DOI 10.1097/FJC.0b013e31821324b6; Bertoia ML, 2011, HYPERTENSION, V58, P361, DOI 10.1161/HYPERTENSIONAHA.111.175463; Bobkova A S, 1991, Vopr Kurortol Fizioter Lech Fiz Kult, P29; Boshtam M, 2002, INT J VITAM NUTR RES, V72, P309, DOI 10.1024/0300-9831.72.5.309; Burke A, 2006, J ALTERN COMPLEM MED, V12, P639, DOI 10.1089/acm.2006.12.639; Cantwell SL, 2010, TOP COMPANION ANIM M, V25, P53, DOI 10.1053/j.tcam.2009.10.006; Chiu YJ, 1997, CLIN EXP HYPERTENS, V19, P1047, DOI 10.3109/10641969709083204; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; CHRISTE ME, 1994, J MOL CELL CARDIOL, V26, P1371, DOI 10.1006/jmcc.1994.1155; Colombari E, 2001, HYPERTENSION, V38, P549, DOI 10.1161/01.HYP.38.3.549; Datla SR, 2010, HYPERTENSION, V56, P325, DOI 10.1161/HYPERTENSIONAHA.109.142422; DeLano FA, 2005, AM J PHYSIOL-HEART C, V288, pH805, DOI 10.1152/ajpheart.00696.2004; Duan Dong-mei, 2008, Zhongguo Zhen Jiu, V28, P369; Engelhard YN, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.05.008; Friedemann T, 2011, LASERS MED SCI; Harrison DG, 2009, MED CLIN N AM, V93, P621, DOI 10.1016/j.mcna.2009.02.015; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; Huang H, 1992, J Tradit Chin Med, V12, P133; Huang Xue-Kuan, 2008, Zhen Ci Yan Jiu, V33, P183; Huang YL, 2005, ACUPUNCTURE ELECTRO, V30, P263, DOI 10.3727/036012905815901235; Hwang HS, 2008, EVID-BASED COMPL ALT, V2011, P1; Kalish LA, 2004, CONTROL CLIN TRIALS, V25, P76, DOI 10.1016/j.cct.2003.08.006; Kaplan NM, 2006, HYPERTENSION, V48, P815, DOI 10.1161/01.HYP.0000241069.80574.76; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kim DD, 2006, MICROCIRCULATION, V13, P577, DOI 10.1080/10739680600885210; Kim LW, 2010, ALTERN THER HEALTH M, V16, P18; Kishi T, 2004, CIRCULATION, V109, P2357, DOI 10.1161/01.CIR.0000128695.49900.12; Kizhakekuttu TJ, 2010, CARDIOVASC THER, V28, pe20, DOI 10.1111/j.1755-5922.2010.00137.x; Kumar A, 2009, PHARMACOL THERAPEUT, V124, P259, DOI 10.1016/j.pharmthera.2009.07.003; LI P, 1983, ACUPUNCTURE ELECTRO, V8, P45, DOI 10.3727/036012983816715019; Liu CZ, 2006, NEUROSCI LETT, V393, P45, DOI 10.1016/j.neulet.2005.09.049; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; Macklin EA, 2006, HYPERTENSION, V48, P838, DOI 10.1161/01.HYP.0000241090.28070.4c; Meng XZ, 2011, BRAIN RES, V1414, P58, DOI 10.1016/j.brainres.2011.08.004; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Park JM, 2010, J ALTERN COMPLEM MED, V16, P883, DOI 10.1089/acm.2009.0427; Perez-Vizcaino F, 2009, PHARMACOL REP, V61, P67, DOI 10.1016/S1734-1140(09)70008-8; Peterson JR, 2006, CURR HYPERTENS REP, V8, P232, DOI 10.1007/s11906-006-0056-1; Pimenta E, 2012, HYPERTENS RES, V35, P148, DOI 10.1038/hr.2011.190; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Stocker SD, 2008, CLIN EXP PHARMACOL P, V35, P695, DOI 10.1111/j.1440-1681.2007.04835.x; SUGIOKA K, 1977, AM J CHINESE MED, V5, P39, DOI 10.1142/S0192415X77000051; Wang F, 2011, PEPTIDES, V32, P2394, DOI 10.1016/j.peptides.2011.10.019; YAO T, 1993, SCAND J REHABIL MED, P7; Yin C, 2007, NEUROL RES, V29, pS98, DOI 10.1179/016164107X172220; Yu YP, 2010, BRAIN RES, V1336, P58, DOI 10.1016/j.brainres.2010.04.020; Zhang WG, 2000, P NATL ACAD SCI USA, V97, P9765, DOI 10.1073/pnas.170160397; Zhang Y, 2011, NEUROCHEM RES, V36, P2104, DOI 10.1007/s11064-011-0534-y; Zhou Y, 1995, Zhen Ci Yan Jiu, V20, P55	51	37	42	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44216	10.1371/journal.pone.0044216	http://dx.doi.org/10.1371/journal.pone.0044216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984478	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500038
J	Mikryukov, A; Moss, T				Mikryukov, Alexander; Moss, Tom			Agonistic and Antagonistic Roles for TNIK and MINK in Non-Canonical and Canonical Wnt Signalling	PLOS ONE			English	Article							N-TERMINAL KINASE; NCK-INTERACTING KINASE; CONVERGENT EXTENSION; XENOPUS EMBRYOS; STE20 KINASE; BETA-CATENIN; STE20-RELATED KINASE; PLANAR POLARITY; ADAPTER PROTEIN; GENE-EXPRESSION	Wnt signalling is a key regulatory factor in animal development and homeostasis and plays an important role in the establishment and progression of cancer. Wnt signals are predominantly transduced via the Frizzled family of serpentine receptors to two distinct pathways, the canonical beta-catenin pathway and a non-canonical pathway controlling planar cell polarity and convergent extension. Interference between these pathways is an important determinant of cellular and phenotypic responses, but is poorly understood. Here we show that TNIK (Traf2 and Nck-interacting kinase) and MINK (Misshapen/NIKs-related kinase) MAP4K signalling kinases are integral components of both canonical and non-canonical pathways in Xenopus. xTNIK and xMINK interact and are proteolytically cleaved in vivo to generate Kinase domain fragments that are active in signal transduction, and Citron-NIK-Homology (CNH) Domain fragments that are suppressive. The catalytic activity of the Kinase domain fragments of both xTNIK and xMINK mediate non-canonical signalling. However, while the Kinase domain fragments of xTNIK also mediate canonical signalling, the analogous fragments derived from xMINK strongly antagonize this signalling. Our data suggest that the proteolytic cleavage of xTNIK and xMINK determines their respective activities and is an important factor in controlling the balance between canonical and non-canonical Wnt signalling in vivo.	[Mikryukov, Alexander; Moss, Tom] Univ Laval, Canc Res Ctr, Lab Growth & Dev, Quebec City, PQ, Canada; [Mikryukov, Alexander; Moss, Tom] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ, Canada; [Mikryukov, Alexander; Moss, Tom] Quebec Univ Hosp Ctr, Res Ctr, Quebec City, PQ, Canada	Laval University; Laval University	Mikryukov, A (corresponding author), Univ Toronto, MaRS Ctr, Keller Lab, Toronto, ON, Canada.	Tom.Moss@crhdq.ulaval.ca		Moss, Thomas (Tom)/0000-0003-2047-4783; Mikryukov, Alexander/0000-0002-7632-9529	National Research Council of Canada (NSERC) [194618-07]; Les Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)	National Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Les Fonds quebecois de la recherche sur la nature et les technologies (FQRNT)(FQRNT)	This work was supported by the National Research Council of Canada (NSERC) grant #194618-07 and by a scholarship to A. M. from Les Fonds quebecois de la recherche sur la nature et les technologies (FQRNT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Becker E, 2000, MOL CELL BIOL, V20, P1537, DOI 10.1128/MCB.20.5.1537-1545.2000; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dan I, 2000, FEBS LETT, V469, P19, DOI 10.1016/S0014-5793(00)01247-3; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Fagotto F, 1997, DEVELOPMENT, V124, P453; Fanto M, 2004, J CELL SCI, V117, P527, DOI 10.1242/jcs.00973; Fu CA, 1999, J BIOL CHEM, V274, P30729, DOI 10.1074/jbc.274.43.30729; Gingras MC, 2002, MOL CELL BIOL, V22, P41, DOI 10.1128/MCB.22.1.41-56.2002; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; HEMMATIBRIVANLOU A, 1990, DEVELOPMENT, V110, P325; Hu YM, 2004, J BIOL CHEM, V279, P54387, DOI 10.1074/jbc.M404497200; Islam N, 1996, TRENDS GENET, V12, P459, DOI 10.1016/0168-9525(96)99990-4; James Richard G., 2008, V468, P131, DOI 10.1007/978-1-59745-249-6_10; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; Kanai-Azuma M, 1999, MECH DEVELOP, V89, P155, DOI 10.1016/S0925-4773(99)00193-8; Kiefer JC, 2005, DEV DYNAM, V233, P695, DOI 10.1002/dvdy.20359; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Lee RHK, 2007, EMBO J, V26, P3592, DOI 10.1038/sj.emboj.7601781; Liu HZ, 1999, CURR BIOL, V9, P101, DOI 10.1016/S0960-9822(99)80023-2; Mahmoudi T, 2009, EMBO J, V28, P3329, DOI 10.1038/emboj.2009.285; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Nakano K, 2000, J BIOL CHEM, V275, P20533, DOI 10.1074/jbc.M001009200; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; Niehrs C, 2001, NATURE, V413, P787, DOI 10.1038/35101682; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Paricio N, 1999, EMBO J, V18, P4669, DOI 10.1093/emboj/18.17.4669; Poinat P, 2002, CURR BIOL, V12, P622, DOI 10.1016/S0960-9822(02)00764-9; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Ruan WJ, 1999, NEURON, V24, P595, DOI 10.1016/S0896-6273(00)81115-0; Satow R, 2010, J BIOL CHEM, V285, P26289, DOI 10.1074/jbc.M109.090597; Schohl A, 2003, EMBO J, V22, P3303, DOI 10.1093/emboj/cdg328; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Su YC, 1998, GENE DEV, V12, P2371, DOI 10.1101/gad.12.15.2371; Su YC, 1997, EMBO J, V16, P1279, DOI 10.1093/emboj/16.6.1279; Su YC, 2000, MOL CELL BIOL, V20, P4736, DOI 10.1128/MCB.20.13.4736-4744.2000; Tada M, 2002, SEMIN CELL DEV BIOL, V13, P251, DOI 10.1016/S1084-9521(02)00052-6; Taira K, 2004, J BIOL CHEM, V279, P49488, DOI 10.1074/jbc.M406370200; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2001, DEVELOPMENT, V128, P2581; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2001, INT J DEV BIOL, V45, P225; Wright JH, 2003, MOL CELL BIOL, V23, P2068, DOI 10.1128/MCB.23.6.2068-2082.2003; Xue YZ, 2001, DEVELOPMENT, V128, P1559; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118	56	16	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43330	10.1371/journal.pone.0043330	http://dx.doi.org/10.1371/journal.pone.0043330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984420	gold, Green Published, Green Submitted			2022-12-25	WOS:000308638700018
J	Ou, XF; Zhang, YH; Xu, CM; Lin, XY; Zang, Q; Zhuang, TT; Jiang, LL; von Wettstein, D; Liu, B				Ou, Xiufang; Zhang, Yunhong; Xu, Chunming; Lin, Xiuyun; Zang, Qi; Zhuang, Tingting; Jiang, Lili; von Wettstein, Diter; Liu, Bao			Transgenerational Inheritance of Modified DNA Methylation Patterns and Enhanced Tolerance Induced by Heavy Metal Stress in Rice (Oryza sativa L.)	PLOS ONE			English	Article							EPIGENETIC INHERITANCE; HERITABLE ALTERATION; GENOME; PLANTS; HYPOMETHYLATION; MEMORY; DEMETHYLATION; ACTIVATION; RESPONSES	Background: DNA methylation is sensitive and responsive to stressful environmental conditions. Nonetheless, the extent to which condition-induced somatic methylation modifications can impose transgenerational effects remains to be fully understood. Even less is known about the biological relevance of the induced epigenetic changes for potentially altered well-being of the organismal progenies regarding adaptation to the specific condition their progenitors experienced. Methodology/Principal Findings: We analyzed DNA methylation pattern by gel-blotting at genomic loci representing transposable elements and protein-coding genes in leaf-tissue of heavy metal-treated rice (Oryza sativa) plants (S0), and its three successive organismal generations. We assessed expression of putative genes involved in establishing and/or maintaining DNA methylation patterns by reverse transcription (RT)-PCR. We measured growth of the stressed plants and their unstressed progenies vs. the control plants. We found (1) relative to control, DNA methylation patterns were modified in leaf-tissue of the immediately treated plants, and the modifications were exclusively confined to CHG hypomethylation; (2) the CHG-demethylated states were heritable via both maternal and paternal germline, albeit often accompanying further hypomethylation; (3) altered expression of genes encoding for DNA methyltransferases, DNA glycosylase and SWI/SNF chromatin remodeling factor (DDM1) were induced by the stress; (4) progenies of the stressed plants exhibited enhanced tolerance to the same stress their progenitor experienced, and this transgenerational inheritance of the effect of condition accompanying heritability of modified methylation patterns. Conclusions/Significance: Our findings suggest that stressful environmental condition can produce transgenerational epigenetic modifications. Progenies of stressed plants may develop enhanced adaptability to the condition, and this acquired trait is inheritable and accord with transmission of the epigenetic modifications. We suggest that environmental induction of heritable modifications in DNA methylation provides a plausible molecular underpinning for the still contentious paradigm of inheritance of acquired traits originally put forward by Jean-Baptiste Lamarck more than 200 years ago.	[Ou, Xiufang; Zhang, Yunhong; Xu, Chunming; Zang, Qi; Zhuang, Tingting; Jiang, Lili; Liu, Bao] NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Peoples R China; [Ou, Xiufang; Zhang, Yunhong; Xu, Chunming; Zang, Qi; Zhuang, Tingting; Jiang, Lili; Liu, Bao] NE Normal Univ, Inst Cytol & Genet, Changchun, Peoples R China; [Lin, Xiuyun] Jilin Acad Agr Sci, Changchun, Peoples R China; [von Wettstein, Diter] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [von Wettstein, Diter] Washington State Univ, Sch Mol Biol, Pullman, WA 99164 USA	Northeast Normal University - China; Northeast Normal University - China; Jilin Academy of Agricultural Sciences; Washington State University; Washington State University	Ou, XF (corresponding author), NE Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Peoples R China.	diter@wsu.edu; baoliu@nenu.edu.cn	Kuznetsov, Aleksey A/M-6859-2015	Xu, Chunming/0000-0002-0986-0993; Liu, Bao/0000-0001-5481-1675; zakaria, seyed moein/0000-0002-0086-1279	National Natural Science Foundation of China [30990243]; Programme for Introducing Talents to Universities [B07017]; Young Faculty Incubation Project of NENU [09QNJJ21]; National Institutes of Health [1R01 GM 080749-01A2]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Programme for Introducing Talents to Universities; Young Faculty Incubation Project of NENU; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Natural Science Foundation of China (No. 30990243), the Programme for Introducing Talents to Universities (B07017), a Young Faculty Incubation Project of NENU (No. 09QNJJ21), and National Institutes of Health grant 1R01 GM 080749-01A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aina R, 2004, PHYSIOL PLANTARUM, V121, P472, DOI 10.1111/j.1399-3054.2004.00343.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Boyko A, 2011, MOL PLANT, V4, P1014, DOI 10.1093/mp/ssr022; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; Boyko A, 2010, PLANT SIGNAL BEHAV, V5, P995, DOI [10.4161/psb.5.8.12227, 10.1371/journal.pone.0009514]; Boyko A, 2010, PLANT CELL PHYSIOL, V51, P1066, DOI 10.1093/pcp/pcq048; Boyko A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009514; BRECKLE CW, 1991, PLANT ROOTS HIDDEN H, P351; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Dyachenko OV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P461, DOI 10.1134/S000629790604016X; Finnegan EJ, 2000, PLANT MOL BIOL, V43, P189, DOI 10.1023/A:1006427226972; Hauser MT, 2011, BBA-GENE REGUL MECH, V1809, P459, DOI 10.1016/j.bbagrm.2011.03.007; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Jablonka E., 1995, EPIGENETIC INHERITAN; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Jullien PE, 2010, TRENDS GENET, V26, P394, DOI 10.1016/j.tig.2010.06.001; Kakutani T, 1999, GENETICS, V151, P831; Kidwell K.K., 1992, SIMPLE PLANT DNA ISO; Kou HP, 2011, J PLANT PHYSIOL, V168, P1685, DOI 10.1016/j.jplph.2011.03.017; Lang-Mladek C, 2010, MOL PLANT, V3, P594, DOI 10.1093/mp/ssq014; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lee S, 2007, PLANT PHYSIOL, V145, P831, DOI 10.1104/pp.107.102236; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Liu ZL, 2004, THEOR APPL GENET, V109, P200, DOI 10.1007/s00122-004-1618-8; Lukens LN, 2007, CURR OPIN PLANT BIOL, V10, P317, DOI 10.1016/j.pbi.2007.04.012; Luna E, 2012, PLANT SIGNAL BEHAV, V7, P615, DOI 10.4161/psb.20155; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; Madlung A, 2004, ANN BOT-LONDON, V94, P481, DOI 10.1093/aob/mch172; Mirouze M, 2011, CURR OPIN PLANT BIOL, V14, P267, DOI 10.1016/j.pbi.2011.03.004; Molinier J, 2006, NATURE, V442, P1046, DOI 10.1038/nature05022; Nies DH, 1999, APPL MICROBIOL BIOT, V51, P730, DOI 10.1007/s002530051457; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Pecinka A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005202; Polle A, 1993, SIGNIFICANCE ANTIOXI; Rahavi MR, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00091; Rangwala SH, 2004, CURR OPIN GENET DEV, V14, P686, DOI 10.1016/j.gde.2004.09.009; Simon SA, 2011, CURR OPIN PLANT BIOL, V14, P148, DOI 10.1016/j.pbi.2010.11.007; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; Turner BM, 2009, PHILOS T R SOC B, V364, P3403, DOI 10.1098/rstb.2009.0125; Vanyushin BF, 2009, DNA METHYLATION PLAN; Vanyushin BF, 2011, BBA-GENE REGUL MECH, V1809, P360, DOI 10.1016/j.bbagrm.2011.04.006; Wada Y, 2004, MOL GENET GENOMICS, V271, P658, DOI 10.1007/s00438-004-1018-4; Whittle CA, 2009, BOTANY, V87, P650, DOI 10.1139/B09-030; WILSON VL, 1983, CELL, V32, P239, DOI 10.1016/0092-8674(83)90514-7	51	112	124	2	120	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e41143	10.1371/journal.pone.0041143	http://dx.doi.org/10.1371/journal.pone.0041143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984395	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700002
J	Safdie, F; Brandhorst, S; Wei, M; Wang, WJ; Lee, C; Hwang, S; Conti, PS; Chen, TC; Longo, VD				Safdie, Fernando; Brandhorst, Sebastian; Wei, Min; Wang, Weijun; Lee, Changhan; Hwang, Saewon; Conti, Peter S.; Chen, Thomas C.; Longo, Valter D.			Fasting Enhances the Response of Glioma to Chemo- and Radiotherapy	PLOS ONE			English	Article							MALIGNANT GLIOMAS; CANCER-RISK; TEMOZOLOMIDE; GLUCOSE; GLIOBLASTOMA; 2-DEOXY-D-GLUCOSE; CHEMOTHERAPY; CONCOMITANT; PROTECTION; CELLS	Background: Glioma, including anaplastic astrocytoma and glioblastoma multiforme (GBM) are among the most commonly diagnosed malignant adult brain tumors. GBM is a highly invasive and angiogenic tumor, resulting in a 12 to 15 months median survival. The treatment of GBM is multimodal and includes surgical resection, followed by adjuvant radio-and chemotherapy. We have previously reported that short-term starvation (STS) enhances the therapeutic index of chemo-treatments by differentially protecting normal cells against and/or sensitizing tumor cells to chemotoxicity. Methodology and Principal Findings: To test the effect of starvation on glioma cells in vitro, we treated primary mouse glia, murine GL26, rat C6 and human U251, LN229 and A172 glioma cells with Temozolomide in ad lib and STS mimicking conditions. In vivo, mice with subcutaneous or intracranial models of GL26 glioma were starved for 48 hours prior to radio- or chemotherapy and the effects on tumor progression and survival were measured. Starvation-mimicking conditions sensitized murine, rat and human glioma cells, but not primary mixed glia, to chemotherapy. In vivo, starvation for 48 hours, which causes a significant reduction in blood glucose and circulating insulin-like growth factor 1 (IGF-1) levels, sensitized both subcutaneous and intracranial glioma models to radio-and chemotherapy. Conclusion: Starvation-induced cancer sensitization to radio-or chemotherapy leads to extended survival in the in vivo glioma models tested. These results indicate that fasting and fasting-mimicking interventions could enhance the efficacy of existing cancer treatments against aggressive glioma in patients.	[Safdie, Fernando; Brandhorst, Sebastian; Wei, Min; Lee, Changhan; Hwang, Saewon; Longo, Valter D.] Univ So Calif, Sch Gerontol, Longev Inst, Los Angeles, CA 90089 USA; [Safdie, Fernando; Brandhorst, Sebastian; Wei, Min; Lee, Changhan; Hwang, Saewon; Longo, Valter D.] Univ So Calif, Sch Gerontol, Dept Biol Sci, Los Angeles, CA USA; [Wang, Weijun; Chen, Thomas C.] USC Keck Sch Med, USC Norris Neurooncol Program, Los Angeles, CA USA; [Conti, Peter S.] USC Keck Sch Med, Mol Imaging Ctr, Dept Radiol, Los Angeles, CA USA; [Brandhorst, Sebastian] Univ Duisburg Essen, Fac Biol, Ctr Med Biotechnol, Essen, Germany	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Duisburg Essen	Safdie, F (corresponding author), Univ So Calif, Sch Gerontol, Longev Inst, Los Angeles, CA 90089 USA.	vlongo@usc.edu	Wei, Min/GSI-8510-2022	Wei, Min/0000-0002-2649-9271	NIH/NIA [AG20642, AG025135]; Bakewell Foundation; V Foundation for Cancer Research; USC Norris Cancer Center pilot grant; NCRR grant [S10RR017964-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG034906, R01AG020642, R01AG025135] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Bakewell Foundation; V Foundation for Cancer Research; USC Norris Cancer Center pilot grant; NCRR grant; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study is funded, in part, by NIH/NIA grants AG20642 and AG025135, The Bakewell Foundation, The V Foundation for Cancer Research and a USC Norris Cancer Center pilot grant to VDL. The Molecular Imaging Center at USC is supported in part by NCRR grant S10RR017964-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Apontes P, 2011, ONCOTARGET, V2, P222, DOI 10.18632/oncotarget.248; Aronen HJ, 2000, CLIN CANCER RES, V6, P2189; FEARON KCH, 1988, AM J CLIN NUTR, V47, P42, DOI 10.1093/ajcn/47.1.42; Fisher PG, 2005, JAMA-J AM MED ASSOC, V293, P615, DOI 10.1001/jama.293.5.615; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Greenspan RJ, 2001, NAT REV GENET, V2, P383, DOI 10.1038/35072018; Gupta T, 2002, LANCET ONCOL, V3, P557, DOI 10.1016/S1470-2045(02)00853-7; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Kari F W, 1999, J Nutr Health Aging, V3, P92; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Kreisl TN, 2009, SEMIN RADIAT ONCOL, V19, P150, DOI 10.1016/j.semradonc.2009.02.003; Kroger N, 1998, BONE MARROW TRANSPL, V21, P1171, DOI 10.1038/sj.bmt.1701245; Lee C, 2011, ONCOGENE; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lee CH, 2010, CANCER RES, V70, P1564, DOI 10.1158/0008-5472.CAN-09-3228; LEWIS C, 1994, DRUG SAFETY, V11, P153, DOI 10.2165/00002018-199411030-00002; Mitchell JR, 2010, AGING CELL, V9, P40, DOI 10.1111/j.1474-9726.2009.00532.x; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Mutter N, 2006, EXPERT REV ANTICANC, V6, P1187, DOI 10.1586/14737140.6.8.1187; Newlands ES, 1997, CANCER TREAT REV, V23, P35, DOI 10.1016/S0305-7372(97)90019-0; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Oudard S, 1997, ANTICANCER RES, V17, P1903; Prins RM, 2003, CANCER RES, V63, P8487; Purow B, 2009, NAT REV NEUROL, V5, P419, DOI 10.1038/nrneurol.2009.96; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Raffaghello L, 2008, P NATL ACAD SCI USA, V105, P8215, DOI 10.1073/pnas.0708100105; Rapp K, 2006, DIABETOLOGIA, V49, P945, DOI 10.1007/s00125-006-0207-6; Roslin M, 2003, J NEURO-ONCOL, V61, P151, DOI 10.1023/A:1022106910017; Safdie FM, 2009, AGING-US, V1, P988, DOI 10.18632/aging.100114; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; SINGH SP, 1990, INT J RADIAT BIOL, V58, P791, DOI 10.1080/09553009014552171; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; STEVENS MFG, 1987, CANCER RES, V47, P5846; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Strohman R, 2002, SCIENCE, V296, P701, DOI 10.1126/science.1070534; Stupp R, 2002, J CLIN ONCOL, V20, P1375, DOI 10.1200/JCO.20.5.1375; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Villano JL, 2009, CANCER CHEMOTH PHARM, V64, P647, DOI 10.1007/s00280-009-1050-5; WARBURG O, 1956, SCIENCE, V124, P269; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; ZIMMERMAN HM, 1955, AM J PATHOL, V31, P1; Zitvogel L, 2011, NAT REV CLIN ONCOL, V8, P151, DOI 10.1038/nrclinonc.2010.223	46	135	144	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44603	10.1371/journal.pone.0044603	http://dx.doi.org/10.1371/journal.pone.0044603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984531	gold, Green Submitted, Green Published			2022-12-25	WOS:000308638700071
J	Zhang, YC; Gao, M; Singer, SD; Fei, ZJ; Wang, H; Wang, XP				Zhang, Yucheng; Gao, Min; Singer, Stacy D.; Fei, Zhangjun; Wang, Hua; Wang, Xiping			Genome-Wide Identification and Analysis of the TIFY Gene Family in Grape	PLOS ONE			English	Article							EVOLUTIONARY ANALYSIS; JASMONATE; ARABIDOPSIS; DUPLICATION; EXPRESSION; RESISTANCE; PROTEINS; SEQUENCE; DEFENSE; STRESS	Background: The TIFY gene family constitutes a plant-specific group of genes with a broad range of functions. This family encodes four subfamilies of proteins, including ZML, TIFY, PPD and JASMONATE ZIM-Domain (JAZ) proteins. JAZ proteins are targets of the SCFCOI1 complex, and function as negative regulators in the JA signaling pathway. Recently, it has been reported in both Arabidopsis and rice that TIFY genes, and especially JAZ genes, may be involved in plant defense against insect feeding, wounding, pathogens and abiotic stresses. Nonetheless, knowledge concerning the specific expression patterns and evolutionary history of plant TIFY family members is limited, especially in a woody species such as grape. Methodology/Principal Findings: A total of two TIFY, four ZML, two PPD and 11 JAZ genes were identified in the Vitis vinifera genome. Phylogenetic analysis of TIFY protein sequences from grape, Arabidopsis and rice indicated that the grape TIFY proteins are more closely related to those of Arabidopsis than those of rice. Both segmental and tandem duplication events have been major contributors to the expansion of the grape TIFY family. In addition, synteny analysis between grape and Arabidopsis demonstrated that homologues of several grape TIFY genes were found in the corresponding syntenic blocks of Arabidopsis, suggesting that these genes arose before the divergence of lineages that led to grape and Arabidopsis. Analyses of microarray and quantitative real-time RT-PCR expression data revealed that grape TIFY genes are not a major player in the defense against biotrophic pathogens or viruses. However, many of these genes were responsive to JA and ABA, but not SA or ET. Conclusion: The genome-wide identification, evolutionary and expression analyses of grape TIFY genes should facilitate further research of this gene family and provide new insights regarding their evolutionary history and regulatory control.	[Zhang, Yucheng; Gao, Min; Wang, Xiping] NW A&F Univ, Minist Agr, Key Lab Hort Plant Biol & Germplasm Innovat NW Ch, Coll Hort, Yangling, Shaanxi, Peoples R China; [Zhang, Yucheng; Wang, Hua] NW A&F Univ, Coll Enol, Shaanxi Engn Res Ctr Viti Viniculture, Yangling, Shaanxi, Peoples R China; [Gao, Min; Wang, Xiping] NW A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Singer, Stacy D.] Univ Alberta, Dept Agr Food & Nutrit Sci, Edmonton, AB, Canada; [Fei, Zhangjun] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Fei, Zhangjun] USDA Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; University of Alberta; Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA)	Wang, H (corresponding author), NW A&F Univ, Coll Enol, Shaanxi Engn Res Ctr Viti Viniculture, Yangling, Shaanxi, Peoples R China.	wanghua@nwsuaf.edu.cn; wangxiping@nwsuaf.edu.cn	Fei, Zhangjun/H-5152-2012; Ye, Miaomiao/A-9123-2016; Ye, Miaomiao/G-8865-2015	Ye, Miaomiao/0000-0002-5546-1133; 	National Natural Science Foundation of China [30871701, 31071782, 30671446]; Program for New Century Excellent Talents in University [NCET-07-0702]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Natural Science Foundation of China (30871701, 31071782 and 30671446), as well as the Program for New Century Excellent Talents in University (NCET-07-0702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertazzi G, 2009, PLANT SCI, V176, P792, DOI 10.1016/j.plantsci.2009.03.001; Bai YH, 2011, GENOMICS, V98, P128, DOI 10.1016/j.ygeno.2011.05.002; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Chung HS, 2009, PHYTOCHEMISTRY, V70, P1547, DOI 10.1016/j.phytochem.2009.08.022; Cramer GR, 2007, FUNCT INTEGR GENOMIC, V7, P111, DOI 10.1007/s10142-006-0039-y; D'Onofrio C, 2009, FUNCT PLANT BIOL, V36, P323, DOI 10.1071/FP08280; Davies WJ, 1991, ABSCISIC ACID PHYSL; Demianski AJ, 2012, MOL PLANT PATHOL, V13, P46, DOI 10.1111/j.1364-3703.2011.00727.x; Devoto A, 2005, PHYSIOL PLANTARUM, V123, P161, DOI 10.1111/j.1399-3054.2004.00418.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Espinoza C, 2007, FUNCT INTEGR GENOMIC, V7, P95, DOI 10.1007/s10142-006-0031-6; FEYS BJF, 1994, PLANT CELL, V6, P751, DOI 10.1105/tpc.6.5.751; Foito A, 2009, PLANT BIOTECHNOL J, V7, P719, DOI 10.1111/j.1467-7652.2009.00437.x; Fung RWM, 2008, PLANT PHYSIOL, V146, P236, DOI 10.1104/pp.107.108712; Giraud E, 2012, PLANT CELL ENVIRON, V35, P405, DOI 10.1111/j.1365-3040.2011.02379.x; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Hren M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-460; Hurley I, 2005, EVOL DEV, V7, P556, DOI 10.1111/j.1525-142X.2005.05059.x; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Katsir L, 2008, CURR OPIN PLANT BIOL, V11, P428, DOI 10.1016/j.pbi.2008.05.004; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Koyama K, 2010, FUNCT INTEGR GENOMIC, V10, P367, DOI 10.1007/s10142-009-0145-8; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li WY, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-90; Ling KS, 2004, J GEN VIROL, V85, P2099, DOI 10.1099/vir.0.80007-0; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Melotto M, 2008, PLANT J, V55, P979, DOI 10.1111/j.1365-313X.2008.03566.x; Merdinoglu D, 2003, ACTA HORTIC, P451, DOI 10.17660/ActaHortic.2003.603.57; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Paterson AH, 2012, PLANT GEN DIVER, V1, P195, DOI DOI 10.1007/978-3-7091-1130-7_13; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Pilon-Smits EAH, 1999, PLANT PHYSIOL BIOCH, V37, P313, DOI 10.1016/S0981-9428(99)80030-8; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Staswick PE, 2008, TRENDS PLANT SCI, V13, P66, DOI 10.1016/j.tplants.2007.11.011; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; Tattersall EAR, 2007, FUNCT INTEGR GENOMIC, V7, P317, DOI 10.1007/s10142-007-0051-x; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Vega A, 2011, PLANT MOL BIOL, V77, P261, DOI 10.1007/s11103-011-9807-8; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wasternack C, 1997, TRENDS PLANT SCI, V2, P302, DOI 10.1016/S1360-1385(97)89952-9; White DWR, 2006, P NATL ACAD SCI USA, V103, P13238, DOI 10.1073/pnas.0604349103; Wise Roger P., 2007, V406, P347; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wong FP, 2001, PLANT DIS, V85, P649, DOI 10.1094/PDIS.2001.85.6.649; Xie DX, 1998, SCIENCE, V280, P1091, DOI 10.1126/science.280.5366.1091; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; Zhang JinJin, 2003, Journal of Fruit Science, V20, P178; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032153	62	644	663	22	198	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44465	10.1371/journal.pone.0044465	http://dx.doi.org/10.1371/journal.pone.0044465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984514	gold, Green Published, Green Submitted			2022-12-25	WOS:000308638700062
J	Harrington, JM; Scelsi, C; Hartel, A; Jones, NG; Engstler, M; Capewell, P; MacLeod, A; Hajduk, S				Harrington, John M.; Scelsi, Chris; Hartel, Andreas; Jones, Nicola G.; Engstler, Markus; Capewell, Paul; MacLeod, Annette; Hajduk, Stephen			Novel African Trypanocidal Agents: Membrane Rigidifying Peptides	PLOS ONE			English	Article							TRYPANOSOME LYTIC FACTOR; SIGNAL PEPTIDES; CELL-SURFACE; PROTEIN; BRUCEI; ENVIRONMENT; BILAYERS; BINDING; PROBES; DEPTH	The bloodstream developmental forms of pathogenic African trypanosomes are uniquely susceptible to killing by small hydrophobic peptides. Trypanocidal activity is conferred by peptide hydrophobicity and charge distribution and results from increased rigidity of the plasma membrane. Structural analysis of lipid-associated peptide suggests a mechanism of phospholipid clamping in which an internal hydrophobic bulge anchors the peptide in the membrane and positively charged moieties at the termini coordinate phosphates of the polar lipid headgroups. This mechanism reveals a necessary phenotype in bloodstream form African trypanosomes, high membrane fluidity, and we suggest that targeting the plasma membrane lipid bilayer as a whole may be a novel strategy for the development of new pharmaceutical agents. Additionally, the peptides we have described may be valuable tools for probing the biosynthetic machinery responsible for the unique composition and characteristics of African trypanosome plasma membranes.	[Harrington, John M.; Scelsi, Chris; Hajduk, Stephen] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Hartel, Andreas; Jones, Nicola G.; Engstler, Markus] Univ Wurzburg, Dept Cell & Dev Biol, Theodor Boveri Inst, Wurzburg, Germany; [Capewell, Paul; MacLeod, Annette] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University System of Georgia; University of Georgia; University of Wurzburg; University of Glasgow	Harrington, JM (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	shajduk@bmb.uga.edu	Jones, Nicola/AAP-5835-2021; Capewell, Paul/R-1935-2017	Jones, Nicola/0000-0003-3384-0156; Capewell, Paul/0000-0002-8803-5034; Hartel, Andreas/0000-0002-2693-4472	National Institutes Health [AI039033]; National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI039033, R01AI039033] Funding Source: NIH RePORTER	National Institutes Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research reported in this manuscript was supported in large part by National Institutes Health grant AI039033 to Stephen L. Hajduk. John M. Harrington was supported by an individual National Research Service Award from the National Institute of Allergy and Infectious Disease and a T32 training grant from the National Institute of Allergy and Infectious Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axler O, 2008, FEBS LETT, V582, P826, DOI 10.1016/j.febslet.2008.02.007; Barrett MP, 2003, LANCET, V362, P1469, DOI 10.1016/S0140-6736(03)14694-6; BRIGGS MS, 1986, SCIENCE, V233, P206, DOI 10.1126/science.2941862; CHATTOPADHYAY A, 1987, BIOCHEMISTRY-US, V26, P39, DOI 10.1021/bi00375a006; CHUPIN V, 1995, BIOCHEMISTRY-US, V34, P11617, DOI 10.1021/bi00036a038; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Fenn K, 2007, CURR OPIN MICROBIOL, V10, P539, DOI 10.1016/j.mib.2007.09.014; Gehrig S, 2008, INT J MOL MED, V22, P411, DOI 10.3892/ijmm_00000037; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Grunfelder CG, 2002, TRAFFIC, V3, P547, DOI 10.1034/j.1600-0854.2002.30805.x; HAJDUK SL, 1989, J BIOL CHEM, V264, P5210; Harrington JM, 2010, J BIOL CHEM, V285, P28659, DOI 10.1074/jbc.M110.151886; JONES JD, 1994, BIOPHYS J, V67, P1534, DOI 10.1016/S0006-3495(94)80627-7; Jones TW, 2001, TRENDS PARASITOL, V17, P99, DOI 10.1016/S1471-4922(00)01777-3; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; MCINTOSH TJ, 1987, BIOCHEMISTRY-US, V26, P1783, DOI 10.1021/bi00380a042; Morrison LJ, 2009, CELL MICROBIOL, V11, P1724, DOI 10.1111/j.1462-5822.2009.01383.x; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Raper J, 1999, INFECT IMMUN, V67, P1910; Shiflett AM, 2007, J EUKARYOT MICROBIOL, V54, P18, DOI 10.1111/j.1550-7408.2006.00228.x; Tyler KM, 2009, J CELL SCI, V122, P859, DOI 10.1242/jcs.037721; Van den Bossche P, 2010, TRENDS PARASITOL, V26, P236, DOI 10.1016/j.pt.2010.02.010; Vignini A, 2011, DIABETES-METAB RES, V27, P277, DOI 10.1002/dmrr.1173; Voglino L, 1999, BIOCHEMISTRY-US, V38, P7509, DOI 10.1021/bi990099q; Widener J, 2007, PLOS PATHOG, V3, P1250, DOI 10.1371/journal.ppat.0030129; Wolkers WF, 2003, BBA-BIOMEMBRANES, V1612, P154, DOI 10.1016/S0005-2736(03)00114-7	27	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44384	10.1371/journal.pone.0044384	http://dx.doi.org/10.1371/journal.pone.0044384			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970207	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000308462000019
J	Cohen, A; Ross, L; Nachman, I; Bar-Nun, S				Cohen, Aviv; Ross, Liron; Nachman, Iftach; Bar-Nun, Shoshana			Aggregation of PolyQ Proteins Is Increased upon Yeast Aging and Affected by Sir2 and Hsf1: Novel Quantitative Biochemical and Microscopic Assays	PLOS ONE			English	Article							HEAT-SHOCK FACTOR; AGE-OF-ONSET; NEURONAL INTRANUCLEAR INCLUSIONS; GENOME-WIDE ANALYSIS; CAG-REPEAT LENGTH; HUNTINGTONS-DISEASE; SACCHAROMYCES-CEREVISIAE; LIFE-SPAN; CAENORHABDITIS-ELEGANS; POLYGLUTAMINE-EXPANSION	Aging-related neurodegenerative disorders, such as Parkinson's, Alzheimer's and Huntington's diseases, are characterized by accumulation of protein aggregates in distinct neuronal cells that eventually die. In Huntington's disease, the protein huntingtin forms aggregates, and the age of disease onset is inversely correlated to the length of the protein's polyglutamine tract. Using quantitative assays to estimate microscopically and capture biochemically protein aggregates, here we study in Saccharomyces cerevisiae aging-related aggregation of GFP-tagged, huntingtin-derived proteins with different polyQ lengths. We find that the short 25Q protein never aggregates whereas the long 103Q version always aggregates. However, the mid-size 47Q protein is soluble in young logarithmically growing yeast but aggregates as the yeast cells enter the stationary phase and age, allowing us to plot an "aggregation timeline". This aging-dependent aggregation was associated with increased cytotoxicity. We also show that two aging-related genes, SIR2 and HSF1, affect aggregation of the polyQ proteins. In Delta sir2 strain the aging-dependent aggregation of the 47Q protein is aggravated, while overexpression of the transcription factor Hsf1 attenuates aggregation. Thus, the mid-size 47Q protein and our quantitative aggregation assays provide valuable tools to unravel the roles of genes and environmental conditions that affect aging-related aggregation.	[Cohen, Aviv; Ross, Liron; Nachman, Iftach; Bar-Nun, Shoshana] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel	Tel Aviv University	Cohen, A (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Tel Aviv, Israel.	shoshbn@tauex.tau.ac.il	Nachman, Iftach/E-6750-2010; Nachman, Iftach/AAK-2051-2020	Nachman, Iftach/0000-0002-4667-0398; 	Chief Scientist Office of the Ministry of Health, Israel [3-3211]; Israel Science Foundation [384/11]; Edmond J. Safra Center for Bioinformatics at Tel Aviv University	Chief Scientist Office of the Ministry of Health, Israel; Israel Science Foundation(Israel Science Foundation); Edmond J. Safra Center for Bioinformatics at Tel Aviv University	Initial stages of this study were supported by a grant from the Chief Scientist Office of the Ministry of Health, Israel (grant no. 3-3211 to SB) and later by a grant from The Israel Science Foundation (grant no. 384/11 to SB). IN is supported in part by the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Beam M, 2012, J BIOL CHEM; BENZVI A, 2009, P NATL ACAD SCI US; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen QH, 2005, BIOGERONTOLOGY, V6, P1, DOI 10.1007/s10522-004-7379-6; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11051, DOI 10.1073/pnas.0604548103; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Eastmond DL, 2006, J BIOL CHEM, V281, P32909, DOI 10.1074/jbc.M602454200; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042; Fabrizio P, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001024; Fischbeck KH, 2001, BRAIN RES BULL, V56, P161, DOI 10.1016/S0361-9230(01)00577-9; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Garigan D, 2002, GENETICS, V161, P1101; Gidalevitz T., 2011, COLD SPRING HARB PER, V3; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; Giorgini F, 2006, METHOD ENZYMOL, V412, P201, DOI 10.1016/S0076-6879(06)12013-3; Giorgini F, 2009, METHODS MOL BIOL, V548, P161, DOI 10.1007/978-1-59745-540-4_9; Gusella JF, 2009, GENOME MED, V1, DOI 10.1186/gm80; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Harper PS, 1991, HUNTINGTONS DIS, P281; HEDREEN JC, 1995, J NEUROPATH EXP NEUR, V54, P105, DOI 10.1097/00005072-199501000-00013; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; KREMER B, 1994, NEW ENGL J MED, V330, P1401, DOI 10.1056/NEJM199405193302001; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Langbehn DR, 2010, AM J MED GENET B, V153B, P397, DOI 10.1002/ajmg.b.30992; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Monteiro JP, 2011, PROTEIN PEPTIDE LETT, V18, P167; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; MULLER I, 1980, MECH AGEING DEV, V12, P47, DOI 10.1016/0047-6374(80)90028-7; MYERS RH, 1993, NAT GENET, V5, P168, DOI 10.1038/ng1093-168; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Novak MJU, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3109; Ohtsuka H, 2011, MOL GENET GENOMICS, V285, P67, DOI 10.1007/s00438-010-0588-6; Outeiro TF, 2004, J MOL NEUROSCI, V23, P49, DOI 10.1385/JMN:23:1-2:049; Parrella E, 2008, METHODS, V46, P256, DOI 10.1016/j.ymeth.2008.10.004; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Ross CA, 2003, P NATL ACAD SCI USA, V100, P1, DOI 10.1073/pnas.0237018100; Saunders HM, 2011, PROTEIN SCI, V20, P1675, DOI 10.1002/pro.698; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Sherman MY, 2003, NEUROMOL MED, V4, P133, DOI 10.1385/NMM:4:1-2:133; Silva MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002438; SNELL RG, 1993, NAT GENET, V4, P393, DOI 10.1038/ng0893-393; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9; SORGER PK, 1991, CELL, V65, P363, DOI 10.1016/0092-8674(91)90452-5; SORGER PK, 1988, CELL, V54, P855, DOI 10.1016/S0092-8674(88)91219-6; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; STINE OC, 1993, HUM MOL GENET, V2, P1547, DOI 10.1093/hmg/2.10.1547; Suopanki J, 2006, J NEUROCHEM, V96, P870, DOI 10.1111/j.1471-4159.2005.03620.x; Swinnen E, 2011, BIOCHEM SOC T, V39, P1476, DOI 10.1042/BST0391476; Tatar M, 1997, NATURE, V390, P30, DOI 10.1038/36237; Taylor R.C., 2011, COLD SPRING HARB PER, V3; TELENIUS H, 1993, HUM MOL GENET, V2, P1535, DOI 10.1093/hmg/2.10.1535; Voisine C, 2010, NEUROBIOL DIS, V40, P12, DOI 10.1016/j.nbd.2010.05.007; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang CL, 2008, GENETICS, V180, P1955, DOI 10.1534/genetics.108.094516; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; Weiss A, 2008, J NEUROCHEM, V104, P846, DOI 10.1111/j.1471-4159.2007.05032.x; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wexler NS, 2004, P NATL ACAD SCI USA, V101, P3498, DOI 10.1073/pnas.0308479101; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Yokoyama K, 2002, FEBS LETT, V516, P53, DOI 10.1016/S0014-5793(02)02470-5; Zoghbi HY, 1999, CURR OPIN NEUROBIOL, V9, P566, DOI 10.1016/S0959-4388(99)00013-6	86	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44785	10.1371/journal.pone.0044785	http://dx.doi.org/10.1371/journal.pone.0044785			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970306	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400119
J	Ibanez, IL; Bracalente, C; Notcovich, C; Tropper, I; Molinari, BL; Policastro, LL; Duran, H				Ibanez, Irene L.; Bracalente, Candelaria; Notcovich, Cintia; Tropper, Ivanna; Molinari, Beatriz L.; Policastro, Lucia L.; Duran, Hebe			Phosphorylation and Subcellular Localization of p27Kip1 Regulated by Hydrogen Peroxide Modulation in Cancer Cells	PLOS ONE			English	Article							PERSISTENT OXIDATIVE STRESS; KINASE INHIBITOR P27(KIP1); RIBOSOMAL S6 KINASE; REACTIVE OXYGEN; CYCLE PROGRESSION; CYTOPLASMIC LOCALIZATION; PHASE-TRANSITION; REDOX REGULATION; NUCLEAR EXPORT; MELANOMA-CELLS	The Cyclin-dependent kinase inhibitor 1B (p27Kip1) is a key protein in the decision between proliferation and cell cycle exit. Quiescent cells show nuclear p27Kip1, but this protein is exported to the cytoplasm in response to proliferating signals. We recently reported that catalase treatment increases the levels of p27Kip1 in vitro and in vivo in a murine model. In order to characterize and broaden these findings, we evaluated the regulation of p27Kip1 by hydrogen peroxide (H2O2) in human melanoma cells and melanocytes. We observed a high percentage of p27Kip1 positive nuclei in melanoma cells overexpressing or treated with exogenous catalase, while non-treated controls showed a cytoplasmic localization of p27Kip1. Then we studied the levels of p27Kip1 phosphorylated (p27p) at serine 10 (S10) and at threonine 198 (T198) because phosphorylation at these sites enables nuclear exportation of this protein, leading to accumulation and stabilization of p27pT198 in the cytoplasm. We demonstrated by western blot a decrease in p27pS10 and p27pT198 levels in response to H2O2 removal in melanoma cells, associated with nuclear p27Kip1. Melanocytes also exhibited nuclear p27Kip1 and lower levels of p27pS10 and p27pT198 than melanoma cells, which showed cytoplasmic p27Kip1. We also showed that the addition of H2O2 (0.1 mu M) to melanoma cells arrested in G1 by serum starvation induces proliferation and increases the levels of p27pS10 and p27pT198 leading to cytoplasmic localization of p27Kip1. Nuclear localization and post-translational modifications of p27Kip1 were also demonstrated by catalase treatment of colorectal carcinoma and neuroblastoma cells, extending our findings to these other human cancer types. In conclusion, we showed in the present work that H2O2 scavenging prevents nuclear exportation of p27Kip1, allowing cell cycle arrest, suggesting that cancer cells take advantage of their intrinsic pro-oxidant state to favor cytoplasmic localization of p27Kip1.	[Ibanez, Irene L.; Bracalente, Candelaria; Notcovich, Cintia; Policastro, Lucia L.; Duran, Hebe] Comis Nacl Energia Atom, Dept Micro & Nanotecnol, San Martin, Argentina; [Ibanez, Irene L.; Bracalente, Candelaria; Molinari, Beatriz L.; Policastro, Lucia L.; Duran, Hebe] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Tropper, Ivanna; Duran, Hebe] Univ Nacl San Martin, Escuela Ciencia & Tecnol, San Martin, Argentina; [Molinari, Beatriz L.] Comis Nacl Energia Atom, Dept Radiobiol, San Martin, Argentina	Comision Nacional de Energia Atomica (CNEA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA)	Ibanez, IL (corresponding author), Comis Nacl Energia Atom, Dept Micro & Nanotecnol, San Martin, Argentina.	irenuliz@yahoo.com; hduran@cnea.gov.ar		Duran, Hebe/0000-0001-6691-7792; Ibanez, Irene Laura/0000-0003-3619-2529	National Agency for Scientific and Technological Promotion (ANPCyT), Argentina [PICT 2007-01628, PICT 05-14330]	National Agency for Scientific and Technological Promotion (ANPCyT), Argentina(ANPCyT)	This work was partially supported by grants from the National Agency for Scientific and Technological Promotion (ANPCyT), Argentina (PICT 2007-01628 and PICT 05-14330) and the non-profit organization Fundacion Florencio Fiorini. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe JI, 2000, J BIOL CHEM, V275, P1739, DOI 10.1074/jbc.275.3.1739; Antunes F, 2001, FREE RADICAL BIO MED, V30, P1008, DOI 10.1016/S0891-5849(01)00493-2; Arnold RS, 2001, P NATL ACAD SCI USA, V98, P5550, DOI 10.1073/pnas.101505898; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Behrend L, 2003, BIOCHEM SOC T, V31, P1441; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Borriello A, 2007, CELL CYCLE, V6, P1053, DOI 10.4161/cc.6.9.4142; Bottini C, 2009, INT J ONCOL, V34, P69, DOI 10.3892/ijo_00000130; Brar SS, 2001, AM J PHYSIOL-CELL PH, V280, pC659, DOI 10.1152/ajpcell.2001.280.3.C659; Burch PM, 2005, ANTIOXID REDOX SIGN, V7, P741, DOI 10.1089/ars.2005.7.741; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Cakir Y, 2005, ANTIOXID REDOX SIGN, V7, P726, DOI 10.1089/ars.2005.7.726; Carreras MC, 2004, HEPATOLOGY, V40, P157, DOI 10.1002/hep.20255; Chen DH, 2003, CANCER RES, V63, P6626; Chen GD, 2011, CANCER EPIDEM BIOMAR, V20, P2212, DOI 10.1158/1055-9965.EPI-11-0472; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Chu IM, 2008, NAT REV CANCER, V8, P253, DOI 10.1038/nrc2347; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; Davies KJA, 2000, IUBMB LIFE, V50, P279, DOI 10.1080/15216540051081010; Deng XM, 2003, BLOOD, V102, P3179, DOI 10.1182/blood-2003-04-1027; Denicourt C, 2007, CANCER RES, V67, P9238, DOI 10.1158/0008-5472.CAN-07-1375; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Felty Q, 2005, ONCOGENE, V24, P4883, DOI 10.1038/sj.onc.1208667; Gidanian S, 2008, PHOTOCHEM PHOTOBIOL, V84, P556, DOI 10.1111/j.1751-1097.2008.00309.x; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Ibanez IL, 2011, BREAKTHROUGHS MELANO, P1; Ibanez IL, 2011, CANCER LETT, V305, P58, DOI 10.1016/j.canlet.2011.02.026; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Kondo S, 1999, FREE RADICAL BIO MED, V27, P401, DOI 10.1016/S0891-5849(99)00087-8; Larrea MD, 2008, MOL CELL BIOL, V28, P6462, DOI 10.1128/MCB.02300-07; Larrea MD, 2009, CELL CYCLE, V8, P3455, DOI 10.4161/cc.8.21.9789; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Laurent A, 2005, CANCER RES, V65, P948; LePoole IC, 1997, IN VITRO CELL DEV-AN, V33, P42, DOI 10.1007/s11626-997-0021-6; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liu YB, 1997, J NEUROCHEM, V69, P581, DOI 10.1046/j.1471-4159.1997.69020581.x; Martin V, 2007, FREE RADICAL BIO MED, V42, P1715, DOI 10.1016/j.freeradbiomed.2007.02.028; MCCORD JM, 1995, P SOC EXP BIOL MED, V209, P112; Menon SG, 2007, CANCER RES, V67, P6392, DOI 10.1158/0008-5472.CAN-07-0225; Menon SG, 2003, CANCER RES, V63, P2109; Nacusi LP, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-11; Onumah OE, 2009, FREE RADICAL BIO MED, V46, P1658, DOI 10.1016/j.freeradbiomed.2009.03.018; Picardo M, 1996, J INVEST DERMATOL, V107, P322, DOI 10.1111/1523-1747.ep12363163; Policastro L, 2004, MOL CARCINOGEN, V39, P103, DOI 10.1002/mc.20001; Policastro LL, 2009, MOL THER, V17, P1355, DOI 10.1038/mt.2009.103; POSO H, 1984, J BIOL CHEM, V259, P2307; Preston TJ, 2001, J BIOL CHEM, V276, P9558, DOI 10.1074/jbc.M004617200; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Sarsour EH, 2009, ANTIOXID REDOX SIGN, V11, P2985, DOI [10.1089/ars.2009.2513, 10.1089/ARS.2009.2513]; Schiappacassi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017673; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shin I, 2002, NAT MED, V8, P1145, DOI 10.1038/nm759; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; SZATROWSKI TP, 1991, CANCER RES, V51, P794; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wander SA, 2011, CLIN CANCER RES, V17, P12, DOI 10.1158/1078-0432.CCR-10-0752; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; Zhang KZ, 1996, P NATL ACAD SCI USA, V93, P4504, DOI 10.1073/pnas.93.9.4504	64	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44502	10.1371/journal.pone.0044502	http://dx.doi.org/10.1371/journal.pone.0044502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970236	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400081
J	McDonald, AC; Denny, L; Wang, CH; Tsai, WY; Wright, TC; Kuhn, L				McDonald, Alicia C.; Denny, Lynette; Wang, Chunhui; Tsai, Wei-Yann; Wright, Thomas C., Jr.; Kuhn, Louise			Distribution of High-Risk Human Papillomavirus Genotypes among HIV-Negative Women with and without Cervical Intraepithelial Neoplasia in South Africa	PLOS ONE			English	Article							PARTICLE VACCINE; HPV INFECTION; YOUNG-WOMEN; CANCER; PREVALENCE; POPULATION; CYTOLOGY; TYPE-16; DNA; METAANALYSIS	Objective: Large studies describing the profile of high-risk Human papillomavirus (hrHPV) genotypes among women in sub-Saharan Africa are lacking. Here we describe the prevalence and distribution of hrHPV genotypes among HIV-negative women in South Africa, with and without cervical intraepithelial neoplasia (CIN). Methods: We report data on 8,050 HIV-negative women, aged 17-65 years, recruited into three sequential studies undertaken in Cape Town, South Africa. Women had no history of previous cervical cancer screening. Cervical samples were tested for hrHPV DNA using the Hybrid Capture 2 (HC2) assay and all positive samples were genotyped using a PCR-based assay (Line Blot). Women underwent colposcopy and biopsy/endocervical curettage to determine CIN status. The prevalence and distribution of specific hrHPV genotypes were examined by age and CIN status. Results: Overall, 20.7% (95% CI, 19.9-21.6%) of women were hrHPV-positive by HC2, with women with CIN having the highest rates of positivity. Prevalence decreased with increasing age among women without CIN; but, a bimodal age curve was observed among women with CIN. HPV 16 and 35 were the most common hrHPV genotypes in all age and CIN groups. HPV 45 became more frequent among older women with CIN grade 2 or 3 (CIN2,3). Younger women (17-29 years) had more multiple hrHPV genotypes overall and in each cervical disease group than older women (40-65 years). Conclusion: HPV 16, 35, and 45 were the leading contributors to CIN 2,3. The current HPV vaccines could significantly reduce HPV-related cervical disease; however, next generation vaccines that include HPV 35 and 45 would further reduce cervical disease in this population.	[McDonald, Alicia C.; Kuhn, Louise] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA; [Denny, Lynette] Univ Cape Town, Dept Obstet & Gynaecol, ZA-7925 Cape Town, South Africa; [Wang, Chunhui; Wright, Thomas C., Jr.] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA; [Tsai, Wei-Yann] Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA; [Kuhn, Louise] Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY 10027 USA	Columbia University; University of Cape Town; Columbia University; Columbia University	McDonald, AC (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10027 USA.	lk24@columbia.edu			Bill and Melinda Gates Foundation through the Alliance for Cervical Cancer Prevention	Bill and Melinda Gates Foundation through the Alliance for Cervical Cancer Prevention	The study reported here was funded by the Bill and Melinda Gates Foundation through the Alliance for Cervical Cancer Prevention. The funders had no role in the study design data collection and analysis, decision to publish or preparation of the manuscript.	Agarossi A, 2009, J MED VIROL, V81, P529, DOI 10.1002/jmv.21347; Allan B, 2008, J CLIN MICROBIOL, V46, P740, DOI 10.1128/JCM.01981-07; [Anonymous], 2007, IARC MON EV CARC RIS; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Castle PE, 2011, J CLIN MICROBIOL, V49, P3029, DOI 10.1128/JCM.00422-11; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; Coutlee F, 2006, J CLIN MICROBIOL, V44, P1998, DOI 10.1128/JCM.00104-06; Cox JT, 2006, CURR OPIN OBSTET GYN, V18, pS5, DOI 10.1097/01.gco.0000216315.72572.fb; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; De Vuyst H, 2003, SEX TRANSM DIS, V30, P137, DOI 10.1097/00007435-200302000-00009; Denny L, 2002, CANCER-AM CANCER SOC, V94, P1699, DOI 10.1002/cncr.10381; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Ferlay J, 2010, IARC CANCERBASE, V10; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hamlin-Douglas LK, 2008, CANCER EPIDEM BIOMAR, V17, P3141, DOI 10.1158/1055-9965.EPI-08-0625; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Jeronimo J, 2007, AM J OBSTET GYNECOL, V197, p[47, e41]; Kjaer SK, 2008, INT J CANCER, V123, P1864, DOI 10.1002/ijc.23712; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Ortiz M, 2006, J CLIN MICROBIOL, V44, P1428, DOI 10.1128/JCM.44.4.1428-1434.2006; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Said HM, 2009, J CLIN VIROL, V44, P318, DOI 10.1016/j.jcv.2009.02.001; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Serwadda D, 1999, J INFECT DIS, V180, P1316, DOI 10.1086/315026; Sherman ME, 2003, JNCI-J NATL CANCER I, V95, P46, DOI 10.1093/jnci/95.1.46; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Steben M, 2007, GYNECOL ONCOL, V107, pS2, DOI 10.1016/j.ygyno.2007.07.067; Stoler MH, 2012, AM J CLIN PATHOL, V137, P295, DOI 10.1309/AJCPGW1V2BBWMOCX; Stoler MH, 2011, AM J CLIN PATHOL, V135, P468, DOI 10.1309/AJCPZ5JY6FCVNMOT; Thomas JO, 2004, BRIT J CANCER, V90, P638, DOI 10.1038/sj.bjc.6601515; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Womack SD, 2000, INT J CANCER, V85, P206, DOI 10.1002/(SICI)1097-0215(20000115)85:2%3C206::AID-; Zhang Q, 2007, INT J CANCER, V120, P351, DOI 10.1002/ijc.22172	38	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44332	10.1371/journal.pone.0044332	http://dx.doi.org/10.1371/journal.pone.0044332			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970201	Green Submitted, Green Published, gold			2022-12-25	WOS:000308458400059
J	Zhu, CB; Wang, C; Chen, LL; Ma, GL; Zhang, SC; Su, L; Tian, JJ; Gai, ZT				Zhu, Cheng-Bao; Wang, Can; Chen, Li-Li; Ma, Guo-Liang; Zhang, Shi-Cai; Su, Liang; Tian, Jian-Jun; Gai, Zhong-Tao			Serum YKL-40 Independently Predicts Outcome after Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma	PLOS ONE			English	Article							PLASMA YKL-40; CANCER; EXPRESSION; BIOMARKER	Background: Transcatheter arterial chemoembolization (TACE) is the most widely used treatment option for unresectable hepatocellular carcinoma (HCC). Elevated serum YKL-40 level has been shown to predict poor prognosis in HCC patients undergoing resection. This study was designed to validate the prognostic significance of serum YKL-40 in patients with HCC undergoing TACE treatment. Methods: Serum YKL-40 level was determined by enzyme-linked immunosorbent assay. Overall survival (OS) was evaluated with the Kaplan-Meier method and compared by the log-rank test. Multivariate study with Cox proportional hazard model was used to evaluate independent prognostic variables of OS. Results: The median pretreatment serum YKL-40 in HCC patients with was significantly higher than that in healthy controls (P < 0.001). The YKL-40 could predict survival precisely either in a dichotomized or continuous fashion (P < 0.001 and P = 0.001, respectively). Multivariate Cox regression analysis indicated that serum YKL-40 was an independent prognostic factor for OS in HCC patients (P = 0.001). In further stratified analyses, YKL-40 could discriminate the outcomes of patients with low and high alpha-fetoprotein (AFP) level (P = 0.006 and 0.016, respectively). Furthermore, the combination of serum YKL-40 and AFP had more capacity to predict patients' outcomes. Conclusions: Serum YKL-40 was demonstrated to be an independent prognostic biomarker in HCC patients treated with TACE. Our results need confirmation in an independent study.	[Zhu, Cheng-Bao; Tian, Jian-Jun] Shandong Univ, Jinan Infect Dis Hosp, Dept Clin Lab, Jinan 250100, Peoples R China; [Wang, Can; Su, Liang; Gai, Zhong-Tao] Shandong Univ, Jinan Infect Dis Hosp, Dept Hepatol, Jinan 250100, Peoples R China; [Chen, Li-Li] Second Peoples Hosp Jinan, Dept Traditonal Chinese Med Ophthalmol, Jinan, Shandong, Peoples R China; [Ma, Guo-Liang] Peoples Hosp Laiwu, Dept Clin Lab, Laiwu, Shandong, Peoples R China; [Zhang, Shi-Cai] Tumour Hosp Taian, Dept Clin Lab, Tai An, Shandong, Peoples R China	Shandong University; Shandong University	Zhu, CB (corresponding author), Shandong Univ, Jinan Infect Dis Hosp, Dept Clin Lab, Jinan 250100, Peoples R China.	tjjjcyy@126.com; gztjcyy@126.com			research fund of the authors' hospital (Jinan Infectious Disease Hospital, Shandong University)	research fund of the authors' hospital (Jinan Infectious Disease Hospital, Shandong University)	This study was supported by a research fund of the authors' hospital (Jinan Infectious Disease Hospital, Shandong University). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2004, GASTROENTEROLOGY, V127, pS179, DOI 10.1053/j.gastro.2004.09.032; Cha C, 2002, J CLIN GASTROENTEROL, V35, pS130, DOI 10.1097/00004836-200211002-00009; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Johansen JS, 2006, CANCER EPIDEM BIOMAR, V15, P194, DOI 10.1158/1055-9965.EPI-05-0011; Johansen JS, 1996, BRIT J RHEUMATOL, V35, P553; Johansen JS, 2006, DAN MED BULL, V53, P172; Johansen JS, 2009, FUTURE ONCOL, V5, P1065, DOI 10.2217/FON.09.66; Johansen JS, 2009, J CLIN ONCOL, V27, P572, DOI 10.1200/JCO.2008.18.8367; Kazakova Maria H, 2009, Folia Med (Plovdiv), V51, P5; Lata Ewelina, 2010, Pol Merkur Lekarski, V28, P505; Lau SH, 2006, ONCOGENE, V25, P1242, DOI 10.1038/sj.onc.1209141; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peng SY, 2010, INT J CANCER, V112, P44; ROYSTON P, 1991, STAT MED, V10, P675, DOI 10.1002/sim.4780100502; Ryder SD, 2003, GUT, V52, pIII1, DOI 10.1136/gut.52.suppl_3.iii1; Schwartz M, 2004, GASTROENTEROLOGY, V127, pS268, DOI 10.1053/j.gastro.2004.09.041; Shackel NA, 2003, HEPATOLOGY, V38, P577, DOI 10.1053/jhep.2003.50376; Takayasu K, 2006, GASTROENTEROLOGY, V131, P461, DOI 10.1053/j.gastro.2006.05.021; Xiao XQ, 2011, HEPATOB PANCREAT DIS, V10, P605, DOI 10.1016/S1499-3872(11)60103-3; Yang JD, 2010, GUT LIVER, V4, P537, DOI 10.5009/gnl.2010.4.4.537; Zhu CB, 2012, ANN SURG ONCOL, V19, P817, DOI 10.1245/s10434-011-2026-3	23	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44648	10.1371/journal.pone.0044648	http://dx.doi.org/10.1371/journal.pone.0044648			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970277	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400101
J	Devauges, V; Marquer, C; Lecart, S; Cossec, JC; Potier, MC; Fort, E; Suhling, K; Leveque-Fort, S				Devauges, Viviane; Marquer, Catherine; Lecart, Sandrine; Cossec, Jack-Christophe; Potier, Marie-Claude; Fort, Emmanuel; Suhling, Klaus; Leveque-Fort, Sandrine			Homodimerization of Amyloid Precursor Protein at the Plasma Membrane: A homoFRET Study by Time-Resolved Fluorescence Anisotropy Imaging	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; LIVING CELLS; FRET MICROSCOPY; GXXXG MOTIFS; LIVE CELLS; A-BETA; APP; POLARIZATION; SPECTROSCOPY; DIMERIZATION	Classical FRET (Forster Resonance Energy Transfer) using two fluorescent labels (one for the donor and another one for the acceptor) is not efficient for studying the homodimerization of a protein as only half of the homodimers formed can be identified by this technique. We thus resorted to homoFRET detected by time-resolved Fluorescence Anisotropy IMaging (tr-FAIM). To specifically image the plasma membrane of living cells, an original combination of tr-FAIM and Total Internal Reflection Fluorescence Lifetime Imaging Microscope (TIRFLIM) was implemented. The correcting factor accounting for the depolarization due to the high numerical aperture (NA) objective, mandatory for TIRF microscopy, was quantified on fluorescein solutions and on HEK293 cells expressing enhanced Green Fluorescence Protein (eGFP). Homodimerization of Amyloid Precursor Protein (APP), a key mechanism in the etiology of Alzheimer's disease, was measured on this original setup. We showed, both in epifluorescence and under TIRF excitation, different energy transfer rates associated with the homodimerization of wild type APP-eGFP or of a mutated APP-eGFP, which forms constitutive dimers. This original set-up thus offers promising prospects for future studies of protein homodimerization in living cells in control and pathological conditions.	[Devauges, Viviane; Leveque-Fort, Sandrine] Univ Paris 11, Inst Sci Mol Orsay, CNRS UMR 8214, Orsay, France; [Devauges, Viviane] Univ Paris 11, Lab Charles Fabry, CNRS UMR 8501, Inst Opt, Palaiseau, France; [Devauges, Viviane; Lecart, Sandrine; Leveque-Fort, Sandrine] Univ Paris 11, Ctr Photon Biomed, CLUPS LUMAT FR2764, Orsay, France; [Marquer, Catherine; Cossec, Jack-Christophe; Potier, Marie-Claude] CNRS UMR 7225, CRICM UPMC, INSERM UMR S975, Paris, France; [Fort, Emmanuel] Univ Paris Diderot, Inst Langevin, ESPCI ParisTech, UMR 7587, Paris, France; [Suhling, Klaus] Kings Coll London, Dept Phys, London WC2R 2LS, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; Universite Paris Cite; University of London; King's College London	Devauges, V (corresponding author), Univ Paris 11, Inst Sci Mol Orsay, CNRS UMR 8214, Orsay, France.	sandrine.leveque-fort@u-psud.fr	Fort, Emmanuel/C-4981-2012	Cossec, Jack-Christophe/0000-0002-0836-1009; Leveque-Fort, Sandrine/0000-0002-9218-3363; suhling, klaus/0000-0001-8797-5430; Potier, Marie-Claude/0000-0003-2462-7150	Ministere de la Recherche; Fondation pour la Recherche Medicale; Agence Nationale de la Recherche; Fondation Institut du Cerveau et de la Moelle; BBSRC [BB/D011086/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011086/1] Funding Source: researchfish	Ministere de la Recherche(Ministry of Science and Innovation, Spain (MICINN)Ministry of Research, France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Institut du Cerveau et de la Moelle; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Viviane Devauges was the recipient of a fellowship from the Ministere de la Recherche. Jack-Christophe Cossec had a fellowship from Ministere de la Recherche and Fondation pour la Recherche Medicale. This work was supported by a grant from Agence Nationale de la Recherche. The authors are also grateful to the Fondation Institut du Cerveau et de la Moelle for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2010, CELL SIGNAL, V22, P23, DOI 10.1016/j.cellsig.2009.08.011; Asada-Utsugi M, 2011, J NEUROCHEM, V119, P354, DOI 10.1111/j.1471-4159.2011.07364.x; AXELROD D, 1989, METHOD CELL BIOL, V30, P333; AXELROD D, 1979, BIOPHYS J, V26, P557, DOI 10.1016/S0006-3495(79)85271-6; Bader AN, 2007, OPT EXPRESS, V15, P6934, DOI 10.1364/OE.15.006934; Ben Khalifa N, 2012, FASEB J, V26, P855, DOI 10.1096/fj.11-190207; Blandin P, 2009, APPL OPTICS, V48, P553, DOI 10.1364/AO.48.000553; Chan FTS, 2011, CHEMPHYSCHEM, V12, P500, DOI 10.1002/cphc.201000833; Cossec JC, 2010, BBA-MOL CELL BIOL L, V1801, P846, DOI 10.1016/j.bbalip.2010.05.010; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; Eggert S, 2009, J BIOL CHEM, V284, P28943, DOI 10.1074/jbc.M109.038646; Festy F, 2007, MOL BIOSYST, V3, P381, DOI 10.1039/b617204k; Fisz JJ, 2007, J PHYS CHEM A, V111, P8606, DOI 10.1021/jp072113b; Fisz JJ, 2009, J PHYS CHEM A, V113, P3505, DOI 10.1021/jp811117a; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Godfrey TM, 1953, GLYCEROL; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; Isbert S, 2012, CELL MOL LIFE SCI, V69, P1353, DOI 10.1007/s00018-011-0882-4; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; KOSHIOKA M, 1995, APPL SPECTROSC, V49, P224, DOI 10.1366/0003702953963652; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Marquer C, 2011, FASEB J, P1; Marquer C, 2010, BIOL CELL, V102, P409, DOI 10.1042/BC20090171; Matthews DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033231; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Pelet S, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2203664; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Selkoe Dennis J, 2008, Handb Clin Neurol, V89, P245, DOI 10.1016/S0072-9752(07)01223-7; Smith TA, 2005, REV FLUORESCENCE, V2, P245; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Suhling K, 2004, OPT LETT, V29, P584, DOI 10.1364/OL.29.000584; Suhling K, 2002, J FLUORESC, V12, P91, DOI 10.1023/A:1015323606154; Thaler C, 2009, P NATL ACAD SCI USA, V106, P6369, DOI 10.1073/pnas.0901913106; Tramier M, 2002, BIOPHYS J, V83, P3570, DOI 10.1016/S0006-3495(02)75357-5; Tramier M, 2000, BIOPHYS J, V78, P2614, DOI 10.1016/S0006-3495(00)76806-8; Valeur B, 2002, MOL FLUORESCENCE; Visser NV, 1999, J FLUORESC, V9, P251, DOI 10.1023/A:1022515902867; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Yan YL, 2003, METHOD ENZYMOL, V360, P561; Yeow EKL, 2007, BIOPHYS J, V92, P3098, DOI [10.1529/biophysj.106.099424, 10.1529/biophysj. 106.099424]; Yum K, 2009, NANO LETT, V9, P2193, DOI 10.1021/nl901047u	45	25	25	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44434	10.1371/journal.pone.0044434	http://dx.doi.org/10.1371/journal.pone.0044434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973448	Green Published, gold, Green Submitted			2022-12-25	WOS:000308577600052
J	Grimm, PR; Taneja, TK; Liu, J; Coleman, R; Chen, YY; Delpire, E; Wade, JB; Welling, PA				Grimm, P. Richard; Taneja, Tarvinder K.; Liu, Jie; Coleman, Richard; Chen, Yang-Yi; Delpire, Eric; Wade, James B.; Welling, Paul A.			SPAK Isoforms and OSR1 Regulate Sodium-Chloride Co-transporters in a Nephron-specific Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-CL-COTRANSPORTER; ALANINE-RICH KINASE; NA+-K+-2CL(-) COTRANSPORTER; NA-K-2CL COTRANSPORTER; BLOOD-PRESSURE; DISTAL TUBULE; ANGIOTENSIN-II; DIETARY SALT; MOUSE MODEL; ACTIVATION	STE20/SPS-1-related proline-alanine-rich protein kinase (SPAK) and oxidative stress-related kinase (OSR1) activate the potassium-dependent sodium-chloride co-transporter, NKCC2, and thiazide-sensitive sodium-chloride cotransporter, NCC, in vitro, and both co-localize with a kinase regulatory molecule, Cab39/MO25 alpha, at the apical membrane of the thick ascending limb (TAL) and distal convoluted tubule (DCT). Yet genetic ablation of SPAK in mice causes a selective loss of NCC function, whereas NKCC2 becomes hyperphosphorylated. Here, we explore the underlying mechanisms in wild-type and SPAK-null mice. Unlike in the DCT, OSR1 remains at the TAL apical membrane of KO mice where it is accompanied by an increase in the active, phosphorylated form of AMP-activated kinase. We found an alterative SPAK isoform (putative SPAK2 form), which modestly inhibits cotransporter activity in vitro, is more abundant in the medulla than the cortex. Thus, enhanced NKCC2 phosphorylation in the SPAK knock-out may be explained by removal of inhibitory SPAK2, sustained activity of OSR1, and activation of other kinases. By contrast, the OSR1/SPAK/M025 alpha signaling apparatus is disrupted in the DCT. OSR1 becomes largely inactive and displaced from M025 alpha and NCC at the apical membrane, and redistributes to dense punctate structures, containing WNK1, within the cytoplasm. These changes are paralleled by a decrease in NCC phosphorylation and a decrease in the mass of the distal convoluted tubule, exclusive to DCT1. As a result of the dependent nature of OSR1 on SPAK in the DCT, NCC is unable to be activated. Consequently, SPAK(-/-) mice are highly sensitive to dietary salt restriction, displaying prolonged negative sodium balance and hypotension.	[Grimm, P. Richard; Taneja, Tarvinder K.; Liu, Jie; Coleman, Richard; Chen, Yang-Yi; Wade, James B.; Welling, Paul A.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Delpire, Eric] Vanderbilt Univ, Sch Med, Dept Anesthesiol, Nashville, TN 37232 USA	University System of Maryland; University of Maryland Baltimore; Vanderbilt University	Welling, PA (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.	pwelling@umaryland.edu		Grimm, Paul/0000-0002-9368-0601	National Institutes of Health [1RC1DK086817, DK32839, GM074771, 5T32HL072751]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032839, RC1DK086817, R01DK063049] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RC1DK086817 (to P. A. W.), DK32839 (to J. B. W.), GM074771 (to E. D.), and 5T32HL072751 (to P. R. G.).	[Anonymous], 1968, MIKROSKOPIE, V22, P132; Belge H, 2007, P NATL ACAD SCI USA, V104, P14849, DOI 10.1073/pnas.0702810104; Carmosino M, 2010, MOL BIOL CELL, V21, P3985, DOI 10.1091/mbc.E10-05-0456; Castaneda-Bueno M, 2012, P NATL ACAD SCI USA, V109, P7929, DOI 10.1073/pnas.1200947109; Chiga M, 2008, KIDNEY INT, V74, P1403, DOI 10.1038/ki.2008.451; Coleman RA, 2000, AM J PHYSIOL-RENAL, V279, pF874, DOI 10.1152/ajprenal.2000.279.5.F874; Delpire E, 2008, BIOCHEM J, V409, P321, DOI 10.1042/BJ20071324; Delpire E, 2011, AM J PHYSIOL-CELL PH, V301, pC1074, DOI 10.1152/ajpcell.00131.2011; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Filippi BM, 2011, EMBO J, V30, P1730, DOI 10.1038/emboj.2011.78; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Fraser SA, 2007, BIOCHEM J, V405, P85, DOI 10.1042/BJ20061850; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KB, 2011, CELL PHYSIOL BIOCHEM, V28, P1219, DOI 10.1159/000335854; Geng Y, 2009, J BIOL CHEM, V284, P14020, DOI 10.1074/jbc.M900142200; GORDON RD, 1986, HYPERTENSION, V8, P93, DOI 10.1161/01.HYP.8.2.93; Kim GH, 1999, AM J PHYSIOL-RENAL, V276, pF96, DOI 10.1152/ajprenal.1999.276.1.F96; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; Lin SH, 2011, P NATL ACAD SCI USA, V108, P17538, DOI 10.1073/pnas.1107452108; Loffing J, 2004, J AM SOC NEPHROL, V15, P2276, DOI 10.1097/01.ASN.0000138234.18569.63; Loffing J, 1996, KIDNEY INT, V50, P1180, DOI 10.1038/ki.1996.426; McCormick JA, 2011, CELL METAB, V14, P352, DOI 10.1016/j.cmet.2011.07.009; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Rafiqi FH, 2010, EMBO MOL MED, V2, P63, DOI 10.1002/emmm.200900058; Reiche J, 2010, MOL CELL BIOL, V30, P3027, DOI 10.1128/MCB.01560-09; Reilly RF, 2000, PHYSIOL REV, V80, P277, DOI 10.1152/physrev.2000.80.1.277; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Richardson C, 2011, J CELL SCI, V124, P789, DOI 10.1242/jcs.077230; San-Cristobal P, 2009, P NATL ACAD SCI USA, V106, P4384, DOI 10.1073/pnas.0813238106; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; Simon DB, 1996, AM J PHYSIOL-RENAL, V271, pF961, DOI 10.1152/ajprenal.1996.271.5.F961; STANTON BA, 1989, AM J PHYSIOL, V257, pF1, DOI 10.1152/ajprenal.1989.257.1.F1; Vallon V, 2009, AM J PHYSIOL-RENAL, V297, pF704, DOI 10.1152/ajprenal.00030.2009; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Yang CL, 2005, J CLIN INVEST, V115, P1379, DOI 10.1172/JCI200522452; Yang SS, 2010, J AM SOC NEPHROL, V21, P1868, DOI 10.1681/ASN.2009121295; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377	41	94	94	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.402800	http://dx.doi.org/10.1074/jbc.M112.402800			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977235	hybrid, Green Published			2022-12-25	WOS:000310642200008
J	Hance, MW; Dole, K; Gopal, U; Bohonowych, JE; Jezierska-Drutel, A; Neumann, CA; Liu, HB; Garraway, IP; Isaacs, JS				Hance, Michael W.; Dole, Krystal; Gopal, Udhayakumar; Bohonowych, Jessica E.; Jezierska-Drutel, Agnieszka; Neumann, Carola A.; Liu, Haibo; Garraway, Isla P.; Isaacs, Jennifer S.			Secreted Hsp90 Is a Novel Regulator of the Epithelial to Mesenchymal Transition (EMT) in Prostate Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR SNAIL; RECEPTOR-RELATED PROTEIN; UP-REGULATION; HEPATOCELLULAR-CARCINOMA; EXTRACELLULAR HSP90; GENE-EXPRESSION; BONE METASTASIS; GROWTH; ACTIVATION; CELLS	Prostate cancer (PCa) is the most frequently diagnosed malignancy in men, and the second highest contributor of male cancer related lethality. Disease mortality is due primarily to metastatic spread, highlighting the urgent need to identify factors involved in this progression. Activation of the genetic epithelial to mesenchymal transition (EMT) program is implicated as a major contributor of PCa progression. Initiation of EMT confers invasive and metastatic behavior in preclinical models and is correlated with poor clinical prognosis. Extracellular Hsp90 (eHsp90) promotes cell motility and invasion in cancer cells and metastasis in preclinical models, however, the mechanistic basis for its widespread tumorigenic function remains unclear. We have identified a novel and pivotal role for eHsp90 in driving EMT events in PCa. In support of this notion, more metastatic PCa lines exhibited increased eHsp90 expression relative to their lineage-related nonmetastatic counterparts. We demonstrate that eHsp90 promoted cell motility in an ERK and matrix metalloproteinase-2/9-dependent manner, and shifted cellular morphology toward a mesenchymal phenotype. Conversely, inhibition of eHsp90 attenuated pro-motility signaling, blocked PCa migration, and shifted cell morphology toward an epithelial phenotype. Last, we report that surface eHsp90 was found in primary PCa tumor specimens, and elevated eHsp90 expression was associated with increased levels of matrix metalloproteinase-2/9 transcripts. We conclude that eHsp90 serves as a driver of EMT events, providing a mechanistic basis for its ability to promote cancer progression and metastasis in preclinical models. Furthermore, its newly identified expression in PCa specimens, and potential regulation of pro-metastatic genes, supports a putative clinical role for eHsp90 in PCa progression.	[Hance, Michael W.; Dole, Krystal; Gopal, Udhayakumar; Bohonowych, Jessica E.; Jezierska-Drutel, Agnieszka; Neumann, Carola A.; Isaacs, Jennifer S.] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA; [Liu, Haibo; Garraway, Isla P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA	Medical University of South Carolina; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Isaacs, JS (corresponding author), Hollings Canc Ctr, 86 Jonathan Lucas St, Charleston, SC 29425 USA.	isaacsj@musc.edu	Gopal, Udhayakumar/K-9092-2019	Neumann, Carola/0000-0003-2801-9531; gopal, Udhayakumar/0000-0003-2110-0601	National Institutes of Health [R01 CA135297, T32 CA119945, K12 GM081265]; Cancer Center Support Grant [P30 CA138313]; NATIONAL CANCER INSTITUTE [R01CA135297, F31CA177015, R01CA131350, P30CA138313, T32CA119945] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM081265] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA135297 (to J. S. I.) and Training Grant T32 CA119945 (to M. W. H.) and Institutional Research and Academic Career Development Award Training Grant K12 GM081265 (to J. E. B.).; We thank Joy Ware for the P69 and M12 cells, Chris Lindsey and Craig Beeson for synthesis of DMAG-N-oxide (NPGA), and Enzo Life Sciences for generous reagent support. Imaging facilities for this research were supported, in part, by Cancer Center Support Grant P30 CA138313 to the Hollings Cancer Center, Medical University of South Carolina. We also thank Phillip Howe and Simon Hayward for critical comments on this manuscript.	Acevedo VD, 2007, CANCER CELL, V12, P559, DOI 10.1016/j.ccr.2007.11.004; Andriole GL, 2009, NAT REV UROL, V6, P188, DOI 10.1038/nrurol.2009.46; Arya M, 2006, SURG ONCOL, V15, P117, DOI 10.1016/j.suronc.2006.10.002; Bae VL, 1998, PROSTATE, V34, P275, DOI 10.1002/(SICI)1097-0045(19980301)34:4<275::AID-PROS5>3.0.CO;2-G; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Becker B, 2004, EXP DERMATOL, V13, P27, DOI 10.1111/j.0906-6705.2004.00114.x; Bohonowych JE, 2010, J ONCOL, V2010, DOI 10.1155/2010/412985; Burgess EF, 2008, PROTEOM CLIN APPL, V2, P1223, DOI 10.1002/prca.200780073; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chambers AF, 1997, J NATL CANCER I, V89, P1260, DOI 10.1093/jnci/89.17.1260; Cheng C. Yan, 2008, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V8, P1, DOI 10.2174/187152208783790778; Contreras HR, 2010, UROL ONCOL-SEMIN ORI, V28, P534, DOI 10.1016/j.urolonc.2009.03.018; Crawford ED, 2009, UROLOGY, V73, P4, DOI 10.1016/j.urology.2009.03.001; Culp S, 2009, BJU INT, V104, P1457, DOI 10.1111/j.1464-410X.2009.08646.x; David JM, 2012, CANCER RES, V72, P2917, DOI 10.1158/0008-5472.CAN-11-3498; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Efstathiou E, 2010, CLIN CANCER RES, V16, P1100, DOI 10.1158/1078-0432.CCR-09-1215; Ellenrieder V, 2001, CANCER RES, V61, P4222; Eustace BK, 2004, NAT CELL BIOL, V6, P507, DOI 10.1038/ncb1131; Figueiredo C, 2009, BLOOD, V113, P3008, DOI 10.1182/blood-2008-06-162727; FU XY, 1992, INT J CANCER, V52, P987; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Grooteclaes ML, 2000, ONCOGENE, V19, P3823, DOI 10.1038/sj.onc.1203721; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanschen M., 2008, COLD SPRING HARBOR P, V86, P710; He H, 2010, PROSTATE, V70, P518, DOI 10.1002/pros.21086; HINCK L, 1994, J CELL BIOL, V125, P1327, DOI 10.1083/jcb.125.6.1327; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Ito H, 2004, CANCER RES, V64, P7439, DOI 10.1158/0008-5472.CAN-04-1177; Janda CY, 2010, NATURE, V465, P507, DOI 10.1038/nature08870; Johnson JL, 2011, ARTERIOSCL THROM VAS, V31, pE35, DOI 10.1161/ATVBAHA.111.225623; Johnson TR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-148; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Josson S, 2011, CANCER RES, V71, P2600, DOI 10.1158/0008-5472.CAN-10-3382; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Lagarrigue F, 2010, CANCER RES, V70, P6978, DOI 10.1158/0008-5472.CAN-10-0861; Langlois B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011584; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Lue HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027720; Luo LY, 2002, BRIT J CANCER, V87, P339, DOI 10.1038/sj.bjc.6600439; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Orr AW, 2003, J CELL BIOL, V161, P1179, DOI 10.1083/jcb.200302069; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Qin Z, 2010, VIROLOGY, V403, P92, DOI 10.1016/j.virol.2010.03.052; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rojas A, 2011, ONCOGENE, V30, P2345, DOI 10.1038/onc.2010.605; Sahu D, 2012, MOL BIOL CELL, V23, P602, DOI 10.1091/mbc.E11-06-0575; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Sims JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018848; Smolen GA, 2010, GENE DEV, V24, P2654, DOI 10.1101/gad.1989110; Song XM, 2010, J BIOL CHEM, V285, P40039, DOI 10.1074/jbc.M110.181941; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; STEPHENSON RA, 1992, J NATL CANCER I, V84, P951, DOI 10.1093/jnci/84.12.951; Strope SA, 2010, NAT REV UROL, V7, P487, DOI 10.1038/nrurol.2010.120; Sun LM, 2008, MOL CANCER RES, V6, P10, DOI 10.1158/1541-7786.MCR-07-0208; Sun YT, 2012, CANCER RES, V72, P527, DOI 10.1158/0008-5472.CAN-11-3004; Tanaka H, 2010, NAT MED, V16, P1414, DOI 10.1038/nm.2236; THALMANN GN, 1994, CANCER RES, V54, P2577; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Tsutsumi S, 2008, ONCOGENE, V27, P2478, DOI 10.1038/sj.onc.1210897; ULLRICH SJ, 1986, P NATL ACAD SCI USA, V83, P3121, DOI 10.1073/pnas.83.10.3121; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vidal CI, 2004, ONCOGENE, V23, P8859, DOI 10.1038/sj.onc.1208082; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xie DX, 2010, P NATL ACAD SCI USA, V107, P2485, DOI 10.1073/pnas.0908133107; Xu JC, 2006, PROSTATE, V66, P1664, DOI 10.1002/pros.20488; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Yoshida T, 2006, ONCOGENE, V25, P6056, DOI 10.1038/sj.onc.1209635; Zhang Q, 2009, CLIN CANCER RES, V15, P3557, DOI 10.1158/1078-0432.CCR-08-1656; Zhang XP, 2009, MOL CANCER THER, V8, P499, DOI 10.1158/1535-7163.MCT-08-0544; Zhao XL, 2011, J CELL MOL MED, V15, P691, DOI 10.1111/j.1582-4934.2010.01052.x; Zhau Haiyen E., 2000, Cancer, V88, P2995, DOI 10.1002/1097-0142(20000615)88:12+<2995::AID-CNCR15>3.0.CO;2-Y; Zhau HE, 2008, CLIN EXP METASTAS, V25, P601, DOI 10.1007/s10585-008-9183-1; Zhau HYE, 1996, P NATL ACAD SCI USA, V93, P15152, DOI 10.1073/pnas.93.26.15152	87	98	102	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.389015	http://dx.doi.org/10.1074/jbc.M112.389015			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989880	Green Published, hybrid			2022-12-25	WOS:000310642200013
J	Flockhart, DTT; Martin, TG; Norris, DR				Flockhart, D. T. Tyler; Martin, Tara G.; Norris, D. Ryan			Experimental Examination of Intraspecific Density-Dependent Competition during the Breeding Period in Monarch Butterflies (Danaus plexippus)	PLOS ONE			English	Article							POPULATION-DYNAMICS; PROTOZOAN PARASITE; ASCLEPIAS-SYRIACA; L LEPIDOPTERA; MILKWEED; SIZE; FLUCTUATIONS; NYMPHALIDAE; TEMPERATURE; FECUNDITY	A central goal of population ecology is to identify the factors that regulate population growth. Monarch butterflies (Danaus plexippus) in eastern North America re-colonize the breeding range over several generations that result in population densities that vary across space and time during the breeding season. We used laboratory experiments to measure the strength of density-dependent intraspecific competition on egg laying rate and larval survival and then applied our results to density estimates of wild monarch populations to model the strength of density dependence during the breeding season. Egg laying rates did not change with density but larvae at high densities were smaller, had lower survival, and weighed less as adults compared to lower densities. Using mean larval densities from field surveys resulted in conservative estimates of density-dependent population reduction that varied between breeding regions and different phases of the breeding season. Our results suggest the highest levels of population reduction due to density-dependent intraspecific competition occur early in the breeding season in the southern portion of the breeding range. However, we also found that the strength of density dependence could be almost five times higher depending on how many life-stages were used as part of field estimates. Our study is the first to link experimental results of a density-dependent reduction in vital rates to observed monarch densities in the wild and show that the effects of density dependent competition in monarchs varies across space and time, providing valuable information for developing robust, year-round population models in this migratory organism.	[Flockhart, D. T. Tyler; Norris, D. Ryan] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Martin, Tara G.] CSIRO Ecosyst Sci, Dutton Pk, Qld, Australia	University of Guelph; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Flockhart, DTT (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	dflockha@uoguelph.ca	Martin, Tara/M-1897-2016; Flockhart, D. T. Tyler/C-3132-2018	Martin, Tara/0000-0001-7165-9812; Flockhart, D. T. Tyler/0000-0002-5832-8610	N.E.W. Zoological Society, Inc.; Natural Sciences and Engineering Council of Canada	N.E.W. Zoological Society, Inc.; Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by a Conservation Grant from the N.E.W. Zoological Society, Inc. (to DTTF) and the Natural Sciences and Engineering Council of Canada (to DTTF, DRN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer SM, 1999, J INVERTEBR PATHOL, V74, P76, DOI 10.1006/jipa.1999.4853; Altizer SM, 2000, ECOL ENTOMOL, V25, P125, DOI 10.1046/j.1365-2311.2000.00246.x; Atterholt AL, 2010, J ENTOMOL SCI, V45, P366, DOI 10.18474/0749-8004-45.4.366; Bartel RA, 2011, ECOLOGY, V92, P342, DOI 10.1890/10-0489.1; Bates D., 2011, IME4 LINEAR MIXED EF; BELLOWS TS, 1981, J ANIM ECOL, V50, P139, DOI 10.2307/4037; BORKIN SS, 1982, GREAT LAKES ENTOMOL, V15, P199; Brower LP, 2012, INSECT CONSERV DIVER, V5, P95, DOI 10.1111/j.1752-4598.2011.00142.x; BROWER LINCOLN P., 1961, PHYSIOL ZOOL, V34, P287; Brower Lincoln P., 1995, Journal of the Lepidopterists' Society, V49, P304; CALVERT WH, 1979, SCIENCE, V204, P847, DOI 10.1126/science.204.4395.847; Cockrell B.J., 1993, NAT HIS LOS-SERIES, P233; DEMPSTER JP, 1983, BIOL REV, V58, P461, DOI 10.1111/j.1469-185X.1983.tb00396.x; Drury KLS, 2005, AM NAT, V166, P731, DOI 10.1086/497542; FOWLER CW, 1981, ECOLOGY, V62, P602, DOI 10.2307/1937727; Goehring L, 2002, ECOL ENTOMOL, V27, P674, DOI 10.1046/j.1365-2311.2002.00454.x; Hartzler RG, 2000, CROP PROT, V19, P363, DOI 10.1016/S0261-2194(00)00024-7; Hartzler RG, 2010, CROP PROT, V29, P1542, DOI 10.1016/j.cropro.2010.07.018; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Hughes Patrick R., 1993, American Entomologist, V39, P109; Lindsey E, 2009, ECOL ENTOMOL, V34, P551, DOI 10.1111/j.1365-2311.2009.01107.x; Lynch SP, 1993, BIOL CONSERVATION MO, P107; MALCOLM SB, 1993, NAT HIS LOS-SERIES, P253; McLaughlin JF, 2002, OECOLOGIA, V132, P538, DOI 10.1007/s00442-002-0997-2; Miller NG, 2011, BIOL LETTERS, V7, P43, DOI 10.1098/rsbl.2010.0525; NICHOLSON AJ, 1954, AUST J ZOOL, V2, P9, DOI 10.1071/ZO9540009; Nowicki P, 2009, OECOLOGIA, V161, P227, DOI 10.1007/s00442-009-1373-2; Oberhauser Karen, 2012, American Entomologist, V58, P19; Oberhauser KS, 1997, FUNCT ECOL, V11, P166, DOI 10.1046/j.1365-2435.1997.00074.x; Oberhauser KS, 2001, P NATL ACAD SCI USA, V98, P11913, DOI 10.1073/pnas.211234298; Pickens BA, 2007, J ZOOL, V273, P229, DOI 10.1111/j.1469-7998.2007.00341.x; Pleasants JM, 2013, INSECT CONSERV DIVER, V6, P135, DOI 10.1111/j.1752-4598.2012.00196.x; Poisot T, 2010, DGITIZE PLOT DIGITIZ; Polis GA, 1998, ECOLOGY, V79, P490, DOI 10.2307/176948; Prysby MD, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P9; Prysby MD, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P27; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Riley TJ, 1993, BIOL CONSERVATION MO, P269; Rodenhouse NL, 2003, P ROY SOC B-BIOL SCI, V270, P2105, DOI 10.1098/rspb.2003.2438; Roy DB, 2001, J ANIM ECOL, V70, P201, DOI 10.1046/j.1365-2656.2001.00480.x; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; SWENGEL AB, 1995, AM MIDL NAT, V134, P205, DOI 10.2307/2426291; Therneau T., 2011, COXME MIXED EFFECTS; Varley G.C., 1973, INSECT POPULATION EC; Wassenaar LI, 1998, P NATL ACAD SCI USA, V95, P15436, DOI 10.1073/pnas.95.26.15436; Watt AD, 1999, OIKOS, V87, P411, DOI 10.2307/3546759; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; ZALUCKI MP, 1982, J ZOOL, V198, P103; ZALUCKI MP, 1981, RES POPUL ECOL, V23, P318, DOI 10.1007/BF02515634; Zalucki MP, 2001, ECOL ENTOMOL, V26, P212, DOI 10.1046/j.1365-2311.2001.00313.x; ZALUCKI MP, 1982, J AUST ENTOMOL SOC, V21, P241	51	35	35	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45080	10.1371/journal.pone.0045080	http://dx.doi.org/10.1371/journal.pone.0045080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984614	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500115
J	Haldar, S; Sankhyan, N; Sharma, N; Bansal, A; Jain, V; Gupta, VK; Juneja, M; Mishra, D; Kapil, A; Singh, UB; Gulati, S; Kalra, V; Tyagi, JS				Haldar, Sagarika; Sankhyan, Naveen; Sharma, Neera; Bansal, Anjali; Jain, Vitul; Gupta, V. K.; Juneja, Monica; Mishra, Devendra; Kapil, Arti; Singh, Urvashi B.; Gulati, Sheffali; Kalra, Veena; Tyagi, Jaya Sivaswami			Detection of Mycobacterium tuberculosis GlcB or HspX Antigens or devR DNA Impacts the Rapid Diagnosis of Tuberculous Meningitis in Children	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; PULMONARY TUBERCULOSIS; ANTIBODY-RESPONSES; PROTEIN; COMPLEX; METAANALYSIS; PERFORMANCE; EXPRESSION; INCIPIENT; LUNG	Background: Tuberculous meningitis (TBM) is the most common form of neurotuberculosis and the fifth most common form of extrapulmonary TB. Early diagnosis and prompt treatment are the cornerstones of effective disease management. The accurate diagnosis of TBM poses a challenge due to an extensive differential diagnosis, low bacterial load and paucity of cerebrospinal fluid (CSF) especially in children. Methodology/Principal Findings: We describe the utility of ELISA and qPCR for the detection of Mycobacterium tuberculosis (M. tb) proteins (GlcB, HspX, MPT51, Ag85B and PstS1) and DNA for the rapid diagnosis of TBM. CSF filtrates (n = 532) derived from children were classified as 'Definite' TBM (M. tb culture positive, n = 29), 'Probable and Possible' TBM (n = 165) and 'Not-TBM' including other cases of meningitis or neurological disorders (n = 338). ROC curves were generated from ELISA and qPCR data of 'Definite' TBM and Non-Tuberculous infectious meningitis (NTIM) samples and cut-off values were derived to provide >= 95% specificity. devR qPCR, GlcB, HspX and PstS1 ELISAs showed 100% (88; 100) sensitivity and 96-97% specificity in 'Definite' TBM samples. The application of these cut-offs to 'Probable and Possible' TBM groups yielded excellent sensitivity (98%, 94; 99) and specificity (98%, 96; 99) for qPCR and for GlcB, HspX and MPT51 antigen ELISAs (sensitivity 92-95% and specificity 93-96%). A test combination of qPCR with GlcB and HspX ELISAs accurately detected all TBM samples at a specificity of similar to 90%. Logistic regression analysis indicated that these tests significantly added value to the currently used algorithms for TBM diagnosis. Conclusions: The detection of M. tb GlcB/HspX antigens/devR DNA in CSF is likely to improve the utility of existing algorithms for TBM diagnosis and also hasten the speed of diagnosis.	[Haldar, Sagarika; Jain, Vitul; Tyagi, Jaya Sivaswami] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Sankhyan, Naveen; Gulati, Sheffali; Kalra, Veena] All India Inst Med Sci, Dept Pediat, New Delhi, India; [Sharma, Neera; Bansal, Anjali; Gupta, V. K.] Dr Ram Manohar Lohia Hosp, Dept Biochem, New Delhi, India; [Sharma, Neera; Bansal, Anjali; Gupta, V. K.] Dr Ram Manohar Lohia Hosp, Dept Pediat, New Delhi, India; [Juneja, Monica; Mishra, Devendra] Maulana Azad Med Coll, Dept Pediat, New Delhi, India; [Juneja, Monica; Mishra, Devendra] Lok Nayak Hosp, New Delhi, India; [Kapil, Arti; Singh, Urvashi B.] All India Inst Med Sci, Dept Microbiol, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Maulana Azad Medical College; All India Institute of Medical Sciences (AIIMS) New Delhi	Haldar, S (corresponding author), Translat Hlth Sci & Technol Inst, Ctr Biodesign, Natl Biodesign Alliance Programme, Gurgaon, Haryana, India.	jstyagi@aiims.ac.in	SANKHYAN, NAVEEN/AAP-6531-2021; Jain, Vitul/AAP-9467-2020; Mishra, Devendra/C-4881-2014	Jain, Vitul/0000-0002-8396-8329; Mishra, Devendra/0000-0002-6810-3095; Juneja, Monica/0000-0003-1894-7801	Department of Biotechnology, Government of India (DBT); DBT	Department of Biotechnology, Government of India (DBT)(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India)	SH and JST are thankful to the Department of Biotechnology, Government of India (DBT) for a Senior Research Fellowship and a Tata Innovation Fellowship, respectively. Financial assistance to JST, US and AK from the DBT for implementing the project is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, GLOB TUB CONTR; Bothamley G H, 1995, Eur Respir J Suppl, V20, p676s; BOTHAMLEY GH, 1992, THORAX, V47, P270, DOI 10.1136/thx.47.4.270; BOTHAMLEY GH, 1992, J INFECT DIS, V166, P182, DOI 10.1093/infdis/166.1.182; Bretl DJ, 2011, MICROBIOL MOL BIOL R, V75, P566, DOI 10.1128/MMBR.05004-11; Chakraborty A. K., 2000, Indian Journal of Tuberculosis, V47, P9; Chakravorty S, 2006, FEMS MICROBIOL LETT, V257, P306, DOI 10.1111/j.1574-6968.2006.00187.x; CHANDRAMUKI A, 1989, J CLIN MICROBIOL, V27, P821, DOI 10.1128/JCM.27.5.821-825.1989; Flores LL, 2011, CLIN VACCINE IMMUNOL, V18, P1616, DOI 10.1128/CVI.05205-11; Garton NJ, 2008, PLOS MED, V5, P634, DOI 10.1371/journal.pmed.0050075; Haldar S, 2009, J MED MICROBIOL, V58, P616, DOI 10.1099/jmm.0.006015-0; HARBOE M, 1992, J INFECT DIS, V166, P874, DOI 10.1093/infdis/166.4.874; Heemskerk D, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-25; Jatana S K, 2000, Indian Pediatr, V37, P375; Kashyap RS, 2005, CLIN DIAGN LAB IMMUN, V12, P752, DOI 10.1128/CDLI.12.6.752-758.2005; Kashyap RS, 2004, NEUROL INDIA, V52, P359; Kumar P, 2008, J CLIN MICROBIOL, V46, P2824, DOI 10.1128/JCM.00210-08; Kumar R, 1999, ARCH DIS CHILD, V81, P221, DOI 10.1136/adc.81.3.221; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Malen H, 2008, SCAND J IMMUNOL, V67, P245, DOI 10.1111/j.1365-3083.2007.02064.x; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; NAGAI S, 1991, INFECT IMMUN, V59, P372, DOI 10.1128/IAI.59.1.372-382.1991; Ohara N, 1997, INFECT IMMUN, V65, P3680, DOI 10.1128/IAI.65.9.3680-3685.1997; Pai NP, 2012, DISCOV MED, V13, P35; Rock RB, 2008, CLIN MICROBIOL REV, V21, P243, DOI 10.1128/CMR.00042-07; Rock RB, 2005, J INFECT DIS, V192, P2054, DOI 10.1086/498165; Ryan GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011108; Saini DK, 2002, PROTEIN EXPRES PURIF, V25, P203, DOI 10.1006/prep.2002.1628; Samanich KM, 1998, J INFECT DIS, V178, P1534, DOI 10.1086/314438; Sharma D, 2006, FEMS IMMUNOL MED MIC, V48, P329, DOI 10.1111/j.1574-695X.2006.00160.x; Shi L, 2004, INFECT IMMUN, V72, P2420, DOI 10.1128/IAI.72.4.2420-2424.2004; Singh KK, 2005, CLIN DIAGN LAB IMMUN, V12, P354, DOI 10.1128/CDLI.12.2.354-358.2005; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; Tandon PN, 1978, HDB CLIN NEUROLOGY I, V33, P195; Thuong Nguyen Thuy Thuong, 2008, PLoS Pathog, V4, pe1000229, DOI 10.1371/journal.ppat.1000229; Wanchu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002071; *WHO, 2011, POL STAT COMM SER TE; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992; Wilkins E. G. L., 1994, P367	39	33	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44630	10.1371/journal.pone.0044630	http://dx.doi.org/10.1371/journal.pone.0044630			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984534	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500070
J	Hartman, AL; Santos, P; Dolce, A; Hardwick, JM				Hartman, Adam L.; Santos, Polan; Dolce, Alison; Hardwick, J. Marie			The mTOR Inhibitor Rapamycin Has Limited Acute Anticonvulsant Effects in Mice	PLOS ONE			English	Article							KETOGENIC DIET; MAMMALIAN TARGET; TUBEROUS SCLEROSIS; SIGNALING PATHWAY; MOUSE MODEL; CHILDHOOD EPILEPSY; KAINIC ACID; SEIZURES; TOPIRAMATE; CURRENTS	Objective: The mammalian target of rapamycin (mTOR) pathway integrates signals from different nutrient sources, including amino acids and glucose. Compounds that inhibit mTOR kinase activity such as rapamycin and everolimus can suppress seizures in some chronic animal models and in patients with tuberous sclerosis. However, it is not known whether mTOR inhibitors exert acute anticonvulsant effects in addition to their longer term antiepileptogenic effects. To gain insights into how rapamycin suppresses seizures, we investigated the anticonvulsant activity of rapamycin using acute seizure tests in mice. Methods: Following intraperitoneal injection of rapamycin, normal four-week-old male NIH Swiss mice were evaluated for susceptibility to a battery of acute seizure tests similar to those currently used to screen potential therapeutics by the US NIH Anticonvulsant Screening Program. To assess the short term effects of rapamycin, mice were seizure tested in <= 6 hours of a single dose of rapamycin, and for longer term effects of rapamycin, mice were tested after 3 or more daily doses of rapamycin. Results: The only seizure test where short-term rapamycin treatment protected mice was against tonic hindlimb extension in the MES threshold test, though this protection waned with longer rapamycin treatment. Longer term rapamycin treatment protected against kainic acid-induced seizure activity, but only at late times after seizure onset. Rapamycin was not protective in the 6 Hz or PTZ seizure tests after short or longer rapamycin treatment times. In contrast to other metabolism-based therapies that protect in acute seizure tests, rapamycin has limited acute anticonvulsant effects in normal mice. Significance: The efficacy of rapamycin as an acute anticonvulsant agent may be limited. Furthermore, the combined pattern of acute seizure test results places rapamycin in a third category distinct from both fasting and the ketogenic diet, and which is more similar to drugs acting on sodium channels.	[Hartman, Adam L.; Santos, Polan; Dolce, Alison; Hardwick, J. Marie] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Hartman, Adam L.; Hardwick, J. Marie] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hartman, AL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA.	Ahartma2@jhmi.edu; hardwick@jhu.edu	Hartman, Adam/W-9782-2019	Hartman, Adam/0000-0001-5672-3409	National Institute of Neurological Disorders and Stroke [K08NS070931, RO1NS037402]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS070931, R01NS037402] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The project described was supported by Grant Numbers K08NS070931 (ALH) and RO1NS037402 (JMH) from the National Institute of Neurological Disorders and Stroke. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Neurological Disorders and Stroke or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Berg AT, 2009, ANN NEUROL, V65, P510, DOI 10.1002/ana.21642; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Chachua T, 2011, EPILEPSIA, V52, P1666, DOI 10.1111/j.1528-1167.2011.03220.x; Chow DK, 2009, NAT NEUROSCI, V12, P116, DOI 10.1038/nn.2255; CRAMER CL, 1994, LIFE SCI, V54, pPL271, DOI 10.1016/0024-3205(94)00845-0; Dalby NO, 1997, EPILEPSY RES, V28, P63, DOI 10.1016/S0920-1211(97)00031-4; Daoud D, 2007, EPILEPSIA, V48, P834, DOI 10.1111/j.1528-1167.2006.00976.x; Eshleman JS, 2002, CANCER RES, V62, P7291; Gibbs JW, 2000, EPILEPSIA, V41, pS10; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hartman AL, 2008, EPILEPSIA, V49, P334, DOI 10.1111/j.1528-1167.2007.01430.x; Hartman AL, 2007, EPILEPSIA, V48, P31, DOI 10.1111/j.1528-1167.2007.00914.x; Hartman AL, 2010, EPILEPSIA, V51, P1395, DOI 10.1111/j.1528-1167.2010.02577.x; Hernandez D, 2012, NEURON, V74, P277, DOI 10.1016/j.neuron.2012.02.020; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huang XX, 2010, NEUROBIOL DIS, V40, P193, DOI 10.1016/j.nbd.2010.05.024; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Kaminski RM, 2004, NEUROPHARMACOLOGY, V46, P1097, DOI 10.1016/j.neuropharm.2004.02.010; Kasap B, 2011, PEDIATR TRANSPLANT, V15, P673, DOI 10.1111/j.1399-3046.2011.01575.x; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Klitgaard H, 1998, EUR J PHARMACOL, V353, P191, DOI 10.1016/S0014-2999(98)00410-5; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Kumar V, 2005, J NEUROSCI, V25, P11288, DOI 10.1523/JNEUROSCI.2284-05.2005; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Ljungberg MC, 2009, DIS MODEL MECH, V2, P389, DOI 10.1242/dmm.002386; McDaniel SS, 2011, EPILEPSIA, V52, pe7, DOI 10.1111/j.1528-1167.2011.02981.x; Meikle L, 2008, J NEUROSCI, V28, P5422, DOI 10.1523/JNEUROSCI.0955-08.2008; Morrison RS, 1996, J NEUROSCI, V16, P1337; Muller-Schwarze AB, 1999, NEUROREPORT, V10, P1517, DOI 10.1097/00001756-199905140-00023; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Orlova KA, 2010, ANN NY ACAD SCI, V1184, P87, DOI 10.1111/j.1749-6632.2009.05117.x; Potter WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008996; Raffo E, 2011, NEUROBIOL DIS, V43, P322, DOI 10.1016/j.nbd.2011.03.021; Ran I, 2009, J NEUROSCI, V29, P5605, DOI 10.1523/JNEUROSCI.5355-08.2009; Ruegg S, 2007, EPILEPSY RES, V77, P85, DOI 10.1016/j.eplepsyres.2007.09.009; Russ SA, 2012, PEDIATRICS, V129, P256, DOI 10.1542/peds.2010-1371; Ryther RC, 2012, CURR NEUROL NEUROSCI; Samala R, 2008, EPILEPSY RES, V81, P119, DOI 10.1016/j.eplepsyres.2008.05.001; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Smith M, 2007, NEUROTHERAPEUTICS, V4, P12, DOI 10.1016/j.nurt.2006.11.009; Stefani A, 1996, EUR J PHARMACOL, V307, P113, DOI 10.1016/0014-2999(96)00265-8; STEPPUHN KG, 1993, J PHARMACOL EXP THER, V265, P1063; Sunnen CN, 2011, EPILEPSIA, V52, P2065, DOI 10.1111/j.1528-1167.2011.03280.x; Talos DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035885; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Taverna S, 1999, J PHARMACOL EXP THER, V288, P960; UHLEMANN ER, 1972, J PHARMACOL EXP THER, V180, P231; Wang CC, 2011, NEURON, V72, P789, DOI 10.1016/j.neuron.2011.09.023; White HS, 1997, EPILEPSY RES, V28, P167, DOI 10.1016/S0920-1211(97)00045-4; Wong M, 2010, EPILEPSY CURR, V11, P66; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhang XL, 2000, EPILEPSIA, V41, pS52; Zhao Q, 2004, PEDIATR RES, V55, P498, DOI 10.1203/01.PDR.0000112032.47575.D1	60	41	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45156	10.1371/journal.pone.0045156	http://dx.doi.org/10.1371/journal.pone.0045156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984623	gold, Green Submitted, Green Published			2022-12-25	WOS:000308738500121
J	Lecours, MP; Segura, M; Fittipaldi, N; Rivest, S; Gottschalk, M				Lecours, Marie-Pier; Segura, Mariela; Fittipaldi, Nahuel; Rivest, Serge; Gottschalk, Marcelo			Immune Receptors Involved in Streptococcus suis Recognition by Dendritic Cells	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; MYCOBACTERIUM-TUBERCULOSIS; INFLAMMATORY RESPONSES; PATHOGEN RECOGNITION; VIRULENCE FACTORS; INNATE IMMUNITY; ZOONOTIC AGENT; MOUSE MODEL; T-CELLS; INFECTION	Streptococcus suis is an important swine pathogen and an emerging zoonotic agent of septicemia and meningitis. Knowledge on host immune responses towards S. suis, and strategies used by this pathogen for subversion of these responses is scarce. The objective of this study was to identify the immune receptors involved in S. suis recognition by dendritic cells (DCs). Production of cytokines and expression of co-stimulatory molecules by DCs were shown to strongly rely on MyD88-dependent signaling pathways, suggesting that DCs recognize S. suis and become activated mostly through Toll-like receptor (TLR) signaling. Supporting this fact, TLR2(-/-) DCs were severely impaired in the release of several cytokines and the surface expression of CD86 and MHC-II. The release of IL-12p70 and CXC10, and the expression of CD40 were found to depend on signaling by both TLR2 and TLR9. The release of IL-23 and CXCL1 were partially dependent on NOD2. Finally, despite the fact that MyD88 signaling was crucial for DC activation and maturation, MyD88-dependent pathways were not implicated in S. suis internalization by DCs. This first study on receptors involved in DC activation by S. suis suggests a major involvement of MyD88 signaling pathways, mainly (but not exclusively) through TLR2. A multimodal recognition involving a combination of different receptors seems essential for DC effective response to S. suis.	[Lecours, Marie-Pier; Segura, Mariela; Gottschalk, Marcelo] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 7C6, Canada; [Fittipaldi, Nahuel] Methodist Hosp Syst, Dept Pathol & Genom Med, Houston, TX USA; [Rivest, Serge] CHU Laval, Lab Endocrinol & Genom, Ste Foy, PQ, Canada	Universite de Montreal; The Methodist Hospital System; The Methodist Hospital - Houston; Laval University	Lecours, MP (corresponding author), Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ J2S 7C6, Canada.	marcelo.gottschalk@umontreal.ca	Segura, Mariela/AAG-5708-2020; Gottschalk, Marcelo/I-8116-2012	Rivest, Serge/0000-0002-6082-770X; Fittipaldi, Nahuel/0000-0001-9553-3798	Natural Sciences and Engineering Research Council of Canada (NSERC) [154280, 380299]; NSERC [342150-07]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) grant #154280 as well as Discovery Accelerator Supplement #380299 to Marcelo Gottschalk and NSERC grant #342150-07 to Mariela Segura. Marie-Pier Lecours is the recipient of a NSERC doctoral award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Baums Christoph Georg, 2009, Animal Health Research Reviews, V10, P65, DOI 10.1017/S146625230999003X; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Chabot-Roy G, 2006, MICROB PATHOGENESIS, V41, P21, DOI 10.1016/j.micpath.2006.04.001; Clarke TB, 2011, IMMUNOL REV, V243, P9, DOI 10.1111/j.1600-065X.2011.01039.x; Corr SC, 2007, FEMS IMMUNOL MED MIC, V50, P380, DOI 10.1111/j.1574-695X.2007.00264.x; Costa A, 2012, J IMMUNOL, V188, P1953, DOI 10.4049/jimmunol.1102543; de Jong EC, 2005, SPRINGER SEMIN IMMUN, V26, P289, DOI 10.1007/s00281-004-0167-1; Dessing MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007993; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Dominguez-Punaro MD, 2010, INFECT IMMUN, V78, P5074, DOI 10.1128/IAI.00698-10; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Ferwerda G, 2005, PLOS PATHOG, V1, P279, DOI 10.1371/journal.ppat.0010034; Fittipaldi N, 2008, MOL MICROBIOL, V70, P1120, DOI 10.1111/j.1365-2958.2008.06463.x; Fittipaldi N, 2008, INFECT IMMUN, V76, P3587, DOI 10.1128/IAI.01568-07; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fittipaldi N, 2011, EMERG INFECT DIS, V17, P2239, DOI 10.3201/eid1712.110609; Gottschalk M, 2000, VET MICROBIOL, V76, P259, DOI 10.1016/S0378-1135(00)00250-9; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Graveline R, 2007, INT IMMUNOL, V19, P375, DOI 10.1093/intimm/dxm003; Henneke P, 2002, J IMMUNOL, V169, P3970, DOI 10.4049/jimmunol.169.7.3970; Kapetanovic R, 2007, INFECT IMMUN, V75, P830, DOI 10.1128/IAI.01199-06; Kawai T, 2001, J IMMUNOL, V167, P5887, DOI 10.4049/jimmunol.167.10.5887; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kobisch M, 1995, J RECH PORCINE FR, V27, P97; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Lecours MP, 2011, J INFECT DIS, V204, P919, DOI 10.1093/infdis/jir415; Lecours MP, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-72; Lee KS, 2007, CELL IMMUNOL, V245, P103, DOI 10.1016/j.cellimm.2007.04.003; Letiembre M, 2005, INFECT IMMUN, V73, P8397, DOI 10.1128/IAI.73.12.8397-8401.2005; Ley K, 2003, MICROCIRCULATION, V10, P289, DOI 10.1038/sj.mn.7800194; Liu XJ, 2010, GLIA, V58, P839, DOI 10.1002/glia.20968; Loof TG, 2008, INFECT IMMUN, V76, P2785, DOI 10.1128/IAI.01680-07; Lun SC, 2003, MICROB PATHOGENESIS, V34, P27, DOI 10.1016/S0882-4010(02)00192-4; Ma L, 2009, CELL MOL IMMUNOL, V6, P199, DOI 10.1038/cmi.2009.27; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; McNeela EA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001191; Meijerink M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035849; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schreur PJW, 2010, VET MICROBIOL, V143, P363, DOI 10.1016/j.vetmic.2009.12.010; Segura M, 2004, FRONT BIOSCI-LANDMRK, V9, P1157, DOI 10.2741/1287; Segura M, 2006, FEMS IMMUNOL MED MIC, V47, P92, DOI 10.1111/j.1574-695X.2006.00067.x; Shida K, 2009, IMMUNOLOGY, V128, pe858, DOI 10.1111/j.1365-2567.2009.03095.x; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; Stockinger B, 1996, J EXP MED, V183, P891, DOI 10.1084/jem.183.3.891; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Takamatsu D, 2001, PLASMID, V45, P101, DOI 10.1006/plas.2000.1510; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tam MA, 2009, IMMUNOLOGY, V128, P429, DOI 10.1111/j.1365-2567.2009.03128.x; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; van Vliet SJ, 2007, CURR OPIN IMMUNOL, V19, P435, DOI 10.1016/j.coi.2007.05.006; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zheng H, 2012, VET MICROBIOL, V156, P147, DOI 10.1016/j.vetmic.2011.10.014	63	30	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44746	10.1371/journal.pone.0044746	http://dx.doi.org/10.1371/journal.pone.0044746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984550	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500079
J	Sun, FJ; Zhang, YQ; Wang, L; Yan, XJ; Tan, YF; Guo, ZB; Qiu, JF; Yang, RF; Xia, PY; Zhou, DS				Sun, Fengjun; Zhang, Yiquan; Wang, Li; Yan, Xiaojuan; Tan, Yafang; Guo, Zhaobiao; Qiu, Jingfu; Yang, Ruifu; Xia, Peiyuan; Zhou, Dongsheng			Molecular Characterization of Direct Target Genes and cis-Acting Consensus Recognized by Quorum-Sensing Regulator AphA in Vibrio parahaemolyticus	PLOS ONE			English	Article							CONTROLS BIOFILM FORMATION; VIRULENCE ACTIVATOR APHA; GENOME SEQUENCE; III SECRETION; CHOLERAE; HARVEYI; EXPRESSION; REPRESSION; PLASMID; BINDING	Background: AphA is the master quorum-sensing (QS) regulator operating at low cell density in vibrios. Molecular regulation of target genes by AphA has been characterized in Vibrio harveyi and V. cholerae, but it is still poorly understood in V. parahaemolyticus. Methodology/Principal Findings: The AphA proteins are extremely conserved in V. parahaemolyticus, Vibrio sp. Ex25, Vibrio sp. EJY3, V. harveyi, V. vulnificus, V. splendidus, V. anguillarum, V. cholerae, and V. furnissii. The above nine AphA orthologs appear to recognize conserved cis-acting DNA signals which can be represented by two consensus constructs, a 20 bp box sequence and a position frequency matrix. V. parahaemolyticus AphA represses the transcription of ahpA, qrr4, and opaR through direct AphA-target promoter DNA association, while it inhibits the qrr2-3 transcription in an indirect manner. Translation and transcription starts, core promoter elements for sigma factor recognition, Shine-Dalgarno sequences for ribosome recognition, and AphA-binding sites (containing corresponding AphA box-like sequences) were determined for the three direct AphA targets ahpA, qrr4, and opaR in V. parahaemolyticus. Conclusions/Significance: AphA-mediated repression of ahpA, qrr2-4, and opaR was characterized in V. parahaemolyticus by using multiple biochemical and molecular experiments. The computational promoter analysis indicated the conserved mechanism of transcriptional regulation of QS regulator-encoding genes ahpA, qrr4, and opaR in vibrios.	[Sun, Fengjun; Xia, Peiyuan] Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing, Peoples R China; [Sun, Fengjun; Zhang, Yiquan; Wang, Li; Yan, Xiaojuan; Tan, Yafang; Guo, Zhaobiao; Yang, Ruifu; Zhou, Dongsheng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Li; Yan, Xiaojuan; Qiu, Jingfu] Chongqing Med Univ, Sch Publ Hlth, Chongqing, Peoples R China	Army Medical University; Beijing Institute of Microbiology & Epidemiology; Chongqing Medical University	Sun, FJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Pharm, Chongqing, Peoples R China.	py_xia@yahoo.com.cn; dongshengzhou1977@gmail.com	Zhang, Yiquan/AAP-3311-2021; Yang, Ruifu/A-2273-2011	Zhang, Yiquan/0000-0003-3935-4079; Yang, Ruifu/0000-0003-3219-7269; Zhou, Dongsheng/0000-0003-3827-5969	National Natural Science Foundation of China [31170127]; National Basic Research Program of China [2009CB522604]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	Financial support was provided by the National Natural Science Foundation of China (31170127), and by the National Basic Research Program of China (2009CB522604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews GP, 1996, INFECT IMMUN, V64, P2180, DOI 10.1128/IAI.64.6.2180-2187.1996; BALBAS P, 1986, GENE, V50, P3, DOI 10.1016/0378-1119(86)90307-0; Casselli T, 2008, INFECT IMMUN, V76, P2202, DOI 10.1128/IAI.01704-07; Chatterjee J, 1996, MOL MICROBIOL, V20, P415, DOI 10.1111/j.1365-2958.1996.tb02628.x; Chen CY, 2003, GENOME RES, V13, P2577, DOI 10.1101/gr.1295503; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Silva RS, 2005, J BIOL CHEM, V280, P13779, DOI 10.1074/jbc.M413781200; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Gode-Potratz CJ, 2011, J BACTERIOL; Hammer BK, 2003, MOL MICROBIOL, V50, P101, DOI 10.1046/j.1365-2958.2003.03688.x; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Henke JM, 2004, J BACTERIOL, V186, P6902, DOI 10.1128/JB.186.20.6902-6914.2004; Henke JM, 2004, J BACTERIOL, V186, P3794, DOI 10.1128/JB.186.12.3794-3805.2004; Hiyoshi H, 2010, INFECT IMMUN, V78, P1772, DOI 10.1128/IAI.01051-09; Kovacikova G, 2005, MOL MICROBIOL, V57, P420, DOI 10.1111/j.1365-2958.2005.04700.x; Kovacikova G, 2004, MOL MICROBIOL, V53, P129, DOI 10.1111/j.1365-2958.2004.04121.x; Kovacikova G, 2003, J BACTERIOL, V185, P4825, DOI 10.1128/JB.185.16.4825-4836.2003; Kovacikova G, 2002, MOL MICROBIOL, V46, P1135, DOI 10.1046/j.1365-2958.2002.03229.x; Kovacikova G, 2001, MOL MICROBIOL, V41, P393, DOI 10.1046/j.1365-2958.2001.02518.x; Le Roux F, 2009, ENVIRON MICROBIOL, V11, P1959, DOI 10.1111/j.1462-2920.2009.01918.x; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x; Lin BC, 2010, ENV MICROBIOL REP, V2, P81, DOI 10.1111/j.1758-2229.2009.00100.x; Lin W, 2005, J BACTERIOL, V187, P3013, DOI 10.1128/JB.187.9.3013-3019.2005; Lin W, 2007, MOL MICROBIOL, V64, P953, DOI 10.1111/j.1365-2958.2007.05693.x; Lux TM, 2011, J BACTERIOL; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Naka H, 2011, INFECT IMMUN, V79, P2889, DOI 10.1128/IAI.05138-11; PARALES RE, 1993, GENE, V133, P23, DOI 10.1016/0378-1119(93)90220-W; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Roh H, 2012, J BACTERIOL, V194, P2773, DOI 10.1128/JB.00303-12; Rutherford ST, 2011, GENE DEV, V25, P397, DOI 10.1101/gad.2015011; Sawabe T, 2007, J BACTERIOL, V189, P7932, DOI 10.1128/JB.00693-07; Shao CP, 2011, J BACTERIOL, V193, P2557, DOI 10.1128/JB.01259-10; Shao Y, 2012, MOL MICROBIOL, V83, P599, DOI 10.1111/j.1365-2958.2011.07959.x; Tamayo R, 2010, INFECT IMMUN, V78, P3560, DOI 10.1128/IAI.00048-10; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teng SW, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.30; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Tsou AM, 2010, INFECT IMMUN, V78, P461, DOI 10.1128/IAI.00590-09; Tu KC, 2008, MOL MICROBIOL, V70, P896, DOI 10.1111/j.1365-2958.2008.06452.x; Tu KC, 2007, GENE DEV, V21, P221, DOI 10.1101/gad.1502407; Tu KC, 2010, MOL CELL, V37, P567, DOI 10.1016/j.molcel.2010.01.022; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Waters CA, 2008, J BACTERIOL, V190, P2527, DOI 10.1128/JB.01756-07; Waters CM, 2006, GENE DEV, V20, P2754, DOI 10.1101/gad.1466506; Waters CM, 2010, APPL ENVIRON MICROB, V76, P4996, DOI 10.1128/AEM.00886-10; Yang MH, 2010, INFECT IMMUN, V78, P697, DOI 10.1128/IAI.00429-09; Yeung P S Marie, 2004, Foodborne Pathog Dis, V1, P74, DOI 10.1089/153531404323143594; Zhang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034622; Zhang YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025484; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	55	32	40	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44210	10.1371/journal.pone.0044210	http://dx.doi.org/10.1371/journal.pone.0044210			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984476	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500037
J	Downie, H; Holden, N; Otten, W; Spiers, AJ; Valentine, TA; Dupuy, LX				Downie, Helen; Holden, Nicola; Otten, Wilfred; Spiers, Andrew J.; Valentine, Tracy A.; Dupuy, Lionel X.			Transparent Soil for Imaging the Rhizosphere	PLOS ONE			English	Article							ESCHERICHIA-COLI; GROWTH; MICROSCOPY; MODEL; COLONIZATION; ARCHITECTURE; ARABIDOPSIS; TRANSPORT; ECOSYSTEM; SILICA	Understanding of soil processes is essential for addressing the global issues of food security, disease transmission and climate change. However, techniques for observing soil biology are lacking. We present a heterogeneous, porous, transparent substrate for in situ 3D imaging of living plants and root-associated microorganisms using particles of the transparent polymer, Nafion, and a solution with matching optical properties. Minerals and fluorescent dyes were adsorbed onto the Nafion particles for nutrient supply and imaging of pore size and geometry. Plant growth in transparent soil was similar to that in soil. We imaged colonization of lettuce roots by the human bacterial pathogen Escherichia coli O157:H7 showing micro-colony development. Micro-colonies may contribute to bacterial survival in soil. Transparent soil has applications in root biology, crop genetics and soil microbiology.	[Downie, Helen; Holden, Nicola; Valentine, Tracy A.; Dupuy, Lionel X.] James Hutton Inst, Dundee, Scotland; [Downie, Helen; Otten, Wilfred; Spiers, Andrew J.] Univ Abertay Dundee, SIMBIOS Ctr, Dundee, Scotland	James Hutton Institute; University of Abertay Dundee	Downie, H (corresponding author), James Hutton Inst, Dundee, Scotland.	Lionel.Dupuy@Hutton.ac.uk	Holden, Nicola/B-3038-2009; Valentine, Tracy A/C-2666-2009; Holden, Nicola/L-1653-2019; Otten, Wilfried/H-7168-2019; Dupuy, Lionel X/C-4433-2008; Spiers, Andrew/I-3535-2012; Otten, Wilfred/A-3990-2012	Holden, Nicola/0000-0002-7904-4529; Valentine, Tracy A/0000-0002-9064-2896; Holden, Nicola/0000-0002-7904-4529; Otten, Wilfried/0000-0002-3847-9825; Dupuy, Lionel X/0000-0001-5221-9037; Spiers, Andrew/0000-0003-0463-8629; Otten, Wilfred/0000-0002-3847-9825; Laurie, Helen/0000-0002-8974-1168	University of Abertay Dundee; James Hutton Institute; Scottish Government Rural and Environment Science and Analytical Services Division (RESAS, Workpackage 3.3)	University of Abertay Dundee; James Hutton Institute; Scottish Government Rural and Environment Science and Analytical Services Division (RESAS, Workpackage 3.3)	This work was funded by a joint studentship from the University of Abertay Dundee and the James Hutton Institute and the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS, Workpackage 3.3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOTTOMLEY PA, 1986, P NATL ACAD SCI USA, V83, P87, DOI 10.1073/pnas.83.1.87; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BUDWIG R, 1994, EXP FLUIDS, V17, P350, DOI 10.1007/BF01874416; CEYNOWA J, 1984, ANGEW MAKROMOL CHEM, V121, P97, DOI 10.1002/apmc.1984.051210109; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; de Villeneuve VWA, 2005, SCIENCE, V309, P1231, DOI 10.1126/science.1113207; Declerck S, 1998, MYCOLOGIA, V90, P579, DOI 10.2307/3761216; Dumais J, 2002, PLANT J, V31, P229, DOI 10.1046/j.1365-313X.2001.01350.x; Dupuy L, 2010, P NATL ACAD SCI USA, V107, P2711, DOI 10.1073/pnas.0906322107; Eickhorst T, 2008, SOIL BIOL BIOCHEM, V40, P1284, DOI 10.1016/j.soilbio.2007.06.019; Federici F, 2012, NATURE METH IN PRESS; Federici F, 2012, NAT METHODS, V9, P483, DOI [10.1038/NMETH.1940, 10.1038/nmeth.1940]; French A, 2009, PLANT PHYSIOL, V150, P1784, DOI 10.1104/pp.109.140558; Friman O, 2008, I S BIOMED IMAGING, P1047, DOI 10.1109/ISBI.2008.4541179; Gregory PJ, 2003, PLANT SOIL, V255, P351, DOI 10.1023/A:1026179919689; Habteselassie MY, 2010, J FOOD PROTECT, V73, P2001, DOI 10.4315/0362-028X-73.11.2001; Haynes JG, 2004, NEW PHYTOL, V163, P661, DOI 10.1111/j.1469-8137.2004.01138.x; Holden N. J., 2010, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V5, P1, DOI 10.1079/PAVSNNR20105047; Holden N, 2009, FEMS MICROBIOL REV, V33, P689, DOI 10.1111/j.1574-6976.2008.00153.x; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Iskander MG, 2002, J GEOTECH GEOENVIRON, V128, P262, DOI 10.1061/(ASCE)1090-0241(2002)128:3(262); Koenig M, 2006, MED IMAGING 2006 VIS; Kurup S, 2005, PLANT J, V42, P444, DOI 10.1111/j.1365-313X.2005.02386.x; LAL R, 2002, ENCY SOIL SCI; Leis AP, 2005, APPL ENVIRON MICROB, V71, P4801, DOI 10.1128/AEM.71.8.4801-4808.2005; Low AS, 2006, ENVIRON MICROBIOL, V8, P1033, DOI 10.1111/j.1462-2920.2006.00995.x; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; MANNHEIMER RJ, 1993, GROUND WATER, V31, P781, DOI 10.1111/j.1745-6584.1993.tb00851.x; Massa GD, 2003, PLANT J, V33, P435, DOI 10.1046/j.1365-313X.2003.01637.x; Mauritz KA, 2004, CHEM REV, V104, P4535, DOI 10.1021/cr0207123; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Miransari M, 2011, APPL MICROBIOL BIOT, V92, P875, DOI 10.1007/s00253-011-3521-y; Pansu M, 2006, HDB SOIL ANAL, P755; Preibisch S, 2010, NAT METHODS, V7, P418, DOI 10.1038/nmeth0610-418; RIEBERER S, 1992, ULTRAMICROSCOPY, V41, P225, DOI 10.1016/0304-3991(92)90111-V; Salerno HLS, 2011, J POLYM SCI B; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schmidt S, 2011, ROOT RESPONSES SOIL; Schroth MH, 1996, SOIL SCI SOC AM J, V60, P1331, DOI 10.2136/sssaj1996.03615995006000050007x; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Thomas G.W., 1982, METHODS SOIL ANAL; Van Nguyen T, 2007, J ELECTROCHEMICAL SO, V154, P4; XUE T, 1989, J MEMBRANE SCI, V45, P261, DOI 10.1016/S0376-7388(00)80518-9; Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394	45	118	124	7	127	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44276	10.1371/journal.pone.0044276	http://dx.doi.org/10.1371/journal.pone.0044276			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984484	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700051
J	Hampson, M; Tokoglu, F; Shen, XL; Scheinost, D; Papademetris, X; Constable, RT				Hampson, Michelle; Tokoglu, Fuyuze; Shen, Xilin; Scheinost, Dustin; Papademetris, Xenophon; Constable, R. Todd			Intrinsic Brain Connectivity Related to Age in Young and Middle Aged Adults	PLOS ONE			English	Article							LIFE-SPAN; FUNCTIONAL CONNECTIVITY; MEMORY PERFORMANCE; EMOTIONAL FACES; DEFAULT NETWORK; WORKING-MEMORY; CORTICAL HUBS; OLDER-ADULTS; SMALL-WORLD; BLOOD-FLOW	Age-related variations in resting state connectivity of the human brain were examined from young adulthood through middle age. A voxel-based network measure, degree, was used to assess age-related differences in tissue connectivity throughout the brain. Increases in connectivity with age were found in paralimbic cortical and subcortical regions. Decreases in connectivity were found in cortical regions, including visual areas and the default mode network. These findings differ from those of recent developmental studies examining earlier growth trajectories, and are consistent with known changes in cognitive function and emotional processing during mature aging. The results support and extend previous findings that relied on a priori definitions of regions of interest for their analyses. This approach of applying a voxel-based measure to examine the functional connectivity of individual tissue elements over time, without the need for a priori region of interest definitions, provides an important new tool in brain science.	[Hampson, Michelle; Tokoglu, Fuyuze; Shen, Xilin; Papademetris, Xenophon; Constable, R. Todd] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Scheinost, Dustin; Papademetris, Xenophon; Constable, R. Todd] Yale Univ, Dept Biomed Engn, New Haven, CT USA	Yale University; Yale University	Hampson, M (corresponding author), Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA.	michelle.hampson@yale.edu	Scheinost, Dustin/Q-2857-2018; Shen, Xilin/F-4349-2011; Constable, R. Todd/ABE-8038-2021; Hampson, Michelle/K-6732-2015	Scheinost, Dustin/0000-0002-6301-1167; Constable, R. Todd/0000-0001-5661-9521; Hampson, Michelle/0000-0003-3173-4210; Shen, Xilin/0000-0003-1006-7404	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health [RO1EB009666-02, R01 EB006494]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009666, R01EB006494] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institute of Biomedical Imaging and Bioengineering at the National Institutes of Health (grant numbers: RO1EB009666-02, R01 EB006494, funder's website: http://www.nibib.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Bentourkia M, 2000, J NEUROL SCI, V181, P19, DOI 10.1016/S0022-510X(00)00396-8; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burdette JH, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00023; Cabeza R, 2004, CEREB CORTEX, V14, P364, DOI 10.1093/cercor/bhg133; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; Charles ST, 2003, J EXP PSYCHOL GEN, V132, P310, DOI 10.1037/0096-3445.132.2.310; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Grady CL, 2007, NEUROPSYCHOLOGY, V21, P371, DOI 10.1037/0894-4105.21.3.371; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Gross JJ, 1997, PSYCHOL AGING, V12, P590, DOI 10.1037/0882-7974.12.4.590; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Holmes CJ, 1998, J COMPUT ASSIST TOMO, V22, P324, DOI 10.1097/00004728-199803000-00032; Jelsing J, 2006, BRAIN RES BULL, V70, P322, DOI 10.1016/j.brainresbull.2006.06.009; LABOUVIEVIEF G, 1989, HUM DEV, V32, P279, DOI 10.1159/000276480; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; LAWTON MP, 1992, PSYCHOL AGING, V7, P171, DOI 10.1037/0882-7974.7.2.171; Levine LJ, 1997, PSYCHOL AGING, V12, P514, DOI 10.1037/0882-7974.12.3.514; Martuzzi R, 2011, NEUROIMAGE; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Mather M, 2003, PSYCHOL SCI, V14, P409, DOI 10.1111/1467-9280.01455; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Orgeta V, 2009, AGING MENT HEALTH, V13, P818, DOI 10.1080/13607860902989661; Papademetris X, 2004, LECT NOTES COMPUT SC, V3216, P763; Park DC, 1996, PSYCHOL AGING, V11, P621, DOI 10.1037/0882-7974.11.4.621; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raz N, 2004, NEUROBIOL AGING, V25, P377, DOI 10.1016/S0197-4580(03)00118-0; Salthouse TA, 2003, PSYCHOL AGING, V18, P91, DOI 10.1037/0882-7974.18.1.91; Salvador Raymond, 2010, Front Neuroinform, V4, P115, DOI 10.3389/fninf.2010.00115; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Scheinost D, 2012, NEUROIMAGE; Shen X, 2010, NEUROIMAGE, V50, P1027, DOI 10.1016/j.neuroimage.2009.12.119; SONG M, 2009, EMBC 2009 ANN INT C, P2212; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Thomas RC, 2006, PSYCHOL AGING, V21, P821, DOI 10.1037/0882-7974.21.4.821; TOMASI D, 2011, NEUROIMAGE; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011	55	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44067	10.1371/journal.pone.0044067	http://dx.doi.org/10.1371/journal.pone.0044067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003VE	22984460	gold, Green Published, Green Submitted			2022-12-25	WOS:000308638700042
J	MacPherson, P; Corbett, EL; Makombe, SD; van Oosterhout, JJ; Manda, E; Choko, AT; Thindwa, D; Squire, SB; Mann, GH; Lalloo, DG				MacPherson, Peter; Corbett, Elizabeth L.; Makombe, Simon D.; van Oosterhout, Joep J.; Manda, Eddie; Choko, Augustine T.; Thindwa, Deus; Squire, S. Bertel; Mann, Gillian H.; Lalloo, David G.			Determinants and Consequences of Failure of Linkage to Antiretroviral Therapy at Primary Care Level in Blantyre, Malawi: A Prospective Cohort Study	PLOS ONE			English	Article							PUBLIC-HEALTH APPROACH; SUB-SAHARAN AFRICA; SOUTH-AFRICA; FOLLOW-UP; TUBERCULOSIS SERVICES; INCOME COUNTRIES; HIV CARE; SCALE-UP; MORTALITY; DURBAN	Background: Poor rates of linkage from HIV diagnosis to ART initiation are a major barrier to universal coverage of ART in sub-Saharan Africa, with reasons for failure poorly understood. In the first study of this kind at primary care level, we investigated the pathway to care in the Malawian National Programme, one of the strongest in Africa. Methods and Findings: A prospective cohort study was undertaken at two primary care clinics in Blantyre, Malawi. Newly diagnosed HIV-positive adults (>15 years) were followed for 6-months to assess completion of eligibility assessments, initiation of ART and death. Two hundred and eighty participants were followed for 82.6 patient-years. ART eligibility assessments were problematic: only 134 (47.9%) received same day WHO staging and 121 (53.2%) completed assessments by 6-months. Completion of CD4 measurement (stage 1/2 only) was 81/153 (52.9%). By 6-months, 87/280 (31.1%) had initiated ART with higher uptake in participants who were ART eligible (68/91, 74.7%), and among participants who received same-day staging (52/134 [38.8%] vs. 35/146 [24.0%] p = 0.007). Non-completion of ART eligibility assessments (adjusted hazard ratio: 0.11, 95% CI: 0.06-0.21) was associated with failure to initiate ART. Retention in pre-ART care for non-ART initiators was low (55/193 [28.5%]). Of the 15 (5.4%) deaths, 11 (73.3%) occurred after ART initiation. Conclusions: Although uptake of ART was high and prompt for patients with known eligibility, there was frequent failure to complete eligibility assessment and poor retention in pre-ART care. HIV care programmes should urgently evaluate the way patients are linked to ART. In particular, there is a critical need for simplified, same-day ART eligibility assessments, reduced requirements for hospital visits, and active defaulter follow-up.	[MacPherson, Peter; Squire, S. Bertel; Mann, Gillian H.; Lalloo, David G.] Univ Liverpool, Liverpool Sch Trop Med, Clin Grp, Liverpool L3 5QA, Merseyside, England; [MacPherson, Peter; Corbett, Elizabeth L.; Choko, Augustine T.; Thindwa, Deus] Malawi Liverpool Wellcome Trust Clin Res Programm, HIV & TB Grp, Blantyre, Malawi; [Corbett, Elizabeth L.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England; [Makombe, Simon D.] Minist Hlth, HIV Unit, Lilongwe, Malawi; [van Oosterhout, Joep J.] Univ Malawi, Coll Med, Blantyre, Malawi; [Manda, Eddie] Blantyre Dist Hlth Off, Blantyre, Malawi	Liverpool School of Tropical Medicine; University of Liverpool; University of Malawi; University of London; London School of Hygiene & Tropical Medicine; University of Malawi	MacPherson, P (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Clin Grp, Liverpool L3 5QA, Merseyside, England.	p.macpherson@liverpool.ac.uk	MacPherson, Peter/AHD-2477-2022	MacPherson, Peter/0000-0002-0329-9613; Corbett, Elizabeth/0000-0002-3552-3181; Squire, Stephen/0000-0001-7173-9038; Thindwa, Deus/0000-0003-4845-7862; Lalloo, David/0000-0001-7680-2200	Wellcome Trust [WT089673]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (grant number: WT089673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; April MD, 2009, JAIDS-J ACQ IMM DEF, V51, P310, DOI 10.1097/QAI.0b013e3181a248e6; Ayalon L, 2009, ARCH INTERN MED, V169, P2156, DOI 10.1001/archinternmed.2009.386; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; Baveewo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019089; Benson T, 2006, C INT ASS AGR EC IAA; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Cohen T, 2011, LANCET, V378, P204, DOI 10.1016/S0140-6736(11)60896-9; COLEBUNDERS R, 1987, LANCET, V1, P492; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Harries AD, 2011, JAIDS-J ACQ IMM DEF, V57, pS64, DOI 10.1097/QAI.0b013e31821f6bab; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; HIV & AIDS Unit-Ministry of Health of Malawi, 2011, Q PROGR REP; Ingle SM, 2010, AIDS, V24, P2717, DOI 10.1097/QAD.0b013e32833fb71f; Jani IV, 2011, LANCET, V378, P1572, DOI 10.1016/S0140-6736(11)61052-0; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Kemp JR, 2007, B WORLD HEALTH ORGAN, V85, P580, DOI 10.2471/BLT.06.033167; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Lowrance DW, 2008, JAIDS-J ACQ IMM DEF, V49, P287, DOI 10.1097/QAI.0b013e3181893ef0; MacPherson P, 2012, TROP MED INT HEALTH, V17, P507, DOI 10.1111/j.1365-3156.2011.02946.x; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Ministry of Health of Malawi, 2011, MAL GUID CLIN MAN HI; National AIDS Commission, 2005, NAT EST HHIV AIDS MA; National Statistics Office of Malawi, 1998, INT HOUS SURV; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Simwaka BN, 2007, INT J TUBERC LUNG D, V11, P65; Tayler-Smith K, 2010, T ROY SOC TROP MED H, V104, P313, DOI 10.1016/j.trstmh.2010.01.007; UNAIDS, 2010, GLOB REP UNAIDS REP; Wanyenze RK, 2011, AIDS BEHAV, V15, P751, DOI 10.1007/s10461-010-9704-1; Zachariah R, 2011, TROP MED INT HEALTH, V16, P37, DOI 10.1111/j.1365-3156.2010.02669.x; Zachariah R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000121	37	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44794	10.1371/journal.pone.0044794	http://dx.doi.org/10.1371/journal.pone.0044794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984560	Green Accepted, gold, Green Published			2022-12-25	WOS:000308638700083
J	Sripada, L; Tomar, D; Prajapati, P; Singh, R; Singh, AK; Singh, R				Sripada, Lakshmi; Tomar, Dhanendra; Prajapati, Paresh; Singh, Rochika; Singh, Arun Kumar; Singh, Rajesh			Systematic Analysis of Small RNAs Associated with Human Mitochondria by Deep Sequencing: Detailed Analysis of Mitochondrial Associated miRNA	PLOS ONE			English	Article							NUAGE FORMATION; PROTEIN IMPORT; STRESS; LIFE; IDENTIFICATION; BIOGENESIS; EXPRESSION; DISORDERS; MICRORNAS; CYTOPLASM	Mitochondria are one of the central regulators of many cellular processes beyond its well established role in energy metabolism. The inter-organellar crosstalk is critical for the optimal function of mitochondria. Many nuclear encoded proteins and RNA are imported to mitochondria. The translocation of small RNA (sRNA) including miRNA to mitochondria and other sub-cellular organelle is still not clear. We characterized here sRNA including miRNA associated with human mitochondria by cellular fractionation and deep sequencing approach. Mitochondria were purified from HEK293 and HeLa cells for RNA isolation. The sRNA library was generated and sequenced using Illumina system. The analysis showed the presence of unique population of sRNA associated with mitochondria including miRNA. Putative novel miRNAs were characterized from unannotated sRNA sequences. The study showed the association of 428 known, 196 putative novel miRNAs to mitochondria of HEK293 and 327 known, 13 putative novel miRNAs to mitochondria of HeLa cells. The alignment of sRNA to mitochondrial genome was also studied. The targets were analyzed using DAVID to classify them in unique networks using GO and KEGG tools. Analysis of identified targets showed that miRNA associated with mitochondria regulates critical cellular processes like RNA turnover, apoptosis, cell cycle and nucleotide metabolism. The six miRNAs (counts >1000) associated with mitochondria of both HEK293 and HeLa were validated by RT-qPCR. To our knowledge, this is the first systematic study demonstrating the associations of sRNA including miRNA with mitochondria that may regulate site-specific turnover of target mRNA important for mitochondrial related functions.	[Sripada, Lakshmi; Tomar, Dhanendra; Prajapati, Paresh; Singh, Arun Kumar; Singh, Rajesh] Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Dept Cell Biol, Gandhinagar, India; [Singh, Rochika] Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Dept Human Hlth & Dis, Gandhinagar, India		Sripada, L (corresponding author), Indian Inst Adv Res, Sch Biol Sci & Biotechnol, Dept Cell Biol, Gandhinagar, India.	rsingh@iiar.res.in	Tomar, Dhanendra/A-1050-2012; Tomar, Dhanendra/H-3358-2019; Prajapati, Paresh/P-1058-2019	Tomar, Dhanendra/0000-0002-3144-7257; Tomar, Dhanendra/0000-0002-3144-7257; Prajapati, Paresh/0000-0002-3734-4662; Singh, Rajesh/0000-0002-4986-3486	Department of Biotechnology, Govt. of India [BT/PR12906/AGR/36/638/2009]; CSIR (Council of Scientific & Industrial Research), Govt. of India; UGC (University Grants Commission), Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); CSIR (Council of Scientific & Industrial Research), Govt. of India; UGC (University Grants Commission), Govt. of India	This work was supported by Department of Biotechnology, Govt. of India (BT/PR12906/AGR/36/638/2009). Dhanendra Tomar received Senior Research Fellowship from CSIR (Council of Scientific & Industrial Research), Govt. of India. Lakshmi Sripada received Junior Research Fellowship from UGC (University Grants Commission), Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Aravin AA, 2011, DEV CELL, V20, P287, DOI 10.1016/j.devcel.2011.03.003; Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Baltzer C, 2010, MITOCHONDRION, V10, P589, DOI 10.1016/j.mito.2010.07.009; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Barrey E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020220; Bian Z, 2010, CELL RES, V20, P1076, DOI 10.1038/cr.2010.119; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Cande C, 2004, J CELL SCI, V117, P4461, DOI 10.1242/jcs.01356; Chatterjee A, 2011, CANCER PREV RES, V4, P638, DOI 10.1158/1940-6207.CAPR-10-0326; Cloonan SM, 2011, CURRENT OPINION IMMU; DiMauro S, 2011, SEMIN FETAL NEONAT M, V16, P181, DOI 10.1016/j.siny.2011.04.010; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Ernoult-Lange M, 2012, BIOCHIMIE; Goetzman ES, 2011, PROG MOL BIOL TRANSL, V100, P389, DOI 10.1016/B978-0-12-384878-9.00010-8; Guerra-Assuncao JA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-133; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI [10.4110/in.2011.11.3.135, 10.4110/in.2011.11.1.11]; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Hernandez-Cid A, 2012, IUBMB LIFE, V64, P521, DOI 10.1002/iub.1052; Huang HY, 2011, DEV CELL, V20, P376, DOI 10.1016/j.devcel.2011.01.004; Huang L, 2011, J BIOL CHEM, V286, P24219, DOI 10.1074/jbc.M111.240259; Hwang AB, 2011, AGING-US, V3, P304, DOI 10.18632/aging.100292; Kaldi K, 1998, BIOFACTORS, V8, P221, DOI 10.1002/biof.5520080308; Kamp DW, 2011, ONCOLOGY-NY, V25, P400; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lindstrom MS, 2008, J BIOL CHEM, V283, P15568, DOI 10.1074/jbc.M801151200; Maniataki E, 2005, RNA, V11, P849, DOI 10.1261/rna.2210805; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Ouyang YB, 2011, MITOCHONDRION; Puranam RS, 2001, MOL CELL BIOL, V21, P548, DOI 10.1128/MCB.21.2.548-561.2001; Rubio MAT, 2011, WIRES RNA, V2, P802, DOI 10.1002/wrna.93; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Sano E, 2008, BBA-MOL CELL RES, V1783, P1036, DOI 10.1016/j.bbamcr.2007.12.009; Schmidt O, 2010, NAT REV MOL CELL BIO, V11, P655, DOI 10.1038/nrm2959; Schneider A, 2011, ANNU REV BIOCHEM, V80, P1033, DOI 10.1146/annurev-biochem-060109-092838; Schon EA, 2011, NEURON, V70, P1033, DOI 10.1016/j.neuron.2011.06.003; Seitz Herve, 2011, Silence, V2, P4, DOI 10.1186/1758-907X-2-4; Sieber F, 2011, INT REV CEL MOL BIO, V287, P145, DOI 10.1016/B978-0-12-386043-9.00004-9; Smirnov A, 2011, GENE DEV, V25, P1289, DOI 10.1101/gad.624711; Tomar D, 2012, BBA-MOL CELL RES, V1823, P316, DOI 10.1016/j.bbamcr.2011.11.015; Wang C, 2011, EXPERT OPIN THER TAR, V15, P647, DOI 10.1517/14728222.2011.561321; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Watanabe T, 2011, DEV CELL, V20, P364, DOI 10.1016/j.devcel.2011.01.005; Yan Z, 2011, NUCLEIC ACIDS RES, V39, P6596, DOI 10.1093/nar/gkr298; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Zhang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004677	54	111	117	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44873	10.1371/journal.pone.0044873	http://dx.doi.org/10.1371/journal.pone.0044873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984580	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700095
J	Tsafnat, N; Gerald, JDF; Le, HN; Stachurski, ZH				Tsafnat, Naomi; Gerald, John D. Fitz; Le, Hai N.; Stachurski, Zbigniew H.			Micromechanics of Sea Urchin Spines	PLOS ONE			English	Article							AMORPHOUS CALCIUM-CARBONATE; STRENGTH; GROWTH; DESIGN; MODEL	The endoskeletal structure of the Sea Urchin, Centrostephanus rodgersii, has numerous long spines whose known functions include locomotion, sensing, and protection against predators. These spines have a remarkable internal microstructure and are made of single-crystal calcite. A finite-element model of the spine's unique porous structure, based on micro-computed tomography (microCT) and incorporating anisotropic material properties, was developed to study its response to mechanical loading. Simulations show that high stress concentrations occur at certain points in the spine's architecture; brittle cracking would likely initiate in these regions. These analyses demonstrate that the organization of single-crystal calcite in the unique, intricate morphology of the sea urchin spine results in a strong, stiff and lightweight structure that enhances its strength despite the brittleness of its constituent material.	[Tsafnat, Naomi] Univ New S Wales, Sch Mech & Mfg Engn, Sydney, NSW, Australia; [Gerald, John D. Fitz] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Le, Hai N.; Stachurski, Zbigniew H.] Australian Natl Univ, Res Sch Engn, Canberra, ACT, Australia	University of New South Wales Sydney; Australian National University; Australian National University	Tsafnat, N (corresponding author), Univ New S Wales, Sch Mech & Mfg Engn, Sydney, NSW, Australia.	n.tsafnat@unsw.edu.au	Stachurski, Zbigniew/ABB-5555-2021; Stachurski, Zbigniew/ABB-3542-2021; Tsafnat, Naomi/F-9710-2012	Stachurski, Zbigniew/0000-0002-1317-0178; Tsafnat, Naomi/0000-0002-6687-3731				Abou Chakra M, 2011, PALEOBIOLOGY, V37, P686, DOI 10.1666/10012.1; Abou Chakra M, 2011, J THEOR BIOL, V285, P113, DOI 10.1016/j.jtbi.2011.06.019; Bejan A., 2000, SHAPE STRUCTURE ENG; Bejan A, 2010, PHILOS T R SOC B, V365, P1335, DOI 10.1098/rstb.2009.0302; BERMAN A, 1990, SCIENCE, V250, P664, DOI 10.1126/science.250.4981.664; BURKHARDT A, 1983, ZOOMORPHOLOGY, V102, P189, DOI 10.1007/BF00310347; Chen CC, 2001, AM MINERAL, V86, P1525; Donovan Stephen K., 1999, P565; Jiang B-Y, 2008, LAS EL 2008 2008 C Q, P1; KARAM GN, 1994, MAT SCI ENG C-BIOMIM, V2, P113, DOI 10.1016/0928-4931(94)90039-6; Lawn B, 1993, CAMBRIDGE AB SOLID S, V2nd, DOI 10.10177cbo9780511623127; Lorente S, 2010, INT J HEAT MASS TRAN, V53, P2963, DOI 10.1016/j.ijheatmasstransfer.2010.03.038; Magdans U, 2004, EUR J MINERAL, V16, P261, DOI 10.1127/0935-1221/2004/0016-0261; Newnham R. E., 2005, PROPERTIES MAT; Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289; Politi Y, 2008, P NATL ACAD SCI USA, V105, P17362, DOI 10.1073/pnas.0806604105; Russ J. C., 1984, FUNDAMENTALS ENERGY; Seto J, 2012, P NATL ACAD SCI USA, V109, P3699, DOI 10.1073/pnas.1109243109; Stock SR, 2010, ECHINODERMS: DURHAM, P263; Stock S.R., 2006, DEV XRAY TOMOGRAPHY, VV; STRATHMANN RR, 1981, PALEOBIOLOGY, V7, P400, DOI 10.1017/S0094837300004693; Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242; Sugarman B, 1967, J MATER SCI, V2, P275, DOI 10.1007/BF00555385; Tsafnat N, 2008, FUEL, V87, P2983, DOI 10.1016/j.fuel.2008.03.027; Woodward AE., 1989, ATLAS POLYM MORPHOLO; Zachos LG, 2009, J THEOR BIOL, V259, P646, DOI 10.1016/j.jtbi.2009.04.007	26	20	20	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44140	10.1371/journal.pone.0044140	http://dx.doi.org/10.1371/journal.pone.0044140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984468	Green Submitted, Green Published, gold			2022-12-25	WOS:000308638700045
J	Olechnowicz, SWZ; Fedele, AO; Peet, DJ				Olechnowicz, Sam W. Z.; Fedele, Anthony O.; Peet, Daniel J.			Hypoxic Induction of the Regulator of G-Protein Signalling 4 Gene Is Mediated by the Hypoxia-Inducible Factor Pathway	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEINS; ENDOTHELIAL GROWTH-FACTOR; HUMAN NEUROBLASTOMA-CELLS; PAS DOMAIN PROTEIN-1; END RULE PATHWAY; TRANSCRIPTION FACTOR; FACTOR (HIF)-1-ALPHA; FACTOR-I; TRANSACTIVATION DOMAIN; PROLYL HYDROXYLATION	The transcriptional response to hypoxia is largely dependent on the Hypoxia Inducible Factors (HIF-1 and HIF-2) in mammalian cells. Many target genes have been characterised for these heterodimeric transcription factors, yet there is evidence that the full range of HIF-regulated genes has not yet been described. We constructed a TetON overexpression system in the rat pheochromocytoma PC-12 cell line to search for novel HIF and hypoxia responsive genes. The Rgs4 gene encodes the Regulator of G-Protein Signalling 4 (RGS4) protein, an inhibitor of signalling from G-protein coupled receptors, and dysregulation of Rgs4 is linked to disease states such as schizophrenia and cardiomyopathy. Rgs4 was found to be responsive to HIF-2 alpha overexpression, hypoxic treatment, and hypoxia mimetic drugs in PC-12 cells. Similar responses were observed in human neuroblastoma cell lines SK-N-SH and SK-N-BE(2) C, but not in endothelial cells, where Rgs4 transcript is readily detected but does not respond to hypoxia. Furthermore, this regulation was found to be dependent on transcription, and occurs in a manner consistent with direct HIF transactivation of Rgs4 transcription. However, no HIF binding site was detectable within 32 kb of the human Rgs4 gene locus, leading to the possibility of regulation by long-distance genomic interactions. Further research into Rgs4 regulation by hypoxia and HIF may result in better understanding of disease states such as schizophrenia, and also shed light on the other roles of HIF yet to be discovered.	[Olechnowicz, Sam W. Z.; Peet, Daniel J.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Olechnowicz, Sam W. Z.; Peet, Daniel J.] Univ Adelaide, ARC Special Res Ctr Mol Genet Dev, Adelaide, SA, Australia; [Fedele, Anthony O.] SA Pathol, LDRU, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; SA Pathology	Olechnowicz, SWZ (corresponding author), Univ Oxford, Nuffield Dept Surg Sci, Oxford, England.	daniel.peet@adelaide.edu.au	Olechnowicz, Sam/I-3082-2014; Peet, Daniel/AAE-6698-2020	Olechnowicz, Sam/0000-0001-7879-7708; Peet, Daniel/0000-0002-6085-8936	ARC Special Centre for the Molecular Genetics of Development (CMGD); National Health and Medical Research Council of Australia (NHMRC)	ARC Special Centre for the Molecular Genetics of Development (CMGD)(Australian Research Council); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the ARC Special Centre for the Molecular Genetics of Development (CMGD, http://www.cmgd.adelaide.edu.au) and the National Health and Medical Research Council of Australia (NHMRC, http://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agani FH, 2000, J BIOL CHEM, V275, P35863, DOI 10.1074/jbc.M005643200; Albig AR, 2005, MOL BIOL CELL, V16, P609, DOI 10.1091/mbc.e04-06-0479; AUGUSTIT.G, 1969, P NATL ACAD SCI USA, V64, P311, DOI 10.1073/pnas.64.1.311; Barrett JM, 2011, MICROCIRCULATION, V18, P583, DOI 10.1111/j.1549-8719.2011.00119.x; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; BIEDLER JL, 1973, CANCER RES, V33, P2643; Bracken CP, 2006, J BIOL CHEM, V281, P22575, DOI 10.1074/jbc.M600288200; Cannon TD, 2000, SCHIZOPHRENIA BULL, V26, P351, DOI 10.1093/oxfordjournals.schbul.a033458; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Conrad PW, 1999, J BIOL CHEM, V274, P33709, DOI 10.1074/jbc.274.47.33709; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Flamme I, 1997, MECH DEVELOP, V63, P51, DOI 10.1016/S0925-4773(97)00674-6; Flamme I, 1998, AM J PATHOL, V153, P25, DOI 10.1016/S0002-9440(10)65541-1; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Garayoa M, 2000, MOL ENDOCRINOL, V14, P848, DOI 10.1210/me.14.6.848; Garnier M, 2003, J PHARMACOL EXP THER, V304, P1299, DOI 10.1124/jpet.102.043471; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gu YZ, 1998, GENE EXPRESSION, V7, P205; Hara S, 2001, BIOCHEM BIOPH RES CO, V287, P808, DOI 10.1006/bbrc.2001.5659; Ho GY, 2007, PHARMACOLOGY, V79, P114, DOI 10.1159/000098097; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jin Y, 2009, J BIOL CHEM, V284, P23436, DOI 10.1074/jbc.M109.032664; Jogi A, 2004, EXP CELL RES, V295, P469, DOI 10.1016/j.yexcr.2004.01.013; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; King M, 2010, MOL GENET GENOMICS, V284, P425, DOI 10.1007/s00438-010-0579-7; Konietzny R, 2009, ANN NY ACAD SCI, V1177, P74, DOI 10.1111/j.1749-6632.2009.05029.x; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Leontiadis LJ, 2009, CELL SIGNAL, V21, P1218, DOI 10.1016/j.cellsig.2009.03.013; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Miyazaki K, 2002, J BIOL CHEM, V277, P47014, DOI 10.1074/jbc.M204938200; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Mosser DD, 1997, BIOTECHNIQUES, V22, P150, DOI 10.2144/97221rr02; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Muller PY, 2001, BIOTECHNIQUES, V31, P1306, DOI 10.2144/01316bc01; Murray RM, 2008, EUR NEUROPSYCHOPHARM, V18, pS129, DOI 10.1016/j.euroneuro.2008.04.002; Nakamura H, 2008, ONCOGENE, V27, P4200, DOI 10.1038/onc.2008.58; Nilsson H, 2005, EXP CELL RES, V303, P447, DOI 10.1016/j.yexcr.2004.10.003; Nomoto S, 1997, BIOCHEM BIOPH RES CO, V241, P281, DOI 10.1006/bbrc.1997.7802; O'Rourke JF, 1999, J BIOL CHEM, V274, P2060, DOI 10.1074/jbc.274.4.2060; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Pescador N, 2005, BIOCHEM J, V390, P189, DOI 10.1042/BJ20042121; Rogers JH, 1999, J CLIN INVEST, V104, P567, DOI 10.1172/JCI6713; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schmidt-Kastner R, 2012, MOL PSYCHIAT; Schmidt-Kastner R, 2006, SCHIZOPHR RES; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Sowter HM, 2003, CANCER RES, V63, P6130; Tamirisa P, 1999, CIRCULATION, V99, P441, DOI 10.1161/01.CIR.99.3.441; Tejkalova H, 2007, PHYSIOL RES, V56, P815, DOI 10.33549/physiolres.931056; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang Q, 2009, J BIOL CHEM, V284, P18357, DOI 10.1074/jbc.M109.015453; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Yan YB, 1997, J BIOL CHEM, V272, P11924, DOI 10.1074/jbc.272.18.11924; Zhang SA, 1998, J MOL CELL CARDIOL, V30, P269, DOI 10.1006/jmcc.1997.0591	71	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44564	10.1371/journal.pone.0044564	http://dx.doi.org/10.1371/journal.pone.0044564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970249	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000029
J	Ayer, A; Fellermeier, S; Fife, C; Li, SS; Smits, G; Meyer, AJ; Dawes, IW; Perrone, GG				Ayer, Anita; Fellermeier, Sina; Fife, Christopher; Li, Simone S.; Smits, Gertien; Meyer, Andreas J.; Dawes, Ian W.; Perrone, Gabriel G.			A Genome-Wide Screen in Yeast Identifies Specific Oxidative Stress Genes Required for the Maintenance of Sub-Cellular Redox Homeostasis	PLOS ONE			English	Article							DISULFIDE RELAY SYSTEM; SACCHAROMYCES-CEREVISIAE; GLUTATHIONE-REDUCTASE; OXIDIZED GLUTATHIONE; THIOREDOXIN; EXPRESSION; GLUTAREDOXIN; MITOCHONDRIA; PEROXISOMES; INVOLVEMENT	Maintenance of an optimal redox environment is critical for appropriate functioning of cellular processes and cell survival. Despite the importance of maintaining redox homeostasis, it is not clear how the optimal redox potential is sensed and set, and the processes that impact redox on a cellular/organellar level are poorly understood. The genetic bases of cellular redox homeostasis were investigated using a green fluorescent protein (GFP) based redox probe, roGFP2 and a pH sensitive GFP-based probe, pHluorin. The use of roGFP2, in conjunction with pHluorin, enabled determination of pH-adjusted sub-cellular redox potential in a non-invasive and real-time manner. A genome-wide screen using both the non-essential and essential gene collections was carried out in Saccharomyces cerevisiae using cytosolic-roGFP2 to identify factors essential for maintenance of cytosolic redox state under steady-state conditions. 102 genes of diverse function were identified that are required for maintenance of cytosolic redox state. Mutations in these genes led to shifts in the half-cell glutathione redox potential by 75-10 mV. Interestingly, some specific oxidative stress-response processes were identified as over-represented in the data set. Further investigation of the role of oxidative stress-responsive systems in sub-cellular redox homeostasis was conducted using roGFP2 constructs targeted to the mitochondrial matrix and peroxisome and E-GSH was measured in cells in exponential and stationary phase. Analyses allowed for the identification of key redox systems on a sub-cellular level and the identification of novel genes involved in the regulation of cellular redox homeostasis.	[Ayer, Anita; Fellermeier, Sina; Fife, Christopher; Li, Simone S.; Dawes, Ian W.] Univ New S Wales, Sydney, NSW, Australia; [Smits, Gertien] Univ Amsterdam, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Meyer, Andreas J.] Univ Bonn, INRES Chem Signalling, Bonn, Germany; [Perrone, Gabriel G.] Univ Western Sydney, Penrith, NSW 1797, Australia	University of New South Wales Sydney; University of Amsterdam; University of Bonn; Western Sydney University	Ayer, A (corresponding author), Univ New S Wales, Sydney, NSW, Australia.	i.dawes@unsw.edu.au	Smits, Gertien J./I-4327-2014; Meyer, Andreas J/C-4734-2013	Smits, Gertien J./0000-0002-8439-7791; Meyer, Andreas J/0000-0001-8144-4364; Li, Simone S/0000-0002-0073-3656; Ayer, Anita/0000-0002-7073-2835	Australian Postgraduate Award; Australian Research Council; Unilever; Deutsche Forschungsgemeinschaft [ME1567/5-1]	Australian Postgraduate Award(Australian Government); Australian Research Council(Australian Research Council); Unilever(Unilever); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was funded by Australian Postgraduate Award (to AA) and a Discovery grant from the Australian Research Council (to IWD and GGP). Work in GJS's lab was partially funded by Unilever and work in AJM's laboratory was funded by the Deutsche Forschungsgemeinschaft (grant ME1567/5-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Ali R, 2004, J BIOL CHEM, V279, P4498, DOI 10.1074/jbc.M307446200; Antonenkov VD, 2010, ANTIOXID REDOX SIGN, V13, P525, DOI 10.1089/ars.2009.2996; Ayer A, 2010, FREE RADICAL BIO MED, V49, P1956, DOI 10.1016/j.freeradbiomed.2010.09.023; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Brace JL, 2005, YEAST, V22, P641, DOI 10.1002/yea.1235; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Charizanis C, 1999, MOL GEN GENET, V262, P437, DOI 10.1007/s004380051103; DAIGNANFORNIER B, 1994, MOL GEN GENET, V243, P575, DOI 10.1007/BF00284206; Dardalhon M, 2012, FREE RADICAL BIO MED, V52, P2254, DOI 10.1016/j.freeradbiomed.2012.04.004; Draculic T, 2000, MOL MICROBIOL, V36, P1167, DOI 10.1046/j.1365-2958.2000.01948.x; Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001; FlatteryOBrien JA, 1997, MOL MICROBIOL, V23, P303, DOI 10.1046/j.1365-2958.1997.2121581.x; FUGE EK, 1994, J BACTERIOL, V176, P5802, DOI 10.1128/JB.176.18.5802-5813.1994; Galeote VA, 2007, CURR GENET, V52, P55, DOI 10.1007/s00294-007-0136-z; Garrido EO, 2002, MOL MICROBIOL, V43, P993, DOI 10.1046/j.1365-2958.2002.02795.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gietz RD, 2007, NAT PROTOC, V2, P5, DOI 10.1038/nprot.2007.16; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; Grant CM, 1997, MOL BIOL CELL, V8, P1699, DOI 10.1091/mbc.8.9.1699; Grant CM, 1997, FEBS LETT, V410, P219, DOI 10.1016/S0014-5793(97)00592-9; Grant CM, 2000, BBA-GENE STRUCT EXPR, V1490, P33, DOI 10.1016/S0167-4781(99)00234-1; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; Hansen RE, 2009, P NATL ACAD SCI USA, V106, P422, DOI 10.1073/pnas.0812149106; Higgins VJ, 2002, YEAST, V19, P203, DOI 10.1002/yea.811; Jamieson DJ, 1998, YEAST, V14, P1511, DOI 10.1002/(SICI)1097-0061(199812)14:16<1511::AID-YEA356>3.3.CO;2-J; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kaneto H, 2007, ANTIOXID REDOX SIGN, V9, P355, DOI 10.1089/ars.2006.1465; Kataya ARA, 2010, PLANT SIGNAL BEHAV, V5, P171, DOI 10.4161/psb.5.2.10527; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KIM JH, 1991, MOL CELL BIOL, V11, P3894, DOI 10.1128/MCB.11.8.3894; Lohman JR, 2008, BIOCHEMISTRY-US, V47, P8678, DOI 10.1021/bi800498g; Marty L, 2009, P NATL ACAD SCI USA, V106, P9109, DOI 10.1073/pnas.0900206106; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; MULLER EGD, 1995, ARCH BIOCHEM BIOPHYS, V318, P356, DOI 10.1006/abbi.1995.1240; Muller EGD, 1996, MOL BIOL CELL, V7, P1805, DOI 10.1091/mbc.7.11.1805; Pedrajas JR, 2000, J BIOL CHEM, V275, P16296, DOI 10.1074/jbc.275.21.16296; Perrone GG, 2005, MOL BIOL CELL, V16, P218, DOI 10.1091/mbc.E04-07-0560; Petrova VY, 2004, BIOCHEM J, V380, P393, DOI 10.1042/BJ20040042; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schwarzlander M, 2008, J MICROSC-OXFORD, V231, P299, DOI 10.1111/j.1365-2818.2008.02030.x; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Tan SX, 2009, MOL BIOL CELL, V20, P1493, DOI 10.1091/mbc.E08-07-0697; Tokatlidis K, 2005, CELL, V121, P965, DOI 10.1016/j.cell.2005.06.019; Trotter EW, 2003, EMBO REP, V4, P184, DOI 10.1038/sj.embor.embor729; Tsujimoto Y, 2000, J BACTERIOL, V182, P5121, DOI 10.1128/JB.182.18.5121-5126.2000; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; van Roermund CWT, 2004, J CELL SCI, V117, P4231, DOI 10.1242/jcs.01305; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Wheeler GL, 2002, MOL MICROBIOL, V46, P545, DOI 10.1046/j.1365-2958.2002.03174.x; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	58	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44278	10.1371/journal.pone.0044278	http://dx.doi.org/10.1371/journal.pone.0044278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970195	gold, Green Published			2022-12-25	WOS:000308458400054
J	Nicol, SM; Bray, SE; Black, HD; Lorimore, SA; Wright, EG; Lane, DP; Meek, DW; Coates, PJ; Fuller-Pace, FV				Nicol, S. M.; Bray, S. E.; Black, H. Derek; Lorimore, S. A.; Wright, E. G.; Lane, D. P.; Meek, D. W.; Coates, P. J.; Fuller-Pace, F. V.			The RNA helicase p68 (DDX5) is selectively required for the induction of p53-dependent p21 expression and cell-cycle arrest after DNA damage	ONCOGENE			English	Article						p68 (DDX5) RNA helicase; p53; DNA damage; cell-cycle arrest; apoptosis	HEMATOPOIETIC STEM-CELLS; ESTROGEN-RECEPTOR-ALPHA; IN-VIVO; TRANSCRIPTIONAL COACTIVATOR; IONIZING-RADIATION; CANCER DEVELOPMENT; TUMOR-SUPPRESSOR; P53; PROTEINS; STRESS	The RNA helicase p68 (DDX5) is an established co-activator of the p53 tumour suppressor that itself has a pivotal role in orchestrating the cellular response to DNA damage. Although several factors influence the biological outcome of p53 activation, the mechanisms governing the choice between cell-cycle arrest and apoptosis remain to be elucidated. In the present study, we show that, while p68 is critical for p53-mediated transactivation of the cell-cycle arrest gene p21(WAF1/CIP1), it is dispensable for induction of several pro-apoptotic genes in response to DNA damage. Moreover, p68 depletion results in a striking inhibition of recruitment of p53 and RNA Pol II to the p21 promoter but not to the Bax or PUMA promoters, providing an explanation for the selective effect on p21 induction. Importantly, these findings are mirrored in a novel inducible p68 knockout mouse model in which p68 depletion results in a selective inhibition of p21 induction in several tissues. Moreover, in the bone marrow, p68 depletion results in an increased sensitivity to g-irradiation, consistent with an increased level of apoptosis. These data highlight a novel function of p68 as a modulator of the decision between p53-mediated growth arrest and apoptosis in vitro and in vivo.	[Nicol, S. M.; Lorimore, S. A.; Wright, E. G.; Meek, D. W.; Fuller-Pace, F. V.] Univ Dundee, Ninewells Hosp & Med Sch, Div Canc Res, Dundee DD1 9SY, Scotland; [Bray, S. E.; Coates, P. J.] Univ Dundee, Ninewells Hosp & Med Sch, Tayside Tissue Bank, Dundee DD1 9SY, Scotland; [Black, H. Derek] Univ Dundee, Ninewells Hosp & Med Sch, Med Sch Resource Unit, Dundee DD1 9SY, Scotland; [Lane, D. P.] ASTAR, Immunos, Lab P53, Singapore, Singapore	University of Dundee; University of Dundee; University of Dundee; Agency for Science Technology & Research (A*STAR)	Fuller-Pace, FV (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Div Canc Res, Dundee DD1 9SY, Scotland.	f.v.fullerpace@dundee.ac.uk	Coates, Philip J/H-6854-2019	Coates, Philip J/0000-0003-1518-6306; Lane, David/0000-0003-0551-3545	Cancer Research UK [C8745/A11216]; Association for International Cancer Research [06-613]	Cancer Research UK(Cancer Research UK); Association for International Cancer Research	We thank Colin Henderson for helpful discussions. This work was supported by grants from Cancer Research UK (C8745/A11216) and the Association for International Cancer Research (06-613).	Aylon Y, 2007, CELL, V130, P597, DOI 10.1016/j.cell.2007.08.005; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Bouvard V, 2000, ONCOGENE, V19, P649, DOI 10.1038/sj.onc.1203366; Budram-Mahadeo V, 2002, ONCOGENE, V21, P6123, DOI 10.1038/sj.onc.1205842; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Causevic M, 2001, ONCOGENE, V20, P7734, DOI 10.1038/sj.onc.1204976; Chene P, 2000, J MOL BIOL, V299, P245, DOI 10.1006/jmbi.2000.3738; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Coates PJ, 2003, J PATHOL, V201, P377, DOI 10.1002/path.1456; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; Endoh H, 1999, MOL CELL BIOL, V19, P5363; Espinosa JM, 2008, ONCOGENE, V27, P4013, DOI 10.1038/onc.2008.37; Espinosa JM, 2003, MOL CELL, V12, P1015, DOI 10.1016/S1097-2765(03)00359-9; Fei PW, 2002, CANCER RES, V62, P7316; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Fuller-Pace FV, 2011, FUTURE ONCOL, V7, P239, DOI 10.2217/FON.11.1; HOY CA, 1993, MUTAT RES, V290, P217, DOI 10.1016/0027-5107(93)90162-9; Hudson CD, 2005, J BIOL CHEM, V280, P11851, DOI 10.1074/jbc.M408679200; Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468; LORIMORE SA, 1995, CELL DEATH DIFFER, V2, P233; LORIMORE SA, 1990, LEUKEMIA RES, V14, P481, DOI 10.1016/0145-2126(90)90036-9; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; Lu X, 1996, ONCOGENE, V13, P413; MacCallum DE, 1996, ONCOGENE, V13, P2575; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; MIDGLEY CA, 1995, J CELL SCI, V108, P1843; Morachis JM, 2010, GENE DEV, V24, P135, DOI 10.1101/gad.1856710; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wallace M, 2001, ONCOGENE, V20, P3597, DOI 10.1038/sj.onc.1204496; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Wortham NC, 2009, ONCOGENE, V28, P4053, DOI 10.1038/onc.2009.261; Yang LQ, 2005, MOL CANCER RES, V3, P355, DOI 10.1158/1541-7786.MCR-05-0022	34	59	63	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JUL 18	2013	32	29					3461	3469		10.1038/onc.2012.426	http://dx.doi.org/10.1038/onc.2012.426			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	186AZ	22986526	Green Accepted			2022-12-25	WOS:000322014900007
J	Bettayeb, K; Oumata, N; Zhang, YY; Luo, WJ; Bustos, V; Galons, H; Greengard, P; Meijer, L; Flajolet, M				Bettayeb, Karima; Oumata, Nassima; Zhang, Yuanyuan; Luo, Wenjie; Bustos, Victor; Galons, Herve; Greengard, Paul; Meijer, Laurent; Flajolet, Marc			Small-molecule inducers of A beta-42 peptide production share a common mechanism of action	FASEB JOURNAL			English	Article						Aftin; Alzheimer's disease; amyloid-beta; trafficking; VDAC1; lipid rafts	FAMILIAL ALZHEIMERS-DISEASE; AMYLOID-BETA; LIPID RAFTS; GAMMA-SECRETASE; SENILE PLAQUES; IN-VIVO; PROTEIN; BRAIN; IDENTIFICATION; MUTATIONS	The pathways leading specifically to the toxic A beta 42 peptide production, a key event in Alzheimer's disease (AD), are unknown. While searching for pathways that mediate pathological increases of A beta 42, we identified Aftin-4, a new compound that selectively and potently increases A beta 42 compared to DMSO (N2a cells: 7-fold; primary neurons: 4-fold; brain lysates: 2-fold) with an EC50 of 30 mu M. These results were confirmed by ELISA and IP-WB. Using affinity chromatography and mass spectrometry, we identified 3 proteins (VDAC1, prohibitin, and mitofilin) relevant to AD that interact with Aftin-4, but not with a structurally similar but inactive molecule. Electron microscopy studies demonstrated that Aftin-4 induces a reversible mitochondrial phenotype reminiscent of the one observed in AD brains. Sucrose gradient fractionation showed that Aftin-4 perturbs the subcellular localization of gamma-secretase components and could, therefore, modify gamma-secretase specificity by locally altering its membrane environment. Remarkably, Aftin-4 shares all these properties with two other "AD accelerator" compounds. In summary, treatment with three A beta 42 raising agents induced similar biochemical alterations that lead to comparable cellular phenotypes in vitro, suggesting a common mechanism of action involving three structural cellular targets.-Bettayeb, K., Oumata, N., Zhang, Y., Luo, W., Bustos, V., Galons, H., Greengard, P., Meijer, L., Flajolet, M. Small-molecule inducers of A beta-42 peptide production share a common mechanism of action. FASEB J. 26, 5115-5123 (2012). www.fasebj.org	[Bettayeb, Karima; Zhang, Yuanyuan; Luo, Wenjie; Bustos, Victor; Greengard, Paul; Flajolet, Marc] Rockefeller Univ, Lab Mol & Cellular Neurosci, New York, NY 10021 USA; [Oumata, Nassima; Galons, Herve] Univ Paris 05, CNRS, UMR, Lab Pharmacochim, Paris, France; [Meijer, Laurent] CNRS, Stn Biol Roscoff, USR 3151, Roscoff, France	Rockefeller University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Flajolet, M (corresponding author), Rockefeller Univ, Lab Mol & Cellular Neurosci, 1230 York Ave, New York, NY 10021 USA.	flajolm@rockefeller.edu	MEIJER, Laurent/ABE-7465-2021; Luo, Wenjie/ABF-8451-2020	Zhang, Yuanyuan/0000-0001-9230-7314; Greengard, Paul/0000-0002-4437-0893	U.S. National Institutes of Health [AG/NIA: AG-09464]; Fisher Center for Alzheimer's Research Foundation; Fonds Unique Interministeriel (FUI) PHARMASEA project; CRITT-Sante Bretagne; NATIONAL INSTITUTE ON AGING [P01AG009464] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fisher Center for Alzheimer's Research Foundation; Fonds Unique Interministeriel (FUI) PHARMASEA project; CRITT-Sante Bretagne; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are grateful to Drs. J. P. Roussarie, G. He, and F. Gorelick for their critical reading of the manuscript; to Drs. K. Uryu and E. Sphicas for their help regarding the electron microscopy; and to Drs. F. Mikhail, A. Starkov, and C. Chinopoulos for their helpful discussions and advice regarding mitochondrial experiments. The authors thank Angie Lin for her technical assistance. This work was supported, in part, by grants from the U.S. National Institutes of Health (AG/NIA: AG-09464; P.G.) and the Fisher Center for Alzheimer's Research Foundation. The authors also acknowledge support from the Fonds Unique Interministeriel (FUI) PHARMASEA project (L.M. and H.G.) and CRITT-Sante Bretagne (L.M.).	Bach S, 2005, J BIOL CHEM, V280, P31208, DOI 10.1074/jbc.M500806200; Bettayeb Karima, 2010, Genes Cancer, V1, P369, DOI 10.1177/1947601910369817; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; COATES PM, 1995, AM J HUM GENET, V57, P233; Cuadrado-Tejedor M, 2011, J ALZHEIMERS DIS, V23, P195, DOI 10.3233/JAD-2010-100966; Czech C, 2007, J NEUROCHEM, V101, P929, DOI 10.1111/j.1471-4159.2007.04467.x; Eckert GP, 2012, MOL NEUROBIOL, V46, P136, DOI 10.1007/s12035-012-8271-z; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Flajolet M, 2007, P NATL ACAD SCI USA, V104, P4159, DOI 10.1073/pnas.0611236104; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Hur JY, 2012, J BIOL CHEM, V287, P11991, DOI 10.1074/jbc.M111.246074; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Jae-Kyung M, 2003, CELL MOL BIOL, V49, P739; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Knockaert M, 2000, CHEM BIOL, V7, P411, DOI 10.1016/S1074-5521(00)00124-1; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Martin V, 2010, J ALZHEIMERS DIS, V19, P489, DOI 10.3233/JAD-2010-1242; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Mielenz D, 2005, J IMMUNOL, V174, P3508, DOI 10.4049/jimmunol.174.6.3508; Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352; O'Connell K, 2009, PROTEOMICS, V9, P5509, DOI 10.1002/pmic.200900472; Oumata N, 2008, J MED CHEM, V51, P5229, DOI 10.1021/jm800109e; Perez-Gracia E, 2008, ACTA NEUROPATHOL, V116, P261, DOI 10.1007/s00401-008-0370-6; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2000, NEUROL CLIN, V18, P903, DOI 10.1016/S0733-8619(05)70232-2; SISODIA SS, 1995, FASEB J, V9, P366, DOI 10.1096/fasebj.9.5.7896005; Sultana R, 2006, NEUROBIOL DIS, V22, P76, DOI 10.1016/j.nbd.2005.10.004; TANZI RE, 1988, NATURE, V331, P528, DOI 10.1038/331528a0; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Tian Y, 2011, FASEB J, V25, P1934, DOI 10.1096/fj.10-175158; Walker ES, 2005, J NEUROCHEM, V92, P294, DOI 10.1111/j.1471-4159.2004.02858.x; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wang QS, 2008, NEUROCHEM RES, V33, P1776, DOI 10.1007/s11064-008-9628-6; Williamson R, 2011, CURR ALZHEIMER RES, V8, P213, DOI 10.2174/156720511795256008; Yoo BC, 2001, ELECTROPHORESIS, V22, P172, DOI 10.1002/1522-2683(200101)22:1<172::AID-ELPS172>3.0.CO;2-P; YU WH, 1995, J BIOL CHEM, V270, P13998, DOI 10.1074/jbc.270.23.13998; Zhu L, 2011, J ALZHEIMERS DIS, V23, P641, DOI 10.3233/JAD-2010-101389	42	18	20	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					5115	5123		10.1096/fj.12-212985	http://dx.doi.org/10.1096/fj.12-212985			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22972917	Green Published			2022-12-25	WOS:000311838300032
J	Kong, HK; Yoon, S; Park, JH				Kong, Hyun Kyung; Yoon, Sukjoon; Park, Jong Hoon			The Regulatory Mechanism of the LY6K Gene Expression in Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; DNA-BINDING ACTIVITIES; LY-6K GENE; AP-1; JUN; METHYLATION; PROTEINS; GROWTH; MEMBER; FOS	LY6K is a cancer biomarker and a therapeutic target that induces invasion and metastasis. However, the molecular mechanisms that determine human LY6K transcription are completely unknown. To elucidate the mechanisms involved in human LY6K gene regulation and expression, multiple cis-elements were predicted using TRANSFAC software, and the LY6K regulatory region was identified using the luciferase assay in the human LY6K gene promoter. We performed ChIP, EMSA, and supershift assays to investigate the transcription factor activity on the LY6K promoter, and the effect of a SNP and CpG site methylation on AP-1 transcription factor binding affinity. AP-1 and the CREB transcription factor bound to LY6K promoter within -550/-1, which was essential for LY6K expression, but only the AP-1 heterodimer, JunD, and Fra-1, modulates LY6K gene transcriptional level. A decrease in LY6K was associated with the SNP242 C allele, a polymorphic G/C-SNP at the 242 nucleotide in the LY6K promoter region (rs2585175), or methylation of the CpG site, which was closely located with the AP-1 site by interfering with binding of the AP-1 transcription factor to the LY6K promoter. Our findings reveal an important role for AP-1 activation in promoting LY6K gene expression that regulates cell mobility of breast cancer cells, whereas the SNP242 C allele or methylation of the CpG site may reduce the risk of invasion or metastasis by interfering AP-1 activation.	[Kong, Hyun Kyung; Yoon, Sukjoon; Park, Jong Hoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea	Sookmyung Women's University	Park, JH (corresponding author), Sookmyung Womens Univ, Dept Biol Sci, Seoul 140742, South Korea.	parkjh@sookmyung.ac.kr			National Research Foundation of Korea [2011-0028816]; Korean government (Ministry of Education, Science and Technology) (Science Research Center program) [2011-0001382]; Bio & Medical Technology Development Program (Korea Genetically Engineered Mouse Center Program)	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (Ministry of Education, Science and Technology) (Science Research Center program); Bio & Medical Technology Development Program (Korea Genetically Engineered Mouse Center Program)	This work was supported by the National Research Foundation of Korea grant funded by the Korean government (Ministry of Education, Science and Technology) (Science Research Center program, 2011-0001382), the Bio & Medical Technology Development Program (Korea Genetically Engineered Mouse Center Program), and the National Research Foundation of Korea 2011-0028816 (National Leading Research Lab program).	Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Boutant M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035810; BRAKENHOFF RH, 1995, J CELL BIOL, V129, P1677, DOI 10.1083/jcb.129.6.1677; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Choi SH, 2009, INT J ONCOL, V35, P601, DOI 10.3892/ijo_00000371; Dalen AGD, 2003, INT J CANCER, V103, P768, DOI 10.1002/ijc.10903; Dang J, 1999, EUR J BIOCHEM, V264, P92, DOI 10.1046/j.1432-1327.1999.00583.x; Del Rosso M, 2011, BLOOD, V117, P3941, DOI 10.1182/blood-2011-02-337733; Deng GR, 2001, ONCOGENE, V20, P7120, DOI 10.1038/sj.onc.1204891; Engle LJ, 2006, ONCOGENE, V25, P1594, DOI 10.1038/sj.onc.1209368; Horie M, 1998, GENOMICS, V53, P365, DOI 10.1006/geno.1998.5462; Ishikawa N, 2007, CANCER RES, V67, P11601, DOI 10.1158/0008-5472.CAN-07-3243; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Lee JW, 2006, ONCOL REP, V16, P1211; Lengyel E, 1996, J BIOL CHEM, V271, P23176, DOI 10.1074/jbc.271.38.23176; Lin F, 2000, CANCER RES, V60, P3271; Liu YM, 2002, ONCOGENE, V21, P7680, DOI 10.1038/sj.onc.1205883; Ludes-Meyers JH, 2001, ONCOGENE, V20, P2771, DOI 10.1038/sj.onc.1204377; Matsuda R, 2011, BRIT J CANCER, V104, P376, DOI 10.1038/sj.bjc.6605990; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; Nayak MS, 2007, CANCER RES, V67, P5831, DOI 10.1158/0008-5472.CAN-06-4533; PALFREE RGE, 1991, IMMUNOL TODAY, V12, P170, DOI 10.1016/0167-5699(91)90086-9; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Pospelova TV, 1999, GENE EXPRESSION, V8, P19; RYSECK RP, 1991, ONCOGENE, V6, P533; Sawai H, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-8; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Smith LM, 1999, ONCOGENE, V18, P6063, DOI 10.1038/sj.onc.1202989; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Vogt PK, 2002, NAT REV CANCER, V2, P465, DOI 10.1038/nrc818; Zhang B, 2012, BIOMARKERS, V17, P372, DOI 10.3109/1354750X.2012.680609	36	23	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38889	38900		10.1074/jbc.M112.394270	http://dx.doi.org/10.1074/jbc.M112.394270			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22988241	hybrid, Green Published			2022-12-25	WOS:000310982800045
J	Fonseca, MJ; Santos, CL; Costa, P; Lencastre, L; Tavares, F				Fonseca, Maria Joao; Santos, Catarina L.; Costa, Patricio; Lencastre, Leonor; Tavares, Fernando			Increasing Awareness about Antibiotic Use and Resistance: A Hands-On Project for High School Students	PLOS ONE			English	Article							BACTERIAL-RESISTANCE; PRACTICAL WORK; KNOWLEDGE; ATTITUDES; SCIENCE; MICROBES; BELIEFS; IMPACT; FLU	Background: Health-promoting education is essential to foster an informed society able to make decisions about socio-scientific issues based on scientifically sustained criteria. Antibiotic resistance is currently a major public health issue. Considering that irrational antibiotic use has been associated with the development and widespread of antibiotic resistant bacteria, educational interventions to promote prudent antibiotic consumption are required. Methodology/Principal Findings: This study focuses on the outcomes of an interventional program implemented at the University of Porto, Portugal, to promote awareness about antibiotic resistance at high school levels (15-17 year old). The project Microbiology recipes: antibiotics a la carte articulates a set of wet and dry lab activities designed to promote the participants' understanding of concepts and processes underlying antibiotics' production and activity, such as the notion of mechanisms of action of antibiotics. Following a mix-method approach based on a pre-/post design, the effectiveness of this project was assessed by gathering data from surveys, direct observation and analysis of artifacts of 42 high school students (aged 15 and 16 years). The results indicate that the participants developed a more comprehensive picture of antibiotic resistance. The project was shown to promote more sophisticated conceptualizations of bacteria and antibiotics, increased awareness about the perils of antibiotic resistance, and enhanced consciousness towards measures that can be undertaken to mitigate the problem. The participants regarded their experiences as enjoyable and useful, and believed that the project contributed to improve their understanding and raise their interest about the issues discussed. Furthermore, there were also improvements in their procedural skills concerning the laboratory techniques performed. Conclusions/Significance: This study evidences the possibility of increasing high school students' awareness about the consequences of antibiotic resistance and the importance of judicious antibiotic use. The findings inform about the educational benefits of incorporating hands-on activities in science education programs.	[Fonseca, Maria Joao; Tavares, Fernando] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Fonseca, Maria Joao; Santos, Catarina L.] Univ Porto, IBMC, P-4100 Oporto, Portugal; [Fonseca, Maria Joao; Tavares, Fernando] Univ Porto, CIBIO Ctr Invest Biodiversidade & Recursos Genet, Vairao, Portugal; [Costa, Patricio; Lencastre, Leonor] Univ Porto, Fac Psicol Ciencias Educ, Vairao, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto	Fonseca, MJ (corresponding author), Univ Porto, Fac Ciencias, Dept Biol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	mjfonseca@ibmc.up.pt	Tavares, Fernando/C-3375-2013; lencastre, leonor/K-4044-2013; Costa, Patrício/A-3072-2013	Tavares, Fernando/0000-0001-9913-1155; lencastre, leonor/0000-0002-8648-3191; Costa, Patrício/0000-0002-1201-9177; Fonseca, Maria Joao/0000-0002-5138-875X; Lopes dos Santos, Catarina/0000-0002-4273-1077	Fundacao para a Ciencia e Tecnologia (FCT, Portugal) [PTDC/AGR-PRO/111857/2009]; FCT [SFRH/BD/37389/2007, SFRH/BPD/62978/2009]	Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by a research grant (PTDC/AGR-PRO/111857/2009) from Fundacao para a Ciencia e Tecnologia (FCT, Portugal). MJF and CLS are supported by the FCT fellowships SFRH/BD/37389/2007 and SFRH/BPD/62978/2009, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbo L, 2011, INFECT CONT HOSP EP, V32, P714, DOI 10.1086/660761; Abrahams I., 2011, PRACTICAL WORK SECON; Abrahams I, 2009, INT J SCI EDUC, V31, P2335, DOI 10.1080/09500690802342836; Alanis AJ, 2005, ARCH MED RES, V36, P697, DOI 10.1016/j.arcmed.2005.06.009; Bandiera M, 2007, CONTRIBUTIONS FROM SCIENCE EDUCATION RESEARCH, P213, DOI 10.1007/978-1-4020-5032-9_16; Belongia EA, 2005, EMERG INFECT DIS, V11, P912; Braund M, 2006, CURRIC J, V17, P213, DOI 10.1080/09585170600909662; Brookes-Howell L, 2011, J GEN INTERN MED, P1; Buke C, 2005, J INFECTION, V51, P135, DOI 10.1016/j.jinf.2004.12.001; Byrne J, 2011, INT J SCI EDUC, V33, P1927, DOI 10.1080/09500693.2010.536999; Cebotarenco N, 2008, HEALTH EDUC RES, V23, P146, DOI 10.1093/her/cym008; Coenen S, 2009, J ANTIMICROB CHEMOTH, V64, P200, DOI 10.1093/jac/dkp135; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Cohen L., 2011, RES METHODS ED; Crowe A, 2008, CBE-LIFE SCI EDUC, V7, P368, DOI 10.1187/cbe.08-05-0024; Davey P, 2002, CLIN MICROBIOL INFEC, V8, P43, DOI 10.1046/j.1469-0691.8.s.2.6.x; de Sande-Bruinsma NV, 2008, EMERG INFECT DIS, V14, P1722, DOI 10.3201/eid1411.070467; Dernain AL, 2006, J IND MICROBIOL BIOT, V33, P486, DOI 10.1007/s10295-005-0076-x; Direccao Geral da Inovacao e de Desenvolvimento Curricular, 2004, PROGR BIOL 12 AN CUR; Direccao Geral de Inovacao e de Desenvolvimento Curricular, 2001, PROGR BIOL GEOL 10 1; Direccao Geral de Inovacao e de Desenvolvimento Curricular, 2003, PROGR BIOL GEOL 11 1; Finkelstein JA, 2008, PEDIATRICS, V121, pE15, DOI 10.1542/peds.2007-0819; Fonseca MJ, 2011, AM BIOL TEACH, V73, P342, DOI 10.1525/abt.2011.73.6.7; Goodwin C.J., 2009, RES PSYCHOL METHODS; Gravetter F. J., 2009, RES METHODS BEHAV SC; Grigoryan L, 2007, PHARMACOEPIDEM DR S, V16, P1234, DOI 10.1002/pds.1479; Hawkey PM, 1998, BRIT MED J, V317, P657, DOI 10.1136/bmj.317.7159.657; Hill T, 2006, STAT METHODS APPL CO; Hofstein A, 2004, SCI EDUC, V88, P28, DOI 10.1002/sce.10106; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Jayaraman R, 2009, CURR SCI INDIA, V96, P1475; Jones MG, 2008, SCHOOL SCI MATH, V108, P263, DOI 10.1111/j.1949-8594.2008.tb17836.x; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Knox K.L., 2003, J SCI EDUC TECHNOL, V12, P471, DOI DOI 10.1023/B:JOST.0000006306.97336.C5; Krapp A, 2011, INT J SCI EDUC, V33, P27, DOI 10.1080/09500693.2010.518645; Krippendorff K., 2004, CONTENT ANAL INTRO I, V2nd ed.; Krist AC, 2007, AM BIOL TEACH, V69, P94, DOI 10.1662/0002-7685(2007)69[94:EEOARI]2.0.CO;2; Lecky DM, 2010, J ANTIMICROB CHEMOTH, V65, P2674, DOI 10.1093/jac/dkq356; Longtin S, 2004, J BIOL EDUC, V39, P32, DOI 10.1080/00219266.2004.9655952; Lord T., 2007, J COLL SCI TEACH, V37, P40; Markowitz DG, 2004, J SCI EDUC TECHNOL, V13, P395, DOI DOI 10.1023/B:JOST.0000045467.67907.7b; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V60, pI63, DOI 10.1093/jac/dkm161; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; Milandri M, 2004, PEDIATR INFECT DIS J, V23, P1077, DOI 10.1097/01.inf.0000145756.58944.f9; Molstad S, 2008, LANCET INFECT DIS, V8, P125, DOI 10.1016/S1473-3099(08)70017-3; Moore B, 2009, CRITICAL THINKING FO; National Research Council (NRC), 1996, NAT SCI ED STAND; Oppenheim A. N., 1992, QUESTIONNAIRE DESIGN; Orzech KM, 2008, ANNU REV ANTHROPOL, V37, P267, DOI 10.1146/annurev.anthro.37.081407.085205; Packer J., 2004, Annals of Leisure Research, V7, P54; Peker D, 2009, RES SCI EDUC, P1; Rudduck J, 2007, IMPROV LEARN TLRP, P1; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; Saleem M, 2010, NAT PROD REP, V27, P238, DOI 10.1039/b916096e; Schunk DH, 2012, HANDBOOK OF RESEARCH ON STUDENT ENGAGEMENT, P219, DOI 10.1007/978-1-4614-2018-7_10; Simonneaux L, 2000, INT J SCI EDUC, V22, P619, DOI 10.1080/095006900289705; Tibell LAE, 2010, CBE-LIFE SCI EDUC, V9, P25, DOI 10.1187/cbe.08-09-0055; Toplis R, 2011, RES SCI EDUC, P1; Wassmer GT, 2006, AM BIOL TEACH, V68, P476, DOI 10.1662/0002-7685(2006)68[476:WFYA]2.0.CO;2; Weber R.P., 1990, BASIC CONTENT ANAL, V2nd ed., DOI 10.4135/9781412983488; Weil D. K., 2004, CRITICAL THINKING LE; Wellington J, 2005, SCI TECHNOL EDUC LIB, V29, P99; Who (World Health Organization), 2000, WHO ANN REP INF DIS	63	15	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44699	10.1371/journal.pone.0044699	http://dx.doi.org/10.1371/journal.pone.0044699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984544	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500075
J	Liu, SJ; Chougule, NP; Vijayendran, D; Bonning, BC				Liu, Sijun; Chougule, Nanasaheb P.; Vijayendran, Diveena; Bonning, Bryony C.			Deep Sequencing of the Transcriptomes of Soybean Aphid and Associated Endosymbionts	PLOS ONE			English	Article							PEA APHID; ACYRTHOSIPHON-PISUM; WOLBACHIA INFECTIONS; HEMIPTERA APHIDIDAE; HORIZONTAL TRANSFER; GENE-EXPRESSION; GENOME; BUCHNERA; SYMBIONT; IDENTIFICATION	Background: The soybean aphid has significantly impacted soybean production in the U. S. Transcriptomic analyses were conducted for further insight into leads for potential novel management strategies. Methodology/Principal Findings: Transcriptomic data were generated from whole aphids and from 2,000 aphid guts using an Illumina GAII sequencer. The sequence data were assembled de novo using the Velvet assembler. In addition to providing a general overview, we demonstrate (i) the use of the Multiple-k/Multiple-C method for de novo assembly of short read sequences, followed by BLAST annotation of contigs for increased transcript identification: From 400,000 contigs analyzed, 16,257 non-redundant BLAST hits were identified; (ii) analysis of species distributions of top non-redundant hits: 80% of BLAST hits (minimum e-value of 1.0-E3) were to the pea aphid or other aphid species, representing about half of the pea aphid genes; (iii) comparison of relative depth of sequence coverage to relative transcript abundance for genes with high (membrane alanyl aminopeptidase N) or low transcript abundance; (iv) analysis of the Buchnera transcriptome: Transcripts from 57.6% of the genes from Buchnera aphidicola were identified; (v) identification of Arsenophonus and Wolbachia as potential secondary endosymbionts; (vi) alignment of full length sequences from RNA-seq data for the putative salivary gland protein C002, the silencing of which has potential for aphid management, and the putative Bacillus thuringiensis Cry toxin receptors, aminopeptidase N and alkaline phosphatase. Conclusions/Significance: This study provides the most comprehensive data set to date for soybean aphid gene expression: This work also illustrates the utility of short-read transcriptome sequencing and the Multiple-k/Multiple-C method followed by BLAST annotation for rapid identification of target genes for organisms for which reference genome sequences are not available, and extends the utility to include the transcriptomes of endosymbionts.	[Liu, Sijun; Chougule, Nanasaheb P.; Vijayendran, Diveena; Bonning, Bryony C.] Iowa State Univ, Dept Entomol, Ames, IA 50011 USA	Iowa State University	Liu, SJ (corresponding author), Iowa State Univ, Dept Entomol, Ames, IA 50011 USA.	bbonning@iastate.edu	Chougule, Nanasaheb/D-6485-2013		Iowa State University Center for Integrated Animal Genomics	Iowa State University Center for Integrated Animal Genomics	Funding for this project was provided by the Iowa State University Center for Integrated Animal Genomics http://www.ciag.iastate.edu/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Augustinos AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028695; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Blackman RL, 2000, APHIDS WORLDS CROPS, V2nd, DOI 10.1016/0261-2194(96)89825-5; Brisson JA, 2010, INSECT MOL BIOL, V19, P63, DOI 10.1111/j.1365-2583.2009.00935.x; Burke GR, 2011, INSECT MOL BIOL, V20, P357, DOI 10.1111/j.1365-2583.2011.01070.x; Charles H, 1999, MOL BIOL EVOL, V16, P1820, DOI 10.1093/oxfordjournals.molbev.a026096; Christiaens O, 2010, INSECT MOL BIOL, V19, P187, DOI 10.1111/j.1365-2583.2009.00957.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cortes T, 2010, INSECT MOL BIOL, V19, P123, DOI 10.1111/j.1365-2583.2009.00931.x; Cristofoletti PT, 2006, FEBS J, V273, P5574, DOI 10.1111/j.1742-4658.2006.05547.x; Dale RP, 2010, INSECT MOL BIOL, V19, P141, DOI 10.1111/j.1365-2583.2009.00975.x; Doudoumis V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S3; Fenn K, 2006, PLOS PATHOG, V2, P887, DOI 10.1371/journal.ppat.0020094; Gauthier JP, 2007, BIOINFORMATICS, V23, P783, DOI 10.1093/bioinformatics/btl682; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Gil R, 2002, P NATL ACAD SCI USA, V99, P4454, DOI 10.1073/pnas.062067299; Godfray HCJ, 2010, INSECT MOL BIOL, V19, P1, DOI 10.1111/j.1365-2583.2009.00980.x; Gomez-Valero L, 2004, J BACTERIOL, V186, P6626, DOI 10.1128/JB.186.19.6626-6633.2004; Hansen AK, 2011, P NATL ACAD SCI USA, V108, P2849, DOI 10.1073/pnas.1013465108; Hill CB, 2010, J ECON ENTOMOL, V103, P509, DOI 10.1603/EC09179; Hill CB, 2009, CROP SCI, V49, P1193, DOI 10.2135/cropsci2008.09.0561; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Jamnongluk W, 2002, CURR MICROBIOL, V45, P255, DOI 10.1007/s00284-002-3746-1; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jones RT, 2011, APPL ENVIRON MICROB, V77, P8345, DOI 10.1128/AEM.05974-11; Kanost M.R., 2005, P247; Kim C. S., 2008, Agricultural and Resource Economics Review, V37, P227; Kim KS, 2008, CROP SCI, V48, P923, DOI 10.2135/cropsci2007.08.0447; Kondo N, 2002, P NATL ACAD SCI USA, V99, P14280, DOI 10.1073/pnas.222228199; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Li HR, 2011, J INVERTEBR PATHOL, V107, P69, DOI 10.1016/j.jip.2011.02.001; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lo N, 2007, INT J SYST EVOL MICR, V57, P654, DOI 10.1099/ijs.0.64515-0; McCornack BP, 2004, J ECON ENTOMOL, V97, P854, DOI 10.1603/0022-0493(2004)097[0854:DOSAHA]2.0.CO;2; McNulty SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011029; Michel AP, 2009, ENVIRON ENTOMOL, V38, P1301, DOI 10.1603/022.038.0442; MILES PW, 1989, APHIDS THEIR BIOL NA, VC, P23; Moran NA, 2005, APPL ENVIRON MICROB, V71, P3302, DOI 10.1128/AEM.71.6.3302-3310.2005; Mutti NS, 2008, P NATL ACAD SCI USA, V105, P9965, DOI 10.1073/pnas.0708958105; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Nakabachi A, 2010, INSECT MOL BIOL, V19, P175, DOI 10.1111/j.1365-2583.2009.00985.x; Ollivier M, 2010, INSECT MOL BIOL, V19, P33, DOI 10.1111/j.1365-2583.2009.00976.x; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Price DRG, 2010, INSECT MOL BIOL, V19, P97, DOI 10.1111/j.1365-2583.2009.00918.x; Ragsdale DW, 2007, J ECON ENTOMOL, V100, P1258, DOI 10.1603/0022-0493(2007)100[1258:ETFSAH]2.0.CO;2; Ragsdale DW, 2004, ANN ENTOMOL SOC AM, V97, P204, DOI 10.1603/0013-8746(2004)097[0204:SABINA]2.0.CO;2; Ramsey JS, 2010, INSECT MOL BIOL, V19, P241, DOI 10.1111/j.1365-2583.2009.00945.x; Richards S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000313; Rider SD, 2010, INSECT MOL BIOL, V19, P201, DOI 10.1111/j.1365-2583.2009.00972.x; Russell JA, 2005, APPL ENVIRON MICROB, V71, P7987, DOI 10.1128/AEM.71.12.7987-7994.2005; Russell JA, 2003, MOL ECOL, V12, P1061, DOI 10.1046/j.1365-294X.2003.01780.x; Sakurai M, 2005, APPL ENVIRON MICROB, V71, P4069, DOI 10.1128/AEM.71.7.4069-4075.2005; Shigenobu S, 2010, INSECT MOL BIOL, V19, P47, DOI 10.1111/j.1365-2583.2009.00944.x; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Soberon M, 2009, CELL MOL LIFE SCI, V66, P1337, DOI 10.1007/s00018-008-8330-9; Srinivasan DG, 2010, INSECT MOL BIOL, V19, P229, DOI 10.1111/j.1365-2583.2009.00960.x; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Sylvester E.S., 1989, World Crop Pests, V2C, P65; Tagu D, 2010, CR BIOL, V333, P464, DOI 10.1016/j.crvi.2010.03.006; Tamborindeguy C, 2010, INSECT MOL BIOL, V19, P259, DOI 10.1111/j.1365-2583.2009.00956.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vinuelas J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-143; Wang RY, 2006, PLANT DIS, V90, P920, DOI 10.1094/PD-90-0920; Wang Z, 2009, EUR J ENTOMOL, V106, P49, DOI 10.14411/eje.2009.007; Wille BD, 2009, ENVIRON ENTOMOL, V38, P110, DOI 10.1603/022.038.0113; Wilson ACC, 2010, INSECT MOL BIOL, V19, P249, DOI 10.1111/j.1365-2583.2009.00942.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	71	35	43	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45161	10.1371/journal.pone.0045161	http://dx.doi.org/10.1371/journal.pone.0045161			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984624	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500122
J	Mahiane, GS; Ouifki, R; Brand, H; Delva, W; Welte, A				Mahiane, Guy Severin; Ouifki, Rachid; Brand, Hilmarie; Delva, Wim; Welte, Alex			A General HIV Incidence Inference Scheme Based on Likelihood of Individual Level Data and a Population Renewal Equation	PLOS ONE			English	Article							AGE-SPECIFIC PREVALENCE; INCIDENCE RATES; INFECTION; SEROPREVALENCE; WOMEN	We derive a new method to estimate the age specific incidence of an infection with a differential mortality, using individual level infection status data from successive surveys. The method consists of a) an SI-type model to express the incidence rate in terms of the prevalence and its derivatives as well as the difference in mortality rate, and b) a maximum likelihood approach to estimate the prevalence and its derivatives. Estimates can in principle be obtained for any chosen age and time, and no particular assumptions are made about the epidemiological or demographic context. This is in contrast with earlier methods for estimating incidence from prevalence data, which work with aggregated data, and the aggregated effect of demographic and epidemiological rates over the time interval between prevalence surveys. Numerical simulation of HIV epidemics, under the presumption of known excess mortality due to infection, shows improved control of bias and variance, compared to previous methods. Our analysis motivates for a) effort to be applied to obtain accurate estimates of excess mortality rates as a function of age and time among HIV infected individuals and b) use of individual level rather than aggregated data in order to estimate HIV incidence rates at times between two prevalence surveys.	[Mahiane, Guy Severin; Ouifki, Rachid; Brand, Hilmarie; Delva, Wim; Welte, Alex] Univ Stellenbosch, S African Ctr Epidemiol Modelling & Anal, ZA-7600 Stellenbosch, South Africa; [Delva, Wim] Univ Ghent, Int Ctr Reprod Hlth, B-9000 Ghent, Belgium	National Research Foundation - South Africa; Stellenbosch University; Ghent University	Mahiane, GS (corresponding author), Univ Stellenbosch, S African Ctr Epidemiol Modelling & Anal, ZA-7600 Stellenbosch, South Africa.	sgmahiane@sun.ac.za	Ouifki, Rachid/A-4064-2017	Ouifki, Rachid/0000-0001-7697-1792; Delva, Wim/0000-0001-8054-1904	Institut National de la Sante et de la Recherche Medicale (INSERM, France); Canadian International Development Agency (CIDA, Canada)	Institut National de la Sante et de la Recherche Medicale (INSERM, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Canadian International Development Agency (CIDA, Canada)	This research was supported by Institut National de la Sante et de la Recherche Medicale (INSERM, France) and the Canadian International Development Agency (CIDA, Canada). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES AE, 1994, STAT MED, V13, P1881, DOI 10.1002/sim.4780131809; ADES AE, 1995, J ACQ IMMUN DEF SYND, V9, P490; [Anonymous], STAT COMMUN INFECT D; Artzrouni M, 2002, AIDS, V16, pW1; Balasubramanian R, 2010, BIOMETRICS, V66, P1, DOI 10.1111/j.1541-0420.2009.01242.x; BATTER V, 1994, AIDS, V8, P811, DOI 10.1097/00002030-199406000-00014; Bhattacharya M, 2010, INDIAN J PUBLIC HLTH, V52, P21; BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; Brunet RC, 1999, THEOR POPUL BIOL, V56, P76, DOI 10.1006/tpbi.1999.1415; Brunet RC, 1996, THEOR POPUL BIOL, V50, P209, DOI 10.1006/tpbi.1996.0029; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Gregson S, 1996, AIDS, V10, P1689, DOI 10.1097/00002030-199612000-00014; Hallett TB, 2008, PLOS MED, V5, P611, DOI 10.1371/journal.pmed.0050080; Hallett TB, 2011, CURR OPIN HIV AIDS, V6, P102, DOI 10.1097/COH.0b013e328343bfdb; Hallett TB, 2010, AIDS, V24, P147, DOI 10.1097/QAD.0b013e32833062dc; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Kaplan EH, 1999, OPER RES, V47, P29, DOI 10.1287/opre.47.1.29; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Kassanjee R, 2012, EPIDEMIOLOGY, V23, P721, DOI 10.1097/EDE.0b013e3182576c07; KEIDING N, 1991, J R STAT SOC A STAT, V154, P371, DOI 10.2307/2983150; Lopman B, 2010, J EPIDEMIOL COMMUN H, V64, P330, DOI 10.1136/jech.2008.081554; Lopman BA, 2006, PLOS MED, V3, P1273, DOI 10.1371/journal.pmed.0030312; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McWalter TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007368; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; PODGOR MJ, 1986, STAT MED, V5, P573, DOI 10.1002/sim.4780050604; R Development Core Team, 2007, R LANG ENV STAT COMP; Rehle TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011094; Sakarovitch C, 2007, JAIDS-J ACQ IMM DEF, V45, P115, DOI 10.1097/QAI.0b013e318050d277; Sakarovitch C, 2007, STAT MED, V26, P320, DOI 10.1002/sim.2540; Welte A, 2010, EURO SURVEILL, V15, p[pii, 19589]; White RG, 2007, EPIDEMIOL INFECT, V135, P922, DOI 10.1017/S0950268806007680; Williams B, 2001, STAT MED, V20, P2003, DOI 10.1002/sim.840	34	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44377	10.1371/journal.pone.0044377	http://dx.doi.org/10.1371/journal.pone.0044377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984497	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500050
J	Oberley-Deegan, RE; Steffan, JJ; Rove, KO; Pate, KM; Weaver, MW; Spasojevic, I; Frederick, B; Raben, D; Meacham, RB; Crapo, JD; Koul, HK				Oberley-Deegan, Rebecca E.; Steffan, Joshua J.; Rove, Kyle O.; Pate, Kathryn M.; Weaver, Michael W.; Spasojevic, Ivan; Frederick, Barbara; Raben, David; Meacham, Randall B.; Crapo, James D.; Koul, Hari K.			The Antioxidant, MnTE-2-PyP, Prevents Side-Effects Incurred by Prostate Cancer Irradiation	PLOS ONE			English	Article							CATALYTIC ANTIOXIDANT; RAT MODEL; RADIATION; INJURY; RADIOTHERAPY; PORPHYRINS; PROTECTS; GROWTH; DAMAGE; CELLS	Prostate cancer is the most commonly diagnosed cancer, with an estimated 240,000 new cases reported annually in the United States. Due to early detection and advances in therapies, more than 90% of patients will survive 10 years post diagnosis and treatment. Radiation is a treatment option often used to treat localized disease; however, while radiation is very effective at killing tumor cells, normal tissues are damaged as well. Potential side-effects due to prostate cancer-related radiation therapy include bowel inflammation, erectile dysfunction, urethral stricture, rectal bleeding and incontinence. Currently, radiation therapy for prostate cancer does not include the administration of therapeutic agents to reduce these side effects and protect normal tissues from radiation-induced damage. In the current study, we show that the small molecular weight antioxidant, MnTE-2-PyP, protects normal tissues from radiation-induced damage in the lower abdomen in rats. Specifically, MnTE-2-PyP protected skin, prostate, and testes from radiation-induced damage. MnTE-2-PyP also protected from erectile dysfunction, a persistent problem regardless of the type of radiation techniques used because the penile neurovascular bundles lay in the peripheral zones of the prostate, where most prostate cancers reside. Based on previous studies showing that MnTE-2-PyP, in combination with radiation, further reduces subcutaneous tumor growth, we believe that MnTE-2-PyP represents an excellent radioprotectant in combination radiotherapy for cancer in general and specifically for prostate cancer.	[Oberley-Deegan, Rebecca E.; Pate, Kathryn M.; Weaver, Michael W.; Crapo, James D.] Natl Jewish Hlth, Dept Med, Div Pulm, Denver, CO USA; [Steffan, Joshua J.; Rove, Kyle O.; Meacham, Randall B.; Koul, Hari K.] Univ Colorado, Sch Med, Dept Surg, Program Urosci,Div Urol, Aurora, CO USA; [Steffan, Joshua J.; Koul, Hari K.] Denver Vet Adm Med Ctr, Denver, CO USA; [Spasojevic, Ivan] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Spasojevic, Ivan] Duke Canc Inst, PD PD Bioanalyt Core Lab, Durham, NC USA; [Frederick, Barbara; Raben, David] Univ Colorado, Hlth Sci Ctr, Dept Canc Biol, Radiat & Canc Biol Div, Aurora, CO USA; [Koul, Hari K.] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Duke University; Duke University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Oberley-Deegan, RE (corresponding author), Natl Jewish Hlth, Dept Med, Div Pulm, Denver, CO USA.	Hari.Koul@ucdenver.edu			Department of Defense Award United States Army Medical Research and Materiel CommandUSAMRMC [07355003]; University of Colorado Academic Enrichment Funds	Department of Defense Award United States Army Medical Research and Materiel CommandUSAMRMC; University of Colorado Academic Enrichment Funds	This work was supported in part by the Department of Defense Award United States Army Medical Research and Materiel CommandUSAMRMC proposal #07355003 (JC) and through University of Colorado Academic Enrichment Funds (HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batinic-Haberle I, 1998, J BIOL CHEM, V273, P24521, DOI 10.1074/jbc.273.38.24521; Batinic-Haberle I, 2011, FREE RADICAL BIO MED, V51, P1035, DOI 10.1016/j.freeradbiomed.2011.04.046; Batinic-Haberle I, 2010, ANTIOXID REDOX SIGN, V13, P877, DOI 10.1089/ars.2009.2876; Cooperberg MR, 2010, J CLIN ONCOL, V28, P1117, DOI 10.1200/JCO.2009.26.0133; Dall'Era JE, 2008, INT J IMPOT RES, V20, P307, DOI 10.1038/ijir.2008.1; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; Day BJ, 1999, FREE RADICAL BIO MED, V26, P730, DOI 10.1016/S0891-5849(98)00261-5; Day BJ, 1997, ARCH BIOCHEM BIOPHYS, V347, P256, DOI 10.1006/abbi.1997.0341; Elliott SP, 2011, WORLD J UROL, V29, P35, DOI 10.1007/s00345-010-0603-x; Ferrer-Sueta G, 2003, J BIOL CHEM, V278, P27432, DOI 10.1074/jbc.M213302200; Gauter-Fleckenstein B, 2010, FREE RADICAL BIO MED, V48, P1034, DOI 10.1016/j.freeradbiomed.2010.01.020; Gridley DS, 2007, ANTICANCER RES, V27, P3101; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Hei TK, 2008, J PHARM PHARMACOL, V60, P943, DOI 10.1211/jpp.60.8.0001; Katz A, 2007, CANCER NURS, V30, P302, DOI 10.1097/01.NCC.0000281726.87490.f2; Kimura M, 2012, J SEX MED; Kimura M, 2011, J SEX MED, V8, P2215, DOI 10.1111/j.1743-6109.2011.02351.x; Mao XW, 2009, CURR EYE RES, V34, P62, DOI 10.1080/02713680802546948; Merlin SL, 2001, INT J IMPOT RES, V13, P104, DOI 10.1038/sj.ijir.3900652; Oberley-Deegan RE, 2009, AM J RESP CELL MOL, V41, P170, DOI 10.1165/rcmb.2008-0138OC; Oury TD, 2001, AM J RESP CELL MOL, V25, P164, DOI 10.1165/ajrcmb.25.2.4235; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spasojevic I, 2008, FREE RADICAL BIO MED, V45, P943, DOI 10.1016/j.freeradbiomed.2008.05.015; Sullivan L, 2009, RADIOTHER ONCOL, V91, P232, DOI 10.1016/j.radonc.2008.11.013; Tse HM, 2004, FREE RADICAL BIO MED, V36, P233, DOI 10.1016/j.freeradbiomed.2003.10.029; van der Wielen GJ, 2009, J SEX MED, V6, P1908, DOI 10.1111/j.1743-6109.2009.01272.x; Vujaskovic Z, 2002, FREE RADICAL BIO MED, V33, P857, DOI 10.1016/S0891-5849(02)00980-2; Zhao W, 2007, BRIT J RADIOL, V80, pS23, DOI 10.1259/bjr/18237646	28	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44178	10.1371/journal.pone.0044178	http://dx.doi.org/10.1371/journal.pone.0044178			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984473	Green Submitted, Green Published, gold			2022-12-25	WOS:000308738500035
J	Ma, XY; Xi, L; Luo, DF; Liu, RH; Li, S; Liu, Y; Fan, LS; Ye, SM; Yang, WH; Yang, SH; Meng, L; Zhou, JF; Wang, SX; Ma, D				Ma, Xiangyi; Xi, Ling; Luo, Danfeng; Liu, Ronghua; Li, Shu; Liu, Yan; Fan, Liangsheng; Ye, Shuangmei; Yang, Wanhua; Yang, Shuhong; Meng, Li; Zhou, Jianfeng; Wang, Shixuan; Ma, Ding			Anti-Tumor Effects of the Peptide TMTP1-GG-(D)(KLAKLAK)(2) on Highly Metastatic Cancers (Publication with Expression of Concern. See vol. 15, 2020)	PLOS ONE			English	Article; Publication with Expression of Concern							PROSTATE; PROTEIN; INHIBITOR; TARGET; CELLS	The treatment of cancer such as oligonucleotides or peptides requires efficient delivery systems. A novel peptide, TMTP1, previously derived and identified in our laboratory showed remarkable ability to target highly metastatic tumors both in vitro and in vivo, even at the early stage of occult metastasis foci. TMTP1 moderately inhibited tumor cell viability, although not enough to deem it an efficient killer of tumor cells. In this study, we sought to enhance the anti-tumor activity of TMTP1. To do this, we fused it to an antimicrobial peptide, (D)(KLAKLAK)(2), and termed the resulting peptide TMTP1-DKK. We found that TMTP1-DKK could trigger rapid apoptosis in human prostate and gastric cancer cells through both the mitochondrial-induced apoptosis pathway and the death receptor pathway. Furthermore, direct injection of TMTP1-DKK into mice with prostate and gastric xenograft cancers resulted in reduction of tumor volumes and a significant delay in tumor progression and metastasis in vivo. These results suggest that TMTP1-DKK may serve as a powerful therapeutic agent for metastatic tumors.	[Ma, Xiangyi; Xi, Ling; Luo, Danfeng; Liu, Ronghua; Li, Shu; Liu, Yan; Fan, Liangsheng; Ye, Shuangmei; Yang, Wanhua; Yang, Shuhong; Meng, Li; Zhou, Jianfeng; Wang, Shixuan; Ma, Ding] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology	Ma, XY (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Canc Biol Res Ctr, Wuhan 430074, Hubei, Peoples R China.	sxwang@tjh.tjmu.edu.cn; dma@tjh.tjmu.edu.cn	meng, li/GVT-2063-2022; Luo, Danfeng/AAH-9140-2020		National Science Foundation of China [30973472, 81001006, 30973148]; Major Innovation Medicine program [2009ZX09103-738, 2009ZX09103-739, 2009ZX09103-740]; "973" Program of China [2009CB521808]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Innovation Medicine program; "973" Program of China(National Basic Research Program of China)	Funding was provided by the National Science Foundation of China (No.30973472; 81001006; 30973148), Major Innovation Medicine program (2009ZX09103-738; 2009ZX09103-739; 2009ZX09103-740), and the "973" Program of China (No. 2009CB521808). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arap W, 2002, P NATL ACAD SCI USA, V99, P1527, DOI 10.1073/pnas.241655998; Brissette R, 2006, CURR OPIN DRUG DISC, V9, P363; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Chongsiriwatana NP, 2008, P NATL ACAD SCI USA, V105, P2794, DOI 10.1073/pnas.0708254105; Copp BR, 2007, NAT PROD REP, V24, P278, DOI 10.1039/b513520f; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; Duquesne S, 2007, NAT PROD REP, V24, P708, DOI 10.1039/b516237h; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Fong S, 2003, P NATL ACAD SCI USA, V100, P13543, DOI 10.1073/pnas.2230238100; FURUKAWA T, 1993, CANCER RES, V53, P1204; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Hansel TT, 2009, LANCET, V374, P744, DOI 10.1016/S0140-6736(09)61342-8; Hu SJ, 2006, BIOCHEM BIOPH RES CO, V341, P964, DOI 10.1016/j.bbrc.2006.01.047; Landon Linda A, 2004, Curr Drug Discov Technol, V1, P113, DOI 10.2174/1570163043335108; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Li G, 2007, BIOMARKERS, V12, P214, DOI 10.1080/13547500601068192; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Oman TJ, 2011, NAT CHEM BIOL, V7, P78, DOI 10.1038/NCHEMBIO.509; Presti JC, 2007, NAT CLIN PRACT UROL, V4, P505, DOI 10.1038/ncpuro0887; Ren WH, 2004, CANCER RES, V64, P6645, DOI 10.1158/0008-5472.CAN-04-1084; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Samoylova T. I., 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P9, DOI 10.2174/187152006774755492; Steeg PS, 2011, NAT REV CANCER, V11, P352, DOI 10.1038/nrc3053; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Wang N, 2006, CANCER RES, V66, P3062, DOI 10.1158/0008-5472.CAN-05-2638; Warshamana-Greene GS, 2005, CLIN CANCER RES, V11, P1563, DOI 10.1158/1078-0432.CCR-04-1544; Yan M, 2005, LAB ANIM COMP MED, V25, P72; Yan M, 2005, SHANGHAI LAB ANIM SC, V25, P8; Yang WH, 2008, CLIN CANCER RES, V14, P5494, DOI 10.1158/1078-0432.CCR-08-0233; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang XY, 2009, CANCER RES, V69, P6506, DOI 10.1158/0008-5472.CAN-08-4721; Zhu W, 1995, Zhonghua Bing Li Xue Za Zhi, V24, P136	33	30	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e42685	10.1371/journal.pone.0042685	http://dx.doi.org/10.1371/journal.pone.0042685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984407	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700009
J	Wang, K; Zhao, XH; Kuang, CY; Qian, DH; Wang, H; Jiang, H; Deng, MY; Huang, L				Wang, Kui; Zhao, Xiaohui; Kuang, Chunyan; Qian, Dehui; Wang, Hang; Jiang, Hong; Deng, Mengyang; Huang, Lan			Overexpression of SDF-1 alpha Enhanced Migration and Engraftment of Cardiac Stem Cells and Reduced Infarcted Size via CXCR4/PI3K Pathway	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MYOCARDIAL-INFARCTION; PHOSPHOINOSITIDE 3-KINASE; SIGNAL-TRANSDUCTION; HEART; ACTIVATION; REGENERATION; RECEPTORS; THERAPY; KINASES	Cardiac stem cells (CSCs) can home to the infarcted area and regenerate myocardium. Stromal cell-derived factor-1 alpha/C-X-C chemokine receptor type 4 (SDF-1 alpha/CXCR4) axis is pivotal in inducing CSCs migration. However, the mechanisms remain unclear. This study set out to detect if SDF-1 alpha promotes migration and engraftment of CSCs through the CXCR4/PI3K (phosphatidylinositol 3-kinase) pathway. In the in vitro experiment, c-kit+ cells were isolated from neonatal mouse heart fragment culture by magnetic cell sorting. Fluorescence-activated cell sorting results demonstrated that a few c-kit+ cells expressed CD45 (4.54%) and Sca-1 (2.58%), the hematopoietic stem cell marker. Conditioned culture could induce c-kit+ cells multipotent differentiation, which was confirmed by cardiac troponin I (cTn-I), alpha-smooth muscle actin (alpha-SMA), and von Willebrand factor (vWF) staining. In vitro chemotaxis assays were performed using Transwell cell chambers to detect CSCs migration. The results showed that the cardiomyocytes infected with rAAV1-SDF-1 alpha-eGFP significantly increased SDF-1 alpha concentration, 5-fold more in supernatant than that in the control group, and subsequently attracted more CSCs migration. This effect was diminished by administration of AMD3100 (10 mg/ml, CXCR4 antagonist) or LY294002 (20 mmol/L, PI3K inhibitor). In myocardial infarction mice, overexpression of SDF-1 alpha in the infarcted area by rAAV1-SDF-1 alpha-eGFP infection resulted in more CSCs retention to the infarcted myocardium, a higher percentage of proliferation, and reduced infarcted area which was attenuated by AMD3100 or ly294002 pretreatment. These results indicated that overexpression of SDF-1 alpha enhanced CSCs migration in vitro and engraftment of transplanted CSCs and reduced infarcted size via CXCR4/PI3K pathway.	[Wang, Kui; Zhao, Xiaohui; Kuang, Chunyan; Qian, Dehui; Wang, Hang; Jiang, Hong; Deng, Mengyang; Huang, Lan] Third Mil Med Univ, Xinqiao Hosp, PLA, Inst Cardiovasc Dis, Chongqing, Peoples R China	Army Medical University	Wang, K (corresponding author), Third Mil Med Univ, Xinqiao Hosp, PLA, Inst Cardiovasc Dis, Chongqing, Peoples R China.	zxhwn2002@yahoo.com.cn		Huang, Lan/0000-0001-9594-4722	National Natural Science Foundation of China [30800480]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Grant from National Natural Science Foundation of China (30800480, http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Andino LM, 2008, J GENE MED, V10, P132, DOI 10.1002/jgm.1131; Barile L, 2007, PROG CARDIOVASC DIS, V50, P31, DOI 10.1016/j.pcad.2007.03.005; Bearzi C, 2007, P NATL ACAD SCI USA, V104, P14068, DOI 10.1073/pnas.0706760104; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Carr CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025669; Downward J, 1998, SCIENCE, V279, P673, DOI 10.1126/science.279.5351.673; Ellison GM, 2011, J AM COLL CARDIOL, V58, P977, DOI 10.1016/j.jacc.2011.05.013; Fischer KM, 2011, CIRC RES, V108, P960, DOI 10.1161/CIRCRESAHA.110.237156; Frati C, 2011, CURR PHARM DESIGN, V17, P3252; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; Guo HD, 2011, TISSUE ENG PT A, V17, P45, DOI [10.1089/ten.tea.2010.0124, 10.1089/ten.TEA.2010.0124]; Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1111/j.1365-2249.2003.02323.x; Huang PH, 2010, ARTERIOSCL THROM VAS, V30, P869, DOI 10.1161/ATVBAHA.109.200618; Koninckx R, 2011, CELL MOL LIFE SCI, V68, P2141, DOI 10.1007/s00018-010-0560-y; Kuang D, 2008, BASIC RES CARDIOL, V103, P265, DOI 10.1007/s00395-007-0690-z; Li M, 2008, CIRC RES, V102, P677, DOI 10.1161/CIRCRESAHA.107.161737; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Ma J, 2005, BASIC RES CARDIOL, V100, P217, DOI 10.1007/s00395-005-0521-z; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miyamoto S, 2010, STEM CELLS DEV, V19, P105, DOI 10.1089/scd.2009.0041; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Takamiya M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025265; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Tang JM, 2009, EXP CELL RES, V315, P3521, DOI 10.1016/j.yexcr.2009.09.026; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Tang YL, 2007, BIOCHEM BIOPH RES CO, V359, P877, DOI 10.1016/j.bbrc.2007.05.216; Theiss HD, 2011, STEM CELL RES, V7, P244, DOI 10.1016/j.scr.2011.05.003; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030503; Yu J, 2010, J CARDIOVASC PHARM, V55, P496, DOI 10.1097/FJC.0b013e3181d7a384; Zakharova L, 2010, CARDIOVASC RES, V87, P40, DOI 10.1093/cvr/cvq027; Zhao XH, 2008, MICROVASC RES, V75, P45, DOI 10.1016/j.mvr.2007.02.009; Zheng H, 2007, J CARDIOVASC PHARM, V50, P274, DOI 10.1097/FJC.0b013e318093ec8f; Zheng H, 2010, J CELL PHYSIOL, V223, P757, DOI 10.1002/jcp.22086	40	37	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43922	10.1371/journal.pone.0043922	http://dx.doi.org/10.1371/journal.pone.0043922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984452	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700033
J	Schwarz, J; Proff, J; Havemeier, A; Ladwein, M; Rottner, K; Barlag, B; Pich, A; Tatge, H; Just, I; Gerhard, R				Schwarz, Janett; Proff, Julia; Haevemeier, Anika; Ladwein, Markus; Rottner, Klemens; Barlag, Britta; Pich, Andreas; Tatge, Helma; Just, Ingo; Gerhard, Ralf			Serine-71 Phosphorylation of Rac1 Modulates Downstream Signaling	PLOS ONE			English	Article							SMALL GTPASE; RHO-GTPASES; DISSOCIATION INHIBITORS; KAPPA-B; PROTEINS; BINDING; KINASE; CDC42; ACTIVATION; PROGRESSION	The Rho GTPases Rac1 and Cdc42 regulate a variety of cellular functions by signaling to different signal pathways. It is believed that the presence of a specific effector at the location of GTPase activation determines the route of downstream signaling. We previously reported about EGF-induced Ser-71 phosphorylation of Rac1/Cdc42. By using the phosphomimetic S71E-mutants of Rac1 and Cdc42 we investigated the impact of Ser-71 phosphorylation on binding to selected effector proteins. Binding of the constitutively active (Q61L) variants of Rac1 and Cdc42 to their specific interaction partners Sra-1 and N-WASP, respectively, as well as to their common effector protein PAK was abrogated when Ser-71 was exchanged to glutamate as phosphomimetic substitution. Interaction with their common effector proteins IQGAP1/2/3 or MRCK alpha was, however, hardly affected. This ambivalent behaviour was obvious in functional assays. In contrast to Rac1 Q61L, phosphomimetic Rac1 Q61L/S71E was not able to induce increased membrane ruffling. Instead, Rac1 Q61L/S71E allowed filopodia formation, which is in accordance with abrogation of the dominant Sra-1/Wave signalling pathway. In addition, in contrast to Rac1 transfected cells Rac1 S71E failed to activate PAK1/2. On the other hand, Rac1 Q61L/S71E was as effective in activation of NF-kappaB as Rac1 Q61L, illustrating positive signal transduction of phosphorylated Rac1. Together, these data suggest that phosphorylation of Rac1 and Cdc42 at serine-71 represents a reversible mechanism to shift specificity of GTPase/effector coupling, and to preferentially address selected downstream pathways.	[Schwarz, Janett; Proff, Julia; Barlag, Britta; Pich, Andreas; Tatge, Helma; Just, Ingo; Gerhard, Ralf] Hannover Med Sch, Dept Toxicol, D-3000 Hannover, Germany; [Haevemeier, Anika] Hannover Med Sch, Dept Virol, D-3000 Hannover, Germany; [Ladwein, Markus; Rottner, Klemens] Helmholtz Ctr Infect Res, Cytoskeleton Dynam Grp, Braunschweig, Germany; [Rottner, Klemens] Univ Bonn, Inst Genet, Bonn, Germany	Hannover Medical School; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; University of Bonn	Schwarz, J (corresponding author), Hannover Med Sch, Dept Toxicol, D-3000 Hannover, Germany.	Gerhard.ralf@mh-hannover.de		Rottner, Klemens/0000-0003-4244-4198	Deutsche Forschungsgemeinschaft [SFB621, B5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported in part by the Deutsche Forschungsgemeinschaft, SFB621, project B5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Chrostek A, 2006, MOL CELL BIOL, V26, P6957, DOI 10.1128/MCB.00075-06; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Fukata M, 1999, J CELL SCI, V112, P4491; Geny B, 2009, CELL MICROBIOL, V11, P1102, DOI 10.1111/j.1462-5822.2009.01314.x; Hall A, 1998, SCIENCE, V280, P2074, DOI 10.1126/science.280.5372.2074; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Jin S, 2006, AM J PHYSIOL-GASTR L, V291, pG1137, DOI 10.1152/ajpgi.00031.2006; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Maroto B, 2008, ONCOGENE, V27, P4900, DOI 10.1038/onc.2008.131; Matos P, 2005, EXP CELL RES, V305, P292, DOI 10.1016/j.yexcr.2004.12.029; Matos P, 2003, J BIOL CHEM, V278, P50442, DOI 10.1074/jbc.M308215200; Matos P, 2003, J BIOL CHEM IN PRESS, V278; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Miyano K, 2007, BIOCHIMIE, V89, P1133, DOI 10.1016/j.biochi.2007.05.003; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; NOBES CD, 1995, J CELL SCI, V108, P225; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Ozaki M, 2003, CELL DEATH DIFFER, V10, P508, DOI 10.1038/sj.cdd.4401172; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Pietrek M, 2010, J VIROL, V84, P8231, DOI 10.1128/JVI.01696-09; PRIGMORE E, 1995, J BIOL CHEM, V270, P10717, DOI 10.1074/jbc.270.18.10717; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Schoentaube J, 2009, CELL MICROBIOL, V11, P1816, DOI 10.1111/j.1462-5822.2009.01373.x; Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088; Tu H, 1999, MOL CELL BIOL, V19, P602; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	39	39	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44358	10.1371/journal.pone.0044358	http://dx.doi.org/10.1371/journal.pone.0044358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970203	Green Published, Green Submitted, gold			2022-12-25	WOS:000308748400015
J	Hofmann, NA; Ortner, A; Jacamo, RO; Reinisch, A; Schallmoser, K; Rohban, R; Etchart, N; Fruehwirth, M; Beham-Schmid, C; Andreeff, M; Strunk, D				Hofmann, Nicole A.; Ortner, Anna; Jacamo, Rodrigo O.; Reinisch, Andreas; Schallmoser, Katharina; Rohban, Rokhsareh; Etchart, Nathalie; Fruehwirth, Margareta; Beham-Schmid, Christine; Andreeff, Michael; Strunk, Dirk			Oxygen Sensing Mesenchymal Progenitors Promote Neo-Vasculogenesis in a Humanized Mouse Model In Vivo	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-2-ALPHA; COLONY-FORMING CELLS; UMBILICAL-CORD BLOOD; ENDOTHELIAL-CELLS; BONE-MARROW; TUMOR ANGIOGENESIS; GENE-EXPRESSION; STROMAL CELLS; STEM-CELLS; THERAPY	Despite insights into the molecular pathways regulating hypoxia-induced gene expression, it is not known which cell types accomplish oxygen sensing during neo-vasculogenesis. We have developed a humanized mouse model of endothelial and mesenchymal progenitor co-transplantation to delineate the cellular compartments responsible for hypoxia response during vasculogenesis. Mesenchymal stem/progenitor cells (MSPCs) accumulated nuclear hypoxia-inducible transcription factor (HIF)-1 alpha earlier and more sensitively than endothelial colony forming progenitor cells (ECFCs) in vitro and in vivo. Hypoxic ECFCs showed reduced function in vitro and underwent apoptosis within 24h in vivo when used without MSPCs. Surprisingly, only in MSPCs did pharmacologic or genetic inhibition of HIF-1 alpha abrogate neo-vasculogenesis. HIF deletion in ECFCs caused no effect. ECFCs could be rescued from hypoxia-induced apoptosis by HIF-competent MSPCs resulting in the formation of patent perfused human vessels. Several angiogenic factors need to act in concert to partially substitute mesenchymal HIF-deficiency. Results demonstrate that ECFCs require HIF-competent vessel wall progenitors to initiate vasculogenesis in vivo and to bypass hypoxia-induced apoptosis. We describe a novel mechanistic role of MSPCs as oxygen sensors promoting vasculogenesis thus underscoring their importance for the development of advanced cellular therapies.	[Hofmann, Nicole A.; Ortner, Anna; Reinisch, Andreas; Schallmoser, Katharina; Rohban, Rokhsareh; Etchart, Nathalie; Fruehwirth, Margareta; Strunk, Dirk] Med Univ Graz, Stem Cell Res Unit, Graz, Austria; [Jacamo, Rodrigo O.; Andreeff, Michael] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Reinisch, Andreas; Etchart, Nathalie; Fruehwirth, Margareta; Strunk, Dirk] Med Univ Graz, Dept Hematol & Stem Cell Transplantat, Graz, Austria; [Schallmoser, Katharina] Med Univ Graz, Dept Blood Grp Serol & Transfus Med, Graz, Austria; [Beham-Schmid, Christine] Med Univ Graz, Inst Pathol, Graz, Austria	Medical University of Graz; University of Texas System; UTMD Anderson Cancer Center; Medical University of Graz; Medical University of Graz; Medical University of Graz	Hofmann, NA (corresponding author), Med Univ Graz, Stem Cell Res Unit, Graz, Austria.	dirk.strunk@medunigraz.at	Schallmoser, Katharina/V-4734-2017; Strunk, Dirk/V-4598-2017	Schallmoser, Katharina/0000-0002-7204-0058; Strunk, Dirk/0000-0003-1810-867X; Reinisch, Andreas/0000-0001-9333-7689	Austrian Research Foundation (FFG) [N211-NAN]; Adult Stem Cell Research Foundation (TASCRF); Medical University of Graz	Austrian Research Foundation (FFG)(Austrian Science Fund (FWF)); Adult Stem Cell Research Foundation (TASCRF); Medical University of Graz	This work was supported by the Austrian Research Foundation (FFG, grant N211-NAN; DS), the Adult Stem Cell Research Foundation (TASCRF) and a young investigator starting grant of the Medical University of Graz (AR). NAH, AO, AR and RR are fellows of the PhD program Molecular Medicine at the Medical University of Graz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2011, J TISSUE ENG REGEN M, V5, pE74, DOI 10.1002/term.389; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Au P, 2008, BLOOD, V111, P1302, DOI 10.1182/blood-2007-06-094318; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chen Y, 2012, BLOOD, V119, P4971, DOI 10.1182/blood-2011-11-389957; Cheng G, 2011, BLOOD, V118, P4740, DOI 10.1182/blood-2011-02-338426; Demidova-Rice TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032146; Dimmeler S, 2008, ARTERIOSCL THROM VAS, V28, P208, DOI 10.1161/ATVBAHA.107.155317; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Frontini MJ, 2011, NAT BIOTECHNOL, V29, P421, DOI 10.1038/nbt.1845; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Greenberger S, 2010, NEW ENGL J MED, V362, P1005, DOI 10.1056/NEJMoa0903036; Hofmann Nicole A, 2009, J Vis Exp, DOI 10.3791/1524; Hofmann Nicole A, 2012, Methods Mol Biol, V879, P381, DOI 10.1007/978-1-61779-815-3_23; Ingram DA, 2005, BLOOD, V105, P2783, DOI 10.1182/blood-2004-08-3057; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Kelly BD, 2003, CIRC RES, V93, P1074, DOI 10.1161/01.RES.0000102937.50486.1B; Kizaka-Kondoh S, 2009, CANCER SCI, V100, P1366, DOI 10.1111/j.1349-7006.2009.01195.x; Koike N, 2004, NATURE, V428, P138, DOI 10.1038/428138a; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Kuschel A, 2012, J CELL PHYSIOL, V227, P514, DOI 10.1002/jcp.22798; Li SH, 2008, MOL CANCER THER, V7, P3729, DOI 10.1158/1535-7163.MCT-08-0074; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Mackman N, 2011, ARTERIOSCL THROM VAS, V31, P2364, DOI 10.1161/ATVBAHA.111.236703; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Mead Laura E, 2008, Curr Protoc Stem Cell Biol, VChapter 2, DOI 10.1002/9780470151808.sc02c01s6; Melero-Martin JM, 2008, CIRC RES, V103, P194, DOI 10.1161/CIRCRESAHA.108.178590; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Melero-Martin JM, 2010, TISSUE ENG PT A, V16, P2457, DOI [10.1089/ten.tea.2010.0024, 10.1089/ten.TEA.2010.0024]; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; Reinisch A, 2007, REGEN MED, V2, P371, DOI 10.2217/17460751.2.4.371; Reinisch Andreas, 2009, J Vis Exp, DOI 10.3791/1525; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Saif J, 2010, ARTERIOSCL THROM VAS, V30, P1897, DOI 10.1161/ATVBAHA.110.207928; Schallmoser K, 2008, TISSUE ENG PT C-METH, V14, P185, DOI 10.1089/ten.tec.2008.0060; Schallmoser Katharina, 2009, J Vis Exp, DOI 10.3791/1523; Schallmoser K, 2010, HAEMATOL-HEMATOL J, V95, P867, DOI 10.3324/haematol.2009.011692; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schwarz TM, 2012, ARTERIOSCL THROM VAS, V32, pE13, DOI 10.1161/ATVBAHA.111.239822; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Skuli N, 2012, J CLIN INVEST, V122, P1427, DOI 10.1172/JCI57322; Skuli N, 2009, BLOOD, V114, P469, DOI 10.1182/blood-2008-12-193581; Strunk D, 2005, TRANSFUSION, V45, P315, DOI 10.1111/j.1537-2995.2005.04056.x; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Templin C, 2012, CIRCULATION IN PRESS; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoon CH, 2010, CIRCULATION, V121, P2001, DOI 10.1161/CIRCULATIONAHA.109.909291; Zhou WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027460	57	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44468	10.1371/journal.pone.0044468	http://dx.doi.org/10.1371/journal.pone.0044468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970226	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000023
J	Hong, HX; Xu, L; Liu, J; Jones, WD; Su, ZQ; Ning, BT; Perkins, R; Ge, WG; Miclaus, K; Zhang, L; Park, K; Green, B; Han, T; Fang, H; Lambert, CG; Vega, SC; Lin, SM; Jafari, N; Czika, W; Wolfinger, RD; Goodsaid, F; Tong, WD; Shi, LM				Hong, Huixiao; Xu, Lei; Liu, Jie; Jones, Wendell D.; Su, Zhenqiang; Ning, Baitang; Perkins, Roger; Ge, Weigong; Miclaus, Kelci; Zhang, Li; Park, Kyunghee; Green, Bridgett; Han, Tao; Fang, Hong; Lambert, Christophe G.; Vega, Silvia C.; Lin, Simon M.; Jafari, Nadereh; Czika, Wendy; Wolfinger, Russell D.; Goodsaid, Federico; Tong, Weida; Shi, Leming			Technical Reproducibility of Genotyping SNP Arrays Used in Genome-Wide Association Studies	PLOS ONE			English	Article							SUSCEPTIBILITY LOCI; GENETIC VARIANT; HAPMAP SAMPLES; BREAST-CANCER; RISK LOCI; DISEASE; ALGORITHM; GWAS; INCONSISTENCIES; REPLICATION	During the last several years, high-density genotyping SNP arrays have facilitated genome-wide association studies (GWAS) that successfully identified common genetic variants associated with a variety of phenotypes. However, each of the identified genetic variants only explains a very small fraction of the underlying genetic contribution to the studied phenotypic trait. Moreover, discordance observed in results between independent GWAS indicates the potential for Type I and II errors. High reliability of genotyping technology is needed to have confidence in using SNP data and interpreting GWAS results. Therefore, reproducibility of two widely genotyping technology platforms from Affymetrix and Illumina was assessed by analyzing four technical replicates from each of the six individuals in five laboratories. Genotype concordance of 99.40% to 99.87% within a laboratory for the sample platform, 98.59% to 99.86% across laboratories for the same platform, and 98.80% across genotyping platforms was observed. Moreover, arrays with low quality data were detected when comparing genotyping data from technical replicates, but they could not be detected according to venders' quality control (QC) suggestions. Our results demonstrated the technical reliability of currently available genotyping platforms but also indicated the importance of incorporating some technical replicates for genotyping QC in order to improve the reliability of GWAS results. The impact of discordant genotypes on association analysis results was simulated and could explain, at least in part, the irreproducibility of some GWAS findings when the effect size (i.e. the odds ratio) and the minor allele frequencies are low.	[Hong, Huixiao; Xu, Lei; Perkins, Roger; Ge, Weigong; Tong, Weida; Shi, Leming] US FDA, Ctr Excellence Bioinformat, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Liu, Jie; Ning, Baitang; Green, Bridgett] US FDA, Div Personalized Nutr & Med, Natl Ctr Toxicol Res, Jefferson, AR USA; [Jones, Wendell D.] Express Anal Inc, Durham, NC USA; [Su, Zhenqiang; Fang, Hong] US FDA, ICF Int Co, Natl Ctr Toxicol Res, Jefferson, AR USA; [Miclaus, Kelci; Czika, Wendy; Wolfinger, Russell D.] SAS Inst Inc, Cary, NC USA; [Zhang, Li; Goodsaid, Federico] US FDA, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Park, Kyunghee] Samsung Adv Inst Technol, Yongin Si Gyeonggi Do, South Korea; [Han, Tao] US FDA, Ctr Excellence Genom, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR USA; [Lambert, Christophe G.] Golden Helix Inc, Bozeman, MT USA; [Vega, Silvia C.] Microsoft Corp, Rosetta BioSoftware, Hlth Solut Grp, Seattle, WA USA; [Lin, Simon M.] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Jafari, Nadereh] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); SAS Institute Inc; US Food & Drug Administration (FDA); Samsung; US Food & Drug Administration (FDA); Microsoft; Northwestern University	Hong, HX (corresponding author), US FDA, Ctr Excellence Bioinformat, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	huixiao.hong@fda.hhs.gov; leming.shi@fda.hhs.gov	Jones, Wendell/AAM-4831-2021; Shi, Leming/B-3150-2010; Lambert, Christophe/AAH-4448-2021; Su, Zhenqiang/H-3914-2012	Shi, Leming/0000-0002-7143-2033; Lambert, Christophe/0000-0003-1994-2893; Jones, Wendell/0000-0002-9676-5387; Hong, Huixiao/0000-0001-8087-3968; Ning, Baitang/0000-0003-0798-0331	Expression Analysis, Inc; Golden Helix Inc	Expression Analysis, Inc; Golden Helix Inc	The authors have read the journal's policy and have the following conflicts: Wendell Jones is a paid employee of Expression Analysis, Inc; Wendy Czika, Kelci Miclaus and Russell D. Wolfinger are employed by SAS Institute Inc; Zhenqiang Su and Hong Fang are employed by ICF International Company at NCTR/FDA (National Center for Toxicological Research/Food and Drug Administration); Christophe G. Lambert is a paid employee of Golden Helix Inc; Silvia Vega has been employed by Rosetta BioSoftware and for Microsoft Corp. in the last five years but at present has no competing interests. All other authors have no competing interests. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Arking DE, 2008, AM J HUM GENET, V82, P160, DOI 10.1016/j.ajhg.2007.09.015; Azzato EM, 2010, CANCER EPIDEM BIOMAR, V19, P1140, DOI 10.1158/1055-9965.EPI-10-0085; Buch S, 2007, NAT GENET, V39, P995, DOI 10.1038/ng2101; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gold B, 2008, P NATL ACAD SCI USA, V105, P4340, DOI 10.1073/pnas.0800441105; Grupe A, 2007, HUM MOL GENET, V16, P865, DOI 10.1093/hmg/ddm031; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hirschhorn JN, 2009, NEW ENGL J MED, V360, P1699, DOI 10.1056/NEJMp0808934; Hong H, 2010, PHARMACOGENOMICS J, V10, P364, DOI 10.1038/tpj.2010.24; Hong H., 2009, BATCH EFFECTS NOISE, P191; Hong HX, 2010, J GENET, V89, P55, DOI 10.1007/s12041-010-0011-4; Hong HX, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S17; Kerkhof HJM, 2010, ARTHRITIS RHEUM-US, V62, P499, DOI 10.1002/art.27184; Knauff EAH, 2009, HUM REPROD, V24, P2372, DOI 10.1093/humrep/dep197; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Landi MT, 2009, AM J HUM GENET, V85, P679, DOI 10.1016/j.ajhg.2009.09.012; Lyssenko V, 2009, CURR OPIN LIPIDOL, V20, P87, DOI 10.1097/MOL.0b013e32832923af; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Miclaus K, 2010, PHARMACOGENOMICS J, V10, P324, DOI 10.1038/tpj.2010.46; Miclaus K, 2010, PHARMACOGENOMICS J, V10, P336, DOI 10.1038/tpj.2010.36; Pearson TA, 2008, JAMA-J AM MED ASSOC, V82, P411; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pfeufer A, 2007, NAT GENET       0527, V42, P153; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rung J, 2009, NAT GENET, V41, P1110, DOI 10.1038/ng.443; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhang L, 2010, PHARMACOGENOMICS J, V10, P347, DOI 10.1038/tpj.2010.27	42	38	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44483	10.1371/journal.pone.0044483	http://dx.doi.org/10.1371/journal.pone.0044483			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970228	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000024
J	Keating, SCJ; Thomas, AA; Flecknell, PA; Leach, MC				Keating, Stephanie C. J.; Thomas, Aurelie A.; Flecknell, Paul A.; Leach, Matthew C.			Evaluation of EMLA Cream for Preventing Pain during Tattooing of Rabbits: Changes in Physiological, Behavioural and Facial Expression Responses	PLOS ONE			English	Article							LIDOCAINE-PRILOCAINE CREAM; LABORATORY-ANIMALS; EUTECTIC MIXTURE; LOCAL-ANESTHESIA; LAPAROTOMY; RATS; CARPROFEN; SKIN; BUPRENORPHINE; ANALGESIA	Background: Ear tattooing is a routine procedure performed on laboratory, commercial and companion rabbits for the purpose of identification. Although this procedure is potentially painful, it is usually performed without the provision of analgesia, so compromising animal welfare. Furthermore, current means to assess pain in rabbits are poor and more reliable methods are required. The objectives of this study were to assess the physiological and behavioural effects of ear tattooing on rabbits, evaluate the analgesic efficacy of topical local anaesthetic cream application prior to this procedure, and to develop a scale to assess pain in rabbits based on changes in facial expression. Methodology/Principal Findings: In a crossover study, eight New Zealand White rabbits each underwent four different treatments of actual or sham ear tattooing, with and without prior application of a topical local anaesthetic (lidocaine/prilocaine). Changes in immediate behaviour, heart rate, arterial blood pressure, serum corticosterone concentrations, facial expression and home pen behaviours were assessed. Changes in facial expression were examined to develop the Rabbit Grimace Scale in order to assess acute pain. Tattooing without EMLA cream resulted in significantly greater struggling behaviour and vocalisation, greater facial expression scores of pain, higher peak heart rate, as well as higher systolic and mean arterial blood pressure compared to all other treatments. Physiological and behavioural changes following tattooing with EMLA cream were similar to those in animals receiving sham tattoos with or without EMLA cream. Behavioural changes 1 hour post-treatment were minimal with no pain behaviours identifiable in any group. Serum corticosterone responses did not differ between sham and tattoo treatments. Conclusions: Ear tattooing causes transient and potentially severe pain in rabbits, which is almost completely prevented by prior application of local anaesthetic cream. The Rabbit Grimace Scale developed appears to be a reliable and accurate way to assess acute pain in rabbits.	[Keating, Stephanie C. J.] Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON N1G 2W1, Canada; [Thomas, Aurelie A.; Flecknell, Paul A.; Leach, Matthew C.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Thomas, Aurelie A.; Flecknell, Paul A.; Leach, Matthew C.] Newcastle Univ, Comparat Biol Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	University of Guelph; Newcastle University - UK; Newcastle University - UK	Keating, SCJ (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Clin Studies, Guelph, ON N1G 2W1, Canada.	Matthew.Leach@Newcastle.ac.uk		Flecknell, Paul/0000-0002-1075-1129	Swedish Board of Agriculture; NC3Rs; BBSRC; National Centre for the Replacement [G1100563/1] Funding Source: researchfish	Swedish Board of Agriculture; NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Centre for the Replacement	Ms. Keating was supported by the Swedish Board of Agriculture, Dr. Leach was supported by the NC3Rs (www.nc3rs.org.uk), and the BBSRC (www.bbsrc.ac.uk). The animals used in this study were donated by Harlan UK (www.harlan.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Rabbit Breeders Association, 2012, INSTR REG; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; BJERRING P, 1990, BRIT J ANAESTH, V64, P173, DOI 10.1093/bja/64.2.173; Brodbelt DC, 2008, VET ANAESTH ANALG, V35, P365, DOI 10.1111/j.1467-2995.2008.00397.x; Donovan John, 2006, Curr Protoc Immunol, VChapter 1, DOI 10.1002/0471142735.im0105s73; FLECKNELL PA, 1990, LAB ANIM-UK, V24, P142, DOI 10.1258/002367790780890121; FLECKNELL PA, 1994, LAB ANIM-UK, V28, P222, DOI 10.1258/002367794780681660; GOODACRE TEE, 1988, BRIT J PLAST SURG, V41, P533, DOI 10.1016/0007-1226(88)90013-6; HIRVONEN J, 1991, PHARMACEUT RES, V8, P933, DOI 10.1023/A:1015824100788; HOLMES HS, 1994, DERMATOL CLIN, V12, P817, DOI 10.1016/S0733-8635(18)30145-1; Kasanen IHE, 2011, LAB ANIM-UK, V45, P154, DOI 10.1258/la.2011.010113; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Leach MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035656; Leach MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0013347; Leach MC, 2009, RES VET SCI, V87, P336, DOI 10.1016/j.rvsc.2009.02.001; LILES JH, 1994, J VET PHARMACOL THER, V17, P284, DOI 10.1111/j.1365-2885.1994.tb00247.x; Martin TJ, 2004, ANESTHESIOLOGY, V101, P191, DOI 10.1097/00000542-200407000-00030; MROZEK M, 1995, LAB ANIM, V29, P339, DOI 10.1258/002367795781088298; National Research Council, 2009, REC ALL PAIN LAB AN; Roughan JV, 2004, BEHAV PHARMACOL, V15, P461, DOI 10.1097/00008877-200411000-00002; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; RYLANDER E, 1990, OBSTET GYNECOL, V75, P302; Sandkuhler J, 2009, PHYSIOL REV, V89, P707, DOI 10.1152/physrev.00025.2008; Shaikh FM, 2009, DERMATOL SURG, V35, P948, DOI 10.1111/j.1524-4725.2009.01160.x; SMITH M, 1990, BRIT J ANAESTH, V65, P240, DOI 10.1093/bja/65.2.240; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Stasiak KL, 2003, CONTEMP TOP LAB ANIM, V42, P13; TADDIO A, 1994, J PEDIATR-US, V124, P643, DOI 10.1016/S0022-3476(05)83150-6; Wahlgren CF, 2000, J AM ACAD DERMATOL, V42, P584, DOI 10.1016/S0190-9622(00)90169-5; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080	31	168	170	3	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44437	10.1371/journal.pone.0044437	http://dx.doi.org/10.1371/journal.pone.0044437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970216	gold, Green Submitted, Green Published			2022-12-25	WOS:000308462000020
J	Crawford, AO; Hamerton, I; Cavalli, G; Howlin, BJ				Crawford, Alasdair O.; Hamerton, Ian; Cavalli, Gabriel; Howlin, Brendan J.			Quantifying the Effect of Polymer Blending through Molecular Modelling of Cyanurate Polymers	PLOS ONE			English	Article							LINKED EPOXY-RESIN; INITIO FORCE-FIELD; CYANATE ESTER; DYNAMICS SIMULATION; MECHANICAL-PROPERTIES; COMPUTER-SIMULATIONS; DIFFUSION; POLYSILOXANES; COMPOSITES; POLYIMIDES	Modification of polymer properties by blending is a common practice in the polymer industry. We report here a study of blends of cyanurate polymers by molecular modelling that shows that the final experimentally determined properties can be predicted from first principles modelling to a good degree of accuracy. There is always a compromise between simulation length, accuracy and speed of prediction. A comparison of simulation times shows that 125ps of molecular dynamics simulation at each temperature provides the optimum compromise for models of this size with current technology. This study opens up the possibility of computer aided design of polymer blends with desired physical and mechanical properties.	[Crawford, Alasdair O.; Hamerton, Ian; Cavalli, Gabriel; Howlin, Brendan J.] Univ Surrey, Dept Chem, Guildford GU2 5XH, Surrey, England	University of Surrey	Crawford, AO (corresponding author), Univ Surrey, Dept Chem, Guildford GU2 5XH, Surrey, England.	b.howlin@surrey.ac.uk	Hamerton, Ian/AAV-8918-2021; Cavalli, Gabriel/B-7207-2009; Cavalli, Gabriel/ABE-2401-2020; Howlin, Brendan J/F-3343-2011	Hamerton, Ian/0000-0003-3113-0345; Cavalli, Gabriel/0000-0002-2856-1956; Cavalli, Gabriel/0000-0002-2856-1956; Howlin, Brendan J/0000-0002-9398-7152	Lonza AG	Lonza AG	The authors thank Lonza AG for funding this work in the form of a PhD studentship (AOC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accelrys, MAT STUD; Allington RD, 2003, POLYMER, V44, P793, DOI 10.1016/S0032-3861(02)00707-3; ANDERSEN HC, 1980, J CHEM PHYS, V72, P2384, DOI 10.1063/1.439486; Auhl R, 2003, J CHEM PHYS, V119, P12718, DOI 10.1063/1.1628670; Crawford AO, 2012, REACT FUNCT POLYM, V72, P596, DOI 10.1016/j.reactfunctpolym.2012.05.012; Fan HB, 2007, POLYMER, V48, P2174, DOI 10.1016/j.polymer.2007.02.007; Fried JR, 2001, COMPUT THEOR POLYM S, V11, P273, DOI 10.1016/S1089-3156(00)00021-0; Gou J, COMPUTATIONAL MAT SC, V31, P225; Gou JH, 2004, COMP MATER SCI, V31, P225, DOI 10.1016/j.commatsci.2004.03.002; Grujicic M, 2007, APPL SURF SCI, V253, P3009, DOI 10.1016/j.apsusc.2006.06.050; Guenthner AJ, 2012, MACROMOLECULES, V45, P211, DOI 10.1021/ma202513h; Hall SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042928; Hamerton I, 2006, POLYMER, V47, P690, DOI 10.1016/j.polymer.2005.11.082; Hamerton I, 2006, REACT FUNCT POLYM, V66, P21, DOI 10.1016/j.reactfunctpolym.2005.07.018; Hamerton I., 1994, CHEM TECHNOLOGY CYAN; Hofmann D, 2000, COMPUT THEOR POLYM S, V10, P419, DOI 10.1016/S1089-3156(00)00007-6; Karad SK, 2002, COMPOS PART A-APPL S, V33, P1665, DOI 10.1016/S1359-835X(02)00176-8; Lin YC, 2005, CHEM PHYS LETT, V412, P322, DOI 10.1016/j.cplett.2005.07.022; MAPLE JR, 1988, P NATL ACAD SCI USA, V85, P5350, DOI 10.1073/pnas.85.15.5350; MAYO SL, 1990, J PHYS CHEM-US, V94, P8897, DOI 10.1021/j100389a010; Nair CPR, 2001, ADV POLYM SCI, V155, P1; Nair CPR, 1999, J APPL POLYM SCI, V74, P2737; Neyertz S, 2006, J MEMBRANE SCI, V280, P517, DOI 10.1016/j.memsci.2006.02.011; Pan R, 2007, COMP MATER SCI, V39, P887, DOI 10.1016/j.commatsci.2006.10.019; Parinello M., 1981, J APPL PHYS, V52, P7182; Pavel D, 2005, POLYMER, V46, P6135, DOI 10.1016/j.polymer.2005.05.085; POWELL MJD, 1977, MATH PROGRAM, V12, P241, DOI 10.1007/BF01593790; Ren H, 2007, POLYMER, V48, P887, DOI 10.1016/j.polymer.2006.12.016; Rigby D, 1997, POLYM INT, V44, P311, DOI 10.1002/(SICI)1097-0126(199711)44:3<311::AID-PI880>3.0.CO;2-H; Rui P., 2007, COMP MATER SCI, V39, P887; Sun H, 1998, J PHYS CHEM B, V102, P7338, DOI 10.1021/jp980939v; Sun H, 1997, SPECTROCHIM ACTA A, V53, P1301, DOI 10.1016/S1386-1425(97)00013-9; Tack JL, 2008, J MOL GRAPH MODEL, V26, P1269, DOI 10.1016/j.jmgm.2007.12.001; Tao QS, 2004, POLYMER, V45, P3505, DOI 10.1016/j.polymer.2004.03.043; Wu CF, 2007, POLYMER, V48, P5802, DOI 10.1016/j.polymer.2007.07.019; Wu CF, 2006, POLYMER, V47, P6004, DOI 10.1016/j.polymer.2006.06.025	36	6	6	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44487	10.1371/journal.pone.0044487	http://dx.doi.org/10.1371/journal.pone.0044487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970230	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400076
J	Ekvall, MK; Hansson, LA				Ekvall, Mattias K.; Hansson, Lars-Anders			Differences in Recruitment and Life-History Strategy Alter Zooplankton Spring Dynamics Under Climate-Change Conditions	PLOS ONE			English	Article							FRESH-WATER ZOOPLANKTON; RESTING STAGES; LAKE PLANKTON; DIAPAUSE; EVENTS; EGGS; TEMPERATURE; TERMINATION; INDUCTION; EMERGENCE	In recent decades temperature elevation has been the focus of many studies on climate change, including effects on planktonic communities, but few studies have examined the effects of increased water color ("brownification"). Since these changes are likely to occur simultaneously, it is important to investigate their potential interactive effects. Accordingly, we performed a mesocosm experiment where we combined a 3 degrees C increase in temperature with a doubling in water color to study how these factors affect zooplankton. In particular, we looked at recruitment of cladocerans and copepods from the sediment in spring, as well as their establishment in the water column. Our results show that an elevated temperature will have considerable effects on recruitment as well as on pelagic abundances of both cladocerans and copepods, whereas increases in water color will have less effects on the recruitment and pelagic establishment. But more importantly, the proportion of cladocerans in the water column, relative to copepods, increased at higher temperature, suggesting that cladocerans benefit more from elevated temperatures than copepods do. Overall, these results likely stem from the combined effect of changes in recruitment and differences in life history between copepods and cladocerans. Taking a wider outlook, this suggests that future climate warming will change the dominance pattern of zooplankton communities in spring, and, in accordance with the experimental data, we here show that cladocerans are more abundant than copepods in natural lake ecosystems during warmer rather than cooler years.	[Ekvall, Mattias K.; Hansson, Lars-Anders] Lund Univ, Dept Biol, Aquat Ecol Unit, Lund, Sweden	Lund University	Ekvall, MK (corresponding author), Lund Univ, Dept Biol, Aquat Ecol Unit, Lund, Sweden.	mattias.ekvall@biol.lu.se	Hansson, Lars-Anders/HCI-2735-2022	Hansson, Lars-Anders/0000-0002-3035-1317	The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Swedish Research Council (VR) through Centre for Animal Movement Research (CAnMove) [349-2007-8690]	The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Research Council (VR) through Centre for Animal Movement Research (CAnMove)(Swedish Research Council)	The project was financed by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) and the Swedish Research Council (VR) through the Centre for Animal Movement Research (CAnMove) through the Linnaeus grant 349-2007-8690. The study was performed within the framework of the Interreg IV A European union project Algae Be Gone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian R, 2006, GLOBAL CHANGE BIOL, V12, P652, DOI 10.1111/j.1365-2486.2006.01125.x; Alekseev VR, 1996, HYDROBIOLOGIA, V320, P15, DOI 10.1007/BF00016801; Caceres CE, 2001, FRESHWATER BIOL, V46, P1179, DOI 10.1046/j.1365-2427.2001.00737.x; Carpenter SR, 1996, ECOLOGY, V77, P677, DOI 10.2307/2265490; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Daniel C, 2005, AQUAT MICROB ECOL, V38, P113, DOI 10.3354/ame038113; DEMEESTER L, 1993, FRESHWATER BIOL, V30, P219; Dussart BH, 1995, COPEPODA INTRO COPEP; ELGMORK K, 1981, HOLARCTIC ECOL, V4, P278; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Evans CD, 2005, ENVIRON POLLUT, V137, P55, DOI 10.1016/j.envpol.2004.12.031; Gerten D, 2002, FRESHWATER BIOL, V47, P2163, DOI 10.1046/j.1365-2427.2002.00970.x; Graham MD, 2009, LIMNOL OCEANOGR, V54, P2481, DOI 10.4319/lo.2009.54.6_part_2.2481; Graneli W, 2012, ENCY LAKES RESERVOIR; Gyllstrom M, 2004, AQUAT SCI, V66, P274, DOI 10.1007/s00027-004-0712-y; Gyllstrom M, 2004, ARCH HYDROBIOL, V161, P81, DOI 10.1127/0003-9136/2004/0161-0081; Hairston NG, 2000, FRESHWATER BIOL, V45, P133; Hansson LA, 2007, LIMNOL OCEANOGR, V52, P696, DOI 10.4319/lo.2007.52.2.0696; Hongve D, 2004, AQUAT SCI, V66, P231, DOI 10.1007/s00027-004-0708-7; Jansson M, 2007, TRENDS ECOL EVOL, V22, P316, DOI 10.1016/j.tree.2007.02.015; LAMPERT W, 1986, LIMNOL OCEANOGR, V31, P478, DOI 10.4319/lo.1986.31.3.0478; MAIER G, 1990, HYDROBIOLOGIA, V206, P11, DOI 10.1007/BF00018965; Nicolle A, 2012, FRESHWATER BIOL, V57, P684, DOI 10.1111/j.1365-2427.2012.02733.x; Scheffer M, 2001, LIMNOL OCEANOGR, V46, P1780, DOI 10.4319/lo.2001.46.7.1780; SCHWARTZ SS, 1987, FRESHWATER BIOL, V17, P373, DOI 10.1111/j.1365-2427.1987.tb01057.x; SOMMER U, 1986, ARCH HYDROBIOL, V106, P433; Stahl-Delbanco A, 2003, J PLANKTON RES, V25, P1099, DOI 10.1093/plankt/25.9.1099; Straile D, 2000, GLOBAL CHANGE BIOL, V6, P663, DOI 10.1046/j.1365-2486.2000.00350.x; STROSS RG, 1966, ECOLOGY, V47, P368, DOI 10.2307/1932977; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Vandekerkhove J, 2005, FRESHWATER BIOL, V50, P96, DOI 10.1111/j.1365-2427.2004.01312.x; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151; Wissel B, 2003, LIMNOL OCEANOGR, V48, P1965, DOI 10.4319/lo.2003.48.5.1965	33	22	25	1	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44614	10.1371/journal.pone.0044614	http://dx.doi.org/10.1371/journal.pone.0044614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970267	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400095
J	Xu, D; Zhang, BJ; Liang, G; Ping, J; Kou, H; Li, XJ; Xiong, J; Hu, DC; Chen, LB; Magdalou, J; Wang, H				Xu, Dan; Zhang, Benjian; Liang, Gai; Ping, Jie; Kou, Hao; Li, Xiaojun; Xiong, Jie; Hu, Dongcai; Chen, Liaobin; Magdalou, Jacques; Wang, Hui			Caffeine-Induced Activated Glucocorticoid Metabolism in the Hippocampus Causes Hypothalamic-Pituitary-Adrenal Axis Inhibition in Fetal Rats	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-2; INTRAUTERINE GROWTH RESTRICTION; GENE-EXPRESSION; MINERALOCORTICOID RECEPTOR; ENVIRONMENTAL EPIGENOMICS; PRENATAL OVEREXPOSURE; EPIGENETIC MECHANISMS; INSULIN SENSITIVITY; PROTEIN-A; CORTISOL	Epidemiological investigations have shown that fetuses with intrauterine growth retardation (IUGR) are susceptible to adult metabolic syndrome. Clinical investigations and experiments have demonstrated that caffeine is a definite inducer of IUGR, as children who ingest caffeine-containing food or drinks are highly susceptible to adult obesity and hypertension. Our goals for this study were to investigate the effect of prenatal caffeine ingestion on the functional development of the fetal hippocampus and the hypothalamic-pituitary-adrenal (HPA) axis and to clarify an intrauterine HPA axis-associated neuroendocrine alteration induced by caffeine. Pregnant Wistar rats were intragastrically administered 20, 60, and 180 mg/kg.d caffeine from gestational days 11-20. The results show that prenatal caffeine ingestion significantly decreased the expression of fetal hypothalamus corticotrophin-releasing hormone. The fetal adrenal cortex changed into slight and the expression of fetal adrenal steroid acute regulatory protein (StAR) and cholesterol side-chain cleavage enzyme (P450scc), as well as the level of fetal adrenal endogenous corticosterone (CORT), were all significantly decreased after caffeine treatment. Moreover, caffeine ingestion significantly increased the levels of maternal and fetal blood CORT and decreased the expression of placental 11 beta-hydroxysteroid dehydrogenase-2 (11 beta-HSD-2). Additionally, both in vivo and in vitro studies show that caffeine can downregulate the expression of fetal hippocampal 11b-HSD-2, promote the expression of 11 beta-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor (GR), and enhance DNA methylation within the hippocampal 11b-HSD-2 promoter. These results suggest that prenatal caffeine ingestion inhibits the development of the fetal HPA axis, which may be associated with the fetal overexposure to maternal glucocorticoid and activated glucocorticoid metabolism in the fetal hippocampus. These results will be beneficial in elucidating the developmental toxicity of caffeine and in exploring the fetal origin of adult HPA axis dysfunction and metabolic syndrome susceptibility for offspring with IUGR induced by caffeine.	[Xu, Dan; Zhang, Benjian; Liang, Gai; Ping, Jie; Kou, Hao; Li, Xiaojun; Xiong, Jie; Wang, Hui] Wuhan Univ, Basic Med Sch, Dept Pharmacol, Wuhan 430072, Peoples R China; [Xu, Dan; Ping, Jie; Wang, Hui] Wuhan Univ, Res Ctr Food & Drug Evaluat, Wuhan 430072, Peoples R China; [Hu, Dongcai; Chen, Liaobin] Wuhan Univ, Zhongnan Hosp, Dept Orthoped Surg, Wuhan 430072, Peoples R China; [Magdalou, Jacques] Univ Nancy, Fac Med, CNRS, UMR 7561, Vandoeuvre Les Nancy, France	Wuhan University; Wuhan University; Wuhan University; Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Xu, D (corresponding author), Wuhan Univ, Basic Med Sch, Dept Pharmacol, Wuhan 430072, Peoples R China.	wanghui19@whu.edu.cn	Hu, Dongcai/F-2375-2014; Zhang, Benjian/ABC-1130-2020	Hu, Dongcai/0000-0002-1239-7215; 	National Natural Science Foundation of China [30830112, 81072709, 812 2]; Chinese Ministry of Education [V200801]; Hubei Province Science Foundation for Innovation Group of China [2009CDA079]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20110141120055]; Postdoctoral Science Foundation of China [20110491196]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Hubei Province Science Foundation for Innovation Group of China; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Postdoctoral Science Foundation of China(China Postdoctoral Science Foundation)	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30830112, 81072709, and 812 2), the Key Grant Project of the Chinese Ministry of Education (No. V200801), the Hubei Province Science Foundation for Innovation Group of China (No. 2009CDA079), the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20110141120055) and the Postdoctoral Science Foundation of China (No. 20110491196). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani-Koopaei R, 2004, J CLIN INVEST, V114, P1146, DOI 10.1172/JCI200421647; Anagnostis P, 2009, J CLIN ENDOCR METAB, V94, P2692, DOI 10.1210/jc.2009-0370; Barbazanges A, 1996, J NEUROSCI, V16, P3943; Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3; Baserga M, 2010, AM J PHYSIOL-REG I, V299, pR334, DOI 10.1152/ajpregu.00122.2010; Boylan SM, 2008, BRIT J NUTR, V100, P875, DOI 10.1017/S0007114508939842; Brabant G, 2005, FASEB J, V19, P1048, DOI 10.1096/fj.04-2846fje; Brown RW, 1996, ENDOCRINOLOGY, V137, P794, DOI 10.1210/en.137.2.794; Burton PJ, 1999, BIOL REPROD, V60, P234, DOI 10.1095/biolreprod60.2.234; Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412; Cayetanot F, 2009, RESP PHYSIOL NEUROBI, V168, P92, DOI 10.1016/j.resp.2009.04.024; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; Chen M, 2007, EXP TOXICOL PATHOL, V59, P245, DOI 10.1016/j.etp.2007.05.007; Christian MS, 2001, TERATOLOGY, V64, P51, DOI 10.1002/tera.1047; Cohen M S, 1982, Drug Ther, P165; de Quervain DJF, 2009, FRONT NEUROENDOCRIN, V30, P358, DOI 10.1016/j.yfrne.2009.03.002; Diaz R, 1998, J NEUROSCI, V18, P2570; Dolinoy DC, 2008, ENVIRON MOL MUTAGEN, V49, P4, DOI 10.1002/em.20366; Fowden AL, 2005, EARLY HUM DEV, V81, P723, DOI 10.1016/j.earlhumdev.2005.06.007; Fowden AL, 1998, P NUTR SOC, V57, P113, DOI 10.1079/PNS19980017; Da Silveira VMF, 2008, REV SAUDE PUBL, V42, P10, DOI 10.1590/S0034-89102008000100002; Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323; Henriquez-Hernandez LA, 2007, J PHARMACOL EXP THER, V320, P695, DOI 10.1124/jpet.106.113209; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Huang J, 2012, CLIN EXP PHARMACOL P, V39, P357, DOI 10.1111/j.1440-1681.2012.05676.x; James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Johren O, 2007, BRAIN RES, V1184, P160, DOI 10.1016/j.brainres.2007.09.036; Kanaka-Gantenbein C, 2010, ANN NY ACAD SCI, V1205, P99, DOI 10.1111/j.1749-6632.2010.05683.x; Kjaer SL, 2011, PHYSIOL BEHAV, V102, P444, DOI 10.1016/j.physbeh.2010.12.015; Kjaer SL, 2010, BRAIN RES, V1320, P106, DOI 10.1016/j.brainres.2010.01.008; Kuczkowski KM, 2007, CURR OPIN OBSTET GYN, V19, P578, DOI 10.1097/GCO.0b013e3282f1bf17; Liang G, 2011, EXP TOXICOL PATHOL, V63, P607, DOI 10.1016/j.etp.2010.04.015; Lin A S, 1997, Depress Anxiety, V5, P21, DOI 10.1002/(SICI)1520-6394(1997)5:1<21::AID-DA4>3.3.CO;2-A; Liu YS, 2012, TOXICOL APP IN PRESS; Lopez-Bermejo A, 2004, CLIN ENDOCRINOL, V60, P256, DOI 10.1046/j.1365-2265.2004.01977.x; Marret S, 1997, BRAIN RES, V773, P213, DOI 10.1016/S0006-8993(97)00938-4; McNeil CJ, 2007, REPRODUCTION, V133, P653, DOI 10.1530/rep.1.01198; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Momoi N, 2008, AM J PHYSIOL-HEART C, V294, pH2248, DOI 10.1152/ajpheart.91469.2007; Morrow AL, 2001, INT REV NEUROBIOL, V46, P349; Neitzke U, 2008, PLACENTA, V29, P246, DOI 10.1016/j.placenta.2007.11.014; Owen D, 2005, J NEUROENDOCRINOL, V17, P220, DOI 10.1111/j.1365-2826.2005.01294.x; Pettenuzzo LF, 2008, PHYSIOL BEHAV, V95, P295, DOI 10.1016/j.physbeh.2008.06.003; Ping J, 2012, CHEM-BIOL INTERACT, V195, P68, DOI 10.1016/j.cbi.2011.11.001; Radosavljevic Tatjana, 2005, Med Pregl, V58, P558, DOI 10.2298/MPNS0512558R; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reichardt HM, 1996, MOL MED, V2, P735, DOI 10.1007/BF03401657; Seckl JR, 1997, FRONT NEUROENDOCRIN, V18, P49, DOI 10.1006/frne.1996.0143; Thayer P S, 1975, CRC Crit Rev Toxicol, V3, P345, DOI 10.3109/10408447509079863; Thompson A, 2004, J STEROID BIOCHEM, V88, P367, DOI 10.1016/j.jsbmb.2003.12.014; Valsamakis G, 2006, ANN NY ACAD SCI, V1092, P138, DOI 10.1196/annals.1365.012; Walker BR, 2006, DIABETIC MED, V23, P1281, DOI 10.1111/j.1464-5491.2006.01998.x; Wan Shun-Lun, 2002, Shengli Xuebao, V54, P473; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Weaver ICG, 2009, SEMIN FETAL NEONAT M, V14, P143, DOI 10.1016/j.siny.2008.12.002; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; WILKINSON JM, 1993, DEV BRAIN RES, V75, P193, DOI 10.1016/0165-3806(93)90023-4; Xita N, 2010, ANN NY ACAD SCI, V1205, P148, DOI 10.1111/j.1749-6632.2010.05658.x; Xu D, 2011, ENVIRON TOXICOL PHAR, V32, P356, DOI 10.1016/j.etap.2011.08.003; Yang Z, 2007, J ENDOCRINOL, V195, P241, DOI 10.1677/JOE-07-0303	61	94	103	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44497	10.1371/journal.pone.0044497	http://dx.doi.org/10.1371/journal.pone.0044497			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970234	Green Submitted, gold, Green Published			2022-12-25	WOS:000308458400080
J	Ding, ZW; Taneva, SG; Huang, HKH; Campbell, SA; Semenec, L; Chen, NS; Cornell, RB				Ding, Ziwei; Taneva, Svetla G.; Huang, Harris K. H.; Campbell, Stephanie A.; Semenec, Lucie; Chen, Nansheng; Cornell, Rosemary B.			A 22-mer Segment in the Structurally Pliable Regulatory Domain of Metazoan CTP: Phosphocholine Cytidylyltransferase Facilitates Both Silencing and Activating Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BINDING DOMAIN; RAT-LIVER CTP; PHOSPHATIDYLCHOLINE SYNTHESIS; CTPPHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; ALPHA-SYNUCLEIN; PHYSICAL-PROPERTIES; AMPHIPATHIC HELIX; LIPID REGULATION; AMINO-ACIDS; IDENTIFICATION	CTP:phosphocholine cytidylyltransferase (CCT), an amphitropic enzyme that regulates phosphatidylcholine synthesis, is composed of a catalytic head domain and a regulatory tail. The tail region has dual functions as a regulator of membrane binding/enzyme activation and as an inhibitor of catalysis in the unbound form of the enzyme, suggesting conformational plasticity. These functions are well conserved in CCTs across diverse phyla, although the sequences of the tail regions are not. CCT regulatory tails of diverse origins are composed of a long membrane lipid-inducible amphipathic helix (m-AH) followed by a highly disordered segment, reminiscent of the Parkinson disease-linked protein, alpha-synuclein, which we show shares a novel sequence motif with vertebrate CCTs. To unravel features required for silencing, we created chimeric enzymes by fusing the catalytic domain of rat CCT alpha to the regulatory tail of CCTs from Drosophila, Caenorhabditis elegans, or Saccharomyces cerevisiae or to alpha-synuclein. Only the tail domains of the two invertebrate CCTs were competent for both suppression of catalytic activity and for activation by lipid vesicles. Thus, both silencing and activating functions of the m-AH can tolerate significant changes in length and sequence. We identified a highly amphipathic 22-residue segment in the m-AH with features conserved among animal CCTs but not yeast CCT or alpha-synuclein. Deletion of this segment from rat CCT increased the lipid-independent V-max by 10-fold, equivalent to the effect of deleting the entire tail, and severely weakened membrane binding affinity. However, membrane binding was required for additional increases in catalytic efficiency. Thus, full activation of CCT may require not only loss of a silencing conformation in the m-AH but a gain of an activating conformation, promoted by membrane binding.	[Ding, Ziwei; Taneva, Svetla G.; Huang, Harris K. H.; Campbell, Stephanie A.; Semenec, Lucie; Chen, Nansheng; Cornell, Rosemary B.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Cornell, RB (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	cornell@sfu.ca	Campbell, Stephanie Ann/AAC-6076-2019	Campbell, Stephanie Ann/0000-0003-1709-9249; Semenec, Lucie/0000-0002-1021-7751	Canadian Institutes for Health Research; Natural Science and Engineering Research Council	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the Canadian Institutes for Health Research (to R. B. C.) and a Natural Science and Engineering Research Council Discovery Grant (to N. C.).	Arnold RS, 1996, BIOCHEMISTRY-US, V35, P9917, DOI 10.1021/bi960397c; Attard GS, 2000, P NATL ACAD SCI USA, V97, P9032, DOI 10.1073/pnas.160260697; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; BECK R, 1994, NUCLEIC ACIDS RES, V22, P886, DOI 10.1093/nar/22.5.886; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; Braker JD, 2009, ARCH BIOCHEM BIOPHYS, V492, P10, DOI 10.1016/j.abb.2009.10.004; Bussell R, 2003, J MOL BIOL, V329, P763, DOI 10.1016/S0022-2836(03)00520-5; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; CORNELL RB, 1991, BIOCHEMISTRY-US, V30, P5881, DOI 10.1021/bi00238a011; CORNELL RB, 1995, BIOCHEM J, V310, P699, DOI 10.1042/bj3100699; Cornell RB, 1998, BIOCHEM SOC T, V26, P539, DOI 10.1042/bst0260539; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; CRAIG L, 1994, J BIOL CHEM, V269, P3311; Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c; Dennis MK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201715; Drin G, 2010, FEBS LETT, V584, P1840, DOI 10.1016/j.febslet.2009.10.022; Drobnies AE, 2002, BBA-BIOMEMBRANES, V1564, P82, DOI 10.1016/S0005-2736(02)00404-2; Dunne SJ, 1996, BIOCHEMISTRY-US, V35, P11975, DOI 10.1021/bi960821+; Eisenberg D., 1982, NATURE, V299, P271; Fauchere J., 1983, EUR J MED CHEM, V8, P369; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Friesen JA, 1999, J BIOL CHEM, V274, P13384, DOI 10.1074/jbc.274.19.13384; Friesen JA, 2001, PROTEIN EXPRES PURIF, V21, P141, DOI 10.1006/prep.2000.1354; Friesen JA, 2001, BBA-MOL CELL BIOL L, V1533, P86, DOI 10.1016/S1388-1981(01)00145-7; Frost A, 2011, CURR BIOL, V21, pR811, DOI 10.1016/j.cub.2011.08.045; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Gehrig K, 2009, J LIPID RES, V50, P966, DOI 10.1194/jlr.M800632-JLR200; Georgieva ER, 2010, J BIOL CHEM, V285, P28261, DOI 10.1074/jbc.M110.157214; Helmink BA, 2004, BBA-MOL CELL BIOL L, V1683, P78, DOI 10.1016/j.bbalip.2004.04.008; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; JAMIL H, 1993, BIOCHEM J, V291, P419, DOI 10.1042/bj2910419; Johnson JE, 1997, BBA-BIOMEMBRANES, V1324, P273, DOI 10.1016/S0005-2736(96)00233-7; JOHNSON JE, 1994, BIOCHEMISTRY-US, V33, P4327, DOI 10.1021/bi00180a029; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Johnson JE, 1998, BIOCHEMISTRY-US, V37, P9509, DOI 10.1021/bi980340l; JOHNSON JE, 1992, BIOCHEM J, V285, P815, DOI 10.1042/bj2850815; KALMAR GB, 1990, P NATL ACAD SCI USA, V87, P6029, DOI 10.1073/pnas.87.16.6029; Larvor MP, 2003, BIOCHEM J, V375, P653, DOI 10.1042/BJ20031011; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Lokappa SB, 2011, J BIOL CHEM, V286, P21450, DOI 10.1074/jbc.M111.224055; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; McGuffin LJ, 2008, BIOINFORMATICS, V24, P1798, DOI 10.1093/bioinformatics/btn326; Neumann P, 2008, P NATL ACAD SCI USA, V105, P17390, DOI 10.1073/pnas.0805027105; Ng MNP, 2004, BBA-MOL CELL BIOL L, V1686, P85, DOI 10.1016/j.bbalip.2004.09.001; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Ridsdale R, 2010, AM J RESP CELL MOL, V43, P74, DOI 10.1165/rcmb.2009-0231OC; Shih YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021425; Taneva S, 2003, BIOCHEMISTRY-US, V42, P11768, DOI 10.1021/bi035234k; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Taneva SG, 2012, BBA-BIOMEMBRANES, V1818, P1173, DOI 10.1016/j.bbamem.2012.01.006; WALKEY CJ, 1994, J BIOL CHEM, V269, P5742; WANG XM, 1990, PLANT PHYSIOL, V93, P250, DOI 10.1104/pp.93.1.250; WANG Y, 1995, J BIOL CHEM, V270, P18948, DOI 10.1074/jbc.270.32.18948; Weidner A, 2009, J MOL CATAL B-ENZYM, V61, P88, DOI 10.1016/j.molcatb.2009.02.020; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xie MT, 2004, J BIOL CHEM, V279, P28817, DOI 10.1074/jbc.M403311200; Yang JL, 1997, BIOCHEM J, V325, P29, DOI 10.1042/bj3250029; YANG W, 1995, J BIOL CHEM, V270, P23951, DOI 10.1074/jbc.270.41.23951	60	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38980	38991		10.1074/jbc.M112.402081	http://dx.doi.org/10.1074/jbc.M112.402081			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22988242	hybrid, Green Published			2022-12-25	WOS:000310982800054
J	Park, HO; Bae, J				Park, Ho-Oak; Bae, Jeehyeon			Disturbed Relaxin Signaling Pathway and Testicular Dysfunction in Mouse Offspring upon Maternal Exposure to Simazine	PLOS ONE			English	Article							DECREASES CELL-PROLIFERATION; NITRIC-OXIDE SYNTHASE; REPRODUCTIVE-TRACT; BINDING CELLS; IN-VITRO; ATRAZINE; RATS; TESTIS; SPERMATOGENESIS; RECEPTORS	Simazine is a triazine herbicide that is being widely applied worldwide and commonly detected in surface and groundwater. Despite its popular use in controlling weeds and algae, very limited information is available regarding its toxicity. In the present study, pregnant mice were orally exposed to low doses (0, 5, 50, or 500 mu g/kg body weight per day) of simazine during gestation and lactation, during which no overt maternal toxic response was detected, and their offspring was assessed. Simazine-exposed male offspring showed decreased body, testicular, and epididymis weight, increased testicular apoptosis, and decreased sperm concentrations. Differentially-expressed genes in the testes of male offspring exposed to simazine were identified by DNA microarray, revealing 775 upregulated and 791 downregulated genes; among these, the relaxin-family peptide receptor 1 (Rxfp1), which is the receptor for relaxin hormone, was significantly downregulated. In addition, the expression of target genes in the relaxin pathway, including nitric oxide synthase 2 (Nos2) and Nos3, was significantly decreased in simazine-exposed F1 testes. Moreover, simazine inhibited NO release, and knockdown of Rxfp1 blocked the inhibitory action of simazine on NO production in testicular Leydig cells. Therefore, the present study provides a better understanding of the toxicities associated with the widely used herbicide simazine at environmentally relevant doses by demonstrating that maternal exposure interferes with the pleotropic relaxin-NO signaling pathway, impairing normal development and reproductive activity of male offspring.	[Park, Ho-Oak; Bae, Jeehyeon] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea	Chung Ang University	Park, HO (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	jeehyeon@cau.ac.kr		bae, jeehyeon/0000-0003-1995-1378	National Research Foundation of Korea; Korean government (MEST) [2010-0026211]	National Research Foundation of Korea(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by the National Research Foundation of Korea grant funded by the Korean government (MEST) (2010-0026211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarikwu SO, 2010, ARCH ENVIRON CON TOX, V58, P874, DOI 10.1007/s00244-009-9371-2; Agency EP, 2006, REREGISTRATION ELIGI; Andric SA, 2010, BIOL REPROD, V83, P434, DOI 10.1095/biolreprod.110.083626; Bathgate RA, 2005, ANN NY ACAD SCI, V1041, P61, DOI 10.1196/annals.1282.010; Belloni V, 2011, TOXICOLOGY, V279, P19, DOI 10.1016/j.tox.2010.07.002; Brevini Tiziana A. L., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P1; Cardoso LC, 2010, REPRODUCTION, V139, P185, DOI 10.1530/REP-09-0146; Carreau S, 1998, ANN ENDOCRINOL-PARIS, V59, P79; Chevrier C, 2011, ENVIRON HEALTH PERSP, V119, P1034, DOI 10.1289/ehp.1002775; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Feng S, 2007, CLIN CANCER RES, V13, P1695, DOI 10.1158/1078-0432.CCR-06-2492; Filonzi M, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-29; Foradori CD, 2009, BIOL REPROD, V81, P1099, DOI 10.1095/biolreprod.109.077453; Fraites MJP, 2011, REPROD TOXICOL, V32, P52, DOI 10.1016/j.reprotox.2011.04.003; Hovey RC, 2011, TOXICOL SCI, V119, P380, DOI 10.1093/toxsci/kfq337; Hsu SY, 2002, SCIENCE, V295, P671, DOI 10.1126/science.1065654; Ivell R, 2002, SCIENCE, V295, P637, DOI 10.1126/science.1069234; Jee BC, 2003, GYNECOL OBSTET INVES, V56, P143, DOI 10.1159/000073773; Jurewicz J, 2009, INT J OCCUP MED ENV, V22, P305, DOI 10.2478/v10001-009-0036-1; Kim KR, 2002, TOXICOL IN VITRO, V16, P517, DOI 10.1016/S0887-2333(02)00047-4; Kmetic I, 2008, B ENVIRON CONTAM TOX, V81, P205, DOI 10.1007/s00128-008-9425-6; Kohsaka T, 1998, BIOL REPROD, V59, P991, DOI 10.1095/biolreprod59.4.991; Krajnc-Franken MAM, 2004, MOL CELL BIOL, V24, P687, DOI 10.1128/MCB.24.2.687-696.2004; KUENZI MJ, 1995, ENDOCRINOLOGY, V136, P1367, DOI 10.1210/en.136.4.1367; Lee NPY, 2008, ADV EXP MED BIOL, V636, P172, DOI 10.1007/978-0-387-09597-4_10; Manske MK, 2004, ARCH ENVIRON CON TOX, V46, P438, DOI 10.1007/s00244-003-3087-5; Marathe N, 2012, J BIOL CHEM, V287, P978, DOI 10.1074/jbc.M111.294959; MASINI E, 1994, J CLIN INVEST, V94, P1974, DOI 10.1172/JCI117549; Nguyen BT, 2003, MOL ENDOCRINOL, V17, P1075, DOI 10.1210/me.2002-0284; Nistri Silvia, 2003, Reprod Biol Endocrinol, V1, P5, DOI 10.1186/1477-7827-1-5; O'Bryan MK, 2000, BIOL REPROD, V63, P1285, DOI 10.1095/biolreprod63.5.1285; O'Donnell L, 2001, ENDOCR REV, V22, P289, DOI 10.1210/er.22.3.289; Ochoa-Acuna H, 2009, ENVIRON HEALTH PERSP, V117, P1619, DOI 10.1289/ehp.0900784; Pomerantz DK, 1998, ENDOCRINOLOGY, V139, P922, DOI 10.1210/en.139.3.922; Powell ER, 2011, TOXICOL IN VITRO, V25, P644, DOI 10.1016/j.tiv.2011.01.001; Rayner JL, 2007, TOXICOL APPL PHARM, V218, P238, DOI 10.1016/j.taap.2006.11.020; Riviere JE, 2011, TOXICOL SCI, V119, P224, DOI 10.1093/toxsci/kfq317; Rohr JR, 2010, ENVIRON HEALTH PERSP, V118, P20, DOI 10.1289/ehp.0901164; SALASNICH L, 1995, PHYS REV A, V51, P4281, DOI 10.1103/PhysRevA.51.4281; Shiraishi K, 2007, BJU INT, V99, P1086, DOI 10.1111/j.1464-410X.2007.06800.x; Swan SH, 2006, INT J ANDROL, V29, P62, DOI 10.1111/j.1365-2605.2005.00620.x; Victor-Costa AB, 2010, REPROD TOXICOL, V29, P323, DOI 10.1016/j.reprotox.2009.12.006; Weissman BA, 2007, AM J PHYSIOL-ENDOC M, V292, pE615, DOI 10.1152/ajpendo.00412.2006; Zamberlam G, 2011, MOL CELL ENDOCRINOL, V335, P189, DOI 10.1016/j.mce.2011.01.013	44	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44856	10.1371/journal.pone.0044856	http://dx.doi.org/10.1371/journal.pone.0044856			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984576	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500092
J	Chen, Q; Chen, TH; Li, WJ; Zhang, W; Zhu, JW; Li, Y; Huang, YJ; Shen, YM; Yu, CD				Chen, Qiang; Chen, Tenghui; Li, Wenjiao; Zhang, Wei; Zhu, Jingwei; Li, Yang; Huang, Yaojian; Shen, Yuemao; Yu, Chundong			Mycoepoxydiene Inhibits Lipopolysaccharide-Induced Inflammatory Responses through the of TRAF6 Polyubiquitination	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TOLL-LIKE RECEPTORS; INNATE IMMUNITY; MAP KINASE; INTERLEUKIN-1; METABOLITES; ENDOTOXIN; PATHWAY; P38	Mycoepoxydiene (MED) is a polyketide isolated from a marine fungus associated with mangrove forests. MED has been shown to be able to induce cell cycle arrest and cancer cell apoptosis. However, its effects on inflammatory response are unclear. Herein we showed that MED exhibited inhibitory effect on inflammatory response induced by lipopolysaccharide (LPS). MED significantly inhibited LPS-induced expression of pro-inflammatory mediators such as tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta, IL-6, and nitric oxide (NO) in macrophages. MED inhibited LPS-induced nuclear translocation of nuclear factor (NF)-kappa B (NF-kappa B) p65, I kappa B degradation, I kappa B kinase (IKK) phosphorylation, and the activation of extracellular signal-regulated kinase (ERK), c-jun N-terminal kinase (JNK), and p38, suggesting that MED blocks the activation of both NF-kappa B and mitogen-activated protein kinase (MAPK) pathways. Furthermore, the effects of MED on LPS-induced activation of upstream signaling molecules such as transforming growth factor-beta-activated kinase 1 (TAK1), tumor necrosis factor receptor-associated factor 6 (TRAF6) and IL-1 receptor associated kinases1 (IRAK1) were investigated. MED significantly inhibited TAK1 phosphorylation and TRAF6 polyubiquitination, but not IRAK1 phosphorylation and TRAF6 dimerization, indicating that MED inhibits LPS-induced inflammatory responses at least in part through suppression of TRAF6 polyubiquitination. Moreover, MED protected mice from LPS-induced endotoxin shock by reducing serum inflammatory cytokines. These results suggest that MED is a potential lead compound for the development of a novel nonsteroidal antiinflammatory drug.	[Chen, Qiang; Chen, Tenghui; Li, Wenjiao; Zhang, Wei; Zhu, Jingwei; Li, Yang; Huang, Yaojian; Yu, Chundong] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China; [Shen, Yuemao] Shandong Univ, Sch Pharmaceut Sci, Jinan, Shandong, Peoples R China	Xiamen University; Shandong University	Chen, Q (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Fujian, Peoples R China.	yshen@sdu.edu.cn; cdyu@xmu.edu.cn	Huang, YJ/G-4624-2010; Li, Wenjiao/J-2198-2019; Yu, C/G-4626-2010; Shen, YM/G-4681-2010	Li, Wenjiao/0000-0003-1308-8489; Shen, Yuemao/0000-0002-3881-0135; Chen, Tenghui/0000-0003-0683-8974	National Basic Research Program of China (973 Program) [2009CB522200, 2010CB833802]; Natural Science Foundation of Fujian Province of China [2010J06014]; Natural Science Foundation of China [31170819, 90913024]; Youth Foundation of Health Department of Fujian Province [2010-2-84]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation of Health Department of Fujian Province	This work was supported by grants from the National Basic Research Program of China (973 Program, 2009CB522200 and 2010CB833802); the Natural Science Foundation of Fujian Province of China (2010J06014); the Natural Science Foundation of China (31170819 and 90913024); and Youth Foundation of Health Department of Fujian Province (2010-2-84). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajizian SJ, 1999, J INFECT DIS, V179, P939, DOI 10.1086/314659; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bian K, 2001, MOL PHARMACOL, V59, P939, DOI 10.1124/mol.59.4.939; Cai P, 1999, TETRAHEDRON LETT, V40, P1479, DOI 10.1016/S0040-4039(98)02700-2; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chiou WF, 2011, BIOCHEM PHARMACOL, V81, P752, DOI 10.1016/j.bcp.2010.12.022; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hu J, 2002, J IMMUNOL, V168, P3910, DOI 10.4049/jimmunol.168.8.3910; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; Lin X, 2005, FEMS MICROBIOL LETT, V251, P53, DOI 10.1016/j.femsle.2005.07.025; Liu SQ, 2011, CELL RES, V21, P6, DOI 10.1038/cr.2010.170; Lomaga MA, 1999, GENE DEV, V13, P1015, DOI 10.1101/gad.13.8.1015; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; SZABO C, 1994, P NATL ACAD SCI USA, V91, P271, DOI 10.1073/pnas.91.1.271; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang JF, 2010, BIOORG MED CHEM LETT, V20, P7054, DOI 10.1016/j.bmcl.2010.09.105; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Yamin TT, 1997, J BIOL CHEM, V272, P21540, DOI 10.1074/jbc.272.34.21540; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948	29	31	35	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44890	10.1371/journal.pone.0044890	http://dx.doi.org/10.1371/journal.pone.0044890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984582	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700097
J	Miller, PE; Rambachan, A; Hubbard, RJ; Li, JB; Meyer, AE; Stephens, P; Mounts, AW; Rolfes, MA; Penn, CR				Miller, Paula E.; Rambachan, Aksharananda; Hubbard, Roderick J.; Li, Jiabai; Meyer, Alison E.; Stephens, Peter; Mounts, Anthony W.; Rolfes, Melissa A.; Penn, Charles R.			Supply of Neuraminidase Inhibitors Related to Reduced Influenza A (H1N1) Mortality during the 2009-2010 H1N1 Pandemic: An Ecological Study	PLOS ONE			English	Article							HOSPITALIZATION; METAANALYSIS; OSELTAMIVIR; EFFICACY; SAFETY; RISK	Background: The influenza A (H1N1) pandemic swept across the globe from April 2009 to August 2010 affecting millions. Many WHO Member States relied on antiviral drugs, specifically neuraminidase inhibitors (NAIs) oseltamivir and zanamivir, to treat influenza patients in critical condition. Such drugs have been found to be effective in reducing severity and duration of influenza illness, and likely reduced morbidity during the pandemic. However, it is less clear whether NAIs used during the pandemic reduced H1N1 mortality. Methods: Country-level data on supply of oseltamivir and zanamivir were used to predict H1N1 mortality (per 100,000 people) from July 2009 to August 2010 in forty-two WHO Member States. Poisson regression was used to model the association between NAI supply and H1N1 mortality, with adjustment for economic, demographic, and health-related confounders. Results: After adjustment for potential confounders, each 10% increase in kilograms of oseltamivir, per 100,000 people, was associated with a 1.6% reduction in H1N1 mortality over the pandemic period (relative rate (RR) = 0.84 per log increase in oseltamivir supply). While the supply of zanamivir was considerably less than that of oseltamivir in each Member State, each 10% increase in kilogram of active zanamivir, per 100,000, was associated with a 0.3% reduction in H1N1 mortality (RR = 0.97 per log increase). Conclusion: While there are limitations to the ecologic nature of these data, this analysis offers evidence of a protective relationship between antiviral drug supply and influenza mortality and supports a role for influenza antiviral use in future pandemics.	[Miller, Paula E.; Rambachan, Aksharananda; Hubbard, Roderick J.; Li, Jiabai; Meyer, Alison E.] St Olaf Coll, Dept Stat, Northfield, MN 55057 USA; [Stephens, Peter] IMS Hlth, London, England; [Mounts, Anthony W.; Penn, Charles R.] WHO, CH-1211 Geneva, Switzerland; [Rolfes, Melissa A.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA	Saint Olaf College; World Health Organization; University of Minnesota System; University of Minnesota Twin Cities	Miller, PE (corresponding author), St Olaf Coll, Dept Stat, Northfield, MN 55057 USA.	riede056@umn.edu		Rolfes, Melissa/0000-0002-0483-9941	National Science Foundation [DMS-0354308]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by National Science Foundation Grant # DMS-0354308. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	[Anonymous], 2010, WHO GUID PHARM MAN P; Cooper NJ, 2003, BRIT MED J, V326, P1235, DOI 10.1136/bmj.326.7401.1235; FERGUSON NM, 2006, CARBON NANOTUBES LON, V442, P448, DOI DOI 10.1038/NATURE04795; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Hernan MA, 2011, CLIN INFECT DIS, V53, P277, DOI 10.1093/cid/cir400; Iglesias ALH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021838; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; Inglesby TV, 2006, BIOSECUR BIOTERROR, V4, P366, DOI 10.1089/bsp.2006.4.366; International Obesity Task Force, OB PREV WORLDW; Lee EH, 2010, CLIN INFECT DIS, V50, P1498, DOI 10.1086/652446; Makela MJ, 2000, J INFECTION, V40, P42, DOI 10.1053/jinf.1999.0602; Maliszewski PJ, 2011, GEOSPATIAL HEALTH, V6, P95, DOI 10.4081/gh.2011.161; Hernandez JM, 2010, J CLIN VIROL, V49, P145, DOI 10.1016/j.jcv.2010.07.001; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Nikolopoulos G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019432; Nukiwa N, 2010, CLIN INFECT DIS, V51, P993, DOI 10.1086/656443; Sugaya N, 2011, J INFECTION, V63, P288, DOI 10.1016/j.jinf.2011.06.008; The Fund for Peace, FAIL STAT IND 2010; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; UNAIDS/WHO, UNAIDS REP GLOB AIDS; United Nations, UN CHILDR FUND CHILD; United Nations, UN POP DIV WORLD POP; United Nations, UN STAT DIV STAT DAT; Van Kerkhove MD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001053; Viboud C, 2010, PLOS CURR; *WHO, CHANG REP REQ PAND H; World Health Organization, GLOB HLTH OBS; World Health Organization, WHO STAT INF SYST WH; Xi XM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-256; Yang P, 2010, J INFECTION, V61, P277, DOI 10.1016/j.jinf.2010.07.010	31	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43491	10.1371/journal.pone.0043491	http://dx.doi.org/10.1371/journal.pone.0043491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984431	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700024
J	Papp, K; Vegh, P; Hobor, R; Szittner, Z; Voko, Z; Podani, J; Czirjak, L; Prechl, J				Papp, Krisztian; Vegh, Peter; Hobor, Renata; Szittner, Zoltan; Voko, Zoltan; Podani, Janos; Czirjak, Laszlo; Prechl, Jozsef			Immune Complex Signatures of Patients with Active and Inactive SLE Revealed by Multiplex Protein Binding Analysis on Antigen Microarrays	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; DOUBLE-STRANDED DNA; FIXING ANTIBODIES; DISEASE-ACTIVITY; IGG ANTIBODIES; ACTIVATION; PRODUCTS; BIOMARKERS; DIAGNOSIS; PATHWAY	Systemic lupus erythematosus is characterized by dysfunctional clearance of apoptotic debris and the development of pathogenic autoantibodies. While the complement system is also involved in the disease no attempt has been made to generate a comprehensive view of immune complex formation from various autoantigens. We increased the complexity of autoantibody profiles by measuring the binding of two complement proteins, C3 and C4, in addition to two antibody classes, IgG and IgM, to a collection of autoantigens. These complement components covalently bind to those microarray features where antibodies and other serum components induce complement activation. Using this technology, we compared functional serum antibody profiles of control subjects (n = 31) and patients with lupus erythematosus (n = 61) in the active (n = 22) and inactive (n = 39) phase of the disease. Multivariate analysis was applied to identify contributions of binding data on 25 antigens to the discrimination of the study groups. Receiver operating characteristic analysis was used to portray the discriminative property of each measured parameter for each antigen in pairwise group comparisons. Complement C3 and C4 deposition increased on autoantibody targets in spite of the decreased serum complement concentrations, and decreased on other autoantigens, demonstrating the imbalance of complement function in patients with lupus erythematosus. Our observations confirmed previously known markers of disease and showed that C3 and C4 deposition data were at least as powerful as Ig binding data in separating the study groups.	[Papp, Krisztian; Szittner, Zoltan] Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary; [Papp, Krisztian; Vegh, Peter; Szittner, Zoltan; Prechl, Jozsef] Diagnosticum Ltd, Budapest, Hungary; [Hobor, Renata; Czirjak, Laszlo] Univ Pecs, Ctr Clin, Dept Rheumatol & Immunol, Pecs, Hungary; [Voko, Zoltan] Eotvos Lorand Univ, Dept Hlth Policy & Hlth Econ, Budapest, Hungary; [Voko, Zoltan] Syreon Res Inst, Budapest, Hungary; [Podani, Janos] Eotvos Lorand Univ, Dept Plant Systemat Ecol & Theoret Biol, Budapest, Hungary; [Prechl, Jozsef] Eotvos Lorand Univ, Hungarian Acad Sci, Immunol Res Grp, Budapest, Hungary	Eotvos Lorand University; University of Pecs; Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand University; Hungarian Academy of Sciences	Papp, K (corresponding author), Eotvos Lorand Univ, Dept Immunol, Budapest, Hungary.	jprechl@gmail.com	Vokó, Zoltán/O-3747-2019; Papp, Krisztián/B-2251-2009; Prechl, József/B-2094-2009; Vokó, Zoltán/H-1153-2017; Podani, Janos/G-3074-2014	Vokó, Zoltán/0000-0002-1004-1848; Papp, Krisztián/0000-0003-0619-8233; Prechl, József/0000-0003-3859-4353; Vokó, Zoltán/0000-0002-1004-1848; Podani, Janos/0000-0002-1452-1486; Vegh, Peter/0000-0002-0133-3240	National Development Agency [KMOP-1.1.1-08/1-2008-0028]; European Union; European Social Fund [TAMOP4.2.1./B-09/1/KMR-2010-0003]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences	National Development Agency; European Union(European Commission); European Social Fund(European Social Fund (ESF)); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by grant KMOP-1.1.1-08/1-2008-0028 from National Development Agency to Diagnosticum. The European Union and the European Social Fund have provided financial support to the project under the grant agreement no. TAMOP4.2.1./B-09/1/KMR-2010-0003. K. P is supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLOU SP, 1979, CLIN EXP IMMUNOL, V37, P58; BEAULIEU A, 1979, ARTHRITIS RHEUM, V22, P565, DOI 10.1002/art.1780220602; EDBERG JC, 1988, J IMMUNOL, V141, P4258; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; ESPARZA RH, 1985, J RHEUMATOL, V12, P1109; Fattal I, 2010, IMMUNOLOGY, V130, P337, DOI 10.1111/j.1365-2567.2010.03245.x; GHARAVI AE, 1981, J CLIN LAB IMMUNOL, V6, P251; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Katsumata Y, 2011, ARTHRITIS RHEUM-US, V63, P2436, DOI 10.1002/art.30401; Li QZ, 2007, CLIN EXP IMMUNOL, V147, P60, DOI 10.1111/j.1365-2249.2006.03251.x; Liu CC, 2009, CTS-CLIN TRANSL SCI, V2, P300, DOI 10.1111/j.1752-8062.2009.00135.x; Liu CC, 2009, BEST PRACT RES CL RH, V23, P507, DOI 10.1016/j.berh.2009.01.008; Manzi S, 2004, ARTHRITIS RHEUM-US, V50, P3596, DOI 10.1002/art.20561; Manzi S, 1996, ARTHRITIS RHEUM, V39, P1178, DOI 10.1002/art.1780390716; Navratil JS, 2006, ARTHRITIS RHEUM-US, V54, P670, DOI 10.1002/art.21627; Papp K, 2007, MOL CELL PROTEOMICS, V6, P133, DOI 10.1074/mcp.T600036-MCP200; Papp K, 2010, RHEUMATOLOGY, V49, P2273, DOI 10.1093/rheumatology/keq278; Podani J., 2001, SYN TAX 2000 COMPUTE; ROTHFIELD NF, 1967, J CLIN INVEST, V46, P1785, DOI 10.1172/JCI105669; SMEENK R, 1990, CLIN RHEUMATOL, V9, P100, DOI 10.1007/BF02205557; Sturfelt G, 2005, RHEUMATOLOGY, V44, P1227, DOI 10.1093/rheumatology/keh719; TEPPO AM, 1984, RHEUMATOL INT, V4, P173, DOI 10.1007/BF00541210; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Truedsson L, 2007, AUTOIMMUNITY, V40, P560, DOI 10.1080/08916930701510673; VALENTIJN RM, 1985, ARTHRITIS RHEUM, V28, P904, DOI 10.1002/art.1780280810; VALLE RR, 1985, CLIN IMMUNOL IMMUNOP, V34, P345, DOI 10.1016/0090-1229(85)90183-7; Witte T, 2008, CLIN REV ALLERG IMMU, V34, P345, DOI 10.1007/s12016-007-8046-x; Xu W, 2008, J IMMUNOL, V180, P7613, DOI 10.4049/jimmunol.180.11.7613; Zhen QL, 2005, J CLIN INVEST, V115, P3428, DOI 10.1172/JCI23587	29	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44824	10.1371/journal.pone.0044824	http://dx.doi.org/10.1371/journal.pone.0044824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984570	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700089
J	Weber, A; Prokazov, Y; Zuschratter, W; Hauser, MJB				Weber, Andre; Prokazov, Yury; Zuschratter, Werner; Hauser, Marcus J. B.			Desynchronisation of Glycolytic Oscillations in Yeast Cell Populations	PLOS ONE			English	Article							SYNCHRONIZATION; MECHANISM; RHYTHM; WAVES; ONSET	Glycolytic oscillations of intact yeast cells of the strain Saccharomyces carlsbergensis were investigated at both the levels of cell populations and of individual cells. Individual cells showed glycolytic oscillations even at very low cell densities (e. g. 1.0 x 10(5) cells/ml). By contrast, the collective behaviour on the population level was cell density-dependent: at high cell densities it is oscillatory, but below the threshold density of 1.0 x 10(6) cells/ml the collective dynamics becomes quiescent. We demonstrate that the transition in the collective dynamics is caused by the desynchronisation of the oscillations of individual cells. This is characteristic for a Kuramoto transition. Spatially resolved measurements at low cell densities revealed that even cells that adhere to their neighbours oscillated with their own, independent frequencies and phases.	[Weber, Andre; Hauser, Marcus J. B.] Univ Magdeburg, Inst Expt Phys, Biophys Grp, D-39106 Magdeburg, Germany; [Weber, Andre; Prokazov, Yury; Zuschratter, Werner] Leibniz Inst Neurobiol, Special Lab Electron & Laserscanning Microscopy, Magdeburg, Germany	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN)	Weber, A (corresponding author), Univ Magdeburg, Inst Expt Phys, Biophys Grp, D-39106 Magdeburg, Germany.	marcus.hauser@physik.uni-magdeburg.de		Hauser, Marcus/0000-0003-2105-3446	Bundesministerium fur Bildung und Forschung [13N10077]; Deutsche Forschungsgemeinschaft [DFG SFB 854 TPZ]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Financial support by the Bundesministerium fur Bildung und Forschung (grant number 13N10077) and the Deutsche Forschungsgemeinschaft (DFG SFB 854 TPZ) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE J, 1976, NATURE, V259, P670, DOI 10.1038/259670a0; AON MA, 1992, J GEN MICROBIOL, V138, P2219, DOI 10.1099/00221287-138-10-2219; BETZ A, 1965, ARCH BIOCHEM BIOPHYS, V109, P585, DOI 10.1016/0003-9861(65)90404-2; Bolyo J, 2010, BIOPHYS CHEM, V153, P54, DOI 10.1016/j.bpc.2010.10.004; BUCK J, 1968, SCIENCE, V159, P1319, DOI 10.1126/science.159.3821.1319; De Monte S, 2007, P NATL ACAD SCI USA, V104, P18377, DOI 10.1073/pnas.0706089104; DUYSENS LNM, 1957, BIOCHIM BIOPHYS ACTA, V24, P19, DOI 10.1016/0006-3002(57)90141-5; Gehrmann E, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.021913; GHOSH A, 1964, BIOCHEM BIOPH RES CO, V16, P174, DOI 10.1016/0006-291X(64)90357-2; GHOSH AK, 1971, ARCH BIOCHEM BIOPHYS, V145, P319, DOI 10.1016/0003-9861(71)90042-7; Gregor T, 2010, SCIENCE, V328, P1021, DOI 10.1126/science.1183415; Henson MA, 2002, BIOCHEM J, V368, P433, DOI 10.1042/BJ20021051; HESS B, 1968, H-S Z PHYSIOL CHEM, V349, P1567, DOI 10.1515/bchm2.1968.349.2.1567; Hynne R, 2001, BIOPHYS CHEM, V94, P121; Kim JR, 2010, J CELL SCI, V123, P537, DOI 10.1242/jcs.060061; Kuramoto Y., 1975, International Symposium on Mathematical Problems in Theoretical Physics, P420, DOI 10.1007/BFb0013365; Kuramoto Y, 2002, NONLINEAR DYNAMICS C; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; O'Neill JS, 2008, J BIOL RHYTHM, V23, P483, DOI 10.1177/0748730408326682; Palkova Z, 2006, FEMS MICROBIOL REV, V30, P806, DOI 10.1111/j.1574-6976.2006.00034.x; Pikovsky A, 2004, SYNCHRONIZATION UNIV; Poulsen AK, 2007, BIOPHYS CHEM, V125, P275, DOI 10.1016/j.bpc.2006.08.009; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Avila GMR, 2011, EPL-EUROPHYS LETT, V94, DOI 10.1209/0295-5075/94/60007; Richard P, 2003, FEMS MICROBIOL REV, V27, P547, DOI 10.1016/S0168-6445(03)00065-2; Richard P, 1996, EUR J BIOCHEM, V235, P238, DOI 10.1111/j.1432-1033.1996.00238.x; Rouzine IM, 2003, P NATL ACAD SCI USA, V100, P3473, DOI 10.1073/pnas.262796299; Schutze J, 2011, BIOPHYS J, V100, P809, DOI 10.1016/j.bpj.2010.12.3704; SHINOMOTO S, 1986, PROG THEOR PHYS, V75, P1105, DOI 10.1143/PTP.75.1105; Stark J, 2007, IMMUNOL REV, V216, P213; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Stumpf K, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/48001; Su Y, 2011, J MATH BIOL, V63, P557, DOI 10.1007/s00285-010-0381-5; Taylor AF, 2009, SCIENCE, V323, P614, DOI 10.1126/science.1166253; Vitali M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015820; Webb AB, 2009, P NATL ACAD SCI USA, V106, P16493, DOI 10.1073/pnas.0902768106; Winfree AT., 1980, GEOMETRY BIOL TIME; Wolf J, 2000, BIOCHEM J, V345, P321, DOI 10.1042/0264-6021:3450321; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	43	46	46	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43276	10.1371/journal.pone.0043276	http://dx.doi.org/10.1371/journal.pone.0043276			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984417	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700017
J	Gao, P; Peterson, YK; Smith, RA; Smith, CD				Gao, Peng; Peterson, Yuri K.; Smith, Ryan A.; Smith, Charles D.			Characterization of Isoenzyme-Selective Inhibitors of Human Sphingosine Kinases	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; MOLECULAR-CLONING; FUNCTIONAL-CHARACTERIZATION; SPHINGOLIPID METABOLISM; DIACYLGLYCEROL KINASES; THERAPEUTIC TARGETS; ANTITUMOR-ACTIVITY; HUMAN LEUKEMIA; TUMOR-CELLS; SPHINGOSINE-1-PHOSPHATE	Sphingosine kinases (SKs) are promising new therapeutic targets for cancer because they regulate the balance between proapoptotic ceramides and mitogenic sphingosine-1-phosphate. The functions of the two SK isoenzymes, SK1 and SK2, are not redundant, with genetic ablation of SK2 having more pronounced anticancer effects than removal of SK1. Although several small molecule inhibitors of SKs have been described in the literature, detailed characterization of their molecular and cellular pharmacology, particularly their activities against human SK1 and SK2, have not been completed. Computational modeling of the putative active sites of SK1 and SK2 suggests structural differences that might allow isozyme-selective inhibitors. Therefore, we characterized several SK-inhibitory compounds which revealed differential inhibitory effects on SK1 and SK2 as follows: SKI-II and ABC294735 are SK1/2-dual inhibitors; CB5468139 is a SK1-selective inhibitor; and ABC294640 is a SK2-selective inhibitor. We examined the effects of the SK inhibitors on several biochemical and phenotypic processes in A498 kidney adenocarcinoma cells. The SK2-selective inhibitor ABC294640 demonstrated the most pronounced effects on SK1 and SK2 mRNA expression, decrease of S1P levels, elevation of ceramide levels, cell cycle arrest, and inhibition of proliferation, migration and invasion. ABC294640 also down-regulated the expression or activation of several signaling proteins, including STAT3, AKT, ERK, p21, p53 and FAK. These effects were equivalent or superior to responses to the SK1/2-dual inhibitors. Overall, these results suggest that inhibition of SK2 results in stronger anticancer effects than does inhibition of SK1 or both SK1 and SK2.	[Gao, Peng; Peterson, Yuri K.; Smith, Charles D.] Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Smith, Ryan A.; Smith, Charles D.] Apogee Biotechnol Corp, Hummelstown, PA USA	Medical University of South Carolina	Gao, P (corresponding author), Med Univ S Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.	smithchd@musc.edu			National Institutes of Health [R01 CA122226]; NATIONAL CANCER INSTITUTE [R01CA122226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health R01 CA122226 to Charles D. Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Antoon JW, 2010, ENDOCRINOLOGY, V151, P5124, DOI 10.1210/en.2010-0420; Bakali HMA, 2007, J BIOL CHEM, V282, P19644, DOI 10.1074/jbc.M604852200; Beljanski V, 2011, INVEST NEW DRUG, V29, P1132, DOI 10.1007/s10637-010-9452-0; Beljanski V, 2011, CANCER BIOL THER, V11, P524, DOI 10.4161/cbt.11.5.14677; Beljanski V, 2010, J PHARMACOL EXP THER, V333, P454, DOI 10.1124/jpet.109.163337; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Edsall LC, 1998, BIOCHEMISTRY-US, V37, P12892, DOI 10.1021/bi980744d; ENDO K, 1991, CANCER RES, V51, P1613; Forrest M, 2004, J PHARMACOL EXP THER, V309, P758, DOI 10.1124/jpet.103.062828; French KJ, 2006, J PHARMACOL EXP THER, V318, P596, DOI 10.1124/jpet.106.101345; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; French KJ, 2003, CANCER RES, V63, P5962; Gao P, 2011, MOL CANCER RES, V9, P1509, DOI 10.1158/1541-7786.MCR-11-0336; Hagen N, 2009, J BIOL CHEM, V284, P11346, DOI 10.1074/jbc.M807336200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HANNUN YA, 1993, BIOCHIM BIOPHYS ACTA, V1154, P223, DOI 10.1016/0304-4157(93)90001-5; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hengst JA, 2010, BIOORG MED CHEM LETT, V20, P7498, DOI 10.1016/j.bmcl.2010.10.005; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; IGARASHI Y, 1989, BIOCHEMISTRY-US, V28, P6796, DOI 10.1021/bi00443a002; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kapitonov D, 2009, CANCER RES, V69, P6915, DOI 10.1158/0008-5472.CAN-09-0664; Kennedy AJ, 2011, J MED CHEM, V54, P3524, DOI 10.1021/jm2001053; Kim JW, 2005, BIOORGAN MED CHEM, V13, P3475, DOI 10.1016/j.bmc.2005.02.053; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Liu H, 2003, J BIOL CHEM, V278, P40330, DOI 10.1074/jbc.M304455200; Loveridge C, 2010, J BIOL CHEM, V285, P38841, DOI 10.1074/jbc.M110.127993; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Maceyka M, 2009, J LIPID RES, V50, pS272, DOI 10.1194/jlr.R800065-JLR200; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Ogretmen B, 2006, FEBS LETT, V580, P5467, DOI 10.1016/j.febslet.2006.08.052; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Ren SY, 2010, CELL PHYSIOL BIOCHEM, V26, P97, DOI 10.1159/000315110; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; SCHAAP D, 1994, BIOCHEM J, V304, P661, DOI 10.1042/bj3040661; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Sugiura M, 2002, J BIOL CHEM, V277, P23294, DOI 10.1074/jbc.M201535200; Sweeney EA, 1996, INT J CANCER, V66, P358, DOI 10.1002/(SICI)1097-0215(19960503)66:3<358::AID-IJC16>3.0.CO;2-7; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; TamiyaKoizumi K, 1997, BIOCHEM MOL BIOL INT, V41, P1179; Tsujimoto Y, 2005, CELL DEATH DIFFER, V12, P1528, DOI 10.1038/sj.cdd.4401777; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Wang F, 1999, J BIOL CHEM, V274, P35343, DOI 10.1074/jbc.274.50.35343; Weigert A, 2009, INT J CANCER, V125, P2114, DOI 10.1002/ijc.24594; Xiang YB, 2009, BIOORG MED CHEM LETT, V19, P6119, DOI 10.1016/j.bmcl.2009.09.022; Yatomi Y, 1996, BIOCHEMISTRY-US, V35, P626, DOI 10.1021/bi9515533; ZHANG H, 1991, J CELL BIOL, V114, P155, DOI 10.1083/jcb.114.1.155	55	87	92	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44543	10.1371/journal.pone.0044543	http://dx.doi.org/10.1371/journal.pone.0044543			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970244	Green Published, Green Submitted, gold			2022-12-25	WOS:000308748400021
J	Ross, PD; Polson, L; Grosbras, MH				Ross, Patrick D.; Polson, Louise; Grosbras, Marie-Helene			Developmental Changes in Emotion Recognition from Full-Light and Point-Light Displays of Body Movement	PLOS ONE			English	Article							BIOLOGICAL MOTION DISPLAYS; FACIAL EXPRESSION; AMYGDALA RESPONSE; PERCEPTION; CHILDREN; CHILDHOOD; NETWORKS; BODIES; FACES	To date, research on the development of emotion recognition has been dominated by studies on facial expression interpretation; very little is known about children's ability to recognize affective meaning from body movements. In the present study, we acquired simultaneous video and motion capture recordings of two actors portraying four basic emotions (Happiness Sadness, Fear and Anger). One hundred and seven primary and secondary school children (aged 4-17) and 14 adult volunteers participated in the study. Each participant viewed the full-light and point-light video clips and was asked to make a forced-choice as to which emotion was being portrayed. As a group, children performed worse than adults for both point-light and full-light conditions. Linear regression showed that both age and lighting condition were significant predictors of performance in children. Using piecewise regression, we found that a bilinear model with a steep improvement in performance until 8.5 years of age, followed by a much slower improvement rate through late childhood and adolescence best explained the data. These findings confirm that, like for facial expression, adolescents' recognition of basic emotions from body language is not fully mature and seems to follow a non-linear development. This is in line with observations of non-linear developmental trajectories for different aspects of human stimuli processing (voices and faces), perhaps suggesting a shift from one perceptual or cognitive strategy to another during adolescence. These results have important implications to understanding the maturation of social cognition.	[Ross, Patrick D.; Polson, Louise; Grosbras, Marie-Helene] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	University of Glasgow	Ross, PD (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	p.ross@psy.gla.ac.uk	Ross, Patrick/I-3031-2012; Ross, Paddy/S-6999-2019; Grosbras, Marie-Helene/C-7371-2009	Ross, Paddy/0000-0001-8481-2070; Grosbras, Marie-Helene/0000-0002-9807-6307	UK ESRC [ES/E020933/1]; ESCR DTC [ES/J500136/1]	UK ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESCR DTC	This study was partly funded by the UK ESRC grant ES/E020933/1 and the ESCR DTC grant ES/J500136/1. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annaz D, 2010, DEVELOPMENTAL SCI, V13, P826, DOI 10.1111/j.1467-7687.2009.00939.x; Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Batty M, 2006, DEVELOPMENTAL SCI, V9, P207, DOI 10.1111/j.1467-7687.2006.00480.x; Boone RT, 1998, DEV PSYCHOL, V34, P1007, DOI 10.1037/0012-1649.34.5.1007; CAREY S, 1980, DEV PSYCHOL, V16, P257, DOI 10.1037/0012-1649.16.4.257; Clarke TJ, 2005, PERCEPTION, V34, P1171, DOI 10.1068/p5203; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 2010, NEUROSCI BIOBEHAV R, V34, P513, DOI 10.1016/j.neubiorev.2009.10.008; De Sonneville LMJ, 2002, J CLIN EXP NEUROPSYC, V24, P200, DOI 10.1076/jcen.24.2.200.989; DEMEIJER M, 1989, J NONVERBAL BEHAV, V13, P247, DOI 10.1007/BF00990296; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; FELLEMAN ES, 1983, DEV PSYCHOL, V19, P405, DOI 10.1037/0012-1649.19.3.405; FLIN RH, 1980, DEV PSYCHOL, V16, P373, DOI 10.1037/0012-1649.16.4.373; FOX R, 1982, SCIENCE, V218, P486, DOI 10.1126/science.7123249; Freire A, 2006, PERCEPTION, V35, P647, DOI 10.1068/p5403; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GOSSELIN P, 1995, J PERS SOC PSYCHOL, V68, P83, DOI 10.1037/0022-3514.68.1.83; Guyer AE, 2008, J COGNITIVE NEUROSCI, V20, P1565, DOI 10.1162/jocn.2008.20114; Herba CM, 2006, J CHILD PSYCHOL PSYC, V47, P1098, DOI 10.1111/j.1469-7610.2006.01652.x; Hill H, 2000, PSYCHOL SCI, V11, P223, DOI 10.1111/1467-9280.00245; Jansson LC, 1974, DEV DEDUCTIVE REASON; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; KOLB B, 1992, BRAIN COGNITION, V20, P74, DOI 10.1016/0278-2626(92)90062-Q; Kret ME, 2010, EXP BRAIN RES, V203, P169, DOI 10.1007/s00221-010-2220-8; Kuhlmeier VA, 2010, INFANCY, V15, P83, DOI 10.1111/j.1532-7078.2009.00003.x; Lagerlof I, 2009, EUR J DEV PSYCHOL, V6, P409, DOI 10.1080/17405620701438475; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; MANN VA, 1979, J EXP CHILD PSYCHOL, V27, P153, DOI 10.1016/0022-0965(79)90067-5; MATHER G, 1994, P ROY SOC B-BIOL SCI, V258, P273, DOI 10.1098/rspb.1994.0173; MCDONNELL R., 2009, ACM T APPL PERCEPT, V6, p[14, 1, 11]; McGivern RF, 2002, BRAIN COGNITION, V50, P73, DOI 10.1016/S0278-2626(02)00012-X; Pavlova M, 2001, PERCEPTION, V30, P925, DOI 10.1068/p3157; Peelen MV, 2009, DEVELOPMENTAL SCI, V12, pF16, DOI 10.1111/j.1467-7687.2009.00916.x; Pollick FE, 2005, J EXP PSYCHOL HUMAN, V31, P1247, DOI 10.1037/0096-1523.31.6.1247; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0; Thomas LA, 2007, DEVELOPMENTAL SCI, V10, P547, DOI 10.1111/j.1467-7687.2007.00614.x; Tonks J, 2007, BRAIN INJURY, V21, P623, DOI 10.1080/02699050701426865; Uhlhaas PJ, 2011, SCHIZOPHRENIA BULL, V37, P514, DOI 10.1093/schbul/sbr034; Van Meel J, 1993, EMPIR STUD ARTS, V11, P117, DOI DOI 10.2190/V69N-VB0T-A9Q3-TJ04; Wade AM, 2006, J APPL STAT, V33, P297, DOI 10.1080/02664760500445756; WALK RD, 1984, B PSYCHONOMIC SOC, V22, P437; Yoon JMD, 2009, CHILD DEV, V80, P1069, DOI 10.1111/j.1467-8624.2009.01317.x	45	41	42	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44815	10.1371/journal.pone.0044815	http://dx.doi.org/10.1371/journal.pone.0044815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005KD	22970310	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000308748400031
J	Ehrentraut, SF; Dorr, A; Ehrentraut, H; Lohner, R; Lee, SH; Hoeft, A; Baumgarten, G; Knuefermann, P; Boehm, O; Meyer, R				Ehrentraut, Stefan Felix; Doerr, Anne; Ehrentraut, Heidi; Lohner, Ralph; Lee, Sun-Hee; Hoeft, Andreas; Baumgarten, Georg; Knuefermann, Pascal; Boehm, Olaf; Meyer, Rainer			Vascular Dysfunction following Polymicrobial Sepsis: Role of Pattern Recognition Receptors	PLOS ONE			English	Article							CARDIAC DYSFUNCTION; NITRIC-OXIDE; CD14-DEFICIENT MICE; INNATE IMMUNITY; CECAL LIGATION; ANIMAL-MODELS; LIPOPOLYSACCHARIDE; INFLAMMATION; TOLL-LIKE-RECEPTOR-9; CONTRACTILITY	Aims: Aim was to elucidate the specific role of pattern recognition receptors in vascular dysfunction during polymicrobial sepsis (colon ascendens stent peritonitis, CASP). Methods and Results: Vascular contractility of C57BL/6 (wildtype) mice and mice deficient for Toll-like receptor 2/4/9 (TLR2-D, TLR4-D, TLR9-D) or CD14 (CD14-D) was measured 18 h following CASP. mRNA expression of pro-(Tumor Necrosis Factor-alpha (TNF alpha), Interleukin (IL)-1 beta, IL-6) and anti-inflammatory cytokines (IL-10) and of vascular inducible NO-Synthase (iNOS) was determined using RT-qPCR. Wildtype mice exhibited a significant loss of vascular contractility after CASP. This was aggravated in TLR2-D mice, blunted in TLR4-D animals and abolished in TLR9-D and CD14-D animals. TNF-alpha expression was significantly up-regulated after CASP in wildtype and TLR2-D animals, but not in mice deficient for TLR4, -9 or CD14. iNOS was significantly up-regulated in TLR2-D animals only. TLR2-D animals showed significantly higher levels of TLR4, -9 and CD14. Application of H154-ODN, a TLR9 antagonist, attenuated CASP-induced cytokine release and vascular dysfunction in wildtype mice. Conclusions: Within our model, CD14 and TLR9 play a decisive role for the development of vascular dysfunction and thus can be effectively antagonized using H154-ODN. TLR2-D animals are more prone to polymicrobial sepsis, presumably due to up-regulation of TLR4, 9 and CD14.	[Ehrentraut, Stefan Felix; Ehrentraut, Heidi; Hoeft, Andreas; Baumgarten, Georg; Knuefermann, Pascal; Boehm, Olaf] Univ Hosp Bonn, Dept Anaesthesiol & Intens Care Med, Bonn, Germany; [Doerr, Anne; Lohner, Ralph; Lee, Sun-Hee; Meyer, Rainer] Univ Bonn, Inst Physiol 2, Bonn, Germany	University of Bonn; University of Bonn	Ehrentraut, SF (corresponding author), Univ Hosp Bonn, Dept Anaesthesiol & Intens Care Med, Bonn, Germany.	Rainer.Meyer@ukb.uni-bonn.de	Meyer, Rainer/H-5871-2013	Ehrentraut, Stefan/0000-0001-5747-6737	Else-Kroner-Fresenius-Stiftung [P46/08//A22/08]	Else-Kroner-Fresenius-Stiftung	Part of the project has been funded through a grant to Pascal Knuefermann, Georg Baumgarten and Rainer Meyer by the Else-Kroner-Fresenius-Stiftung (P46/08//A22/08); www.ekfs.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Araujo AV, 2011, VASC PHARMACOL, V54, P44, DOI 10.1016/j.vph.2010.12.002; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Baumgarten G, 2006, SHOCK, V25, P43, DOI 10.1097/01.shk.0000196498.57306.a6; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cowan DB, 2000, AM J PHYSIOL-HEART C, V279, pH619, DOI 10.1152/ajpheart.2000.279.2.H619; David S, 2011, CYTOKINE, V55, P251, DOI 10.1016/j.cyto.2011.04.005; Davis JS, 2010, CRIT CARE, V14, DOI 10.1186/cc9020; Dyson A, 2009, CRIT CARE MED, V37, pS30, DOI 10.1097/CCM.0b013e3181922bd3; Echchannaoui H, 2002, J INFECT DIS, V186, P798, DOI 10.1086/342845; Ehrentraut S, 2007, ARTERIOSCL THROM VAS, V27, P2170, DOI 10.1161/ATVBAHA.107.146100; Ehrentraut S, 2011, SHOCK, V36, P613, DOI 10.1097/SHK.0b013e318235805f; Grandel U, 2000, CIRCULATION, V102, P2758, DOI 10.1161/01.CIR.102.22.2758; Ha TZ, 2010, AM J PHYSIOL-HEART C, V298, pH984, DOI 10.1152/ajpheart.01109.2009; Hall E, 2005, REGUL PEPTIDES, V131, P34, DOI 10.1016/j.regpep.2005.06.006; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Knuefermann P, 2002, CIRCULATION, V106, P2608, DOI 10.1161/01.CIR.0000038110.69369.4C; Knuefermann P, 2008, CARDIOVASC RES, V78, P26, DOI 10.1093/cvr/cvn011; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Loh G, 2008, ENVIRON MICROBIOL, V10, P709, DOI 10.1111/j.1462-2920.2007.01493.x; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Maier S, 2004, SHOCK, V21, P505, DOI 10.1097/01.shk.0000126906.52367.dd; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Perera PY, 1997, J IMMUNOL, V158, P4422; Plitas G, 2008, J EXP MED, V205, P1277, DOI 10.1084/jem.20080162; Rudiger A, 2007, CRIT CARE MED, V35, P1599, DOI 10.1097/01.CCM.0000266683.64081.02; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Texereau J, 2005, CLIN INFECT DIS, V41, pS408, DOI 10.1086/431990; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vromen A, 1996, SHOCK, V6, P248, DOI 10.1097/00024382-199610000-00004; Wang CH, 2004, FUND CLIN PHARMACOL, V18, P679, DOI 10.1111/j.1472-8206.2004.00293.x; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Williams DL, 2003, CRIT CARE MED, V31, P1808, DOI 10.1097/01.CCM.0000069343.27691.F3; Yamada H, 2002, J IMMUNOL, V169, P5590, DOI 10.4049/jimmunol.169.10.5590; Yasuda H, 2008, AM J PHYSIOL-RENAL, V294, pF1050, DOI 10.1152/ajprenal.00461.2007; Zanotti-Cavazzoni SL, 2009, CURR OPIN CRIT CARE, V15, P392, DOI 10.1097/MCC.0b013e3283307a4e; Zou L, 2010, CRIT CARE MED, V38, P1335, DOI 10.1097/CCM.0b013e3181d99e67	39	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44531	10.1371/journal.pone.0044531	http://dx.doi.org/10.1371/journal.pone.0044531			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970242	Green Submitted, Green Published, gold			2022-12-25	WOS:000308462000027
J	Bayfield, OW; Chen, CS; Patterson, AR; Luan, WS; Smits, C; Gollnick, P; Antson, AA				Bayfield, Oliver W.; Chen, Chao-Sheng; Patterson, Andrea R.; Luan, Weisha; Smits, Callum; Gollnick, Paul; Antson, Alfred A.			Trp RNA-Binding Attenuation Protein: Modifying Symmetry and Stability of a Circular Oligomer	PLOS ONE			English	Article							MOLECULAR-GRAPHICS; TRAP; DNA; TRANSLOCATION; REFINEMENT; MUTANT; MOTOR	Background: Subunit number is amongst the most important structural parameters that determine size, symmetry and geometry of a circular protein oligomer. The L-tryptophan biosynthesis regulator, TRAP, present in several Bacilli, is a good model system for investigating determinants of the oligomeric state. A short segment of C-terminal residues defines whether TRAP forms an 11-mer or 12-mer assembly. To understand which oligomeric state is more stable, we examine the stability of several wild type and mutant TRAP proteins. Methodology/Principal Findings: Among the wild type B. stearothermophilus, B. halodurans and B. subtilis TRAP, we find that the former is the most stable whilst the latter is the least. Thermal stability of all TRAP is shown to increase with L-tryptophan concentration. We also find that mutant TRAP molecules that are truncated at the C-terminus - and hence induced to form 12-mers, distinct from their 11-mer wild type counterparts - have increased melting temperatures. We show that the same effect can be achieved by a point mutation S72N at a subunit interface, which leads to exclusion of C-terminal residues from the interface. Our findings are supported by dye-based scanning fluorimetry, CD spectroscopy, and by crystal structure and mass spectrometry analysis of the B. subtilis S72N TRAP. Conclusions/Significance: We conclude that the oligomeric state of a circular protein can be changed by introducing a point mutation at a subunit interface. Exclusion (or deletion) of the C-terminus from the subunit interface has a major impact on properties of TRAP oligomers, making them more stable, and we argue that the cause of these changes is the altered oligomeric state. The more stable TRAP oligomers could be used in potential applications of TRAP in bionanotechnology.	[Bayfield, Oliver W.; Chen, Chao-Sheng; Luan, Weisha; Smits, Callum; Antson, Alfred A.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England; [Patterson, Andrea R.; Gollnick, Paul] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	University of York - UK; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bayfield, OW (corresponding author), Univ York, Dept Chem, York Struct Biol Lab, York YO10 5DD, N Yorkshire, England.	fred.antson@york.ac.uk	Antson, Alfred/N-2551-2016	Antson, Alfred/0000-0002-4533-3816; Bayfield, Oliver William/0000-0003-1421-7780	Engineering and Physical Sciences Research Council; Department of Chemistry Vacation Bursary Scheme; Wild Fund awards; National Science Foundation Molecular and Cellular Biology [1019960]; Wellcome Trust [081916]; Div Of Molecular and Cellular Bioscience [1019960] Funding Source: National Science Foundation	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Department of Chemistry Vacation Bursary Scheme; Wild Fund awards; National Science Foundation Molecular and Cellular Biology(National Science Foundation (NSF)); Wellcome Trust(Wellcome TrustEuropean Commission); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Engineering and Physical Sciences Research Council studentship 2011 and the Department of Chemistry Vacation Bursary Scheme 2011 to OWB, Wild Fund awards to C-SC and WL, by National Science Foundation Molecular and Cellular Biology grant 1019960 to PG and by the Wellcome Trust fellowship 081916 to AAA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antson AA, 1999, NATURE, V401, P235, DOI 10.1038/45730; ANTSON AA, 1995, NATURE, V374, P693, DOI 10.1038/374693a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Casjens SR, 2011, NAT REV MICROBIOL, V9, P647, DOI 10.1038/nrmicro2632; Chen CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025296; Chen XP, 1999, J MOL BIOL, V289, P1003, DOI 10.1006/jmbi.1999.2834; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gollnick P, 2005, ANNU REV GENET, V39, P47, DOI 10.1146/annurev.genet.39.073003.093745; Heddle JG, 2007, SMALL, V3, P1950, DOI 10.1002/smll.200700400; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Li PTX, 2004, J MOL BIOL, V335, P707, DOI 10.1016/j.jmb.2003.11.002; Malay AD, 2011, BIOCHEM J, V434, P427, DOI 10.1042/BJ20101813; McElroy C, 2002, J MOL BIOL, V323, P463, DOI 10.1016/S0022-2836(02)00940-3; McElroy CA, 2006, BIOCHEMISTRY-US, V45, P7844, DOI 10.1021/bi0526074; Minamino T, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000616; Miranda FF, 2009, SMALL, V5, P2077, DOI 10.1002/smll.200900667; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Weber J, 2003, FEBS LETT, V545, P61, DOI 10.1016/S0014-5793(03)00394-6; Wendell D, 2009, NAT NANOTECHNOL, V4, P765, DOI [10.1038/NNANO.2009.259, 10.1038/nnano.2009.259]	30	5	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44309	10.1371/journal.pone.0044309	http://dx.doi.org/10.1371/journal.pone.0044309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970197	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400056
J	Kim, YJ; Yeu, SY; Park, BS; Koh, HJ; Song, JT; Seo, HS				Kim, Yeon Jeong; Yeu, Song Yion; Park, Bong Soo; Koh, Hee-Jong; Song, Jong Tae; Seo, Hak Soo			Protein Disulfide Isomerase-Like Protein 1-1 Controls Endosperm Development through Regulation of the Amount and Composition of Seed Proteins in Rice	PLOS ONE			English	Article							CHAPERONE-LIKE ACTIVITY; PROGRAMMED CELL-DEATH; ENDOPLASMIC-RETICULUM; AMYLOPECTIN BIOSYNTHESIS; STORAGE PROTEINS; STARCH; MUTATIONS; GENE; QUALITY; ACCUMULATION	Protein disulfide isomerase (PDI) is a chaperone protein involved in oxidative protein folding by acting as a catalyst and assisting folding in the endoplasmic reticulum (ER). A genome database search showed that rice contains 19 PDI-like genes. However, their functions are not clearly identified. This paper shows possible functions of rice PDI-like protein 1-1 (PDIL1-1) during seed development. Seeds of the T-DNA insertion PDIL1-1 mutant, PDIL1-1D, identified by genomic DNA PCR and western blot analysis, display a chalky phenotype and a thick aleurone layer. Protein content per seed was significantly lower and free sugar content higher in PDIL1-1D mutant seeds than in the wild type. Proteomic analysis of PDIL1-1D mutant seeds showed that PDIL1-1 is post-translationally regulated, and its loss causes accumulation of many types of seed proteins including glucose/starch metabolism-and ROS (reactive oxygen species) scavenging-related proteins. In addition, PDIL1-1 strongly interacts with the cysteine protease OsCP1. Our data indicate that the opaque phenotype of PDIL1-1D mutant seeds results from production of irregular starch granules and protein body through loss of regulatory activity for various proteins involved in the synthesis of seed components.	[Kim, Yeon Jeong; Park, Bong Soo; Koh, Hee-Jong; Seo, Hak Soo] Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Plant Sci, Seoul, South Korea; [Yeu, Song Yion] Seoul Natl Univ, Sch Agr Biotechnol, Seoul, South Korea; [Koh, Hee-Jong; Seo, Hak Soo] Seoul Natl Univ, Plant Genom & Breeding Inst, Seoul, South Korea; [Seo, Hak Soo] Seoul Natl Univ, BioMAX Inst, Seoul, South Korea; [Song, Jong Tae] Kyungpook Natl Univ, Sch Appl Biosci, Taegu, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Kyungpook National University	Kim, YJ (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Dept Plant Sci, Seoul, South Korea.	seohs@snu.ac.kr		Song, Jong Tae/0000-0002-2052-6582	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea [PJ008123]	Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center), Rural Development Administration, Republic of Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (Plant Molecular Breeding Center no. PJ008123), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTENBACH SB, 1981, VIROLOGY, V112, P25, DOI 10.1016/0042-6822(81)90608-5; Balmer Y, 2006, P NATL ACAD SCI USA, V103, P2988, DOI 10.1073/pnas.0511040103; CAI H, 1994, J BIOL CHEM, V269, P24550; d'Aloisio E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-101; Dietz KJ, 2003, ANNU REV PLANT BIOL, V54, P93, DOI 10.1146/annurev.arplant.54.031902.134934; Dinges JR, 2001, PLANT PHYSIOL, V125, P1406, DOI 10.1104/pp.125.3.1406; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Fath A, 2000, PLANT MOL BIOL, V44, P255, DOI 10.1023/A:1026584207243; Fujita N, 2003, PLANT CELL PHYSIOL, V44, P607, DOI 10.1093/pcp/pcg079; Gallant DJ, 1997, CARBOHYD POLYM, V32, P177, DOI 10.1016/S0144-8617(97)00008-8; Han XH, 2012, J EXP BOT, V63, P121, DOI 10.1093/jxb/err262; Houston NL, 2005, PLANT PHYSIOL, V137, P762, DOI 10.1104/pp.104.056507; Hunter BG, 2002, PLANT CELL, V14, P2591, DOI 10.1105/tpc.003905; Jacquot JP, 2002, BIOCHEM PHARMACOL, V64, P1065, DOI 10.1016/S0006-2952(02)01177-2; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Jeong DH, 2006, PLANT J, V45, P123, DOI 10.1111/j.1365-313X.2005.02610.x; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; Kang HG, 2005, PLANT J, V42, P901, DOI 10.1111/j.1365-313X.2005.02423.x; Kawakatsu T, 2010, PLANT PHYSIOL, V154, P1842, DOI 10.1104/pp.110.164343; Kim YJ, 2010, J KOREAN SOC APPL BI, V53, P508, DOI 10.3839/jksabc.2010.077; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Kossmann J, 2000, CRIT REV PLANT SCI, V19, P171, DOI 10.1016/S0735-2689(00)80002-7; Kubo A, 1999, PLANT PHYSIOL, V121, P399, DOI 10.1104/pp.121.2.399; Kubo A, 2005, PLANT PHYSIOL, V137, P43, DOI 10.1104/pp.104.051359; Liu XL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-730; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; MILES MJ, 1985, CARBOHYD RES, V135, P271, DOI 10.1016/S0008-6215(00)90778-X; MIZUNO K, 1993, J BIOL CHEM, V268, P19084; Muntz K, 1998, PLANT MOL BIOL, V38, P77, DOI 10.1023/A:1006020208380; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Nakamura Y, 1996, PHYSIOL PLANTARUM, V97, P491, DOI [10.1111/j.1399-3054.1996.tb00508.x, 10.1034/j.1399-3054.1996.970311.x]; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; Nishi A, 2001, PLANT PHYSIOL, V127, P459, DOI [10.1104/pp.010127, 10.1104/pp.127.2.459]; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; Onda Y, 2011, PLANT CELL, V23, P210, DOI 10.1105/tpc.110.079509; Ondzighi CA, 2008, PLANT CELL, V20, P2205, DOI 10.1105/tpc.108.058339; PUIG A, 1994, J BIOL CHEM, V269, P7764; SATOH H, 1981, JPN J BREED, V31, P316; Satoh-Cruz M, 2010, PLANT CELL PHYSIOL, V51, P1581, DOI 10.1093/pcp/pcq098; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith AM, 1997, ANNU REV PLANT PHYS, V48, P65, DOI 10.1146/annurev.arplant.48.1.67; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; Takemoto Y, 2002, PLANT PHYSIOL, V128, P1212, DOI 10.1104/pp.010624; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson DB, 2000, CARBOHYD POLYM, V43, P223, DOI 10.1016/S0144-8617(00)00150-8; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; TSAI CY, 1978, BIOCHEM GENET, V16, P883, DOI 10.1007/BF00483740; Urade R, 2007, FEBS J, V274, P1152, DOI 10.1111/j.1742-4658.2007.05664.x; Wakasa Y, 2011, PLANT J, V65, P675, DOI 10.1111/j.1365-313X.2010.04453.x; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wong JH, 2003, FEBS LETT, V547, P151, DOI 10.1016/S0014-5793(03)00696-3; Yasuda H, 2009, PLANT CELL PHYSIOL, V50, P1532, DOI 10.1093/pcp/pcp098; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	54	43	46	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44493	10.1371/journal.pone.0044493	http://dx.doi.org/10.1371/journal.pone.0044493			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970232	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400078
J	Tan, KW; Jobichen, C; Ong, TC; Gao, YF; Tiong, YS; Wong, KN; Chew, FT; Sivaraman, J; Mok, YK				Tan, Kang Wei; Jobichen, Chacko; Ong, Tan Ching; Gao, Yun Feng; Tiong, Yuen Sung; Wong, Kang Ning; Chew, Fook Tim; Sivaraman, J.; Mok, Yu Keung			Crystal Structure of Der f 7, a Dust Mite Allergen from Dermatophagoides farinae	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY BINDING; X-RAY-DIFFRACTION; AMINO-ACID; MOLECULAR-CLONING; PROTEIN; SYSTEM; IGE; SENSITIVITY; EXPRESSION; ALIGNMENT	Background: Der f 7 is the group 7 allergen from the dust mite Dermatophagoides farinae, homologous to the major allergen Der p 7 from D. pteronyssinus. Monoclonal antibody that bind to residues Leu48 and Phe50 was found to inhibit IgE binding to residue Asp159, which is important for the cross-reactivity between Der f 7 and Der p 7. Methodology/Principal Findings: Here, we report the crystal structure of Der f 7 that shows an elongated and curved molecule consisting of two anti-parallel beta-sheets - one 4-stranded and the other 5-stranded - that wrap around a long C-terminal helix. The overall fold of Der f 7 is similar to Der p 7 but key difference was found in the beta 1-beta 2 loop region. In Der f 7, Leu48 and Phe50 are in close proximity to Asp159, explaining why monoclonal antibody binding to Leu48 and Phe50 can inhibit IgE binding to Asp159. Both Der f 7 and Der p 7 bind weakly to polymyxin B via a similar binding site that is formed by the N-terminal helix, the 4-stranded beta-sheet and the C-terminal helix. The thermal stability of Der f 7 is significantly lower than that of Der p 7, and the stabilities of both allergens are highly depend on pH. Conclusion/Significance: Der f 7 is homologous to Der p 7 in terms of the amino acid sequence and overall 3D structure but with significant differences in the region proximal to the IgE epitope and in thermal stability. The crystal structure of Der f 7 provides a basis for studying the function and allergenicity of this group of allergens.	[Tan, Kang Wei; Jobichen, Chacko; Ong, Tan Ching; Gao, Yun Feng; Tiong, Yuen Sung; Wong, Kang Ning; Chew, Fook Tim; Sivaraman, J.; Mok, Yu Keung] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Tan, KW (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbsmokh@nus.edu.sg	Mok, Yu Keung/H-8019-2012; Jobichen, Chacko/AAR-7637-2020; Jobichen, Chacko/D-1978-2014; Chew, Fook Tim/E-7259-2010	Mok, Yu Keung/0000-0002-2829-4878; Jobichen, Chacko/0000-0001-5927-1815; Chew, Fook Tim/0000-0003-1337-5146; J, Sivaraman/0000-0001-9781-5326	Biomedical Research Council [04/1/21/19/315]; National Medical Research Council of Singapore [NMRC/1150/2008]	Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); National Medical Research Council of Singapore(National Medical Research Council, Singapore)	This study was supported by grants from the Biomedical Research Council (04/1/21/19/315) and the National Medical Research Council (NMRC/1150/2008) of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beamer LJ, 1997, SCIENCE, V276, P1861, DOI 10.1126/science.276.5320.1861; Bingle CD, 2002, HUM MOL GENET, V11, P937, DOI 10.1093/hmg/11.8.937; Cabrera AR, 2009, J INSECT PHYSIOL, V55, P1079, DOI 10.1016/j.jinsphys.2009.08.007; Cardoso LS, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-1; Chou H, 2011, MOL IMMUNOL, V48, P2130, DOI 10.1016/j.molimm.2011.07.004; Cui YB, 2010, J MED ENTOMOL, V47, P868, DOI 10.1603/ME09180; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; DOWNING AS, 1990, EXP APPL ACAROL, V9, P123, DOI 10.1007/BF01198990; Elsbach P, 1998, CURR OPIN IMMUNOL, V10, P45, DOI 10.1016/S0952-7915(98)80030-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goddard T.D., SPARKY 3; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Hamiaux C, 2009, J BIOL CHEM, V284, P3496, DOI 10.1074/jbc.M807467200; Kidon MI, 2011, PEDIAT ALLERG IMM-UK, V22, P202, DOI 10.1111/j.1399-3038.2010.01094.x; Kleiger G, 2000, J MOL BIOL, V299, P1019, DOI 10.1006/jmbi.2000.3805; Kolodziejczyk R, 2008, J MOL BIOL, V377, P870, DOI 10.1016/j.jmb.2008.01.026; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mueller GA, 2010, J ALLERGY CLIN IMMUN, V125, P909, DOI 10.1016/j.jaci.2009.12.016; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qiu XY, 2007, NAT STRUCT MOL BIOL, V14, P106, DOI 10.1038/nsmb1197; RUIZSANZ J, 1995, BIOCHEMISTRY-US, V34, P1695, DOI 10.1021/bi00005a026; SHEN HD, 1993, CLIN EXP ALLERGY, V23, P934, DOI 10.1111/j.1365-2222.1993.tb00278.x; SHEN HD, 1995, CLIN EXP ALLERGY, V25, P1000, DOI 10.1111/j.1365-2222.1995.tb00403.x; Shen HD, 1996, CLIN EXP ALLERGY, V26, P308, DOI 10.1111/j.1365-2222.1996.tb00096.x; Shen HD, 1997, CLIN EXP ALLERGY, V27, P824, DOI 10.1046/j.1365-2222.1997.650890.x; Shen HD, 2011, IMMUNOL CELL BIOL, V89, P225, DOI 10.1038/icb.2010.77; Sippl MJ, 2008, BIOINFORMATICS, V24, P872, DOI 10.1093/bioinformatics/btn040; Sippl MJ, 2008, BIOINFORMATICS, V24, P426, DOI 10.1093/bioinformatics/btm622; Tan KW, 2011, ACTA CRYSTALLOGR F, V67, P1612, DOI 10.1107/S174430911103836X; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wheeler TT, 2002, BBA-GENE STRUCT EXPR, V1579, P92, DOI 10.1016/S0167-4781(02)00508-0; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033	37	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44850	10.1371/journal.pone.0044850	http://dx.doi.org/10.1371/journal.pone.0044850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970319	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400124
J	Zhang, LX; Xie, JP; Patel, M; Bakhtyar, A; Ehrlich, GD; Ahmed, A; Earl, J; Marrs, CF; Clemans, D; Murphy, TF; Gilsdorf, JR				Zhang, Lixin; Xie, Jingping; Patel, Mayuri; Bakhtyar, Arsala; Ehrlich, Garth D.; Ahmed, Azad; Earl, Josh; Marrs, Carl F.; Clemans, Daniel; Murphy, Timothy F.; Gilsdorf, Janet R.			Nontypeable Haemophilus influenzae Genetic Islands Associated with Chronic Pulmonary Infection	PLOS ONE			English	Article							COMPARATIVE GENOMICS; RESPIRATORY-TRACT; OTITIS-MEDIA; MULTIPLE STRAINS; DISEASE; IDENTIFICATION; COLONIZATION; COMMENSAL; VIRULENCE; BACTERIA	Background: Haemophilus influenzae (Hi) colonizes the human respiratory tract and is an important pathogen associated with chronic obstructive pulmonary disease (COPD). Bacterial factors that interact with the human host may be important in the pathogenesis of COPD. These factors, however, have not been well defined. The overall goal of this study was to identify bacterial genetic elements with increased prevalence among H. influenzae strains isolated from patients with COPD compared to those isolated from the pharynges of healthy individuals. Methodology/Principal Findings: Four nontypeable H. influenzae (NTHi) strains, two isolated from the airways of patients with COPD and two from a healthy individual, were subjected to whole genome sequencing using 454 FLX Titanium technology. COPD strain-specific genetic islands greater than 500 bp in size were identified by in silico subtraction. Open reading frames residing within these islands include known Hi virulence genes such as lic2b, hgbA, iga, hmw1 and hmw2, as well as genes encoding urease and other enzymes involving metabolic pathways. The distributions of seven selected genetic islands were assessed among a panel of 421 NTHi strains of both disease and commensal origins using a Library-on-a-Slide high throughput dot blot DNA hybridization procedure. Four of the seven islands screened, containing genes that encode a methyltransferase, a dehydrogenase, a urease synthesis enzyme, and a set of unknown short ORFs, respectively, were more prevalent in COPD strains than in colonizing strains with prevalence ratios ranging from 1.21 to 2.85 (p <= 0.0002). Surprisingly, none of these sequences show increased prevalence among NTHi isolated from the airways of patients with cystic fibrosis. Conclusions/Significance: Our data suggest that specific bacterial genes, many involved in metabolic functions, are associated with the ability of NTHi strains to survive in the lower airways of patients with COPD.	[Zhang, Lixin; Xie, Jingping; Marrs, Carl F.; Gilsdorf, Janet R.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Patel, Mayuri; Bakhtyar, Arsala; Gilsdorf, Janet R.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Ehrlich, Garth D.; Ahmed, Azad; Earl, Josh] Allegheny Singer Res Inst, Ctr Genom Sci, Pittsburgh, PA 15212 USA; [Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Pittsburgh, PA USA; [Ehrlich, Garth D.] Drexel Univ, Coll Med, Dept Otolaryngol Head & Neck Surg, Pittsburgh, PA USA; [Clemans, Daniel] Eastern Michigan Univ, Dept Biol, Ypsilanti, MI 48197 USA; [Murphy, Timothy F.] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Dept Microbiol, Div Infect Dis,Dept Med, Buffalo, NY 14260 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Drexel University; Drexel University; Eastern Michigan University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Zhang, LX (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.	lxzhang@umich.edu	Zhang, Li/GWM-7501-2022	Ehrlich, Garth/0000-0003-1140-6594; Murphy, Timothy/0000-0002-3496-2641	National Institutes of Health [RO1 HL083893, DC05840, R15 HL071526, AI19641]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083893, R15HL071526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study is supported in part by National Institutes of Health grants RO1 HL083893 and DC05840 (JG), R15 HL071526 (DLC), AI19641 (TFM) and by the Department of Veterans Affairs (TFM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012617; Abdul-Tehrani H, 1999, J BACTERIOL, V181, P1415, DOI 10.1128/JB.181.5.1415-1428.1999; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergman NH, 2003, INFECT IMMUN, V71, P1098, DOI 10.1128/IAI.71.3.1098-1108.2003; Binks MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034083; Boissy R, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-187; Boucher Y, 2001, CURR OPIN MICROBIOL, V4, P285, DOI 10.1016/S1369-5274(00)00204-6; Campos JM, 1999, MANUAL CLIN MICROBIO, P604; Davis GS, 2011, J CLIN MICROBIOL, V49, P2594, DOI 10.1128/JCM.02509-10; Dhooge I, 2000, INT J PEDIATR OTORHI, V54, P7, DOI 10.1016/S0165-5876(00)00321-9; Ecevit IZ, 2004, J CLIN MICROBIOL, V42, P3065, DOI 10.1128/JCM.42.7.3065-3072.2004; Erwin AL, 2007, TRENDS MICROBIOL, V15, P355, DOI 10.1016/j.tim.2007.06.004; FADEN H, 1995, J INFECT DIS, V172, P132, DOI 10.1093/infdis/172.1.132; Farjo RS, 2004, PEDIATR INFECT DIS J, V23, P41, DOI 10.1097/01.inf.0000106981.89572.d1; Fernaays MM, 2006, INFECT IMMUN, V74, P5860, DOI 10.1128/IAI.00796-06; Fernaays MM, 2006, INFECT IMMUN, V74, P3366, DOI 10.1128/IAI.01904-05; Gilsdorf JR, 2004, INFECT IMMUN, V72, P2457, DOI 10.1128/IAI.72.5.2457-2461.2004; GRATTEN M, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P501; Harb OS, 1998, INFECT IMMUN, V66, P1898, DOI 10.1128/IAI.66.5.1898-1903.1998; Hogg JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r103; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Juliao PC, 2007, J BACTERIOL, V189, P4994, DOI 10.1128/JB.00146-07; Kilian M., 2005, BERGEYS MANUAL SYSTE, V2B, P883; Kong Y, 2006, J CLIN MICROBIOL, V44, P3940, DOI 10.1128/JCM.01146-06; Mannino DM, 2002, CHEST, V121, p121S, DOI 10.1378/chest.121.5_suppl.121S; McCrea KW, 2008, J CLIN MICROBIOL, V46, P406, DOI 10.1128/JCM.01832-07; Minino AM, 2011, NATL VITAL STAT REP, V59, P1; MOLLER LVM, 1995, J INFECT DIS, V172, P1388, DOI 10.1093/infdis/172.5.1388; Munson RS, 2004, INFECT IMMUN, V72, P3002, DOI 10.1128/IAI.72.5.3002-3010.2004; Murphy TF, 2004, AM J RESP CRIT CARE, V170, P266, DOI 10.1164/rccm.200403-354OC; Murphy TF, 2003, CURR OPIN INFECT DIS, V16, P129, DOI 10.1097/00001432-200304000-00009; Murphy TF, 2002, DRUG AGING, V19, P761, DOI 10.2165/00002512-200219100-00005; Murphy TF, 1999, J INFECT DIS, V180, P404, DOI 10.1086/314870; Murphy TF, 2007, J INFECT DIS, V195, P81, DOI 10.1086/509824; Nakamura S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001247; Patel IS, 2002, THORAX, V57, P759, DOI 10.1136/thorax.57.9.759; Pettigrew MM, 2002, INFECT IMMUN, V70, P3551, DOI 10.1128/IAI.70.7.3551-3556.2002; Qu J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-162; Sachs G, 2006, J MEMBRANE BIOL, V212, P71, DOI 10.1007/s00232-006-0867-7; Sagel SD, 2009, J PEDIATR-US, V154, P183, DOI 10.1016/j.jpeds.2008.08.001; SAMUELSON A, 1995, J CLIN MICROBIOL, V33, P2027, DOI 10.1128/JCM.33.8.2027-2031.1995; Sandstedt SA, 2008, J MICROBIOL METH, V75, P369, DOI 10.1016/j.mimet.2008.06.023; Sandstedt SA, 2010, J CLIN MICROBIOL, V48, P2565, DOI 10.1128/JCM.02453-09; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schoolnik GK, 2002, CURR OPIN MICROBIOL, V5, P20, DOI 10.1016/S1369-5274(02)00280-1; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Seale TW, 2006, INFECT IMMUN, V74, P6213, DOI 10.1128/IAI.00744-06; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Sethi S, 2001, CLIN MICROBIOL REV, V14, P336, DOI 10.1128/CMR.14.2.336-363.2001; SmithVaughan HC, 1996, EPIDEMIOL INFECT, V116, P177, DOI 10.1017/S0950268800052419; St Sauver J, 2000, EMERG INFECT DIS, V6, P622, DOI 10.3201/eid0606.000611; STGEME JW, 1993, P NATL ACAD SCI USA, V90, P2875, DOI 10.1073/pnas.90.7.2875; TROTTIER S, 1989, J CLIN MICROBIOL, V27, P2175, DOI 10.1128/JCM.27.10.2175-2179.1989; Vitovski S, 2002, JAMA-J AM MED ASSOC, V287, P1699, DOI 10.1001/jama.287.13.1699; Weiser LN, 2000, TRENDS MICROBIOL, V8, P433, DOI 10.1016/S0966-842X(00)01839-4; Whitby PW, 2006, J BACTERIOL, V188, P5640, DOI 10.1128/JB.00417-06; Whitby PW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-6; Whittam TS, 2002, CURR OPIN GENET DEV, V12, P719, DOI 10.1016/S0959-437X(02)00361-1; Wilson R, 2001, EUR RESPIR J, V17, P995, DOI 10.1183/09031936.01.17509950; Wong SMS, 2011, INFECT IMMUN, V79, P1971, DOI 10.1128/IAI.01269-10; Xie JP, 2006, J CLIN MICROBIOL, V44, P4316, DOI 10.1128/JCM.01331-06; Zhang LX, 2005, BIOTECHNIQUES, V39, P640, DOI 10.2144/000112038; Zhang LX, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-12	64	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44730	10.1371/journal.pone.0044730	http://dx.doi.org/10.1371/journal.pone.0044730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970300	Green Submitted, Green Published, gold			2022-12-25	WOS:000308458400115
J	Schauer, D; Starlinger, P; Reiter, C; Jahn, N; Zajc, P; Buchberger, E; Bachleitner-Hofmann, T; Bergmann, M; Stift, A; Gruenberger, T; Brostjan, C				Schauer, Dominic; Starlinger, Patrick; Reiter, Christian; Jahn, Nikolaus; Zajc, Philipp; Buchberger, Elisabeth; Bachleitner-Hofmann, Thomas; Bergmann, Michael; Stift, Anton; Gruenberger, Thomas; Brostjan, Christine			Intermediate Monocytes but Not TIE2-Expressing Monocytes Are a Sensitive Diagnostic Indicator for Colorectal Cancer	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; HUMAN PERIPHERAL-BLOOD; GROWTH-FACTOR-BETA; GAMMA-RIII CD16; GENE-EXPRESSION; INDUCTION; SUBSETS; SEPSIS; ANGIOPOIETIN-2; IDENTIFICATION	We have conducted the first study to determine the diagnostic potential of the CD14++CD16+ intermediate monocytes as compared to the pro-angiogenic subset of CD14++CD16+TIE2+ TIE2-expressing monocytes (TEMs) in cancer. These monocyte populations were investigated by flow cytometry in healthy volunteers (N = 32) and in colorectal carcinoma patients with localized (N = 24) or metastatic (N = 37) disease. We further determined blood levels of cytokines associated with monocyte regulation. The results revealed the intermediate monocyte subset to be significantly elevated in colorectal cancer patients and to show the highest frequencies in localized disease. Multivariate regression analysis identified intermediate monocytes as a significant independent variable in cancer prediction. With a cut-off value at 0.37% (intermediate monocytes of total leukocytes) the diagnostic sensitivity and specificity ranged at 69% and 81%, respectively. In contrast, TEM levels were elevated in localized cancer but did not differ significantly between groups and none of the cytokines correlated with monocyte subpopulations. Of interest, in vitro analyses supported the observation that intermediate monocytes were more potently induced by primary as opposed to metastatic cancer cells which may relate to the immunosuppressive milieu established in the advanced stage of metastatic disease. In conclusion, intermediate monocytes as compared to TIE2-expressing monocytes are a more sensitive diagnostic indicator of colorectal cancer.	[Schauer, Dominic; Starlinger, Patrick; Reiter, Christian; Jahn, Nikolaus; Zajc, Philipp; Buchberger, Elisabeth; Bachleitner-Hofmann, Thomas; Bergmann, Michael; Stift, Anton; Gruenberger, Thomas; Brostjan, Christine] Med Univ Vienna, Dept Surg, Gen Hosp, Vienna, Austria	Medical University of Vienna	Schauer, D (corresponding author), Med Univ Vienna, Dept Surg, Gen Hosp, Vienna, Austria.	Christine.Brostjan@meduniwien.ac.at	Bergmann, Michael/GZK-7700-2022; Gruenberger, Thomas/ABA-1661-2020	Gruenberger, Thomas/0000-0002-2671-0540; Starlinger, Patrick/0000-0002-4666-5337; Stift, Anton/0000-0002-7243-8138; Bergmann, Michael/0000-0001-8529-1166; Bachleitner-Hofmann, Thomas/0000-0002-4201-8247; Brostjan, Christine/0000-0003-1462-5397	Medical Scientific Fund of the Mayor of the City of Vienna [8064]	Medical Scientific Fund of the Mayor of the City of Vienna	This work was supported by the Medical Scientific Fund of the Mayor of the City of Vienna (http://www.wien.gv.at/gesundheit/einrichtungen/medwiss-fonds/) by grant no. 8064 issued to T. Gruenberger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ancuta P, 2003, J EXP MED, V197, P1701, DOI 10.1084/jem.20022156; CLARKSON SB, 1988, J EXP MED, V167, P408, DOI 10.1084/jem.167.2.408; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; De Palma M, 2007, TRENDS IMMUNOL, V28, P519, DOI 10.1016/j.it.2007.09.004; Feng AL, 2011, CLIN EXP IMMUNOL, V164, P57, DOI 10.1111/j.1365-2249.2011.04321.x; FINGERLE G, 1993, BLOOD, V82, P3170; Goede V, 2012, CANCER INVEST, V30, P225, DOI 10.3109/07357907.2011.636114; Heimbeck I, 2010, CYTOM PART A, V77A, P823, DOI 10.1002/cyto.a.20942; Heine GH, 2008, KIDNEY INT, V73, P622, DOI 10.1038/sj.ki.5002744; Herra CM, 1996, J MED MICROBIOL, V44, P135, DOI 10.1099/00222615-44-2-135; Hristov M, 2009, CYTOM PART A, V75A, P848, DOI 10.1002/cyto.a.20772; Kruger M, 1996, IMMUNOLOGY, V87, P162; Marron MB, 2007, J BIOL CHEM, V282, P30509, DOI 10.1074/jbc.M702535200; Moniuszko M, 2009, CLIN IMMUNOL, V130, P338, DOI 10.1016/j.clim.2008.09.011; MUNN DH, 1989, J EXP MED, V170, P511, DOI 10.1084/jem.170.2.511; Murdoch C, 2007, J IMMUNOL, V178, P7405, DOI 10.4049/jimmunol.178.11.7405; Nijziel MR, 2000, AM J HEMATOL, V64, P282, DOI 10.1002/1096-8652(200008)64:4<282::AID-AJH8>3.0.CO;2-2; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; SALEH MN, 1995, BLOOD, V85, P2910, DOI 10.1182/blood.V85.10.2910.bloodjournal85102910; Schaaf B, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-12; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; SCHMID I, 1995, CYTOMETRY, V22, P103, DOI 10.1002/cyto.990220205; Skrzeczynska J, 2002, SCAND J IMMUNOL, V55, P629, DOI 10.1046/j.1365-3083.2002.01092.x; Skrzeczynska-Moncznik J, 2008, SCAND J IMMUNOL, V67, P152, DOI 10.1111/j.1365-3083.2007.02051.x; Starlinger P, 2011, DIS MARKERS, V31, P55, DOI [10.1155/2011/535109, 10.3233/DMA-2011-0798]; Subimerb C, 2010, CLIN EXP IMMUNOL, V161, P471, DOI 10.1111/j.1365-2249.2010.04200.x; Szaflarska A, 2004, EXP HEMATOL, V32, P748, DOI 10.1016/j.exphem.2004.05.027; Tsujimoto H, 2004, J ENDOTOXIN RES, V10, P229, DOI 10.1179/096805104225005814; Venneri MA, 2007, BLOOD, V109, P5276, DOI 10.1182/blood-2006-10-053504; WONG HL, 1991, J IMMUNOL, V147, P1843; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Yona S, 2010, CURR OPIN HEMATOL, V17, P53, DOI 10.1097/MOH.0b013e3283324f80; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Zhang JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017484; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; ZIEGLERHEITBROCK HWL, 1988, HYBRIDOMA, V7, P521, DOI 10.1089/hyb.1988.7.521; ZIEGLERHEITBROCK HWL, 1993, EUR J IMMUNOL, V23, P2053, DOI 10.1002/eji.1830230902	40	33	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44450	10.1371/journal.pone.0044450	http://dx.doi.org/10.1371/journal.pone.0044450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973451	Green Submitted, Green Published, gold			2022-12-25	WOS:000308577600056
J	Yu, EJ; Kim, SH; Kim, MJ; Seo, WY; Song, KA; Kang, MS; Yang, CK; Stallcup, MR; Kim, JH				Yu, E. J.; Kim, S-H; Kim, M. J.; Seo, W-Y; Song, K-A; Kang, M-S; Yang, C. K.; Stallcup, M. R.; Kim, J. H.			SUMOylation of ZFP282 potentiates its positive effect on estrogen signaling in breast tumorigenesis	ONCOGENE			English	Article						breast cancer; co-activator; CoCoA; SUMOylation; ZFP282	TERMINAL ACTIVATION DOMAIN; ZINC-FINGER PROTEIN; TRANSCRIPTIONAL ACTIVITY; RECEPTOR-ALPHA; COACTIVATOR COCOA; SUMO MODIFICATION; RECRUITMENT; EXPRESSION; REPRESSES; SYNERGY	Estrogen receptor alpha (ER alpha) has critical roles in the development and progression of breast cancer, and the coiled-coil co-activator (CoCoA) is an important ER alpha co-activator for estrogen-induced gene expression. The small ubiquitin-like modifier (SUMO) pathway is hyperactivated in breast cancer, but the mechanism by which SUMOylation regulates ER alpha-mediated transcription remains poorly understood. Here, we identified ZFP282 as a CoCoA-binding protein. ZFP282 associates directly with ER alpha and cooperates synergistically with CoCoA to enhance ER alpha function. ZFP282 is required for estrogen-induced expression of ER alpha target genes and estrogen-dependent breast cancer cell growth and tumorigenesis. In addition, we found that ZFP282 is SUMOylated and that SUMOylation positively regulates the co-activator activity of ZFP282 by increasing its binding affinity to ER alpha and CoCoA, and consequently increasing recruitment of ZFP282-CoCoA complex to the promoter of ER alpha target genes. These findings reveal essential roles for ZFP282 and its SUMOylation in estrogen signaling and breast tumorigenesis.	[Yu, E. J.; Kim, S-H; Kim, M. J.; Seo, W-Y; Song, K-A; Kang, M-S; Kim, J. H.] Sungkyunkwan Univ, Samsung Adv Inst Hlth Sci & Technol, Dept Hlth Sci & Technol, Seoul, South Korea; [Kim, S-H] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Seo, W-Y; Kang, M-S; Kim, J. H.] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Samsung Biomed Res Inst, Seoul, South Korea; [Yang, C. K.; Stallcup, M. R.] Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; University of Southern California	Stallcup, MR (corresponding author), Univ So Calif, Dept Biochem & Mol Biol, Los Angeles, CA 90089 USA.	stallcup@usc.edu; jeongkim@skku.edu			National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0021428]; Samsung Biomedical Research Institute [GE1-B2-061]; Korea Healthcare Technology RD Project; Ministry for Health Welfare [A092255]; United States National Institutes of Health [DK43093]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043093] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Samsung Biomedical Research Institute(Samsung); Korea Healthcare Technology RD Project; Ministry for Health Welfare; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr Geoffrey L Greene (University of Chicago) for pET-23d-hER alpha-LBD, Dr David K Ann (City of Hope Beckman Research Institute) for SENP1 and Ubc9 expression vectors, Dr Hisato Saitoh (Kimamoto University) for pT-E1E2S1, and Dr Ichi Fujisawa (Kansai Medical University) for pLTR-GL3. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0021428) (to JHK), by the Samsung Biomedical Research Institute grant (GE1-B2-061 to JHK), by Korea Healthcare Technology R&D Project funded by the Ministry for Health & Welfare (A092255), and by grant DK43093 from the United States National Institutes of Health (to MRS).	Buache E, 2011, ONCOGENE, V30, P3261, DOI 10.1038/onc.2011.41; Chupreta S, 2007, J BIOL CHEM, V282, P36155, DOI 10.1074/jbc.M708130200; Conroy AT, 2002, J BIOL CHEM, V277, P9326, DOI 10.1074/jbc.M107702200; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Karamouzis MV, 2008, BREAST CANCER RES TR, V107, P195, DOI 10.1007/s10549-007-9552-5; Kim JH, 2008, MOL CELL, V31, P510, DOI 10.1016/j.molcel.2008.08.001; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P2736, DOI 10.1093/nar/gkl361; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Kotaja N, 2002, J BIOL CHEM, V277, P30283, DOI 10.1074/jbc.M204768200; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Li SS, 2007, CELL SIGNAL, V19, P1101, DOI 10.1016/j.cellsig.2007.02.002; Mo YY, 2005, ONCOGENE, V24, P2677, DOI 10.1038/sj.onc.1208210; Okumura K, 1997, NUCLEIC ACIDS RES, V25, P5025, DOI 10.1093/nar/25.24.5025; Sentis S, 2005, MOL ENDOCRINOL, V19, P2671, DOI 10.1210/me.2005-0042; Stallcup MR, 2003, J STEROID BIOCHEM, V85, P139, DOI 10.1016/S0960-0760(03)00222-X; Tamura T, 2004, J HEALTH SCI, V50, P417, DOI 10.1248/jhs.50.417; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Yang CK, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-12; Yu EJ, 2011, NUCLEIC ACIDS RES, V39, P6932, DOI 10.1093/nar/gkr347	23	12	13	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 29	2013	32	35					4160	4168		10.1038/onc.2012.420	http://dx.doi.org/10.1038/onc.2012.420			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IG	22986521	Green Accepted, hybrid			2022-12-25	WOS:000323748500011
J	Liu, Y; Wang, DL; Chen, S; Zhao, L; Sun, FL				Liu, Yan; Wang, Da-Liang; Chen, Su; Zhao, Lei; Sun, Fang-Lin			Oncogene Ras/Phosphatidylinositol 3-Kinase Signaling Targets Histone H3 Acetylation at Lysine 56	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; DNA-DAMAGE RESPONSE; ACETYLTRANSFERASE ACTIVITY; H3K56 ACETYLATION; ONCOPROTEIN E1A; CANCER CELLS; ACTIVATION; PATHWAY; CYCLE; RAS	It is well established that the small GTPase Ras promotes tumor initiation by activating at least three different mediators: Raf, PI3K, and Ras-like (Ral) guanine nucleotide exchange factors. However, the exact mechanisms that underlie these different Ras signaling pathways, which are involved in tumor progression, remain to be elucidated. In this study, we report that the Ras-PI3K pathway, but not Raf or the Ral guanine nucleotide exchange factors, specifically targets the acetylation of H3 at lysine 56 (H3K56ac), thereby regulating tumor cell activity. We demonstrate that the Ras-PI3K-induced reduction in H3K56ac is associated with the proliferation and migration of tumor cells by targeting the transcription of tumor-associated genes. The depletion of the histone deacetyltransferases Sirt1 and Sirt2 rescues the Ras-PI3K-induced decrease in H3K56ac, gene transcription, tumor cell proliferation, and tumor cell migration. Furthermore, we demonstrate that the Ras-PI3K-AKT pathway regulates H3K56ac via the MDM2-dependent degradation of CREB-binding protein/p300. Taken together, the results of this study demonstrate that the Ras-PI3K signaling pathway targets specific epigenetic modifications in tumor cells.	[Liu, Yan; Wang, Da-Liang; Zhao, Lei; Sun, Fang-Lin] Tsinghua Univ, Inst Epigenet & Canc Res, Sch Med, Beijing 100084, Peoples R China; [Chen, Su; Sun, Fang-Lin] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Liu, Yan] Hebei United Univ, Dept Bioengn, Coll Life Sci, Tangshan 063000, Hebei, Peoples R China	Tsinghua University; Tongji University; North China University of Science & Technology	Sun, FL (corresponding author), Tsinghua Univ, Inst Epigenet & Canc Res, Sch Med, Beijing 100084, Peoples R China.	sfl@tongji.edu.cn						Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Carnero A, 2010, CURR PHARM DESIGN, V16, P34, DOI 10.2174/138161210789941865; Cascone I, 2008, EMBO J, V27, P2375, DOI 10.1038/emboj.2008.166; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chari R, 2010, CANCER METAST REV, V29, P73, DOI 10.1007/s10555-010-9199-2; Chen CC, 2008, CELL, V134, P231, DOI 10.1016/j.cell.2008.06.035; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Downs JA, 2008, DNA REPAIR, V7, P2020, DOI 10.1016/j.dnarep.2008.08.016; Erkmann JA, 2009, DNA REPAIR, V8, P1371, DOI 10.1016/j.dnarep.2009.09.004; Feig LA, 2003, TRENDS CELL BIOL, V13, P419, DOI 10.1016/S0962-8924(03)00152-1; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Hansen CA, 2008, CELL CYCLE, V7, P325, DOI 10.4161/cc.7.3.5354; Hebert C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r51; Hiraga S, 2008, J CELL BIOL, V183, P641, DOI 10.1083/jcb.200806065; Horwitz GA, 2008, SCIENCE, V321, P1084, DOI 10.1126/science.1155544; Hosoda H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-34; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Jin YT, 2004, J BIOL CHEM, V279, P20035, DOI 10.1074/jbc.M309916200; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Kaur B, 2009, CANCER RES, V69, P1212, DOI 10.1158/0008-5472.CAN-08-1166; Korzus E, 1998, SCIENCE, V279, P703, DOI 10.1126/science.279.5351.703; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lee KB, 2012, CANCER LETT, V315, P86, DOI 10.1016/j.canlet.2011.10.016; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Lim KH, 2005, CANCER CELL, V8, P381, DOI 10.1016/j.ccr.2005.10.014; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Mailand N, 2002, NAT CELL BIOL, V4, P317, DOI 10.1038/ncb777; Martelli AM, 2010, HISTOL HISTOPATHOL, V25, P669, DOI 10.14670/HH-25.669; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Miller A, 2008, DIABETES RES CLIN PR, V80, P1, DOI 10.1016/SO168-8227(08)00123-X; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; Morrison DK, 1997, CURR OPIN CELL BIOL, V9, P174, DOI 10.1016/S0955-0674(97)80060-9; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Perissi V, 1999, P NATL ACAD SCI USA, V96, P3652, DOI 10.1073/pnas.96.7.3652; Rosman DS, 2008, CANCER RES, V68, P1319, DOI 10.1158/0008-5472.CAN-07-5424; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Sanchez-Molina S, 2006, BIOCHEM J, V398, P215, DOI 10.1042/BJ20060052; Schneider J, 2006, J BIOL CHEM, V281, P37270, DOI 10.1074/jbc.C600265200; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Vempati R. K., 2010, J BIOL CHEM, V10, P1074; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Xie W, 2009, MOL CELL, V33, P417, DOI 10.1016/j.molcel.2009.02.004; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245	58	41	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41469	41480		10.1074/jbc.M112.367847	http://dx.doi.org/10.1074/jbc.M112.367847			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	22982396	hybrid, Green Published			2022-12-25	WOS:000311887600058
J	Ma, F; Wu, D; Deng, LW; Secrest, P; Zhao, J; Varki, N; Lindheim, S; Gagneux, P				Ma, Fang; Wu, Diana; Deng, Liwen; Secrest, Patrick; Zhao, June; Varki, Nissi; Lindheim, Steven; Gagneux, Pascal			Sialidases on Mammalian Sperm Mediate Deciduous Sialylation during Capacitation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO CAPACITATION; SIALIC-ACID; LEUKOCYTIC REACTION; MOUSE SPERMATOZOA; BINDING-SITE; SURFACE; IDENTIFICATION; GANGLIOSIDE; EXPRESSION; PROTEINS	Sialic acids (Sias) mediate many biological functions, including molecular recognition during development, immune response, and fertilization. A Sia-rich glycocalyx coats the surface of sperm, allowing them to survive as allogeneic cells in the female reproductive tract despite female immunity. During capacitation, sperm lose a fraction of their Sias. We quantified shed Sia monosaccharides released from capacitated sperm and measured sperm sialidase activity. We report the presence of two sialidases (neuraminidases Neu1 and Neu3) on mammalian sperm. These are themselves shed from sperm during capacitation. Inhibiting sialidase activity interferes with sperm binding to the zona pellucida of the ovum. A survey of human sperm samples for the presence of sialidases NEU1 and NEU3 identified a lack of one or both sialidases in sperm of some male idiopathic infertility cases. The results contribute new insights into the dynamic remodeling of the sperm glycocalyx prior to fertilization.	[Ma, Fang; Deng, Liwen; Secrest, Patrick; Varki, Nissi; Gagneux, Pascal] Univ Calif San Diego, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA; [Ma, Fang; Deng, Liwen; Secrest, Patrick; Varki, Nissi; Gagneux, Pascal] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Zhao, June] Univ Calif San Diego, Dept Transgen Mouse Core, La Jolla, CA 92093 USA; [Wu, Diana; Lindheim, Steven] Univ Cincinnati, Ctr Reprod Hlth, Cincinnati, OH 45219 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University System of Ohio; University of Cincinnati	Gagneux, P (corresponding author), Univ Calif San Diego, Glycobiol Res & Training Ctr, 9500 Gilman Dr, La Jolla, CA 92093 USA.	pgagneux@ucsd.edu		Deng, Liwen/0000-0002-7984-8471; Ma, Fang/0000-0002-7781-821X	National Institutes of Health [R01 GM095882, P30 NS047101]; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM095882. This work was also supported by the G. Harold and Leila Y. Mathers Charitable Foundation.; We gratefully acknowledge the Neuroscience Microscopy Facility of the University of California, San Diego (supported by National Institutes of Health Grant P30 NS047101). We thank Stevan Springer for help with the figures.	BERNAL A, 1980, BIOL REPROD, V23, P290, DOI 10.1095/biolreprod23.2.290; Brandtzaeg P, 1997, J REPROD IMMUNOL, V36, P23, DOI 10.1016/S0165-0378(97)00061-2; Cheng MC, 1998, ANAL BIOCHEM, V260, P154, DOI 10.1006/abio.1998.2701; Chiu PCN, 2007, J BIOL CHEM, V282, P5378, DOI 10.1074/jbc.M607482200; Coutinho MF, 2012, CLIN GENET, V81, P379, DOI 10.1111/j.1399-0004.2011.01625.x; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; DAVIS BK, 1980, P NATL ACAD SCI-BIOL, V77, P1546, DOI 10.1073/pnas.77.3.1546; Drobnis E Z, 1992, Oxf Rev Reprod Biol, V14, P1; FAMILIARI G, 1980, ACTA BIOL ACAD SCI H, V31, P57; FOCARELLI R, 1995, HUM REPROD, V10, P2755, DOI 10.1093/oxfordjournals.humrep.a135787; FOCARELLI R, 1990, J ANDROL, V11, P97; FOURNIER.S, 1973, CR SOC BIOL, V167, P1989; GANGULY S, 1976, ACTA ENDOCRINOL-COP, V81, P574, DOI 10.1530/acta.0.0810574; Velasquez JG, 2007, MOL REPROD DEV, V74, P617, DOI 10.1002/mrd.20619; Hasegawa T, 2000, J BIOL CHEM, V275, P8007, DOI 10.1074/jbc.275.11.8007; LASSALLE B, 1994, J REPROD FERTIL, V101, P703; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; MANZI AE, 1990, ANAL BIOCHEM, V188, P20, DOI 10.1016/0003-2697(90)90523-C; MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982; Miyagi T., 2012, GLYCOCONJ J IN PRESS; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Moore ML, 2007, J IMMUNOL, V178, P2651, DOI 10.4049/jimmunol.178.5.2651; MUNNE S, 1993, HUM REPROD, V8, P581, DOI 10.1093/oxfordjournals.humrep.a138100; Nixon B, 2006, BIOL REPROD, V74, P275, DOI 10.1095/biolreprod.105.044644; Osheroff JE, 1999, MOL HUM REPROD, V5, P1017, DOI 10.1093/molehr/5.11.1017; PANDYA IJ, 1985, FERTIL STERIL, V43, P417; Pang PC, 2011, SCIENCE, V333, P1761, DOI 10.1126/science.1207438; Ram S, 1998, J EXP MED, V187, P743, DOI 10.1084/jem.187.5.743; Schauer R, 2004, ZOOLOGY, V107, P49, DOI 10.1016/j.zool.2003.10.002; SCHAUER R, 1982, ADV CARBOHYD CHEM BI, V40, P131, DOI 10.1016/S0065-2318(08)60109-2; Schroter S, 1999, J BIOL CHEM, V274, P29862, DOI 10.1074/jbc.274.42.29862; Schroter S, 1999, HUM REPROD UPDATE, V5, P302, DOI 10.1093/humupd/5.4.302; Shetty J, 2001, ELECTROPHORESIS, V22, P3053, DOI 10.1002/1522-2683(200108)22:14<3053::AID-ELPS3053>3.0.CO;2-K; Singavarapu R, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-98; SRIVASTAVA PN, 1970, BIOCHEM BIOPH RES CO, V39, P575, DOI 10.1016/0006-291X(70)90242-1; Stamatos NM, 2010, J LEUKOCYTE BIOL, V88, P1227, DOI 10.1189/jlb.1209776; Tash JS, 1998, BIOCHEM BIOPH RES CO, V251, P557, DOI 10.1006/bbrc.1998.9516; THOMPSON LA, 1992, AM J REPROD IMMUNOL, V28, P85, DOI 10.1111/j.1600-0897.1992.tb00765.x; Tijani HA, 2010, HUM FERTIL, V13, P226, DOI 10.3109/14647273.2010.533811; TOSHIMORI K, 1991, ARCH ANDROLOGY, V27, P79, DOI 10.3109/01485019108987656; Varki A, 2009, ESSENTIALS GLYCOBIOL, P199; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Wang JF, 2009, J IMMUNOL, V182, P4036, DOI 10.4049/jimmunol.0802981; Yamauchi Y, 2007, BIOL REPROD, V77, P636, DOI 10.1095/biolreprod.107.062406; Yudin AI, 2005, BIOL REPROD, V73, P1243, DOI 10.1095/biolreprod.105.042432	45	48	54	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.380584	http://dx.doi.org/10.1074/jbc.M112.380584			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989879	hybrid, Green Published			2022-12-25	WOS:000310642200041
J	Wu, ZT; Yang, M; Liu, HJ; Guo, HC; Wang, Y; Cheng, H; Chen, LY				Wu, Zhaoting; Yang, Meng; Liu, Hongjie; Guo, Hongchao; Wang, Yuan; Cheng, Hong; Chen, Lingyi			Role of Nuclear Receptor Coactivator 3 (Ncoa3) in Pluripotency Maintenance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; TRANSCRIPTIONAL COACTIVATOR; GENE-EXPRESSION; SELF-RENEWAL; PROTEIN METHYLTRANSFERASE; SRC-3/AIB1 COACTIVATOR; P160 COACTIVATORS; HORMONE RECEPTOR; OCT4 EXPRESSION; MOUSE EMBRYOS	Nuclear receptors, including Esrrb, Dax1, and Nr5a2, have been shown to be involved in pluripotency maintenance. Yet, the role of their coactivators in mouse embryonic stem cells remains unexplored. Here, we demonstrated that the nuclear receptor coactivator 3 (Ncoa3) is essential for pluripotency maintenance. Knockdown of Ncoa3 not only compromises the expression of pluripotency markers but also impairs in vitro and in vivo differentiation potential of mouse ESCs. Ncoa3 binds to the Nanog promoter and recruits the histone acetyltransferase CREB binding protein (CBP) and the histone arginine methyltransferase CARM1 to activate Nanog expression. Moreover, glycogen synthase kinase 3 GSK3 signaling down-regulates the Ncoa3 protein level to suppress Nanog expression. Thus, Ncoa3 not only contributes to self-renewal by activating Nanog but also facilitates ESC differentiation as a break point to disrupt the core transcriptional circuitry of pluripotency.	[Wu, Zhaoting; Yang, Meng; Liu, Hongjie; Guo, Hongchao; Chen, Lingyi] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Wu, Zhaoting; Yang, Meng; Liu, Hongjie; Guo, Hongchao; Chen, Lingyi] Nankai Univ, Collaborat Innovat Ctr Tianjin Med Epigenet 2011, Tianjin 300071, Peoples R China; [Wang, Yuan] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200241, Peoples R China; [Wang, Yuan] E China Normal Univ, Sch Life Sci, Shanghai 200241, Peoples R China; [Cheng, Hong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Cell Biol, Shanghai 200031, Peoples R China	Nankai University; Nankai University; East China Normal University; East China Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Chen, LY (corresponding author), Nankai Univ, Coll Life Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.	lingyichen@nankai.edu.cn	Guo, Hongchao/AAG-8981-2020; Guo, Hongchao/AAM-4717-2020; Chen, Lingyi/G-6309-2013	Guo, Hongchao/0000-0002-8884-7358; wang, Yuan/0000-0002-0939-1269; Yang, Meng/0000-0003-3669-721X	National Natural Science Foundation of China [90919009, 31271547]; National Basic Research Program of China [2009CB941000, 2010CB833603]; Ministry of Agriculture of China [2009ZX08006-010B, 2009ZX08006-011B]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by National Natural Science Foundation of China Grant 90919009 and 31271547, by National Basic Research Program of China Grants 2009CB941000 and 2010CB833603, and by the Transgenic Program from Ministry of Agriculture of China Grants 2009ZX08006-010B and 2009ZX08006-011B.	Anafi M, 2000, MOL ENDOCRINOL, V14, P718, DOI 10.1210/me.14.5.718; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Belandia B, 2000, J BIOL CHEM, V275, P30801, DOI 10.1074/jbc.C000484200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Chen LY, 2009, CELL RES, V19, P1052, DOI 10.1038/cr.2009.79; Chen SL, 2000, GENE DEV, V14, P1209; Chen XA, 2010, MOL ENDOCRINOL, V24, P1917, DOI 10.1210/me.2010-0201; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; de Mora JF, 2000, MOL CELL BIOL, V20, P5041, DOI 10.1128/MCB.20.14.5041-5047.2000; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Guan XY, 1996, CANCER RES, V56, P3446; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Heng JCD, 2010, CELL STEM CELL, V6, P167, DOI 10.1016/j.stem.2009.12.009; Hong H, 1996, P NATL ACAD SCI USA, V93, P4948, DOI 10.1073/pnas.93.10.4948; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kelly VR, 2010, MOL ENDOCRINOL, V24, P2281, DOI 10.1210/me.2010-0133; Khalfallah O, 2009, STEM CELLS, V27, P1529, DOI 10.1002/stem.78; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Koh SS, 2001, J BIOL CHEM, V276, P1089, DOI 10.1074/jbc.M004228200; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Lu R, 2011, J BIOL CHEM, V286, P8425, DOI 10.1074/jbc.M110.202150; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Naeem H, 2007, MOL CELL BIOL, V27, P120, DOI 10.1128/MCB.00815-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2001, DEVELOPMENT, V128, P2333; Oh AS, 2008, MOL CELL BIOL, V28, P6580, DOI 10.1128/MCB.00118-08; ONATE SA, 1995, SCIENCE, V270, P1354; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Torchia J, 1997, NATURE, V387, P677, DOI 10.1038/42652; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wagner RT, 2010, STEM CELLS, V28, P1794, DOI 10.1002/stem.502; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Xie CQ, 2009, MOL ENDOCRINOL, V23, P724, DOI 10.1210/me.2008-0465; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Xu JM, 1998, SCIENCE, V279, P1922, DOI 10.1126/science.279.5358.1922; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; York B, 2010, J BIOL CHEM, V285, P38743, DOI 10.1074/jbc.R110.193367; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	53	33	35	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.373092	http://dx.doi.org/10.1074/jbc.M112.373092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977234	Green Published, hybrid			2022-12-25	WOS:000310642200062
J	Konig, M; Holzhutter, HG				Koenig, Matthias; Holzhuetter, Hermann-Georg			Kinetic Modeling of Human Hepatic Glucose Metabolism in Type 2 Diabetes Mellitus Predicts Higher Risk of Hypoglycemic Events in Rigorous Insulin Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTPRANDIAL HYPERGLYCEMIA; PYRUVATE-KINASE; GLUCAGON; GLUCONEOGENESIS; COUNTERREGULATION; SECRETION; COMPLICATIONS; SUPPRESSION; INFUSION; LOAD	A major problem in the insulin therapy of patients with diabetes type 2 (T2DM) is the increased occurrence of hypoglycemic events which, if left untreated, may cause confusion or fainting and in severe cases seizures, coma, and even death. To elucidate the potential contribution of the liver to hypoglycemia in T2DM we applied a detailed kinetic model of human hepatic glucose metabolism to simulate changes in glycolysis, gluconeogenesis, and glycogen metabolism induced by deviations of the hormones insulin, glucagon, and epinephrine from their normal plasma profiles. Our simulations reveal in line with experimental and clinical data from a multitude of studies in T2DM, (i) significant changes in the relative contribution of glycolysis, gluconeogenesis, and glycogen metabolism to hepatic glucose production and hepatic glucose utilization; (ii) decreased postprandial glycogen storage as well as increased glycogen depletion in overnight fasting and short term fasting; and (iii) a shift of the set point defining the switch between hepatic glucose production and hepatic glucose utilization to elevated plasma glucose levels, respectively, in T2DM relative to normal, healthy subjects. Intriguingly, our model simulations predict a restricted gluconeogenic response of the liver under impaired hormonal signals observed in T2DM, resulting in an increased risk of hypoglycemia. The inability of hepatic glucose metabolism to effectively counterbalance a decline of the blood glucose level becomes even more pronounced in case of tightly controlled insulin treatment. Given this Janus face mode of action of insulin, our model simulations underline the great potential that normalization of the plasma glucagon profile may have for the treatment of T2DM.	[Koenig, Matthias; Holzhuetter, Hermann-Georg] Charite, Inst Biochem, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Konig, M (corresponding author), Charite Crossover CCO, Virchowweg 6, D-10117 Berlin, Germany.	matthias.koenig@charite.de		Konig, Matthias/0000-0003-1725-179X; Holzhutter, Hermann-Georg/0000-0002-5054-6023	Federal Ministry of Education and Research (BMBF, Germany) under Virtual Liver Network VLN Grant [0315741]	Federal Ministry of Education and Research (BMBF, Germany) under Virtual Liver Network VLN Grant(Federal Ministry of Education & Research (BMBF))	This work was supported by the Federal Ministry of Education and Research (BMBF, Germany) under Virtual Liver Network VLN Grant 0315741.	Akram K, 2006, J DIABETES COMPLICAT, V20, P402, DOI 10.1016/j.jdiacomp.2005.08.005; Ali S, 2009, AM J PHYSIOL-ENDOC M, V296, pE415, DOI 10.1152/ajpendo.90887.2008; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Basu A, 2009, DIABETES CARE, V32, P866, DOI 10.2337/dc08-1826; Basu R, 2004, DIABETES, V53, P2042, DOI 10.2337/diabetes.53.8.2042; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; BEAVO JA, 1974, P NATL ACAD SCI USA, V71, P3580, DOI 10.1073/pnas.71.9.3580; Boden G, 2001, AM J PHYSIOL-ENDOC M, V280, pE23, DOI 10.1152/ajpendo.2001.280.1.E23; BOGARDUS C, 1984, J CLIN INVEST, V74, P1238, DOI 10.1172/JCI111533; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; BUTLER PC, 1991, DIABETES, V40, P73, DOI 10.2337/diabetes.40.1.73; CONSOLI A, 1989, DIABETES, V38, P550, DOI 10.2337/diabetes.38.5.550; Cryer PE, 2003, DIABETES CARE, V26, P1902, DOI 10.2337/diacare.26.6.1902; CRYER PE, 1993, AM J PHYSIOL, V264, pE149, DOI 10.1152/ajpendo.1993.264.2.E149; Cryer PE, 2007, NAT CLIN PRACT ENDOC, V3, P4, DOI 10.1038/ncpendmet0355; DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z; Degenhardt TP, 1998, CELL MOL BIOL, V44, P1139; Degn KB, 2004, DIABETES, V53, P2397, DOI 10.2337/diabetes.53.9.2397; FERRANNINI E, 1988, METABOLISM, V37, P79, DOI 10.1016/0026-0495(88)90033-9; FERY F, 1993, METABOLISM, V42, P522, DOI 10.1016/0026-0495(93)90113-3; Gastaldelli A, 2006, J CLIN ENDOCR METAB, V91, P806, DOI 10.1210/jc.2005-1159; Gastaldelli A, 2001, DIABETES, V50, P1807, DOI 10.2337/diabetes.50.8.1807; GERICH JE, 1993, BAILLIERE CLIN ENDOC, V7, P551, DOI 10.1016/S0950-351X(05)80207-1; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Henkel E, 2005, METABOLISM, V54, P1168, DOI 10.1016/j.metabol.2005.03.024; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; ISHIBASHI H, 1978, J BIOL CHEM, V253, P8767; Israelian Z, 2006, METABOLISM, V55, P593, DOI 10.1016/j.metabol.2005.11.013; Jones TW, 1998, NEW ENGL J MED, V338, P1657, DOI 10.1056/NEJM199806043382303; Knop FK, 2007, DIABETOLOGIA, V50, P797, DOI 10.1007/s00125-006-0566-z; Konig M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002577; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Lerche S, 2009, CLIN ENDOCRINOL, V71, P500, DOI 10.1111/j.1365-2265.2008.03510.x; Levy CJ, 1998, DIABETES CARE, V21, P1330, DOI 10.2337/diacare.21.8.1330; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; MITRAKOU A, 1992, NEW ENGL J MED, V326, P22, DOI 10.1056/NEJM199201023260104; MITRAKOU A, 1991, AM J PHYSIOL, V260, pE67, DOI 10.1152/ajpendo.1991.260.1.E67; MULLER WA, 1970, NEW ENGL J MED, V283, P109, DOI 10.1056/NEJM197007162830301; NAUCK MA, 1993, DIABETOLOGIA, V36, P741, DOI 10.1007/BF00401145; Nuttall FQ, 2008, DIABETES-METAB RES, V24, P438, DOI 10.1002/dmrr.863; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Segel SA, 2002, DIABETES, V51, P724, DOI 10.2337/diabetes.51.3.724; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Skyler JS, 1996, ENDOCRIN METAB CLIN, V25, P243, DOI 10.1016/S0889-8529(05)70323-6; Sloop KW, 2005, EXPERT OPIN THER TAR, V9, P593, DOI 10.1517/14728222.9.3.593; Spellman CW, 2010, J AM OSTEOPATH ASSOC, V110, pS2; Swinnen SG, 2009, DIABETES CARE, V32, pS253, DOI 10.2337/dc09-S318; VANBERKEL TJC, 1978, EUR J BIOCHEM, V92, P553; Wajngot A, 2001, METABOLISM, V50, P47, DOI 10.1053/meta.2001.19422; Woerle HJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE67, DOI 10.1152/ajpendo.00529.2004; Yan H, 2009, J PHARMACOL EXP THER, V329, P102, DOI 10.1124/jpet.108.147009	52	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36978	36989		10.1074/jbc.M112.382069	http://dx.doi.org/10.1074/jbc.M112.382069			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977253	Green Published, hybrid			2022-12-25	WOS:000310588500033
J	Rasmussen, LD; Mathiesen, ER; Kronborg, G; Pedersen, C; Gerstoft, J; Obel, N				Rasmussen, Line D.; Mathiesen, Elisabeth R.; Kronborg, Gitte; Pedersen, Court; Gerstoft, Jan; Obel, Niels			Risk of Diabetes Mellitus in Persons with and without HIV: A Danish Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							ORAL GLUCOSE-TOLERANCE; ANTIRETROVIRAL THERAPY; INSULIN-RESISTANCE; INFECTED PATIENTS; PROTEASE INHIBITORS; INDINAVIR; PREVALENCE; EXPOSURE; DENMARK	Objective: In a nationwide, population-based cohort study we assessed the risk of diabetes mellitus (DM) in HIV-infected individuals compared with the general population, and evaluated the impact of risk factors for DM in HIV-infected individuals. Methods: We identified 4,984 Danish-born HIV-infected individuals from the Danish HIV Cohort Study and a Danish born population-based age-and gender-matched comparison cohort of 19,936 individuals (study period: 1996-2009). Data on DM was obtained from the Danish National Hospital Registry and the Danish National Prescription Registry. Incidence rate ratios (IRR) and impact of risk factors including exposure to Highly Active Antiretroviral Therapy (HAART) and antiretroviral drugs were estimated by Poisson regression analyses. Results: In the period 1996-1999 risk of DM was higher in HIV-infected individuals compared to the comparison cohort (adjusted IRR: 2.83; 95%CI: 1.57-5.09), both before (adjusted IRR: 2.40; 95%CI: 1.03-5.62) and after HAART initiation (adjusted IRR: 3.24; 95% CI: 1.42-7.39). In the period 1999-2010 the risk of DM in HIV-infected individuals did not differ from that of the comparison cohort (adjusted IRR: 0.90; 95% CI: 0.72-1.13), although the risk was decreased before HAART-initiation (adjusted IRR: 0.45; 95% CI: 0.21-0.96). Increasing age, BMI and the presence of lipoatrophy increased the risk of DM, as did exposure to indinavir, saquinavir, stavudine and didanosine. Conclusion: Native HIV-infected individuals do not have an increased risk of developing DM compared to a native background population after year 1998. Some antiretroviral drugs, not used in modern antiretroviral treatment, seem to increase the risk of DM.	[Rasmussen, Line D.; Pedersen, Court] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Mathiesen, Elisabeth R.] Rigshosp, Dept Endocrinol, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Kronborg, Gitte] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Gerstoft, Jan; Obel, Niels] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark	University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Rasmussen, LD (corresponding author), Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark.	linedahlerup@hotmail.com		Mathiesen, elisabeth/0000-0003-3279-0863; Obel, Niels/0000-0002-5031-0045	Preben and Anna Simonsen's Foundation; NOVO Nordic Foundation; University of Southern Denmark; Clinical Institute of Copenhagen University; Roche; Bristol-Myers Squibb; Merck Sharp Dohme; GlaxoSmithKline; Abbott; Boehringer Ingelheim; Janssen-Cilag; Swedish Orphan Drugs; Pharmasia	Preben and Anna Simonsen's Foundation; NOVO Nordic Foundation(Novo Nordisk Foundation); University of Southern Denmark; Clinical Institute of Copenhagen University; Roche(Roche Holding); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck Sharp Dohme(Merck & Company); GlaxoSmithKline(GlaxoSmithKline); Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Swedish Orphan Drugs; Pharmasia	The authors thank Preben and Anna Simonsen's Foundation, the NOVO Nordic Foundation, University of Southern Denmark and the Clinical Institute of Copenhagen University for financial support of the Danish HIV cohort study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors read the journal's policy and declare the following potential conflicts of interest. N. Obel has received research funding from Roche, Bristol-Myers Squibb, Merck Sharp & Dohme, GlaxoSmithKline, Abbott, Boehringer Ingelheim, Janssen-Cilag and Swedish Orphan Drugs. C. Pedersen has received research funding from Abbott, Roche, Bristol-Myers Squibb, Merck Sharp & Dohme, GlaxoSmithKline, Swedish Orphan Drugs and Boehringer Ingelheim. J. Gerstoft has received research funding from Abbott, Roche, Bristol-Myers Squibb, Mecrk Sharp & Dohme, Pharmasia, GlaxoSmithKline, Swedish Orphan Drugs and Boehringer Ingelheim. E. R. Mathiesen, G. Kronborg and L. D. Rasmussen report no conflicts of interest. The potential conflicts of interest described above do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Andersen TF, 1999, DAN MED BULL, V46, P263; Brambilla AM, 2003, AIDS, V17, P1993, DOI 10.1097/00002030-200309050-00022; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Brown TT, 2005, AIDS, V19, P1375, DOI 10.1097/01.aids.0000181011.62385.91; Butt AA, 2009, AIDS, V23, P1227, DOI 10.1097/QAD.0b013e32832bd7af; Calza L, 2004, METAB SYNDR RELAT D, V2, P241, DOI 10.1089/met.2004.2.241; Capeau J, 2012, AIDS, V26, P303, DOI 10.1097/QAD.0b013e32834e8776; Danoff A, 2005, JAIDS-J ACQ IMM DEF, V39, P55, DOI 10.1097/01.qai.0000147659.80642.5a; De Wit S, 2008, DIABETES CARE, V31, P1224, DOI 10.2337/dc07-2013; Dube MP, 1997, LANCET, V350, P713, DOI 10.1016/S0140-6736(05)63513-1; Glumer C, 2004, DIABETES CARE, V27, P727, DOI 10.2337/diacare.27.3.727; Grinspoon S, 2003, CLIN INFECT DIS, V37, pS85, DOI 10.1086/375885; HARRIS MI, 1991, DIABETES CARE, V14, P639, DOI 10.2337/diacare.14.7.639; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hommel K, 2010, NEPHROL DIAL TRANSPL, V25, P947, DOI 10.1093/ndt/gfp571; Howard AA, 2010, JAIDS-J ACQ IMM DEF, V54, P152, DOI 10.1097/QAI.0b013e3181d0c911; Idiculla J, 2011, INT J GEN MED, V4, P73, DOI 10.2147/IJGM.S15818; Justman JE, 2003, JAIDS-J ACQ IMM DEF, V32, P298, DOI 10.1097/00126334-200303010-00009; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Ledergerber B, 2007, CLIN INFECT DIS, V45, P111, DOI 10.1086/518619; Lo YC, 2009, HIV MED, V10, P302, DOI 10.1111/j.1468-1293.2008.00687.x; Lohse N, 2005, SCAND J INFECT DIS, V37, P338, DOI 10.1080/00365540510031692; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Lumpkin M. M., 1997, REPORTS DIABETES HYP; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Noor MA, 2002, AIDS, V16, pF1, DOI 10.1097/00002030-200203290-00002; Noor MA, 2001, AIDS, V15, pF11, DOI 10.1097/00002030-200105040-00001; Obel N, 2009, INT J EPIDEMIOL, V38, P1202, DOI 10.1093/ije/dyn192; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Petersen I, 2011, DIABETOLOGIA, V54, P2016, DOI 10.1007/s00125-011-2128-2; Polsky S, 2011, ANTIVIR THER, V16, P181, DOI 10.3851/IMP1711; Safrin S, 1999, AIDS, V13, P2493, DOI 10.1097/00002030-199912240-00002; Statistics Denmark, POP EL; Tien PC, 2007, AIDS, V21, P1739, DOI 10.1097/QAD.0b013e32827038d0; Tsiodras S, 2000, ARCH INTERN MED, V160, P2050, DOI 10.1001/archinte.160.13.2050; Visnegarwala F, 2005, J INFECTION, V50, P331, DOI 10.1016/j.jinf.2004.06.001; Walli R, 1998, AIDS, V12, pF167, DOI 10.1097/00002030-199815000-00001	37	88	91	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44575	10.1371/journal.pone.0044575	http://dx.doi.org/10.1371/journal.pone.0044575			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984529	Green Submitted, Green Published, gold			2022-12-25	WOS:000308738500067
J	Bystrom, C; Sheng, SJ; Zhang, K; Caulfield, M; Clarke, NJ; Reitz, R				Bystrom, Cory; Sheng, Shijun; Zhang, Ke; Caulfield, Michael; Clarke, Nigel J.; Reitz, Richard			Clinical Utility of Insulin-Like Growth Factor 1 and 2; Determination by High Resolution Mass Spectrometry	PLOS ONE			English	Article							IGF-I ASSAYS; REFERENCE VALUES; PROTEINS; PLASMA; SERUM; RADIOIMMUNOASSAY; QUANTIFICATION; RADIORECEPTOR; THYROGLOBULIN; HYPOGLYCEMIA	Measurement of insulin-like growth factor-1 (IGF-I) has utility for the diagnosis and management of growth disorders, but inter-assay comparison of results has been complicated by a multitude of reference standards, antibodies, detection methods, and pre-analytical preparation strategies. We developed a quantitative LC-MS method for intact IGF-I, which has advantages in throughput and complexity when compared to mass spectrometric approaches that rely on stable isotope dilution analysis of tryptic peptides. Since the method makes use of full-scan data, the assay was easily extended to provide quantitative measurement of IGF-II using the same assay protocol. The validated LC-MS assay for IGF-I and IGF-II provides accurate results across the pediatric and adult reference range and is suitable for clinical use.	[Bystrom, Cory] Cleveland Heart Lab, Cleveland, OH USA; [Sheng, Shijun] Thermo Sci, San Jose, CA USA; [Zhang, Ke; Caulfield, Michael; Clarke, Nigel J.; Reitz, Richard] Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA	Nichols Institute	Bystrom, C (corresponding author), Cleveland Heart Lab, Cleveland, OH USA.	Richard.e.reitz@questdiagnostics.com			Quest Diagnostics	Quest Diagnostics	Funding for this work was provided by Quest Diagnostics. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The manuscript was reviewed by IP attorneys before providing approval for publication. Patent rights for the methods used in this research have been applied for.	Addona TA, 2009, NAT BIOTECHNOL, V27, P633, DOI 10.1038/nbt.1546; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Anderson NL, 2004, J PROTEOME RES, V3, P235, DOI 10.1021/pr034086h; Brabant G, 2003, HORM RES, V60, P53, DOI 10.1159/000071871; BREIER BH, 1991, J ENDOCRINOL, V128, P347, DOI 10.1677/joe.0.1280347; Bystrom CE, 2011, ANAL CHEM, V83, P9005, DOI 10.1021/ac201800g; Clemmons DR, 2007, PITUITARY, V10, P121, DOI 10.1007/s11102-007-0032-z; COTTERILL AM, 1992, J CLIN ENDOCR METAB, V74, P56, DOI 10.1210/jc.74.1.56; DAUGHADAY WH, 1980, J CLIN ENDOCR METAB, V51, P781, DOI 10.1210/jcem-51-4-781; Elmlinger MW, 2005, CLIN LAB, V51, P145; Frystyk J, 2010, GROWTH HORM IGF RES, V20, P8, DOI 10.1016/j.ghir.2009.09.004; Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100; Hoofnagle AN, 2008, CLIN CHEM, V54, P1796, DOI 10.1373/clinchem.2008.109652; HORNER JM, 1978, J CLIN ENDOCR METAB, V47, P1287, DOI 10.1210/jcem-47-6-1287; Krebs A, 2008, CLIN CHEM LAB MED, V46, P1776, DOI 10.1515/CCLM.2008.349; Lofqvist C, 2001, J CLIN ENDOCR METAB, V86, P5870, DOI 10.1210/jc.86.12.5870; MORAND K, 1993, RAPID COMMUN MASS SP, V7, P738, DOI 10.1002/rcm.1290070811; Nedelkov D, 2003, FEBS LETT, V536, P130, DOI 10.1016/S0014-5793(03)00042-5; Pink D, 2005, J CLIN ONCOL, V23, P6809, DOI 10.1200/JCO.2005.02.4828; Renehan AG, 2003, GROWTH HORM IGF RES, V13, P341, DOI 10.1016/S1096-6374(03)00112-6; Spencer CA, 1998, J CLIN ENDOCR METAB, V83, P1121, DOI 10.1210/jc.83.4.1121; Wilton P, 1992, Acta Paediatr Suppl, V383, P137; Yu H, 1999, J CLIN LAB ANAL, V13, P166, DOI 10.1002/(SICI)1098-2825(1999)13:4<166::AID-JCLA5>3.3.CO;2-O; ZAPF J, 1981, J CLIN INVEST, V68, P1321, DOI 10.1172/JCI110379; Zhang NR, 2009, RAPID COMMUN MASS SP, V23, P1085, DOI 10.1002/rcm.3975	25	54	57	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43457	10.1371/journal.pone.0043457	http://dx.doi.org/10.1371/journal.pone.0043457			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984427	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700021
J	Gilbert, M; Jambal, L; Karesh, WB; Fine, A; Shiilegdamba, E; Dulam, P; Sodnomdarjaa, R; Ganzorig, K; Batchuluun, D; Tseveenmyadag, N; Bolortuya, P; Cardona, CJ; Leung, CYH; Peiris, JSM; Spackman, E; Swayne, DE; Joly, DO				Gilbert, Martin; Jambal, Losolmaa; Karesh, William B.; Fine, Amanda; Shiilegdamba, Enkhtuvshin; Dulam, Purevtseren; Sodnomdarjaa, Ruuragchaa; Ganzorig, Khuukhenbaatar; Batchuluun, Damdinjav; Tseveenmyadag, Natsagdorj; Bolortuya, Purevsuren; Cardona, Carol J.; Leung, Connie Y. H.; Peiris, J. S. Malik; Spackman, Erica; Swayne, David E.; Joly, Damien O.			Highly Pathogenic Avian Influenza Virus among Wild Birds in Mongolia	PLOS ONE			English	Article							TIME RT-PCR; H5N1 VIRUSES; HPAI H5N1; HONG-KONG; WATERFOWL; DUCKS; HEMAGGLUTININ; OUTBREAK; GEESE; INFECTIONS	Mongolia combines a near absence of domestic poultry, with an abundance of migratory waterbirds, to create an ideal location to study the epidemiology of highly pathogenic avian influenza virus (HPAIV) in a purely wild bird system. Here we present the findings of active and passive surveillance for HPAIV subtype H5N1 in Mongolia from 2005-2011, together with the results of five outbreak investigations. In total eight HPAIV outbreaks were confirmed in Mongolia during this period. Of these, one was detected during active surveillance employed by this project, three by active surveillance performed by Mongolian government agencies, and four through passive surveillance. A further three outbreaks were recorded in the neighbouring Tyva Republic of Russia on a lake that bisects the international border. No HPAIV was isolated (cultured) from 7,855 environmental fecal samples (primarily from ducks), or from 2,765 live, clinically healthy birds captured during active surveillance (primarily shelducks, geese and swans), while four HPAIVs were isolated from 141 clinically ill or dead birds located through active surveillance. Two low pathogenic avian influenza viruses (LPAIV) were cultured from ill or dead birds during active surveillance, while environmental feces and live healthy birds yielded 56 and 1 LPAIV respectively. All Mongolian outbreaks occurred in 2005 and 2006 (clade 2.2), or 2009 and 2010 (clade 2.3.2.1); all years in which spring HPAIV outbreaks were reported in Tibet and/or Qinghai provinces in China. The occurrence of outbreaks in areas deficient in domestic poultry is strong evidence that wild birds can carry HPAIV over at least moderate distances. However, failure to detect further outbreaks of clade 2.2 after June 2006, and clade 2.3.2.1 after June 2010 suggests that wild birds migrating to and from Mongolia may not be competent as indefinite reservoirs of HPAIV, or that HPAIV did not reach susceptible populations during our study.	[Gilbert, Martin; Jambal, Losolmaa; Karesh, William B.; Fine, Amanda; Shiilegdamba, Enkhtuvshin; Joly, Damien O.] Wildlife Conservat Soc, Bronx, NY USA; [Karesh, William B.] EcoHealth Alliance, New York, NY USA; [Dulam, Purevtseren; Sodnomdarjaa, Ruuragchaa; Ganzorig, Khuukhenbaatar; Batchuluun, Damdinjav] Avian Influenza Sect, State Cent Vet Lab, Transboundary Anim Dis Lab, Ulaanbaatar, Mongolia; [Tseveenmyadag, Natsagdorj] Mongolian Acad Sci, Inst Biol, Ulaanbaatar, Mongolia; [Bolortuya, Purevsuren] Natl Emergency Management Agcy, World Bank, Avian & Human Influenza Project, Ulaanbaatar, Mongolia; [Cardona, Carol J.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Leung, Connie Y. H.; Peiris, J. S. Malik] Univ Hong Kong, Sch Publ Hlth, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Spackman, Erica; Swayne, David E.] USDA ARS, SE Poultry Res Lab, Athens, GA 30605 USA	Wildlife Conservation Society; Mongolian Academy of Sciences; The World Bank; University of Minnesota System; University of Minnesota Twin Cities; University of Hong Kong; United States Department of Agriculture (USDA)	Gilbert, M (corresponding author), Wildlife Conservat Soc, Bronx, NY USA.	mgilbert@wcs.org	Swayne, David/AAP-7166-2020; Karesh, William/AAU-9084-2020; Peiris, Joseph Sriyal Malik/C-4380-2009	Karesh, William/0000-0001-6042-2860; Gilbert, Martin/0000-0002-9930-4383; Spackman, Erica/0000-0002-4935-2360; Shiilegdamba, Enkhtuvshin/0000-0003-1316-0591; Leung, Connie YH/0000-0003-1102-4684; Peiris, Joseph Sriyal Malik/0000-0001-8217-5995; Swayne, David/0000-0001-7472-1992	National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services [HHSN266200700007C, HHSN266200700009C, HHSN266200700005C]; United States Agency for International Development (USAID); World Bank; Food and Agriculture Organization of the United Nations; Dunemere private foundation	National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); World Bank(The World Bank India); Food and Agriculture Organization of the United Nations; Dunemere private foundation	Support for this project was provided by the National Institute of Allergy and Infectious Disease, National Institutes of Health, Department of Health and Human Services (Contracts HHSN266200700007C, HHSN266200700009C, and HHSN266200700005C), the United States Agency for International Development (USAID), the World Bank, and the Food and Agriculture Organization of the United Nations. DOJ was supported by generous funding from the Dunemere private foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Batbayar Nyambayar, 2011, Wildfowl, V61, P90; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Chan S., 2004, IMPORTANT BIRD AREAS; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; Cui P, 2011, J ORNITHOL, V152, P83, DOI 10.1007/s10336-010-0552-6; Das A, 2006, J CLIN MICROBIOL, V44, P3065, DOI 10.1128/JCM.00639-06; Delaney S, 2005, GUIDELINES PARTICIPA; Ducatez MF, 2007, EMERG INFECT DIS, V13, P611, DOI 10.3201/eid1304.061356; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; FAO, 2007, GRIDDED LIVESTOCK WO; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Hawkes LA, 2011, P NATL ACAD SCI USA, V108, P9516, DOI 10.1073/pnas.1017295108; HINSHAW VS, 1985, B WORLD HEALTH ORGAN, V63, P711; Islam MR, 2012, TRANSBOUND EMERG DIS, V59, P460, DOI 10.1111/j.1865-1682.2011.01297.x; Karesh WB, 2007, J WILDLIFE DIS, V43, pS55; Keawcharoen J, 2005, ACTA VIROL, V49, P277; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Komar N, 2008, EMERG INFECT DIS, V14, P1176, DOI 10.3201/eid1407.080161; Kwon YK, 2005, J WILDLIFE DIS, V41, P618, DOI 10.7589/0090-3558-41.3.618; Lee DH, 2011, J WILDLIFE DIS, V47, P994, DOI 10.7589/0090-3558-47.4.994; Lei FM, 2007, AVIAN DIS, V51, P568, DOI 10.1637/0005-2086(2007)51[568:COHIVI]2.0.CO;2; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Meyburg BU, 2010, RAPTORS SCI CONSERVA, P52; Minton Clive, 2005, Stilt, V48, P42; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Newman SH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005729; Prosser DJ, 2009, IBIS, V151, P568, DOI 10.1111/j.1474-919X.2009.00932.x; Reid SM, 2011, TRANSBOUND EMERG DIS, V58, P76, DOI 10.1111/j.1865-1682.2010.01175.x; Runstadler JA, 2007, ARCH VIROL, V152, P1901, DOI 10.1007/s00705-007-0994-1; Siembieda JL, 2010, VECTOR-BORNE ZOONOT, V10, P793, DOI 10.1089/vbz.2009.0095; Sims L, 2005, TCPRAS3007 UN FAO, P1; Smith GJD, 2009, EMERG INFECT DIS, V15, P402, DOI 10.3201/eid1503.081190; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2003, AVIAN DIS, V47, P1087, DOI 10.1637/0005-2086-47.s3.1087; Spackman E, 2003, AVIAN DIS, V47, P1079, DOI 10.1637/0005-2086-47.s3.1079; Spackman E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-190; Spackman Erica, 2008, V436, P27, DOI 10.1007/978-1-59745-279-3_5; Stallknecht DE, 2009, REV SCI TECH OIE, V28, P59; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Suarez DL, 1999, J VIROL, V73, P3567, DOI 10.1128/JVI.73.5.3567-3573.1999; SWAYNE D., 1998, LAB MANUAL ISOLATION, P150; Takekawa JY, 2010, AVIAN DIS, V54, P466, DOI 10.1637/8914-043009-Reg.1; Wingard J., 2006, MONGOLIA DISCUSSION; World Health Organization, 2011, UPD UN NOM SYST HIGH; World Health Organization, 2011, ARCH TABL CUM NUMB C; Zahler P, 2007, POVERTY HLTH ECOSYST, P89	50	32	32	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44097	10.1371/journal.pone.0044097	http://dx.doi.org/10.1371/journal.pone.0044097			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984464	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700044
J	Herzer, K; Carbow, A; Sydor, S; Sowa, JP; Biesterfeld, S; Hofmann, TG; Galle, PR; Gerken, G; Canbay, A				Herzer, Kerstin; Carbow, Anna; Sydor, Svenja; Sowa, Jan-Peter; Biesterfeld, Stefan; Hofmann, Thomas-Georg; Galle, Peter-Robert; Gerken, Guido; Canbay, Ali			Deficiency of the Promyelocytic Leukemia Protein Fosters Hepatitis C-Associated Hepatocarcinogenesis in Mice	PLOS ONE			English	Article							HUMAN HEPATOMA-CELLS; PML NUCLEAR-BODIES; LIVER-CANCER; APOPTOSIS; VIRUS; TRAIL; EXPRESSION; PATHWAYS; GROWTH; BETA	Overwhelming lines of epidemiological evidence have indicated that persistent infection with hepatitis C virus (HCV) is a major risk for the development of hepatocellular carcinoma (HCC). We have recently shown that HCV core protein mediates functional inactivation of the promyelocytic leukemia (PML) tumor suppressor pathway. However, the role of PML in HCC development yet remains unclear. To clarify the function of PML in liver carcinogenesis and HCV-associated pathogenesis we crossed PML-deficient mice with HCV transgene (HCV-Tg) expressing mice and treated the resulting animals with DEN/Phenobarbital, an established protocol for liver carcinogenesis. Seven months after treatment, livers were examined macroscopically and histologically. Genetic depletion of the tumor suppressor PML coincided with an increase in hepatocyte proliferation, resulting in development of multiple dysplastic nodules in 100% of the PML-deficient livers and of HCCs in 53%, establishing a tumor suppressive function of PML in the liver. In animals expressing the HCV-transgene in PML-deficient background, HCC development occurred even in 73%, while only 7% of their wildtype littermates developed HCC. The neoplastic nature of the tumors was confirmed by histology and expression of the HCC marker glutamine synthetase. Several pro-and antiapoptotic factors were tested for differential expression and liver carcinogenesis was associated with impaired expression of the proapoptotic molecule TRAIL in PML-deficient mice. In conclusion, this study provides first in vivo evidence that the tumor suppressor PML acts as an important barrier in liver carcinogenesis and HCV-dependent liver pathology.	[Herzer, Kerstin; Sydor, Svenja; Sowa, Jan-Peter; Gerken, Guido; Canbay, Ali] Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany; [Carbow, Anna] Spital STS Ag, Dept Surg, Zweisimmern, Switzerland; [Biesterfeld, Stefan] Univ Hosp Dusseldorf, Dept Cytopathol, Dusseldorf, Germany; [Hofmann, Thomas-Georg] Univ Heidelberg Alliance, Deutsch Krebsforschungszentrum, Zentrum Mol Biol, Res Grp Cellular Senescence, Heidelberg, Germany; [Galle, Peter-Robert] Johannes Gutenberg Univ Mainz, Dept Med 1, Univ Med, D-6500 Mainz, Germany	University of Duisburg Essen; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz	Herzer, K (corresponding author), Univ Hosp, Dept Gastroenterol & Hepatol, Essen, Germany.	kerstin.herzer@uk-essen.de	Sydor, Svenja/AAV-9951-2021; Sydor, Svenja/ABG-6622-2020; Galle, Peter/ABE-2872-2021; Canbay, Ali/AAL-9620-2020; Galle, Peter R/T-5292-2018; Sowa, Jan-Peter/AAQ-6318-2020	Sydor, Svenja/0000-0002-1349-8309; Galle, Peter/0000-0001-8294-0992; Galle, Peter R/0000-0001-8294-0992; Canbay, Ali/0000-0001-6069-7899; Sowa, Jan-Peter/0000-0003-2943-0015; Gerken, Guido/0000-0001-6734-5001	Deutsche Krebshilfe [108990]; Deutsche Forschungsgemeinschaft (DFG) [267/8-1]; Wilhelm Laupitz Foundation	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Wilhelm Laupitz Foundation	Funding provided by Deutsche Krebshilfe grant no. 108990. This work was further supported by the Deutsche Forschungsgemeinschaft (DFG, grant 267/8-1), and the Wilhelm Laupitz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzola Monica, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006926; Bartenschlager R, TRENDS MICROBIOL, V19, P95; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Castello G, CLIN IMMUNOL, V134, P237; Dechene A, HEPATOLOGY, V52, P1008; Everett RD, 2001, ONCOGENE, V20, P7266, DOI 10.1038/sj.onc.1204759; Gieseler RK, J VIRAL HEPAT; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Herr I, 2007, HEPATOLOGY, V46, P266, DOI 10.1002/hep.21740; Herzer K, 2007, LIVER INT, V27, P293, DOI 10.1111/j.1478-3231.2006.01422.x; Herzer K, 2005, CANCER RES, V65, P10830, DOI 10.1158/0008-5472.CAN-05-0880; Herzer K, 2005, HEPATOLOGY, V42, P183, DOI 10.1002/hep.20757; Herzer K, 2009, CANCER RES, V69, P855, DOI 10.1158/0008-5472.CAN-08-2831; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Jacobson IM, CLIN GASTROENTEROL H, V8, P924; Jacobson IM, CLIN GASTROENTEROL H, V8, pe117; Kanzler S, 2001, ONCOGENE, V20, P5015, DOI 10.1038/sj.onc.1204544; Koike K, 2007, J GASTROEN HEPATOL, V22, pS108, DOI 10.1111/j.1440-1746.2006.04669.x; Koike Kazuhiko, 2005, Clin Gastroenterol Hepatol, V3, pS132, DOI 10.1016/S1542-3565(05)00700-7; Krieghoff-Henning E, 2008, BBA-MOL CELL RES, V1783, P2185, DOI 10.1016/j.bbamcr.2008.07.002; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; McGivern DR, ONCOGENE, V30, P1969; Nash KL, WORLD J GASTROENTERO, V16, P4061; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Salomoni P, 2008, CELL RES, V18, P620, DOI 10.1038/cr.2008.58; Trivedi PJ, DIG DIS SCI, V56, P276; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wang ZG, 1998, SCIENCE, V279, P1547; Washburn ML, GASTROENTEROLOGY, V140, P1334; Worns MA, DIG LIVER DIS S3, V42, pS302	31	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44474	10.1371/journal.pone.0044474	http://dx.doi.org/10.1371/journal.pone.0044474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984515	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700063
J	Mewes, A; Franke, H; Singer, D				Mewes, Agneta; Franke, Heike; Singer, David			Organotypic Brain Slice Cultures of Adult Transgenic P301S Mice-A Model for Tauopathy Studies	PLOS ONE			English	Article							SURVIVAL-PROMOTING PEPTIDE; LONG-TERM POTENTIATION; CELL-DEATH; IN-VITRO; MICROGLIAL ACTIVATION; HIPPOCAMPAL SLICES; POSTISCHEMIC HYPOTHERMIA; ALZHEIMERS-DISEASE; MILD HYPOTHERMIA; CEREBRAL-CORTEX	Background: Organotypic brain slice cultures represent an excellent compromise between single cell cultures and complete animal studies, in this way replacing and reducing the number of animal experiments. Organotypic brain slices are widely applied to model neuronal development and regeneration as well as neuronal pathology concerning stroke, epilepsy and Alzheimer's disease (AD). AD is characterized by two protein alterations, namely tau hyperphosphorylation and excessive amyloid beta deposition, both causing microglia and astrocyte activation. Deposits of hyperphosphorylated tau, called neurofibrillary tangles (NFTs), surrounded by activated glia are modeled in transgenic mice, e. g. the tauopathy model P301S. Methodology/Principal Findings: In this study we explore the benefits and limitations of organotypic brain slice cultures made of mature adult transgenic mice as a potential model system for the multifactorial phenotype of AD. First, neonatal (P1) and adult organotypic brain slice cultures from 7- to 10-month-old transgenic P301S mice have been compared with regard to vitality, which was monitored with the lactate dehydrogenase (LDH)- and the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assays over 15 days. Neonatal slices displayed a constant high vitality level, while the vitality of adult slice cultures decreased significantly upon cultivation. Various preparation and cultivation conditions were tested to augment the vitality of adult slices and improvements were achieved with a reduced slice thickness, a mild hypothermic cultivation temperature and a cultivation CO2 concentration of 5%. Furthermore, we present a substantial immunohistochemical characterization analyzing the morphology of neurons, astrocytes and microglia in comparison to neonatal tissue. Conclusion/Significance: Until now only adolescent animals with a maximum age of two months have been used to prepare organotypic brain slices. The current study provides evidence that adult organotypic brain slice cultures from 7- to 10-month-old mice independently of the transgenic modification undergo slow programmed cell death, caused by a dysfunction of the neuronal repair systems.	[Mewes, Agneta; Singer, David] Univ Leipzig, Ctr Biotechnol & Biomed BBZ, Inst Bioanalyt Chem, Leipzig, Germany; [Franke, Heike] Univ Leipzig, Rudolf Boehm Inst Pharmacol & Toxicol, Leipzig, Germany	Leipzig University; Leipzig University	Mewes, A (corresponding author), Univ Leipzig, Ctr Biotechnol & Biomed BBZ, Inst Bioanalyt Chem, Leipzig, Germany.	david.singer@bbz.uni-leipzig.de			European Social Fund (ESF) [080937179]; initiative of the European Union; Free State of Saxony	European Social Fund (ESF)(European Social Fund (ESF)); initiative of the European Union; Free State of Saxony	The study was supported by the European Social Fund (ESF, grand number 080937179), an initiative of the European Union and the Free State of Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamchik Y, 2000, BRAIN RES PROTOC, V5, P153, DOI 10.1016/S1385-299X(00)00007-6; Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; Allen B, 2002, J NEUROSCI, V22, P9340; Barros LF, 2010, BRAIN RES REV, V63, P149, DOI 10.1016/j.brainresrev.2009.10.002; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; BINGMANN D, 1982, EXP BRAIN RES, V48, P89; Braithwaite SP, 2010, NEUROBIOL DIS, V39, P311, DOI 10.1016/j.nbd.2010.04.015; Chechneva O, 2005, NEUROSCIENCE, V136, P343, DOI 10.1016/j.neuroscience.2005.07.058; Cronin M, 2006, FRONT BIOSCI-LANDMRK, V11, P2967, DOI 10.2741/2025; Cunningham TJ, 1998, J NEUROSCI, V18, P7047; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; DELRIO JA, 1991, NEUROSCIENCE, V43, P335, DOI 10.1016/0306-4522(91)90298-3; DEROUICHE A, 1993, EUR J NEUROSCI, V5, P122, DOI 10.1111/j.1460-9568.1993.tb00477.x; FERRER I, 1990, NEUROSCIENCE, V39, P451, DOI 10.1016/0306-4522(90)90281-8; FINLAY BL, 1992, J NEUROBIOL, V23, P1159, DOI 10.1002/neu.480230908; Finley M, 2004, BRAIN RES, V1001, P125, DOI 10.1016/j.brainres.2003.12.009; Franke H, 2003, NEUROCHEM INT, V42, P431, DOI 10.1016/S0197-0186(02)00134-1; Frantseva MV, 1999, J NEUROSCI METH, V89, P25, DOI 10.1016/S0165-0270(99)00030-8; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0; Gallagher CN, 2009, BRAIN, V132, P2839, DOI 10.1093/brain/awp202; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Greiner C, 1998, BRAIN RES, V786, P267, DOI 10.1016/S0006-8993(97)01465-0; Hailer NP, 2001, EUR J NEUROSCI, V14, P315, DOI 10.1046/j.0953-816x.2001.01649.x; Hailer NP, 1996, GLIA, V18, P319, DOI 10.1002/(SICI)1098-1136(199612)18:4<319::AID-GLIA6>3.0.CO;2-S; Halliday G, 2000, CLIN EXP PHARMACOL P, V27, P1, DOI 10.1046/j.1440-1681.2000.03200.x; Hassen GW, 2004, BRAIN RES PROTOC, V13, P135, DOI 10.1016/j.brainresprot.2004.03.004; HAWKINS RA, 1971, BIOCHEM J, V122, P13, DOI 10.1042/bj1220013; Heine C, 2012, NEUROSIGNAL IN PRESS; Huh PW, 2000, J NEUROSURG, V92, P91, DOI 10.3171/jns.2000.92.1.0091; Hulse RE, 2001, GLIA, V33, P169, DOI 10.1002/1098-1136(200102)33:2<169::AID-GLIA1016>3.0.CO;2-B; KLEINBERGERDORON N, 1990, BRAIN RES, V533, P239, DOI 10.1016/0006-8993(90)91345-H; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Lee VM, 1989, LOGIC CIRCUITS CARBO, V251, P675; Legradi A, 2011, BRAIN RES BULL, V84, P39, DOI 10.1016/j.brainresbull.2010.10.008; Leutgeb JK, 2005, NEUROSCIENCE, V131, P601, DOI 10.1016/j.neuroscience.2004.12.002; Leutgeb JK, 2003, J NEUROSCI METH, V130, P19, DOI 10.1016/S0165-0270(03)00228-0; Liang L, 2004, FEBS LETT, V566, P261, DOI 10.1016/j.febslet.2004.04.047; Lindroos MM, 2005, INT J DEV NEUROSCI, V23, P65, DOI 10.1016/j.ijdevneu.2004.08.003; Liu B, 2001, J NEUROCHEM, V77, P182, DOI 10.1046/j.1471-4159.2001.t01-1-00216.x; Liu D, 1999, MOL BRAIN RES, V68, P29, DOI 10.1016/S0169-328X(99)00063-7; Liu L, 2005, J NEUROCHEM, V92, P546, DOI 10.1111/j.1471-4159.2004.02909.x; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; Maier CM, 1998, STROKE, V29, P2171, DOI 10.1161/01.STR.29.10.2171; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; Niblock MM, 2001, J NEUROSCI RES, V65, P455, DOI 10.1002/jnr.1174; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Penfield S.W., 1928, SPECIAL CYTOLOGY FOR, P1033; Petito CK, 1998, J NEUROPATH EXP NEUR, V57, P231, DOI 10.1097/00005072-199803000-00004; Potter SM, 2001, J NEUROSCI METH, V110, P17, DOI 10.1016/S0165-0270(01)00412-5; Pringle AK, 1997, BRAIN RES, V755, P36, DOI 10.1016/S0006-8993(97)00089-9; Prins ML, 2008, J CEREBR BLOOD F MET, V28, P1, DOI 10.1038/sj.jcbfm.9600543; Ronicke R, 2009, N-S ARCH PHARMACOL, V379, P233, DOI 10.1007/s00210-008-0364-x; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Schneeberg J, 2009, EUR J PHARMACOL, V616, P81, DOI 10.1016/j.ejphar.2009.05.029; Schrag M, 2008, HIPPOCAMPUS, V18, P239, DOI 10.1002/hipo.20387; Schwartzkroin PA, 1981, ELECTROPHYSIOLOGY IS, P15; SPREAFICO R, 1995, J COMP NEUROL, V363, P281, DOI 10.1002/cne.903630209; Staal JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022040; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Su T, 2011, BRAIN RES, V1385, P68, DOI 10.1016/j.brainres.2011.01.115; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; VALVERDE F, 1995, J NEUROSCI, V15, P5014; Wilhelmi E, 2002, ATLA-ALTERN LAB ANIM, V30, P275, DOI 10.1177/026119290203000304; Xiang ZM, 2000, J NEUROSCI METH, V98, P145, DOI 10.1016/S0165-0270(00)00197-7; Xu LJ, 2001, EXP NEUROL, V169, P416, DOI 10.1006/exnr.2001.7678; Yanamoto H, 1999, STROKE, V30, P2720, DOI 10.1161/01.STR.30.12.2720; Yoon JJ, 2010, BRAIN RES, V1353, P194, DOI 10.1016/j.brainres.2010.07.005; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhao XR, 2003, GLIA, V44, P140, DOI 10.1002/glia.10283; Zilberter Y, 2010, TRENDS PHARMACOL SCI, V31, P394, DOI 10.1016/j.tips.2010.06.005; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	74	41	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e45017	10.1371/journal.pone.0045017	http://dx.doi.org/10.1371/journal.pone.0045017			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984603	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700104
J	van Balkom, IDC; Bresnahan, M; Vuijk, PJ; Hubert, J; Susser, E; Hoek, HW				van Balkom, Ingrid D. C.; Bresnahan, Michaeline; Vuijk, Pieter Jelle; Hubert, Jan; Susser, Ezra; Hoek, Hans W.			Paternal Age and Risk of Autism in an Ethnically Diverse, Non-Industrialized Setting: Aruba	PLOS ONE			English	Article							SPECTRUM DISORDERS; PERINATAL FACTORS; BIRTH-WEIGHT; POPULATION; PRETERM; TRAITS	Objective: The aim of this study was to examine paternal age in relation to risk of autism spectrum disorders (ASDs) in a setting other than the industrialized west. Design: A case-control study of Aruban-born children (1990-2003). Cases (N = 95) were identified at the Child and Adolescent Psychiatry Clinic, the only such clinic in Aruba; gender and age matched controls (N = 347) were gathered from public health records. Parental age was defined categorically (<= 29, 30-39, 40-49, >= 50y). The analysis was made, using conditional logistic regression. Results: Advanced paternal age was associated with increased risk of ASDs in offspring. In comparison to the youngest paternal age group (<= 29y), risk of autism increased 2.18 times for children born from fathers in their thirties, 2.71 times for fathers in their forties, and 3.22 thereafter. Conclusion: This study, part of the first epidemiologic study of autism in the Caribbean, contributes additional evidence, from a distinctive sociocultural setting, of the risk of ASD associated with increased paternal age.	[van Balkom, Ingrid D. C.] Lentis Psychiat Inst, Jonx Dept Youth Mental Hlth, Groningen, Netherlands; [van Balkom, Ingrid D. C.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Rob Giel Res Ctr, Groningen, Netherlands; [Bresnahan, Michaeline; Susser, Ezra; Hoek, Hans W.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Bresnahan, Michaeline; Susser, Ezra] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Vuijk, Pieter Jelle] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Susser, Ezra] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Hoek, Hans W.] Parnassia Bavo Psychiat Inst, The Hague, Netherlands	University of Groningen; Columbia University; New York State Psychiatry Institute; Vrije Universiteit Amsterdam; Columbia University; Parnassia Psychiatric Institute		idc.vanbalkom@lentis.nl	Vuijk, Pieter Jelle/H-2428-2013	Vuijk, Pieter/0000-0002-2181-5220; Hoek, Hans/0000-0001-6353-5465				Alter MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016715; Bailey A, 1998, J AUTISM DEV DISORD, V28, P369, DOI 10.1023/A:1026048320785; Bongaarts J, 2003, POP STUD-J DEMOG, V57, P321, DOI 10.1080/0032472032000137835; Buchmayer S, 2009, PEDIATRICS, V124, pE817, DOI 10.1542/peds.2008-3582; Buizer-Voskamp JE, 2011, SCHIZOPHR RES, V129, P128, DOI 10.1016/j.schres.2011.03.021; Buwe A, 2005, CYTOGENET GENOME RES, V111, P213, DOI 10.1159/000086892; Central Bureau of Statistics (CBS), 2002, CENS 2000 SPEC REP; Charman T, 2005, J AUTISM DEV DISORD, V35, P539, DOI 10.1007/s10803-005-5068-1; Cheslack-Postava K, 2011, PEDIATRICS, V127, P246, DOI 10.1542/peds.2010-2371; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Croen LA, 2007, ARCH PEDIAT ADOL MED, V161, P334, DOI 10.1001/archpedi.161.4.334; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Grether JK, 2009, AM J EPIDEMIOL, V170, P1118, DOI 10.1093/aje/kwp247; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Larsson HJ, 2005, AM J EPIDEMIOL, V161, P916, DOI 10.1093/aje/kwi123; Lauritsen MB, 2005, J CHILD PSYCHOL PSYC, V46, P963, DOI 10.1111/j.1469-7610.2004.00391.x; Leonard H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017875; Parner ET, 2012, ANN EPIDEMIOL, V22, P143, DOI 10.1016/j.annepidem.2011.12.006; Puleo CM, 2008, MOL PSYCHIATR, V13, P243, DOI 10.1038/sj.mp.4002102; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Sasanfar R, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-2; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shah PS, 2010, AM J OBSTET GYNECOL, V202, P103, DOI 10.1016/j.ajog.2009.08.026; Shelton JF, 2010, AUTISM RES, V3, P30, DOI 10.1002/aur.116; Toro-Labrador G, 2003, CARIBB J SCI, V39, P11; Tough SC, 2002, PEDIATRICS, V109, P399, DOI 10.1542/peds.109.3.399; van Balkom IDC, 2009, J NEURODEV DISORD, V1, P197, DOI 10.1007/s11689-009-9011-1; Zhang X, 2010, J AUTISM DEV DISORD, V40, P1311, DOI 10.1007/s10803-010-0992-0	30	21	22	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e45090	10.1371/journal.pone.0045090	http://dx.doi.org/10.1371/journal.pone.0045090			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003VE	22984615	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700108
J	Joyce, G; Williams, KJ; Robb, M; Noens, E; Tizzano, B; Shahrezaei, V; Robertson, BD				Joyce, Graham; Williams, Kerstin J.; Robb, Matthew; Noens, Elke; Tizzano, Barbara; Shahrezaei, Vahid; Robertson, Brian D.			Cell Division Site Placement and Asymmetric Growth in Mycobacteria	PLOS ONE			English	Article							ACTINOMYCETE CORYNEBACTERIUM-GLUTAMICUM; PENICILLIN-BINDING PROTEINS; TO-POLE OSCILLATION; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; WALL SYNTHESIS; LOCALIZATION; DIVIVA; TUBERCULOSIS; SMEGMATIS	Mycobacteria are members of the actinomycetes that grow by tip extension and lack apparent homologues of the known cell division regulators found in other rod-shaped bacteria. Previous work using static microscopy on dividing mycobacteria led to the hypothesis that these cells can grow and divide asymmetrically, and at a wide range of sizes, in contrast to the cell growth and division patterns observed in the model rod-shaped organisms. In this study, we test this hypothesis using livecell time-lapse imaging of dividing Mycobacterium smegmatis labelled with fluorescent PBP1a, to probe peptidoglycan synthesis and label the cell septum. We demonstrate that the new septum is placed accurately at mid-cell, and that the asymmetric division observed is a result of differential growth from the cell tips, with a more than 2-fold difference in growth rate between fast and slow growing poles. We also show that the division site is not selected at a characteristic cell length, suggesting this is not an important cue during the mycobacterial cell cycle.	[Joyce, Graham; Williams, Kerstin J.; Robertson, Brian D.] Univ London Imperial Coll Sci Technol & Med, Dept Med, MRC Ctr Mol Bacteriol & Infect, London, England; [Robb, Matthew; Shahrezaei, Vahid] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Noens, Elke; Tizzano, Barbara] DESY, European Mol Biol Lab, D-2000 Hamburg, Germany	Imperial College London; Imperial College London; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Joyce, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, MRC Ctr Mol Bacteriol & Infect, London, England.	b.robertson@imperial.ac.uk	Noens, Elke/H-3556-2012; Noens, Elke/A-6742-2015	Shahrezaei, Vahid/0000-0002-4013-5458; Robertson, Brian D./0000-0001-5785-5307	Biotechnology and Biological Sciences Research Council; European Union's Seventh Framework Programme (FP7) [241587]; Biotechnology and Biological Sciences Research Council [BB/C519670/1] Funding Source: researchfish; MRC [MR/J006874/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union's Seventh Framework Programme (FP7); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	G.J. was supported by a studentship from the Biotechnology and Biological Sciences Research Council. B.T. and E.N. are supported by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 241587. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012; Born P, 2006, J BIOL CHEM, V281, P26985, DOI 10.1074/jbc.M604083200; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Dahl JL, 2004, FEMS MICROBIOL LETT, V240, P15, DOI 10.1016/j.femsle.2004.09.004; Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Dziadek J, 2003, MICROBIOL-SGM, V149, P1593, DOI 10.1099/mic.0.26023-0; Dziedzic R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011058; Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x; EMBLEY TM, 1994, ANNU REV MICROBIOL, V48, P257, DOI 10.1146/annurev.mi.48.100194.001353; England K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-79; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Hallez R, 2004, TRENDS MICROBIOL, V12, P361, DOI 10.1016/j.tim.2004.06.002; Hartmans S, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P889, DOI 10.1007/0-387-30743-5_33; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Hett EC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001020; Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2; Joyce Graham, 2011, BMC Res Notes, V4, P73, DOI 10.1186/1756-0500-4-73; Kang CM, 2008, MICROBIOL-SGM, V154, P725, DOI 10.1099/mic.0.2007/014076-0; LEDERBERG J, 1956, P NATL ACAD SCI USA, V42, P574, DOI 10.1073/pnas.42.9.574; Lenarcic R, 2009, EMBO J, V28, P2272, DOI 10.1038/emboj.2009.129; Letek M, 2008, ANTON LEEUW INT J G, V94, P99, DOI 10.1007/s10482-008-9224-4; Letek M, 2008, J BACTERIOL, V190, P3283, DOI 10.1128/JB.01934-07; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Margolin W, 2009, CURR BIOL, V19, pR812, DOI 10.1016/j.cub.2009.06.033; Pedersen LB, 1999, J BACTERIOL, V181, P3201, DOI 10.1128/JB.181.10.3201-3211.1999; Plocinski P, 2011, J BACTERIOL, V193, P3246, DOI 10.1128/JB.00188-11; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Ramamurthi KS, 2009, SCIENCE, V323, P1354, DOI 10.1126/science.1169218; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Scheffers DJ, 2004, MOL MICROBIOL, V51, P749, DOI 10.1046/j.1365-2958.2003.03854.x; Singh B, 2010, ANTON LEEUW INT J G, V98, P165, DOI 10.1007/s10482-010-9446-0; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Thanky NR, 2007, TUBERCULOSIS, V87, P231, DOI 10.1016/j.tube.2006.10.004; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; TRUEBA FJ, 1982, ARCH MICROBIOL, V131, P55, DOI 10.1007/BF00451499; UDOU T, 1982, J BACTERIOL, V151, P1035, DOI 10.1128/JB.151.2.1035-1039.1982; Valbuena N, 2007, MOL MICROBIOL, V66, P643, DOI 10.1111/j.1365-2958.2007.05943.x; WEIBULL C, 1953, J BACTERIOL, V66, P688, DOI 10.1128/JB.66.6.688-695.1953; WEIDEL W, 1960, J GEN MICROBIOL, V22, P158, DOI 10.1099/00221287-22-1-158; Whitman W., 2015, SOLIRUBROBACTERACEAE, DOI [10.1002/9781118960608.fbm00055, DOI 10.1002/9781118960608.FBM00055]; Williams KJ, 2010, PLASMID, V64, P69, DOI 10.1016/j.plasmid.2010.04.003; Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002; Xu HB, 2008, J BACTERIOL, V190, P4971, DOI 10.1128/JB.01849-07; Young D, 2008, NAT REV MICROBIOL, V6, P520, DOI 10.1038/nrmicro1919; Young KD, 2010, ANNU REV MICROBIOL, V64, P223, DOI 10.1146/annurev.micro.112408.134102	51	60	62	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44582	10.1371/journal.pone.0044582	http://dx.doi.org/10.1371/journal.pone.0044582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970255	Green Submitted, gold, Green Published			2022-12-25	WOS:000308748400024
J	Zhang, MY; Yuan, TT; Li, JJ; Borges, AR; Watkins, JD; Guenaga, J; Yang, Z; Wang, YP; Wilson, R; Li, YX; Polonis, VR; Pincus, SH; Ruprecht, RM; Dimitrov, DS				Zhang, Mei-Yun; Yuan, Tingting; Li, Jingjing; Borges, Andrew Rosa; Watkins, Jennifer D.; Guenaga, Javier; Yang, Zheng; Wang, Yanping; Wilson, Richard; Li, Yuxing; Polonis, Victoria R.; Pincus, Seth H.; Ruprecht, Ruth M.; Dimitrov, Dimiter S.			Identification and Characterization of a Broadly Cross-Reactive HIV-1 Human Monoclonal Antibody That Binds to Both gp120 and gp41	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING ANTIBODIES; CRYSTAL-STRUCTURE; PHAGE LIBRARY; POTENT; CELL; RECOGNIZES; EFFICACY; EPITOPE; IMMUNOTOXINS	Identification of broadly cross-reactive HIV-1-neutralizing antibodies (bnAbs) may assist vaccine immunogen design. Here we report a novel human monoclonal antibody (mAb), designated m43, which co-targets the gp120 and gp41 subunits of the HIV-1 envelope glycoprotein (Env). M43 bound to recombinant gp140 s from various primary isolates, to membrane-associated Envs on transfected cells and HIV-1 infected cells, as well as to recombinant gp120 s and gp41 fusion intermediate structures containing N-trimer structure, but did not bind to denatured recombinant gp140 s and the CD4 binding site (CD4bs) mutant, gp120 D368R, suggesting that the m43 epitope is conformational and overlaps the CD4bs on gp120 and the N-trimer structure on gp41. M43 neutralized 34% of the HIV-1 primary isolates from different clades and all the SHIVs tested in assays based on infection of peripheral blood mononuclear cells (PBMCs) by replication-competent virus, but was less potent in cell line-based pseudovirus assays. In contrast to CD4, m43 did not induce Env conformational changes upon binding leading to exposure of the coreceptor binding site, enhanced binding of mAbs 2F5 and 4E10 specific for the membrane proximal external region (MPER) of gp41 Envs, or increased gp120 shedding. The overall modest neutralization activity of m43 is likely due to the limited binding of m43 to functional Envs which could be increased by antibody engineering if needed. M43 may represent a new class of bnAbs targeting conformational epitopes overlapping structures on both gp120 and gp41. Its novel epitope and possibly new mechanism(s) of neutralization could helpdesign improved vaccine immunogens and candidate therapeutics.	[Zhang, Mei-Yun; Yuan, Tingting; Li, Jingjing; Yang, Zheng] Univ Hong Kong, AIDS Inst, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Zhang, Mei-Yun; Yuan, Tingting; Li, Jingjing; Yang, Zheng] Univ Hong Kong, Dept Microbiol, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Borges, Andrew Rosa] Henry M Jackson Fdn, Dept Vaccine Res, US Mil HIV Res Program, Rockville, MD USA; [Watkins, Jennifer D.; Ruprecht, Ruth M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Watkins, Jennifer D.; Ruprecht, Ruth M.] Harvard Univ, Sch Med, Boston, MA USA; [Guenaga, Javier; Wilson, Richard; Li, Yuxing] Scripps Res Inst, Dept Immunol & Microbial Sci, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Wang, Yanping; Dimitrov, Dimiter S.] NCI, CCRNP, Ctr Canc Res, NIH, Frederick, MD 21701 USA; [Polonis, Victoria R.] Walter Reed Army Inst Res, Div Retrovirol, US Mil HIV Res Program, Rockville, MD USA; [Pincus, Seth H.] Childrens Hosp, New Orleans, LA USA; [Pincus, Seth H.] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA	University of Hong Kong; University of Hong Kong; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; Walter Reed Army Institute of Research (WRAIR); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; International AIDS Vaccine Initiative; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Children's Hospital of New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Zhang, MY (corresponding author), Univ Hong Kong, AIDS Inst, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.	zhangmy@hku.hk		Yang, Zheng/0000-0003-0217-6694	Intramural Research Program of the University of Hong Kong; Hong Kong Research Grants Council (RGC) General Research Fund (GRF) grant [785210]; National Institutes of Health (NIH) [R37 AI034266, P01 AI048240]; Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH; Bill and Melinda Gates Foundation; NATIONAL CANCER INSTITUTE [ZIABC011155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI048240, R37AI034266] Funding Source: NIH RePORTER	Intramural Research Program of the University of Hong Kong; Hong Kong Research Grants Council (RGC) General Research Fund (GRF) grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the University of Hong Kong, and by Hong Kong Research Grants Council (RGC) General Research Fund (GRF) grant #785210 to MYZ, National Institutes of Health (NIH) R37 AI034266 and P01 AI048240 to RMR, and by the Intramural Research Program of the Center for Cancer Research, National Cancer Institute, NIH, and the Bill and Melinda Gates Foundation to DSD. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does the mention of trade names, commercial products, or organizations imply endorsement by the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Chapal N, 2000, J IMMUNOL, V164, P4162, DOI 10.4049/jimmunol.164.8.4162; Chapal N, 2001, ENDOCRINOLOGY, V142, P4740, DOI 10.1210/en.142.11.4740; Choudhry V, 2007, VIROLOGY, V363, P79, DOI 10.1016/j.virol.2007.01.015; Choudhry V, 2006, BIOCHEM BIOPH RES CO, V348, P1107, DOI 10.1016/j.bbrc.2006.07.163; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Dreyer K, 1999, AIDS RES HUM RETROV, V15, P1563, DOI 10.1089/088922299309856; Gauduin MC, 1998, J VIROL, V72, P3475, DOI 10.1128/JVI.72.4.3475-3478.1998; Geonnotti AR, 2010, AIDS RES HUM RETROV, V26, P279, DOI 10.1089/aid.2009.0186; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Krowicka H, 2008, AIDS RES HU IN PRESS; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Louis JM, 2005, J MOL BIOL, V353, P945, DOI 10.1016/j.jmb.2005.09.044; Louis JM, 2003, J BIOL CHEM, V278, P20278, DOI 10.1074/jbc.M301627200; Louis JM, 2001, J BIOL CHEM, V276, P29485, DOI 10.1074/jbc.C100317200; McLellan JS, 2011, CARBON NANOTUBES LON; MONTEFIORI D, 2004, EVALUATING NEUTRALIZ; Montefiori DC, 1996, J INFECT DIS, V173, P60, DOI 10.1093/infdis/173.1.60; Mouquet H, 2012, P NATL ACAD SCI USA, V109, P875, DOI 10.1073/pnas.1120059109; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; PINCUS SH, 1991, J IMMUNOL, V146, P4315; PINCUS SH, 1990, J INFECT DIS, V162, P1233, DOI 10.1093/infdis/162.6.1233; Pincus SH, 2003, J IMMUNOL, V170, P2236, DOI 10.4049/jimmunol.170.4.2236; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Siddappa NB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011689; Siddappa NB, 2009, J VIROL, V83, P1422, DOI 10.1128/JVI.02066-08; Song RJ, 2006, J VIROL, V80, P8729, DOI 10.1128/JVI.00558-06; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Tan RCH, 1999, J MED PRIMATOL, V28, P164, DOI 10.1111/j.1600-0684.1999.tb00265.x; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Walker LM, 2011, CARBON NANOTUBES LON; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhang MY, 2008, J VIROL, V82, P6869, DOI 10.1128/JVI.00033-08; Zhang MY, 2006, J IMMUNOL METHODS, V317, P21, DOI 10.1016/j.jim.2006.09.016; Zhang Mei-Yun, 2009, V525, P175, DOI 10.1007/978-1-59745-554-1_9; Zhang MY, 2003, J IMMUNOL METHODS, V283, P17, DOI 10.1016/j.jim.2003.07.003; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	50	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44241	10.1371/journal.pone.0044241	http://dx.doi.org/10.1371/journal.pone.0044241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970187	Green Published, gold, Green Submitted			2022-12-25	WOS:000308748400013
J	Daugela, L; Nusgen, N; Walier, M; Oldenburg, J; Schwaab, R; El-Maarri, O				Daugela, Laurynas; Nuesgen, Nicole; Walier, Maja; Oldenburg, Johannes; Schwaab, Rainer; El-Maarri, Osman			Measurements of DNA Methylation at Seven Loci in Various Tissues of CD1 Mice	PLOS ONE			English	Article							IP-RP-HPLC; ACTIVE-DEMETHYLATION; CPG SITES; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; GENOME; AGE; 5-CARBOXYLCYTOSINE; 5-FORMYLCYTOSINE; WIDESPREAD	In humans, considerable variation in methylation at single loci and repetitive elements in various cells and tissues is observed. Recently, several inter- and intra-tissue correlations for DNA methylation have been reported. To investigate the extent and reproducibility of such correlations, we investigated inter- and intra-tissue methylation correlations among seven different loci in 9 different tissues in a population of 100 healthy seven-week-old CD1 outbred mice. We used a highly quantitative approach to measure methylation levels to high accuracy at two single loci in the alpha-actin and myosine light chain promoters, at three differentially methylated regions of the Peg3, Snrpn and Lit1 genes associated with imprinted loci, and at two repetitive elements in the Line-1 and IAP-LTR genes in the various tissues. In this population of mice, methylation at several loci was sex-associated and intra-tissue correlations among the studied loci were observed for brain and spleen. Inter-tissue correlations were rarely observed. To investigate method-dependent experimental variability, we re-analyzed the same spleen and tongue samples using SIRPH and pyrosequencing methods and reconfirmed intra-tissue correlations for spleen and sex-associated correlations for DNA methylation for tongue. When we repeated DNA methylation measurements for a second mouse population raised under similar conditions three months later, we did not detect sex-associated or intra-tissues correlations. Additional studies that examine large numbers of loci may be required to further understand the factors that influence stability of DNA methylation.	[Daugela, Laurynas; Nuesgen, Nicole; Oldenburg, Johannes; Schwaab, Rainer; El-Maarri, Osman] Univ Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany; [Walier, Maja] Univ Bonn, IMBIE, Bonn, Germany	University of Bonn; University of Bonn	Daugela, L (corresponding author), Univ Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany.	osman.elmaarri@ukb.uni-bonn.de	Oldenburg, Johannes/ABB-7817-2020	Oldenburg, Johannes/0000-0002-1585-4100; El-Maarri, Osman/0000-0002-6859-5819				Adkins RM, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-47; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Bartolomei MS, 2011, COLD SPRING HARB PER; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bock C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn122; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Buchner A, 1996, CONSCIOUS COGN, V5, P581, DOI 10.1006/ccog.1996.0034; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Dauksa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037509; El-Maarri O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e25; El-Maarri O, 2001, NAT GENET, V27, P341, DOI 10.1038/85927; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; El-Maarri Osman, 2004, Methods Mol Biol, V287, P195; El-Maarri O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016252; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Harrison J, 1998, ANAL BIOCHEM, V264, P129, DOI 10.1006/abio.1998.2833; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hernandez DG, 2011, HUM MOL GENET, V20, P1164, DOI 10.1093/hmg/ddq561; Irahara N, 2010, J MOL DIAGN, V12, P177, DOI 10.2353/jmoldx.2010.090106; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kerkel K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001212; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Li CCY, 2011, PLOS GENET, V7, DOI [10.1371/journal.pgen.1001380, 10.1371/journal.pgen.1002196]; Liang P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-231; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010028; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02; Warnecke PM, 2002, METHODS, V27, P101, DOI 10.1016/S1046-2023(02)00060-9; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138	42	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44585	10.1371/journal.pone.0044585	http://dx.doi.org/10.1371/journal.pone.0044585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970256	gold, Green Published, Green Submitted			2022-12-25	WOS:000308462000032
J	Blokland, YM; Farquhar, JDR; Mourisse, J; Scheffer, GJ; Lerou, JGC; Bruhn, J				Blokland, Yvonne M.; Farquhar, Jason D. R.; Mourisse, Jo; Scheffer, Gert J.; Lerou, Jos G. C.; Bruhn, Jorgen			Towards a Novel Monitor of Intraoperative Awareness: Selecting Paradigm Settings for a Movement-Based Brain-Computer Interface	PLOS ONE			English	Article							GENERAL-ANESTHESIA; MOTOR IMAGERY; SET	During 0.1-0.2% of operations with general anesthesia, patients become aware during surgery. Unfortunately, pharmacologically paralyzed patients cannot seek attention by moving. Their attempted movements may however induce detectable EEG changes over the motor cortex. Here, methods from the area of movement-based brain-computer interfacing are proposed as a novel direction in anesthesia monitoring. Optimal settings for development of such a paradigm are studied to allow for a clinically feasible system. A classifier was trained on recorded EEG data of ten healthy non-anesthetized participants executing 3-second movement tasks. Extensive analysis was performed on this data to obtain an optimal EEG channel set and optimal features for use in a movement detection paradigm. EEG during movement could be distinguished from EEG during non-movement with very high accuracy. After a short calibration session, an average classification rate of 92% was obtained using nine EEG channels over the motor cortex, combined movement and post-movement signals, a frequency resolution of 4 Hz and a frequency range of 8-24 Hz. Using Monte Carlo simulation and a simple decision making paradigm, this translated into a probability of 99% of true positive movement detection within the first two and a half minutes after movement onset. A very low mean false positive rate of <0.01% was obtained. The current results corroborate the feasibility of detecting movement-related EEG signals, bearing in mind the clinical demands for use during surgery. Based on these results further clinical testing can be initiated.	[Blokland, Yvonne M.; Mourisse, Jo; Scheffer, Gert J.; Lerou, Jos G. C.; Bruhn, Jorgen] Radboud Univ Nijmegen, Med Ctr, Dept Anaesthesiol Pain & Palliat Med, NL-6525 ED Nijmegen, Netherlands; [Blokland, Yvonne M.; Farquhar, Jason D. R.; Bruhn, Jorgen] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Blokland, YM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Anaesthesiol Pain & Palliat Med, NL-6525 ED Nijmegen, Netherlands.	Y.Blokland@anes.umcn.nl	Scheffer, G.J./H-8086-2014; Bruhn, Jörgen/H-3703-2012; Mourisse, J.M.J./L-4531-2015; Farquhar, Jason/D-2285-2010; wilson, nozaspi/H-9769-2012; Lerou, J.G.C./L-4488-2015	Farquhar, Jason/0000-0002-8560-0712; Lerou, Jos/0000-0003-4006-292X	Netherlands Organisation for Scientific Research (NWO) [91710346]; BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science	This work was supported by VIDI grant number 91710346 from the Netherlands Organisation for Scientific Research (NWO) and the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan MS, 2011, NEW ENGL J MED, V365, P591, DOI 10.1056/NEJMoa1100403; Bishop C.M., 2006, PATTERN RECOGNITION; Blokland Y, 2011, P 5 INT BRAIN COMP I, P300; Errando CL, 2008, BRIT J ANAESTH, V101, P178, DOI 10.1093/bja/aen144; Ghoneim MM, 2009, ANESTH ANALG, V108, P527, DOI 10.1213/ane.0b013e318193c634; Grosse-Wentrup M, 2011, NEUROIMAGE, V56, P837, DOI 10.1016/j.neuroimage.2010.04.265; JASPER HH, 1958, ELECTROENCEPHALOGRAP, V10, P370, DOI DOI 10.1016/0013-4694(58)90053-1; Kent CD, 2009, CURR OPIN ANESTHESIO, V22, P782, DOI 10.1097/ACO.0b013e3283326986; Leslie K, 2010, MINERVA ANESTESIOL, V76, P624; Long JY, 2010, COGN NEURODYNAMICS, V4, P207, DOI 10.1007/s11571-010-9114-0; Mooney C.Z., 1997, MONTE CARLO SIMULATI; Muller-Putz GR, 2010, MED BIOL ENG COMPUT, V48, P229, DOI 10.1007/s11517-009-0572-7; Muralidharan A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00039; Nikulin VV, 2008, NEUROPSYCHOLOGIA, V46, P727, DOI 10.1016/j.neuropsychologia.2007.10.008; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Qian K, 2010, CLIN NEUROPHYSIOL, V121, P1304, DOI 10.1016/j.clinph.2010.03.001; Reuderink B, 2011, P 33 C EMBS IEEE 201; Sandin RH, 2000, LANCET, V355, P707, DOI 10.1016/S0140-6736(99)11010-9; Sannelli C, 2010, BRAIN TOPOGR, V23, P186, DOI 10.1007/s10548-010-0135-0; Sebel PS, 2004, ANESTH ANALG, V99, P833, DOI 10.1213/01.ANE.0000130261.90896.6C; Stoica P, 1997, INTRO SPECTRAL ANAL, V51; Tam WK, 2011, IEEE T NEUR SYS REH, V19, P617, DOI 10.1109/TNSRE.2011.2168542; van Gerven M, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/041001; Whithain EM, 2007, CLIN NEUROPHYSIOL, V118, P1877, DOI 10.1016/j.clinph.2007.04.027; Whitlock EL, 2011, ANESTHESIOLOGY, V115, P1209, DOI 10.1097/ALN.0b013e3182395dcb; Xu L, 2009, ACTA ANAESTH SCAND, V53, P873, DOI 10.1111/j.1399-6576.2009.02016.x; Zhang L, 2010, J MED SYST, V34, P51, DOI 10.1007/s10916-008-9215-z; Zhu J, 2005, J COMPUT GRAPH STAT, V14, P185, DOI 10.1198/106186005X25619	29	6	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44336	10.1371/journal.pone.0044336	http://dx.doi.org/10.1371/journal.pone.0044336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970202	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400060
J	Bossard, C; Busson, M; Vindrieux, D; Gaudin, F; Machelon, R; Brigitte, M; Jacquard, C; Pillon, A; Balaguer, P; Balabanian, K; Lazennec, G				Bossard, Carine; Busson, Muriel; Vindrieux, David; Gaudin, Francoise; Machelon, Veronique; Brigitte, Madly; Jacquard, Carine; Pillon, Arnaud; Balaguer, Patrick; Balabanian, Karl; Lazennec, Gwendal			Potential Role of Estrogen Receptor Beta as a Tumor Suppressor of Epithelial Ovarian Cancer	PLOS ONE			English	Article							MENOPAUSAL HORMONE-THERAPY; ER-BETA; CELL-LINE; ALPHA; EXPRESSION; PROTEASOME; PROLIFERATION; TRANSCRIPTION; CARCINOMA; GROWTH	Ovarian cancer is the gynecological cancer exhibiting the highest morbidity and improvement of treatments is still required. Previous studies have shown that Estrogen-receptor beta (ER beta) levels decreased along with ovarian carcinogenesis. Here, we present evidence that reintroduction of ER beta in BG-1 epithelial ovarian cancer cells, which express ER alpha, leads in vitro to a decrease of basal and estradiol-promoted cell proliferation. ER beta reduced the frequency of cells in S phase and increased the one of cells in G2/M phase. At the molecular level, we found that ER beta downregulated total retinoblastoma (Rb), phosphorylated Rb and phospho-AKT cellular content as well as cyclins D1 and A2. In addition, ER beta had a direct effect on ER alpha, by strongly inhibiting its expression and activity, which could explain part of the anti-proliferative action of ER beta. By developing a novel preclinical model of ovarian cancer based on a luminescent orthotopic xenograft in athymic Nude mice, we further revealed that ER beta expression reduces tumor growth and the presence of tumor cells in sites of metastasis, hence resulting in improved survival of mice. Altogether, these findings unveil a potential tumor-suppressor role of ER beta in ovarian carcinogenesis, which could be of potential clinical relevance for the selection of the most appropriate treatment for patients.	[Bossard, Carine; Busson, Muriel; Vindrieux, David; Brigitte, Madly; Jacquard, Carine; Lazennec, Gwendal] Univ Montpellier I, INSERM, U844, F-34091 Montpellier, France; [Gaudin, Francoise; Machelon, Veronique; Balabanian, Karl] Univ Paris 11, UMR S996, INSERM, LERMIT, Clamart, France; [Pillon, Arnaud; Balaguer, Patrick] IRCM, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UNICANCER; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Bossard, C (corresponding author), Univ Montpellier I, INSERM, U844, F-34091 Montpellier, France.	Gwendal.Lazennec@inserm.fr	Balabanian, Karl/S-6250-2019; Balaguer, Patrick/I-2973-2016; Balabanian, Karl/I-2990-2016	Balabanian, Karl/0000-0002-0534-3198; Balabanian, Karl/0000-0002-0534-3198; Jacquard, Carine/0000-0003-0972-8455; Lazennec, Gwendal/0000-0002-8522-1763; Vindrieux, David/0000-0002-4713-5768	ARC (Association pour la Recherche contre le Cancer) [3582]; Ligue Nationale Contre le Cancer; FRM (Fondation pour la Recherche Medicale); HFSP fellowship; Agence Nationale de la Recherche (ANR) [2010 JCJC 1104 01]; Universite Paris-Sud; Institut National de la Sante et de la Recherche Medicale (INSERM); Ligue Nationale Contre le Cancer (Comite Val d'Oise); ANR (Investissements dAvenir)	ARC (Association pour la Recherche contre le Cancer)(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); HFSP fellowship; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Universite Paris-Sud; Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ligue Nationale Contre le Cancer (Comite Val d'Oise)(Institut National du Cancer (INCA) France); ANR (Investissements dAvenir)(French National Research Agency (ANR))	This work was supported by grants from ARC (Association pour la Recherche contre le Cancer, Grant No. 3582) (http://www.arc-cancer.net), The Ligue Nationale Contre le Cancer (http://www.ligue-cancer.net). Muriel Busson was supported by FRM (Fondation pour la Recherche Medicale) (http://www.frm.org). DV was a recipient of the Ligue Nationale contre le Cancer. CB was supported by a HFSP fellowship (http://www.hfsp.org/). The K. B. lab is supported by the Agence Nationale de la Recherche (ANR, grant number 2010 JCJC 1104 01) (http://www.agence-nationale-recherche.fr/), the Universite Paris-Sud, the Institut National de la Sante et de la Recherche Medicale (INSERM) and the Ligue Nationale Contre le Cancer (Comite Val d'Oise), and is a member of the Laboratory of Excellence LERMIT (Laboratory of Excellence in Research on Medication and Innovative Therapeutics) supported by a grant from ANR (Investissements dAvenir). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Baldwin WS, 1998, IN VITRO CELL DEV-AN, V34, P649; Bardin A, 2004, ENDOCR-RELAT CANCER, V11, P537, DOI 10.1677/erc.1.00800; BERAL V, 1988, LANCET, V2, P1331; Beral V, 2007, LANCET, V369, P1703, DOI 10.1016/S0140-6736(07)60534-0; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; Burges A, 2010, ARCH GYNECOL OBSTET, V281, P511, DOI 10.1007/s00404-009-1185-y; Chan KKL, 2008, OBSTET GYNECOL, V111, P144, DOI 10.1097/01.AOG.0000296715.07705.e9; Cheng J, 2004, FEBS LETT, V566, P169, DOI 10.1016/j.febslet.2004.04.025; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Couse JF, 2005, ENDOCRINOLOGY, V146, P3247, DOI 10.1210/en.2005-0213; Couse JF, 2000, J STEROID BIOCHEM, V74, P287, DOI 10.1016/S0960-0760(00)00105-9; Cowley SM, 1997, J BIOL CHEM, V272, P19858, DOI 10.1074/jbc.272.32.19858; De Stefano I, 2011, GYNECOL ONCOL, V122, P573, DOI 10.1016/j.ygyno.2011.05.025; Deligeoroglou E, 2003, ANN NY ACAD SCI, V997, P199, DOI 10.1196/annals.1290.023; Drummond AE, 2010, J ENDOCRINOL, V205, P15, DOI 10.1677/JOE-09-0379; Duong V, 2006, ONCOGENE, V25, P1799, DOI 10.1038/sj.onc.1209102; Emmen JMA, 2005, ENDOCRINOLOGY, V146, P2817, DOI 10.1210/en.2004-1108; Foster JS, 2001, TRENDS ENDOCRIN MET, V12, P320, DOI 10.1016/S1043-2760(01)00436-2; Freund A, 2003, ONCOGENE, V22, P256, DOI 10.1038/sj.onc.1206113; GEISINGER KR, 1989, CANCER-AM CANCER SOC, V63, P280, DOI 10.1002/1097-0142(19890115)63:2<280::AID-CNCR2820630213>3.0.CO;2-N; Glud E, 2004, ARCH INTERN MED, V164, P2253, DOI 10.1001/archinte.164.20.2253; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Halon A, 2011, ANTICANCER RES, V31, P711; HATCH KD, 1991, CANCER, V68, P269, DOI 10.1002/1097-0142(19910715)68:2<269::AID-CNCR2820680209>3.0.CO;2-O; Johnson DG, 1999, ANNU REV PHARMACOL, V39, P295, DOI 10.1146/annurev.pharmtox.39.1.295; Katzenellenbogen BS, 2000, BREAST CANCER RES, V2, P335, DOI 10.1186/bcr78; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Lacey JV, 2006, JNCI-J NATL CANCER I, V98, P1397, DOI 10.1093/jnci/djj375; LANGDON SP, 1988, CANCER RES, V48, P6166; Lazennec G, 2006, CANCER LETT, V231, P151, DOI 10.1016/j.canlet.2005.01.021; Lazennec G, 2001, ENDOCRINOLOGY, V142, P4120, DOI 10.1210/en.142.9.4120; Licznar A, 2003, FEBS LETT, V553, P445, DOI 10.1016/S0014-5793(03)01090-1; Lindberg MK, 2003, MOL ENDOCRINOL, V17, P203, DOI 10.1210/me.2002-0206; Lonard DM, 2000, MOL CELL, V5, P939, DOI 10.1016/S1097-2765(00)80259-2; Lucas A, 2003, BIOCHEM BIOPH RES CO, V309, P1011, DOI 10.1016/j.bbrc.2003.08.101; Lurie G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020703; Matthews J, 2006, MOL ENDOCRINOL, V20, P534, DOI 10.1210/me.2005-0140; Moll F, 2002, ONCOGENE, V21, P1097, DOI 10.1038/sj.onc.1205171; Paruthiyil S, 2004, CANCER RES, V64, P423, DOI 10.1158/0008-5472.CAN-03-2446; Pettersson K, 1997, MOL ENDOCRINOL, V11, P1486, DOI 10.1210/me.11.10.1486; Picard N, 2008, MOL ENDOCRINOL, V22, P317, DOI 10.1210/me.2007-0281; Pillon A, 2005, ANAL BIOCHEM, V340, P295, DOI 10.1016/j.ab.2005.02.032; Pujol P, 1998, CANCER RES, V58, P5367; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Rosenfeld CS, 2001, REPRODUCTION, V122, P215, DOI 10.1530/rep.0.1220215; Rossing MA, 2007, CANCER EPIDEM BIOMAR, V16, P2548, DOI 10.1158/1055-9965.EPI-07-0550; Rutherford T, 2000, OBSTET GYNECOL, V96, P417, DOI 10.1016/S0029-7844(00)00917-0; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Suzuki F, 2008, CANCER SCI, V99, P2365, DOI 10.1111/j.1349-7006.2008.00988.x; Treeck O, 2007, J ENDOCRINOL, V193, P421, DOI 10.1677/JOE-07-0087; Williams C, 2008, ONCOGENE, V27, P1019, DOI 10.1038/sj.onc.1210712; Yap OWS, 2009, ANTICANCER RES, V29, P139	54	77	81	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44787	10.1371/journal.pone.0044787	http://dx.doi.org/10.1371/journal.pone.0044787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970307	Green Submitted, Green Published, gold			2022-12-25	WOS:000308458400120
J	Feitosa, E; Adati, RD; Hansson, P; Malmsten, M				Feitosa, Eloi; Adati, Renata D.; Hansson, Per; Malmsten, Martin			Thermal and Structural Behavior of Dioctadecyldimethylammonium Bromide Dispersions Studied by Differential Scanning Calorimetry and X-Ray Scattering	PLOS ONE			English	Article							PHASE-TRANSITION; VESICLES; CHLORIDE; DODAB	Dioctadecyldimethylammonium bromide (DODAB) is a double chain cationic lipid, which assembles as bilayer structures in aqueous solution. The precise structures formed depend on, e.g., lipid concentration and temperature. We here combine differential scanning calorimetry (DSC) and X-ray scattering (SAXS and WAXS) to investigate the thermal and structural behavior of up to 120 mM DODAB in water within the temperature range 1-70 degrees C. Below 1 mM, this system is dominated by unilamellar vesicles (ULVs). Between 1 and 65 mM, ULVs and multilamellar structures (MLSs) co-exist, while above 65 mM, the MLSs are the preferred structure. Depending on temperature, DSC and X-ray data show that the vesicles can be either in the subgel (SG), gel, or liquid crystalline (LC) state, while the MLSs (with lattice distance d = 36.7 angstrom) consist of interdigitated lamellae in the SG state, and ULVs in the LC state (no Bragg peak). Critical temperatures related to the thermal transitions of these bilayer structures obtained in the heating and cooling modes are reported, together with the corresponding transition enthalpies.	[Feitosa, Eloi; Hansson, Per; Malmsten, Martin] Uppsala Univ, Dept Pharm, Uppsala, Sweden; [Adati, Renata D.] Sao Paulo State Univ, Dept Phys, Sao Jose Do Rio Preto, Brazil	Uppsala University; Universidade Estadual Paulista	Feitosa, E (corresponding author), Uppsala Univ, Dept Pharm, Uppsala, Sweden.	eloi@ibilce.unesp.br	ADATI, RENATA DANIELLE/AAC-9284-2021	Adati, Renata/0000-0003-0443-591X; Feitosa, Eloi/0000-0002-1141-9494	FAPESP [2011/00796-4, 2011/07414-0]; Swedish Research Council [2009-3009]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was funded by FAPESP (www.fapesp.br), grants 2011/00796-4 and 2011/07414-0. Swedish Research Council (http://www.vr.se/) (2009-3009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreleiro PCA, 2000, J PHYS CHEM B, V104, P7795, DOI 10.1021/jp000636c; Benatti CR, 2001, CHEM PHYS LIPIDS, V111, P93, DOI 10.1016/S0009-3084(01)00134-7; BLANDAMER MJ, 1992, J CHEM SOC FARADAY T, V88, P3431, DOI 10.1039/ft9928803431; Brito RO, 2005, CHEM PHYS LIPIDS, V137, P18, DOI 10.1016/j.chemphyslip.2005.05.001; Coppola L, 2009, J COLLOID INTERF SCI, V338, P550, DOI 10.1016/j.jcis.2009.06.054; Cullity B.D., 1967, ELEMENTS XRAY DIFFRA; Dong YD, 2011, INT J PHARMACEUT, V417, P101, DOI 10.1016/j.ijpharm.2011.01.022; Feitosa E, 2006, CHEM PHYS LIPIDS, V140, P66, DOI 10.1016/j.chemphyslip.2006.01.005; Feitosa E, 2004, PROG COLL POL SCI S, V128, P163, DOI 10.1007/b97125; Feitosa E, 2000, CHEM PHYS LIPIDS, V105, P201, DOI 10.1016/S0009-3084(00)00127-4; Feitosa E, 2012, STRUCTURAL ORG UNPUB; Feitosa E, 2012, REVERSIBILITY UNPUB; Feitosa E, 2009, COLLOID POLYM SCI, V287, P591, DOI 10.1007/s00396-009-2008-1; Furuike S, 1999, BIOPHYS J, V77, P2015, DOI 10.1016/S0006-3495(99)77042-6; Lopes A, 2008, J COLLOID INTERF SCI, V322, P582, DOI 10.1016/j.jcis.2008.03.015; Saveyn P, 2009, SOFT MATTER, V5, P1735, DOI 10.1039/b821387a; Tanford C., 1991, HYDROPHOBIC EFFECT F, V2nd; Wu FG, 2011, LANGMUIR, V27, P2349, DOI 10.1021/la1049474	18	18	18	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44702	10.1371/journal.pone.0044702	http://dx.doi.org/10.1371/journal.pone.0044702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970291	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400106
J	Ruiz, JD; Martinez, C; Anderson, K; Gross, M; Lang, NP; Garcia-Martin, E; Agundez, JAG				Ruiz, Jhon D.; Martinez, Carmen; Anderson, Kristin; Gross, Myron; Lang, Nicholas P.; Garcia-Martin, Elena; Agundez, Jose A. G.			The Differential Effect of NAT2 Variant Alleles Permits Refinement in Phenotype Inference and Identifies a Very Slow Acetylation Genotype	PLOS ONE			English	Article							N-ACETYLTRANSFERASES; POLYMORPHISMS; CAFFEINE; RISK; ASSOCIATIONS; CONCORDANCE; METABOLISM; GENES	Indirect evidences suggest that acetylation phenotype categories are heterogeneous and that subcategories, related to specific NAT2 variant alleles might exist. We analyzed the in vivo acetylation phenotype and genotype in 504 north-American subjects of Caucasian origin. The analyses of the SNPs rs1801280 and rs1799930 allowed the discrimination of five categories with different acetylation status within the study population. These categories are related to the distinct effect of NAT2 alleles on the acetylation status in vivo and to the occurrence of a gene-dose effect. These five phenotype categories, from higher to lower acetylation capacity, correspond to the genotypes NAT2*4/*4, NAT2*4/*5 or *4/*6, NAT2*5/*5, NAT2*5/*6 and NAT2*6/*6 (p <= 0.001 for all comparisons). The NAT2*6/*6 genotype correspond to a phenotype category of very-slow acetylators. The refinement in phenotype prediction may help to identify risks associated to phenotype subcategories, and warrants the re-analysis of previous studies that may have overlooked phenotype subcategory-specific risks.	[Ruiz, Jhon D.; Martinez, Carmen; Agundez, Jose A. G.] Univ Extremadura, Sch Med, Dept Pharmacol, Badajoz, Spain; [Anderson, Kristin] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Gross, Myron] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Lang, Nicholas P.] Univ Arkansas Med Sci, Dept Surg, Little Rock, AR 72205 USA; [Garcia-Martin, Elena] Univ Extremadura, Sch Biol Sci, Dept Biochem & Mol Biol, Caceres, Spain; [Ruiz, Jhon D.; Martinez, Carmen; Agundez, Jose A. G.] Univ Extremadura, Sch Med, Dept Pharmacol, Caceres, Spain	Universidad de Extremadura; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Arkansas System; University of Arkansas Medical Sciences; Universidad de Extremadura; Universidad de Extremadura	Ruiz, JD (corresponding author), Univ Extremadura, Sch Med, Dept Pharmacol, Badajoz, Spain.	jagundez@unex.es	Ruiz, Jhon D/Q-1887-2016; García-Martin, Elena/H-9828-2016; Agúndez, José A. G./A-5503-2008	Ruiz, Jhon D/0000-0003-4410-4349; García-Martin, Elena/0000-0002-8094-046X; Agúndez, José A. G./0000-0001-6895-9160	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain [FIS PS09/00943, PS09/00469, RETICS RD07/0064/0016]; Junta de Extremadura, Spain [GR10068]; European Union	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Junta de Extremadura, Spain; European Union(European Commission)	Financial support provided by FIS PS09/00943, PS09/00469, and RETICS RD07/0064/0016 from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III, Spain, and GR10068 from Junta de Extremadura, Spain. Financed in part with FEDER funds from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agundez JAG, 2008, CURR DRUG METAB, V9, P520, DOI 10.2174/138920008784892083; Agundez JAG, 2008, CLIN CHEM, V54, P1390, DOI 10.1373/clinchem.2008.105569; Agundez JAG, 2008, CURR DRUG METAB, V9, P463, DOI 10.2174/138920008784892146; Agundez JAG, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00002; Anderson KE, 2005, CANCER EPIDEM BIOMAR, V14, P2261, DOI 10.1158/1055-9965.EPI-04-0514; Anderson KE, 2002, MUTAT RES-FUND MOL M, V506, P225, DOI 10.1016/S0027-5107(02)00169-0; Andrade RJ, 2009, CURR DRUG METAB, V10, P956, DOI 10.2174/138920009790711805; Bartsch H, 1998, EUR J CANCER PREV, V7, P215, DOI 10.1097/00008469-199806000-00006; Bolt HM, 2005, ARCH TOXICOL, V79, P196, DOI 10.1007/s00204-004-0622-8; BUTLER MA, 1992, PHARMACOGENETICS, V2, P116, DOI 10.1097/00008571-199206000-00003; Cascorbi I, 1999, DRUG METAB REV, V31, P489, DOI 10.1081/DMR-100101932; EVANS DAP, 1960, AM REV RESPIR DIS, V82, P853; EVANS DAP, 1960, BRIT MED J, V2, P485, DOI 10.1136/bmj.2.5197.485; Garcia-Martin E, 2008, CURR DRUG METAB, V9, P487, DOI 10.2174/138920008784892155; Gross M, 1999, CANCER EPIDEM BIOMAR, V8, P683; Hein DW, 2009, EXPERT OPIN DRUG MET, V5, P353, DOI [10.1517/17425250902877698, 10.1517/17425250902877698 ]; Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102; Leiro-Fernandez V, 2011, INT J TUBERC LUNG D, V15, P1403, DOI 10.5588/ijtld.10.0648; MCQUILKIN SH, 1995, CANCER EPIDEM BIOMAR, V4, P139; Miners JO, 1996, GEN PHARMACOL-VASC S, V27, P245, DOI 10.1016/0306-3623(95)02014-4; Moslehi R, 2006, PHARMACOGENOMICS, V7, P819, DOI 10.2217/14622416.7.6.819; Selinski S, 2011, PHARMACOGENET GENOM, V21, P673, DOI 10.1097/FPC.0b013e3283493a23; TANG BK, 1987, CLIN PHARMACOL THER, V42, P509, DOI 10.1038/clpt.1987.189; Walraven JM, 2008, CURR DRUG METAB, V9, P471, DOI 10.2174/138920008784892065; Zhang JJ, 2011, INT J MOL EPIDEMIOL, V2, P236	25	36	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44629	10.1371/journal.pone.0044629	http://dx.doi.org/10.1371/journal.pone.0044629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970273	Green Submitted, Green Published, gold			2022-12-25	WOS:000308458400098
J	Moulton, EA; Becerra, L; Rosenthal, P; Borsook, D				Moulton, Eric A.; Becerra, Lino; Rosenthal, Perry; Borsook, David			An Approach to Localizing Corneal Pain Representation in Human Primary Somatosensory Cortex	PLOS ONE			English	Article							EYE BLINKING; INNERVATION; FMRI; ACTIVATION; NERVES; EOG	The cornea has been a focus of animal electrophysiological research for decades, but little is known regarding its cortical representation in the human brain. This study attempts to localize the somatotopic representation of the cornea to painful stimuli in human primary somatosensory cortex using functional magnetic resonance imaging (fMRI). In this case study, a subject was imaged at 3T while bright light was presented in a block-design, which either produced pain and blinking (during photophobia) or blinking alone (after recovery from photophobia). Pain and blinking produced precisely localized activations in primary somatosensory cortex and primary motor cortex. These results indicate that noxious stimulation of the cornea can produce somatotopic activation in primary somatosensory cortex. This finding opens future avenues of research to evaluate the relationship between corneal pain and central brain mechanisms relating to the development of chronic pain conditions, such as dry eye-like symptoms.	[Moulton, Eric A.; Becerra, Lino; Borsook, David] Harvard Univ, Massachusetts Gen Hosp, Sch Med,McLean Hosp, Ctr Pain & Brain,Childrens Hosp Boston,PAIN Grp, Boston, MA 02114 USA; [Rosenthal, Perry] Boston Fdn Sight, Needham, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts General Hospital; McLean Hospital	Moulton, EA (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med,McLean Hosp, Ctr Pain & Brain,Childrens Hosp Boston,PAIN Grp, Boston, MA 02114 USA.	eric.moulton@childrens.harvard.edu	Moulton, Eric/AAF-8225-2019	Moulton, Eric/0000-0002-7959-8441	National Institute on Drug Abuse [DA024289]; Neurological Institute of Neurological Disorders and Stroke [NS064050]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Neurological Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a K01 grant from the National Institute on Drug Abuse (DA024289) to EAM and a K24 grant from the Neurological Institute of Neurological Disorders and Stroke (NS064050) to DB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balslev D, 2011, HUM BRAIN MAPP, V32, P624, DOI 10.1002/hbm.21050; Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; Belmonte Carlos, 2004, Ocul Surf, V2, P248; BERGMANSON JPG, 1977, EXP EYE RES, V24, P225, DOI 10.1016/0014-4835(77)90160-9; Chung JY, 2006, NEUROSCI LETT, V395, P196, DOI 10.1016/j.neulet.2005.10.094; Cruzat A, 2010, SEMIN OPHTHALMOL, V25, P171, DOI 10.3109/08820538.2010.518133; DaSilva AFM, 2002, J NEUROSCI, V22, P8183; Gong SZ, 2005, BRAIN RES, V1047, P177, DOI 10.1016/j.brainres.2005.04.045; Kato M, 2003, NEUROIMAGE, V19, P1260, DOI 10.1016/S1053-8119(03)00223-4; LELE PP, 1959, EXP NEUROL, V1, P334, DOI 10.1016/0014-4886(59)90025-1; Marfurt CF, 2010, EXP EYE RES, V90, P478, DOI 10.1016/j.exer.2009.12.010; Moulton EA, 2009, PAIN, V145, P358, DOI 10.1016/j.pain.2009.07.018; Moulton EA, 2009, HUM BRAIN MAPP, V30, P757, DOI 10.1002/hbm.20541; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Penfield W, 1950, CEREBRAL CORTEX MAN; Rosenthal P, 2012, OCUL SURF, V10, P2, DOI 10.1016/j.jtos.2012.01.002; TERENGHI G, 1985, J COMP NEUROL, V233, P506, DOI 10.1002/cne.902330410; Xu YX, 2011, J NEUROPHYSIOL, V106, P71, DOI 10.1152/jn.00668.2010; Yoon HW, 2005, NEUROSCI LETT, V381, P26, DOI 10.1016/j.neulet.2005.01.077	19	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44643	10.1371/journal.pone.0044643	http://dx.doi.org/10.1371/journal.pone.0044643			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973463	Green Submitted, gold, Green Published			2022-12-25	WOS:000308577600074
J	Zelinka, CP; Scott, MA; Volkov, L; Fischer, AJ				Zelinka, Christopher P.; Scott, Melissa A.; Volkov, Leo; Fischer, Andy J.			The Reactivity, Distribution and Abundance of Non-Astrocytic Inner Retinal Glial (NIRG) Cells Are Regulated by Microglia, Acute Damage, and IGF1	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MULLER GLIA; CHICKEN RETINA; COMMON PROGENITOR; GANGLION-CELLS; OCULAR GROWTH; QUAIL RETINA; OPTIC-NERVE; RAT RETINA; IN-VIVO	Recent studies have described a novel type of glial cell that is scattered across the inner layers of the avian retina and possibly the retinas of primates. These cells have been termed Non-astrocytic Inner Retinal Glial (NIRG) cells. These cells are stimulated by insulin-like growth factor 1 (IGF1) to proliferate, migrate distally into the retina, and become reactive. These changes in glial activity correlate with increased susceptibility of retinal neurons and Muller glia to excitotoxic damage. The purpose of this study was to further study the NIRG cells in retinas treated with IGF1 or acute damage. In response to IGF1, the reactivity, proliferation and migration of NIRG cells persists through 3 days after treatment. At 7 days after treatment, the numbers and distribution of NIRG cells returns to normal, suggesting that homeostatic mechanisms are in place within the retina to maintain the numbers and distribution of these glial cells. By comparison, IGF1-induced microglial reactivity persists for at least 7 days after treatment. In damaged retinas, we find a transient accumulation of NIRG cells, which parallels the accumulation of reactive microglia, suggesting that the reactivity of NIRG cells and microglia are linked. When the microglia are selectively ablated by the combination of interleukin 6 and clodronate-liposomes, the NIRG cells down-regulate transitin and perish within the following week, suggesting that the survival and phenotype of NIRG cells are somehow linked to the microglia. We conclude that the abundance, reactivity and retinal distribution of NIRG cells can be dynamic, are regulated by homoestatic mechanisms and are tethered to the microglia.	[Zelinka, Christopher P.; Scott, Melissa A.; Volkov, Leo; Fischer, Andy J.] Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Zelinka, CP (corresponding author), Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA.	fischer.412@osu.edu	Fischer, Andy J./AFF-1827-2022; Fischer, Andy J./AAE-9817-2022; Fischer, Andrew J/E-3061-2011	Fischer, Andy J./0000-0001-6123-7405; Fischer, Andy J./0000-0001-6123-7405; 	National Institutes of Health [EY016043-05]; NATIONAL EYE INSTITUTE [R01EY016043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by a grant (EY016043-05) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg ND, 2010, ENDOCR DEV, V17, P63, DOI 10.1159/000262529; Bailey TJ, 2010, EXP EYE RES, V91, P601, DOI 10.1016/j.exer.2010.07.017; Boije H, 2010, DEV DYNAM, V239, P1858, DOI 10.1002/dvdy.22309; Bredariol ASD, 2001, J COMP NEUROL, V441, P58, DOI 10.1002/cne.1397; Diem R, 2003, MOL CELL NEUROSCI, V22, P487, DOI 10.1016/S1044-7431(02)00042-8; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fischer AJ, 2006, J COMP NEUROL, V496, P479, DOI 10.1002/cne.20937; Fischer AJ, 2002, DEV BIOL, V251, P367, DOI 10.1006/dbio.2002.0813; Fischer AJ, 2004, MOL VIS, V10, P973; Fischer AJ, 1999, VISION RES, V39, P685, DOI 10.1016/S0042-6989(98)00178-3; Fischer AJ, 1998, J COMP NEUROL, V393, P1; Fischer AJ, 1998, VISUAL NEUROSCI, V15, P1089, DOI 10.1017/S0952523898156080; Fischer AJ, 2008, DEV BIOL, V317, P196, DOI 10.1016/j.ydbio.2008.02.023; Fischer AJ, 2007, J COMP NEUROL, V503, P538, DOI 10.1002/cne.21404; Fischer AJ, 2011, INVEST OPHTH VIS SCI, V52, P7705, DOI 10.1167/iovs.11-8330; Fischer AJ, 2010, MOL NEUROBIOL, V42, P199, DOI 10.1007/s12035-010-8152-2; Fischer AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010774; Fischer AJ, 2010, GLIA, V58, P633, DOI 10.1002/glia.20950; Fischer AJ, 2009, GLIA, V57, P1538, DOI 10.1002/glia.20868; Fischer AJ, 2009, GLIA, V57, P166, DOI 10.1002/glia.20743; Francke M, 2001, J NEUROCYTOL, V30, P131, DOI 10.1023/A:1011987107034; Fujita Y, 2001, TISSUE CELL, V33, P129, DOI 10.1054/tice.2000.0152; Ghai K, 2010, J NEUROSCI, V30, P3101, DOI 10.1523/JNEUROSCI.4919-09.2010; Ghai K, 2009, J NEUROCHEM, V111, P1, DOI 10.1111/j.1471-4159.2009.06270.x; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hayes S, 2007, DEV BIOL, V312, P300, DOI 10.1016/j.ydbio.2007.09.046; Ide CF, 1996, PROG BRAIN RES, V108, P365, DOI 10.1016/S0079-6123(08)62552-2; Kido N, 2001, BRAIN RES, V910, P153, DOI 10.1016/S0006-8993(01)02706-8; KOHSAKA S, 1980, J NEUROCHEM, V34, P662, DOI 10.1111/j.1471-4159.1980.tb11195.x; Lamas M, 2005, INVEST OPHTH VIS SCI, V46, P3570, DOI 10.1167/iovs.04-1398; Lebrun-Julien F, 2009, J NEUROSCI, V29, P5536, DOI 10.1523/JNEUROSCI.0831-09.2009; Magnus T, 2002, J NEUROPATH EXP NEUR, V61, P760, DOI 10.1093/jnen/61.9.760; Marin-Teva JL, 1999, J COMP NEUROL, V412, P255; Marin-Teva JL, 1998, GLIA, V22, P31, DOI 10.1002/(SICI)1098-1136(199801)22:1<31::AID-GLIA4>3.0.CO;2-B; Mascarelli F, 1991, GROWTH FACTORS, V4, P81, DOI 10.3109/08977199109000260; MORGAN IG, 1981, NEUROSCI LETT, V24, P255, DOI 10.1016/0304-3940(81)90167-1; Moyse E, 2008, CURR STEM CELL RES T, V3, P163, DOI 10.2174/157488808785740334; Murphy M, 1997, PROG NEUROBIOL, V52, P355, DOI 10.1016/S0301-0082(97)00020-8; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; NARANG HK, 1977, NATURE, V266, P858, DOI 10.1038/266855a0; Neumann H, 1996, EUR J NEUROSCI, V8, P2582, DOI 10.1111/j.1460-9568.1996.tb01552.x; Park KM, 2010, CELL SIGNAL, V22, P977, DOI 10.1016/j.cellsig.2010.01.010; Rompani SB, 2010, J NEUROSCI, V30, P4970, DOI 10.1523/JNEUROSCI.3456-09.2010; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Stanke J, 2010, J COMP NEUROL, V518, P2316, DOI 10.1002/cne.22335; Stanke JJ, 2010, INVEST OPHTH VIS SCI, V51, P2208, DOI 10.1167/iovs.09-4447; Stoll G, 1998, PROG NEUROBIOL, V56, P149, DOI 10.1016/S0301-0082(98)00034-3; Torrado J., 2003, Current Pharmaceutical Biotechnology, V4, P123, DOI 10.2174/1389201033489865; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; VANROOIJEN N, 1992, RES IMMUNOL, V143, P215; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6; Won MH, 2000, MICROSC RES TECHNIQ, V50, P151, DOI 10.1002/1097-0029(20000715)50:2<151::AID-JEMT7>3.0.CO;2-5; WYSE JPH, 1981, ACTA NEUROPATHOL, V54, P203, DOI 10.1007/BF00687743; Yoneda S, 2001, EXP EYE RES, V73, P661, DOI 10.1006/exer.2001.1072	56	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44477	10.1371/journal.pone.0044477	http://dx.doi.org/10.1371/journal.pone.0044477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973454	Green Published, gold, Green Submitted			2022-12-25	WOS:000308577600060
J	Uemura, Y; Shibata, R; Ohashi, K; Enomoto, T; Kambara, T; Yamamoto, T; Ogura, Y; Yuasa, D; Joki, Y; Matsuo, K; Miyabe, M; Kataoka, Y; Murohara, T; Ouchi, N				Uemura, Yusuke; Shibata, Rei; Ohashi, Koji; Enomoto, Takashi; Kambara, Takahiro; Yamamoto, Takashi; Ogura, Yasuhiro; Yuasa, Daisuke; Joki, Yusuke; Matsuo, Kazuhiro; Miyabe, Megumi; Kataoka, Yoshiyuki; Murohara, Toyoaki; Ouchi, Noriyuki			Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation	FASEB JOURNAL			English	Article						adipocytokine; vascular remodeling; cAMP	ACTIVATED PROTEIN-KINASE; ENDOTHELIAL PROGENITOR CELLS; GROWTH-FACTOR; ISCHEMIA-REPERFUSION; INSULIN-RESISTANCE; BINDING PROTEIN; ADIPONECTIN; OBESITY; RESTENOSIS; INHIBITION	Obesity is closely associated with the progression of vascular disorders, including atherosclerosis and postangioplasty restenosis. C1q/TNF-related protein (CTRP) 9 is an adipocytokine that is down-regulated in obese mice. Here we investigated whether CTRP9 modulates neointimal hyperplasia and vascular smooth muscle cell (VSMC) proliferation in vivo and in vitro. Left femoral arteries of wild-type (WT) mice were injured by a steel wire. An adenoviral vector expressing CTRP9 (Ad-CTRP9) or beta-galactosidase as a control was intravenously injected into WT mice 3 d before vascular injury. Delivery of Ad-CTRP9 significantly attenuated the neointimal thickening and the number of bromode-oxyuridine-positive proliferating cells in the injured arteries compared with that of control. Treatment of VSMCs with CTRP9 protein attenuated the proliferative and chemotactic activities induced by growth factors including platelet-derived growth factor (PDGF)BB, and suppressed PDGF-BB-stimulated phosphorylation of ERK. CTRP9 treatment dose-dependently increased cAMP levels in VSMCs. Blockade of cAMP-PKA pathway reversed the inhibitory effect of CTRP9 on DNA synthesis and ERK phosphorylation in response to PDGF-BB. The present data indicate that CTRP9 functions to attenuate neointimal formation following vascular injury through its ability to inhibit VSMC growth via cAMP-dependent mechanism, suggesting that the therapeutic approaches to enhance CTRP9 production could be valuable for prevention of vascular restenosis after angioplasty.-Uemura, Y., Shibata, R., Ohashi, K., Enomoto, T., Kambara, T., Yamamoto, T., Ogura, Y., Yuasa, D., Joki, Y., Matsuo, K., Miyabe, M., Kataoka, Y., Murohara, T., Ouchi, N. Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation. FASEB J. 27, 25-33 (2013). www.fasebj.org	[Uemura, Yusuke; Shibata, Rei; Enomoto, Takashi; Kambara, Takahiro; Yamamoto, Takashi; Ogura, Yasuhiro; Yuasa, Daisuke; Joki, Yusuke; Matsuo, Kazuhiro; Miyabe, Megumi; Kataoka, Yoshiyuki; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Showa Ku, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University	Shibata, R (corresponding author), Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	rshibata@med.nagoya-u.ac.jp; nouchi@med.nagoya-u.ac.jp	OUCHI, Noriyuki/I-7306-2014; Murohara, Toyoaki/M-4958-2014; OHASHI, Koji/I-7307-2014	Enomoto, Takashi/0000-0002-7370-8013	Japan Society for the Promotion of Science; Senshin Medical Research Foundation; Japan Research Foundation for Clinical Pharmacology; Takeda Science Foundation; Japan Ministry of Education, Culture, Sports, Science, and Technology; Uehara Memorial Foundation; Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology; Japan Heart Foundation; Astellas/Pfizer Grant for Research on Atherosclerosis Update	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Senshin Medical Research Foundation(SENSHIN Medical Research Foundation); Japan Research Foundation for Clinical Pharmacology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology; Japan Heart Foundation; Astellas/Pfizer Grant for Research on Atherosclerosis Update	This work was supported by a Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research and grants from the Senshin Medical Research Foundation, the Japan Research Foundation for Clinical Pharmacology, and the Takeda Science Foundation to N.O.; R. S. was supported by a Japan Ministry of Education, Culture, Sports, Science, and Technology Grant-in-Aid for Young Scientists (B), the Uehara Memorial Foundation, a Japan Heart Foundation/Novartis Grant for Research Award on Molecular and Cellular Cardiology, and a Japan Heart Foundation and Astellas/Pfizer Grant for Research on Atherosclerosis Update. The authors gratefully acknowledge the technical assistance of Yoko Inoue and Miho Sakai.	Arita Y, 2002, CIRCULATION, V105, P2893, DOI 10.1161/01.CIR.0000018622.84402.FF; ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; Cospedal R., 1999, BIOCH J 2, V342, P407; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Erlinge D, 1998, GEN PHARMACOL-VASC S, V31, P1, DOI 10.1016/S0306-3623(97)00420-5; Gennaro G, 2004, CIRCULATION, V110, P3367, DOI 10.1161/01.CIR.0000147773.86866.CD; Giasson E, 1997, J BIOL CHEM, V272, P26879, DOI 10.1074/jbc.272.43.26879; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Indolfi C, 2002, CIRC RES, V91, P1190, DOI 10.1161/01.RES.0000046233.94299.D6; Indolfi C, 1997, NAT MED, V3, P775, DOI 10.1038/nm0797-775; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Kambara T, 2012, J BIOL CHEM, V287, P18965, DOI 10.1074/jbc.M112.357939; Kawabe J, 2010, ARTERIOSCL THROM VAS, V30, P464, DOI 10.1161/ATVBAHA.109.193730; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Matsuda M, 2002, J BIOL CHEM, V277, P37487, DOI 10.1074/jbc.M206083200; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Mii S, 1996, AM J PHYSIOL-HEART C, V270, pH142, DOI 10.1152/ajpheart.1996.270.1.H142; Miyake H, 2011, CIRC RES, V108, P1170, DOI 10.1161/CIRCRESAHA.110.236174; Nielsen S, 1997, CURR OPIN LIPIDOL, V8, P200, DOI 10.1097/00041433-199708000-00002; Nikolsky E, 2005, AM J CARDIOL, V95, P709, DOI 10.1016/j.amjcard.2004.11.020; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Rana JS, 2005, AM HEART J, V150, P821, DOI 10.1016/j.ahj.2004.11.022; ROSS R, 1995, ANN NY ACAD SCI, V748, P1; Ross R., 1995, ANN NY ACAD SCI, V748, P4; Rossi F, 2009, ATHEROSCLEROSIS, V203, P97, DOI 10.1016/j.atherosclerosis.2008.06.015; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Takaoka M, 2009, CIRC RES, V105, P906, DOI 10.1161/CIRCRESAHA.109.199653; Tao L, 2007, CIRCULATION, V115, P1408, DOI 10.1161/CIRCULATIONAHA.106.666941; Wang Y, 2005, J BIOL CHEM, V280, P18341, DOI 10.1074/jbc.M501149200; Wong GW, 2009, FASEB J, V23, P241, DOI 10.1096/fj.08-114991; Wong GW, 2008, BIOCHEM J, V416, P161, DOI 10.1042/BJ20081240; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wu YJ, 2006, CIRC RES, V98, P1141, DOI 10.1161/01.RES.0000219905.16312.28; Zheng QJ, 2011, ARTERIOSCL THROM VAS, V31, P2616, DOI 10.1161/ATVBAHA.111.231050	44	84	90	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					25	33		10.1096/fj.12-213744	http://dx.doi.org/10.1096/fj.12-213744			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	22972916				2022-12-25	WOS:000313103200004
J	Lin, CW; Liao, MY; Lin, WW; Wang, YP; Lu, TY; Wu, HC				Lin, Cheng-Wei; Liao, Mei-Yin; Lin, Wen-Wei; Wang, Yi-Ping; Lu, Tung-Yin; Wu, Han-Chung			Epithelial Cell Adhesion Molecule Regulates Tumor Initiation and Tumorigenesis via Activating Reprogramming Factors and Epithelial-Mesenchymal Transition Gene Expression in Colon Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; BREAST-CANCER; SELF-RENEWAL; EP-CAM; C-MYC; EPCAM; MAINTENANCE; GROWTH; ANTIBODY; MARKER	Epithelial cell adhesion molecule (EpCAM) is highly expressed in epithelial-transformed neoplasia and tumor-initiated cells (TICs), but the role that EpCAM plays in the stemness properties of TICs is still unclear. Here we show that EpCAM and reprogramming factors (c-Myc, Oct4, Nanog, and Sox2) were concomitantly elevated in TICs, which were shown to have superior self-renewal, invasiveness, and tumor-initiating abilities. Elevation of EpCAM enhanced tumorsphere formation and tumor initiation. Knock-down of EpCAM inhibited the expressions of reprogramming factors and epithelial-mesenchymal transition genes, thereby suppressing tumor initiation, self-renewal, and invasiveness. In addition, EpCAM, especially intracellular domain of EpCAM (EpICD), bound to and activated the promoter of reprogramming factors. Treatment with the inhibitor of gamma-secretase (DAPT) led to the blockage of the expressions of reprogramming factors and epithelial-mesenchymal transition genes, which was accompanied by the reduction of tumor self-renewal and invasion. Furthermore, the increased release of EpEX enhanced production of EpICD and regulated the expression of reprogramming factors. Together, these findings suggest that EpCAM plays an important role in regulating cancer-initiating abilities in TICs of colon cancer. This discovery can be used in the development of new strategies for cancer therapy.	[Lin, Cheng-Wei; Liao, Mei-Yin; Lin, Wen-Wei; Wang, Yi-Ping; Lu, Tung-Yin; Wu, Han-Chung] Acad Sinica, Inst Cellular Organism Biol, Taipei 115, Taiwan; [Wu, Han-Chung] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lin, Cheng-Wei] Taipei Med Univ, Sch Med, Dept Biochem, Taipei 110, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Taipei Medical University	Wu, HC (corresponding author), Acad Sinica, Inst Cellular & Organism Biol, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	hcw0928@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011	Wu, Han-Chung/0000-0002-5185-1169; Wang, Yi-Ping/0000-0001-9574-2194	Academia Sinica; Taiwan National Science Council [NSC-99-3111-B-001-007, NSC-100-2325-B-001-011]	Academia Sinica(Academia Sinica - Taiwan); Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica and Taiwan National Science Council Grants NSC-99-3111-B-001-007 and NSC-100-2325-B-001-011 (to H.-C.W.).	Bae KM, 2010, J UROLOGY, V183, P2045, DOI 10.1016/j.juro.2009.12.092; Burges A, 2007, CLIN CANCER RES, V13, P3899, DOI 10.1158/1078-0432.CCR-06-2769; Chaves-Perez A, 2013, ONCOGENE, V32, P641, DOI 10.1038/onc.2012.75; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Denzel S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-402; El-Sahwi K, 2010, MOL CANCER THER, V9, P57, DOI 10.1158/1535-7163.MCT-09-0675; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Herrmann I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013474; Huang HP, 2011, J BIOL CHEM, V286, P33520, DOI 10.1074/jbc.M111.256164; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; Litvinov SV, 1996, AM J PATHOL, V148, P865; Liu MR, 2009, P NATL ACAD SCI USA, V106, P19035, DOI 10.1073/pnas.0910009106; Lu TY, 2010, J BIOL CHEM, V285, P8719, DOI 10.1074/jbc.M109.077081; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Miyamoto A, 2006, J BIOL CHEM, V281, P10089, DOI 10.1074/jbc.M600298200; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Najy AJ, 2008, J BIOL CHEM, V283, P18393, DOI 10.1074/jbc.M801329200; Nubel T, 2009, MOL CANCER RES, V7, P285, DOI 10.1158/1541-7786.MCR-08-0200; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Ralhan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014130; Ralhan R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-331; Sankpal NV, 2009, CANCER RES, V69, P753, DOI 10.1158/0008-5472.CAN-08-2708; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Terris B, 2010, J HEPATOL, V52, P280, DOI 10.1016/j.jhep.2009.10.026; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Winkler J, 2009, MOL CANCER THER, V8, P2674, DOI 10.1158/1535-7163.MCT-09-0402; Xu J, 2010, CELL TRANSPLANT, V19, P43, DOI 10.3727/096368909X474339; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137	42	78	81	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.386235	http://dx.doi.org/10.1074/jbc.M112.386235			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	22989882	Green Published, hybrid			2022-12-25	WOS:000311233800017
J	Chen, CJ; Porche, K; Rayment, I; Gilbert, SP				Chen, Chun Ju; Porche, Ken; Rayment, Ivan; Gilbert, Susan P.			The ATPase Pathway That Drives the Kinesin-14 Kar3Vik1 Powerstroke	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR PROTEIN; MITOTIC MOTORS; NCD; DROSOPHILA; MICROTUBULES; CIK1; PROCESSIVITY; SEGREGATION; ROTATION; KINETICS	Kar3, a Saccharomyces cerevisiae microtubule minus-end-directed kinesin-14, dimerizes with either Vik1 or Cik1. The C-terminal globular domain of Vik1 exhibits the structure of a kinesin motor domain and binds microtubules independently of Kar3 but lacks a nucleotide binding site. The only known function of Kar3Vik1 is to cross-link parallel microtubules at the spindle poles during mitosis. In contrast, Kar3Cik1 depolymerizes microtubules during mating but cross-links antiparallel microtubules in the spindle overlap zone during mitosis. A recent study showed that Kar3Vik1 binds across adjacent microtubule protofilaments and uses a minus-end-directed power-stroke to drive ATP-dependent motility. The presteady-state experiments presented here extend this study and establish an ATPase model for the power-stroke mechanism. The results incorporated into the model indicate that Kar3Vik1 collides with the microtubule at 2.4 mu M-1 s(-1) through Vik1, promoting microtubule binding by Kar3 followed by ADP release at 14 s(-1). The tight binding of Kar3 to the microtubule destabilizes the Vik1 interaction with the microtubule, positioning Kar3Vik1 for the start of the powerstroke. Rapid ATP binding to Kar3 is associated with rotation of the coiled-coil stalk, and the post-powerstroke ATP hydrolysis at 26 s(-1) is independent of Vik1, providing further evidence that Vik1 rotates with the coiled coil during the powerstroke. Detachment of Kar3Vik1 from the microtubule at 6 s(-1) completes the cycle and allows the motor to return to its initial conformation. The results also reveal key differences in the ATPase cycles of Kar3Vik1 and Kar3Cik1, supporting the fact that these two motors have distinctive biological functions.	[Chen, Chun Ju; Porche, Ken; Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Chen, Chun Ju; Porche, Ken; Gilbert, Susan P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Wisconsin System; University of Wisconsin Madison	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Dept Biol, 110 8th St, Troy, NY 12180 USA.	sgilbert@rpi.edu	Porche, Ken/ABE-4218-2020; rayment, ivan/A-2720-2008	Porche, Ken/0000-0002-2616-5853; rayment, ivan/0000-0001-9279-7835	National Institutes of Health [GM54141, GM086351]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086351, R37GM054141, R01GM054141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54141 (to S. P. G.) and GM086351 (to I. R.).	Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; Braun M, 2009, NAT CELL BIOL, V11, P724, DOI 10.1038/ncb1878; Cai S, 2009, MOL BIOL CELL, V20, P1348, DOI 10.1091/mbc.E08-09-0971; Chen CJ, 2011, J BIOL CHEM, V286, P29261, DOI 10.1074/jbc.M111.255554; Cope J, 2010, J STRUCT BIOL, V170, P257, DOI 10.1016/j.jsb.2009.12.004; deCastro MJ, 2000, NAT CELL BIOL, V2, P724, DOI 10.1038/35036357; Endow SA, 1996, J CELL SCI, V109, P2429; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Foster KA, 1998, J BIOL CHEM, V273, P35307, DOI 10.1074/jbc.273.52.35307; Foster KA, 2000, BIOCHEMISTRY-US, V39, P1784, DOI 10.1021/bi991500b; Foster KA, 2001, J BIOL CHEM, V276, P19259, DOI 10.1074/jbc.M008347200; Gardner MK, 2008, J CELL BIOL, V180, P91, DOI 10.1083/jcb.200710164; Gilbert SP, 2011, COMPREHENSIVE BIOPHYSICS, VOL 4: MOLECULAR MOTORS AND MOTILITY, P321, DOI 10.1016/B978-0-12-374920-8.00421-5; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Krzysiak TC, 2006, J BIOL CHEM, V281, P39444, DOI 10.1074/jbc.M608056200; Mackey AT, 2004, J BIOL CHEM, V279, P51354, DOI 10.1074/jbc.M406268200; Mackey AT, 2003, J BIOL CHEM, V278, P3527, DOI 10.1074/jbc.M206219200; Manning BD, 1999, J CELL BIOL, V144, P1219, DOI 10.1083/jcb.144.6.1219; Manning BD, 2000, TRENDS CELL BIOL, V10, P281, DOI 10.1016/S0962-8924(00)01774-8; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCDONALD HB, 1990, CELL, V61, P991, DOI 10.1016/0092-8674(90)90064-L; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Oladipo A, 2007, MOL BIOL CELL, V18, P3601, DOI 10.1091/mbc.e06-12-1085; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414; PAGE BD, 1994, J CELL BIOL, V124, P507, DOI 10.1083/jcb.124.4.507; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; Rank KC, 2012, J CELL BIOL, V197, P957, DOI 10.1083/jcb.201201132; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241; Sharp DJ, 1999, NAT CELL BIOL, V1, P51, DOI 10.1038/9025; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Winey M, 2012, GENETICS, V190, P1197, DOI 10.1534/genetics.111.128710; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	51	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36673	36682		10.1074/jbc.M112.395590	http://dx.doi.org/10.1074/jbc.M112.395590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977241	hybrid, Green Published			2022-12-25	WOS:000310588500005
J	Kim, YD; Li, TG; Ahn, SW; Kim, DK; Lee, JM; Hwang, SL; Kim, YH; Lee, CH; Lee, IK; Chiang, JYL; Choi, HS				Kim, Yong Deuk; Li, Tiangang; Ahn, Seung-Won; Kim, Don-Kyu; Lee, Ji-Min; Hwang, Seung-Lark; Kim, Yong-Hoon; Lee, Chul-Ho; Lee, In-Kyu; Chiang, John Y. L.; Choi, Hueng-Sik			Orphan Nuclear Receptor Small Heterodimer Partner Negatively Regulates Growth Hormone-mediated Induction of Hepatic Gluconeogenesis through Inhibition of Signal Transducer and Activator of Transcription 5 (STAT5) Transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; GLUCOSE-6-PHOSPHATASE GENE; ATAXIA-TELANGIECTASIA; AMPK; ATM; METFORMIN; GLUCOSE; INVOLVEMENT; EXPRESSION; MECHANISM	Growth hormone (GH) is a key metabolic regulator mediating glucose and lipid metabolism. Ataxia telangiectasia mutated (ATM) is a member of the phosphatidylinositol 3-kinase superfamily and regulates cell cycle progression. The orphan nuclear receptor small heterodimer partner (SHP: NR0B2) plays a pivotal role in regulating metabolic processes. Here, we studied the role of ATM on GH-dependent regulation of hepatic gluconeogenesis in the liver. GH induced phosphoenolpyruvate carboxykinase (PEPCK) and glucose 6-phosphatase gene expression in primary hepatocytes. GH treatment and adenovirus-mediated STAT5 overexpression in hepatocytes increased glucose production, which was blocked by a JAK2 inhibitor, AG490, dominant negative STAT5, and STAT5 knockdown. We identified a STAT5 binding site on the PEPCK gene promoter using reporter assays and point mutation analysis. Up-regulation of SHP by metformin-mediated activation of the ATM-AMP-activated protein kinase pathway led to inhibition of GH-mediated induction of hepatic gluconeogenesis, which was abolished by an ATM inhibitor, KU-55933. Immunoprecipitation studies showed that SHP physically interacted with STAT5 and inhibited STAT5 recruitment on the PEPCK gene promoter. GH-induced hepatic gluconeogenesis was decreased by either metformin or Ad-SHP, whereas the inhibition by metformin was abolished by SHP knockdown. Finally, the increase of hepatic gluconeogenesis following GH treatment was significantly higher in the liver of SHP null mice compared with that of wildtype mice. Overall, our results suggest that the ATM-AMP-activated protein kinase-SHP network, as a novel mechanism for regulating hepatic glucose homeostasis via a GH-dependent pathway, may be a potential therapeutic target for insulin resistance.	[Kim, Yong Deuk; Ahn, Seung-Won; Kim, Don-Kyu; Lee, Ji-Min; Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Dept Biomed Sci, Sch Med, Res Inst Med Sci, Kwangju 501746, South Korea; [Kim, Yong Deuk; Hwang, Seung-Lark; Lee, In-Kyu] Kyungpook Natl Univ, Res Inst Aging & Metab, World Class Univ Program, Sch Med, Taegu 700721, South Korea; [Li, Tiangang; Chiang, John Y. L.] NE Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Kim, Yong-Hoon; Lee, Chul-Ho] Univ Sci & Technol, Lab Anim Ctr, Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea	Chonnam National University; Chonnam National University; Kyungpook National University; Northeast Ohio Medical University (NEOMED); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, HS (corresponding author), Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Lee, In-Kyu/AAR-6374-2021; Chiang, John Y. L./G-2658-2011	Chiang, John Y. L./0000-0001-9360-7650	National Creative Research Initiatives Center for Nuclear Receptor Signals Grant, Korean Ministry of Education, Science and Technology [20110018305]; National Research Foundation of Korea; Ministry of Education, Science and Technology [20100019512, R32-10064]; Ministry of Health Welfare [A111345]; World Class University Program through National Research Foundation of Korea; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058379, R01DK044442] Funding Source: NIH RePORTER	National Creative Research Initiatives Center for Nuclear Receptor Signals Grant, Korean Ministry of Education, Science and Technology; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health Welfare; World Class University Program through National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Creative Research Initiatives Center for Nuclear Receptor Signals Grant 20110018305 from the Korean Ministry of Education, Science and Technology and the Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant 20100019512 (to H. S. C.) and a grant of the Korea Health Technology R & D Project, Ministry of Health & Welfare Grant A111345, World Class University Program through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant R32-10064 (to I.-K. L.).	Barclay JL, 2011, ENDOCRINOLOGY, V152, P181, DOI 10.1210/en.2010-0537; Buitenhuis M, 2004, INT J BIOCHEM CELL B, V36, P2120, DOI 10.1016/j.biocel.2003.11.008; CarterSu C, 1996, ANNU REV PHYSIOL, V58, P187, DOI 10.1146/annurev.ph.58.030196.001155; Chanda D, 2008, AM J PHYSIOL-ENDOC M, V295, pE368, DOI 10.1152/ajpendo.00800.2007; Chanda D, 2008, ENDOCR J, V55, P253, DOI 10.1507/endocrj.K07E-103; Chanda D, 2009, J BIOL CHEM, V284, P28510, DOI 10.1074/jbc.M109.022244; Cho Y, 2006, ENDOCRINOLOGY, V147, P5374, DOI 10.1210/en.2006-0518; DAVIDSON MB, 1987, J ENDOCRINOL INVEST, V10, P569, DOI 10.1007/BF03346996; Dominici FP, 2002, EXP BIOL MED, V227, P149, DOI 10.1177/153537020222700301; Ghanaat F, 2005, METABOLISM, V54, P604, DOI 10.1016/j.metabol.2004.12.003; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Hogan JC, 2005, DIABETES, V54, P1968, DOI 10.2337/diabetes.54.7.1968; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim JY, 2004, MOL ENDOCRINOL, V18, P2880, DOI 10.1210/me.2004-0211; Kim ST, 2002, GENE DEV, V16, P560, DOI 10.1101/gad.970602; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Lahuna O, 2000, MOL ENDOCRINOL, V14, P285, DOI 10.1210/me.14.2.285; Lanning NJ, 2006, REV ENDOCR METAB DIS, V7, P225, DOI 10.1007/s11154-007-9025-5; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Lee YS, 2008, BIOCHEM J, V413, P559, DOI 10.1042/BJ20071637; Lee YS, 2007, INT REV CYTOL, V261, P117, DOI 10.1016/S0074-7696(07)61003-1; Lichanska AM, 2008, TRENDS GENET, V24, P41, DOI 10.1016/j.tig.2007.10.006; Massillon D, 2001, J BIOL CHEM, V276, P4055, DOI 10.1074/jbc.M007939200; McKinnon PJ, 2004, EMBO REP, V5, P772, DOI 10.1038/sj.embor.7400210; Miles PD, 2007, AM J PHYSIOL-ENDOC M, V293, pE70, DOI 10.1152/ajpendo.00259.2006; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Park YJ, 2011, J LIPID RES, V52, P2234, DOI 10.1194/jlr.M016048; Rotella CM, 2006, CURR DIABETES REV, V2, P307, DOI 10.2174/157339906777950651; SCHALCH DS, 1970, NEW ENGL J MED, V282, P1396, DOI 10.1056/NEJM197006182822503; Schmoll D, 2001, BIOCHEM J, V357, P867, DOI 10.1042/0264-6021:3570867; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sun Y, 2007, MOL CELL BIOCHEM, V306, P239, DOI 10.1007/s11010-007-9575-6; Suzuki A, 2004, BIOCHEM BIOPH RES CO, V324, P986, DOI 10.1016/j.bbrc.2004.09.145; Vijayakumar A, 2010, GROWTH HORM IGF RES, V20, P1, DOI 10.1016/j.ghir.2009.09.002; White UA, 2007, DIABETES, V56, P1623, DOI 10.2337/db06-1286; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735	39	30	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37098	37108		10.1074/jbc.M112.339887	http://dx.doi.org/10.1074/jbc.M112.339887			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977252	hybrid, Green Published			2022-12-25	WOS:000310588500044
J	Berendes, S; Adeyemi, O; Oladele, EA; Oresanya, OB; Okoh, F; Valadez, JJ				Berendes, Sima; Adeyemi, Olusegun; Oladele, Edward Adekola; Oresanya, Olusola Bukola; Okoh, Festus; Valadez, Joseph J.			Are Patent Medicine Vendors Effective Agents in Malaria Control? Using Lot Quality Assurance Sampling to Assess Quality of Practice in Jigawa, Nigeria	PLOS ONE			English	Article							SOUTH-EAST NIGERIA; RURAL TANZANIA; FALCIPARUM-MALARIA; ANTIMALARIAL-DRUGS; PRIVATE-SECTOR; CARE; SELLERS; URBAN; KENYA; AVAILABILITY	Background: Patent medicine vendors (PMV) provide antimalarial treatment and care throughout Sub-Saharan Africa, and can play an important role in the fight against malaria. Their close-to-client infrastructure could enable lifesaving artemisinin-based combination therapy (ACT) to reach patients in time. However, systematic assessments of drug sellers' performance quality are crucial if their role is to be managed within the health system. Lot quality assurance sampling (LQAS) could be an efficient method to monitor and evaluate PMV practice, but has so far never been used for this purpose. Methods: In support of the Nigeria Malaria Booster Program we assessed PMV practices in three Senatorial Districts (SDs) of Jigawa, Nigeria. A two-stage LQAS assessed whether at least 80% of PMV stores in SDs used national treatment guidelines. Acceptable sampling errors were set in consultation with government officials (alpha and beta <0.10). The hypergeometric formula determined sample sizes and cut-off values for SDs. A structured assessment tool identified high and low performing SDs for quality of care indicators. Findings: Drug vendors performed poorly in all SDs of Jigawa for all indicators. For example, all SDs failed for stocking and selling first-line antimalarials. PMV sold no longer recommended antimalarials, such as Chloroquine, Sulfadoxine-Pyrimethamine and oral Artesunate monotherapy. Most PMV were ignorant of and lacked training about new treatment guidelines that had endorsed ACTs as first-line treatment for uncomplicated malaria. Conclusion: There is urgent need to regularly monitor and improve the availability and quality of malaria treatment provided by medicine sellers in Nigeria; the irrational use of antimalarials in the ACT era revealed in this study bears a high risk of economic loss, death and development of drug resistance. LQAS has been shown to be a suitable method for monitoring malaria-related indicators among PMV, and should be applied in Nigeria and elsewhere to improve service delivery.	[Berendes, Sima; Adeyemi, Olusegun; Oladele, Edward Adekola; Valadez, Joseph J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Oladele, Edward Adekola] LAUTECH Univ Teaching Hosp, Osogbo, Osun State, Nigeria; [Oresanya, Olusola Bukola; Okoh, Festus] Fed Minist Hlth, Natl Malaria Control Program, Abuja, Nigeria	Liverpool School of Tropical Medicine; University of Liverpool	Berendes, S (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	berendes@liverpool.ac.uk	Oresanya, Olusola/AAV-5050-2020; Berendes, Sima/AAH-9616-2019	Oresanya, Olusola/0000-0002-8261-705X; Berendes, Sima/0000-0001-7000-868X; Valadez, Joseph/0000-0002-6575-6592; Oladele, Edward Adekola/0000-0003-4999-1397	National Malaria Control Programme of Nigeria; ExxonMobil Foundation; Liverpool School of Tropical Medicine International Health Group; Kenneth Newell Memorial Award	National Malaria Control Programme of Nigeria; ExxonMobil Foundation(Exxon Mobil Corporation); Liverpool School of Tropical Medicine International Health Group; Kenneth Newell Memorial Award	This work was supported by the National Malaria Control Programme of Nigeria and a grant from the ExxonMobil Foundation to the World Bank to support the Malaria Control Booster Project for Africa. It was also supported by funding through the Liverpool School of Tropical Medicine International Health Group, and a Kenneth Newell Memorial Award which financed the data entry cleaning and analysis. Neither funder had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008937; ACT Watch, 2008, OUTL SURV REP BAS; Akuse RM, 2010, MALARIA RES TREATMEN, V2010; [Anonymous], 2012, NIG MAL IND SURV 201; [Anonymous], 2001, ANT DRUG COMB THER; [Anonymous], BRIXT HLTH LQAS SAMP; Berenson MLD, 2007, CONFIDENCE INTERVAL; Biedron C, 2010, INT J EPIDEMIOL, V39, P72, DOI 10.1093/ije/dyp363; Brieger WR, 2004, HEALTH POLICY PLANN, V19, P177, DOI 10.1093/heapol/czh021; Brooker S, 2005, TROP MED INT HEALTH, V10, P647, DOI 10.1111/j.1365-3156.2005.01446.x; Brugha R, 1998, HEALTH POLICY PLANN, V13, P107, DOI 10.1093/heapol/13.2.107; Brugha R, 1999, TROP MED INT HEALTH, V4, P402, DOI 10.1046/j.1365-3156.1999.00411.x; Buabeng KO, 2008, CLIN PHARMACOL THER, V84, P613, DOI 10.1038/clpt.2008.130; CSTS+, 2006, RAP HLTH FAC ASS 2 1; Dodge HF, 1929, BELL SYST TECH J, V8, P398; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Federal Ministry of Health, 2006, 5 YEAR STRAT PLAN 20; Federal Ministry of Health, 2011, FED REP NIG NAT POL; FOSTER SD, 1991, B WORLD HEALTH ORGAN, V69, P349; Gilpin U, 2006, ARTEMISININ COMBINAT; Goodman C, 2004, TROP MED INT HEALTH, V9, P655, DOI 10.1111/j.1365-3156.2004.01245.x; Goodman C, 2007, AM J TROP MED HYG, V77, P203, DOI 10.4269/ajtmh.2007.77.203; Goodman C, 2007, HEALTH POLICY PLANN, V22, P393, DOI 10.1093/heapol/czm033; Greer G, 2004, IMPROVING MANAGEMENT; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; Hetzel MW, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-83; Hetzel MW, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-157; K Punith, 2008, Indian J Community Med, V33, P151, DOI 10.4103/0970-0218.42049; Kachur SP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-25; Mangham LJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-155; Marsh VM, 2004, TROP MED INT HEALTH, V9, P451, DOI 10.1111/j.1365-3156.2004.01223.x; National Malaria Control Program, 2009, DET IMPL PLAN HLTH F; National Malaria Control Programme, 2011, IMPL GUID PAR BAS DI; Okeke TA, 2010, HEALTH POLICY, V95, P62, DOI 10.1016/j.healthpol.2009.11.005; Okeke TA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-260; Okeke TA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-97; Oladepo O, 2007, MALARIA TREATMENT PO, V11, P1; Oladepo O, 2008, MALARIA TREATMENT NI, P1; Onwujekwe O, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-22; Onwujekwe O, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-5; Palafox B, 2009, PRIVATE COMMERCIAL S; Pharmacists council of Nigeria, 2003, APPR PAT MED LIST; Robertson SE, 2006, SOC SCI MED, V63, P1648, DOI 10.1016/j.socscimed.2006.04.011; Robertson Susan E., 1997, World Health Statistics Quarterly, V50, P199; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2012, AFF MED FAC MAL 1 LI; Uzochukwu BSC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001788; Valadez J, 2002, DECENTRALIZED SUPERV; Valadez JJ, 1997, STUD FAMILY PLANN, V28, P143, DOI 10.2307/2138116; VALADEZ JJ, 1995, AM J PUBLIC HEALTH, V85, P1165, DOI 10.2105/AJPH.85.8_Pt_1.1165-a; Valadez JJ, 1996, INT J EPIDEMIOL, V25, P381, DOI 10.1093/ije/25.2.381; Valadez JJ, 1991, ASSESSING CHILD SURV; WHO, 2010, WORLD MALARIA REPORT 2010, P1; *WHO, 2006, PARTN MAL CONTR ENG; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; World Bank, 2006, PROJ APPR DOC PROP C	55	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44775	10.1371/journal.pone.0044775	http://dx.doi.org/10.1371/journal.pone.0044775			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984555	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000308738500082
J	Chen, LX; Ren, YL; Lin, JQ; Liu, XM; Pang, X; Lin, JQ				Chen, Linxu; Ren, Yilin; Lin, Jianqun; Liu, Xiangmei; Pang, Xin; Lin, Jianqiang			Acidithiobacillus caldus Sulfur Oxidation Model Based on Transcriptome Analysis between the Wild Type and Sulfur Oxygenase Reductase Defective Mutant	PLOS ONE			English	Article							PARACOCCUS-PANTOTROPHUS; THIOBACILLUS-CALDUS; GENOME SEQUENCE; FERROOXIDANS; GENE; IRON; PURIFICATION; EXPRESSION; RHODANESE; BACTERIA	Background: Acidithiobacillus caldus (A. caldus) is widely used in bio-leaching. It gains energy and electrons from oxidation of elemental sulfur and reduced inorganic sulfur compounds (RISCs) for carbon dioxide fixation and growth. Genomic analyses suggest that its sulfur oxidation system involves a truncated sulfur oxidation (Sox) system (omitting SoxCD), non-Sox sulfur oxidation system similar to the sulfur oxidation in A. ferrooxidans, and sulfur oxygenase reductase (SOR). The complexity of the sulfur oxidation system of A. caldus generates a big obstacle on the research of its sulfur oxidation mechanism. However, the development of genetic manipulation method for A. caldus in recent years provides powerful tools for constructing genetic mutants to study the sulfur oxidation system. Results: An A. caldus mutant lacking the sulfur oxygenase reductase gene (sor) was created and its growth abilities were measured in media using elemental sulfur (S-0) and tetrathionate (K2S4O6) as the substrates, respectively. Then, comparative transcriptome analysis (microarrays and real-time quantitative PCR) of the wild type and the Delta sor mutant in S-0 and K2S4O6 media were employed to detect the differentially expressed genes involved in sulfur oxidation. SOR was concluded to oxidize the cytoplasmic elemental sulfur, but could not couple the sulfur oxidation with the electron transfer chain or substrate-level phosphorylation. Other elemental sulfur oxidation pathways including sulfur diooxygenase (SDO) and heterodisulfide reductase (HDR), the truncated Sox pathway, and the S4I pathway for hydrolysis of tetrathionate and oxidation of thiosulfate in A. caldus are proposed according to expression patterns of sulfur oxidation genes and growth abilities of the wild type and the mutant in different substrates media. Conclusion: An integrated sulfur oxidation model with various sulfur oxidation pathways of A. caldus is proposed and the features of this model are summarized.	[Chen, Linxu; Lin, Jianqun; Liu, Xiangmei; Pang, Xin; Lin, Jianqiang] Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China; [Ren, Yilin] Shandong Normal Univ, Sch Life Sci, Jinan, Peoples R China	Shandong University; Shandong Normal University	Chen, LX (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	jianqunlin@sdu.edu.cn	Lin, Jianqiang/ABC-6345-2021	, Linxu/0000-0001-6620-6798	National Basic Research Program [2010CB630902, 2004CB619202]; National Natural Science Foundation [31070034]; Knowledge Innovation Program of CAS of China [2AKSCX2-YW-JS401]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of CAS of China	This research was supported by the National Basic Research Program (http://www.973.gov.cn)(2010CB630902, 2004CB619202), the National Natural Science Foundation (http://www.nsfc.gov.cn)(31070034), and the Knowledge Innovation Program of CAS (http://www.cas.cn)(2AKSCX2-YW-JS401) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billaut-Laden I, 2006, TOXICOLOGY, V225, P1, DOI 10.1016/j.tox.2006.04.054; Bugaytsova Z, 2004, EUR J BIOCHEM, V271, P272, DOI 10.1046/j.1432-1033.2003.03926.x; BUONFIGLIO V, 1993, FEMS MICROBIOL REV, V11, P43, DOI 10.1016/0168-6445(93)90022-2; Cabrejos ME, 1999, FEMS MICROBIOL LETT, V175, P223, DOI 10.1111/j.1574-6968.1999.tb13624.x; Castelle C, 2008, J BIOL CHEM, V283, P25803, DOI 10.1074/jbc.M802496200; Chen LX, 2010, J MICROBIOL BIOTECHN, V20, P39, DOI 10.4014/jmb.0905.05023; Chen ZW, 2007, APPL MICROBIOL BIOT, V74, P688, DOI 10.1007/s00253-006-0691-0; Dahl Christiane, 2006, V1, P21, DOI 10.1007/7171_002; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; Dopson M, 1999, APPL ENVIRON MICROB, V65, P36; Edwards KJ, 2000, ENVIRON MICROBIOL, V2, P324, DOI 10.1046/j.1462-2920.2000.00111.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Friedrich CG, 2000, J BACTERIOL, V182, P4677, DOI 10.1128/JB.182.17.4677-4687.2000; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Gardner MN, 2000, J APPL MICROBIOL, V89, P185, DOI 10.1046/j.1365-2672.2000.01117.x; Ghosh W, 2009, FEMS MICROBIOL REV, V33, P999, DOI 10.1111/j.1574-6976.2009.00187.x; Hallberg KB, 1996, J BACTERIOL, V178, P6, DOI 10.1128/jb.178.1.6-11.1996; Hallberg KB, 1996, APPL ENVIRON MICROB, V62, P4243, DOI 10.1128/AEM.62.11.4243-4246.1996; HALLBERG KB, 1994, MICROBIOL-SGM, V140, P3451, DOI 10.1099/13500872-140-12-3451; Huan H, 2009, STUDY SPECIATION TRA; JIN SM, 1992, APPL ENVIRON MICROB, V58, P429, DOI 10.1128/AEM.58.1.429-430.1992; Kamimura K, 1999, MICROBIOS, V99, P7; KLETZIN A, 1992, J BACTERIOL, V174, P5854, DOI 10.1128/jb.174.18.5854-5859.1992; Kletzin A, 2004, J BIOENERG BIOMEMBR, V36, P77, DOI 10.1023/B:JOBB.0000019600.36757.8c; KLETZIN A, 1989, J BACTERIOL, V171, P1638, DOI 10.1128/jb.171.3.1638-1643.1989; Liu XM, 2007, J MICROBIOL BIOTECHN, V17, P162; [刘缨 Liu Ying], 2004, [微生物学报, Acta Microbiologica Sinica], V44, P382; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mangold S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00017; MEULENBERG R, 1992, ARCH MICROBIOL, V157, P161, DOI 10.1007/BF00245285; Muller FH, 2004, MOL MICROBIOL, V53, P1147, DOI 10.1111/j.1365-2958.2004.04193.x; Okibe N, 2003, APPL ENVIRON MICROB, V69, P1936, DOI 10.1128/AEM.69.4.1936-1943.2003; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Quatrini R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-394; Quentmeier A, 2001, FEBS LETT, V503, P168, DOI 10.1016/S0014-5793(01)02727-2; Rainey FA, 1999, INT J SYST BACTERIOL, V49, P645, DOI 10.1099/00207713-49-2-645; Ramirez P, 2004, APPL ENVIRON MICROB, V70, P4491, DOI 10.1128/AEM.70.8.4491-4498.2004; Rawlings DE, 1998, J IND MICROBIOL BIOT, V20, P268, DOI 10.1038/sj.jim.2900522; Rohwerder T, 2007, ENG LIFE SCI, V7, P301, DOI 10.1002/elsc.200720204; Rohwerder T, 2003, MICROBIOL-SGM, V149, P1699, DOI 10.1099/mic.0.26212-0; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; SCHLESINGER P, 1974, J BIOL CHEM, V249, P780; SCHRADER JA, 1988, J BACTERIOL, V170, P3915, DOI 10.1128/jb.170.9.3915-3923.1988; Steudel R, 2000, CHEM SULFUR CYCLE; Sugio T, 2005, P 16 INT BIOH S CAP, P25; Sun CW, 2003, EXTREMOPHILES, V7, P131, DOI 10.1007/s00792-002-0304-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Urich T, 2004, BIOCHEM J, V381, P137, DOI 10.1042/BJ20040003; Valdes J, 2008, HYDROMETALLURGY, V94, P180, DOI 10.1016/j.hydromet.2008.05.039; Valdes J, 2009, J BACTERIOL, V191, P5877, DOI 10.1128/JB.00843-09; Valdes J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-597; van Zyl LJ, 2008, APPL ENVIRON MICROB, V74, P5686, DOI 10.1128/AEM.01235-08; Wakai S, 2004, BIOSCI BIOTECH BIOCH, V68, P2519, DOI 10.1271/bbb.68.2519; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; You XY, 2011, J GENET GENOMICS, V38, P243, DOI 10.1016/j.jgg.2011.04.006	58	70	75	11	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e39470	10.1371/journal.pone.0039470	http://dx.doi.org/10.1371/journal.pone.0039470			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984393	Green Submitted, Green Published, gold			2022-12-25	WOS:000308738500001
J	Engels, S; Hein, CM; Lefeldt, N; Prior, H; Mouritsen, H				Engels, Svenja; Hein, Christine Maira; Lefeldt, Nele; Prior, Helmut; Mouritsen, Henrik			Night-Migratory Songbirds Possess a Magnetic Compass in Both Eyes	PLOS ONE			English	Article							PHOTORECEPTOR-BASED MAGNETORECEPTION; POLARIZED-LIGHT CUES; VISUAL LATERALIZATION; CLUSTER-N; ORIENTATION; BIRDS; CRYPTOCHROME; BRAIN; MODEL; CALIBRATION	Previous studies on European robins, Erithacus rubecula, and Australian silvereyes, Zosterops lateralis, had suggested that magnetic compass information is being processed only in the right eye and left brain hemisphere of migratory birds. However, recently it was demonstrated that both garden warblers, Sylvia borin, and European robins have a magnetic compass in both eyes. These results raise the question if the strong lateralization effect observed in earlier experiments might have arisen from artifacts or from differences in experimental conditions rather than reflecting a true all-or-none lateralization of the magnetic compass in European robins. Here we show that (1) European robins having only their left eye open can orient in their seasonally appropriate direction both during autumn and spring, i.e. there are no strong lateralization differences between the outward journey and the way home, that (2) their directional choices are based on the standard inclination compass as they are turned 180 degrees when the inclination is reversed, and that (3) the capability to use the magnetic compass does not depend on monocular learning or intraocular transfer as it is already present in the first tests of the birds with only one eye open.	[Engels, Svenja; Hein, Christine Maira; Lefeldt, Nele; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, IBU, AG Neurosensor Anim Nav, D-2900 Oldenburg, Germany; [Engels, Svenja; Hein, Christine Maira; Lefeldt, Nele; Mouritsen, Henrik] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, D-2900 Oldenburg, Germany; [Prior, Helmut] Goethe Univ Frankfurt, Inst Psychol, Frankfurt, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Goethe University Frankfurt	Engels, S (corresponding author), Carl von Ossietzky Univ Oldenburg, IBU, AG Neurosensor Anim Nav, D-2900 Oldenburg, Germany.	henrik.mouritsen@uni-oldenburg.de	Mouritsen, Henrik/A-5401-2010	Mouritsen, Henrik/0000-0001-7082-4839	Volkswagen-Stiftung; Deutsche Forschungsgemeinschaft [FOR 701, Pr 489/4-2]; Heinz Neumuller Stiftung	Volkswagen-Stiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heinz Neumuller Stiftung	This work was supported by the Volkswagen-Stiftung (Lichtenberg-Professorship grant to HM), the Deutsche Forschungsgemeinschaft (FOR 701 grant to HM; Pr 489/4-2 to HP) and the Heinz Neumuller Stiftung (SE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batschelet E, 1981, CIRCULAR STAT BIOL; Chernetsov N, 2008, CURR BIOL, V18, P188, DOI 10.1016/j.cub.2008.01.018; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; COWAN WM, 1963, PROC R SOC SER B-BIO, V158, P232, DOI 10.1098/rspb.1963.0045; Diekamp B, 2002, BEHAV BRAIN RES, V136, P103, DOI 10.1016/S0166-4328(02)00106-7; EMLEN ST, 1966, AUK, V83, P361, DOI 10.2307/4083048; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Freire R, 2010, J EXP BIOL, V213, P3423, DOI 10.1242/jeb.047613; Gagliardo A, 2005, EUR J NEUROSCI, V22, P2549, DOI 10.1111/j.1460-9568.2005.04444.x; Gagliardo A, 2005, EUR J NEUROSCI, V22, P189, DOI 10.1111/j.1460-9568.2005.04204.x; Gunturkun O, 1997, NEUROREPORT, V8, pR3; Hart NS, 2000, CURR BIOL, V10, P115, DOI 10.1016/S0960-9822(00)00297-9; Hein CM, 2011, NATURE, V471, pE11, DOI 10.1038/nature09875; Hein CM, 2010, J R SOC INTERFACE, V7, pS227, DOI 10.1098/rsif.2009.0376.focus; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Liedvogel M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001106; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Liedvogel M, 2010, J R SOC INTERFACE, V7, pS147, DOI 10.1098/rsif.2009.0411.focus; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; MCGILL JI, 1966, J ANAT, V100, P5; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Mouritsen H, 1998, J EXP BIOL, V201, P2927; Mouritsen H, 1998, ANIM BEHAV, V55, P1311, DOI 10.1006/anbe.1997.0696; Mouritsen H, 2000, J THEOR BIOL, V207, P283, DOI 10.1006/jtbi.2000.2171; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Mouritsen H, 2005, P NATL ACAD SCI USA, V102, P8339, DOI 10.1073/pnas.0409575102; Mouritsen H, 2004, CURR BIOL, V14, P1946, DOI 10.1016/j.cub.2004.10.025; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Mouritsen H, 2003, AVIAN MIGRATION, P493; Mouritsen H, 2012, CURR OPIN NEUROBIOL, V22, P343, DOI 10.1016/j.conb.2012.01.005; Mouritsen H, 2009, J ORNITHOL, V150, P713, DOI 10.1007/s10336-009-0421-3; Muheim R, 2006, J EXP BIOL, V209, P2, DOI 10.1242/jeb.01960; Muheim R, 2006, SCIENCE, V313, P837, DOI 10.1126/science.1129709; Muheim R, 2009, J EXP BIOL, V212, P3466, DOI 10.1242/jeb.032771; PERDECK A. C., 1958, ARDEA, V46, P1; Prior H, 2004, BEHAV BRAIN RES, V154, P301, DOI 10.1016/j.bbr.2004.02.018; Prior H, 2002, J EXP BIOL, V205, P1795; Prior H, 2006, MOL BIOL INTELL UNIT, P75; Rattenborg NC, 2006, NATURWISSENSCHAFTEN, V93, P413, DOI 10.1007/s00114-006-0120-3; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2010, J R SOC INTERFACE, V7, pS135, DOI 10.1098/rsif.2009.0456.focus; Rogers LJ, 2008, BEHAV BRAIN RES, V186, P66, DOI 10.1016/j.bbr.2007.07.029; Rogers LJ., 2002, COMP VERTEBRATE LATE; SCHULTEN K, 1978, BIOPHYS J, V24, P295, DOI 10.1016/S0006-3495(78)85378-8; SCHULTEN K, 1978, Z PHYS CHEM NEUE FOL, V111, P1, DOI 10.1524/zpch.1978.111.1.001; Skiba M, 2000, BRAIN LANG, V73, P254, DOI 10.1006/brln.2000.2306; Solov'yov IA, 2010, BIOPHYS J, V99, P40, DOI 10.1016/j.bpj.2010.03.053; Ulrich C, 1999, BEHAV BRAIN RES, V104, P169, DOI 10.1016/S0166-4328(99)00062-5; Wiltschko R, 2005, CURR BIOL, V15, P1518, DOI 10.1016/j.cub.2005.07.037; Wiltschko R, 2010, CURR ZOOL, V56, P265, DOI 10.1093/czoolo/56.3.265; Wiltschko R, 2010, J R SOC INTERFACE, V7, pS163, DOI 10.1098/rsif.2009.0367.focus; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Wiltschko W, 2003, AUST J ZOOL, V51, P597, DOI 10.1071/ZO03022; WILTSCHKO W, 1993, NATURE, V364, P525, DOI 10.1038/364525a0; Wiltschko W, 2002, NATURWISSENSCHAFTEN, V89, P445, DOI 10.1007/s00114-002-0356-5; Wiltschko W, 2002, NATURE, V419, P467, DOI 10.1038/nature00958; Wiltschko W, 2007, J ORNITHOL, V148, pS61, DOI 10.1007/s10336-007-0233-2; Wiltschko W, 2011, NATURE, V471, pE12, DOI 10.1038/nature09876; Wilzeck C, 2010, J R SOC INTERFACE, V7, pS235, DOI 10.1098/rsif.2009.0436.focus; Zapka M, 2010, EUR J NEUROSCI, V32, P619, DOI 10.1111/j.1460-9568.2010.07311.x; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	63	23	23	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43271	10.1371/journal.pone.0043271	http://dx.doi.org/10.1371/journal.pone.0043271			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984416	Green Submitted, gold, Green Published			2022-12-25	WOS:000308738500008
J	Thanwisai, A; Tandhavanant, S; Saiprom, N; Waterfield, NR; Long, PK; Bode, HB; Peacock, SJ; Chantratita, N				Thanwisai, Aunchalee; Tandhavanant, Sarunporn; Saiprom, Natnaree; Waterfield, Nick R.; Phan Ke Long; Bode, Helge B.; Peacock, Sharon J.; Chantratita, Narisara			Diversity of Xenorhabdus and Photorhabdus spp. and Their Symbiotic Entomopathogenic Nematodes from Thailand	PLOS ONE			English	Article							HETERORHABDITIDAE; LUMINESCENS; ASYMBIOTICA; PHYLOGENY; SEQUENCES; PATHOGEN; DNA	Xenorhabdus and Photorhabdus spp. are bacterial symbionts of entomopathogenic nematodes (EPNs). In this study, we isolated and characterized Xenorhabdus and Photorhabdus spp. from across Thailand together with their associated nematode symbionts, and characterized their phylogenetic diversity. EPNs were isolated from soil samples using a Galleria-baiting technique. Bacteria from EPNs were cultured and genotyped based on recA sequence. The nematodes were identified based on sequences of 28S rDNA and internal transcribed spacer regions. A total of 795 soil samples were collected from 159 sites in 13 provinces across Thailand. A total of 126 EPNs isolated from samples taken from 10 provinces were positive for Xenorhabdus (n = 69) or Photorhabdus spp. (n = 57). Phylogenetic analysis separated the 69 Xenorhabdus isolates into 4 groups. Groups 1, 2 and 3 consisting of 52, 13 and 1 isolates related to X. stockiae, and group 4 consisting of 3 isolates related to X. miraniensis. The EPN host for isolates related to X. stockiae was S. websteri, and for X. miraniensis was S. khoisanae. The Photorhabdus species were identified as P. luminescens (n = 56) and P. asymbiotica (n = 1). Phylogenenic analysis divided P. luminescens into five groups. Groups 1 and 2 consisted of 45 and 8 isolates defined as subspecies hainanensis and akhurstii, respectively. One isolate was related to hainanensis and akhurstii, two isolates were related to laumondii, and one isolate was the pathogenic species P. asymbiotica subsp. australis. H. indica was the major EPN host for Photorhabdus. This study reveals the genetic diversity of Xenorhabdus and Photorhabdus spp. and describes new associations between EPNs and their bacterial symbionts in Thailand.	[Thanwisai, Aunchalee; Tandhavanant, Sarunporn; Saiprom, Natnaree; Peacock, Sharon J.; Chantratita, Narisara] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand; [Thanwisai, Aunchalee; Tandhavanant, Sarunporn; Peacock, Sharon J.; Chantratita, Narisara] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand; [Waterfield, Nick R.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Phan Ke Long] Vietnam Acad Sci & Technol, Vietnam Natl Museum Nat, Hanoi, Vietnam; [Bode, Helge B.] Goethe Univ Frankfurt, Inst Mol Biosci, Frankfurt, Germany; [Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England	Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Bath; Vietnam Academy of Science & Technology (VAST); Goethe University Frankfurt; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Thanwisai, A (corresponding author), Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand.	narisara@tropmedres.ac	Bode, Helge B/F-7022-2014; Chantratita, Narisara/P-2169-2019; Tandhavanant, Sarunporn/Q-7376-2019; Tandhavanant, Sarunporn/R-7620-2019; Peacock, Sharon J/ABE-6331-2020	Bode, Helge B/0000-0001-6048-5909; Tandhavanant, Sarunporn/0000-0003-0261-3233; Tandhavanant, Sarunporn/0000-0003-0261-3233; Waterfield, Nicholas/0000-0002-8044-7763; Peacock, Sharon/0000-0002-1718-2782	European Commission [HEALTH-F3-2009-223328-GAMEXP]; PhD Sandwich Program of Commission on Higher Education, Ministry of Education of Thailand; Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK [087769/Z/08/Z]; NIHR Cambridge Biomedical Research Centre; BBSRC [BB/E021328/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E021328/1] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); PhD Sandwich Program of Commission on Higher Education, Ministry of Education of Thailand; Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK(Wellcome Trust); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the European Commission under the seventh Framework Programme Grant HEALTH-F3-2009-223328-GAMEXP. AT is supported by a scholarship under a PhD Sandwich Program of Commission on Higher Education, Ministry of Education of Thailand. NC is supported by a Wellcome Trust Career Development award in Public Health and Tropical Medicine, UK (grant 087769/Z/08/Z). SJP is supported by the NIHR Cambridge Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahantarig A, 2009, APPL ENVIRON MICROB, V75, P4627, DOI 10.1128/AEM.00221-09; AKHURST RJ, 1980, J GEN MICROBIOL, V121, P303; BEDDING RA, 1975, NEMATOLOGICA, V21, P109, DOI 10.1163/187529275X00419; Chaston JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027909; Dolinski C, 2008, MEM I OSWALDO CRUZ, V103, P150, DOI 10.1590/S0074-02762008000200005; Edgington S, 2011, J HELMINTHOL, V85, P381, DOI 10.1017/S0022149X10000702; Ferreira TD, 2011, J INVERTEBR PATHOL, V107, P164, DOI 10.1016/j.jip.2011.04.002; Gerrard JG, 2006, EMERG INFECT DIS, V12, P1562, DOI 10.3201/eid1210.060464; Goodrich-Blair H, 2007, MOL MICROBIOL, V64, P260, DOI 10.1111/j.1365-2958.2007.05671.x; Hominick WM, 1996, BIOCONTROL SCI TECHN, V6, P317, DOI 10.1080/09583159631307; Hominick WM, 1997, J HELMINTHOL, V71, P271, DOI 10.1017/S0022149X00016096; Joyce SA, 2008, ANGEW CHEM INT EDIT, V47, P1942, DOI 10.1002/anie.200705148; Kanga FN, 2012, J INVERTEBR PATHOL, V109, P41, DOI 10.1016/j.jip.2011.09.008; Lee MM, 2010, J INVERTEBR PATHOL, V104, P67, DOI 10.1016/j.jip.2010.01.005; Maneesakorn P, 2011, MOL PHYLOGENET EVOL, V59, P271, DOI 10.1016/j.ympev.2011.02.012; Nguyen KB, 2010, J INVERTEBR PATHOL, V103, P8, DOI 10.1016/j.jip.2009.09.004; Phan KL, 2003, NEMATOLOGY, V5, P367, DOI 10.1163/156854103769224368; RAINEY FA, 1995, INT J SYST BACTERIOL, V45, P379, DOI 10.1099/00207713-45-2-379; Sharma S, 2002, FEMS MICROBIOL LETT, V214, P241, DOI 10.1111/j.1574-6968.2002.tb11354.x; Stock SP, 2009, J INVERTEBR PATHOL, V100, P175, DOI 10.1016/j.jip.2008.11.011; Stock SP, 2001, J PARASITOL, V87, P877, DOI 10.2307/3285148; Szallas E, 1997, INT J SYST BACTERIOL, V47, P402, DOI 10.1099/00207713-47-2-402; Tailliez P, 2006, INT J SYST EVOL MICR, V56, P2805, DOI 10.1099/ijs.0.64287-0; Tailliez P, 2010, INT J SYST EVOL MICR, V60, P1921, DOI 10.1099/ijs.0.014308-0; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Weissfeld AS, 2005, J CLIN MICROBIOL, V43, P4152, DOI 10.1128/JCM.43.8.4152-4155.2005; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a	30	56	56	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43835	10.1371/journal.pone.0043835	http://dx.doi.org/10.1371/journal.pone.0043835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984446	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500024
J	Patalay, R; Talbot, C; Alexandrov, Y; Lenz, MO; Kumar, S; Warren, S; Munro, I; Neil, MAA; Konig, K; French, PMW; Chu, A; Stamp, GWH; Dunsby, C				Patalay, Rakesh; Talbot, Clifford; Alexandrov, Yuriy; Lenz, Martin O.; Kumar, Sunil; Warren, Sean; Munro, Ian; Neil, Mark A. A.; Koenig, Karsten; French, Paul M. W.; Chu, Anthony; Stamp, Gordon W. H.; Dunsby, Chris			Multiphoton Multispectral Fluorescence Lifetime Tomography for the Evaluation of Basal Cell Carcinomas	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; IN-VIVO; MICROSCOPY; TRENDS	We present the first detailed study using multispectral multiphoton fluorescence lifetime imaging to differentiate basal cell carcinoma cells (BCCs) from normal keratinocytes. Images were acquired from 19 freshly excised BCCs and 27 samples of normal skin (in & ex vivo). Features from fluorescence lifetime images were used to discriminate BCCs with a sensitivity/specificity of 79%/93% respectively. A mosaic of BCC fluorescence lifetime images covering >1 mm(2) is also presented, demonstrating the potential for tumour margin delineation. Using 10,462 manually segmented cells from the image data, we quantify the cellular morphology and spectroscopic differences between BCCs and normal skin for the first time. Statistically significant increases were found in the fluorescence lifetimes of cells from BCCs in all spectral channels, ranging from 19.9% (425-515 nm spectral emission) to 39.8% (620-655 nm emission). A discriminant analysis based diagnostic algorithm allowed the fraction of cells classified as malignant to be calculated for each patient. This yielded a receiver operator characteristic area under the curve for the detection of BCC of 0.83. We have used both morphological and spectroscopic parameters to discriminate BCC from normal skin, and provide a comprehensive base for how this technique could be used for BCC assessment in clinical practice.	[Patalay, Rakesh; Talbot, Clifford; Alexandrov, Yuriy; Lenz, Martin O.; Kumar, Sunil; Warren, Sean; Munro, Ian; Neil, Mark A. A.; French, Paul M. W.; Dunsby, Chris] Univ London Imperial Coll Sci Technol & Med, Dept Phys, Photon Grp, London, England; [Patalay, Rakesh; Chu, Anthony] Imperial Coll Healthcare NHS Trust, Dept Dermatol, London, England; [Dunsby, Chris] Imperial Coll Healthcare NHS Trust, Dept Med, London, England; [Koenig, Karsten] JenLab GmbH, Jena, Germany; [Stamp, Gordon W. H.] CRUK London Res Inst, London, England	Imperial College London; Imperial College London; Imperial College London; JenLab GmbH; Cancer Research UK	Patalay, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Phys, Photon Grp, S Kensington Campus, London, England.	christopher.dunsby@imperial.ac.uk	French, Paul/E-8649-2011; Warren, Sean C./A-9392-2016; Lenz, Martin/ABE-1640-2020; Neil, Mark A/B-1184-2010	Warren, Sean C./0000-0002-5253-7147; Neil, Mark A/0000-0002-7720-8868; French, Paul/0000-0002-0478-6755; Kumar, Sunil/0000-0001-8200-9671	European Commission [FP7-HEALTH-2007-A, 201577, PHOTONICS-4-LIFE, FP7-ICT-2007-2, 224014]; Institute of Chemical Biology EPSRC; Royal Society Wolfson Research Merit Award	European Commission(European CommissionEuropean Commission Joint Research Centre); Institute of Chemical Biology EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society Wolfson Research Merit Award(Royal Society of London)	The authors gratefully acknowledge funding from the European Commission (SKINSPECTION, FP7-HEALTH-2007-A, 201577 and PHOTONICS-4-LIFE, FP7-ICT-2007-2, 224014), the Institute of Chemical Biology EPSRC funded Doctoral Training Centre (SW) and a Royal Society Wolfson Research Merit Award (PF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benati E, 2011, SKIN RES TECHNOL, V17, P295, DOI 10.1111/j.1600-0846.2011.00496.x; Christenson LJ, 2005, JAMA-J AM MED ASSOC, V294, P681, DOI 10.1001/jama.294.6.681; Cicchi R, 2008, J BIOPHOTONICS, V1, P62, DOI 10.1002/jbio.200710003; Cicchi R, 2007, OPT EXPRESS, V15, P10135, DOI 10.1364/OE.15.010135; De Giorgi V, 2009, J EUR ACAD DERMATOL, V23, P314, DOI 10.1111/j.1468-3083.2008.03045.x; Demers AA, 2005, J AM ACAD DERMATOL, V53, P320, DOI 10.1016/j.jaad.2005.03.043; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Dimitrow E, 2009, EXP DERMATOL, V18, P509, DOI 10.1111/j.1600-0625.2008.00815.x; Koenig K, 1994, J Fluoresc, V4, P17, DOI 10.1007/BF01876650; Konig K, 2011, ADV DRUG DELIVER REV, V63, P388, DOI 10.1016/j.addr.2011.03.002; Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349; Levitt JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024765; Masters BR, 1997, BIOPHYS J, V72, P2405, DOI 10.1016/S0006-3495(97)78886-6; Mogensen M, 2007, DERMATOL SURG, V33, P1158, DOI 10.1111/j.1524-4725.2007.33251.x; Palero JA, 2007, BIOPHYS J, V93, P992, DOI 10.1529/biophysj.106.099457; Paoli J, 2008, J INVEST DERMATOL, V128, P1248, DOI 10.1038/sj.jid.5701139; Patalay R, 2011, BIOMED OPT EXPRESS, V2, P3295, DOI 10.1364/BOE.2.003295; Sanchez WY, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3466580; Santos AF, 2008, ASSAY DRUG DEV TECHN, V6, P693, DOI 10.1089/adt.2008.146; Seidenari S, 2012, EXPT DERMAT IN PRESS; Seidenari S, 2013, SKIN RES TECHNOL, V19, pE297, DOI 10.1111/j.1600-0846.2012.00643.x; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; Staples MP, 2006, MED J AUSTRALIA, V184, P6, DOI 10.5694/j.1326-5377.2006.tb00086.x; Talbot CB, 2011, OPT EXPRESS, V19, P13848, DOI 10.1364/OE.19.013848; Teuchner K, 1999, PHOTOCHEM PHOTOBIOL, V70, P146, DOI 10.1562/0031-8655(1999)070<0146:FTPEFO>2.3.CO;2	26	41	43	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43460	10.1371/journal.pone.0043460	http://dx.doi.org/10.1371/journal.pone.0043460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984428	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700022
J	Wadhwa, PD; Simhan, HN; Entringer, S; Buss, C; Smith, R; Hobel, CJ; Farhana, N; Shimmin, L; Hixson, JE; Sing, CF				Wadhwa, Pathik D.; Simhan, Hyagriv N.; Entringer, Sonja; Buss, Claudia; Smith, Roger; Hobel, Calvin J.; Farhana, Naveed; Shimmin, Lawrence; Hixson, James E.; Sing, Charles F.			Variation in the Maternal Corticotrophin Releasing Hormone-Binding Protein (CRH-BP) Gene and Birth Weight in Blacks, Hispanics and Whites	PLOS ONE			English	Article							FETAL-GROWTH; PREGNANCY; PLASMA; LOCALIZATION; PREECLAMPSIA; ASSOCIATION; UROCORTIN; PLACENTA; DISEASE; BLOOD	Background: Given the unique role of the corticotrophin-releasing hormone (CRH) system in human fetal development, the aim of our study was to estimate the association of birth weight with DNA sequence variation in three maternal genes involved in regulating CRH production, bioavailability and action: CRH, CRH-Binding Protein (CRH-BP), and CRH type 1 receptor (CRH-R1), respectively, in three racial groups (African-Americans, Hispanics, and non-Hispanic Whites). Methods: Our study was carried out on a population-based sample of 575 mother-child dyads. We resequenced the three genes in mouse-human hybrid somatic cell lines and selected SNPs for genotyping. Results: A significant association was observed in each race between birth weight and maternal CRH-BP SNP genotypes. Estimates of linkage disequilibrium and haplotypes established three common haplotypes marked by the rs1053989 SNP in all three races. This SNP predicted significant birth weight variation after adjustment for gestational age, maternal BMI, parity, and smoking. African American and Hispanic mothers carrying the A allele had infants whose birth weight was on average 254 and 302 grams, respectively, less than infants having C/C mothers. Non-Hispanic White mothers homozygous for the A allele had infants who were on average 148 grams less than those infants having A/C and C/C mothers. Conclusions: The magnitudes of the estimates of the birth weight effects are comparable to the combined effects of multiple SNPs reported in a recent meta-analysis of 6 GWAS studies and is quantitatively larger than that associated with maternal cigarette smoking. This effect was persistent across subpopulations that vary with respect to ancestry and environment.	[Wadhwa, Pathik D.] Univ Calif Irvine, Dept Psychiat, Irvine, CA 92717 USA; [Wadhwa, Pathik D.] Univ Calif Irvine, Dept Human Behav, Irvine, CA USA; [Wadhwa, Pathik D.; Entringer, Sonja; Buss, Claudia] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Wadhwa, Pathik D.] Univ Calif Irvine, Dept Obstet & Gynecol, Irvine, CA 92717 USA; [Wadhwa, Pathik D.] Univ Calif Irvine, Dept Epidemiol, Irvine, CA USA; [Simhan, Hyagriv N.] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Smith, Roger] Univ Newcastle, Endocrine Unit, Mothers & Babies Res Ctr, Newcastle, NSW 2300, Australia; [Hobel, Calvin J.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Obstet Gynecol & Pediat, Los Angeles, CA 90048 USA; [Hobel, Calvin J.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Farhana, Naveed; Shimmin, Lawrence; Hixson, James E.] Univ Texas Hlth Sci Ctr, Dept Epidemiol Human Genet & Environm Sci, Houston, TX USA; [Sing, Charles F.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Newcastle; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan	Wadhwa, PD (corresponding author), Univ Calif Irvine, Dept Psychiat, Irvine, CA 92717 USA.	pwadhwa@uci.edu	Buss, Claudia/ABC-3687-2020; Entringer, Sonja/ABB-9405-2020	Buss, Claudia/0000-0002-8738-3133; Sing, Charles/0000-0001-5872-7956; Hixson, James/0000-0002-0849-9315; Smith, Roger/0000-0003-4720-0280; Entringer, Sonja/0000-0002-9926-7076	United States Public Health Service (National Institutes of Health) [PO1 HD-047609, RO1 HD-060628]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060628] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD047609] Funding Source: NIH RePORTER	United States Public Health Service (National Institutes of Health)(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by United States Public Health Service (National Institutes of Health) grants PO1 HD-047609 and RO1 HD-060628 to PDW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2000, J CLIN ENDOCR METAB, V85, P755, DOI 10.1210/jc.85.2.755; Bale TL, 2004, P NATL ACAD SCI USA, V101, P3697, DOI 10.1073/pnas.0307324101; BATTAGLI.FC, 1967, J PEDIATR-US, V71, P159, DOI 10.1016/S0022-3476(67)80066-0; Bhattacharjee J, 2010, PLACENTA, V31, P423, DOI 10.1016/j.placenta.2010.02.015; Bowers K, 2011, PEDIATRICS, V127, pE1272, DOI 10.1542/peds.2010-2213; Clifton VL, 2000, PLACENTA, V21, P782, DOI 10.1053/plac.2000.0570; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Florio P, 2004, J CLIN ENDOCR METAB, V89, P4673, DOI 10.1210/jc.2004-0186; Florio P, 2007, FRONT BIOSCI-LANDMRK, V12, P551, DOI 10.2741/2081; Freathy RM, 2010, NAT GENET, V42, P430, DOI 10.1038/ng.567; Gao L, 2012, ENDOCRINOLOGY, V153, P1464, DOI 10.1210/en.2011-1673; Gardosi J, 2009, AM J OBSTET GYNECOL, V25, pe21, DOI DOI 10.1016/J.AJ0G.2009.04.035; Gillman MW, 2006, OBESITY, V14, P1647, DOI 10.1038/oby.2006.189; Godfrey KM, 2011, SEMIN REPROD MED, V29, P257, DOI 10.1055/s-0031-1275518; GOLAND RS, 1988, AM J OBSTET GYNECOL, V159, P884, DOI 10.1016/S0002-9378(88)80162-5; GOLAND RS, 1995, PLACENTA, V16, P375, DOI 10.1016/0143-4004(95)90095-0; Gouin K, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.013; Hutcheon JA, 2011, AM J EPIDEMIOL, V173, P459, DOI 10.1093/aje/kwq399; Kalantaridou SN, 2010, J REPROD IMMUNOL, V85, P33, DOI 10.1016/j.jri.2010.02.005; Kochanek KD, 2012, PEDIATRICS, V129, P338, DOI 10.1542/peds.2011-3435; La Merrill M, 2011, ANN EPIDEMIOL, V21, P413, DOI 10.1016/j.annepidem.2010.11.012; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Larkin JC, 2011, AM J OBSTET GYNECOL, V204, p[499, e491]; Mayor-Lynn K, 2011, REPROD SCI, V18, P46, DOI 10.1177/1933719110374115; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; Misra VK, 2011, OBESITY, V19, P1476, DOI 10.1038/oby.2011.43; Najafi-Shoushtari SH, 2010, SCIENCE, V328, P1566, DOI 10.1126/science.1189123; OBRIEN GD, 1981, AM J OBSTET GYNECOL, V139, P540, DOI 10.1016/0002-9378(81)90514-7; PERKINS AV, 1993, J ENDOCRINOL, V138, P149, DOI 10.1677/joe.0.1380149; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; RILEY SC, 1991, J CLIN ENDOCR METAB, V72, P1001, DOI 10.1210/jcem-72-5-1001; Shimmin LC, 2007, DNA SEQUENCE, V18, P432, DOI 10.1080/10425170701388719; SMITH R, 1993, J CLIN ENDOCR METAB, V76, P1063, DOI 10.1210/jc.76.4.1063; Smith R, 1999, J CLIN ENDOCR METAB, V84, P2820, DOI 10.1210/jc.84.8.2820; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Smith R, 2007, FRONT BIOSCI, V12, P912, DOI 10.2741/2113; Smith R, 2012, ENDOCRINOLOGY, V153, P1572, DOI 10.1210/en.2012-1010; Wadhwa PD, 2004, AM J OBSTET GYNECOL, V191, P1063, DOI 10.1016/j.ajog.2004.06.070; Weir B. S., 1996, GENETIC DATA ANAL; Westphal NJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1878, DOI 10.2741/1931; Wolf JB, 2011, GENETICS, V189, P1069, DOI 10.1534/genetics.111.130591; WOODS RJ, 1994, J CLIN ENDOCR METAB, V78, P73, DOI 10.1210/jc.78.1.73; WOODS RJ, 1994, ENDOCRINOLOGY, V135, P768, DOI 10.1210/en.135.2.768; Zhao XJ, 1997, HORM METAB RES, V29, P373, DOI 10.1055/s-2007-979058	44	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43931	10.1371/journal.pone.0043931	http://dx.doi.org/10.1371/journal.pone.0043931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984453	gold, Green Published, Green Accepted			2022-12-25	WOS:000308638700034
J	Flechas, SV; Sarmiento, C; Cardenas, ME; Medina, EM; Restrepo, S; Amezquita, A				Flechas, Sandra V.; Sarmiento, Carolina; Cardenas, Martha E.; Medina, Edgar M.; Restrepo, Silvia; Amezquita, Adolfo			Surviving Chytridiomycosis: Differential Anti-Batrachochytrium dendrobatidis Activity in Bacterial Isolates from Three Lowland Species of Atelopus	PLOS ONE			English	Article							AMPHIBIAN CHYTRID FUNGUS; POPULATION DECLINES; CUTANEOUS BACTERIA; SKIN BACTERIA; DISEASE; FROG; SALAMANDER; INFECTION; PERSISTENCE; EXTINCTION	In the Neotropics, almost every species of the stream-dwelling harlequin toads (genus Atelopus) have experienced catastrophic declines. The persistence of lowland species of Atelopus could be explained by the lower growth rate of Batrachochytrium dendrobatidis (Bd) at temperatures above 25 degrees C. We tested the complementary hypothesis that the toads' skin bacterial microbiota acts as a protective barrier against the pathogen, perhaps delaying or impeding the symptomatic phase of chytridiomycosis. We isolated 148 cultivable bacterial strains from three lowland Atelopus species and quantified the anti-Bd activity through antagonism assays. Twenty-six percent (38 strains representing 12 species) of the bacteria inhibited Bd growth and just two of them were shared among the toad species sampled in different localities. Interestingly, the strongest anti-Bd activity was measured in bacteria isolated from A. elegans, the only species that tested positive for the pathogen. The cutaneous bacterial microbiota is thus likely a fitness-enhancing trait that may (adaptation) or not (exaptation) have appeared because of natural selection mediated by chytridiomycosis. Our findings reveal bacterial strains for development of local probiotic treatments against chytridiomycosis and also shed light on the mechanisms behind the frog-bacteria-pathogen interaction.	[Flechas, Sandra V.; Sarmiento, Carolina; Cardenas, Martha E.; Medina, Edgar M.; Restrepo, Silvia; Amezquita, Adolfo] Univ Los Andes, Dept Biol Sci, Bogota, Colombia	Universidad de los Andes (Colombia)	Flechas, SV (corresponding author), Univ Los Andes, Dept Biol Sci, Bogota, Colombia.	s-flecha@uniandes.edu.co	Sarmiento, Carolina/ABF-3966-2020	Sarmiento, Carolina/0000-0002-8575-7170; Flechas, Sandra/0000-0002-3967-5991; Cardenas, Martha/0000-0002-2009-4126; Medina, Edgar M./0000-0002-5518-5933; Amezquita, Adolfo/0000-0001-7320-1143; Restrepo, Silvia/0000-0001-9016-1040	Association of Zoos and Aquariums [CEF 08-836]; US Fish and Wildlife Service [96200-0-G228)]	Association of Zoos and Aquariums; US Fish and Wildlife Service(US Fish & Wildlife Service)	This work was supported by the Association of Zoos and Aquariums (grant CEF 08-836) and US Fish and Wildlife Service (grant 96200-0-G228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amphibia Web, 2012, INF AMPH BIOL CONS; Becker MH, 2011, ECOHEALTH, V8, P501, DOI 10.1007/s10393-012-0743-0; Becker MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010957; Becker MH, 2009, APPL ENVIRON MICROB, V75, P6635, DOI 10.1128/AEM.01294-09; Belden LK, 2007, FRONT ECOL ENVIRON, V5, P533; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Boopathy R, 1998, CURR MICROBIOL, V37, P127, DOI 10.1007/s002849900350; Boyle DG, 2003, DIS AQUAT ORGAN, V56, P59, DOI 10.3354/dao056059; Briggs CJ, 2005, ECOLOGY, V86, P3149, DOI 10.1890/04-1428; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Bustamante HM, 2010, INTEGR ZOOL, V5, P143, DOI 10.1111/j.1749-4877.2010.00197.x; Carey C, 1999, DEV COMP IMMUNOL, V23, P459, DOI 10.1016/S0145-305X(99)00028-2; COOPER EL, 1992, CRYOBIOLOGY, V29, P616, DOI 10.1016/0011-2240(92)90066-B; Daskin JH, 2012, P ROY SOC B-BIOL SCI, V279, P1457, DOI 10.1098/rspb.2011.2276; Daszak P, 2004, HERPETOL J, V14, P201; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Dierckx P., 1993, CURVE SURFACE FITTIN; Drummond A., 2011, GENEIOUS V5 5; Duellman WE, 1999, PATTERNS OF DISTRIBUTION OF AMPHIBIANS: A GLOBAL PERSPECTIVE, P1; Flechas SV, ECOHEALTH IN PRESS, DOI [10.007/s10393-10012-10771-10399, DOI 10.1007/S10393-10012-10771-10399]; Forrest MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028444; Garbeva P, 2011, ISME J, V5, P973, DOI 10.1038/ismej.2010.196; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Harris RN, 2009, DIS AQUAT ORGAN, V83, P11, DOI 10.3354/dao02004; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Hof C, 2011, CARBON NANOTUBES LON, V480, P519; IUCN, 2022, IUCN RED LIST THREAT; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lam BA, 2010, BIOL CONSERV, V143, P529, DOI 10.1016/j.biocon.2009.11.015; Lane DS, 1990, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0; Lauer A, 2007, COPEIA, P630, DOI 10.1643/0045-8511(2007)2007[630:CCBFTE]2.0.CO;2; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Lips KR, 2003, CONSERV BIOL, V37, P222, DOI [10.1046/j.1523-1739.2003.01623.x, DOI 10.1046/J.1523-1739.2003.01623.X]; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2010, ECOHEALTH, V7, P185, DOI 10.1007/s10393-010-0327-9; McKenzie VJ, 2011, ISME J, V2011, P1; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puschendorf R, 2006, BIOL CONSERV, V132, P136, DOI 10.1016/j.biocon.2006.03.010; Rahman KSM, 2003, BIORESOURCE TECHNOL, V90, P159, DOI 10.1016/S0960-8524(03)00114-7; Retallick RWR, 2004, PLOS BIOL, V2, P1965, DOI 10.1371/journal.pbio.0020351; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; Rueda-Almonacid JV, 2005, RANAS ARLEQUINES, P158; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Vredenburg V.T., 2011, FUNGAL DIS EMERGING, P342; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Walke JB, 2011, BIOTROPICA, V43, P396, DOI 10.1111/j.1744-7429.2011.00787.x; Woodhams DC, 2007, ANIM CONSERV, V10, P409, DOI 10.1111/j.1469-1795.2007.00130.x; Woodhams DC, 2006, OECOLOGIA, V146, P531, DOI 10.1007/s00442-005-0228-8; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Woodhams DC, 2007, BIOL CONSERV, V138, P390, DOI 10.1016/j.biocon.2007.05.004; Woodhams DC, 2006, J WILDLIFE DIS, V42, P207, DOI 10.7589/0090-3558-42.2.207; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8; Woodhams DC, 2008, ECOHEALTH, V5, P268, DOI 10.1007/s10393-008-0190-0	58	63	64	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44832	10.1371/journal.pone.0044832	http://dx.doi.org/10.1371/journal.pone.0044832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970314	Green Published, Green Submitted, gold			2022-12-25	WOS:000308748400032
J	De Kimpe, L; Bennis, A; Zwart, R; van Haastert, ES; Hoozemans, JJM; Scheper, W				De Kimpe, Line; Bennis, Anna; Zwart, Rob; van Haastert, Elise S.; Hoozemans, Jeroen J. M.; Scheper, Wiep			Disturbed Ca2+ Homeostasis Increases Glutaminyl Cyclase Expression; Connecting Two Early Pathogenic Events in Alzheimer's Disease In Vitro	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; PYROGLUTAMATE A-BETA; INTRACELLULAR CALCIUM; C-FOS; LEAK; STORES; CELLS; DYSREGULATION; MOBILIZATION; HYPOTHESIS	A major neuropathological hallmark of Alzheimer's disease (AD) is the deposition of aggregated beta amyloid (A beta) peptide in the senile plaques. Ab is a peptide of 38-43 amino acids and its accumulation and aggregation plays a key role early in the disease. A large fraction of beta amyloid is N-terminally truncated rendering a glutamine that can subsequently be cyclized into pyroglutamate (pE). This makes the peptide more resistant to proteases, more prone to aggregation and increases its neurotoxicity. The enzyme glutaminyl cyclase (QC) catalyzes this conversion of glutamine to pE. In brains of AD patients, the expression of QC is increased in the earliest stages of pathology, which may be an important event in the pathogenesis. In this study we aimed to investigate the regulatory mechanism underlying the upregulation of QC expression in AD. Using differentiated SK-N-SH as a neuronal cell model, we found that neither the presence of A beta peptides nor the unfolded protein response, two early events in AD, leads to increased QC levels. In contrast, we demonstrated increased QC mRNA levels and enzyme activity in response to another pathogenic factor in AD, perturbed intracellular Ca2+ homeostasis. The QC promoter contains a putative binding site for the Ca2+ dependent transcription factors c-fos and c-jun. C-fos and c-jun are induced by the same Ca2+-related stimuli as QC and their upregulation precedes QC expression. We show that in the human brain QC is predominantly expressed by neurons. Interestingly, the Ca2+-dependent regulation of both c-fos and QC is not observed in non-neuronal cells. Our results indicate that perturbed Ca2+ homeostasis results in upregulation of QC selectively in neuronal cells via Ca2+-dependent transcription factors. This suggests that disruption of Ca2+ homeostasis may contribute to the formation of the neurotoxic pE A beta peptides in Alzheimer's disease.	[De Kimpe, Line; Bennis, Anna; Zwart, Rob; Scheper, Wiep] Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, NL-1105 AZ Amsterdam, Netherlands; [Scheper, Wiep] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [van Haastert, Elise S.; Hoozemans, Jeroen J. M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	De Kimpe, L (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Genome Anal, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	w.scheper@amc.uva.nl	Scheper, Wiep/AAI-7323-2020	Hoozemans, Jeroen/0000-0002-2888-8967; Scheper, Wiep/0000-0002-1431-4559	European Commission as part of the 6th Framework Program (EDAR) [37670]; 7th Framework program (NAD) [212043]; Internationale Stichting Alzheimer Onderzoek Nederland (ISAO) [07506]; Netherlands Organisation for Scientific Research (NWO) [836.05.060]	European Commission as part of the 6th Framework Program (EDAR); 7th Framework program (NAD); Internationale Stichting Alzheimer Onderzoek Nederland (ISAO); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by the European Commission as part of the 6th Framework Program (EDAR, contract # 37670) and the 7th Framework program (NAD, grant agreement # 212043), Internationale Stichting Alzheimer Onderzoek Nederland (ISAO #07506) and the Netherlands Organisation for Scientific Research (NWO; Meervoud Grant #836.05.060). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Camello C, 2002, CELL CALCIUM, V32, P355, DOI 10.1016/S0143416002001926; Chafekar SM, 2008, CURR ALZHEIMER RES, V5, P469, DOI 10.2174/156720508785908883; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Chung KC, 2001, J BIOL CHEM, V276, P2132, DOI 10.1074/jbc.M007492200; Cynis H, 2008, BIOCHEMISTRY-US, V47, P7405, DOI 10.1021/bi800250p; Cynis H, 2011, EMBO MOL MED, V3, P545, DOI 10.1002/emmm.201100158; De Kimpe L, 2010, CURR MED CHEM, V17, P198, DOI 10.2174/092986710790149765; De Kimpe L, 2013, AGE, V35, P673, DOI 10.1007/s11357-012-9403-0; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004; Gissel C, 1997, J NEUROCHEM, V69, P2538; Gruszczynska-Biegala J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019285; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Herrera DG, 1996, PROG NEUROBIOL, V50, P83, DOI 10.1016/S0301-0082(96)00021-4; Hinke SA, 2000, J BIOL CHEM, V275, P3827, DOI 10.1074/jbc.275.6.3827; Hofer AM, 1996, FASEB J, V10, P302, DOI 10.1096/fasebj.10.2.8641563; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Jawhar S, 2011, J BIOL CHEM, V286, P4454, DOI 10.1074/jbc.M110.185819; KHACHATURIAN ZS, 1987, NEUROBIOL AGING, V8, P345, DOI 10.1016/0197-4580(87)90073-X; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; MOORE WC, 1991, NEUROREPORT, V2, P124, DOI 10.1097/00001756-199103000-00003; MORI H, 1992, J BIOL CHEM, V267, P17082; MUALLEM S, 1990, J BIOL CHEM, V265, P2011; Murchison D, 2007, AGING CELL, V6, P297, DOI 10.1111/j.1474-9726.2007.00293.x; PRESTON SF, 1992, CELL CALCIUM, V13, P303, DOI 10.1016/0143-4160(92)90065-Z; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Sajan Farrah D, 2007, Am J Alzheimers Dis Other Demen, V22, P319, DOI 10.1177/1533317507302447; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2008, BIOL CHEM, V389, P983, DOI 10.1515/BC.2008.111; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; Smith IF, 2005, CELL CALCIUM, V38, P427, DOI 10.1016/j.ceca.2005.06.021; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Supnet C, 2011, CELL CALCIUM, V50, P303, DOI 10.1016/j.ceca.2011.05.013; Supnet C, 2010, CELL CALCIUM, V47, P183, DOI 10.1016/j.ceca.2009.12.014; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Toescu EC, 2010, CELL CALCIUM, V47, P158, DOI 10.1016/j.ceca.2009.11.013; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Van Coillie E, 1998, BIOCHEMISTRY-US, V37, P12672, DOI 10.1021/bi980497d; Weber JT, 2001, J BIOL CHEM, V276, P1800, DOI 10.1074/jbc.M009209200; Wirths O, 2010, J BIOL CHEM, V285, P41517, DOI 10.1074/jbc.M110.178707	46	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44674	10.1371/journal.pone.0044674	http://dx.doi.org/10.1371/journal.pone.0044674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970285	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000043
J	Hahm, ER; Chandra-Kuntal, K; Desai, D; Amin, S; Singh, SV				Hahm, Eun-Ryeong; Chandra-Kuntal, Kumar; Desai, Dhimant; Amin, Shantu; Singh, Shivendra V.			Notch Activation Is Dispensable for D, L-Sulforaphane-Mediated Inhibition of Human Prostate Cancer Cell Migration	PLOS ONE			English	Article							NF-KAPPA-B; PHENETHYL ISOTHIOCYANATE; CYCLE ARREST; APOPTOSIS; PATHWAY; CHEMOPREVENTION; CONSTITUENT; EXPRESSION; GROWTH; MICE	D, L-Sulforaphane (SFN), a synthetic racemic analog of broccoli constituent L-sulforaphane, is a highly promising cancer chemopreventive agent with in vivo efficacy against chemically-induced as well as oncogene-driven cancer in preclinical rodent models. Cancer chemopreventive effect of SFN is characterized by G(2)/M phase cell cycle arrest, apoptosis induction, and inhibition of cell migration and invasion. Moreover, SFN inhibits multiple oncogenic signaling pathways often hyperactive in human cancers, including nuclear factor-kappa B, Akt, signal transducer and activator of transcription 3, and androgen receptor. The present study was designed to determine the role of Notch signaling, which is constitutively active in many human cancers, in anticancer effects of SFN using prostate cancer cells as a model. Exposure of human prostate cancer cells (PC-3, LNCaP, and/or LNCaP-C4-2B) to SFN as well as its naturally-occurring thio-, sulfinyl-, and sulfonyl-analogs resulted in cleavage (activation) of Notch1, Notch2, and Notch4, which was accompanied by a decrease in levels of full-length Notch forms especially at the 16- and 24-hour time points. The SFN-mediated cleavage of Notch isoforms was associated with its transcriptional activation as evidenced by RBP-Jk-, HES-1A/B- and HEY-1 luciferase reporter assays. Migration of PC-3 and LNCaP cells was decreased significantly by RNA interference of Notch1 and Notch2, but not Notch4. Furthermore, SFN-mediated inhibition of PC-3 and LNCaP cell migration was only marginally affected by knockdown of Notch1 and Notch2. Strikingly, SFN administration to Transgenic Adenocarcinoma of Mouse Prostate transgenic mice failed to increase levels of cleaved Notch1, cleaved Notch2, and HES-1 proteins in vivo in prostatic intraepithelial neoplasia, well-differentiated carcinoma or poorly-differentiated prostate cancer lesions. These results indicate that Notch activation is largely dispensable for SFN-mediated inhibition of cell migration, which should be viewed as a therapeutic advantage as Notch activation is frequent in human prostate cancers.	[Hahm, Eun-Ryeong; Chandra-Kuntal, Kumar; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Hahm, Eun-Ryeong; Chandra-Kuntal, Kumar; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA USA; [Desai, Dhimant; Amin, Shantu] Penn State Milton S Hershey Med Ctr, Dept Pharmacol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Hahm, ER (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	singhs@upmc.edu			National Cancer Institute [CA115498-07, P30 CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA115498] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported by the National Cancer Institute grant CA115498-07. This research used a tissue and research pathology facility supported by a grant from the National Cancer Institute (P30 CA047904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcelo S, 1996, CARCINOGENESIS, V17, P277, DOI 10.1093/carcin/17.2.277; Bertl E, 2006, MOL CANCER THER, V5, P575, DOI 10.1158/1535-7163.MCT-05-0324; Bin Hafeez B, 2009, CLIN CANCER RES, V15, P452, DOI 10.1158/1078-0432.CCR-08-1631; Bommareddy A, 2009, CANCER RES, V69, P3704, DOI 10.1158/0008-5472.CAN-08-4344; Chung FL, 2000, CARCINOGENESIS, V21, P2287, DOI 10.1093/carcin/21.12.2287; Clarke JD, 2008, CANCER LETT, V269, P291, DOI 10.1016/j.canlet.2008.04.018; Conaway CC, 2005, CANCER RES, V65, P8548, DOI 10.1158/0008-5472.CAN-05-0237; Fahey JW, 2002, P NATL ACAD SCI USA, V99, P7610, DOI 10.1073/pnas.112203099; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Hahm ER, 2010, CANCER PREV RES, V3, P484, DOI 10.1158/1940-6207.CAPR-09-0250; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Hu R, 2006, CARCINOGENESIS, V27, P2038, DOI 10.1093/carcin/bgl049; Keum YS, 2009, PHARM RES-DORDR, V26, P2324, DOI 10.1007/s11095-009-9948-5; Kim SH, 2012, BREAST CANC IN PRESS; Kim SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026615; Kim SH, 2009, MOL CANCER THER, V8, P1946, DOI 10.1158/1535-7163.MCT-09-0104; Leong KG, 2008, DIFFERENTIATION, V76, P699, DOI 10.1111/j.1432-0436.2008.00288.x; Li YY, 2010, CLIN CANCER RES, V16, P2580, DOI 10.1158/1078-0432.CCR-09-2937; Meeran SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011457; Mi LX, 2007, CANCER RES, V67, P6409, DOI 10.1158/0008-5472.CAN-07-0340; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326; O'Neill CF, 2007, AM J PATHOL, V171, P1023, DOI 10.2353/ajpath.2007.061029; Powolny AA, 2011, JNCI-J NATL CANCER I, V103, P571, DOI 10.1093/jnci/djr029; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Singh AV, 2004, CARCINOGENESIS, V25, P83, DOI 10.1093/carcin/bgg178; Singh SV, 2009, CANCER RES, V69, P2117, DOI 10.1158/0008-5472.CAN-08-3502; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; Singh SV, 2004, J BIOL CHEM, V279, P25813, DOI 10.1074/jbc.M313538200; Singh SV, 2012, CARCINOGENE IN PRESS; Tan XL, 2010, J NUTR, V140, P1404, DOI 10.3945/jn.110.121905; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Xiao D, 2009, PHARM RES-DORDR, V26, P1729, DOI 10.1007/s11095-009-9883-5; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; ZHANG YS, 1994, P NATL ACAD SCI USA, V91, P3147, DOI 10.1073/pnas.91.8.3147	38	22	23	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44957	10.1371/journal.pone.0044957	http://dx.doi.org/10.1371/journal.pone.0044957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970326	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000308462000056
J	Oswald, DJ; Lee, A; Trinidad, M; Chi, C; Ren, RY; Rich, CB; Trinkaus-Randall, V				Oswald, Duane J.; Lee, Albert; Trinidad, Monique; Chi, Cheryl; Ren, Ruiyi; Rich, Celeste B.; Trinkaus-Randall, Vickery			Communication between Corneal Epithelial Cells and Trigeminal Neurons Is Facilitated by Purinergic (P2) and Glutamatergic Receptors	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; V PYRAMIDAL NEURONS; NMDA RECEPTORS; CALCIUM WAVES; ATP RELEASE; SPINAL-CORD; CA2+ WAVES; ACTIVATION; MIGRATION; P2X(2)	Previously, we demonstrated that nucleotides released upon mechanical injury to corneal epithelium activate purinergic (P2) receptors resulting in mobilization of a Ca2+ wave. However, the tissue is extensively innervated and communication between epithelium and neurons is critical and not well understood. Therefore, we developed a co-culture of primary trigeminal neurons and human corneal limbal epithelial cells. We demonstrated that trigeminal neurons expressed a repertoire of P2Yand P2X receptor transcripts and responded to P2 agonists in a concentration-dependent manner. Mechanical injuries to epithelia in the co-cultures elicited a Ca2+ wave that mobilized to neurons and was attenuated by Apyrase, an ectonucleotidase. To elucidate the role of factors released from each cell type, epithelial and neuronal cells were cultured, injured, and the wound media from one cell type was collected and added to the other cell type. Epithelial wound media generated a rapid Ca2+ mobilization in neuronal cells that was abrogated in the presence of Apyrase, while neuronal wound media elicited a complex response in epithelial cells. The rapid Ca2+ mobilization was detected, which was abrogated with Apyrase, but it was followed by Ca2+ waves that occurred in cell clusters. When neuronal wound media was preincubated with a cocktail of N-methyl-D-aspartate (NMDA) receptor inhibitors, the secondary response in epithelia was diminished. Glutamate was detected in the neuronal wound media and epithelial expression of NMDA receptor subunit transcripts was demonstrated. Our results indicate that corneal epithelia and neurons communicate via purinergic and NMDA receptors that mediate the wound response in a highly orchestrated manner.	[Oswald, Duane J.; Lee, Albert; Ren, Ruiyi; Rich, Celeste B.; Trinkaus-Randall, Vickery] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Oswald, Duane J.; Lee, Albert; Ren, Ruiyi; Rich, Celeste B.; Trinkaus-Randall, Vickery] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA	Boston University; Boston University	Oswald, DJ (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	vickery@bu.edu		Ren, Ruiyi/0000-0001-5785-2165; Trinkaus-Randall, Vickery/0000-0002-8573-9108	National Institutes of Health/Nuclear Energy Institute [EY06000]; Mass Lions Foundation; New England Corneal Transplant Fund; NATIONAL EYE INSTITUTE [R01EY006000] Funding Source: NIH RePORTER	National Institutes of Health/Nuclear Energy Institute; Mass Lions Foundation; New England Corneal Transplant Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health/Nuclear Energy Institute EY06000, General support to the Department from the Mass Lions Foundation and the New England Corneal Transplant Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Alvarez FJ, 2004, J COMP NEUROL, V472, P257, DOI 10.1002/cne.20012; Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; BELMONTE C, 1981, J PHYSIOL-LONDON, V321, P355, DOI 10.1113/jphysiol.1981.sp013989; BELMONTE C, 1991, J PHYSIOL-LONDON, V437, P709, DOI 10.1113/jphysiol.1991.sp018621; BEUERMAN RW, 1980, EXP NEUROL, V69, P196, DOI 10.1016/0014-4886(80)90154-5; BLEEHEN T, 1978, BRIT J PHARMACOL, V62, P573, DOI 10.1111/j.1476-5381.1978.tb07764.x; BOITANO S, 1992, SCIENCE, V258, P292, DOI 10.1126/science.1411526; Boucher I, 2011, AM J PATHOL, V178, P1092, DOI 10.1016/j.ajpath.2010.11.060; Boucher I, 2010, AM J PHYSIOL-CELL PH, V299, pC411, DOI 10.1152/ajpcell.00100.2009; Braet K, 2003, CELL CALCIUM, V33, P37, DOI 10.1016/S0143-4160(02)00180-X; Burgard EC, 1999, J NEUROPHYSIOL, V82, P1590, DOI 10.1152/jn.1999.82.3.1590; Burnstock G, 1980, Prog Biochem Pharmacol, V16, P141; Burnstock G, 1996, CURR OPIN NEUROBIOL, V6, P526, DOI 10.1016/S0959-4388(96)80060-2; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cajal SRY, 1999, TEXTURE OF THE NERVOUS SYSTEM OF MAN AND THE VERTEBRATES, VOL I, P1; Ceruti S, 2008, CELL CALCIUM, V43, P576, DOI 10.1016/j.ceca.2007.10.003; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Chorna NE, 2004, J NEUROCHEM, V91, P119, DOI 10.1111/j.1471-4159.2004.02699.x; Cockayne DA, 2005, J PHYSIOL-LONDON, V567, P621, DOI 10.1113/jphysiol.2005.088435; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; CORNELLBELL AH, 1991, CELL CALCIUM, V12, P185, DOI 10.1016/0143-4160(91)90020-F; Danjo Y, 1998, J CELL SCI, V111, P3323; De Vuyst E, 2006, EMBO J, V25, P34, DOI 10.1038/sj.emboj.7600908; Ding SH, 2000, J PHYSIOL-LONDON, V522, P199, DOI 10.1111/j.1469-7793.2000.t01-1-00199.x; GALLAR J, 1993, J PHYSIOL-LONDON, V468, P609, DOI 10.1113/jphysiol.1993.sp019791; GARCIAHIRSCHFELD J, 1994, EXP EYE RES, V59, P597, DOI 10.1006/exer.1994.1145; GARCIAHIRSCHFELD J, 1995, NEUROSCIENCE, V67, P235, DOI 10.1016/0306-4522(95)00055-N; Gipson IK, 2003, INVEST OPHTH VIS SCI, V44, P2496, DOI 10.1167/iovs.02-0851; Gomes P, 2005, INVEST OPHTH VIS SCI, V46, P1208, DOI 10.1167/iovs.04-1181; ISHIDA N, 1984, ARCH OPHTHALMOL-CHIC, V102, P1380; Klepeis VE, 2004, J CELL BIOCHEM, V93, P1115, DOI 10.1002/jcb.20258; Klepeis VE, 2001, J CELL SCI, V114, P4185; Koizumi N, 2007, INVEST OPHTH VIS SCI, V48, P4519, DOI 10.1167/iovs.07-0567; Kukulski F, 2007, J LEUKOCYTE BIOL, V81, P1269, DOI 10.1189/jlb.1206758; Langford MP, 2010, CURR EYE RES, V35, P202, DOI 10.3109/02713680903461489; Luthardt J, 2003, NEUROCHEM INT, V42, P161, DOI 10.1016/S0197-0186(02)00069-4; Mankus C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028541; Mayo C, 2008, INVEST OPHTH VIS SCI, V49, P4384, DOI 10.1167/iovs.08-1688; Monis GF, 2006, AM J PATHOL, V169, P1939, DOI 10.2353/ajpath.2006.060183; Muller L, 1996, INVEST OPHTH VIS SCI, V37, P476; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Nakamura A, 2007, J CHEM NEUROANAT, V34, P95, DOI 10.1016/j.jchemneu.2007.05.005; Nakamura M, 1997, EXP EYE RES, V65, P321, DOI 10.1006/exer.1997.0345; Netto MV, 2005, CORNEA, V24, P509, DOI 10.1097/01.ico.0000151544.23360.17; Nicke A, 2005, J NEUROCHEM, V92, P925, DOI 10.1111/j.1471-4159.2004.02939.x; Ortinau S, 2003, J NEUROSCI, V23, P4996; Paemeleire K, 2000, MOL BIOL CELL, V11, P1815, DOI 10.1091/mbc.11.5.1815; Pal-Ghosh S, 2011, J CELL SCI, V124, P2666, DOI 10.1242/jcs.085480; Piet R, 2007, J NEUROSCI, V27, P4027, DOI 10.1523/JNEUROSCI.0462-07.2007; Pintor J, 2004, OPHTHAL PHYSL OPT, V24, P186, DOI 10.1111/j.1475-1313.2004.00182.x; POZO MA, 1993, J NEUROPHYSIOL, V70, P2370, DOI 10.1152/jn.1993.70.6.2370; Ralevic V, 1998, PHARMACOL REV, V50, P413; Reigada D, 2006, J PHYSIOL-LONDON, V575, P707, DOI 10.1113/jphysiol.2006.114439; Schultz R O, 1983, Trans Am Ophthalmol Soc, V81, P107; Song QH, 2003, CELL TISSUE RES, V312, P203, DOI 10.1007/s00441-002-0693-x; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; VAUGHAN RB, 1966, J CELL SCI, V1, P407; VINORES SA, 1995, EXP EYE RES, V60, P385, DOI 10.1016/S0014-4835(05)80095-8; Wang XH, 2004, NAT MED, V10, P821, DOI 10.1038/nm1082; Weinger Ilene, 2005, Purinergic Signal, V1, P281, DOI 10.1007/s11302-005-8132-6; Wilson SE, 2001, AM J OPHTHALMOL, V132, P405, DOI 10.1016/S0002-9394(01)00995-3; Wirkner K, 2002, NEUROPHARMACOLOGY, V42, P476, DOI 10.1016/S0028-3908(01)00199-X; Yang LL, 2004, J CELL BIOCHEM, V91, P938, DOI 10.1002/jcb.10774; ZIESKE JD, 1986, INVEST OPHTH VIS SCI, V27, P1; ZIESKE JD, 1989, J CELL BIOL, V109, P571, DOI 10.1083/jcb.109.2.571	66	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44574	10.1371/journal.pone.0044574	http://dx.doi.org/10.1371/journal.pone.0044574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970252	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000031
J	Bedke, N; Sammut, D; Green, B; Kehagia, V; Dennison, P; Jenkins, G; Tatler, A; Howarth, PH; Holgate, ST; Davies, DE				Bedke, Nicole; Sammut, David; Green, Ben; Kehagia, Valia; Dennison, Patrick; Jenkins, Gisli; Tatler, Amanda; Howarth, Peter H.; Holgate, Stephen T.; Davies, Donna E.			Transforming Growth Factor-Beta Promotes Rhinovirus Replication in Bronchial Epithelial Cells by Suppressing the Innate Immune Response	PLOS ONE			English	Article							IN-VITRO; ASTHMA; EXPRESSION; ACTIVATION; MECHANISMS; INFECTION; PROTEINS; AIRWAYS; EXACERBATIONS; INFLAMMATION	Rhinovirus (RV) infection is a major cause of asthma exacerbations which may be due to a deficient innate immune response in the bronchial epithelium. We hypothesized that the pleiotropic cytokine, TGF-beta, influences interferon (IFN) production by primary bronchial epithelial cells (PBECs) following RV infection. Exogenous TGF-beta(2) increased RV replication and decreased IFN protein secretion in response to RV or double-stranded RNA (dsRNA). Conversely, neutralizing TGF-beta antibodies decreased RV replication and increased IFN expression in response to RV or dsRNA. Endogenous TGF-beta(2) levels were higher in conditioned media of PBECs from asthmatic donors and the suppressive effect of anti-TGF-beta on RV replication was significantly greater in these cells. Basal SMAD-2 activation was reduced when asthmatic PBECs were treated with anti-TGF-beta and this was accompanied by suppression of SOCS-1 and SOCS-3 expression. Our results suggest that endogenous TGF-beta contributes to a suppressed IFN response to RV infection possibly via SOCS-1 and SOCS-3.	[Bedke, Nicole; Sammut, David; Green, Ben; Kehagia, Valia; Dennison, Patrick; Howarth, Peter H.; Holgate, Stephen T.; Davies, Donna E.] Univ Southampton, Fac Med, Southampton Univ Hosp, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Dennison, Patrick; Howarth, Peter H.; Holgate, Stephen T.; Davies, Donna E.] Southampton Univ Hosp, Natl Inst Hlth Res, Resp Biomed Res Unit, Southampton, Hants, England; [Jenkins, Gisli; Tatler, Amanda] Univ Nottingham, City Hosp Nottingham, Nottingham NG7 2RD, England	University of Southampton; University of Southampton; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	Bedke, N (corresponding author), Univ Southampton, Fac Med, Southampton Univ Hosp, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England.	donnad@soton.ac.uk	tatler, amanda/I-2620-2019; Davies, Donna E/H-2993-2012; Jenkins, Gisli/R-8143-2017; Sammut, David/AAM-9164-2021	tatler, amanda/0000-0002-4644-4614; Jenkins, Gisli/0000-0002-7929-2119; Davies, Donna/0000-0002-5117-2991; Howarth, Peter/0000-0003-0619-7927	Medical Research Council (United Kingdom) Capacity Building Studentship; Medical Research Council [G0501506]; Asthma, Allergy & Inflammation Research Charity; MRC [G0900453, G0501506] Funding Source: UKRI; Medical Research Council [G0900453] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10021] Funding Source: researchfish; Asthma UK [10/020] Funding Source: researchfish	Medical Research Council (United Kingdom) Capacity Building Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma, Allergy & Inflammation Research Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	This work was supported by a Medical Research Council (United Kingdom) Capacity Building Studentship to NB, Medical Research Council grant (G0501506) and the Asthma, Allergy & Inflammation Research Charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; AUBERT JD, 1994, THORAX, V49, P225, DOI 10.1136/thx.49.3.225; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; BRANDES ME, 1991, J IMMUNOL, V147, P1600; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Dalpke A, 2008, IMMUNOBIOLOGY, V213, P225, DOI 10.1016/j.imbio.2007.10.008; Fox SW, 2003, J IMMUNOL, V170, P3679, DOI 10.4049/jimmunol.170.7.3679; FRAENKEL DJ, 1995, AM J RESP CRIT CARE, V151, P879; Gibbs JD, 2009, J VIROL, V83, P12424, DOI 10.1128/JVI.00806-09; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hansbro NG, 2008, PHARMACOL THERAPEUT, V117, P313, DOI 10.1016/j.pharmthera.2007.11.002; Harada M, 2007, AM J RESP CELL MOL, V36, P491, DOI 10.1165/rcmb.2006-0090OC; Hatsushika K, 2007, CLIN EXP ALLERGY, V37, P1165, DOI 10.1111/j.1365-2222.2007.02768.x; Holgate ST, 2006, LANCET, V368, P780, DOI 10.1016/S0140-6736(06)69288-X; Hoshino M, 1998, THORAX, V53, P21, DOI 10.1136/thx.53.1.21; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMARRE J, 1990, LAB INVEST, V62, P545; McCann KL, 2007, J VIROL, V81, P2880, DOI 10.1128/JVI.02583-06; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Thomas BJ, 2009, AM J RESP CELL MOL, V41, P339, DOI 10.1165/rcmb.2008-0316OC; Torrego A, 2007, THORAX, V62, P307, DOI 10.1136/thx.2006.063487; Tschumperlin DJ, 2003, AM J RESP CELL MOL, V28, P142, DOI 10.1165/rcmb.2002-0121OC; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Wahl SM, 2007, CURR OPIN IMMUNOL, V19, P55, DOI 10.1016/j.coi.2006.11.008; WAHL SM, 1987, P NATL ACAD SCI USA, V84, P5788, DOI 10.1073/pnas.84.16.5788; WAKEFIELD LM, 1990, J CLIN INVEST, V86, P1976, DOI 10.1172/JCI114932; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160; Zhang SL, 1999, LAB INVEST, V79, P395	38	60	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44580	10.1371/journal.pone.0044580	http://dx.doi.org/10.1371/journal.pone.0044580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970254	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000308458400090
J	Giordano, S; Lee, J; Darley-Usmar, VM; Zhang, JH				Giordano, Samantha; Lee, Jisun; Darley-Usmar, Victor M.; Zhang, Jianhua			Distinct Effects of Rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on Cellular Bioenergetics and Cell Death	PLOS ONE			English	Article							ELECTRON-TRANSPORT CHAIN; MITOCHONDRIAL COMPLEX-I; NEUROBLASTOMA SH-SY5Y CELLS; PARKINSONS-DISEASE; DOPAMINE TRANSPORTER; HYDROGEN-PEROXIDE; CYTOTOXIC AGENTS; VITRO MODEL; NDI1 GENE; WILD-TYPE	Parkinson's disease is characterized by dopaminergic neurodegeneration and is associated with mitochondrial dysfunction. The bioenergetic susceptibility of dopaminergic neurons to toxins which induce Parkinson's like syndromes in animal models is then of particular interest. For example, rotenone, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its active metabolite 1-methyl-4-phenylpyridinium (MPP+), and 6-hydroxydopamine (6-OHDA), have been shown to induce dopaminergic cell death in vivo and in vitro. Exposure of animals to these compounds induce a range of responses characteristics of Parkinson's disease, including dopaminergic cell death, and Reactive Oxygen Species (ROS) production. Here we test the hypothesis that cellular bioenergetic dysfunction caused by these compounds correlates with induction of cell death in differentiated dopaminergic neuroblastoma SH-SY5Y cells. At increasing doses, rotenone induced significant cell death accompanied with caspase 3 activation. At these concentrations, rotenone had an immediate inhibition of mitochondrial basal oxygen consumption rate (OCR) concomitant with a decrease of ATP-linked OCR and reserve capacity, as well as a stimulation of glycolysis. MPP+ exhibited a different behavior with less pronounced cell death at doses that nearly eliminated basal and ATP-linked OCR. Interestingly, MPP+, unlike rotenone, stimulated bioenergetic reserve capacity. The effects of 6-OHDA on bioenergetic function was markedly less than the effects of rotenone or MPP+ at cytotoxic doses, suggesting a mechanism largely independent of bioenergetic dysfunction. These studies suggest that these dopaminergic neurotoxins induce cell death through distinct mechanisms and differential effects on cellular bioenergetics.	[Giordano, Samantha; Lee, Jisun; Darley-Usmar, Victor M.; Zhang, Jianhua] Univ Alabama Birmingham, Dept Pathol, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Zhang, Jianhua] Birmingham VA Med Ctr, Dept Vet Affairs, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Giordano, S (corresponding author), Univ Alabama Birmingham, Dept Pathol, Ctr Free Rad Biol, Birmingham, AL 35294 USA.	zhanja@uab.edu	; Lee, Junyoung/D-5463-2012	Darley-Usmar, Victor/0000-0001-8921-7086; Lee, Junyoung/0000-0001-6689-2759; Zhang, Jianhua/0000-0002-2128-9574	United States National Institutes of Health [NIH-ES/HL10167, NIH-DK75865]; VA merit award;  [NIH-NS064090];  [P30 DK079337];  [P30 AR50948];  [S10 RR19231]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075865, R56DK075865, P30DK079337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064090] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA merit award(US Department of Veterans Affairs); ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by United States National Institutes of Health NIH-ES/HL10167, and NIH-DK75865 (to VM DU); NIH-NS064090 and a VA merit award (to JZ). MPP+ mass spectrometry was supported by P30 DK079337, P30 AR50948 and S10 RR19231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Fischer D, 2008, EXP NEUROL, V210, P182, DOI 10.1016/j.expneurol.2007.10.012; ANDREW R, 1993, NEUROCHEM RES, V18, P1175, DOI 10.1007/BF00978370; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BINDOFF LA, 1989, LANCET, V2, P49, DOI 10.1016/S0140-6736(89)90291-2; Borland MK, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-21; Bove J., 2011, NEUROSCIENCE; Brand MD, 2011, BIOCHEM J, V437, P575; Brill LB, 2003, EXP NEUROL, V181, P25, DOI 10.1016/S0014-4886(02)00045-6; Brown TP, 2006, ENVIRON HEALTH PERSP, V114, P156, DOI 10.1289/ehp.8095; Cantu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007095; Chen S, 2008, FEBS LETT, V582, P603, DOI 10.1016/j.febslet.2008.01.028; Cheung YT, 2009, NEUROTOXICOLOGY, V30, P127, DOI 10.1016/j.neuro.2008.11.001; Choi WS, 2008, P NATL ACAD SCI USA, V105, P15136, DOI 10.1073/pnas.0807581105; COHEN G, 1974, J BIOL CHEM, V249, P2447; Conn KJ, 2004, BRAIN RES, V1022, P164, DOI 10.1016/j.brainres.2004.07.026; CURTIUS HC, 1974, J CHROMATOGR, V99, P529, DOI 10.1016/S0021-9673(00)90882-3; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Desai VG, 1996, BRAIN RES, V715, P1, DOI 10.1016/0006-8993(95)01255-9; Dranka B.P., 2012, J NEUROCHEM; Dranka BP, 2011, FREE RADIC BIOL MED; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Esteves AR, 2010, J NEUROCHEM, V113, P674, DOI 10.1111/j.1471-4159.2010.06631.x; Esteves ARF, 2008, MITOCHONDRION, V8, P219, DOI 10.1016/j.mito.2008.03.004; Fasano M, 2006, J NEUROCHEM, V96, P909, DOI 10.1111/j.1471-4159.2005.03638.x; Glinka Y, 1997, J NEURAL TRANSM-SUPP, P55; Glinka Y, 1996, J NEUROCHEM, V66, P2004; GLINKA YY, 1995, EUR J PHARM-ENVIRON, V292, P329, DOI 10.1016/0926-6917(95)90040-3; GLUCK MR, 1994, J NEUROCHEM, V63, P655; HEIKKILA R, 1972, MOL PHARMACOL, V8, P241; Higgins DS, 1996, J NEUROSCI, V16, P3807; Jameson GNL, 2004, ORG BIOMOL CHEM, V2, P2346, DOI 10.1039/b408044k; Jaworska-Feil L, 2010, NEUROPEPTIDES, V44, P495, DOI 10.1016/j.npep.2010.08.004; Kim-Han JS, 2011, J NEUROSCI, V31, P7212, DOI 10.1523/JNEUROSCI.0711-11.2011; Kitayama S, 1998, BBA-MOL CELL RES, V1404, P305, DOI 10.1016/S0167-4889(98)00071-8; Klivenyi P, 1998, NEUROBIOL DIS, V5, P253, DOI 10.1006/nbdi.1998.0191; Kobayashi H, 2008, FREE RADICAL RES, V42, P651, DOI 10.1080/10715760802270334; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; LANGSTON JW, 1983, NEW ENGL J MED, V309, P310; LINDAHL PE, 1960, NATURE, V187, P784, DOI 10.1038/187784a0; LINDAHL PE, 1961, EXP CELL RES, V23, P228, DOI 10.1016/0014-4827(61)90033-7; Linert W, 1996, BBA-MOL BASIS DIS, V1316, P160, DOI 10.1016/0925-4439(96)00020-8; Lopes FM, 2012, NEUROTOX RES, V22, P138, DOI 10.1007/s12640-012-9311-1; Lopes FM, 2010, BRAIN RES, V1337, P85, DOI 10.1016/j.brainres.2010.03.102; Marella M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001433; Marella M, 2007, J BIOL CHEM, V282, P24146, DOI 10.1074/jbc.M701819200; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Martinez TN, 2012, ANTIOXID REDOX SIGN, V16, P920, DOI 10.1089/ars.2011.4033; MURPHY MP, 1995, BIOCHEM J, V306, P359, DOI 10.1042/bj3060359; Nakaso K, 2008, NEUROSCI LETT, V432, P146, DOI 10.1016/j.neulet.2007.12.034; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; OFORI S, 1989, J PHARMACOL EXP THER, V251, P258; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; PARKER WD, 1989, ANN NEUROL, V26, P719, DOI 10.1002/ana.410260606; Parker WD, 1998, AM J HUM GENET, V62, P758, DOI 10.1086/301812; PIFL C, 1993, J NEUROSCI, V13, P4246, DOI 10.1523/jneurosci.13-10-04246.1993; Poltl D., 2011, NEUROTOXICOLOGY; PORTER CC, 1963, J PHARMACOL EXP THER, V140, P308; PORTER CC, 1965, J PHARMACOL EXP THER, V150, P17; Presgraves SP, 2004, NEUROTOX RES, V5, P579, DOI 10.1007/bf03033178; Priyadarshi A, 2001, ENVIRON RES, V86, P122, DOI 10.1006/enrs.2001.4264; Priyadarshi A, 2000, NEUROTOXICOLOGY, V21, P435; PRZEDBORSKI S, 1992, J NEUROSCI, V12, P1658; RAMSAY RR, 1986, J BIOL CHEM, V261, P7585; RAMSAY RR, 1987, ARCH BIOCHEM BIOPHYS, V259, P645, DOI 10.1016/0003-9861(87)90531-5; RAMSAY RR, 1991, BIOCHEM J, V273, P481, DOI 10.1042/bj2730481; Richardson JR, 2007, TOXICOL SCI, V95, P196, DOI 10.1093/toxsci/kfl133; Schapira AHV, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/159160; Schneider L, 2011, FREE RADICAL BIO MED, V51, P2007, DOI 10.1016/j.freeradbiomed.2011.08.030; Seo BB, 2000, J BIOL CHEM, V275, P37774, DOI 10.1074/jbc.M007033200; Seo BB, 2006, J BIOL CHEM, V281, P14250, DOI 10.1074/jbc.M600922200; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Sherer TB, 2002, J NEUROSCI, V22, P7006; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; SINGER TP, 1993, ADV NEUROL, V60, P300; Smigrodzki R, 2004, NEUROBIOL AGING, V25, P1273, DOI 10.1016/j.neurobiolaging.2004.02.020; Swerdlow RH, 2001, EXP NEUROL, V169, P479, DOI 10.1006/exnr.2001.7674; Swerdlow RH, 1999, BIOCHEM BIOPH RES CO, V261, P701, DOI 10.1006/bbrc.1999.1095; Swerdlow RH, 2012, ANTIOXID REDOX SIGN, V16, P950, DOI 10.1089/ars.2011.3948; Tanner CM, 2011, ENVIRON HEALTH PERSP, V119, P866, DOI 10.1289/ehp.1002839; Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333; Trimmer PA, 2004, J NEUROCHEM, V88, P800, DOI 10.1046/j.1471-4159.2003.02168.x; van der Mark M, 2012, ENVIRON HEALTH PERSP, V120, P340, DOI 10.1289/ehp.1103881; Verhaar R, 2012, NEUROBIOL DIS, V45, P839, DOI 10.1016/j.nbd.2011.10.012; VYAS I, 1986, J NEUROCHEM, V46, P1501, DOI 10.1111/j.1471-4159.1986.tb01768.x; Wernicke C, 2010, PHARMACOL REP, V62, P649, DOI 10.1016/S1734-1140(10)70322-4; Xie HR, 2010, CHINESE MED J-PEKING, V123, P1086, DOI 10.3760/cma.j.issn.0366-6999.2010.08.021; Yacoubian TA, 2009, BBA-MOL BASIS DIS, V1792, P676, DOI 10.1016/j.bbadis.2008.09.009; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	90	121	122	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44610	10.1371/journal.pone.0044610	http://dx.doi.org/10.1371/journal.pone.0044610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970265	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400093
J	von Neuhoff, N; Oumeraci, T; Wolf, T; Kollewe, K; Bewerunge, P; Neumann, B; Brors, B; Bufler, J; Wurster, U; Schlegelberger, B; Dengler, R; Zapatka, M; Petri, S				von Neuhoff, Nils; Oumeraci, Tonio; Wolf, Thomas; Kollewe, Katja; Bewerunge, Peter; Neumann, Boris; Brors, Benedikt; Bufler, Johannes; Wurster, Ulrich; Schlegelberger, Brigitte; Dengler, Reinhard; Zapatka, Marc; Petri, Susanne			Monitoring CSF Proteome Alterations in Amyotrophic Lateral Sclerosis: Obstacles and Perspectives in Translating a Novel Marker Panel to the Clinic	PLOS ONE			English	Article							CEREBROSPINAL-FLUID BIOMARKERS; BUNINA BODIES; CHROMOGRANIN PEPTIDES; EL-ESCORIAL; DISEASE; IMMUNOREACTIVITY; DEMENTIA; GENE; ALS; IDENTIFICATION	Background: Amyotrophic lateral sclerosis (ALS) is a fatal disorder of the motor neuron system with poor prognosis and marginal therapeutic options. Current clinical diagnostic criteria are based on electrophysiological examination and exclusion of other ALS-mimicking conditions. Neuroprotective treatments are, however, most promising in early disease stages. Identification of disease-specific CSF biomarkers and associated biochemical pathways is therefore most relevant to monitor disease progression, response to neuroprotective agents and to enable early inclusion of patients into clinical trials. Methods and Findings: CSF from 35 patients with ALS diagnosed according to the revised El Escorial criteria and 23 age-matched controls was processed using paramagnetic bead chromatography for protein isolation and subsequently analyzed by MALDI-TOF mass spectrometry. CSF protein profiles were integrated into a Random Forest model constructed from 153 mass peaks. After reducing this peak set to the top 25%, a classifier was built which enabled prediction of ALS with high accuracy, sensitivity and specificity. Further analysis of the identified peptides resulted in a panel of five highly sensitive ALS biomarkers. Upregulation of secreted phosphoprotein 1 in ALS-CSF samples was confirmed by univariate analysis of ELISA and mass spectrometry data. Further quantitative validation of the five biomarkers was achieved in an 80-plex Multiple Reaction Monitoring mass spectrometry assay. Conclusions: ALS classification based on the CSF biomarker panel proposed in this study could become a valuable predictive tool for early clinical risk stratification. Of the numerous CSF proteins identified, many have putative roles in ALS-related metabolic processes, particularly in chromogranin-mediated secretion signaling pathways. While a stand-alone clinical application of this classifier will only be possible after further validation and a multicenter trial, it could be readily used to complement current ALS diagnostics and might also provide new insights into the pathomechanisms of this disease in the future.	[von Neuhoff, Nils; Oumeraci, Tonio; Wolf, Thomas; Schlegelberger, Brigitte] Hannover Med Sch, Inst Cell & Mol Pathol, D-3000 Hannover, Germany; [Wolf, Thomas; Bewerunge, Peter; Brors, Benedikt; Zapatka, Marc] German Canc Res Ctr, Res Program Struct & Funct Genom, Div Theoret Bioinformat, INF 580, D-6900 Heidelberg, Germany; [Kollewe, Katja; Bufler, Johannes; Wurster, Ulrich; Dengler, Reinhard; Petri, Susanne] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; [Neumann, Boris] Proteome Factory AG, Berlin, Germany	Hannover Medical School; Helmholtz Association; German Cancer Research Center (DKFZ); Hannover Medical School	von Neuhoff, N (corresponding author), Hannover Med Sch, Inst Cell & Mol Pathol, D-3000 Hannover, Germany.	neuhoff.nils.von@mh-hannover.de	Zapatka, Marc/G-9896-2013; Brors, Benedikt/E-5620-2013; Petri, Susanne/AID-7665-2022	Zapatka, Marc/0000-0001-8287-5967; Brors, Benedikt/0000-0001-5940-3101; 				Abou Ezzi S, 2007, J NEUROCHEM, V102, P170, DOI 10.1111/j.1471-4159.2007.04531.x; Bartolomucci A, 2010, NEUROSCIENCE, V170, P289, DOI 10.1016/j.neuroscience.2010.06.057; Blasco H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013223; Bos IWM, 2006, NEUROCHEM INT, V48, P306, DOI 10.1016/j.neuint.2005.09.009; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brettschneider J, 2008, NEUROCHEM RES, V33, P2358, DOI 10.1007/s11064-008-9742-5; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chiu IM, 2008, P NATL ACAD SCI USA, V105, P17913, DOI 10.1073/pnas.0804610105; Cho HJ, 2009, MOL CELLS, V27, P105, DOI 10.1007/s10059-009-0011-5; Findeisen P, 2009, J CLIN ONCOL, V27, P2199, DOI 10.1200/JCO.2008.18.0554; GEORGE PM, 1989, CLIN CHEM, V35, P179; GOLLIN PA, 1992, NEUROREPORT, V3, P201, DOI 10.1097/00001756-199202000-00020; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jahn H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026540; Lausch E, 2011, NAT GENET, V43, P132, DOI 10.1038/ng.749; Lechner T, 2004, EXP GERONTOL, V39, P101, DOI 10.1016/j.exger.2003.09.018; Li X., PROCESS CIPHERGEN SE; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Marksteiner J, 2000, ACTA NEUROPATHOL, V100, P205, DOI 10.1007/s004010000239; Martin A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-91; Nagai A, 2005, BRAIN RES, V1066, P120, DOI 10.1016/j.brainres.2005.10.063; Nielsen HM, 2007, NEUROLOGY, V69, P1569, DOI 10.1212/01.wnl.0000271077.82508.a0; OKAMOTO K, 1993, NEUROSCI LETT, V162, P125, DOI 10.1016/0304-3940(93)90576-7; Okamoto K, 2008, NEUROPATHOLOGY, V28, P109, DOI 10.1111/j.1440-1789.2007.00873.x; Ono S, 2000, ACTA NEUROL SCAND, V102, P47, DOI 10.1034/j.1600-0404.2000.102001047.x; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07; Pendyala G, 2009, J PROTEOME RES, V8, P2253, DOI 10.1021/pr800854t; Ranganathan S, 2005, J NEUROCHEM, V95, P1461, DOI 10.1111/j.1471-4159.2005.03478.x; Ranganathan S, 2007, AMYOTROPH LATERAL SC, V8, P373, DOI 10.1080/17482960701549681; Rangon CM, 2003, NEUROREPORT, V14, P755, DOI 10.1097/00001756-200304150-00019; Ruetschi U, 2005, EXP NEUROL, V196, P273, DOI 10.1016/j.expneurol.2005.08.002; Ryberg H, 2010, MUSCLE NERVE, V42, P104, DOI 10.1002/mus.21683; Schrott-Fischer A, 2009, REGUL PEPTIDES, V152, P13, DOI 10.1016/j.regpep.2008.07.009; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Simonsen AH, 2007, DEMENT GERIATR COGN, V24, P434, DOI 10.1159/000110576; Simonsen AH, 2007, ARCH NEUROL-CHICAGO, V64, P366, DOI 10.1001/archneur.64.3.366; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sussmuth SD, 2008, CURR MED CHEM, V15, P1788, DOI 10.2174/092986708785133031; Sugaya K, 1998, NEUROBIOL AGING, V19, P351, DOI 10.1016/S0197-4580(98)00072-4; Sun L, 2011, J RHEUMATOL, V38, P454, DOI 10.3899/jrheum.100550; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Therneau TM, 2009, RPART RECURSIVE PART, P45; THOMPSON EJ, 1995, J NEUROL NEUROSUR PS, V59, P349, DOI 10.1136/jnnp.59.4.349; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P1171, DOI 10.1001/archneur.57.8.1171; TU GF, 1992, AM J PHYSIOL, V263, pR195, DOI 10.1152/ajpregu.1992.263.1.R195; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Vogt MHJ, 2003, ANN NEUROL, V53, P819, DOI 10.1002/ana.10606; Wada M, 1999, ACTA NEUROPATHOL, V98, P150, DOI 10.1007/s004010051063; Wilson KE, 2004, J NEUROL NEUROSUR PS, V75, P529, DOI 10.1136/jnnp.2003.026260; Wilson ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015133; Wootz H, 2006, NEUROSCIENCE, V143, P419, DOI 10.1016/j.neuroscience.2006.07.048; Wuolikainen A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017947; Xu L, 2005, NEUROBIOL DIS, V18, P152, DOI 10.1016/j.nbd.2004.08.012; Yang YR, 2008, CELL MOL NEUROBIOL, V28, P737, DOI 10.1007/s10571-007-9257-7; Zhao Zhong, 2008, Int J Med Sci, V5, P92	57	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44401	10.1371/journal.pone.0044401	http://dx.doi.org/10.1371/journal.pone.0044401			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970211	Green Submitted, Green Published, gold			2022-12-25	WOS:000308458400067
J	Goosen, P; Swart, AC; Storbeck, KH; Swart, P				Goosen, Pierre; Swart, Amanda C.; Storbeck, Karl-Heinz; Swart, Pieter			Allosteric interaction between 3 beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase and cytochrome b(5) influences cofactor binding	FASEB JOURNAL			English	Article						adrenal steroidogenesis; dehydroepiandrosterone; androstenedione; UPLC-MS/MS; FRET; NAD(+)	PLACENTAL 3-BETA-HYDROXY-5-ENE-STEROID DEHYDROGENASE; BETA-HYDROXYSTEROID DEHYDROGENASE; STEROID 5->4-ENE-ISOMERASE; 17,20-LYASE ACTIVITY; MOLECULAR-BIOLOGY; ADRENAL-CORTEX; PURIFICATION; EXPRESSION; P450C17; STEROIDOGENESIS	The biosynthesis of steroid hormones, essential to the survival of all mammals, is dependent on the activity of 3 beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase (3 beta HSD). 3 beta HSD activity is, in turn, influenced by cytochrome-b(5) (Cyt-b(5)). However, the mechanism through which this occurs is unknown. In this study, we investigated this mechanism by evaluating the influence of Cyt-b(5) on the dehydrogenase and isomerase activities of 3 beta HSD. Capra hircus 3 beta HSD was overexpressed in SF-9 cells, using a baculovirus expression system, and purified. Substrate and cofactor kinetics were determined spectrophotometrically in the presence and absence of purified Ovis aries liver Cyt-b(5). Nonspecific enzyme activity was evaluated by zero-enzyme, -substrate, and -cofactor blanks. Fusion proteins, 3 beta HSD-eCFP, and Cyt-b(5)-eYFP were subsequently coexpressed in COS-1 cells and analyzed for FRET. A CFP-YFP fusion protein served as positive control, while coexpression of 3 beta HSD-eCFP and cytochrome P450 17 alpha-hydroxylase/17,20 lyase-eYFP (CYP17A1-eYFP) served as negative control. Results showed Cyt-b(5) to decrease the K-m,K-NAD+ value of 3 beta HSD approximate to 3.5-fold while increasing the V-max,V-app of the dehydrogenase reaction approximate to 17%. FRET analysis showed COS-1 cells coexpressing 3 beta HSD-eCFP and Cyt-b(5)-eYFP to exhibit a FRET signal approximate to 9-fold greater than that of the negative control. These results indicate that Cyt-b(5) augments 3 beta HSD activity via an allosteric mechanism by increasing the affinity of the enzyme toward NAD(+).-Goosen, P., Swart, A. C., Storbeck, K.-H., Swart, P. Allosteric interaction between 3 beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase and cytochrome b(5) influences cofactor binding. FASEB J. 27, 322-332 (2013). www.fasebj.org	[Goosen, Pierre; Swart, Amanda C.; Storbeck, Karl-Heinz; Swart, Pieter] Univ Stellenbosch, Dept Biochem, ZA-7602 Stellenbosch, South Africa	Stellenbosch University	Swart, P (corresponding author), Unvers Stellenbosch, Private Bag X1, ZA-7602 Stellenbosch, South Africa.	pswart@sun.ac.za	Storbeck, Karl/AAF-5126-2020; Swart, Pieter/J-3856-2015; Swart, Amanda C/O-5939-2017	Swart, Pieter/0000-0001-8610-4799; Swart, Amanda C/0000-0001-7529-8989; Storbeck, Karl-Heinz/0000-0003-1669-6383	South Africa National Research Foundation; Harry Crossly Foundation; Claude Leon Foundation; University of Stellenbosch	South Africa National Research Foundation(National Research Foundation - South Africa); Harry Crossly Foundation; Claude Leon Foundation; University of Stellenbosch	The authors thank James L. Thomas (Division of Basic Medical Sciences, Department of Obstetics-Gynecology, Mercer University School of Medicine, Macon, GA, USA) for technical assistance in the expression and purification of 3 beta HSD, and Jacky Snoep (Department of Biochemistry, Stellenbosch University, Stellenbosch, South Africa) for fruitful discussions. The plasmids containing the eCFP-GR and eYFP-GR constructs were a generous gift from Ann Louw (Department of Biochemistry, University of Stellenbosch, Stellenbosch, South Africa). The Cer-5-Ven plasmid containing both CFP and YFP was a generous gift from Ammasi Periasamy (W. M. Keck Center for Cellular Imaging, Department of Biology, University of Virginia, Charlottesville, VA, USA). The authors thank Patricia Storbeck for assistance in the preparation of the colocalization SDS-PAGE figures. This work was financially supported by the South Africa National Research Foundation, the Harry Crossly Foundation, the Claude Leon Foundation, and the University of Stellenbosch.	Agarwal AK, 2005, ENDOCRINOLOGY, V146, P2531, DOI 10.1210/en.2005-0061; Auchus RJ, 1998, J BIOL CHEM, V273, P3158, DOI 10.1074/jbc.273.6.3158; BRETON R, 1994, J STEROID BIOCHEM, V50, P275, DOI 10.1016/0960-0760(94)90132-5; Burger HG, 2002, FERTIL STERIL, V77, pS3; Chapman JC, 2005, REPROD BIOL ENDOCRIN, V3, P1, DOI 10.1186/1477-7827-3-11; Cherradi N, 1995, J STEROID BIOCHEM, V55, P507, DOI 10.1016/0960-0760(95)00199-9; Conley AJ, 1997, BIOL REPROD, V56, P789, DOI 10.1095/biolreprod56.4.789; DETOMASO AW, 1993, J BIOL CHEM, V268, P1470; Dharia S, 2004, BIOL REPROD, V71, P83, DOI 10.1095/biolreprod.103.026732; Fluck CE, 2003, J CLIN ENDOCR METAB, V88, P3762, DOI 10.1210/jc.2003-030143; GEORGIADIS EI, 1992, HORM METAB RES, V24, P488, DOI 10.1055/s-2007-1003369; Goosen P, 2011, J STEROID BIOCHEM, V127, P238, DOI 10.1016/j.jsbmb.2011.09.001; Goosen P, 2010, MOL CELL ENDOCRINOL, V315, P182, DOI 10.1016/j.mce.2009.07.026; KATAGIRI M, 1982, BIOCHEM BIOPH RES CO, V108, P379, DOI 10.1016/0006-291X(82)91877-0; KATAGIRI M, 1995, ARCH BIOCHEM BIOPHYS, V317, P343, DOI 10.1006/abbi.1995.1173; Lombard N, 2002, ENDOCR RES, V28, P485, DOI 10.1081/ERC-120016827; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Nakamura Y, 2011, J STEROID BIOCHEM, V123, P122, DOI 10.1016/j.jsbmb.2010.12.001; NASH WE, 1994, J STEROID BIOCHEM, V50, P235, DOI 10.1016/0960-0760(94)90127-9; Nguyen PTT, 2012, J STEROID BIOCHEM, V128, P12, DOI 10.1016/j.jsbmb.2011.10.003; Pandey AV, 2005, J BIOL CHEM, V280, P13265, DOI 10.1074/jbc.M414673200; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Piltonen T, 2002, HUM REPROD, V17, P620, DOI 10.1093/humrep/17.3.620; Rainey WE, 2008, J STEROID BIOCHEM, V108, P281, DOI 10.1016/j.jsbmb.2007.09.015; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Storbeck KH, 2008, ANAL BIOCHEM, V372, P11, DOI 10.1016/j.ab.2007.09.036; Storbeck KH, 2007, DRUG METAB REV, V39, P467, DOI 10.1080/03602530701468649; Suzuki T, 2000, CLIN ENDOCRINOL, V53, P739, DOI 10.1046/j.1365-2265.2000.01144.x; Swart P, 2003, ARCH BIOCHEM BIOPHYS, V409, P145, DOI 10.1016/S0003-9861(02)00547-7; THOMAS JL, 1988, J STEROID BIOCHEM, V31, P785, DOI 10.1016/0022-4731(88)90287-7; Thomas JL, 2003, J BIOL CHEM, V278, P35483, DOI 10.1074/jbc.M304752200; THOMAS JL, 1989, J STEROID BIOCHEM, V33, P209, DOI 10.1016/0022-4731(89)90296-3; THOMAS JL, 1995, J BIOL CHEM, V270, P21003, DOI 10.1074/jbc.270.36.21003; TRON L, 1984, BIOPHYS J, V45, P939, DOI 10.1016/S0006-3495(84)84240-X; Van L., 1991, BIOCHEMISTRY-US, V36, P8861; Yamazaki H, 1996, J BIOL CHEM, V271, P27438, DOI 10.1074/jbc.271.44.27438; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Zhou M, 1996, J CRYST GROWTH, V168, P142, DOI 10.1016/0022-0248(96)00372-7	38	4	4	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					322	332		10.1096/fj.12-213736	http://dx.doi.org/10.1096/fj.12-213736			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	22982379				2022-12-25	WOS:000313103200030
J	Nairn, AV; Aoki, K; dela Rosa, M; Porterfield, M; Lim, JM; Kulik, M; Pierce, JM; Wells, L; Dalton, S; Tiemeyer, M; Moremen, KW				Nairn, Alison V.; Aoki, Kazuhiro; dela Rosa, Mitche; Porterfield, Mindy; Lim, Jae-Min; Kulik, Michael; Pierce, J. Michael; Wells, Lance; Dalton, Stephen; Tiemeyer, Michael; Moremen, Kelley W.			Regulation of Glycan Structures in Murine Embryonic Stem Cells COMBINED TRANSCRIPT PROFILING OF GLYCAN-RELATED GENES AND GLYCAN STRUCTURAL ANALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; STAGE-SPECIFIC EXPRESSION; SPERM RECEPTOR-ACTIVITY; ADHESION MOLECULE NCAM; HUMAN FACTOR-IX; POLYSIALIC ACID; MONOCLONAL-ANTIBODIES; MOUSE EMBRYOGENESIS; DROSOPHILA-MELANOGASTER; BRAIN-DEVELOPMENT	The abundance and structural diversity of glycans on glycoproteins and glycolipids are highly regulated and play important roles during vertebrate development. Because of the challenges associated with studying glycan regulation in vertebrate embryos, we have chosen to study mouse embryonic stem (ES) cells as they differentiate into embryoid bodies (EBs) or into extraembryonic endodermal (ExE) cells as a model for cellular differentiation. We profiled N- and O-glycan structures isolated from these cell populations and examined transcripts encoding the corresponding enzymatic machinery for glycan biosynthesis in an effort to probe the mechanisms that drive the regulation of glycan diversity. During differentiation from mouse ES cells to either EBs or ExE cells, general trends were detected. The predominance of high mannose N-glycans in ES cells shifted to an equal abundance of complex and high mannose structures, increased sialylation, and increased alpha-Gal termination in the differentiated cell populations. Whereas core 1 O-glycan structures predominated in all three cell populations, increased sialylation and increased core diversity characterized the O-glycans of both differentiated cell types. Increased polysialylation was also found in both differentiated cell types. Differences between the two differentiated cell types included greater sialylation of N-glycans in EBs, whereas alpha-Gal-capped structures were more prevalent in ExE cells. Changes in glycan structures generally, but not uniformly, correlated with alterations in transcript abundance for the corresponding biosynthetic enzymes, suggesting that transcriptional regulation contributes significantly to the regulation of glycan expression. Knowledge of glycan structural diversity and transcript regulation should provide greater understanding of the roles of protein glycosylation in vertebrate development.	[Nairn, Alison V.; Aoki, Kazuhiro; dela Rosa, Mitche; Porterfield, Mindy; Lim, Jae-Min; Pierce, J. Michael; Wells, Lance; Tiemeyer, Michael; Moremen, Kelley W.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Kulik, Michael; Pierce, J. Michael; Wells, Lance; Dalton, Stephen; Tiemeyer, Michael; Moremen, Kelley W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Tiemeyer, M (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	mtiemeyer@ccrc.uga.edu; moremen@uga.edu	Wells, Lance/H-3118-2013; Aoki, Kazuhiro/H-8283-2014; Moremen, Kelley/AAD-4661-2019	Dalton, Stephen/0000-0002-3450-1263; Aoki, Kazuhiro/0000-0003-0029-4291; Nairn, Alison/0000-0002-4453-7593; Wells, Lance/0000-0003-4956-5363	National Institutes of Health [P41RR018502, P41GM103490, P01GM085354]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354, P41GM103490] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41RR018502 and P41GM103490 (to J. M. P.) and P01GM085354 (to S. D.).	Akama TO, 2002, SCIENCE, V295, P124, DOI 10.1126/science.1065570; Alvarez-Manilla G, 2010, J PROTEOME RES, V9, P2062, DOI 10.1021/pr8007489; Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Amano M, 2010, MOL CELL PROTEOMICS, V9, P523, DOI 10.1074/mcp.M900559-MCP200; An HJ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010660; Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 2010, METHOD ENZYMOL, V479, P25, DOI 10.1016/S0076-6879(10)79002-9; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Aoki K, 2008, J BIOL CHEM, V283, P30385, DOI 10.1074/jbc.M804925200; Aoki K, 2007, J BIOL CHEM, V282, P9127, DOI 10.1074/jbc.M606711200; Aoki K, 2010, METHOD ENZYMOL, V480, P297, DOI 10.1016/S0076-6879(10)80014-X; Badcock G, 1999, CANCER RES, V59, P4715; Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; BIERHUIZEN MFA, 1992, P NATL ACAD SCI USA, V89, P9326, DOI 10.1073/pnas.89.19.9326; Biswas A, 2007, STEM CELLS DEV, V16, P213, DOI 10.1089/scd.2006.0081; BLANCHARD D, 1983, J BIOL CHEM, V258, P7691; BLEIL JD, 1988, P NATL ACAD SCI USA, V85, P6778, DOI 10.1073/pnas.85.18.6778; BOURRILLON R, 1989, INT REV CYTOL, V116, P257; CHAMOW SM, 1986, FEBS LETT, V206, P353, DOI 10.1016/0014-5793(86)81011-0; Chiba A, 1997, J BIOL CHEM, V272, P2156; Colley KJ, 2010, ADV EXP MED BIOL, V663, P111, DOI 10.1007/978-1-4419-1170-4_7; Coutinho PM, 1999, ROY SOC CH, P3; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Daley GQ, 2003, ANN NY ACAD SCI, V996, P122, DOI 10.1111/j.1749-6632.2003.tb03240.x; Dasgupta S, 1996, GLYCOCONJUGATE J, V13, P367, DOI 10.1007/BF00731469; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; DOHERTY P, 1990, NEURON, V5, P209, DOI 10.1016/0896-6273(90)90310-C; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; FENDERSON BA, 1990, BIOESSAYS, V12, P173, DOI 10.1002/bies.950120406; FERGUSON MW, 1988, CURR MICROBIOL, V17, P127, DOI 10.1007/BF01573467; FLEMING S, 1990, J ANAT, V170, P151; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; Freeze HH, 2007, CURR MOL MED, V7, P389, DOI 10.2174/156652407780831548; FUKUDA M, 1981, J SUPRAMOL STR CELL, V17, P313, DOI 10.1002/jsscb.380170403; Furukawa T, 1999, J HUM GENET, V44, P397, DOI 10.1007/s100380050186; GILLESPIE W, 1992, J BIOL CHEM, V267, P21004; Guo S, 2001, GLYCOBIOLOGY, V11, P813, DOI 10.1093/glycob/11.10.813; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Harduin-Lepers A, 2005, GLYCOBIOLOGY, V15, P805, DOI 10.1093/glycob/cwi063; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; HARRIS RJ, 1993, BIOCHEMISTRY-US, V32, P6539, DOI 10.1021/bi00077a007; HART GW, 1976, J BIOL CHEM, V251, P6513; Hedrick Jerry L, 2007, Soc Reprod Fertil Suppl, V63, P409; Huang CL, 2010, J CELL PHYSIOL, V225, P92, DOI 10.1002/jcp.22200; JESSELL TM, 1990, ANNU REV NEUROSCI, V13, P227, DOI 10.1146/annurev.ne.13.030190.001303; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Johnston DS, 1998, J BIOL CHEM, V273, P1888, DOI 10.1074/jbc.273.4.1888; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; JUNGALWALA FB, 1994, NEUROCHEM RES, V19, P945, DOI 10.1007/BF00968704; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kim PTW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014146; Kiss JZ, 1997, CURR OPIN NEUROBIOL, V7, P640, DOI 10.1016/S0959-4388(97)80083-9; Knowles B B, 1978, Curr Top Microbiol Immunol, V81, P51; Kwak DH, 2011, EXP MOL MED, V43, P379, DOI 10.3858/emm.2011.43.7.048; LANDMESSER L, 1990, NEURON, V4, P655, DOI 10.1016/0896-6273(90)90193-J; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARK M P, 1990, International Journal of Developmental Biology, V34, P191; Marth J. D., 1999, ESSENTIALS GLYCOBIOL; Martinez-Ceballos E, 2005, J BIOL CHEM, V280, P16484, DOI 10.1074/jbc.M414397200; MIYAKE M, 1988, CANCER RES, V48, P7150; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Muhlenhoff M, 2009, BIOL CHEM, V390, P567, DOI 10.1515/BC.2009.078; MURAMATSU T, 1988, J CELL BIOCHEM, V36, P1, DOI 10.1002/jcb.240360102; MURAMATSU T, 1980, J EMBRYOL EXP MORPH, V57, P25; Muramatsu T, 2004, GLYCOCONJUGATE J, V21, P41, DOI 10.1023/B:GLYC.0000043746.77504.28; Nairn A, 2009, HANDBOOK OF GLYCOMICS, P95; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Nairn AV, 2007, J PROTEOME RES, V6, P4374, DOI 10.1021/pr070446f; Nairn AV, 2010, METHOD ENZYMOL, V479, P73, DOI 10.1016/S0076-6879(10)79004-2; NISHIMURA H, 1992, J BIOL CHEM, V267, P17520; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Oka M, 2002, MOL BIOL CELL, V13, P1274, DOI 10.1091/mbc.02-01-0600; Okajima T, 1999, J BIOL CHEM, V274, P30557, DOI 10.1074/jbc.274.43.30557; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; OZAWA M, 1985, CELL DIFFER DEV, V16, P169, DOI 10.1016/0045-6039(85)90514-7; Park H, 2010, J LIPID RES, V51, P480, DOI 10.1194/jlr.M000984; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; PENNINGTON JE, 1985, J EMBRYOL EXP MORPH, V90, P335; Poirier F, 1997, MOL HUM REPROD, V3, P907, DOI 10.1093/molehr/3.10.907; Porterfield M., 2013, J PROTEOME IN PRESS; Quill TA, 1996, ARCH BIOCHEM BIOPHYS, V333, P326, DOI 10.1006/abbi.1996.0398; Rendic D, 2010, GLYCOBIOLOGY, V20, P1353, DOI 10.1093/glycob/cwq119; Rutishauser U, 2008, NAT REV NEUROSCI, V9, P26, DOI 10.1038/nrn2285; Sakamoto Y, 2000, J BIOL CHEM, V275, P36029, DOI 10.1074/jbc.M005860200; SASAKI K, 1993, J BIOL CHEM, V268, P22782; Sathananthan Henry, 2002, Reprod Biomed Online, V4, P56; Satomaa T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-42; Schwientek T, 1999, J BIOL CHEM, V274, P4504, DOI 10.1074/jbc.274.8.4504; Smith ER, 2001, J BIOL CHEM, V276, P47303, DOI 10.1074/jbc.M106158200; SMITH PL, 1994, J BIOL CHEM, V269, P15162; Solter D, 1979, Curr Top Dev Biol, V13 Pt 1, P139; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Stalnaker SH, 2011, CURR OPIN STRUC BIOL, V21, P603, DOI 10.1016/j.sbi.2011.09.001; Stanton LW, 2007, CURR OPIN CHEM BIOL, V11, P399, DOI 10.1016/j.cbpa.2007.05.029; SUTTONSMITH M, 2002, BIOCH SOC S, V69, P105; Taniguchi N., 2002, HDB GLYCOSYLTRANSFER; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; Taylor ME, 2009, GLYCOBIOLOGY, V19, P1155, DOI 10.1093/glycob/cwp076; Tsuda M, 1999, NATURE, V400, P276, DOI 10.1038/22336; Ujita M, 1999, J BIOL CHEM, V274, P9296, DOI 10.1074/jbc.274.14.9296; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Varki A., 2008, ESSENTIALS GLYCOBIOL, P513; WEINSTEIN J, 1982, J BIOL CHEM, V257, P13845; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Wobus Anna M., 2001, Molecular Aspects of Medicine, V22, P149, DOI 10.1016/S0098-2997(01)00006-1; Wong NK, 2003, J BIOL CHEM, V278, P28619, DOI 10.1074/jbc.M302741200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; Yeh JC, 1999, J BIOL CHEM, V274, P3215, DOI 10.1074/jbc.274.5.3215; Yoon JH, 2009, MOL CELL NEUROSCI, V41, P448, DOI 10.1016/j.mcn.2009.04.013	116	69	70	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.405233	http://dx.doi.org/10.1074/jbc.M112.405233			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988249	Green Published, hybrid			2022-12-25	WOS:000310642200021
J	Petrosyan, A; Ali, MF; Cheng, PW				Petrosyan, Armen; Ali, Mohamed F.; Cheng, Pi-Wan			Glycosyltransferase-specific Golgi-targeting Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETHERING PROTEIN P115; ENDOPLASMIC-RETICULUM; INTERMEDIATE COMPARTMENT; MOLECULAR CHAPERONE; GIANTIN INTERACTS; SECRETORY PATHWAY; CYTOPLASMIC TAIL; O-GLYCOSYLATION; MATRIX PROTEIN; GM130	Glycosylation of secreted and membrane-bound mucins is carried out by glycosyltransferases localized to specific Golgi compartments according to the step in which each enzyme participates. However, the Golgi-targeting mechanisms of these enzymes are not clear. Herein, we investigate the Golgi-targeting mechanisms of core 1 beta 3 galactosyltransferase (C1GalT1) and core 2 beta 1,6-N-acetylglucosaminyltransferase-2 or mucus type (C2GnT-M), which participate in the early O-glycosylation steps. siRNAs, co-immunoprecipitation, and confocal fluorescence microscopy were employed to identify the golgins involved in the Golgi docking of vesicular complexes (VCs) that carry these two enzymes. We have found that these VCs use different golgins for docking: C2GnT-M-carrying VC (C2GnT-M-VC) utilizes Giantin, whereas C1GalT1-VC employs GM130-GRASP65 complex. However, in the absence of GRASP65, C1GalT1-VC utilizes GM130-Giantin complex. Also, we have found that these VCs are 1.1-1.2 mu m in diameter, specific for each enzyme, and independent of coat protein complex II and I (COPII and COPI). These two fluorescently tagged enzymes exhibit different fluorescence recovery times in the Golgi after photobleaching. Thus, novel enzyme-specific Golgi-targeting mechanisms are employed by glycosyltransferases, and multiple Golgi docking strategies are utilized by C1GalT1.	[Petrosyan, Armen; Ali, Mohamed F.; Cheng, Pi-Wan] Univ Nebraska Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; Vet Affairs Nebraska Western Iowa Hlth Care Syst, Dept Res Serv, Omaha, NE 68105 USA; [Cheng, Pi-Wan] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; University of Nebraska System; University of Nebraska Medical Center	Cheng, PW (corresponding author), Univ Nebraska Med Ctr, Coll Med, Dept Biochem & Mol Biol, Omaha, NE 68198 USA.	pcheng@unmc.edu	Petrosyan, Armen/T-7071-2018	Petrosyan, Armen/0000-0003-3895-3993	Office of Research and Development, Department of Veterans Affairs [VA 1I1BX000985]; National Institutes of Health [1R21HL097238, 2RO1HL48282]; State of Nebraska [LB506]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097238, R01HL048282] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000985] Funding Source: NIH RePORTER	Office of Research and Development, Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Nebraska; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the Office of Research and Development, Department of Veterans Affairs (Grant VA 1I1BX000985), the National Institutes of Health (Grants 1R21HL097238 and 2RO1HL48282) (to P. W. C.), and the State of Nebraska (Grant LB506) (to P.W.C.).	Alvarez C, 2001, J BIOL CHEM, V276, P2693, DOI 10.1074/jbc.M007957200; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156; Cheng P. W., 2011, MOL IMMUNOLOGY COMPL, V705, P465; Choi KH, 2005, GLYCOCONJUGATE J, V22, P63, DOI 10.1007/s10719-005-0326-1; Colley KJ, 1997, GLYCOBIOLOGY, V7, P1, DOI 10.1093/glycob/7.1.1-b; Fan JY, 2003, HISTOCHEM CELL BIOL, V120, P455, DOI 10.1007/s00418-003-0597-1; Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Hauri HP, 2000, J CELL SCI, V113, P587; Huang MC, 2006, ONCOGENE, V25, P3267, DOI 10.1038/sj.onc.1209350; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kodani A, 2008, MOL BIOL CELL, V19, P745, DOI 10.1091/mbc.E07-08-0847; Lesa GM, 2000, J BIOL CHEM, V275, P2831, DOI 10.1074/jbc.275.4.2831; LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679, DOI 10.1091/mbc.4.7.679; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Martinez-Alonso E, 2005, TRAFFIC, V6, P32, DOI 10.1111/j.1600-0854.2004.00242.x; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Narimatsu Y, 2008, BIOCHEM BIOPH RES CO, V366, P199, DOI 10.1016/j.bbrc.2007.11.121; Nickel W, 2002, J CELL SCI, V115, P3235; Petrosyan A, 2012, INT J BIOCHEM CELL B, V44, P1153, DOI 10.1016/j.biocel.2012.04.004; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Quintero CA, 2010, J BIOL CHEM, V285, P30340, DOI 10.1074/jbc.M110.128868; Rosing M, 2007, EXP CELL RES, V313, P2318, DOI 10.1016/j.yexcr.2007.03.031; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Simpson JC, 2006, MOL BIOL CELL, V17, P723, DOI 10.1091/mbc.E05-06-0580; Singh J, 2004, J BIOL CHEM, V279, P38969, DOI 10.1074/jbc.M401046200; Stanley P., 2009, ESSENTIALS GLYCOBIOL; Stephens DJ, 2001, J CELL SCI, V114, P1053; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Tu LN, 2010, CELL MOL LIFE SCI, V67, P29, DOI 10.1007/s00018-009-0126-z; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Weide T, 2001, EMBO REP, V2, P336, DOI 10.1093/embo-reports/kve065; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112	39	36	38	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.C112.403006	http://dx.doi.org/10.1074/jbc.C112.403006			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988244	hybrid, Green Published			2022-12-25	WOS:000310642200004
J	Pradhan, A; Khalaf, H; Ochsner, SA; Sreenivasan, R; Koskinen, J; Karlsson, M; Karlsson, J; McKenna, NJ; Orban, L; Olsson, PE				Pradhan, Ajay; Khalaf, Hazem; Ochsner, Scott A.; Sreenivasan, Rajini; Koskinen, Jarno; Karlsson, Marie; Karlsson, Jesper; McKenna, Neil J.; Orban, Laszlo; Olsson, Per-Erik			Activation of NF-kappa B Protein Prevents the Transition from Juvenile Ovary to Testis and Promotes Ovarian Development in Zebrafish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; SEX-DIFFERENTIATION; GENE-EXPRESSION; DANIO-RERIO; CELL LINE; GERM-LINE; MECHANISMS; SOX9; INFLAMMATION; APOPTOSIS	Testis differentiation in zebrafish involves juvenile ovary to testis transformation initiated by an apoptotic wave. The molecular regulation of this transformation process is not fully understood. NF-kappa B is activated at an early stage of development and has been shown to interact with steroidogenic factor-1 in mammals, leading to the suppression of anti-Mullerian hormone (Amh) gene expression. Because steroidogenic factor-1 and Amh are important for proper testis development, NF-kappa B-mediated induction of anti-apoptotic genes could, therefore, also play a role in zebrafish gonad differentiation. The aim of this study was to examine the potential role of NF-kappa B in zebrafish gonad differentiation. Exposure of juvenile zebrafish to heat-killed Escherichia coli activated the NF-kappa B pathways and resulted in an increased ratio of females from 30 to 85%. Microarray and quantitative real-time-PCR analysis of gonads showed elevated expression of NF-kappa B-regulated genes. To confirm the involvement of NF-kappa B-induced anti-apoptotic effects, zebrafish were treated with sodium deoxycholate, a known inducer of NF-kappa B or NF-kappa B activation inhibitor (NAI). Sodium deoxycholate treatment mimicked the effect of heat-killed bacteria and resulted in an increased proportion of females from 25 to 45%, whereas the inhibition of NF-kappa B using NAI resulted in a decrease in females from 45 to 20%. This study provides proof for an essential role of NF-kappa B in gonadal differentiation of zebrafish and represents an important step toward the complete understanding of the complicated process of sex differentiation in this species and possibly other cyprinid teleosts as well.	[Pradhan, Ajay; Khalaf, Hazem; Koskinen, Jarno; Karlsson, Marie; Karlsson, Jesper; Olsson, Per-Erik] Univ Orebro, Sch Sci & Technol, Orebro Life Sci Ctr, Dept Biol, SE-70182 Orebro, Sweden; [Ochsner, Scott A.; McKenna, Neil J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Sreenivasan, Rajini; Orban, Laszlo] Temasek Life Sci Lab, Strateg Res Program, Dept Reprod Genom, Singapore 117604, Singapore; [Orban, Laszlo] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Orban, Laszlo] Univ Pannonia, Georgikon Fac, Dept Anim Sci & Breeding, H-8360 Keszthely, Hungary	Orebro University; Baylor College of Medicine; National University of Singapore; University of Pannonia	Olsson, PE (corresponding author), Univ Orebro, Sch Sci & Technol, Orebro Life Sci Ctr, Dept Biol, SE-70182 Orebro, Sweden.	per-erik.olsson@oru.se	Orbán, László/A-3030-2009; Sreenivasan, Rajini/G-6930-2019	Orbán, László/0000-0001-5435-5948; Sreenivasan, Rajini/0000-0002-6357-5392; Khalaf, Hazem/0000-0002-3373-7864; Pradhan, Ajay/0000-0003-2305-8574; Olsson, Per-Erik/0000-0001-7336-6335; Ochsner, Scott/0000-0003-1099-7863; McKenna, Neil/0000-0001-6689-0104	Swedish Research Council; Knowledge Foundation, Sweden; Orebro University; Agri-Food and Veterinary Authority; Temasek Life Sciences Laboratory, Singapore	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knowledge Foundation, Sweden; Orebro University; Agri-Food and Veterinary Authority; Temasek Life Sciences Laboratory, Singapore(National University of Singapore)	This research was financed by the Swedish Research Council, the Knowledge Foundation, Sweden, and Orebro University (to P.E.-O.) and by the Agri-Food and Veterinary Authority as well as Temasek Life Sciences Laboratory, Singapore (to L.O.).	Aggarwal BB, 2006, CURR SIGNAL TRANSD T, V1, P25, DOI 10.2174/157436206775269235; Anderson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040701; Arango NA, 1999, CELL, V99, P409, DOI 10.1016/S0092-8674(00)81527-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradley KM, 2011, G3-GENES GENOM GENET, V1, P3, DOI 10.1534/g3.111.000190; Delfino F, 1998, MOL ENDOCRINOL, V12, P1696, DOI 10.1210/me.12.11.1696; FINCO TS, 1995, IMMUNITY, V3, P263, DOI 10.1016/1074-7613(95)90112-4; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilardelli CN, 2004, DEV DYNAM, V230, P494, DOI 10.1002/dvdy.20073; Hong CY, 2003, MOL CELL BIOL, V23, P6000, DOI 10.1128/MCB.23.17.6000-6012.2003; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Lasala C, 2004, DNA CELL BIOL, V23, P572, DOI 10.1089/dna.2004.23.572; Lasala C, 2011, AM J PHYSIOL-ENDOC M, V301, pE539, DOI 10.1152/ajpendo.00187.2011; Liew WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034397; Lister A, 2002, J EXP ZOOL, V292, P477, DOI 10.1002/jez.10066; Meijer AH, 2008, DEV COMP IMMUNOL, V32, P36, DOI 10.1016/j.dci.2007.04.003; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Orban L, 2009, MOL CELL ENDOCRINOL, V312, P35, DOI 10.1016/j.mce.2009.04.014; Palvimo JJ, 1996, J BIOL CHEM, V271, P24151, DOI 10.1074/jbc.271.39.24151; Payne CM, 2007, CARCINOGENESIS, V28, P215, DOI 10.1093/carcin/bgl139; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Rigou P, 2009, EMBO J, V28, P1576, DOI 10.1038/emboj.2009.106; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sekiguchi T, 2004, EXP CELL RES, V300, P213, DOI 10.1016/j.yexcr.2004.07.005; Shiozaki EN, 2004, TRENDS BIOCHEM SCI, V29, P486, DOI 10.1016/j.tibs.2004.07.003; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Siegfried KR, 2008, DEV BIOL, V324, P277, DOI 10.1016/j.ydbio.2008.09.025; Singer A, 2002, GENETICS, V160, P649; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sola L, 2001, GENETICA, V111, P397, DOI 10.1023/A:1013776323077; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; Srinivasula SM, 2008, MOL CELL, V30, P123, DOI 10.1016/j.molcel.2008.03.008; TAKAHASHI H, 1977, Bulletin of the Faculty of Fisheries Hokkaido University, V28, P57; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; Uchida D, 2002, J EXP BIOL, V205, P711; von Hofsten J, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-63; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Wallace BMN, 2003, HEREDITY, V90, P136, DOI 10.1038/sj.hdy.6800184; Wang XG, 2007, J FISH BIOL, V70, P33, DOI 10.1111/j.1095-8649.2007.01363.x; Xiao WH, 2004, CELL MOL IMMUNOL, V1, P425	47	47	48	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.386284	http://dx.doi.org/10.1074/jbc.M112.386284			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988238	Green Published, hybrid			2022-12-25	WOS:000310642200028
J	Wu-Zhang, AX; Murphy, AN; Bachman, M; Newton, AC				Wu-Zhang, Alyssa X.; Murphy, Anne N.; Bachman, Mackenzie; Newton, Alexandra C.			Isozyme-specific Interaction of Protein Kinase C delta with Mitochondria Dissected Using Live Cell Fluorescence Imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNNATURAL NUCLEOTIDE SPECIFICITY; ACTIVATION LOOP PHOSPHORYLATION; PYRUVATE-DEHYDROGENASE COMPLEX; DAMAGE-INDUCED APOPTOSIS; PKC-DELTA; TYROSINE PHOSPHORYLATION; ENERGY HOMEOSTASIS; ACTIVITY REPORTER; STRUCTURAL BASIS; PHORBOL ESTERS	PKC delta signaling to mitochondria has been implicated in both mitochondrial apoptosis and metabolism. However, the mechanism by which PKC delta interacts with mitochondria is not well understood. Using FRET-based imaging, we show that PKC delta interacts with mitochondria by a novel and isozyme-specific mechanism distinct from its canonical recruitment to other membranes such as the plasma membrane or Golgi. Specifically, we show that PKC delta interacts with mitochondria following stimulation with phorbol esters or, in L6 myocytes, with insulin via a mechanism that requires two steps. In the first step, PKC delta trans-locates acutely to mitochondria by a mechanism that requires its C1A and C1B domains and a Leu-Asn sequence in its turn motif. In the second step, PKC delta is retained at mitochondria by a mechanism that depends on its C2 domain, a unique Glu residue in its activation loop, intrinsic catalytic activity, and the mitochondrial membrane potential. In contrast, of these determinants, only the C1B domain is required for the phorbol ester-stimulated translocation of PKC delta to other membranes. PKC delta also basally localizes to mitochondria and increases mitochondrial respiration via many of the same determinants that promote its agonist-evoked interaction. PKC delta localized to mitochondria has robust activity, as revealed by a FRET reporter of PKC delta-specific activity (delta CKAR). These data support a model in which multiple determinants unique to PKC delta drive a specific interaction with mitochondria that promotes mitochondrial respiration.	[Wu-Zhang, Alyssa X.; Murphy, Anne N.; Bachman, Mackenzie; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Wu-Zhang, Alyssa X.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@ucsd.edu	Murphy, Anne N/H-3217-2016	Murphy, Anne N/0000-0002-5222-9902	National Institutes of Health [GM43154, P01 DK054441]; University of California from the National Institute of General Medical Sciences [T32 GM007752]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM043154, R37GM043154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California from the National Institute of General Medical Sciences; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM43154 (to A. C. N.) and P01 DK054441 (to A. C. N. and A. N. M.).; Supported in part by the University of California San Diego Graduate Training Program in Cellular and Molecular Pharmacology through Training Grant T32 GM007752 from the National Institute of General Medical Sciences.	Acin-Perez R, 2010, FASEB J, V24, P5033, DOI 10.1096/fj.10-166934; Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281; Adwan TS, 2011, J BIOL CHEM, V286, P35716, DOI 10.1074/jbc.M111.255950; BAIER G, 1993, J BIOL CHEM, V268, P4997; Basu A, 2003, J CELL MOL MED, V7, P341, DOI 10.1111/j.1582-4934.2003.tb00237.x; Basu A, 2001, CELL DEATH DIFFER, V8, P899, DOI 10.1038/sj.cdd.4400885; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Blass M, 2002, MOL CELL BIOL, V22, P182, DOI 10.1128/MCB.22.1.182-195.2002; Cameron AJ, 2007, BIOCHEM SOC T, V35, P1013, DOI 10.1042/BST0351013; Caruso M, 2001, J BIOL CHEM, V276, P45088, DOI 10.1074/jbc.M105451200; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Colon-Gonzalez F, 2006, BBA-MOL CELL BIOL L, V1761, P827, DOI 10.1016/j.bbalip.2006.05.001; Denning MF, 2002, CELL DEATH DIFFER, V9, P40, DOI 10.1038/sj.cdd.4400929; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gallegos LL, 2008, IUBMB LIFE, V60, P782, DOI 10.1002/iub.122; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Gong JL, 2012, FASEB J, V26, P3537, DOI 10.1096/fj.11-197376; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Humphries MJ, 2008, ONCOGENE, V27, P3045, DOI 10.1038/sj.onc.1210967; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Kajimoto T, 2010, J BIOL CHEM, V285, P41896, DOI 10.1074/jbc.M110.184028; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Kaul S, 2005, J BIOL CHEM, V280, P28721, DOI 10.1074/jbc.M501092200; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P14679, DOI 10.1074/jbc.270.24.14679; Konishi H, 2001, P NATL ACAD SCI USA, V98, P6587, DOI 10.1073/pnas.111158798; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Leitges M, 2001, J CLIN INVEST, V108, P1505; Li LW, 1999, MOL CELL BIOL, V19, P8547; Liu Y, 2006, J BIOL CHEM, V281, P12102, DOI 10.1074/jbc.M600508200; Liu Y, 1998, CHEM BIOL, V5, P91, DOI 10.1016/S1074-5521(98)90143-0; Majumder PK, 2000, J BIOL CHEM, V275, P21793, DOI 10.1074/jbc.C000048200; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH946, DOI 10.1152/ajpheart.00878.2003; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH937, DOI 10.1152/ajpheart.00877.2003; Mayr M, 2004, CIRC RES, V94, pE87, DOI 10.1161/01.RES.0000131496.49135.1d; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nguyen T, 2008, J BIOL CHEM, V283, P29831, DOI 10.1074/jbc.M801642200; OSADA S, 1992, MOL CELL BIOL, V12, P3930, DOI 10.1128/MCB.12.9.3930; Pu YM, 2009, J BIOL CHEM, V284, P1302, DOI 10.1074/jbc.M804796200; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Rybin VO, 2007, J BIOL CHEM, V282, P23631, DOI 10.1074/jbc.M701676200; Rybin VO, 2004, J BIOL CHEM, V279, P19350, DOI 10.1074/jbc.M311096200; Sasaki K, 2003, J BIOL CHEM, V278, P30945, DOI 10.1074/jbc.M212167200; Sato T, 1998, CIRC RES, V83, P110, DOI 10.1161/01.RES.83.1.110; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Siwko S, 2007, INT J BIOCHEM CELL B, V39, P978, DOI 10.1016/j.biocel.2007.01.018; Slater SJ, 2002, CHEM PHYS LIPIDS, V116, P75, DOI 10.1016/S0009-3084(02)00021-X; Soltoff SP, 2001, J BIOL CHEM, V276, P37986; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Sossin WS, 2007, LEARN MEMORY, V14, P236, DOI 10.1101/lm.469707; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stempka L, 1999, J BIOL CHEM, V274, P8886, DOI 10.1074/jbc.274.13.8886; TRAN PL, 1985, CARCINOGENESIS, V6, P433, DOI 10.1093/carcin/6.3.433; Violin JD, 2003, IUBMB LIFE, V55, P653, DOI 10.1080/152165401310001642216; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125	62	16	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.412635	http://dx.doi.org/10.1074/jbc.M112.412635			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988234	hybrid, Green Published			2022-12-25	WOS:000310642200025
J	Brucker, RM; Funkhouser, LJ; Setia, S; Pauly, R; Bordenstein, SR				Brucker, Robert M.; Funkhouser, Lisa J.; Setia, Shefali; Pauly, Rini; Bordenstein, Seth R.			Insect Innate Immunity Database (IIID): An Annotation Tool for Identifying Immune Genes in Insect Genomes	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE; SERINE-PROTEASE; DROSOPHILA; NASONIA; ACTIVATION; MELANIZATION; PATHWAYS; PREFERENCE; EVOLUTION; TOLL	The innate immune system is an ancient component of host defense. Since innate immunity pathways are well conserved throughout many eukaryotes, immune genes in model animals can be used to putatively identify homologous genes in newly sequenced genomes of non-model organisms. With the initiation of the "i5k" project, which aims to sequence 5,000 insect genomes by 2016, many novel insect genomes will soon become publicly available, yet few annotation resources are currently available for insects. Thus, we developed an online tool called the Insect Innate Immunity Database (IIID) to provide an open access resource for insect immunity and comparative biology research (http://www.vanderbilt.edu/IIID). The database provides users with simple exploratory tools to search the immune repertoires of five insect models (including Nasonia), spanning three orders, for specific immunity genes or genes within a particular immunity pathway. As a proof of principle, we used an initial database with only four insect models to annotate potential immune genes in the parasitoid wasp genus Nasonia. Results specify 306 putative immune genes in the genomes of N. vitripennis and its two sister species N. giraulti and N. longicornis. Of these genes, 146 were not found in previous annotations of Nasonia immunity genes. Combining these newly identified immune genes with those in previous annotations, Nasonia possess 489 putative immunity genes, the largest immune repertoire found in insects to date. While these computational predictions need to be complemented with functional studies, the IIID database can help initiate and augment annotations of the immune system in the plethora of insect genomes that will soon become available.	[Brucker, Robert M.; Funkhouser, Lisa J.; Setia, Shefali; Pauly, Rini; Bordenstein, Seth R.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Brucker, RM (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA.	s.bordenstein@vanderbilt.edu	Brucker, Robert/F-3052-2013	Brucker, Robert/0000-0002-0854-848X	NSF (National Science Foundation) [DEB 1046149]; Vanderbilt Discovery Grant; Direct For Biological Sciences [1046149] Funding Source: National Science Foundation	NSF (National Science Foundation)(National Science Foundation (NSF)); Vanderbilt Discovery Grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support of this work was provided by NSF (National Science Foundation) award DEB 1046149 and a Vanderbilt Discovery Grant to SRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckage NE, 2008, INSECT IMMUNOLOTY; Blaul B, 2011, P ROY SOC B-BIOL SCI, V278, P3286, DOI 10.1098/rspb.2011.0001; Bordenstein SR, 2007, HEREDITY, V99, P278, DOI 10.1038/sj.hdy.6800994; Brucker RM, 2012, EVOLUTION, V66, P349, DOI 10.1111/j.1558-5646.2011.01454.x; Chafee ME, 2011, GENETICS, V187, P203, DOI 10.1534/genetics.110.120675; CHASAN R, 1989, CELL, V56, P391, DOI 10.1016/0092-8674(89)90242-0; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Clark ME, 2010, HEREDITY, V104, P289, DOI 10.1038/hdy.2009.152; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; Desjardins CA, 2010, HEREDITY, V104, P270, DOI 10.1038/hdy.2009.145; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; KATSUMI Y, 1995, EUR J BIOCHEM, V228, P870, DOI 10.1111/j.1432-1033.1995.tb20334.x; Keller RG, 2010, INSECT MOL BIOL, V19, P109, DOI 10.1111/j.1365-2583.2009.00921.x; Lazzaro BP, 2009, PHILOS T R SOC B, V364, P15, DOI 10.1098/rstb.2008.0141; Leclerc V, 2006, EMBO REP, V7, P231, DOI 10.1038/sj.embor.7400592; Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391; Loehlin DW, 2012, SCIENCE, V335, P943, DOI 10.1126/science.1215193; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Lynch JA, 2012, WIRES DEV BIOL, V1, P16, DOI 10.1002/wdev.3; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Muhlia-Almazan A, 2008, J COMP PHYSIOL B, V178, P655, DOI 10.1007/s00360-008-0263-y; Niehuis O, 2011, HEREDITY, V107, P61, DOI 10.1038/hdy.2010.157; Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698; Parmakelis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008885; Robinson GE, 2011, SCIENCE, V331, P1386, DOI 10.1126/science.331.6023.1386; SCHNEIDER DS, 1994, DEVELOPMENT, V120, P1243; Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200; Tian CH, 2010, J INSECT PHYSIOL, V56, P1857, DOI 10.1016/j.jinsphys.2010.08.004; Tian CH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-187; Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Ye JL, 2010, TOXICON, V56, P101, DOI 10.1016/j.toxicon.2010.03.024; Zou Z, 2010, IMMUNITY, V32, P41, DOI 10.1016/j.immuni.2009.11.011	36	35	37	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45125	10.1371/journal.pone.0045125	http://dx.doi.org/10.1371/journal.pone.0045125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984621	Green Published, gold			2022-12-25	WOS:000308738500119
J	El-Ferzli, GT; Dreher, M; Patel, RP; Ambalavanan, N				El-Ferzli, George T.; Dreher, Mackenzie; Patel, Rakesh P.; Ambalavanan, Namasivayam			ABO Blood Group Is Associated with Response to Inhaled Nitric Oxide in Neonates with Respiratory Failure	PLOS ONE			English	Article							PERSISTENT PULMONARY-HYPERTENSION; CONTROLLED-TRIAL; VENTILATION; SELECTIN; NEWBORN; INFANTS; RISK	Background: Inhaled nitric oxide (iNO) reduces death or need for extracorporeal membrane oxygenation (ECMO) in infants with persistent pulmonary hypertension of the newborn (PPHN). However, the response to iNO is variable and only 50-60% of infants demonstrate a response to iNO. It is not known why only some infants respond to iNO. Adults and children with blood groups B or AB do not respond as well to iNO as those with blood groups O/A. Methods/Principal Findings: To determine if blood group was associated with iNO response in newborn infants, a retrospective medical record review was done of infants admitted to a regional NICU from 2002-9 with a diagnosis of PPHN. Data were collected during the first twelve hours post-initiation of treatment. Of 86 infants diagnosed with PPHN, 23 infants had blood group A [18 received iNO], 21 had group B [18 with iNO], 40 had group O [36 with iNO], and 2 had group AB [both received iNO]. Change in PaO2/FiO(2) was less in infants with blood group A, of whom less than half were responders (Delta PaO2/FiO(2)>20%) at 12 h versus 90% of infants with either O or B. Race, sex, birth weight, gestational age, Apgar scores at 1 and 5 minutes, and baseline PaO2/FiO(2) were similar among groups. Outcomes including need for ECMO, death, length of ventilatory support, length of iNO use, and hospital stay were statistically not different by blood groups. Conclusions/Significance: Our results indicate that blood group influences iNO response in neonates. We hypothesize that either there is genetic linkage of the ABO gene locus with vasoregulatory genes, or that blood group antigens directly affect vascular reactivity.	[El-Ferzli, George T.; Dreher, Mackenzie; Ambalavanan, Namasivayam] Univ Alabama Birmingham, Dept Pediat, Ctr Free Radical Biol, Birmingham, AL USA; [El-Ferzli, George T.; Dreher, Mackenzie; Ambalavanan, Namasivayam] Univ Alabama Birmingham, Dept Pediat, Pulm Injury Repair Ctr, Birmingham, AL USA; [Patel, Rakesh P.] Univ Alabama Birmingham, Dept Pathol, Ctr Free Radical Biol, Birmingham, AL 35294 USA; [Patel, Rakesh P.] Univ Alabama Birmingham, Dept Pathol, Pulm Injury Repair Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	El-Ferzli, GT (corresponding author), Univ Alabama Birmingham, Dept Pediat, Ctr Free Radical Biol, Birmingham, AL USA.	ambal@uab.edu	Ambalavanan, Namasivayam/AAI-4088-2020; Ambalavanan, Namasivayam/AAL-3832-2020	Ambalavanan, Namasivayam/0000-0003-0731-9092; Patel, Rakesh/0000-0002-1526-4303	National Institutes of Health (NIH) [R01 HL092906]; IKARIA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092906] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IKARIA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded in part by National Institutes of Health (NIH) R01 HL092906 and Grant funding from IKARIA for trainee research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barbalic M, 2010, HUM MOL GENET, V19, P1863, DOI 10.1093/hmg/ddq061; Cartron JP, 2001, TRANSFUS CLIN BIOL, V8, P163, DOI 10.1016/S1246-7820(01)00142-2; Chasman DI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000730; Chung CM, 2010, PHARMACOGENOMICS J, V10, P537, DOI 10.1038/tpj.2009.70; Field D, 2005, PEDIATRICS, V115, P926, DOI 10.1542/peds.2004-1209; Finer NN, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000399.pub2; Kinsella JP, 1997, J PEDIATR-US, V131, P55, DOI 10.1016/S0022-3476(97)70124-0; McFadzean J, 1999, LANCET, V353, P1414, DOI 10.1016/S0140-6736(99)00705-9; Pare G, 2008, PLOS GENET, V4; Qi L, 2010, HUM MOL GENET, V19, P1856, DOI 10.1093/hmg/ddq057; Roberts JD, 1997, NEW ENGL J MED, V336, P605, DOI 10.1056/NEJM199702273360902; Wang YF, 2011, CHINESE MED J-PEKING, V124, P1156, DOI 10.3760/cma.j.issn.0366-6999.2011.08.006; Weimann J, 1998, LANCET, V351, P1786, DOI 10.1016/S0140-6736(05)78748-1; Wiggins KL, 2009, J THROMB HAEMOST, V7, P263, DOI 10.1111/j.1538-7836.2008.03243.x; Wu O, 2008, J THROMB HAEMOST, V6, P62; 1997, N ENGL J MED, V336, P597	16	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45164	10.1371/journal.pone.0045164	http://dx.doi.org/10.1371/journal.pone.0045164			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984626	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500124
J	Larson, CM; Pillsworth, EG; Haselton, MG				Larson, Christina M.; Pillsworth, Elizabeth G.; Haselton, Martie G.			Ovulatory Shifts in Women's Attractions to Primary Partners and Other Men: Further Evidence of the Importance of Primary Partner Sexual Attractiveness	PLOS ONE			English	Article							MENSTRUAL-CYCLE; PHYSICAL ATTRACTIVENESS; MATE PREFERENCES; MASCULINITY; INTERESTS; SYMMETRY; SCENT; INTERCOURSE; CONCEPTION; RETENTION	Previous research has documented shifts in women's attractions to their romantic partner and to men other than their partner across the ovulation cycle, contingent on the degree to which her partner displays hypothesized indicators of high-fitness genes. The current study set out to replicate and extend this finding. Forty-one couples in which the woman was naturally cycling participated. Female partners reported their feelings of in-pair attraction and extra-pair attraction on two occasions, once on a low-fertility day of the cycle and once on a high-fertility day of the cycle just prior to ovulation. Ovulation was confirmed using luteinizing hormone tests. We collected two measures of male partner sexual attractiveness. First, the women in the study rated their partner's sexual attractiveness. Second, we photographed the partners and had the photos independently rated for attractiveness. Shifts in women's in-pair attractions across the cycle were significantly moderated by women's ratings of partner sexual attractiveness, such that the less sexually attractive women rated their partner, the less in-pair attraction they reported at high fertility compared with low fertility (partial r = .37, p(dir) = .01). Shifts in women's extra-pair attractions across the cycle were significantly moderated by third-party ratings of partner attractiveness, such that the less attractive the partner was, the more extra-pair attraction women reported at high relative to low fertility (partial r = -.33, p(dir) = .03). In line with previous findings, we found support for the hypothesis that the degree to which a woman's romantic partner displays indicators of high-fitness genes affects women's attractions to their own partner and other men at high fertility.	[Larson, Christina M.; Haselton, Martie G.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Pillsworth, Elizabeth G.] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA; [Haselton, Martie G.] Univ Calif Los Angeles, Dept Commun Studies, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Larson, CM (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA.	cmlarson1@ucla.edu	Pillsworth, Elizabeth G/C-3327-2011		National Science Foundation; University of California Los Angeles Council on Research Faculty Grants Program	National Science Foundation(National Science Foundation (NSF)); University of California Los Angeles Council on Research Faculty Grants Program	This research was supported by funding for Christina Larson from the National Science Foundation-funded University of California Los Angeles Interdisciplinary Relationship Science Program http://www.irsp.ucla.edu/, and was funded by grants from the University of California Los Angeles Council on Research Faculty Grants Program awarded to Martie Haselton http://www.senate.ucla.edu/committees/cor/fgp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Barber N, 1995, ETHOL SOCIOBIOL, V16, P395, DOI 10.1016/0162-3095(95)00068-2; DeBruine L, 2010, EVOL PSYCHOL-US, V8, P768; Dixson BJ, 2010, ARCH SEX BEHAV, V39, P798, DOI 10.1007/s10508-008-9441-y; Feinberg DR, 2006, HORM BEHAV, V49, P215, DOI 10.1016/j.yhbeh.2005.07.004; Frederick DA, 2007, PERS SOC PSYCHOL B, V33, P1167, DOI 10.1177/0146167207303022; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Gangestad SW, 2007, J PERS SOC PSYCHOL, V92, P151, DOI 10.1037/0022-3514.92.1.151; Gangestad SW, 2010, EVOL HUM BEHAV, V31, P412, DOI 10.1016/j.evolhumbehav.2010.06.001; Gangestad SW, 1998, P ROY SOC B-BIOL SCI, V265, P927, DOI 10.1098/rspb.1998.0380; Gangestad SW, 2005, ANNU REV ANTHROPOL, V34, P523, DOI 10.1146/annurev.anthro.33.070203.143733; Gangestad SW, 2005, P ROY SOC B-BIOL SCI, V272, P2023, DOI 10.1098/rspb.2005.3112; Gangestad SW, 2002, P ROY SOC B-BIOL SCI, V269, P975, DOI 10.1098/rspb.2001.1952; Gangestad SW, 2000, BEHAV BRAIN SCI, V23, P573, DOI 10.1017/S0140525X0000337X; Gangestad SW, 2004, PSYCHOL SCI, V15, P203, DOI 10.1111/j.0956-7976.2004.01503010.x; Garver-Apgar CE, 2006, PSYCHOL SCI, V17, P830, DOI 10.1111/j.1467-9280.2006.01789.x; Guermandi E, 2001, OBSTET GYNECOL, V97, P92, DOI 10.1016/S0029-7844(00)01083-8; Haselton MG, 2006, HORM BEHAV, V49, P509, DOI 10.1016/j.yhbeh.2005.10.006; Havlicek J, 2009, PSYCHONEUROENDOCRINO, V34, P497, DOI 10.1016/j.psyneuen.2008.10.007; Lancaster JB, 2010, HUM BEH EV SOC 22 AN; Larson CM, I LOVE YOU IN PRESS; Little AC, 2007, HORM BEHAV, V51, P633, DOI 10.1016/j.yhbeh.2007.03.006; Lukaszewski AW, 2009, PERS INDIV DIFFER, V47, P191, DOI 10.1016/j.paid.2009.02.019; Pawlowski B, 2005, BIOL PSYCHOL, V70, P38, DOI 10.1016/j.biopsycho.2005.02.002; Penn DJ, 2002, P NATL ACAD SCI USA, V99, P11260, DOI 10.1073/pnas.162006499; Pillsworth E. G., 2006, ANN REV SEX RES, V17, P59, DOI DOI 10.1080/10532528.2006.10559837; Pillsworth EG, 2006, EVOL HUM BEHAV, V27, P247, DOI 10.1016/j.evolhumbehav.2005.10.002; Puts DA, 2005, EVOL HUM BEHAV, V26, P388, DOI 10.1016/j.evolhumbehav.2005.03.001; RICE WR, 1994, TRENDS ECOL EVOL, V9, P235, DOI 10.1016/0169-5347(94)90258-5; Rikowski A, 1999, P ROY SOC B-BIOL SCI, V266, P869, DOI 10.1098/rspb.1999.0717; Roney JR, 2011, PSYCHONEUROENDOCRINO, V36, P742, DOI 10.1016/j.psyneuen.2010.10.010; Rusbult CE, 1998, PERS RELATIONSHIP, V5, P357, DOI 10.1111/j.1475-6811.1998.tb00177.x; SIMPSON JA, 1991, J PERS SOC PSYCHOL, V60, P870, DOI 10.1037/0022-3514.60.6.870; Thornhill R, 1999, EVOL HUM BEHAV, V20, P175, DOI 10.1016/S1090-5138(99)00005-7; Thornhill R, 2003, BEHAV ECOL, V14, P668, DOI 10.1093/beheco/arg043; Thornhill R., 2008, EVOLUTIONARY BIOL HU; WILCOX AJ, 1995, NEW ENGL J MED, V333, P1517, DOI 10.1056/NEJM199512073332301; Wilcox AJ, 2001, CONTRACEPTION, V63, P211, DOI 10.1016/S0010-7824(01)00191-3	38	44	44	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44456	10.1371/journal.pone.0044456	http://dx.doi.org/10.1371/journal.pone.0044456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984512	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500059
J	Hill, V; Zozio, T; Sadikalay, S; Viegas, S; Streit, E; Kallenius, G; Rastogi, N				Hill, Veronique; Zozio, Thierry; Sadikalay, Syndia; Viegas, Sofia; Streit, Elisabeth; Kallenius, Gunilla; Rastogi, Nalin			MLVA Based Classification of Mycobacterium tuberculosis Complex Lineages for a Robust Phylogeographic Snapshot of Its Worldwide Molecular Diversity	PLOS ONE			English	Article							DIRECT REPEAT LOCUS; HUMAN GENETIC HISTORY; Y-CHROMOSOME; SPACER OLIGONUCLEOTIDES; EVOLUTIONARY SCENARIO; IS6110 TRANSPOSITION; GLOBAL DISSEMINATION; EPIDEMIOLOGY; POLYMORPHISM; IDENTIFICATION	Multiple-locus variable-number tandem repeat analysis (MLVA) is useful to establish transmission routes and sources of infections for various microorganisms including Mycobacterium tuberculosis complex (MTC). The recently released SITVITWEB database contains 12-loci Mycobacterial Interspersed Repetitive Units - Variable Number of Tandem DNA Repeats (MIRU-VNTR) profiles and spoligotype patterns for thousands of MTC strains; it uses MIRU International Types (MIT) and Spoligotype International Types (SIT) to designate clustered patterns worldwide. Considering existing doubts on the ability of spoligotyping alone to reveal exact phylogenetic relationships between MTC strains, we developed a MLVA based classification for MTC genotypic lineages. We studied 6 different subsets of MTC isolates encompassing 7793 strains worldwide. Minimum spanning trees (MST) were constructed to identify major lineages, and the most common representative located as a central node was taken as the prototype defining different phylogenetic groups. A total of 7 major lineages with their respective prototypes were identified: Indo-Oceanic/MIT57, East Asian and African Indian/MIT17, Euro American/MIT116, West African-I/MIT934, West African-II/MIT664, M. bovis/MIT49, M. canettii/MIT60. Further MST subdivision identified an additional 34 sublineage MIT prototypes. The phylogenetic relationships among the 37 newly defined MIRU-VNTR lineages were inferred using a classification algorithm based on a bayesian approach. This information was used to construct an updated phylogenetic and phylogeographic snapshot of worldwide MTC diversity studied both at the regional, sub-regional, and country level according to the United Nations specifications. We also looked for IS6110 insertional events that are known to modify the results of the spoligotyping in specific circumstances, and showed that a fair portion of convergence leading to the currently observed bias in phylogenetic classification of strains may be traced back to the presence of IS6110. These results shed new light on the evolutionary history of the pathogen in relation to the history of peopling and human migration.	[Hill, Veronique; Zozio, Thierry; Sadikalay, Syndia; Streit, Elisabeth; Rastogi, Nalin] Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranatl TB Reference Lab, Abymes, France; [Viegas, Sofia] Minist Hlth, Natl Inst Hlth, Maputo, Mozambique; [Kallenius, Gunilla] Karolinska Inst, Dept Clin Sci & Educ, Sodersjukhuset, Stockholm, Sweden	Karolinska Institutet; Sodersjukhuset Hospital	Hill, V (corresponding author), Inst Pasteur Guadeloupe, TB & Mycobacteria Unit, WHO Supranatl TB Reference Lab, Abymes, France.	nrastogi@pasteur-guadeloupe.fr	Källenius, Gunilla/AGZ-3956-2022; RASTOGI, NALIN/AAP-1958-2020	RASTOGI, NALIN/0000-0002-7199-7747; Kallenius, Gunilla/0000-0002-8921-0551	European Social Funds through the Regional Council of Guadeloupe; International Network of the Pasteur Institutes	European Social Funds through the Regional Council of Guadeloupe; International Network of the Pasteur Institutes	Veronique Hill was awarded a Ph.D. fellowship by the European Social Funds through the Regional Council of Guadeloupe. The project was partially financed by the International Network of the Pasteur Institutes. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Alexander DC, 2003, ANTIMICROB AGENTS CH, V47, P3208, DOI 10.1128/AAC.47.10.3208-3213.2003; Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P2692, DOI 10.1128/JCM.00540-08; Asgharzadeh M, 2011, INFECT GENET EVOL, V11, P124, DOI 10.1016/j.meegid.2010.09.013; Brodin P, 2002, INFECT IMMUN, V70, P5568, DOI 10.1128/IAI.70.10.5568-5578.2002; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Brudey K, 2004, J CLIN MICROBIOL, V42, P5053, DOI 10.1128/JCM.42.11.5053-5057.2004; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caimi K, 2001, J CLIN MICROBIOL, V39, P1067, DOI 10.1128/JCM.39.3.1067-1072.2001; Comas I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007815; Cruciani F, 2010, EUR J HUM GENET, V18, P800, DOI 10.1038/ejhg.2009.231; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Fang Z, 1998, J BACTERIOL, V180, P2102, DOI 10.1128/JB.180.8.2102-2109.1998; Fang ZG, 1997, J CLIN MICROBIOL, V35, P479, DOI 10.1128/JCM.35.2.479-481.1997; Fenner L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024737; Filliol I, 2006, J BACTERIOL, V188, P759, DOI 10.1128/JB.188.2.759-772.2006; Filliol I, 2000, J CLIN MICROBIOL, V38, P1231, DOI 10.1128/JCM.38.3.1231-1234.2000; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gibson AL, 2008, J CLIN MICROBIOL, V46, P1259, DOI 10.1128/JCM.02231-07; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Kayser M, 2010, CURR BIOL, V20, pR194, DOI 10.1016/j.cub.2009.12.004; Lari N, 2001, J MED MICROBIOL, V50, P805, DOI 10.1099/0022-1317-50-9-805; Legrand E, 2001, J CLIN MICROBIOL, V39, P1595, DOI 10.1128/JCM.39.4.1595-1599.2001; Majumder PP, 2010, CURR BIOL, V20, pR184, DOI 10.1016/j.cub.2009.11.053; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Mokrousov I, 2009, INFECT GENET EVOL, V9, P1400, DOI 10.1016/j.meegid.2009.07.007; Myres NM, 2011, EUR J HUM GENET, V19, P95, DOI 10.1038/ejhg.2010.146; Lazzarini LCO, 2007, J CLIN MICROBIOL, V45, P3891, DOI 10.1128/JCM.01394-07; Rao KR, 2005, J CLIN MICROBIOL, V43, P5978, DOI 10.1128/JCM.43.12.5978-5982.2005; Rastogi N., 2007, TUBERCULOSIS 2007 BA, V2007, P53; Renfrew C, 2010, CURR BIOL, V20, pR162, DOI 10.1016/j.cub.2009.11.056; ROBERTS DE, 1991, GENETICS, V128, P37; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sampson SL, 2003, J BACTERIOL, V185, P2856, DOI 10.1128/JB.185.9.2856-2866.2003; Schurch AC, 2011, J CLIN MICROBIOL, V49, P1318, DOI 10.1128/JCM.01848-10; Sola Christophe, 2005, Infection Genetics and Evolution, V5, P145, DOI 10.1016/j.meegid.2004.08.003; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; van der Zanden AGM, 2002, J CLIN MICROBIOL, V40, P4628, DOI 10.1128/JCM.40.12.4628-4639.2002; van Embden JDA, 2000, J BACTERIOL, V182, P2393, DOI 10.1128/JB.182.9.2393-2401.2000; Viegas SO, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-195	48	22	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e41991	10.1371/journal.pone.0041991	http://dx.doi.org/10.1371/journal.pone.0041991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984400	Green Submitted, Green Published, gold			2022-12-25	WOS:000308638700003
J	Bauer, L; Langer, R; Becker, K; Hapfelmeier, A; Ott, K; Novotny, A; Hofler, H; Keller, G				Bauer, Lukas; Langer, Rupert; Becker, Karen; Hapfelmeier, Alexander; Ott, Katja; Novotny, Alexander; Hoefler, Heinz; Keller, Gisela			Expression Profiling of Stem Cell-Related Genes in Neoadjuvant-Treated Gastric Cancer: A NOTCH2, GSK3B and beta-catenin Gene Signature Predicts Survival	PLOS ONE			English	Article							BREAST-CANCER; SELF-RENEWAL; MARKERS; CHEMOTHERAPY; CARCINOMAS; REGRESSION; PATTERNS; TUMOR; PHOSPHORYLATION; CARCINOGENESIS	Cancer stem cell (CSC) based gene expression signatures are associated with prognosis in various tumour types and CSCs are suggested to be particularly drug resistant. The aim of our study was first, to determine the prognostic significance of CSC-related gene expression in residual tumour cells of neoadjuvant-treated gastric cancer (GC) patients. Second, we wished to examine, whether expression alterations between pre- and post-therapeutic tumour samples exist, consistent with an enrichment of drug resistant tumour cells. The expression of 44 genes was analysed in 63 formalin-fixed, paraffin embedded tumour specimens with partial tumour regression (10-50% residual tumour) after neoadjuvant chemotherapy by quantitative real time PCR low-density arrays. A signature of combined GSK3B(high), beta-catenin (CTNNB1)(high) and NOTCH2(low) expression was strongly correlated with better patient survival (p < 0.001). A prognostic relevance of these genes was also found analysing publically available gene expression data. The expression of 9 genes was compared between pretherapeutic biopsies and post-therapeutic resected specimens. A significant post-therapeutic increase in NOTCH2, LGR5 and POU5F1 expression was found in tumours with different tumour regression grades. No significant alterations were observed for GSK3B and CTNNB1. Immunohistochemical analysis demonstrated a chemotherapy-associated increase in the intensity of NOTCH2 staining, but not in the percentage of NOTCH2. Taken together, the GSK3B, CTNNB1 and NOTCH2 expression signature is a novel, promising prognostic parameter for GC. The results of the differential expression analysis indicate a prominent role for NOTCH2 and chemotherapy resistance in GC, which seems to be related to an effect of the drugs on NOTCH2 expression rather than to an enrichment of NOTCH2 expressing tumour cells.	[Bauer, Lukas; Langer, Rupert; Becker, Karen; Hoefler, Heinz; Keller, Gisela] Tech Univ Munich, Inst Pathol, Munich, Germany; [Ott, Katja] Heidelberg Univ, Dept Surg, D-6900 Heidelberg, Germany; [Novotny, Alexander] Tech Univ Munich, Dept Surg, Munich, Germany; [Hapfelmeier, Alexander] Tech Univ Munich, Inst Med Stat & Epidemiol, Munich, Germany; [Hoefler, Heinz] Helmholtz Zentrum Munchen, Inst Pathol, Neuherberg, Germany	Technical University of Munich; Ruprecht Karls University Heidelberg; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Bauer, L (corresponding author), Tech Univ Munich, Inst Pathol, Munich, Germany.	gisela.keller@lrz.tum.de	Langer, Rupert/AAU-1174-2021; Hapfelmeier, Alexander/I-9966-2019	Langer, Rupert/0000-0001-9491-3609; Hapfelmeier, Alexander/0000-0001-6765-6352	Deutsche Krebshilfe Mildred Scheel Stiftung [108524]	Deutsche Krebshilfe Mildred Scheel Stiftung(Deutsche Krebshilfe)	The study was supported by the Deutsche Krebshilfe Mildred Scheel Stiftung, grant number 108524 to GK and KB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Becker K, 2011, ANN SURG, V253, P934, DOI 10.1097/SLA.0b013e318216f449; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Chen X, 2003, MOL BIOL CELL, V14, P3208, DOI 10.1091/mbc.E02-12-0833; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Sousa e Melo F, 2011, CELL STEM CELL, V9, P476, DOI 10.1016/j.stem.2011.10.008; Espinosa I, 2011, MODERN PATHOL, V24, P846, DOI 10.1038/modpathol.2011.12; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Filiz AI, 2010, COLORECTAL DIS, V12, P1223, DOI 10.1111/j.1463-1318.2009.01994.x; Freeman TJ, 2012, GASTROENTEROLOGY, V142, P562, DOI 10.1053/j.gastro.2011.11.026; Grabsch H, 2001, HISTOPATHOLOGY, V39, P141, DOI 10.1046/j.1365-2559.2001.01177.x; Groth C, 2012, SEMIN CELL DEV BIOL; Hothorn T, 2008, BIOMETRICS, V64, P1263, DOI 10.1111/j.1541-0420.2008.00995.x; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Lee HE, 2011, BRIT J CANCER, V104, P1730, DOI 10.1038/bjc.2011.159; Li Da-Wei, 2007, Ai Zheng, V26, P1183; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lordick Florian, 2005, Gastric Cancer, V8, P78, DOI 10.1007/s10120-005-0321-z; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Nabais S, 2003, INT J SURG PATHOL, V11, P1, DOI 10.1177/106689690301100102; Napieralski R, 2005, CLIN CANCER RES, V11, P3025, DOI 10.1158/1078-0432.CCR-04-1605; O'Brien CA, 2010, CLIN CANCER RES, V16, P3113, DOI 10.1158/1078-0432.CCR-09-2824; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Ott Katja, 2003, Gastric Cancer, V6, P159, DOI 10.1007/s10120-003-0245-4; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Qiao XTT, 2011, J GASTROENTEROL, V46, P855, DOI 10.1007/s00535-011-0413-y; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rocco A, 2012, J CELL PHYSIOL, V227, P2686, DOI 10.1002/jcp.23013; Saigusa S, 2009, ANN SURG ONCOL, V16, P3488, DOI 10.1245/s10434-009-0617-z; Saikawa Y, 2010, GASTRIC CANCER, V13, P11, DOI 10.1007/s10120-009-0537-4; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuhmacher CP, 2001, CANCER-AM CANCER SOC, V91, P918, DOI 10.1002/1097-0142(20010301)91:5<918::AID-CNCR1081>3.3.CO;2-N; Shats I, 2011, CANCER RES, V71, P1772, DOI 10.1158/0008-5472.CAN-10-1735; Takaishi S, 2008, J CLIN ONCOL, V26, P2876, DOI 10.1200/JCO.2007.15.2603; Takebe N, 2010, CLIN CANCER RES, V16, P3106, DOI 10.1158/1078-0432.CCR-09-2934; Tseng YC, 2011, MOL CARCINOG; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Vries RGJ, 2010, MOL ONCOL, V4, P373, DOI 10.1016/j.molonc.2010.05.001; Wakamatsu Y, 2012, PATHOL INT, V62, P112, DOI 10.1111/j.1440-1827.2011.02760.x; Wang T, 2011, BRIT J CANCER, V105, P658, DOI 10.1038/bjc.2011.287; Yeh TS, 2009, CANCER RES, V69, P5039, DOI 10.1158/0008-5472.CAN-08-4021; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zhang CJ, 2011, J CANCER RES CLIN, V137, P1679, DOI 10.1007/s00432-011-1038-5; Zhao YD, 2008, CANCER INFORM, V6, P9	51	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44566	10.1371/journal.pone.0044566	http://dx.doi.org/10.1371/journal.pone.0044566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970250	gold, Green Submitted, Green Published			2022-12-25	WOS:000308748400023
J	Villa, E; Vukotic, R; Camma, C; Petta, S; Di Leo, A; Gitto, S; Turola, E; Karampatou, A; Losi, L; Bernabucci, V; Cenci, A; Tagliavini, S; Baraldi, E; De Maria, N; Gelmini, R; Bertolini, E; Rendina, M; Francavilla, A				Villa, Erica; Vukotic, Ranka; Camma, Calogero; Petta, Salvatore; Di Leo, Alfredo; Gitto, Stefano; Turola, Elena; Karampatou, Aimilia; Losi, Luisa; Bernabucci, Veronica; Cenci, Annamaria; Tagliavini, Simonetta; Baraldi, Enrica; De Maria, Nicola; Gelmini, Roberta; Bertolini, Elena; Rendina, Maria; Francavilla, Antonio		Research Network Women Hepatology	Reproductive Status Is Associated with the Severity of Fibrosis in Women with Hepatitis C	PLOS ONE			English	Article							LIVER FIBROSIS; STELLATE CELLS; PROGRESSION; ESTRADIOL; TESTOSTERONE; ACTIVATION; THERAPY; BENEFIT	Introduction: Chronic hepatitis C is the main cause of death in patients with end-stage liver disease. Prognosis depends on the increase of fibrosis, whose progression is twice as rapid in men as in women. Aim of the study was to evaluate the effects of reproductive stage on fibrosis severity in women and to compare these findings with age-matched men. Materials and Methods: A retrospective study of 710 consecutive patients with biopsy-proven chronic hepatitis C was conducted, using data from a clinical database of two tertiary Italian care centers. Four age-matched groups of men served as controls. Data about demographics, biochemistry, liver biopsy and ultrasonography were analyzed. Contributing factors were assessed by multivariate logistic regression analysis. Results: Liver fibrosis was more advanced in the early menopausal than in the fully reproductive (P<0.0001) or premenopausal (P = 0.042) group. Late menopausal women had higher liver fibrosis compared with the other groups (fully reproductive, P<0.0001; premenopausal, P = <0.0001; early menopausal, P = 0.052). Multivariate analyses showed that male sex was independently associated with more severe fibrosis in the groups corresponding to premenopausal (P = 0.048) and early menopausal (P = 0.004) but not late menopausal pairs. In women, estradiol/testosterone ratio decreased markedly in early (vs. reproductive age: P = 0.002 and vs. premenopausal: P<0.0001) and late menopause (vs. reproductive age: P = 0.001; vs. premenopausal: P<0.0001). In men age-matched with menopausal women, estradiol/testosterone ratio instead increased (reproductive age group vs. early: P = 0.002 and vs. late M: P = 0.001). Conclusions: The severity of fibrosis in women worsens in parallel with increasing estrogen deprivation and estradiol/testosterone ratio decrease. Our data provide evidence why fibrosis progression is discontinuous in women and more linear and severe in men, in whom aging-associated estradiol/testosterone ratio increase occurs too late to noticeably influence the inflammatory process leading to fibrosis.	[Villa, Erica; Vukotic, Ranka; Gitto, Stefano; Turola, Elena; Karampatou, Aimilia; Bernabucci, Veronica; De Maria, Nicola; Bertolini, Elena] Azienda Osped Univ, Dept Gastroenterol, Modena, Italy; [Villa, Erica; Vukotic, Ranka; Gitto, Stefano; Turola, Elena; Karampatou, Aimilia; Bernabucci, Veronica; De Maria, Nicola; Bertolini, Elena] Univ Modena & Reggio Emilia, Modena, Italy; [Camma, Calogero; Petta, Salvatore] Univ Palermo, Sez Gastroenterol, DiBiMIS, Palermo, Italy; [Di Leo, Alfredo; Rendina, Maria] Univ Bari, Dept Gastroenterol, I-70124 Bari, Italy; [Losi, Luisa] Azienda Osped Univ, Dept Pathol, Modena, Italy; [Cenci, Annamaria; Tagliavini, Simonetta; Baraldi, Enrica] NOCSAE, Dept Clin Pathol, Modena, Italy; [Gelmini, Roberta] Azienda Osped Univ, Dept Gen Surg, Modena, Italy; [Francavilla, Antonio] Ist Ricovero & Cura Saverio de Bellis, Castellana Grotte, Italy	Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; University of Palermo; Universita degli Studi di Bari Aldo Moro; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; IRCCS Saverio de Bellis	Villa, E (corresponding author), Azienda Osped Univ, Dept Gastroenterol, Modena, Italy.	erica.villa@unimore.it	Gelmini, Roberta/J-8234-2016; Gelmini, Roberta/F-7184-2017; Gitto, Stefano/J-9922-2018; Villa, Erica/A-7576-2012; GELMINI, Roberta/N-6881-2019	Gelmini, Roberta/0000-0002-8471-710X; Gelmini, Roberta/0000-0002-8471-710X; Gitto, Stefano/0000-0002-8042-6508; Villa, Erica/0000-0001-6388-7022; GELMINI, Roberta/0000-0002-8471-710X; Di Leo, Alfredo/0000-0003-2026-1200; Petta, Salvatore/0000-0002-0822-9673; CAMMA', CALOGERO/0000-0002-9224-1914; Elena, Turola/0000-0002-1810-8648	Merck & Co (Whitehouse Station, NJ, USA)	Merck & Co (Whitehouse Station, NJ, USA)(Merck & Company)	The study was supported by an unrestricted grant by Merck & Co (Whitehouse Station, NJ, USA). The funding source had no role in the design of the study; collection, analysis, and interpretation of the data; drafting of the manuscript or decision to submit the manuscript for publication.; The study was supported by an unrestricted grant by Merck & Co (Whitehouse Station, NJ, USA). The funding source had no role in the design of the study; collection, analysis, and interpretation of the data; drafting of the manuscript or decision to submit the manuscript for publication. Corresponding Author is serving as Academic Editor for PLOS ONE. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Codes L, 2007, GUT, V56, P390, DOI 10.1136/gut.2006.101931; Conte D, 2000, HEPATOLOGY, V31, P751, DOI 10.1002/hep.510310328; Deuffic-Burban S, 2002, J VIRAL HEPATITIS, V9, P114, DOI 10.1046/j.1365-2893.2002.00340.x; Di Martino V, 2004, HEPATOLOGY, V40, P1426, DOI 10.1002/hep.20463; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; George SL, 2009, HEPATOLOGY, V49, P729, DOI 10.1002/hep.22694; Hoefs JC, 2011, GASTROENTEROLOGY, V141, P900, DOI 10.1053/j.gastro.2011.06.007; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Itagaki T, 2005, GUT, V54, P1782, DOI 10.1136/gut.2005.053278; Kireev RA, 2010, BIOGERONTOLOGY, V11, P229, DOI 10.1007/s10522-009-9242-2; La Marca A, 2009, HUM REPROD, V24, P2264, DOI 10.1093/humrep/dep210; Maffei L, 2004, J CLIN ENDOCR METAB, V89, P61, DOI 10.1210/jc.2003-030313; Miyaaki H, 2011, INTERNAL MED, V50, P1137, DOI 10.2169/internalmedicine.50.4447; Petta S, 2010, HEPATOLOGY, V52, P1543, DOI 10.1002/hep.23859; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Riggs RM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.05.004; Rogers A, 2001, BONE, V29, P30, DOI 10.1016/S8756-3282(01)00468-9; SAS Technical Report SAS/STAS software, 1992, SAS TECHN REP SAS ST, V7; Seifer DB, 2011, FERTIL STERIL, V95, P747, DOI 10.1016/j.fertnstert.2010.10.011; Shimizu I, 1999, GUT, V44, P127, DOI 10.1136/gut.44.1.127; Shimizu I, 2001, INTERNAL MED, V40, P100, DOI 10.2169/internalmedicine.40.100; Sweeting MJ, 2006, J CLIN EPIDEMIOL, V59, P144, DOI 10.1016/j.jclinepi.2005.06.008; van Disseldorp J, 2008, J CLIN ENDOCR METAB, V93, P2129, DOI 10.1210/jc.2007-2093; Villa E, 2011, GASTROENTEROLOGY, V140, P818, DOI 10.1053/j.gastro.2010.12.027; White DL, 2012, HEPATOLOGY, V55, P759, DOI 10.1002/hep.24618; Xu JW, 2002, WORLD J GASTROENTERO, V8, P883, DOI 10.3748/wjg.v8.i5.883; Yasuda M, 1999, HEPATOLOGY, V29, P719, DOI 10.1002/hep.510290307; Yen T, 2003, J CLIN GASTROENTEROL, V36, P47, DOI 10.1097/00004836-200301000-00015	29	49	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44624	10.1371/journal.pone.0044624	http://dx.doi.org/10.1371/journal.pone.0044624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970270	Green Published, Green Submitted, gold			2022-12-25	WOS:000308748400026
J	Shen, XP; He, Z; Li, HD; Yao, C; Zhang, Y; He, L; Li, S; Huang, J; Guo, Z				Shen, Xiaopei; He, Zheng; Li, Hongdong; Yao, Chen; Zhang, Yang; He, Lang; Li, Shan; Huang, Jian; Guo, Zheng			Distinct Functional Patterns of Gene Promoter Hypomethylation and Hypermethylation in Cancer Genomes	PLOS ONE			English	Article							FALSE DISCOVERY RATE; DNA METHYLATION; EPIGENETIC REGULATION; EXPRESSION; DISEASE; DEMETHYLATION; INFLAMMATION; MECHANISMS; RECEPTORS; REVEALS	Background: Aberrant DNA methylation plays important roles in carcinogenesis. However, the functional significance of genome-wide hypermethylation and hypomethylation of gene promoters in carcinogenesis currently remain unclear. Principal Findings: Based on genome-wide methylation data for five cancer types, we showed that genes with promoter hypermethylation were highly consistent in function across different cancer types, and so were genes with promoter hypomethylation. Functions related to "developmental processes" and "regulation of biology processes" were significantly enriched with hypermethylated genes but were depleted of hypomethylated genes. In contrast, functions related to "cell killing" and "response to stimulus", including immune and inflammatory response, were associated with an enrichment of hypomethylated genes and depletion of hypermethylated genes. We also observed that some families of cytokines secreted by immune cells, such as IL10 family cytokines and chemokines, tended to be hypomethylated in various cancer types. These results provide new hints for understanding the distinct functional roles of genome-wide hypermethylation and hypomethylation of gene promoters in carcinogenesis. Conclusions: Genes with promoter hypermethylation and hypomethylation are highly consistent in function across different cancer types, respectively, but these two groups of genes tend to be enriched in different functions associated with cancer. Especially, we speculate that hypomethylation of gene promoters may play roles in inducing immunity and inflammation disorders in precancerous conditions, which may provide hints for improving epigenetic therapy and immunotherapy of cancer.	[Shen, Xiaopei; He, Zheng; Li, Hongdong; Yao, Chen; Zhang, Yang; He, Lang; Li, Shan; Huang, Jian; Guo, Zheng] Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China; [Guo, Zheng] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	University of Electronic Science & Technology of China; Harbin Medical University	Shen, XP (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China.	guoz@ems.hrbmu.edu.cn	Shen, Xiaopei/B-2773-2017; Zhang, Yang/CAG-6008-2022; Huang, Jian/G-8437-2011; Zhang, Yang/ACU-6405-2022	Shen, Xiaopei/0000-0002-0004-4228; Zhang, Yang/0000-0002-1317-120X; Huang, Jian/0000-0003-3282-8892; 	National Natural Science Foundation of China [30970668, 31100901, 81071646, 91029717]; Excellent Youth Foundation of Heilongjiang Province [JC200808]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Heilongjiang Province	This work was supported in part by the National Natural Science Foundation of China (30970668, 31100901, 81071646 and 91029717), Excellent Youth Foundation of Heilongjiang Province (JC200808): http://www.nsfc.gov.cn/and http://jj.hljkj.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisowicz Anthony, 2008, BMC Cancer, V8, P222, DOI 10.1186/1471-2407-8-222; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; Cash HL, 2011, INT J CANC; Colotta F, 2009, CARCINOGENESIS, V30, P1073, DOI 10.1093/carcin/bgp127; Cooke J, 2012, INFLAMM BOWEL DIS; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Dedeurwaerder S, 2011, EMBO MOL MED, V3, P726, DOI 10.1002/emmm.201100801; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Ehrlich M, 2006, ONCOGENE, V25, P2636, DOI 10.1038/sj.onc.1209145; Ehrlich M, 2002, J NUTR, V132, p2424S, DOI 10.1093/jn/132.8.2424S; Ehrlich M, 2002, ONCOGENE, V21, P6694, DOI 10.1038/sj.onc.1205890; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Ferguson AT, 1997, J BIOL CHEM, V272, P32260, DOI 10.1074/jbc.272.51.32260; Frigola J, 2005, HUM MOL GENET, V14, P319, DOI 10.1093/hmg/ddi028; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Hoffmann MJ, 2005, BIOCHEM CELL BIOL, V83, P296, DOI 10.1139/o05-036; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; J Wang, 2011, BRIEF BIOINFORM; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim EH, 2010, ONCOGENE, V29, P4725, DOI 10.1038/onc.2010.223; Kim YH, 2011, ANN SURG ONCOL, V18, P2338, DOI 10.1245/s10434-011-1573-y; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; MIYAJIMA A, 1992, ANNU REV IMMUNOL, V10, P295, DOI 10.1146/annurev.immunol.10.1.295; Nimmo ER, 2012, INFLAMM BOWEL DIS, V18, P889, DOI 10.1002/ibd.21912; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Pakneshan P, 2004, J BIOL CHEM, V279, P31735, DOI 10.1074/jbc.M401669200; Pawitan Y, 2005, BIOINFORMATICS, V21, P3017, DOI 10.1093/bioinformatics/bti448; Pulukuri SMK, 2007, CANCER RES, V67, P930, DOI 10.1158/0008-5472.CAN-06-2892; Qiu WL, 2012, AM J RESP CRIT CARE, V185, P373, DOI 10.1164/rccm.201108-1382OC; Richards KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004941; Rivals I, 2007, BIOINFORMATICS, V23, P401, DOI 10.1093/bioinformatics/btl633; Sadikovic B, 2009, HUM MOL GENET, V18, P1962, DOI 10.1093/hmg/ddp117; Son KS, 2010, BREAST, V19, P484, DOI 10.1016/j.breast.2010.05.011; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ushijima T, 2010, CANCER SCI, V101, P300, DOI 10.1111/j.1349-7006.2009.01434.x; Wang ZQ, 2006, INT J CANCER, V118, P1436, DOI 10.1002/ijc.21499; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Yao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029686; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; [邹金凤 Zou Jinfeng], 2012, [生物物理学报, Acta Biophysica Sinica], V28, P232	50	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44822	10.1371/journal.pone.0044822	http://dx.doi.org/10.1371/journal.pone.0044822			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970311	Green Submitted, Green Published, gold			2022-12-25	WOS:000308462000049
J	Platania, CBM; Salomone, S; Leggio, GM; Drago, F; Bucolo, C				Platania, Chiara Bianca Maria; Salomone, Salvatore; Leggio, Gian Marco; Drago, Filippo; Bucolo, Claudio			Homology Modeling of Dopamine D-2 and D-3 Receptors: Molecular Dynamics Refinement and Docking Evaluation	PLOS ONE			English	Article							LOWERS INTRAOCULAR-PRESSURE; PROTEIN-COUPLED RECEPTORS; PARKINSONS-DISEASE; CRYSTAL-STRUCTURE; D3 RECEPTOR; IONIC LOCK; BINDING; AGONIST; LIGAND; SITES	Dopamine (DA) receptors, a class of G-protein coupled receptors (GPCRs), have been targeted for drug development for the treatment of neurological, psychiatric and ocular disorders. The lack of structural information about GPCRs and their ligand complexes has prompted the development of homology models of these proteins aimed at structure-based drug design. Crystal structure of human dopamine D-3 (hD(3)) receptor has been recently solved. Based on the hD(3) receptor crystal structure we generated dopamine D-2 and D-3 receptor models and refined them with molecular dynamics (MD) protocol. Refined structures, obtained from the MD simulations in membrane environment, were subsequently used in molecular docking studies in order to investigate potential sites of interaction. The structure of hD(3) and hD(2L) receptors was differentiated by means of MD simulations and D-3 selective ligands were discriminated, in terms of binding energy, by docking calculation. Robust correlation of computed and experimental K-i was obtained for hD(3) and hD(2L) receptor ligands. In conclusion, the present computational approach seems suitable to build and refine structure models of homologous dopamine receptors that may be of value for structure-based drug discovery of selective dopaminergic ligands.	[Platania, Chiara Bianca Maria; Salomone, Salvatore; Leggio, Gian Marco; Drago, Filippo; Bucolo, Claudio] Catania Univ, Sect Pharmacol & Biochem, Dept Clin & Mol Biomed, Catania, Italy	University of Catania	Platania, CBM (corresponding author), Catania Univ, Sect Pharmacol & Biochem, Dept Clin & Mol Biomed, Catania, Italy.	claudio.bucolo@unict.it	Drago, Francesco/H-7563-2019; Leggio, Gian Marco/AHE-1151-2022; Drago, Filippo/AAC-5090-2022; Platania, Chiara BM/AHE-1140-2022; Drago, Filippo/K-5619-2018	Leggio, Gian Marco/0000-0002-7280-4871; Platania, Chiara Bianca Maria/0000-0002-8630-5993; Bucolo, Claudio/0000-0002-4879-4140; Salomone, Salvatore/0000-0001-5307-6103; Leggio, Gian Marco/0000-0003-4440-3373; Drago, Filippo/0000-0003-2887-5223	International Ph.D. Program in Neuropharmacology, University of Catania, Italy;  [PON01-00110]	International Ph.D. Program in Neuropharmacology, University of Catania, Italy; 	This work was supported in part by a National grant PON01-00110. Dr. Chiara B. M. Platania was supported by the International Ph.D. Program in Neuropharmacology, University of Catania, Italy. The authors wish to thank the "Consorzio Cometa'' [http://www.consorzio-cometa.it/] for the computational hours. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Ballesteros JA, 2001, MOL PHARMACOL, V60, P1, DOI 10.1124/mol.60.1.1; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bettinetti L, 2002, J MED CHEM, V45, P4594, DOI 10.1021/jm025558r; Bucolo C, 2011, BIOCHEM PHARMACOL, V83, P680; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Chen PC, 2009, J NEUROCHEM, V110, P1180, DOI 10.1111/j.1471-4159.2009.06209.x; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chu E, 2000, J PHARMACOL EXP THER, V293, P710; CHUMPRADIT S, 1993, J MED CHEM, V36, P4308, DOI 10.1021/jm00078a021; CHUMPRADIT S, 1994, J MED CHEM, V37, P4245, DOI 10.1021/jm00050a021; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Diaz J, 2000, J NEUROSCI, V20, P8677; GEYER O, 1987, J OCUL PHARMACOL, V3, P291, DOI 10.1089/jop.1987.3.291; Ghosh B, 2010, J MED CHEM, V53, P1023, DOI 10.1021/jm901184n; GLASE SA, 1995, J MED CHEM, V38, P3132, DOI 10.1021/jm00016a016; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kortagere S, 2011, BIOCHEM PHARMACOL, V81, P157, DOI 10.1016/j.bcp.2010.08.026; Kuzhikandathil EV, 2012, PHARM RES; LANDWEHRMEYER B, 1993, MOL BRAIN RES, V18, P187, DOI 10.1016/0169-328X(93)90188-U; Lape M, 2010, BIOPHYS CHEM, V150, P88, DOI 10.1016/j.bpc.2010.01.011; Le Guilloux V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-168; Levant B, 1997, PHARMACOL REV, V49, P231; Lindgren N, 2003, P NATL ACAD SCI USA, V100, P4305, DOI 10.1073/pnas.0730708100; Lopez L, 2010, CHEMMEDCHEM, V5, P1300, DOI 10.1002/cmdc.201000101; MALMBERG A, 1994, MOL PHARMACOL, V46, P299; MARTIN PL, 1993, J PHARMACOL EXP THER, V267, P1342; MEKKI QA, 1983, LANCET, V1, P1250; MIERAU J, 1995, EUR J PHARM-MOLEC PH, V290, P29, DOI 10.1016/0922-4106(95)90013-6; Millan MJ, 2000, SYNAPSE, V35, P79, DOI 10.1002/(SICI)1098-2396(200002)35:2<79::AID-SYN1>3.0.CO;2-X; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Obiol-Pardo C, 2011, PROTEINS, V79, P1695, DOI 10.1002/prot.23021; OGIDIGBEN M, 1993, J PHARMACOL EXP THER, V267, P822; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Ortega R, 2011, BIOORG MED CHEM LETT, V21, P2670, DOI 10.1016/j.bmcl.2010.12.083; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POTTER DE, 1987, J OCUL PHARMACOL, V3, P309, DOI 10.1089/jop.1987.3.309; Potter DE, 1998, PHARMACOLOGY, V57, P249, DOI 10.1159/000028249; Reynolds NA, 2005, CNS DRUGS, V19, P973, DOI 10.2165/00023210-200519110-00006; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Scheideler MA, 1997, EUR J PHARMACOL, V339, P261, DOI 10.1016/S0014-2999(97)01372-1; Scheller D, 2009, N-S ARCH PHARMACOL, V379, P73, DOI 10.1007/s00210-008-0341-4; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shi L, 2002, ANNU REV PHARMACOL, V42, P437, DOI 10.1146/annurev.pharmtox.42.091101.144224; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; Sokoloff P., 2006, CNS & Neurological Disorders-Drug Targets, V5, P25, DOI 10.2174/187152706784111551; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SOKOLOFF P, 1992, EUR J PHARM-MOLEC PH, V225, P331, DOI 10.1016/0922-4106(92)90107-7; Tadori Y, 2011, EUR J PHARMACOL, V666, P43, DOI 10.1016/j.ejphar.2011.05.050; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tschammer N, 2011, J MED CHEM, V54, P2477, DOI 10.1021/jm101639t; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Wang Q, 2010, J CHEM INF MODEL, V50, P1970, DOI 10.1021/ci1002747; Yap BK, 2012, J MOL MODELING; Yap BK, 2012, J MOL MODEL; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022; Zhang J, 2010, BIOINFORMATICS, V26, P3004, DOI 10.1093/bioinformatics/btq563	65	59	61	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44316	10.1371/journal.pone.0044316	http://dx.doi.org/10.1371/journal.pone.0044316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970199	Green Submitted, Green Published, gold			2022-12-25	WOS:000308458400058
J	van Bokhorst-van de Veen, M; van Swam, I; Wels, M; Bron, PA; Kleerebezem, M				van Bokhorst-van de Veen, Hermien; van Swam, Iris; Wels, Michiel; Bron, Peter A.; Kleerebezem, Michiel			Congruent Strain Specific Intestinal Persistence of Lactobacillus plantarum in an Intestine-Mimicking In Vitro System and in Human Volunteers	PLOS ONE			English	Article							GASTROINTESTINAL-TRACT; PROBIOTIC LACTOBACILLI; CLUSTER-ANALYSIS; LIFE-STYLE; IDENTIFICATION; GENES; SURVIVAL; COLONIZATION; DIVERSITY; BACTERIA	Background: An important trait of probiotics is their capability to reach their intestinal target sites alive to optimally exert their beneficial effects. Assessment of this trait in intestine-mimicking in vitro model systems has revealed differential survival of individual strains of a species. However, data on the in situ persistence characteristics of individual or mixtures of strains of the same species in the gastrointestinal tract of healthy human volunteers have not been reported to date. Methodology/Principal Findings: The GI-tract survival of individual L. plantarum strains was determined using an intestine mimicking model system, revealing substantial inter-strain differences. The obtained data were correlated to genomic diversity of the strains using comparative genome hybridization (CGH) datasets, but this approach failed to discover specific genetic loci that explain the observed differences between the strains. Moreover, we developed a next-generation sequencing-based method that targets a variable intergenic region, and employed this method to assess the in vivo GI-tract persistence of different L. plantarum strains when administered in mixtures to healthy human volunteers. Remarkable consistency of the strain-specific persistence curves were observed between individual volunteers, which also correlated significantly with the GI-tract survival predicted on basis of the in vitro assay. Conclusion: The survival of individual L. plantarum strains in the GI-tract could not be correlated to the absence or presence of specific genes compared to the reference strain L. plantarum WCFS1. Nevertheless, in vivo persistence analysis in the human GI-tract confirmed the strain-specific persistence, which appeared to be remarkably similar in different healthy volunteers. Moreover, the relative strain-specific persistence in vivo appeared to be accurately and significantly predicted by their relative survival in the intestine-mimicking in vitro assay, supporting the use of this assay for screening of strain-specific GI persistence.	[van Bokhorst-van de Veen, Hermien; van Swam, Iris; Wels, Michiel; Bron, Peter A.; Kleerebezem, Michiel] TI Food & Nutr, Wageningen, Netherlands; [van Bokhorst-van de Veen, Hermien; van Swam, Iris; Wels, Michiel; Bron, Peter A.; Kleerebezem, Michiel] NIZO Food Res, Ede, Netherlands; [van Bokhorst-van de Veen, Hermien; Kleerebezem, Michiel] Univ Wageningen & Res Ctr, Microbiol Lab, Wageningen, Netherlands; [Wels, Michiel] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat CMBI 260, NL-6525 ED Nijmegen, Netherlands; [Bron, Peter A.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands	Top Institute Food & Nutrition; NIZO Food Research; Wageningen University & Research; Radboud University Nijmegen	van Bokhorst-van de Veen, M (corresponding author), TI Food & Nutr, Wageningen, Netherlands.	Peter.Bron@nizo.com	Kleerebezem, Michiel/AAT-2078-2021; van Bokhorst-van de Veen, Hermien/K-2111-2013	van Bokhorst-van de Veen, Hermien/0000-0003-4159-5955; Kleerebezem, Michiel/0000-0001-8552-2235				Ahrne S, 1998, J APPL MICROBIOL, V85, P88; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brigidi P, 2003, INT J FOOD MICROBIOL, V81, P203, DOI 10.1016/S0168-1605(02)00245-3; Bringel F, 2005, INT J SYST EVOL MICR, V55, P1629, DOI 10.1099/ijs.0.63333-0; Bron PA, 2007, J APPL MICROBIOL, V103, P1424, DOI 10.1111/j.1365-2672.2007.03376.x; Bron PA, 2006, J APPL MICROBIOL, V100, P728, DOI 10.1111/j.1365-2672.2006.02891.x; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Bron PA, 2004, J BACTERIOL, V186, P7829, DOI 10.1128/JB.186.23.7829-7835.2004; Bron PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038720; Bron PA, 2011, FOOD MICROBIOL FOOD, P369, DOI 10.1007/978-0-387-92771-8_16; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CORAZZIARI E, 1987, J CLIN GASTROENTEROL, V9, P427, DOI 10.1097/00004836-198708000-00014; Corcoran BM, 2007, MICROBIOL-SGM, V153, P291, DOI 10.1099/mic.0.28966-0; de Vries MC, 2006, INT DAIRY J, V16, P1018, DOI 10.1016/j.idairyj.2005.09.003; Denou E, 2008, J BACTERIOL, V190, P3161, DOI 10.1128/JB.01637-07; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FAO/WHO, 2001, EV HLTH NUTR PROP PO; Goodman AL, 2011, NAT PROTOC, V6, P1969, DOI 10.1038/nprot.2011.417; Hutt P, 2011, BENEF MICROBES, V2, P79, DOI 10.3920/BM2010.0023; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; JOHANSSON ML, 1993, APPL ENVIRON MICROB, V59, P15, DOI 10.1128/AEM.59.1.15-20.1993; Kleerebezem M, 2003, P NATL ACAD SCI USA, V100, P1990, DOI 10.1073/pnas.0337704100; Kleerebezem M, 2009, ANNU REV MICROBIOL, V63, P269, DOI 10.1146/annurev.micro.091208.073341; Klingberg TD, 2006, INT J FOOD MICROBIOL, V109, P157, DOI 10.1016/j.ijfoodmicro.2006.01.014; Kovatcheva-Datchary P, 2009, ENVIRON MICROBIOL, V11, P914, DOI 10.1111/j.1462-2920.2008.01815.x; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lebeer S, 2010, NAT REV MICROBIOL, V8, P171, DOI 10.1038/nrmicro2297; Marco ML, 2010, ISME J, V4, P1481, DOI 10.1038/ismej.2010.61; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; Marteau P, 1997, J DAIRY SCI, V80, P1031, DOI 10.3168/jds.S0022-0302(97)76027-2; Meijerink M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010632; Mills S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S19; Molenaar D, 2005, J BACTERIOL, V187, P6119, DOI 10.1128/JB.187.17.6119-6127.2005; Molly K, 1996, MICROB ECOL HEALTH D, V9, P79, DOI 10.1002/(SICI)1234-987X(199603)9:2<79::AID-MEH415>3.3.CO;2-V; Pitino L, 2010, FOOD MICROBIOL, V27, P1121, DOI 10.1016/j.fm.2010.07.019; Pretzer G, 2005, J BACTERIOL, V187, P6128, DOI 10.1128/JB.187.17.6128-6136.2005; Serrano LM, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-29; Siezen RJ, 2010, ENVIRON MICROBIOL, V12, P758, DOI 10.1111/j.1462-2920.2009.02119.x; Smith TJ, 2011, J AM COLL NUTR, V30, P259, DOI 10.1080/07315724.2011.10719968; Stevens MJA, 2010, APPL ENVIRON MICROB, V76, P3748, DOI 10.1128/AEM.00073-10; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Teusink B, 2005, APPL ENVIRON MICROB, V71, P7253, DOI 10.1128/AEM.71.11.7253-7262.2005; TURNBULL GK, 1988, DIS COLON RECTUM, V31, P190, DOI 10.1007/BF02552545; Valeur N, 2004, APPL ENVIRON MICROB, V70, P1176, DOI 10.1128/AEM.70.2.1176-1181.2004; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; van Bokhorst-van de Veen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039053; van Bokhorst-van de Veen H, 2011, APPL ENVIRON MICROB, V77, P5247, DOI 10.1128/AEM.00515-11; van Hemert S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-293; Verdenelli MC, 2011, LETT APPL MICROBIOL, V52, P596, DOI 10.1111/j.1472-765X.2011.03042.x; Vesa T, 2000, ALIMENT PHARM THER, V14, P823; Wels M, 2011, MICROB BIOTECHNOL, V4, P333, DOI 10.1111/j.1751-7915.2010.00217.x; WOLF BW, 1995, MICROB ECOL HEALTH D, V8, P41, DOI 10.3109/08910609509141381; Zoetendal EG, 2001, SYST APPL MICROBIOL, V24, P405, DOI 10.1078/0723-2020-00060	55	8	8	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44588	10.1371/journal.pone.0044588	http://dx.doi.org/10.1371/journal.pone.0044588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970257	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400091
J	Ha, S; Iqbal, NJ; Mita, P; Ruoff, R; Gerald, WL; Lepor, H; Taneja, SS; Lee, P; Melamed, J; Garabedian, MJ; Logan, SK				Ha, S.; Iqbal, N. J.; Mita, P.; Ruoff, R.; Gerald, W. L.; Lepor, H.; Taneja, S. S.; Lee, P.; Melamed, J.; Garabedian, M. J.; Logan, S. K.			Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer	ONCOGENE			English	Article						PIM1; AR; phosphorylation; prostate cancer; hormone refractory	C-MYC; GROWTH-FACTOR; TUMOR-GROWTH; CYCLIN A1; KINASE; PROGRESSION; PROTEIN; CELLS; ACTIVATION; EXPRESSION	Integration of cellular signaling pathways with androgen receptor (AR) signaling can be achieved through phosphorylation of AR by cellular kinases. However, the kinases responsible for phosphorylating the AR at numerous sites and the functional consequences of AR phosphorylation are only partially understood. Bioinformatic analysis revealed AR serine 213 (S213) as a putative substrate for PIM1, a kinase overexpressed in prostate cancer. Therefore, phosphorylation of AR serine 213 by PIM1 was examined using a phosphorylation site-specific antibody. Wild-type PIM1, but not catalytically inactive PIM1, specifically phosphorylated AR but not an AR serine-to-alanine mutant (S213A). In vitro kinase assays confirmed that PIM1 can phosphorylate AR S213 in a ligand-independent manner and cell type-specific phosphorylation was observed in prostate cancer cell lines. Upon PIM1 overexpression, AR phosphorylation was observed in the absence of hormone and was further increased in the presence of hormone in LNCaP, LNCaP-abl and VCaP cells. Moreover, phosphorylation of AR was reduced in the presence of PIM kinase inhibitors. An examination of AR-mediated transcription showed that reporter gene activity was reduced in the presence of PIM1 and wild-type AR, but not S213A mutant AR. Androgen-mediated transcription of endogenous PSA, Nkx3.1 and IGFBP5 was also decreased in the presence of PIM1, whereas IL6, cyclin A1 and caveolin 2 were increased. Immunohistochemical analysis of prostate cancer tissue microarrays showed significant P-AR S213 expression that was associated with hormone refractory prostate cancers, likely identifying cells with catalytically active PIM1. In addition, prostate cancers expressing a high level of P-AR S213 were twice as likely to be from biochemically recurrent cancers. Thus, AR phosphorylation by PIM1 at S213 impacts gene transcription and is highly prevalent in aggressive prostate cancer.	[Ha, S.; Iqbal, N. J.; Mita, P.; Ruoff, R.; Lepor, H.; Taneja, S. S.; Garabedian, M. J.; Logan, S. K.] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Ha, S.; Ruoff, R.; Logan, S. K.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Gerald, W. L.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Lee, P.; Melamed, J.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Garabedian, M. J.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University; Memorial Sloan Kettering Cancer Center; New York University; New York University	Logan, SK (corresponding author), NYU, Sch Med, Dept Urol, 550 1st Ave,MSB 424, New York, NY 10016 USA.	susan.logan@nyumc.org	Melamed, Jonathan/AAV-3769-2020	Melamed, Jonathan/0000-0003-2844-7990; Logan, Susan/0000-0002-7904-5927; Iqbal, Niloy/0000-0003-0367-2569	New York University School of Medicine Department of Urology at New York University School of Medicine; NIH [R01CA112226, UO1 1U01CA149556-01]; NYU Department of Urology; DOD [PC094786, PC080010]; NATIONAL CANCER INSTITUTE [R01CA112226, U01CA149556] Funding Source: NIH RePORTER	New York University School of Medicine Department of Urology at New York University School of Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYU Department of Urology; DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge funding from the New York University School of Medicine Department of Urology at New York University School of Medicine. This work was supported by NIH R01CA112226 (SL), funds from the NYU Department of Urology, DOD grant PC094786 for the Prostate Cancer Biorepository Network (PCBN, JM), DOD grant PC080010 (PL) and NIH UO1 1U01CA149556-01(PL).	Aho TLT, 2004, FEBS LETT, V571, P43, DOI 10.1016/j.febslet.2004.06.050; Beharry Z, 2011, P NATL ACAD SCI USA, V108, P528, DOI 10.1073/pnas.1013214108; Bowen C, 2000, CANCER RES, V60, P6111; Chen SY, 2012, J BIOL CHEM, V287, P8571, DOI 10.1074/jbc.M111.325290; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chen WW, 2005, MOL CANCER RES, V3, P443, DOI 10.1158/1541-7786.MCR-05-0007; Chun JY, 2009, CLIN CANCER RES, V15, P4815, DOI 10.1158/1078-0432.CCR-09-0640; Cibull TL, 2006, J CLIN PATHOL, V59, P285, DOI 10.1136/jcp.2005.027672; Culig Z, 1999, BRIT J CANCER, V81, P242, DOI 10.1038/sj.bjc.6690684; CUYPERS HT, 1984, CELL, V37, P141; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Drachenberg DE, 1999, PROSTATE, V41, P127, DOI 10.1002/(SICI)1097-0045(19991001)41:2<127::AID-PROS7>3.0.CO;2-H; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Gould ML, 2010, PROSTATE, V70, P1609, DOI 10.1002/pros.21195; Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401; Ha S, 2011, ENDOCR-RELAT CANCER, P11; Ha S, 2011, ENDOCR-RELAT CANCER, V18, P245, DOI 10.1530/ERC-10-0204; Hendriksen PJM, 2006, CANCER RES, V66, P5012, DOI 10.1158/0008-5472.CAN-05-3082; Kim J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-248; Kim O, 2004, ONCOGENE, V23, P1838, DOI 10.1038/sj.onc.1207304; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lin HK, 2001, P NATL ACAD SCI USA, V98, P7200, DOI 10.1073/pnas.121173298; Michalaki V, 2004, BRIT J CANCER, V90, P2312, DOI 10.1038/sj.bjc.6601814; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Morishita D, 2008, CANCER RES, V68, P5076, DOI 10.1158/0008-5472.CAN-08-0634; Mumenthaler SM, 2009, MOL CANCER THER, V8, P2882, DOI 10.1158/1535-7163.MCT-09-0293; Nwachukwu JC, 2009, CANCER RES, V69, P3140, DOI 10.1158/0008-5472.CAN-08-3738; Payne H, 2011, UROL ONCOL-SEMIN ORI, V29, P593, DOI 10.1016/j.urolonc.2009.11.003; Qin JC, 2012, CELL STEM CELL, V10, P556, DOI 10.1016/j.stem.2012.03.009; RENNIE PS, 1993, MOL ENDOCRINOL, V7, P23, DOI 10.1210/me.7.1.23; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Song H, 2009, ONCOGENE, V28, P3307, DOI 10.1038/onc.2009.181; Su Y, 2011, ONCOGENE, V30, P3907, DOI 10.1038/onc.2011.97; Taneja SS, 2005, J BIOL CHEM, V280, P40916, DOI 10.1074/jbc.M508442200; Thompson J, 2003, LAB INVEST, V83, P1301, DOI 10.1097/01.LAB.0000087585.03162.A3; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; TWILLIE DA, 1995, UROLOGY, V45, P542, DOI 10.1016/S0090-4295(99)80034-X; Valdman A, 2004, PROSTATE, V60, P367, DOI 10.1002/pros.20064; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; VERBEEK S, 1991, MOL CELL BIOL, V11, P1176, DOI 10.1128/MCB.11.2.1176; Wang J, 2010, ONCOGENE, V29, P2477, DOI 10.1038/onc.2010.10; Wang ZP, 2002, BBA-MOL CELL RES, V1593, P45, DOI 10.1016/S0167-4889(02)00347-6; Ward RD, 2009, BIOFACTORS, V35, P528, DOI 10.1002/biof.66; Wegiel B, 2005, ONCOGENE, V24, P6385, DOI 10.1038/sj.onc.1208795; Wegiel B, 2008, JNCI-J NATL CANCER I, V100, P1022, DOI 10.1093/jnci/djn214; Wen Y, 2000, CANCER RES, V60, P6841; Xia ZP, 2009, J MED CHEM, V52, P74, DOI 10.1021/jm800937p; Xie Y, 2006, ONCOGENE, V25, P70, DOI 10.1038/sj.onc.1209058; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	55	38	41	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 22	2013	32	34					3992	4000		10.1038/onc.2012.412	http://dx.doi.org/10.1038/onc.2012.412			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IC	22986532	Green Accepted			2022-12-25	WOS:000323748100007
J	Pedersen, HL; Fangel, JU; McCleary, B; Ruzanski, C; Rydahl, MG; Ralet, MC; Farkas, V; von Schantz, L; Marcus, SE; Andersen, MCF; Field, R; Ohlin, M; Knox, JP; Clausen, MH; Willats, WGT				Pedersen, Henriette L.; Fangel, Jonatan U.; McCleary, Barry; Ruzanski, Christian; Rydahl, Maja G.; Ralet, Marie-Christine; Farkas, Vladimir; von Schantz, Laura; Marcus, Susan E.; Andersen, Mathias C. F.; Field, Rob; Ohlin, Mats; Knox, J. Paul; Clausen, Mads H.; Willats, William G. T.			Versatile High Resolution Oligosaccharide Microarrays for Plant Glycobiology and Cell Wall Research	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING MODULES; MONOCLONAL-ANTIBODY; PROTEIN; SPECIFICITY; POLYSACCHARIDES; METABOLISM; EXPRESSION; DIVERSITY; POLYMERS; LOCATION	Microarrays are powerful tools for high throughput analysis, and hundreds or thousands of molecular interactions can be assessed simultaneously using very small amounts of analytes. Nucleotide microarrays are well established in plant research, but carbohydrate microarrays are much less established, and one reason for this is a lack of suitable glycans with which to populate arrays. Polysaccharide microarrays are relatively easy to produce because of the ease of immobilizing large polymers noncovalently onto a variety of microarray surfaces, but they lack analytical resolution because polysaccharides often contain multiple distinct carbohydrate substructures. Microarrays of defined oligosaccharides potentially overcome this problem but are harder to produce because oligosaccharides usually require coupling prior to immobilization. We have assembled a library of well characterized plant oligosaccharides produced either by partial hydrolysis from polysaccharides or by de novo chemical synthesis. Once coupled to protein, these neoglycoconjugates are versatile reagents that can be printed as microarrays onto a variety of slide types and membranes. We show that these microarrays are suitable for the high throughput characterization of the recognition capabilities of monoclonal antibodies, carbohydrate-binding modules, and other oligosaccharide-binding proteins of biological significance and also that they have potential for the characterization of carbohydrate-active enzymes.	[Pedersen, Henriette L.; Fangel, Jonatan U.; Rydahl, Maja G.; Willats, William G. T.] Univ Copenhagen, Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg, Denmark; [McCleary, Barry] Megazyme Int Ireland Ltd, Bray, County Wicklow, Ireland; [Ruzanski, Christian; Field, Rob] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England; [Ralet, Marie-Christine] INRA, F-44316 Nantes 03, France; [Farkas, Vladimir] Slovak Acad Sci, Ctr Glycobiol, Inst Chem, SK-84538 Bratislava, Slovakia; [von Schantz, Laura; Ohlin, Mats] Lund Univ, Dept Immunotechnol, S-22184 Lund, Sweden; [Marcus, Susan E.; Knox, J. Paul] Univ Leeds, Fac Biol Sci, Ctr Plant Sci, Leeds LS2 9JT, W Yorkshire, England; [Andersen, Mathias C. F.; Clausen, Mads H.] Tech Univ Denmark, Ctr Nanomed & Theranost, DK-2800 Kongens Lyngby, Denmark; [Andersen, Mathias C. F.; Clausen, Mads H.] Tech Univ Denmark, Dept Chem, DK-2800 Kongens Lyngby, Denmark	University of Copenhagen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; INRAE; Slovak Academy of Sciences; Lund University; University of Leeds; Technical University of Denmark; Technical University of Denmark	Willats, WGT (corresponding author), Univ Copenhagen, Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg, Denmark.	willats@life.ku.dk	Clausen, Mads H/A-9656-2015; Ohlin, Mats/A-7307-2010; Rydahl, Maja G/F-7458-2014; Knox, Paul/H-4577-2012	Clausen, Mads H/0000-0001-9649-1729; Ohlin, Mats/0000-0002-5105-1938; Rydahl, Maja G/0000-0002-9388-0873; Knox, Paul/0000-0002-9231-6891; Field, Rob/0000-0001-8574-0275; Willats, William/0000-0003-2064-4025; Farkas, Vladimir/0000-0002-8219-4288; Ralet, Marie-Christine/0000-0002-0292-5272	Danish Research Council; Scientific Grant Agency (VEGA) (Slovakia) [2/0011/09]; Danish Research Council for Strategic Research; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0618] Funding Source: researchfish; BBSRC [BBS/E/J/000C0618] Funding Source: UKRI	Danish Research Council(Det Frie Forskningsrad (DFF)); Scientific Grant Agency (VEGA) (Slovakia)(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)); Danish Research Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Danish Research Council grants (to W. G. T. W.) and in part by Grant 2/0011/09 from the Scientific Grant Agency (VEGA) (Slovakia) (to V. F.). This work was also supported by the Danish Research Council for Strategic Research (to M. C. F. A., M. H. C., and W. G. T. W.).	Abou Hachem M, 2000, BIOCHEM J, V345, P53, DOI 10.1042/0264-6021:3450053; Albersheim P, 2011, PLANT CELL WALLS: FROM CHEMISTRY TO BIOLOGY, P1; Bacic A., 1988, BIOCH PLANTS, P52; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Clausen MH, 2004, PLANTA, V219, P1036, DOI 10.1007/s00425-004-1309-3; Clausen MH, 2003, CHEM-EUR J, V9, P3821, DOI 10.1002/chem.200204636; De Lorenzo G, 2002, CURR OPIN PLANT BIOL, V5, P295, DOI 10.1016/S1369-5266(02)00271-6; Ekins R, 1999, TRENDS BIOTECHNOL, V17, P217, DOI 10.1016/S0167-7799(99)01329-3; Feizi T, 2004, NAT REV MOL CELL BIO, V5, P582, DOI 10.1038/nrm1428; Feizi T, 2003, CURR OPIN STRUC BIOL, V13, P637, DOI 10.1016/j.sbi.2003.09.002; Feizi T, 2000, GLYCOCONJUGATE J, V17, P553, DOI 10.1023/A:1011022509500; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2004.00980.x; Fukui S, 2002, NAT BIOTECHNOL, V20, P1011, DOI 10.1038/nbt735; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Gunnarsson LC, 2007, BIOCHEM J, V406, P209, DOI 10.1042/BJ20070128; Gunnarsson LC, 2006, GLYCOBIOLOGY, V16, P1171, DOI 10.1093/glycob/cwl038; Gunnarsson LC, 2004, PROTEIN ENG DES SEL, V17, P213, DOI 10.1093/protein/gzh026; Johansson R, 2006, J MOL RECOGNIT, V19, P275, DOI 10.1002/jmr.794; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Knox JP, 2008, CURR OPIN PLANT BIOL, V11, P308, DOI 10.1016/j.pbi.2008.03.001; Knox JP, 1997, INT REV CYTOL, V171, P79; Kosik O, 2010, GLYCOCONJUGATE J, V27, P79, DOI 10.1007/s10719-009-9271-8; Lee KJD, 2011, MOL PLANT, V4, P212, DOI 10.1093/mp/ssq075; Liu Y, 2009, BIOL CHEM, V390, P647, DOI 10.1515/BC.2009.071; Marcus SE, 2010, PLANT J, V64, P191, DOI 10.1111/j.1365-313X.2010.04319.x; Marcus SE, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-60; McCartney L, 2005, J HISTOCHEM CYTOCHEM, V53, P543, DOI 10.1369/jhc.4B6578.2005; McWilliam I, 2011, METHODS MOL BIOL, V785, P345, DOI 10.1007/978-1-61779-286-1_23; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; MEIKLE PJ, 1994, PLANT J, V5, P1, DOI 10.1046/j.1365-313X.1994.5010001.x; Moller I, 2008, GLYCOCONJUGATE J, V25, P37, DOI 10.1007/s10719-007-9059-7; Palma AS, 2010, METHOD ENZYMOL, V478, P265, DOI 10.1016/S0076-6879(10)78013-7; Park S, 2008, CHEM COMMUN, P4389, DOI 10.1039/b806699j; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; Pauly M, 2010, CURR OPIN PLANT BIOL, V13, P305, DOI 10.1016/j.pbi.2009.12.009; Pettolino FA, 2001, PLANTA, V214, P235, DOI 10.1007/s004250100606; Ralet MC, 2005, PHYTOCHEMISTRY, V66, P2800, DOI 10.1016/j.phytochem.2005.09.039; ROY R, 1984, CAN J BIOCHEM CELL B, V62, P270, DOI 10.1139/o84-037; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Shipp M, 2008, GLYCOCONJUGATE J, V25, P49, DOI 10.1007/s10719-007-9060-1; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Sorensen I, 2011, METHODS MOL BIOL, V715, P115, DOI 10.1007/978-1-61779-008-9_8; Sorensen I, 2008, PLANT SIGNAL BEHAV, V3, P743, DOI 10.4161/psb.3.9.6633; Van den Ende W, 2004, TRENDS PLANT SCI, V9, P523, DOI 10.1016/j.tplants.2004.09.008; Verhertbruggen Y, 2009, PLANT J, V59, P413, DOI 10.1111/j.1365-313X.2009.03876.x; von Schantz L, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-92; Wang DN, 2002, NAT BIOTECHNOL, V20, P275, DOI 10.1038/nbt0302-275; Willats WGT, 2006, TRENDS FOOD SCI TECH, V17, P97, DOI 10.1016/j.tifs.2005.10.008; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Willats WGT, 2002, PROTEOMICS, V2, P1666, DOI 10.1002/1615-9861(200212)2:12<1666::AID-PROT1666>3.0.CO;2-E; Yates EA, 1996, GLYCOBIOLOGY, V6, P131, DOI 10.1093/glycob/6.2.131; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301	55	174	174	2	83	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 16	2012	287	47								10.1074/jbc.M112.396598	http://dx.doi.org/10.1074/jbc.M112.396598			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	039GY	22988248	Green Published, hybrid			2022-12-25	WOS:000311233800015
J	Lang, BS; Gorren, ACF; Oberdorfer, G; Wenzl, MV; Furdui, CM; Poole, LB; Mayer, B; Gruber, K				Lang, Barbara S.; Gorren, Antonius C. F.; Oberdorfer, Gustav; Wenzl, M. Verena; Furdui, Cristina M.; Poole, Leslie B.; Mayer, Bernd; Gruber, Karl			Vascular Bioactivation of Nitroglycerin by Aldehyde Dehydrogenase-2 REACTION INTERMEDIATES REVEALED BY CRYSTALLOGRAPHY AND MASS SPECTROMETRY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ORGANIC NITRATES; SUBSTRATE-SPECIFICITY; COENZYME BINDING; NO DONORS; MITOCHONDRIAL; TOLERANCE; MECHANISM; SITE; IDENTIFICATION	Aldehyde dehydrogenase-2 (ALDH2) catalyzes the bioactivation of nitroglycerin (glyceryl trinitrate, GTN) in blood vessels, resulting in vasodilation by nitric oxide (NO) or a related species. Because the mechanism of this reaction is still unclear we determined the three-dimensional structures of wild-type (WT) ALDH2 and of a triple mutant of the protein that exhibits low denitration activity (E268Q/C301S/C303S) in complex with GTN. The structure of the triple mutant showed that GTN binds to the active site via polar contacts to the oxyanion hole and to residues 268 and 301 as well as by van der Waals interactions to hydrophobic residues of the catalytic pocket. The structure of the GTN-soaked wild-type protein revealed a thionitrate adduct to Cys-302 as the first reaction intermediate, which was also found by mass spectrometry (MS) experiments. In addition, the MS data identified sulfinic acid as the irreversibly inactivated enzyme species. Assuming that the structures of the triple mutant and wild-type ALDH2 reflect binding of GTN to the catalytic site and the first reaction step, respectively, superposition of the two structures indicates that denitration of GTN is initiated by nucleophilic attack of Cys-302 at one of the terminal nitrate groups, resulting in formation of the observed thionitrate intermediate and release of 1,2-glyceryl dinitrate. Our results shed light on the molecular mechanism of the GTN denitration reaction and provide useful information on the structural requirements for high affinity binding of organic nitrates to the catalytic site of ALDH2.	[Lang, Barbara S.; Gorren, Antonius C. F.; Wenzl, M. Verena; Mayer, Bernd] Graz Univ, Dept Pharmacol & Toxicol, A-8010 Graz, Austria; [Oberdorfer, Gustav; Gruber, Karl] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Furdui, Cristina M.] Wake Forest Sch Med, Dept Internal Med, Winston Salem, NC 27157 USA; [Poole, Leslie B.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	University of Graz; University of Graz; Wake Forest University; Wake Forest University	Mayer, B (corresponding author), Graz Univ, Dept Pharmacol & Toxicol, Univ Pl 2, A-8010 Graz, Austria.	mayer@uni-graz.at; karl.gruber@uni-graz.at	Gruber, Karl/GPP-6706-2022	Gruber, Karl/0000-0002-3485-9740; Oberdorfer, Gustav/0000-0002-6144-9114; Mayer, Bernd/0000-0002-2921-3494; Gorren, Antonius Cornelis Franciscus/0000-0003-3476-6162; Poole, Leslie/0000-0003-0334-7328; Furdui, Cristina M./0000-0003-3771-7999	National Institutes of Health [R01 GM050389]; Austrian Science Fund (FWF) [P20669, P21693, P19858, W901]; Austrian Science Fund (FWF) [W 901, P 21693] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM050389 (to L. B. P.) and the Austrian Science Fund (FWF) through Project Grants P20669 and P21693 (to B. M.) and P19858 (to K. G.) and through the Ph.D. program "Molecular Enzymology" W901 (to B. M. and K. G.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AHLNER J, 1991, PHARMACOL REV, V43, P351; Beretta M, 2008, J BIOL CHEM, V283, P17873, DOI [10.1074/jbc.M801182200, 10.1074/jbc.M804001200]; Beretta M, 2012, CIRC RES, V110, P385, DOI 10.1161/CIRCRESAHA.111.245837; Beretta M, 2010, J BIOL CHEM, V285, P943, DOI 10.1074/jbc.M109.014548; BRIEN JF, 1986, J PHARMACOL EXP THER, V237, P608; Chegaev K, 2009, J MED CHEM, V52, P4020, DOI 10.1021/jm9002236; Chen ZQ, 2006, TRENDS CARDIOVAS MED, V16, P259, DOI 10.1016/j.tcm.2006.05.001; Chen ZQ, 2002, P NATL ACAD SCI USA, V99, P8306, DOI 10.1073/pnas.122225199; Cobessi D, 1999, J MOL BIOL, V290, P161, DOI 10.1006/jmbi.1999.2853; D'Ambrosio K, 2006, BIOCHEMISTRY-US, V45, P2978, DOI 10.1021/bi0515117; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESPENBETOV AA, 1984, ACTA CRYSTALLOGR C, V40, P2096, DOI 10.1107/S0108270184010775; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FELDMAN RI, 1972, J BIOL CHEM, V247, P267; FELDMAN RI, 1972, J BIOL CHEM, V247, P260; Fung HL, 2004, ANNU REV PHARMACOL, V44, P67, DOI 10.1146/annurev.pharmtox.44.101802.121646; GOEDDE HW, 1992, HUM GENET, V88, P344; Gonzalez-Segura L, 2009, J MOL BIOL, V385, P542, DOI 10.1016/j.jmb.2008.10.082; Goto K, 2000, TETRAHEDRON LETT, V41, P8479, DOI 10.1016/S0040-4039(00)01487-8; Gruez A, 2004, J MOL BIOL, V343, P29, DOI 10.1016/j.jmb.2004.08.030; Hammen PK, 2002, BIOCHEMISTRY-US, V41, P7156, DOI 10.1021/bi012197t; Hurley TD, 2001, CHEM-BIOL INTERACT, V130, P3, DOI 10.1016/S0009-2797(00)00217-9; Inagaki E, 2006, J MOL BIOL, V362, P490, DOI 10.1016/j.jmb.2006.07.048; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keung WM, 1997, P NATL ACAD SCI USA, V94, P1675, DOI 10.1073/pnas.94.5.1675; Klyosov AA, 1996, BIOCHEMISTRY-US, V35, P4445, DOI 10.1021/bi9521093; Koenig A, 2007, BIOORG MED CHEM LETT, V17, P5881, DOI 10.1016/j.bmcl.2007.08.046; Kollau A, 2005, BIOCHEM J, V385, P769, DOI 10.1042/BJ20041354; Larson HN, 2007, J BIOL CHEM, V282, P12940, DOI 10.1074/jbc.M607959200; Larson HN, 2005, J BIOL CHEM, V280, P30550, DOI 10.1074/jbc.M502345200; Li ZL, 2005, ANAL BIOCHEM, V343, P35, DOI 10.1016/j.ab.2005.04.021; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; Lorentzen E, 2004, J MOL BIOL, V341, P815, DOI 10.1016/j.jmb.2004.05.032; Lowe ED, 2008, J MED CHEM, V51, P4482, DOI 10.1021/jm800488j; Marchitti SA, 2008, EXPERT OPIN DRUG MET, V4, P697, DOI [10.1517/17425255.4.6.697, 10.1517/17425255.4.6.697 ]; Marsh N, 2000, CLIN EXP PHARMACOL P, V27, P313, DOI 10.1046/j.1440-1681.2000.03240.x; Mayer B, 2008, BRIT J PHARMACOL, V155, P170, DOI 10.1038/bjp.2008.263; McCarthy AA, 2009, J SYNCHROTRON RADIAT, V16, P803, DOI 10.1107/S0909049509035377; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MUKERJEE N, 1992, ARCH BIOCHEM BIOPHYS, V299, P23, DOI 10.1016/0003-9861(92)90239-S; Munoz-Clares RA, 2011, CHEM-BIOL INTERACT, V191, P137, DOI 10.1016/j.cbi.2010.12.024; Munoz-Clares RA, 2010, ARCH BIOCHEM BIOPHYS, V493, P71, DOI 10.1016/j.abb.2009.09.006; Munzel T, 2005, CIRC RES, V97, P618, DOI 10.1161/01.RES.0000184694.03262.6d; Muto M, 2000, GUT, V47, P256, DOI 10.1136/gut.47.2.256; Ni L, 1999, PROTEIN SCI, V8, P2784; Perez-Miller S, 2010, NAT STRUCT MOL BIOL, V17, P159, DOI 10.1038/nsmb.1737; Perez-Miller SJ, 2003, BIOCHEMISTRY-US, V42, P7100, DOI 10.1021/bi034182w; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; RACKER E, 1949, J BIOL CHEM, V177, P883; Sage PR, 2000, CIRCULATION, V102, P2810; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Steinmetz CG, 1997, STRUCTURE, V5, P701, DOI 10.1016/S0969-2126(97)00224-4; Terwilliger TC, 2007, ACTA CRYSTALLOGR D, V63, P101, DOI 10.1107/S0907444906046233; Terwilliger TC, 2006, ACTA CRYSTALLOGR D, V62, P915, DOI 10.1107/S0907444906017161; Tsybovsky Y, 2007, BIOCHEMISTRY-US, V46, P2917, DOI 10.1021/bi0619573; TU GC, 1988, J BIOL CHEM, V263, P1218; TZENG TB, 1992, MED HYPOTHESES, V37, P58, DOI 10.1016/0306-9877(92)90015-5; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Wenzel P, 2007, BRIT J PHARMACOL, V150, P526, DOI 10.1038/sj.bjp.0707116; Wenzl MV, 2011, MOL PHARMACOL, V80, P258, DOI 10.1124/mol.111.071704; Wenzl MV, 2009, J BIOL CHEM, V284, P19878, DOI 10.1074/jbc.M109.005652; Wessler C, 2003, EUR J MED CHEM, V38, P581, DOI 10.1016/S0223-5234(03)00079-5; Yang J, 2007, BIOCHEMISTRY-US, V46, P709, DOI 10.1021/bi061546m; Yokoyama A, 1999, ALCOHOL CLIN EXP RES, V23, P1705, DOI 10.1097/00000374-199911000-00001; Yoshida A, 1998, EUR J BIOCHEM, V251, P549, DOI 10.1046/j.1432-1327.1998.2510549.x; ZHENG CF, 1993, ALCOHOL CLIN EXP RES, V17, P828, DOI 10.1111/j.1530-0277.1993.tb00849.x	68	23	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.371716	http://dx.doi.org/10.1074/jbc.M112.371716			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988236	hybrid, Green Published			2022-12-25	WOS:000310642200046
J	Alfonsi, E; Hassani, S; Carpentier, FG; Le Clec'h, JY; Dabin, W; Van Canneyt, O; Fontaine, MC; Jung, JL				Alfonsi, Eric; Hassani, Sami; Carpentier, Francois-Gilles; Le Clec'h, Jean-Yves; Dabin, Willy; Van Canneyt, Olivier; Fontaine, Michael C.; Jung, Jean-Luc			A European Melting Pot of Harbour Porpoise in the French Atlantic Coasts Inferred from Mitochondrial and Nuclear Data	PLOS ONE			English	Article							SOUTHERN NORTH-SEA; PHOCOENA-PHOCOENA; POPULATION-STRUCTURE; CLIMATE-CHANGE; CONTROL REGION; EASTERN; CETACEANS; SOFTWARE; DIFFERENTIATION; VARIABILITY	Field surveys have reported a global shift in harbour porpoise distribution in European waters during the last 15 years, including a return to the Atlantic coasts of France. In this study, we analyzed genetic polymorphisms at a fragment of the mitochondrial control region (mtDNA CR) and 7 nuclear microsatellite loci, for 52 animals stranded and by-caught between 2000 and 2010 along the Atlantic coasts of France. The analysis of nuclear and mitochondrial loci provided contrasting results. The mtDNA revealed two genetically distinct groups, one closely related to the Iberian and African harbour porpoises, and the second related to individuals from the more northern waters of Europe. In contrast, nuclear polymorphisms did not display such a distinction. Nuclear markers suggested that harbour porpoises behaved as a randomly mating population along the Atlantic coasts of France. The difference between the two kinds of markers can be explained by differences in their mode of inheritance, the mtDNA being maternally inherited in contrast to nuclear loci that are bi-parentally inherited. Our results provide evidence that a major proportion of the animals we sampled are admixed individuals from the two genetically distinct populations previously identified along the Iberian coasts and in the North East Atlantic. The French Atlantic coasts are clearly the place where these two previously separated populations of harbour porpoises are now admixing. The present shifts in distribution of harbour porpoises along this coast is likely caused by habitat changes that will need to be further studied.	[Alfonsi, Eric; Carpentier, Francois-Gilles; Jung, Jean-Luc] Univ Europeenne Bretagne, Lab BioGeMME Biol & Genet Mammiferes Marins Leur, Brest, France; [Alfonsi, Eric; Carpentier, Francois-Gilles; Jung, Jean-Luc] Univ Bretagne Occidentale, Brest, France; [Alfonsi, Eric; Hassani, Sami; Le Clec'h, Jean-Yves] Oceanopolis, Lab Etude Mammiferes Marins, Brest, France; [Alfonsi, Eric] Univ Europeenne Bretagne, LEMAR, Brest, France; [Dabin, Willy; Van Canneyt, Olivier] Univ La Rochelle, CNRS, UMS 3462, Observ PELAGIS, La Rochelle, France; [Fontaine, Michael C.] Univ Paris 11, CNRS, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; [Fontaine, Michael C.] Univ Paris 07, CNRS, MNHN, Musee Homme,UMR 5145, Paris, France	Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); La Rochelle Universite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite	Alfonsi, E (corresponding author), Univ Europeenne Bretagne, Lab BioGeMME Biol & Genet Mammiferes Marins Leur, Brest, France.	jung@univ-brest.fr	Jung, Jean-Luc/H-5108-2011; Fontaine, Michael/G-5350-2011	Jung, Jean-Luc/0000-0002-8795-8056; Fontaine, Michael/0000-0003-1156-4154	ANRT (Association Nationale de la Recherche et de la Technologie); ANR NUTGENEVOL research project	ANRT (Association Nationale de la Recherche et de la Technologie)(French National Research Agency (ANR)); ANR NUTGENEVOL research project(French National Research Agency (ANR))	Eric Alfonsi is supported by a grant "Cifre" of the ANRT (Association Nationale de la Recherche et de la Technologie, http://www.anrt.asso.fr). MCF is currently a post-doc supported by the ANR NUTGENEVOL research project. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andersen LW, 2001, CONSERV GENET, V2, P309, DOI 10.1023/A:1012534212853; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; [Anonymous], 2006, SMALL CETACEANS EURO, P1; Berggren P, 2002, BIOL CONSERV, V103, P313, DOI 10.1016/S0006-3207(01)00142-2; Camphuysen Kees C. J., 2004, Lutra, V47, P113; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Chivers S. J., 2002, Journal of Cetacean Research and Management, V4, P111; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Donovan G. P., 1995, V16, P3; Duguy R., 1977, Report int Whal Commn, V27, P500; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fontaine MC, 2012, P NATL ACAD IN PRESS; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Fontaine MC, 2010, P ROY SOC B-BIOL SCI, V277, P2829, DOI 10.1098/rspb.2010.0412; Gambaiani DD, 2009, J MAR BIOL ASSOC UK, V89, P179, DOI 10.1017/S0025315408002476; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gaskin D.E., 1984, REP INT WHAL COMMN, V34, P569; Goloboff P, 2008, CLADISTICS, V24, P91; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hammond PS, 2002, J APPL ECOL, V39, P361, DOI 10.1046/j.1365-2664.2002.00713.x; Hartl D., 2007, PRINCIPLES POPULATIO; Herr H, 2009, BIOL CONSERV, V142, P2962, DOI 10.1016/j.biocon.2009.07.025; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hudson RD, 1998, MOL BIOL EVOL, V9, P138; Hudson RR, 2000, GENETICS, V155, P2011; Jayasankar P, 2008, CURR SCI INDIA, V94, P1513; Johnston DW, 2005, MAR ECOL PROG SER, V295, P279, DOI 10.3354/meps295279; Jung JL, 2009, J MAR BIOL ASSOC UK, V89, P1045, DOI 10.1017/S0025315409000307; Kiszka Jeremy, 2004, Lutra, V47, P33; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Koopman HN, 2002, PHYSIOL BIOCHEM ZOOL, V75, P498, DOI 10.1086/342799; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lischer H, 2009, PGDSPIDER V1 0 1 4; Lockyer C., 2003, NAMMCO Scientific Publications, V5, P71; Lockyer C, 2007, J MAR BIOL ASSOC UK, V87, P1035, DOI 10.1017/S0025315407054720; MacLeod CD, 2007, BIOL LETTERS, V3, P185, DOI 10.1098/rsbl.2006.0588; Northridge S, 1999, SCI COMM INT WHAL CO; Palacios DM, 2011, CLIMATE CHANGE VULNE, P69; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pikesley SK, 2012, J MAR BIOL ASSOC UK, V92, P1809, DOI 10.1017/S0025315411000464; Poulard JC, 2005, ICES J MAR SCI, V62, P1436, DOI 10.1016/j.icesjms.2005.04.017; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Read AJ., 1999, HDB MARINE MAMMALS, P323; Reijnders Peter J. H., 1992, Netherlands Journal of Aquatic Ecology, V26, P75, DOI 10.1007/BF02298029; Reijnders PJH, 2009, 16 ADV COMM M 16 BRU, P16; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosel PE, 2003, CONSERV GENET, V4, P647, DOI 10.1023/A:1025666212967; ROSEL PE, 1995, CAN J FISH AQUAT SCI, V52, P1210, DOI 10.1139/f95-118; Rosel PE, 1999, MOL ECOL, V8, pS41, DOI 10.1046/j.1365-294X.1999.00758.x; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Santos MB, 2004, MAR MAMMAL SCI, V20, P1, DOI 10.1111/j.1748-7692.2004.tb01138.x; Santos MB, 2003, OCEANOGR MAR BIOL, V41, P355; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Siebert U, 2006, J SEA RES, V56, P65, DOI 10.1016/j.seares.2006.01.003; Simmonds MP, 2009, J MAR BIOL ASSOC UK, V89, P203, DOI 10.1017/S0025315408003196; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Stenson G.B., 2003, NAMMCO Scientific Publications, V5, P271; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; TAJIMA F, 1989, GENETICS, V123, P585; Thomsen F, 2006, HELGOLAND MAR RES, V60, P189, DOI 10.1007/s10152-006-0021-z; Tiedemann R, 1996, Z SAUGETIERKD, V61, P104; Tolley KA, 2006, MAR ECOL PROG SER, V327, P297, DOI 10.3354/meps327297; Tolley KA, 2001, J CETACEAN RES MANAG, V1, P265; Tolley KA, 2001, CONSERV GENET, V2, P349, DOI 10.1023/A:1012561811074; Tregenza NJC, 1997, ICES J MAR SCI, V54, P896, DOI 10.1006/jmsc.1996.0212; van der Meij Sancia E. T., 2006, Lutra, V49, P3; Viaud-Martinez KA, 2007, MAR ECOL PROG SER, V338, P281, DOI 10.3354/meps338281; Walton MJ, 1997, P ROY SOC B-BIOL SCI, V264, P89, DOI 10.1098/rspb.1997.0013; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wiemann A, 2010, CONSERV GENET, V11, P195, DOI 10.1007/s10592-009-0023-x	77	14	14	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44425	10.1371/journal.pone.0044425	http://dx.doi.org/10.1371/journal.pone.0044425			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984507	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500055
J	Bonmassar, G; Fujimoto, K; Golby, AJ				Bonmassar, Giorgio; Fujimoto, Kyoko; Golby, Alexandra J.			PTFOS: Flexible and Absorbable Intracranial Electrodes for Magnetic Resonance Imaging	PLOS ONE			English	Article							FLIP-ANGLE; ARTIFACTS; STIMULATION; IMPLANTS; SIGNALS	Intracranial electrocortical recording and stimulation can provide unique knowledge about functional brain anatomy in patients undergoing brain surgery. This approach is commonly used in the treatment of medically refractory epilepsy. However, it can be very difficult to integrate the results of cortical recordings with other brain mapping modalities, particularly functional magnetic resonance imaging (fMRI). The ability to integrate imaging and electrophysiological information with simultaneous subdural electrocortical recording/stimulation and fMRI could offer significant insight for cognitive and systems neuroscience as well as for clinical neurology, particularly for patients with epilepsy or functional disorders. However, standard subdural electrodes cause significant artifact in MRI images, and concerns about risks such as cortical heating have generally precluded obtaining MRI in patients with implanted electrodes. We propose an electrode set based on polymer thick film organic substrate (PTFOS), an organic absorbable, flexible and stretchable electrode grid for intracranial use. These new types of MRI transparent intracranial electrodes are based on nano-particle ink technology that builds on our earlier development of an EEG/fMRI electrode set for scalp recording. The development of MRI-compatible recording/stimulation electrodes with a very thin profile could allow functional mapping at the individual subject level of the underlying feedback and feed forward networks. The thin flexible substrate would allow the electrodes to optimally contact the convoluted brain surface. Performance properties of the PTFOS were assessed by MRI measurements, finite difference time domain (FDTD) simulations, micro-volt recording, and injecting currents using standard electrocortical stimulation in phantoms. In contrast to the large artifacts exhibited with standard electrode sets, the PTFOS exhibited no artifact due to the reduced amount of metal and conductivity of the electrode/trace ink and had similar electrical properties to a standard subdural electrode set. The enhanced image quality could enable routine MRI exams of patients with intracranial electrode implantation and could also lead to chronic implantation solutions.	[Bonmassar, Giorgio; Fujimoto, Kyoko] Harvard Univ, Sch Med, Massachusetts Gen Hosp, AA Martinos Ctr, Charlestown, MA USA; [Golby, Alexandra J.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg & Radiol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bonmassar, G (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, AA Martinos Ctr, Charlestown, MA USA.	giorgio@nmr.mgh.harvard.edu		Fujimoto, Kyoko/0000-0002-0087-1397	Center for Integration of Medicine and Innovative Technology for the award [CIMIT 07-153]; National Institutes of Health [R43NS071988 (NINDS), R01EB006385 (NIBIB), R01NS037462 (NINDS), P41RR14075 (NCRR), P41EB015898 (NCRR), P41RR019703 (NIBIB)]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR019703, P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015898, R01EB006385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R43NS071988, R01NS037462] Funding Source: NIH RePORTER	Center for Integration of Medicine and Innovative Technology for the award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by Center for Integration of Medicine and Innovative Technology for the award # CIMIT 07-153 (www.cimit.org). Furthermore, this project was supported by the National Institutes of Health through grant numbers: R43NS071988 (NINDS), R01EB006385 (NIBIB), R01NS037462 (NINDS), P41RR14075 (NCRR), P41EB015898 (NCRR) and P41RR019703 (NIBIB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLESTRASSE CL, 1988, IEEE T BIO-MED ENG, V35, P870, DOI 10.1109/10.7294; Bartels LW, 2002, MAGNET RESON MED, V47, P171, DOI 10.1002/mrm.10004; Bennett LH, 1996, J APPL PHYS, V79, P4712, DOI 10.1063/1.361649; BERENGER JP, 1994, J COMPUT PHYS, V114, P185, DOI 10.1006/jcph.1994.1159; Bhavaraju NC, 2002, MAGN RESON IMAGING, V20, P351, DOI 10.1016/S0730-725X(02)00506-4; Bonmassar G, 2001, HUM BRAIN MAPP, V14, P108, DOI 10.1002/hbm.1045; Bonmassar Giorgio, 2010, Int J Bioelectromagn, V12, P32; CAMACHO CR, 1995, JMRI-J MAGN RESON IM, V5, P75, DOI 10.1002/jmri.1880050115; Christ A, 2010, PHYS MED BIOL, V55, pN23, DOI 10.1088/0031-9155/55/2/N01; Davis LM, 1999, EPILEPSY RES, V35, P95, DOI 10.1016/S0920-1211(99)00007-8; Dziedzic A, 1998, J PHYS D APPL PHYS, V31, P2091, DOI 10.1088/0022-3727/31/17/003; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Ferrier CH, 2006, EPILEPSIA, V47, P1477, DOI 10.1111/j.1528-1167.2006.00619.x; Finelli DA, 1997, AM J NEURORADIOL, V18, P147; Gilleo K, 1996, POLYM THICK FILM, Vxvi, P421; Gotman J, 2008, EPILEPSIA, V49, P42, DOI 10.1111/j.1528-1167.2008.01509.x; Graf H, 2005, MAGN RESON IMAGING, V23, P493, DOI 10.1016/j.mri.2004.12.009; Hartwig V, 2011, MAGN RESON IMAGING, V29, P717, DOI 10.1016/j.mri.2011.01.004; Kay S. M., 1993, FUNDAMENTALS STAT SI; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Li W, 2009, PROC IEEE MICR ELECT, P248, DOI 10.1109/MEMSYS.2009.4805365; MALKO JA, 1989, RADIOLOGY, V173, P563, DOI 10.1148/radiology.173.2.2798891; Niedermeyer E, 2005, ELECTROENCEPHALOGRAP, Vxiii, P1309; Purdon PL, 2008, J NEUROSCI METH, V175, P165, DOI 10.1016/j.jneumeth.2008.07.017; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Schalk Gerwin, 2011, IEEE Rev Biomed Eng, V4, P140, DOI 10.1109/RBME.2011.2172408; Schueler BA, 1999, JMRI-J MAGN RESON IM, V9, P596, DOI 10.1002/(SICI)1522-2586(199904)9:4<596::AID-JMRI14>3.0.CO;2-T; SHELLOCK FG, 1990, RADIOLOGY, V175, P586; SIEGFRIED J, 1985, APPL NEUROPHYSIOL, V48, P408; Silberbusch MA, 1998, AM J NEURORADIOL, V19, P1089; Smith SW, 1997, SCI ENG GUIDE DIGITA, Vxiv, P626; Suarez RO, 2009, EPILEPSY BEHAV, V16, P288, DOI 10.1016/j.yebeh.2009.07.034; Szelenyi A, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.12.FOCUS09237; Vasios CE, 2006, NEUROIMAGE, V33, P1082, DOI 10.1016/j.neuroimage.2006.07.038; Voskerician G, 2005, IEEE SENS J, V5, P1147, DOI 10.1109/JSEN.2005.857877; Yarnykh VL, 2007, MAGN RESON MED, V57, P192, DOI 10.1002/mrm.21120; YEE KS, 1966, IEEE T ANTENN PROPAG, VAP14, P302; Zumsteg D, 2005, CLIN NEUROPHYSIOL, V116, P2810, DOI 10.1016/j.clinph.2005.08.009	39	11	11	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e41187	10.1371/journal.pone.0041187	http://dx.doi.org/10.1371/journal.pone.0041187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984396	Green Submitted, Green Published, gold			2022-12-25	WOS:000308738500002
J	Cartwright, SP; Bill, RM; Hipkiss, AR				Cartwright, Stephanie P.; Bill, Roslyn M.; Hipkiss, Alan R.			L-Carnosine Affects the Growth of Saccharomyces cerevisiae in a Metabolism-Dependent Manner	PLOS ONE			English	Article							CHRONOLOGICAL LIFE-SPAN; INCREASED RESPIRATION; YEAST; MUSCLE; CELLS; TOR; HISTIDINE; ATP	The dipeptide L-carnosine (beta-alanyl-L-histidine) has been described as enigmatic: it inhibits growth of cancer cells but delays senescence in cultured human fibroblasts and extends the lifespan of male fruit flies. In an attempt to understand these observations, the effects of L-carnosine on the model eukaryote, Saccharomyces cerevisiae, were examined on account of its unique metabolic properties; S. cerevisiae can respire aerobically, but like some tumor cells, it can also exhibit a metabolism in which aerobic respiration is down regulated. L-Carnosine exhibited both inhibitory and stimulatory effects on yeast cells, dependent upon the carbon source in the growth medium. When yeast cells were not reliant on oxidative phosphorylation for energy generation (e. g. when grown on a fermentable carbon source such as 2% glucose), 10-30 mM L-carnosine slowed growth rates in a dose-dependent manner and increased cell death by up to 17%. In contrast, in media containing a non-fermentable carbon source in which yeast are dependent on aerobic respiration (e. g. 2% glycerol), L-carnosine did not provoke cell death. This latter observation was confirmed in the respiratory yeast, Pichia pastoris. Moreover, when deletion strains in the yeast nutrient-sensing pathway were treated with L-carnosine, the cells showed resistance to its inhibitory effects. These findings suggest that L-carnosine affects cells in a metabolism-dependent manner and provide a rationale for its effects on different cell types.	[Cartwright, Stephanie P.; Bill, Roslyn M.; Hipkiss, Alan R.] Aston Univ, Sch Hlth & Life Sci, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England	Aston University	Cartwright, SP (corresponding author), Aston Univ, Sch Hlth & Life Sci, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England.	r.m.bill@aston.ac.uk; alanandjill@lineone.net	Bill, Roslyn M/D-4554-2012	Bill, Roslyn M/0000-0003-1331-0852	BBSRC (Biotechnology and Biological Sciences Research Council) Targetted Priority Studentship in Ageing	BBSRC (Biotechnology and Biological Sciences Research Council) Targetted Priority Studentship in Ageing	This work was funded by a BBSRC (Biotechnology and Biological Sciences Research Council) Targetted Priority Studentship in Ageing to RMB supporting SPC. The authors also acknowledge Aston Research Centre for Healthy Ageing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2000, BIOCHEMISTRY-MOSCOW+, V65, P757; Asperger A, 2011, CANCER INVEST, V29, P272, DOI 10.3109/07357907.2010.550666; Bauer K, 2005, NEUROCHEM RES, V30, P1339, DOI 10.1007/s11064-005-8806-z; Bonander N, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-10; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Chen JCY, 2006, CURR GENET, V49, P281, DOI 10.1007/s00294-005-0055-9; Crabtree HG, 1929, BIOCHEM J, V23, P536, DOI 10.1042/bj0230536; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; Diaz-Ruiz R, 2009, BBA-REV CANCER, V1796, P252, DOI 10.1016/j.bbcan.2009.07.003; Diaz-Ruiz R, 2011, BBA-BIOENERGETICS, V1807, P568, DOI 10.1016/j.bbabio.2010.08.010; Hipkiss AR, 2009, ADV FOOD NUTR RES, V57, P87, DOI 10.1016/S1043-4526(09)57003-9; Holliday R, 1996, BRIT J CANCER, V73, P966, DOI 10.1038/bjc.1996.189; Holliday R, 2000, BIOCHEMISTRY-MOSCOW+, V65, P843; IKEDA T, 1980, J BIOCHEM-TOKYO, V87, P179, DOI 10.1093/oxfordjournals.jbchem.a132723; Iovine B, 2012, CANCER LETT, V315, P122, DOI 10.1016/j.canlet.2011.07.021; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Lavoie H, 2008, EUKARYOT CELL, V7, P1127, DOI 10.1128/EC.00330-07; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; MANNION AF, 1992, EUR J APPL PHYSIOL O, V64, P47, DOI 10.1007/BF00376439; Mattanovich D, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-29; MCFARLAND GA, 1994, EXP CELL RES, V212, P167, DOI 10.1006/excr.1994.1132; Nagai K, 1986, Nihon Seirigaku Zasshi, V48, P741; Pepper ED, 2010, APPL ENVIRON MICROB, V76, P7925, DOI 10.1128/AEM.01369-10; QUINN PJ, 1992, MOL ASPECTS MED, V13, P379, DOI 10.1016/0098-2997(92)90006-L; Renner C, 2010, NEUROL RES, V32, P101, DOI 10.1179/016164109X12518779082237; Skinner C, 2010, APPL MICROBIOL BIOT, V88, P817, DOI 10.1007/s00253-010-2824-8; WARBURG O, 1956, SCIENCE, V124, P269; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; Yuneva AO, 2002, B EXP BIOL MED+, V133, P559, DOI 10.1023/A:1020273506970	29	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45006	10.1371/journal.pone.0045006	http://dx.doi.org/10.1371/journal.pone.0045006			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984600	gold, Green Published, Green Accepted			2022-12-25	WOS:000308738500106
J	Hauck, Y; Soler, C; Jault, P; Merens, A; Gerome, P; Mac Nab, C; Trueba, F; Bargues, L; Thien, HV; Vergnaud, G; Pourcel, C				Hauck, Yolande; Soler, Charles; Jault, Patrick; Merens, Audrey; Gerome, Patrick; Mac Nab, Christine; Trueba, Francois; Bargues, Laurent; Hoang Vu Thien; Vergnaud, Gilles; Pourcel, Christine			Diversity of Acinetobacter baumannii in Four French Military Hospitals, as Assessed by Multiple Locus Variable Number of Tandem Repeats Analysis	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ANTIMICROBIAL SUSCEPTIBILITIES; IDENTIFICATION; STRAINS; INFECTIONS; COMPLEX; EPIDEMIOLOGY; BACTEREMIA; FOSFOMYCIN; OUTBREAK	Background: Infections by A. calcoaceticus-A. baumannii (ACB) complex isolates represent a serious threat for wounded and burn patients. Three international multidrug-resistant (MDR) clones (EU clone I-III) are responsible for a large proportion of nosocomial infections with A. baumannii but other emerging strains with high epidemic potential also occur. Methodology/Principal Findings: We automatized a Multiple locus variable number of tandem repeats (VNTR) analysis (MLVA) protocol and used it to investigate the genetic diversity of 136 ACB isolates from four military hospitals and one childrens hospital. Acinetobacter sp other than baumannii isolates represented 22.6% (31/137) with a majority being A. pittii. The genotyping protocol designed for A. baumannii was also efficient to cluster A. pittii isolates. Fifty-five percent of A. baumannii isolates belonged to the two international clones I and II, and we identified new clones which members were found in the different hospitals. Analysis of two CRISPR-cas systems helped define two clonal complexes and provided phylogenetic information to help trace back their emergence. Conclusions/Significance: The increasing occurrence of A. baumannii infections in the hospital calls for measures to rapidly characterize the isolates and identify emerging clones. The automatized MLVA protocol can be the instrument for such surveys. In addition, the investigation of CRISPR/cas systems may give important keys to understand the evolution of some highly successful clonal complexes.	[Hauck, Yolande; Vergnaud, Gilles; Pourcel, Christine] Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France; [Hauck, Yolande; Vergnaud, Gilles; Pourcel, Christine] CNRS, F-91405 Orsay, France; [Soler, Charles; Jault, Patrick; Mac Nab, Christine; Bargues, Laurent] HIA Percy, Lab Biol Clin, Clamart, France; [Merens, Audrey] HIA Begin, Lab Biol Clin, St Mande, France; [Gerome, Patrick] HIA Desgenettes, Serv Biol Med, Lyon, France; [Trueba, Francois] HIA Val de Grace, Serv Biol Med, Paris, France; [Hoang Vu Thien] Hop Armand Trousseau, APHP, Paris, France; [Vergnaud, Gilles] DGA MRIS Mission Rech & Innovat Sci, Bagneux, France	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Val-de-Grace Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite	Hauck, Y (corresponding author), Univ Paris 11, Inst Genet & Microbiol, UMR8621, F-91405 Orsay, France.	christine.pourcel@u-psud.fr	Vergnaud, Gilles/P-1304-2015; Pourcel, Christine/E-4949-2017; Vergnaud, Gilles/AAC-1162-2020	Vergnaud, Gilles/0000-0003-0913-194X; Pourcel, Christine/0000-0002-8951-466X; Vergnaud, Gilles/0000-0003-0913-194X; JAULT, Patrick/0000-0001-8021-9149				Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Berlau J, 1999, J HOSP INFECT, V42, P201, DOI 10.1053/jhin.1999.0602; Boo TW, 2009, J MED MICROBIOL, V58, P209, DOI 10.1099/jmm.0.004911-0; Carretto E, 2011, INFECT GENET EVOL, V11, P1319, DOI 10.1016/j.meegid.2011.04.024; Chakraborty S, 2010, MOL PHYLOGENET EVOL, V56, P878, DOI 10.1016/j.ympev.2010.05.020; Chuang YC, 2011, CLIN INFECT DIS, V52, P352, DOI 10.1093/cid/ciq154; Di Nocera PP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-224; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Ecker JA, 2006, J CLIN MICROBIOL, V44, P2921, DOI 10.1128/JCM.00619-06; Falagas ME, 2008, CLIN INFECT DIS, V46, P1069, DOI 10.1086/527442; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Fournier PE, 2006, PLOS GENET, V2, P62, DOI 10.1371/journal.pgen.0020007; Gant VA, 2007, J ANTIMICROB CHEMOTH, V60, P294, DOI 10.1093/jac/dkm201; GERNERSMIDT P, 1991, J CLIN MICROBIOL, V29, P277, DOI 10.1128/JCM.29.2.277-282.1991; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2009, METHODS MOL BIOL, V551, P105, DOI 10.1007/978-1-60327-999-4_9; Hamouda A, 2010, J CLIN MICROBIOL, V48, P2476, DOI 10.1128/JCM.02431-09; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Houang ETS, 2001, J CLIN MICROBIOL, V39, P228, DOI 10.1128/JCM.39.1.228-234.2001; Iacono M, 2008, ANTIMICROB AGENTS CH, V52, P2616, DOI 10.1128/AAC.01643-07; Ko WC, 2008, J CLIN MICROBIOL, V46, P2052, DOI 10.1128/JCM.00014-08; La Scola B, 2006, J CLIN MICROBIOL, V44, P827, DOI 10.1128/JCM.44.3.827-832.2006; Lee YC, 2011, J ANTIMICROB CHEMOTH, V66, P1839, DOI 10.1093/jac/dkr200; Lin YC, 2008, J CLIN MICROBIOL, V46, P612, DOI 10.1128/JCM.01798-07; Lista F, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-33; Lu CL, 2011, ANTIMICROB AGENTS CH, V55, P4295, DOI 10.1128/AAC.00349-11; Magiorakos AP, 2011, CLIN MICROBIOL INFEC; Minandri F, 2012, J CLIN MICROBIOL, V50, P590, DOI 10.1128/JCM.05555-11; Nemec A, 2001, INT J SYST EVOL MICR, V51, P1891, DOI 10.1099/00207713-51-5-1891; Nemec A, 2011, RES MICROBIOL, V162, P393, DOI 10.1016/j.resmic.2011.02.006; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Petersen K, 2011, J CLIN MICROBIOL, V49, P159, DOI 10.1128/JCM.00766-10; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Pourcel C, 2011, J CLIN MICROBIOL, V49, P539, DOI 10.1128/JCM.02003-10; Sachdev D, 2010, MICROBIOL RES, V165, P627, DOI 10.1016/j.micres.2009.12.002; Scott P, 2007, CLIN INFECT DIS, V44, P1577, DOI 10.1086/518170; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Snitkin ES, 2011, P NATL ACAD SCI USA, V108, P13758, DOI 10.1073/pnas.1104404108; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Turton JF, 2009, EUR J CLIN MICROBIOL, V28, P499, DOI 10.1007/s10096-008-0659-3; Turton JF, 2011, J CLIN MICROBIOL, V49, P1260, DOI 10.1128/JCM.02335-10; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; van den Broek PJ, 2009, J CLIN MICROBIOL, V47, P3593, DOI 10.1128/JCM.00967-09; van Dessel H, 2004, RES MICROBIOL, V155, P105, DOI 10.1016/j.resmic.2003.10.003; Vergnaud G, 2009, METHODS MOL BIOL, V551, P141, DOI 10.1007/978-1-60327-999-4_12; Visca P, 2011, MICROBIOL-SGM, V157, P2582, DOI 10.1099/mic.0.047258-0; Wisplinghoff H, 2012, J INFECTION, V64, P282, DOI 10.1016/j.jinf.2011.12.008	53	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44597	10.1371/journal.pone.0044597	http://dx.doi.org/10.1371/journal.pone.0044597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984530	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500068
J	Nogues, C; Leh, H; Lautru, J; Delelis, O; Buckle, M				Nogues, Claude; Leh, Herve; Lautru, Joseph; Delelis, Olivier; Buckle, Malcolm			Efficient Antifouling Surface for Quantitative Surface Plasmon Resonance Based Biosensor Analysis	PLOS ONE			English	Article							SELF-ASSEMBLED MONOLAYERS; GOLD NANOPARTICLES; PROTEIN ADSORPTION; HIV-1 INTEGRASE; MODEL SYSTEM; DNA; BINDING; HYBRIDIZATION; OLIGONUCLEOTIDES; LIGANDS	Non-specific binding to biosensor surfaces is a major obstacle to quantitative analysis of selective retention of analytes at immobilized target molecules. Although a range of chemical antifouling monolayers has been developed to address this problem, many macromolecular interactions still remain refractive to analysis due to the prevalent high degree of nonspecific binding. In this manuscript we explore the dynamic process of the formation of self-assembled monolayers and optimize physical and chemical properties thus reducing considerably non-specific binding while maintaining the integrity of the immobilized biomolecules. As a result, analysis of specific binding of analytes to immobilized target molecules is significantly facilitated.	[Nogues, Claude; Leh, Herve; Delelis, Olivier; Buckle, Malcolm] CNRS, ENS Cachan, LBPA, Cachan, France; [Lautru, Joseph] ENS Cachan, Inst Alembert, Cachan, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Nogues, C (corresponding author), CNRS, ENS Cachan, LBPA, Cachan, France.	buckle@lbpa.ens-cachan.fr			Eurotransbio financed project [Qubis ETB-2006-066]; CONCOURS NATIONAL aide a la creation d'entreprise de technologies innovantes du ministere de l'Enseignement superieur et de OSEO/ANVAR (Agence Nationale de la Valorisation de la Recherche); Association National pour la Recherche Scientifique (ANRS) [ANR-06-PCVI-0015-04 IMFOVIR]; Centre National de la Recherche Francaise (CNRS)	Eurotransbio financed project; CONCOURS NATIONAL aide a la creation d'entreprise de technologies innovantes du ministere de l'Enseignement superieur et de OSEO/ANVAR (Agence Nationale de la Valorisation de la Recherche)(French National Research Agency (ANR)); Association National pour la Recherche Scientifique (ANRS)(French National Research Agency (ANR)); Centre National de la Recherche Francaise (CNRS)	This work was supported by: 1) Eurotransbio financed project (Qubis ETB-2006-066). http://www.eurotransbio.eu; 2) CONCOURS NATIONAL 2008 aide a la creation d'entreprise de technologies innovantes du ministere de l'Enseignement superieur et de OSEO/ANVAR (Agence Nationale de la Valorisation de la Recherche). http://www.oseo.fr/; 3) Association National pour la Recherche Scientifique (ANRS) for support of the ANR-06-PCVI-0015-04 IMFOVIR. http://www.agence-nationale-recherche.fr; 4) Centre National de la Recherche Francaise (CNRS). http://www.cnrs.fr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouffartigues E, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm030; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Buckle M, 1996, P NATL ACAD SCI USA, V93, P889, DOI 10.1073/pnas.93.2.889; Caumont A, 1999, FEBS LETT, V455, P154, DOI 10.1016/S0014-5793(99)00859-5; Coffin J, 1997, RETROVIRUSES; Delelis O, 2008, J BIOL CHEM, V283, P27838, DOI 10.1074/jbc.M803257200; Demers LM, 2000, ANAL CHEM, V72, P5535, DOI 10.1021/ac0006627; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Halperin A, 2006, J PHYS-CONDENS MAT, V18, pS463, DOI 10.1088/0953-8984/18/18/S01; Harder P, 1998, J PHYS CHEM B, V102, P426, DOI 10.1021/jp972635z; Harris JM, 1992, POLYETHYLENE GLYCOL, P408; Herne TM, 1997, J AM CHEM SOC, V119, P8916, DOI 10.1021/ja9719586; Herrwerth S, 2003, J AM CHEM SOC, V125, P9359, DOI 10.1021/ja034820y; Hucknall A, 2009, ADV MATER, V21, P2441, DOI 10.1002/adma.200900383; Lahiri J, 1999, LANGMUIR, V15, P7186, DOI 10.1021/la9815650; Lahiri J, 1999, ANAL CHEM, V71, P777, DOI 10.1021/ac980959t; Nogues C, 2004, PHYS CHEM CHEM PHYS, V6, P4459, DOI 10.1039/b410862k; Nogues C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012152; Peled D, 2008, LANGMUIR, V24, P11842, DOI 10.1021/la801437n; Peled D, 2010, J PHYS CHEM B, V114, P8581, DOI 10.1021/jp104533q; Pertsin AJ, 1998, J PHYS CHEM B, V102, P4918, DOI 10.1021/jp9806617; Petrovykh DY, 2003, J AM CHEM SOC, V125, P5219, DOI 10.1021/ja029450c; PRIME KL, 1993, J AM CHEM SOC, V115, P10714, DOI 10.1021/ja00076a032; Smolov M, 2006, FEBS J, V273, P1137, DOI 10.1111/j.1742-4658.2006.05139.x; Steel AB, 1998, ANAL CHEM, V70, P4670, DOI 10.1021/ac980037q; Storhoff JJ, 2002, P SOC PHOTO-OPT INS, V4937, P1, DOI 10.1117/12.476069; Xu J, 2005, J AM CHEM SOC, V127, P13227, DOI 10.1021/ja052352h	27	16	16	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44287	10.1371/journal.pone.0044287	http://dx.doi.org/10.1371/journal.pone.0044287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984487	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500043
J	Kintscher, M; Breustedt, J; Miceli, S; Schmitz, D; Wozny, C				Kintscher, Michael; Breustedt, Joerg; Miceli, Stephanie; Schmitz, Dietmar; Wozny, Christian			Group II Metabotropic Glutamate Receptors Depress Synaptic Transmission onto Subicular Burst Firing Neurons	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; HIPPOCAMPAL OUTPUT SYNAPSES; MOSSY FIBER SYNAPSES; IN-VITRO; PYRAMIDAL NEURONS; RAT HIPPOCAMPUS; PRESYNAPTIC INHIBITION; EXCITATORY SYNAPSES; INTERICTAL ACTIVITY; AREA CA1	The subiculum (SUB) is a pivotal structure positioned between the hippocampus proper and various cortical and subcortical areas. Despite the growing body of anatomical and intrinsic electrophysiological data of subicular neurons, modulation of synaptic transmission in the SUB is not well understood. In the present study we investigated the role of group II metabotropic glutamate receptors (mGluRs), which have been shown to be involved in the regulation of synaptic transmission by suppressing presynaptic cAMP activity. Using field potential and patch-clamp whole cell recordings we demonstrate that glutamatergic transmission at CA1-SUB synapses is depressed by group II mGluRs in a cell-type specific manner. Application of the group II mGluR agonist (2S,1'R,2'R,3'R)-2-(2, 3-dicarboxycyclopropyl)glycine (DCG-IV) led to a significantly higher reduction of excitatory postsynaptic currents in subicular bursting cells than in regular firing cells. We further used low-frequency stimulation protocols and brief high-frequency bursts to test whether synaptically released glutamate is capable of activating presynaptic mGluRs. However, neither frequency facilitation is enhanced in the presence of the group II mGluR antagonist LY341495, nor is a test stimulus given after a high-frequency burst. In summary, we present pharmacological evidence for presynaptic group II mGluRs targeting subicular bursting cells, but both low- and high-frequency stimulation protocols failed to activate presynaptically located mGluRs.	[Kintscher, Michael; Breustedt, Joerg; Miceli, Stephanie; Schmitz, Dietmar; Wozny, Christian] Charite, Neurosci Res Ctr, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kintscher, M (corresponding author), Charite, Neurosci Res Ctr, D-13353 Berlin, Germany.	christian.wozny@charite.de	Wozny, Christian/A-1498-2015	Wozny, Christian/0000-0003-4220-2033; Kintscher, Michael/0000-0003-2355-1369; Schmitz, Dietmar/0000-0003-2741-5241; Miceli, Stephanie/0000-0001-8513-0549	Deutsche Forschungsgemeinschaft (DFG); Bundesministerium fur Bildung und Forschung (BMBF) [SFB618, SFB665]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The work was supported by Deutsche Forschungsgemeinschaft (DFG) and Bundesministerium fur Bildung und Forschung (BMBF) grants to D. Schmitz (SFB618, SFB665, Cluster NeuroCure, Bernstein-Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GM, 2006, EPILEPSY RES, V71, P1, DOI 10.1016/j.eplepsyres.2006.05.012; Alexander GM, 2005, J NEUROPHYSIOL, V94, P163, DOI 10.1152/jn.01198.2004; Beed P, 2010, NEURON, V68, P1059, DOI 10.1016/j.neuron.2010.12.009; Behr J, 2009, PROG NEUROBIOL; Bendels MHK, 2008, J NEUROSCI METH, V175, P44, DOI 10.1016/j.jneumeth.2008.08.010; Billups B, 2005, J PHYSIOL-LONDON, V565, P885, DOI 10.1113/jphysiol.2005.086736; Cohen I, 2002, SCIENCE, V298, P1418, DOI 10.1126/science.1076510; de la Prida LM, 2004, J NEUROSCI, V24, P5525, DOI 10.1523/JNEUROSCI.0309-04.2004; de la Prida LM, 2003, HIPPOCAMPUS, V13, P728, DOI 10.1002/hipo.10123; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Fabo D, 2008, BRAIN, V131, P485, DOI 10.1093/brain/awm297; Ferraguti F, 2006, CELL TISSUE RES, V326, P483, DOI 10.1007/s00441-006-0266-5; Fidzinski P, 2008, EUR J NEUROSCI, V27, P1111, DOI 10.1111/j.1460-9568.2008.06089.x; GEREAU RW, 1995, J NEUROSCI, V15, P6879; ISHIDA M, 1993, BRIT J PHARMACOL, V109, P1169, DOI 10.1111/j.1476-5381.1993.tb13745.x; Ishizuka N, 2001, J COMP NEUROL, V435, P89, DOI 10.1002/cne.1195; Kim Y, 2012, HIPPOCAMPUS, V22, P693, DOI 10.1002/hipo.20931; Knopp A, 2005, J COMP NEUROL, V483, P476, DOI 10.1002/cne.20460; Manzoni O, 1995, EUR J NEUROSCI, V7, P2518, DOI 10.1111/j.1460-9568.1995.tb01051.x; MASON A, 1993, BRAIN RES, V600, P174, DOI 10.1016/0006-8993(93)90418-M; Moore KA, 2003, P NATL ACAD SCI USA, V100, P14397, DOI 10.1073/pnas.1835831100; Naber PA, 2000, ANN NY ACAD SCI, V911, P392; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; O'Mara SM, 2001, PROG NEUROBIOL, V64, P129, DOI 10.1016/S0301-0082(00)00054-X; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; Price CJ, 2005, NEUROPHARMACOLOGY, V49, P45, DOI 10.1016/j.neuropharm.2005.05.009; Renger JJ, 2002, P NATL ACAD SCI USA, V99, P1041, DOI 10.1073/pnas.022618799; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Rogawski MA, 2011, EPILEPSY CURR, V11, P56, DOI 10.5698/1535-7511-11.2.56; Rosoklija G, 2000, ARCH GEN PSYCHIAT, V57, P349, DOI 10.1001/archpsyc.57.4.349; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schoepp DD, 2001, J PHARMACOL EXP THER, V299, P12; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Staff NP, 2000, J NEUROPHYSIOL, V84, P2398, DOI 10.1152/jn.2000.84.5.2398; Stewart M, 1997, BRAIN RES, V769, P71, DOI 10.1016/S0006-8993(97)00690-2; STEWART M, 1993, J NEUROPHYSIOL, V70, P232, DOI 10.1152/jn.1993.70.1.232; TAUBE JS, 1993, EXP BRAIN RES, V96, P304; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Wozny C, 2003, SCIENCE, V301, P463; Wozny C, 2008, J PHYSIOL-LONDON, V586, P2725, DOI 10.1113/jphysiol.2007.149203; Wozny C, 2008, J NEUROSCI, V28, P14358, DOI 10.1523/JNEUROSCI.4973-08.2008; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	44	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e45039	10.1371/journal.pone.0045039	http://dx.doi.org/10.1371/journal.pone.0045039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984605	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000308638700106
J	Pravincumar, P; Bader, DL; Knight, MM				Pravincumar, Priyanka; Bader, Dan L.; Knight, Martin M.			Viscoelastic Cell Mechanics and Actin Remodelling Are Dependent on the Rate of Applied Pressure	PLOS ONE			English	Article							ARTICULAR CHONDROCYTES; DEFORMATION; COMPRESSION; STRESS; CYTOSKELETON; NETWORKS; DYNAMICS; ORGANIZATION; BEHAVIOR; MODEL	Background: Living cells are subjected to external and internal mechanical stresses. The effects of these stresses on the deformation and subsequent biological response of the cells remains unclear. This study tested the hypothesis that the rate at which pressure (or stress) is applied influence the viscoelastic properties of the cell associated with differences in the dynamics of the actin cytoskeleton. Principal Finding: Micropipette aspiration was used to determine the instantaneous and equilibrium moduli and the viscosity of isolated chondrocytes based on the standard linear solid (SLS) model and a variation of this incorporating Boltzmann superposition. Cells were visualised for 180 seconds following aspiration to 7 cmH(2)O at 0.35, 0.70 and 5.48 cmH(2)O/sec. Cell recovery was then examined for a further 180 seconds once the pressure had been removed. Reducing the rate of application of pressure reduced the levels of cell deformation and recovery associated with a significant increase in modulus and viscosity. Using GFP transfection and confocal microscopy, we show that chondrocyte deformation involves distortion, disassembly and subsequent reassembly of the cortical actin cytoskeleton. At faster pressure rates, cell deformation produced an increase in cell volume associated with membrane bleb formation. GFP-actin transfection inhibited the pressure rate dependent variation in cell mechanics indicating that this behaviour is regulated by GFP-sensitive actin dynamics. Conclusion: We suggest that slower rates of aspiration pressure enable greater levels of cortical actin distortion. This is partially inhibited by GFP or faster aspiration rates leading to membrane bleb formation and an increase in cell volume. Thus the rate of application of pressure regulates the viscoelastic mechanical properties of living cells through pressure rate sensitive differences in actin dynamics. Therefore cells appear softer when aspirated at a faster rate in contrast to what is expected of a normal viscoelastic material.	[Pravincumar, Priyanka; Bader, Dan L.; Knight, Martin M.] Queen Mary Univ London, Sch Mat Sci & Engn, Inst Bioengn, London, England	University of London; Queen Mary University London	Pravincumar, P (corresponding author), Queen Mary Univ London, Sch Mat Sci & Engn, Inst Bioengn, London, England.	m.m.knight@qmul.ac.uk	Bader, Dan/ABF-1240-2020	Knight, Martin/0000-0003-3755-1597	UK Platform grant from the Engineering and Physical Sciences Research Council (EPSRC); Queen Mary University of London	UK Platform grant from the Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Queen Mary University of London	The research was partly supported by a UK Platform grant from the Engineering and Physical Sciences Research Council (EPSRC) entitled 'Mechanobiology for Tissue Engineering'. Priyanka Pravincumar is funded on a PhD studentship from Queen Mary University of London. No additional external funding was received for this study.	Bader DL, 2002, BIORHEOLOGY, V39, P69; BUSCHMANN MD, 1995, J CELL SCI, V108, P1497; Campbell JJ, 2007, MICROSC RES TECHNIQ, V70, P1034, DOI 10.1002/jemt.20513; Campbell JJ, 2007, BIOCHEM BIOPH RES CO, V361, P329, DOI 10.1016/j.bbrc.2007.06.185; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Chaudhuri O, 2007, NATURE, V445, P295, DOI 10.1038/nature05459; Chen C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012035; Darling EM, 2006, OSTEOARTHR CARTILAGE, V14, P571, DOI 10.1016/j.joca.2005.12.003; Darling EM, 2008, J BIOMECH, V41, P454, DOI 10.1016/j.jbiomech.2007.06.019; Deibler M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022941; DiPaolo BC, 2010, AM J PHYSIOL-CELL PH, V299, pC345, DOI 10.1152/ajpcell.00379.2009; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Guilak F, 1999, OSTEOARTHR CARTILAGE, V7, P59, DOI 10.1053/joca.1998.0162; Guilak F, 2002, BIOPHYS J, V82, P720, DOI 10.1016/S0006-3495(02)75434-9; Haider MA, 2002, J BIOMECH ENG-T ASME, V124, P586, DOI 10.1115/1.1504444; Humphrey D, 2002, NATURE, V416, P413, DOI 10.1038/416413; INGBER DE, 1994, INT REV CYTOL, V150, P173; Janmey PA, 2004, TRENDS BIOCHEM SCI, V29, P364, DOI 10.1016/j.tibs.2004.05.003; Jones WR, 1999, J BIOMECH, V32, P119, DOI 10.1016/S0021-9290(98)00166-3; Keller H, 2002, EXP CELL RES, V277, P161, DOI 10.1006/excr.2002.5552; Keller HU, 2000, CELL MOTIL CYTOSKEL, V46, P247, DOI 10.1002/1097-0169(200008)46:4<247::AID-CM2>3.0.CO;2-8; Ketelaar T, 2004, PLANT PHYSIOL, V136, P3990, DOI 10.1104/pp.104.050799; Knight MM, 2002, BBA-GEN SUBJECTS, V1570, P1, DOI 10.1016/S0304-4165(02)00144-7; Koay EJ, 2003, J BIOMECH ENG-T ASME, V125, P334, DOI 10.1115/1.1572517; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Laster SM, 1996, MICROSC RES TECHNIQ, V34, P272, DOI 10.1002/(SICI)1097-0029(19960615)34:3<272::AID-JEMT10>3.0.CO;2-J; Lee DA, 2000, BIORHEOLOGY, V37, P149; Leipzig ND, 2005, J BIOMECH, V38, P77, DOI 10.1016/j.jbiomech.2004.03.013; Lieleg O, 2009, CHEMPHYSCHEM, V10, P2813, DOI 10.1002/cphc.200900604; Loening AM, 2000, ARCH BIOCHEM BIOPHYS, V381, P205, DOI 10.1006/abbi.2000.1988; LUM H, 1994, AM J PHYSIOL, V267, pL223, DOI 10.1152/ajplung.1994.267.3.L223; Merryman WD, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3049821; Ofek G, 2010, BIOMECH MODEL MECHAN, V9, P153, DOI 10.1007/s10237-009-0166-1; Ohashi T, 2006, BIORHEOLOGY, V43, P201; SATO M, 1990, J BIOMECH ENG-T ASME, V112, P263, DOI 10.1115/1.2891183; SCHROEDER TE, 1978, DEV BIOL, V64, P342, DOI 10.1016/0012-1606(78)90085-4; THERET DP, 1988, J BIOMECH ENG-T ASME, V110, P190, DOI 10.1115/1.3108430; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Trickey WR, 2004, J ORTHOPAED RES, V22, P131, DOI 10.1016/S0736-0266(03)00150-5; Trickey WR, 2000, J ORTHOPAED RES, V18, P891, DOI 10.1002/jor.1100180607; Wu JZ, 2000, ANN BIOMED ENG, V28, P318, DOI 10.1114/1.271; Xu JY, 2000, J BIOL CHEM, V275, P35886, DOI 10.1074/jbc.M002377200; Zhao RG, 2009, J BIOMECH, V42, P2768, DOI 10.1016/j.jbiomech.2009.07.035	43	50	51	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43938	10.1371/journal.pone.0043938	http://dx.doi.org/10.1371/journal.pone.0043938			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984454	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000308638700035
J	Shapiro, RS; Zaas, AK; Betancourt-Quiroz, M; Perfect, JR; Cowen, LE				Shapiro, Rebecca S.; Zaas, Aimee K.; Betancourt-Quiroz, Marisol; Perfect, John R.; Cowen, Leah E.			The Hsp90 Co-Chaperone Sgt1 Governs Candida albicans Morphogenesis and Drug Resistance	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; ADENYLYL-CYCLASE; HYPHAL GROWTH; KINASE; IDENTIFICATION; EPIDEMIOLOGY; VIRULENCE; EVOLUTION; PATHWAY; CDC37	The molecular chaperone Hsp90 orchestrates regulatory circuitry governing fungal morphogenesis, biofilm development, drug resistance, and virulence. Hsp90 functions in concert with co-chaperones to regulate stability and activation of client proteins, many of which are signal transducers. Here, we characterize the first Hsp90 co-chaperone in the leading human fungal pathogen, Candida albicans. We demonstrate that Sgt1 physically interacts with Hsp90, and that it governs C. albicans morphogenesis and drug resistance. Genetic depletion of Sgt1 phenocopies depletion of Hsp90, inducing yeast to filament morphogenesis and invasive growth. Sgt1 governs these traits by bridging two morphogenetic regulators: Hsp90 and the adenylyl cyclase of the cAMP-PKA signaling cascade, Cyr1. Sgt1 physically interacts with Cyr1, and depletion of either Sgt1 or Hsp90 activates cAMP-PKA signaling, revealing the elusive link between Hsp90 and the PKA signaling cascade. Sgt1 also mediates tolerance and resistance to the two most widely deployed classes of antifungal drugs, azoles and echinocandins. Depletion of Sgt1 abrogates basal tolerance and acquired resistance to azoles, which target the cell membrane. Depletion of Sgt1 also abrogates tolerance and resistance to echinocandins, which target the cell wall, and renders echinocandins fungicidal. Though Sgt1 and Hsp90 have a conserved impact on drug resistance, the underlying mechanisms are distinct. Depletion of Hsp90 destabilizes the client protein calcineurin, thereby blocking crucial responses to drug-induced stress; in contrast, depletion of Sgt1 does not destabilize calcineurin, but blocks calcineurin activation in response to drug-induced stress. Sgt1 influences not only morphogenesis and drug resistance, but also virulence, as genetic depletion of C. albicans Sgt1 leads to reduced kidney fungal burden in a murine model of systemic infection. Thus, our characterization of the first Hsp90 co-chaperone in a fungal pathogen establishes C. albicans Sgt1 as a global regulator of morphogenesis and drug resistance, providing a new target for treatment of life-threatening fungal infections.	[Shapiro, Rebecca S.; Cowen, Leah E.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Zaas, Aimee K.; Betancourt-Quiroz, Marisol; Perfect, John R.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Zaas, Aimee K.; Perfect, John R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	University of Toronto; Duke University; Duke University	Shapiro, RS (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON, Canada.	leah.cowen@utoronto.ca	Shapiro, Rebecca/I-9247-2019	Shapiro, Rebecca/0000-0002-7119-8865; Betancourt Quiroz, Marisol/0000-0002-6920-9182; Cowen, Leah/0000-0001-5797-0110	Natural Sciences and Engineering Research Council of Canada (NSERC) CGS-D Award; Public Health Service [R01-AI73896]; Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund; Ministry of Research and Innovation Early Researcher Award; Canada Research Chair in Microbial Genomics and Infectious Disease; Canadian Institutes of Health Research Grant [MOP-86452]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073896] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada (NSERC) CGS-D Award; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ministry of Research and Innovation Early Researcher Award(Ministry of Research and Innovation, Ontario); Canada Research Chair in Microbial Genomics and Infectious Disease(Canada Research Chairs); Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RSS is supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) CGS-D Award; JRP by Public Health Service Grants R01-AI73896; LEC by a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund, by a Ministry of Research and Innovation Early Researcher Award, by a Canada Research Chair in Microbial Genomics and Infectious Disease, and by Canadian Institutes of Health Research Grant MOP-86452. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JB, 2005, NAT REV MICROBIOL, V3, P547, DOI 10.1038/nrmicro1179; Bachewich C, 2003, MOL BIOL CELL, V14, P2163, DOI 10.1091/mbc.02-05-0076; Bahn YS, 2003, MOL MICROBIOL, V50, P391, DOI 10.1046/j.1365-2958.2003.03692.x; Balashov SV, 2006, ANTIMICROB AGENTS CH, V50, P2058, DOI 10.1128/AAC.01653-05; BALDAUF SL, 1993, P NATL ACAD SCI USA, V90, P11558, DOI 10.1073/pnas.90.24.11558; Bansal PK, 2004, MOL CELL BIOL, V24, P8069, DOI 10.1128/MCB.24.18.8069-8079.2004; Berman J, 2006, CURR OPIN MICROBIOL, V9, P595, DOI 10.1016/j.mib.2006.10.007; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 2001, EMBO J, V20, P4753, DOI 10.1093/emboj/20.17.4753; Burt ET, 2003, ANN CLIN LAB SCI, V33, P86; Calderone RA., 2002, CANDIDA CANDIDIASIS; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Catlett MG, 2006, J BIOL CHEM, V281, P33739, DOI 10.1074/jbc.M603847200; Chen GB, 2012, NATURE, V482, P246, DOI 10.1038/nature10795; Correia JD, 2007, P NATL ACAD SCI USA, V104, P6764, DOI 10.1073/pnas.0610926104; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Cowen LE, 2008, EUKARYOT CELL, V7, P747, DOI 10.1128/EC.00041-08; Cowen LE, 2008, NAT REV MICROBIOL, V6, P187, DOI 10.1038/nrmicro1835; Cowen LE, 2009, P NATL ACAD SCI USA, V106, P2818, DOI 10.1073/pnas.0813394106; d'Enfert C, 2006, CURR DRUG TARGETS, V7, P465, DOI 10.2174/138945006776359458; Diezmann S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002562; Dubacq C, 2002, EUKARYOT CELL, V1, P568, DOI 10.1128/EC.1.4.568-582.2002; Fang HM, 2006, MOL MICROBIOL, V61, P484, DOI 10.1111/j.1365-2958.2006.05248.x; Flom GA, 2012, CURR GENET, V58, P149, DOI 10.1007/s00294-012-0373-7; GERBER MR, 1995, P NATL ACAD SCI USA, V92, P4651, DOI 10.1073/pnas.92.10.4651; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Hnisz D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000889; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Karababa M, 2006, MOL MICROBIOL, V59, P1429, DOI 10.1111/j.1365-2958.2005.05037.x; Kelly SL, 1997, FEBS LETT, V400, P80, DOI 10.1016/S0014-5793(96)01360-9; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Krueger KE, 2004, MICROBIOL-SGM, V150, P229, DOI 10.1099/mic.0.26792-0; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Kumar R, 2005, MOL BIOCHEM PARASIT, V141, P29, DOI 10.1016/j.molbiopara.2005.01.012; LaFayette SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001069; Leberer E, 2001, MOL MICROBIOL, V42, P673, DOI 10.1046/j.1365-2958.2001.02672.x; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Lingelbach LB, 2004, MOL CELL BIOL, V24, P8938, DOI 10.1128/MCB.24.20.8938-8950.2004; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Martins T, 2009, EMBO J, V28, P234, DOI 10.1038/emboj.2008.283; Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Pallavi R, 2010, J BIOL CHEM, V285, P37964, DOI 10.1074/jbc.M110.155317; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Perlin DS, 2007, DRUG RESIST UPDATE, V10, P121, DOI 10.1016/j.drup.2007.04.002; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Richard ML, 2005, EUKARYOT CELL, V4, P1493, DOI 10.1128/EC.4.8.1493-1502.2005; Robbins N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002257; Robbins N, 2010, FUNGAL GENET BIOL, V47, P81, DOI 10.1016/j.fgb.2009.07.004; Rocha CRC, 2001, MOL BIOL CELL, V12, P3631, DOI 10.1091/mbc.12.11.3631; Senn H, 2012, MOL BIOL CELL, V23, P268, DOI 10.1091/mbc.E11-08-0729; Shapiro RS, 2012, CURR BIOL, V22, P461, DOI 10.1016/j.cub.2012.01.062; Shapiro RS, 2011, MICROBIOL MOL BIOL R, V75, P213, DOI 10.1128/MMBR.00045-10; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Singh SD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000532; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Steensgaard P, 2004, EMBO REP, V5, P626, DOI 10.1038/sj.embor.7400154; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; WAINRIGHT PO, 1993, SCIENCE, V260, P340, DOI 10.1126/science.8469985; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wiederhold NP, 2008, ANTIMICROB AGENTS CH, V52, P4145, DOI 10.1128/AAC.00959-08; Wilson LS, 2002, VALUE HEALTH, V5, P26, DOI 10.1046/j.1524-4733.2002.51108.x; Xu XL, 2008, CELL HOST MICROBE, V4, P28, DOI 10.1016/j.chom.2008.05.014; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhu WD, 2010, CELL MICROBIOL, V12, P273, DOI 10.1111/j.1462-5822.2009.01412.x; Zuehlke A, 2010, BIOPOLYMERS, V93, P211, DOI 10.1002/bip.21292	72	63	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44734	10.1371/journal.pone.0044734	http://dx.doi.org/10.1371/journal.pone.0044734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970302	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400116
J	Aynaud, MM; Suspene, R; Vidalain, PO; Mussil, B; Guetard, D; Tangy, F; Wain-Hobson, S; Vartanian, JP				Aynaud, Marie-Ming; Suspene, Rodolphe; Vidalain, Pierre-Olivier; Mussil, Bianka; Guetard, Denise; Tangy, Frederic; Wain-Hobson, Simon; Vartanian, Jean-Pierre			Human Tribbles 3 Protects Nuclear DNA from Cytidine Deamination by APOBEC3A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-B-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; SOMATIC HYPERMUTATION; HUMAN HEPATOCYTES; EDITING ENZYMES; VIF PROTEIN; CELL-DEATH; HIV-1 DNA; IN-VIVO; EXPRESSION	The human polydeoxynucleotide cytidine deaminases APOBEC3A, APOBEC3C, and APOBEC3H are capable of mutating viral DNA in the nucleus, whereas APOBEC3A alone efficiently edits nuclear DNA. Deamination is rapidly followed by excision of uracil residues and can lead to double-stranded breaks. It is not known to which protein networks these DNA mutators belong. Using a yeast two-hybrid screen, we identified the human homolog of Drosophila Tribbles 3, TRIB3, as an interactor for APOBEC3A and APOBEC3C. The interaction was confirmed by co-affinity purification. Co-transfection of APOBEC3A with a TRIB3 expression vector reduced nuclear DNA editing whereas siRNA knockdown of TRIB3 increased the levels of nuclear DNA editing, indicating that TRIB3 functioned as a repressor of A3A. It also repressed A3A-associated gamma H2AX positive double-stranded breaks. The interaction results in degradation of A3A in a proteasome-independent manner. TRIB3 has been linked to cancer and via its own interactors and links the A3A DNA mutators to the Rb-BRCA1-ATM network. TRIB3 emerges as an important guardian of genome integrity.	[Aynaud, Marie-Ming; Suspene, Rodolphe; Mussil, Bianka; Guetard, Denise; Wain-Hobson, Simon; Vartanian, Jean-Pierre] Inst Pasteur, CNRS URA3015, Mol Retrovirol Unit, F-75724 Paris 15, France; [Vidalain, Pierre-Olivier; Tangy, Frederic] Inst Pasteur, CNRS URA3015, Viral Genom & Vaccinat Unit, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wain-Hobson, S (corresponding author), Inst Pasteur, CNRS URA3015, Mol Retrovirol Unit, 28 Rue Dr Roux, F-75724 Paris 15, France.	simon.wain-hobson@pasteur.fr	Vidalain, Pierre-Olivier/F-9778-2019	Vidalain, Pierre-Olivier/0000-0003-3082-7407; Vartanian, Jean-Pierre/0000-0001-8079-8814	Institut Pasteur; CNRS; la Ligue pour la Recherche contre le Cancer; l'Association pour la Recherche contre le Cancer	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); la Ligue pour la Recherche contre le Cancer; l'Association pour la Recherche contre le Cancer	This work was supported by grants from Institut Pasteur and the CNRS. The Molecular Retrovirology Unit is equipe labellise par la Ligue pour la Recherche contre le Cancer.; Supported by a graduate fellowship from la Ligue pour la Recherche contre le Cancer.; Supported by a postdoctoral fellowship from l'Association pour la Recherche contre le Cancer.	Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Bross L, 2002, J EXP MED, V195, P1187, DOI 10.1084/jem.20011749; Bulliard Y, 2011, J VIROL, V85, P1765, DOI 10.1128/JVI.01651-10; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Chinnadurai G, 2006, BBA-REV CANCER, V1765, P67, DOI 10.1016/j.bbcan.2005.09.002; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hasham MG, 2010, NAT IMMUNOL, V11, P820, DOI 10.1038/ni.1909; Hegedus Z, 2007, CELL SIGNAL, V19, P238, DOI 10.1016/j.cellsig.2006.06.010; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Humphrey RK, 2010, J BIOL CHEM, V285, P22426, DOI 10.1074/jbc.M110.123786; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Komori J, 2008, HEPATOLOGY, V47, P888, DOI 10.1002/hep.22125; Koning FA, 2009, J VIROL, V83, P9474, DOI 10.1128/JVI.01089-09; Kou T, 2007, INT J CANCER, V120, P469, DOI 10.1002/ijc.22292; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Mayumi-Matsuda K, 1999, BIOCHEM BIOPH RES CO, V258, P260, DOI 10.1006/bbrc.1999.0576; Mendoza JA, 2006, J VIROL, V80, P12420, DOI 10.1128/JVI.02576-05; Noguchi C, 2005, HEPATOLOGY, V41, P626, DOI 10.1002/hep.20580; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Refsland EW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002800; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Renehan AG, 2012, DIABETOLOGIA, V55, P1619, DOI 10.1007/s00125-012-2526-0; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rosler C, 2005, HEPATOLOGY, V42, P301, DOI 10.1002/hep.20801; Sakai S, 2010, BIOL PHARM BULL, V33, P1112, DOI 10.1248/bpb.33.1112; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Smith SM, 2011, J IMMUNOL, V186, P2462, DOI 10.4049/jimmunol.1000864; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; Takai A, 2009, ONCOGENE, V28, P469, DOI 10.1038/onc.2008.415; Tsuge M, 2010, VIRUS RES, V149, P211, DOI 10.1016/j.virusres.2010.01.019; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; WANG ZG, 1988, J BACTERIOL, V170, P1082, DOI 10.1128/jb.170.3.1082-1091.1988; Wiegand HL, 2004, EMBO J, V23, P2451, DOI 10.1038/sj.emboj.7600246; Xu JM, 2007, BBA-GEN SUBJECTS, V1770, P273, DOI 10.1016/j.bbagen.2006.09.025; Wasef SZY, 2006, AM J PHYSIOL-ENDOC M, V291, pE1274, DOI 10.1052/ajpendo.00117.2006; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	61	51	60	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39182	39192		10.1074/jbc.M112.372722	http://dx.doi.org/10.1074/jbc.M112.372722			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22977230	hybrid, Green Published			2022-12-25	WOS:000310982800073
J	Ulrich, JD; Kim, MS; Houlihan, PR; Shutov, LP; Mohapatra, DP; Strack, S; Usachev, YM				Ulrich, Jason D.; Kim, Man-Su; Houlihan, Patrick R.; Shutov, Leonid P.; Mohapatra, Durga P.; Strack, Stefan; Usachev, Yuriy M.			Distinct Activation Properties of the Nuclear Factor of Activated T-cells (NFAT) Isoforms NFATc3 and NFATc4 in Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; TRANSCRIPTION FACTOR NFAT; CALCINEURIN BINDING-SITE; GENE-EXPRESSION; DEPENDENT TRANSCRIPTION; CREB PHOSPHORYLATION; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; NEURAL DEVELOPMENT; CARDIAC MYOCYTES	The Ca2+/calcineurin-dependent transcription factor NFAT (nuclear factor of activated T-cells) is implicated in regulating dendritic and axonal development, synaptogenesis, and neuronal survival. Despite the increasing appreciation for the importance of NFAT-dependent transcription in the nervous system, the regulation and function of specific NFAT isoforms in neurons are poorly understood. Here, we compare the activation of NFATc3 and NFATc4 in hippocampal and dorsal root ganglion neurons following electrically evoked elevations of intracellular Ca2+ concentration ([Ca2+](i)). We find that NFATc3 undergoes rapid dephosphorylation and nuclear translocation that are essentially complete within 20 min, although NFATc4 remains phosphorylated and localized to the cytosol, only exhibiting nuclear localization following prolonged (1-3 h) depolarization. Knocking down NFATc3, but not NFATc4, strongly diminished NFAT-mediated transcription induced by mild depolarization in neurons. By analyzing NFATc3/NFATc4 chimeras, we find that the region containing the serine-rich region-1 (SRR1) mildly affects initial NFAT translocation, although the region containing the serine-proline repeats is critical for determining the magnitude of NFAT activation and nuclear localization upon depolarization. Knockdown of glycogen synthase kinase 3 beta (GSK3 beta) significantly increased the depolarization-induced nuclear localization of NFATc4. In contrast, inhibition of p38 or mammalian target of rapamycin (mTOR) kinases had no significant effect on nuclear import of NFATc4. Thus, electrically evoked [Ca2+](i) elevation in neurons rapidly and strongly activates NFATc3, whereas activation of NFATc4 requires a coincident increase in [Ca2+](i) and suppression of GSK3 beta, with differences in the serine-proline-containing region giving rise to these distinct activation properties of NFATc3 and NFATc4.	[Ulrich, Jason D.; Kim, Man-Su; Houlihan, Patrick R.; Shutov, Leonid P.; Mohapatra, Durga P.; Strack, Stefan; Usachev, Yuriy M.] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA; [Kim, Man-Su] Inje Univ, Coll Pharm, Gimhae, South Korea	University of Iowa; Inje University	Usachev, YM (corresponding author), Univ Iowa, Dept Pharmacol, Carver Coll Med, 2-250 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	yuriy-usachev@uiowa.edu	Mohapatra, Durga/M-2133-2017	Mohapatra, Durga/0000-0001-5016-1281; Strack, Stefan/0000-0002-6175-7280; Usachev, Yuriy/0000-0002-6948-4627	National Institutes of Health [NS054614, NS072432, NS043254, NS056244, NS069898]; NRSA [F31 MH081420]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067795] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH081420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS056244, R01NS043254, R01NS056244, R01NS054614, R01NS072432, R01NS069898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS054614 and NS072432 (to Y.M.U.), NS043254 and NS056244 (to S. S.), NS069898 (to D. P. M.), and F31 MH081420 from NRSA (to J.D.U.).	Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Benedito AB, 2005, J BIOL CHEM, V280, P2818, DOI 10.1074/jbc.M408741200; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bushdid PB, 2003, CIRC RES, V92, P1305, DOI 10.1161/01.RES.0000077045.84609.9F; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chow CW, 1997, SCIENCE, V278, P1638, DOI 10.1126/science.278.5343.1638; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; del Arco PG, 2000, J BIOL CHEM, V275, P13872, DOI 10.1074/jbc.275.18.13872; Dolmetsch Ricardo, 2003, Sci STKE, V2003, pPE4; Gomez-Sintes R, 2010, J CLIN INVEST, V120, P2432, DOI 10.1172/JCI37873; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Groth RD, 2008, EUR J NEUROSCI, V27, P31, DOI 10.1111/j.1460-9568.2007.05980.x; Groth RD, 2007, J NEUROCHEM, V102, P1162, DOI 10.1111/j.1471-4159.2007.04632.x; Groth RD, 2003, J NEUROSCI, V23, P8125; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Hudry E, 2012, J NEUROSCI, V32, P3176, DOI 10.1523/JNEUROSCI.6439-11.2012; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Ichida M, 2001, J BIOL CHEM, V276, P3524, DOI 10.1074/jbc.M004275200; Jackson JG, 2007, MOL PHARMACOL, V72, P303, DOI 10.1124/mol.107.035048; Jayanthi S, 2005, P NATL ACAD SCI USA, V102, P868, DOI 10.1073/pnas.0404990102; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kim MS, 2009, J NEUROSCI, V29, P12101, DOI 10.1523/JNEUROSCI.3384-09.2009; Layne JJ, 2008, AM J PHYSIOL-CELL PH, V295, pC611, DOI 10.1152/ajpcell.00435.2007; Li HM, 2004, J MOL BIOL, V342, P1659, DOI 10.1016/j.jmb.2004.07.068; Liu J, 1999, J IMMUNOL, V162, P4755; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Luoma JI, 2008, J NEUROSCI, V28, P3159, DOI 10.1523/JNEUROSCI.5227-07.2008; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Martinez-Martinez S, 2006, J BIOL CHEM, V281, P6227, DOI 10.1074/jbc.M513885200; Martinez-Martinez S, 2004, CURR MED CHEM, V11, P997, DOI 10.2174/0929867043455576; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Muller MR, 2009, P NATL ACAD SCI USA, V106, P7034, DOI 10.1073/pnas.0813296106; Nguyen T, 2008, INT J DEV NEUROSCI, V26, P141, DOI 10.1016/j.ijdevneu.2007.10.004; Nguyen T, 2009, J BIOL CHEM, V284, P18816, DOI 10.1074/jbc.M109.015719; Nieves-Cintron M, 2007, J BIOL CHEM, V282, P3231, DOI 10.1074/jbc.M608822200; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Park S, 2000, P NATL ACAD SCI USA, V97, P7130, DOI 10.1073/pnas.97.13.7130; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; PITTMAN RN, 1993, J NEUROSCI, V13, P3669; Rinne A, 2010, AM J PHYSIOL-HEART C, V298, pH2001, DOI 10.1152/ajpheart.01072.2009; Rossow CF, 2004, CIRC RES, V94, P1340, DOI 10.1161/01.RES.0000128406.08418.34; Santana LF, 2008, CIRC RES, V103, P681, DOI 10.1161/CIRCRESAHA.108.185090; Schwartz N, 2009, NEURON, V62, P655, DOI 10.1016/j.neuron.2009.05.007; Sharma S, 2011, P NATL ACAD SCI USA, V108, P11381, DOI 10.1073/pnas.1019711108; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; Shen TS, 2006, MOL BIOL CELL, V17, P1570, DOI 10.1091/mbc.E05-08-0780; Sheridan CM, 2002, J BIOL CHEM, V277, P48664, DOI 10.1074/jbc.M207029200; Soutar MPM, 2010, J NEUROCHEM, V115, P974, DOI 10.1111/j.1471-4159.2010.06988.x; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Usachev YM, 1999, J PHYSIOL-LONDON, V519, P115, DOI 10.1111/j.1469-7793.1999.0115o.x; Vashishta A, 2009, J NEUROSCI, V29, P15331, DOI 10.1523/JNEUROSCI.4873-09.2009; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010; Yang TTC, 2008, MOL CELL BIOL, V28, P3489, DOI 10.1128/MCB.01847-07; Yang TTC, 2002, MOL CELL BIOL, V22, P3892, DOI 10.1128/MCB.22.11.3892-3904.2002; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zhou WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043262; Zhu JY, 1999, NATURE, V398, P256, DOI 10.1038/18473; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	81	29	29	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.365197	http://dx.doi.org/10.1074/jbc.M112.365197			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977251	Green Published, hybrid			2022-12-25	WOS:000310642200002
J	Lin, AHM; Lee, BH; Nichols, BL; Quezada-Calvillo, R; Rose, DR; Naim, HY; Hamaker, BR				Lin, Amy Hui-Mei; Lee, Byung-Hoo; Nichols, Buford L.; Quezada-Calvillo, Roberto; Rose, David R.; Naim, Hassan Y.; Hamaker, Bruce R.			Starch Source Influences Dietary Glucose Generation at the Mucosal alpha-Glucosidase Level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL MALTASE-GLUCOAMYLASE; SUBSTRATE BRAKE; CHAIN-LENGTH; DIGESTION; INHIBITION	The quality of starch digestion, related to the rate and extent of release of dietary glucose, is associated with glycemia-related problems such as diabetes and other metabolic syndrome conditions. Here, we found that the rate of glucose generation from starch is unexpectedly associated with mucosal alpha-glucosidases and not just alpha-amylase. This understanding could lead to a new approach to regulate the glycemic response and glucose-related physiologic responses in the human body. There are six digestive enzymes for starch: salivary and pancreatic alpha-amylases and four mucosal alpha-glucosidases, including N- and C-terminal subunits of both maltase-glucoamylase and sucrase-isomaltase. Only the mucosal alpha-glucosidases provide the final hydrolytic activities to produce substantial free glucose. We report here the unique and shared roles of the individual alpha-glucosidases for alpha-glucans persisting after starch is extensively hydrolyzed by alpha-amylase (to produce alpha-limit dextrins (alpha-LDx)). All four alpha-glucosidases share digestion of linear regions of alpha-LDx, and three can hydrolyze branched fractions. The alpha-LDx, which were derived from different maize cultivars, were not all equally digested, revealing that the starch source influences glucose generation at the mucosal alpha-glucosidase level. We further discovered a fraction of alpha-LDx that was resistant to the extensive digestion by the mucosal alpha-glucosidases. Our study further challenges the conventional view that alpha-amylase is the only rate-determining enzyme involved in starch digestion and better defines the roles of individual and collective mucosal alpha-glucosidases. Strategies to control the rate of glucogenesis at the mucosal level could lead to regulation of the glycemic response and improved glucose management in the human body.	[Lin, Amy Hui-Mei; Lee, Byung-Hoo; Hamaker, Bruce R.] Purdue Univ, Whistler Ctr Carbohydrate Res, W Lafayette, IN 47907 USA; [Lin, Amy Hui-Mei; Lee, Byung-Hoo; Hamaker, Bruce R.] Purdue Univ, Dept Food Sci, W Lafayette, IN 47907 USA; [Nichols, Buford L.; Quezada-Calvillo, Roberto] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Nichols, Buford L.; Quezada-Calvillo, Roberto] Baylor Univ, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Rose, David R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Naim, Hassan Y.] Univ Vet Med Hannover, Inst Physiol Chem, D-30559 Hannover, Germany	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Baylor College of Medicine; Baylor University; United States Department of Agriculture (USDA); University of Waterloo; University of Veterinary Medicine Hannover, Foundation	Lin, AHM (corresponding author), Purdue Univ, Whistler Ctr Carbohydrate Res, 745 Agr Mall Dr, W Lafayette, IN 47907 USA.	amylin@purdue.edu; hamakerb@purdue.edu	Yoo, Sang-Ho/AAI-4446-2020		Whistler Center for Carbohydrate Research; United States Department of Agriculture/Agricultural Research Service (USDA/ARS) [6250-51000-052]; Heart and Stroke Foundation of Ontario [NA-6305]; Canadian Institutes of Health Research [MOP 111237]; National Institutes of Health [DK58338]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R13DK058338] Funding Source: NIH RePORTER	Whistler Center for Carbohydrate Research; United States Department of Agriculture/Agricultural Research Service (USDA/ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Whistler Center for Carbohydrate Research and in part by United States Department of Agriculture/Agricultural Research Service (USDA/ARS) Grant 6250-51000-052, Heart and Stroke Foundation of Ontario Grant NA-6305, and Canadian Institutes of Health Research Grant MOP 111237. Part of this work was carried by at the Texas Medical Center Digestive Diseases Center (supported by National Institutes of Health Grant DK58338).	Ao ZH, 2007, J AGR FOOD CHEM, V55, P4540, DOI 10.1021/jf063123x; ENGLYST HN, 1992, EUR J CLIN NUTR, V46, pS33; Eskandari R, 2011, CHEM-EUR J, V17, P14817, DOI 10.1002/chem.201102109; FUWA H, 1987, STARCH-STARKE, V39, P295, DOI 10.1002/star.19870390902; Hizukuri S., 1996, CARBOHYDRATES FOOD, P347; Lee BH, 2012, J BIOL CHEM, V287, P31929, DOI 10.1074/jbc.M112.351858; Lin AHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035473; Nelson N, 1944, J BIOL CHEM, V153, P375; Quezada-Calvillo R, 2008, J NUTR, V138, P685, DOI 10.1093/jn/138.4.685; Quezada-Calvillo R, 2007, J PEDIATR GASTR NUTR, V45, P32, DOI 10.1097/MPG.0b013e31804216fc; ROBYT J, 1963, ARCH BIOCHEM BIOPHYS, V100, P451, DOI 10.1016/0003-9861(63)90112-7; SIDDONS RC, 1970, BIOCHEM J, V116, P71, DOI 10.1042/bj1160071; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; Sim L, 2010, BIOCHEMISTRY-US, V49, P443, DOI 10.1021/bi9016457; TRINDER P, 1969, J CLIN PATHOL, V22, P246, DOI 10.1136/jcp.22.2.246-b; YUAN RC, 1993, CEREAL CHEM, V70, P81	17	38	39	0	49	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36917	36921		10.1074/jbc.M112.378331	http://dx.doi.org/10.1074/jbc.M112.378331			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22988246	Green Published, hybrid			2022-12-25	WOS:000310588500028
J	Hsu, CW; Chuang, SM; Wu, WL; Hou, MH				Hsu, Chun-Wei; Chuang, Show-Mei; Wu, Wen-Ling; Hou, Ming-Hon			The Crucial Role of Divalent Metal Ions in the DNA-Acting Efficacy and Inhibition of the Transcription of Dimeric Chromomycin A3	PLOS ONE			English	Article							BINDING DRUGS MITHRAMYCIN; IN-VITRO; C-MYC; COMPLEX; A(3); CLEAVAGE; ANALOGS; CYTOTOXICITY; SPECIFICITY; POLYAMINES	Chromomycin A3 (Chro) is capable of forming a stable dimeric complex via chelation with Ni(II), Fe(II) and Co(II). According to the circular dichroism study, the dimer conformations are significantly different among the Fe(II)-, Co(II)-, and Ni(II)containing dimeric Chro complexes; however, the dimer conformations were preserved at high temperatures. Furthermore, we conducted a systematic study to determine the effects of these divalent metal ions on the DNA-acting efficacy of dimeric Chro, including its DNA-binding affinity, DNA stabilization capacity, DNA cleavage activity, and the inhibition of transcription both in vitro and within cells. Kinetic analyses using surface plasmon resonance (SPR) showed that Ni-II(Chro)(2) exhibited the highest K-a with a value of 1.26 x 10(7) M-1, which is approximately 1.6- and 3.7-fold higher than the K-a values obtained for Co-II(Chro)(2) and Fe-II(Chro)(2), respectively. The T-m and Delta(G) values for the DNA duplex increased after the addition of drug complexes in the following order: Ni-II(Chro)(2)>Co-II(Chro)(2)>Fe-II(Chro)(2). In the DNA integrity assays, the DNA cleavage rate of Co-II(Chro)(2) (1.26 x 10(-3) s(-1)) is higher than those of Fe-II(Chro)(2) and Ni-II(Chro)(2), which were calculated to be 1 x 10(-4) and 3.1 x 10(-4) s(-1), respectively. Consistent with the SPR and UV melting results, Ni-II(Chro)(2) possesses the highest inhibitory effect on in vitro transcription and c-myc transcription within cells compared to Co-II(Chro)(2) and Fe-II(Chro)(2). By comparing the cytotoxicity among Co-II(Chro)(2), Fe-II(Chro)(2), and Ni-II(Chro)(2) to several cancer cell lines, our studies concluded that Ni-II(Chro)(2) displayed more potential antitumor activities than Co-II(Chro)(2) and Fe-II(Chro)(2) did due to its higher DNA-acting efficacy. Changes to the divalent metal ions in the dimeric Chro complexes have been correlated with improved anticancer profiles. The availability of new metal derivatives of Chro may introduce new possibilities for exploiting the unique properties of this class of compounds for therapeutic applications.	[Hsu, Chun-Wei; Wu, Wen-Ling; Hou, Ming-Hon] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan; [Chuang, Show-Mei] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Wu, Wen-Ling; Hou, Ming-Hon] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan; [Hou, Ming-Hon] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University	Hsu, CW (corresponding author), Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan.	mhho@dragon.nchu.edu.tw		Chuang, Show-Mei/0000-0003-2986-0736; Hou, Ming-hon/0000-0003-4170-1527	NSC (National Science Council) [100-2113-M-005-004-MY3]	NSC (National Science Council)(Ministry of Science and Technology, Taiwan)	This work was supported by the NSC (National Science Council) grant 100-2113-M-005-004-MY3 to M-HH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICH P, 1992, BIOCHEMISTRY-US, V31, P2988, DOI 10.1021/bi00126a021; Barcelo F, 2010, BIOCHEMISTRY-US, V49, P10543, DOI 10.1021/bi101398s; Bianchi N, 1997, BIOCHEM J, V326, P919, DOI 10.1042/bj3260919; Bianchi N, 1999, BRIT J HAEMATOL, V104, P258, DOI 10.1046/j.1365-2141.1999.01173.x; CAMPBELL VW, 1994, AM J MED SCI, V307, P167, DOI 10.1097/00000441-199403000-00002; CANTOR CR, 1965, J MOL BIOL, V13, P65, DOI 10.1016/S0022-2836(65)80080-8; Chakrabarti S, 2000, J BIOMOL STRUCT DYN, V18, P209, DOI 10.1080/07391102.2000.10506659; Chang YM, 2012, INT J MOL SCI, V13, P3394, DOI 10.3390/ijms13033394; Chatterjee S, 2001, ANN NEUROL, V49, P345, DOI 10.1002/ana.71.abs; Chen SX, 2011, BIOCHEMISTRY-US, V50, P9340, DOI 10.1021/bi201291p; CONS BMG, 1989, BIOCHEM BIOPH RES CO, V160, P517, DOI 10.1016/0006-291X(89)92463-7; Devi PG, 2007, J INORG BIOCHEM, V101, P127, DOI 10.1016/j.jinorgbio.2006.08.018; DUPRIEST RW, 1973, ONCOLOGY-BASEL, V28, P147; FOLEY JF, 1972, J UROLOGY, V108, P439, DOI 10.1016/S0022-5347(17)60765-1; Gambari R, 2000, J PHARMACOL EXP THER, V294, P370; GAO XL, 1992, J MOL BIOL, V223, P259, DOI 10.1016/0022-2836(92)90730-8; Gao Y, 2011, CANCER RES, V71, P5182, DOI 10.1158/0008-5472.CAN-10-2016; Gochin M, 2000, STRUCT FOLD DES, V8, P441, DOI 10.1016/S0969-2126(00)00124-6; HARDENBOL P, 1992, BIOCHEM BIOPH RES CO, V185, P553, DOI 10.1016/0006-291X(92)91660-I; Hou MH, 2005, NUCLEIC ACIDS RES, V33, P1352, DOI 10.1093/nar/gki276; Hou MH, 2004, NUCLEIC ACIDS RES, V32, P2214, DOI 10.1093/nar/gkh549; Hou MH, 2001, NUCLEIC ACIDS RES, V29, P5121, DOI 10.1093/nar/29.24.5121; Hou MH, 2008, BIOCHEMISTRY-US, V47, P5493, DOI 10.1021/bi701915f; Hou MH, 2009, BIOCHEMISTRY-US, V48, P4691, DOI 10.1021/bi900092w; Huang HW, 1995, BIOCHIMIE, V77, P729, DOI 10.1016/0300-9084(96)88190-9; ITZHAKI L, 1990, BIOPOLYMERS, V29, P481, DOI 10.1002/bip.360290303; KENIRY MA, 1993, J MOL BIOL, V231, P753, DOI 10.1006/jmbi.1993.1324; Lahiri S, 2012, BIOMETALS, V25, P435, DOI 10.1007/s10534-011-9516-4; Lai Michael M. C., 2001, Antiviral Chemistry and Chemotherapy, V12, P143; Lu WJ, 2009, J INORG BIOCHEM, V103, P1626, DOI 10.1016/j.jinorgbio.2009.09.003; Majee S, 1997, BIOCHEMISTRY-US, V36, P2291, DOI 10.1021/bi9613281; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; Merkel O, 2012, LEUKEMIA; Ming LJ, 2003, MED RES REV, V23, P697, DOI 10.1002/med.10052; Piestrzeniewicz M, 1998, ACTA BIOCHIM POL, V45, P127, DOI 10.18388/abp.1998_4295; Remsing LL, 2003, BIOCHEMISTRY-US, V42, P8313, DOI 10.1021/bi034091z; REUSSER F, 1975, BIOCHIM BIOPHYS ACTA, V383, P266, DOI 10.1016/0005-2787(75)90055-6; Rey NA, 2009, J INORG BIOCHEM, V103, P1323, DOI 10.1016/j.jinorgbio.2009.05.008; Safe S, 2005, EUR J CANCER, V41, P2438, DOI 10.1016/j.ejca.2005.08.006; SASTRY M, 1995, J MOL BIOL, V251, P674, DOI 10.1006/jmbi.1995.0464; SASTRY M, 1993, BIOCHEMISTRY-US, V32, P6588, DOI 10.1021/bi00077a012; Scott D, 2011, INT J NANOMED, V6, P2757, DOI 10.2147/IJN.S25427; Seznec J, 2011, J NEURO-ONCOL, V101, P365, DOI 10.1007/s11060-010-0266-x; SHIRAISHI H, 1993, FREE RADICAL RES COM, V19, P315, DOI 10.3109/10715769309056520; Slavik M, 1975, Adv Pharmacol Chemother, V12, P1, DOI 10.1016/S1054-3589(08)60218-5; Song YM, 2006, J INORG BIOCHEM, V100, P1685, DOI 10.1016/j.jinorgbio.2006.06.001; Wang HF, 2009, EUR J MED CHEM, V44, P4509, DOI 10.1016/j.ejmech.2009.06.019; WHITE RJ, 1989, BIOCHEMISTRY-US, V28, P4277, DOI 10.1021/bi00436a024; Yuann JMP, 2012, BBA-PROTEINS PROTEOM, V1824, P1009, DOI 10.1016/j.bbapap.2012.05.011; ZAJAC AJ, 1985, CLIN EXP RHEUMATOL, V3, P75; Zihlif Malek, 2010, Cancer Genomics & Proteomics, V7, P323	51	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43792	10.1371/journal.pone.0043792	http://dx.doi.org/10.1371/journal.pone.0043792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984445	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500023
J	Morrison, C; Simpkins, C; Castley, JG; Buckley, RC				Morrison, Clare; Simpkins, Clay; Castley, J. Guy; Buckley, Ralf C.			Tourism and the Conservation of Critically Endangered Frogs	PLOS ONE			English	Article							PROTECTED AREAS; RELATIVE IMPORTANCE; NATIONAL-PARK; BIODIVERSITY; COSTS; BENEFITS; COVERAGE; PAY	Protected areas are critical for the conservation of many threatened species. Despite this, many protected areas are acutely underfunded, which reduces their effectiveness significantly. Tourism is one mechanism to promote and fund conservation in protected areas, but there are few studies analyzing its tangible conservation outcomes for threatened species. This study uses the 415 IUCN critically endangered frog species to evaluate the contribution of protected area tourism revenue to conservation. Contributions were calculated for each species as the proportion of geographic range inside protected areas multiplied by the proportion of protected area revenues derived from tourism. Geographic ranges were determined from IUCN Extent of Occurrence maps. Almost 60% (239) of critically endangered frog species occur in protected areas. Higher proportions of total range are protected in Nearctic, Australasian and Afrotopical regions. Tourism contributions to protected area budgets ranged from 5-100%. These financial contributions are highest for developing countries in the Afrotropical, Indomalayan and Neotropical regions. Data for both geographic range and budget are available for 201 critically endangered frog species with proportional contributions from tourism to species protection ranging from 0.8-99%. Tourism's financial contributions to critically endangered frog species protection are highest in the Afrotropical region. This study uses a coarse measure but at the global scale it demonstrates that tourism has significant potential to contribute to global frog conservation efforts.	[Morrison, Clare; Castley, J. Guy; Buckley, Ralf C.] Griffith Univ, Griffith Sch Environm, Int Ctr Ecotourism Res, Nathan, Qld 4111, Australia; [Simpkins, Clay] Griffith Univ, Griffith Sch Environm, Environm Futures Ctr, Nathan, Qld 4111, Australia	Griffith University; Griffith University	Morrison, C (corresponding author), Griffith Univ, Griffith Sch Environm, Int Ctr Ecotourism Res, Nathan, Qld 4111, Australia.	c.morrison@griffith.edu.au	Castley, James Guy/A-7056-2010; Buckley, Ralf/G-7032-2014	Castley, James Guy/0000-0002-8418-5828; Buckley, Ralf/0000-0003-0442-5818	Griffith University in the Area of Strategic Investment in Sustainable Tourism	Griffith University in the Area of Strategic Investment in Sustainable Tourism	Funding for this project was provided by Griffith University in the Area of Strategic Investment in Sustainable Tourism. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, SUSTAINABLE FINANCIN; [Anonymous], 2010, CONSERVATION TOURISM; Balmford A, 2003, ORYX, V37, P238, DOI 10.1017/S0030605303000413; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Biggs D., 2011, Conservation and Society, V9, P80, DOI 10.4103/0972-4923.79198; Bovarnick A, 2010, FINANCIAL SUSTAINABI; Brooks TM, 2004, BIOSCIENCE, V54, P1081, DOI 10.1641/0006-3568(2004)054[1081:CPBTGP]2.0.CO;2; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; Buckley R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000143; Buckley RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044134; Castley G, 2010, CONSERVATION TOURISM, P145, DOI 10.1079/9781845936655.0145; Convention on Biological Diversity, 2011, PREAMBL CONV BIOL DI; Eagles P, 2008, 2 M AD HOC OP END WO; Eagles P. F., 2002, SUSTAINABLE TOURISM; Flores M, 2008, FINANCIAL PLANNING N; Fuller RA, 2010, NATURE, V466, P365, DOI 10.1038/nature09180; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Hall CM, 2010, J HERIT TOUR, V5, P253, DOI 10.1080/1743873X.2010.517843; Hayward MW, 2011, BIODIVERS CONSERV, V20, P2563, DOI 10.1007/s10531-011-0091-3; Herbert ME, 2010, CONSERV BIOL, V24, P1002, DOI 10.1111/j.1523-1739.2010.01460.x; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Isaacs JC, 2000, WILDLIFE SOC B, V28, P61; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Kuenzi C, 2008, INT RISK GOV COUNC B, V1, P155; Loucks C, 2008, J BIOGEOGR, V35, P1337, DOI 10.1111/j.1365-2699.2008.01899.x; Mbaiwa JE, 2003, J ARID ENVIRON, V54, P447, DOI 10.1006/jare.2002.1101; McKinney ML, 2002, CONSERV BIOL, V16, P539, DOI 10.1046/j.1523-1739.2002.00442.x; Naidoo R, 2005, P NATL ACAD SCI USA, V102, P16712, DOI 10.1073/pnas.0508036102; Okello MM, 2008, TOURISM MANAGE, V29, P751, DOI 10.1016/j.tourman.2007.08.003; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Rodrigues ASL, 2011, ANIM CONSERV, V14, P108, DOI 10.1111/j.1469-1795.2011.00451.x; Rodrigues Ana S.L., 2008, P125; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Saunders DL, 2002, CONSERV BIOL, V16, P30, DOI 10.1046/j.1523-1739.2002.99562.x; Steven R, 2011, THESIS GRIFFITH U AU; Tisdell C., 2001, Tourism Economics, V7, P233; Turpie J., 2010, SUSTAINABLE FINANCIN; UNDP (United Nations Development Program), 2011, ENV EN PROT AR; United Nations World Tourism Organisation, 2011, TOUR HIGHL; Verissimo D, 2009, ANIM CONSERV, V12, P549, DOI 10.1111/j.1469-1795.2009.00282.x; Vreugdenhil D., 2003, COMPREHENSIVE PROTEC; Walpole MJ, 2001, CONSERV BIOL, V15, P218, DOI 10.1046/j.1523-1739.2001.99231.x; Watson JEM, 2011, CONSERV BIOL, V25, P324, DOI 10.1111/j.1523-1739.2010.01587.x; WDPA Consortium, 2009, WORLD DAT PROT AR; White PCL, 2001, MAMMAL REV, V31, P151, DOI 10.1046/j.1365-2907.2001.00083.x; Wilkie DS, 2001, BIODIVERS CONSERV, V10, P691, DOI 10.1023/A:1016662027017; Wyman M, 2011, FORESTS, V2, P913, DOI 10.3390/f2040913; Zimbabwe Tourism Authority, 2000, ZIMB TOUR TRENDS STA	50	25	27	8	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43757	10.1371/journal.pone.0043757	http://dx.doi.org/10.1371/journal.pone.0043757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984440	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500020
J	Katzenberger, RJ; Rach, EA; Anderson, AK; Ohler, U; Wassarman, DA				Katzenberger, Rebeccah J.; Rach, Elizabeth A.; Anderson, Ashley K.; Ohler, Uwe; Wassarman, David A.			The Drosophila Translational Control Element (TCE) Is Required for High-Level Transcription of Many Genes That Are Specifically Expressed in Testes	PLOS ONE			English	Article							RNA-POLYMERASE-II; DEVELOPMENTAL REGULATION; PROMOTER ELEMENT; CORE PROMOTERS; MESSENGER-RNA; SPERMATOGENESIS; BINDING; MELANOGASTER; TAFS; MECHANISMS	To investigate the importance of core promoter elements for tissue-specific transcription of RNA polymerase II genes, we examined testis-specific transcription in Drosophila melanogaster. Bioinformatic analyses of core promoter sequences from 190 genes that are specifically expressed in testes identified a 10 bp A/T-rich motif that is identical to the translational control element (TCE). The TCE functions in the 59 untranslated region of Mst(3) CGP mRNAs to repress translation, and it also functions in a heterologous gene to regulate transcription. We found that among genes with focused initiation patterns, the TCE is significantly enriched in core promoters of genes that are specifically expressed in testes but not in core promoters of genes that are specifically expressed in other tissues. The TCE is variably located in core promoters and is conserved in melanogaster subgroup species, but conservation dramatically drops in more distant species. In transgenic flies, short (300400 bp) genomic regions containing a TCE directed testis-specific transcription of a reporter gene. Mutation of the TCE significantly reduced but did not abolish reporter gene transcription indicating that the TCE is important but not essential for transcription activation. Finally, mutation of testis-specific TFIID (tTFIID) subunits significantly reduced the transcription of a subset of endogenous TCE-containing but not TCE-lacking genes, suggesting that tTFIID activity is limited to TCE-containing genes but that tTFIID is not an obligatory regulator of TCE-containing genes. Thus, the TCE is a core promoter element in a subset of genes that are specifically expressed in testes. Furthermore, the TCE regulates transcription in the context of short genomic regions, from variable locations in the core promoter, and both dependently and independently of tTFIID. These findings set the stage for determining the mechanism by which the TCE regulates testis-specific transcription and understanding the dual role of the TCE in translational and transcriptional regulation.	[Katzenberger, Rebeccah J.; Anderson, Ashley K.; Wassarman, David A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53715 USA; [Rach, Elizabeth A.; Ohler, Uwe] Duke Univ, Dept Biostat, Inst Genome Sci & Policy, Durham, NC USA; [Rach, Elizabeth A.; Ohler, Uwe] Duke Univ, Dept Bioinformat & Comp Sci, Durham, NC USA	University of Wisconsin System; University of Wisconsin Madison; Duke University; Duke University	Katzenberger, RJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53715 USA.	uwe.ohler@duke.edu; dawassarman@wisc.edu			National Institutes of Health (NIH) [R01-HG004065]; National Science Foundation (NSF) [MCB-1118456]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004065] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health (NIH) grant R01-HG004065 (to U.O.) and National Science Foundation (NSF) grant MCB-1118456 (to D. A. W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Che DS, 2005, BIOINFORMATICS, V21, P2909, DOI 10.1093/bioinformatics/bti425; Chen X, 2005, SCIENCE, V310, P869, DOI 10.1126/science.1118101; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeJong J, 2006, GENE, V366, P39, DOI 10.1016/j.gene.2005.10.012; Down TA, 2007, PLOS COMPUT BIOL, V3, P95, DOI 10.1371/journal.pcbi.0030007; FitzGerald PC, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r53; Freiman RN, 2009, BBA-GENE REGUL MECH, V1789, P161, DOI 10.1016/j.bbagrm.2009.01.005; Gershenzon NI, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-161; GLASER RL, 1986, EMBO J, V5, P747, DOI 10.1002/j.1460-2075.1986.tb04277.x; Goodrich JA, 2010, NAT REV GENET, V11, P549, DOI 10.1038/nrg2847; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Hiller M, 2004, DEVELOPMENT, V131, P5297, DOI 10.1242/dev.01314; Hiller MA, 2001, GENE DEV, V15, P1021, DOI 10.1101/gad.869101; Hochheimer A, 2002, CARBON NANOTUBES LON, V420, P429; Honeycutt E, 2004, GENET RES, V83, P177, DOI 10.1017/S0016672304006780; Jacobi UG, 2007, EMBO J, V26, P3900, DOI 10.1038/sj.emboj.7601822; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Katzenberger RJ, 2006, MOL CELL BIOL, V26, P9256, DOI 10.1128/MCB.01125-06; KEMPE E, 1993, DEV GENET, V14, P449, DOI 10.1002/dvg.1020140606; KUHN R, 1988, EMBO J, V7, P447, DOI 10.1002/j.1460-2075.1988.tb02832.x; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JI, 2001, DEVELOPMENT, V128, P1671; Metcalf CE, 2007, DEV DYNAM, V236, P2836, DOI 10.1002/dvdy.21294; MICHIELS F, 1989, EMBO J, V8, P1559, DOI 10.1002/j.1460-2075.1989.tb03540.x; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; Ohler U, 2002, GENOME BIOL, V3, P87, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0087; Ohler U, 2010, DEVELOPMENT, V137, P15, DOI 10.1242/dev.035493; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Rach EA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r73; Reddi PP, 1999, BIOL REPROD, V61, P1256, DOI 10.1095/biolreprod61.5.1256; Renkawitz-Pohl R., 2005, P157; Santel A, 2000, NUCLEIC ACIDS RES, V28, P1439, DOI 10.1093/nar/28.6.1439; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; SCHAFER M, 1990, EMBO J, V9, P4519, DOI 10.1002/j.1460-2075.1990.tb07903.x; Schafer M, 1995, DEV BIOL, V172, P344, DOI 10.1006/dbio.1995.8049; Skawran B, 2005, MOL CELL BIOCHEM, V276, P159, DOI 10.1007/s11010-005-3801-x; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; White-Cooper H, 2010, REPRODUCTION, V139, P11, DOI 10.1530/REP-09-0083; Yamashita A, 2008, GENE, V427, P93, DOI 10.1016/j.gene.2008.08.018	46	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e45009	10.1371/journal.pone.0045009	http://dx.doi.org/10.1371/journal.pone.0045009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984601	Green Submitted, Green Published, gold			2022-12-25	WOS:000308638700103
J	Patel, TR; Butler, G; McFarlane, A; Xie, I; Overall, CM; Stetefeld, J				Patel, Trushar R.; Butler, Georgina; McFarlane, Ainsley; Xie, Irene; Overall, Christopher M.; Stetefeld, Joerg			Site Specific Cleavage Mediated by MMPs Regulates Function of Agrin	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; BASAL LAMINA; BINDING; DOMAIN; RECEPTOR; DYSTROGLYCAN; ACTIVATION; EXPRESSION; INHIBITORS; MECHANISM	Background: Agrin is the key inducer of postsynaptic differentiations at the neuromuscular junction. The multidomain heparan sulfate proteoglycan is mediating via its N-terminal segment the interaction with laminin, whereas the C-terminal portion is responsible for Dystroglycan binding and clustering of the Acetylcholine receptor. Matrix metalloproteinases (MMP) are known to play essential roles in matrix remodeling, degradation and regulation of extracellular signaling networks. Principal Findings: Site-specific processing of Agrin provides key insight into regulatory effects of Matrix metalloproteinases (MMPs). Here, we present a detailed study of agrin processing by different MMPs together with a molecular understanding of binding and cleavage at both terminal fragments. The data suggest for a regulatory effect of MMP cleavage at particularly important functional sites of agrin. Cleave of agrin abolishes the agrin-laminin complex formation and the Acetylcholine receptor clustering at the neuromuscular junction. Conclusion/Significance: Agrin is a target of specific MMP processing resulting in agrin subfragments with different regulatory activities. MMP processing is a powerful tool to regulate extracellular signaling networks.	[Patel, Trushar R.; McFarlane, Ainsley; Xie, Irene; Stetefeld, Joerg] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada; [Butler, Georgina; Overall, Christopher M.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada	University of Manitoba; University of British Columbia	Patel, TR (corresponding author), Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada.	stetefel@cc.umanitoba.ca	Patel, Trushar R/F-2776-2011; Stetefeld, Joerg/H-7630-2017; Patel, Trushar R./AAB-6250-2020; Butler, Georgina/GQP-7553-2022	Patel, Trushar R/0000-0003-0627-2923; Stetefeld, Joerg/0000-0003-1478-3248; Patel, Trushar R./0000-0003-0627-2923; Butler, Georgina/0000-0003-1172-1578	Canadian Institute of Health Research (CIHR); Manitoba Institute of Child Health	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Manitoba Institute of Child Health	This work was supported by an Operating Grant from the Canadian Institute of Health Research (CIHR) and the Manitoba Institute of Child Health. TRP is a CIHR postdoctoral fellow and JS is a Canada Research Chair in Structural Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banyai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010758; Bertini I, 2006, ANGEW CHEM INT EDIT, V45, P7952, DOI 10.1002/anie.200603100; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURDEN SJ, 1979, J CELL BIOL, V82, P412, DOI 10.1083/jcb.82.2.412; Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671; DENZER AJ, 1995, J CELL BIOL, V131, P1547, DOI 10.1083/jcb.131.6.1547; Denzer AJ, 1997, CELL TISSUE RES, V290, P357, DOI 10.1007/s004410050941; Fowlkes John L., 1995, Progress in Growth Factor Research, V6, P255, DOI 10.1016/0955-2235(95)00017-8; FUKAI F, 1995, BIOCHEMISTRY-US, V34, P11453, DOI 10.1021/bi00036a018; Gabb HA, 1997, J MOL BIOL, V272, P106, DOI 10.1006/jmbi.1997.1203; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Kleiner DE, 1999, CANCER CHEMOTH PHARM, V43, pS42, DOI 10.1007/s002800051097; Luckman SP, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/151258; Mascarenhas JB, 2005, MATRIX BIOL, V23, P507, DOI 10.1016/j.matbio.2004.11.003; Mascarenhas JB, 2003, EMBO J, V22, P529, DOI 10.1093/emboj/cdg041; Maskos K, 2003, MOL BIOTECHNOL, V25, P241, DOI 10.1385/MB:25:3:241; McFarlane AA, 2009, PROTEIN SCI, V18, P2421, DOI 10.1002/pro.276; Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; MURPHY G, 1982, BIOCHEM J, V203, P209, DOI 10.1042/bj2030209; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932; Noell S, 2012, CELL TISSUE RES, V347, P429, DOI 10.1007/s00441-011-1321-4; Philippsen A, 2005, ACTA CRYSTALLOGR D, V61, P374, DOI 10.1107/S0907444904034390; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Scotton P, 2006, J BIOL CHEM, V281, P36835, DOI 10.1074/jbc.M607887200; Sole S, 2004, J NEUROPATH EXP NEUR, V63, P338, DOI 10.1093/jnen/63.4.338; Stetefeld J, 2005, TRENDS BIOCHEM SCI, V30, P515, DOI 10.1016/j.tibs.2005.07.001; Stetefeld J, 2004, STRUCTURE, V12, P503, DOI 10.1016/j.str.2004.02.001; Stetefeld J, 2001, NAT STRUCT BIOL, V8, P705, DOI 10.1038/90422; VanSaun M, 2000, J NEUROBIOL, V43, P140, DOI 10.1002/(SICI)1097-4695(200005)43:2<140::AID-NEU4>3.3.CO;2-B; Vansaun M, 2003, J NEUROCYTOL, V32, P1129, DOI 10.1023/B:NEUR.0000021907.68461.9c; Wang H, 2012, SYNAPSE; Werle MJ, 2003, J NEUROCYTOL, V32, P905, DOI 10.1023/B:NEUR.0000020631.69804.f5	43	21	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43669	10.1371/journal.pone.0043669	http://dx.doi.org/10.1371/journal.pone.0043669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984437	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700026
J	Yermakova, A; Vance, DJ; Mantis, NJ				Yermakova, Anastasiya; Vance, David J.; Mantis, Nicholas J.			Sub-Domains of Ricin's B Subunit as Targets of Toxin Neutralizing and Non-Neutralizing Monoclonal Antibodies	PLOS ONE			English	Article							GALACTOSE-BINDING; A-CHAIN; EUKARYOTIC RIBOSOMES; LECTINS ABRIN; IN-VITRO; TOXICITY; MICE; IDENTIFICATION; INTOXICATION; MECHANISM	The B subunit (RTB) of ricin toxin is a galactose (Gal)-/N-acetylgalactosamine (GalNac)-specific lectin that mediates attachment, entry, and intracellular trafficking of ricin in host cells. Structurally, RTB consists of two globular domains with identical folding topologies. Domains 1 and 2 are each comprised of three homologous sub-domains (alpha, beta, gamma) that likely arose by gene duplication from a primordial carbohydrate recognition domain (CRD), although only sub-domains 1 alpha and 2 gamma retain functional lectin activity. As part of our ongoing effort to generate a comprehensive B cell epitope map of ricin, we report the characterization of three new RTB-specific monoclonal antibodies (mAbs). All three mAbs, JB4, B/J F9 and C/M A2, were initially identified based on their abilities to neutralize ricin in a Vero cell cytotoxicty assay and to partially (or completely) block ricin attachment to cell surfaces. However, only JB4 proved capable of neutralizing ricin in a macrophage apoptosis assay and in imparting passive immunity to mice in a model of systemic intoxication. Using a combination of techniques, including competitive ELISAs, pepscan analysis, differential reactivity by Western blot, as well as affinity enrichment of phage displayed peptides, we tentatively localized the epitopes recognized by the non-neutralizing mAbs B/J F9 and C/M A2 to sub-domains 2 alpha and 2 beta, respectively. Furthermore, we propose that the epitope recognized by JB4 is within sub-domain 2 gamma, adjacent to RTB's high affinity Gal/GalNAc CRD. These data suggest that recognition of RTB's subdomains 1 alpha and 2 gamma are critical determinants of antibody neutralizing activity and protective immunity to ricin.	[Yermakova, Anastasiya; Vance, David J.; Mantis, Nicholas J.] New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY USA; [Yermakova, Anastasiya; Mantis, Nicholas J.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Yermakova, A (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Div Infect Dis, Albany, NY USA.	nmantis@wadsworth.org	Vance, David/ABF-5998-2020	Vance, David/0000-0002-9913-7722; Mantis, Nicholas/0000-0002-5083-8640	National Institutes of Health (USA) [AI081053, AI097688]; Wadsworth Center's Biodefense and Emerging Infectious Diseases program [T32AI055429]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI097688, T32AI055429, R21AI081053] Funding Source: NIH RePORTER	National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wadsworth Center's Biodefense and Emerging Infectious Diseases program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported through National Institutes of Health (USA) grants AI081053 and AI097688 to NJM. AY was the recipient of a pre-doctoral fellowship from the Wadsworth Center's Biodefense and Emerging Infectious Diseases program (T32AI055429; PI-McDonough). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audi J, 2005, JAMA-J AM MED ASSOC, V294, P2342, DOI 10.1001/jama.294.18.2342; CHANH TC, 1995, VACCINE, V13, P479, DOI 10.1016/0264-410X(94)00020-N; CHANH TC, 1993, IMMUNOL INVEST, V22, P63, DOI 10.3109/08820139309066194; COLOMBATTI M, 1986, HYBRIDOMA, V5, P9, DOI 10.1089/hyb.1986.5.9; COLOMBATTI M, 1987, J IMMUNOL, V138, P3339; Dai JX, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.196584; Dertzbaugh MT, 2005, HYBRIDOMA, V24, P236, DOI 10.1089/hyb.2005.24.236; ENDO Y, 1987, J BIOL CHEM, V262, P8128; ENDO Y, 1987, J BIOL CHEM, V262, P5908; FODSTAD O, 1976, BRIT J CANCER, V34, P418, DOI 10.1038/bjc.1976.187; FRANZ DR, 1997, TXB MILITARY MED, P631; Furukawa-Stoffer TL, 1999, HYBRIDOMA, V18, P505; Gage E, 2011, TOXINS, V3, P1131, DOI 10.3390/toxins3091131; Guo JW, 2006, HYBRIDOMA, V25, P225, DOI 10.1089/hyb.2006.25.225; Guo JW, 2005, HYBRIDOMA, V24, P263, DOI 10.1089/hyb.2005.24.263; KATZIN BJ, 1991, PROTEINS, V10, P251, DOI 10.1002/prot.340100309; Kelly-Cirino CD, 2009, INFECT IMMUN, V77, P4859, DOI 10.1128/IAI.00117-09; LEMLEY PV, 1994, HYBRIDOMA, V13, P417, DOI 10.1089/hyb.1994.13.417; Maddaloni M, 2004, J IMMUNOL, V172, P6221, DOI 10.4049/jimmunol.172.10.6221; Mantis NJ, 2006, INFECT IMMUN, V74, P3455, DOI 10.1128/IAI.02088-05; Mantis NJ, 2005, ADV DRUG DELIVER REV, V57, P1424, DOI 10.1016/j.addr.2005.01.017; McGuinness CR, 2006, INFECT IMMUN, V74, P3463, DOI 10.1128/IAI.00324-06; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; Neal LM, 2011, VACCINE, V29, P681, DOI 10.1016/j.vaccine.2010.11.030; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; NEWTON DL, 1992, J BIOL CHEM, V267, P11917; O'Hara JM, 2012, CURR TOP MICROBIOL, V357, P209, DOI 10.1007/82_2011_193; O'Hara JM, 2010, VACCINE, V28, P7035, DOI 10.1016/j.vaccine.2010.08.020; Olsnes S, 2004, TOXICON, V44, P361, DOI 10.1016/j.toxicon.2004.05.003; Pauly D, 2009, ANALYST, V134, P2028, DOI 10.1039/b911525k; Pelat T, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-60; Pincus SH, 2002, COMPARATIVE MED, V52, P530; Prigent J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020166; ROBERTS LM, 1985, J BIOL CHEM, V260, P5682; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; RUTENBER E, 1991, PROTEINS, V10, P240, DOI 10.1002/prot.340100308; SANDVIG K, 1976, J BIOL CHEM, V251, P3977; SIMMONS BM, 1986, J BIOL CHEM, V261, P7912; Smallshaw JE, 2002, VACCINE, V20, P3422, DOI 10.1016/S0264-410X(02)00312-2; Smallshaw JE, 2012, CURR TOP MICROBIOL, V357, P259, DOI 10.1007/82_2011_156; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Stirpe F, 2004, TOXICON, V44, P371, DOI 10.1016/j.toxicon.2004.05.004; SWIMMER C, 1992, P NATL ACAD SCI USA, V89, P3756, DOI 10.1073/pnas.89.9.3756; Wang YG, 2007, BIOTECHNOL LETT, V29, P1811, DOI 10.1007/s10529-007-9478-3; Yermakova A, 2011, VACCINE, V29, P7925, DOI 10.1016/j.vaccine.2011.08.075; ZENTZ C, 1978, BIOCHIM BIOPHYS ACTA, V536, P18, DOI 10.1016/0005-2795(78)90047-8	46	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44317	10.1371/journal.pone.0044317	http://dx.doi.org/10.1371/journal.pone.0044317			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984492	gold, Green Submitted, Green Published			2022-12-25	WOS:000308638700054
J	Makeyev, AV; Enkhmandakh, B; Hong, SH; Joshi, P; Shin, DG; Bayarsaihan, D				Makeyev, Aleksandr V.; Enkhmandakh, Badam; Hong, Seung-Hyun; Joshi, Pujan; Shin, Dong-Guk; Bayarsaihan, Dashzeveg			Diversity and Complexity in Chromatin Recognition by TFII-I Transcription Factors in Pluripotent Embryonic Stem Cells and Embryonic Tissues	PLOS ONE			English	Article							WILLIAMS-BEUREN-SYNDROME; FAMILY TARGET GENES; BINDING PROTEIN; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; ELEMENT; GENOME; MEMBER; BEN	GTF2I and GTF2IRD1 encode a family of closely related transcription factors TFII-I and BEN critical in embryonic development. Both genes are deleted in Williams-Beuren syndrome, a complex genetic disorder associated with neurocognitive, craniofacial, dental and skeletal abnormalities. Although genome-wide promoter analysis has revealed the existence of multiple TFII-I binding sites in embryonic stem cells (ESCs), there was no correlation between TFII-I occupancy and gene expression. Surprisingly, TFII-I recognizes the promoter sequences enriched for H3K4me3/K27me3 bivalent domain, an epigenetic signature of developmentally important genes. Moreover, we discovered significant differences in the association between TFII-I and BEN with the cis-regulatory elements in ESCs and embryonic craniofacial tissues. Our data indicate that in embryonic tissues BEN, but not the highly homologous TFII-I, is primarily recruited to target gene promoters. We propose a "feed-forward model" of gene regulation to explain the specificity of promoter recognition by TFII-I factors in eukaryotic cells.	[Makeyev, Aleksandr V.; Enkhmandakh, Badam; Bayarsaihan, Dashzeveg] Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Ctr Regenerat Med & Skeletal Dev,Sch Dent, Farmington, CT USA; [Hong, Seung-Hyun; Joshi, Pujan; Shin, Dong-Guk] Univ Connecticut, Sch Engn, Storrs, CT USA	University of Connecticut; University of Connecticut	Makeyev, AV (corresponding author), Univ Connecticut, Ctr Hlth, Dept Reconstruct Sci, Ctr Regenerat Med & Skeletal Dev,Sch Dent, Farmington, CT USA.	dashzeveg@uchc.edu			National Institutes of Health (NIH) [K02 DE18412, R01DE017205]; State of Connecticut Stem Cell Initiative [09-SCB-UCHC, 06SCC04]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE017205, K02DE018412] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of Connecticut Stem Cell Initiative; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health (NIH) grants K02 DE18412 and R01DE017205 and State of Connecticut Stem Cell Initiative 09-SCB-UCHC to DB. The work by SH, PJ and DG was supported in part by the funding from State of Connecticut Stem Cell Initiative (Project No. 06SCC04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bayarsaihan D, 2003, GENE EXPR PATTERNS, V3, P579, DOI 10.1016/S1567-133X(03)00118-2; Bayarsaihan D, 2000, P NATL ACAD SCI USA, V97, P7342, DOI 10.1073/pnas.97.13.7342; Bayarsaihan D, 2012, J CELL BIOCHEM, V113, P3056, DOI 10.1002/jcb.24202; Chen JG, 2005, J VIROL, V79, P4396, DOI 10.1128/JVI.79.7.4396-4406.2005; Chimge NO, 2008, P NATL ACAD SCI USA, V105, P9006, DOI 10.1073/pnas.0803051105; Chimge NO, 2012, J CELL BIOCHEM, V113, P1122, DOI 10.1002/jcb.23441; Crusselle-Davis VJ, 2006, MOL CELL BIOL, V26, P6832, DOI 10.1128/MCB.01770-05; Dahl JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009150; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Enkhmandakh B, 2004, GENE EXPR PATTERNS, V4, P25, DOI 10.1016/S1567-133X(03)00155-8; Enkhmandakh B, 2009, P NATL ACAD SCI USA, V106, P181, DOI 10.1073/pnas.0811531106; Grueneberg DA, 1997, GENE DEV, V11, P2482, DOI 10.1101/gad.11.19.2482; Hoppe R, 2003, GENOME RES, V13, P2674, DOI 10.1101/gr.1372203; Jackson TA, 2005, J BIOL CHEM, V280, P29856, DOI 10.1074/jbc.M500335200; Kambere MB, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-S3-S2; Ku MC, 2005, MOL CELL BIOL, V25, P7144, DOI 10.1128/MCB.25.16.7144-7157.2005; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lazebnik MB, 2008, J BIOL CHEM, V283, P11078, DOI 10.1074/jbc.C800049200; Li QR, 2011, MOL CELLULAR PROTOMI, V10, pM110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; Makeyev AV, 2011, CLEFT PALATE-CRAN J, V48, P109, DOI 10.1597/09-093; Makeyev AV, 2009, BIOCHEM BIOPH RES CO, V386, P554, DOI 10.1016/j.bbrc.2009.06.045; Maurer J, 2007, DIFFERENTIATION, V75, P580, DOI 10.1111/j.1432-0436.2007.00164.x; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; O'Mahoney JV, 1998, MOL CELL BIOL, V18, P6641, DOI 10.1128/MCB.18.11.6641; Ogura Y, 2006, GENES CELLS, V11, P373, DOI 10.1111/j.1365-2443.2006.00952.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ring C, 2002, GENE DEV, V16, P820, DOI 10.1101/gad.963802; Roy AL, 1997, EMBO J, V16, P7091, DOI 10.1093/emboj/16.23.7091; Salbaum JM, 2010, BIRTH DEFECTS RES A, V88, P601, DOI 10.1002/bdra.20680; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; Tantin D, 2004, J BIOL CHEM, V279, P5460, DOI 10.1074/jbc.M311177200; Vassalli A, 2011, MOL CELL NEUROSCI, V46, P381, DOI 10.1016/j.mcn.2010.11.001; Vullhorst D, 2005, J BIOL CHEM, V280, P31722, DOI 10.1074/jbc.M500593200; Yoshikawa T, 2006, GENE EXPR PATTERNS, V6, P213, DOI 10.1016/j.modgep.2005.06.003	38	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44443	10.1371/journal.pone.0044443	http://dx.doi.org/10.1371/journal.pone.0044443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970219	Green Submitted, Green Published, gold			2022-12-25	WOS:000308748400018
J	Pellissier, G; Yazdanpanah, Y; Adehossi, E; Tosini, W; Madougou, B; Ibrahima, K; Lolom, I; Legac, S; Rouveix, E; Champenois, K; Rabaud, C; Bouvet, E				Pellissier, Gerard; Yazdanpanah, Yazdan; Adehossi, Eric; Tosini, William; Madougou, Boubacar; Ibrahima, Kaza; Lolom, Isabelle; Legac, Sylvie; Rouveix, Elisabeth; Champenois, Karen; Rabaud, Christian; Bouvet, Elisabeth			Is Universal HBV Vaccination of Healthcare Workers a Relevant Strategy in Developing Endemic Countries? The Case of a University Hospital in Niger	PLOS ONE			English	Article							B-VIRUS INFECTION; HEPATITIS-B; BLOOD; PREVALENCE; RISK; MANAGEMENT; EXPOSURES; SURGEONS; MARKERS; AFRICA	Background: Exposure to hepatitis B virus (HBV) remains a serious risk to healthcare workers (HCWs) in endemic developing countries owing to the strong prevalence of HBV in the general and hospital populations, and to the high rate of occupational blood exposure. Routine HBV vaccination programs targeted to high-risk groups and especially to HCWs are generally considered as a key element of prevention strategies. However, the high rate of natural immunization among adults in such countries where most infections occur perinatally or during early childhood must be taken into account. Methodology/Principal Findings: We conducted a cross sectional study in 207 personnel of 4 occupational groups (medical, paramedical, cleaning staff, and administrative) in Niamey's National Hospital, Niger, in order to assess the prevalence of HBV markers, to evaluate susceptibility to HBV infection, and to identify personnel who might benefit from vaccination. The proportion of those who declared a history of occupational blood exposure ranged from 18.9% in the administrative staff to 46.9% in paramedical staff. Only 7.2% had a history of vaccination against HBV with at least 3 injections. Ninety two percent were anti-HBc positive. When we focused on170 HCWs, only 12 (7.1%) showed no biological HBV contact. Twenty six were HBsAg positive (15,3%; 95% confidence interval: 9.9%-20.7%) of whom 8 (32%) had a viral load >2000 IU/ml. Conclusions/Significance: The very small proportion of HCWs susceptible to HBV infection in our study and other studies suggests that in a global approach to prevent occupational infection by bloodborne pathogens, a universal hepatitis B vaccination of HCWs is not priority in these settings. The greatest impact on the risk will most likely be achieved by focusing efforts on primary prevention strategies to reduce occupational blood exposure. HBV screening in HCWs and treatment of those with chronic HBV infection should be however considered.	[Pellissier, Gerard; Tosini, William; Lolom, Isabelle; Legac, Sylvie; Rouveix, Elisabeth; Rabaud, Christian; Bouvet, Elisabeth] Fac Med Paris VII Bichat, Grp Etud Risque Exposit Soignants Agents Infect G, Paris, France; [Yazdanpanah, Yazdan; Legac, Sylvie; Bouvet, Elisabeth] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, F-75877 Paris 18, France; [Yazdanpanah, Yazdan; Champenois, Karen] ATIP Avenir Inserm Modelisat Aide Decis & Cout Ef, Lille, France; [Adehossi, Eric; Madougou, Boubacar; Ibrahima, Kaza] Hop Natl Niamey, Dept Med, Niamey, Niger; [Madougou, Boubacar] GIP ESTHER, Niamey, Niger; [Madougou, Boubacar] GIP ESTHER, Paris, France; [Lolom, Isabelle] Hop Bichat Claude Bernard, AP HP, Unite Hyg & Lutte Infect Nosocomiale, F-75877 Paris 18, France; [Rouveix, Elisabeth] Entraide Sante 92, Vaucresson, France; [Rouveix, Elisabeth] Hop Ambroise Pare, AP HP, Med Serv, Boulogne, France; [Rabaud, Christian] Ctr Hosp Univ, Serv Malad Infect, Nancy, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; CHU de Nancy	Pellissier, G (corresponding author), Fac Med Paris VII Bichat, Grp Etud Risque Exposit Soignants Agents Infect G, Paris, France.	gerard.pellissier@geres.org	Pellissier, Gerard/AAE-9058-2020	Pellissier, Gerard/0000-0002-3872-4536	French Ministries of Health and Co-operation	French Ministries of Health and Co-operation	Financial assistance for this study was obtained from the Public Interest Group ESTHER created by the French Ministries of Health and Co-operation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1; Barrigar DL, 2001, BMC MED ETHICS, V2, P4, DOI DOI 10.1186/1472-6939-2-4; Belo AC, 2000, E AFR MED J, V77, P283; Beltrami EM, 2000, CLIN MICROBIOL REV, V13, P385, DOI 10.1128/CMR.13.3.385-407.2000; Beutels P, 2001, HEALTH ECON, V10, P751, DOI 10.1002/hec.625; Bonanni P, 2001, VACCINE, V19, P2389, DOI 10.1016/S0264-410X(00)00460-6; Braka F, 2006, VACCINE, V24, P6930, DOI 10.1016/j.vaccine.2006.08.029; Burnett RJ, 2011, VACCINE, V29, P4293, DOI 10.1016/j.vaccine.2011.03.001; De Schryver A, 2011, EUR J PUBLIC HEALTH, V21, P338, DOI 10.1093/eurpub/ckq122; FORTUIN M, 1993, LANCET, V341, P1129, DOI 10.1016/0140-6736(93)93137-P; GERBERDING JL, 1995, NEW ENGL J MED, V332, P444, DOI 10.1056/NEJM199502163320707; Goldstein ST, 2005, INT J EPIDEMIOL, V34, P1329, DOI 10.1093/ije/dyi206; Hou Jinlin, 2005, Int J Med Sci, V2, P50; KANE M, 1995, VACCINE, V13, pS47; Kesieme Emeka B, 2011, Hepat Res Treat, V2011, P157089, DOI 10.1155/2011/157089; Kim SR, 2011, HEPAT MON, V11, P601, DOI 10.5812/kowsar.1735143X.657; Mahoney FJ, 1999, CLIN MICROBIOL REV, V12, P351, DOI 10.1128/CMR.12.2.351; Mamadou S, 2010, ANN U ABDOU MOUMOUNI, V11, P28; Mamadou S, 2009, J SOC BIOL CLIN, V013, P42; Mamadou S, 2012, HIV AIDS-RES PALLIAT, V4, P1, DOI 10.2147/HIV.S27881; Mast EE, 1999, VACCINE, V17, P1730, DOI 10.1016/S0264-410X(98)00415-0; Ngatu NR, 2012, AM J INFECT CONTROL, V40, P68, DOI 10.1016/j.ajic.2011.01.021; Olubuyide IO, 1997, QJM-MON J ASSOC PHYS, V90, P417, DOI 10.1093/qjmed/90.6.417; Phillips EK, 2007, INFECT CONT HOSP EP, V28, P1334, DOI 10.1086/522681; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; ROMIEU I, 1989, J MED VIROL, V27, P282, DOI 10.1002/jmv.1890270405; Sagoe-Moses C, 2001, NEW ENGL J MED, V345, P538, DOI 10.1056/NEJM200108163450711; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; SOUBIRAN G, 1987, T ROY SOC TROP MED H, V81, P998, DOI 10.1016/0035-9203(87)90376-2; SOUBIRAN G, 1984, ANN INST PASTEUR VIR, V135, P213, DOI 10.1016/S0769-2617(84)80057-X; Suckling RM, 2006, J HOSP INFECT, V64, P271, DOI 10.1016/j.jhin.2006.06.024; Tarantola A, 2005, J HOSP INFECT, V60, P276, DOI 10.1016/j.jhin.2004.11.025; Tarantola A, 2006, AM J INFECT CONTROL, V34, P367, DOI 10.1016/j.ajic.2004.11.011; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Wiersma Steven T, 2011, Liver Int, V31, P755, DOI 10.1111/j.1478-3231.2010.02373.x; World Health Organization, 2008, HEP B; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; Ziraba AK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-191	38	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44442	10.1371/journal.pone.0044442	http://dx.doi.org/10.1371/journal.pone.0044442			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	001LK	22970218	Green Published, gold, Green Submitted			2022-12-25	WOS:000308462000021
J	Mezrich, JD; Nguyen, LP; Kennedy, G; Nukaya, M; Fechner, JH; Zhang, XJ; Xing, YN; Bradfield, CA				Mezrich, Joshua D.; Nguyen, Linh P.; Kennedy, Greg; Nukaya, Manabu; Fechner, John H.; Zhang, Xiaoji; Xing, Yongna; Bradfield, Christopher A.			SU5416, a VEGF Receptor Inhibitor and Ligand of the AHR, Represents a New Alternative for Immunomodulation	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; ENDOTHELIAL GROWTH-FACTOR; REGULATORY T-CELLS; SMALL-MOLECULE INHIBITOR; AROMATIC-HYDROCARBONS; INDOLEAMINE 2,3-DIOXYGENASE; TUMOR ANGIOGENESIS; GENE-EXPRESSION; DENDRITIC CELLS; IN-VITRO	The experimental compound SU5416 went as far as Phase III clinical trials as an anticancer agent, putatively because of its activity as a VEGFR-2 inhibitor, but showed poor results. Here, we show that SU5416 is also an aryl hydrocarbon receptor (AHR) agonist with unique properties. Like TCDD, SU5416 favors induction of indoleamine 2,3 dioxygenase (IDO) in immunologically relevant populations such as dendritic cells in an AHR-dependent manner, leading to generation of regulatory T-cells in vitro. These characteristics lead us to suggest that SU5416 may be an ideal clinical agent for treatment of autoimmune diseases and prevention of transplant rejection, two areas where regulatory ligands of the AHR have shown promise. At the same time, AHR agonism might represent a poor characteristic for an anticancer drug, as regulatory T-cells can inhibit clearance of cancer cells, and activation of the AHR can lead to upregulation of xenobiotic metabolizing enzymes that might influence the half-lives of co-administered chemotherapeutic agents. Not only does SU5416 activate the human AHR with a potency approaching 2,3,7,8-tetrachlorodibenzo-p-dioxin, but it also activates polymorphic murine receptor isoforms (encoded by the Ahr(d) and Ahr(b1) alleles) with similar potency, a finding that has rarely been described and may have implications in identifying true endogenous ligands of this receptor.	[Mezrich, Joshua D.; Kennedy, Greg; Nukaya, Manabu; Fechner, John H.; Zhang, Xiaoji] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI 53706 USA; [Nguyen, Linh P.] Stanford Univ, Sch Med, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA; [Xing, Yongna; Bradfield, Christopher A.] Univ Wisconsin, Sch Med & Publ Hlth, McArdle Lab Canc Res, Dept Oncol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Stanford University; University of Wisconsin System; University of Wisconsin Madison	Mezrich, JD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Madison, WI 53706 USA.	Mezrich@surgery.wisc.edu	Fechner, John/C-5962-2016	Fechner, John/0000-0002-8220-7237; Nukaya, Manabu/0000-0002-6204-0978	Clinical and Translational Science Award program of the National Center for Research Resources, National Institutes of Health [1UL1RR025011]; National Institutes of Environmental Health Services Grant [R37ES005703]; National Cancer Institute [P30CA014520]; American Society of Nephrology; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES005703, R01ES005703, K08ES017283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM096060] Funding Source: NIH RePORTER	Clinical and Translational Science Award program of the National Center for Research Resources, National Institutes of Health; National Institutes of Environmental Health Services Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Society of Nephrology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Grant 1UL1RR025011 from the Clinical and Translational Science Award program of the National Center for Research Resources, National Institutes of Health (JDM), National Institutes of Environmental Health Services Grant R37ES005703 (CAB), National Cancer Institute Grant P30CA014520 (CAB). JDM is a John Merrill Grant Scholar of the American Society of Nephrology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amacher DE, 2010, TOXICOL MECH METHOD, V20, P159, DOI 10.3109/15376511003690307; BRADFIELD CA, 1988, MOL PHARMACOL, V34, P229; Bunger MK, 2003, J BIOL CHEM, V278, P17767, DOI 10.1074/jbc.M209594200; BURKE MD, 1985, BIOCHEM PHARMACOL, V34, P3337, DOI 10.1016/0006-2952(85)90355-7; Cao YH, 2009, FRONT BIOSCI-LANDMRK, V14, P3962, DOI [10.2741/3504, 10.2735/3504]; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Chen W, 2008, J IMMUNOL, V181, P5396, DOI 10.4049/jimmunol.181.8.5396; Edelbauer M, 2010, BLOOD, V116, P1980, DOI 10.1182/blood-2009-11-252460; Flaveny CA, 2009, MOL PHARMACOL, V75, P1412, DOI 10.1124/mol.109.054825; Flegal KM, 2005, PHYSIOL BEHAV, V86, P599, DOI 10.1016/j.physbeh.2005.08.050; Fong TAT, 1999, CANCER RES, V59, P99; Carvalho JF, 2007, J CLIN IMMUNOL, V27, P246, DOI 10.1007/s10875-007-9083-1; Fury MG, 2007, INVEST NEW DRUG, V25, P165, DOI 10.1007/s10637-006-9011-x; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HARPER PA, 1991, MOL PHARMACOL, V40, P818; Hauben E, 2008, BLOOD, V112, P1214, DOI 10.1182/blood-2007-08-109843; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Ishimaru N, 2009, J IMMUNOL, V182, P6576, DOI 10.4049/jimmunol.0802289; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; KARENLAMPI SO, 1988, J BIOL CHEM, V263, P10111; KENNEDY SW, 1994, ANAL BIOCHEM, V222, P217, DOI 10.1006/abio.1994.1476; Kieran MW, 2009, PEDIATR BLOOD CANCER, V52, P169, DOI 10.1002/pbc.21873; Kim YS, 2009, J IMMUNOL, V183, P5113, DOI 10.4049/jimmunol.0901566; Kimura A, 2008, P NATL ACAD SCI USA, V105, P9721, DOI 10.1073/pnas.0804231105; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Knerr S, 2006, MOL NUTR FOOD RES, V50, P897, DOI 10.1002/mnfr.200600006; Lahvis GP, 2000, P NATL ACAD SCI USA, V97, P10442, DOI 10.1073/pnas.190256997; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McMillan BJ, 2007, MOL PHARMACOL, V72, P487, DOI 10.1124/mol.107.037259; Mendel DB, 2000, ANTI-CANCER DRUG DES, V15, P29; Mendel DB, 2000, CLIN CANCER RES, V6, P4848; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Munn DH, 2005, BLOOD, V105, P2618, DOI 10.1182/blood-2005-01-0122; NIWA A, 1975, ARCH BIOCHEM BIOPHYS, V166, P559, DOI 10.1016/0003-9861(75)90420-8; OKEY AB, 1989, MOL PHARMACOL, V35, P823; Overmoyer B, 2007, CLIN CANCER RES, V13, P5862, DOI 10.1158/1078-0432.CCR-07-0688; Pauly SK, 2012, TOXICOL ENVIRON CHEM, V94, P1175, DOI 10.1080/02772248.2012.688546; POLAND A, 1986, J BIOL CHEM, V261, P6352; POLAND A, 1987, MOL PHARMACOL, V32, P471; POSTLIND H, 1993, TOXICOL APPL PHARM, V118, P255, DOI 10.1006/taap.1993.1031; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Quintana FJ, 2010, P NATL ACAD SCI USA, V107, P20768, DOI 10.1073/pnas.1009201107; Reinders MEJ, 2003, J CLIN INVEST, V112, P1655, DOI 10.1172/JCI200317712; REISZPORSZASZ S, 1994, MOL CELL BIOL, V14, P6075, DOI 10.1128/MCB.14.9.6075; Roscoe WA, 2009, J NEUROIMMUNOL, V209, P6, DOI 10.1016/j.jneuroim.2009.01.009; Rushing SR, 2002, ARCH BIOCHEM BIOPHYS, V403, P189, DOI 10.1016/S0003-9861(02)00233-3; Sanderson JT, 1996, TOXICOL APPL PHARM, V137, P316, DOI 10.1006/taap.1996.0086; SCHMIDT JV, 1993, J BIOL CHEM, V268, P22203; Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731; Singer K, 2011, CANC IMMUNOL IMMUNOT; Sun WM, 1997, J BIOL CHEM, V272, P31845, DOI 10.1074/jbc.272.50.31845; SWANSON HI, 1993, PHARMACOGENETICS, V3, P213, DOI 10.1097/00008571-199310000-00001; Thackaberry E A, 2002, Cardiovasc Toxicol, V2, P263, DOI 10.1385/CT:2:4:263; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vogel CFA, 2008, BIOCHEM BIOPH RES CO, V375, P331, DOI 10.1016/j.bbrc.2008.07.156; Walisser JA, 2004, P NATL ACAD SCI USA, V101, P16677, DOI 10.1073/pnas.0404379101; Walisser JA, 2004, J BIOL CHEM, V279, P16326, DOI 10.1074/jbc.M400784200; Weiss C, 1996, EXP CELL RES, V226, P154, DOI 10.1006/excr.1996.0214; Wood SM, 1996, J BIOL CHEM, V271, P15117, DOI 10.1074/jbc.271.25.15117	64	31	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44547	10.1371/journal.pone.0044547	http://dx.doi.org/10.1371/journal.pone.0044547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970246	Green Published, gold			2022-12-25	WOS:000308458400088
J	Shirreffs, A; Lee, DP; Henry, J; Golden, MR; Stekler, JD				Shirreffs, Alexandra; Lee, David P.; Henry, Jsani; Golden, Matthew R.; Stekler, Joanne D.			Understanding Barriers to Routine HIV Screening: Knowledge, Attitudes, and Practices of Healthcare Providers in King County, Washington	PLOS ONE			English	Article							FOR-DISEASE-CONTROL; UNITED-STATES; TESTING RECOMMENDATIONS; ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; PERSONS AWARE; VIRUS; PREVENTION; SETTINGS; TRANSMISSION	Objective: In 2006, the Centers for Disease Control and Prevention (CDC) recommended routine HIV screening in healthcare settings for persons between 13 and 64 years old. In 2010, the Washington Administrative Code (WAC) was changed to align testing rules with these recommendations. We designed this survey to ascertain the current state of HIV testing and barriers to routine screening in King County, Washington. Methods: Between March 23 and April 16, 2010, a convenience sample of healthcare providers completed an online survey. Providers answered true-false and multiple choice questions about national recommendations and the WAC, policies in their primary clinical settings, and their personal HIV testing practices. Providers were asked to agree or disagree whether commonly reported barriers limited their implementation of routine HIV screening. Results: Although 76% of the 221 respondents knew that the CDC recommended routine HIV screening for persons regardless of their risk, 99 (45%) providers reported that their primary clinical setting had a policy to target testing based on patient risk factors. Forty-four (20%) providers reported that their primary clinical setting had a policy of routine HIV screening, 54 (25%) reported no official policy, and 15 (7%) did not know whether a policy existed. Only 11 (5%) providers offer HIV testing to all patients at initial visits. When asked about barriers to routine screening, 57% of providers agreed that perception that their patient population is low risk limits the number of HIV tests they perform. Only 26 (13%) providers agreed that concern about reimbursement posed a barrier to testing. Conclusions: Most providers participating in this survey continue to target HIV testing, despite knowledge of national recommendations. Efforts are still needed to educate providers and policymakers, clarify the recent WAC revisions, and implement structural changes in order to increase HIV testing in Washington State.	[Shirreffs, Alexandra; Henry, Jsani] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Lee, David P.; Golden, Matthew R.; Stekler, Joanne D.] Univ Washington, Dept Med, Seattle, WA USA; [Golden, Matthew R.; Stekler, Joanne D.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Henry, Jsani; Golden, Matthew R.; Stekler, Joanne D.] Publ Hlth Seattle & King Cty, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shirreffs, A (corresponding author), Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA.	golden@u.washington.edu; jstekler@uw.edu	Golden, Matthew/AAE-4314-2020		National Institute of Health [K23 AI65243]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI065243] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Stekler was supported by National Institute of Health grant K23 AI65243. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRQ, 2007, AHRQ PUB; Anaya HD, 2008, J GEN INTERN MED, V23, P800, DOI 10.1007/s11606-008-0617-x; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P661; [Anonymous], 2010, MMWR MORB MORTAL WKL, V59, P1550; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Burke RC, 2007, AIDS, V21, P1617, DOI 10.1097/QAD.0b013e32823f91ff; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; d'Almeida KW, 2012, ARCH INTERN MED, V172, P12, DOI 10.1001/archinternmed.2011.535; Goetz MB, 2009, J GEN INTERN MED, V24, P1275, DOI 10.1007/s11606-009-1120-8; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; HIV/AIDS Epidemiology Unit Public Health-Seattle & King County and the Infectious Disease and Reproductive Health Assessment Unit Washington State Department of Health, 2009, HIV AIDS EP REP 1 HA, V74; Hutchinson AB, 2011, AIDS EDUC PREV, V23, P58, DOI 10.1521/aeap.2011.23.3_supp.58; Jain CL, 2009, AIDS PATIENT CARE ST, V23, P167, DOI 10.1089/apc.2008.0130; Jenkins TC, 2006, SEX TRANSM DIS, V33, P329, DOI 10.1097/01.olq.0000194617.91454.3f; Korthuis PT, 2011, AIDS EDUC PREV, V23, P70, DOI 10.1521/aeap.2011.23.3_supp.70; Liddicoat RV, 2004, J GEN INTERN MED, V19, P349, DOI 10.1111/j.1525-1497.2004.21251.x; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Neff S, 2011, JAMA-J AM MED ASSOC, V305, P1767, DOI 10.1001/jama.2011.564; Ogbuanu IU, 2009, AM J PUBLIC HEALTH, V99, pS111, DOI 10.2105/AJPH.2006.104323; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; The Voluntary HIV-1 Counseling and Testing Efficacy Study Group, 2000, J GERONTOL B-PSYCHOL, V356, P103; Wolf LE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001005; 2002, MMWR MORB MORTAL WKL, V51, P1013; 2008, MMWR MORB MORTAL WKL, V57, P1073	27	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44417	10.1371/journal.pone.0044417	http://dx.doi.org/10.1371/journal.pone.0044417			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970215	Green Submitted, gold, Green Published			2022-12-25	WOS:000308458400069
J	Diskin, S; Chen, WS; Cao, ZY; Gyawali, S; Gong, HY; Soza, A; Gonzalez, A; Panjwani, N				Diskin, Shiri; Chen, Wei-Sheng; Cao, Zhiyi; Gyawali, Smita; Gong, Haiyan; Soza, Andrea; Gonzalez, Alfonso; Panjwani, Noorjahan			Galectin-8 Promotes Cytoskeletal Rearrangement in Trabecular Meshwork Cells through Activation of Rho Signaling	PLOS ONE			English	Article							AQUEOUS-HUMOR OUTFLOW; OPEN-ANGLE GLAUCOMA; KINASE INHIBITOR; PROTEIN-KINASE; BETA(1) INTEGRIN; CYTOCHALASIN-B; ADHESION; FACILITY; FIBRONECTIN; EXPRESSION	Purpose: The trabecular meshwork (TM) cell-matrix interactions and factors that influence Rho signaling in TM cells are thought to play a pivotal role in the regulation of aqueous outflow. The current study was designed to evaluate the role of a carbohydrate-binding protein, galectin-8 (Gal8), in TM cell adhesion and Rho signaling. Methods: Normal human TM cells were assayed for Gal8 expression by immunohistochemistry and Western blot analysis. To assess the role of Gal8 in TM cell adhesion and Rho signaling, the cell adhesion and spreading assays were performed on Gal8-coated culture plates in the presence and the absence of anti-beta(1) integrin antibody and Rho and Rho-kinase inhibitors. In addition, the effect of Gal8-mediated cell-matrix interactions on TM cell cytoskeleton arrangement and myosin light chain 2 (MLC2) phosphorylation was examined. Principal Findings: We demonstrate here that Gal8 is expressed in the TM and a function-blocking anti-beta(1) integrin antibody inhibits the adhesion and spreading of TM cells to Gal8-coated wells. Cell spreading on Gal8 substratum was associated with the accumulation of phosphorylated myosin light chain and the formation of stress fibers that was inhibited by the Rho inhibitor, C3 transferase, as well as by the Rho-kinase inhibitor, Y27632. Conclusions/Significance: The above findings present a novel function for Gal8 in activating Rho signaling in TM cells. This function may allow Gal8 to participate in the regulation of aqueous outflow.	[Diskin, Shiri; Chen, Wei-Sheng; Panjwani, Noorjahan] Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA; [Cao, Zhiyi; Gyawali, Smita; Panjwani, Noorjahan] Tufts Univ, New England Eye Ctr, Boston, MA 02111 USA; [Cao, Zhiyi; Gyawali, Smita; Panjwani, Noorjahan] Tufts Univ, Dept Ophthalmol, Boston, MA 02111 USA; [Gong, Haiyan] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Soza, Andrea; Gonzalez, Alfonso] Pontificia Univ Catolica Chile, Dept Inmunol Clin & Reumatol, Fac Med, Ctr Regulac Celular & Patol, Santiago, Chile; [Soza, Andrea; Gonzalez, Alfonso] Pontificia Univ Catolica Chile, Ctr Envejecimiento & Regenerac, Fac Ciencias Biol, Santiago, Chile; [Soza, Andrea; Gonzalez, Alfonso] Millennium Inst Fundamental & Appl Biol, Santiago, Chile; [Panjwani, Noorjahan] Tufts Univ, Dept Biochem, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University; Boston University; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Tufts University	Diskin, S (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Program Cell Mol & Dev Biol, Boston, MA 02111 USA.	Noorjahan.Panjwani@tufts.edu		Gong, Haiyan/0000-0002-7204-5019; Soza, Andrea/0000-0003-3783-5231	National Institutes of Health [R03EY015168, P30EY13078]; Research to Prevent Blindness; FONDECYT (National Fund for Scientific and Technological Development) [1050715]; FONDAP (Fund for Advanced Research in Priority Areas (Centers of Excellence FONDAP) [19800001]; NATIONAL EYE INSTITUTE [P30EY013078, R03EY015168, R01EY007088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); FONDECYT (National Fund for Scientific and Technological Development)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDAP (Fund for Advanced Research in Priority Areas (Centers of Excellence FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grants R03EY015168 (N.P.), a core grant for vision research P30EY13078, Mass Lions Eye Research fund and a grant from Research to Prevent Blindness. A. G. was funded by Grants FONDECYT (National Fund for Scientific and Technological Development) #1050715 and FONDAP (Fund for Advanced Research in Priority Areas (Centers of Excellence FONDAP) #19800001. New England Eye Center (NEEC) is not a company. It is a nonprofit physician group dedicated to providing patients with an unprecedented level of care and responsive service. NEEC is the Ophthalmology Department of Tufts University School of Medcine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimov SS, 2000, J CELL BIOL, V148, P825, DOI 10.1083/jcb.148.4.825; Barry ST, 1996, CELL ADHES COMMUN, V4, P387, DOI 10.3109/15419069709004456; Bidon N, 2001, INT J MOL MED, V8, P245; CAIXIA S, 1991, CELL IMMUNOL, V138, P216, DOI 10.1016/0008-8749(91)90146-3; Carcamo C, 2006, EXP CELL RES, V312, P374, DOI 10.1016/j.yexcr.2005.10.025; Chen NY, 2000, J BIOL CHEM, V275, P24953, DOI 10.1074/jbc.M003040200; Clark AF, 2005, CELL MOTIL CYTOSKEL, V60, P83, DOI 10.1002/cm.20049; CLARK AF, 1994, INVEST OPHTH VIS SCI, V35, P281; Dallabrida SM, 2000, BLOOD, V95, P2586, DOI 10.1182/blood.V95.8.2586.008k04_2586_2592; Dickerson JE, 1998, EXP EYE RES, V66, P731, DOI 10.1006/exer.1997.0470; Diskin S, 2006, INVEST OPHTH VIS SCI, V47, P1491, DOI 10.1167/iovs.05-0736; Diskin S, 2009, GLYCOBIOLOGY, V19, P29, DOI 10.1093/glycob/cwn100; Filla MS, 2011, INVEST OPHTH VIS SCI, V52, P2952, DOI 10.1167/iovs.10-6618; Johnson M, 2006, EXP EYE RES, V82, P545, DOI 10.1016/j.exer.2005.10.011; Kaibuchi K, 1999, Prog Mol Subcell Biol, V22, P23; KAUFMAN PL, 1982, INVEST OPHTH VIS SCI, V23, P646; Koga T, 2006, EXP EYE RES, V82, P362, DOI 10.1016/j.exer.2005.07.006; Levy Y, 2001, J BIOL CHEM, V276, P31285, DOI 10.1074/jbc.M100340200; Levy Y, 2003, J BIOL CHEM, V278, P14533, DOI 10.1074/jbc.M207380200; Levy Y, 2006, GLYCOBIOLOGY, V16, P463, DOI 10.1093/glycob/cwj097; Ni HY, 1998, CELL ADHES COMMUN, V5, P257, DOI 10.3109/15419069809040296; Pal Z, 2012, BIOCH BIOPHYS ACTA; Peterson JA, 2000, INVEST OPHTH VIS SCI, V41, P1749; POLANSKY JR, 1994, PRINCIPLES PRACTICE, P226; Rao PV, 2005, EXP EYE RES, V80, P197, DOI 10.1016/j.exer.2004.08.029; Rao PV, 2005, MOL VIS, V11, P288; Rao PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; Ridley A J, 1999, Prog Mol Subcell Biol, V22, P1; Shiokawa S, 1999, BIOL REPROD, V60, P1468, DOI 10.1095/biolreprod60.6.1468; STAMER WD, 1995, CURR EYE RES, V14, P611, DOI 10.3109/02713689508998409; STUPACK DG, 1991, SCAND J IMMUNOL, V34, P761, DOI 10.1111/j.1365-3083.1991.tb01601.x; Summers L, 2009, MOL CELL NEUROSCI, V41, P148, DOI 10.1016/j.mcn.2009.02.007; Tian BH, 2005, EXP EYE RES, V80, P215, DOI 10.1016/j.exer.2004.09.002; Tian BH, 1998, ARCH OPHTHALMOL-CHIC, V116, P633, DOI 10.1001/archopht.116.5.633; Tian BH, 1999, EXP EYE RES, V68, P649, DOI 10.1006/exer.1998.0647; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Veevers-Lowe J, 2011, J CELL SCI, V124, P1288, DOI 10.1242/jcs.076935; Vittitow JL, 2002, MOL VIS, V8, P32; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Wilde C, 2001, TOXICON, V39, P1647, DOI 10.1016/S0041-0101(01)00152-0; Williams RD, 2011, AM J OPHTHALMOL, V152, P834, DOI 10.1016/j.ajo.2011.04.012; Wu YJ, 2002, J BIOL CHEM, V277, P12294, DOI 10.1074/jbc.M110748200; Zhou LL, 1996, INVEST OPHTH VIS SCI, V37, P104	43	26	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44400	10.1371/journal.pone.0044400	http://dx.doi.org/10.1371/journal.pone.0044400			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973445	Green Published, Green Submitted, gold			2022-12-25	WOS:000308577600049
J	Hu, Q; Lu, YY; Noh, H; Hong, S; Dong, Z; Ding, HF; Su, SB; Huang, S				Hu, Q.; Lu, Y-Y; Noh, H.; Hong, S.; Dong, Z.; Ding, H-F; Su, S-B; Huang, S.			Interleukin enhancer-binding factor 3 promotes breast tumor progression by regulating sustained urokinase-type plasminogen activator expression	ONCOGENE			English	Article						uPA; ILF3; transcription; miRNA	MESSENGER-RNA STABILITY; GENE-EXPRESSION; SIGNALING PATHWAYS; NUCLEAR FACTOR; KAPPA-B; CANCER; RECEPTOR; NF90; TRANSCRIPTION; METASTASIS	Sustained urokinase-type plasminogen activator (uPA) expression is detected in aggressive breast tumors. Although uPA can be transiently upregulated by diverse extracellular stimuli, sustained, but not transiently upregulated uPA expression contributes to breast cancer invasion/metastasis. Unfortunately, how sustained uPA expression is achieved in invasive/metastatic breast cancer cells is unknown. Here, we show that sustained and transiently upregulated uPA expression are regulated by distinct mechanisms. Using a collection of transcription factor-targeted small-interfering RNAs, we discovered that interleukin enhancer-binding factor 3 (ILF3) is required for sustained uPA expression. Two discrete mechanisms mediate ILF3 action. The first is that ILF3 activates uPA transcription by binding to the CTGTT sequence in the nucleotides - 1004B similar to - 1000 of the uPA promoter; the second is that ILF3 inhibits the processing of uPA mRNA-targeting primary microRNAs (pri-miRNAs). Knockdown of ILF3 led to significant reduction in in vitro cell growth/migration/invasion and in vivo breast tumor development. Importantly, immunohistochemistry (IHC) showed that nuclear ILF3, but not cytoplasmic ILF3 staining correlates with elevated uPA level and higher grades of human breast tumor specimens. Nuclear localization of ILF3 highlights the role of ILF3 in sustained uPA expression as a transcription activator and pri-miRNA processing blocker. In conclusion, this study shows that ILF3 promotes breast tumorigenicity by regulating sustained uPA expression.	[Hu, Q.; Noh, H.; Hong, S.; Huang, S.] Georgia Hlth Sci Univ, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Lu, Y-Y; Su, S-B; Huang, S.] Shanghai Univ Tradit Chinese Med, Res Ctr Tradit Chinese Med Complex Syst, Shanghai, Peoples R China; [Dong, Z.] Georgia Hlth Sci Univ, Dept Cellular Biol & Anat, Augusta, GA 30912 USA; [Ding, H-F] Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA; [Ding, H-F; Huang, S.] Georgia Hlth Sci Univ, Ctr Canc, Augusta, GA 30912 USA	University System of Georgia; Augusta University; Shanghai University of Traditional Chinese Medicine; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Huang, S (corresponding author), Georgia Hlth Sci Univ, Dept Biochem & Mol Biol, Augusta, GA 30912 USA.	shuang@georgiahealth.edu		Ding, Han-Fei/0000-0001-5702-3439	NIH [CA093926]; NSF of China [81 073 134]; Shanghai Eastern Scholar Fund; NATIONAL CANCER INSTITUTE [R01CA093926] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF of China(National Natural Science Foundation of China (NSFC)); Shanghai Eastern Scholar Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from NIH CA093926 (SH), NSF of China Fund 81 073 134 (SBS) and Shanghai Eastern Scholar Fund (SH). We would like to thank Dr Michael Mathews for providing ILF3 splicing isoform constructs.	Almholt K, 2005, INT J CANCER, V113, P525, DOI 10.1002/ijc.20631; Amorino GP, 2002, MOL BIOL CELL, V13, P2233, DOI 10.1091/mbc.01-12-0572; Annecke K, 2008, ADV CLIN CHEM, V45, P31, DOI 10.1016/S0065-2423(07)00002-9; Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Bandyopadhyay A, 1999, CANCER RES, V59, P5041; Blasi F, 1999, THROMB HAEMOSTASIS, V82, P298; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Crippa MP, 2007, INT J BIOCHEM CELL B, V39, P690, DOI 10.1016/j.biocel.2006.10.008; Das R, 2004, J BIOL CHEM, V279, P11051, DOI 10.1074/jbc.M310256200; Das R, 2003, J BIOL CHEM, V278, P28593, DOI 10.1074/jbc.M303445200; Duchange N, 2000, GENE, V261, P345, DOI 10.1016/S0378-1119(00)00495-9; Duffy MJ, 1999, J SURG ONCOL, V71, P130, DOI 10.1002/(SICI)1096-9098(199906)71:2<130::AID-JSO14>3.0.CO;2-9; Dunn SE, 2001, CANCER RES, V61, P1367; Foekens JA, 2000, CANCER RES, V60, P636; Fung LF, 2000, LIFE SCI, V67, P923, DOI 10.1016/S0024-3205(00)00684-6; Ghiso JAA, 1999, EUR J BIOCHEM, V263, P295, DOI 10.1046/j.1432-1327.1999.00507.x; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; Guo NL, 2008, CLIN CANCER RES, V14, P8213, DOI 10.1158/1078-0432.CCR-08-0095; Guo Y, 2012, ONCOL REP, V27, P286, DOI 10.3892/or.2011.1483; Han QW, 2002, J BIOL CHEM, V277, P48379, DOI 10.1074/jbc.M209542200; Harbeck Nadia, 2004, Clin Breast Cancer, V5, P348, DOI 10.3816/CBC.2004.n.040; HUANG SA, 1994, J BIOL CHEM, V269, P28764; Johnson MD, 1999, EXP CELL RES, V247, P105, DOI 10.1006/excr.1998.4336; KAO PN, 1994, J BIOL CHEM, V269, P20691; Kiesler P, 2010, J BIOL CHEM, V285, P8256, DOI 10.1074/jbc.M109.041004; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Li HB, 2005, J BIOL CHEM, V280, P10564, DOI 10.1074/jbc.M412152200; Li Y, 2008, MOL CELL BIOL, V28, P4275, DOI 10.1128/MCB.00369-08; Mahanivong C, 2008, ONCOGENE, V27, P1273, DOI 10.1038/sj.onc.1210746; Mahanivong C, 2007, MOL CARCINOGEN, V46, P165, DOI 10.1002/mc.20249; Mazumdar A, 2001, CANCER RES, V61, P400; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Noh Hyangsoon, 2011, Genes Cancer, V2, P140, DOI 10.1177/1947601911408888; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; PRICE JE, 1990, CANCER RES, V50, P717; Reichman TW, 2003, J MOL BIOL, V332, P85, DOI 10.1016/S0022-2836(03)00885-4; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Shi LF, 2007, J EXP MED, V204, P971, DOI 10.1084/jem.20052078; Sliva D, 2002, BIOCHEM BIOPH RES CO, V290, P552, DOI 10.1006/bbrc.2001.6225; Su S, 2009, ONCOGENE, V28, P3047, DOI 10.1038/onc.2009.163; Vanden Berghe W, 2006, CANCER RES, V66, P4852, DOI 10.1158/0008-5472.CAN-05-2957; Vumbaca F, 2008, MOL CELL BIOL, V28, P772, DOI 10.1128/MCB.02078-06; Watabe T, 1998, INT J CANCER, V77, P128, DOI 10.1002/(SICI)1097-0215(19980703)77:1<128::AID-IJC20>3.0.CO;2-9	46	50	50	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 22	2013	32	34					3933	3943		10.1038/onc.2012.414	http://dx.doi.org/10.1038/onc.2012.414			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IC	22986534	Green Accepted			2022-12-25	WOS:000323748100002
J	Wolyniec, K; Levav-Cohen, Y; Jiang, YH; Haupt, S; Haupt, Y				Wolyniec, K.; Levav-Cohen, Y.; Jiang, Y-H; Haupt, S.; Haupt, Y.			The E6AP E3 ubiquitin ligase regulates the cellular response to oxidative stress	ONCOGENE			English	Article						reactive oxygen species; cellular senescence; anti-oxidants; oxidative stress; cell death; peroxiredoxin 1	INDUCED DNA-DAMAGE; REACTIVE OXYGEN; HYDROGEN-PEROXIDE; TUMOR SUPPRESSION; GROWTH ARREST; INDUCE SENESCENCE; FIBROBLAST CELLS; CERVICAL-CANCER; C-MYC; P53	The E6AP E3 ubiquitin ligase has been linked to the regulation of cell growth and to the cellular stress response. However, the specific stress conditions that are controlled by E6AP have not been defined. An important stress condition that controls cell growth is oxidative stress, where the levels of intracellular reactive oxygen species (ROS) regulate the appropriate cellular response. Here, we describe a novel role for E6AP in the control of oxidative stress response. Cells lacking E6AP expression have reduced capacity to accumulate ROS, and oxidative DNA damage, in response to 20% cell culture oxygen levels, treatment with hydrogen peroxide and expression of oncogenic RAS. This effect of E6AP is associated with the regulation of the anti-oxidant enzyme, Prx1, a previously identified target of E6AP, and can be corrected by downregulation of Prx1 or by reconstitution of E6AP expression. Consequently, cells with compromised E6AP have impaired senescent and apoptotic response to sub-lethal and lethal doses of oxidative stress, respectively. In a xenograft model, downregulation of E6AP renders transplanted tumours refractory to growth-suppressive effects of hydrogen peroxide. Our results provide the first demonstration that E6AP is an important regulator of ROS-mediated cellular senescence and cell death.	[Wolyniec, K.; Haupt, S.; Haupt, Y.] Peter MacCallum Canc Ctr, Tumour Suppress Lab, East Melbourne, Vic, Australia; [Wolyniec, K.; Haupt, S.; Haupt, Y.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Levav-Cohen, Y.] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Sch Med, Jerusalem, Israel; [Jiang, Y-H] Duke Univ, Sch Med, Dept Pediat & Neurobiol, Div Med Genet, Durham, NC USA; [Haupt, Y.] Univ Melbourne, Dept Pathol, Melbourne, Vic, Australia; [Haupt, Y.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; Hebrew University of Jerusalem; Hadassah University Medical Center; Duke University; University of Melbourne; Monash University	Haupt, Y (corresponding author), Peter MacCallum Canc Ctr, Tumour Suppress Lab, St Andrews Pl, Melbourne, Vic 3002, Australia.	ygal.haupt@petermac.org		Haupt, Ygal/0000-0001-5925-0096	National Health and Medical Research Council (NHMRC) of Australia [509196, 509197, 1026990, 1026988]; Cancer Council Victoria; VESKI award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD043494] Funding Source: NIH RePORTER	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); VESKI award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank Scott Lowe, Martin Scheffner and Ikuo Shoji who generously provided plasmids. This work was supported by grants from the National Health and Medical Research Council (NHMRC) of Australia to YH (NHMRC #509196, #509197, #1026990, #1026988), by a grant from the Cancer Council Victoria, and by the VESKI award. YH is NHMRC Senior Research Fellow.	Bacsi A, 2007, MECH AGEING DEV, V128, P637, DOI 10.1016/j.mad.2007.09.005; Beaudenon S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S4; BENYOSEPH O, 1994, BRIT J CANCER, V70, P1131, DOI 10.1038/bjc.1994.460; Bertram C, 2008, BIOL CHEM, V389, P211, DOI 10.1515/BC.2008.031; Bladier C, 1997, CELL GROWTH DIFFER, V8, P589; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; Cha MK, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-93; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; Hengstermann A, 2001, P NATL ACAD SCI USA, V98, P1218, DOI 10.1073/pnas.031470698; Howley Peter M, 2006, Trans Am Clin Climatol Assoc, V117, P113; Jones FS, 2001, CIRC RES, V89, P131, DOI 10.1161/hh1401.093582; Lee AC, 1999, J BIOL CHEM, V274, P7936, DOI 10.1074/jbc.274.12.7936; Leikam C, 2008, ONCOGENE, V27, P7070, DOI 10.1038/onc.2008.323; Levav-Cohen Y, 2012, ONCOGENE, V31, P2199, DOI 10.1038/onc.2011.402; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Matentzoglu K, 2008, BIOCHEM SOC T, V36, P797, DOI 10.1042/BST0360797; Nasu J, 2010, J CELL BIOCHEM, V111, P676, DOI 10.1002/jcb.22752; NATHAN CF, 1981, J EXP MED, V154, P1539, DOI 10.1084/jem.154.5.1539; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Ramamoorthy S, 2012, BREAST CANCER RES TR, V132, P97, DOI 10.1007/s10549-011-1567-2; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SUGIURA K, 1958, NATURE, V182, P1310, DOI 10.1038/1821310a0; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; Vurusaner B, 2012, FREE RADICAL BIO MED, V52, P7, DOI 10.1016/j.freeradbiomed.2011.09.035; Weyemi U, 2012, ONCOGENE, V31, P1117, DOI 10.1038/onc.2011.327; Wolyniec K, 2009, ONCOGENE, V28, P2502, DOI 10.1038/onc.2009.101; Yoshizaki K, 2009, BIOSCI BIOTECH BIOCH, V73, P311, DOI 10.1271/bbb.80517; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584	43	18	18	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 25	2013	32	30					3510	3519		10.1038/onc.2012.365	http://dx.doi.org/10.1038/onc.2012.365			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	188UQ	22986523				2022-12-25	WOS:000322220800004
J	Linke, C; Siemens, N; Oehmcke, S; Radjainia, M; Law, RHP; Whisstock, JC; Baker, EN; Kreikemeyer, B				Linke, Christian; Siemens, Nikolai; Oehmcke, Sonja; Radjainia, Mazdak; Law, Ruby H. P.; Whisstock, James C.; Baker, Edward N.; Kreikemeyer, Bernd			The Extracellular Protein Factor Epf from Streptococcus pyogenes Is a Cell Surface Adhesin That Binds to Cells through an N-terminal Domain Containing a Carbohydrate-binding Module	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-ANGLE SCATTERING; GROUP-A STREPTOCOCCI; VIRULENCE FACTOR EXPRESSION; PATHOGENICITY REGION; SECONDARY-STRUCTURE; CRYSTAL-STRUCTURE; EPITHELIAL-CELLS; LIGAND-BINDING; FIBRONECTIN; PLASMINOGEN	Streptococcus pyogenes is an exclusively human pathogen. Streptococcal attachment to and entry into epithelial cells is a prerequisite for a successful infection of the human host and requires adhesins. Here, we demonstrate that the multidomain protein Epf from S. pyogenes serotype M49 is a streptococcal adhesin. An epf-deficient mutant showed significantly decreased adhesion to and internalization into human keratinocytes. Cell adhesion is mediated by the N-terminal domain of Epf (EpfN) and increased by the human plasma protein plasminogen. The crystal structure of EpfN, solved at 1.6 angstrom resolution, shows that it consists of two subdomains: a carbohydrate-binding module and a fibronectin type III domain. Both fold types commonly participate in ligand receptor and protein-protein interactions. EpfN is followed by 18 repeats of a domain classified as DUF1542 (domain of unknown function 1542) and a C-terminal cell wall sorting signal. The DUF1542 repeats are not involved in adhesion, but biophysical studies show they are predominantly alpha-helical and form a fiber-like stalk of tandem DUF1542 domains. Epf thus conforms with the widespread family of adhesins known as MSCRAMMs (microbial surface components recognizing adhesive matrix molecules), in which a cell wall-attached stalk enables long range interactions via its adhesive N-terminal domain.	[Linke, Christian; Radjainia, Mazdak; Baker, Edward N.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand; [Linke, Christian; Radjainia, Mazdak; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Siemens, Nikolai; Oehmcke, Sonja; Kreikemeyer, Bernd] Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, D-18057 Rostock, Germany; [Law, Ruby H. P.; Whisstock, James C.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	University of Auckland; University of Auckland; University of Rostock; Monash University	Baker, EN (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand.	ted.baker@auckland.ac.nz; bernd.kreikemeyer@med.uni-rostock.de	Linke-Winnebeck, Christian/P-1585-2019; Linke-Winnebeck, Christian/F-4091-2010	Linke-Winnebeck, Christian/0000-0002-2306-247X; Linke-Winnebeck, Christian/0000-0002-2306-247X; Siemens, Nikolai/0000-0003-0657-3822; Kreikemeyer, Bernd/0000-0001-9527-5098; Baker, Edward/0000-0003-2456-7661; Whisstock, James/0000-0003-4200-5611; law, ruby/0000-0001-5432-5781	Medical Faculty of the University of Rostock; German Federal Ministry of Education and Research (BMBF); Health Research Council of New Zealand; Tertiary Education Commission of New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery; National Health and Medical Research Council of Australia; New Zealand International Doctoral Research Scholarship (Education New Zealand); Australian Research Council Federation Fellowship; National Health and Medical Research Council of Australia Principal Research Fellowship	Medical Faculty of the University of Rostock; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Health Research Council of New Zealand(Health Research Council of New Zealand); Tertiary Education Commission of New Zealand; Maurice Wilkins Centre for Molecular Biodiscovery; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); New Zealand International Doctoral Research Scholarship (Education New Zealand); Australian Research Council Federation Fellowship(Australian Research Council); National Health and Medical Research Council of Australia Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Medical Faculty of the University of Rostock in the framework of the FORUN program, the German Federal Ministry of Education and Research (BMBF) in the framework of the ERANet "Patho-GenoMics" I and II program, the Health Research Council of New Zealand, the Tertiary Education Commission of New Zealand through funding of the Maurice Wilkins Centre for Molecular Biodiscovery and the National Health and Medical Research Council of Australia. Access to the Australian Synchrotron was supported by the New Zealand Synchrotron Group Ltd.; Supported by a New Zealand International Doctoral Research Scholarship (Education New Zealand).; Supported by an Australian Research Council Federation Fellowship and an honorary National Health and Medical Research Council of Australia Principal Research Fellowship.	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Arnon TI, 2008, J MOL BIOL, V381, P1012, DOI 10.1016/j.jmb.2008.06.082; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boraston AB, 2003, J MOL BIOL, V327, P659, DOI 10.1016/S0022-2836(03)00152-9; Boraston AB, 2002, J MOL BIOL, V319, P1143, DOI 10.1016/S0022-2836(02)00374-1; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; Cue D, 1998, INFECT IMMUN, V66, P4593, DOI 10.1128/IAI.66.10.4593-4601.1998; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gullfot F, 2010, PROTEINS, V78, P785, DOI 10.1002/prot.22642; Himanen JP, 2009, EMBO REP, V10, P722, DOI 10.1038/embor.2009.91; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Joh D, 1999, MATRIX BIOL, V18, P211, DOI 10.1016/S0945-053X(99)00025-6; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kreikemeyer B, 2004, INT J MED MICROBIOL, V294, P177, DOI 10.1016/j.ijmm.2004.06.017; Kreikemeyer B, 2004, J BIOL CHEM, V279, P15850, DOI 10.1074/jbc.M313613200; Kreikemeyer B, 2007, INFECT IMMUN, V75, P5698, DOI 10.1128/IAI.00175-07; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwinn LA, 2007, J BACTERIOL, V189, P1322, DOI 10.1128/JB.01256-06; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115; Linke C, 2012, ACTA CRYSTALLOGR F, V68, P793, DOI 10.1107/S1744309112020313; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLellan JS, 2008, NATURE, V455, P979, DOI 10.1038/nature07358; Osterlund A, 1997, ACTA OTO-LARYNGOL, V117, P883, DOI 10.3109/00016489709114219; Ozeri V, 1998, MOL MICROBIOL, V30, P625, DOI 10.1046/j.1365-2958.1998.01097.x; PATTI JM, 1992, J BIOL CHEM, V267, P4766; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Podbielski A, 2001, LANCET, V358, P3, DOI 10.1016/S0140-6736(00)05296-X; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Siemens N, 2012, J BACTERIOL, V194, P3618, DOI 10.1128/JB.00227-12; Siemens N, 2011, J BIOL CHEM, V286, P21612, DOI 10.1074/jbc.M110.202671; Simpson PJ, 2002, BIOCHEMISTRY-US, V41, P5712, DOI 10.1021/bi012093i; SMITH HE, 1993, INFECT IMMUN, V61, P3318, DOI 10.1128/IAI.61.8.3318-3326.1993; Unneberg P, 2001, PROTEINS, V42, P460, DOI 10.1002/1097-0134(20010301)42:4<460::AID-PROT50>3.0.CO;2-U; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vengadesan K, 2011, PROTEIN SCI, V20, P759, DOI 10.1002/pro.613; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006	53	17	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.376434	http://dx.doi.org/10.1074/jbc.M112.376434			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977243	Green Published, hybrid			2022-12-25	WOS:000310642200051
J	Borg, C; de Jong, PJ				Borg, Charmaine; de Jong, Peter J.			Feelings of Disgust and Disgust-Induced Avoidance Weaken following Induced Sexual Arousal in Women	PLOS ONE			English	Article							CONTAMINATION SENSITIVITY; VAGINISMUS; DYSPAREUNIA; BEHAVIOR; DISEASE; RISK; SELF	Background: Sex and disgust are basic, evolutionary relevant functions that are often construed as paradoxical. In general the stimuli involved in sexual encounters are, at least out of context strongly perceived to hold high disgust qualities. Saliva, sweat, semen and body odours are among the strongest disgust elicitors. This results in the intriguing question of how people succeed in having pleasurable sex at all. One possible explanation could be that sexual engagement temporarily reduces the disgust eliciting properties of particular stimuli or that sexual engagement might weaken the hesitation to actually approach these stimuli. Methodology: Participants were healthy women (n = 90) randomly allocated to one of three groups: the sexual arousal, the non-sexual positive arousal, or the neutral control group. Film clips were used to elicit the relevant mood state. Participants engaged in 16 behavioural tasks, involving sex related (e. g., lubricate the vibrator) and non-sex related (e. g., take a sip of juice with a large insect in the cup) stimuli, to measure the impact of sexual arousal on feelings of disgust and actual avoidance behaviour. Principal Findings: The sexual arousal group rated the sex related stimuli as less disgusting compared to the other groups. A similar tendency was evident for the non-sex disgusting stimuli. For both the sex and non-sex related behavioural tasks the sexual arousal group showed less avoidance behaviour (i.e., they conducted the highest percentage of tasks compared to the other groups). Significance: This study has investigated how sexual arousal interplays with disgust and disgust eliciting properties in women, and has demonstrated that this relationship goes beyond subjective report by affecting the actual approach to disgusting stimuli. Hence, this could explain how we still manage to engage in pleasurable sexual activity. Moreover, these findings suggest that low sexual arousal might be a key feature in the maintenance of particular sexual dysfunctions.	[Borg, Charmaine; de Jong, Peter J.] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands	University of Groningen	Borg, C (corresponding author), Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands.	c.borg@med.umcg.nl	de Jong, Peter/ABB-1750-2020; de Jong, Peter/E-9095-2014	de Jong, Peter/0000-0002-3512-3663; de Jong, Peter/0000-0002-3512-3663; Borg, Charmaine/0000-0002-0122-1118	University of Groningen; University Medical Centre Groningen; Malta Government [MGSS_PHD_2008-12]	University of Groningen; University Medical Centre Groningen; Malta Government	The University of Groningen and University Medical Centre Groningen support this study, together with Malta Government Scholarship Scheme grant number MGSS_PHD_2008-12 which partially funds the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariely D, 2006, J BEHAV DECIS MAKING, V19, P87, DOI 10.1002/bdm.501; Borg C, 2013, SOC COGN AFFECT NEUR, V8, P351, DOI 10.1093/scan/nss006; Borg C, 2010, J SEX MED, V7, P2149, DOI 10.1111/j.1743-6109.2010.01800.x; Connolly KM, 2008, PERS INDIV DIFFER, V44, P898, DOI 10.1016/j.paid.2007.10.020; Curtis V, 2004, P ROY SOC B-BIOL SCI, V271, pS131, DOI 10.1098/rsbl.2003.0144; Curtis V, 2011, PHILOS T R SOC B, V366, P389, DOI 10.1098/rstb.2010.0117; de Jong PJ, 2009, ARCH SEX BEHAV, V38, P244, DOI 10.1007/s10508-007-9240-x; Ditto PH, 2006, J BEHAV DECIS MAKING, V19, P99, DOI 10.1002/bdm.520; Fergus TA, 2009, J ANXIETY DISORD, V23, P703, DOI 10.1016/j.janxdis.2009.02.009; Fessler DMT, 2003, APPETITE, V41, P31, DOI 10.1016/S0195-6663(03)00037-0; HAIDT J, 1994, PERS INDIV DIFFER, V16, P701, DOI 10.1016/0191-8869(94)90212-7; Koukounas E, 1997, BEHAV RES THER, V35, P221, DOI 10.1016/S0005-7967(96)00097-6; Olatunji BO, 2008, J RES PERS, V42, P1243, DOI 10.1016/j.jrp.2008.03.009; ROZIN P, 1995, J RES PERS, V29, P318, DOI 10.1006/jrpe.1995.1019; Rozin P., 2008, HDB EMOTIONS, P637; Salvatore S, 2011, EUR J OBSTET GYN R B, V156, P131, DOI 10.1016/j.ejogrb.2011.01.028; Stevenson RJ, 2011, ARCH SEX BEHAV, V40, P79, DOI 10.1007/s10508-009-9529-z; van der Velde J, 2001, BEHAV RES THER, V39, P395, DOI 10.1016/S0005-7967(00)00007-3; van Overveld M, 2010, PERS INDIV DIFFER, V49, P706, DOI 10.1016/j.paid.2010.06.008; van Overveld WJM, 2006, PERS INDIV DIFFER, V41, P1241, DOI 10.1016/j.paid.2006.04.021	20	69	69	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44111	10.1371/journal.pone.0044111	http://dx.doi.org/10.1371/journal.pone.0044111			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984465	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500030
J	Pascalis, H; Temmam, S; Turpin, M; Rollot, O; Flahault, A; Carrat, F; de Lamballerie, X; Gerardin, P; Dellagi, K				Pascalis, Herve; Temmam, Sarah; Turpin, Magali; Rollot, Olivier; Flahault, Antoine; Carrat, Fabrice; de Lamballerie, Xavier; Gerardin, Patrick; Dellagi, Koussay			Intense Co-Circulation of Non-Influenza Respiratory Viruses during the First Wave of Pandemic Influenza pH1N1/2009: A Cohort Study in Reunion Island	PLOS ONE			English	Article							SYNCYTIAL VIRUS; SWINE-ORIGIN; INFECTIONS; TRANSMISSION; ASSAYS; CHILDREN; ADULTS; PCR; HIV	Objective: The aim of the present study was to weigh up, at the community level, the respective roles played by pandemic Influenza (pH1N1) virus and co-circulating human Non-Influenza Respiratory Viruses (NIRVs) during the first wave of the 2009 pH1N1 pandemic. Methods: A population-based prospective cohort study was conducted in Reunion Island during the austral winter 2009 (weeks 30-44) that allowed identification of 125 households with at least one member who developed symptoms of Influenza-like illness (ILI). Three consecutive nasal swabs were collected from each household member (443 individuals) on day 0, 3 and 8 post-ILI report and tested for pH1N1 and 15 NIRVs by RT-PCR. Results: Two successive waves of viral infections were identified: a first wave (W33-37) when pH1N1 was dominant and co-circulated with NIRVs, sharply interrupted by a second wave (W38-44), almost exclusively composed of NIRVs, mainly human Rhinoviruses (hRV) and Coronaviruses (hCoV). Data suggest that some interference may occur between NIRVs and pH1N1 when they co-circulate within the same household, where NIRVs were more likely to infect pH1N1 negative individuals than pH1N1 positive peers (relative risk: 3.13, 95% CI: 1.80-5.46, P<0.001). Viral shedding was significantly shorter (P = 0.035) in patients who were co-infected by pH1N1 and NIRV or by two different NIRVs compared to those who were infected with only one virus, whatever this virus was (pH1N1 or NIRVs). Although intense co-circulation of NIRVs (especially hRV) likely brought pH1N1 under the detection threshold, it did not prevent spread of the pandemic Influenza virus within the susceptible population nor induction of an extensive herd immunity to it. Conclusion: Our results suggest that NIRV co-infections during Influenza epidemics may act as cofactors that contribute to shape an outbreak and modulate the attack rate. They further warrant broad spectrum studies to fully understand viral epidemics.	[Pascalis, Herve; Temmam, Sarah; Turpin, Magali; Dellagi, Koussay] Ctr Rech & Veille Malad Emergentes Ocean Indien C, St Clotilde, Reunion, France; [Pascalis, Herve; Turpin, Magali; Dellagi, Koussay] IRD, St Clotilde, Reunion, France; [Rollot, Olivier; Gerardin, Patrick] Univ St Pierre, CHR, CIC EC, INSERM,URMLR, St Pierre, Reunion, France; [Temmam, Sarah] Univ Lyon 1, CNRS, Ecol Microbienne UMR 5557, F-69365 Lyon, France; [de Lamballerie, Xavier] Univ Mediterranee, IRD, Unite Virus Emergents UMR S 190, Marseille, France; [Carrat, Fabrice] Univ Paris 06, INSERM, Epidemiol Malad Infect & Modelisat UMR S 707, Paris, France; [Flahault, Antoine] EHESP, Rennes, France	Institut de Recherche pour le Developpement (IRD); CHU Reunion; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Ecole des Hautes Etudes en Sante Publique (EHESP)	Pascalis, H (corresponding author), Ctr Rech & Veille Malad Emergentes Ocean Indien C, St Clotilde, Reunion, France.	koussay.dellagi@ird.fr	Carrat, Fabrice/AAU-8480-2020; Pascalis, Herve/F-5726-2014; TEMMAM, Sarah/AAX-3717-2021; Pascalis, Herve/M-9410-2019	Carrat, Fabrice/0000-0002-8672-7918; Pascalis, Herve/0000-0002-6822-7311; TEMMAM, Sarah/0000-0003-3655-9220; Abid, sayda/0000-0003-2488-1431	CPER-ERDF (Contrat Programme Etat-Region and European Regional Development Fund); INSERM/IMMI (L'Institut de Microbiologie et des Maladies Infectieuses); CRVOI (The Centre for Research and Intelligence on Emerging Diseases in the Indian Ocean); CPER-ERDF (Contrat Programme Etat-Region and European Regional Development Fund); INSERM/IMMI (L'Institut de Microbiologie et des Maladies Infectieuses); CRVOI (The Centre for Research and Intelligence on Emerging Diseases in the Indian Ocean)	CPER-ERDF (Contrat Programme Etat-Region and European Regional Development Fund); INSERM/IMMI (L'Institut de Microbiologie et des Maladies Infectieuses); CRVOI (The Centre for Research and Intelligence on Emerging Diseases in the Indian Ocean); CPER-ERDF (Contrat Programme Etat-Region and European Regional Development Fund); INSERM/IMMI (L'Institut de Microbiologie et des Maladies Infectieuses); CRVOI (The Centre for Research and Intelligence on Emerging Diseases in the Indian Ocean)	This study was supported by funds from CPER-ERDF (Contrat Programme Etat-Region and European Regional Development Fund), INSERM/IMMI (L'Institut de Microbiologie et des Maladies Infectieuses) and CRVOI (The Centre for Research and Intelligence on Emerging Diseases in the Indian Ocean). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Laguna-Torres VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011719; Anestad G, 2011, MED HYPOTHESES, V77, P1132, DOI 10.1016/j.mehy.2011.09.021; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bibby DF, 2011, J MED VIROL, V83, P1469, DOI 10.1002/jmv.22125; Brunstein JD, 2008, J CLIN MICROBIOL, V46, P97, DOI 10.1128/JCM.01117-07; BVS, 2010, B VEILLE SANITAIRE; Casalegno JS, 2010, CLIN MICROBIOL INFEC, V16, P326, DOI 10.1111/j.1469-0691.2010.03167.x; D'Ortenzio E, 2010, CLIN MICROBIOL INFEC, V16, P309, DOI 10.1111/j.1469-0691.2010.03171.x; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dellagi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025738; Drummond AJ, 2010, GENEIOUS V5 3; Esposito S, 2011, VIROLOGY J, V8; Flasche S, 2011, EPIDEMICS-NETH, V3, P125, DOI 10.1016/j.epidem.2011.03.005; Follin P, 2009, EUROSURVEILLANCE, V14; Ford ES, 2009, CURR OPIN HIV AIDS, V4, P206, DOI 10.1097/COH.0b013e328329c68c; Freymuth F, 2006, J MED VIROL, V78, P1498, DOI 10.1002/jmv.20725; Gharabaghi F, 2011, CLIN MICROBIOL INFEC, V17, P1900, DOI 10.1111/j.1469-0691.2011.03529.x; Gonzalez JP, 2010, ECOHEALTH, V7, P237, DOI 10.1007/s10393-010-0326-x; Graham AL, 2007, TRENDS PARASITOL, V23, P284, DOI 10.1016/j.pt.2007.04.005; GRAHAM NMH, 1990, EPIDEMIOL REV, V12, P149, DOI 10.1093/oxfordjournals.epirev.a036050; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Ki CS, 2008, J VIROL METHODS; Larios OE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021335; Li H, 2007, J CLIN MICROBIOL, V45, P2105, DOI 10.1128/JCM.00210-07; Li JG, 2012, J INFECTION, V64, P96, DOI 10.1016/j.jinf.2011.10.011; Linde A, 2009, EUROSURVEILLANCE, V14, P2; Ninove L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016142; Ninove L, 2010, VECTOR-BORNE ZOONOT, V10, P237, DOI 10.1089/vbz.2009.0110; Nisii C, 2010, J CLIN MICROBIOL, V48, P3383, DOI 10.1128/JCM.01179-10; Nougairede A, 2009, PLOS CURR, V1; Pawlowski A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002464; Razanajatovo NH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017579; Sapin G, 2001, B SOC PATHOL EXOT, V94, P3; Schnepf N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023514; Stensballe LG, 2003, PEDIATR INFECT DIS J, V22, pS21, DOI 10.1097/00006454-200302001-00004; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Waiboci LW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020320; Wang W, 2009, J VIROL METHODS, V162, P40, DOI 10.1016/j.jviromet.2009.07.004; Yang X.Y., 2012, PLOS ONE, V7	42	28	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44755	10.1371/journal.pone.0044755	http://dx.doi.org/10.1371/journal.pone.0044755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984554	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500081
J	Jensen, B; Boukens, BJD; Postma, AV; Gunst, QD; van den Hoff, MJB; Moorman, AFM; Wang, T; Christoffels, VM				Jensen, Bjarke; Boukens, Bastiaan J. D.; Postma, Alex V.; Gunst, Quinn D.; van den Hoff, Maurice J. B.; Moorman, Antoon F. M.; Wang, Tobias; Christoffels, Vincent M.			Identifying the Evolutionary Building Blocks of the Cardiac Conduction System	PLOS ONE			English	Article							T-BOX GENES; ATRIOVENTRICULAR-CANAL FORMATION; HEART DEVELOPMENT; ELECTRICAL ACTIVATION; CHAMBER FORMATION; AVIAN HEART; MOUSE HEART; EXPRESSION; TISSUES; ELECTROCARDIOGRAPHY	The endothermic state of mammals and birds requires high heart rates to accommodate the high rates of oxygen consumption. These high heart rates are driven by very similar conduction systems consisting of an atrioventricular node that slows the electrical impulse and a His-Purkinje system that efficiently activates the ventricular chambers. While ectothermic vertebrates have similar contraction patterns, they do not possess anatomical evidence for a conduction system. This lack amongst extant ectotherms is surprising because mammals and birds evolved independently from reptile-like ancestors. Using conserved genetic markers, we found that the conduction system design of lizard (Anolis carolinensis and A. sagrei), frog (Xenopus laevis) and zebrafish (Danio rerio) adults is strikingly similar to that of embryos of mammals (mouse Mus musculus, and man) and chicken (Gallus gallus). Thus, in ectothermic adults, the slow conducting atrioventricular canal muscle is present, no fibrous insulating plane is formed, and the spongy ventricle serves the dual purpose of conduction and contraction. Optical mapping showed base-to-apex activation of the ventricles of the ectothermic animals, similar to the activation pattern of mammalian and avian embryonic ventricles and to the His-Purkinje systems of the formed hearts. Mammalian and avian ventricles uniquely develop thick compact walls and septum and, hence, form a discrete ventricular conduction system from the embryonic spongy ventricle. Our study uncovers the evolutionary building plan of heart and indicates that the building blocks of the conduction system of adult ectothermic vertebrates and embryos of endotherms are similar.	[Jensen, Bjarke; Boukens, Bastiaan J. D.; Postma, Alex V.; Gunst, Quinn D.; van den Hoff, Maurice J. B.; Moorman, Antoon F. M.; Christoffels, Vincent M.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands; [Jensen, Bjarke; Wang, Tobias] Aarhus Univ, Dept Biol Sci, Aarhus, Denmark	University of Amsterdam; Academic Medical Center Amsterdam; Aarhus University	Jensen, B (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	v.m.christoffels@amc.uva.nl	Postma, Alex V/H-4806-2019; Jensen, Bjarke/I-7490-2019; Wang, Tobias/I-7946-2013; Jensen, Bjarke/GQI-3989-2022	Postma, Alex V/0000-0003-4874-2487; Jensen, Bjarke/0000-0002-7750-8035; Wang, Tobias/0000-0002-4350-3682; Boukens, Bastiaan J/0000-0001-6449-145X; van den Hoff, Maurice/0000-0002-3837-8055	European Community ['CardioGeNet' 223463]; Netherlands Heart Foundation [NHS 2008B062]; Danish Council for Independent Research \ Natural Sciences	European Community(European Commission); Netherlands Heart Foundation(Netherlands Heart Foundation); Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF))	This work was supported by grants from the European Community's Seventh Framework Programme contract ('CardioGeNet' 223463 to VMC) and the Netherlands Heart Foundation (NHS 2008B062 to VMC). Tobias Wang and Bjarke Jensen were supported by The Danish Council for Independent Research vertical bar Natural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanhaanen WTJ, 2010, CIRC RES, V107, P728, DOI 10.1161/CIRCRESAHA.110.222992; Aanhaanen WTJ, 2009, CIRC RES, V104, P1267, DOI 10.1161/CIRCRESAHA.108.192450; ANDERSON RH, 1974, CIRCULATION, V50, P911, DOI 10.1161/01.CIR.50.5.911; ARBEL ER, 1977, AM J PHYSIOL, V232, pH24, DOI 10.1152/ajpheart.1977.232.1.H24; Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Azarov JE, 2007, COMP BIOCHEM PHYS A, V146, P310, DOI 10.1016/j.cbpa.2006.10.036; Bakker ML, 2008, CIRC RES, V102, P1340, DOI 10.1161/CIRCRESAHA.107.169565; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; BEYER EC, 1990, J BIOL CHEM, V265, P14439; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Burggren W., 2010, VERTEBRATE CARDIOVAS; BURGGREN WW, 1978, J PHYSIOL-LONDON, V278, P349, DOI 10.1113/jphysiol.1978.sp012308; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Chi NC, 2008, PLOS BIOL, V6, P1006, DOI 10.1371/journal.pbio.0060109; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Christian E, 1999, COMP BIOCHEM PHYS A, V123, P17, DOI 10.1016/S1095-6433(99)00024-0; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Christoffels VM, 2009, CIRC-ARRHYTHMIA ELEC, V2, P195, DOI 10.1161/CIRCEP.108.829341; Chuck ET, 2004, ANAT REC PART A, V280A, P990, DOI 10.1002/ar.a.20083; DAVIES F, 1946, BIOL REV, V21, P173, DOI 10.1111/j.1469-185X.1946.tb00323.x; DILLON S, 1981, SCIENCE, V214, P453, DOI 10.1126/science.6974891; DURRER D, 1970, CIRCULATION, V41, P899, DOI 10.1161/01.CIR.41.6.899; FURMAN K. I., 1960, S AFRICAN JOUR MED SCI, V25, P109; Gibson-Brown JJ, 1998, MECH DEVELOP, V74, P165, DOI 10.1016/S0925-4773(98)00056-2; GOURDIE RG, 1993, CIRC RES, V72, P278, DOI 10.1161/01.RES.72.2.278; GRAY SW, 1950, AM J PHYSIOL, V162, P249, DOI 10.1152/ajplegacy.1950.162.1.249; Hall CE, 2004, DEVELOPMENT, V131, P581, DOI 10.1242/dev.00947; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harris AS, 1941, AM J PHYSIOL, V134, P0319; HEATONJONES TG, 1994, J ZOO WILDLIFE MED, V25, P40; Hoogaars WMH, 2004, CARDIOVASC RES, V62, P489, DOI 10.1016/j.cardiores.2004.01.030; Houweling AC, 2005, DEV DYNAM, V233, P1076, DOI 10.1002/dvdy.20423; Houweling AC, 2002, ANAT RECORD, V266, P93, DOI 10.1002/ar.10042; Kokubo N, 2010, EVOL DEV, V12, P34, DOI 10.1111/j.1525-142X.2009.00389.x; Kolditz DP, 2008, CIRCULATION, V117, P1508, DOI 10.1161/CIRCULATIONAHA.107.726315; Koshiba-Takeuchi K, 2009, NATURE, V461, P95, DOI 10.1038/nature08324; Lewis T, 1916, PHILOS T R SOC LON B, V207, P221, DOI 10.1098/rstb.1916.0006; Lillywhite HB, 1999, COMP BIOCHEM PHYS A, V124, P369, DOI 10.1016/S1095-6433(99)00129-4; Ma LJ, 2005, DEVELOPMENT, V132, P5601, DOI 10.1242/dev.02156; Martinez-Palomo A, 1980, HEARTS HEART LIKE OR, P171; MCDONALD HS, 1971, COMP BIOCHEM PHYSIOL, V40, P881, DOI 10.1016/0300-9629(71)90277-5; Meek WJ, 1912, AM J PHYSIOL, V31, P31; Miquerol L, 2004, CARDIOVASC RES, V63, P77, DOI 10.1016/j.cardiores.2004.03.007; Miquerol L, 2011, CARDIOVASC RES, V91, P232, DOI 10.1093/cvr/cvr069; Moorman AFM, 2004, ANN NY ACAD SCI, V1015, P171, DOI 10.1196/annals.1302.014; Moorman AFM, 2003, PHYSIOL REV, V83, P1223, DOI 10.1152/physrev.00006.2003; Moorman AFM, 2001, J HISTOCHEM CYTOCHEM, V49, P1, DOI 10.1177/002215540104900101; Moorman AFM, 2005, CARDIOVASCULAR DEVELOPMENT AND CONGENITAL MALFORMATIONS: MOLECULAR AND GENETIC MECHANISMS, P84; MULLEN RK, 1974, COMP BIOCHEM PHYSIOL, V49, P647, DOI 10.1016/0300-9629(74)90892-5; MULLEN RK, 1967, PHYSIOL ZOOL, V40, P114, DOI 10.1086/physzool.40.2.30152446; MURAKAMI T, 1985, JPN J VET SCI, V47, P73; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; NOSEDA V, 1962, EXPERIENTIA, V18, P380, DOI 10.1007/BF02172263; NOSEDA V, 1963, NATURE, V197, P816, DOI 10.1038/197816a0; PETERS JA, 1966, PHYSIOL ZOOL, V39, P193, DOI 10.1086/physzool.39.3.30152847; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Poss KD, 2010, NAT REV GENET, V11, P710, DOI 10.1038/nrg2879; Reckova M, 2003, CIRC RES, V93, P77, DOI 10.1161/01.RES.0000079488.91342.B7; Rentschler S, 2002, P NATL ACAD SCI USA, V99, P10464, DOI 10.1073/pnas.162301699; Sanger TJ, 2008, J MORPHOL, V269, P129, DOI 10.1002/jmor.10563; Sedmera D, 2005, MICROSC MICROANAL, V11, P209, DOI 10.1017/S1431927605050452; Sedmera D, 2003, AM J PHYSIOL-HEART C, V284, pH1152, DOI 10.1152/ajpheart.00870.2002; Sedmera D, 2011, CARDIOVASC RES, V91, P252, DOI 10.1093/cvr/cvr062; Singh R, 2011, CELL MOL LIFE SCI; Sizarov A, 2011, CIRC-ARRHYTHMIA ELEC, V4, P532, DOI 10.1161/CIRCEP.111.963421; Sizarov A, 2011, CIRCULATION, V123, P1125, DOI 10.1161/CIRCULATIONAHA.110.980607; Skovgaard N, 2009, AM J PHYSIOL-REG I, V296, pR774, DOI 10.1152/ajpregu.90466.2008; Somi S, 2004, ANAT REC PART A, V279A, P636, DOI 10.1002/ar.a.20031; Soufan AT, 2007, J MICROSC-OXFORD, V225, P269, DOI 10.1111/j.1365-2818.2007.01742.x; Syme DA, 2002, J EXP BIOL, V205, P1843; Takabatake Y, 2000, MECH DEVELOP, V91, P433, DOI 10.1016/S0925-4773(99)00329-9; Takei Y, 2011, GEN COMP ENDOCR, V171, P258, DOI 10.1016/j.ygcen.2011.02.021; Vaikshnoraite M A, 2008, Zh Evol Biokhim Fiziol, V44, P173; Valderrabano M, 2006, CIRCULATION, V114, P543, DOI 10.1161/CIRCULATIONAHA.106.633727; Valentinuzzi M E, 1969, J Electrocardiol, V2, P245, DOI 10.1016/S0022-0736(69)80084-1; Vaykshnorayte MA, 2011, COMP BIOCHEM PHYS A, V159, P39, DOI 10.1016/j.cbpa.2011.01.016; Verhoeven MC, 2011, BIRTH DEFECTS RES A, V91, P435, DOI 10.1002/bdra.20804; Wessels A, 1996, CIRC RES, V78, P110, DOI 10.1161/01.RES.78.1.110; Yamada M, 2000, DEV BIOL, V228, P95, DOI 10.1006/dbio.2000.9927; Zhao-Xian W, 1991, COMP BIOCH PHYSL A, V98A, P89	81	80	81	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44231	10.1371/journal.pone.0044231	http://dx.doi.org/10.1371/journal.pone.0044231			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984480	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700050
J	Miersch, C; Doring, F				Miersch, Claudia; Doering, Frank			Sex Differences in Carbohydrate Metabolism Are Linked to Gene Expression in Caenorhabditis elegans	PLOS ONE			English	Article							MALE MATING-BEHAVIOR; GENOME-WIDE ANALYSIS; C-ELEGANS; TRANSCRIPTION FACTOR; TREHALOSE METABOLISM; BODY-COMPOSITION; CELL LINEAGES; LIFE-SPAN; NEMATODE; SPERM	The male and the hermaphrodite forms of the nematode Caenorhabditis elegans (C. elegans) differ markedly in anatomy, nervous system and behavior at adulthood. Using the male mutants fog-2, him-5, and him-8, we compared body proportions and composition, and aspects of carbohydrate metabolism and gene expression between the C. elegans sexes in three adult stages. In all experiments, both sexes were grown on the same plate and separated using flow cytometry. The fat to fat-free mass ratio and the body volume-adjusted fat mass is similar between the sexes, although the body size is more than 50% smaller in adult males than in age-matched hermaphrodites. The volume-adjusted total RNA content is approximately 2-fold lower in males. Biochemical and NMR-based analyses reveal higher trehalose levels and much lower glucose levels in males than in hermaphrodites. The resulting trehalose-to-glucose ratio is 5.4-fold higher in males. These sex differences are reflected in gene expression data because the genes encoding key enzymes of the glycolysis and trehalose synthesis pathways are more highly expressed in males than in hermaphrodites. Notably, expression of the phosphofructokinase gene (C50F4.2) is 29-fold higher in males. Comparative analysis of gene expression data identifies 285 male-specific and 160 hermaphrodite-specific genes. These include transcription factor and C-type lectin-encoding genes. More than 35% of all C-type lectin genes are more highly expressed in males. The expression of many C-type lectin genes differs by a factor of >100 between the sexes. In conclusion, we found sex differences in carbohydrate metabolism that are linked to gene expression and identified certain lectin genes that are differentially expressed by the C. elegans sexes.	[Miersch, Claudia; Doering, Frank] Univ Kiel, Inst Human Nutr & Food Sci, Dept Mol Prevent, Kiel, Germany	University of Kiel	Miersch, C (corresponding author), Univ Kiel, Inst Human Nutr & Food Sci, Dept Mol Prevent, Kiel, Germany.	sek@molprev.uni-kiel.de			Deutsche Forschungsgemeinschaft in the context of the Cluster of Excellence "Inflammation at Interfaces" at the University of Kiel; German Ministry of Education and Research [BMBF 0315681]	Deutsche Forschungsgemeinschaft in the context of the Cluster of Excellence "Inflammation at Interfaces" at the University of Kiel; German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by a structural grand from the Deutsche Forschungsgemeinschaft in the context of the Cluster of Excellence "Inflammation at Interfaces" at the University of Kiel and by a grant form the German Ministry of Education and Research (BMBF 0315681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andachi Y, 2004, GENES CELLS, V9, P331, DOI 10.1111/j.1356-9597.2004.00725.x; Azevedo RBR, 2002, GENETICS, V162, P755; Barr MM, 1999, NATURE, V401, P386, DOI 10.1038/43916; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Behm CA, 1997, INT J PARASITOL, V27, P215, DOI 10.1016/S0020-7519(96)00151-8; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonnet X, 1998, P ROY SOC B-BIOL SCI, V265, P179, DOI 10.1098/rspb.1998.0280; Boos M, 2002, BIRD STUDY, V49, P212, DOI 10.1080/00063650209461268; BRENNER S, 1974, GENETICS, V77, P71; Chu DS, 2006, NATURE, V443, P101, DOI 10.1038/nature05050; Crowe JH, 2000, NAT BIOTECHNOL, V18, P145, DOI 10.1038/72580; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; EMMONS SW, 1997, C ELEGANS, V2, P295; Gems D, 1996, NATURE, V379, P723, DOI 10.1038/379723a0; Gems D, 2000, GENETICS, V154, P1597; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hardaker LA, 2001, J NEUROBIOL, V49, P303, DOI 10.1002/neu.10014; Hirose T, 2003, DEVELOPMENT, V130, P1089, DOI 10.1242/dev.00330; HODGKIN J, 1979, GENETICS, V91, P67; Hodgkin J., 1988, NEMATODE CAENORHABDI, P243; Honda Y, 2010, AGING CELL, V9, P558, DOI 10.1111/j.1474-9726.2010.00582.x; Honjoh S, 2011, C EL M 2011; HOPE IA, 1994, DEVELOPMENT, V120, P505; Inoue H, 2010, MOL CELL BIOL, V30, P3453, DOI 10.1128/MCB.01459-09; Jagdale GB, 2005, J PARASITOL, V91, P988, DOI 10.1645/GE-504R.1; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Jonassen T, 2002, J BIOL CHEM, V277, P45020, DOI 10.1074/jbc.M204758200; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kagoshima H, 1999, DEV GENES EVOL, V209, P59, DOI 10.1007/s004270050227; Kilpatrick DC, 2002, BBA-GEN SUBJECTS, V1572, P187, DOI 10.1016/S0304-4165(02)00308-2; KIMBLE J, 1979, DEV BIOL, V70, P396, DOI 10.1016/0012-1606(79)90035-6; Kirchengast S, 2010, J LIFE SCI, V2, P1, DOI [DOI 10.1371/journal.pmed.0040097, 10.1080/09751270.2010.11885146, DOI 10.1080/09751270.2010.11885146]; Klapper M, 2011, J LIPID RES, V52, P1281, DOI 10.1194/jlr.D011940; Kormish JD, 2005, DEV BIOL, V287, P35, DOI 10.1016/j.ydbio.2005.08.027; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; LaMunyon CW, 1998, P ROY SOC B-BIOL SCI, V265, P1997, DOI 10.1098/rspb.1998.0531; Lee KH, 2007, CURR BIOL, V17, P1858, DOI 10.1016/j.cub.2007.10.015; Lindberg J, GENOMICS, V95, P1; Lints R, 2002, GENE DEV, V16, P2390, DOI 10.1101/gad.1012602; Lipton J, 2004, J NEUROSCI, V24, P7427, DOI 10.1523/JNEUROSCI.1746-04.2004; LIU KS, 1995, NEURON, V14, P79, DOI 10.1016/0896-6273(95)90242-2; LOER CM, 1993, J NEUROSCI, V13, P5407, DOI 10.1523/JNEUROSCI.13-12-05407.1993; MAH KB, 1992, BEHAV NEURAL BIOL, V58, P211, DOI 10.1016/0163-1047(92)90496-Q; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Pasche B, 2005, INFECT IMMUN, V73, P5952, DOI 10.1128/IAI.73.9.5952-5960.2005; Pellerone FI, 2003, INT J PARASITOL, V33, P1195, DOI 10.1016/S0020-7519(03)00173-5; Peterson R N, 1969, Biol Reprod, V1, P238, DOI 10.1095/biolreprod1.3.238; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Pickett CL, 2007, DEV BIOL, V310, P226, DOI 10.1016/j.ydbio.2007.07.034; Portman DS, 2007, ADV GENET, V59, P1, DOI 10.1016/S0065-2660(07)59001-2; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Salomon MP, 2009, GENETICS, V183, P685, DOI 10.1534/genetics.109.107383; SCHEDL T, 1988, GENETICS, V119, P43; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Schulte-Hostedde AI, 2001, CAN J ZOOL, V79, P1016, DOI 10.1139/cjz-79-6-1016; SHEN MM, 1988, CELL, V54, P1019, DOI 10.1016/0092-8674(88)90117-1; SMITH DWE, 1989, BIOL REV, V64, P1, DOI 10.1111/j.1469-185X.1989.tb00635.x; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1980, DEV BIOL, V78, P542, DOI 10.1016/0012-1606(80)90352-8; Takahashi K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004104; Thoemke K, 2005, DEV BIOL, V284, P500, DOI 10.1016/j.ydbio.2005.05.017; van den Berg MCW, 2006, GENETICS, V173, P677, DOI 10.1534/genetics.106.056093; Vellai T, 2006, GENETICS, V174, P309, DOI 10.1534/genetics.106.061499; Vemuganti SA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-285; WARD S, 1983, DEV BIOL, V98, P70, DOI 10.1016/0012-1606(83)90336-6; WARD S, 1979, DEV BIOL, V73, P304, DOI 10.1016/0012-1606(79)90069-1; Zarse K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004062; Zhang FF, 2011, GENETICS, V188, P753, DOI 10.1534/genetics.111.129064	72	10	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44748	10.1371/journal.pone.0044748	http://dx.doi.org/10.1371/journal.pone.0044748			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984551	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700080
J	Rate, A; Bosco, A; McKenna, KL; Holt, PG; Upham, JW				Rate, Angela; Bosco, Anthony; McKenna, Kathy L.; Holt, Patrick G.; Upham, John W.			Airway Epithelial Cells Condition Dendritic Cells to Express Multiple Immune Surveillance Genes	PLOS ONE			English	Article							LUNG INFLAMMATION; DIFFERENTIAL EXPRESSION; CHEMOKINE RECEPTORS; CROSS-PRESENTATION; MATURATION; RECRUITMENT; ACTIVATION; MONOCYTES; RESPONSES; ALLERGEN	Increasing evidence suggests that crosstalk between airway epithelial cells (AEC) and adjacent dendritic cells (DC) tightly regulates airway mucosal DC function in steady state. AEC are known to express multiple immmuno-modulatory factors, though detailed information on how this influences human DC function remains incomplete. We recently demonstrated using an in vitro coculture model that AEC alter differentiation of monocytes into DC in a manner that inhibits expression of potentially damaging Th2 effector function. In the current study, we have extended these findings to examine other aspects of DC function. Using micro-array technology we show that multiple genes important for immune surveillance are significantly over expressed in purified AEC-conditioned DC, compared to control DC. These findings were confirmed by quantitative real time PCR or flow cytometry in an independent sample set. In particular, AEC-conditioned DC showed selective upregulation of chemokines that recruit Th1 cells, but minimal change in chemokines linked to Th2 cell recruitment. AEC-conditioned DC were also characterized by enhanced expression of complement family genes (C1QB, C2, CD59 and SERPING1), Fcc receptor genes (FCGR1A, FCGR2A, FCGR2B and FCGR2C), signaling lymphocytic activation molecule family member 1 (SLAM), programmed death ligands 1 and 2, CD54 and CD200R1, relative to control DC. These findings suggest that AEC conditioning facilitates the capacity of DC to react to danger signals, to enhance leukocyte recruitment, especially of Th1 effector cells, and to interact with other immune cell populations while minimizing the risks of excessive inflammation leading to tissue damage.	[Rate, Angela; Bosco, Anthony; McKenna, Kathy L.; Holt, Patrick G.] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Rate, Angela; Bosco, Anthony; McKenna, Kathy L.; Holt, Patrick G.] Univ Western Australia, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Upham, John W.] Univ Queensland, Sch Med, Brisbane, Qld, Australia	Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Queensland	Rate, A (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia.	j.upham@uq.edu.au	Holt, Patrick G/H-1548-2011; Bosco, Anthony/AAC-6900-2022; Upham, John/F-4420-2010	Holt, Patrick G/0000-0003-1193-0935; Upham, John/0000-0002-0017-3433; Bosco, Anthony/0000-0002-4335-615X	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, MUCOSAL IMMUNOL, V3, P81; Amigorena S, 2002, J EXP MED, V195, pF1, DOI 10.1084/jem.20011925; Beaty SR, 2007, J IMMUNOL, V178, P1882, DOI 10.4049/jimmunol.178.3.1882; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Bleck B, 2008, J CLIN IMMUNOL, V28, P147, DOI 10.1007/s10875-007-9149-0; Bleck B, 2006, J IMMUNOL, V176, P7431, DOI 10.4049/jimmunol.176.12.7431; Bolstad BM, 2005, STAT BIOL HEALTH, P33; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Boruchov AM, 2005, J CLIN INVEST, V115, P2914, DOI 10.1172/JCI24772; Carballido JM, 1997, J IMMUNOL, V159, P4316; Castellano G, 2004, BLOOD, V103, P3813, DOI 10.1182/blood-2003-09-3046; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; Cochand L, 1999, AM J RESP CELL MOL, V21, P547, DOI 10.1165/ajrcmb.21.5.3785; Demedts IK, 2005, AM J RESP CELL MOL, V32, P177, DOI 10.1165/rcmb.2004-0279OC; Hammad H, 2011, ALLERGY, V66, P579, DOI 10.1111/j.1398-9995.2010.02528.x; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Holt PG, 2008, NAT IMMUNOL, V9, P1011, DOI 10.1038/ni0908-1011; Holt PG, 2004, CURR OPIN ALLERGY CL, V4, P39, DOI 10.1097/01.all.0000113677.18759.dc; HOLT PG, 1994, J IMMUNOL, V153, P256; Huang Y, 2006, J BIOL CHEM, V281, P27398, DOI 10.1074/jbc.M603690200; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Jahnsen FL, 2001, THORAX, V56, P823, DOI 10.1136/thorax.56.11.823; Landsman L, 2007, J IMMUNOL, V178, P2000, DOI 10.4049/jimmunol.178.4.2000; Lebre MC, 2005, IMMUNOL CELL BIOL, V83, P525, DOI 10.1111/j.1440-1711.2005.01365.x; Liu Y, 2006, J IMMUNOL, V177, P8440, DOI 10.4049/jimmunol.177.12.8440; Longhi MP, 2007, EUR J IMMUNOL, V37, P1266, DOI 10.1002/eji.200636755; Matsumoto K, 2004, J IMMUNOL, V172, P2530, DOI 10.4049/jimmunol.172.4.2530; Mayer AK, 2008, EUR J IMMUNOL, V38, P1689, DOI 10.1002/eji.200737936; McWilliam AS, 1996, J EXP MED, V184, P2429, DOI 10.1084/jem.184.6.2429; Nauta AJ, 2004, J IMMUNOL, V173, P3044, DOI 10.4049/jimmunol.173.5.3044; Parlato S, 2001, BLOOD, V98, P3022, DOI 10.1182/blood.V98.10.3022; Petersen SV, 2000, MOL IMMUNOL, V37, P803, DOI 10.1016/S0161-5890(01)00004-9; Pichavant M, 2006, J IMMUNOL, V177, P5912, DOI 10.4049/jimmunol.177.9.5912; Rate A, 2009, J IMMUNOL, V182, P72, DOI 10.4049/jimmunol.182.1.72; Regamey N, 2007, AM J RESP CELL MOL, V37, P75, DOI 10.1165/rcmb.2006-0235OC; Reis ES, 2007, IMMUNOBIOLOGY, V212, P151, DOI 10.1016/j.imbio.2006.11.010; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Samsom JN, 2005, J IMMUNOL, V174, P5279, DOI 10.4049/jimmunol.174.9.5279; Smits HH, 2002, J IMMUNOL, V168, P1710, DOI 10.4049/jimmunol.168.4.1710; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Stumbles PA, 2001, J IMMUNOL, V167, P228, DOI 10.4049/jimmunol.167.1.228; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Upham JW, 2006, CURR DRUG TARGETS, V7, P541, DOI 10.2174/138945006776818647; Upham JW, 2002, CLIN EXP ALLERGY, V32, P818, DOI 10.1046/j.1365-2222.2002.01375.x; van Kooten C, 2008, MOL IMMUNOL, V45, P4064, DOI 10.1016/j.molimm.2008.07.015; Vegh Z, 2003, INT IMMUNOPHARMACOL, V3, P345, DOI 10.1016/S1567-5769(02)00234-5; Ward C, 2009, THORAX, V64, P430, DOI 10.1136/thx.2008.104067	48	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44941	10.1371/journal.pone.0044941	http://dx.doi.org/10.1371/journal.pone.0044941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984588	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700101
J	Rodriguez-Castaneda, G; Hof, AR; Jansson, R; Harding, LE				Rodriguez-Castaneda, Genoveva; Hof, Anouschka R.; Jansson, Roland; Harding, Larisa E.			Predicting the Fate of Biodiversity Using Species' Distribution Models: Enhancing Model Comparability and Repeatability	PLOS ONE			English	Article							CLIMATE-CHANGE; GEOGRAPHIC DISTRIBUTIONS; CONSERVATION; PERFORMANCE; THREATS; SIZES; RANGE; AREA	Species distribution modeling (SDM) is an increasingly important tool to predict the geographic distribution of species. Even though many problems associated with this method have been highlighted and solutions have been proposed, little has been done to increase comparability among studies. We reviewed recent publications applying SDMs and found that seventy nine percent failed to report methods that ensure comparability among studies, such as disclosing the maximum probability range produced by the models and reporting on the number of species occurrences used. We modeled six species of Falco from northern Europe and demonstrate that model results are altered by (1) spatial bias in species' occurrence data, (2) differences in the geographic extent of the environmental data, and (3) the effects of transformation of model output to presence/absence data when applying thresholds. Depending on the modeling decisions, forecasts of the future geographic distribution of Falco ranged from range contraction in 80% of the species to no net loss in any species, with the best model predicting no net loss of habitat in Northern Europe. The fact that predictions of range changes in response to climate change in published studies may be influenced by decisions in the modeling process seriously hampers the possibility of making sound management recommendations. Thus, each of the decisions made in generating SDMs should be reported and evaluated to ensure conclusions and policies are based on the biology and ecology of the species being modeled.	[Rodriguez-Castaneda, Genoveva] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Hof, Anouschka R.; Jansson, Roland; Harding, Larisa E.] Umea Univ, Dept Ecol & Environm Sci, Landscape Ecol Grp, Umea, Sweden; [Hof, Anouschka R.] Swedish Univ Agr Sci SLU, Dept Wildlife Fish & Environm Studies, Umea, Sweden	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Umea University; Swedish University of Agricultural Sciences	Rodriguez-Castaneda, G (corresponding author), SUNY Stony Brook, Stony Brook, NY 11794 USA.	genoveva@life.bio.sunysb.edu	Jansson, Roland/B-7972-2013; Hof, Anouschka R/V-5994-2019	Jansson, Roland/0000-0003-1767-7010; Hof, Anouschka R/0000-0001-6743-0089	Umea University; Nordic Council of Ministers	Umea University; Nordic Council of Ministers	This work was supported by a young researcher award from Umea University (to RJ) and a grant from the Nordic Council of Ministers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2010, J BIOGEOGR, V37, P1378, DOI 10.1111/j.1365-2699.2010.02290.x; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Benito Garzon M, 2008, APPL VEG SCI, V11, P169, DOI 10.3170/2008-7-18348; Bennett P. M., 2002, OX ECOL EV; Bradley BA, 2012, DIVERS DISTRIB, V18, P425, DOI 10.1111/j.1472-4642.2011.00875.x; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Donalisio MR, 2011, ACTA TROP, V119, P125, DOI 10.1016/j.actatropica.2011.04.019; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fernandez Miguel A., 2009, Biodiversity Informatics, V6, P36; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Gaston KJ, 2009, J APPL ECOL, V46, P1, DOI 10.1111/j.1365-2664.2008.01596.x; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Grinnell J., 1917, Auk Cambridge Mass, V34; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Hof AR, 2012, DIVERS DISTRIB, V18, P554, DOI 10.1111/j.1472-4642.2011.00876.x; Jakob SS, 2009, MOL BIOL EVOL, V26, P907, DOI 10.1093/molbev/msp012; Jimenez-Valverde A, 2011, GLOBAL ECOL BIOGEOGR, V20, P114, DOI 10.1111/j.1466-8238.2010.00574.x; Jimenez-Valverde A, 2010, ECOL RES, V25, P947, DOI 10.1007/s11284-010-0753-8; Kinnard C, 2011, NATURE, V479, P509, DOI 10.1038/nature10581; Larson SR, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.11001; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; McPherson JM, 2004, J APPL ECOL, V41, P811, DOI 10.1111/j.0021-8901.2004.00943.x; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Peterson AT, 2008, EVOLUTION, V62, P173, DOI 10.1111/j.1558-5646.2007.00258.x; Peterson AT, 2002, CARBON NANOTUBES LON, V416; Petitpierre B, 2012, SCIENCE, V335, P1344, DOI 10.1126/science.1215933; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Portner HO, 2002, J EXP BIOL, V205, P2217; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Sundseth K, 2009, EUROPEAN COMMISSION; Svensson L, 1999, BIRD GUIDE MOST COMP; Thomas CD, 2011, METHODS ECOL EVOL, V2, P125, DOI 10.1111/j.2041-210X.2010.00065.x; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Vaughan IP, 2005, J APPL ECOL, V42, P720, DOI 10.1111/j.1365-2664.2005.01052.x; Waltari E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000563; Wollan AK, 2008, J BIOGEOGR, V35, P2298, DOI 10.1111/j.1365-2699.2008.01965.x	48	47	47	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44402	10.1371/journal.pone.0044402	http://dx.doi.org/10.1371/journal.pone.0044402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984502	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000308638700057
J	Christian, SL; Zu, D; Licursi, M; Komatsu, Y; Pongnopparat, T; Codner, DA; Hirasawa, K				Christian, Sherri L.; Zu, Dong; Licursi, Maria; Komatsu, Yumiko; Pongnopparat, Theerawat; Codner, Dianne A.; Hirasawa, Kensuke			Suppression of IFN-Induced Transcription Underlies IFN Defects Generated by Activated Ras/MEK in Human Cancer Cells	PLOS ONE			English	Article							INTERFERON-ALPHA RESISTANCE; RAS SIGNALING PATHWAY; ANTIVIRAL RESPONSE; INDUCIBLE GENES; TUMOR-CELLS; MICROARRAY EXPERIMENTS; NEGATIVE REGULATION; ONCOLYTIC VIRUS; RIG-I; KINASE	Certain oncolytic viruses exploit activated Ras signaling in order to replicate in cancer cells. Constitutive activation of the Ras/MEK pathway is known to suppress the effectiveness of the interferon (IFN) antiviral response, which may contribute to Ras-dependent viral oncolysis. Here, we identified 10 human cancer cell lines (out of 16) with increased sensitivity to the anti-viral effects of IFN-alpha after treatment with the MEK inhibitor U0126, suggesting that the Ras/MEK pathway underlies their reduced sensitivity to IFN. To determine how Ras/MEK suppresses the IFN response in these cells, we used DNA microarrays to compare IFN-induced transcription in IFN-sensitive SKOV3 cells, moderately resistant HT1080 cells, and HT1080 cells treated with U0126. We found that 267 genes were induced by IFN in SKOV3 cells, while only 98 genes were induced in HT1080 cells at the same time point. Furthermore, the expression of a distinct subset of IFN inducible genes, that included RIGI, GBP2, IFIT2, BTN3A3, MAP2, MMP7 and STAT2, was restored or increased in HT1080 cells when the cells were co-treated with U0126 and IFN. Bioinformatic analysis of the biological processes represented by these genes revealed increased representation of genes involved in the anti-viral response, regulation of apoptosis, cell differentiation and metabolism. Furthermore, introduction of constitutively active Ras into IFN sensitive SKOV3 cells reduced their IFN sensitivity and ability to activate IFN-induced transcription. This work demonstrates for the first time that activated Ras/MEK in human cancer cells induces downregulation of a specific subset of IFN-inducible genes.	[Christian, Sherri L.; Zu, Dong; Licursi, Maria; Komatsu, Yumiko; Pongnopparat, Theerawat; Codner, Dianne A.; Hirasawa, Kensuke] Mem Univ Newfoundland, Fac Med, Div Biomed Sci, St John, NF, Canada	Memorial University Newfoundland	Christian, SL (corresponding author), Mem Univ Newfoundland, Dept Biochem, St John, NF, Canada.	sherri.christian@mun.ca; kensuke@mun.ca		Christian, Sherri/0000-0002-4289-4386	Canadian Institutes for Health Research [MOP74429, ROP99020]; Beatrice Hunter Cancer Research Institute; Cancer Research Training Program, Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Beatrice Hunter Cancer Research Institute; Cancer Research Training Program, Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR	This work was supported by Canadian Institutes for Health Research (www.cihr-irsc.gc.ca), grant numbers MOP74429 and ROP99020. SLC was supported by a trainee award from the Beatrice Hunter Cancer Research Institute with funds provided by the Cancer Research Training Program as part of The Terry Fox Foundation Strategic Health Research Training Program in Cancer Research at CIHR (www.bhcri.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balachandran S, 2001, J VIROL, V75, P3474, DOI 10.1128/JVI.75.7.3474-3479.2001; Battcock SA, 2006, J VIROL, V80, P4422, DOI 10.1128/JVI.80.9.4422-4430.2006; Bergmann M, 2001, CANCER RES, V61, P8188; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Cascallo M, 2003, CANCER RES, V63, P5544; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Christian SL, 2009, J VIROL, V83, P6717, DOI 10.1128/JVI.02213-08; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Cully M, 2008, CELL, V133, P1292, DOI 10.1016/j.cell.2008.06.020; Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Dehmelt L, 2005, GENOME BIOL, V6; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Farassati F, 2001, NAT CELL BIOL, V3, P745, DOI 10.1038/35087061; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goetz C, 2010, MOL THER, V18, P1937, DOI 10.1038/mt.2010.145; GOLDSTEIN D, 1986, CANCER RES, V46, P4315; GOLDSTEIN D, 1988, CA-CANCER J CLIN, V38, P258, DOI 10.3322/canjclin.38.5.258; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Guo Z, 2005, J IMMUNOL, V175, P7407, DOI 10.4049/jimmunol.175.11.7407; Hirasawa K, 2002, CANCER RES, V62, P1696; Hirasawa K, 2003, J VIROL, V77, P5649, DOI 10.1128/JVI.77.10.5649-5656.2003; Horvath CM, 1996, MOL CELL BIOL, V16, P6957; Huang M, 2002, NAT CELL BIOL, V4, P774, DOI 10.1038/ncb855; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Landolfo S, 2000, Hematol J, V1, P7, DOI 10.1038/sj.thj.6200004; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Lu RQ, 2000, J BIOL CHEM, V275, P31805, DOI 10.1074/jbc.M005288200; Marcato P, 2007, MOL THER, V15, P1522, DOI 10.1038/sj.mt.6300179; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; McCusker D, 1999, IMMUNOGENETICS, V49, P438, DOI 10.1007/s002510050517; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Noser JA, 2007, MOL THER, V15, P1531, DOI 10.1038/sj.mt.6300193; Noser JA, 2006, J VIROL, V80, P7769, DOI 10.1128/JVI.02427-05; NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6; Okeoma CM, 2007, NATURE, V445, P927, DOI 10.1038/nature05540; Pelaez IM, 2010, INT J BIOCHEM CELL B, V42, P911, DOI 10.1016/j.biocel.2010.01.024; Perwitasari O, 2011, J BIOL CHEM, V286, P44412, DOI 10.1074/jbc.M111.285205; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puhlmann J, 2010, ONCOGENE, V29, P2205, DOI 10.1038/onc.2009.507; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rhodes DA, 2001, GENOMICS, V71, P351, DOI 10.1006/geno.2000.6406; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Saha S, 2006, J GEN VIROL, V87, P3285, DOI 10.1099/vir.0.82107-0; Sakai I, 2002, BLOOD, V100, P2926, DOI 10.1182/blood-2002-01-0073; Schindler C, 1999, EXP CELL RES, V253, P7, DOI 10.1006/excr.1999.4670; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sebolt-Leopold JS, 2000, ONCOGENE, V19, P6594, DOI 10.1038/sj.onc.1204083; Shang D, 2007, CANCER SCI, V98, P1259, DOI 10.1111/j.1349-7006.2007.00526.x; Shmulevitz M, 2010, CANCER RES, V70, P4912, DOI 10.1158/0008-5472.CAN-09-4676; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068; Stojdl DF, 2000, NAT MED, V6, P821, DOI 10.1038/77558; Strong JE, 1998, EMBO J, V17, P3351, DOI 10.1093/emboj/17.12.3351; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sun WH, 1998, BLOOD, V91, P570, DOI 10.1182/blood.V91.2.570.570_570_576; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; Ungefroren H, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-18; Ward SV, 2003, VIROLOGY, V313, P553, DOI 10.1016/S0042-6822(03)00347-7; Wei L, 2006, J BIOL CHEM, V281, P11678, DOI 10.1074/jbc.M513286200; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zeeberg BR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-168; Zhang FW, 2006, VIROLOGY, V353, P396, DOI 10.1016/j.virol.2006.05.035; Zitzmann K, 2007, CANCER RES, V67, P5025, DOI 10.1158/0008-5472.CAN-06-2575	72	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44267	10.1371/journal.pone.0044267	http://dx.doi.org/10.1371/journal.pone.0044267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970192	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000308462000016
J	Das Ghosh, D; Bhattacharjee, B; Sen, S; Premi, L; Mukhopadhyay, I; Chowdhury, RR; Roy, S; Sengupta, S				Das Ghosh, Damayanti; Bhattacharjee, Bornali; Sen, Shrinka; Premi, Laikangbam; Mukhopadhyay, Indranil; Chowdhury, Rahul Roy; Roy, Sudipta; Sengupta, Sharmila			Some Novel Insights on HPV16 Related Cervical Cancer Pathogenesis Based on Analyses of LCR Methylation, Viral Load, E7 and E2/E4 Expressions	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CPG METHYLATION; E2 PROTEIN; SEQUENCE VARIATIONS; INDIAN WOMEN; DNA; INTEGRATION; GENOME; CARCINOMA; BINDING	This study was undertaken to decipher the interdependent roles of (i) methylation within E2 binding site I and II (E2BS-I/II) and replication origin (nt 7862) in the long control region (LCR), (ii) expression of viral oncogene E7, (iii) expression of the transcript (E7-E1(boolean AND)E4) that encodes E2 repressor protein and (iv) viral load, in human papillomavirus 16 (HPV16) related cervical cancer (CaCx) pathogenesis. The results revealed over-representation (p < 0.001) of methylation at nucleotide 58 of E2BS-I among E2-intact CaCx cases compared to E2-disrupted cases. Bisulphite sequencing of LCR revealed overrepresentation of methylation at nucleotide 58 or other CpGs in E2BS-I/II, among E2-intact cases than E2-disrupted cases and lack of methylation at replication origin in case of both. The viral transcript (E7-E1(boolean AND)E4) that produces the repressor E2 was analyzed by APOT (amplification of papillomavirus oncogenic transcript)-coupled-quantitative-RT-PCR (of E7 and E4 genes) to distinguish episomal (pure or concomitant with integrated) from purely integrated viral genomes based on the ratio, E7 C-T/E4 C-T. Relative quantification based on comparative C-T (theshold cycle) method revealed 75.087 folds higher E7 mRNA expression in episomal cases over purely integrated cases. Viral load and E2 gene copy numbers were negatively correlated with E7 C-T (p = 0.007) and E2 C-T (p < 0.0001), respectively, each normalized with ACTB C-T, among episomal cases only. The k-means clustering analysis considering E7 C-T from APOT-coupled-quantitative-RT-PCR assay, in conjunction with viral load, revealed immense heterogeneity among the HPV16 positive CaCx cases portraying integrated viral genomes. The findings provide novel insights into HPV16 related CaCx pathogenesis and highlight that CaCx cases that harbour episomal HPV16 genomes with intact E2 are likely to be distinct biologically, from the purely integrated viral genomes in terms of host genes and/or pathways involved in cervical carcinogenesis.	[Das Ghosh, Damayanti; Bhattacharjee, Bornali; Premi, Laikangbam; Mukhopadhyay, Indranil] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Chowdhury, Rahul Roy] Saroj Gupta Canc Ctr & Res Inst, Dept Gynecol, Kolkata, India; [Roy, Sudipta] Suraksha Diagnost Private Ltd, Dept Pathol, Kolkata, India; [Sen, Shrinka; Sengupta, Sharmila] Natl Inst Biomed Genom, Dist Nadia, W Bengal, India	Indian Statistical Institute; Indian Statistical Institute Kolkata; Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG)	Das Ghosh, D (corresponding author), Indian Stat Inst, Human Genet Unit, Kolkata, India.	ssg1@nibmg.ac.in		Bhattacharjee, Bornali/0000-0002-0801-1543	Department of Biotechnology, Government of India [BT/PR8014/Med/14/1220/2006]; Council of Scientific and Industrial Research, Government of India; Indian Statistical Institute; UGC	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Indian Statistical Institute; UGC(University Grants Commission, India)	This work was supported by Department of Biotechnology (Grant No. BT/PR8014/Med/14/1220/2006),r We thank Cancer Centre Welfare Home and Research Institute (Thakurpukur, South 24 Parganas, West Bengal, India), for support in sample collection; Human Genetics Unit, Indian Statistical Institute, Kolkata, India for technical support; Professor Partha P Majumder, Director, National Institute of Biomedical Genomics (NIBMG) and members of NIBMG for their co-operation and special thanks also to (i) Council of Scientific and Industrial Research, Government of India, for providing Dr. Bornali Bhattacharjee with a Fellowship (JRF and SRF) and Dr. Laikangbam Premi with a Fellowship (SRF), (ii) Indian Statistical Institute for providing Fellowships to Ms. Damayanti Das (JRF and SRF), and (iii) UGC for providing fellowship to Ms Shrinka Sen (JRF) to work on this project.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2003, INT J GYNECOL CANCER, V13, P154, DOI 10.1136/ijgc-00009577-200303000-00009; Alloul N, 1999, J GEN VIROL, V80, P29, DOI 10.1099/0022-1317-80-1-29; Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Badal V, 2003, J VIROL, V77, P6227, DOI 10.1128/JVI.77.11.6227-6234.2003; BAKER CC, 1987, J VIROL, V61, P962, DOI 10.1128/JVI.61.4.962-971.1987; Baxter MK, 2005, J VIROL, V79, P4806, DOI 10.1128/JVI.79.8.4806-4818.2005; Berg M, 1997, J VIROL, V71, P3853, DOI 10.1128/JVI.71.5.3853-3863.1997; BERUMEN J, 1994, INT J CANCER, V56, P640, DOI 10.1002/ijc.2910560506; Berumen J, 2001, JNCI-J NATL CANCER I, V93, P1325, DOI 10.1093/jnci/93.17.1325; Bhattacharjee B, 2006, GYNECOL ONCOL, V100, P372, DOI 10.1016/j.ygyno.2005.09.016; Bhattacharjee B, 2008, VIROLOGY, V377, P143, DOI 10.1016/j.virol.2008.04.007; Bhattacharjee B, 2006, VIROLOGY, V354, P280, DOI 10.1016/j.virol.2006.06.018; Bhattacharya P, 2007, TISSUE ANTIGENS, V70, P283, DOI 10.1111/j.1399-0039.2007.00894.x; Brandsma JL, 2009, VIROLOGY, V389, P100, DOI 10.1016/j.virol.2009.03.029; Das D, 2010, VIROLOGY, V402, P197, DOI 10.1016/j.virol.2010.03.030; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Gillitzer E, 2000, EMBO J, V19, P3069, DOI 10.1093/emboj/19.12.3069; Hafner N, 2008, ONCOGENE, V27, P1610, DOI 10.1038/sj.onc.1210791; JEON S, 1995, P NATL ACAD SCI USA, V92, P1654, DOI 10.1073/pnas.92.5.1654; Kalantari M, 2004, J VIROL, V78, P12762, DOI 10.1128/JVI.78.23.12762-12772.2004; Kalantari M, 2008, VIROLOGY, V374, P292, DOI 10.1016/j.virol.2007.12.016; Kim K, 2003, J VIROL, V77, P12450, DOI 10.1128/JVI.77.23.12450-12459.2003; Klaes R, 1999, CANCER RES, V59, P6132; MATSUKURA T, 1989, VIROLOGY, V172, P63, DOI 10.1016/0042-6822(89)90107-4; Ordonez RM, 2004, J GEN VIROL, V85, P1433, DOI 10.1099/vir.0.19317-0; ROMANCZUK H, 1992, P NATL ACAD SCI USA, V89, P3159, DOI 10.1073/pnas.89.7.3159; Sathish N, 2004, GYNECOL ONCOL, V95, P363, DOI 10.1016/j.ygyno.2004.08.025; Singh RK, 2006, INT J GYNECOL CANCER, V16, P1048, DOI 10.1111/j.1525-1438.2006.00550.x; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; Sowjanya AP, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-116; Thain A, 1996, J VIROL, V70, P7233, DOI 10.1128/JVI.70.10.7233-7235.1996; Van Tine BA, 2004, J VIROL, V78, P11172, DOI 10.1128/JVI.78.20.11172-11186.2004; Van Tine BA, 2004, P NATL ACAD SCI USA, V101, P4030, DOI 10.1073/pnas.0306848101; Yamada T, 1997, J VIROL, V71, P2463, DOI 10.1128/JVI.71.3.2463-2472.1997; Yasugi T, 1997, J VIROL, V71, P891, DOI 10.1128/JVI.71.2.891-899.1997; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971; Ziegert C, 2003, ONCOGENE, V22, P3977, DOI 10.1038/sj.onc.1206629; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	39	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44678	10.1371/journal.pone.0044678	http://dx.doi.org/10.1371/journal.pone.0044678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970286	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400105
J	Esworthy, RS; Kim, BW; Rivas, GE; Leto, TL; Doroshow, JH; Chu, FF				Esworthy, R. Steven; Kim, Byung-Wook; Rivas, Guillermo E.; Leto, Thomas L.; Doroshow, James H.; Chu, Fong-Fong			Analysis of Candidate Colitis Genes in the Gdac1 Locus of Mice Deficient in Glutathione Peroxidase-1 and-2	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIUM; BINDING-PROTEIN; DUAL OXIDASE; CELL-CYCLE; EXPRESSION; MOUSE; RESPONSES; GPX2	Background: Mice that are deficient for glutathione peroxidases 1 and 2 (GPX) show large variations in the penetrance and severity of colitis in C57BL/6J and 129S1/SvImJ backgrounds. We mapped a locus contributing to this difference to distal chromosome 2 (similar to 119-133 mbp) and named it glutathione peroxidase-deficiency-associated colitis 1 (Gdac1). The aim of this study was to identify the best gene candidates within the Gdac1 locus contributing to the murine colitis phenotype. Method/Principal Findings: We refined the boundaries of Gdac1 to 118-125 mbp (95% confidence interval) by increasing sample size and marker density across the interval. The narrowed region contains 128 well-annotated protein coding genes but it excludes Fermt1, a human inflammatory bowel disease candidate that was within the original boundaries of Gdac1. The locus we identified may be the Cdcs3 locus mapped by others studying IL10-knockout mice. Using in silico analysis of the 128 genes, based on published colon expression data, the relevance of pathways to colitis, gene mutations, presence of non-synonymous-single-nucleotide polymorphisms (nsSNPs) and whether the nsSNPs are predicted to have an impact on protein function or expression, we excluded 42 genes. Based on a similar analysis, twenty-five genes from the remaining 86 genes were analyzed for expression-quantitative-trait loci, and another 15 genes were excluded. Conclusion/Significance: Among the remaining 10 genes, we identified Pla2g4f and Duox2 as the most likely colitis gene candidates, because GPX metabolizes PLA2G4F and DUOX2 products. Pla2g4f is a phospholipase A2 that has three potentially significant nsSNP variants and showed expression differences across mouse strains. PLA2G4F produces arachidonic acid, which is a substrate for lipoxygenases and, in turn, for GPXs. DUOX2 produces H2O2 and may control microbial populations. DUOX-1 and -2 control microbial populations in mammalian lung and in the gut of several insects and zebrafish. Dysbiosis is a phenotype that differentiates 129S1/SvImJ from C57BL/6J and may be due to strain differences in DUOX2 activity.	[Esworthy, R. Steven; Kim, Byung-Wook; Chu, Fong-Fong] Beckman Res Inst City Hope, Dept Radiat Biol, Duarte, CA USA; [Leto, Thomas L.] NIAID, Host Def Lab, NIH, Rockville, MD USA; [Doroshow, James H.] NCI, NIH, Bethesda, MD 20892 USA	City of Hope; Beckman Research Institute of City of Hope; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Esworthy, RS (corresponding author), Beckman Res Inst City Hope, Dept Radiat Biol, Duarte, CA USA.	fchu@coh.org	Esworthy, Steve/AAN-3152-2020	Esworthy, Steve/0000-0002-4111-3349	National Institutes of Health [R01CA114569]; NATIONAL CANCER INSTITUTE [R01CA114569, ZIABC011076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by National Institutes of Health R01CA114569 (FFC)http://projectreporter.nih.gov/reporter_searchresults.cfm. No additional external funding sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler DH, 2008, J CLIN INVEST, V118, P2121, DOI 10.1172/JCI30473; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akamine R, 2007, J BIOCHEM BIOPH METH, V70, P481, DOI 10.1016/j.jbbm.2006.11.008; Arisawa T, 2008, HEPATO-GASTROENTEROL, V55, P394; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Bonventre JV, 1999, J AM SOC NEPHROL, V10, P404; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Brown JK, 2008, INT J PARASITOL, V38, P143, DOI 10.1016/j.ijpara.2007.10.002; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Cassidy AJ, 2005, AM J HUM GENET, V77, P909, DOI 10.1086/497707; Castrop H, 2008, AM J PHYSIOL-RENAL, V295, pF859, DOI 10.1152/ajprenal.00106.2008; Chavez V, 2009, INFECT IMMUN, V77, P4983, DOI 10.1128/IAI.00627-09; Chiba H, 2004, J BIOL CHEM, V279, P12890, DOI 10.1074/jbc.M305801200; CHU FF, 1993, J BIOL CHEM, V268, P2571; Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272; Chu FF, 1997, BIOMED ENVIRON SCI, V10, P156; Dalerba P, 2011, NAT BIOTECHNOL, V29, P1120, DOI 10.1038/nbt.2038; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; de Buhr MF, 2006, PHYSIOL GENOMICS, V25, P426, DOI 10.1152/physiolgenomics.00022.2005; Dgany O, 2002, AM J HUM GENET, V71, P1467, DOI 10.1086/344781; Esworthy RS, 2010, INT J INFLAMM, V2010, DOI 10.4061/2010/986046; Esworthy RS, 2011, INFLAMM BOWEL DIS, V17, P1373, DOI 10.1002/ibd.21479; Esworthy RS, 2003, BIOL CHEM, V384, P597, DOI 10.1515/BC.2003.067; Farmer MA, 2001, P NATL ACAD SCI USA, V98, P13820, DOI 10.1073/pnas.241258698; Festen EAM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001283; Fischer H, 2009, ANTIOXID REDOX SIGN, V11, P2453, DOI [10.1089/ars.2009.2558, 10.1089/ARS.2009.2558]; Fisler JS, 1997, J NUTR, V127, pS1909, DOI 10.1093/jn/127.9.1909S; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Flores MV, 2010, BIOCHEM BIOPH RES CO, V400, P164, DOI 10.1016/j.bbrc.2010.08.037; Furtado LV, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-119; Geiszt M, 2003, FASEB J, V17, P1502, DOI 10.1096/fj.02-1104fje; Ghomashchi F, 2010, J BIOL CHEM, V285, P36100, DOI 10.1074/jbc.M110.165647; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Gulati AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032403; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; HAAS S, 1995, J BIOL CHEM, V270, P12503, DOI 10.1074/jbc.270.21.12503; Hesketh J, 2008, ANNU REV NUTR, V28, P157, DOI 10.1146/annurev.nutr.28.061807.155446; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Kim BW, 2012, FREE RADICAL BIO MED, V52, P1569, DOI 10.1016/j.freeradbiomed.2012.02.009; Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005; Kiyomitsu T, 2011, MOL CELL BIOL, V31, P998, DOI 10.1128/MCB.00815-10; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lipinski S, 2009, J CELL SCI, V122, P3522, DOI 10.1242/jcs.050690; Liu G, 2009, P NATL ACAD SCI USA, V106, P15819, DOI 10.1073/pnas.0901216106; Lopes MC, 2012, HUM HERED, V73, P47, DOI 10.1159/000334984; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Mahler M, 1999, GENOMICS, V55, P147, DOI 10.1006/geno.1998.5636; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Morand S, 2009, FASEB J, V23, P1205, DOI 10.1096/fj.08-120006; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Murano M, 2000, CLIN EXP IMMUNOL, V120, P51, DOI 10.1046/j.1365-2249.2000.01183.x; Naetar N, 2007, J CELL SCI, V120, P737, DOI 10.1242/jcs.03390; Ohto T, 2005, J BIOL CHEM, V280, P24576, DOI 10.1074/jbc.M413711200; Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Renella R, 2011, BLOOD, V117, P6928, DOI 10.1182/blood-2010-09-308478; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Romanoski CE, 2011, CIRC RES, V109, pE27, DOI 10.1161/CIRCRESAHA.111.241869; SAVAGE DC, 1968, J EXP MED, V127, P67, DOI 10.1084/jem.127.1.67; Southgate L, 2010, NEUROGENETICS, V11, P379, DOI 10.1007/s10048-010-0243-8; Szabo R, 2007, ONCOGENE, V26, P1546, DOI 10.1038/sj.onc.1209966; Ussar S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000289; Verpy E, 2008, NATURE, V456, P255, DOI 10.1038/nature07380; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Wohlgemuth S, 2009, ENVIRON MICROBIOL, V11, P1562, DOI 10.1111/j.1462-2920.2009.01883.x; Xiao H, 2009, MOL BIOL CELL, V20, P21, DOI 10.1091/mbc.E08-04-0441; Ye JHQ, 2009, WORLD J GASTROENTERO, V15, P4491, DOI 10.3748/wjg.15.4491; Zhang Y, 2007, J MED GENET, V44, P233, DOI 10.1136/jmg.2006.045765	78	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44262	10.1371/journal.pone.0044262	http://dx.doi.org/10.1371/journal.pone.0044262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970191	Green Submitted, Green Published, gold			2022-12-25	WOS:000308458400052
J	Guazzi, P; Goitre, L; Ferro, E; Cutano, V; Martino, C; Trabalzini, L; Retta, SF				Guazzi, Paolo; Goitre, Luca; Ferro, Elisa; Cutano, Valentina; Martino, Chiara; Trabalzini, Lorenza; Retta, Saverio Francesco			Identification of the Kelch Family Protein Nd1-L as a Novel Molecular Interactor of KRIT1	PLOS ONE			English	Article							CEREBRAL CAVERNOUS MALFORMATIONS; INTEGRIN ACTIVATION; RECENT INSIGHTS; ANKYRIN REPEAT; RHO KINASE; PATHOGENESIS; TALIN; BINDING; RAP1; DOMAIN	Loss-of-function mutations of the KRIT1 gene (CCM1) have been associated with the Cerebral Cavernous Malformation (CCM) disease, which is characterized by serious alterations of brain capillary architecture. The KRIT1 protein contains multiple interaction domains and motifs, suggesting that it might act as a scaffold for the assembly of functional protein complexes involved in signaling networks. In previous work, we defined structure-function relationships underlying KRIT1 intramolecular and intermolecular interactions and nucleocytoplasmic shuttling, and found that KRIT1 plays an important role in molecular mechanisms involved in the maintenance of the intracellular Reactive Oxygen Species (ROS) homeostasis to prevent oxidative cellular damage. Here we report the identification of the Kelch family protein Nd1-L as a novel molecular interactor of KRIT1. This interaction was discovered through yeast two-hybrid screening of a mouse embryo cDNA library, and confirmed by pull-down and co-immunoprecipitation assays of recombinant proteins, as well as by co-immunoprecipitation of endogenous proteins in human endothelial cells. Furthermore, using distinct KRIT1 isoforms and mutants, we defined the role of KRIT1 domains in the Nd1-L/KRIT1 interaction. Finally, functional assays showed that Nd1-L may contribute to the regulation of KRIT1 nucleocytoplasmic shuttling and cooperate with KRIT1 in modulating the expression levels of the antioxidant protein SOD2, opening a novel avenue for future mechanistic studies. The identification of Nd1-L as a novel KRIT1 interacting protein provides a novel piece of the molecular puzzle involving KRIT1 and suggests a potential functional cooperation in cellular responses to oxidative stress, thus expanding the framework of molecular complexes and mechanisms that may underlie the pathogenesis of CCM disease.	[Guazzi, Paolo; Ferro, Elisa; Trabalzini, Lorenza] Univ Siena, Dept Biotechnol Chem & Pharm, I-53100 Siena, Italy; [Goitre, Luca; Cutano, Valentina; Martino, Chiara; Retta, Saverio Francesco] Univ Turin, Dept Clin & Biol Sci, Orbassano, TO, Italy	University of Siena; University of Turin	Guazzi, P (corresponding author), Univ Siena, Dept Biotechnol Chem & Pharm, Via Laterina 8, I-53100 Siena, Italy.	francesco.retta@unito.it	Retta, Saverio Francesco/Q-4770-2019	Retta, Saverio Francesco/0000-0001-9761-2959; Trabalzini, Lorenza/0000-0002-0850-7186	MIUR (Italian Ministry of University and Research) [2004052127, 2008BP25KN]; Fondazione Telethon [GGP06222]	MIUR (Italian Ministry of University and Research)(Ministry of Education, Universities and Research (MIUR)); Fondazione Telethon(Fondazione TelethonEuropean Commission)	This work was supported by MIUR (Italian Ministry of University and Research, PRIN National Projects no. 2004052127 to LT and SFR, and no. 2008BP25KN to SFR) and Fondazione Telethon (grant no. GGP06222 to SFR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Balzac F, 2005, J CELL SCI, V118, P4765, DOI 10.1242/jcs.02584; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Borikova AL, 2010, J BIOL CHEM, V285, P11760, DOI 10.1074/jbc.C109.097220; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188; Critchley DR, 2008, J CELL SCI, V121, P1345, DOI 10.1242/jcs.018085; Faurobert E, 2010, FEBS J, V277, P1084, DOI 10.1111/j.1742-4658.2009.07537.x; Felbor U, 2006, ZBL NEUROCHIR, V67, P110, DOI 10.1055/s-2006-933537; Francalanci F, 2009, EXP CELL RES, V315, P285, DOI 10.1016/j.yexcr.2008.10.006; Fujimura L, 2004, CARDIOVASC RES, V64, P315, DOI 10.1016/j.cardiores.2004.07.009; Gault J, 2004, NEUROSURGERY, V55, P1, DOI 10.1227/01.NEU.0000126872.23715.E5; Gingras AR, 2009, J BIOL CHEM, V284, P8857, DOI 10.1074/jbc.M805937200; Giovanni P, 2007, BBA-MOL CELL RES, V1773, P1774, DOI 10.1016/j.bbamcr.2007.09.002; Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175; Glading AJ, 2010, DIS MODEL MECH, V3, P73, DOI 10.1242/dmm.003293; Goitre L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011786; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Kang M, 2001, BBA-GENE STRUCT EXPR, V1519, P167, DOI 10.1016/S0167-4781(01)00231-7; Labouge P, 2007, LANCET NEUROL, V6, P237, DOI 10.1016/S1474-4422(07)70053-4; Leblanc GG, 2009, STROKE, V40, pE694, DOI 10.1161/STROKEAHA.109.563692; LI B, 1993, FASEB J, V7, P957, DOI 10.1096/fasebj.7.10.8344494; Matsudo Y, 2006, TRANSGENIC RES, V15, P573, DOI 10.1007/s11248-006-9010-x; Ohta Y, 2010, INT J ONCOL, V36, P427, DOI 10.3892/ijo_00000516; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Retta SF, 2006, EUR J CELL BIOL, V85, P283, DOI 10.1016/j.ejcb.2005.09.007; Retta SF, 2004, GENE, V325, P63, DOI 10.1016/j.gene.2003.09.046; Riant F, 2010, FEBS J, V277, P1070, DOI 10.1111/j.1742-4658.2009.07535.x; Sasagawa K, 2002, J BIOL CHEM, V277, P44140, DOI 10.1074/jbc.M202596200; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Serebriiskii I, 1997, ONCOGENE, V15, P1043, DOI 10.1038/sj.onc.1201268; Stockton RA, 2010, J EXP MED, V207, P881, DOI 10.1084/jem.20091258; Stogios PJ, 2004, TRENDS BIOCHEM SCI, V29, P634, DOI 10.1016/j.tibs.2004.10.003; Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036; Wolff T, 1998, J VIROL, V72, P7170, DOI 10.1128/JVI.72.9.7170-7180.1998; Yadla S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.5.FOCUS10121; Zawistowski JS, 2002, HUM MOL GENET, V11, P389, DOI 10.1093/hmg/11.4.389; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256; Zhang J, 2001, HUM MOL GENET, V10, P2953, DOI 10.1093/hmg/10.25.2953; Zhang J, 2007, NEUROSURGERY, V60, P353, DOI 10.1227/01.NEU.0000249268.11074.83; Ziegler WH, 2008, BIOCHEM SOC T, V36, P235, DOI 10.1042/BST0360235	43	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44705	10.1371/journal.pone.0044705	http://dx.doi.org/10.1371/journal.pone.0044705			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970292	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400107
J	Singh, D; Takahashi, K; Adams, JM				Singh, Dharmesh; Takahashi, Koichi; Adams, Jonathan M.			Elevational Patterns in Archaeal Diversity on Mt. Fuji	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; MESOPHILIC CRENARCHAEOTA; KINGDOM CRENARCHAEOTA; PHYLOGENETIC ANALYSIS; COMMUNITY STRUCTURE; SOIL; ABUNDANCE; OXIDATION; EURYARCHAEOTA; MOUNTAINSIDES	Little is known of how archaeal diversity and community ecology behaves along elevational gradients. We chose to study Mount Fuji of Japan as a geologically and topographically uniform mountain system, with a wide range of elevational zones. PCR-amplified soil DNA for the archaeal 16 S rRNA gene was pyrosequenced and taxonomically classified against EzTaxon-e archaeal database. At a bootstrap cut-off of 80%, most of the archaeal sequences were classified into phylum Thaumarchaeota (96%) and Euryarchaeota (3.9%), with no sequences classified into other phyla. Archaeal OTU richness and diversity on Fuji showed a pronounced 'peak' in the mid-elevations, around 1500 masl, within the boreal forest zone, compared to the temperate forest zone below and the alpine fell-field and desert zones above. Diversity decreased towards higher elevations followed by a subtle increase at the summit, mainly due to an increase in the relative abundance of the group I. 1b of Thaumarchaeota. Archaeal diversity showed a strong positive correlation with soil NH4+, K and NO32. Archaeal diversity does not parallel plant diversity, although it does roughly parallel bacterial diversity. Ecological hypotheses to explain the mid diversity bulge on Fuji include intermediate disturbance effects, and the result of mid elevations combining a mosaic of upper and lower slope environments. Our findings show clearly that archaeal soil communities are highly responsive to soil environmental gradients, in terms of both their diversity and community composition. Distinct communities of archaea specific to each elevational zone suggest that many archaea may be quite finely niche-adapted within the range of soil environments. A further interesting finding is the presence of a mesophilic component of archaea at high altitudes on a mountain that is not volcanically active. This emphasizes the importance of microclimate - in this case solar heating of the black volcanic ash surface - for the ecology of soil archaea.	[Singh, Dharmesh; Adams, Jonathan M.] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Seoul 151742, South Korea; [Takahashi, Koichi] Shinshu Univ, Fac Sci, Dept Biol, Matsumoto, Nagano, Japan; [Takahashi, Koichi] Shinshu Univ, Inst Mt Sci, Matsumoto, Nagano 390, Japan	Seoul National University (SNU); Shinshu University; Shinshu University	Singh, D (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Seoul 151742, South Korea.	jonadams@snu.ac.kr		Singh, Dharmesh/0000-0002-4251-6617	National Research Foundation (NRF); Korean government, Ministry of Education, Science and Technology (MEST) [NRF-2011-0015787]	National Research Foundation (NRF); Korean government, Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by a grant from the National Research Foundation (NRF) grant funded by the Korean government, Ministry of Education, Science and Technology (MEST) (NRF-2011-0015787). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu C, 2001, J APPL MICROBIOL, V90, P713, DOI 10.1046/j.1365-2672.2001.01297.x; Adams J, 2009, S-P B ENVIRON SCI; Angel R, 2010, ISME J, V4, P553, DOI 10.1038/ismej.2009.136; Angelov A, 2006, J BIOTECHNOL, V126, P3, DOI 10.1016/j.jbiotec.2006.02.017; Auguet JC, 2010, ISME J, V4, P182, DOI 10.1038/ismej.2009.109; Bates ST, 2011, ISME J, V5, P908, DOI 10.1038/ismej.2010.171; Bintrim SB, 1997, P NATL ACAD SCI USA, V94, P277, DOI 10.1073/pnas.94.1.277; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Brochier-Armanet C, 2008, NAT REV MICROBIOL, V6, P245, DOI 10.1038/nrmicro1852; Brochier-Armanet C, 2011, CURR OPIN MICROBIOL, V14, P274, DOI 10.1016/j.mib.2011.04.015; Brown JH, 2001, GLOBAL ECOL BIOGEOGR, V10, P101, DOI 10.1046/j.1466-822x.2001.00228.x; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Buckley DH, 1998, APPL ENVIRON MICROB, V64, P4333; Buee M, 2009, PLANT SOIL, V321, P189, DOI 10.1007/s11104-009-9991-3; Chen XP, 2008, ENVIRON MICROBIOL, V10, P1978, DOI 10.1111/j.1462-2920.2008.01613.x; Clarke K.R, 2006, PRIMER V6 USER MANUA; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; DeLong EF, 1998, CURR OPIN GENET DEV, V8, P649, DOI 10.1016/S0959-437X(98)80032-4; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Di HJ, 2010, FEMS MICROBIOL ECOL, V72, P386, DOI 10.1111/j.1574-6941.2010.00861.x; Ehrhardt CJ, 2007, ENVIRON MICROBIOL, V9, P900, DOI 10.1111/j.1462-2920.2006.01211.x; Fierer N, 2011, ECOLOGY, V92, P797, DOI 10.1890/10-1170.1; Friedrich MW, 2001, APPL ENVIRON MICROB, V67, P4880, DOI 10.1128/AEM.67.10.4880-4890.2001; FUHRMAN JA, 1992, NATURE, V356, P148, DOI 10.1038/356148a0; Furlong MA, 2002, APPL ENVIRON MICROB, V68, P1265, DOI 10.1128/AEM.68.3.1265-1279.2002; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; Hatzenpichler R, 2008, P NATL ACAD SCI USA, V105, P2134, DOI 10.1073/pnas.0708857105; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Herrmann M, 2008, APPL ENVIRON MICROB, V74, P3279, DOI 10.1128/AEM.02802-07; Hershberger KL, 1996, NATURE, V384, P420, DOI 10.1038/384420a0; Hu JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022873; Hur M, 2011, APPL ENVIRON MICROB, V77, P7611, DOI 10.1128/AEM.06102-11; Huston M. A., 1994, BIOL DIVERSITY; Jia ZJ, 2009, ENVIRON MICROBIOL, V11, P1658, DOI 10.1111/j.1462-2920.2009.01891.x; Jung MY, 2011, APPL ENVIRON MICROB, V77, P8635, DOI 10.1128/AEM.05787-11; Jurgens G, 2000, FEMS MICROBIOL ECOL, V34, P45, DOI 10.1111/j.1574-6941.2000.tb00753.x; Jurgens G, 1997, APPL ENVIRON MICROB, V63, P803, DOI 10.1128/AEM.63.2.803-805.1997; Kan JJ, 2011, ISME J, V5, P1784, DOI 10.1038/ismej.2011.56; Kim JG, 2012, ENVIRON MICROBIOL, V14, P1528, DOI 10.1111/j.1462-2920.2012.02740.x; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; KORNER C, 1986, OECOLOGIA, V69, P577, DOI 10.1007/BF00410366; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; Lehtovirta LE, 2009, FEMS MICROBIOL ECOL, V70, P367, DOI 10.1111/j.1574-6941.2009.00748.x; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Li L, 1999, MAR BIOTECHNOL, V1, P391, DOI 10.1007/PL00011793; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Magurran A.E, 2004, MEASURING BIOL DIVER; Manerkar MA, 2008, MICROB ECOL, V56, P467, DOI 10.1007/s00248-008-9365-z; Martens-Habbena W, 2009, NATURE, V461, P976, DOI 10.1038/nature08465; MASUZAWA T, 1991, Reports of Faculty of Science Shizuoka University, V25, P69; McCain CM, 2005, ECOLOGY, V86, P366, DOI 10.1890/03-3147; Miehe G, 1994, PHYTOCOENOLOGIA, V24, P53, DOI 10.1127/phyto/24/1994/53; Nicol GW, 2008, ENVIRON MICROBIOL, V10, P2966, DOI 10.1111/j.1462-2920.2008.01701.x; Ochsenreiter T, 2003, ENVIRON MICROBIOL, V5, P787, DOI 10.1046/j.1462-2920.2003.00476.x; OHSAWA M, 1984, VEGETATIO, V57, P15, DOI 10.1007/BF00031929; Oline DK, 2006, MICROB ECOL, V52, P480, DOI 10.1007/s00248-006-9101-5; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Park HD, 2007, J APPL MICROBIOL, V102, P1401, DOI 10.1111/j.1365-2672.2006.03176.x; Robertson CE, 2005, CURR OPIN MICROBIOL, V8, P638, DOI 10.1016/j.mib.2005.10.003; Sandaa RA, 1999, APPL ENVIRON MICROB, V65, P3293; Sarle, 1990, VARCLUS PROCEDURE SA; Schleper C, 1997, APPL ENVIRON MICROB, V63, P321, DOI 10.1128/AEM.63.1.321-323.1997; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Singh D, 2012, MICROB ECOL, V63, P429, DOI 10.1007/s00248-011-9900-1; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEHR G, 1995, FEMS MICROBIOL ECOL, V17, P177, DOI 10.1016/0168-6496(95)00022-3; Takai K, 2001, APPL ENVIRON MICROB, V67, P5750, DOI 10.1128/AEM.67.21.5750-5760.2001; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tourna M, 2011, P NATL ACAD SCI USA, V108, P8420, DOI 10.1073/pnas.1013488108; Treusch AH, 2005, ENVIRON MICROBIOL, V7, P1985, DOI 10.1111/j.1462-2920.2005.00906.x; Verhamme DT, 2011, ISME J, V5, P1067, DOI 10.1038/ismej.2010.191; Winiger M., 1981, ERDKUNDE, V35, P248; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Zhang LM, 2009, FEMS MICROBIOL ECOL, V70, P208, DOI 10.1111/j.1574-6941.2009.00775.x	76	37	44	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44494	10.1371/journal.pone.0044494	http://dx.doi.org/10.1371/journal.pone.0044494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970233	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400079
J	Franzetti, GA; Laud-Duval, K; Bellanger, D; Stern, MH; Sastre-Garau, X; Delattre, O				Franzetti, G-A; Laud-Duval, K.; Bellanger, D.; Stern, M-H; Sastre-Garau, X.; Delattre, O.			MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor	ONCOGENE			English	Article						Ewing sarcoma; EWS-FLI1; CD99; microRNAs; miR-30a-5p	MESENCHYMAL PROGENITOR CELLS; SARCOMA CELLS; TRANSCRIPTION FACTOR; FUSION PROTEINS; STEM-CELLS; EXPRESSION; MICRORNAS; IDENTIFICATION; CANCER; GENE	Ewing sarcoma is a pediatric bone tumor characterized in 85% of cases by the fusion between EWS and FLI1 genes that results in the expression of the EWS-FLI1 aberrant transcription factor. Histologically, the Ewing tumor expresses high levels of the CD99 membrane glycoprotein. It has been recently described that CD99 expression contributes to the Ewing tumor oncogenesis by modulating growth and differentiation of tumor cells. Different studies have also shown that overexpression of EWS-FLI1 induces CD99 expression in non-Ewing cells. At the opposite, the knockdown of EWS-FLI1 expression by siRNA approaches has no significant effect on CD99 mRNA level in Ewing cells. Here, by in vivo and in vitro studies, we show that while EWS-FLI1 inhibition has only slight effects on the amount of CD99 transcript, it induces a dramatic decrease of the CD99 protein expression level, hence suggesting post-transcriptional regulations, possibly mediated by microRNAs. To further investigate this issue, we identified a set of 91 miRNAs that demonstrate EWS-FLI1 modulation, three of them being predicted to bind CD99 3' untranslated region (3'UTR). Among these, we show that miR-30a-5p has the ability to interact with the 3'UTR region of CD99 and to regulate its expression. Moreover, the re-expression of miRNA-30a-5p in Ewing cell line induces decreased cell proliferation and invasion. In this study, we therefore show that miR-30a-5p constitutes a major functional link between EWS-FLI1 and CD99, two critical biomarkers and therapeutic targets in Ewing sarcoma.	[Franzetti, G-A; Laud-Duval, K.; Bellanger, D.; Stern, M-H; Delattre, O.] Inst Curie, Ctr Rech, INSERM U830, F-75248 Paris 05, France; [Franzetti, G-A; Laud-Duval, K.; Bellanger, D.; Stern, M-H; Delattre, O.] Inst Curie, Ctr Rech, F-75248 Paris 05, France; [Sastre-Garau, X.] Grp Hosp Pitie Salpetriere, Inst Curie, Serv Pathol, F-75634 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Delattre, O (corresponding author), Inst Curie, Ctr Rech, INSERM U830, 26 Rue Ulm, F-75248 Paris 05, France.	Olivier.delattre@curie.fr	Stern, Marc-Henri/A-2728-2011	Stern, Marc-Henri/0000-0002-8100-2272; delattre, olivier/0000-0002-8730-2276; Sastre-Garau, Xavier/0000-0001-5992-2083	Ligue Nationale Contre le Cancer (Equipe labelise); INCa [2009-1-PLBIO-04-IC-1]; Courir pour Mathieu; Dans les pas du Geant; Olivier Chape; Les Bagouzamanon; les Amis de Claire; Ministere de l'Enseignement Superieur et de la Recherche (France)	Ligue Nationale Contre le Cancer (Equipe labelise); INCa(Institut National du Cancer (INCA) France); Courir pour Mathieu; Dans les pas du Geant; Olivier Chape; Les Bagouzamanon; les Amis de Claire; Ministere de l'Enseignement Superieur et de la Recherche (France)	We thank the members of the cytometry plateform of tumor biology department of the Institut Curie for the cell selection by FACS. This work was supported by grants from the Ligue Nationale Contre le Cancer (Equipe labelise), the INCa (no 2009-1-PLBIO-04-IC-1), and the following associations: Courir pour Mathieu, Dans les pas du Geant, Olivier Chape, Les Bagouzamanon and les Amis de Claire. Georges-Alain Franzetti is a recipient of a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche (France).	Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Ban J, 2011, ONCOGENE, V30, P2173, DOI 10.1038/onc.2010.581; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Bernard G, 2000, EUR J IMMUNOL, V30, P3061, DOI 10.1002/1521-4141(200010)30:10<3061::AID-IMMU3061>3.0.CO;2-M; Bernard G, 1997, J IMMUNOL, V158, P2543; Boeva V, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq217; Braunreiter CL, 2006, CELL CYCLE, V5, P2753, DOI 10.4161/cc.5.23.3505; Bremond A, 2009, BLOOD, V113, P347, DOI 10.1182/blood-2008-02-137745; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Cerisano V, 2004, ONCOGENE, V23, P5664, DOI 10.1038/sj.onc.1207741; Chansky HA, 2001, CANCER RES, V61, P3586; Cironi L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002634; De Vito C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023592; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Erkizan HV, 2010, CLIN CANCER RES, V16, P4077, DOI 10.1158/1078-0432.CCR-09-2261; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fujita S, 2008, BIOINFORMATICS, V24, P303, DOI 10.1093/bioinformatics/btm589; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Guillon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004932; Hu-Lieskovan S, 2005, CANCER RES, V65, P4633, DOI 10.1158/0008-5472.CAN-04-2857; Kreppel M, 2006, ONCOGENE, V25, P2795, DOI 10.1038/sj.onc.1209300; Kumarswamy R, 2012, INT J CANCER, V130, P2044, DOI 10.1002/ijc.26218; Lee MTM, 2003, J VIROL, V77, P11964, DOI 10.1128/JVI.77.22.11964-11972.2003; Lessnick SL, 2002, CANCER CELL, V1, P393, DOI 10.1016/S1535-6108(02)00056-9; Li Jun-cai, 2010, Xibei Zhiwu Xuebao, V30, P30; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; McKinsey EL, 2011, ONCOGENE, V30, P4910, DOI 10.1038/onc.2011.197; Melot T, 2001, EUR J BIOCHEM, V268, P3483, DOI 10.1046/j.1432-1327.2001.02251.x; Melot T, 1997, HYBRIDOMA, V16, P457, DOI 10.1089/hyb.1997.16.457; Miyagawa Y, 2008, MOL CELL BIOL, V28, P2125, DOI 10.1128/MCB.00740-07; Pettersen RD, 2001, J IMMUNOL, V166, P4931, DOI 10.4049/jimmunol.166.8.4931; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Rocchi A, 2010, J CLIN INVEST, V120, P668, DOI 10.1172/JCI36667; Rorie CJ, 2004, CANCER RES, V64, P1266, DOI 10.1158/0008-5472.CAN-03-3274; Sanchez G, 2008, CELL CYCLE, V7, P2299, DOI 10.4161/cc.6445; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Scotlandi K, 2000, CANCER RES, V60, P5134; Sohn HW, 1998, AM J PATHOL, V153, P1937, DOI 10.1016/S0002-9440(10)65707-0; Sohn HW, 2001, J IMMUNOL, V166, P787, DOI 10.4049/jimmunol.166.2.787; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Toomey EC, 2010, ONCOGENE, V29, P4504, DOI 10.1038/onc.2010.205; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang L, 2000, J BIOL CHEM, V275, P37612, DOI 10.1074/jbc.M005739200; Yeny CT, 2005, CANCER RES, V65, P8698, DOI 10.1158/0008-5472.CAN-05-1704; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Zaragosi LE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-r64; Zhong XM, 2010, J BIOL CHEM, V285, P41961, DOI 10.1074/jbc.M110.169607	54	51	53	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2013	32	33					3915	3921		10.1038/onc.2012.403	http://dx.doi.org/10.1038/onc.2012.403			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	202JH	22986530				2022-12-25	WOS:000323210200014
J	Hochrath, K; Krawczyk, M; Goebel, R; Langhirt, M; Rathkolb, B; Micklich, K; Rozman, J; Horsch, M; Beckers, J; Klingenspor, M; Fuchs, H; Gailus-Durner, V; Wolf, E; Acalovschi, M; Volmer, DA; de Angelis, MH; Lammert, F				Hochrath, Katrin; Krawczyk, Marcin; Goebel, Reinhild; Langhirt, Miriam; Rathkolb, Birgit; Micklich, Kateryna; Rozman, Jan; Horsch, Marion; Beckers, Johannes; Klingenspor, Martin; Fuchs, Helmut; Gailus-Durner, Valerie; Wolf, Eckhard; Acalovschi, Monica; Volmer, Dietrich A.; de Angelis, Martin Hrabe; Lammert, Frank			The hepatic phosphatidylcholine transporter ABCB4 as modulator of glucose homeostasis	FASEB JOURNAL			English	Article						ATP-binding cassette transporter; chronic cholangitis; liver fibrosis; liver receptor homolog	INTRAHEPATIC CHOLESTASIS; INSULIN-RESISTANCE; TRANSFER PROTEIN; GALLSTONE RISK; LIVER-INJURY; BILE-ACIDS; GENE; MICE; EXPRESSION; FIBROSIS	The hepatic phosphatidylcholine (PC) transporter ATP-binding cassette (ABC) B4 flops PC from hepatocytes into bile, and its dysfunction causes chronic cholestasis and fibrosis. Because a nuclear receptor-dependent PC pathway has been determined to exert antidiabetic effects, we now analyzed the role of ABCB4 in glucose metabolism. We bred congenic Abcb4-knockout (Abcb4(-/-)) mice on the fibrosis-susceptible BALB/cJ background. Knockout mice and wild-type controls were phenotyped by measuring plasma glucose concentrations, intraperitoneal glucose tolerance, hepatic RNA expression profiles, and liver histology. In addition, 4 procholestatic ABCB4 gene variants were correlated with blood glucose levels in 682 individuals from 2 independent European cohorts. Systemic glucose levels differ significantly between Abcb4(-/-) mice and wild-type controls, and knockout mice display improved glucose tolerance with significantly lower area under the curve values on intraperitoneal glucose challenge. Of note, hepatic expression of the antidiabetic nuclear receptor 5A2 (LRH-1) is induced consistently in Abcb4(-/-) mice, and its specific rare PC ligands are detected in liver by mass spectrometry imaging. In humans, serum glucose levels are associated significantly with the common ABCB4 variant c.711A>T. In summary, ABCB4 might play a critical role in glucose homeostasis in mice and humans. We speculate that the effects could be mediated via LRH-1-dependent PC pathways.-Hochrath, K., Krawczyk, M., Goebel, R., Langhirt, M., Rathkolb, B., Micklich, K., Rozman, J., Horsch, M., Beckers, J., Klingenspor, M., Fuchs, H., Gailus- Durner, V., Wolf, E., Acalovschi, M., Volmer, D. A., Hrabe. de Angelis, M., Lammert, F. The hepatic phosphatidylcholine transporter ABCB4 as modulator of glucose homeostasis. FASEB J. 26, 5081-5091 (2012). www.fasebj.org	[Hochrath, Katrin; Krawczyk, Marcin; Goebel, Reinhild; Langhirt, Miriam; Lammert, Frank] Univ Saarland, Med Ctr, Dept Med 2, D-66421 Homburg, Germany; [Rathkolb, Birgit; Micklich, Kateryna; Wolf, Eckhard] Univ Munich, Inst Mol Anim Breeding & Biotechnol, Munich, Germany; [Rathkolb, Birgit; Micklich, Kateryna; Rozman, Jan; Horsch, Marion; Beckers, Johannes; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Expt Genet, German Mouse Clin, Neuherberg, Germany; [Rozman, Jan; Klingenspor, Martin] Tech Univ Munich, Dept Mol Nutr Med, Else Kroner Fresenius Ctr, Freising Weihenstephan, Germany; [Rozman, Jan; Beckers, Johannes] Tech Univ Munich, Zent Inst Ernahrungs & Lebensmittelforsch ZIEL, Res Ctr Nutr & Food Sci, Freising Weihenstephan, Germany; [Beckers, Johannes] Tech Univ Munich, Dept Expt Genet, Freising Weihenstephan, Germany; [Acalovschi, Monica; de Angelis, Martin Hrabe] Iuliu Hatieganu Univ Med & Pharm, Dept Med 3, Cluj Napoca, Romania; [Volmer, Dietrich A.] Univ Saarland, Inst Bioanalyt Chem, D-6600 Saarbrucken, Germany; [de Angelis, Martin Hrabe] German Ctr Diabet Res, Neuherberg, Germany	Saarland University; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Technical University of Munich; Iuliu Hatieganu University of Medicine & Pharmacy; Regional Institute of Gastroenterology & Hepatology; Saarland University	Lammert, F (corresponding author), Univ Saarland, Med Ctr, Dept Med 2, Kirrberger Str 100, D-66421 Homburg, Germany.	frank.lammert@uks.eu	Rathkolb, Birgit/F-7041-2013; Klingenspor, Martin/D-6930-2011; Beckers, Johannes/K-7237-2012; Krawczyk, Marcin/AAG-4356-2020; Gailus-Durner, Valerie/M-7337-2014; Klingenspor, Martin/K-5033-2019; Fuchs, Helmut/M-7347-2014; Rozman, Jan/A-2540-2010; Volmer, Dietrich/G-7900-2012; de Angelis, Martin Hrabe/F-5531-2012	Klingenspor, Martin/0000-0002-4502-6664; Beckers, Johannes/0000-0001-7874-3822; Krawczyk, Marcin/0000-0002-0113-0777; Fuchs, Helmut/0000-0002-5143-2677; Rozman, Jan/0000-0002-8035-8904; Volmer, Dietrich/0000-0003-2820-1480; de Angelis, Martin Hrabe/0000-0002-7898-2353; Wolf, Eckhard/0000-0002-0430-9510	Deutsche Forschungsgemeinschaft [SFB/TRR57 TP01]; German Federal Ministry of Education and Research [01GS0851, 01GS0850, 01GS0869, 01KX1012]; European Union [EUMODIC LSHG-2006-037188, 211404]; Alfried Krupp von Bohlen and Halbach-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Alfried Krupp von Bohlen and Halbach-Stiftung	The authors thank all patients for participating in this study and providing blood samples. The authors also thank the technicians, especially Annika Bohner for setting up cell culture experiments, and Sandra Geissler, Elfi Holupirek, Ann-Elisabeth Schwarz, and Reinhard Seeliger, as well as the animal caretaker team of the German Mouse Clinic (Michael Gerstlauer, Manuela Huber, Renate Huber, Heidi Marr, Annica Miedl, Tina Reichelt, Boris Schn, and Horst Wenig), for technical assistance in mouse phenotyping. The authors also thank Christine Gau for help with statistical analyses. This study was supported by Deutsche Forschungsgemeinschaft (SFB/TRR57 TP01 to F. L.), by a grant from the German Federal Ministry of Education and Research to the German Center for Diabetes Research, NGFN-Plus (01GS0851 to E. W., 01GS0850 to M. H. A., and 01GS0869 to M. K.), and Infrafrontier (01KX1012). The German Mouse Clinic received funding from the European Union (EUMODIC LSHG-2006-037188 and Infrafrontier Contract No. 211404). D. A. V. acknowledges research support by the Alfried Krupp von Bohlen and Halbach-Stiftung. The results of this article were included, in part, in an oral presentation at the 60th Annual Meeting of the American Association for the Study of Liver Diseases in Boston, November 3, 2009, and were published in abstract form in Hepatology [2009; 50(Suppl. 4), A232].	Acalovschi M, 2009, LIPIDS, V44, P521, DOI 10.1007/s11745-009-3300-z; Baghdasaryan A, 2008, LIVER INT, V28, P948, DOI 10.1111/j.1478-3231.2008.01758.x; Baghy K, 2011, LAB INVEST, V91, P439, DOI 10.1038/labinvest.2010.172; Biddinger SB, 2008, NAT MED, V14, P778, DOI 10.1038/nm1785; Borkham-Kamphorst E, 2011, LIVER INT, V31, P656, DOI 10.1111/j.1478-3231.2011.02495.x; Carey M C, 1992, Prog Liver Dis, V10, P139; De Vree JML, 1998, P NATL ACAD SCI USA, V95, P282, DOI 10.1073/pnas.95.1.282; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Elferink RPJO, 2006, GASTROENTEROLOGY, V130, P908, DOI 10.1053/j.gastro.2005.08.052; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009; Forman BM, 2005, CELL METAB, V1, P153, DOI 10.1016/j.cmet.2005.02.006; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Grunhage F, 2007, HEPATOLOGY, V46, P793, DOI 10.1002/hep.21847; Hegde P, 2000, BIOTECHNIQUES, V29, P548, DOI 10.2144/00293bi01; Hillebrandt S, 2005, NAT GENET, V37, P835, DOI 10.1038/ng1599; Hillebrandt S, 2002, GASTROENTEROLOGY, V123, P2041, DOI 10.1053/gast.2002.37069; Hohenester Simon, 2011, Hepatology, V54, P2265, DOI 10.1002/hep.24697; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iyengar SK, 2007, DIABETES, V56, P1577, DOI 10.2337/db06-1154; JAMALL IS, 1981, ANAL BIOCHEM, V112, P70, DOI 10.1016/0003-2697(81)90261-X; Jung C, 2007, J PEDIATR GASTR NUTR, V44, P453, DOI 10.1097/MPG.0b013e318036a569; Keitel V, 2012, HEPATOBILIARY TRANSP, P117; Kovacs P, 2008, J HEPATOL, V48, P116, DOI 10.1016/j.jhep.2007.07.027; Krawczyk M, 2011, J PHYSIOL PHARMACOL, V62, P369; Krawczyk M, 2011, SEMIN LIVER DIS, V31, P157, DOI 10.1055/s-0031-1276645; Krawczyk M, 2010, J GASTROINTEST LIVER, V19, P273; Lammert F, 2004, HEPATOLOGY, V39, P117, DOI 10.1002/hep.20022; Lang C, 2007, PHARMACOGENET GENOM, V17, P47, DOI 10.1097/01.fpc.0000230418.28091.76; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Lee YK, 2008, MOL ENDOCRINOL, V22, P1345, DOI 10.1210/me.2007-0565; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mochizuki H, 1998, GENE, V213, P149, DOI 10.1016/S0378-1119(98)00193-0; Moles A, 2012, J BIOL CHEM, V287, P1178, DOI 10.1074/jbc.M111.272393; Mullenbach R, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e70; Mullenbach R., 2011, J LIPIDS; Oosterveer MH, 2012, J CLIN INVEST, V122, P2817, DOI 10.1172/JCI62368; Ortlund EA, 2005, NAT STRUCT MOL BIOL, V12, P357, DOI 10.1038/nsmb910; Perez-Carreon J. I., 2010, INT J BIOCHEM CELL B, V42, P287; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; PROCHAZKA M, 1995, DIABETOLOGIA, V38, P461, DOI 10.1007/s001250050306; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Rosmorduc O, 2003, GASTROENTEROLOGY, V125, P452, DOI 10.1016/S0016-5085(03)00898-9; Rosmorduc O, 2001, GASTROENTEROLOGY, V120, P1459, DOI 10.1053/gast.2001.23947; Scapa EF, 2008, FASEB J, V22, P2579, DOI 10.1096/fj.07-105395; Shishova EY, 2011, HEPATOLOGY, V54, P664, DOI 10.1002/hep.24393; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vacca M, 2007, CURR MED CHEM, V14, P2081; Varela-Rey M, 2010, HEPATOLOGY, V52, P105, DOI 10.1002/hep.23639; Wasmuth HE, 2007, GUT, V56, P265, DOI 10.1136/gut.2006.092742; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wopereis S, 2012, PHYSIOL GENOMICS, V44, P293, DOI 10.1152/physiolgenomics.00072.2011	55	20	21	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					5081	5091		10.1096/fj.12-209379	http://dx.doi.org/10.1096/fj.12-209379			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22982378				2022-12-25	WOS:000311838300029
J	Miyazaki, T; Iwasawa, M; Nakashima, T; Mori, S; Shigemoto, K; Nakamura, H; Katagiri, H; Takayanagi, H; Tanaka, S				Miyazaki, Tsuyoshi; Iwasawa, Mitsuyasu; Nakashima, Tomoki; Mori, Shuuichi; Shigemoto, Kazuhiro; Nakamura, Hiroaki; Katagiri, Hideki; Takayanagi, Hiroshi; Tanaka, Sakae			Intracellular and Extracellular ATP Coordinately Regulate the Inverse Correlation between Osteoclast Survival and Bone Resorption	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL TRANSCRIPTION FACTOR; DNA GENE-EXPRESSION; COPY NUMBER; CELL-PROLIFERATION; SKELETAL-MUSCLE; APOPTOSIS; ACTIVATION; RECEPTOR; RELEASE; MTDNA	Osteoclasts, highly differentiated bone-resorbing cells of hematopoietic origin, have two conflicting tendencies: a lower capacity to survive and a higher capacity to execute energy-consuming activities such as bone resorption. Here, we report that when compared with their precursors, mature mitochondria-rich osteoclasts have lower levels of intracellular ATP, which is associated with receptor activator of nuclear factor kappa-B ligand (RANKL)-induced Bcl-xL down-regulation. Severe ATP depletion, caused by disrupting mitochondrial transcription factor A (Tfam) gene, leads to increased bone-resorbing activity despite accelerated apoptosis. Although AMP-activated protein kinase (AMPK) activation by ATP depletion is not involved in the regulation of osteoclast function, the release of ATP from intracellular stores negatively regulates bone-resorbing activity through an autocrine/paracrine feedback loop by altering cytoskeletal structures. Furthermore, osteoclasts derived from aged mice exhibit reduced mitochondrial DNA(mtDNA) and intracellular ATP levels with increased bone-resorbing activity, implicating the possible involvement of age-related mitochondrial dysfunction in osteoporosis. Thus, our study provides evidence for a mechanism underlying the control of cellular functions by reciprocal changes in intracellular and extracellular ATP, which regulate the negative correlation between osteoclast survival and bone resorption.	[Miyazaki, Tsuyoshi; Mori, Shuuichi; Shigemoto, Kazuhiro] Tokyo Metropolitan Geriatr Hosp, Dept Geriatr Med, Itabashi Ku, Tokyo 1730015, Japan; [Miyazaki, Tsuyoshi] Tokyo Metropolitan Geriatr Hosp, Dept Orthopaed Surg, Itabashi Ku, Tokyo 1730015, Japan; [Iwasawa, Mitsuyasu; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1130033, Japan; [Nakashima, Tomoki; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Grad Sch, Dept Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan; [Nakamura, Hiroaki] Matsumoto Dent Univ, Dept Histol & Cell Biol, Nagano 3990781, Japan; [Katagiri, Hideki] Tohoku Univ, Grad Sch Med, Ctr Metab Dis, Dept Metab Dis,Aoba Ku, Sendai, Miyagi 9808575, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU); Matsumoto Dental University; Tohoku University	Miyazaki, T (corresponding author), Tokyo Metropolitan Geriatr Hosp, Dept Geriatr Med, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	miyazak14@tmig.or.jp	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414; Miyazaki, Tsuyoshi/0000-0003-0715-9017	Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22591698] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was in part supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science.	Akiyama T, 2005, BIOL PROCED ONLINE, V7, P48, DOI 10.1251/bpo105; Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Alavian KN, 2011, NAT CELL BIOL, V13, P1224, DOI 10.1038/ncb2330; Auger R, 2005, J BIOL CHEM, V280, P28142, DOI 10.1074/jbc.M501290200; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bodin P, 2001, NEUROCHEM RES, V26, P959, DOI 10.1023/A:1012388618693; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Burnstock G, 2002, ARTERIOSCL THROM VAS, V22, P364, DOI 10.1161/hq0302.105360; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Clarke BL, 2002, CALCIFIED TISSUE INT, V70, P137, DOI 10.1007/s00223-001-1072-4; CORRALDEBRINSKI M, 1992, MUTAT RES, V275, P169, DOI 10.1016/0921-8734(92)90021-G; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fatayerji D, 1999, J BONE MINER RES, V14, P1203, DOI 10.1359/jbmr.1999.14.7.1203; Feldenberg LR, 1999, AM J PHYSIOL-RENAL, V276, pF837, DOI 10.1152/ajprenal.1999.276.6.F837; Fields RD, 2011, SEMIN CELL DEV BIOL, V22, P214, DOI 10.1016/j.semcdb.2011.02.009; Gallagher JC, 1998, J BONE MINER RES, V13, P475, DOI 10.1359/jbmr.1998.13.3.475; Gaspari M, 2004, BBA-BIOENERGETICS, V1659, P148, DOI 10.1016/j.bbabio.2004.10.003; Genetos DC, 2005, J BONE MINER RES, V20, P41, DOI 10.1359/jbmr.041009; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hazama R, 2009, GENES CELLS, V14, P871, DOI 10.1111/j.1365-2443.2009.01317.x; Huang Y, 2007, GLIA, V55, P46, DOI 10.1002/glia.20435; Hwang SM, 2009, J DENT RES, V88, P927, DOI 10.1177/0022034509342227; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Iwasawa M, 2009, J CLIN INVEST, V119, P3149, DOI 10.1172/JCI39819; Izyumov DS, 2004, BBA-BIOENERGETICS, V1658, P141, DOI 10.1016/j.bbabio.2004.05.007; Jeng JY, 2008, J CELL BIOCHEM, V103, P347, DOI 10.1002/jcb.21625; Katz S, 2011, ARCH BIOCHEM BIOPHYS, V513, P144, DOI 10.1016/j.abb.2011.06.013; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Li H, 2000, P NATL ACAD SCI USA, V97, P3467, DOI 10.1073/pnas.97.7.3467; Li JL, 2005, J BIOL CHEM, V280, P42952, DOI 10.1074/jbc.M506415200; MacVicar BA, 2010, TRENDS NEUROSCI, V33, P93, DOI 10.1016/j.tins.2009.11.007; MARTIN SJ, 1995, J BIOL CHEM, V270, P6425, DOI 10.1074/jbc.270.12.6425; Matsumoto T, 2011, ARTHRITIS RHEUM-US, V63, P3908, DOI 10.1002/art.30646; MILLER DS, 1986, J BIOL CHEM, V261, P13911; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Morelli A, 2003, MOL BIOL CELL, V14, P2655, DOI 10.1091/mbc.02-04-0061; Nagase Y, 2009, J BIOL CHEM, V284, P36659, DOI 10.1074/jbc.M109.016915; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Orriss IR, 2009, J CELL PHYSIOL, V220, P155, DOI 10.1002/jcp.21745; Oshima Y, 2008, J BIOL CHEM, V283, P26499, DOI 10.1074/jbc.M800933200; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Pederson L, 2008, P NATL ACAD SCI USA, V105, P20764, DOI 10.1073/pnas.0805133106; Pellegatti P, 2011, FASEB J, V25, P1264, DOI 10.1096/fj.10-169854; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanaka S, 2006, ANN NY ACAD SCI, V1068, P180, DOI 10.1196/annals.1346.020; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wang JM, 2001, P NATL ACAD SCI USA, V98, P4038, DOI 10.1073/pnas.061038798; Winkeler CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042005; WISHART JM, 1995, CLIN ENDOCRINOL, V42, P141, DOI 10.1111/j.1365-2265.1995.tb01854.x; Yi CH, 2011, CELL, V146, P607, DOI 10.1016/j.cell.2011.06.050	66	79	84	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.385369	http://dx.doi.org/10.1074/jbc.M112.385369			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988253	Green Published, hybrid			2022-12-25	WOS:000310642200019
J	Aulds, J; Wierzbicki, S; McNairn, A; Schmitt, ME				Aulds, Jason; Wierzbicki, Sara; McNairn, Adrian; Schmitt, Mark E.			Global Identification of New Substrates for the Yeast Endoribonuclease, RNase Mitochondrial RNA Processing (MRP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARTILAGE-HAIR HYPOPLASIA; UNIQUE PROTEIN-COMPONENT; CELL-CYCLE PROGRESSION; SACCHAROMYCES-CEREVISIAE; BINDING PROTEIN; RIBOSOMAL-RNA; U2 SNRNA; REVEALS; MUTATIONS; ACE2P	RNase mitochondrial RNA processing (MRP) is an essential, evolutionarily conserved endoribonuclease composed of 10 different protein subunits and a single RNA. RNase MRP has established roles in multiple pathways including ribosome biogenesis, cell cycle regulation, and mitochondrial DNA replication. Although each of these functions is important to cell growth, additional functions may exist given the essential nature of the complex. To identify novel RNase MRP substrates, we utilized RNA immunoprecipitation and microarray chip analysis to identify RNA that physically associates with RNase MRP. We identified several new potential substrates for RNase MRP including a cell cycle-regulated transcript, CTS1; the yeast homolog of the mammalian p27(Kip1), SIC1; and the U2 RNA component of the spliceosome. In addition, we found RNase MRP to be involved in the regulation of the Ty1 transposon RNA. These results reinforce and broaden the role of RNase MRP in cell cycle regulation and help to identify new roles of this endoribonuclease.	[Aulds, Jason; Wierzbicki, Sara; McNairn, Adrian; Schmitt, Mark E.] State Univ New York Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [McNairn, Adrian] Cornell Univ, Dept Biomed Sci, Coll Vet Med, Ithaca, NY 14853 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Cornell University	Schmitt, ME (corresponding author), State Univ New York Upstate Med Univ, Dept Biochem & Mol Biol, 750 E Adams St, Syracuse, NY 13210 USA.	schmittm@upstate.edu	McNairn, Adrian/AAZ-9221-2021	McNairn, Adrian/0000-0003-4727-3770	National Institutes of Health Grant, NIGMS [GM063798]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063798] Funding Source: NIH RePORTER	National Institutes of Health Grant, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM063798 from the NIGMS.	Aye M, 2004, GENETICS, V168, P1159, DOI 10.1534/genetics.104.028126; Barberis M, 2005, BIOCHEM J, V387, P639, DOI 10.1042/BJ20041299; Behm-Ansmant I, 2003, RNA, V9, P1371, DOI 10.1261/rna.5520403; BROWN JW, 1990, CELL, V62, P407, DOI 10.1016/0092-8674(90)90003-W; Cai T, 1999, MOL CELL BIOL, V19, P7857; Cai T, 2002, GENETICS, V161, P1029; CHANG DD, 1987, EMBO J, V6, P409, DOI 10.1002/j.1460-2075.1987.tb04770.x; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; Doolin MT, 2001, MOL MICROBIOL, V40, P422, DOI 10.1046/j.1365-2958.2001.02388.x; Esakova O, 2011, RNA, V17, P356, DOI 10.1261/rna.2393711; Gill T, 2006, J CELL BIOL, V173, P35, DOI 10.1083/jcb.200512025; Gill T, 2004, MOL CELL BIOL, V24, P945, DOI 10.1128/MCB.24.3.945-953.2004; Houser-Scott F, 2002, P NATL ACAD SCI USA, V99, P2684, DOI 10.1073/pnas.052586299; Jaag HM, 2011, J VIROL, V85, P243, DOI 10.1128/JVI.01749-10; Jain R, 2011, METHODS MOL BIOL, V703, P247, DOI 10.1007/978-1-59745-248-9_17; KARWAN R, 1991, GENE DEV, V5, P1264, DOI 10.1101/gad.5.7.1264; Larsen LSZ, 2008, J VIROL, V82, P2501, DOI 10.1128/JVI.01814-07; Larsen LSZ, 2007, J VIROL, V81, P6957, DOI 10.1128/JVI.02207-06; LI K, 1994, J CELL BIOL, V124, P871, DOI 10.1083/jcb.124.6.871; Lu QS, 2010, RNA, V16, P529, DOI 10.1261/rna.1893710; Lygerou Z, 1996, SCIENCE, V272, P268, DOI 10.1126/science.272.5259.268; Ma XJ, 2003, EMBO J, V22, P1889, DOI 10.1093/emboj/cdg191; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; O'Conallain C, 1999, MOL GEN GENET, V262, P275, DOI 10.1007/s004380051084; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Roth JF, 2000, YEAST, V16, P785, DOI 10.1002/1097-0061(20000630)16:9<785::AID-YEA550>3.0.CO;2-L; Salinas K, 2005, J BIOL CHEM, V280, P11352, DOI 10.1074/jbc.M409568200; Sambrook J, 2001, MOL CLONING LAB MANU; SCHMITT ME, 1994, GENE DEV, V8, P2617, DOI 10.1101/gad.8.21.2617; SCHMITT ME, 1993, MOL CELL BIOL, V13, P7935, DOI 10.1128/MCB.13.12.7935; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Shadel GS, 2000, GENE, V245, P175, DOI 10.1016/S0378-1119(00)00013-5; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Stevens SW, 2002, MOL CELL, V9, P31, DOI 10.1016/S1097-2765(02)00436-7; Taskinen M, 2008, AM J MED GENET A, V146A, P2370, DOI 10.1002/ajmg.a.32478; Thiel CT, 2011, BEST PRACT RES CL EN, V25, P131, DOI 10.1016/j.beem.2010.08.004; Thiel CT, 2005, AM J HUM GENET, V77, P795, DOI 10.1086/497708; Ufano S, 2004, J CELL SCI, V117, P545, DOI 10.1242/jcs.00880; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106	41	9	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					37089	37097		10.1074/jbc.M112.389023	http://dx.doi.org/10.1074/jbc.M112.389023			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977255	hybrid, Green Published			2022-12-25	WOS:000310588500043
J	Ginsberg, MR; Rubin, RA; Falcone, T; Ting, AH; Natowicz, MR				Ginsberg, Matthew R.; Rubin, Robert A.; Falcone, Tatiana; Ting, Angela H.; Natowicz, Marvin R.			Brain Transcriptional and Epigenetic Associations with Autism	PLOS ONE			English	Article							COPY-NUMBER VARIATION; DE-NOVO MUTATIONS; SPECTRUM DISORDERS; GENE-EXPRESSION; CHILDREN; NETWORK; GENOME; PATHOPHYSIOLOGY; DYSFUNCTION; VARIANTS	Background: Autism is a common neurodevelopmental syndrome. Numerous rare genetic etiologies are reported; most cases are idiopathic. Methodology/Principal Findings: To uncover important gene dysregulation in autism we analyzed carefully selected idiopathic autistic and control cerebellar and BA19 (occipital) brain tissues using high resolution whole genome gene expression and whole genome DNA methylation microarrays. No changes in DNA methylation were identified in autistic brain but gene expression abnormalities in two areas of metabolism were apparent: down-regulation of genes of mitochondrial oxidative phosphorylation and of protein translation. We also found associations between specific behavioral domains of autism and specific brain gene expression modules related to myelin/myelination, inflammation/immune response and purinergic signaling. Conclusions/Significance: This work highlights two largely unrecognized molecular pathophysiological themes in autism and suggests differing molecular bases for autism behavioral endophenotypes.	[Ginsberg, Matthew R.; Natowicz, Marvin R.] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Rubin, Robert A.] Whittier Coll, Dept Math, Whittier, CA USA; [Falcone, Tatiana; Natowicz, Marvin R.] Cleveland Clin, Neurol Inst, Cleveland, OH 44106 USA; [Ting, Angela H.; Natowicz, Marvin R.] Cleveland Clin, Genom Med Inst, Cleveland, OH 44106 USA; [Natowicz, Marvin R.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Natowicz, Marvin R.] Cleveland Clin, Inst Pediat, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Ginsberg, MR (corresponding author), Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.	natowim@ccf.org		Falcone, Tatiana/0000-0002-4431-6782	Cleveland Clinic Research Program Committee; Autism Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	Cleveland Clinic Research Program Committee; Autism Research Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the Cleveland Clinic Research Program Committee and the Autism Research Institute (www.autism.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou E, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-4; Auerbach BD, 2011, NATURE, V480, P63, DOI 10.1038/nature10658; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Burnstock G, 2011, CURR TOP MED CHEM, V11, P973, DOI 10.2174/156802611795347627; Chahrour MH, 2012, PLOS GENET, V8, P236, DOI 10.1371/journal.pgen.1002635; Chauhan A, 2011, J NEUROCHEM, V117, P209, DOI 10.1111/j.1471-4159.2011.07189.x; Cheung C, 2009, J CHILD PSYCHOL PSYC, V50, P1102, DOI 10.1111/j.1469-7610.2009.02086.x; Darnell JC, 2011, CURR OPIN GENET DEV, V21, P465, DOI 10.1016/j.gde.2011.05.002; Devlin B, 2012, CURR OPIN GENET DEV, V22, P229, DOI 10.1016/j.gde.2012.03.002; Fatemi SH, 2012, CEREBELLUM, V11, P777, DOI 10.1007/s12311-012-0355-9; Filipovic-Sadic S, 2010, CLIN CHEM, V56, P399, DOI 10.1373/clinchem.2009.136101; Garbett K, 2008, NEUROBIOL DIS, V30, P303, DOI 10.1016/j.nbd.2008.01.012; Geschwind DH, 2011, TRENDS COGN SCI, V15, P409, DOI 10.1016/j.tics.2011.07.003; Gillis RF, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-12; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gregg JP, 2008, GENOMICS, V91, P22, DOI 10.1016/j.ygeno.2007.09.003; Gregory SG, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-62; Haas RH, 2010, DEV DISABIL RES REV, V16, P144, DOI 10.1002/ddrr.112; Hazlett EA, 2004, NEUROPSYCHOBIOLOGY, V49, P115, DOI 10.1159/000076719; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; Jiang YH, 2004, AM J MED GENET A, V131A, P1, DOI 10.1002/ajmg.a.30297; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Levitt P, 2009, J CLIN INVEST, V119, P747, DOI 10.1172/JCI37934; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Levy SE, 2009, LANCET, V374, P1627, DOI 10.1016/S0140-6736(09)61376-3; Nagarajan RP, 2008, AUTISM RES, V1, P169, DOI 10.1002/aur.24; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nguyen A, 2010, FASEB J, V24, P3036, DOI 10.1096/fj.10-154484; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Ring HA, 1999, BRAIN, V122, P1305, DOI 10.1093/brain/122.7.1305; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sbacchi S, 2010, CURR GENOMICS, V11, P136, DOI 10.2174/138920210790886880; Voineagu I, 2012, NEUROBIOL DIS, V45, P69, DOI 10.1016/j.nbd.2011.07.017; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wintle RF, 2011, AUTISM RES, V4, P89, DOI 10.1002/aur.173; Xin YR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011357; Xu HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-499; Xu LM, 2012, NUCLEIC ACIDS RES, V40, pD1016, DOI 10.1093/nar/gkr1145	43	110	111	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44736	10.1371/journal.pone.0044736	http://dx.doi.org/10.1371/journal.pone.0044736			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984548	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500077
J	Schiotis, R; Bartolome, N; Sanchez, A; Szczypiorska, M; Sanz, J; Cuende, E; Estevez, EC; Martinez, A; Tejedor, D; Artieda, M; Buzoianu, A; Mulero, J				Schiotis, Ruxandra; Bartolome, Nerea; Sanchez, Alejandra; Szczypiorska, Magdalena; Sanz, Jesus; Cuende, Eduardo; Collantes Estevez, Eduardo; Martinez, Antonio; Tejedor, Diego; Artieda, Marta; Buzoianu, Anca; Mulero, Juan			Both Baseline Clinical Factors and Genetic Polymorphisms Influence the Development of Severe Functional Status in Ankylosing Spondylitis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RADIOGRAPHIC SEVERITY; SUSCEPTIBILITY LOCI; DISEASE SEVERITY; HLA-B27; ERAP1; CONCORDANCE; DISABILITY; PREDICTION; ONSET	Functional severity in ankylosing spondylitis (AS) patients is variable and difficult to predict early. The aim of our study was to assess whether a combination of baseline clinical factors and genetic markers may predict the development of severe functional status in AS. We performed a cross-sectional association study on AS patients included in the Spanish National Registry of Spondyloarthropathies-REGISPONSER. Bath Ankylosing Spondylitis Functional Index (BASFI) was standardized by adjusting for disease duration since the first symptoms (BASFI/t). We considered as severe functional status the values of BASFI/t in the top of the 60th (p60), 65th (p65), 70th (p70), and 75th (p75) percentile. We selected 384 single nucleotide polymorphisms (SNPs) distributed in 190 genes to be analyzed. The study cohort included 456 patients with mean age 50.8(+/- 10.5) years and with mean disease duration since first symptoms 24.7 (+/- 10.1) years. Older age at disease onset and neck pain at baseline showed statistical significant association with severe BASFI/t. Polymorphisms associated in the allele frequencies test with severe BASFI/t in all classifications were: rs2542151 (p60 [P=.04], p65 [P=.04], p70 [P=.001] and p75 [P=.001]) and rs2254441 (p60 [P=.004], p65 [P=.02], p70 [P=.01] and p75 [P<.001]).. Genotype association, after adjustment for covariates, found an association in three of the four patients' classifications for rs2542151 and in two of the classifications for rs2254441. Forward logistic regression did not identify any model with a good predictive power for severe functional development. In our study we identified clinical factors and 24 polymorphisms associated with development of severe functional status in AS patients. Validation of these results in other cohorts is required.	[Schiotis, Ruxandra; Buzoianu, Anca] Iuliu Hatieganu Univ Med & Pharm, Dept Pharmacol, Cluj Napoca, Romania; [Schiotis, Ruxandra] SCBI Rheumatol Dept, Cluj Napoca, Romania; [Schiotis, Ruxandra; Collantes Estevez, Eduardo] Univ Hosp Reina Sofia IMIBIC, Dept Rheumatol, Cordoba, Spain; [Bartolome, Nerea; Szczypiorska, Magdalena; Martinez, Antonio; Tejedor, Diego; Artieda, Marta] Progenika Biopharma SA, Dept R D, Derio Vizcaya, Spain; [Sanchez, Alejandra; Sanz, Jesus; Mulero, Juan] Univ Hosp, Dept Rheumatol, Madrid, Spain; [Cuende, Eduardo] Univ Hosp Principe de Asturias, Dept Rheumatol, Madrid, Spain	Iuliu Hatieganu University of Medicine & Pharmacy; Grifols; Prince of Asturias University Hospital	Schiotis, R (corresponding author), Iuliu Hatieganu Univ Med & Pharm, Dept Pharmacol, Cluj Napoca, Romania.	Elena.Schiotis@umfcluj.ro	Buzoianu, Anca D/M-1050-2017; Sanz, Jesús Sanz/H-8795-2017; Sánchez, Alejandra/G-7826-2012; Buzoianu, Anca D./I-3139-2016; Collantes-Estevez, Eduardo/ABI-3550-2020; Collantes-Estevez, Eduardo/M-9549-2019; schiotis, ruxandra/AAO-5265-2020	Buzoianu, Anca D/0000-0002-3511-2788; Sanz, Jesús Sanz/0000-0001-8740-0063; Sánchez, Alejandra/0000-0003-4620-6744; Collantes-Estevez, Eduardo/0000-0002-7647-6289; 	Ministerio de Ciencia e Innovacion of Spain [Proyect PSE-01000-2006-1]; Progenika Biopharma S.A.; Pfizer	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Progenika Biopharma S.A.; Pfizer(Pfizer)	This work was supported by the Ministerio de Ciencia e Innovacion of Spain [Proyect PSE-01000-2006-1] and by Progenika Biopharma S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare the following interests: M.S., N.B., M.A., A.M. and D.T. are currently employees of Progenika Biopharma, SA. A.S. is supported by an unrestricted grant from Pfizer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors have declared no conflicts of interest.	AMOR B, 1994, J RHEUMATOL, V21, P1883; Ariza-Ariza R, 2009, J RHEUMATOL, V36, P2512, DOI 10.3899/jrheum.090481; Assassi S, 2011, J RHEUMATOL, V38, P87, DOI 10.3899/jrheum.100469; Bartolome N, 2012, RHEUMATOLOGY, V51, P1471, DOI 10.1093/rheumatology/kes056; Boonen A, 2009, J RHEUMATOL, V36, P1249, DOI 10.3899/jrheum.080831; Brophy S, 2004, J RHEUMATOL, V31, P1775; Brophy S, 2001, J RHEUMATOL, V28, P2283; Brown MA, 1998, ARTHRITIS RHEUM, V41, P588, DOI 10.1002/1529-0131(199804)41:4<588::AID-ART5>3.0.CO;2-0; Brown MA, 2003, ARTHRITIS RHEUM, V48, P2234, DOI 10.1002/art.11106; Brown MA, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2692; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cakar E, 2009, CLIN RHEUMATOL, V28, P1309, DOI 10.1007/s10067-009-1249-1; CALIN A, 1994, J RHEUMATOL, V21, P2281; Cansu DU, 2011, CLIN RHEUMATOL, V30, P557, DOI 10.1007/s10067-010-1665-2; CARETTE S, 1983, ARTHRITIS RHEUM, V26, P186, DOI 10.1002/art.1780260210; Carter N, 2000, RHEUMATOLOGY, V39, P445, DOI 10.1093/rheumatology/39.4.445; Cho SY, 2008, KOR J LAB MED, V28, P239, DOI 10.3343/kjlm.2008.28.3.239; Collantes E, 2007, RHEUMATOLOGY, V46, P1309, DOI 10.1093/rheumatology/kem084; Day TG, 2008, ARTHRITIS RHEUM-US, V58, P2142, DOI 10.1002/art.23604; Doran MF, 2003, J RHEUMATOL, V30, P316; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Falkenbach A, 2003, J RHEUMATOL, V30, P2186; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Gensler LS, 2008, ANN RHEUM DIS, V67, P233, DOI 10.1136/ard.2007.072512; Goedecke V, 2003, GENES IMMUN, V4, P74, DOI 10.1038/sj.gene.6363930; Grainger DJ, 1999, OSTEOPOROSIS INT, V9, P398, DOI 10.1007/s001980050163; Guo C, 2012, SCAND J RHEUMATOL, V41, P29, DOI 10.3109/03009742.2011.600700; Hamersma J, 2001, ARTHRITIS RHEUM, V44, P1396, DOI 10.1002/1529-0131(200106)44:6<1396::AID-ART233>3.0.CO;2-A; Harvey D, 2009, HUM MOL GENET, V18, P4204, DOI 10.1093/hmg/ddp371; Kamiya M, 2001, SPINE, V26, P1264, DOI 10.1097/00007632-200106010-00017; KHAN MA, 1978, TISSUE ANTIGENS, V11, P434, DOI 10.1111/j.1399-0039.1978.tb01280.x; Landewe R, 2009, ANN RHEUM DIS, V68, P863, DOI 10.1136/ard.2008.091793; Lin ZM, 2012, NAT GENET, V44, P73, DOI 10.1038/ng.1005; Low YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001012; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; Morgan AR, 2010, TISSUE ANTIGENS, V76, P119, DOI 10.1111/j.1399-0039.2010.01493.x; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; OLERUP O, 1994, TISSUE ANTIGENS, V43, P253, DOI 10.1111/j.1399-0039.1994.tb02334.x; Paynter RA, 2006, CANCER EPIDEM BIOMAR, V15, P2533, DOI 10.1158/1055-9965.EPI-06-0219; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Robertson LP, 2004, RHEUMATOLOGY, V43, P1565, DOI 10.1093/rheumatology/keh386; Rudwaleit M, 2004, ANN RHEUM DIS, V63, P665, DOI 10.1136/ard.2003.016386; Rueda B, 2008, ANN RHEUM DIS, V67, P1451, DOI 10.1136/ard.2007.080283; SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704, DOI 10.1056/NEJM197304052881403; Szczypiorska M, 2011, RHEUMATOLOGY, V50, P1969, DOI 10.1093/rheumatology/ker229; Vander Cruyssen B, 2010, RHEUMATOLOGY, V49, P73, DOI 10.1093/rheumatology/kep174; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Vang T, 2008, ANNU REV IMMUNOL, V26, P29, DOI 10.1146/annurev.immunol.26.021607.090418; Ward MM, 2009, ARTHRIT RHEUM-ARTHR, V61, P859, DOI 10.1002/art.24585; Wollina U, 2011, CURR OPIN RHEUMATOL, V23, P50, DOI 10.1097/BOR.0b013e328341152f	50	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43428	10.1371/journal.pone.0043428	http://dx.doi.org/10.1371/journal.pone.0043428			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984424	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500013
J	Zhai, GJ; Yan, KW; Ji, XX; Xu, WR; Yang, JL; Xiong, FX; Su, J; McNutt, MA; Yang, H				Zhai, Guojun; Yan, Kaowen; Ji, Xiaoxu; Xu, Wenrui; Yang, Jiuling; Xiong, Fuxia; Su, Jing; McNutt, Michael A.; Yang, Hua			LAPTM4B Allele*2 Is a Marker of Poor Prognosis for Gallbladder Carcinoma	PLOS ONE			English	Article							GENE POLYMORPHISM; OVEREXPRESSION; SUSCEPTIBILITY; RESISTANCE; EXPRESSION; SURVIVAL; CANCER	Background: Lysosomal protein transmembrane 4 beta (LAPTM4B) is a novel cancer-related gene which has two alleles designated LAPTM4B*1 and LAPTM4B*2. In this study we investigated the correlation of LAPTM4B genotype with prognosis and clinicopathologic features in patients who had undergone curative resection for gallbladder carcinoma (GBC). Methodology/Principal Findings: PCR assay was performed to determine the LAPTM4B genotype in 85 patients. The correlation of LAPTM4B genotype with clinicopathologic parameters was assessed with the Chi-squared test. Differences in patient survival were determined by the Kaplan-Meier method. Multivariate analysis of prognostic factors was carried out with Cox regression analysis. Patients with LAPTM4B *2 had both significantly shorter overall survival (OS) and shorter disease-free survival (DFS) (both P < 0.001). Multivariate analysis showed that LAPTM4B genotype is a prognostic factor for OS and DFS (both P < 0.001). Conclusions/Significance: LAPTM4B allele *2 is a risk factor associated with poor prognosis in patients with resected GBC, and LAPTM4B status may be therefore be useful preoperatively as an adjunct in evaluation of the operability of GBC.	[Zhai, Guojun] Peking Univ, Hosp 3, Dept Intervent Radiol & Vasc Surg, Beijing 100871, Peoples R China; [Yan, Kaowen; Xu, Wenrui; Yang, Jiuling; Yang, Hua] Peking Univ, Sch Basic Med Sci, Dept Cell Biol, Beijing 100871, Peoples R China; [Ji, Xiaoxu] Peking Univ, Hosp 3, Dept Gen Surg, Beijing 100871, Peoples R China; [Xiong, Fuxia] Loma Linda Univ, Dept Pharmacol, Loma Linda, CA 92350 USA; [Su, Jing; McNutt, Michael A.] Peking Univ, Sch Basic Med Sci, Dept Pathol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Loma Linda University; Peking University	Zhai, GJ (corresponding author), Peking Univ, Hosp 3, Dept Intervent Radiol & Vasc Surg, Beijing 100871, Peoples R China.	yanghua@bjmu.edu.cn		Yang, Jiuling/0000-0002-5301-6976	National Nature Science Fund [31000622]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100001120043]	National Nature Science Fund(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the National Nature Science Fund (No. 31000622) and Specialized Research Fund for the Doctoral Program of Higher Education of China (20100001120043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng XJ, 2008, ANN ONCOL, V19, P527, DOI 10.1093/annonc/mdm469; Fong Y, 2000, ANN SURG, V232, P557, DOI 10.1097/00000658-200010000-00011; Gabbi C, 2010, P NATL ACAD SCI USA, V107, P14763, DOI 10.1073/pnas.1009483107; HENSON DE, 1992, CANCER, V70, P1493, DOI 10.1002/1097-0142(19920915)70:6<1493::AID-CNCR2820700608>3.0.CO;2-U; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Lazcano-Ponce EC, 2001, CA-CANCER J CLIN, V51, P349, DOI 10.3322/canjclin.51.6.349; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Liu XR, 2009, CANCER SCI, V100, P2335, DOI 10.1111/j.1349-7006.2009.01346.x; Liu Y, 2007, ANN ONCOL, V18, P311, DOI 10.1093/annonc/mdl394; MATSUMOTO Y, 1992, AM J SURG, V163, P239, DOI 10.1016/0002-9610(92)90109-5; Meng FL, 2010, INT J GYNECOL CANCER, V20, P745, DOI 10.1111/IGC.0b013e3181e02f90; Meng FL, 2011, CANCER-AM CANCER SOC, V117, P2652, DOI 10.1002/cncr.25833; Misra S, 2003, LANCET ONCOL, V4, P167, DOI 10.1016/S1470-2045(03)01021-0; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Wang S, 2012, ANN ONCOL, V23, P1864, DOI 10.1093/annonc/mdr538; Yang H, 2012, PLOS ONE, V4; Yang H, 2012, MED ONCOL, V29, P2809, DOI 10.1007/s12032-012-0173-4; Yang H, 2010, CANCER LETT, V294, P236, DOI 10.1016/j.canlet.2010.02.006; Yang H, 2010, J SURG ONCOL, V101, P363, DOI 10.1002/jso.21489; Yang H, 2010, J CANCER RES CLIN, V136, P275, DOI 10.1007/s00432-009-0659-4; Yang Y, 2008, ONCOL REP, V20, P1077, DOI 10.3892/or_00000112; Yin MZ, 2012, INT J GYNECOL CANCER, V22, P54, DOI 10.1097/IGC.0b013e318234f9ac; Yin MZ, 2011, INT J CANCER, V129, P629, DOI 10.1002/ijc.25689; Zhai GJ, 2012, MED ONCOL, V29, P2744, DOI 10.1007/s12032-011-0139-y; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025; Zhou L, 2010, HEPATO-GASTROENTEROL, V57, P207; Zhou L, 2010, AM J SURG, V199, P515, DOI 10.1016/j.amjsurg.2009.03.031	29	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45290	10.1371/journal.pone.0045290	http://dx.doi.org/10.1371/journal.pone.0045290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984631	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500129
J	Wu, CY; Taneyhill, LA				Wu, Chyong-Yi; Taneyhill, Lisa A.			Annexin A6 Modulates Chick Cranial Neural Crest Cell Emigration	PLOS ONE			English	Article							VI; CADHERIN6B; EXPRESSION; MIGRATION; COMPLEX; SNAIL2; EXPORT; GOLGI	The vertebrate neural crest is a population of migratory cells that originates in the dorsal aspect of the embryonic neural tube. These cells undergo an epithelial-to-mesencyhmal transition (EMT), delaminate from the neural tube and migrate extensively to generate an array of differentiated cell types. Elucidating the gene regulatory networks involved in neural crest cell induction, migration and differentiation are thus crucial to understanding vertebrate development. To this end, we have identified Annexin A6 as an important regulator of chick midbrain neural crest cell emigration. Annexin proteins comprise a family of calcium-dependent, membrane-binding molecules that mediate a variety of cellular and physiological processes including cell adhesion, migration and invasion. Our data indicate that Annexin A6 is expressed in the proper spatio-temporal pattern in the chick midbrain to play a potential role in neural crest cell ontogeny. To investigate Annexin A6 function, we have depleted or overexpressed Annexin A6 in the developing midbrain neural crest cell population. Our results show that knock-down or overexpression of Annexin A6 reduces or expands the migratory neural crest cell domain, respectively. Importantly, this phenotype is not due to any change in cell proliferation or cell death but can be correlated with changes in the size of the premigratory neural crest cell population and with markers associated with EMT. Taken together, our data indicate that Annexin A6 plays a pivotal role in modulating the formation of cranial migratory neural crest cells during vertebrate development.	[Wu, Chyong-Yi; Taneyhill, Lisa A.] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Wu, CY (corresponding author), Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA.	ltaney@umd.edu	Taneyhill, Lisa/K-1815-2013		National Institutes of Health [R00 HD055034]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD055034] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by a grant from the National Institutes of Health (R00 HD055034) to L. A. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avila-Sakar AJ, 1998, BBA-PROTEIN STRUCT M, V1387, P103, DOI 10.1016/S0167-4838(98)00111-3; Avila-Sakar AJ, 2000, J STRUCT BIOL, V130, P54, DOI 10.1006/jsbi.2000.4246; Babiychuk EB, 2006, BIOCHEM J, V397, P407, DOI 10.1042/BJ20060056; CAO X, 1993, BIOCHEM BIOPH RES CO, V197, P556, DOI 10.1006/bbrc.1993.2515; Coles EG, 2007, DEV BIOL, V312, P533, DOI 10.1016/j.ydbio.2007.09.056; Creutz CE, 2005, BIOCHEMISTRY-US, V44, P13795, DOI 10.1021/bi051160w; Cubells L, 2008, J BIOL CHEM, V283, P10174, DOI 10.1074/jbc.M706618200; Cubells L, 2007, TRAFFIC, V8, P1568, DOI 10.1111/j.1600-0854.2007.00640.x; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Grewal T, 2006, BIOESSAYS, V28, P1211, DOI 10.1002/bies.20503; Grewal T, 2010, INT J BIOCHEM CELL B, V42, P580, DOI 10.1016/j.biocel.2009.12.020; Grewal T, 2009, CELL SIGNAL, V21, P847, DOI 10.1016/j.cellsig.2009.01.031; Itasaki N, 1999, NAT CELL BIOL, V1, pE203, DOI 10.1038/70231; Jhingory S, 2010, DEV BIOL, V344, P896, DOI 10.1016/j.ydbio.2010.06.006; Kalcheim C, 1999, NEURAL CREST; Monastyrskaya K, 2009, J BIOL CHEM, V284, P17227, DOI 10.1074/jbc.M109.004457; Sakwe AM, 2011, EXP CELL RES, V317, P823, DOI 10.1016/j.yexcr.2010.12.008; SMYTHE E, 1994, J CELL BIOL, V124, P301, DOI 10.1083/jcb.124.3.301; Taneyhill LA, 2007, DEVELOPMENT, V134, P1481, DOI 10.1242/dev.02834; de Muga SV, 2009, ONCOGENE, V28, P363, DOI 10.1038/onc.2008.386; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO, P75; Wu CY, 2011, DEV DYNAM, V240, P2309, DOI 10.1002/dvdy.22735	23	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44903	10.1371/journal.pone.0044903	http://dx.doi.org/10.1371/journal.pone.0044903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984583	gold, Green Published, Green Submitted			2022-12-25	WOS:000308638700098
J	Tyagi, AM; Srivastava, K; Mansoori, MN; Trivedi, R; Chattopadhyay, N; Singh, D				Tyagi, Abdul M.; Srivastava, Kamini; Mansoori, Mohd Nizam; Trivedi, Ritu; Chattopadhyay, Naibedya; Singh, Divya			Estrogen Deficiency Induces the Differentiation of IL-17 Secreting Th17 Cells: A New Candidate in the Pathogenesis of Osteoporosis	PLOS ONE			English	Article							T-CELLS; BONE LOSS; RHEUMATOID-ARTHRITIS; INFLAMMATORY CYTOKINE; OSTEOCLAST FORMATION; PANCREATIC-ISLETS; INTERLEUKIN-17; DESTRUCTION; GAMMA; AGE	Th17 cells produce IL-17, and the latter promotes bone loss in collagen-induced arthritis in mice. Blocking IL-17 action in mouse model of rheumatoid arthritis reduces disease symptoms. These observations suggest that Th17 cells may be involved in the pathogenesis of bone loss. However, the role of Th17 cell in estrogen (E2) deficiency-induced bone loss is still not very clear. We investigated the effect of E2 on Th17 differentiation in vivo and IL-17 mediated regulation of osteoclast and osteoblast differentiation. Additionally, effect of IL-17 functional block under E2 deficiency-induced bone loss was studied. In murine bone marrow cells, E2 suppressed IL-17 mediated osteoclast differentiation. IL-17 inhibited formation of mineralized nodules in osteoblasts and this effect was suppressed by E2. E2 treatment to mouse calvarial osteoblasts inhibited the IL-17-induced production of osteoclastogenic cytokines and NF-kappa B translocation. In ovariectomized mice, there was increase in the number of Th17 cells, transcription factors promoting Th17 cell differentiation and circulating IL-17 levels. These effects were reversed by E2 supplementation. Treatment of neutralizing IL-17 monoclonal antibody to Ovx mice mitigated the E2 deficiency-induced trabecular bone loss and reversed the decreased osteoprotegerin-to-receptor activator of nuclear factor kappa B ligand (RANKL) transcript levels in long bones, increased osteoclast differentiation from the bone marrow precursor cells and decreased osteoblast differentiation from the bone marrow stromal cells. Our findings indicate that E2 deficiency leads to increased differentiation of Th17 cells with attendant up regulation of STAT3, ROR-gamma t and ROR-alpha and downregulation of Foxp3 which antagonizes Th17 cell differentiation. Increased IL-17 production in turn induces bone loss by increasing pro-osteoclastogenic cytokines including TNF-alpha, IL-6 and RANKL from osteoblasts and functional block of IL-17 prevents bone loss. IL-17 thus plays a critical causal role in Ovx-induced bone loss and may be considered a potential therapeutic target in pathogenesis of post menopausal osteoporosis.	[Tyagi, Abdul M.; Srivastava, Kamini; Mansoori, Mohd Nizam; Trivedi, Ritu; Chattopadhyay, Naibedya; Singh, Divya] Cent Drug Res Inst, Div Endocrinol, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Tyagi, AM (corresponding author), Cent Drug Res Inst, Div Endocrinol, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India.	divya_singh@cdri.res.in	Chattopadhyay, Naibedya/AAF-2058-2019; Malik, Abdul/AAX-5715-2020; Chattopadhyay, Naibedya/AAQ-3213-2021	Malik, Abdul/0000-0001-9012-5779; Chattopadhyay, Naibedya/0000-0003-2473-0246; SRIVASTAVA, KAMINI/0000-0002-3928-0885	Ministry of Health and Family Welfare; Council of Scientific and Industrial Research; Department of Science and Technology, Govt of India	Ministry of Health and Family Welfare; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Govt of India(Department of Science & Technology (India))	This work was supported by generous funding by the Ministry of Health and Family Welfare, Council of Scientific and Industrial Research and Department of Science and Technology, Govt of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul Tyagi DS, 2011, OSTEOPOROS INT  0421, V22, pS214; Annunziato F, 2009, NAT REV RHEUMATOL, V5, P325, DOI 10.1038/nrrheum.2009.80; Ariyoshi W, 2008, J CELL BIOCHEM, V103, P1707, DOI 10.1002/jcb.21559; Arron JR, 2000, NATURE, V408, P535, DOI 10.1038/35046196; Baker PJ, 1999, INFECT IMMUN, V67, P2804, DOI 10.1128/IAI.67.6.2804-2809.1999; Bhargavan B, 2009, J CELL BIOCHEM, V108, P388, DOI 10.1002/jcb.22264; BIANCHI F, 1993, TISSUE CELL, V25, P817, DOI 10.1016/0040-8166(93)90030-O; Bryl E, 2005, ARTHRITIS RHEUM-US, V52, P2996, DOI 10.1002/art.21353; Burger HG, 2001, HORM RES, V56, P82, DOI 10.1159/000048141; Calvo MS, 1996, ENDOCR REV, V17, P333, DOI 10.1210/er.17.4.333; Cenci S, 2003, P NATL ACAD SCI USA, V100, P10405, DOI 10.1073/pnas.1533207100; Clarke B, 2008, CLIN J AM SOC NEPHRO, V3, pS131, DOI 10.2215/CJN.04151206; Clowes JA, 2005, IMMUNOL REV, V208, P207, DOI 10.1111/j.0105-2896.2005.00334.x; DeSelm CJ, 2012, J CELL BIOCHEM, V113, P2895, DOI 10.1002/jcb.24165; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Garnero P, 1998, OSTEOPOROSIS INT, V8, P563, DOI 10.1007/s001980050100; Gautam AK, 2011, J NUTR BIOCHEM, V22, P318, DOI 10.1016/j.jnutbio.2010.02.010; Ginaldi Lia, 2005, Immun Ageing, V2, P14, DOI 10.1186/1742-4933-2-14; Goswami J, 2009, EUR J IMMUNOL, V39, P2831, DOI 10.1002/eji.200939670; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Holland JC, 2011, J ANAT, V218, P619, DOI 10.1111/j.1469-7580.2011.01376.x; Huang H, 2009, CELL DEATH DIFFER, V16, P1332, DOI 10.1038/cdd.2009.74; Kamiya S, 2007, J BONE MINER METAB, V25, P277, DOI 10.1007/s00774-007-0766-8; Kim SH, 2005, EXP BIOL MED, V230, P681; Kitami S, 2010, BIOCHIMIE, V92, P398, DOI 10.1016/j.biochi.2009.12.011; Kocic J, 2012, BBA-MOL CELL RES, V1823, P838, DOI 10.1016/j.bbamcr.2012.01.001; Kong YY, 1999, NATURE, V402, P304, DOI 10.1038/35005552; Kong YY, 2000, EXP GERONTOL, V35, P947, DOI 10.1016/S0531-5565(00)00178-9; Kosmaczewska A, 2011, POSTEP HIG MED DOSW, V65, P397, DOI 10.5604/17322693.948971; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Kotake S, 2001, ARTHRITIS RHEUM, V44, P1003, DOI 10.1002/1529-0131(200105)44:5<1003::AID-ANR179>3.0.CO;2-#; Kozlowska E, 2007, IMMUNOLOGY, V122, P445, DOI 10.1111/j.1365-2567.2007.02667.x; Kramer JM, 2007, J PERIODONTOL, V78, P1083, DOI 10.1902/jop.2007.060392; Kumar A, 2010, PROTEOMICS, V10, P1730, DOI 10.1002/pmic.200900666; Lelu K, 2011, J IMMUNOL, V187, P2386, DOI 10.4049/jimmunol.1101578; Lubberts E, 2004, ARTHRITIS RHEUM-US, V50, P650, DOI 10.1002/art.20001; Luo CY, 2011, CELL MOL IMMUNOL, V8, P50, DOI 10.1038/cmi.2010.54; Mainini G, 2011, CLIN EXP OBSTET GYN, V38, P355; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MARCHETTI P, 1994, TRANSPLANTATION, V57, P1532; Maurya R, 2009, BIOORG MED CHEM LETT, V19, P610, DOI 10.1016/j.bmcl.2008.12.064; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Oostlander AE, 2012, J CELL BIOCHEM, V113, P260, DOI 10.1002/jcb.23352; Pacifici R, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2126; Pandey R, 2010, MENOPAUSE, V17, P602, DOI 10.1097/gme.0b013e3181d0f7f0; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; Sarkar S, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2838; Sato K, 2006, J EXP MED, V203, P2673, DOI 10.1084/jem.20061775; Stamp LK, 2004, IMMUNOL CELL BIOL, V82, P1, DOI 10.1111/j.1440-1711.2004.01212.x; Tarjanyi Oktavia, 2009, Immun Ageing, V6, P8, DOI 10.1186/1742-4933-6-8; Tyagi AM, 2012, OSTEOPOROSIS INT, V23, P1151, DOI 10.1007/s00198-011-1650-x; Tyagi AM, 2010, MOL CELL ENDOCRINOL, V325, P101, DOI 10.1016/j.mce.2010.05.016; Tyagi AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021216; Weitzmann MN, 2005, IMMUNOL REV, V208, P154, DOI 10.1111/j.0105-2896.2005.00324.x; Weitzmann MN, 2001, J BONE MINER RES, V16, P328, DOI 10.1359/jbmr.2001.16.2.328; Witowski J, 2004, CELL MOL LIFE SCI, V61, P567, DOI 10.1007/s00018-003-3228-z; Won HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018168; Yago T, 2009, J CELL BIOCHEM, V108, P947, DOI 10.1002/jcb.22326; Yang W, 2011, J MOL MED, V89, P399, DOI 10.1007/s00109-010-0711-5; Yu JJ, 2008, INFECT IMMUN, V76, P4206, DOI 10.1128/IAI.01209-07; Yu JJ, 2008, FRONT BIOSCI-LANDMRK, V13, P170, DOI 10.2741/2667; Yuan FL, 2012, MOL BIOL REP, V39, P771, DOI 10.1007/s11033-011-0797-z	62	189	200	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44552	10.1371/journal.pone.0044552	http://dx.doi.org/10.1371/journal.pone.0044552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970248	Green Submitted, Green Published, gold			2022-12-25	WOS:000308748400022
J	Wen, RY; Moore, G; Shaw, PJ				Wen, Ruoyu; Moore, Graham; Shaw, Peter J.			Centromeres Cluster De Novo at the Beginning of Meiosis in Brachypodium distachyon	PLOS ONE			English	Article							BOUQUET FORMATION; SATELLITE REPEAT; DNA ELEMENT; PH1 LOCUS; CHROMOSOMES; TELOMERES; THALIANA; YEAST; RECOMBINATION; ORGANIZATION	In most eukaryotes that have been studied, the telomeres cluster into a bouquet early in meiosis, and in wheat and its relatives and in Arabidopsis the centromeres pair at the same time. In Arabidopsis, the telomeres do not cluster as a typical telomere bouquet on the nuclear membrane but are associated with the nucleolus both somatically and at the onset of meiosis. We therefore assessed whether Brachypodium distachyon, a monocot species related to cereals and whose genome is approximately twice the size of Arabidopsis thaliana, also exhibited an atypical telomere bouquet and centromere pairing. In order to investigate the occurrence of a bouquet and centromere pairing in B distachyon, we first had to establish protocols for studying meiosis in this species. This enabled us to visualize chromosome behaviour in meiocytes derived from young B distachyon spikelets in three-dimensions by fluorescent in situ hybridization (FISH), and accurately to stage meiosis based on chromatin morphology in relation to spikelet size and the timing of sample collection. Surprisingly, this study revealed that the centromeres clustered as a single site at the same time as the telomeres also formed a bouquet or single cluster.	[Wen, Ruoyu; Moore, Graham; Shaw, Peter J.] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Wen, RY (corresponding author), John Innes Ctr Plant Sci Res, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	peter.shaw@jic.ac.uk	shaw, peter j/E-5511-2011	shaw, peter j/0000-0003-1076-2669	China Scholarship Council (CSC) from the Biological and Biotechnology Research Council (BBSRC) [BB/J004588/1]; John Innes Foundation; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000128] Funding Source: researchfish; BBSRC [BBS/E/J/00000128] Funding Source: UKRI	China Scholarship Council (CSC) from the Biological and Biotechnology Research Council (BBSRC); John Innes Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the China Scholarship Council (CSC), by grant BB/J004588/1 from the Biological and Biotechnology Research Council (BBSRC) and the John Innes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2002, IEEE T MED IMAGING, V21, P296, DOI 10.1109/TMI.2002.1000254; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Alves SC, 2009, NAT PROTOC, V4, P638, DOI 10.1038/nprot.2009.30; Aragon-Alcaide L, 1998, PLANT J, V14, P503, DOI 10.1046/j.1365-313X.1998.00148.x; AragonAlcaide L, 1996, CHROMOSOMA, V105, P261, DOI 10.1007/BF02524643; AragonAlcaide L, 1997, CURR BIOL, V7, P905, DOI 10.1016/S0960-9822(06)00383-6; Bass HW, 1997, J CELL BIOL, V137, P5, DOI 10.1083/jcb.137.1.5; Cheng ZK, 2002, PLANT CELL, V14, P1691, DOI 10.1105/tpc.003079; Chikashige Y, 1997, EMBO J, V16, P193, DOI 10.1093/emboj/16.1.193; Colas I, 2008, P NATL ACAD SCI USA, V105, P6075, DOI 10.1073/pnas.0801521105; Corredor E, 2007, GENETICS, V177, P699, DOI 10.1534/genetics.107.078121; Da Ines O, 2012, PLOS GENET, V8, P245, DOI 10.1371/journal.pgen.1002636; Fransz PF, 2000, CELL, V100, P367, DOI 10.1016/S0092-8674(00)80672-8; Greer E, 2012, PLANT CELL, V24, P152, DOI 10.1105/tpc.111.094771; IJDO JW, 1991, NUCLEIC ACIDS RES, V19, P4780, DOI 10.1093/nar/19.17.4780; Jenkins G, 2007, NAT PROTOC, V2, P88, DOI 10.1038/nprot.2006.490; Jiang JM, 1996, P NATL ACAD SCI USA, V93, P14210, DOI 10.1073/pnas.93.24.14210; Kumekawa N, 2001, DNA RES, V8, P285, DOI 10.1093/dnares/8.6.285; Martinez-Perez E, 2003, PLANT J, V36, P21, DOI 10.1046/j.1365-313X.2003.01853.x; Martinez-Perez E, 1999, J CELL SCI, V112, P1761; Martinez-Perez E, 2000, J CELL BIOL, V148, P233, DOI 10.1083/jcb.148.2.233; Martinez-Perez E, 2001, NATURE, V411, P204, DOI 10.1038/35075597; Mikhailova EI, 2001, J CELL SCI, V114, P1875; Miller JT, 1998, GENETICS, V150, P1615; Moore G, 2009, CURR OPIN GENET DEV, V19, P99, DOI 10.1016/j.gde.2009.02.006; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; Nagaki K, 2003, GENETICS, V163, P1221; Nagaki K, 2003, GENETICS, V163, P759; Niwa O, 2000, EMBO J, V19, P3831, DOI 10.1093/emboj/19.14.3831; Opanowicz M, 2008, TRENDS PLANT SCI, V13, P172, DOI 10.1016/j.tplants.2008.01.007; Opanowicz M, 2011, J EXP BOT, V62, P735, DOI 10.1093/jxb/erq309; Osman K, 2011, NEW PHYTOL, V190, P523, DOI 10.1111/j.1469-8137.2011.03665.x; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Penfold CA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002496; Presting GG, 1998, PLANT J, V16, P721, DOI 10.1046/j.1365-313x.1998.00341.x; Prieto P, 2004, NAT CELL BIOL, V6, P906, DOI 10.1038/ncb1168; Prieto P, 2004, CHROMOSOMA, V112, P300, DOI 10.1007/s00412-004-0274-8; Prieto P, 2007, NAT PROTOC, V2, P1831, DOI 10.1038/nprot.2007.265; Trelles-Sticken E, 1999, J CELL SCI, V112, P651; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wu JZ, 2004, PLANT CELL, V16, P967, DOI 10.1105/tpc.019273; Zhang Y, 2004, NUCLEIC ACIDS RES, V32, P2023, DOI 10.1093/nar/gkh521; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	43	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44681	10.1371/journal.pone.0044681	http://dx.doi.org/10.1371/journal.pone.0044681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970287	Green Submitted, Green Published, gold			2022-12-25	WOS:000308462000044
J	Kondo, N; Melikyan, GB				Kondo, Naoyuki; Melikyan, Gregory B.			Intercellular Adhesion Molecule 1 Promotes HIV-1 Attachment but Not Fusion to Target Cells	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MONOCYTE-DERIVED MACROPHAGES; FUNCTION-ASSOCIATED ANTIGEN-1; CD4(+) T-LYMPHOCYTES; HOST ICAM-1; ENVELOPE GLYCOPROTEIN; REPLICATION-COMPETENT; MEMBRANE-PROTEINS; TYPE-1 PARTICLES; MEDIATED FUSION	Incorporation of intercellular adhesion molecule 1 (ICAM-1) into HIV-1 particles is known to markedly enhance the virus binding and infection of cells expressing lymphocyte function-associated antigen-1 (LFA-1). At the same time, ICAM-1 has been reported to exert a less pronounced effect on HIV-1 fusion with lymphoid cells. Here we examined the role of ICAM-1/LFA-1 interactions in productive HIV-1 entry into lymphoid cells using a direct virus-cell fusion assay. ICAM-1 promoted HIV1 attachment to cells in a temperature-dependent manner. It exerted a marginal effect on virus binding in the cold, but enhanced binding up to 4-fold at physiological temperature. ICAM-1-independent attachment in the cold was readily reversible upon subsequent incubation at elevated temperature, whereas ICAM-1-bearing particles were largely retained by cells. The better virus retention resulted in a proportional increase in HIV-1 internalization and fusion, suggesting that ICAM-1 did not specifically accelerate endocytosis or fusion steps. We also measured the rates of CD4 engagement, productive endocytosis and HIV-endosome fusion using specific fusion inhibitors. These rates were virtually independent of the presence of ICAM-1 in viral particles. Importantly, irrespective of the presence of ICAM-1, HIV-1 escaped from the low temperature block, which stopped virus endocytosis and fusion, much later than from a membrane-impermeant fusion inhibitor targeting surface-accessible particles. This result, along with the complete inhibition of HIV-1 fusion by a small molecule dynamin inhibitor, implies this virus enters lymphoid cells used in this study via endocytosis and that this pathway is not altered by the viral ICAM-1. Our data highlight the role of ICAM-1 in stabilizing the HIV-1 attachment to LFA-1 expressing cells, which leads to a proportional enhancement of the receptor-mediated uptake and fusion with endosomes.	[Kondo, Naoyuki; Melikyan, Gregory B.] Emory Childrens Ctr, Div Pediat Infect Dis, Atlanta, GA USA; [Melikyan, Gregory B.] Childrens Healthcare Atlanta, Atlanta, GA USA	Children's Healthcare of Atlanta (CHOA)	Kondo, N (corresponding author), Emory Childrens Ctr, Div Pediat Infect Dis, Atlanta, GA USA.	gmeliki@emory.edu	Kondo, Naoyuki/W-5845-2019	Kondo, Naoyuki/0000-0002-6624-5989	National Institutes of Health [R01 GM054787]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health R01 GM054787 grant to GBM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias RA, 2003, VIROLOGY, V307, P266, DOI 10.1016/S0042-6822(02)00040-5; ARTHUR LO, 1992, SCIENCE, V258, P1935, DOI 10.1126/science.1470916; Ashkenazi A, 2011, EUR BIOPHYS J BIOPHY, V40, P349, DOI 10.1007/s00249-010-0666-z; BAZIL V, 1990, FOLIA BIOL-PRAGUE, V36, P41; Beausejour Y, 2004, J VIROL, V78, P11916, DOI 10.1128/JVI.78.21.11916-11925.2004; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; Bosch B, 2008, ANTIVIR RES, V80, P185, DOI 10.1016/j.antiviral.2008.06.004; Bounou S, 2002, J VIROL, V76, P1004, DOI 10.1128/JVI.76.3.1004-1014.2002; BOURINBAIAR AS, 1994, ACTA VIROL, V38, P59; Cabanas C, 1999, J BIOL REG HOMEOS AG, V13, P126; CAPOBIANCHI MR, 1994, J INFECT DIS, V169, P886, DOI 10.1093/infdis/169.4.886; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; Carter GC, 2011, VIROLOGY, V409, P234, DOI 10.1016/j.virol.2010.10.018; Cavrois M, 2002, NAT BIOTECHNOL, V20, P1151, DOI 10.1038/nbt745; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Daecke J, 2005, J VIROL, V79, P1581, DOI 10.1128/JVI.79.3.1581-1594.2005; de la Vega M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-99; Deng YQ, 2007, BIOCHEMISTRY-US, V46, P4360, DOI 10.1021/bi7001289; Ding ZM, 1999, J IMMUNOL, V163, P5029; Fortin JF, 2000, VIROLOGY, V268, P493, DOI 10.1006/viro.2000.0190; Fortin JF, 1997, J VIROL, V71, P3588, DOI 10.1128/JVI.71.5.3588-3596.1997; Fortin JF, 1998, J VIROL, V72, P2105, DOI 10.1128/JVI.72.3.2105-2112.1998; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Fromentin R, 2010, VIROLOGY, V398, P168, DOI 10.1016/j.virol.2009.12.008; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; GELDERBLOM H, 1987, Z NATURFORSCH C, V42, P1328; Hammonds J, 2007, VACCINE, V25, P8036, DOI 10.1016/j.vaccine.2007.09.016; Henderson RB, 2001, J EXP MED, V194, P219, DOI 10.1084/jem.194.2.219; HILDRETH JEK, 1989, SCIENCE, V244, P1075, DOI 10.1126/science.2543075; Hioe CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023202; Hogg N, 2004, IMMUNOL LETT, V92, P51, DOI 10.1016/j.imlet.2003.10.014; HOXIE JA, 1987, HUM IMMUNOL, V18, P39, DOI 10.1016/0198-8859(87)90111-X; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Jolly C, 2004, J EXP MED, V199, P283, DOI 10.1084/jem.20030648; Jolly C, 2007, J VIROL, V81, P13916, DOI 10.1128/JVI.01585-07; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Krummel MF, 2002, CURR OPIN IMMUNOL, V14, P66, DOI 10.1016/S0952-7915(01)00299-0; Laudanna C, 2005, NAT IMMUNOL, V6, P429, DOI 10.1038/ni0505-429; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; LAYNE SP, 1992, VIROLOGY, V189, P695, DOI 10.1016/0042-6822(92)90593-E; Lin PF, 2003, P NATL ACAD SCI USA, V100, P11013, DOI 10.1073/pnas.1832214100; Losier M, 2003, CLIN IMMUNOL, V108, P111, DOI 10.1016/S1521-6616(03)00093-7; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MALIM MH, 1988, NATURE, V335, P181, DOI 10.1038/335181a0; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; Marozsan AJ, 2004, J VIROL, V78, P11130, DOI 10.1128/JVI.78.20.11130-11141.2004; Melikyan GB, 2011, CURR TOP MEMBR, V68, P81, DOI 10.1016/B978-0-12-385891-7.00004-0; Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111; Miyauchi K, 2011, BIOCHEM J, V434, P559, DOI 10.1042/BJ20101588; Miyauchi K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000585; Miyauchi K, 2009, CELL, V137, P433, DOI 10.1016/j.cell.2009.02.046; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; ORENTAS RJ, 1993, AIDS RES HUM RETROV, V9, P1157, DOI 10.1089/aid.1993.9.1157; Paquette JS, 1998, J VIROL, V72, P9329, DOI 10.1128/JVI.72.11.9329-9336.1998; PIATAK M, 1993, SCIENCE, V259, P1749, DOI 10.1126/science.8096089; Platt EJ, 2010, J VIROL, V84, P3106, DOI 10.1128/JVI.01958-09; Puigdomenech I, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-32; Rizzuto CD, 1997, J VIROL, V71, P4847, DOI 10.1128/JVI.71.6.4847-4851.1997; Rusert P, 2004, VIROLOGY, V326, P113, DOI 10.1016/j.virol.2004.05.022; Sanders RW, 2002, J VIROL, V76, P7812, DOI 10.1128/JVI.76.15.7812-7821.2002; Saphire ACS, 2006, J PROTEOME RES, V5, P530, DOI 10.1021/pr050276b; SATO H, 1992, VIROLOGY, V186, P712, DOI 10.1016/0042-6822(92)90038-Q; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Scholer A, 2008, IMMUNITY, V28, P258, DOI 10.1016/j.immuni.2007.12.016; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Si ZH, 2004, P NATL ACAD SCI USA, V101, P5036, DOI 10.1073/pnas.0307953101; SMITH CW, 1989, J CLIN INVEST, V83, P2008, DOI 10.1172/JCI114111; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; Tardif MR, 2009, ANTIMICROB AGENTS CH, V53, P4656, DOI 10.1128/AAC.00117-09; Tardif MR, 2005, J IMMUNOL, V175, P926, DOI 10.4049/jimmunol.175.2.926; Tardif MR, 2005, J VIROL, V79, P13714, DOI 10.1128/JVI.79.21.13714-13724.2005; Tardif MR, 2003, J VIROL, V77, P12299, DOI 10.1128/JVI.77.22.12299-12309.2003; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Tremblay MJ, 1998, IMMUNOL TODAY, V19, P346, DOI 10.1016/S0167-5699(98)01286-9; WANG SCT, 1995, J LEUKOCYTE BIOL, V57, P343, DOI 10.1002/jlb.57.2.343; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Yi YJ, 1999, J VIROL, V73, P7117, DOI 10.1128/JVI.73.9.7117-7125.1999	81	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44827	10.1371/journal.pone.0044827	http://dx.doi.org/10.1371/journal.pone.0044827			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970312	Green Submitted, gold, Green Published			2022-12-25	WOS:000308458400122
J	Shirure, VS; Reynolds, NM; Burdick, MM				Shirure, Venktesh S.; Reynolds, Nathan M.; Burdick, Monica M.			Mac-2 Binding Protein Is a Novel E-Selectin Ligand Expressed by Breast Cancer Cells	PLOS ONE			English	Article							MAJOR E-SELECTIN; MAC-2-BINDING PROTEIN; TUMOR-CELLS; TRANSENDOTHELIAL MIGRATION; P-SELECTIN; ADHESION; CD44; METASTASIS; GALECTIN-1; ENDOTHELIUM	Hematogenous metastasis involves the adhesion of circulating tumor cells to vascular endothelium of the secondary site. We hypothesized that breast cancer cell adhesion is mediated by interaction of endothelial E-selectin with its glycoprotein counter-receptor(s) expressed on breast cancer cells. At a hematogenous wall shear rate, ZR-75-1 breast cancer cells specifically adhered to E-selectin expressing human umbilical vein endothelial cells when tested in parallel plate flow chamber adhesion assays. Consistent with their E-selectin ligand activity, ZR-75-1 cells expressed flow cytometrically detectable epitopes of HECA-452 mAb, which recognizes high efficiency E-selectin ligands typified by sialofucosylated moieties. Multiple E-selectin reactive proteins expressed by ZR-75-1 cells were revealed by immunoprecipitation with E-selectin chimera (E-Ig chimera) followed by Western blotting. Mass spectrometry analysis of the 72 kDa protein, which exhibited the most prominent E-selectin ligand activity, corresponded to Mac-2 binding protein (Mac-2BP), a heretofore unidentified E-selectin ligand. Immunoprecipitated Mac-2BP expressed sialofucosylated epitopes and possessed E-selectin ligand activity when tested by Western blot analysis using HECA-452 mAb and E-Ig chimera, respectively, demonstrating that Mac-2BP is a novel high efficiency E-selectin ligand. Furthermore, silencing the expression of Mac-2BP from ZR-75-1 cells by shRNA markedly reduced their adhesion to E-selectin expressing cells under physiological flow conditions, confirming the functional E-selectin ligand activity of Mac-2BP on intact cells. In addition to ZR-75-1 cells, several other E-selectin ligand positive breast cancer cell lines expressed Mac-2BP as detected by Western blot and flow cytometry, suggesting that Mac-2BP may be an E-selectin ligand in a variety of breast cancer types. Further, invasive breast carcinoma tissue showed co-localized expression of Mac-2BP and HECA-452 antigens by fluorescence microscopy, underscoring the possible role of Mac-2BP as an E-selectin ligand. In summary, breast cancer cells express Mac-2BP as a novel E-selectin ligand, potentially revealing a new prognostic and therapeutic target for breast cancer.	[Shirure, Venktesh S.; Reynolds, Nathan M.; Burdick, Monica M.] Ohio Univ, Russ Coll Engn & Technol, Dept Chem & Biomol Engn, Athens, OH USA; [Burdick, Monica M.] Ohio Univ, Russ Coll Engn & Technol, Biomed Engn Program, Athens, OH USA	University System of Ohio; Ohio University; University System of Ohio; Ohio University	Shirure, VS (corresponding author), Ohio Univ, Russ Coll Engn & Technol, Dept Chem & Biomol Engn, Athens, OH USA.	burdick@ohio.edu	Shirure, Venktesh/M-8806-2015	Shirure, Venktesh/0000-0002-4430-2612; Burdick, Monica/0000-0003-3168-0072	seed grant from the Ohio Cancer Research Associates; United States National Institutes of Health grant [1R15CA161830-01]; National Science Foundation Major Research Instrumentation grant [1039869]; NATIONAL CANCER INSTITUTE [R15CA161830] Funding Source: NIH RePORTER	seed grant from the Ohio Cancer Research Associates; United States National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Major Research Instrumentation grant(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a seed grant from the Ohio Cancer Research Associates (to MMB), a United States National Institutes of Health grant (1R15CA161830-01; to MMB), and a National Science Foundation Major Research Instrumentation grant (1039869; to MMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Barthel SR, 2009, P NATL ACAD SCI USA, V106, P19491, DOI 10.1073/pnas.0906074106; Becker R, 2008, FASEB J, V22, P3059, DOI 10.1096/fj.07-101386; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brunk DK, 1996, BIOPHYS J, V71, P2902, DOI 10.1016/S0006-3495(96)79487-0; Burdick MM, 2003, AM J PHYSIOL-CELL PH, V284, pC977, DOI 10.1152/ajpcell.00423.2002; Burdick MM, 2001, BIOCHEM BIOPH RES CO, V284, P42, DOI 10.1006/bbrc.2001.4899; Burdick MM, 2006, J BIOL CHEM, V281, P13899, DOI 10.1074/jbc.M513617200; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Chen SH, 2012, FASEB J, V26, P1349, DOI 10.1096/fj.11-195669; Cooper D, 2008, J LEUKOCYTE BIOL, V83, P1459, DOI 10.1189/jlb.1207831; Dimitroff CJ, 2000, P NATL ACAD SCI USA, V97, P13841, DOI 10.1073/pnas.250484797; Dimitroff CJ, 2004, CANCER RES, V64, P5261, DOI 10.1158/0008-5472.CAN-04-0691; Dimitroff CJ, 2001, J CELL BIOL, V153, P1277, DOI 10.1083/jcb.153.6.1277; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; GIAVAZZI R, 1993, J CLIN INVEST, V92, P3038, DOI 10.1172/JCI116928; Gout S, 2008, CLIN EXP METASTAS, V25, P335, DOI 10.1007/s10585-007-9096-4; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; Hernandez JD, 2006, J IMMUNOL, V177, P5328, DOI 10.4049/jimmunol.177.8.5328; Hirata T, 2000, J EXP MED, V192, P1669, DOI 10.1084/jem.192.11.1669; IACOBELLI S, 1993, FEBS LETT, V319, P59, DOI 10.1016/0014-5793(93)80037-U; Inohara H, 1996, CANCER RES, V56, P4530; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Julien S, 2011, CANCER RES, V71, P7683, DOI 10.1158/0008-5472.CAN-11-1139; Kannagi R, 2001, Adv Exp Med Biol, V491, P587; Konstantopoulos K, 2011, ADV EXP MED BIOL, V705, P601, DOI 10.1007/978-1-4419-7877-6_32; KOTHS K, 1993, J BIOL CHEM, V268, P14245; Krause T, 1999, CLIN EXP METASTAS, V17, P183, DOI 10.1023/A:1006626500852; Mannori G, 1997, AM J PATHOL, V151, P233; Marchetti A, 2002, CANCER RES, V62, P2535; Matsumoto M, 2005, J IMMUNOL, V175, P8042, DOI 10.4049/jimmunol.175.12.8042; Mazo IB, 1998, J EXP MED, V188, P465, DOI 10.1084/jem.188.3.465; Moss MA, 2000, ANTICANCER RES, V20, P1425; Myung JH, 2011, ANAL CHEM, V83, P1078, DOI 10.1021/ac102901e; Narita, 1996, Breast Cancer, V3, P19, DOI 10.1007/BF02966958; Robertson D, 2011, METHODS MOL BIOL, V724, P69, DOI 10.1007/978-1-61779-055-3_4; Rubinstein N, 2004, CANCER CELL, V5, P241, DOI 10.1016/S1535-6108(04)00024-8; Sasaki T, 1998, EMBO J, V17, P1606, DOI 10.1093/emboj/17.6.1606; SATO S, 1994, J BIOL CHEM, V269, P4424; Schweitzer KM, 1996, AM J PATHOL, V148, P165; Shirure VS, 2011, BIOCHEM BIOPH RES CO, V406, P423, DOI 10.1016/j.bbrc.2011.02.061; Srirajaskanthan R, 2010, MOL CELL PROTEOMICS, V9, P656, DOI 10.1074/mcp.M900401-MCP200; Sutherland RL, 1999, HUMAN CELL CULTURE 2, VII; Thomas SN, 2008, J BIOL CHEM, V283, P15647, DOI 10.1074/jbc.M800543200; Thomas SN, 2009, AM J PHYSIOL-CELL PH, V296, pC505, DOI 10.1152/ajpcell.00472.2008; Tinari N, 2001, INT J CANCER, V91, P167, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1022>3.3.CO;2-Q; Tinari N, 2009, INT J CANCER, V124, P333, DOI 10.1002/ijc.23970; TOZEREN A, 1995, INT J CANCER, V60, P426; Tremblay PL, 2006, ONCOGENE, V25, P6563, DOI 10.1038/sj.onc.1209664; Ulmer TA, 2006, J CELL BIOCHEM, V98, P1351, DOI 10.1002/jcb.20784; Wang HS, 2005, EXP CELL RES, V304, P116, DOI 10.1016/j.yexcr.2004.10.015; Wang L, 2011, MOL CARCINOGEN, V50, P58, DOI 10.1002/mc.20696; WEISS L, 1980, AM J PATHOL, V101, P101; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Yin JJ, 2003, P NATL ACAD SCI USA, V100, P10954, DOI 10.1073/pnas.1830978100; Zen K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001826; Zou XY, 2005, AM J PHYSIOL-CELL PH, V289, pC415, DOI 10.1152/ajpcell.00289.2004	58	43	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44529	10.1371/journal.pone.0044529	http://dx.doi.org/10.1371/journal.pone.0044529			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970241	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400085
J	Taub, DD; Hesdorffer, CS; Ferrucci, L; Madara, K; Schwartz, JB; Goetzl, EJ				Taub, Dennis D.; Hesdorffer, Charles S.; Ferrucci, Luigi; Madara, Karen; Schwartz, Janice B.; Goetzl, Edward J.			Distinct energy requirements for human memory CD4 T-cell homeostatic functions	FASEB JOURNAL			English	Article						adherence; chemotaxis; apoptosis; glycolysis; fatty acid oxidation; immunosenescence	ACTIVATED PROTEIN-KINASE; LIPID-METABOLISM; GLUCOSE-UPTAKE; EXPRESSION; GENERATION; EFFECTOR; FATE	Differentiation and activation of CD4 memory T cells (T-mem cells) require energy from different sources, but little is known about energy sources for maintenance and surveillance activities of unactivated T-mem cells. Mitochondrial fatty acid oxidation (FAO) in human unactivated CD4 T-mem cells was significantly enhanced by inhibition of glycolysis, with respective means of 1.7- and 4.5-fold for subjects <45 yr and >65 yr, and by stimulation of AMP-activated protein kinase, with respective means of 1.3- and 5.2-fold. However, CCL19 and sphingosine 1-phosphate (S1P), which control homeostatic lymphoid trafficking of unactivated T-mem cells, altered FAO and glycolysis only minimally or not at all. Inhibition of CD4 T-mem-cell basal FAO, but not basal glycolysis, significantly suppressed CCL19- and S1P-mediated adherence to collagen by >50 and 20%, respectively, and chemotaxis by >20 and 50%. Apoptosis of unactivated T-mem cells induced by IL-2 deprivation or CCL19 was increased significantly by >150 and 70%, respectively, with inhibition of FAO and by >110 and 30% with inhibition of glycolysis. Anti-TCR antibody activation of T-mem cells increased their chemotaxis to CCL5, which was dependent predominantly on glycolysis rather than FAO. The sources supplying energy for diverse functions of unactivated T-mem cells differ from that required for function after immune activation.-Taub, D. D., Hesdorffer, C. S., Ferrucci, L., Madara, K., Schwartz, J. B., Goetzl, E. J. Distinct energy requirements for human memory CD4 T-cell homeostatic functions. FASEB J. 27, 342-349 (2013). www.fasebj.org	[Schwartz, Janice B.; Goetzl, Edward J.] Jewish Home San Francisco, Geriatr Res Labs, San Francisco, CA 94112 USA; [Taub, Dennis D.; Hesdorffer, Charles S.; Ferrucci, Luigi; Madara, Karen; Goetzl, Edward J.] NIA, NIH, Baltimore, MD 21224 USA; [Schwartz, Janice B.; Goetzl, Edward J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Francisco	Goetzl, EJ (corresponding author), Jewish Home San Francisco, UCSF Geriatr Res Labs, 302 Silver Ave, San Francisco, CA 94112 USA.	edward.goetzl@ucsf.edu	Schwartz, Janice/K-6354-2019		endowment funds of the Jewish Home of San Francisco; U.S. National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000104] Funding Source: NIH RePORTER	endowment funds of the Jewish Home of San Francisco; U.S. National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by endowment funds of the Jewish Home of San Francisco and the intramural research program of the U.S. National Institute on Aging. The authors are grateful to Judith H. Goetzl for preparation of the figures and table. The authors declare no conflicts of interest.	Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Chan O, 2012, J BIOL CHEM, V287, P29406, DOI 10.1074/jbc.M112.348946; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Finkel T, 2012, J BIOL CHEM, V287, P4434, DOI 10.1074/jbc.R111.271999; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; FRANCUS T, 1991, CELL IMMUNOL, V134, P520, DOI 10.1016/0008-8749(91)90323-4; Gerriets VA, 2012, TRENDS IMMUNOL, V33, P168, DOI 10.1016/j.it.2012.01.010; Goetzl EJ, 2010, FASEB J, V24, P3580, DOI 10.1096/fj.10-160911; Graeler M, 2002, J IMMUNOL, V169, P4084, DOI 10.4049/jimmunol.169.8.4084; Hardie DG, 1999, BIOCHEM J, V338, P717, DOI 10.1042/0264-6021:3380717; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; MacIver NJ, 2008, J LEUKOCYTE BIOL, V84, P949, DOI 10.1189/jlb.0108024; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; MacLeod MKL, 2010, IMMUNOLOGY, V130, P10, DOI 10.1111/j.1365-2567.2010.03260.x; McKinstry KK, 2012, J CLIN INVEST, V122, P2847, DOI 10.1172/JCI63689; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Naik E, 2011, J EXP MED, V208, P417, DOI 10.1084/jem.20110367; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Sun JC, 2004, NAT IMMUNOL, V5, P927, DOI 10.1038/ni1105; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Watt MJ, 2012, AM J PHYSIOL-ENDOC M, V302, pE1315, DOI 10.1152/ajpendo.00561.2011; Younes SA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001171	26	9	9	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					342	349		10.1096/fj.12-217620	http://dx.doi.org/10.1096/fj.12-217620			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	22972918	Green Published			2022-12-25	WOS:000313103200032
J	Kotapati, S; Maddukuri, L; Wickramaratne, S; Seneviratne, U; Goggin, M; Pence, MG; Villalta, P; Guengerich, FP; Marnett, L; Tretyakova, N				Kotapati, Srikanth; Maddukuri, Leena; Wickramaratne, Susith; Seneviratne, Uthpala; Goggin, Melissa; Pence, Matthew G.; Villalta, Peter; Guengerich, F. Peter; Marnett, Lawrence; Tretyakova, Natalia			Translesion Synthesis across 1,N-6-(2-Hydroxy-3-hydroxymethylpropan-1,3-diyl)-2 '-deoxyadenosine (1,N-6-gamma-HMHP-dA) Adducts by Human and Archebacterial DNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXOCYCLIC DEOXYADENOSINE ADDUCTS; IN-VITRO BYPASS; LESION-BYPASS; Y-FAMILY; 1,2,3,4-DIEPOXYBUTANE SYNTHESIS; CROSS-LINKS; BUTADIENE; O-6-METHYLGUANINE; N-2-ETHYLGUANINE; 1,3-BUTADIENE	The 1,N-6-(2-Hydroxy-3-hydroxymethylpropan-1,3-diyl)-2'-deoxyadenosine (1,N-6-gamma-HMHP-dA) adducts are formed upon bifunctional alkylation of adenine nucleobases in DNA by 1,2,3,4-diepoxybutane, the putative ultimate carcinogenic metabolite of 1,3-butadiene. The presence of a substituted 1,N-6-propano group on 1,N-6-gamma-HMHP-dA is expected to block the Watson-Crick base pairing of the adducted adenine with thymine, potentially contributing to mutagenesis. In this study, the enzymology of replication past site-specific 1,N-6-gamma-HMHP-dA lesions in the presence of human DNA polymerases (hpols) beta, eta, kappa, and iota and archebacterial polymerase Dpo4 was investigated. Run-on gel analysis with all four dNTPs revealed that hpol eta, kappa, and Dpo4 were able to copy the modified template. In contrast, hpol iota inserted a single base opposite 1,N-6-gamma-HMHP-dA but was unable to extend beyond the damaged site, and a complete replication block was observed with hpol beta. Single nucleotide incorporation experiments indicated that although hpol eta, kappa, and Dpo4 incorporated the correct nucleotide (dTMP) opposite the lesion, dGMP and dAMP were inserted with a comparable frequency. HPLC-ESI-MS/MS analysis of primer extension products confirmed the ability of bypass polymerases to insert dTMP, dAMP, or dGMP opposite 1,N-6-gamma-HMHP-dA and detected large amounts of -1 and -2 deletion products. Taken together, these results indicate that hpol eta and kappa enzymes bypass 1,N-6-gamma-HMHP-dA lesions in an error-prone fashion, potentially contributing to A-->T and A-->C transversions and frameshift mutations observed in cells following treatment with 1,2,3,4-diepoxybutane.	[Maddukuri, Leena; Pence, Matthew G.; Guengerich, F. Peter; Marnett, Lawrence] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; [Maddukuri, Leena; Pence, Matthew G.; Guengerich, F. Peter; Marnett, Lawrence] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Kotapati, Srikanth; Goggin, Melissa; Tretyakova, Natalia] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA; [Wickramaratne, Susith] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Kotapati, Srikanth; Wickramaratne, Susith; Seneviratne, Uthpala; Goggin, Melissa; Villalta, Peter; Tretyakova, Natalia] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	Vanderbilt University; Vanderbilt University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Marnett, L (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.	larry.marnett@vanderbilt.edu; trety001@umn.edu	Villalta, Peter W/J-4091-2019; Pence, Matthew/J-1379-2012	Pence, Matthew/0000-0003-2271-789X; Villalta, Peter/0000-0002-0067-3083; Kotapati, Srikanth/0000-0003-2302-5350	National Institutes of Health [CA-100670, ES-010375]; National Institutes of Health from the NCI [~ CA-77598]; NATIONAL CANCER INSTITUTE [P30CA077598, R37CA087819, R01CA100670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010375] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-100670 and ES-010375.; We thank Dr. Michael Stone (Vanderbilt University) for providing recombinant Dpo4 polymerase for these experiments. We are also thankful to Dr. Sarah Shuck (Vanderbilt University) for help with experimental protocols and PAGE experimental setup. HPLC-MS/MS analyses were performed in the Analytical Biochemistry Facility of the Masonic Cancer Center, which is supported in part by National Institutes of Health Grant CA-77598 from the NCI.	Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Burgers PMJ, 2001, J BIOL CHEM, V276, P43487, DOI 10.1074/jbc.R100056200; Carmical JR, 2000, J BIOL CHEM, V275, P19482, DOI 10.1074/jbc.M002037200; Carmical JR, 2000, ENVIRON MOL MUTAGEN, V35, P48, DOI 10.1002/(SICI)1098-2280(2000)35:1<48::AID-EM7>3.3.CO;2-3; Carmical JR, 2000, CHEM RES TOXICOL, V13, P18, DOI 10.1021/tx9901332; Choi JY, 2006, CHEM RES TOXICOL, V19, P879, DOI 10.1021/tx060051v; Choi JY, 2005, J MOL BIOL, V352, P72, DOI 10.1016/j.jmb.2005.06.079; Christov PP, 2009, CHEM RES TOXICOL, V22, P1086, DOI 10.1021/tx900047c; COCHRANE JE, 1994, CARCINOGENESIS, V15, P719, DOI 10.1093/carcin/15.4.719; De Bont R, 2004, MUTAGENESIS, V19, P169, DOI 10.1093/mutage/geh025; Eoff RL, 2007, J BIOL CHEM, V282, P1456, DOI 10.1074/jbc.M609661200; Eoff RL, 2009, BIOCHEMISTRY-US, V48, P7079, DOI 10.1021/bi9003588; Fiala KA, 2007, J MOL BIOL, V365, P590, DOI 10.1016/j.jmb.2006.10.008; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Goggin M, 2011, CHEM RES TOXICOL, V24, P809, DOI 10.1021/tx200009b; Goggin M, 2010, CHEM RES TOXICOL, V23, P808, DOI 10.1021/tx900439w; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Kanuri M, 2002, CHEM RES TOXICOL, V15, P1572, DOI 10.1021/tx025591g; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Levine RL, 2001, J BIOL CHEM, V276, P18717, DOI 10.1074/jbc.M102158200; Maddukuri L, 2010, BIOCHEMISTRY-US, V49, P8415, DOI 10.1021/bi1009024; Michaelson-Richie ED, 2010, J PROTEOME RES, V9, P4356, DOI 10.1021/pr1000835; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Pence MG, 2010, J BIOL CHEM, V285, P40666, DOI 10.1074/jbc.M110.183665; Pence MG, 2011, DNA REPAIR, V10, P56, DOI 10.1016/j.dnarep.2010.09.007; Pence MG, 2009, J BIOL CHEM, V284, P1732, DOI 10.1074/jbc.M807296200; Perrino FW, 2003, CHEM RES TOXICOL, V16, P1616, DOI 10.1021/tx034164f; Plosky BS, 2004, CURR OPIN GENET DEV, V14, P113, DOI 10.1016/j.gde.2004.02.002; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Prakash S, 2002, GENE DEV, V16, P1872, DOI 10.1101/gad.1009802; Recio L, 2001, CHEM-BIOL INTERACT, V135, P325, DOI 10.1016/S0009-2797(01)00220-4; Seneviratne U, 2010, CHEM RES TOXICOL, V23, P1556, DOI 10.1021/tx100146v; Seneviratne U, 2010, CHEM RES TOXICOL, V23, P118, DOI 10.1021/tx900312e; Steen AM, 1997, MUTAGENESIS, V12, P61, DOI 10.1093/mutage/12.2.61; Swenberg JA, 2011, CHEM-BIOL INTERACT, V192, P150, DOI 10.1016/j.cbi.2010.10.010; Tissier A, 2000, GENE DEV, V14, P1642; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Yang W, 2005, FEBS LETT, V579, P868, DOI 10.1016/j.febslet.2004.11.047; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang YB, 2000, MOL CELL BIOL, V20, P7099, DOI 10.1128/MCB.20.19.7099-7108.2000	45	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38800	38811		10.1074/jbc.M112.396788	http://dx.doi.org/10.1074/jbc.M112.396788			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22977231	Green Published, hybrid			2022-12-25	WOS:000310982800037
J	Lee, CL; Lam, EYF; Lam, KKW; Koistinen, H; Seppala, M; Ng, EHY; Yeung, WSB; Chiu, PCN				Lee, Cheuk-Lun; Lam, Eve Y. F.; Lam, Kevin K. W.; Koistinen, Hannu; Seppala, Markku; Ng, Ernest H. Y.; Yeung, William S. B.; Chiu, Philip C. N.			Glycodelin-A Stimulates Interleukin-6 Secretion by Human Monocytes and Macrophages through L-selectin and the Extracellular Signal-regulated Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZONA PELLUCIDA BINDING; NATURAL-KILLER-CELLS; PLACENTAL PROTEIN-14; GENE-EXPRESSION; DENDRITIC CELLS; ENDOMETRIAL PROTEIN; ADHESION MOLECULES; CUMULUS-OOPHORUS; AMNIOTIC-FLUID; IMMUNE CELL	Macrophages represent the second major type of decidual leukocytes at the fetomaternal interface. Changes in macrophage number and activity are associated with fetal loss and pregnancy complications. Glycodelin-A (GdA) is an abundant glycoprotein in the first-trimester decidua. It is involved in fetomaternal defense and early placental development through its regulatory activities in various immune cells. The N-glycosylation of GdA mediates the binding and therefore the activities of the molecule. In this study, we studied the biological activities of GdA in the functions of human monocytes/macrophages. GdA was purified from amniotic fluid by affinity chromatography. GdA treatment did not affect the viability, cell death, or phagocytic activity of the monocytes/macrophages. GdA, but not recombinant glycodelin without glycosylation, induced IL-6 production as demonstrated by cytokine array, intracellular staining, and ELISA. GdA also induced phosphorylation of ERK in monocytes/macrophages. The involvement of ERKs in IL-6 induction was confirmed using pharmacological inhibitors. Co-immunoprecipitation showed that L-selectin on the monocytes/macrophages was the binding protein of GdA. Treatment with anti-L-selectin antibody reduced GdA binding and GdA-induced IL-6 production. GdA-treated macrophages suppressed IFN-gamma expression by co-cultured T-helper cells in an IL-6-dependent manner. These results show that GdA interacts with L-selectin to induce IL-6 production in monocytes/macrophages by activating the ERK signaling pathway. In turn, the increased IL-6 production suppresses IFN-gamma expression in T-helper cells, which may play an important role in inducing a Th-2-polarized cytokine environment that flavors the immunotolerance of the fetoplacental unit.	[Lee, Cheuk-Lun; Lam, Eve Y. F.; Lam, Kevin K. W.; Ng, Ernest H. Y.; Yeung, William S. B.; Chiu, Philip C. N.] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Lee, Cheuk-Lun; Yeung, William S. B.; Chiu, Philip C. N.] Univ Hong Kong, Ctr Reprod Dev & Growth, Hong Kong, Hong Kong, Peoples R China; [Koistinen, Hannu; Seppala, Markku] Univ Helsinki, Cent Hosp, Dept Clin Chem, Helsinki 00014, Finland; [Koistinen, Hannu; Seppala, Markku] Univ Helsinki, FIN-00014 Helsinki, Finland	University of Hong Kong; University of Hong Kong; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Chiu, PCN (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China.	pchiucn@hku.hk	Chiu, Chi Ngong/C-4245-2009; Seppala, Markku/AAT-6618-2021; Lee, Cheuk Lun/AGX-5720-2022; Koistinen, Hannu/AGU-1279-2022	Chiu, Chi Ngong/0000-0001-6217-1970; Koistinen, Hannu/0000-0003-0926-3109; Lee, Cheuk Lun/0000-0003-1553-3478; Ng, Ernest/0000-0002-7688-4557	University of Hong Kong [201007176033]; Hong Kong Research Grant Council [HKU774212]; Helsinki University; Academy of Finland	University of Hong Kong(University of Hong Kong); Hong Kong Research Grant Council(Hong Kong Research Grants Council); Helsinki University; Academy of Finland(Academy of Finland)	This work was supported in part by University of Hong Kong Grant 201007176033, Hong Kong Research Grant Council Grant HKU774212, the Helsinki University Central Hospital Research Fund, and the Academy of Finland.	Alok A, 2009, INT J BIOCHEM CELL B, V41, P1138, DOI 10.1016/j.biocel.2008.10.009; Breckpot K, 2004, HUM GENE THER, V15, P562, DOI 10.1089/104303404323142015; Brenner B, 1996, P NATL ACAD SCI USA, V93, P15376, DOI 10.1073/pnas.93.26.15376; Challis JR, 2009, REPROD SCI, V16, P206, DOI 10.1177/1933719108329095; Chiu PCN, 2007, J BIOL CHEM, V282, P5378, DOI 10.1074/jbc.M607482200; Chiu PCN, 2007, J CELL SCI, V120, P33, DOI 10.1242/jcs.03258; Chiu PCN, 2010, HUM REPROD, V25, P2721, DOI 10.1093/humrep/deq243; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crockett-Torabi E, 1998, J LEUKOCYTE BIOL, V63, P1; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; Dimitriadis E, 2005, HUM REPROD UPDATE, V11, P613, DOI 10.1093/humupd/dmi023; Dominguez F, 2008, MOL HUM REPROD, V14, P423, DOI 10.1093/molehr/gan032; DUCLOS AJ, 1995, AM J REPROD IMMUNOL, V33, P354, DOI 10.1111/j.1600-0897.1995.tb00904.x; Grailer JJ, 2009, J DERMATOL SCI, V56, P141, DOI 10.1016/j.jdermsci.2009.10.001; Hashimoto S, 1999, BLOOD, V94, P837, DOI 10.1182/blood.V94.3.837.413k02_837_844; Haugen TS, 1999, RESPIRATION, V66, P528, DOI 10.1159/000029430; Houser BL, 2011, J IMMUNOL, V186, P2633, DOI 10.4049/jimmunol.1003153; Jauniaux E, 1996, MOL HUM REPROD, V2, P239, DOI 10.1093/molehr/2.4.239; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Kim JH, 2009, OSTEOARTHR CARTILAGE, V17, P1662, DOI 10.1016/j.joca.2009.06.004; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Laird SM, 2003, HUM REPROD UPDATE, V9, P163, DOI 10.1093/humupd/dmg013; LAIRD SM, 1994, HUM REPROD, V9, P1339, DOI 10.1093/oxfordjournals.humrep.a138706; Lam KKW, 2011, J BIOL CHEM, V286, P37118, DOI 10.1074/jbc.M111.233841; Lam KKW, 2009, HUM REPROD, V24, P2093, DOI 10.1093/humrep/dep205; LAUDANNA C, 1994, J BIOL CHEM, V269, P4021; Lee CL, 2011, J REPROD IMMUNOL, V90, P29, DOI 10.1016/j.jri.2011.04.007; Lee CL, 2011, HUM REPROD, V26, P517, DOI 10.1093/humrep/deq381; Lee CL, 2011, DIABETES, V60, P909, DOI 10.2337/db10-1186; Lee CL, 2010, FERTIL STERIL, V94, P769, DOI 10.1016/j.fertnstert.2009.10.009; Lee CL, 2009, J BIOL CHEM, V284, P15084, DOI 10.1074/jbc.M807960200; Lehtonen A, 2007, J LEUKOCYTE BIOL, V82, P710, DOI 10.1189/jlb.0307194; Li CL, 2009, P NATL ACAD SCI USA, V106, P5767, DOI 10.1073/pnas.0901173106; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Link A, 1997, CLIN HEMORHEOL MICRO, V17, P175; MACKENNA A, 1993, FERTIL STERIL, V59, P577; Martinez E, 1996, BONE MARROW TRANSPL, V18, P1; Meisser A, 1999, MOL HUM REPROD, V5, P1055, DOI 10.1093/molehr/5.11.1055; Mishan-Eisenberg G, 2004, J IMMUNOL, V173, P5524, DOI 10.4049/jimmunol.173.9.5524; Mor Gil, 2003, Reprod Biol Endocrinol, V1, P119, DOI 10.1186/1477-7827-1-119; Mukhopadhyay D, 2001, J BIOL CHEM, V276, P28268, DOI 10.1074/jbc.M010487200; Murphy SP, 2009, BIOL REPROD, V80, P848, DOI 10.1095/biolreprod.108.073353; NISHINO E, 1990, J CLIN ENDOCR METAB, V71, P436, DOI 10.1210/jcem-71-2-436; Olsnes C, 2011, SCAND J IMMUNOL, V74, P114, DOI 10.1111/j.1365-3083.2011.02555.x; Patel KD, 2002, SEMIN IMMUNOL, V14, P73, DOI 10.1006/smim.2001.0344; Piccinni MP, 2007, GYNECOL OBSTET INVES, V64, P144, DOI 10.1159/000101738; Po JL, 1995, BIOCHEM BIOPH RES CO, V217, P1145, DOI 10.1006/bbrc.1995.2888; Poornima BL, 2007, FEBS LETT, V581, P4366, DOI 10.1016/j.febslet.2007.07.078; PRIETO J, 1994, CELL IMMUNOL, V156, P191, DOI 10.1006/cimm.1994.1164; Rachmilewitz J, 2003, J BIOL CHEM, V278, P14059, DOI 10.1074/jbc.M211716200; Renaud SJ, 2008, IMMUNOL INVEST, V37, P535, DOI 10.1080/08820130802191375; RIITTINEN L, 1989, CLIN CHIM ACTA, V184, P19, DOI 10.1016/0009-8981(89)90253-2; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Scholz C, 2008, AM J REPROD IMMUNOL, V60, P501, DOI 10.1111/j.1600-0897.2008.00647.x; Seppala M, 2007, HUM REPROD UPDATE, V13, P275, DOI 10.1093/humupd/dmm004; Seppala M, 2002, ENDOCR REV, V23, P401, DOI 10.1210/er.2001-0026; SILVER RM, 1993, AM J OBSTET GYNECOL, V169, P1101, DOI 10.1016/0002-9378(93)90263-I; Smith SD, 2009, AM J PATHOL, V174, P1959, DOI 10.2353/ajpath.2009.080995; Smolen JE, 2000, J BIOL CHEM, V275, P15876, DOI 10.1074/jbc.M906232199; So KH, 2012, REPROD BIOMED ONLINE, V24, P639, DOI 10.1016/j.rbmo.2012.03.004; Tee MK, 2008, J LEUKOCYTE BIOL, V83, P843, DOI 10.1189/jlb.0406291; TSENG SS, 1977, J ORG CHEM, V42, P3645, DOI 10.1021/jo00443a002; ULEVITCH RJ, 1993, ADV IMMUNOL, V53, P267, DOI 10.1016/S0065-2776(08)60502-7; Varki A., 2009, ESSENTIALS GLYCOBIOL; Vellenga E, 1999, BRIT J PHARMACOL, V127, P441, DOI 10.1038/sj.bjp.0702577; Vigne JL, 2001, J BIOL CHEM, V276, P17101, DOI 10.1074/jbc.M010451200; WADDELL TK, 1995, J BIOL CHEM, V270, P15403, DOI 10.1074/jbc.270.25.15403; Yaniv E, 2003, CELL IMMUNOL, V222, P156, DOI 10.1016/S0008-8749(03)00129-1; Yeung WSB, 2009, J REPROD IMMUNOL, V83, P26, DOI 10.1016/j.jri.2009.04.012; Zhao S, 2008, PLACENTA, V29, P1024, DOI 10.1016/j.placenta.2008.09.011	71	24	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36999	37009		10.1074/jbc.M112.385336	http://dx.doi.org/10.1074/jbc.M112.385336			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977256	hybrid, Green Published			2022-12-25	WOS:000310588500035
J	Guan, DW; van der Sanden, S; Zeng, HR; Li, W; Zheng, HY; Ma, C; Su, J; Liu, Z; Guo, X; Zhang, X; Liu, L; Koopmans, M; Ke, CW				Guan, Dawei; van der Sanden, Sabine; Zeng, Hanri; Li, Wei; Zheng, Huanying; Ma, Cong; Su, Juan; Liu, Zheng; Guo, Xue; Zhang, Xin; Liu, Leng; Koopmans, Marion; Ke, Changwen			Population Dynamics and Genetic Diversity of C4 Strains of Human Enterovirus 71 in Mainland China, 1998-2010	PLOS ONE			English	Article							POLIOMYELITIS-LIKE DISEASE; MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; EVOLUTIONARY GENETICS; NEUROLOGICAL DISEASE; HAND; FOOT; OUTBREAK; VP1; INFECTION	Background: Since 1997, several countries within the Asian Pacific region have been affected by one or more massive outbreaks of Hand Foot and Mouth Disease (HFMD). Virus typing experiments revealed that these outbreaks were caused by strains of human enterovirus 71 (EV71) belonging to several different, recently emerged subgenogroups. In mainland China, a different situation was observed. The first outbreak, localized in Shangdong Province, was reported in 2007, and was followed by a wide-spread outbreak in mainland China in 2008. Since then, numbers of reported HFMD cases have been persistently high. Methodology/Principal Findings: To gain insight in the epidemiological behavior of EV71 in China, we studied genetic diversity and EV71 population dynamics to address whether the increase in number of reported EV71 infections reflects a real increase in viral spread or is just the result of increased awareness and surveillance. We used systematically collected VP1 gene sequences of 257 EV71 strains collected in Guangdong province from 2008 to 2010 as part of HFMD surveillance activities, and supplemented them with 305 GenBank EV71 reference stains collected in China from 1998 to 2010. All isolates from Guangdong Province belonged to subgenogroup C4. Viral population dynamics indicated that the increased reporting of HFMD in China since 2007 reflects a real increase in viral spread and continued replacement of viral lineages through time. Amino acid sequence comparisons revealed substitution of amino acid in residues 22, 145 and 289 through time regularly with the VP1 gene of EV71 strains isolated in mainland China from 1998 to 2010. Conclusions: EV71 strains isolated in mainland China mainly belonged to subgenogroup C4. There was exponential growth of the EV71 virus population in 2007 and 2008. There was amino acid substitution through time regularly with the VP1 gene which possibly increased viral spread and/or ability of the virus to circulate persistently among the Chinese population.	[Guan, Dawei; Zeng, Hanri; Li, Wei; Zheng, Huanying; Ma, Cong; Su, Juan; Liu, Zheng; Guo, Xue; Zhang, Xin; Liu, Leng; Ke, Changwen] Ctr Dis Control & Prevent Guangdong Prov, Key Lab Pathogen Detect Emergency Response Guangd, Guangzhou, Guangdong, Peoples R China; [van der Sanden, Sabine; Koopmans, Marion] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands	Netherlands National Institute for Public Health & the Environment	Guan, DW (corresponding author), Ctr Dis Control & Prevent Guangdong Prov, Key Lab Pathogen Detect Emergency Response Guangd, Guangzhou, Guangdong, Peoples R China.	kecw1965@yahoo.com.cn	liu, Zheng/H-4193-2013	liu, Zheng/0000-0002-9351-200X; Koopmans, Marion/0000-0002-5204-2312	Technology Research Center for Pathogen Detection of Emerging Infectious Disease of Guangdong Province, China [(2008)1216 -2]	Technology Research Center for Pathogen Detection of Emerging Infectious Disease of Guangdong Province, China	This work was supported by Technology Research Center for Pathogen Detection of Emerging Infectious Disease of Guangdong Province, China (Grant no. (2008)1216 -2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; Bible JM, 2007, REV MED VIROL, V17, P371, DOI 10.1002/rmv.538; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chu PY, 2001, ARCH VIROL, V146, P589, DOI 10.1007/s007050170164; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Iwai M, 2009, JPN J INFECT DIS, V62, P254; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn P, 2001, CLIN INFECT DIS, V32, P236, DOI 10.1086/318454; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Mizuta K, 2005, J CLIN MICROBIOL, V43, P6171, DOI 10.1128/JCM.43.12.6171-6175.2005; Ortner B, 2009, J MED VIROL, V81, P317, DOI 10.1002/jmv.21374; Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shih SR, 2000, VIRUS RES, V68, P127, DOI 10.1016/S0168-1702(00)00162-3; SHINDAROV LM, 1979, J HYG EPID MICROB IM, V23, P284; Sun LM, 2011, JPN J INFECT DIS, V64, P13; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; van der Sanden S, 2010, J GEN VIROL, V91, P1949, DOI 10.1099/vir.0.019695-0; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Wang SM, 2009, EXPERT REV ANTI-INFE, V7, P735, DOI 10.1586/ERI.09.45; YANG CF, 1992, VIRUS RES, V24, P277, DOI 10.1016/0168-1702(92)90124-R; Zhang Y, 2011, PLOS ONE, V6, P262; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	37	26	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44386	10.1371/journal.pone.0044386	http://dx.doi.org/10.1371/journal.pone.0044386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984501	Green Submitted, Green Published, gold			2022-12-25	WOS:000308738500053
J	Hale, ML; Burg, TM; Steeves, TE				Hale, Marie L.; Burg, Theresa M.; Steeves, Tammy E.			Sampling for Microsatellite-Based Population Genetic Studies: 25 to 30 Individuals per Population Is Enough to Accurately Estimate Allele Frequencies	PLOS ONE			English	Article							COMPUTER-PROGRAM; MARKERS; DIVERSITY; ALBATROSSES; RICHNESS; DISTANCE; NUMBER; SIZES; LOCI; DNA	One of the most common questions asked before starting a new population genetic study using microsatellite allele frequencies is "how many individuals do I need to sample from each population?" This question has previously been answered by addressing how many individuals are needed to detect all of the alleles present in a population (i.e. rarefaction based analyses). However, we argue that obtaining accurate allele frequencies and accurate estimates of diversity are much more important than detecting all of the alleles, given that very rare alleles (i.e. new mutations) are not very informative for assessing genetic diversity within a population or genetic structure among populations. Here we present a comparison of allele frequencies, expected heterozygosities and genetic distances between real and simulated populations by randomly subsampling 5-100 individuals from four empirical microsatellite genotype datasets (Formica lugubris, Sciurus vulgaris, Thalassarche melanophris, and Himantopus novaezelandia) to create 100 replicate datasets at each sample size. Despite differences in taxon (two birds, one mammal, one insect), population size, number of loci and polymorphism across loci, the degree of differences between simulated and empirical dataset allele frequencies, expected heterozygosities and pairwise FST values were almost identical among the four datasets at each sample size. Variability in allele frequency and expected heterozygosity among replicates decreased with increasing sample size, but these decreases were minimal above sample sizes of 25 to 30. Therefore, there appears to be little benefit in sampling more than 25 to 30 individuals per population for population genetic studies based on microsatellite allele frequencies.	[Hale, Marie L.; Steeves, Tammy E.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Burg, Theresa M.] Univ Lethbridge, Dept Biol, Lethbridge, AB T1K 3M4, Canada	University of Canterbury; University of Lethbridge	Hale, ML (corresponding author), Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand.	marie.hale@canterbury.ac.nz			University of Newcastle (UK)	University of Newcastle (UK)	The unpublished ant and dataset was collected by MLH and Dr. Kirsten Wolff, funded by the University of Newcastle (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashalkhanov S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-84; BAVERSTOCK PR, 1996, MOL SYSTEMATICS; Burg TM, 1999, MOL ECOL, V8, P338; Burg TM, 2001, MOL ECOL, V10, P2647, DOI 10.1046/j.0962-1083.2001.01392.x; Chapuisat M, 1996, MOL ECOL, V5, P599, DOI 10.1111/j.1365-294X.1996.tb00354.x; Gyllenstrand N, 2002, MOL ECOL NOTES, V2, P67, DOI 10.1046/j.1471-8286.2002.00152.x; Hale ML, 2001, SCIENCE, V293, P2246, DOI 10.1126/science.1062574; Hale ML, 2001, MOL ECOL NOTES, V1, P47, DOI 10.1046/j.1471-8278 .2000.00020.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2005, HEREDITY, V94, P33, DOI 10.1038/sj.hdy.6800548; Landguth EL, 2012, MOL ECOL RESOUR, V12, P276, DOI 10.1111/j.1755-0998.2011.03077.x; Miyamoto N, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008014; NEI M, 1978, GENETICS, V89, P583; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pruett CL, 2008, J AVIAN BIOL, V39, P252, DOI 10.1111/j.2008.0908-8857.04094.x; Ruzzante DE, 1998, CAN J FISH AQUAT SCI, V55, P1, DOI 10.1139/cjfas-55-1-1; Ryman N, 2006, MOL ECOL NOTES, V6, P600, DOI 10.1111/j.1471-8286.2006.01378.x; Steeves TE, 2008, MOL ECOL RESOUR, V8, P1105, DOI 10.1111/j.1755-0998.2008.02170.x; Steeves TE, 2010, MOL ECOL, V19, P5090, DOI 10.1111/j.1365-294X.2010.04895.x; Yan Lu-Na, 2004, Acta Zoologica Sinica, V50, P279	21	298	301	3	115	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45170	10.1371/journal.pone.0045170	http://dx.doi.org/10.1371/journal.pone.0045170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984627	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500125
J	Sellmyer, MA; Chen, LC; Egeler, EL; Rakhit, R; Wandless, TJ				Sellmyer, Mark A.; Chen, Ling-chun; Egeler, Emily L.; Rakhit, Rishi; Wandless, Thomas J.			Intracellular Context Affects Levels of a Chemically Dependent Destabilizing Domain	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; UBIQUITIN-PROTEASOME SYSTEM; ENDOPLASMIC-RETICULUM; IN-VIVO; PLASMODIUM-FALCIPARUM; MITOCHONDRIAL IMPORT; FLUORESCENT PROTEIN; GAUSSIA LUCIFERASE; MESSENGER-RNA; ER STRESS	The ability to regulate protein levels in live cells is crucial to understanding protein function. In the interest of advancing the tool set for protein perturbation, we developed a protein destabilizing domain (DD) that can confer its instability to a fused protein of interest. This destabilization and consequent degradation can be rescued in a reversible and dose-dependent manner with the addition of a small molecule that is specific for the DD, Shield-1. Proteins encounter different local protein quality control (QC) machinery when targeted to cellular compartments such as the mitochondrial matrix or endoplasmic reticulum (ER). These varied environments could have profound effects on the levels and regulation of the cytoplasmically derived DD. Here we show that DD fusions in the cytoplasm or nucleus can be efficiently degraded in mammalian cells; however, targeting fusions to the mitochondrial matrix or ER lumen leads to accumulation even in the absence of Shield-1. Additionally, we characterize the behavior of the DD with perturbants that modulate protein production, degradation, and local protein QC machinery. Chemical induction of the unfolded protein response in the ER results in decreased levels of an ER-targeted DD indicating the sensitivity of the DD to the degradation environment. These data reinforce that DD is an effective tool for protein perturbation, show that the local QC machinery affects levels of the DD, and suggest that the DD may be a useful probe for monitoring protein quality control machinery.	[Sellmyer, Mark A.; Chen, Ling-chun; Egeler, Emily L.; Rakhit, Rishi; Wandless, Thomas J.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA	Stanford University	Sellmyer, MA (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wandless@stanford.edu		Sellmyer, Mark/0000-0002-1407-1905	National Institute of General Medical Sciences of the National Institutes of Health [GM073046]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073046] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institute of General Medical Sciences of the National Institutes of Health (GM073046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Baker BM, 2011, TRENDS BIOCHEM SCI, V36, P254, DOI 10.1016/j.tibs.2011.01.004; Balch W, 2008, SCIENCE; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101; Glass M, 2009, NAT METHODS, V6, P577, DOI 10.1038/nmeth.1346; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kaser M, 2000, SEMIN CELL DEV BIOL, V11, P181, DOI 10.1006/scdb.2000.0166; Kim HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020252; Leong HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030177; Mu TW, 2008, CELL, V134, P769, DOI 10.1016/j.cell.2008.06.037; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ni L, 1999, J BIOL CHEM, V274, P12685, DOI 10.1074/jbc.274.18.12685; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Rivera VM, 2000, SCIENCE, V287, P826, DOI 10.1126/science.287.5454.826; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schreiber SL, 2003, CHEM ENG NEWS, V81, P51, DOI 10.1021/cen-v081n009.p051; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Wilcox AJ, 2005, P NATL ACAD SCI USA, V102, P15435, DOI 10.1073/pnas.0507324102; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Wurdinger T, 2008, NAT METHODS, V5, P171, DOI 10.1038/NMETH.1177; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145	35	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43297	10.1371/journal.pone.0043297	http://dx.doi.org/10.1371/journal.pone.0043297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984418	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500009
J	Tattersall, MC; Gangnon, RE; Karmali, KN; Keevil, JG				Tattersall, Matthew C.; Gangnon, Ronald E.; Karmali, Kunal N.; Keevil, Jon G.			Women Up, Men Down: The Clinical Impact of Replacing the Framingham Risk Score with the Reynolds Risk Score in the United States Population	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; GLOBAL CARDIOVASCULAR RISK; C-REACTIVE PROTEIN; DENSITY-LIPOPROTEIN CHOLESTEROL; US ADULTS; PRIMARY PREVENTION; NATIONAL-HEALTH; LIFETIME RISK; 10-YEAR RISK; PREDICTION	Background: The Reynolds Risk Score (RRS) is one alternative to the Framingham Risk Score (FRS) for cardiovascular risk assessment. The Adult Treatment Panel III (ATP III) integrated the FRS a decade ago, but with the anticipated release of ATP IV, it remains uncertain how and which risk models will be integrated into the recommendations. We sought to define the effects in the United States population of a transition from the FRS to the RRS for cardiovascular risk assessment. Methods: Using the National Health and Nutrition Examination Surveys, we assessed FRS and RRS in 2,502 subjects representing approximately 53.6 Million (M) men (ages 50-79) and women (ages 45-79), without cardiovascular disease or diabetes. We calculated the proportion reclassified by RRS and the subset whose LDL-C goal achievement changed. Results: Compared to FRS, the RRS assigns a higher risk category to 13.9% of women and 9.1% of men while assigning a lower risk to 35.7% of men and 2% of women. Overall, 4.7% of women and 1.1% of men fail to meet newly intensified LDLC goals using the RRS. Conversely, 10.5% of men and 0.6% of women now meet LDL-C goal using RRS when they had not by FRS. Conclusion: In the U. S. population the RRS assigns a new risk category for one in six women and four of nine men. In general, women increase while men decrease risk. In conclusion, adopting the RRS for the 53.6 million eligible U. S. adults would result in intensification of clinical management in 1.6 M additional women and 2.10 M fewer men.	[Tattersall, Matthew C.; Karmali, Kunal N.; Keevil, Jon G.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Div Cardiovasc Med, Madison, WI 53706 USA; [Gangnon, Ronald E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tattersall, MC (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Div Cardiovasc Med, Madison, WI 53706 USA.	jgk@medicine.wisc.edu		Gangnon, Ronald/0000-0003-2587-6714	National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the National Heart Lung and Blood Institute [T32 HL 07936]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007936] Funding Source: NIH RePORTER	National Institutes of Health under Ruth L. Kirschstein National Research Service Award from the National Heart Lung and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This investigation was supported by the National Institutes of Health, under Ruth L. Kirschstein National Research Service Award T32 HL 07936 from the National Heart Lung and Blood Institute to the UW-Madison Cardiovascular Research Center, Madison WI, USA. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Amarenco P, 2009, LANCET NEUROL, V8, P453, DOI 10.1016/S1474-4422(09)70058-4; [Anonymous], 2005, NAT HLTH NUTR EX SUR; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Cook NR, 2012, CIRCULATION, V125, P1748, DOI 10.1161/CIRCULATIONAHA.111.075929; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Ford ES, 2004, DIABETES CARE, V27, P2444, DOI 10.2337/diacare.27.10.2444; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Greenland P, 2001, CIRCULATION, V104, P1863, DOI 10.1161/hc4201.097189; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; Kuczmarski RJ, 2002, SERIES-J SPAN ECON, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Lloyd-Jones DM, 2004, AM J CARDIOL, V94, P20, DOI 10.1016/j.amjcard.2004.03.023; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Michos ED, 2009, J AM COLL CARDIOL, V53, P931, DOI 10.1016/j.jacc.2008.12.010; Pasternak Richard C., 2003, Journal of the American College of Cardiology, V41, P1863, DOI 10.1016/S0735-1097(03)00358-9; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Redberg RF, 2009, J AM COLL CARDIOL, V54, P1364, DOI 10.1016/j.jacc.2009.08.005; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sheridan SL, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-60; Sundquist J, 2001, J AM GERIATR SOC, V49, P109, DOI 10.1046/j.1532-5415.2001.49030.x; Voight BF, 2012, LANCET; Wensley F, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d548; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	33	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44347	10.1371/journal.pone.0044347	http://dx.doi.org/10.1371/journal.pone.0044347			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984495	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500049
J	Zhao, J; Li, H; Ding, C; Chen, AT				Zhao, Jing; Li, Hong; Ding, Cody; Chen, Antao			Distractor Detection and Suppression Have a Beneficial Effect on Attentional Blink	PLOS ONE			English	Article							SERIAL VISUAL PRESENTATION; INDIVIDUAL-DIFFERENCES; TEMPORAL ATTENTION; MODEL; TASK; INFORMATION; MEMORY	Background: Attentional blink (AB) is a phenomenon that describes the difficulty individuals have in reporting the second of two masked targets if the second target (T2) arrives 200-500 ms after the first target (T1). Recent studies explain the AB from cognitive resources limitation to distractors interference. For example, the temporary loss of control (TLC) hypothesis suggests that the AB is conduced by distractors disrupting the input filter for target processing. The inhibition models suggest that the T1+1 distractor triggers a suppression mechanism which could be beneficial for T1 processing but would suppress T2 at short T1-T2 lags. These models consider that the AB is caused by the appearance of distractors. However, in the present study, two methods were taken to help individuals to detect the distractors more effectively. An attenuated AB deficit was found when the distractors could be excluded or suppressed in time. We consider that under an appropriate condition the distractors detection and suppression have a beneficial effect on attentional blink. Methodology/Principal Findings: Two methods were employed to help individuals to detect the distractors more effectively: enlarging the low-level-physical characteristic difference between targets and distractors (Experiment 1) and restricting the sets of distractors (Experiment 2). Attenuated AB deficits were found as using the above manipulations. Conclusions/Significance: The present study found when the distractors are detected or identified quickly, they could be effectively suppressed, in order to reduce the interference from the targets and result in a smaller AB deficit. We suggest that the suppression mechanism for distractors have a beneficial effect on AB.	[Zhao, Jing; Chen, Antao] Southwest Univ, Sch Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Li, Hong] Liaoning Normal Univ, Res Ctr Psychol Dev & Educ, Dalian, Liaoning, Peoples R China; [Ding, Cody] Univ Missouri, Coll Educ, St Louis, MO 63121 USA	Southwest University - China; Liaoning Normal University; University of Missouri System; University of Missouri Saint Louis	Zhao, J (corresponding author), Southwest Univ, Sch Psychol, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	xscat@swu.edu.cn			National Natural Science Foundation of China [31170980]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201107]; New Century Excellent Talents in University [NCET-11-0698]; Fundamental Research Funds for the Central Universities [SWU1009001]; Key Discipline Fund of National 211 Project [NSKD11006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Discipline Fund of National 211 Project	This work was supported by the National Natural Science Foundation of China (31170980), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201107), the New Century Excellent Talents in University (NCET-11-0698), the Fundamental Research Funds for the Central Universities (SWU1009001), and the Key Discipline Fund of National 211 Project (NSKD11006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowman H, 2007, PSYCHOL REV, V114, P38, DOI 10.1037/0033-295X.114.1.38; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Fragopanagos N, 2005, COGNITIVE BRAIN RES, V24, P568, DOI 10.1016/j.cogbrainres.2005.03.010; LANDAUER TK, 1968, J VERB LEARN VERB BE, V7, P291, DOI 10.1016/S0022-5371(68)80003-9; Martens S., 2010, PLOS ONE, V5; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2009, EXP PSYCHOL, V56, P18, DOI 10.1027/1618-3169.56.1.18; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Potter MC, 1998, J EXP PSYCHOL LEARN, V24, P979, DOI 10.1037/0278-7393.24.4.979; RAYMOND JE, 1995, J EXP PSYCHOL HUMAN, V21, P653, DOI 10.1037/0096-1523.21.3.653; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Shapiro K, 1994, TEMPORAL ALLOCATION; Shih SI, 2008, COGNITIVE PSYCHOL, V56, P210, DOI 10.1016/j.cogpsych.2007.06.001	18	2	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44786	10.1371/journal.pone.0044786	http://dx.doi.org/10.1371/journal.pone.0044786			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984558	Green Published, gold			2022-12-25	WOS:000308738500084
J	Zhao, Y; Zhu, HP; Zou, MH				Zhao, Yu; Zhu, Huaiping; Zou, Ming-Hui			Non-Covalent Interaction between Polyubiquitin and GTP Cyclohydrolase 1 Dictates Its Degradation	PLOS ONE			English	Article							UBIQUITIN-BINDING DOMAINS; NITRIC-OXIDE SYNTHASE; DOPA-RESPONSIVE DYSTONIA; UBA DOMAIN; IN-VIVO; ENDOTHELIAL FUNCTION; TYROSINE NITRATION; 26S PROTEASOME; HIV-1 VPR; TETRAHYDROBIOPTERIN	GTP cyclohydrolase 1 (GTPCH1) is the rate-limiting enzyme in the de novo synthesis of tetrahydrobiopterin (BH4). GTPCH1 protein degradation has been reported in animal models of several diseases, including diabetes mellitus and hypertension. However, the molecular mechanisms by which GTPCH1 is degraded remain uncharacterized. Here we report a novel non-covalent interaction between polyubiquitin and GTPCH1 in vitro and in vivo. The non-covalent binding of GTPCH1 to polyubiquitin via an ubiquitin-binding domain (UBD) results in ubiquitination and degradation. Ectopic expression of ubiquitin in cultured cells accelerated GTPCH1 degradation. In cultured cells and in vitro assays, Lys48-linked ubiquitin chains, but not Lys63-linked chains, interacted with GTPCH1 and targeted it for degradation. Consistently, proteasome inhibition attenuated GTPCH1 degradation. Finally, direct mutagenesis of an isoleucine (Ile131) in the hydrophobic patch of the GTPCH1 UBD affected its ubiquitin binding and the enzyme stability. Taken together, we conclude that GTPCH1 non-covalently interacts with polyubiquitin via an ubiquitin-binding domain. The polyubiquitin binding directs GTPCH1 ubiquitination and proteasome degradation.	[Zhao, Yu; Zhu, Huaiping; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK USA; [Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhao, Y (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK USA.	ming-hui-zou@ouhsc.edu			NIH [HL074399, HL079584, HL080499, HL089920, HL096032, HL105157, HL110448]; American Diabetes Association; Warren Chair in Diabetes Research from the University of Oklahoma Health Sciences Center; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074399, R01HL110488, R01HL105157, R01HL079584, R01HL089920, R01HL080499, R43HL110448, R01HL096032] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Warren Chair in Diabetes Research from the University of Oklahoma Health Sciences Center; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by NIH grants (HL074399, HL079584, HL080499, HL089920, HL096032, HL105157, and HL110448), by a research award from the American Diabetes Association, and by the Warren Chair in Diabetes Research from the University of Oklahoma Health Sciences Center (to Dr. Zou). Dr. Zou is a recipient of the National Established Investigator Award of the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alp NJ, 2004, ARTERIOSCL THROM VAS, V24, P413, DOI 10.1161/01.ATV.0000110785.96039.f6; Alp NJ, 2003, J CLIN INVEST, V112, P725, DOI 10.1172/JCI200317786; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Clot F, 2009, BRAIN, V132, P1753, DOI 10.1093/brain/awp084; Crinelli R, 2008, MOL CELL BIOCHEM, V318, P129, DOI 10.1007/s11010-008-9864-8; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dunbar AY, 2006, DRUG METAB DISPOS, V34, P1448, DOI 10.1124/dmd.106.009951; Foxton RH, 2007, NEUROCHEM RES, V32, P751, DOI 10.1007/s11064-006-9201-0; Garavaglia B, 2004, J INHERIT METAB DIS, V27, P455, DOI 10.1023/B:BOLI.0000037349.08483.96; Gorren ACF, 2002, CURR DRUG METAB, V3, P133, DOI 10.2174/1389200024605154; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Higashi Y, 2002, AM J HYPERTENS, V15, P326, DOI 10.1016/S0895-7061(01)02317-2; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ikeda F, 2010, CELL, V143, P677, DOI 10.1016/j.cell.2010.10.026; KWON NS, 1989, J BIOL CHEM, V264, P20496; Longo N, 2009, J INHERIT METAB DIS, V32, P333, DOI 10.1007/s10545-009-1067-2; LOVENBERG W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Muller U, 2002, J NEURAL TRANSM, V109, P321, DOI 10.1007/s007020200026; Nie H, 2006, DIABETES, V55, P3133, DOI 10.2337/db06-0505; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Pickart CM, 2001, MOL CELL, V8, P499, DOI 10.1016/S1097-2765(01)00347-1; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Schwartz AL, 1999, ANNU REV MED, V50, P57; Stroes E, 1997, J CLIN INVEST, V99, P41, DOI 10.1172/JCI119131; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; Thony B, 2006, HUM MUTAT, V27, P870, DOI 10.1002/humu.20366; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Wang SX, 2009, DIABETES, V58, P1893, DOI 10.2337/db09-0267; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Withers-Ward ES, 2000, BIOCHEMISTRY-US, V39, P14103, DOI 10.1021/bi0017071; Xu J, 2007, CIRCULATION, V116, P944, DOI 10.1161/CIRCULATIONAHA.106.684795; Xu J, 2009, HYPERTENSION, V54, P625, DOI 10.1161/HYPERTENSIONAHA.109.133736	39	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43306	10.1371/journal.pone.0043306	http://dx.doi.org/10.1371/journal.pone.0043306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984419	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500010
J	Choudhury, SR; Roy, S; Nag, A; Singh, SK; Sengupta, DN				Choudhury, Swarup Roy; Roy, Sujit; Nag, Anish; Singh, Sanjay Kumar; Sengupta, Dibyendu N.			Characterization of an AGAMOUS-like MADS Box Protein, a Probable Constituent of Flowering and Fruit Ripening Regulatory System in Banana	PLOS ONE			English	Article							PHOSPHATE SYNTHASE GENE; DNA-BINDING-PROTEIN; TRANSCRIPTION FACTORS; OVULE DEVELOPMENT; IN-VITRO; ARABIDOPSIS; TOMATO; DOMAIN; EXPRESSION; ETHYLENE	The MADS-box family of genes has been shown to play a significant role in the development of reproductive organs, including dry and fleshy fruits. In this study, the molecular properties of an AGAMOUS like MADS box transcription factor in banana cultivar Giant governor (Musa sp, AAA group, subgroup Cavendish) has been elucidated. We have detected a CArG-box sequence binding AGAMOUS MADS-box protein in banana flower and fruit nuclear extracts in DNA-protein interaction assays. The protein fraction in the DNA-protein complex was analyzed by mass spectrometry and using this information we have obtained the full length cDNA of the corresponding protein. The deduced protein sequence showed similar to 95% amino acid sequence homology with MA-MADS5, a MADS-box protein described previously from banana. We have characterized the domains of the identified AGAMOUS MADS-box protein involved in DNA binding and homodimer formation in vitro using full-length and truncated versions of affinity purified recombinant proteins. Furthermore, in order to gain insight about how DNA bending is achieved by this MADS-box factor, we performed circular permutation and phasing analysis using the wild type recombinant protein. The AGAMOUS MADS-box protein identified in this study has been found to predominantly accumulate in the climacteric fruit pulp and also in female flower ovary. In vivo and in vitro assays have revealed specific binding of the identified AGAMOUS MADS-box protein to CArG-box sequence in the promoters of major ripening genes in banana fruit. Overall, the expression patterns of this MADS-box protein in banana female flower ovary and during various phases of fruit ripening along with the interaction of the protein to the CArG-box sequence in the promoters of major ripening genes lead to interesting assumption about the possible involvement of this AGAMOUS MADS-box factor in banana fruit ripening and floral reproductive organ development.	[Choudhury, Swarup Roy; Nag, Anish; Singh, Sanjay Kumar; Sengupta, Dibyendu N.] Bose Inst, Div Plant Biol, Kolkata, W Bengal, India; [Roy, Sujit] Bose Inst, Dept Chem, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute; Department of Science & Technology (India); Bose Institute	Choudhury, SR (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO USA.	src.bose@gmail.com	Nag, Anish/ABH-8581-2020; Pandey, Sona/M-2847-2013	Nag, Anish/0000-0001-9435-3795; Pandey, Sona/0000-0002-5570-3120	CSIR project [38(1181)/08/EMR-II]; CSIR; Govt. of India	CSIR project(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Govt. of India	The work is financially supported by research grant from CSIR project [38(1181)/08/EMR-II], CSIR, Govt. of India to DNS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bhattacharyya J, 1998, BIOCHEM MOL BIOL INT, V46, P249; Boss PK, 2001, PLANT MOL BIOL, V45, P541, DOI 10.1023/A:1010634132156; Bowler C, 2004, PLANT J, V39, P776, DOI 10.1111/j.1365-313X.2004.02169.x; BRADLEY D, 1993, CELL, V72, P85, DOI 10.1016/0092-8674(93)90052-R; Causier B, 2005, CURR BIOL, V15, P1508, DOI 10.1016/j.cub.2005.07.063; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Cho SC, 1999, PLANT MOL BIOL, V40, P419, DOI 10.1023/A:1006273127067; Choudhury SR, 2008, PLANT CELL REP, V27, P1235, DOI 10.1007/s00299-008-0547-4; Choudhury SR, 2009, POSTHARVEST BIOL TEC, V54, P15, DOI 10.1016/j.postharvbio.2009.05.003; Choudhury SR, 2008, PLANTA, V229, P207, DOI 10.1007/s00425-008-0821-2; Choudhury SR, 2008, J PLANT PHYSIOL, V165, P1865, DOI 10.1016/j.jplph.2008.04.012; Davies B, 1999, EMBO J, V18, P4023, DOI 10.1093/emboj/18.14.4023; de Folter S, 2006, TRENDS PLANT SCI, V11, P224, DOI 10.1016/j.tplants.2006.03.008; Dominique SR, 2004, J PROTEOME RES, V3, P662, DOI 10.1021/pr049966q; DRAK J, 1991, P NATL ACAD SCI USA, V88, P3074, DOI 10.1073/pnas.88.8.3074; Elitzur T, 2010, J EXP BOT, V61, P1523, DOI 10.1093/jxb/erq017; Flanagan CA, 1996, PLANT J, V10, P343, DOI 10.1046/j.1365-313X.1996.10020343.x; Fujisawa M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-26; Garcia-Maroto F, 2003, BIOL PLANTARUM, V46, P321, DOI 10.1023/A:1024353514081; Harlow E., 1988, ANTIBODIES LAB MANUA; Hileman LC, 2006, MOL BIOL EVOL, V23, P2245, DOI 10.1093/molbev/msl095; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Huang H, 1996, PLANT CELL, V8, P81, DOI 10.1105/tpc.8.1.81; HUANG H, 1995, PLANT MOL BIOL, V28, P549, DOI 10.1007/BF00020401; HUANG H, 1993, NUCLEIC ACIDS RES, V21, P4769, DOI 10.1093/nar/21.20.4769; INABA A, 1986, J JPN SOC HORTIC SCI, V55, P348, DOI 10.2503/jjshs.55.348; Itkin M, 2009, PLANT J, V60, P1081, DOI 10.1111/j.1365-313X.2009.04064.x; Ito T, 2007, PLANT CELL, V19, P3516, DOI 10.1105/tpc.107.055467; Ito Y, 2008, PLANT J, V55, P212, DOI 10.1111/j.1365-313X.2008.03491.x; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P5479, DOI 10.1128/MCB.13.9.5479; Kramer EM, 2004, GENETICS, V166, P1011, DOI 10.1534/genetics.166.2.1011; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Liljegren SJ, 2000, NATURE, V404, P766, DOI 10.1038/35008089; Liu JH, 2009, PLANT CELL REP, V28, P103, DOI 10.1007/s00299-008-0613-y; Lockhart SR, 1998, J BACTERIOL, V180, P6607, DOI 10.1128/JB.180.24.6607-6616.1998; Manning K, 2006, NAT GENET, V38, P948, DOI 10.1038/ng1841; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; Messenguy F, 2003, GENE, V316, P1, DOI 10.1016/S0378-1119(03)00747-9; Paciorek T, 2006, J CELL SCI, V119, P1199, DOI 10.1242/jcs.02910; Pan IL, 2010, J EXP BOT, V61, P1795, DOI 10.1093/jxb/erq046; PELLEGRINI L, 1995, NATURE, V376, P490, DOI 10.1038/376490a0; Peumans WJ, 2000, PLANTA, V211, P546, DOI 10.1007/s004250000307; Pinyopich A, 2003, NATURE, V424, P85, DOI 10.1038/nature01741; PNUELI L, 1994, PLANT CELL, V6, P163, DOI 10.1105/tpc.6.2.163; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Santelli E, 2000, J MOL BIOL, V297, P437, DOI 10.1006/jmbi.2000.3568; Seymour GB, 2011, J EXP BOT, V62, P1179, DOI 10.1093/jxb/erq360; SHARROCKS AD, 1995, NUCLEIC ACIDS RES, V23, P2442, DOI 10.1093/nar/23.13.2442; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SHIRAISHI H, 1993, PLANT J, V4, P385, DOI 10.1046/j.1365-313X.1993.04020385.x; Tadiello A, 2009, J EXP BOT, V60, P651, DOI 10.1093/jxb/ern313; Tang WN, 2003, J BIOL CHEM, V278, P28154, DOI 10.1074/jbc.M212976200; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trivedi PK, 2004, PLANT SCI, V167, P1351, DOI 10.1016/j.plantsci.2004.07.005; Victoria BM, 2003, PLANT MOL BIOL, V52, P801, DOI 10.1023/A:1025001402838; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang Xin-Li, 2001, Chinese Journal of Biotechnology, V17, P428; Wang Xin-Li, 2001, Chinese Journal of Biotechnology, V17, P293; West AG, 1998, NUCLEIC ACIDS RES, V26, P5277, DOI 10.1093/nar/26.23.5277; West AG, 1997, MOL CELL BIOL, V17, P2876, DOI 10.1128/MCB.17.5.2876; Xu Bi-Yu, 2006, Sheng Wu Gong Cheng Xue Bao, V22, P945; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Yao JL, 1999, J AM SOC HORTIC SCI, V124, P8, DOI 10.21273/JASHS.124.1.8	69	30	32	4	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44361	10.1371/journal.pone.0044361	http://dx.doi.org/10.1371/journal.pone.0044361			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984496	gold, Green Published			2022-12-25	WOS:000308638700055
J	Gould, RA; Sinha, R; Aziz, H; Rouf, R; Dietz, HC; Judge, DP; Butcher, J				Gould, Russell A.; Sinha, Ravi; Aziz, Hamza; Rouf, Rosanne; Dietz, Harry C., III; Judge, Daniel P.; Butcher, Jonathan			Multi-Scale Biomechanical Remodeling in Aging and Genetic Mutant Murine Mitral Valve Leaflets: Insights into Marfan Syndrome	PLOS ONE			English	Article							INTERSTITIAL-CELLS; ANTERIOR LEAFLET; AORTIC-ANEURYSM; MOUSE MODEL; TISSUE; FIBRILLIN-1; PRESSURE; PARALLEL; PROLAPSE; MICROFIBRILS	Mitral valve degeneration is a key component of the pathophysiology of Marfan syndrome. The biomechanical consequences of aging and genetic mutation in mitral valves are poorly understood because of limited tools to study this in mouse models. Our aim was to determine the global biomechanical and local cell-matrix deformation relationships in the aging and Marfan related Fbn1 mutated murine mitral valve. To conduct this investigation, a novel stretching apparatus and gripping method was implemented to directly quantify both global tissue biomechanics and local cellular deformation and matrix fiber realignment in murine mitral valves. Excised mitral valve leaflets from wild-type and Fbn1 mutant mice from 2 weeks to 10 months in age were tested in circumferential orientation under continuous laser optical imaging. Mouse mitral valves stiffen with age, correlating with increases in collagen fraction and matrix fiber alignment. Fbn1 mutation resulted in significantly more compliant valves (modulus 1.34 +/- 0.12 vs. 2.51 +/- 0.31 MPa, respectively, P<.01) at 4 months, corresponding with an increase in proportion of GAGs and decrease in elastin fraction. Local cellular deformation and fiber alignment change linearly with global tissue stretch, and these slopes become more extreme with aging. In comparison, Fbn1 mutated valves have decoupled cellular deformation and fiber alignment with tissue stretch. Taken together, quantitative understanding of multi-scale murine planar tissue biomechanics is essential for establishing consequences of aging and genetic mutations. Decoupling of local cell-matrix deformation kinematics with global tissue stretch may be an important mechanism of normal and pathological biomechanical remodeling in valves.	[Gould, Russell A.; Sinha, Ravi; Butcher, Jonathan] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA; [Aziz, Hamza; Rouf, Rosanne; Dietz, Harry C., III; Judge, Daniel P.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Dietz, Harry C., III] Howard Hughes Med Inst, Bethesda, MD 20817 USA	Cornell University; Johns Hopkins University; Howard Hughes Medical Institute	Gould, RA (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.	jtb47@cornell.edu	Butcher, Jonathan/AAE-8239-2020; Butcher, Jonathan T/D-2280-2012	Butcher, Jonathan/0000-0002-9309-6296; Butcher, Jonathan T/0000-0002-9309-6296; Sinha, Ravi/0000-0003-4185-5198; Judge, Daniel/0000-0002-3407-0248	National Science Foundation; National Institutes of Health [HL110328]; American Heart Association; Leducq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL110328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041135] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Leducq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by grants from the National Science Foundation (CAREER award, JTB), National Institutes of Health (HL110328, JTB), American Heart Association (JTB), and the Leducq Foundation (JTB, RR and DJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberts JJJ, 2010, NETH HEART J, V18, P85, DOI 10.1007/BF03091743; Barber JE, 2001, J THORAC CARDIOV SUR, V122, P955, DOI 10.1067/mtc.2001.117621; BARLOW JB, 1966, AM HEART J, V71, P166, DOI 10.1016/0002-8703(66)90179-7; Bax DV, 2003, J BIOL CHEM, V278, P34605, DOI 10.1074/jbc.M303159200; Bhudia SK, 2006, ANN THORAC SURG, V81, P843, DOI 10.1016/j.athoracsur.2005.08.055; Bowles RD, 2010, TISSUE ENG PT A, V16, P1339, DOI [10.1089/ten.tea.2009.0442, 10.1089/ten.TEA.2009.0442]; Butcher JT, 2007, CIRC RES, V100, P1503, DOI 10.1161/CIRCRESAHA.107.148684; Cao L, 2006, J BIOMECH ENG-T ASME, V128, P766, DOI 10.1115/1.2246237; Dal-Bianco JP, 2009, CIRCULATION, V120, P334, DOI 10.1161/CIRCULATIONAHA.108.846782; Dietz HC, 2005, AM J MED GENET C, V139C, P4, DOI 10.1002/ajmg.c.30068; Durbin AD, 2002, CARDIOVASC PATHOL, V11, P69, DOI 10.1016/S1054-8807(01)00109-0; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; FUNG YCB, 1967, AM J PHYSIOL, V213, P1532, DOI 10.1152/ajplegacy.1967.213.6.1532; Gleason RL, 2004, J BIOMECH ENG-T ASME, V126, P787, DOI 10.1115/1.1824130; Grande-Allen KJ, 2003, J AM COLL CARDIOL, V42, P271, DOI 10.1016/S0735-1097(03)00626-0; Grashow JS, 2006, ANN BIOMED ENG, V34, P315, DOI [10.1007/s10439-005-9027-y, 10.1007/s10439-005-9027-v]; Habashi JP, 2011, SCIENCE, V332, P361, DOI 10.1126/science.1192152; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Helmke BP, 2000, CIRC RES, V86, P745, DOI 10.1161/01.RES.86.7.745; Hinton RB, 2008, AM J PHYSIOL-HEART C, V294, pH2480, DOI 10.1152/ajpheart.91431.2007; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Ikhumetse JD, 2006, J HEART VALVE DIS, V15, P295; Judge DP, 2008, ANNU REV MED, V59, P43, DOI 10.1146/annurev.med.59.103106.103801; Judge DP, 2011, J CARDIOVASC TRANSL, V4, P741, DOI 10.1007/s12265-011-9314-y; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Krishnamurthy VK, 2011, J BIOMECH, V44, P77, DOI 10.1016/j.jbiomech.2010.08.026; Ku CH, 2006, CARDIOVASC RES, V71, P548, DOI 10.1016/j.cardiores.2006.03.022; KUNZELMAN KS, 1992, J CARDIAC SURG, V7, P71, DOI 10.1111/j.1540-8191.1992.tb00777.x; Lee SSJ, 2004, STRUCTURE, V12, P717, DOI 10.1016/j.str.2004.02.023; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z; Montgomery RA, 1998, AM J HUM GENET, V63, P1703, DOI 10.1086/302144; Mulholland DL, 1997, CARDIOVASC PATHOL, V6, P167; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489; Sacks MS, 2006, ANN THORAC SURG, V82, P1369, DOI 10.1016/j.athoracsur.2006.03.117; SAHASAKUL Y, 1988, AM J CARDIOL, V62, P424, DOI 10.1016/0002-9149(88)90971-X; Sakamoto H, 1996, J BIOL CHEM, V271, P4916; Sasoglu FM, 2007, J MICROMECH MICROENG, V17, P623, DOI 10.1088/0960-1317/17/3/027; Shawn L, 2010, RADIOFREQUENCY ABLAT, V1, P194; Sherratt MJ, 2003, J MOL BIOL, V332, P183, DOI 10.1016/S0022-2836(03)00829-5; TAMURA K, 1995, AM HEART J, V129, P1149, DOI 10.1016/0002-8703(95)90397-6; Tiemann K, 2003, AM J PHYSIOL-HEART C, V284, pH464, DOI 10.1152/ajpheart.00540.2002; Weyman AE, 2004, J CLIN INVEST, V114, P1543, DOI 10.1172/JCI200423701; Yang B, 1999, AM J PHYSIOL-HEART C, V277, pH1906, DOI 10.1152/ajpheart.1999.277.5.H1906; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041	47	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44639	10.1371/journal.pone.0044639	http://dx.doi.org/10.1371/journal.pone.0044639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984535	gold, Green Submitted, Green Published			2022-12-25	WOS:000308638700073
J	Laszkiewicz, A; Sniezewski, L; Kasztura, M; Bzdzion, L; Cebrat, M; Kisielow, P				Laszkiewicz, Agnieszka; Sniezewski, Lukasz; Kasztura, Monika; Bzdzion, Lukasz; Cebrat, Malgorzata; Kisielow, Pawel			Bidirectional Activity of the NWC Promoter Is Responsible for RAG-2 Transcription in Non-Lymphoid Cells	PLOS ONE			English	Article							RECOMBINATION ACTIVATING GENE; CONSERVED GENE; EXPRESSION; LOCUS; DNA; ELEMENTS; MICE; IDENTIFICATION	The recombination-activating genes (RAG-1 and RAG-2) encode a V(D)J recombinase responsible for rearrangements of antigen-receptor genes during T and B cell development, and RAG expression is known to correlate strictly with the process of rearrangement. In contrast to RAG-1, the expression of RAG-2 was not previously detected during any other stage of lymphopoiesis or in any other normal tissue. Here we report that the CpG island-associated promoter of the NWC gene (the third evolutionarily conserved gene in the RAG locus), which is located in the second intron of RAG-2, has bidirectional activity and is responsible for the detectable transcription of RAG-2 in some non-lymphoid tissues. We also identify evolutionarily conserved promoter fragments responsible for this bidirectional activity, and show that it is activated by transcription factor ZFP143. The possible implications of our findings are briefly discussed.	[Laszkiewicz, Agnieszka; Sniezewski, Lukasz; Kasztura, Monika; Bzdzion, Lukasz; Cebrat, Malgorzata; Kisielow, Pawel] Polish Acad Sci, Inst Immunol & Expt Therapy, Dept Tumor Immunol, Lab Mol & Cellular Immunol, PL-53114 Wroclaw, Poland	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	Laszkiewicz, A (corresponding author), Polish Acad Sci, Inst Immunol & Expt Therapy, Dept Tumor Immunol, Lab Mol & Cellular Immunol, PL-53114 Wroclaw, Poland.	cebrat@iitd.pan.wroc.pl		Kasztura, Monika/0000-0001-7304-3798; Laszkiewicz, Agnieszka/0000-0002-0317-4255; Cebrat, Malgorzata/0000-0003-4544-3289	Polish Ministry of Science and Higher Education [N N401 049138]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Polish Ministry of Science and Higher Education (grant N N401 049138). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anno YN, 2011, NUCLEIC ACIDS RES, V39, P3116, DOI 10.1093/nar/gkq1301; Barreto V, 2001, EUR J IMMUNOL, V31, P3763, DOI 10.1002/1521-4141(200112)31:12<3763::AID-IMMU3763>3.0.CO;2-Y; Cebrat M, 2005, EUR J IMMUNOL, V35, P2230, DOI 10.1002/eji.200526225; Cebrat M, 2008, MOL IMMUNOL, V45, P2297, DOI 10.1016/j.molimm.2007.11.009; Chen ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020475; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; Fugmann SD, 2010, SEMIN IMMUNOL, V22, P10, DOI 10.1016/j.smim.2009.11.004; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Kalitsis P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-498; Kasztura M, 2009, ACTA BIOCHIM POL, V56, P177; Kisielow P, 2008, INT J IMMUNOGENET, V35, P395, DOI 10.1111/j.1744-313X.2008.00791.x; Kuwata N, 1999, J IMMUNOL, V163, P6355; Laszkiewicz A, 2011, IMMUNOGENETICS, V63, P183, DOI 10.1007/s00251-011-0511-2; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Monroe RJ, 1999, IMMUNITY, V11, P201, DOI 10.1016/S1074-7613(00)80095-3; Myslinski E, 1998, J BIOL CHEM, V273, P21998, DOI 10.1074/jbc.273.34.21998; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Rose AB, 2008, CURR TOP MICROBIOL, V326, P277; Schatz DG, 2004, SEMIN IMMUNOL, V16, P245, DOI 10.1016/j.smim.2004.08.004; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schaub M, 2000, NUCLEIC ACIDS RES, V28, P2114, DOI 10.1093/nar/28.10.2114; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Valencia P, 2008, P NATL ACAD SCI USA, V105, P3386, DOI 10.1073/pnas.0800250105; Wei XC, 2002, J IMMUNOL, V169, P873, DOI 10.4049/jimmunol.169.2.873; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; Yang MQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S3; Yannoutsos N, 2004, NAT IMMUNOL, V5, P443, DOI 10.1038/ni1053; Yu W, 1999, SCIENCE, V285, P1080, DOI 10.1126/science.285.5430.1080	31	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44807	10.1371/journal.pone.0044807	http://dx.doi.org/10.1371/journal.pone.0044807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984564	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700085
J	Li, X; Chen, L; Hong, MY; Zhang, Y; Zu, F; Wen, J; Yi, B; Ma, CZ; Shen, JX; Tu, JX; Fu, TD				Li, Xia; Chen, Li; Hong, Meiyan; Zhang, Yan; Zu, Feng; Wen, Jing; Yi, Bin; Ma, Chaozhi; Shen, Jinxiong; Tu, Jinxing; Fu, Tingdong			A Large Insertion in bHLH Transcription Factor BrTT8 Resulting in Yellow Seed Coat in Brassica rapa	PLOS ONE			English	Article							PROANTHOCYANIDIN SYNTHESIS; ANTHOCYANIN PATHWAY; DOMAIN PROTEIN; GENE ENCODES; COLOR GENE; NAPUS L.; ARABIDOPSIS; IDENTIFICATION; INHERITANCE; EXPRESSION	Yellow seed is a desirable quality trait of the Brassica oilseed species. Previously, several seed coat color genes have been mapped in the Brassica species, but the molecular mechanism is still unknown. In the present investigation, map-based cloning method was used to identify a seed coat color gene, located on A9 in B. rapa. Blast analysis with the Arabidopsis genome showed that there were 22 Arabidopsis genes in this region including at4g09820 to at4g10620. Functional complementation test exhibited a phenotype reversion in the Arabidopsis thaliana tt8-1 mutant and yellow-seeded plant. These results suggested that the candidate gene was a homolog of TRANSPARENT TESTA8 (TT8) locus. BrTT8 regulated the accumulation of proanthocyanidins (PAs) in the seed coat. Sequence analysis of two alleles revealed a large insertion of a new class of transposable elements, Helitron in yellow sarson. In addition, no mRNA expression of BrTT8 was detected in the yellow-seeded line. It indicated that the natural transposon might have caused the loss in function of BrTT8. BrTT8 encodes a basic/helix-loop-helix (bHLH) protein that shares a high degree of similarity with other bHLH proteins in the Brassica. Further expression analysis also revealed that BrTT8 was involved in controlling the late biosynthetic genes (LBGs) of the flavonoid pathway. Our present findings provided with further studies could assist in understanding the molecular mechanism involved in seed coat color formation in Brassica species, which is an important oil yielding quality trait.	[Li, Xia; Hong, Meiyan; Wen, Jing; Yi, Bin; Ma, Chaozhi; Shen, Jinxiong; Tu, Jinxing; Fu, Tingdong] Huazhong Agr Univ, Natl Ctr Rapeseed Improvement Wuhan, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Chen, Li] Guizhou Acad Agr Sci, Guizhou Rapeseed Inst, Guiyang, Peoples R China; [Zhang, Yan] Guangdong Acad Agr Sci, Vegetable Res Inst, Guangzhou, Guangdong, Peoples R China; [Zu, Feng] Yunnan Acad Agr Sci, Ind Crop Res Inst, Kunming, Peoples R China	Huazhong Agricultural University; Guizhou Academy of Agricultural Sciences; Guangdong Academy of Agricultural Sciences; Yunnan Academy of Agricultural Sciences	Li, X (corresponding author), Huazhong Agr Univ, Natl Ctr Rapeseed Improvement Wuhan, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	tujx@mail.hzau.edu.cn	Shen, Jinxiong/AAT-3318-2021; Shen, Jinxiong/Z-3988-2019; wen, jing/HDM-2205-2022		National Key Basic Research Special Foundation of China "973" Project [2011CB109302]; National Natural Science Foundation of China [30971803]	National Key Basic Research Special Foundation of China "973" Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Key Basic Research Special Foundation of China "973" Project (No. 2011CB109302) and the National Natural Science Foundation of China "30971803." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASTRUP S, 1984, CARLSBERG RES COMMUN, V49, P105, DOI 10.1007/BF02913969; Abrahams S, 2003, PLANT J, V35, P624, DOI 10.1046/j.1365-313X.2003.01834.x; Auger B, 2009, PLANTA, V230, P1167, DOI 10.1007/s00425-009-1017-0; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Baudry A, 2006, PLANT J, V46, P768, DOI 10.1111/j.1365-313X.2006.02733.x; Bennetzen JL, 2005, CURR OPIN GENET DEV, V15, P621, DOI 10.1016/j.gde.2005.09.010; Broun P, 2005, CURR OPIN PLANT BIOL, V8, P272, DOI 10.1016/j.pbi.2005.03.006; Carey CC, 2004, PLANT CELL, V16, P450, DOI 10.1105/tpc.018796; CHANDLER VL, 1989, PLANT CELL, V1, P1175, DOI 10.1105/tpc.1.12.1175; CHEN BY, 1988, PLANT BREEDING, V101, P52, DOI 10.1111/j.1439-0523.1988.tb00266.x; Chen BY, 1997, HEREDITAS, V126, P133, DOI 10.1111/j.1601-5223.1997.00133.x; Choi JD, 2007, PLANT J, V49, P924, DOI 10.1111/j.1365-313X.2006.03007.x; Ding Y, 2006, THESIS HUAZHONG AGR, P21; Dun XL, 2011, PLANT J, V68, P532, DOI 10.1111/j.1365-313X.2011.04708.x; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Furukawa T, 2007, PLANT J, V49, P91, DOI 10.1111/j.1365-313X.2006.02958.x; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; Kitamura S, 2004, PLANT J, V37, P104, DOI 10.1046/j.1365-313X.2003.01943.x; Kurauchi T, 2011, J PLANT PHYSIOL, V168, P1264, DOI 10.1016/j.jplph.2011.01.003; Lal SK, 2003, PLANT CELL, V15, P381, DOI 10.1105/tpc.008375; Lei SL, 2007, THEOR APPL GENET, V115, P643, DOI 10.1007/s00122-007-0594-1; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu ZW, 2005, THEOR APPL GENET, V110, P303, DOI 10.1007/s00122-004-1835-1; Meng JL, 1998, EUPHYTICA, V103, P329, DOI 10.1023/A:1018646223643; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Nesi N, 2002, PLANT CELL, V14, P2463, DOI 10.1105/tpc.004127; Nesi N, 2009, PLANT CELL REP, V28, P601, DOI 10.1007/s00299-008-0667-x; Ohno S, 2011, J EXP BOT, V62, P5105, DOI 10.1093/jxb/err216; Pelletier MK, 1997, PLANT PHYSIOL, V113, P1437, DOI 10.1104/pp.113.4.1437; Pires N, 2010, MOL BIOL EVOL, V27, P862, DOI 10.1093/molbev/msp288; Pourcel L, 2005, PLANT CELL, V17, P2966, DOI 10.1105/tpc.105.035154; Rahman MH, 2001, PLANT BREEDING, V120, P463, DOI 10.1046/j.1439-0523.2001.00640.x; Rahman MH, 2001, PLANT BREEDING, V120, P197, DOI 10.1046/j.1439-0523.2001.00607.x; Rahman M, 2007, THEOR APPL GENET, V115, P1101, DOI 10.1007/s00122-007-0636-8; SCHWETKA A, 1982, THEOR APPL GENET, V62, P161, DOI 10.1007/BF00293352; SHIRZADEGAN M, 1985, FETT WISS TECHNOL, V87, P235, DOI 10.1002/lipi.19850870605; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Tang ZL, 1997, PLANT BREEDING, V116, P471, DOI 10.1111/j.1439-0523.1997.tb01033.x; Wei YL, 2007, MOL BIOL REP, V34, P105, DOI 10.1007/s11033-006-9024-8; Yang LX, 2009, P NATL ACAD SCI USA, V106, P19922, DOI 10.1073/pnas.0908008106; Yang LX, 2009, P NATL ACAD SCI USA, V106, P12832, DOI 10.1073/pnas.0905563106; Yi B, 2010, PLANT J, V63, P925, DOI 10.1111/j.1365-313X.2010.04289.x; Zaman M. W., 1989, Sveriges Utsadesforenings Tidskrift, V99, P205; Zhang F, 2003, DEVELOPMENT, V130, P4859, DOI 10.1242/dev.00681; Zhang JF, 2009, PLANT MOL BIOL, V69, P553, DOI 10.1007/s11103-008-9437-y	48	65	76	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44145	10.1371/journal.pone.0044145	http://dx.doi.org/10.1371/journal.pone.0044145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984469	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700046
J	Roy, S; Watkins, N; Heck, D				Roy, Snigdha; Watkins, Nick; Heck, Detlef			Comprehensive Analysis of Ultrasonic Vocalizations in a Mouse Model of Fragile X Syndrome Reveals Limited, Call Type Specific Deficits	PLOS ONE			English	Article							UNUSUAL REPERTOIRE; MATERNAL-BEHAVIOR; YOUNG MALES; RAT PUPS; AUTISM; MICE; LANGUAGE; TF/J; COMMUNICATION; DISORDERS	Fragile X syndrome (FXS) is a well-recognized form of inherited mental retardation, caused by a mutation in the fragile X mental retardation 1 (Fmr1) gene. The gene is located on the long arm of the X chromosome and encodes fragile X mental retardation protein (FMRP). Absence of FMRP in fragile X patients as well as in Fmr1 knockout (KO) mice results, among other changes, in abnormal dendritic spine formation and altered synaptic plasticity in the neocortex and hippocampus. Clinical features of FXS include cognitive impairment, anxiety, abnormal social interaction, mental retardation, motor coordination and speech articulation deficits. Mouse pups generate ultrasonic vocalizations (USVs) when isolated from their mothers. Whether those social ultrasonic vocalizations are deficient in mouse models of FXS is unknown. Here we compared isolation-induced USVs generated by pups of Fmr1-KO mice with those of their wild type (WT) littermates. Though the total number of calls was not significantly different between genotypes, a detailed analysis of 10 different categories of calls revealed that loss of Fmr1 expression in mice causes limited and call-type specific deficits in ultrasonic vocalization: the carrier frequency of flat calls was higher, the percentage of downward calls was lower and that the frequency range of complex calls was wider in Fmr1-KO mice compared to their WT littermates.	[Roy, Snigdha; Heck, Detlef] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Watkins, Nick] Christian Bros Univ, Dept Biol, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center	Roy, S (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	sroy3@uthsc.edu	Heck, Detlef/GPS-4854-2022	Heck, Detlef/0000-0003-2438-4064	National Institutes of Health [R01NS063009, R01NS060887]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063009, R01NS060887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health to D. H. H. (R01NS063009 and R01NS060887). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbeduto L, 2007, MENT RETARD DEV D R, V13, P36, DOI 10.1002/mrdd.20142; Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Barnes EF, 2006, J SPEECH LANG HEAR R, V49, P903, DOI 10.1044/1092-4388(2006/065); BROUETTELAHLOU I, 1992, BEHAV BRAIN RES, V50, P147, DOI 10.1016/S0166-4328(05)80296-7; Brudzynski SM, 1999, DEV PSYCHOBIOL, V34, P195, DOI 10.1002/(SICI)1098-2302(199904)34:3<195::AID-DEV4>3.0.CO;2-S; BRUNELLI SA, 1994, J COMP PSYCHOL, V108, P298, DOI 10.1037/0735-7036.108.3.298; Bryant JL, 2010, EUR J NEUROSCI, V32, P41, DOI 10.1111/j.1460-9568.2010.07244.x; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; EHRET G, 1986, ANIM BEHAV, V34, P821, DOI 10.1016/S0003-3472(86)80067-7; EHRET G, 1992, ANIM BEHAV, V43, P409, DOI 10.1016/S0003-3472(05)80101-0; Ellegood J, 2010, NEUROIMAGE, V53, P1023, DOI 10.1016/j.neuroimage.2010.03.038; Farrell WJ, 2002, J COMP PSYCHOL, V116, P297, DOI 10.1037//0735-7036.116.3.297; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Gordon N, 1996, EUR J DISORDER COMM, V31, P359; Hagerman R, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-12; Hahn ME, 2005, BEHAV GENET, V35, P31, DOI 10.1007/s10519-004-0854-7; Harris SW, 2008, AM J MENT RETARD, V113, P427, DOI 10.1352/2008.113:427-438; Heck DH, 2008, HUM MOL GENET, V17, P2181, DOI 10.1093/hmg/ddn117; LOESCH DZ, 1988, J MED GENET, V25, P407, DOI 10.1136/jmg.25.6.407; MADISON LS, 1986, J MENT DEFIC RES, V30, P129; Mostofsky SH, 1998, NEUROLOGY, V50, P121, DOI 10.1212/WNL.50.1.121; NEWELL K, 1983, FRAGILE X SYNDROME D, P175; PAUL R, 1987, J AUTISM DEV DISORD, V17, P457, DOI 10.1007/BF01486963; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; REISS AL, 1991, ANN NEUROL, V29, P26, DOI 10.1002/ana.410290107; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Roy S, 2011, BEHAV NEUROSCI, V125, P962, DOI 10.1037/a0025920; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; Shair HN, 2007, BEHAV BRAIN RES, V182, P180, DOI 10.1016/j.bbr.2007.02.016; SHAMBES GM, 1978, BRAIN BEHAV EVOLUT, V15, P94, DOI 10.1159/000123774; SMITH JC, 1976, J COMP PHYSIOL PSYCH, V90, P1105, DOI 10.1037/h0077287; WELSH JP, 1995, NATURE, V374, P453, DOI 10.1038/374453a0; Wohr M, 2011, GENES BRAIN BEHAV, V10, P35, DOI 10.1111/j.1601-183X.2010.00582.x; Wohr M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020631; Yang M, 2007, FRONT BEHAV NEUROSCI, V1, DOI [10.3389/neuro.08/001.2007, 10.3389/neuro.08.001.2007]; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107; Zajac DJ, 2006, J SPEECH LANG HEAR R, V49, P1147, DOI 10.1044/1092-4388(2006/082); ZESKIND PS, 1988, CHILD DEV, V59, P193; Zingerevich C, 2009, J INTELL DISABIL RES, V53, P11, DOI 10.1111/j.1365-2788.2008.01107.x	41	54	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44816	10.1371/journal.pone.0044816	http://dx.doi.org/10.1371/journal.pone.0044816			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984567	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700087
J	Torta, DME; Vizzari, V; Castelli, L; Zibetti, M; Lanotte, M; Lopiano, L; Geminiani, G				Torta, Diana M. E.; Vizzari, Vincenzo; Castelli, Lorys; Zibetti, Maurizio; Lanotte, Michele; Lopiano, Leonardo; Geminiani, Giuliano			Impulsivities and Parkinson's Disease: Delay Aversion Is Not Worsened by Deep Brain Stimulation of the Subthalamic Nucleus	PLOS ONE			English	Article							IMPULSE CONTROL; BILATERAL STIMULATION; COGNITIVE FUNCTION; DECISION-MAKING; BASAL GANGLIA; FOLLOW-UP; STN DBS; MEDICATION; LEVODOPA; BEHAVIOR	Deep Brain Stimulation (DBS) of the Subthalamic Nucleus (STN) improves motor symptoms in Parkinson's disease (PD), but can exert detrimental effects on impulsivity. These effects are especially related to the inability to slow down when high-conflict choices have to be made. However, the influence that DBS has on delay aversion is still under-investigated. Here, we tested a group of 21 PD patients on and off stimulation (off medication) by using the Cambridge Gamble Task (CGT), a computerized task that allows the investigation of risk-related behaviours and delay aversion, and psychological questionnaires such as the Barratt Impulsiveness Scale (BIS), the Sensitivity to Punishment and to Reward Questionnaire (SPSRQ), and the Quick Delay Questionnaire (QDQ). We found that delay aversion scores on the CGT were no higher when patients were on stimulation as compared to when they were off stimulation. In contrast, PD patients reported feeling more impulsive in the off stimulation state, as revealed by significantly higher scores on the BIS. Higher scores on the sensitivity to punishment subscale of the SPSRQ highlighted that possible punishments influence patients' behaviours more than possible rewards. Significant correlations between delay aversion scores on the CGT and QDQ delay aversion subscale suggest that these two instruments can be used in synergy to reach a convergent validity. In conclusion, our results show that not all impulsivities are detrimentally affected by DBS of the STN and that the joint use of experimental paradigms and psychological questionnaires can provide useful insights in the study of impulsivity.	[Torta, Diana M. E.; Vizzari, Vincenzo; Castelli, Lorys; Geminiani, Giuliano] Univ Turin, Dept Psychol, Turin, Italy; [Zibetti, Maurizio; Lanotte, Michele; Lopiano, Leonardo] Univ Turin, Dept Neurosci, Turin, Italy	University of Turin; University of Turin	Torta, DME (corresponding author), Univ Turin, Dept Psychol, Turin, Italy.	diana.torta@unito.it	Zibetti, Maurizio/B-6969-2013; Lanotte, Michele M./I-2647-2012; Castelli, Lorys/G-9973-2012	Zibetti, Maurizio/0000-0002-2939-343X; Lanotte, Michele M./0000-0002-4184-028X; Castelli, Lorys/0000-0001-5009-2271; Lopiano, Leonardo/0000-0001-9098-387X; Torta, Diana/0000-0002-3499-3982	'Progetto Alfieri' research grant	'Progetto Alfieri' research grant	This research was funded by a 'Progetto Alfieri' research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzio M, 2011, MOVEMENT DISORDERS; Amanzio M, 2010, BRAIN COGNITION, V72, P337, DOI 10.1016/j.bandc.2009.10.011; Antonelli F, 2011, J NEUROL SCI, V310, P202, DOI 10.1016/j.jns.2011.06.006; Ardouin C, 1999, ANN NEUROL, V46, P217, DOI 10.1002/1531-8249(199908)46:2<217::AID-ANA11>3.0.CO;2-Z; Ardouin C, 2006, MOVEMENT DISORD, V21, P1941, DOI 10.1002/mds.21098; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Ballanger B, 2009, ANN NEUROL, V66, P817, DOI 10.1002/ana.21795; Bandini F, 2007, PARKINSONISM RELAT D, V13, P369, DOI 10.1016/j.parkreldis.2006.07.011; Berlin HA, 2013, WORLD J BIOL PSYCHIA, V14, P121, DOI 10.3109/15622975.2011.560964; Berney A, 2007, MOVEMENT DISORD, V22, P1093, DOI 10.1002/mds.21245; Broen M, 2011, PARKINSONISM RELAT D, V17, P413, DOI 10.1016/j.parkreldis.2011.02.013; Bronstein JM, 2011, ARCH NEUROL-CHICAGO, V68, P165, DOI 10.1001/archneurol.2010.260; Campbell MC, 2008, NEUROPSYCHOLOGIA, V46, P3162, DOI 10.1016/j.neuropsychologia.2008.07.012; Castelli L, 2010, PARKINSONISM RELAT D, V16, P115, DOI 10.1016/j.parkreldis.2009.08.010; Cavanagh JF, 2011, NAT NEUROSCI, V14, P1462, DOI 10.1038/nn.2925; Chabardes S, 2013, WORLD NEUROSURG, V80, DOI 10.1016/j.wneu.2012.03.010; Chamberlain SR, 2007, CURR OPIN PSYCHIATR, V20, P255, DOI 10.1097/yco.0b013e3280ba4989; Clare S, 2010, ADHD-ATTEND DEFICIT, V2, P43, DOI 10.1007/s12402-010-0020-4; Cools R, 2003, NEUROPSYCHOLOGIA, V41, P1431, DOI 10.1016/S0028-3932(03)00117-9; Dujardin K, 2001, J NEUROL, V248, P603, DOI 10.1007/s004150170139; Bermejo PE, 2010, J NEUROL, V257, P1682, DOI 10.1007/s00415-010-5603-7; Evenden JL, 1999, PSYCHOPHARMACOLOGY, V146, P348, DOI 10.1007/PL00005481; Fossati A, 2001, J CLIN PSYCHOL, V57, P815, DOI 10.1002/jclp.1051; Fox SH, 2011, MOVEMENT DISORD, V26, pS2, DOI 10.1002/mds.23829; Frank MJ, 2007, SCIENCE, V318, P1309, DOI 10.1126/science.1146157; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Funkiewiez A, 2003, MOVEMENT DISORD, V18, P524, DOI 10.1002/mds.10441; Funkiewiez A, 2006, MOVEMENT DISORD, V21, P1656, DOI 10.1002/mds.21029; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; Grafen A., 2002, MODERN STAT LIFE SCI; Gray J.A., 1981, MODEL PERSONALITY, P246, DOI DOI 10.1007/978-3-642-67783-0_8; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; HAERTZEN CA, 1963, PSYCHOPHARMACOLOGIA, V4, P155, DOI 10.1007/BF02584088; Halbig TD, 2009, EUR J NEUROL, V16, P493, DOI 10.1111/j.1468-1331.2008.02509.x; Halpern CH, 2009, INT J GERIATR PSYCH, V24, P443, DOI 10.1002/gps.2149; Hershey T, 2004, NEUROLOGY, V62, P1110, DOI 10.1212/01.WNL.0000118202.19098.10; Hershey T, 2010, BRAIN, V133, P3625, DOI 10.1093/brain/awq256; Housden CR, 2010, NEUROPSYCHOPHARMACOL, V35, P2155, DOI 10.1038/npp.2010.84; Inase M, 1999, BRAIN RES, V833, P191, DOI 10.1016/S0006-8993(99)01531-0; Knobel D, 2008, COGN BEHAV NEUROL, V21, P187, DOI 10.1097/WNN.0b013e318185e6e2; Krack P, 2003, NEW ENGL J MED, V349, P1925, DOI 10.1056/NEJMoa035275; Lhommee E, 2012, BRAIN, V135, P1463, DOI 10.1093/brain/aws078; Lim SY, 2009, J CLIN NEUROSCI, V16, P1148, DOI 10.1016/j.jocn.2008.12.010; Limousin P, 1998, NEW ENGL J MED, V339, P1105, DOI 10.1056/NEJM199810153391603; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Meck WH, 2008, CURR OPIN NEUROBIOL, V18, P145, DOI 10.1016/j.conb.2008.08.002; Merchant H, 2008, EXP BRAIN RES, V184, P233, DOI 10.1007/s00221-007-1097-7; Nambu A, 2002, NEUROSCI RES, V43, P111, DOI 10.1016/S0168-0102(02)00027-5; Pattij T, 2008, TRENDS PHARMACOL SCI, V29, P192, DOI 10.1016/j.tips.2008.01.002; Ray NJ, 2009, NEUROPSYCHOLOGIA, V47, P2828, DOI 10.1016/j.neuropsychologia.2009.06.011; Robert G, 2009, MOVEMENT DISORD, V24, P2316, DOI 10.1002/mds.22836; Rodriguez-Oroz MC, 2011, BRAIN, V134, P36, DOI 10.1093/brain/awq301; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Smeding HMM, 2007, J NEUROL NEUROSUR PS, V78, P517, DOI 10.1136/jnnp.2006.102061; Swainson R, 2000, NEUROPSYCHOLOGIA, V38, P596, DOI 10.1016/S0028-3932(99)00103-7; Torrubia R, 2001, PERS INDIV DIFFER, V31, P837, DOI 10.1016/S0191-8869(00)00183-5; Torta DME, 2010, J NEUROL, V257, P1356, DOI 10.1007/s00415-010-5532-5; Torta DME, 2009, BRAIN COGNITION, V71, P84, DOI 10.1016/j.bandc.2009.04.003; Uslaner JM, 2006, EUR J NEUROSCI, V24, P2345, DOI 10.1111/j.1460-9568.2006.05117.x; Volkmann J, 2007, PARKINSONISM RELAT D, V13, pS462, DOI 10.1016/S1353-8020(08)70050-6; Voon V, 2008, BRAIN, V131, P2720, DOI 10.1093/brain/awn214; Wild-Wall N, 2008, NEUROSCI LETT, V442, P34, DOI 10.1016/j.neulet.2008.06.069; Winstanley CA, 2004, NEUROPSYCHOPHARMACOL, V29, P1331, DOI 10.1038/sj.npp.1300434; Winstanley CA, 2005, EUR J NEUROSCI, V21, P3107, DOI 10.1111/j.1460-9568.2005.04143.x; Witjas T, 2005, MOVEMENT DISORD, V20, P1052, DOI 10.1002/mds.20501; Witt K, 2004, ARCH NEUROL-CHICAGO, V61, P697, DOI 10.1001/archneur.61.5.697; Wylie SA, 2010, BRAIN, V133, P3611, DOI 10.1093/brain/awq239	68	12	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43261	10.1371/journal.pone.0043261	http://dx.doi.org/10.1371/journal.pone.0043261			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984415	gold, Green Published, Green Submitted			2022-12-25	WOS:000308638700016
J	Pena, J; Rochat, Y				Pena, Jorge; Rochat, Yannick			Bipartite Graphs as Models of Population Structures in Evolutionary Multiplayer Games	PLOS ONE			English	Article							DIVERSITY PROMOTES; COOPERATION; EMERGENCE; NETWORKS; ORGANIZATION; ALTRUISM; DYNAMICS	By combining evolutionary game theory and graph theory, "games on graphs" study the evolutionary dynamics of frequency-dependent selection in population structures modeled as geographical or social networks. Networks are usually represented by means of unipartite graphs, and social interactions by two-person games such as the famous prisoner's dilemma. Unipartite graphs have also been used for modeling interactions going beyond pairwise interactions. In this paper, we argue that bipartite graphs are a better alternative to unipartite graphs for describing population structures in evolutionary multiplayer games. To illustrate this point, we make use of bipartite graphs to investigate, by means of computer simulations, the evolution of cooperation under the conventional and the distributed N-person prisoner's dilemma. We show that several implicit assumptions arising from the standard approach based on unipartite graphs (such as the definition of replacement neighborhoods, the intertwining of individual and group diversity, and the large overlap of interaction neighborhoods) can have a large impact on the resulting evolutionary dynamics. Our work provides a clear example of the importance of construction procedures in games on graphs, of the suitability of bigraphs and hypergraphs for computational modeling, and of the importance of concepts from social network analysis such as centrality, centralization and bipartite clustering for the understanding of dynamical processes occurring on networked population structures.	[Pena, Jorge; Rochat, Yannick] Univ Lausanne, Fac Social & Polit Sci, Inst Appl Math, Lausanne, Switzerland	University of Lausanne	Pena, J (corresponding author), Univ Basel, Fac Business & Econ, Basel, Switzerland.	jorge.pena@unibas.ch	Peña, Jorge/H-8235-2014; Peña, Jorge/GXI-0458-2022	Peña, Jorge/0000-0002-4137-1823; Rochat, Yannick/0000-0002-9588-9855				Archetti M, 2011, EVOLUTION, V65, P1140, DOI 10.1111/j.1558-5646.2010.01185.x; Assenza S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.017101; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Birmele E, 2009, DISCRETE APPL MATH, V157, P2267, DOI 10.1016/j.dam.2008.06.052; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; Csardi N., 2006, INT J COMP SYST, V1695, P1; Davis G. F., 2003, Strategic Organization, V1, P301, DOI 10.1177/14761270030013002; Fu F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.046707; Gomez-Gardenes J, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/68003; Gomez-Gardenes J, 2011, CHAOS, V21, DOI 10.1063/1.3535579; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Grafen A, 2007, J EVOLUTION BIOL, V20, P2278, DOI 10.1111/j.1420-9101.2007.01413.x; Grafen A, 2008, J THEOR BIOL, V252, P694, DOI 10.1016/j.jtbi.2008.01.021; Guillaume JL, 2006, PHYSICA A, V371, P795, DOI 10.1016/j.physa.2006.04.047; HAMBURGER H, 1973, J MATH SOCIOL, V3, P27, DOI 10.1080/0022250X.1973.9989822; Hamilton WD, 1975, BIOSOCIAL ANTHR, P135; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C., 2003, Complexity, V8, P31, DOI 10.1002/cplx.10092; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Huang ZG, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50008; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Lehmann L, 2007, J EVOLUTION BIOL, V20, P2284, DOI 10.1111/j.1420-9101.2007.01414.x; Lei CA, 2010, PHYSICA A, V389, P4708, DOI 10.1016/j.physa.2010.06.002; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Lubin Y, 2007, ADV STUD BEHAV, V37, P83, DOI 10.1016/S0065-3454(07)37003-4; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; Maynard Smith J., 1982, pi; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Nacher JC, 2011, PHYSICA A, V390, P4636, DOI 10.1016/j.physa.2011.06.073; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak Martin A., 2007, P7; Ohtsuki H, 2007, J THEOR BIOL, V246, P681, DOI 10.1016/j.jtbi.2007.01.024; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000596; PACKER C, 1988, AM NAT, V132, P159, DOI 10.1086/284844; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pena J, 2012, EVOLUTION, V66, P623, DOI 10.1111/j.1558-5646.2011.01504.x; Pena J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016110; Pfeiffer T, 2001, SCIENCE, V292, P504, DOI 10.1126/science.1058079; Pusch A, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.036120; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; Rong ZH, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.027101; Rong ZH, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.047101; Rong ZH, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/30001; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Samuelson PA, 1954, REV ECON STAT, V36, P387, DOI 10.2307/1925895; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, J EVOLUTION BIOL, V19, P726, DOI 10.1111/j.1420-9101.2005.01063.x; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Shi DM, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/58003; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Szabo G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.118101; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Taylor C, 2007, EVOLUTION, V61, P2281, DOI 10.1111/j.1558-5646.2007.00196.x; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Tomassini M, 2007, INT J MOD PHYS C, V18, P1173, DOI 10.1142/S0129183107011212; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Viger F, 2005, EFFICIENT SIMPLE GEN; von Hippel E, 2003, ORGAN SCI, V14, P209, DOI 10.1287/orsc.14.2.209.14992; Wasserman S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yang HX, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.056107; Zhang HF, 2010, PHYSICA A, V389, P1099, DOI 10.1016/j.physa.2009.11.029	76	24	24	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44514	10.1371/journal.pone.0044514	http://dx.doi.org/10.1371/journal.pone.0044514			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970237	Green Published, Green Submitted, gold			2022-12-25	WOS:000308748400020
J	Santos, NDD; de Moura, KS; Napoleao, TH; Santos, GKN; Coelho, LCBB; Navarro, DMDF; Paiva, PMG				de Lima Santos, Nataly Diniz; de Moura, Kezia Santana; Napoleao, Thiago Henrique; Novais Santos, Geanne Karla; Breitenbach Barroso Coelho, Luana Cassandra; do Amaral Ferraz Navarro, Daniela Maria; Guedes Paiva, Patricia Maria			Oviposition-Stimulant and Ovicidal Activities of Moringa oleifera Lectin on Aedes aegypti	PLOS ONE			English	Article							CULEX-QUINQUEFASCIATUS; ANOPHELES-STEPHENSI; DIPTERA-CULICIDAE; MALARIAL VECTOR; ESSENTIAL OILS; MYRACRODRUON-URUNDEUVA; LARVICIDAL ACTIVITY; SEED EXTRACT; LINN.; L.	Background: Natural insecticides against the vector mosquito Aedes aegypti have been the object of research due to their high level of eco-safety. The water-soluble Moringa oleifera lectin (WSMoL) is a larvicidal agent against A. aegypti. This work reports the effects of WSMoL on oviposition and egg hatching of A. aegypti. Methodology/Principal Findings: WSMoL crude preparations (seed extract and 0-60 protein fraction), at 0.1 mg/mL protein concentration, did not affect oviposition, while A. aegypti gravid females laid their eggs preferentially (73%) in vessels containing isolated WSMoL (0.1 mg/mL), compared with vessels containing only distilled water (control). Volatile compounds were not detected in WSMoL preparation. The hatchability of fresh eggs deposited in the solutions in the oviposition assay was evaluated. The numbers of hatched larvae in seed extract, 0-60 protein fraction and WSMoL were 45 +/- 8.7 %, 20 +/- 11 % and 55 +/- 7.5 %, respectively, significantly (p<0.05) lower than in controls containing only distilled water (75-95%). Embryos were visualized inside fresh control eggs, but not within eggs that were laid and maintained in WSMoL solution. Ovicidal activity was also assessed using stored A. aegypti eggs. The protein concentrations able to reduce the hatching rate by 50% (EC50) were 0.32, 0.16 and 0.1 mg/mL for seed extract, 0-60 protein fraction and WSMoL, respectively. The absence of hatching of stored eggs treated with WSMoL at 0.3 mg/mL (EC99) after transfer to medium without lectin indicates that embryos within the eggs were killed by WSMoL. The reduction in hatching rate of A. aegypti was not linked to decrease in bacteria population. Conclusions/Significance: WSMoL acted both as a chemical stimulant cue for ovipositing females and ovicidal agent at a given concentration. The oviposition-stimulant and ovicidal activities, combined with the previously reported larvicidal activity, make WSMoL a very interesting candidate in integrated A. aegypti control.	[de Lima Santos, Nataly Diniz; de Moura, Kezia Santana; Napoleao, Thiago Henrique; Breitenbach Barroso Coelho, Luana Cassandra; Guedes Paiva, Patricia Maria] Univ Fed Pernambuco, Dept Bioquim, Ctr Ciencias Biol, Recife, PE, Brazil; [Novais Santos, Geanne Karla; do Amaral Ferraz Navarro, Daniela Maria] Univ Fed Pernambuco, Ctr Ciencias Exatas & Nat, Dept Quim Fundamental, Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	Santos, NDD (corresponding author), Univ Fed Pernambuco, Dept Bioquim, Ctr Ciencias Biol, Cidade Univ, Recife, PE, Brazil.	ppaivaufpe@yahoo.com.br	Santos, Geanne K N/Q-8702-2016; Navarro, Daniela Maria do Amaral Ferraz/C-4975-2013; Paiva, Patricia Maria Guedes/S-4038-2019; Navarro, Daniela Maria do Amaral Ferraz/GXM-4019-2022; Napoleao, Thiago Henrique/P-2364-2019; Santos, Nataly/AAX-6876-2020	Navarro, Daniela Maria do Amaral Ferraz/0000-0003-0158-7221; Paiva, Patricia Maria Guedes/0000-0003-3467-708X; Napoleao, Thiago Henrique/0000-0002-0065-2602; Santos, Nataly/0000-0001-9155-6773	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco [IBPG-0063.2.08/09, APQ-0653-2.08/10]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (IBPG-0063.2.08/09 to N.D.L.S. and APQ-0653-2.08/10 to P.M.G.P.; www.facepe.br), the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (L.C.B.B.C. and P.M.G.P.; www.cnpq.br), and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (www.capes.gov.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Autran ES, 2009, BIORESOURCE TECHNOL, V100, P2284, DOI 10.1016/j.biortech.2008.10.055; BEEHLER JW, 1994, MED VET ENTOMOL, V8, P381, DOI 10.1111/j.1365-2915.1994.tb00103.x; Benedet F, 2002, P ROY SOC B-BIOL SCI, V269, P1879, DOI 10.1098/rspb.2002.2077; BENTLEY MD, 1979, ENVIRON ENTOMOL, V8, P206, DOI 10.1093/ee/8.2.206; BING DH, 1967, P SOC EXP BIOL MED, V124, P1166; Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010; Boyer S, 2006, CHEMOSPHERE, V65, P721, DOI 10.1016/j.chemosphere.2006.02.032; Chenniappan Kuppusamy, 2008, Entomological Research, V38, P119, DOI 10.1111/j.1748-5967.2008.00147.x; Coelho JS, 2009, CHEMOSPHERE, V77, P934, DOI 10.1016/j.chemosphere.2009.08.022; CONSOLI RAGB, 1989, MEM I OSWALDO CRUZ, V84, P47, DOI 10.1590/S0074-02761989000100009; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Elango G, 2008, PARASITOL RES, V103, P691; Ferreira PMP, 2009, AN ACAD BRAS CIENC, V81, P207, DOI 10.1590/S0001-37652009000200007; Ferreira RS, 2011, LETT APPL MICROBIOL, V53, P186, DOI 10.1111/j.1472-765X.2011.03089.x; FRINGS HUBERT, 1950, JOUR NEW YORK ENT SOC, V58, P133; Govindarajan M, 2008, PARASITOL RES, V102, P289, DOI [10.1007/s00436-007-0761-y, 10.1007/s00436-008-0907-6]; Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P24, DOI 10.1016/S1995-7645(11)60026-6; Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P176, DOI 10.1016/S1995-7645(11)60064-3; GREEN AA, 1955, METHOD ENZYMOL, V1, P67, DOI 10.1016/0076-6879(55)01014-8; Hay F. C., 2002, PRACTICAL IMMUNOLOGY, DOI DOI 10.1002/9780470757475.CH7; HUYTON PM, 1980, PHYSIOL ENTOMOL, V5, P253, DOI 10.1111/j.1365-3032.1980.tb00233.x; Kent U M, 1999, Methods Mol Biol, V115, P11; Lampman RL, 1996, J AM MOSQUITO CONTR, V12, P119; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maheswaran R, 2012, PARASITOL RES, V110, P1801, DOI 10.1007/s00436-011-2702-z; Mandal S, 2010, ASIAN PAC J TROP MED, V3, P605, DOI 10.1016/S1995-7645(10)60147-2; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Moreira MF, 2007, INSECT BIOCHEM MOLEC, V37, P1249, DOI 10.1016/j.ibmb.2007.07.017; MORTENSON EARL W., 1950, MOSQUITO NEWS, V10, P211; Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008; Napoleao TH, 2012, PARASITOL RES, V110, P609, DOI 10.1007/s00436-011-2529-7; Navarro DMAF, 2003, J APPL ENTOMOL, V127, P46, DOI 10.1046/j.1439-0418.2003.00690.x; Paiva P.M., 2010, CURR RES TECHNOL ED, V1, P396; PAIVA PMG, 1992, APPL BIOCHEM BIOTECH, V36, P113, DOI 10.1007/BF02929691; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Ponnusamy L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024409; Ponnusamy L, 2010, J CHEM ECOL, V36, P709, DOI 10.1007/s10886-010-9806-2; Pontual EV, 2012, ARCH INSECT BIOCHEM, V79, P135, DOI 10.1002/arch.21012; Prabhu K., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P124, DOI 10.1016/S2221-1691(11)60009-9; Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007; Ramos MV, 2006, MEM I OSWALDO CRUZ, V101, P503, DOI 10.1590/S0074-02762006000500004; Regnault-Roger C, 2004, BIOPESTICIDAS ORIGEN; Ritchie SA, 2001, J AM MOSQUITO CONTR, V17, P206; Barbosa RMR, 2011, MEM I OSWALDO CRUZ, V106, P451, DOI 10.1590/S0074-02762011000400011; Rodriguez MM, 2007, J AM MOSQUITO CONTR, V23, P420, DOI 10.2987/5588.1; Rolim LADMM, 2011, J FOOD SCI, V76, pT53, DOI 10.1111/j.1750-3841.2010.01990.x; Russell BM, 2001, J MED ENTOMOL, V38, P441, DOI 10.1603/0022-2585-38.3.441; Sa RA, 2009, COMP BIOCHEM PHYS C, V149, P300, DOI 10.1016/j.cbpc.2008.08.004; Samidurai K, 2011, PARASITOL RES, V109, P1107, DOI 10.1007/s00436-011-2353-0; Sanchez-Fortun S, 2005, CHEMOSPHERE, V59, P553, DOI 10.1016/j.chemosphere.2004.12.023; Santos E, 2010, NEOTROP ENTOMOL, V39, P299, DOI 10.1590/S1519-566X2010000200023; Santos GKN, 2012, IND CROP PROD, V40, P254, DOI 10.1016/j.indcrop.2012.03.020; Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018; Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048; TianFu D, 2009, J ZHEJIANG U AGR LIF, V35, P532; Urdaneta-Marquez L, 2011, INFECT GENET EVOL, V11, P253, DOI 10.1016/j.meegid.2010.11.020; Warikoo R, 2011, PARASITOL RES, V109, P1125, DOI 10.1007/s00436-011-2355-y; WHO, 2009, DENG DENG HAEM FEV	58	31	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44840	10.1371/journal.pone.0044840	http://dx.doi.org/10.1371/journal.pone.0044840			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970317	gold, Green Submitted, Green Published			2022-12-25	WOS:000308458400123
J	Maunsell, F; Brown, MB; Powe, J; Ivey, J; Woolard, M; Love, W; Simecka, JW				Maunsell, Fiona; Brown, Mary B.; Powe, Joshua; Ivey, James; Woolard, Matthew; Love, Wees; Simecka, Jerry W.			Oral Inoculation of Young Dairy Calves with Mycoplasma bovis Results in Colonization of Tonsils, Development of Otitis Media and Local Immunity	PLOS ONE			English	Article							VIRAL DIARRHEA VIRUS; RESPIRATORY-TRACT; PASTEURELLA-HAEMOLYTICA; INFECTION; PNEUMONIA; HYORHINIS; DISEASE; CALF; EUSTACHITIS; PATHOGEN	Because M. bovis otitis media is an economically important problem, there is a need to understand the pathogenesis of disease, not only to improve our understanding of the factors contributing to the development of this disease but also to inform the development of improved diagnostic tests and therapy. Oral ingestion of M. bovis-contaminated milk is linked, but not definitively proven, to development of otitis media. In the current study, we demonstrate that oral ingestion of M. bovis infected colostrum can result in an ascending infection and development of otitis media. Importantly, M. bovis was found to have a previously unrecognized tendency for colonization of the tonsils of calves, which most likely contributed to the subsequent development of otitis media. In contrast, transtracheal inoculation failed to produce clinically significant upper respiratory tract disease, although did induce lower respiratory tract disease. The upper respiratory tract was the major site of M. bovis-specific B cell and mucosal IgA responses in calves inoculated by the oral route. The oral inoculation route of infection presented here is particularly suited to the study of host-pathogen interactions during initial colonization of the tonsils, expansion of infection and dissemination to the lower respiratory tract and middle ear. In addition, it could be used to investigate potential new preventative or control strategies, especially those aimed at limiting colonization of the tonsils and/or spread to the middle ear.	[Maunsell, Fiona; Brown, Mary B.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32610 USA; [Powe, Joshua] Millennium Pharmaceut Inc, Cambridge, MA USA; [Ivey, James] Univ Texas SW Med Ctr Dallas, Dept Microbiol & Immunol, Dallas, TX 75390 USA; [Woolard, Matthew] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Shreveport, LA USA; [Love, Wees; Simecka, Jerry W.] Univ N Texas Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX USA	State University System of Florida; University of Florida; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; University of Texas System; University of Texas Southwestern Medical Center Dallas; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of North Texas System; University of North Texas Health Science Center	Maunsell, F (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32610 USA.	jerry.simecka@unthsc.edu	Woolard, Matthew/AAE-1536-2020	Woolard, Matthew/0000-0002-8497-5838	UF Alumni Fellowship; residency in Anatomic Pathology at the UF College of Veterinary Medicine; USDA CREES grant [2002-35204-12362]	UF Alumni Fellowship; residency in Anatomic Pathology at the UF College of Veterinary Medicine; USDA CREES grant	FM was supported by a UF Alumni Fellowship, and JP was supported by a residency in Anatomic Pathology at the UF College of Veterinary Medicine. This work was supported by a USDA CREES grant 2002-35204-12362 to JWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEGBOYE DS, 1995, J VET DIAGN INVEST, V7, P333, DOI 10.1177/104063879500700306; Ayling RD, 2004, VET REC, V155, P413, DOI 10.1136/vr.155.14.413; BENNETT RH, 1977, CORNELL VET, V67, P361; BRYS A, 1989, ARCH EXP VET MED, V43, P677; BRYS A, 1989, ARCH EXP VET MED, V43, P667; Bush TJV, 2003, VET IMMUNOL IMMUNOP, V94, P23, DOI 10.1016/S0165-2427(03)00056-4; Butler JA, 2000, J DAIRY SCI, V83, P2285, DOI 10.3168/jds.S0022-0302(00)75114-9; Cartner SC, 1998, INFECT IMMUN, V66, P3485, DOI 10.1128/IAI.66.8.3485-3491.1998; Francoz D, 2004, CAN VET J, V45, P661; Friis NF, 2002, ACTA VET SCAND, V43, P191; GOURLAY RN, 1989, VET REC, V124, P420, DOI 10.1136/vr.124.16.420; GOURLAY RN, 1985, RES VET SCI, V38, P377, DOI 10.1016/S0034-5288(18)31813-7; Hewicker-Trautwein M, 2002, VET REC, V151, P699; Hodge LM, 2002, J INFECT DIS, V186, P290, DOI 10.1086/341280; HOWARD CJ, 1980, RES VET SCI, V28, P242, DOI 10.1016/S0034-5288(18)32755-3; Jones HP, 2002, J IMMUNOL, V168, P3493, DOI 10.4049/jimmunol.168.7.3493; Lamm CG, 2004, J VET DIAGN INVEST, V16, P397, DOI 10.1177/104063870401600505; LOPEZ A, 1986, AM J VET RES, V47, P1283; Maeda T, 2003, J COMP PATHOL, V129, P100, DOI 10.1016/S0021-9975(03)00009-4; Miles K, 2005, VET MICROBIOL, V107, P301, DOI 10.1016/j.vetmic.2005.02.003; MORITA T, 1995, VET PATHOL, V32, P107, DOI 10.1177/030098589503200202; MORITA T, 1993, J VET MED SCI, V55, P475, DOI 10.1292/jvms.55.475; Morita T, 1999, VET PATHOL, V36, P174, DOI 10.1354/vp.36-2-174; Morita T, 1998, AM J VET RES, V59, P869; Nicholas RAJ, 2002, VACCINE, V20, P3569, DOI 10.1016/S0264-410X(02)00340-7; PFUTZNER H, 1983, ARCH EXP VET MED, V37, P445; RYAN MJ, 1983, VET PATHOL, V20, P472, DOI 10.1177/030098588302000410; Shahriar FM, 2002, CAN VET J, V43, P863; SIMECKA J W, 1989, Regional Immunology, V2, P385; SIMECKA JW, 1987, ISRAEL J MED SCI, V23, P485; Stipkovits L, 2001, VET REC, V148, P399, DOI 10.1136/vr.148.13.399; Stipkovits L, 2000, ACTA VET HUNG, V48, P387, DOI 10.1556/004.48.2000.4.2; Tschopp R, 2001, SCHWEIZ ARCH TIERH, V143, P461; van der Merwe J, 2010, INFECT IMMUN, V78, P4570, DOI 10.1128/IAI.00707-10; Walz PH, 1997, J VET DIAGN INVEST, V9, P250, DOI 10.1177/104063879700900305; Woolard MD, 2004, J IMMUNOL, V172, P6875, DOI 10.4049/jimmunol.172.11.6875	36	39	40	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44523	10.1371/journal.pone.0044523	http://dx.doi.org/10.1371/journal.pone.0044523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970240	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400084
J	Iqbal, M; Ho, HL; Petropoulos, S; Moisiadis, VG; Gibb, W; Matthews, SG				Iqbal, Majid; Ho, Hay Lam; Petropoulos, Sophie; Moisiadis, Vasilis G.; Gibb, William; Matthews, Stephen G.			Pro-Inflammatory Cytokine Regulation of P-glycoprotein in the Developing Blood-Brain Barrier	PLOS ONE			English	Article							NF-KAPPA-B; RESISTANCE PHOSPHOGLYCOPROTEIN ABCB1; NECROSIS-FACTOR-ALPHA; LIPOPOLYSACCHARIDE-INDUCED INFLAMMATION; MDR1 GENE-EXPRESSION; DRUG TRANSPORTERS; DECREASED EXPRESSION; EFFLUX TRANSPORTERS; ADVANCING GESTATION; MEDIATED TRANSPORT	Placental P-glycoprotein (P-gp) acts to protect the developing fetus from exogenous compounds. This protection declines with advancing gestation leaving the fetus and fetal brain vulnerable to these compounds and potential teratogens in maternal circulation. This vulnerability may be more pronounced in pregnancies complicated by infection, which is common during pregnancy. Pro-inflammatory cytokines (released during infection) have been shown to be potent inhibitors of P-gp, but nothing is known regarding their effects at the developing blood-brain barrier (BBB). We hypothesized that P-gp function and expression in endothelial cells of the developing BBB will be inhibited by proinflammatory cytokines. We have derived brain endothelial cell (BEC) cultures from various stages of development of the guinea pig: gestational day (GD) 50, 65 (term similar to 68 days) and postnatal day (PND) 14. Once these cultures reached confluence, BECs were treated with various doses (10(0) - 10(4) pg/mL) of pro-inflammatory cytokines: interleukin-1 beta (IL-1 beta), interleukin-6 (IL-6) or tumor necrosis factor-alpha (TNF-alpha). P-gp function or abcb1 mRNA (encodes P-gp) expression was assessed following treatment. Incubation of GD50 BECs with IL-1 beta, IL-6 or TNF-alpha resulted in no change in P-gp function. GD65 BECs displayed a dose-dependent decrease in function with all cytokines tested; maximal effects at 42%, 65% and 34% with IL-1 beta, IL-6 and TNF-alpha treatment, respectively (P<0.01). Inhibition of P-gp function by IL-1 beta, IL-6 and TNF-alpha was even greater in PND14 BECs; maximal effects at 36% (P<0.01), 84% (P<0.05) and 55% (P<0.01), respectively. Cytokine-induced reductions in P-gp function were associated with decreased abcb1 mRNA expression. These data suggest that BBB P-gp function is increasingly responsive to the inhibitory effects of pro-inflammatory cytokines, with increasing developmental age. Thus, women who experience infection and take prescription medication during pregnancy may expose the developing fetal brain to greater amounts of exogenous compounds - many of which are considered potentially teratogenic.	[Iqbal, Majid; Ho, Hay Lam; Petropoulos, Sophie; Moisiadis, Vasilis G.; Matthews, Stephen G.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Gibb, William] Univ Ottawa, Dept Obstet & Gynecol, Ottawa, ON, Canada; [Gibb, William] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Matthews, Stephen G.] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Matthews, Stephen G.] Univ Toronto, Dept Med, Fac Med, Toronto, ON, Canada	University of Toronto; University of Ottawa; University of Ottawa; University of Toronto; University of Toronto	Iqbal, M (corresponding author), Univ Toronto, Dept Physiol, Toronto, ON, Canada.	majid.iqbal@utoronto.ca	Petropoulos, Sophie/M-3090-2017; Matthews, Stephen/R-5147-2019; Matthews, Stephen G/N-7555-2018; Petropoulos, Sophie/D-6861-2016	Matthews, Stephen/0000-0002-9654-9940; Matthews, Stephen G/0000-0002-9654-9940; Petropoulos, Sophie/0000-0003-2293-8238	Canadian Institutes for Health Research [FRN-57746]; Doctoral Research Award	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Doctoral Research Award	This study was funded by the Canadian Institutes for Health Research, FRN-57746; to WG and SGM and Doctoral Research Award to MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P546, DOI 10.1002/pds.1235; Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; Babic Z, 2009, COLLEGIUM ANTROPOL, V33, P1145; Bauer B, 2007, MOL PHARMACOL, V71, P667, DOI 10.1124/mol.106.029512; Bentires-Alj M, 2003, ONCOGENE, V22, P90, DOI 10.1038/sj.onc.1206056; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Chen YH, 2005, TOXICOLOGY, V211, P242, DOI 10.1016/j.tox.2005.03.011; Davis TME, 2010, FUTURE MICROBIOL, V5, P1599, DOI 10.2217/FMB.10.113; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Dokladny K, 2010, CELL STRESS CHAPERON, V15, P153, DOI 10.1007/s12192-009-0129-6; Ek CJ, 2010, TOXICOL LETT, V197, P51, DOI 10.1016/j.toxlet.2010.04.025; Feng B, 2008, DRUG METAB DISPOS, V36, P268, DOI 10.1124/dmd.107.017434; Finney SJ, 2012, INTENS CARE MED, V38, P324, DOI 10.1007/s00134-011-2444-5; Gao XJ, 2012, PARASITOLOGY, V139, P139, DOI 10.1017/S0031182011001880; Garcia AM, 1999, AM J EPIDEMIOL, V149, P64, DOI 10.1093/oxfordjournals.aje.a009729; Agren J, 2006, SCAND J IMMUNOL, V64, P61, DOI 10.1111/j.1365-3083.2006.01779.x; Hartkoorn RC, 2007, TUBERCULOSIS, V87, P248, DOI 10.1016/j.tube.2006.12.001; Hartmann G, 2001, INT IMMUNOPHARMACOL, V1, P189, DOI 10.1016/S0162-3109(00)00271-X; Hartz AMS, 2006, MOL PHARMACOL, V69, P462, DOI 10.1124/mol.105.017954; Higa JK, 2011, CYTOKINE, V55, P18, DOI 10.1016/j.cyto.2011.02.019; Hilgendorf C, 2000, J PHARM SCI-US, V89, P63, DOI 10.1002/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6; IKEGUCHI M, 1991, DNA CELL BIOL, V10, P639, DOI 10.1089/dna.1991.10.639; Iqbal M, 2012, PLACENTA, V33, P137, DOI 10.1016/j.placenta.2012.01.008; Iqbal M, 2011, ENDOCRINOLOGY, V152, P1067, DOI 10.1210/en.2010-1227; Irvine L, 2010, DRUG SAFETY, V33, P593, DOI 10.2165/11532330-000000000-00000; Kalabis GM, 2005, BIOL REPROD, V73, P591, DOI 10.1095/biolreprod.105.042242; Kalabis GM, 2009, CAN J PHYSIOL PHARM, V87, P973, DOI [10.1139/Y09-087, 10.1139/y09-087]; Kalitsky-Szirtes J, 2004, DRUG METAB DISPOS, V32, P20, DOI 10.1124/dmd.32.1.20; Kapoor A, 2008, BRAIN RES REV, V57, P586, DOI 10.1016/j.brainresrev.2007.06.013; Khalaf H, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-26; Kim-Fine S, 2012, J MATERN FETAL NEONA; Kuo MT, 2002, ONCOGENE, V21, P1945, DOI 10.1038/sj.onc.1205117; Lacroix I, 2000, LANCET, V356, P1735, DOI 10.1016/S0140-6736(00)03209-8; Lagas JS, 2009, MOL INTERV, V9, P136, DOI 10.1124/mi.9.3.7; Lamont RF, 2005, BJOG-INT J OBSTET GY, V112, P67, DOI 10.1111/j.1471-0528.2005.00589.x; Lee E, 2006, PHARMACOEPIDEM DR S, V15, P537, DOI 10.1002/pds.1241; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Loffredo CA, 2001, AM J EPIDEMIOL, V153, P529, DOI 10.1093/aje/153.6.529; Mackenzie R, 2006, AM J OBSTET GYNECOL, V194, P1234, DOI 10.1016/j.ajog.2005.06.049; Malm H, 2004, DRUG SAFETY, V27, P899, DOI 10.2165/00002018-200427120-00006; Marino T, 2010, VIRAL INFECT PREGNAN; McRae MP, 2003, DRUG METAB REV, V35, P19, DOI 10.1081/DMR-120018247; Nezic L, 2009, GEN PHYSIOL BIOPHYS, V28, P119; Nwaozuzu OM, 2003, J NEUROCHEM, V87, P1043, DOI 10.1046/j.1471-4159.2003.02061.x; Pedroza M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022667; Petropoulos S, 2007, REPROD SCI, V14, P321, DOI 10.1177/1933719107303856; Petropoulos S, 2010, BRAIN RES, V1357, P9, DOI 10.1016/j.brainres.2010.08.016; Petrovic V, 2010, DRUG METAB DISPOS, V38, P1760, DOI 10.1124/dmd.110.034470; Piquette-Miller M, 1998, PHARMACEUT RES, V15, P706, DOI 10.1023/A:1011962818051; Poller B, 2010, CELL MOL NEUROBIOL, V30, P63, DOI 10.1007/s10571-009-9431-1; Rahmat D, 2012, INT J PHARMACEUT, V422, P40, DOI 10.1016/j.ijpharm.2011.10.024; Regidor E, 2004, OCCUP ENVIRON MED, V61, P334, DOI 10.1136/oem.2003.009043; Romero Roberto, 2002, Semin Neonatol, V7, P259, DOI 10.1053/siny.2002.0121; Schumacher U, 1997, HISTOCHEM CELL BIOL, V108, P179, DOI 10.1007/s004180050159; Scotto KW, 2003, ONCOGENE, V22, P7496, DOI 10.1038/sj.onc.1206950; Shaw SY, 2008, P NATL ACAD SCI USA, V105, P7387, DOI 10.1073/pnas.0802878105; Simhan HN, 2007, NEW ENGL J MED, V357, P477, DOI 10.1056/NEJMra050435; Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0; Sukhai M, 2001, INFLAMM RES, V50, P362, DOI 10.1007/PL00000257; Sukhai Mahadeo, 2000, Molecular Cell Biology Research Communications, V4, P248, DOI 10.1006/mcbr.2001.0288; Sun M, 2006, PLACENTA, V27, P602, DOI 10.1016/j.placenta.2005.05.007; Thevenod F, 2000, J BIOL CHEM, V275, P1887, DOI 10.1074/jbc.275.3.1887; Trickler WJ, 2005, BRAIN RES, V1048, P24, DOI 10.1016/j.brainres.2005.04.028; VANKALKEN CK, 1992, AM J PATHOL, V141, P1063; Viale M, 2011, INVEST NEW DRUG, V29, P98, DOI 10.1007/s10637-009-9340-7; Virgintino D, 2008, J NEUROPATH EXP NEUR, V67, P50, DOI 10.1097/nen.0b013e31815f65d9; von Wedel-Parlow M, 2009, J NEUROCHEM, V111, P111, DOI 10.1111/j.1471-4159.2009.06305.x; Wang JH, 2005, J NUCL MED, V46, P1537; Wang XY, 2006, SEMIN FETAL NEONAT M, V11, P343, DOI 10.1016/j.siny.2006.04.002; Weidler M, 2000, BIOCHEM BIOPH RES CO, V276, P447, DOI 10.1006/bbrc.2000.3499; Weiss J, 2003, J PHARMACOL EXP THER, V305, P197, DOI 10.1124/jpet.102.046532; Yun HC, 2010, BACTERIAL INFECT PRE; Zhang WD, 2003, FASEB J, V17, P2085, DOI 10.1096/fj.02-1131fje; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 	75	37	38	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 13	2012	7	8							e43022	10.1371/journal.pone.0043022	http://dx.doi.org/10.1371/journal.pone.0043022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	988OJ	22973436	Green Submitted, gold, Green Published			2022-12-25	WOS:000307500100052
J	Kulczyk, AW; Akabayov, B; Lee, SJ; Bostina, M; Berkowitz, SA; Richardson, CC				Kulczyk, Arkadiusz W.; Akabayov, Barak; Lee, Seung-Joo; Bostina, Mihnea; Berkowitz, Steven A.; Richardson, Charles C.			An Interaction between DNA Polymerase and Helicase Is Essential for the High Processivity of the Bacteriophage T7 Replisome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN BINDS DNA; CRYSTAL-STRUCTURE; REPLICATION FORK; GENE-4 PROTEIN; PRIMASE; COMPLEX; MECHANISM; DOMAIN; HYDROLYSIS	Synthesis of the leading DNA strand requires the coordinated activity of DNA polymerase and DNA helicase, whereas synthesis of the lagging strand involves interactions of these proteins with DNA primase. We present the first structural model of a bacteriophage T7 DNA helicase-DNA polymerase complex using a combination of small angle x-ray scattering, single-molecule, and biochemical methods. We propose that the protein-protein interface stabilizing the leading strand synthesis involves two distinct interactions: a stable binding of the helicase to the palm domain of the polymerase and an electrostatic binding of the carboxyl-terminal tail of the helicase to a basic patch on the polymerase. DNA primase facilitates binding of DNA helicase to ssDNA and contributes to formation of the DNA helicase-DNA polymerase complex by stabilizing DNA helicase.	[Kulczyk, Arkadiusz W.; Akabayov, Barak; Lee, Seung-Joo; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Bostina, Mihnea] McGill Univ, Facil Electron Microscopy Res, Montreal, PQ H3A 2B2, Canada; [Berkowitz, Steven A.] Biogen Idec Inc, Cambridge, MA 02142 USA	Harvard University; Harvard Medical School; McGill University; Biogen	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu	Akabayov, Barak/Y-5786-2019	Akabayov, Barak/0000-0002-3882-2742; Bostina, Mihnea/0000-0003-3621-3772	National Institutes of Health [GM-54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-54397 (to C. C. R.).	Ahnert P, 2000, EMBO J, V19, P3418, DOI 10.1093/emboj/19.13.3418; Akabayov B, 2010, P NATL ACAD SCI USA, V107, P15033, DOI 10.1073/pnas.1010141107; Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; BERNSTEIN JA, 1988, P NATL ACAD SCI USA, V85, P396, DOI 10.1073/pnas.85.2.396; Bird LE, 2000, BIOCHEMISTRY-US, V39, P171, DOI 10.1021/bi9918801; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; HUBER HE, 1987, J BIOL CHEM, V262, P16224; Johnson DE, 2007, P NATL ACAD SCI USA, V104, P5312, DOI 10.1073/pnas.0701062104; Kato M, 2004, J BIOL CHEM, V279, P30554, DOI 10.1074/jbc.M403485200; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; Komori K, 2000, J BIOL CHEM, V275, P33791, DOI 10.1074/jbc.M004556200; Kulczyk A. W., 2010, J VIS EXP, V23, P37; Kulczyk AW, 2012, P NATL ACAD SCI USA, V109, P9408, DOI 10.1073/pnas.1207033109; Lasker K, 2010, PROTEINS, V78, P3205, DOI 10.1002/prot.22845; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lipfert J, 2007, J MOL BIOL, V365, P1393, DOI 10.1016/j.jmb.2006.10.022; Loparo JJ, 2011, P NATL ACAD SCI USA, V108, P3584, DOI 10.1073/pnas.1018824108; MATSON SW, 1983, J BIOL CHEM, V258, P4017; Notarnicola SM, 1997, J BIOL CHEM, V272, P18425, DOI 10.1074/jbc.272.29.18425; NOTARNICOLA SM, 1993, J BIOL CHEM, V268, P27198; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Okorokov AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008586; Passy SI, 1999, P NATL ACAD SCI USA, V96, P10684, DOI 10.1073/pnas.96.19.10684; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; ROMANO LJ, 1979, J BIOL CHEM, V254, P483; Satapathy AK, 2011, J BIOL CHEM, V286, P34468, DOI 10.1074/jbc.M111.283796; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shin DS, 2003, EMBO J, V22, P4566, DOI 10.1093/emboj/cdg429; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; TABOR S, 1987, J BIOL CHEM, V262, P16212; Toth EA, 2003, MOL CELL, V12, P1113, DOI 10.1016/S1097-2765(03)00442-8; Yang SX, 2001, J MOL BIOL, V314, P1077, DOI 10.1006/jmbi.2000.5213; Yu X, 1997, NAT STRUCT BIOL, V4, P101, DOI 10.1038/nsb0297-101; Zhang HD, 2011, P NATL ACAD SCI USA, V108, P9372, DOI 10.1073/pnas.1106678108	45	21	22	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					39050	39060		10.1074/jbc.M112.410647	http://dx.doi.org/10.1074/jbc.M112.410647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22977246	Green Published, hybrid			2022-12-25	WOS:000310982800061
J	Dollezal, LV; Beutelmann, R; Klump, GM				Dollezal, Lena-Vanessa; Beutelmann, Rainer; Klump, Georg M.			Stream Segregation in the Perception of Sinusoidally Amplitude-Modulated Tones	PLOS ONE			English	Article							SONGBIRD FOREBRAIN; AUDITORY-CORTEX; MODEL STRUCTURE; TIME INTERVALS; SPECTRAL CUES; FREQUENCY; SEQUENCES; CARRIERS; MASKING; NOISE	Amplitude modulation can serve as a cue for segregating streams of sounds from different sources. Here we evaluate stream segregation in humans using ABA-sequences of sinusoidally amplitude modulated (SAM) tones. A and B represent SAM tones with the same carrier frequency (1000, 4000 Hz) and modulation depth (30, 100%). The modulation frequency of the A signals (f(modA)) was 30, 100 or 300 Hz, respectively. The modulation frequency of the B signals was up to four octaves higher (Delta f(mod)). Three different ABA-tone patterns varying in tone duration and stimulus onset asynchrony were presented to evaluate the effect of forward suppression. Subjects indicated their 1- or 2-stream percept on a touch screen at the end of each ABA-sequence (presentation time 5 or 15 s). Tone pattern, f(modA), Delta f(mod), carrier frequency, modulation depth and presentation time significantly affected the percentage of a 2-stream percept. The human psychophysical results are compared to responses of avian forebrain neurons evoked by different ABA-SAM tone conditions [1] that were broadly overlapping those of the present study. The neurons also showed significant effects of tone pattern and Delta f(mod) that were comparable to effects observed in the present psychophysical study. Depending on the carrier frequency, modulation frequency, modulation depth and the width of the auditory filters, SAM tones may provide mainly temporal cues (sidebands fall within the range of the filter), spectral cues (sidebands fall outside the range of the filter) or possibly both. A computational model based on excitation pattern differences was used to predict the 50% threshold of 2-stream responses. In conditions for which the model predicts a considerably larger 50% threshold of 2-stream responses (i.e., larger Delta f(mod) at threshold) than was observed, it is unlikely that spectral cues can provide an explanation of stream segregation by SAM.	[Dollezal, Lena-Vanessa; Beutelmann, Rainer; Klump, Georg M.] Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, Anim Physiol & Behav Grp, D-2900 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg	Dollezal, LV (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, Anim Physiol & Behav Grp, D-2900 Oldenburg, Germany.	lena.vanessa.dollezal@uni-oldenburg.de		Beutelmann, Rainer/0000-0001-9708-4113	Deutsche Forschungsgemeinschaft [SFB TRR 31, GRK 591]; Georg Christoph Lichtenberg stipend of the country of Lower Saxony	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Georg Christoph Lichtenberg stipend of the country of Lower Saxony	This research was supported by the Deutsche Forschungsgemeinschaft (SFB TRR 31, GRK 591) and by a Georg Christoph Lichtenberg stipend of the country of Lower Saxony to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSTIS S, 1985, J EXP PSYCHOL HUMAN, V11, P257, DOI 10.1037/0096-1523.11.3.257; Beauvois MW, 1996, J ACOUST SOC AM, V99, P2270, DOI 10.1121/1.415414; Beauvois MW, 1998, PERCEPT PSYCHOPHYS, V60, P852, DOI 10.3758/BF03206068; Bee MA, 2005, BRAIN BEHAV EVOLUT, V66, P197, DOI 10.1159/000087854; Bee MA, 2004, J NEUROPHYSIOL, V92, P1088, DOI 10.1152/jn.00884.2003; Bee MA, 2010, J COMP PHYSIOL A, V196, P543, DOI 10.1007/s00359-010-0542-4; Breebaart J, 2001, J ACOUST SOC AM, V110, P1074, DOI 10.1121/1.1383297; Bregman A.S., 1990, AUDITORY SCENE ANAL; BREGMAN AS, 1978, J EXP PSYCHOL HUMAN, V4, P380, DOI 10.1037/0096-1523.4.3.380; Bregman AS, 2000, PERCEPT PSYCHOPHYS, V62, P626, DOI 10.3758/BF03212114; Cusack R, 1999, PERCEPTION, V28, P1281, DOI 10.1068/p2804; Dau T, 1996, J ACOUST SOC AM, V99, P3615, DOI 10.1121/1.414959; Dau T, 1997, J ACOUST SOC AM, V102, P2892, DOI 10.1121/1.420344; Fishman YI, 2004, J ACOUST SOC AM, V116, P1656, DOI 10.1121/1.1778903; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Grimault N, 2002, J ACOUST SOC AM, V111, P1340, DOI 10.1121/1.1452740; Gutschalk A, 2007, J NEUROSCI, V27, P13074, DOI 10.1523/JNEUROSCI.2299-07.2007; HARTMANN WM, 1991, MUSIC PERCEPT, V9, P155; HAUSER R, 1991, J ACOUST SOC AM, V89, P280, DOI 10.1121/1.400511; Hohmann V, 2002, ACTA ACUST UNITED AC, V88, P433; Itatani N, 2011, J NEUROPHYSIOL, V105, P188, DOI 10.1152/jn.00496.2010; Itatani N, 2009, J NEUROPHYSIOL, V101, P3212, DOI 10.1152/jn.91333.2008; Klump Georg, 2000, P193, DOI 10.1002/9783527609734.ch7; Kohlrausch A, 2000, J ACOUST SOC AM, V108, P723, DOI 10.1121/1.429605; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; Micheyl C, 2007, HEARING RES, V229, P116, DOI 10.1016/j.heares.2007.01.007; Moore BCJ, 2002, ACTA ACUST UNITED AC, V88, P320; MOORE BCJ, 1983, J ACOUST SOC AM, V73, P1249, DOI 10.1121/1.389273; MOORE BCJ, 1983, J ACOUST SOC AM, V74, P750, DOI 10.1121/1.389861; Moore BCJ, 2001, J ACOUST SOC AM, V110, P1067, DOI 10.1121/1.1385177; Roberts B, 2002, J ACOUST SOC AM, V112, P2074, DOI 10.1121/1.1508784; Strickland EA, 1997, J ACOUST SOC AM, V102, P1799, DOI 10.1121/1.419617; van Noorden L.P.A.S., 1975, TEMPORAL COHERENCE P; Vliegen J, 1999, J ACOUST SOC AM, V105, P339, DOI 10.1121/1.424503; Wiegrebe L, 1999, J ACOUST SOC AM, V106, P2709, DOI 10.1121/1.428099; Wilson EC, 2007, J NEUROPHYSIOL, V97, P2230, DOI 10.1152/jn.00788.2006; Wojtczak M, 2005, J ACOUST SOC AM, V118, P3198, DOI 10.1121/1.2042970; Wojtczak M, 2011, JARO-J ASSOC RES OTO, V12, P361, DOI 10.1007/s10162-010-0251-2	39	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43615	10.1371/journal.pone.0043615	http://dx.doi.org/10.1371/journal.pone.0043615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984436	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500019
J	Gutierrez, PS; Monteoliva, D; Diambra, L				Gutierrez, Pablo S.; Monteoliva, Diana; Diambra, Luis			Cooperative Binding of Transcription Factors Promotes Bimodal Gene Expression Response	PLOS ONE			English	Article							ESCHERICHIA-COLI; DNA RECOGNITION; NOISE; CELL; STOCHASTICITY; MECHANISM; NETWORKS; BINARY; DIFFERENTIATION; CONSEQUENCES	In the present work we extend and analyze the scope of our recently proposed stochastic model for transcriptional regulation, which considers an arbitrarily complex cis-regulatory system using only elementary reactions. Previously, we determined the role of cooperativity on the intrinsic fluctuations of gene expression for activating transcriptional switches, by means of master equation formalism and computer simulation. This model allowed us to distinguish between two cooperative binding mechanisms and, even though the mean expression levels were not affected differently by the acting mechanism, we showed that the associated fluctuations were different. In the present generalized model we include other regulatory functions in addition to those associated to an activator switch. Namely, we introduce repressive regulatory functions and two theoretical mechanisms that account for the biphasic response that some cis-regulatory systems show to the transcription factor concentration. We have also extended our previous master equation formalism in order to include protein production by stochastic translation of mRNA. Furthermore, we examine the graded/binary scenarios in the context of the interaction energy between transcription factors. In this sense, this is the first report to show that the cooperative binding of transcription factors to DNA promotes the "all-or-none" phenomenon observed in eukaryotic systems. In addition, we confirm that gene expression fluctuation levels associated with one of two cooperative binding mechanism never exceed the fluctuation levels of the other.	[Gutierrez, Pablo S.; Diambra, Luis] Univ Nacl La Plata, Ctr Reg Estudios Genm, Buenos Aires, DF, Argentina; [Monteoliva, Diana] Univ Nacl La Plata, Inst Fis, Buenos Aires, DF, Argentina	National University of La Plata; National University of La Plata	Gutierrez, PS (corresponding author), Univ Nacl La Plata, Ctr Reg Estudios Genm, Buenos Aires, DF, Argentina.	ldiambra@gmail.com	L, Diambra/F-6319-2015	L, Diambra/0000-0001-8052-4880				Abeliovich H, 2005, BIOPHYS J, V89, P76, DOI 10.1529/biophysj.105.060194; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; ACKERS GK, 1982, P NATL ACAD SCI-BIOL, V79, P1129, DOI 10.1073/pnas.79.4.1129; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Biggar SR, 2001, EMBO J, V20, P3167, DOI 10.1093/emboj/20.12.3167; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Buetti-Dinh A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.61; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Dellarole M, 2010, BIOCHEMISTRY-US, V49, P10277, DOI 10.1021/bi1014908; Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Ferreiro DU, 2008, P NATL ACAD SCI USA, V105, P10797, DOI 10.1073/pnas.0802383105; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Fiering S, 2000, BIOESSAYS, V22, P381, DOI 10.1002/(SICI)1521-1878(200004)22:4<381::AID-BIES8>3.0.CO;2-E; Freedman JA, 2009, ONCOGENE, V28, P2873, DOI 10.1038/onc.2009.153; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gaston K, 2003, CELL MOL LIFE SCI, V60, P721, DOI 10.1007/s00018-003-2260-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gutierrez PS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011914; Hill T. L., 1985, COOPERATIVITY THEORY; Hofer Thomas, 2005, Genome Inform, V16, P73; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; LI LH, 1994, EMBO J, V13, P4070, DOI 10.1002/j.1460-2075.1994.tb06724.x; Mugler A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041921; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; NEGULESCU PA, 1994, P NATL ACAD SCI USA, V91, P2873, DOI 10.1073/pnas.91.7.2873; Ochab-Marcinek A, 2010, P NATL ACAD SCI USA, V107, P22096, DOI 10.1073/pnas.1008965107; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Pirone JR, 2004, J THEOR BIOL, V226, P111, DOI 10.1016/j.jtbi.2003.08.008; PTASHNE M, 2002, GENES SIGNALS; PTASHNE M, 2004, GENETIC SWITCH; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rossi FMV, 2000, MOL CELL, V6, P723, DOI 10.1016/S1097-2765(00)00070-8; Sanchez A, 2008, P NATL ACAD SCI USA, V105, P5081, DOI 10.1073/pnas.0707904105; Sanchez A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001100; Sasai M, 2003, P NATL ACAD SCI USA, V100, P2374, DOI 10.1073/pnas.2627987100; SAUER F, 1993, NATURE, V364, P454, DOI 10.1038/364454a0; Shahrezaei V, 2008, P NATL ACAD SCI USA, V105, P17256, DOI 10.1073/pnas.0803850105; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Shu CC, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002140; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Soto-Nieves N, 2009, J EXP MED, V206, P867, DOI 10.1084/jem.20082731; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Walczak AM, 2009, P NATL ACAD SCI USA, V106, P6529, DOI 10.1073/pnas.0811999106; WALTERS MC, 1995, P NATL ACAD SCI USA, V92, P7125, DOI 10.1073/pnas.92.15.7125; Weiss JN, 1997, FASEB J, V11, P835, DOI 10.1096/fasebj.11.11.9285481; Wilhelm T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-90; Wong JV, 2011, MOL CELL, V41, P275, DOI 10.1016/j.molcel.2011.01.014; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84	58	26	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44812	10.1371/journal.pone.0044812	http://dx.doi.org/10.1371/journal.pone.0044812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984566	Green Submitted, gold, Green Published			2022-12-25	WOS:000308738500088
J	Koval, AP; Gogolevskaya, IK; Tatosyan, KA; Kramerov, DA				Koval, Anastasia P.; Gogolevskaya, Irina K.; Tatosyan, Karina A.; Kramerov, Dmitri A.			Complementarity of End Regions Increases the Lifetime of Small RNAs in Mammalian Cells	PLOS ONE			English	Article							AU-RICH ELEMENTS; NEURAL BC1 RNA; POLYMERASE-III; 5'-FLANKING SEQUENCES; EVOLUTIONARY HISTORY; NUCLEOTIDE-SEQUENCES; GENE-TRANSCRIPTION; NONCODING RNAS; MESSENGER-RNAS; NEURONAL BC1	Two RNAs (4.5SH and 4.5SI) with unknown functions share a number of features: short length (about 100 nt), transcription by RNA polymerase III, predominately nuclear localization, the presence in various tissues, and relatively narrow taxonomic distribution (4 and 3 rodent families, respectively). It was reported that 4.5SH RNA turns over rapidly, whereas 4.5SI RNA is stable in the cell, but their lifetimes remained unknown. We showed that 4.5SH is indeed short-lived (t(1/2)similar to 18 min) and 4.5SI is long-lived (t(1/2)similar to 22 h) in Krebs ascites carcinoma cells. The RNA structures specifying rapid or slow decay of different small cellular RNAs remain unstudied. We searched for RNA structural features that determine the short lifetime of 4.5SH in comparison with the long lifetime of 4.5SI RNA. The sequences of genes of 4.5SH and 4.5SI RNAs were altered and human cells (HeLa) were transfected with these genes. The decay rate of the original and altered RNAs was measured. The complementarity of 16-nt end regions of 4.5SI RNA proved to contribute to its stability in cells, whereas the lack of such complementarity in 4.5SH RNA caused its rapid decay. Possible mechanisms of the phenomenon are discussed.	[Koval, Anastasia P.; Gogolevskaya, Irina K.; Tatosyan, Karina A.; Kramerov, Dmitri A.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Koval, AP (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	kramerov@eimb.ru	Koval, Anastasia/AAB-5984-2020; Kramerov, Dmitri A/B-2108-2018	Kramerov, Dmitri A/0000-0002-9877-7103; Koval, Anastasia/0000-0002-6228-4622; Tatosyan, Karina/0000-0001-8171-6294	Russian Academy of Sciences; Russian Foundation for Basic Research [11-04-00439]	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	The study was supported by the program "Molecular and Cell Biology" of the Russian Academy of Sciences and Russian Foundation for Basic Research (www.rfbr.ru; grant 11-04-00439). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bail S, 2010, RNA, V16, P1032, DOI 10.1261/rna.1851510; Borodulina OR, 2008, RNA, V14, P1865, DOI 10.1261/rna.1006608; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chernyakov I, 2008, GENE DEV, V22, P1369, DOI 10.1101/gad.1654308; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; DECHIARA TM, 1987, P NATL ACAD SCI USA, V84, P2624, DOI 10.1073/pnas.84.9.2624; Diribarne G, 2009, RNA BIOL, V6, P122, DOI 10.4161/rna.6.2.8115; Fierro-Monti I, 2000, TRENDS BIOCHEM SCI, V25, P241, DOI 10.1016/S0968-0004(00)01580-2; Franks TM, 2007, GENE DEV, V21, P719, DOI 10.1101/gad.1494707; Gogolevskaya IK, 2005, MOL BIOL EVOL, V22, P1546, DOI 10.1093/molbev/msi140; Gogolevskaya IK, 2002, J MOL EVOL, V54, P354, DOI 10.1007/s00239-001-0050-9; Gogolevskaya IK, 2010, GENE, V460, P30, DOI 10.1016/j.gene.2010.04.002; Gogolevskaya IK, 2010, GENE, V451, P32, DOI 10.1016/j.gene.2009.11.007; HARADA F, 1979, NUCLEIC ACIDS RES, V7, P909, DOI 10.1093/nar/7.4.909; HARADA F, 1980, NUCLEIC ACIDS RES, V8, P1273, DOI 10.1093/nar/8.6.1273; Jones CI, 2012, WILEY INTERDISCIP RE; KIM JM, 1994, P NATL ACAD SCI USA, V91, P3607, DOI 10.1073/pnas.91.9.3607; Koval AP, 2009, GENE, V446, P75, DOI 10.1016/j.gene.2009.07.005; Kramerov DA, 2011, WIRES RNA, V2, P772, DOI 10.1002/wrna.91; Krude T, 2010, SUBCELL BIOCHEM, V50, P105, DOI 10.1007/978-90-481-3471-7_6; LABUDA D, 1994, J MOL EVOL, V39, P506; LEE SY, 1990, BIOTECHNIQUES, V9, P676; Lin D, 2008, MOL CELL BIOL, V28, P3008, DOI 10.1128/MCB.01800-07; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Makarova Iu A, 2007, Mol Biol (Mosk), V41, P246; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P9698, DOI 10.1073/pnas.90.20.9698; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Muddashetty RS, 2002, J MOL BIOL, V321, P433, DOI 10.1016/S0022-2836(02)00655-1; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Parrott AM, 2007, NUCLEIC ACIDS RES, V35, P6249, DOI 10.1093/nar/gkm668; Parrott AM, 2011, NUCLEIC ACIDS RES, V39, P1485, DOI 10.1093/nar/gkq856; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; QUENTIN Y, 1994, GENETICA, V93, P203, DOI 10.1007/BF01435252; Ro-Choi T.S., 1974, CELL NUCLEUS, P151; ROCHOI TS, 1972, J BIOL CHEM, V247, P3205; Rozhdestvensky TS, 2001, RNA, V7, P722, DOI 10.1017/S1355838201002485; Saunders LR, 2003, FASEB J, V17, P961, DOI 10.1096/fj.02-0958rev; SCHOENIGER LO, 1986, MOL CELL BIOL, V6, P1508, DOI 10.1128/MCB.6.5.1508; Serdobova IM, 1998, J MOL EVOL, V46, P202, DOI 10.1007/PL00006295; WEINBERG RA, 1968, J MOL BIOL, V38, P289, DOI 10.1016/0022-2836(68)90387-2; Wilusz JE, 2011, SCIENCE, V334, P817, DOI 10.1126/science.1213671; YUSHOK W. D., 1956, JOUR FRANKLIN INST, V262, P507, DOI 10.1016/0016-0032(56)90688-3; ZIEVE G, 1976, CELL, V8, P19, DOI 10.1016/0092-8674(76)90181-1; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44157	10.1371/journal.pone.0044157	http://dx.doi.org/10.1371/journal.pone.0044157			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984470	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500033
J	van Wietmarschen, HA; Dai, WD; van der Kooij, AJ; Reijmers, TH; Schroen, Y; Wang, M; Xu, ZL; Wang, XC; Kong, HW; Xu, GW; Hankemeier, T; Meulman, JJ; van der Greef, J				van Wietmarschen, Herman A.; Dai, Weidong; van der Kooij, Anita J.; Reijmers, Theo H.; Schroen, Yan; Wang, Mei; Xu, Zhiliang; Wang, Xinchang; Kong, Hongwei; Xu, Guowang; Hankemeier, Thomas; Meulman, Jacqueline J.; van der Greef, Jan			Characterization of Rheumatoid Arthritis Subtypes Using Symptom Profiles, Clinical Chemistry and Metabolomics Measurements	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; PRINCIPAL-COMPONENTS-ANALYSIS; MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; DISEASE-ACTIVITY; ACYLCARNITINES; SYSTEMS; CLASSIFICATION; METABONOMICS; STRATEGY	Objective: The aim is to characterize subgroups or phenotypes of rheumatoid arthritis (RA) patients using a systems biology approach. The discovery of subtypes of rheumatoid arthritis patients is an essential research area for the improvement of response to therapy and the development of personalized medicine strategies. Methods: In this study, 39 RA patients are phenotyped using clinical chemistry measurements, urine and plasma metabolomics analysis and symptom profiles. In addition, a Chinese medicine expert classified each RA patient as a Cold or Heat type according to Chinese medicine theory. Multivariate data analysis techniques are employed to detect and validate biochemical and symptom relationships with the classification. Results: The questionnaire items 'Red joints', 'Swollen joints', 'Warm joints' suggest differences in the level of inflammation between the groups although c-reactive protein (CRP) and rheumatoid factor (RHF) levels were equal. Multivariate analysis of the urine metabolomics data revealed that the levels of 11 acylcarnitines were lower in the Cold RA than in the Heat RA patients, suggesting differences in muscle breakdown. Additionally, higher dehydroepiandrosterone sulfate (DHEAS) levels in Heat patients compared to Cold patients were found suggesting that the Cold RA group has a more suppressed hypothalamic-pituitary-adrenal (HPA) axis function. Conclusion: Significant and relevant biochemical differences are found between Cold and Heat RA patients. Differences in immune function, HPA axis involvement and muscle breakdown point towards opportunities to tailor disease management strategies to each of the subgroups RA patient.	[van Wietmarschen, Herman A.; Reijmers, Theo H.; Hankemeier, Thomas; van der Greef, Jan] Leiden Univ, LACDR, Div Analyt Biosci, Leiden, Netherlands; [van Wietmarschen, Herman A.; Schroen, Yan; Wang, Mei; van der Greef, Jan] Sino Dutch Ctr Prevent & Personalized Med, Zeist, Netherlands; [Dai, Weidong; Kong, Hongwei; Xu, Guowang] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [van der Kooij, Anita J.; Meulman, Jacqueline J.] Leiden Univ, Inst Math, NL-2300 RA Leiden, Netherlands; [Reijmers, Theo H.; Hankemeier, Thomas] Leiden Univ, Netherlands Metabol Ctr, Leiden, Netherlands; [Schroen, Yan] Oxrider, Educ & Res, Nieuwegein, Netherlands; [Wang, Mei; van der Greef, Jan] SU BioMed, Utrechtseweg, Zeist, Netherlands; [Xu, Zhiliang] Coll Life Sci Co Ltd, Hangzhou, Zhejiang, Peoples R China; [Wang, Xinchang] Zhejiang Xinhua Hosp, Dept Rheumatol & Immunol, Hangzhou, Zhejiang, Peoples R China; [van der Greef, Jan] TNO Pharma, TNO Netherlands Org Appl Sci Res, Zeist, Netherlands	Leiden University; Leiden University - Excl LUMC; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Zhejiang Chinese Medical University; Netherlands Organization Applied Science Research	van Wietmarschen, HA (corresponding author), Leiden Univ, LACDR, Div Analyt Biosci, Leiden, Netherlands.	h.vanwietmarschen@lacdr.leidenuniv.nl; xugw@dicp.ac.cn	Dai, Weidong/C-7636-2013; , 戴伟东/AAU-6590-2020; Hankemeier, Thomas/V-5407-2019; Xu, Guowang/L-6910-2014; , 戴伟东/GQP-9052-2022	, 戴伟东/0000-0002-9593-138X; Hankemeier, Thomas/0000-0001-7871-2073; Xu, Guowang/0000-0003-4298-3554; , 戴伟东/0000-0002-9593-138X	State Ministry of Science & Technology of China [2009DFA41250]; key foundation from National Natural Science Foundation of China [20835006]; National Natural Science Foundation of China [21021004]; Osteo- and Rheumatoid Arthritis Foundation	State Ministry of Science & Technology of China(Ministry of Science and Technology, China); key foundation from National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Osteo- and Rheumatoid Arthritis Foundation	This study has been supported by the International cooperation project (No. 2009DFA41250) from the State Ministry of Science & Technology of China and the key foundation (No. 20835006), the creative research group project (No. 21021004) from National Natural Science Foundation of China and the Osteo- and Rheumatoid Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2005, NAT CLIN PRACT RHEUM, V1, P62, DOI 10.1038/ncprheum0050; Anderson JJ, 2000, ARTHRITIS RHEUM, V43, P22, DOI 10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Callard R, 1999, IMMUNITY, V11, P507, DOI 10.1016/S1074-7613(00)80125-9; Conaghan PG, 2011, CLIN RHEUMATOL, V30, pS41, DOI 10.1007/s10067-010-1639-4; Cutolo M, 2000, ANN NY ACAD SCI, V917, P835; Dai WD, 2011, J PHARMACEUT BIOMED, V56, P86, DOI 10.1016/j.jpba.2011.04.020; Dessein Patrick H, 2007, BMC Cardiovasc Disord, V7, P31, DOI 10.1186/1471-2261-7-31; George-Gay Beverly, 2003, J Perianesth Nurs, V18, P96, DOI 10.1053/jpan.2003.50013; Gika HG, 2007, J PROTEOME RES, V6, P3291, DOI 10.1021/pr070183p; Glocker MO, 2006, MED RES REV, V26, P63, DOI 10.1002/med.20045; Gu Y, 2012, MOL BIOSYST, V8, P1535, DOI 10.1039/c2mb25022e; Guebre-Egziabher F, 2008, EUR J CLIN NUTR, V62, P1287, DOI 10.1038/sj.ejcn.1602857; He YT, 2007, JCR-J CLIN RHEUMATOL, V13, P317, DOI 10.1097/RHU.0b013e31815d019b; Hendriks MMWB, 2007, PROTEOMICS, V7, P3672, DOI 10.1002/pmic.200700046; Higgins JP, 2002, YALE J BIOL MED, V75, P247; Isaacs JD, 2011, ANN RHEUM DIS, V70, P4, DOI 10.1136/ard.2010.135376; Jiang Miao, 2011, Front Med, V5, P219, DOI 10.1007/s11684-011-0133-y; Jiang WY, 2005, TRENDS PHARMACOL SCI, V26, P558, DOI 10.1016/j.tips.2005.09.006; Jones MG, 2005, CLIN CHIM ACTA, V360, P173, DOI 10.1016/j.cccn.2005.04.029; Kang GL, 2008, EVID-BASED COMPL ALT, V5, P273, DOI 10.1093/ecam/nem026; Kazory A, 2010, AM J CARDIOL, V106, P694, DOI 10.1016/j.amjcard.2010.04.024; Khan NA, 2012, ARTHRIT CARE RES, V64, P206, DOI 10.1002/acr.20685; KIND T, 2010, BIOANAL REV, V12, P23, DOI DOI 10.1007/S12566-010-0015-9; Kraan TCTMV, 2007, ANN RHEUM DIS, V66, P1008, DOI 10.1136/ard.2006.063412; Krahenbuhl S, 1999, CLIN CHIM ACTA, V279, P35, DOI 10.1016/S0009-8981(98)00161-2; Li S, 2007, IET SYST BIOL, V1, P51, DOI 10.1049/iet-syb:20060032; Linting M, 2007, PSYCHOL METHODS, V12, P336, DOI 10.1037/1082-989X.12.3.336; Linting M, 2012, J PERS ASSESS, V94, P12, DOI 10.1080/00223891.2011.627965; Lu C, 2010, RHEUMATOL INT, V32, P61; Lu C, 2009, J ALTERN COMPLEM MED, V15, P1021, DOI 10.1089/acm.2009.0065; Maillefert JF, 2010, JOINT BONE SPINE, V77, P558, DOI 10.1016/j.jbspin.2010.02.018; McClellan JE, 2002, ANAL CHEM, V74, P5799, DOI 10.1021/ac026073d; Meulman JJ, 2009, SPSS CATEGORIES 17 0; Ni M., 1995, YELLOW EMPERORS CLAS; NISHISATO S, 1984, PSYCHOMETRIKA, V49, P25, DOI 10.1007/BF02294203; Paglia G, 2008, RAPID COMMUN MASS SP, V22, P3809, DOI 10.1002/rcm.3799; Patterson AD, 2009, J PROTEOME RES, V8, P4293, DOI 10.1021/pr9004103; Reuter SE, 2011, J INTERN MED, V270, P76, DOI 10.1111/j.1365-2796.2010.02341.x; RITCHIE DM, 1968, Q J MED, V37, P393; Robinson V, 2002, COCHRANE DATABASE SY; Ryu H, 2010, J ALTERN COMPLEM MED, V16, P663, DOI 10.1089/acm.2009.0331; SEWELL AC, 1995, EUR J PEDIATR, V154, P871, DOI 10.1007/BF01957495; van Baarsen LGM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2912; van der Greef J, 2005, NAT REV DRUG DISCOV, V4, P961, DOI 10.1038/nrd1904; van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767; Van der Kooij A. J., 2004, SAGE HDB QUANTITATIV, P49; van Wietmarschen H, 2009, JCR-J CLIN RHEUMATOL, V15, P330, DOI 10.1097/RHU.0b013e3181ba3926; van Wietmarschen HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024846; Vandeginste BGM, 1998, HDB CHEMOMETRICS Q B, P374; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; Verhagen AP, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000518, DOI 10.1002/14651858.CD000518]; WOLFE F, 1991, J RHEUMATOL, V18, P973	55	57	57	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44331	10.1371/journal.pone.0044331	http://dx.doi.org/10.1371/journal.pone.0044331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984493	Green Published, gold			2022-12-25	WOS:000308738500047
J	Vatolin, S; Khan, SN; Reu, FJ				Vatolin, Sergei; Khan, Shahper N.; Reu, Frederic J.			Direct Chromatin PCR (DC-PCR): Hypotonic Conditions Allow Differentiation of Chromatin States during Thermal Cycling	PLOS ONE			English	Article							GENES; CANCER	Current methods to study chromatin configuration are not well suited for high throughput drug screening since they require large cell numbers and multiple experimental steps that include centrifugation for isolation of nuclei or DNA. Here we show that site specific chromatin analysis can be achieved in one step by simply performing direct chromatin PCR (DC-PCR) on cells. The basic underlying observation was that standard hypotonic PCR buffers prevent global cellular chromatin solubilization during thermal cycling while more loosely organized chromatin can be amplified. Despite repeated heating to >90 degrees C, 41 of 61 tested 5' sequences of silenced genes (CDKN2A, PU.1, IRF4, FOSB, CD34) were not amplifiable while 47 could be amplified from expressing cells. Two gene regions (IRF4, FOSB) even required pre-heating of cells in isotonic media to allow this differentiation; otherwise none of 19 assayed sequences yielded PCR products. Cells with baseline expression or epigenetic reactivation gave similar DC-PCR results. Silencing during differentiation of CD34 positive cord blood cells closed respective chromatin while treatment of myeloma cells with an IRF4 transcriptional inhibitor opened a site to DC-PCR that was occupied by RNA polymerase II and NF kappa B as determined by ChIP. Translation into real-time PCR can not be achieved with commercial real-time PCR buffers which potently open chromatin, but even with simple ethidium bromide addition to standard PCR mastermix we were able to identify hits in small molecules screens that suppressed IRF4 expression or reactivated CDKN2A in myeloma cells using densitometry or visual inspection of PCR plates under UV light. While need in drug development inspired this work, application to genome-wide analysis appears feasible using phi29 for selective amplification of open cellular chromatin followed by library construction from supernatants since such supernatants yielded similar results as gene specific DC-PCR.	[Vatolin, Sergei; Khan, Shahper N.; Reu, Frederic J.] Cleveland Clin Fdn, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, Cleveland, OH 44195 USA; [Reu, Frederic J.] Cleveland Clin Fdn, Dept Hematol Oncol & Blood Disorders, Taussig Canc Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Vatolin, S (corresponding author), Cleveland Clin Fdn, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA.	reuf@ccf.org		Reu, Frederic/0000-0003-1160-8030; Vatolin, Sergei/0000-0002-7752-3921; Khan, Shahper N./0000-0002-3931-6702	Scott Hamilton CARES grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER	Scott Hamilton CARES grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The work was supported by a Scott Hamilton CARES grant to F.J. Reu. The authors thank Nancy N. Vacc and Robert J. Tomsich for generous financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKOWITZ EM, 1975, P NATL ACAD SCI USA, V72, P3328, DOI 10.1073/pnas.72.9.3328; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Dulac C, 2010, NATURE, V465, P728, DOI 10.1038/nature09231; FRENSTER JH, 1965, NATURE, V206, P680, DOI 10.1038/206680a0; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Juengel A, 2010, CURR OPIN RHEUMATOL, V22, P284, DOI 10.1097/BOR.0b013e3283389641; Liu JH, 2006, EMBO J, V25, P2119, DOI 10.1038/sj.emboj.7601101; Maunakea AK, 2010, CIRC RES, V107, P327, DOI 10.1161/CIRCRESAHA.110.222463; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; SAELAND S, 1988, BLOOD, V72, P1580; Shaffer AL, 2008, NATURE, V454, P226, DOI 10.1038/nature07064; Shaffer AL, 2009, CLIN CANCER RES, V15, P2954, DOI 10.1158/1078-0432.CCR-08-1845; Shandrick S, 2002, ELECTROPHORESIS, V23, P591, DOI 10.1002/1522-2683(200202)23:4<591::AID-ELPS591>3.0.CO;2-W; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; WU C, 1979, CELL, V16, P807, DOI 10.1016/0092-8674(79)90096-5; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0	17	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44690	10.1371/journal.pone.0044690	http://dx.doi.org/10.1371/journal.pone.0044690			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984542	Green Submitted, Green Published, gold			2022-12-25	WOS:000308738500074
J	de Souza, CF; Xander, P; Monteiro, AC; Silva, AGD; da Silva, DCP; Mai, S; Bernardo, V; Lopes, JD; Jasiulionis, MG				de Souza, Camila Ferreira; Xander, Patricia; Monteiro, Ana Carolina; dos Santos Silva, Amanda Goncalves; Pereira da Silva, Debora Castanheira; Mai, Sabine; Bernardo, Viviane; Lopes, Jose Daniel; Jasiulionis, Miriam Galvonas			Mining Gene Expression Signature for the Detection of Pre-Malignant Melanocytes and Early Melanomas with Risk for Metastasis	PLOS ONE			English	Article							DNA METHYLATION; EPIGENETIC REGULATION; TRANSCRIPTION FACTOR; MINIMUM INFORMATION; MICROARRAY DATA; TUMOR-CELLS; STEM-CELLS; CHROMATIN; GROWTH; MOUSE	Background: Metastatic melanoma is a highly aggressive skin cancer and currently resistant to systemic therapy. Melanomas may involve genetic, epigenetic and metabolic abnormalities. Evidence is emerging that epigenetic changes might play a significant role in tumor cell plasticity and metastatic phenotype of melanoma cells. Principal findings: In this study, we developed a systematic approach to identify genes implicated in melanoma progression. To do this, we used the Affymetrix GeneChip Arrays to screen 34,000 mouse transcripts in melan-a melanocytes, 4C pre-malignant melanocytes, 4C11- non-metastatic and 4C11+ metastatic melanoma cell lines. The genome-wide association studies revealed pathways commonly over-represented in the transition from immortalized to pre-malignant stage, and under-represented in the transition from non-metastatic to metastatic stage. Additionally, the treatment of cells with 10 mM 5-aza-29-deoxycytidine (5AzaCdR) for 48 hours allowed us to identify genes differentially re-expressed at specific stages of melan-a malignant transformation. Treatment of human primary melanocytes with the demethylating agent 5AzaCdR in combination to the histone deacetylase inhibitor Trichostatin A (TSA) revealed changes on melanocyte morphology and gene expression which could be an indicator of epigenetic flexibility in normal melanocytes. Moreover, changes on gene expression recognized by affecting the melanocyte biology (NDRG2 and VDR), phenotype of metastatic melanoma cells (HSPB1 and SERPINE1) and response to cancer therapy (CTCF, NSD1 and SRC) were found when Mel-2 and/or Mel-3-derived patient metastases were exposed to 5AzaCdR plus TSA treatment. Hierarchical clustering and network analyses in a panel of five patient-derived metastatic melanoma cells showed gene interactions that have never been described in melanomas. Significance: Despite the heterogeneity observed in melanomas, this study demonstrates the utility of our murine melanoma progression model to identify molecular markers commonly perturbed in metastasis. Additionally, the novel gene expression signature identified here may be useful in the future into a model more closely related to translational research.	[de Souza, Camila Ferreira; Monteiro, Ana Carolina; Jasiulionis, Miriam Galvonas] Univ Fed Sao Paulo, Dept Farmacol, Sao Paulo, Brazil; [Xander, Patricia] Univ Fed Sao Paulo, Dept Ciencias Biol, Sao Paulo, Brazil; [dos Santos Silva, Amanda Goncalves] Hosp AC Camargo Fund Antonio Prudente, CIPE, Sao Paulo, Brazil; [Pereira da Silva, Debora Castanheira] Hosp AC Camargo Fund Antonio Prudente, Dept Oncol Cutanea, Sao Paulo, Brazil; [Mai, Sabine] Univ Manitoba, Manitoba Inst Cell Biol, Canc Care Manitoba, Winnipeg, MB, Canada; [Bernardo, Viviane] Univ Fed Sao Paulo, Dept Informat Saude, Sao Paulo, Brazil; [Lopes, Jose Daniel] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; University of Manitoba; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	de Souza, CF (corresponding author), Univ Fed Sao Paulo, Dept Farmacol, Sao Paulo, Brazil.	mjasiulionis@gmail.com	Jasiulionis, Miriam/G-2207-2012; Xander, Patricia/E-4682-2012; Mai, Sabine/E-5667-2017; Silva, Amanda/G-4992-2010	Jasiulionis, Miriam/0000-0002-4135-0440; Xander, Patricia/0000-0002-6329-6449; Mai, Sabine/0000-0002-5797-2201; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [09/51462-9, 06/61293-1, 2006/61293-1, 11/12306-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [09/51462-9 to C. F. S. & 06/61293-1 and 2006/61293-1 AND 11/12306-1 to M.G.J.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrian S, 2003, CELL STRESS CHAPERON, V8, P249, DOI 10.1379/1466-1268(2003)008<0249:OOHIAH>2.0.CO;2; Aldrian S, 2002, CELL STRESS CHAPERON, V7, P177, DOI 10.1379/1466-1268(2002)007<0177:OOHATM>2.0.CO;2; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brozyna AA, 2011, HUM PATHOL, V42, P618, DOI 10.1016/j.humpath.2010.09.014; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; Costa FF, 2009, EPIGENOMICS-UK, V1, P387, DOI 10.2217/EPI.09.25; Do JT, 2008, STEM CELLS, V26, P2821, DOI 10.1634/stemcells.2008-0482; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Escamilla-Del-Arenal M, 2011, HUM GENET, V130, P307, DOI 10.1007/s00439-011-1029-2; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gallagher WM, 2005, CARCINOGENESIS, V26, P1856, DOI 10.1093/carcin/bgi152; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kim A, 2008, PIGM CELL MELANOMA R, V21, P653, DOI 10.1111/j.1755-148X.2008.00503.x; Kim A, 2009, CARCINOGENESIS, V30, P927, DOI 10.1093/carcin/bgp072; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; LYON MF, 1962, AM J HUM GENET, V14, P135; Meeran SM, 2010, PLOS ONE, V5; Mendes-Pereira AM, 2012, P NATL ACAD SCI USA, V109, P2730, DOI 10.1073/pnas.1018872108; Molognoni F, 2011, EPIGENETICS-US, V6, P451, DOI 10.4161/epi.6.4.14917; Montecino M, 2007, ARCH BIOCHEM BIOPHYS, V460, P293, DOI 10.1016/j.abb.2006.12.015; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Mossman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023127; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Oba-Shinjo SM, 2006, NEOPLASIA, V8, P231, DOI 10.1593/neo.05781; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Parker KA, 2010, J CLIN PATHOL, V63, P1012, DOI 10.1136/jcp.2010.080119; Ricca TI, 2009, TRANSL ONCOL, V2, P329, DOI 10.1593/tlo.09220; Roesch A, 2010, CELL, V141, P583, DOI 10.1016/j.cell.2010.04.020; Roschke AV, 2005, P NATL ACAD SCI USA, V102, P2964, DOI 10.1073/pnas.0405578102; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Seftor EA, 2006, J CELL MOL MED, V10, P174, DOI 10.1111/j.1582-4934.2006.tb00299.x; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Silva AGS, 2010, NEOPLASIA, V12, P11, DOI 10.1593/neo.91004; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2009, EXP DERMATOL, V18, P760, DOI 10.1111/j.1600-0625.2009.00892.x; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Soto-Reyes E, 2010, ONCOGENE, V29, P2217, DOI 10.1038/onc.2009.509; Souza CF, 2012, DERMATOL RES PRACT; Steele N, 2009, BRIT J CANCER, V100, P758, DOI 10.1038/sj.bjc.6604932; Szyf M, 2009, ANNU REV PHARMACOL, V49, P243, DOI 10.1146/annurev-pharmtox-061008-103102; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Vergani E, 2011, NEOPLASIA, V13, P1132, DOI 10.1593/neo.111102; Vidwans SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018257; Zhao JP, 2009, J BIOL CHEM, V284, P34308, DOI 10.1074/jbc.M109.045021	61	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44800	10.1371/journal.pone.0044800	http://dx.doi.org/10.1371/journal.pone.0044800			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984562	Green Submitted, Green Published, gold			2022-12-25	WOS:000308638700084
J	Doan, LT; Javier, AL; Furr, NM; Nguyen, KL; Cho, KW; Monuki, ES				Doan, Linda T.; Javier, Anna L.; Furr, Nicole M.; Nguyen, Kevin L.; Cho, Ken W.; Monuki, Edwin S.			A Bmp Reporter with Ultrasensitive Characteristics Reveals That High Bmp Signaling Is Not Required for Cortical Hem Fate	PLOS ONE			English	Article							NEURAL STEM-CELLS; CAJAL-RETZIUS CELLS; ROOF PLATE; HIPPOCAMPAL NEUROGENESIS; ADULT HIPPOCAMPUS; CEREBRAL-CORTEX; IN-VIVO; TRANSCRIPTIONAL ACTIVITY; GRADIENT MORPHOGEN; RESPONSE ELEMENTS	Insights into Bone morphogenetic protein (Bmp) functions during forebrain development have been limited by a lack of Bmp signaling readouts. Here we used a novel Bmp signaling reporter ("BRE-gal" mice) to study Bmp signaling in the dorsal telencephalon. At early stages, BRE-gal expression was restricted to the dorsal telencephalic midline. At later stages, strong BRE-gal expression occurred in neurons of the marginal zone and dentate gyrus. Comparisons to nuclear phospho-Smad1/5/8 (pSmad) and Msx1 indicated that BRE-gal expression occurred exclusively in neural cells with high-level Bmp signaling. BRE-gal responsiveness to Bmps was confirmed in reporter-negative cortical cells cultured with Bmp4, and both in vivo and in vitro, BRE-gal expression was switch-like, or ultrasensitive. In the early dorsal telencephalon, BRE-gal expression negatively correlated with the cortical selector gene Lhx2, indicating a BRE-gal expression border that coincides with the cortex-hem boundary. However, in Lhx2 null chimeras, neither BRE-gal nor nuclear pSmad increases were observed in ectopic hem cells. These findings establish BRE-gal as an ultrasensitive reporter of Bmp signaling in the dorsal telencephalon, imply that hem fate can be specified at different Bmp signaling intensities, and suggest that Lhx2 primarily regulates the responses to rather than the intensity of - Bmp signaling in dorsal telencephalic cells.	[Doan, Linda T.; Javier, Anna L.; Furr, Nicole M.; Nguyen, Kevin L.; Cho, Ken W.; Monuki, Edwin S.] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Doan, Linda T.; Monuki, Edwin S.] Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92717 USA; [Doan, Linda T.; Monuki, Edwin S.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Doan, LT (corresponding author), Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	emonuki@uci.edu		Doan, Linda/0000-0003-0274-2529; Monuki, Edwin/0000-0001-5130-781X	University of California Irvine Medical Scientist Training Program program; National Institutes of Health [R01 NS064587]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056219] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064587] Funding Source: NIH RePORTER	University of California Irvine Medical Scientist Training Program program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the University of California Irvine Medical Scientist Training Program program (LTD) and National Institutes of Health grant R01 NS064587 (ESM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Alexander C, 2011, DEVELOPMENT, V138, P5135, DOI 10.1242/dev.067801; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Badea TC, 2003, J NEUROSCI, V23, P2314; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Blank U, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-86; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Cheng X, 2006, J NEUROSCI, V26, P7640, DOI 10.1523/JNEUROSCI.0714-06.2006; Chizhikov VV, 2010, P NATL ACAD SCI USA, V107, P10725, DOI 10.1073/pnas.0910786107; Chizhikov VV, 2005, DEV BIOL, V277, P287, DOI 10.1016/j.ydbio.2004.10.011; Chowdhury TG, 2010, FRONT NEUROANAT, V4, DOI 10.3389/neuro.05.010.2010; Cornell RA, 2000, CURR OPIN NEUROBIOL, V10, P63, DOI 10.1016/S0959-4388(99)00049-5; Currle DS, 2005, DEVELOPMENT, V132, P3549, DOI 10.1242/dev.01915; DelRio JA, 1996, J NEUROSCI, V16, P6896; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Fernandes M, 2007, DEVELOPMENT, V134, P3789, DOI 10.1242/dev.004325; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; Hebert JM, 2003, GENESIS, V35, P214, DOI 10.1002/gene.10183; Houzelstein D, 1997, MECH DEVELOP, V65, P123, DOI 10.1016/S0925-4773(97)00065-8; Hu JS, 2008, P NATL ACAD SCI USA, V105, P3398, DOI 10.1073/pnas.0709100105; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Kalinovsky A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001013; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lehtinen MK, 2011, NEURON, V69, P893, DOI 10.1016/j.neuron.2011.01.023; Liu AM, 2005, NAT REV NEUROSCI, V6, P945, DOI 10.1038/nrn1805; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Monteiro RM, 2004, J CELL SCI, V117, P4653, DOI 10.1242/jcs.01337; Monteiro RM, 2008, GENESIS, V46, P335, DOI 10.1002/dvg.20402; Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9; Porter FD, 1997, DEVELOPMENT, V124, P2935; Ragsdale CW, 2001, CURR OPIN NEUROBIOL, V11, P50, DOI 10.1016/S0959-4388(00)00173-2; Ramos C, 2005, TRENDS GENET, V21, P624, DOI 10.1016/j.tig.2005.09.001; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; STRYER L, 1995, BIOCHEMISTRY-US, pR34; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Tang J, 2009, BIOCHEM BIOPH RES CO, V385, P341, DOI 10.1016/j.bbrc.2009.05.067; Tsai MJ, 2007, J NEUROSCI RES, V85, P2950, DOI 10.1002/jnr.21395; Venza I, 2011, HUM MOL GENET, V20, P1016, DOI 10.1093/hmg/ddq547; von Bubnoff A, 2005, DEV BIOL, V281, P210, DOI 10.1016/j.ydbio.2005.02.014; Yao LC, 2006, DEVELOPMENT, V133, P4025, DOI 10.1242/dev.02561	49	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44009	10.1371/journal.pone.0044009	http://dx.doi.org/10.1371/journal.pone.0044009			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984456	Green Published, gold			2022-12-25	WOS:000308638700037
J	Patrelli, TS; Gizzo, S; Sianesi, N; Levati, L; Pezzuto, A; Ferrari, B; Modena, AB				Patrelli, Tito Silvio; Gizzo, Salvatore; Sianesi, Nicoletta; Levati, Luca; Pezzuto, Antonio; Ferrari, Bruno; Modena, Alberto Bacchi			Anti-Mullerian Hormone Serum Values and Ovarian Reserve: Can It Predict a Decrease in Fertility after Ovarian Stimulation by ART Cycles?	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; ASSISTED REPRODUCTIVE TECHNOLOGY; SPONTANEOUS MENSTRUAL-CYCLE; ANTRAL FOLLICLE COUNT; INHIBIN-B; ANTIMULLERIAN-HORMONE; GRANULOSA-CELLS; ESTROUS-CYCLE; RAT OVARY; EXPRESSION	Background: A variety of indicators of potentially successful ovarian stimulation cycles are available, including biomarkers such as anti-Mullerian hormone. The aim of our study was to confirm the usefulness of serum anti-Mullerian hormone assay in predicting ovarian response and reproductive outcome in women eligible for ART cycles. Materials: Forty-six women undergoing ART cycles at the Centre for Reproductive Medicine in Parma were recruited from March-to-June 2010. Inclusion criteria: age <42 years; body-mass-index =20-25; regular menstrual cycles; basal serum FSH concentration <12 IU/L and basal serum estradiol concentration <70 pg/mL. The couples included in our study reported a variety of primary infertility causes. All women underwent FSH stimulation and pituitary suppression (GnRH-agonist/GnRH-antagonist protocols). Women were considered poor-responders if thay had <= 3 oocytes; normal-responders 4-9 oocytes and high-responders >= 10 oocytes. Serum samples for the AMH assays were obtained on the first and last days of stimulation. A P value <= 0.05 was considered statistically significant. Result: FSH levels increased significantly when AMH levels decreased. The total dose of r-FSH administered to induce ovulation was not correlated to AMH. The number of follicles on the hCG, serum estradiol levels on the hCG-day, and the number of retrieved oocytes were significantly correlated to AMH. The number of fertilized oocytes was significantly correlated to the AMH levels. No significant correlation was found between obtained embryos or transferred embryos and AMH. Basal serum AMH levels were significantly higher than those measured on the hCG-day, which appeared significantly reduced. There was a significant correlation between AMH in normal responders and AMH in both high and poor responders. Conclusions: Our data confirm the clinical usefulness of AMH in ART-cycles to customize treatment protocols and suggest the necessity of verifying an eventual permanent decrease in AMH levels after IVF.	[Patrelli, Tito Silvio; Gizzo, Salvatore; Sianesi, Nicoletta; Levati, Luca; Pezzuto, Antonio; Ferrari, Bruno; Modena, Alberto Bacchi] Univ Parma, Dept Gynecol Obstet & Neonatol, I-43100 Parma, Italy	University of Parma	Patrelli, TS (corresponding author), Univ Parma, Dept Gynecol Obstet & Neonatol, I-43100 Parma, Italy.	titosilvio.patrelli@gmail.com						ABMA JC, 1997, VITAL HLTH STAT, V0019; BAARENDS WM, 1995, ENDOCRINOLOGY, V136, P4951, DOI 10.1210/en.136.11.4951; Bancsi LFJMM, 2002, FERTIL STERIL, V77, P328, DOI 10.1016/S0015-0282(01)02983-1; Bancsi LFJMM, 2000, FERTIL STERIL, V73, P552, DOI 10.1016/S0015-0282(99)00552-X; Broekmans FJ, 2006, HUM REPROD UPDATE, V12, P685, DOI 10.1093/humupd/dml034; Chang MY, 1998, FERTIL STERIL, V69, P505, DOI 10.1016/S0015-0282(97)00557-8; de Vet A, 2002, FERTIL STERIL, V77, P357, DOI 10.1016/S0015-0282(01)02993-4; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Eldar-Geva T, 2005, HUM REPROD, V20, P3178, DOI 10.1093/humrep/dei203; Fanchin R, 2005, HUM REPROD, V20, P747, DOI 10.1093/humrep/deh669; Fanchin R, 2003, HUM REPROD, V18, P323, DOI 10.1093/humrep/deg042; Ficicioglu C, 2006, FERTIL STERIL, V85, P592, DOI 10.1016/j.fertnstert.2005.09.019; Guibourdenche J, 2003, MOL CELL ENDOCRINOL, V211, P55, DOI 10.1016/j.mce.2003.09.011; Hazout A, 2004, FERTIL STERIL, V82, P1323, DOI 10.1016/j.fertnstert.2004.03.061; Hehenkamp WJK, 2006, J CLIN ENDOCR METAB, V91, P4057, DOI 10.1210/jc.2006-0331; HIROBE S, 1994, BIOL REPROD, V50, P1238, DOI 10.1095/biolreprod50.6.1238; Klein NA, 1996, J CLIN ENDOCR METAB, V81, P1038, DOI 10.1210/jc.81.3.1038; Kwee J, 2008, FERTIL STERIL, V90, P737, DOI 10.1016/j.fertnstert.2007.07.1293; La Marca A, 2005, J SOC GYNECOL INVEST, V12, P545, DOI 10.1016/j.jsgi.2005.06.001; La Marca A, 2007, HUM REPROD, V22, P766, DOI 10.1093/humrep/del421; La Marca A, 2006, HUM REPROD, V21, P3103, DOI 10.1093/humrep/del291; La Marca A, 2006, CLIN ENDOCRINOL, V64, P603, DOI 10.1111/j.1365-2265.2006.02533.x; La Marca A, 2004, HUM REPROD, V19, P2738, DOI 10.1093/humrep/deh508; Long WQ, 2000, J CLIN ENDOCR METAB, V85, P540, DOI 10.1210/jc.85.2.540; Loverro G, 2003, Reprod Biomed Online, V7, P200; Lukas-Croisier C, 2003, MOL ENDOCRINOL, V17, P550, DOI 10.1210/me.2002-0186; MUNSTERBERG A, 1991, DEVELOPMENT, V113, P613; Muttukrishna S, 2005, BJOG-INT J OBSTET GY, V112, P1384, DOI 10.1111/j.1471-0528.2005.00670.x; Muttukrishna S, 2004, BJOG-INT J OBSTET GY, V111, P1248, DOI 10.1111/j.1471-0528.2004.00452.x; Rajpert-De Meyts E, 1999, J CLIN ENDOCR METAB, V84, P3836, DOI 10.1210/jc.84.10.3836; Rey R, 2000, HUM PATHOL, V31, P1202, DOI 10.1053/hupa.2000.18498; Rey RA, 1996, AM J OBSTET GYNECOL, V174, P958, DOI 10.1016/S0002-9378(96)70333-2; Sowers MR, 2008, J CLIN ENDOCR METAB, V93, P3478, DOI 10.1210/jc.2008-0567; TAKAHASHI M, 1986, BIOL REPROD, V35, P447, DOI 10.1095/biolreprod35.2.447; Templeton A, 1996, LANCET, V348, P1402, DOI 10.1016/S0140-6736(96)05291-9; Tremellen KP, 2005, AUST NZ J OBSTET GYN, V45, P20, DOI 10.1111/j.1479-828X.2005.00332.x; UENO S, 1989, ENDOCRINOLOGY, V125, P1060, DOI 10.1210/endo-125-2-1060; van Rooij IAJ, 2002, HUM REPROD, V17, P3065, DOI 10.1093/humrep/17.12.3065; van Rooij IAJ, 2005, FERTIL STERIL, V83, P979, DOI 10.1016/j.fertnstert.2004.11.029; van Rooij Ilse A J, 2004, Menopause, V11, P601, DOI 10.1097/01.GME.0000123642.76105.6E; vanKooij RJ, 1996, FERTIL STERIL, V66, P769, DOI 10.1016/S0015-0282(16)58634-8; Ventura S J, 2001, Natl Vital Stat Rep, V49, P1; Weenen C, 2004, MOL HUM REPROD, V10, P77, DOI 10.1093/molehr/gah015; Weinstein M, 1993, BIOMEDICAL DEMOGRAPH, P209; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_	46	32	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44571	10.1371/journal.pone.0044571	http://dx.doi.org/10.1371/journal.pone.0044571			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984527	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700070
J	Sivitz, AB; Hermand, V; Curie, C; Vert, G				Sivitz, Alicia B.; Hermand, Victor; Curie, Catherine; Vert, Gregory			Arabidopsis bHLH100 and bHLH101 Control Iron Homeostasis via a FIT-Independent Pathway	PLOS ONE			English	Article							DEFICIENCY RESPONSES; THALIANA; ROOTS; GENES; TRANSFORMATION; STRESS	Iron deficiency induces a complex set of responses in plants, including developmental and physiological changes, to increase iron uptake from soil. In Arabidopsis, many transporters involved in the absorption and distribution of iron have been identified over the past decade. However, little is known about the signaling pathways and networks driving the various responses to low iron. Only the basic helix-loop-helix (bHLH) transcription factor FIT has been shown to control the expression of the root iron uptake machinery genes FRO2 and IRT1. Here, we characterize the biological role of two other iron-regulated transcription factors, bHLH100 and bHLH101, in iron homeostasis. First direct transcriptional targets of FIT were determined in vivo. We show that bHLH100 and bHLH101 do not regulate FIT target genes, suggesting that they play a non-redundant role with the two closely related bHLH factors bHLH038 and bHLH039 that have been suggested to act in concert with FIT. bHLH100 and bHLH101 play a crucial role in iron-deficiency responses, as attested by their severe growth defects and iron homeostasis related phenotypes on low-iron media. To gain further insight into the biological role of bHLH100 and bHLH101, we performed microarray analysis using the corresponding double mutant and showed that bHLH100 and bHLH101 likely regulate genes involved in the distribution of iron within the plant. Altogether, this work establishes bHLH100 and bHLH101 as key regulators of iron-deficiency responses independent of the master regulator FIT and sheds light on new regulatory networks important for proper growth and development under low iron conditions.	[Sivitz, Alicia B.; Hermand, Victor; Curie, Catherine; Vert, Gregory] Ctr Natl Rech Sci, Inst Biol Integrat Plantes, Unite Mixte Rech 5004, Montpellier, France; [Sivitz, Alicia B.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Vert, Gregory] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Institut Agro; Montpellier SupAgro; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Dartmouth College; Salk Institute	Sivitz, AB (corresponding author), Ctr Natl Rech Sci, Inst Biol Integrat Plantes, Unite Mixte Rech 5004, Montpellier, France.	Gregory.Vert@supagro.inra.fr	Hermand, Victor/AAD-4414-2022	Vert, Greg/0000-0002-0844-9991	European Molecular Biology Organization [ALTF 160-2009]; Human Frontier Science Program Organization [CDA0005/2007]; Agence Nationale de la Recherche [ANR-08-JCJC-0058]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program Organization(Human Frontier Science Program); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by a European Molecular Biology Organization long-term fellowship to ABS (ALTF 160-2009) and grants to GV from the Human Frontier Science Program Organization (CDA0005/2007) and the Agence Nationale de la Recherche (ANR-08-JCJC-0058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; Dereeper A, 2008, NUCL ACIDS RES; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Jakoby M, 2004, FEBS LETT, V577, P528, DOI 10.1016/j.febslet.2004.10.062; Katari MS, 2010, PLANT PHYSIOL, V152, P500, DOI 10.1104/pp.109.147025; Klatte M, 2009, PLANT PHYSIOL, V150, P257, DOI 10.1104/pp.109.136374; LOBREAUX S, 1991, BIOCHEM J, V274, P601, DOI 10.1042/bj2740601; Long TA, 2010, PLANT CELL, V22, P2219, DOI 10.1105/tpc.110.074096; Meiser J, 2011, PLANT PHYSIOL, V157, P2154, DOI 10.1104/pp.111.183285; Murgia I, 2011, J PLANT PHYSIOL, V168, P894, DOI 10.1016/j.jplph.2010.11.020; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Ritchie RJ, 2006, PHOTOSYNTH RES, V89, P27, DOI 10.1007/s11120-006-9065-9; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Santi S, 2009, NEW PHYTOL, V183, P1072, DOI 10.1111/j.1469-8137.2009.02908.x; Sivitz A, 2011, PLANT J, V66, P1044, DOI 10.1111/j.1365-313X.2011.04565.x; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Wang HY, 2007, PLANTA, V226, P897, DOI 10.1007/s00425-007-0535-x; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26; Yuan YX, 2005, CELL RES, V15, P613, DOI 10.1038/sj.cr.7290331	22	136	145	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44843	10.1371/journal.pone.0044843	http://dx.doi.org/10.1371/journal.pone.0044843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984573	Green Submitted, gold, Green Published			2022-12-25	WOS:000308638700091
J	Suganuma, N; Ito, S; Aso, H; Kondo, M; Sato, M; Sokabe, M; Hasegawa, Y				Suganuma, Nobukazu; Ito, Satoru; Aso, Hiromichi; Kondo, Masashi; Sato, Mitsuo; Sokabe, Masahiro; Hasegawa, Yoshinori			STIM1 Regulates Platelet-Derived Growth Factor-Induced Migration and Ca2+ Influx in Human Airway Smooth Muscle Cells	PLOS ONE			English	Article							OPERATED CALCIUM INFLUX; CHANNEL; ENTRY; ACTIVATION; RECEPTOR; ORAI1; PROLIFERATION; CONTRACTION; CHEMOTAXIS; INHIBITOR	It is suggested that migration of airway smooth muscle (ASM) cells plays an important role in the pathogenesis of airway remodeling in asthma. Increases in intracellular Ca2+ concentrations ([Ca2+](i)) regulate most ASM cell functions related to asthma, such as contraction and proliferation. Recently, STIM1 was identified as a sarcoplasmic reticulum (SR) Ca2+ sensor that activates Orai1, the Ca2+ channel responsible for store-operated Ca2+ entry (SOCE). We investigated the role of STIM1 in [Ca2+](i) and cell migration induced by platelet-derived growth factor (PDGF)-BB in human ASM cells. Cell migration was assessed by a chemotaxis chamber assay. Human ASM cells express STIM1, STIM2, and Orai1 mRNAs. SOCE activated by thapsigargin, an inhibitor of SR Ca2+-ATPase, was significantly blocked by STIM1 siRNA and Orai1 siRNA but not by STIM2 siRNA. PDGF-BB induced a transient increase in [Ca2+](i) followed by sustained [Ca2+](i) elevation. Sustained increases in [Ca2+](i) due to PDGF-BB were significantly inhibited by a Ca2+ chelating agent EGTA or by siRNA for STIM1 or Orai1. The numbers of migrating cells were significantly increased by PDGF-BB treatment for 6 h. Knockdown of STIM1 and Orai1 by siRNA transfection inhibited PDGF-induced cell migration. Similarly, EGTA significantly inhibited PDGF-induced cell migration. In contrast, transfection with siRNA for STIM2 did not inhibit the sustained elevation of [Ca2+](i) or cell migration induced by PDGF-BB. These results demonstrate that STIM1 and Orai1 are essential for PDGF-induced cell migration and Ca2+ influx in human ASM cells. STIM1 could be an important molecule responsible for airway remodeling.	[Suganuma, Nobukazu; Ito, Satoru; Aso, Hiromichi; Kondo, Masashi; Sato, Mitsuo; Hasegawa, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4648601, Japan; [Sokabe, Masahiro] Nagoya Univ, Grad Sch Med, Dept Physiol, Nagoya, Aichi 4648601, Japan	Nagoya University; Nagoya University	Suganuma, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4648601, Japan.	itori@med.nagoya-u.ac.jp	Sato, MITSUO/I-7280-2014; Ito, Satoru/AAT-5219-2020; Hasegawa, Yoshinori/I-1277-2012; Kondo, Masashi/I-7378-2014; Sokabe, Masahiro/I-1565-2012	Sato, MITSUO/0000-0001-5458-9576; Ito, Satoru/0000-0001-7885-4653; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [22890837]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid (#22890837) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to S. Ito). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aso H, 2012, AM J PHYSIOL-LUNG C, V302, pL266, DOI 10.1152/ajplung.00248.2011; Aubart FC, 2009, MOL THER, V17, P455, DOI 10.1038/mt.2008.291; Ay B, 2004, AM J PHYSIOL-LUNG C, V286, pL909, DOI 10.1152/ajplung.00317.2003; Baba Y, 2008, NAT IMMUNOL, V9, P81, DOI 10.1038/ni1546; Bisaillon JM, 2010, AM J PHYSIOL-CELL PH, V298, pC993, DOI 10.1152/ajpcell.00325.2009; Bonner JC, 1996, AM J PHYSIOL-LUNG C, V271, pL880, DOI 10.1152/ajplung.1996.271.6.L880; BRUNDAGE RA, 1991, SCIENCE, V254, P703, DOI 10.1126/science.1948048; Carlin SM, 2003, AM J PHYSIOL-LUNG C, V284, pL1020, DOI 10.1152/ajplung.00092.2002; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Darbellay B, 2010, J BIOL CHEM, V285, P22437, DOI 10.1074/jbc.M110.118984; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Gerthoffer William T, 2008, Proc Am Thorac Soc, V5, P97, DOI 10.1513/pats.200704-051VS; Goncharova EA, 2006, NAT PROTOC, V1, P2933, DOI 10.1038/nprot.2006.434; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Helli PB, 2008, EUR RESPIR J, V32, P1529, DOI 10.1183/09031936.00054608; Ito S, 2004, EUR J PHARMACOL, V486, P325, DOI 10.1016/j.ejphar.2004.01.013; Ito S, 2002, AM J RESP CELL MOL, V26, P491, DOI 10.1165/ajrcmb.26.4.4701; Ito S, 2008, AM J RESP CELL MOL, V38, P407, DOI 10.1165/rcmb.2007-0259OC; Ito S, 2010, AM J RESP CELL MOL, V43, P26, DOI 10.1165/rcmb.2009-0073OC; Iwata S, 2009, EUR J PHARMACOL, V605, P15, DOI 10.1016/j.ejphar.2008.12.045; James AL, 2002, AM J RESP CRIT CARE, V166, P1590, DOI 10.1164/rccm.2108069; Joubert P, 2005, J ALLERGY CLIN IMMUN, V116, P713, DOI 10.1016/j.jaci.2005.05.042; Krymskaya VP, 2004, FASEB J, V18, P428, DOI 10.1096/fj.04-2869fje; Lazaar AL, 2005, J ALLERGY CLIN IMMUN, V116, P488, DOI 10.1016/j.jaci.2005.06.030; Li J, 2011, BRIT J PHARMACOL, V164, P382, DOI 10.1111/j.1476-5381.2011.01368.x; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Liu B, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-168; Madison JM, 2003, AM J RESP CELL MOL, V29, P8, DOI 10.1165/rcmb.F272; Morioka M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026384; Parameswaran K, 2002, AM J RESP CRIT CARE, V166, P738, DOI 10.1164/rccm.200204-291OC; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peel SE, 2008, AM J RESP CELL MOL, V38, P744, DOI 10.1165/rcmb.2007-0395OC; Peel SE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-119; Perez-Zoghbi JF, 2009, PULM PHARMACOL THER, V22, P388, DOI 10.1016/j.pupt.2008.09.006; Pfitzer G, 2001, J APPL PHYSIOL, V91, P497, DOI 10.1152/jappl.2001.91.1.497; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sathish V, 2012, EUR RESPIR J, V40, P470, DOI 10.1183/09031936.00090511; Sweeney M, 2002, J APPL PHYSIOL, V92, P1594, DOI 10.1152/japplphysiol.00722.2001; Takeda N, 2006, AM J RESP CELL MOL, V35, P722, DOI 10.1165/rcmb.2006-0034OC; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Zou JJ, 2011, J APPL PHYSIOL, V110, P1256, DOI 10.1152/japplphysiol.01124.2010; Zuyderduyn S, 2008, EUR RESPIR J, V32, P265, DOI 10.1183/09031936.00051407	51	38	39	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e45056	10.1371/journal.pone.0045056	http://dx.doi.org/10.1371/journal.pone.0045056			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984609	gold, Green Published, Green Submitted			2022-12-25	WOS:000308638700107
J	Zujovic, V; Doucerain, C; Hidalgo, A; Bachelin, C; Lachapelle, F; Weissert, R; Stadelmann, C; Linington, C; Baron-Van Evercooren, A				Zujovic, Violetta; Doucerain, Cedric; Hidalgo, Antoine; Bachelin, Corinne; Lachapelle, Francois; Weissert, Robert; Stadelmann, Christine; Linington, Chris; Baron-Van Evercooren, Anne			Exogenous Schwann Cells Migrate, Remyelinate and Promote Clinical Recovery in Experimental Auto-Immune Encephalomyelitis	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; SKIN-DERIVED PRECURSORS; NEURAL CREST CELLS; MULTIPLE-SCLEROSIS; SPINAL-CORD; OLIGODENDROCYTE PROGENITORS; FUNCTIONAL RECOVERY; PERIPHERAL-NERVE; MYELIN REPAIR	Schwann cell (SC) transplantation is currently being discussed as a strategy that may promote functional recovery in patients with multiple sclerosis (MS) and other inflammatory demyelinating diseases of the central nervous system (CNS). However this assumes they will not only survive but also remyelinate demyelinated axons in the chronically inflamed CNS. To address this question we investigated the fate of transplanted SCs in myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE) in the Dark Agouti rat; an animal model that reproduces the complex inflammatory demyelinating immunopathology of MS. We now report that SCs expressing green fluorescent protein (GFP-SCs) allografted after disease onset not only survive but also migrate to remyelinate lesions in the inflamed CNS. GFP-SCs were detected more frequently in the parenchyma after direct injection into the spinal cord, than via intrathecal delivery into the cerebrospinal fluid. In both cases the transplanted cells intermingled with astrocytes in demyelinated lesions, aligned with axons and by twenty one days post transplantation had formed Pzero protein immunoreactive internodes. Strikingly, GFP-SCs transplantation was associated with marked decrease in clinical disease severity in terms of mortality; all GFP-SCs transplanted animals survived whilst 80% of controls died within 40 days of disease.	[Zujovic, Violetta; Doucerain, Cedric; Hidalgo, Antoine; Bachelin, Corinne; Lachapelle, Francois; Baron-Van Evercooren, Anne] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Zujovic, Violetta; Doucerain, Cedric; Hidalgo, Antoine; Bachelin, Corinne; Lachapelle, Francois; Baron-Van Evercooren, Anne] INSERM, U975, Paris, France; [Zujovic, Violetta; Doucerain, Cedric; Hidalgo, Antoine; Bachelin, Corinne; Lachapelle, Francois; Baron-Van Evercooren, Anne] CNRS, UMR 7225, Paris, France; [Baron-Van Evercooren, Anne] Hop La Pitie Salpetriere, AP HP, Paris, France; [Weissert, Robert] Univ Regensburg, Dept Neurol, Regensburg, Germany; [Stadelmann, Christine] Inst Neuropathol, Gottingen, Germany; [Linington, Chris] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Regensburg; University of Glasgow	Zujovic, V (corresponding author), Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France.	anne.baron@upmc.fr	Violetta, Zujovic/I-8784-2017; Weissert, Robert/AAA-4791-2019; Weissert, Robert/B-2585-2009; Linington, Chris/M-4883-2019; Evercooren, Anne S Baron-Van/G-3632-2013	Violetta, Zujovic/0000-0002-6786-065X; Weissert, Robert/0000-0002-1295-1271; Baron-Van Evercooren, Anne/0000-0002-4150-2205; Stadelmann, Christine/0000-0003-1766-5458; violetta, zujovic/0000-0002-2741-6052; Linington, Christopher/0000-0002-0937-9526	European Leukodystrophy Association (ELA) Foundation; INSERM; Association Francaise contre les Myopathies (AFM); ELA Foundation	European Leukodystrophy Association (ELA) Foundation; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); ELA Foundation	This study was supported by European Leukodystrophy Association (ELA) Foundation, and INSERM. VZ and CD were recipients of fellowships from Association Francaise contre les Myopathies (AFM), and ELA Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari FT, 2010, J NEUROSCI, V30, P4246, DOI 10.1523/JNEUROSCI.3351-09.2010; Avellana-Adalid V, 1998, EUR J NEUROSCI, V10, P291; Bachelin C, 2010, BRAIN, V133, P406, DOI 10.1093/brain/awp256; Bachelin C, 2005, BRAIN, V128, P540, DOI 10.1093/brain/awh406; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Einstein O, 2006, EXP NEUROL, V198, P275, DOI 10.1016/j.expneurol.2005.11.007; Fairless R, 2005, MOL CELL NEUROSCI, V28, P253, DOI 10.1016/j.mcn.2004.09.009; FEIGIN I, 1971, J NEUROPATH EXP NEUR, V30, P603, DOI 10.1097/00005072-197110000-00005; Fernandes KJL, 2006, EXP NEUROL, V201, P32, DOI 10.1016/j.expneurol.2006.03.018; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; FRANKLIN RJM, 1993, INT J DEV NEUROSCI, V11, P641, DOI 10.1016/0736-5748(93)90052-F; Girard C, 2005, J NEUROSCI, V25, P7924, DOI 10.1523/JNEUROSCI.4890-04.2005; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Honmou O, 1996, J NEUROSCI, V16, P3199; ITOYAMA Y, 1983, ANN NEUROL, V14, P339, DOI 10.1002/ana.410140313; Jessen KR, 2002, J ANAT, V200, P367, DOI 10.1046/j.1469-7580.2002.00046.x; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Lavdas AA, 2008, CURR MED CHEM, V15, P151; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Martino G, 2010, NAT REV NEUROL, V6, P247, DOI 10.1038/nrneurol.2010.35; Meiron M, 2008, J EXP MED, V205, P2643, DOI 10.1084/jem.20080730; Menendez L, 2011, P NATL ACAD SCI USA, V108, P19240, DOI 10.1073/pnas.1113746108; Mimouni-Rongy M, 2011, J NEUROIMMUNOL, V230, P17, DOI 10.1016/j.jneuroim.2010.08.010; Moll NM, 2009, ARCH NEUROL-CHICAGO, V66, P44, DOI 10.1001/archneurol.2008.512; Mueller AM, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-20; Odemis V, 2010, J CELL SCI, V123, P1081, DOI 10.1242/jcs.062810; Opatz J, 2009, MOL CELL NEUROSCI, V40, P293, DOI 10.1016/j.mcn.2008.11.002; Patel JR, 2010, P NATL ACAD SCI USA, V107, P11062, DOI 10.1073/pnas.1006301107; Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; PRINEAS JW, 1979, ANN NEUROL, V5, P22, DOI 10.1002/ana.410050105; Reynolds R, 2002, J NEUROCYTOL, V31, P523, DOI 10.1023/A:1025747832215; Rosner BI, 2005, EXP NEUROL, V195, P81, DOI 10.1016/j.expneurol.2005.04.003; RUTKOWSKI JL, 1995, NAT MED, V1, P80, DOI 10.1038/nm0195-80; Santos-Silva A, 2007, J NEUROSCI, V27, P7154, DOI 10.1523/JNEUROSCI.1184-07.2007; Shields SA, 2000, J NEUROSCI RES, V60, P571, DOI 10.1002/(SICI)1097-4547(20000601)60:5<571::AID-JNR1>3.0.CO;2-Q; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; Storch MK, 1998, BRAIN PATHOL, V8, P681, DOI 10.1111/j.1750-3639.1998.tb00194.x; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; VANEVERCOOREN AB, 1992, J NEUROIMMUNOL, V40, P235, DOI 10.1016/0165-5728(92)90139-C; Wang AJ, 2011, BIOMATERIALS, V32, P5023, DOI 10.1016/j.biomaterials.2011.03.070; Wohlleben G, 2000, GLIA, V30, P373, DOI 10.1002/(SICI)1098-1136(200006)30:4<373::AID-GLIA60>3.3.CO;2-R; WOOD PM, 1976, BRAIN RES, V115, P361, DOI 10.1016/0006-8993(76)90355-3; Woodhoo A, 2007, BRAIN, V130, P2175, DOI 10.1093/brain/awm125; YAMAMOTO T, 1991, J NEUROL SCI, V102, P163, DOI 10.1016/0022-510X(91)90064-E; Zujovic V, 2010, STEM CELLS, V28, P470, DOI 10.1002/stem.290; Zujovic V, 2007, NEUROSCIENTIST, V13, P383, DOI 10.1177/10738584070130041001	49	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e42667	10.1371/journal.pone.0042667	http://dx.doi.org/10.1371/journal.pone.0042667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984406	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000308638700008
J	Carriquiry, G; Otero, L; Gonzalez-Lagos, E; Zamudio, C; Sanchez, E; Nabeta, P; Campos, M; Echevarria, J; Seas, C; Gotuzzo, E				Carriquiry, Gabriela; Otero, Larissa; Gonzalez-Lagos, Elsa; Zamudio, Carlos; Sanchez, Eduardo; Nabeta, Pamela; Campos, Miguel; Echevarria, Juan; Seas, Carlos; Gotuzzo, Eduardo			A Diagnostic Accuracy Study of Xpert (R) MTB/RIF in HIV-Positive Patients with High Clinical Suspicion of Pulmonary Tuberculosis in Lima, Peru	PLOS ONE			English	Article							XPERT MTB/RIF; MYCOBACTERIUM-TUBERCULOSIS; RIFAMPICIN RESISTANCE; ASSAY; IMPLEMENTATION; COUNTRIES; BURDEN; TB	Background: Diagnosis of pulmonary tuberculosis (TB) among human immunodeficiency virus (HIV) patients remains complex and demands easy to perform and accurate tests. Xpert (R) MTB/RIF (MTB/RIF) is a molecular TB diagnostic test which is rapid and convenient; the test requires minimal human resources and reports results within two hours. The majority of performance studies of MTB/RIF have been performed in high HIV burden settings, thus TB diagnostic studies among HIV patients in low HIV prevalence settings such as Peru are still needed. Methodology/Principal Findings: From April 2010 to May 2011, HIV-positive patients with high clinical suspicion of TB were enrolled from two tertiary hospitals in Lima, Peru. Detection of TB by MTB/RIF was compared to a composite reference standard Lowenstein-Jensen (LJ) and liquid culture. Detection of rifampicin resistance was compared to the LJ proportion method. We included 131 patients, the median CD4 cell count was 154.5 cells/mm(3) and 45 (34.4%) had TB. For TB detection among HIV patients, sensitivity of MTB/RIF was 97.8% (95% CI 88.4-99.6) (44/45); specificity was 97.7% (95% CI 91.9-99.4) (84/86); the positive predictive value was 95.7% (95% CI 85.5-98.8) (44/46); and the negative predictive value, 98.8% (95% CI 93.6-99.8) (84/85). MTB/RIF detected 13/14 smear-negative TB cases, outperforming smear microscopy [97.8% (44/45) vs. 68.9% (31/45); p = 0.0002]. For rifampicin resistance detection, sensitivity of MTB/RIF was 100% (95% CI 61.0-100.0) (6/6); specificity was 91.0% (95% CI 76.4-96.9) (30/33); the positive predictive value was 66.7% (95% CI 35.4-87.9) (6/9); and the negative predictive value was 100% (95% CI 88.7 -100.0) (30/30). Conclusions/Significance: In HIV patients in our population with a high clinical suspicion of TB, MTB/RIF performed well for TB diagnosis and outperformed smear microscopy.	[Carriquiry, Gabriela; Gonzalez-Lagos, Elsa; Campos, Miguel; Echevarria, Juan; Seas, Carlos; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru; [Carriquiry, Gabriela; Otero, Larissa; Gonzalez-Lagos, Elsa; Zamudio, Carlos; Campos, Miguel; Echevarria, Juan; Seas, Carlos; Gotuzzo, Eduardo] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Sanchez, Eduardo] Hosp Nacl Hipolito Unanue, Serv Enfermedades Infecciosas & Trop, Lima, Peru; [Nabeta, Pamela] Fdn Innovat New Diagnost, Geneva, Switzerland; [Echevarria, Juan; Seas, Carlos; Gotuzzo, Eduardo] Hosp Nacl Cayetano Heredia, Dept Enfermedades Infecciosas & Trop, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Foundation For Innovative New Diagnostics	Carriquiry, G (corresponding author), Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru.	gabriela.carriquiry.c@upch.pe		Otero, Larissa/0000-0002-8348-4340; Seas, Carlos/0000-0001-7067-9141; Campos-Sanchez, Miguel/0000-0003-4650-1225; Zamudio, Carlos/0000-0001-7479-127X	Fogarty International Center at the U.S. National Institutes of Health (NIH) (Peru ICOHRTA network for AIDS/TB research) [1U2RTW007368-01A1]; FOGARTY INTERNATIONAL CENTER [U2RTW007368] Funding Source: NIH RePORTER	Fogarty International Center at the U.S. National Institutes of Health (NIH) (Peru ICOHRTA network for AIDS/TB research); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by Fogarty International Center at the U.S. National Institutes of Health (NIH) through Peru International Clinical, Operational, and Health Services Research and Training Award (Peru ICOHRTA network for AIDS/TB research) [grant number 1U2RTW007368-01A1] and received partial funding of the Belgian Cooperation through a project of institutional collaboration with the Institute of Tropical Medicine in Antwerp, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, OPENEPI OPEN SOURCE; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2005, INT J TUBERC LUNG D, V9, P1409; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Kent PT, 1985, GUIDE LEVEL 3 LAB; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Lawn SD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001067; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Mathew P, 2002, J CLIN MICROBIOL, V40, P3482, DOI 10.1128/JCM.40.9.3482-3484.2002; Ministerio de Salud, 2010, ESTR SAN NAC PREV CO; Moure R, 2011, J CLIN MICROBIOL, V49, P1137, DOI 10.1128/JCM.01831-10; Rachow A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020458; Scott LE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001061; Sterling TR, 2010, CLIN INFECT DIS, V50, pS223, DOI 10.1086/651495; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Toman K, 2004, TOMAN, P23; Tortoli E, 2012, EUR RESPIR J, V40, P442, DOI 10.1183/09031936.00176311; Trebucq A, 2011, INT J TUBERC LUNG D, V15, P1567, DOI 10.5588/ijtld.11.0392; Van Rie A, 2012, INT J TUBERC LUNG D, V16, P206, DOI 10.5588/ijtld.11.0395; Van Rie A, 2010, EXPERT REV MOL DIAGN, V10, P937, DOI [10.1586/erm.10.67, 10.1586/ERM.10.67]; Vassall A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001120; Wechsler S., 1997, STAT SQUARE ONE; World Health Organization, 2011, WHO PUBL	29	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44626	10.1371/journal.pone.0044626	http://dx.doi.org/10.1371/journal.pone.0044626			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970271	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000039
J	Park, YY; Park, ES; Kim, SB; Kim, SC; Sohn, BH; Chu, IS; Jeong, W; Mills, GB; Byers, LA; Lee, JS				Park, Yun-Yong; Park, Eun Sung; Kim, Sang Bae; Kim, Sang Cheol; Sohn, Bo Hwa; Chu, In-Sun; Jeong, Woojin; Mills, Gordon B.; Byers, Lauren Averett; Lee, Ju-Seog			Development and Validation of a Prognostic Gene-Expression Signature for Lung Adenocarcinoma	PLOS ONE			English	Article							BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; THYMIDYLATE SYNTHASE; SQUAMOUS-CELL; SURVIVAL; CLASSIFICATION; IDENTIFICATION; ASSOCIATION; CISPLATIN; PROFILES	Although several prognostic signatures have been developed in lung cancer, their application in clinical practice has been limited because they have not been validated in multiple independent data sets. Moreover, the lack of common genes between the signatures makes it difficult to know what biological process may be reflected or measured by the signature. By using classical data exploration approach with gene expression data from patients with lung adenocarcinoma (n = 186), we uncovered two distinct subgroups of lung adenocarcinoma and identified prognostic 193-gene gene expression signature associated with two subgroups. The signature was validated in 4 independent lung adenocarcinoma cohorts, including 556 patients. In multivariate analysis, the signature was an independent predictor of overall survival (hazard ratio, 2.4; 95% confidence interval, 1.2 to 4.8; p = 0.01). An integrated analysis of the signature revealed that E2F1 plays key roles in regulating genes in the signature. Subset analysis demonstrated that the gene signature could identify high-risk patients in early stage (stage I disease), and patients who would have benefit of adjuvant chemotherapy. Thus, our study provided evidence for molecular basis of clinically relevant two distinct two subtypes of lung adenocarcinoma.	[Park, Yun-Yong; Park, Eun Sung; Kim, Sang Bae; Sohn, Bo Hwa; Jeong, Woojin; Mills, Gordon B.; Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Park, Eun Sung] Yonsei Univ, Coll Med, Inst Med Convergence, Seoul, South Korea; [Kim, Sang Bae] Univ Texas Grad Sch Biomed Sci, Houston, TX USA; [Kim, Sang Cheol; Chu, In-Sun] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Jeong, Woojin] Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Ctr Cell Signaling & Drug Discovery Res, Seoul, South Korea; [Byers, Lauren Averett] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Yonsei University; Yonsei University Health System; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Ewha Womans University; University of Texas System; UTMD Anderson Cancer Center	Park, YY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.	jlee@mdanderson.org	Lee, Ju-Seog/X-1786-2018	Lee, Ju-Seog/0000-0002-5666-9753	University of Texas MD Anderson Cancer Center; KRIBB Research Initiative Program; National Cancer Institute at National Institutes of Health CCSG [CA106672]; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA098258] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	University of Texas MD Anderson Cancer Center; KRIBB Research Initiative Program; National Cancer Institute at National Institutes of Health CCSG; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by the intramural faculty fund of The University of Texas MD Anderson Cancer Center to JSL and a grant from "KRIBB Research Initiative Program" to ISC. MD Anderson Cancer Center is partially funded by National Cancer Institute at National Institutes of Health CCSG Core Grant CA106672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chansky K, 2009, J THORAC ONCOL, V4, P792, DOI 10.1097/JTO.0b013e3181a7716e; Chen CW, 2011, INT J BIOL SCI, V7, P551, DOI 10.7150/ijbs.7.551; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Douillard JY, 2006, LANCET ONCOL, V7, P719, DOI 10.1016/S1470-2045(06)70804-X; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fujiwara T, 2012, LUNG CANCER, V75, P119, DOI 10.1016/j.lungcan.2011.05.028; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gomez HL, 2006, CLIN CANCER RES, V12, P832, DOI 10.1158/1078-0432.CCR-05-0295; Guo L, 2006, CLIN CANCER RES, V12, P3344, DOI 10.1158/1078-0432.CCR-05-2336; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hashimoto H, 2006, CANCER-AM CANCER SOC, V106, P1595, DOI 10.1002/cncr.21777; Inamura K, 2005, ONCOGENE, V24, P7105, DOI 10.1038/sj.onc.1208858; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kadara H, 2010, NEOPLASIA, V12, P499, DOI 10.1593/neo.10390; Kattan MW, 2003, J NATL CANCER I, V95, P634, DOI 10.1093/jnci/95.9.634; Katz EM, 2005, NAT CLIN PRACT ONCOL, V2, P482, DOI 10.1038/ncponc0318; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Larsen JE, 2007, CLIN CANCER RES, V13, P2946, DOI 10.1158/1078-0432.CCR-06-2525; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Li C, 2004, ONCOGENE, V23, P9336, DOI 10.1038/sj.onc.1208114; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Lu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030880; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; NARUKE T, 1988, J THORAC CARDIOV SUR, V96, P440; Neumann J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-77; Oh SC, 2012, GUT, V61, P1291, DOI 10.1136/gutjnl-2011-300812; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; PAIROLERO PC, 1984, ANN THORAC SURG, V38, P331, DOI 10.1016/S0003-4975(10)62281-3; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Roepman P, 2009, CLIN CANCER RES, V15, P284, DOI 10.1158/1078-0432.CCR-08-1258; Rose Michal G, 2002, Clin Colorectal Cancer, V1, P220, DOI 10.3816/CCC.2002.n.003; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Selvaggi G, 2009, ONCOLOGY-NY, V23, P1133; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shih C, 1997, CANCER RES, V57, P1116; Shimokawa H, 2011, LUNG CANCER, V72, P360, DOI 10.1016/j.lungcan.2010.08.024; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Simon R, 2007, CANCER INFORM, V3, P11; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Subramanian J, 2010, JNCI-J NATL CANCER I, V102, P464, DOI 10.1093/jnci/djq025; Sun ZF, 2008, J CLIN ONCOL, V26, P877, DOI 10.1200/JCO.2007.13.1516; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Takezawa K, 2011, BRIT J CANCER, V104, P1594, DOI 10.1038/bjc.2011.129; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162	58	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44225	10.1371/journal.pone.0044225	http://dx.doi.org/10.1371/journal.pone.0044225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970185	Green Published, gold			2022-12-25	WOS:000308462000014
J	Wang, QF; Huang, ZH; Ni, SJ; Xiao, XY; Xu, QH; Wang, LS; Huang, D; Tan, C; Sheng, WQ; Du, X				Wang, Qifeng; Huang, Zhaohui; Ni, Shujuan; Xiao, Xiuying; Xu, Qinghua; Wang, Lisha; Huang, Dan; Tan, Cong; Sheng, Weiqi; Du, Xiang			Plasma miR-601 and miR-760 Are Novel Biomarkers for the Early Detection of Colorectal Cancer	PLOS ONE			English	Article							CIRCULATING MICRORNAS; EXPRESSION; SERUM; DIAGNOSIS; MARKER; CHINA	Background: Colorectal cancer (CRC) is a major cause of death worldwide. Sensitive, non-invasive diagnostic screen methods are urgently needed to improve its survival rates. Stable circulating microRNA offers unique opportunities for the early diagnosis of several diseases, including cancers. Our aim has been to find new plasma miRNAs that can be used as biomarkers for the detection of CRC. Methodology/Principal Findings: According to the results of miRNA profiling performed on pooling plasma samples form 10 CRC patients or 10 healthy controls, a panel of miRNAs (hsa-miR-10a, -19a, -22*, -24, -92a, 125a-5p, -141, -150, -188-3p, 192, -210, -221, -224*, -376a, -425*, -495, -572, -601, -720, -760 and hsa-let-7a, -7e) were deregulated in CRC plasma with fold changes.5. After large scale validation by qRT-PCR performed on another 191 independent individuals (90 CRC, 43 advanced adenoma and 58 healthy participants), we found that the levels of plasma miR-601 and miR-760 were significantly decreased in colorectal neoplasia (carcinomas and advanced adenomas) compared with healthy controls. ROC curve analysis showed that plasma miR-601 and miR-760 were of significant diagnostic value for advanced neoplasia. These two miRNAs together yield an AUC of 0.792 with 83.3% sensitivity and 69.1% specificity for separating CRC from normal controls, and yield an AUC of 0.683 with 72.1% sensitivity and 62.1% specificity in discriminating advanced adenomas from normal controls. Conclusions/Significance: Plasma miR-601 and miR-760 can potentially serve as promising non-invasive biomarkers for the early detection of CRC.	[Wang, Qifeng; Ni, Shujuan; Xiao, Xiuying; Xu, Qinghua; Wang, Lisha; Huang, Dan; Tan, Cong; Sheng, Weiqi; Du, Xiang] Fudan Univ, Canc Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Wang, Qifeng; Ni, Shujuan; Xiao, Xiuying; Xu, Qinghua; Wang, Lisha; Huang, Dan; Tan, Cong; Sheng, Weiqi; Du, Xiang] Fudan Univ, Shanghai Med Sch, Dept Oncol, Shanghai 200433, Peoples R China; [Wang, Qifeng; Ni, Shujuan; Xiao, Xiuying; Xu, Qinghua; Wang, Lisha; Huang, Dan; Tan, Cong; Sheng, Weiqi; Du, Xiang] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Wang, Qifeng; Huang, Zhaohui] Suzhou Univ, Affiliated Hosp 4, Wuxi Oncol Inst, Wuxi, Jiangsu, Peoples R China; [Xu, Qinghua] Fudan Univ, Shanghai Canc Ctr, Inst Merieux Lab, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University	Wang, QF (corresponding author), Fudan Univ, Canc Hosp, Dept Pathol, Shanghai 200433, Peoples R China.	dx2008cn@yahoo.com.cn	XU, Qinghua/AAZ-9641-2021; Huang, Zhaohui/S-9410-2019	XU, Qinghua/0000-0002-9380-5566; Huang, Zhaohui/0000-0002-0117-9976; Guo, Weijie/0000-0001-7167-9899	National Natural Science Foundation of China [81000867, 81071791]; Science and TechnologyCommission of Shanghai Municipality [09JC1403700, 10XD1401300]; Starting Merieux Research Grants	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and TechnologyCommission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Starting Merieux Research Grants	This study was partially supported by grants from National Natural Science Foundation of China (Grant Nos. 81000867 and 81071791), Science and TechnologyCommission of Shanghai Municipality (Grant No. 09JC1403700 and 10XD1401300), and Starting Merieux Research Grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, ANN SURG, V251, P499; Butterly LF, 2008, NEW ENGL J MED, V358, P89; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Catto JWF, 2009, CANCER RES, V69, P8472, DOI 10.1158/0008-5472.CAN-09-0744; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng H, PLOS ONE, V6; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; El-Maraghi RH, 2009, ACAD RADIOL, V16, P564, DOI 10.1016/j.acra.2009.01.008; Fichtlscherer S, CIRC RES, V107, P677; Huang ZH, 2010, INT J CANCER, V127, P118, DOI 10.1002/ijc.25007; Komatsu S, BR J CANC, V105, P104; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Liu G, MOL BIOL REP, V37, P3575; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Ohdaira H, 2009, COMPUT BIOL CHEM, V33, P429, DOI 10.1016/j.compbiolchem.2009.09.003; Pu XX, 2010, J GASTROEN HEPATOL, V25, P1674, DOI 10.1111/j.1440-1746.2010.06417.x; Resnick KE, 2009, GYNECOL ONCOL, V112, P55, DOI 10.1016/j.ygyno.2008.08.036; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schrauder MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029770; Shen J., 2012, PROSTATE; Shigoka M, 1992, PATHOL INT, V60, P351; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Tsujiura M, BR J CANC, V102, P1174; Waldman SA, 2008, CLIN CHEM, V54, P943, DOI 10.1373/clinchem.2008.105353; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Yang L, 2003, INT J CANCER, V106, P771, DOI 10.1002/ijc.11300; Zhang YL, 2002, WORLD J GASTROENTERO, V8, P21, DOI 10.3748/wjg.v8.i1.21	32	207	222	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44398	10.1371/journal.pone.0044398	http://dx.doi.org/10.1371/journal.pone.0044398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970209	Green Submitted, Green Published, gold			2022-12-25	WOS:000308458400065
J	Herranz, D; Maraver, A; Canamero, M; Gomez-Lopez, G; Inglada-Perez, L; Robledo, M; Castelblanco, E; Matias-Guiu, X; Serrano, M				Herranz, D.; Maraver, A.; Canamero, M.; Gomez-Lopez, G.; Inglada-Perez, L.; Robledo, M.; Castelblanco, E.; Matias-Guiu, X.; Serrano, M.			SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency	ONCOGENE			English	Article						SIRT1; c-MYC; PTEN; thyroid cancer; prostate cancer	C-MYC; ONCOPROTEIN; BIOGENESIS; MUTATION; MOUSE; P53	Current genetic evidence in mice indicates that SIRT1 has potent tumor suppressor activity in a variety of cancer models, with no evidence yet for SIRT1 oncogenic activity in vivo. We report here that transgenic Sirt1 expression is oncogenic in murine thyroid and prostate carcinogenesis initiated by Pten-deficiency. Based on mRNA expression analyses of pre-tumoral murine thyroids, we find that SIRT1 increases c-MYC transcriptional programs. Moreover, we show higher c-MYC protein levels in murine thyroid cancers from Sirt1 transgenic mice. Similarly, SIRT1 is overexpressed in human thyroid cancers and it is positively correlated with c-MYC protein levels. Finally, we show in cultured thyroid cancer cells that SIRT1 stabilizes c-MYC protein. These results implicate SIRT1 as a new candidate target for the treatment of thyroid carcinomas.	[Herranz, D.; Maraver, A.; Serrano, M.] Spanish Natl Canc Res Ctr CNIO, Tumor Suppress Grp, E-28029 Madrid, Spain; [Canamero, M.] Spanish Natl Canc Res Ctr CNIO, Comparat Pathol Unit, E-28029 Madrid, Spain; [Gomez-Lopez, G.] Spanish Natl Canc Res Ctr CNIO, Bioinformat Unit, E-28029 Madrid, Spain; [Inglada-Perez, L.; Robledo, M.] Spanish Natl Canc Res Ctr CNIO, CIBERER, E-28029 Madrid, Spain; [Inglada-Perez, L.; Robledo, M.] Spanish Natl Canc Res Ctr CNIO, Hereditary Endocrine Canc Grp, E-28029 Madrid, Spain; [Castelblanco, E.; Matias-Guiu, X.] Univ Lleida, Hosp Univ Arnau de Vilanova, Dept Pathol & Mol Genet, Irblleida, Lleida, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Centro Nacional de Investigaciones Oncologicas (CNIO); Universitat de Lleida; University Hospital Arnau de Vilanova	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, 3 Melchor Fernandez Almagro St, E-28029 Madrid, Spain.	mserrano@cnio.es	Maraver, Antonio/G-2666-2015; inglada-perez, lucia/H-5378-2015; /AAI-3238-2021; Herranz, Daniel/L-6986-2017; matias-guiu, xavier/C-3039-2009; Serrano, Manuel/H-2634-2015; Robledo, Mercedes/O-2230-2013; Gomez-Lopez, Gonzalo/D-9123-2016; Inglada-Perez, Lucia/Z-3020-2019; E, Esmeralda Castelblanco/A-7588-2011	Herranz, Daniel/0000-0003-1768-5969; matias-guiu, xavier/0000-0002-7201-6605; Serrano, Manuel/0000-0001-7177-9312; Robledo, Mercedes/0000-0001-6256-5902; Gomez-Lopez, Gonzalo/0000-0002-4146-0551; E, Esmeralda Castelblanco/0000-0002-2061-6270; Inglada-Perez, Lucia/0000-0001-9814-4368; INGLADA, LUCIA/0000-0001-9523-2717; Maraver, Antonio/0000-0002-5527-5680	CNIO; Spanish Ministry of Science (SAF); Spanish Ministry of Science (CONSOLIDER); European Research Council (ERC); 'Marcelino Botin' Foundation; AXA Foundation; 'Ramon Areces' Foundation; Spanish Ministry of Health; CIBERER;  [RD09/0076/00059]	CNIO; Spanish Ministry of Science (SAF)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science (CONSOLIDER)(Ministry of Science and Innovation, Spain (MICINN)); European Research Council (ERC)(European Research Council (ERC)European Commission); 'Marcelino Botin' Foundation; AXA Foundation; 'Ramon Areces' Foundation; Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); CIBERER; 	We thank Maribel Munoz and Gema Iglesias for excellent mouse handling. Work in the laboratory of MS is funded by the CNIO and by grants from the Spanish Ministry of Science (SAF and CONSOLIDER), the European Research Council (ERC Advanced Grant), the 'Marcelino Botin' Foundation, the AXA Foundation and the 'Ramon Areces' Foundation. AM is funded by a 'Miguel Servet' grant from the Spanish Ministry of Health. LI-P is supported by CIBERER. Human tumor samples were obtained with the support of Xarxa Catalana de Bancs de Tumors, the Tumor Bank Platform of RTICC, and project RD09/0076/00059.	Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Cerutti J, 1996, CLIN CANCER RES, V2, P119; Chen X, 2008, COLD SH Q B, V73, P203, DOI 10.1101/sqb.2008.73.026; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Lin CJ, 2009, CANCER RES, V69, P7491, DOI 10.1158/0008-5472.CAN-09-0813; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mao BB, 2011, INT J BIOCHEM CELL B, V43, P1573, DOI 10.1016/j.biocel.2011.07.006; Marshall GM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002135; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; ROMANO MI, 1993, HORM RES, V39, P161, DOI 10.1159/000182718; Schmidt EV, 2004, ONCOGENE, V23, P3217, DOI 10.1038/sj.onc.1207548; Smith KN, 2010, CELL STEM CELL, V7, P343, DOI 10.1016/j.stem.2010.06.023; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Suzuki A, 1998, CURR BIOL, V8, P1169, DOI 10.1016/S0960-9822(07)00488-5; Thomas LR, 2011, ADV CANCER RES, V110, P77, DOI 10.1016/B978-0-12-386469-7.00004-9; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yuan J, 2009, J CELL BIOL, V185, P203, DOI 10.1083/jcb.200809167	25	50	52	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 22	2013	32	34					4052	4056		10.1038/onc.2012.407	http://dx.doi.org/10.1038/onc.2012.407			5	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IC	22986535				2022-12-25	WOS:000323748100014
J	Dikshit, B; Irshad, K; Madan, E; Aggarwal, N; Sarkar, C; Chandra, PS; Gupta, DK; Chattopadhyay, P; Sinha, S; Chosdol, K				Dikshit, B.; Irshad, K.; Madan, E.; Aggarwal, N.; Sarkar, C.; Chandra, P. S.; Gupta, D. K.; Chattopadhyay, P.; Sinha, S.; Chosdol, K.			FAT1 acts as an upstream regulator of oncogenic and inflammatory pathways, via PDCD4, in glioma cells	ONCOGENE			English	Article						FAT1; inflammation; PDCD4; AP-1; COX-2; glioma	TUMOR-SUPPRESSOR GENE; INDEPENDENT PROGNOSTIC-FACTOR; HUMAN LUNG-CANCER; BREAST-CANCER; TRANSCRIPTION FACTOR; DEATH 4; C-JUN; DOWN-REGULATION; TRANSFORMATION SUPPRESSOR; FREQUENT LOSS	Glioblastoma multiforme (GBM) is the most aggressive and the commonest primary brain tumor with a tendency for local invasiveness. The pathways of neoplasia, invasion and inflammation are inextricably linked in cancer and aberrations in several regulatory pathways for these processes have been identified. Here we have studied the FAT1 (Homo sapiens FAT tumor-suppressor homolog 1 (Drosophila)) gene to identify its role in the tumorigenecity of the gliomas. The expression of FAT1 was found to be high in grade IV glioma cell lines (U87MG, A172, U373MG and T98G) but low in grade III glioma cell lines (GOS3 and SW1088). Two cell lines (U87MG and A172) with high FAT1 expression were chosen for in vitro FAT1-knockdown studies. FAT1 knockdown by small interfering RNA resulted in decreased migration and invasion of both the cell lines along with increased expression of the tumor-suppressor gene programmed cell death 4 (PDCD4). Increased PDCD4 expression led to the attenuation of activator protein-1 (AP-1) transcription by inhibiting c-Jun phosphorylation and resulted in concomitant decrease in the expression of AP-1-target genes like MMP3, VEGF-C and PLAU, the pro-inflammatory regulator COX-2 and cytokines IL1 beta and IL-6. Conversely, simultaneous silencing of PDCD4 and FAT1 in these cells significantly enhanced AP-1 activity and expression of its target genes, resulting in increase in mediators of inflammation and in enhanced migratory and invasive properties of the cells. We also observed a negative correlation between the expression of FAT1 and PDCD4 (P = 0.0145), a positive correlation between the expression of FAT1 and COX-2 (P = 0.048) and a similar positive trend between FAT1 and IL-6 expression in 35 primary human GBM samples studied. Taken together, this study identifies a novel signaling mechanism mediated by FAT1 in regulating the activity of PDCD4 and thereby the key transcription factor AP-1, which then affects known mediators of neoplasia and inflammation.	[Dikshit, B.; Irshad, K.; Madan, E.; Aggarwal, N.; Chattopadhyay, P.; Sinha, S.; Chosdol, K.] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Sarkar, C.] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India; [Chandra, P. S.] All India Inst Med Sci, Dept Neurosurg, New Delhi 110029, India; [Sinha, S.] Natl Brain Res Ctr, Gurgaon, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Sinha, S (corresponding author), Natl Brain Res Ctr, Near NSG Campus, Manesar 122050, Gurgaon, India.	sub_sinha@hotmail.com; kunzangchosdol@yahoo.com	Irshad, Khushboo/AAT-6842-2020; Aggarwal, Nupur/K-1296-2019	Irshad, Khushboo/0000-0002-1552-3686; Aggarwal, Nupur/0000-0002-7992-0023; chosdol, kunzang/0000-0002-7065-3395	Defense Research and Development Organization (DRDO), India [LSRB167-2008]; National Brain Research Center, India; Council of Scientific and Industrial Research (CSIR, India); Indian Council of Medical Research (ICMR, India)	Defense Research and Development Organization (DRDO), India(Defence Research & Development Organisation (DRDO)); National Brain Research Center, India; Council of Scientific and Industrial Research (CSIR, India)(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research (ICMR, India)(Indian Council of Medical Research (ICMR))	The work has been supported by grant from Defense Research and Development Organization (DRDO), India (no. LSRB167-2008) to KC and National Brain Research Center, India, core intramural grant to SS. RF (Research fellowship) to BD and EM from Council of Scientific and Industrial Research (CSIR, India) and RF to KI from Indian Council of Medical Research (ICMR, India). We would like to acknowledge Dr Miguel Iniguez for providing COX-2 promoter luciferase plasmid and Dr Shayamal Goswami, Dr Balaji and Dr Sandeep Saxena for their help during the progress of the work. We thank our Lab technician Ms Jyoti and Lab attendants Late Mathura Prasad, Mr Pappu, Mr Gopal and Mr Ajay for their assistance in routine lab work and cell-culture work.	Afonja O, 2004, ONCOGENE, V23, P8135, DOI 10.1038/sj.onc.1207983; Aggarwal BB, 2009, CURR OPIN PHARMACOL, V9, P351, DOI 10.1016/j.coph.2009.06.020; Alves TR, 2011, LIFE SCI, V89, P532, DOI 10.1016/j.lfs.2011.04.022; ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Balkwill F, 2010, CLIN PHARMACOL THER, V87, P401, DOI 10.1038/clpt.2009.312; Bendavid C, 2007, EUR J MED GENET, V50, P66, DOI 10.1016/j.ejmg.2006.09.003; Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Bhattacharya A, 2001, CLIN CANCER RES, V7, P267; Bitomsky N, 2004, ONCOGENE, V23, P7484, DOI 10.1038/sj.onc.1208064; Borrello MG, 2008, CANCER LETT, V267, P262, DOI 10.1016/j.canlet.2008.03.060; Braun GS, 2007, J BIOL CHEM, V282, P22823, DOI 10.1074/jbc.M701758200; Chen Y, 2003, J PATHOL, V200, P640, DOI 10.1002/path.1378; Chiu WT, 2010, NEUROBIOL DIS, V37, P118, DOI 10.1016/j.nbd.2009.09.015; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Chosdol K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-5; Dannenberg AJ, 2003, CANCER CELL, V4, P431, DOI 10.1016/S1535-6108(03)00310-6; de Bock CE, 2012, LEUKEMIA, V26, P918, DOI 10.1038/leu.2011.319; de la Iglesia N, 2008, GENE DEV, V22, P449, DOI 10.1101/gad.1606508; de Visser KE, 2009, CURR PHARM DESIGN, V15, P1844, DOI 10.2174/138161209788453239; Demaria S, 2010, J IMMUNOTHER, V33, P335, DOI 10.1097/CJI.0b013e3181d32e74; Deorukhkar A, 2010, BIOCHEM PHARMACOL, V80, P1904, DOI 10.1016/j.bcp.2010.06.039; Ding LL, 2012, MED ONCOL, V29, P1758, DOI 10.1007/s12032-011-0042-6; DUNNE J, 1995, GENOMICS, V30, P207, DOI 10.1006/geno.1995.9884; Eberstal S, 2012, CANCER IMMUNOL IMMUN, V61, P1191, DOI 10.1007/s00262-011-1196-y; Fleenor DL, 2003, INVEST OPHTH VIS SCI, V44, P3494, DOI 10.1167/iovs.02-0757; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; Fuchs SY, 1996, ONCOGENE, V13, P1531; Gao F, 2007, ONCOL REP, V17, P123; Gao F, 2009, J CELL MOL MED, V13, P4257, DOI 10.1111/j.1582-4934.2008.00497.x; Garodia Prachi, 2007, J Soc Integr Oncol, V5, P25, DOI 10.2310/7200.2006.029; Gaur AB, 2011, NEURO-ONCOLOGY, V13, P580, DOI 10.1093/neuonc/nor033; Goldbrunner RH, 1998, MICROSC RES TECHNIQ, V43, P250, DOI 10.1002/(SICI)1097-0029(19981101)43:3<250::AID-JEMT7>3.0.CO;2-C; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Grivennikov SI, 2010, CURR OPIN GENET DEV, V20, P65, DOI 10.1016/j.gde.2009.11.004; Hara A, 2004, ACTA NEUROPATHOL, V108, P43, DOI 10.1007/s00401-004-0860-0; Harris Randall E, 2007, Subcell Biochem, V42, P193; Harris Randall E, 2007, Subcell Biochem, V42, P93; Harris RE, 2007, INT J BIOL SCI, V3, P328; Herseth JI, 2009, TOXICOL IN VITRO, V23, P1342, DOI 10.1016/j.tiv.2009.06.031; Hou R, 2006, J CELL BIOL, V173, P417, DOI 10.1083/jcb.200508121; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Iniguez MA, 2000, J BIOL CHEM, V275, P23627, DOI 10.1074/jbc.M001381200; Joki T, 2000, CANCER RES, V60, P4926; Karamouzis MV, 2007, MOL CANCER RES, V5, P109, DOI 10.1158/1541-7786.MCR-06-0311; Katoh Y, 2006, INT J MOL MED, V18, P523; Krakauer Teresa, 2004, Current Drug Targets - Inflammation and Allergy, V3, P317; Kwaepila N, 2006, PATHOLOGY, V38, P125, DOI 10.1080/00313020600559975; Lankat-Buttgereit B, 2003, BIOL CELL, V95, P515, DOI 10.1016/j.biolcel.2003.09.003; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; Leaner VD, 2003, ONCOGENE, V22, P5619, DOI 10.1038/sj.onc.1206644; Leaner VD, 2009, AM J PATHOL, V174, P265, DOI 10.2353/ajpath.2009.071006; Leupold JH, 2007, ONCOGENE, V26, P4550, DOI 10.1038/sj.onc.1210234; Lim SK, 2011, BMB REP, V44, P158, DOI 10.5483/BMBRep.2011.44.3.158; Liu YM, 2002, ONCOGENE, V21, P7680, DOI 10.1038/sj.onc.1205883; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Mandal RK, 2011, ARCH MED RES, V42, P620, DOI 10.1016/j.arcmed.2011.10.005; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Moeller MJ, 2004, EMBO J, V23, P3769, DOI 10.1038/sj.emboj.7600380; Moore MM, 2010, CLIN PHARMACOL THER, V87, P504, DOI 10.1038/clpt.2009.254; Mudduluru G, 2007, CANCER-AM CANCER SOC, V110, P1697, DOI 10.1002/cncr.22983; Munshi A., 2009, Indian Journal of Cancer, V46, P127, DOI 10.4103/0019-509X.49150; Muraoka-Cook RS, 2005, CLIN CANCER RES, V11, p937S; Nakaya K, 2007, ONCOGENE, V26, P5300, DOI 10.1038/sj.onc.1210330; New Pamela, 2004, Cancer Control, V11, P152; Nieves-Alicea R, 2009, BREAST CANCER RES TR, V114, P203, DOI 10.1007/s10549-008-9993-5; Nishikawa Y, 2011, ONCOL REP, V26, P587, DOI 10.3892/or.2011.1324; Noble M, 1997, J NEURO-ONCOL, V35, P193, DOI 10.1023/A:1005898228116; Ozanne BW, 2000, EUR J CANCER, V36, P1640, DOI 10.1016/S0959-8049(00)00175-1; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Santhanam AN, 2010, ONCOGENE, V29, P3921, DOI 10.1038/onc.2010.158; Sareddy GR, 2012, J NEURO-ONCOL, V106, P99, DOI 10.1007/s11060-011-0662-x; Schmid T, 2011, CARCINOGENESIS, V32, P1427, DOI 10.1093/carcin/bgr131; SCHONTHAL A, 1992, P NATL ACAD SCI USA, V89, P4972, DOI 10.1073/pnas.89.11.4972; Sen E, 2011, DRUG DISCOV TODAY, V16, P1044, DOI 10.1016/j.drudis.2011.09.003; Sharma V, 2011, NEUROCHEM INT, V59, P567, DOI 10.1016/j.neuint.2011.06.018; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Shibahara K, 1995, GENE, V166, P297, DOI 10.1016/0378-1119(95)00607-9; Shono T, 2001, CANCER RES, V61, P4375; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Sinha S, 2011, CELL SIGNAL, V23, P1869, DOI 10.1016/j.cellsig.2011.06.024; Subbaramaiah K, 2002, CANCER RES, V62, P2522; Subbaramaiah K, 2002, J BIOL CHEM, V277, P18649, DOI 10.1074/jbc.M111415200; Tafani M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-32; Tanoue T, 2005, J CELL SCI, V118, P2347, DOI 10.1242/jcs.02398; Tanoue T, 2004, J CELL BIOL, V165, P517, DOI 10.1083/jcb.200403006; Teodorczyk M, 2010, J CELL PHYSIOL, V222, P1, DOI 10.1002/jcp.21901; Tewari R, 2012, J MOL MED, V90, P67, DOI 10.1007/s00109-011-0807-6; Tsuji F, 2007, INT IMMUNOPHARMACOL, V7, P1569, DOI 10.1016/j.intimp.2007.07.020; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wang WQ, 2010, MOL DIAGN THER, V14, P155, DOI 10.2165/11536340-000000000-00000; Wang XY, 2008, ANTICANCER RES, V28, P2991; Waters LC, 2011, J BIOL CHEM, V286, P17270, DOI 10.1074/jbc.M110.166157; Wei ZT, 2009, CANCER SCI, V100, P1408, DOI 10.1111/j.1349-7006.2009.01210.x; Wen YH, 2007, ONCOL REP, V18, P1387; Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005; Yang HS, 2006, MOL CELL BIOL, V26, P1297, DOI 10.1128/MCB.26.4.1297-1306.2006; Yang HS, 2003, ONCOGENE, V22, P3712, DOI 10.1038/sj.onc.1206433; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Yasuda M, 2010, MOL CARCINOGEN, V49, P837, DOI 10.1002/mc.20660; Zhang ZH, 2001, ONCOGENE, V20, P4450, DOI 10.1038/sj.onc.1204588	104	44	48	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2013	32	33					3798	3808		10.1038/onc.2012.393	http://dx.doi.org/10.1038/onc.2012.393			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	202JH	22986533				2022-12-25	WOS:000323210200002
J	Du, YT; Zhang, HH; Lu, J; Holmgren, A				Du, Yatao; Zhang, Huihui; Lu, Jun; Holmgren, Arne			Glutathione and Glutaredoxin Act as a Backup of Human Thioredoxin Reductase 1 to Reduce Thioredoxin 1 Preventing Cell Death by Aurothioglucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN THIOREDOXIN; CANCER-THERAPY; IN-VIVO; PROTEIN OXIDATION; DNA-REPLICATION; REDOX STATE; SYSTEM; EBSELEN; DITHIOTHREITOL; IDENTIFICATION	Thioredoxin reductase 1 (TrxR1) in cytosol is the only known reductant of oxidized thioredoxin 1 (Trx1) in vivo so far. We and others found that aurothioglucose (ATG), a well known active-site inhibitor of TrxR1, inhibited TrxR1 activity in HeLa cell cytosol but had no effect on the viability of the cells. Using a redox Western blot analysis, no change was observed in redox state of Trx1, which was mainly fully reduced with five sulfhydryl groups. In contrast, auranofin killed cells and oxidized Trx1, also targeting mitochondrial TrxR2 and Trx2. Combining ATG with ebselen gave a strong synergistic effect, leading to Trx1 oxidation, reactive oxygen species accumulation, and cell death. We hypothesized that there should exist a backup system to reduce Trx1 when only TrxR1 activity was lost. Our results showed that physiological concentrations of glutathione, NADPH, and glutathione reductase reduced Trx1 in vitro and that the reaction was strongly stimulated by glutaredoxin1. Simultaneous depletion of TrxR activity by ATG and glutathione by buthionine sulfoximine led to overoxidation of Trx1 and loss of HeLa cell viability. In conclusion, the glutaredoxin system and glutathione have a backup role to keep Trx1 reduced in cells with loss of TrxR1 activity. Monitoring the redox state of Trx1 shows that cell death occurs when Trx1 is oxidized, followed by general protein oxidation catalyzed by the disulfide form of thioredoxin.	[Du, Yatao; Zhang, Huihui; Lu, Jun; Holmgren, Arne] Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, S-17177 Stockholm, Sweden	Karolinska Institutet	Holmgren, A (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Biochem, S-17177 Stockholm, Sweden.	Arne.Holmgren@ki.se	Lu, Jun/E-9701-2017; Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022	Lu, Jun/0000-0002-1699-8835; Du, Yatao/0000-0002-6881-0080	Swedish Research Council Medicine; Swedish Cancer Society; K.A. Wallenberg Foundation	Swedish Research Council Medicine(Swedish Research Council); Swedish Cancer Society(Swedish Cancer Society); K.A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council Medicine, the Swedish Cancer Society, and the K.A. Wallenberg Foundation.	Ahsan MK, 2009, ANTIOXID REDOX SIGN, V11, P2741, DOI [10.1089/ars.2009.2683, 10.1089/ARS.2009.2683]; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Becker K, 2000, EUR J BIOCHEM, V267, P6118, DOI 10.1046/j.1432-1327.2000.01703.x; Berg D, 2004, CELL TISSUE RES, V318, P201, DOI 10.1007/s00441-004-0976-5; Bersani NA, 2002, METHOD ENZYMOL, V347, P317; Bindoli A, 2009, COORDIN CHEM REV, V253, P1692, DOI 10.1016/j.ccr.2009.02.026; Butterfield DA, 1998, ANN NY ACAD SCI, V854, P448, DOI 10.1111/j.1749-6632.1998.tb09924.x; Drechsel DA, 2010, J BIOL CHEM, V285, P27850, DOI 10.1074/jbc.M110.101196; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Fang Jianguo, 2005, Toxicol Appl Pharmacol, V207, P103, DOI 10.1016/j.taap.2005.02.022; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Greetham D., 2012, ANTIOXID REDOX SIGNA; Gromer S, 1998, J BIOL CHEM, V273, P20096, DOI 10.1074/jbc.273.32.20096; Gutscher M, 2008, NAT METHODS, V5, P553, DOI [10.1038/nmeth.1212, 10.1038/NMETH.1212]; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Kondo N, 2006, ANTIOXID REDOX SIGN, V8, P1881, DOI 10.1089/ars.2006.8.1881; Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25; Lu J, 2006, CANCER RES, V66, P4410, DOI 10.1158/0008-5472.CAN-05-3310; Lu J, 2009, J BIOL CHEM, V284, P723, DOI 10.1074/jbc.R800045200; Lu J, 2007, P NATL ACAD SCI USA, V104, P12288, DOI 10.1073/pnas.0701549104; Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Mustacich D, 2000, BIOCHEM J, V346, P1, DOI 10.1042/0264-6021:3460001; Myers JM, 2009, FREE RADICAL BIO MED, V47, P1477, DOI 10.1016/j.freeradbiomed.2009.08.015; Nordberg J, 2001, FREE RADICAL BIO MED, V31, P1287, DOI 10.1016/S0891-5849(01)00724-9; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Pourahmad J, 2001, FREE RADICAL BIO MED, V30, P89, DOI 10.1016/S0891-5849(00)00450-0; Prigge JR, 2012, FREE RADICAL BIO MED, V52, P803, DOI 10.1016/j.freeradbiomed.2011.11.025; Rengby O, 2004, APPL ENVIRON MICROB, V70, P5159, DOI 10.1128/AEM.70.9.5159-5167.2004; Rollins MF, 2010, J CELL SCI, V123, P2402, DOI 10.1242/jcs.068106; ROTHWARF DM, 1992, P NATL ACAD SCI USA, V89, P7944, DOI 10.1073/pnas.89.17.7944; Sallmyr A, 2008, CANCER LETT, V270, P1, DOI 10.1016/j.canlet.2008.03.036; Sasada T, 1999, FREE RADICAL BIO MED, V27, P504, DOI 10.1016/S0891-5849(99)00101-X; SIES H, 1993, FREE RADICAL BIO MED, V14, P313, DOI 10.1016/0891-5849(93)90028-S; Smith AD, 1999, J NUTR, V129, P194, DOI 10.1093/jn/129.1.194; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Stadtman ER, 1998, DRUG METAB REV, V30, P225, DOI 10.3109/03602539808996310; TAKAHASHI N, 1990, ANAL BIOCHEM, V188, P359, DOI 10.1016/0003-2697(90)90621-F; Tan SX, 2010, J BIOL CHEM, V285, P6118, DOI 10.1074/jbc.M109.062844; Tonissen KF, 2009, MOL NUTR FOOD RES, V53, P87, DOI 10.1002/mnfr.200700492; Traber KE, 1999, INT IMMUNOL, V11, P143, DOI 10.1093/intimm/11.2.143; Trotter EW, 2003, EMBO REP, V4, P184, DOI 10.1038/sj.embor.embor729; Urig S, 2006, SEMIN CANCER BIOL, V16, P452, DOI 10.1016/j.semcancer.2006.09.004; Wang XF, 2007, TOXICOL APPL PHARM, V218, P88, DOI 10.1016/j.taap.2006.10.029; Watson WH, 2008, BIOCHEM BIOPH RES CO, V368, P832, DOI 10.1016/j.bbrc.2008.02.006; Watson WH, 2003, J BIOL CHEM, V278, P33408, DOI 10.1074/jbc.M211107200; Yang CF, 2000, ARCH BIOCHEM BIOPHYS, V374, P142, DOI 10.1006/abbi.1999.1574; Yla-Herttuala S, 1999, ANN NY ACAD SCI, V874, P134, DOI 10.1111/j.1749-6632.1999.tb09231.x; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200; Yoo MH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001112; Zhao R, 2002, J BIOL CHEM, V277, P39456, DOI 10.1074/jbc.M206452200; Zhao R, 2002, P NATL ACAD SCI USA, V99, P8579, DOI 10.1073/pnas.122061399	55	159	163	2	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.392225	http://dx.doi.org/10.1074/jbc.M112.392225			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977247	Green Published, hybrid			2022-12-25	WOS:000310642200054
J	Bhat, R; Crowe, EP; Bitto, A; Moh, M; Katsetos, CD; Garcia, FU; Johnson, FB; Trojanowski, JQ; Sell, C; Torres, C				Bhat, Rekha; Crowe, Elizabeth P.; Bitto, Alessandro; Moh, Michelle; Katsetos, Christos D.; Garcia, Fernando U.; Johnson, Frederick Bradley; Trojanowski, John Q.; Sell, Christian; Torres, Claudio			Astrocyte Senescence as a Component of Alzheimer's Disease	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; CELLULAR SENESCENCE; IN-VITRO; NATURAL OLIGOMERS; DNA-DAMAGE; CELLS; BIOMARKER; COLLAGENASE; P16(INK4A); ACTIVATION	Aging is the main risk factor for Alzheimer's disease (AD); however, the aspects of the aging process that predispose the brain to the development of AD are largely unknown. Astrocytes perform a myriad of functions in the central nervous system to maintain homeostasis and support neuronal function. In vitro, human astrocytes are highly sensitive to oxidative stress and trigger a senescence program when faced with multiple types of stress. In order to determine whether senescent astrocytes appear in vivo, brain tissue from aged individuals and patients with AD was examined for the presence of senescent astrocytes using p16(INK4a) and matrix metalloproteinase-1 (MMP-1) expression as markers of senescence. Compared with fetal tissue samples (n=4), a significant increase in p16(INK4a)-positive astrocytes was observed in subjects aged 35 to 50 years (n=6; P=0.02) and 78 to 90 years (n=11; P, 10(-6)). In addition, the frontal cortex of AD patients (n=15) harbored a significantly greater burden of p16(INK4a)-positive astrocytes compared with non-AD adult control subjects of similar ages (n=25; P=0.02) and fetal controls (n=4; P, 10(-7)). Consistent with the senescent nature of the p16(INK4a)-positive astrocytes, increased metalloproteinase MMP-1 correlated with p16(INK4a). In vitro, beta-amyloid 1-42 (A beta(1-42)) triggered senescence, driving the expression of p16(INK4a) and senescence-associated beta-galactosidase. In addition, we found that senescent astrocytes produce a number of inflammatory cytokines including interleukin-6 (IL-6), which seems to be regulated by p38MAPK. We propose that an accumulation of p16(INK4a)-positive senescent astrocytes may link increased age and increased risk for sporadic AD.	[Bhat, Rekha; Crowe, Elizabeth P.; Bitto, Alessandro; Moh, Michelle; Katsetos, Christos D.; Garcia, Fernando U.; Sell, Christian; Torres, Claudio] Drexel Univ, Coll Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Johnson, Frederick Bradley; Trojanowski, John Q.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Drexel University; University of Pennsylvania	Bhat, R (corresponding author), Drexel Univ, Coll Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	claudio.torres@drexelmed.edu		Crowe, Elizabeth/0000-0003-1910-2800	National Institutes of Health/National Institute on Aging [AG022443, AG022443-S1]; Resident Research Fellowship; Drexel University College of Medicine; Medical Student Summer Research Fellowship; Aging Initiative Fellowship, Drexel University College of Medicine; Department of Pathology, Drexel University College of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022443] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Resident Research Fellowship; Drexel University College of Medicine; Medical Student Summer Research Fellowship; Aging Initiative Fellowship, Drexel University College of Medicine; Department of Pathology, Drexel University College of Medicine; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by National Institutes of Health/National Institute on Aging grants AG022443 (CS) and AG022443-S1 (CT); the Resident Research Fellowship, Drexel University College of Medicine, awarded to RB; the Medical Student Summer Research Fellowship, Drexel University College of Medicine, awarded to MM; and the Aging Initiative Fellowship, Drexel University College of Medicine, awarded to AB. EPC was supported by funds from the Department of Pathology, Drexel University College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; AHRONHEIM JC, 1983, JAMA-J AM MED ASSOC, V250, P1182, DOI 10.1001/jama.250.9.1182; Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Baker DJ, 2011, NATURE; Bitto A, 2010, EXP CELL RES, V316, P2961, DOI 10.1016/j.yexcr.2010.06.021; Campisi J, 2011, SEMIN CANCER BIOL, V21, P354, DOI 10.1016/j.semcancer.2011.09.001; Chimenti C, 2003, CIRC RES, V93, P604, DOI 10.1161/01.RES.0000093985.76901.AF; Chkhotua AB, 2003, AM J KIDNEY DIS, V41, P1303, DOI 10.1016/S0272-6386(03)00363-9; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Coppe JP, 2011, J BIOL CHEM, V286, P36396, DOI 10.1074/jbc.M111.257071; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Davalos AR, 2010, CANCER METAST REV, V29, P273, DOI 10.1007/s10555-010-9220-9; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Donnini S, 2010, FASEB J, V24, P2385, DOI 10.1096/fj.09-146456; Fa M, 2010, J VIS EXP; Freir DB, 2011, NEUROBIOL AGING, V32, P2211, DOI 10.1016/j.neurobiolaging.2010.01.001; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Golde TE, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt5; Halassa MM, 2009, NEUROPHARMACOLOGY, V57, P343, DOI 10.1016/j.neuropharm.2009.06.031; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Hou LL, 2011, IN VITRO CELL DEV-AN, V47, P573, DOI 10.1007/s11626-011-9439-y; Hu JG, 1998, BRAIN RES, V785, P195, DOI 10.1016/S0006-8993(97)01318-8; Iwasa H, 2003, GENES CELLS, V8, P131, DOI 10.1046/j.1365-2443.2003.00620.x; Jeyapalan JC, 2008, MECH AGEING DEV, V129, P467, DOI 10.1016/j.mad.2008.04.001; Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008; KOO EH, 1994, J BIOL CHEM, V269, P17386; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; LI YT, 1994, NEUROBIOL AGING, V15, P1, DOI 10.1016/0197-4580(94)90139-2; Livney MG, 2011, AM J GERIAT PSYCHIAT, V19, P430, DOI 10.1097/JGP.0b013e3181f7d881; Maggio M, 2006, J GERONTOL A-BIOL, V61, P575, DOI 10.1093/gerona/61.6.575; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010; Myung NH, 2008, AGE, V30, P209, DOI 10.1007/s11357-008-9050-7; Pertusa M, 2007, J NEUROCHEM, V101, P794, DOI 10.1111/j.1471-4159.2006.04369.x; Poling A, 2008, BEHAV BRAIN RES, V193, P230, DOI 10.1016/j.bbr.2008.06.001; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Ressler S, 2006, AGING CELL, V5, P379, DOI 10.1111/j.1474-9726.2006.00231.x; Rhein V, 2009, CELL MOL NEUROBIOL, V29, P1063, DOI 10.1007/s10571-009-9398-y; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Tresini M, 1998, CANCER RES, V58, P1; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Verkhratsky A, 2012, ASN NEURO, V4, DOI 10.1042/AN20120010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Wang HY, 2002, NEUROBIOL AGING, V23, P213, DOI 10.1016/S0197-4580(01)00279-2; WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8; Zeng GY, 1996, EXP CELL RES, V222, P150, DOI 10.1006/excr.1996.0019	62	307	321	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45069	10.1371/journal.pone.0045069	http://dx.doi.org/10.1371/journal.pone.0045069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984612	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500113
J	Ouyang, F; Men, XY; Yang, B; Su, JW; Zhang, YS; Zhao, ZH; Ge, F				Ouyang, Fang; Men, Xingyuan; Yang, Bing; Su, Jianwei; Zhang, Yongsheng; Zhao, Zihua; Ge, Feng			Maize Benefits the Predatory Beetle, Propylea japonica (Thunberg), to Provide Potential to Enhance Biological Control for Aphids in Cotton	PLOS ONE			English	Article							TRANSGENIC BT COTTON; STABLE-ISOTOPE RATIOS; NONTRANSGENIC COTTON; NATURAL ENEMIES; CARBON; BIODIVERSITY; MANAGEMENT; DELTA-C-13; SURVIVAL; PESTS	Background: Biological control provided by natural enemies play an important role in integrated pest management. Generalist insect predators provide an important biological service in the regulation of agricultural insect pests. Our goal is to understand the explicit process of oviposition preference, habitat selection and feeding behavior of predators in farmland ecosystem consisting of multiple crops, which is central to devising and delivering an integrated pest management program. Methodology: The hypotheses was that maize can serve as habitat for natural enemies and benefits predators to provide potential to enhance biological control for pest insects in cotton. This explicit process of a predatory beetle, Propylea japonica, in agricultural ecosystem composed of cotton and maize were examined by field investigation and stable carbon isotope analysis during 2008-2010. Principal Finding: Field investigation showed that P. japonica adults will search host plants for high prey abundance before laying eggs, indicating indirectly that P. japonica adults prefer to inhabit maize plants and travel to cotton plants to actively prey on aphids. The delta C-13 values of adult P. japonica in a dietary shift experiment found that individual beetles were shifting from a C-3- to a C-4-based diet of aphids reared on maize or cotton, respectively, and began to reflect the isotope ratio of their new C-4 resources within one week. Approximately 80-100% of the diet of P. japonica adults in maize originated from a C-3-based resource in June, July and August, while approximately 80% of the diet originated from a C-4-based resource in September. Conclusion/Significance: Results suggest that maize can serve as a habitat or refuge source for the predator beetle, P. Japonica, and benefits predators to provide potential to enhance biological control for insect pests in cotton.	[Ouyang, Fang; Yang, Bing; Su, Jianwei; Zhao, Zihua; Ge, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Men, Xingyuan] Shandong Acad Agr Sci, Inst Plant Protect, Jinan, Peoples R China; [Zhang, Yongsheng] Hunan Agr Univ, Coll Biosafety Sci & Technol, Changsha, Hunan, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Shandong Academy of Agricultural Sciences; Hunan Agricultural University	Ouyang, F (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	gef@ioz.ac.cn	Ouyang, Fang/AAQ-3601-2021	Ouyang, Fang/0000-0002-4291-8149	National Nature Science Fund of China [31030012, 30921063]; National Key Technology RD Program [2012BAD19B05]	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program)	This project was supported by National Nature Science Fund of China (No. 31030012, 30921063) and National Key Technology R&D Program (2012BAD19B05). The funders had not role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; China NoBoSo, 2009, CHIN STAT YB; Crist TO, 2006, OECOLOGIA, V147, P510, DOI 10.1007/s00442-005-0275-1; Gao F, 2010, ENTOMOL EXP APPL, V136, P72, DOI 10.1111/j.1570-7458.2010.01005.x; Ge Feng, 1995, Acta Entomologica Sinica, V38, P436; Gould F, 2002, P NATL ACAD SCI USA, V99, P16581, DOI 10.1073/pnas.242382499; Gratton C, 2006, OECOLOGIA, V147, P615, DOI 10.1007/s00442-005-0322-y; Horner TA, 2003, J ECON ENTOMOL, V96, P914, DOI 10.1603/0022-0493-96.3.914; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Liu J, 2004, ANN ENTOMOL SOC AM, V97, P235, DOI 10.1603/0013-8746(2004)097[0235:PDOAGH]2.0.CO;2; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; LU YH, 2010, LOGIC CIRCUITS CARBO, V328, P1151, DOI DOI 10.1126/SCIENCE.1187881; Markow TA, 2000, FUNCT ECOL, V14, P261, DOI 10.1046/j.1365-2435.2000.00408.x; Men X, 2005, CROP PROT, V24, P319, DOI 10.1016/j.cropro.2004.08.006; Men XY, 2003, ENVIRON ENTOMOL, V32, P270, DOI 10.1603/0046-225X-32.2.270; Oelbermann K, 2002, OECOLOGIA, V130, P337, DOI 10.1007/s004420100813; Ostrom PH, 1997, OECOLOGIA, V109, P108, DOI 10.1007/s004420050064; Ouyang F, 2011, J INSECT PHYSIOL, V57, P153, DOI 10.1016/j.jinsphys.2010.10.007; PETELLE M, 1979, OECOLOGIA, V38, P159, DOI 10.1007/BF00346561; Prasifka JR, 2004, ECOL ENTOMOL, V29, P226, DOI 10.1111/j.0307-6946.2004.00585.x; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Schallhart N, 2009, AGR FOREST ENTOMOL, V11, P333, DOI 10.1111/j.1461-9563.2009.00428.x; TEERI JA, 1979, OECOLOGIA, V39, P197, DOI 10.1007/BF00348068; TURNER MG, 1989, ANNU REV ECOL SYST, V20, P171, DOI 10.1146/annurev.es.20.110189.001131; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; With KA, 2002, ECOL APPL, V12, P52, DOI 10.1890/1051-0761(2002)012[0052:TEOLSO]2.0.CO;2; Wu J., 2000, CHINESE J ECOL, V11, P42, DOI [10.13292/j.1000-4890.2000.0008, DOI 10.13292/J.1000-4890.2000.0008]; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; WU KM, 2008, LOGIC CIRCUITS CARBO, V321, P1676, DOI DOI 10.1126/SCIENCE.1160550	31	29	37	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44379	10.1371/journal.pone.0044379	http://dx.doi.org/10.1371/journal.pone.0044379			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984499	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500052
J	Simoes, JM; Teles, MC; Oliveira, RF; Van der Linden, A; Verhoye, M				Simoes, Jose M.; Teles, Magda C.; Oliveira, Rui F.; Van der Linden, Annemie; Verhoye, Marleen			A Three-Dimensional Stereotaxic MRI Brain Atlas of the Cichlid Fish Oreochromis mossambicus	PLOS ONE			English	Article							SOCIAL-BEHAVIOR; MOUSE-BRAIN; EVOLUTION; ORGANIZATION; POPULATION; DATABASES; FIGHTS	The African cichlid Oreochromis mossambicus (Mozambique tilapia) has been used as a model system in a wide range of behavioural and neurobiological studies. The increasing number of genetic tools available for this species, together with the emerging interest in its use for neurobiological studies, increased the need for an accurate hodological mapping of the tilapia brain to supplement the available histological data. The goal of our study was to elaborate a three-dimensional, high-resolution digital atlas using magnetic resonance imaging, supported by Nissl staining. Resulting images were viewed and analysed in all orientations (transverse, sagittal, and horizontal) and manually labelled to reveal structures in the olfactory bulb, telencephalon, diencephalon, optic tectum, and cerebellum. This high resolution tilapia brain atlas is expected to become a very useful tool for neuroscientists using this fish model and will certainly expand their use in future studies regarding the central nervous system.	[Simoes, Jose M.; Teles, Magda C.; Oliveira, Rui F.] Inst Super Psicol Aplicada, Unidade Invest Ecoetol, Lisbon, Portugal; [Simoes, Jose M.; Teles, Magda C.; Oliveira, Rui F.] Gulbenkian Inst Sci, Champalimaud Neurosci Programme, Oeiras, Portugal; [Van der Linden, Annemie; Verhoye, Marleen] Univ Antwerp, Bioimaging Lab, B-2020 Antwerp, Belgium	Instituto Superior Psicologia Aplicada (ISPA); Fundacao Champalimaud; University of Antwerp	Simoes, JM (corresponding author), Inst Super Psicol Aplicada, Unidade Invest Ecoetol, Lisbon, Portugal.	jsimoes@ispa.pt	Oliveira, Rui/A-3581-2013; Simões, José Miguel/M-5330-2014; Van der Linden, Annemie/L-7855-2017	Oliveira, Rui/0000-0003-1528-618X; Simões, José Miguel/0000-0001-9808-8378; Van der Linden, Annemie/0000-0003-2941-6520; Verhoye, Marleen/0000-0002-6267-0611; Teles, Magda C/0000-0002-3051-8332	FCT (Fundacao para Ciencia e Tecnologia, Portugal) [PTDC/PSI/71811/2006]; Plurianual Programme RD unit [MAR-LVT-Lisboa-331]; FCT [SFRH/BD/40976/2007, SFRH/BD/44848/2008]	FCT (Fundacao para Ciencia e Tecnologia, Portugal)(Portuguese Foundation for Science and Technology); Plurianual Programme RD unit; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was funded by FCT (Fundacao para Ciencia e Tecnologia, Portugal) with the grant PTDC/PSI/71811/2006 and the Plurianual Programme R&D unit MAR-LVT-Lisboa-331). During this study JMS and MCT were supported by FCT Ph.D. fellowships (SFRH/BD/40976/2007 and SFRH/BD/44848/2008, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes RA, 2009, P NATL ACAD SCI USA, V106, P15985, DOI 10.1073/pnas.0900817106; Baerends G.P., 1950, BEHAVIOUR          S, V1, P1; Bauerle A, 1993, OREOCHROMIS MOSSAMBI, V34, P375; Burmeister SS, 2009, BRAIN BEHAV EVOLUT, V74, P110, DOI 10.1159/000235613; Burmeister SS, 2005, PLOS BIOL, V3, P1996, DOI 10.1371/journal.pbio.0030363; Cannestra AF, 1997, BRAIN RES BULL, V43, P141, DOI 10.1016/S0361-9230(96)00429-7; Dhenain M, 2001, DEV BIOL, V232, P458, DOI 10.1006/dbio.2001.0189; Ebbesson SO., 1980, COMP NEUROLOGY TELEN, P41, DOI 10.1007/978-1-4613-2988-6_3; FERNALD RD, 1985, J COMP NEUROL, V238, P202, DOI 10.1002/cne.902380207; Fryer G., 1972, CICHLID FISHES GREAT; GHOSH P, 1994, NEUROIMAGE, V1, P345, DOI 10.1006/nimg.1994.1019; Gonzalez-Voyer A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014355; Gonzalez-Voyer A, 2009, P ROY SOC B-BIOL SCI, V276, P161, DOI 10.1098/rspb.2008.0979; Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; Kovacevic N, 2005, CEREB CORTEX, V15, P639, DOI 10.1093/cercor/bhh165; McLaren DG, 2009, NEUROIMAGE, V45, P52, DOI 10.1016/j.neuroimage.2008.10.058; Meek J., 1998, CENTRAL NERVOUS SYST, P758; MEYER A, 1993, TRENDS ECOL EVOL, V8, P279, DOI 10.1016/0169-5347(93)90255-N; Natt O, 2002, J NEUROSCI METH, V120, P203, DOI 10.1016/S0165-0270(02)00211-X; Newman JD, 2009, BRAIN RES REV, V62, P1, DOI 10.1016/j.brainresrev.2009.09.001; Nieuwenhuys R., 1990, Cerebral Cortex, V8A, P31; Northcutt RG, 2006, J COMP NEUROL, V494, P903, DOI 10.1002/cne.20853; Northcutt RG, 1983, FISH NEUROBIOLOGY, P117; Oliveira RF, 2005, NATURE, V437, P207, DOI 10.1038/437207a; Oliveira RF, 2001, NATURE, V409, P475, DOI 10.1038/35054128; Oliveira RF, 2009, INTEGR COMP BIOL, V49, P423, DOI 10.1093/icb/icp055; Pepels PPLM, 2002, PEPTIDES, V23, P1053, DOI 10.1016/S0196-9781(02)00037-2; Poirier C, 2008, NEUROIMAGE, V41, P1, DOI 10.1016/j.neuroimage.2008.01.069; Pollen AA, 2007, BRAIN BEHAV EVOLUT, V70, P21, DOI 10.1159/000101067; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Roland P E, 1994, Hum Brain Mapp, V1, P173, DOI 10.1002/hbm.460010303; Sakharkar AJ, 2005, J COMP NEUROL, V489, P148, DOI 10.1002/cne.20614; Salzburger W, 2004, NATURWISSENSCHAFTEN, V91, P277, DOI 10.1007/s00114-004-0528-6; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Schwarz AJ, 2006, NEUROIMAGE, V32, P538, DOI 10.1016/j.neuroimage.2006.04.214; Sefc KM, 2011, INT J EVOLUTIONARY B, V2011; Smith PF, 2003, MOL ECOL, V12, P2497, DOI 10.1046/j.1365-294X.2003.01905.x; Toga AW, 2002, NAT REV NEUROSCI, V3, P302, DOI 10.1038/nrn782; Ullmann JFP, 2010, NEUROIMAGE, V51, P76, DOI 10.1016/j.neuroimage.2010.01.086; Van Essen DC, 2002, CURR OPIN NEUROBIOL, V12, P574, DOI 10.1016/S0959-4388(02)00361-6; Vellema M, 2011, NEUROIMAGE, V57, P352, DOI 10.1016/j.neuroimage.2011.04.033; Wong M, 2011, BIOL REV, V86, P511, DOI 10.1111/j.1469-185X.2010.00158.x; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6	44	24	25	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44086	10.1371/journal.pone.0044086	http://dx.doi.org/10.1371/journal.pone.0044086			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984463	gold, Green Published			2022-12-25	WOS:000308638700043
J	Zhao, QF; Qian, Y; Li, RM; Tan, BH; Han, HH; Liu, MY; Qian, M; Du, B				Zhao, Qufei; Qian, Yu; Li, Ruimei; Tan, Binghe; Han, Honghui; Liu, Mingyao; Qian, Min; Du, Bing			Norcantharidin Facilitates LPS-Mediated Immune Responses by Up-Regulation of AKT/NF-kappa B Signaling in Macrophages	PLOS ONE			English	Article							INNATE IMMUNITY; BACTERIAL-INFECTION; RELA/P65 SUBUNIT; BINDING PROTEIN; ACTIVATION; RECEPTOR; PHOSPHORYLATION; RECOGNITION; KINASE; ALPHA	Norcantharidin (NCTD), a demethylated analog of cantharidin, is a common used clinical drug to inhibit proliferation and metastasis of cancer cells. But the role of NCTD in modulating immune responses remains unknown. Here, we investigated the function and mechanism of NCTD in regulation of TLR4 associated immune response in macrophages. We evaluated the influence of NCTD on host defense against invaded pathogens by acute peritonitis mouse model, ELISA, Q-PCR, nitrite quantification, phagocytosis assay and gelatin zymography assay. Our data showed that the survival and the serum concentrations of IL-6 and TNF-alpha were all enhanced by NCTD significantly in peritonitis mouse model. Accordingly, LPS-induced cytokine, nitric oxide and MMP-9 production as well as the phagocytosis of bacteria were all up-regulated by NCTD in a dose dependent manner in both RAW264.7 cells and bone marrow-derived macrophages (BMMs). Then we further analyzed TLR4 associated signaling pathway by Western blot, Immunofluorescence and EMSA in the presence or absence of LPS. The phosphorylation of AKT and p65 at serine 536 but not serine 468 was enhanced obviously by NCTD in a dose dependent manner, whereas the degradation of I kappa B alpha was little effected. Consequently, the nuclear translocation and DNA binding ability of NF-kappa B was also increased by NCTD obviously in RAW264.7 cells. Our results demonstrated that NCTD could facilitate LPS-mediated immune response through promoting the phosphorylation of AKT/p65 and transcriptional activity of NF-kappa B, thus reprofiling the traditional anti-tumor drug NCTD as a novel immune regulator in promoting host defense against bacterial infection.	[Zhao, Qufei] E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China; E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Zhao, QF (corresponding author), E China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai 200062, Peoples R China.	mqian@bio.ecnu.edu.cn; bdu.ecnu@gmail.com		Liu, Mingyao/0000-0001-7339-5048; Du, Bing/0000-0002-5402-6527	National Basic Research Program of China [2012CB910400]; National Natural Science Foundation of China [31000398, 81172816]; Science and Technology Commission of Shanghai Municipality [09JC1405200, 11DZ2260300]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by National Basic Research Program of China [2012CB910400]; National Natural Science Foundation of China [31000398 and 81172816]; and The Science and Technology Commission of Shanghai Municipality [09JC1405200 and 11DZ2260300]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; CARREL JE, 1974, SCIENCE, V183, P755, DOI 10.1126/science.183.4126.755; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Chang C, 2011, MOL BIOL REP, V38, P163, DOI 10.1007/s11033-010-0090-6; Chen YJ, 2009, CHEM-BIOL INTERACT, V181, P440, DOI 10.1016/j.cbi.2009.07.004; Chen YJ, 2009, LIFE SCI, V85, P642, DOI 10.1016/j.lfs.2009.09.003; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Douillette A, 2006, J BIOL CHEM, V281, P13275, DOI 10.1074/jbc.M512815200; Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237; Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200; Fraser IP, 1998, SEMIN IMMUNOL, V10, P363, DOI 10.1006/smim.1998.0141; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Huang Y, 2009, CYTOTECHNOLOGY, V59, P201, DOI [10.1007/s10616-009-9210-3, 10.1007/s10616-009-9221-0]; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kim JH, 2006, MOL PHARMACOL, V69, P1783, DOI 10.1124/mol.105.021048; Kok SH, 2005, CANCER LETT, V217, P43, DOI 10.1016/j.canlet.2004.07.045; Lambert LA, 2007, ANN SURG ONCOL, V14, P3037, DOI 10.1245/s10434-007-9548-8; Liu L, 2004, BIOCHEM J, V380, P31, DOI 10.1042/BJ20031300; Luan JL, 2010, CYTOTECHNOLOGY, V62, P349, DOI 10.1007/s10616-009-9250-8; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Odeh M, 2004, LIVER INT, V24, P110, DOI 10.1111/j.1478-3231.2004.0894.x; OKAHARA H, 1994, CANCER RES, V54, P3233; Pearson AM, 1996, CURR OPIN IMMUNOL, V8, P20, DOI 10.1016/S0952-7915(96)80100-2; Picozzi VJ, 2001, ONCOLOGY-NY, V15, P1296; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Sasaki CY, 2005, J BIOL CHEM, V280, P34538, DOI 10.1074/jbc.M504943200; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; STEINKAMP JA, 1982, SCIENCE, V215, P64, DOI 10.1126/science.7053559; Tobinick EL, 2009, DRUG NEWS PERSPECT, V22, P119, DOI 10.1358/dnp.2009.22.2.1303818; Ulevitch RJ, 2000, IMMUNOL RES, V21, P49, DOI 10.1385/IR:21:2-3:49; Willenborg DO, 1999, J NEUROIMMUNOL, V100, P21, DOI 10.1016/S0165-5728(99)00212-X; Worthington HV, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001972.pub4; Xu P, 2001, BIOL REPROD, V65, P240, DOI 10.1095/biolreprod65.1.240; Zhang Z, 2011, J IMMUNOL, V186, P5376, DOI 10.4049/jimmunol.1002946; Zhao M, 2001, P NATL ACAD SCI USA, V98, P9814, DOI 10.1073/pnas.161275798	43	23	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44956	10.1371/journal.pone.0044956	http://dx.doi.org/10.1371/journal.pone.0044956			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984593	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700102
J	Liu, B; Xu, Y; Voss, C; Qiu, FH; Zhao, MZ; Liu, YD; Nie, J; Wang, ZL				Liu, Bin; Xu, Yun; Voss, Courtney; Qiu, Fang-hua; Zhao, Ming-zhe; Liu, Yong-dong; Nie, Jing; Wang, Zi-lian			Altered Protein Expression in Gestational Diabetes Mellitus Placentas Provides Insight into Insulin Resistance and Coagulation/Fibrinolysis Pathways	PLOS ONE			English	Article							ANNEXIN-II; FIBRINOLYTIC REGULATORS; VASCULAR DYSFUNCTION; GLYCATION; BINDING; PHOSPHORYLATION; DEGRADATION; GENERATION; EXPOSURE; SURFACE	Objective: To investigate the placental proteome differences between pregnant women complicated with gestational diabetes mellitus (GDM) and those with normal glucose tolerance (NGT). Methods: We used two-dimensional electrophoresis (2DE) to separate and compare placental protein levels from GDM and NGT groups. Differentially expressed proteins between the two groups were identified by MALDI-TOF/TOF mass spectrometry and further confirmed by Western blotting. The mRNA levels of related proteins were measured by realtime RT-PCR. Immunohistochemistry (IHC) was performed to examine the cellular location of the proteins expressed in placenta villi. Results: Twenty-one protein spots were differentially expressed between GDM and NGT placenta villi in the tested samples, fifteen of which were successfully identified by mass spectrometry. The molecular functions of these differentially expressed proteins include blood coagulation, signal transduction, anti-apoptosis, ATP binding, phospholipid binding, calcium ion binding, platelet activation, and tryptophan-tRNA ligase activity. Both protein and mRNA levels of Annexin A2, Annexin A5 and 14-3-3 protein f/d were up-regulated, while the expression of the Ras-related protein Rap1A was down-regulated in the GDM placenta group. Conclusion: Placenta villi derived from GDM pregnant women exhibit significant proteome differences compared to those of NGT mothers. The identified differentially expressed proteins are mainly associated with the development of insulin resistance, transplacental transportation of glucose, hyperglucose-mediated coagulation and fibrinolysis disorders in the GDM placenta villi.	[Liu, Bin; Wang, Zi-lian] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [Nie, Jing] So Med Univ, Nanfang Hosp, Div Nephrol, Guangzhou, Guangdong, Peoples R China; [Xu, Yun] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Endocrinol, Guangzhou 510275, Guangdong, Peoples R China; [Voss, Courtney] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Qiu, Fang-hua; Zhao, Ming-zhe] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Prote, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Yong-dong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Southern Medical University - China; Sun Yat Sen University; Western University (University of Western Ontario); Sun Yat Sen University; Sun Yat Sen University	Liu, B (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China.	niejing@fimmu.com; zilianwang@gmail.com			Science and Technology Planning Project of Guangdong Province, China [2009B03081099]; Scholarship Award for Excellent Doctoral Student; Ministry of Education of China	Science and Technology Planning Project of Guangdong Province, China; Scholarship Award for Excellent Doctoral Student; Ministry of Education of China(Ministry of Education, China)	This work was supported by Science and Technology Planning Project of Guangdong Province, China (No. 2009B03081099, to Prof. Zi-lian Wang) and Scholarship Award for Excellent Doctoral Student (to Dr. Bin Liu and Prof. Zi-lian Wang as supervisor) granted by Ministry of Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2006, DIABETES CARE, V29, pS43; Aso Y, 2007, FRONT BIOSCI-LANDMRK, V12, P2957, DOI 10.2741/2285; Biener Y, 1996, J BIOL CHEM, V271, P29489, DOI 10.1074/jbc.271.46.29489; Catalano PM, 2011, AM J OBSTET GYNECOL, V204, P479, DOI 10.1016/j.ajog.2010.11.039; Catalano PM, 2003, J NUTR, V133, p1674S, DOI 10.1093/jn/133.5.1674S; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Desoye G, 2007, DIABETES CARE, V30, pS120, DOI 10.2337/dc07-s203; Di Guglielmo GM, 1998, MOL CELL BIOCHEM, V182, P59, DOI 10.1023/A:1006883311233; EMANS N, 1993, J CELL BIOL, V120, P1357, DOI 10.1083/jcb.120.6.1357; Engelke H, 2011, J PHYS CHEM B, V115, P12963, DOI 10.1021/jp2048579; Enquobahrie DA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.022; Falcone DJ, 2001, BLOOD, V97, P777, DOI 10.1182/blood.V97.3.777; GRUNDMANN U, 1988, P NATL ACAD SCI USA, V85, P3708, DOI 10.1073/pnas.85.11.3708; Hiden U, 2009, CURR VASC PHARMACOL, V7, P460, DOI 10.2174/157016109789043973; Hu CD, 1999, J BIOL CHEM, V274, P48, DOI 10.1074/jbc.274.1.48; Ishii H, 2001, ANN NY ACAD SCI, V947, P308; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; Kosaki A, 1998, J BIOL CHEM, V273, P940, DOI 10.1074/jbc.273.2.940; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Leach L, 2011, MICROCIRCULATION, V18, P263, DOI 10.1111/j.1549-8719.2011.00091.x; Leach L, 2009, J ANAT, V215, P69, DOI 10.1111/j.1469-7580.2009.01098.x; Lee AJ, 2007, DIABETES CARE, V30, P878, DOI 10.2337/dc06-1816; Lei HT, 2004, CIRC RES, V94, P902, DOI 10.1161/01.RES.0000124979.46214.E3; LYONS TJ, 1993, AM J CARDIOL, V71, pB26, DOI 10.1016/0002-9149(93)90142-Y; Mayran N, 2003, EMBO J, V22, P3242, DOI 10.1093/emboj/cdg321; Meigs JB, 2000, JAMA-J AM MED ASSOC, V283, P221, DOI 10.1001/jama.283.2.221; Mine K, 2007, PLACENTA, V28, P676, DOI 10.1016/j.placenta.2006.10.005; Morel E, 2009, J BIOL CHEM, V284, P1604, DOI 10.1074/jbc.M806499200; Ogihara T, 1997, J BIOL CHEM, V272, P25267, DOI 10.1074/jbc.272.40.25267; PEDERSEN J, 1977, PREGNANT DIABETIC HE; Person Maria D, 2006, J Biomol Tech, V17, P145; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Radaelli T, 2003, DIABETES, V52, P2951, DOI 10.2337/diabetes.52.12.2951; Ren S, 2002, J CLIN ENDOCR METAB, V87, P286, DOI 10.1210/jc.87.1.286; Sangle GV, 2010, ENDOCRINOLOGY, V151, P4455, DOI 10.1210/en.2010-0323; Takata K, 1997, MICROSC RES TECHNIQ, V38, P145; TAMES FJ, 1992, ATHEROSCLEROSIS, V93, P237, DOI 10.1016/0021-9150(92)90260-N; THIAGARAJAN P, 1990, J BIOL CHEM, V265, P17420; Wilson JD., HARRISONS PRINCIPLES, V1994, P472; Xiang XQ, 2002, MOL ENDOCRINOL, V16, P552, DOI 10.1210/me.16.3.552; Zhang JY, 1998, ARTERIOSCL THROM VAS, V18, P1140, DOI 10.1161/01.ATV.18.7.1140; Zhu K, 2005, ANAL CHEM, V77, P2745, DOI 10.1021/ac048494w	43	36	38	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44701	10.1371/journal.pone.0044701	http://dx.doi.org/10.1371/journal.pone.0044701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970290	gold, Green Published, Green Submitted			2022-12-25	WOS:000308462000047
J	Yew, KH; Carpenter, C; Duncan, RS; Harrison, CJ				Yew, Kok-Hooi; Carpenter, Cory; Duncan, R. Scott; Harrison, Christopher J.			Human Cytomegalovirus Induces TLR4 Signaling Components in Monocytes Altering TIRAP, TRAM and Downstream Interferon-Beta and TNF-Alpha Expression	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; GENE-EXPRESSION; CD14; LIPOPOLYSACCHARIDE; CELLS; LPS; ACTIVATION; MD-2; INFECTION; PATHWAY	Using TLR pathways, primary human cytomegalovirus (HCMV) induces innate responses including the production of inflammatory cytokines. Mounting evidence suggests that LPS recognition by TLR4/MD2/CD14 results in differential utilization of TIRAP-TRAF6 and TRAM-TRIF signaling, thereby leading to transcriptional activation of various cytokine genes. However, relative roles of the TLR4/MD2/CD14 complex and its adaptor proteins TIRAP and TRAM involved in regulating monocyte responses to HCMV are incomplete. Here, we provided evidence supporting the notion that the TLR4/MD2/CD14 complex contributes notably to HCMV-induced signaling and subsequent cytokine production in monocytes. In particular, induction of both IL-6 and IL-8 is associated with elevated TIRAP and reduced TRAM mRNA expression. The latter may serve in a compensatory pathway that yields a robust IFN response when TIRAP signaling is blocked in monocytes incubated with Toledo strain HCMV. Inhibitory studies using antisense oligonucleotides or neutralizing antibodies indicate that IL-6 induction by TLR4/MD2 complex is important for the activation of endogenous CD14 which later acts in concert or synergy with TLR4/MD2 as a factor resulting in IL-8 gene expression. We further show that exogenous recombinant CD14 can potentiate innate immune response via TLR4-dependent and possibly via TLR9-dependent pathways to promote enhanced expression/production of IL-8 and IFN-beta, respectively.	[Yew, Kok-Hooi; Carpenter, Cory; Duncan, R. Scott; Harrison, Christopher J.] Childrens Mercy Hosp, Kansas City, MO 64108 USA; [Yew, Kok-Hooi; Harrison, Christopher J.] Univ Missouri, Sch Med, Dept Pediat, Kansas City, MO 64108 USA; [Carpenter, Cory] Kansas City Univ Med & Biosci, Kansas City, MO USA	Children's Mercy Hospital; University of Missouri System; University of Missouri Kansas City; Kansas City University of Medicine & Biosciences	Yew, KH (corresponding author), Childrens Mercy Hosp, Kansas City, MO 64108 USA.	hyew@kumc.edu	Harrison, Christopher/Q-6670-2019; Duncan, Raymond/AAD-1969-2019		Katharine B. Richardson Foundation [01.4247]	Katharine B. Richardson Foundation	This work was supported by a grant from the Katharine B. Richardson Foundation (Grant No. 01.4247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi S, 2003, J EXP MED, V198, P1035, DOI 10.1084/jem.20031076; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Boehme KW, 2006, J IMMUNOL, V177, P7094, DOI 10.4049/jimmunol.177.10.7094; Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Duesberg U, 2002, IMMUNOL LETT, V84, P89, DOI 10.1016/S0165-2478(02)00178-5; Fearns C, 1997, INFECT IMMUN, V65, P4822, DOI 10.1128/IAI.65.11.4822-4831.1997; Fitzgerald KA, 2006, CELL, V125, P834, DOI 10.1016/j.cell.2006.05.014; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; Humar A, 1999, J INFECT DIS, V179, P484, DOI 10.1086/314602; Iwamoto GK, 1997, J INVEST MED, V45, P175; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kennedy MN, 2004, J BIOL CHEM, V279, P34698, DOI 10.1074/jbc.M405444200; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Landmann R, 1998, INFECT IMMUN, V66, P2264, DOI 10.1128/IAI.66.5.2264-2271.1998; Murayama T, 1998, J LEUKOCYTE BIOL, V64, P62, DOI 10.1002/jlb.64.1.62; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Okumura A, 2010, J VIROL, V84, P27, DOI 10.1128/JVI.01462-09; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Sacre SM, 2007, J IMMUNOL, V178, P2148, DOI 10.4049/jimmunol.178.4.2148; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Watts C, 2008, NAT IMMUNOL, V9, P343, DOI 10.1038/ni0408-343; Xie XH, 2009, PEDIATR RES, V65, P156, DOI 10.1203/PDR.0b013e318191f5c6; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yew KH, 2010, MOL IMMUNOL, V47, P883, DOI 10.1016/j.molimm.2009.10.009	25	36	39	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44500	10.1371/journal.pone.0044500	http://dx.doi.org/10.1371/journal.pone.0044500			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970235	gold, Green Published, Green Submitted			2022-12-25	WOS:000308462000026
J	Cebulla, CM; Zelinka, CP; Scott, MA; Lubow, M; Bingham, A; Rasiah, S; Mahmoud, AM; Fischer, AJ				Cebulla, Colleen M.; Zelinka, Chris P.; Scott, Melissa A.; Lubow, Martin; Bingham, Amanda; Rasiah, Stephen; Mahmoud, Ashraf M.; Fischer, Andy J.			A Chick Model of Retinal Detachment: Cone Rich and Novel	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FIBRILLARY ACIDIC PROTEIN; CELL NUCLEAR ANTIGEN; PROLIFERATIVE VITREORETINOPATHY; VISUAL RECOVERY; MULLER GLIA; GROUND-SQUIRREL; PHOTORECEPTOR DEGENERATION; MICE DEFICIENT; POTENTIAL ROLE	Background: Development of retinal detachment models in small animals can be difficult and expensive. Here we create and characterize a novel, cone-rich retinal detachment (RD) model in the chick. Methodology/Principal Findings: Retinal detachments were created in chicks between postnatal days 7 and 21 by subretinal injections of either saline (SA) or hyaluronic acid (HA). Injections were performed through a dilated pupil with observation via surgical microscope, using the fellow eye as a control. Immunohistochemical analyses were performed at days 1, 3, 7, 10 and 14 after retinal detachment to evaluate the cellular responses of photoreceptors, Muller glia, microglia and nonastrocytic inner retinal glia (NIRG). Cell proliferation was detected with bromodeoxyuridine (BrdU)-incorporation and by the expression of proliferating cell nuclear antigen (PCNA). Cell death was detected with terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL). As in mammalian models of RD, there is shortening of photoreceptor outer segments and mis-trafficking of photoreceptor opsins in areas of RD. Photoreceptor cell death was maximal 1 day after RD, but continued until 14 days after RD. Muller glia up-regulated glial fibriliary acidic protein (GFAP), proliferated, showed interkinetic nuclear migration, and migrated to the subretinal space in areas of detachment. Microglia became reactive; they up-regulated CD45, acquired amoeboid morphology, and migrated toward outer retina in areas of RD. Reactive NIRG cells accumulated in detached areas. Conclusions/Significance: Subretinal injections of SA or HA in the chick eye successfully produced retinal detachments and cellular responses similar to those seen in standard mammalian models. Given the relatively large eye size, and considering the low cost, the chick model of RD offers advantages for high-throughput studies.	[Cebulla, Colleen M.; Lubow, Martin; Bingham, Amanda; Rasiah, Stephen; Mahmoud, Ashraf M.] Ohio State Univ, Dept Ophthalmol & Visual Sci, Havener Eye Inst, Columbus, OH 43210 USA; [Zelinka, Chris P.; Scott, Melissa A.; Fischer, Andy J.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Cebulla, CM (corresponding author), Ohio State Univ, Dept Ophthalmol & Visual Sci, Havener Eye Inst, Columbus, OH 43210 USA.	Colleen.Cebulla@osumc.edu	Fischer, Andy J./AAE-9817-2022; Cebulla, Colleen/E-2861-2011; Fischer, Andy J./AFF-1827-2022	Fischer, Andy J./0000-0001-6123-7405; Fischer, Andy J./0000-0001-6123-7405; Cebulla, Colleen/0000-0002-5636-4968	National Center for Research Resources [KL2RR025754]; Ohio State University Department of Ophthalmology; NICHD; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025754] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Ohio State University Department of Ophthalmology; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by award number KL2RR025754 from the National Center for Research Resources and by The Ohio State University Department of Ophthalmology start-up funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The antibody to rhodopsin (Rho 4D2) was a generous gift Dr. R. Molday, University British Columbia. The antibody to BrdU (G3G4) was developed by S.J. Kaufman and the antibody to transitin (clone EAP3) was developed by G.J. Cole; both antibodies were obtained by the Developmental Studies Hybridoma Bank developed under the auspices of the NICHD and maintained by The University of Iowa, Department of Biology, Iowa City, IA 52242. We thank Bongsu Kim for helpful technical assistance.	Agrawal RN, 2007, NAT PROTOC, V2, P67, DOI 10.1038/nprot.2007.4; ANDERSON DH, 1983, INVEST OPHTH VIS SCI, V24, P906; ANDERSON DH, 1986, INVEST OPHTH VIS SCI, V27, P168; Andrews A, 1999, INVEST OPHTH VIS SCI, V40, P2683; BOWMAKER JK, 1977, VISION RES, V17, P17, DOI 10.1016/0042-6989(77)90195-X; Bruhn SL, 1996, J NEUROSCI, V16, P1430; Burt DW, 2007, POULTRY SCI, V86, P1460, DOI 10.1093/ps/86.7.1460; Cebulla CM, 2010, EXP EYE RES, V90, P521, DOI 10.1016/j.exer.2010.01.008; CHANG CJ, 1995, ARCH OPHTHALMOL-CHIC, V113, P880, DOI 10.1001/archopht.1995.01100070054025; COOK B, 1995, INVEST OPHTH VIS SCI, V36, P990; Cuadros MA, 2006, J HISTOCHEM CYTOCHEM, V54, P727, DOI 10.1369/jhc.5A6832.2006; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Davidorf F H, 1975, Ophthalmic Surg, V6, P74; Diederen RMH, 2007, OPHTHALMOLOGY, V114, P705, DOI 10.1016/j.ophtha.2006.09.004; ERICKSON PA, 1983, INVEST OPHTH VIS SCI, V24, P927; Fariss RN, 1997, J COMP NEUROL, V387, P148, DOI 10.1002/(SICI)1096-9861(19971013)387:1<148::AID-CNE12>3.0.CO;2-Q; Fischer AJ, 2011, NEUROSCIENCE, V178, P250, DOI 10.1016/j.neuroscience.2011.01.022; Fischer AJ, 2006, J COMP NEUROL, V496, P479, DOI 10.1002/cne.20937; Fischer AJ, 2004, MOL VIS, V10, P973; Fischer AJ, 2004, MOL CELL NEUROSCI, V27, P531, DOI 10.1016/j.mcn.2004.08.007; Fischer AJ, 2010, MOL NEUROBIOL, V42, P199, DOI 10.1007/s12035-010-8152-2; Fischer AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010774; Fischer AJ, 2010, GLIA, V58, P633, DOI 10.1002/glia.20950; FISHER SK, 1991, INVEST OPHTH VIS SCI, V32, P1739; Fisher SK, 2003, VISION RES, V43, P887, DOI 10.1016/S0042-6989(02)00680-6; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; GELLER SF, 1995, INVEST OPHTH VIS SCI, V36, P737; Ghai K, 2008, BRAIN RES, V1192, P76, DOI 10.1016/j.brainres.2007.01.105; Ghai K, 2010, J NEUROSCI, V30, P3101, DOI 10.1523/JNEUROSCI.4919-09.2010; Gharbiya M, 2012, RETINA-J RET VIT DIS, V32, P43, DOI 10.1097/IAE.0b013e3182180114; Hassan TS, 2002, OPHTHALMOLOGY, V109, P146, DOI 10.1016/S0161-6420(01)00886-7; Headington K, 2011, CURR EYE RES, V36, P947, DOI 10.3109/02713683.2011.587934; Hisatomi T, 2003, AM J PATHOL, V162, P1869, DOI 10.1016/S0002-9440(10)64321-0; HUI YN, 1989, AM J OPHTHALMOL, V108, P176, DOI 10.1016/0002-9394(89)90014-7; Iribarne M, 2008, AM J PATHOL, V172, P1030, DOI 10.2353/ajpath.2008.070605; Jacobs Gerald H., 2002, Documenta Ophthalmologica, V104, P119, DOI 10.1023/A:1014431701523; JACOBS GH, 1985, J COMP PHYSIOL A, V156, P503, DOI 10.1007/BF00613974; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P505, DOI 10.1007/BF00181769; Kaneko H, 2008, INVEST OPHTH VIS SCI, V49, P4162, DOI 10.1167/iovs.08-1738; Kram YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008992; KROLL AJ, 1968, AM J OPHTHALMOL, V66, P410, DOI 10.1016/0002-9394(68)91524-9; Kryger Z, 1998, VISUAL NEUROSCI, V15, P685, DOI 10.1017/S0952523898154081; Lei HT, 2007, INVEST OPHTH VIS SCI, V48, P2335, DOI 10.1167/iovs.06-0965; Lewis GP, 2010, MOL VIS, V16, P1361; LEWIS GP, 1994, AM J OPHTHALMOL, V118, P368, DOI 10.1016/S0002-9394(14)72962-9; Lewis GP, 2005, MOL VIS, V11, P491; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; LEWIS GP, 1991, EXP EYE RES, V53, P629, DOI 10.1016/0014-4835(91)90223-2; Lewis GP, 2002, EYE, V16, P375, DOI 10.1038/sj.eye.6700202; Linberg KA, 2002, VISUAL NEUROSCI, V19, P603, DOI 10.1017/S095252380219506X; Luna G, 2009, INVEST OPHTH VIS SCI, V50, P3977, DOI 10.1167/iovs.08-2910; Mandava N, 2002, INVEST OPHTH VIS SCI, V43, P3338; Mey J, 2000, BRAIN RES REV, V32, P343, DOI 10.1016/S0165-0173(99)00022-3; MORRIS VB, 1970, J COMP NEUROL, V140, P359, DOI 10.1002/cne.901400308; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Nakazawa T, 2007, P NATL ACAD SCI USA, V104, P2425, DOI 10.1073/pnas.0608167104; NORK TM, 1995, ARCH OPHTHALMOL-CHIC, V113, P1066, DOI 10.1001/archopht.1995.01100080118039; Ochrietor JD, 2010, MOL VIS, V16, P961; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; PILAR G, 1987, J NEUROSCI, V7, P3813, DOI 10.1523/jneurosci.07-12-03813.1987; Rex TS, 2002, MOL VIS, V8, P114; Rex TS, 2002, INVEST OPHTH VIS SCI, V43, P1234; Ross WH, 2002, EYE, V16, P440, DOI 10.1038/sj.eye.6700192; Ross WH, 1998, OPHTHALMOLOGY, V105, P2149, DOI 10.1016/S0161-6420(98)91142-3; Sakai T, 2003, INVEST OPHTH VIS SCI, V44, P416, DOI 10.1167/iovs.02-0633; Salicone A, 2006, OPHTHALMOLOGY, V113, P1734, DOI 10.1016/j.ophtha.2006.03.064; Schiff WM, 2007, ARCH OPHTHALMOL-CHIC, V125, P1161, DOI 10.1001/archopht.125.9.1161; Sethi CS, 2005, INVEST OPHTH VIS SCI, V46, P329, DOI 10.1167/iovs.03-0518; Thanos S, 2001, BRAIN RES REV, V35, P205, DOI 10.1016/S0165-0173(01)00049-2; Verardo MR, 2008, INVEST OPHTH VIS SCI, V49, P3659, DOI 10.1167/iovs.07-1474; Wenningmann I, 2001, MOL PHARMACOL, V60, P790	72	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44257	10.1371/journal.pone.0044257	http://dx.doi.org/10.1371/journal.pone.0044257			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970190	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400051
J	Godwin, S; Bent, E; Borneman, J; Pereg, L				Godwin, Scott; Bent, Elizabeth; Borneman, James; Pereg, Lily			The Role of Coral-Associated Bacterial Communities in Australian Subtropical White Syndrome of Turbinaria mesenterina	PLOS ONE			English	Article							BLACK-BAND-DISEASE; JUVENILE-OYSTER-DISEASE; PLAGUE-LIKE DISEASE; SP-NOV.; ROSEOVARIUS-CRASSOSTREAE; ROSEOBACTER CLADE; CAUSATIVE AGENT; VIBRIO-SHILOI; ELKHORN CORAL; TISSUE	Australian Subtropical White Syndrome (ASWS) is an infectious, temperature dependent disease of the subtropical coral Turbinaria mesenterina involving a hitherto unknown transmissible causative agent. This report describes significant changes in the coral associated bacterial community as the disease progresses from the apparently healthy tissue of ASWS affected coral colonies, to areas of the colony affected by ASWS lesions, to the dead coral skeleton exposed by ASWS. In an effort to better understand the potential roles of bacteria in the formation of disease lesions, the effect of antibacterials on the rate of lesion progression was tested, and both culture based and culture independent techniques were used to investigate the bacterial communities associated with colonies of T. mesenterina. Culture-independent analysis was performed using the Oligonucleotide Fingerprinting of Ribosomal Genes (OFRG) technique, which allowed a library of 8094 cloned bacterial 16S ribosomal genes to be analysed. Interestingly, the bacterial communities associated with both healthy and disease affected corals were very diverse and ASWS associated communities were not characterized by a single dominant organism. Treatment with antibacterials had a significant effect on the rate of progress of disease lesions (p = 0.006), suggesting that bacteria may play direct roles as the causative agents of ASWS. A number of potential aetiological agents of ASWS were identified in both the culture-based and culture-independent studies. In the culture-independent study an Alphaproteobacterium closely related to Roseovarius crassostreae, the apparent aetiological agent of juvenile oyster disease, was found to be significantly associated with disease lesions. In the culture-based study Vibrio harveyi was consistently associated with ASWS affected coral colonies and was not isolated from any healthy colonies. The differing results of the culture based and culture-independent studies highlight the importance of using both approaches in the investigation of microbial communities.	[Godwin, Scott; Pereg, Lily] Univ New England, Sch Sci & Technol, Res Ctr Mol Biol, Armidale, NSW, Australia; [Bent, Elizabeth; Borneman, James] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Bent, Elizabeth] Univ Guelph, Dept Integrat Biol, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada	University of New England; University of California System; University of California Riverside; University of Guelph	Godwin, S (corresponding author), Univ New England, Sch Sci & Technol, Res Ctr Mol Biol, Armidale, NSW, Australia.	lperegge@une.edu.au			University of New England, Armidale, NSW, Australia	University of New England, Armidale, NSW, Australia	This work was funded by a University Research Grant provided by the University of New England, Armidale, NSW, Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Bent E, 2006, J MICROBIOL METH, V67, P171, DOI 10.1016/j.mimet.2006.03.023; Boettcher KJ, 2000, APPL ENVIRON MICROB, V66, P3924, DOI 10.1128/AEM.66.9.3924-3930.2000; Boettcher KJ, 2005, INT J SYST EVOL MICR, V55, P1531, DOI 10.1099/ijs.0.63620-0; Borneman J, 2001, Bioinformatics, V17 Suppl 1, pS39; Bourne D, 2007, AQUACULTURE, V268, P274, DOI 10.1016/j.aquaculture.2007.04.067; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Cardenas A, 2011, ISME J; Cervino JM, 2008, J APPL MICROBIOL, V105, P1658, DOI 10.1111/j.1365-2672.2008.03871.x; Cervino JM, 2004, APPL ENVIRON MICROB, V70, P6855, DOI 10.1128/AEM.70.11.6855-6864.2004; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Choi DH, 2006, INT J SYST EVOL MICR, V56, P1869, DOI 10.1099/ijs.0.64235-0; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Dalton SJ, 2006, CORAL REEFS, V25, P529, DOI 10.1007/s00338-006-0139-0; Dalton SJ, 2010, MARINE FRESHWATER RE, V61, P1; Dalton SJ, 2010, PUBLIC HEALTH 21ST C, P187; Denner EBM, 2003, INT J SYST EVOL MICR, V53, P1115, DOI 10.1099/ijs.0.02359-0; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Figueroa A, 2004, J COMPUT BIOL, V11, P887, DOI 10.1089/cmb.2004.11.887; Frias-Lopez J, 2004, APPL ENVIRON MICROB, V70, P5955, DOI 10.1128/AEM.70.10.5955-5962.2004; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Gil-Agudelo D. L, 2006, Rev. biol. trop, V54, P59; HARRIOTT VJ, 1995, MAR FRESHWATER RES, V46, P457, DOI 10.1071/MF9950457; HARRIOTT VJ, 1994, MAR ECOL PROG SER, V109, P67, DOI 10.3354/meps109067; Israely T, 2001, AQUAT MICROB ECOL, V24, P1, DOI 10.3354/ame024001; Kapley A, 2007, WORLD J MICROB BIOT, V23, P923, DOI 10.1007/s11274-006-9315-1; Kline DI, 2006, MAR ECOL PROG SER, V314, P119, DOI 10.3354/meps314119; Koren O, 2007, MICROB ECOL, V55, P523; Kushmaro A, 1997, MAR ECOL PROG SER, V147, P159, DOI 10.3354/meps147159; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.4135/9781446279281.N7; Luna GM, 2007, ENVIRON MICROBIOL, V9, P1851, DOI 10.1111/j.1462-2920.2007.01287.x; Maloy AP, 2007, AQUACULTURE, V269, P71, DOI 10.1016/j.aquaculture.2007.04.008; McCune B., 2002, ANAL ECOLOGICAL COMM; McCune B., 2006, PC ORD MULTIVARIATE; Oren U, 2001, ECOLOGY, V82, P802, DOI 10.2307/2680199; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Pantos O, 2006, DIS AQUAT ORGAN, V69, P79, DOI 10.3354/dao069079; Patterson KL, 2002, P NATL ACAD SCI USA, V99, P8725, DOI 10.1073/pnas.092260099; Payne MS, 2008, J APPL MICROBIOL, V105, P340, DOI 10.1111/j.1365-2672.2008.03749.x; Richardson LL, 1996, MICROBIAL ECOL, V32, P323; Richardson LL, 2003, FEMS MICROBIOL ECOL, V43, P287, DOI 10.1016/S0168-6496(03)00025-4; Richardson LL, 1998, NATURE, V392, P557, DOI 10.1038/33302; Ritchie KB, 1998, REV BIOL TROP, V46, P199; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; SAR N, 1987, MICROB ECOL, V13, P193, DOI 10.1007/BF02024997; Sekar R, 2006, APPL ENVIRON MICROB, V72, P5963, DOI 10.1128/AEM.00843-06; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Sweatman H, 2011, CORAL REEFS, V30, P521, DOI 10.1007/s00338-010-0715-1; Swofford D.L, 2002, PAUP PYLOGENETIC ANA; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson FL, 2006, INT J SYST EVOL MICR, V56, P365, DOI 10.1099/ijs.0.63800-0; Valinsky L, 2002, APPL ENVIRON MICROB, V68, P3243, DOI 10.1128/AEM.68.7.3243-3250.2002; Valinsky L, 2004, MOL MICROBIAL ECOLOG, P569; van Oppen MJH, 2009, SYMBIOSIS, V47, P1; Vattakaven T, 2006, APPL ENVIRON MICROB, V72, P6508, DOI 10.1128/AEM.00798-06; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weil E, 2006, DIS AQUAT ORGAN, V69, P1, DOI 10.3354/dao069001; Willis BL, 2004, CORAL HLTH DIS	66	26	26	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44243	10.1371/journal.pone.0044243	http://dx.doi.org/10.1371/journal.pone.0044243			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970188	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400050
J	Riepl, RL; Fischer, R; Hautmann, H; Hartmann, G; Muller, TD; Tschop, M; Toepfer, M; Otto, B				Riepl, Rudolf L.; Fischer, Rainald; Hautmann, Hubert; Hartmann, Gunther; Mueller, Timo D.; Tschoep, Matthias; Toepfer, Marcell; Otto, Baerbel			Influence of Acute Exposure to High Altitude on Basal and Postprandial Plasma Levels of Gastroenteropancreatic Peptides	PLOS ONE			English	Article							EXOCRINE PANCREATIC-SECRETION; INTRADUODENAL BILE; PHYSICAL-EXERCISE; CHRONIC HYPOXIA; POLYPEPTIDE; GHRELIN; SOMATOSTATIN; LEPTIN; TAURODEOXYCHOLATE; CHOLECYSTOKININ	Acute mountain sickness (AMS) is characterized by headache often accompanied by gastrointestinal complaints that vary from anorexia through nausea to vomiting. The aim of this study was to investigate the influence of high altitude on plasma levels of gastroenteropancreatic (GEP) peptides and their association to AMS symptoms. Plasma levels of 6 GEP peptides were measured by radioimmunoassay in 11 subjects at 490 m (Munich, Germany) and, after rapid passive ascent to 3454 m (Jungfraujoch, Switzerland), over the course of three days. In a second study (n = 5), the same peptides and ghrelin were measured in subjects who consumed standardized liquid meals at these two elevations. AMS symptoms and oxygen saturation were monitored. In the first study, both fasting (morning 8 a. m.) and stimulated (evening 8 p. m.) plasma levels of pancreatic polypeptide (PP) and cholecystokinin (CCK) were significantly lower at high altitude as compared to baseline, whereas gastrin and motilin concentrations were significantly increased. Fasting plasma neurotensin was significantly enhanced whereas stimulated levels were reduced. Both fasting and stimulated plasma motilin levels correlated with gastrointestinal symptom severity (r = 0.294, p = 0.05, and r = 0.41, p = 0.006, respectively). Mean O2-saturation dropped from 96% to 88% at high altitude. In the second study, meal-stimulated integrated (= area under curve) plasma CCK, PP, and neurotensin values were significantly suppressed at high altitude, whereas integrated levels of gastrin were increased and integrated VIP and ghrelin levels were unchanged. In summary, our data show that acute exposure to a hypobaric hypoxic environment causes significant changes in fasting and stimulated plasma levels of GEP peptides over consecutive days and after a standardized meal. The changes of peptide levels were not uniform. Based on the inhibition of PP and neurotensin release a reduction of the cholinergic tone can be postulated.	[Riepl, Rudolf L.] Kreiskrankenhaus Erding, Dept Med, Erding, Germany; [Fischer, Rainald; Otto, Baerbel] Klin Univ Munchen, Med Klin & Poliklin 4, Munich, Germany; [Hautmann, Hubert] Tech Univ Munich, Dept Med, Munich, Germany; [Hartmann, Gunther] Univ Hosp Bonn, Bonn, Germany; [Mueller, Timo D.; Tschoep, Matthias] Tech Univ Munich, Dept Med, Helmholtz Ctr Munich, Inst Diabet & Obes, Munich, Germany	University of Munich; Technical University of Munich; University of Bonn; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Riepl, RL (corresponding author), Kreiskrankenhaus Erding, Dept Med, Erding, Germany.	rudolf.riepl@kkh-erding.de	Hartmann, Gunther/P-7492-2017; Tschoep, Matthias H/I-5443-2014; Müller, Timo D./AAZ-4445-2020	Hartmann, Gunther/0000-0003-1021-2018; Muller, Timo/0000-0002-0624-9339; Tschoep, Matthias/0000-0002-4744-371X				Bailey D M, 2000, High Alt Med Biol, V1, P9, DOI 10.1089/152702900320649; Bailey DM, 2001, J APPL PHYSIOL, V90, P105, DOI 10.1152/jappl.2001.90.1.105; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Benso A, 2007, EUR J ENDOCRINOL, V157, P733, DOI 10.1530/EJE-07-0355; Chaiban JT, 2008, METABOLISM, V57, P1019, DOI 10.1016/j.metabol.2007.02.011; Daniel EE, 1991, NEUROPEPTIDE FUNCTIO; Dockray GJ, 1994, GUT PEPTIDES BIOCH P, P175; Gritti I, 2000, PHARMACOL RES, V41, P265, DOI 10.1006/phrs.1999.0586; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; JO N, 1987, HORM METAB RES, V19, P182, DOI 10.1055/s-2007-1011772; Jo N, 1990, Rev Gastroenterol Peru, V10, P9; JO N, 1992, REV ESP ENFERM DIG, V81, P99; KNUDTZON J, 1989, AVIAT SPACE ENVIR MD, V60, P1072; Li X, 1990, Zhonghua Nei Ke Za Zhi, V29, P8; Liddle RA., 1994, GUT PEPTIDES BIOCH P; Lippl FJ, 2010, OBESITY, V18, P675, DOI 10.1038/oby.2009.509; Mannon P, 1994, GUT PEPTIDES BIOCH P, P341; MATERIA A, 1982, ANN SURG, V196, P48, DOI 10.1097/00000658-198207000-00011; Mouats A, 1990, Reprod Nutr Dev, VSuppl 2, p219s; Poitras P, 1994, GUT PEPTIDES BIOCH P, P261; PONCET L, 1994, NEUROSCI LETT, V176, P1, DOI 10.1016/0304-3940(94)90856-7; RIEPL RL, 1994, PANCREAS, V9, P109, DOI 10.1097/00006676-199401000-00016; Riepl RL, 1996, BRIT J CLIN PHARMACO, V42, P371, DOI 10.1046/j.1365-2125.1996.42013.x; RIEPL RL, 1990, SCAND J GASTROENTERO, V25, P45, DOI 10.3109/00365529008999208; Riepl RL, 1996, ITAL J GASTROENTEROL, V28, P421; Riepl RL, 1996, EUR J MED RES, V2, P23; ROACH RC, 1993, HYPOXIA AND MOLECULAR MEDICINE, P272; Sakio H, 1980, RESP CIRC, V28, P1161; SCHWARTZ TW, 1983, GASTROENTEROLOGY, V85, P1411; Shen DY, 1998, MIL MED, V163, P120, DOI 10.1093/milmed/163.2.120; Shintani M, 2001, DIABETES, V50, P227, DOI 10.2337/diabetes.50.2.227; Shukla V, 2005, NUTR NEUROSCI, V8, P161, DOI 10.1080/10284150500132823; Shulkes A, 1994, GUT PEPTIDES BIOCH P, P371; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Tschop M, 2001, ADV EXP MED BIOL, V502, P237; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037; Walsh JH, 1994, GUT PEPTIDES BIOCH P; Westerterp KR, 2006, EUR J GASTROEN HEPAT, V18, P1, DOI 10.1097/00042737-200601000-00001; Westerterp-Plantenga MS, 1999, J APPL PHYSIOL, V87, P391, DOI 10.1152/jappl.1999.87.1.391; Wren AM, 2007, GASTROENTEROLOGY, V132, P2116, DOI 10.1053/j.gastro.2007.03.048; Yang Chun-min, 2006, Zhonghua Yi Xue Za Zhi, V86, P2391	42	25	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44445	10.1371/journal.pone.0044445	http://dx.doi.org/10.1371/journal.pone.0044445			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970220	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400071
J	Ohashi, T; Fujiyama, K; Takegawa, K				Ohashi, Takao; Fujiyama, Kazuhito; Takegawa, Kaoru			Identification of Novel alpha 1,3-Galactosyltransferase and Elimination of alpha-Galactose-containing Glycans by Disruption of Multiple alpha-Galactosyltransferase Genes in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; FISSION-YEAST; SACCHAROMYCES-CEREVISIAE; GOLGI-APPARATUS; NONSEXUAL FLOCCULATION; HETEROLOGOUS PROTEINS; ENDOPLASMIC-RETICULUM; GLYCOSYLATION MUTANT; TRANSPORT; ALPHA-1,6-MANNOSYLTRANSFERASE	The oligosaccharides from fission yeast Schizosaccharomyces pombe contain large amounts of D-galactose (Gal) in addition to D-mannose (Man), in contrast to the budding yeast Saccharomyces cerevisiae. Detailed structural analysis has revealed that the Gal residues are attached to the N- and O-linked oligosaccharides via alpha 1,2- or alpha 1,3-linkages. Previously we constructed and characterized a septuple alpha-galactosyltransferase disruptant (7GalT Delta) anticipating a complete lack of alpha-Gal residues. However, the 7GalT Delta strain still contained oligosaccharides consisting of alpha 1,3-linked Gal residues, indicating the presence of at least one more additional unidentified alpha 1,3-galactosyltransferase. In this study we searched for unidentified putative glycosyltransferases in the S. pombe genome sequence and identified three novel genes, named otg1(+)-otg3(+) (alpha one, three-galactosyltransferase), that belong to glycosyltransferase gene family 8 in the Carbohydrate Active EnZymes (CAZY) database. Gal-recognizing lectin blotting and HPLC analyses of pyridylaminated oligosaccharides after deletion of these three additional genes from 7GalT Delta strain demonstrated that the resultant disruptant missing 10 alpha-galactosyltransferase genes, 10GalT Delta, exhibited a complete loss of galactosylation. In an in vitro galactosylation assay, the otg2(+) gene product had Gal transfer activity toward a pyridylaminated Man(9)GlcNAc(2) oligosaccharide and pyridylaminated Man alpha 1,2-Man alpha 1,2-Man oligosaccharide. In addition, the otg3(+) gene product exhibited Gal transfer activity toward the pyridylaminated Man9GlcNAc2 oligosaccharide. Generation of an alpha 1,3-linkage was confirmed by HPLC analysis, alpha-galactosidase digestion analysis, H-1 NMR spectroscopy, and LC-MS/MS analysis. These results indicate that Otg2p and Otg3p are involved in alpha 1,3-galactosylation of S. pombe oligosaccharides.	[Ohashi, Takao; Takegawa, Kaoru] Kyushu Univ, Dept Biosci & Biotechnol, Higashi Ku, Fukuoka 8128581, Japan; [Ohashi, Takao] Asahi Glass Co Ltd, Res Ctr, ASPEX Div, Kanagawa Ku, Yokohama, Kanagawa 2218755, Japan; [Ohashi, Takao; Fujiyama, Kazuhito] Osaka Univ, Int Ctr Biotechnol, Suita, Osaka 5650871, Japan	Kyushu University; AGC Inc; Osaka University	Takegawa, K (corresponding author), Kyushu Univ, Dept Biosci & Biotechnol, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	takegawa@agr.kyushu-u.ac.jp			Project for Development of a Technological Infrastructure for Industrial Bioprocesses on R&D of New Industrial Science and Technology Frontiers by the Ministry of Economy, Trade, and Industry (METI) of Japan; Noda Institute for Scientific Research	Project for Development of a Technological Infrastructure for Industrial Bioprocesses on R&D of New Industrial Science and Technology Frontiers by the Ministry of Economy, Trade, and Industry (METI) of Japan; Noda Institute for Scientific Research(Noda Institute for Scientific Research)	This work was supported in part by the Project for Development of a Technological Infrastructure for Industrial Bioprocesses on R&D of New Industrial Science and Technology Frontiers by the Ministry of Economy, Trade, and Industry (METI) of Japan, entrusted by the New Energy and Industrial Technology Development Organization (NEDO) (to T. O. and K. T.), and a grant from the Noda Institute for Scientific Research (to T. O.).	Alfa C, 2003, EXPT FISSION YEAST L; Andreishcheva EN, 2004, J BIOL CHEM, V279, P35644, DOI 10.1074/jbc.M403574200; BALLOU CE, 1994, P NATL ACAD SCI USA, V91, P9327, DOI 10.1073/pnas.91.20.9327; BALLOU L, 1995, P NATL ACAD SCI USA, V92, P2790, DOI 10.1073/pnas.92.7.2790; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHAPPELL TG, 1989, J CELL BIOL, V109, P2693, DOI 10.1083/jcb.109.6.2693; CHAPPELL TG, 1994, MOL BIOL CELL, V5, P519, DOI 10.1091/mbc.5.5.519; Chayakulkeeree M, 2006, INFECT DIS CLIN N AM, V20, P507, DOI 10.1016/j.idc.2006.07.001; De Pourcq K, 2010, APPL MICROBIOL BIOT, V87, P1617, DOI 10.1007/s00253-010-2721-1; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; DEAN N, 1995, P NATL ACAD SCI USA, V92, P1287, DOI 10.1073/pnas.92.5.1287; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Elliott CE, 2007, MOL PLANT PATHOL, V8, P791, DOI [10.1111/j.1364-3703.2007.00433.x, 10.1111/J.1364-3703.2007.00433.X]; Gemmill TR, 1998, GLYCOBIOLOGY, V8, P1087, DOI 10.1093/glycob/8.11.1087; Gemmill TR, 1996, J BIOL CHEM, V271, P25945, DOI 10.1074/jbc.271.42.25945; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gemmill TR, 1999, GLYCOBIOLOGY, V9, P507, DOI 10.1093/glycob/9.5.507; Giga-Hama Y, 2007, BIOTECHNOL APPL BIOC, V46, P147, DOI 10.1042/BA20060106; GRIMM C, 1988, MOL GEN GENET, V215, P81, DOI 10.1007/BF00331307; Hamilton SR, 2006, SCIENCE, V313, P1441, DOI 10.1126/science.1130256; HASE S, 1994, METHOD ENZYMOL, V230, P225; HASE S, 1978, BIOCHEM BIOPH RES CO, V85, P257, DOI 10.1016/S0006-291X(78)80037-0; Idiris A, 2006, YEAST, V23, P83, DOI 10.1002/yea.1342; Idiris A, 2010, APPL MICROBIOL BIOT, V86, P403, DOI 10.1007/s00253-010-2447-0; Ikeda Y, 2009, FEMS YEAST RES, V9, P115, DOI 10.1111/j.1567-1364.2008.00458.x; Kajiura H, 2012, J BIOSCI BIOENG, V113, P48, DOI 10.1016/j.jbiosc.2011.09.011; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Macher BA, 2008, BBA-GEN SUBJECTS, V1780, P75, DOI 10.1016/j.bbagen.2007.11.003; Matsuzawa T, 2011, MOL MICROBIOL, V82, P1531, DOI 10.1111/j.1365-2958.2011.07908.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morita T, 2004, YEAST, V21, P613, DOI 10.1002/yea.1104; Nakamura T, 2001, MOL BIOL CELL, V12, P3955, DOI 10.1091/mbc.12.12.3955; Nordbring-Hertz B., 2004, Mycologist, V18, P125, DOI 10.1017/S0269915X04003052; Ohashi T, 2011, GLYCOBIOLOGY, V21, P340, DOI 10.1093/glycob/cwq167; Ohashi T, 2010, J BIOTECHNOL, V150, P348, DOI 10.1016/j.jbiotec.2010.09.942; Ohashi T, 2010, APPL MICROBIOL BIOT, V86, P263, DOI 10.1007/s00253-009-2297-9; Ohashi T, 2009, BIOSCI BIOTECH BIOCH, V73, P407, DOI 10.1271/bbb.80712; Okamoto M, 2008, EUKARYOT CELL, V7, P310, DOI 10.1128/EC.00333-07; OKAZAKI K, 1990, NUCLEIC ACIDS RES, V18, P6485, DOI 10.1093/nar/18.22.6485; Suzuki S, 2010, MICROBIOL-SGM, V156, P708, DOI 10.1099/mic.0.035279-0; Tabuchi M, 1997, BIOCHEM BIOPH RES CO, V232, P121, DOI 10.1006/bbrc.1997.6239; Takegawa K, 1996, BIOSCI BIOTECH BIOCH, V60, P1156; Takegawa K, 2009, BIOTECHNOL APPL BIOC, V53, P227, DOI 10.1042/BA20090048; Tanaka N, 1999, J BACTERIOL, V181, P1356, DOI 10.1128/JB.181.4.1356-1359.1999; Tanaka N, 2001, YEAST, V18, P745, DOI 10.1002/yea.725; Tanaka N, 2001, YEAST, V18, P903, DOI 10.1002/yea.740; Todorow Z, 2000, P NATL ACAD SCI USA, V97, P13643, DOI 10.1073/pnas.250472397; Yoko-O T, 1998, EUR J BIOCHEM, V257, P630, DOI 10.1046/j.1432-1327.1998.2570630.x; Yoko-o T, 2003, GLYCOBIOLOGY, V13, P581, DOI 10.1093/glycob/cwg063; Yoko-o T, 2001, FEBS LETT, V489, P75, DOI 10.1016/S0014-5793(01)02082-8; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536; Ziegler FD, 1999, GLYCOBIOLOGY, V9, P497, DOI 10.1093/glycob/9.5.497	52	12	12	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38866	38875		10.1074/jbc.M112.347351	http://dx.doi.org/10.1074/jbc.M112.347351			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22988247	Green Published, hybrid			2022-12-25	WOS:000310982800043
J	Lin, DH; Malpede, BM; Batchelor, JD; Tolia, NH				Lin, Daniel H.; Malpede, Brian M.; Batchelor, Joseph D.; Tolia, Niraj H.			Crystal and Solution Structures of Plasmodium falciparum Erythrocyte-binding Antigen 140 Reveal Determinants of Receptor Specificity during Erythrocyte Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITES; GLYCOPHORIN-C; LIGAND; SCATTERING; RECOGNITION; PROTEINS; FAMILY; BAEBL	Erythrocyte-binding antigen 140 (PfEBA-140) is a critical Plasmodium falciparum erythrocyte invasion ligand that engages glycophorin C on host erythrocytes during malaria infection. The minimal receptor-binding region of PfEBA-140 contains two conserved Duffy binding-like (DBL) domains, a fold unique to Plasmodium species. Here, we present the crystal structure of the receptor-binding region of PfEBA-140 at 2.4 angstrom resolution. The two-domain binding region is present as a monomer in the asymmetric unit, and the structure reveals novel features in PfEBA-140 that are likely determinants of receptor specificity. Analysis by small-angle x-ray scattering demonstrated that the minimal binding region is monomeric in solution, consistent with the crystal structure. Erythrocyte binding assays showed that the full-length binding region containing the tandem DBL domains is required for erythrocyte engagement, suggesting that both domains contain critical receptor contact sites. The electrostatic surface of PfEBA-140 elucidates a basic patch that constitutes a putative high-affinity binding interface spanning both DBL domains. Mutation of residues within this interface results in severely diminished erythrocyte binding. This study provides insight into the structural basis and mechanism of PfEBA-140 receptor engagement and forms a basis for future studies of this critical interaction. In addition, the solution and crystal structures allow the first identification of likely determinants of erythrocyte receptor specificity for P. falciparum invasion ligands. A complete understanding of the PfEBA-140 erythrocyte invasion pathway will aid in the design of invasion inhibitory therapeutics and vaccines.	[Lin, Daniel H.; Malpede, Brian M.; Batchelor, Joseph D.; Tolia, Niraj H.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Tolia, NH (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	tolia@wustl.edu	Tolia, Niraj H/D-2332-2014	Tolia, Niraj H/0000-0002-2689-1337	National Institutes of Health Grant [AI 080792]; Edward Mallinckrodt, Jr. Foundation; National Science Foundation Graduate Research Fellowship [DGE-1143954]; Office of Science, Office of Basic Energy Sciences of the United States Department of Energy [DE-AC02-05CH11231]; Department of Energy IDAT Grant [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080792, R56AI080792] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt, Jr. Foundation; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Office of Science, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Department of Energy IDAT Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 080792. This work was also supported by the Edward Mallinckrodt, Jr. Foundation (to N. H. T.) and National Science Foundation Graduate Research Fellowship DGE-1143954 (to B. M. M.).; We thank N. Salinas and W. Beatty for assistance with experiments, D. Sibley for constructive comments on the manuscript, and J. Nix (Molecular Biology Consortium Beamline 4.2.2, Advanced Light Source) for help with data collection. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences of the United States Department of Energy under Contract DE-AC02-05CH11231. We thank G. Hura, K. Dyer, and the Structurally Integrated Biology for Life Sciences Team at the Advanced Light Source for assistance in SAXS data collection (funded by Department of Energy IDAT Grant DE-AC02-05CH11231).	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Batchelor JD, 2011, NAT STRUCT MOL BIOL, V18, P908, DOI 10.1038/nsmb.2088; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ford L, 2007, AM J TROP MED HYG, V77, P977, DOI 10.4269/ajtmh.2007.77.977; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gilberger TW, 2003, J BIOL CHEM, V278, P14480, DOI 10.1074/jbc.M211446200; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kraemer SM, 2006, CURR OPIN MICROBIOL, V9, P374, DOI 10.1016/j.mib.2006.06.006; Lobo CA, 2004, INFECT IMMUN, V72, P5886, DOI 10.1128/IAI.72.10.5886-5891.2004; Lobo CA, 2003, BLOOD, V101, P4628, DOI 10.1182/blood-2002-10-3076; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Lopaticki S, 2011, INFECT IMMUN, V79, P1107, DOI 10.1128/IAI.01021-10; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Mayer DCG, 2009, P NATL ACAD SCI USA, V106, P5348, DOI 10.1073/pnas.0900878106; Mayer DCG, 2006, P NATL ACAD SCI USA, V103, P2358, DOI 10.1073/pnas.0510648103; ORLANDI PA, 1992, J CELL BIOL, V116, P901, DOI 10.1083/jcb.116.4.901; Singh SK, 2006, NATURE, V439, P741, DOI 10.1038/nature04443; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033	23	44	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36830	36836		10.1074/jbc.M112.409276	http://dx.doi.org/10.1074/jbc.M112.409276			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22989878	hybrid, Green Published			2022-12-25	WOS:000310588500019
J	Grellety, E; Shepherd, S; Roederer, T; Manzo, ML; Doyon, S; Ategbo, EA; Grais, RF				Grellety, Emmanuel; Shepherd, Susan; Roederer, Thomas; Manzo, Mahamane L.; Doyon, Stephane; Ategbo, Eric-Alain; Grais, Rebecca F.			Effect of Mass Supplementation with Ready-to-Use Supplementary Food during an Anticipated Nutritional Emergency	PLOS ONE			English	Article							USE THERAPEUTIC FOOD; MALNOURISHED MALAWIAN CHILDREN; PROPENSITY SCORE; DEVELOPING-COUNTRIES; MALNUTRITION; MORTALITY; GROWTH; INTERVENTIONS; TRIAL	Background: Previous studies have shown the benefits of ready-to-use supplementary food (RUSF) distribution in reducing the incidence and prevalence of severe acute malnutrition. Methods and Findings: To compare the incidence of wasting, stunting and mortality between children aged 6 to 23 mo participating and not participating in distributions of RUSF, we implemented two exhaustive prospective cohorts including all children 60 cm to 80 cm, resident in villages of two districts of Maradi region in Niger (n = 2238). Villages (20) were selected to be representative of the population. All registered children were eligible for the monthly distributions between July and October 2010. Age, sex, height, weight, and Mid-Upper Arm Circumference (MUAC) were measured at baseline and two weeks after each distribution; the amount and type of distribution and the amount shared and remaining were also assessed. We compared the incidence of wasting, stunting, and mortality among children participating in the distribution (intervention) of RUSF versus children not participating in the distribution (comparison). The absolute rate of wasting was 4.71 events per child-year (503 events/106.59 child-year) in the intervention group and 4.98 events per child-year (322 events/64.54 child-year) in the comparison group. The intervention group had a small but higher weight-for-length Z-score gain (-0.2z vs. -0.3z) and less loss of MUAC than the comparison group (-2.8 vs. -4.0 mm). There was no difference in length gain (2.7 vs. 2.8 cm). Mortality was lower for children whose households received the intervention than those who did not (adjusted HR 0.55, 95% CI: 0.32-0.98). Conclusions: Short-term distribution with RUSF for children 6 to 23 months improve the nutritional status of children at risk for malnutrition. Fewer children who participated in the RUSF distribution died than those who did not.	[Grellety, Emmanuel; Roederer, Thomas; Grais, Rebecca F.] Epicentre, Paris, France; [Shepherd, Susan; Doyon, Stephane] Med Sans Frontieres, Paris, France; [Manzo, Mahamane L.] Minist Hlth, Reg Dept, Maradi, Niger; [Ategbo, Eric-Alain] United Nations Int Children Emergency Fund, Niamey, Niger	Doctors Without Borders	Grellety, E (corresponding author), Epicentre, Paris, France.	Emmanuel.GRELLETY@epicentre.msf.org	Roederer, Thomas/AAW-4175-2021	Roederer, Thomas/0000-0003-1733-8721; Grellety Bosviel, Emmanuel/0000-0001-9736-414X	Medecins Sans Frontieres (MSF); United Nations International Children Emergency Fund (UNICEF)	Medecins Sans Frontieres (MSF); United Nations International Children Emergency Fund (UNICEF)	This study was supported by Medecins Sans Frontieres (MSF) and the United Nations International Children Emergency Fund (UNICEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R., 2008, SAGE U PAPER SERIES; [Anonymous], 2010, ANNUAIRE STAT SANITA; Briend A, 1999, LANCET, V353, P1767, DOI 10.1016/S0140-6736(99)01078-8; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; Cohuet S, 2010, APPETITE IN PRESS; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; de Pee S, 2009, FOOD NUTR BULL, V30, P3; Defourny I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005455; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; Direction des Enquetes et Recensements de l'Institut National de la Statistique (INS), 2010, RAPP ENQ NAT NUTR JU; GOLDEN MHN, 1993, LANCET, V342, P360, DOI 10.1016/0140-6736(93)91491-4; GOLDEN MHN, 1991, ACTA PAEDIATR SCAND, P95; Golden MH, 2009, FOOD NUTR BULL, V30, pS267, DOI 10.1177/15648265090303S302; Hall A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026854; HEIKENS GT, 1989, EUR J CLIN NUTR, V43, P145; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Isanaka S, 2009, JAMA-J AM MED ASSOC, V301, P277, DOI 10.1001/jama.2008.1018; Little RJ, 2009, BIOMETRICS, V65, P640, DOI 10.1111/j.1541-0420.2008.01066.x; Maleta T, 2004, J PEDIATR GASTR NUTR, V38, P152; Patel MP, 2005, J HEALTH POPUL NUTR, V23, P351; PELLETIER DL, 1993, AM J PUBLIC HEALTH, V83, P1130, DOI 10.2105/AJPH.83.8.1130; PELLETIER DL, 1995, B WORLD HEALTH ORGAN, V73, P443; Rivera JA, 2004, JAMA-J AM MED ASSOC, V291, P2563, DOI 10.1001/jama.291.21.2563; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sandige H, 2004, J PEDIATR GASTR NUTR, V39, P141, DOI 10.1097/00005176-200408000-00003; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519	26	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44549	10.1371/journal.pone.0044549	http://dx.doi.org/10.1371/journal.pone.0044549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984524	gold, Green Published			2022-12-25	WOS:000308738500064
J	Gruter, C; Schurch, R; Czaczkes, TJ; Taylor, K; Durance, T; Jones, SM; Ratnieks, FLW				Grueter, Christoph; Schuerch, Roger; Czaczkes, Tomer J.; Taylor, Keeley; Durance, Thomas; Jones, Sam M.; Ratnieks, Francis L. W.			Negative Feedback Enables Fast and Flexible Collective Decision-Making in Ants	PLOS ONE			English	Article							FOOD RECRUITMENT; PHEROMONES; MUTUALISMS; LANDMARKS; FORAGERS; PATTERNS; GEOMETRY; HONEYDEW; PROTOCOL; BEHAVIOR	Positive feedback plays a major role in the emergence of many collective animal behaviours. In many ants pheromone trails recruit and direct nestmate foragers to food sources. The strong positive feedback caused by trail pheromones allows fast collective responses but can compromise flexibility. Previous laboratory experiments have shown that when the environment changes, colonies are often unable to reallocate their foragers to a more rewarding food source. Here we show both experimentally, using colonies of Lasius niger, and with an agent-based simulation model, that negative feedback caused by crowding at feeding sites allows ant colonies to maintain foraging flexibility even with strong recruitment to food sources. In a constant environment, negative feedback prevents the frequently found bias towards one feeder (symmetry breaking) and leads to equal distribution of foragers. In a changing environment, negative feedback allows a colony to quickly reallocate the majority of its foragers to a superior food patch that becomes available when foraging at an inferior patch is already well underway. The model confirms these experimental findings and shows that the ability of colonies to switch to a superior food source does not require the decay of trail pheromones. Our results help to resolve inconsistencies between collective foraging patterns seen in laboratory studies and observations in the wild, and show that the simultaneous action of negative and positive feedback is important for efficient foraging in mass-recruiting insect colonies.	[Grueter, Christoph; Czaczkes, Tomer J.; Taylor, Keeley; Durance, Thomas; Jones, Sam M.; Ratnieks, Francis L. W.] Univ Sussex, Lab Apiculture & Social Insects, Sch Life Sci, Falmer, England; [Schuerch, Roger] Univ Sussex, Social Evolut Res Grp, Sch Life Sci, Falmer, England	University of Sussex; University of Sussex	Gruter, C (corresponding author), Univ Sussex, Lab Apiculture & Social Insects, Sch Life Sci, Falmer, England.	cg213@sussex.ac.uk	Schurch, Roger/J-8744-2019	Schurch, Roger/0000-0001-9075-8912; Czaczkes, Tomer/0000-0002-1350-4975; Gruter, Christoph/0000-0001-5553-5465	Swiss National Science Foundation [PA00P3_129134, PBBEP3_133529]; Biotechnology and Biological Sciences Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Christoph Gruter was supported by a postdoctoral fellowship from the Swiss National Science Foundation (grant-no. PA00P3_129134) (www.snf.ch). Tomer J.Czaczkes was supported by a PhD studentship from the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/). Roger Schurch was also supported by a fellowship from the Swiss National Science Foundation (grant-no. PBBEP3_133529). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JM, 2006, P NATL ACAD SCI USA, V103, P5835, DOI 10.1073/pnas.0507877103; BECKERS R, 1992, INSECT SOC, V39, P59, DOI 10.1007/BF01240531; BECKERS R, 1993, J INSECT BEHAV, V6, P751, DOI 10.1007/BF01201674; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Bonabeau E, 1997, TRENDS ECOL EVOL, V12, P188, DOI 10.1016/S0169-5347(97)01048-3; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; Collett M, 2009, CURR BIOL, V19, pR1103, DOI 10.1016/j.cub.2009.10.004; Collett TS, 2003, CURR OPIN NEUROBIOL, V13, P718, DOI 10.1016/j.conb.2003.10.004; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Czaczkes TJ, 2011, BIOL LETTERS, V7, P521, DOI 10.1098/rsbl.2011.0067; DENEUBOURG JL, 1983, J THEOR BIOL, V105, P259, DOI 10.1016/S0022-5193(83)80007-1; Detrain C, 2008, ADV INSECT PHYSIOL, V35, P123, DOI 10.1016/S0065-2806(08)00002-7; DREISIG H, 1988, ECOL ENTOMOL, V13, P143, DOI 10.1111/j.1365-2311.1988.tb00342.x; Dussutour A, 2004, NATURE, V428, P70, DOI 10.1038/nature02345; Dussutour A, 2009, P ROY SOC B-BIOL SCI, V276, P4353, DOI 10.1098/rspb.2009.1235; Dussutour A, 2009, J EXP BIOL, V212, P2337, DOI 10.1242/jeb.029827; Evison SEF, 2008, BEHAV ECOL SOCIOBIOL, V63, P261, DOI 10.1007/s00265-008-0657-6; Gerbier G, 2008, ANIM COGN, V11, P637, DOI 10.1007/s10071-008-0153-4; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Gruter C, 2011, BEHAV ECOL SOCIOBIOL, V65, P141, DOI 10.1007/s00265-010-1020-2; Halloy J, 2007, SCIENCE, V318, P1155, DOI 10.1126/science.1144259; Helantera H, 2011, SOCIOBIOLOGY, V57, P445; Jackson DE, 2004, NATURE, V432, P907, DOI 10.1038/nature03105; Jeanson R, 2004, ANIM BEHAV, V67, P531, DOI 10.1016/j.anbehav.2003.06.013; Jeanson Raphael, 2009, P460; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Mailleux AC, 2005, J INSECT PHYSIOL, V51, P297, DOI 10.1016/j.jinsphys.2004.12.001; Mailleux AC, 2003, P ROY SOC B-BIOL SCI, V270, P1609, DOI 10.1098/rspb.2003.2398; Nieh JC, 2010, CURR BIOL, V20, P310, DOI 10.1016/j.cub.2009.12.060; O'Toole DV, 1999, J THEOR BIOL, V198, P305, DOI 10.1006/jtbi.1999.0917; Oliver TH, 2008, J EVOLUTION BIOL, V21, P1597, DOI 10.1111/j.1420-9101.2008.01600.x; R Development Core Team, 2009, R FDN STAT COMP; Robinson EJH, 2005, NATURE, V438, P442, DOI 10.1038/438442a; Robinson EJH, 2008, J THEOR BIOL, V255, P250, DOI 10.1016/j.jtbi.2008.08.015; Schmidt VM, 2006, ANIM BEHAV, V72, P1309, DOI 10.1016/j.anbehav.2006.03.023; Seeley T., 1995, WISDOM HIVE SOCIAL P; Seeley T.D., 2010, HONEYBEE DEMOCRACY; Seeley TD, 2012, SCIENCE, V335, P108, DOI 10.1126/science.1210361; Sokal RR, 1995, BIOMETRY; Steck K, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-5; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224; Traniello James F.A., 1995, P241; VERHAEGHE JC, 1983, INSECT SOC, V30, P347, DOI 10.1007/BF02223992; Volkl W, 1999, OECOLOGIA, V118, P483, DOI 10.1007/s004420050751; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Wilensky U, 1999, NETLOGO; WILSON EDWARD O., 1962, ANIMAL BEHAVIOR, V10, P134, DOI 10.1016/0003-3472(62)90141-0; Zhang HP, 2010, P NATL ACAD SCI USA, V107, P13626, DOI 10.1073/pnas.1001651107; Zuur Alain F., 2009, P1	53	34	34	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44501	10.1371/journal.pone.0044501	http://dx.doi.org/10.1371/journal.pone.0044501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984518	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500061
J	Weghofer, A; Tea, MK; Barad, DH; Kim, A; Singer, CF; Wagner, K; Gleicher, N				Weghofer, Andrea; Tea, Muy-Kheng; Barad, David H.; Kim, Ann; Singer, Christian F.; Wagner, Klaus; Gleicher, Norbert			BRCA1/2 Mutations Appear Embryo-Lethal Unless Rescued by Low (CGG n < 26) FMR1 Sub-Genotypes: Explanation for the "BRCA Paradox"?	PLOS ONE			English	Article							BREAST-CANCER; GENE; PREVALENCE; REPEAT; RISK; CARRIERS; WOMEN; WHITE; P53	BRCA1/2 mutations and recently described constitutional FMR1 genotypes have, independently, been associated with prematurely diminished ovarian reserve. Whether they interrelate in distribution, and whether observed effects of BRCA1/2 and FMR1 on ovaries are independent of each other, is unknown. In a prospective comparative cohort study, we, therefore, investigated the distribution of constitutional FMR1 genotypes, normal (norm), heterozygous (het) and homozygous (hom), and of their respective sub-genotypes (high/low), in 99 BRCA1/2 mutation-positive women and 410 female controls to determine whether distribution patterns differed between study and control patients. In contrast to controls, BRCA1/2 carriers demonstrated almost complete absence of all constitutional FMR1 genotypes except for sub-genotypes with low (CGG (n<26)) alleles. Cross tabulation between BRCA1/2-positive patients and controls confirmed significant group membership, related to FMR1 distribution (P < 0.0001). These results offer as most likely explanation the conclusion that BRCA1/2 mutations are embryo-lethal, unless rescued by low (CGG (n<26)) FMR1 sub-genotypes, present in approximately one quarter of all women. Women with low FMR1 sub-genotypes, therefore, should reflect increased BRCA1/2-associated cancer risks, while the remaining approximately 75 percent should face almost no such risks. If confirmed, this observation offers opportunities for more efficient and less costly BRCA1/2 cancer screening. The study also suggests that previously reported risk towards prematurely diminished ovarian reserve in association with BRCA mutations is FMR1-mediated, and offers a possible explanation for the so-called "BRCA paradox" by raising the possibility that the widely perceived BRCA1/2-associated tumor risk is actually FMR1-mediated.	[Weghofer, Andrea; Barad, David H.; Kim, Ann; Gleicher, Norbert] Ctr Human Reprod, New York, NY USA; [Weghofer, Andrea] Med Univ Vienna, Dept Gynecol Endocrinol & Reprod Med, Vienna, Austria; [Tea, Muy-Kheng; Singer, Christian F.] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Barad, David H.; Gleicher, Norbert] Fdn Reprod Med, New York, NY USA; [Wagner, Klaus] Med Univ Graz, Dept Human Genet, Graz, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Graz	Weghofer, A (corresponding author), Ctr Human Reprod, New York, NY USA.	ngleicher@thechr.com	Barad, David/AAF-4332-2021		Foundation for Reproductive Medicine, New York, N.Y., USA; Center for Human Reproduction (CHR) - New York; Merck-Serono; Schering Plough; Ferring Pharmaceuticals; Bard Medical	Foundation for Reproductive Medicine, New York, N.Y., USA; Center for Human Reproduction (CHR) - New York; Merck-Serono(Merck & Company); Schering Plough(Merck & CompanySchering Plough Corporation); Ferring Pharmaceuticals(Ferring Pharmaceuticals); Bard Medical	This study was supported by funds from the not-for-profit Foundation for Reproductive Medicine, New York, N.Y., 10021, USA and intramural funds from the Center for Human Reproduction (CHR) - New York, a for-profit fertility and research center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; N.G., A. W. and D. H. B. have in the past received research support, speakers' honoraria and travel funds from EDM Serono (now Merck-Serono), Organon Pharmaceutical (now Schering Plough), Ferring Pharmaceuticals and Bard Medical, none, however, related to the subject of this paper. N.G. and D. H. B. are listed as co-inventors on pending U. S. patent applications, claiming diagnostic benefits from determining of ovarian FMR1 genotypes and sub-genotypes in association with female infertility. The patent claims are (1) Diagnostic relevance of CGG repeat numbers on the FMR1 gene in predicting functional ovarian reserve over time (i.e., ovarian aging patterns); (2) Newly described, so-called "ovarian" genotypes and sub-genotypes, based on a normal range of 26-34 CGG repeats as "normal" range; (3) Diagnostic relevance of these newly described genotypes and sub-genotypes in defining specific ovarian aging patterns and relevance to defining autoimmune risk. N.G. is the owner of The CHR, and A. K. and D. H. B. are employed there. A. W. is an associate visiting scientist at The CHR. The CHR was a funder of this study and where this research was conducted. The medical corporation, however, exerted no influence on this study. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Ademuyiwa FO, 2011, CANCER RES, V71, P640, DOI 10.1158/0008-5472.CAN-10-3021; Altekruse S. F., 1975, SEER CANC STAT REV 1; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Campeau PM, 2008, HUM GENET, V124, P31, DOI 10.1007/s00439-008-0529-1; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Chen LS, 2003, HUM MOL GENET, V12, P3067, DOI 10.1093/hmg/ddg331; Crook T, 1997, LANCET, V350, P638, DOI 10.1016/S0140-6736(05)63327-2; Davis-Dao C, 2012, J CLIN ENDOCR METAB, V97, pE393, DOI 10.1210/jc.2011-2439; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; GLEICHER N, 1980, MT SINAI J MED, V47, P511; Gleicher N, 1981, Prog Clin Biol Res, V70, P339; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; Gleicher N, 2012, J AUTOIMMUN, V38, pJ74, DOI 10.1016/j.jaut.2011.05.016; Gleicher N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018781; Gleicher N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015303; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P768, DOI 10.1016/j.rbmo.2010.02.020; Gleicher N, 2010, REPROD BIOMED ONLINE, V20, P485, DOI 10.1016/j.rbmo.2009.12.017; Hakem R, 1997, NAT GENET, V16, P298, DOI 10.1038/ng0797-298; Ikegami H, 2007, DIABETES RES CLIN PR, V77, pS116, DOI 10.1016/j.diabres.2007.01.044; John EM, 2007, JAMA-J AM MED ASSOC, V298, P2869, DOI 10.1001/jama.298.24.2869; Kadouri L, 2007, J MED GENET, V44, P467, DOI 10.1136/jmg.2006.048173; Krausz C, 2012, J CLIN ENDOCR METAB, V97, P764, DOI 10.1210/jc.2012-1130; Ludwig T, 1997, GENE DEV, V11, P1226, DOI 10.1101/gad.11.10.1226; Malone KE, 2006, CANCER RES, V66, P8297, DOI 10.1158/0008-5472.CAN-06-0503; Oktay K, 2010, J CLIN ONCOL, V28, P240, DOI 10.1200/JCO.2009.24.2057; Petek E, 1999, AM J MED GENET, V84, P229, DOI 10.1002/(SICI)1096-8628(19990528)84:3<229::AID-AJMG13>3.3.CO;2-K; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Terplan M, 2011, GYNECOL ONCOL; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Vogel KJ, 2007, J CLIN ONCOL, V25, P4635, DOI 10.1200/JCO.2006.10.4703; Wagner T, 1999, GENOMICS, V62, P369, DOI 10.1006/geno.1999.6026; Willemsen R, 2011, CLIN GENET, V80, P214, DOI 10.1111/j.1399-0004.2011.01723.x; Wittenberger MD, 2007, FERTIL STERIL, V87, P456, DOI 10.1016/j.fertnstert.2006.09.004; Xu CF, 1997, GENE CHROMOSOME CANC, V18, P102, DOI 10.1002/(SICI)1098-2264(199702)18:2<102::AID-GCC4>3.3.CO;2-A	35	18	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44753	10.1371/journal.pone.0044753	http://dx.doi.org/10.1371/journal.pone.0044753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984553	gold, Green Submitted, Green Published			2022-12-25	WOS:000308738500080
J	White, O; Lefevre, P; Wing, AM; Bracewell, RM; Thonnard, JL				White, Olivier; Lefevre, Philippe; Wing, Alan M.; Bracewell, R. Martyn; Thonnard, Jean-Louis			Active Collisions in Altered Gravity Reveal Eye-Hand Coordination Strategies	PLOS ONE			English	Article							GRIP FORCE ADJUSTMENTS; OBJECT MANIPULATION; VISUAL INFORMATION; LOAD PERTURBATIONS; POINTING MOVEMENT; HEAD MOVEMENTS; ARM MOVEMENTS; TARGET; TASK; DIRECTION	Most object manipulation tasks involve a series of actions demarcated by mechanical contact events, and gaze is usually directed to the locations of these events as the task unfolds. Typically, gaze foveates the target 200 ms in advance of the contact. This strategy improves manual accuracy through visual feedback and the use of gaze-related signals to guide the hand/ object. Many studies have investigated eye-hand coordination in experimental and natural tasks; most of them highlighted a strong link between eye movements and hand or object kinematics. In this experiment, we analyzed gaze strategies in a collision task but in a very challenging dynamical context. Participants performed collisions while they were exposed to alternating episodes of microgravity, hypergravity and normal gravity. First, by isolating the effects of inertia in microgravity, we found that peak hand acceleration marked the transition between two modes of grip force control. Participants exerted grip forces that paralleled load force profiles, and then increased grip up to a maximum shifted after the collision. Second, we found that the oculomotor strategy adapted visual feedback of the controlled object around the collision, as demonstrated by longer durations of fixation after collision in new gravitational environments. Finally, despite large variability of arm dynamics in altered gravity, we found that saccades were remarkably time-locked to the peak hand acceleration in all conditions. In conclusion, altered gravity allowed light to be shed on predictive mechanisms used by the central nervous system to coordinate gaze, hand and grip motor actions during a mixed task that involved transport of an object and high impact loads.	[White, Olivier] Univ Bourgogne, Unite Format & Rech Sci & Tech Act Phys & Sport, Dijon, France; [White, Olivier] INSERM, Cognit Act & Sensorimotor Plast U1093, Dijon, France; [Lefevre, Philippe] Catholic Univ Louvain, Inst Informat & Commun Technol Elect & Appl Math, B-3000 Louvain, Belgium; [Lefevre, Philippe; Thonnard, Jean-Louis] Catholic Univ Louvain, Inst Neurosci, B-1200 Brussels, Belgium; [Wing, Alan M.; Bracewell, R. Martyn] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Bracewell, R. Martyn] Bangor Univ, Wolfson Ctr Clin & Cognit Neurosci, Bangor, Gwynedd, Wales	Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite Catholique Louvain; Universite Catholique Louvain; University of Birmingham; Bangor University	White, O (corresponding author), Univ Bourgogne, Unite Format & Rech Sci & Tech Act Phys & Sport, Dijon, France.	olivier.white@u-bourgogne.fr	White, Olivier/AAJ-6914-2020	White, Olivier/0000-0002-9119-1329; Wing, Alan/0000-0002-2623-3801	Prodex (PROgramme for the Development of Scientific EXperiments by the European Space Agency); OSTC (Office for Scientific, Technical and Cultural Affairs); ESA/ESTEC (European Space Agency/European Space Research and Technology Centre) from the UK Medical Research Council [14725/00/NL/JS]; European Union Information Society Technologies; INSERM; Universite de Bourgogne	Prodex (PROgramme for the Development of Scientific EXperiments by the European Space Agency); OSTC (Office for Scientific, Technical and Cultural Affairs); ESA/ESTEC (European Space Agency/European Space Research and Technology Centre) from the UK Medical Research Council; European Union Information Society Technologies; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite de Bourgogne	This research was supported by grants from Prodex (PROgramme for the Development of Scientific EXperiments by the European Space Agency), OSTC (Office for Scientific, Technical and Cultural Affairs) and ESA/ESTEC (European Space Agency/European Space Research and Technology Centre) Contract 14725/00/NL/JS to JLT, from the UK Medical Research Council to AMW, and European Union Information Society Technologies to AMW and RMB and by INSERM and Universite de Bourgogne to OWH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS RA, 1990, J EXP PSYCHOL HUMAN, V16, P248, DOI 10.1037/0096-1523.16.2.248; Augurelle AS, 2003, EXP BRAIN RES, V148, P533, DOI 10.1007/s00221-002-1322-3; Binsted G, 1999, EXP BRAIN RES, V127, P193, DOI 10.1007/s002210050789; Binsted G, 2001, HUM MOVEMENT SCI, V20, P563, DOI 10.1016/S0167-9457(01)00068-9; BOOTSMA RJ, 1993, J EXP PSYCHOL HUMAN, V19, P1041, DOI 10.1037/0096-1523.19.5.1041; Bowman M, 2009, EXP BRAIN RES, V195, P273, DOI 10.1007/s00221-009-1781-x; CARNAHAN H, 1991, J MOTOR BEHAV, V23, P109, DOI 10.1080/00222895.1991.9942028; Clarke AH, 2002, BEHAV RES METH INS C, V34, P549, DOI 10.3758/BF03195484; Crevecoeur F, 2009, NEUROSCIENCE, V161, P589, DOI 10.1016/j.neuroscience.2009.03.025; de Brouwer S, 2002, J NEUROPHYSIOL, V87, P1646, DOI 10.1152/jn.00432.2001; Delevoye-Turrell YN, 2003, Q J EXP PSYCHOL-A, V56, P1113, DOI 10.1080/02724980245000025; Flanagan JR, 2006, CURR OPIN NEUROBIOL, V16, P650, DOI 10.1016/j.conb.2006.10.005; Foerster RM, 2011, J VISION, V11, DOI 10.1167/11.7.9; Gentili R, 2007, NEUROSCIENCE, V145, P20, DOI 10.1016/j.neuroscience.2006.11.035; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; HagerRoss C, 1996, EXP BRAIN RES, V110, P142; Helsen WF, 2000, J MOTOR BEHAV, V32, P241, DOI 10.1080/00222890009601375; Hermsdorfer J, 2000, EXP BRAIN RES, V132, P52, DOI 10.1007/s002219900325; Johansson RS, 2001, J NEUROSCI, V21, P6917, DOI 10.1523/JNEUROSCI.21-17-06917.2001; Land M, 1999, PERCEPTION, V28, P1311, DOI 10.1068/p2935; LAND MF, 1992, NATURE, V359, P318, DOI 10.1038/359318a0; McIntyre J, 2001, ACTA ASTRONAUT, V49, P111, DOI 10.1016/S0094-5765(01)00087-X; Mrotek LA, 2004, EXP BRAIN RES, V155, P413, DOI 10.1007/s00221-003-1748-2; Nanayakkara T, 2003, J NEUROPHYSIOL, V90, P4016, DOI 10.1152/jn.00430.2003; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Neggers SFW, 2001, J NEUROPHYSIOL, V86, P961, DOI 10.1152/jn.2001.86.2.961; Nowak DA, 2002, SOMATOSENS MOT RES, V19, P49, DOI 10.1080/08990220120113048; Nowak DA, 2001, MOTOR CONTROL, V5, P231, DOI 10.1123/mcj.5.3.231; Nowak DA, 2006, EXP BRAIN RES, V173, P650, DOI 10.1007/s00221-006-0409-7; Papaxanthis C, 1998, EXP BRAIN RES, V120, P496, DOI 10.1007/s002210050423; Pelz J, 2001, EXP BRAIN RES, V139, P266, DOI 10.1007/s002210100745; Rodrigues ST, 2002, J SPORT SCI, V20, P187, DOI 10.1080/026404102317284754; Ronsse R, 2007, J NEUROSCI METH, V159, P158, DOI 10.1016/j.jneumeth.2006.06.016; Saunders JA, 2003, EXP BRAIN RES, V152, P341, DOI 10.1007/s00221-003-1525-2; Senot P, 2005, J NEUROPHYSIOL, V94, P4471, DOI 10.1152/jn.00527.2005; Serrien DJ, 1999, EXP BRAIN RES, V124, P100, DOI 10.1007/s002210050604; Starkes J, 2002, J SPORT SCI, V20, P217, DOI 10.1080/026404102317284772; Turrell YN, 1999, EXP BRAIN RES, V128, P86, DOI 10.1007/s002210050822; Vercher JL, 1996, J NEUROPHYSIOL, V76, P1133, DOI 10.1152/jn.1996.76.2.1133; WERKHOVEN P, 1992, VISION RES, V32, P2313, DOI 10.1016/0042-6989(92)90095-Z; White O, 2005, EXP BRAIN RES, V163, P324, DOI 10.1007/s00221-004-2175-8; White O, 2011, NEUROSCIENCE, V189, P269, DOI 10.1016/j.neuroscience.2011.04.055; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Zago M, 2005, J NEUROPHYSIOL, V93, P1055, DOI 10.1152/jn.00833.2004	44	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44291	10.1371/journal.pone.0044291	http://dx.doi.org/10.1371/journal.pone.0044291			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984488	Green Submitted, Green Published, gold			2022-12-25	WOS:000308738500044
J	Ali, Z; Mishra, A; Kumar, R; Alam, P; Pandey, P; Ram, R; Thinlas, T; Mohammad, G; Pasha, MAQ				Ali, Zahara; Mishra, Aastha; Kumar, Rahul; Alam, Perwez; Pandey, Priyanka; Ram, Rekhbala; Thinlas, Tashi; Mohammad, Ghulam; Pasha, M. A. Qadar			Interactions among Vascular-Tone Modulators Contribute to High Altitude Pulmonary Edema and Augmented Vasoreactivity in Highlanders	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; NITRIC-OXIDE; OXIDATIVE STRESS; ASYMMETRIC DIMETHYLARGININE; L-ARGININE; ARTERIAL-HYPERTENSION; CONVERTING ENZYME; HYPOBARIC HYPOXIA; NATURAL-SELECTION; ADAPTATION	Background: The interactions among various biomarkers remained unexplored under the stressful environment of high-altitude. Present study evaluated interactions among biomarkers to study susceptibility for high altitude pulmonary edema (HAPE) in HAPE-patients (HAPE-p) and adaptation in highland natives (HLs); both in comparison to HAPE-free sojourners (HAPE-f). Methodology/Principal Findings: All the subjects were recruited at 3500 m. We measured clinical parameters, biochemical levels in plasma and gene expression using RNA from blood; analyzed various correlations between and among the clinical parameters, especially arterial oxygen saturation (SaO(2)) and mean arterial pressure (MAP) and biochemical parameters like, asymmetric dimethylarginine (ADMA), serotonin (5-HT), 8-iso-prostaglandin F2 alpha (8-isoPGF2 alpha), endothelin-1 (ET-1), plasma renin activity (PRA), plasma aldosterone concentration (PAC), superoxide dismutase (SOD) and nitric oxide (NO) in HAPE-p, HAPE-f and HLs. ADMA, 5-HT, 8-isoPGF2 alpha, ET-1 levels, and PAC were significantly higher (p<0.0001, each), whereas SOD activity and NO level were significantly lower in HAPE-p than HAPE-f (p <= 0.001). Furthermore, ADMA, 5-HT, 8-isoPGF2 alpha, NO levels and PAC were significantly higher (p<0.0001), whereas ET-1 level significantly (p, 0.0001) and SOD activity non-significantly (p. 0.05) lower in HLs than HAPE-f. The expression of respective genes differed in the three groups. In the correlations, SaO(2) inversely correlated with ADMA, 5-HT and 8-isoPGF2 alpha and positively with SOD in HAPE-p (p <= 0.009). MAP correlated positively with 5-HT and 8-isoPGF2 alpha in HAPE-p and HLs (p <= 0.004). A strong positive correlation was observed between ADMA and 5-HT, 5-HT and 8-isoPGF2 alpha (p <= 0.001), whereas inverse correlation of SOD with ET-1 in HAPE-p and HLs (p <= 0.004), with 5-HT and 8-isoPGF2 alpha in HAPE-p (p = 0.01) and with 5-HT in HLs (p = 0.05). Conclusions/Significance: The interactions among these markers confer enhanced vascular activity in HLs and HAPE in sojourners.	[Ali, Zahara; Mishra, Aastha; Kumar, Rahul; Alam, Perwez; Pandey, Priyanka; Ram, Rekhbala; Pasha, M. A. Qadar] Inst Genom & Integrat Biol, Delhi, India; [Ali, Zahara; Mishra, Aastha; Alam, Perwez; Pandey, Priyanka; Pasha, M. A. Qadar] Univ Pune, Dept Biotechnol, Pune, Maharashtra, India; [Thinlas, Tashi; Mohammad, Ghulam] SNM Hosp, Dept Med, Ladakh, Jammu & Kashmir, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Savitribai Phule Pune University	Ali, Z (corresponding author), Inst Genom & Integrat Biol, Delhi, India.	qpasha@igib.res.in		Alam, Perwez/0000-0002-7229-8008; Kumar, Rahul/0000-0002-2709-5981; Alam, Perwez/0000-0003-0668-2236	Council of Scientific and Industrial Research, India under the Supra-Institutional Project [SIP0006]	Council of Scientific and Industrial Research, India under the Supra-Institutional Project	The Council of Scientific and Industrial Research, India, financially supported under the Supra-Institutional Project-SIP0006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2010, P NATL ACAD SCI USA, V107, P18961, DOI 10.1073/pnas.1006108107; Ahsan A, 2004, THORAX, V59, P1000, DOI 10.1136/thx.2004.029124; Arrigoni FI, 2003, CIRCULATION, V107, P1195, DOI 10.1161/01.CIR.0000051466.00227.13; Basnyat B, 2003, LANCET, V361, P1967, DOI 10.1016/S0140-6736(03)13591-X; Beall CM, 2001, NATURE, V414, P411, DOI 10.1038/35106641; Beall CA, 2007, RESP PHYSIOL NEUROBI, V158, P161, DOI 10.1016/j.resp.2007.05.013; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Berger MM, 2009, HIGH ALT MED BIOL, V10, P17, DOI 10.1089/ham.2008.1053; Busch T, 2001, AM J RESP CRIT CARE, V163, P368, DOI 10.1164/ajrccm.163.2.2001134; Charu R, 2006, THORAX, V61, P1011, DOI 10.1136/thx.2006.066019; Cooke JP, 1997, CIRCULATION, V96, P379; Dosek A, 2007, RESP PHYSIOL NEUROBI, V158, P128, DOI 10.1016/j.resp.2007.03.013; Droma Y, 1996, EUR RESPIR J, V9, P1947, DOI 10.1183/09031936.96.09091947; Eddahibi S, 1999, CIRC RES, V84, P329, DOI 10.1161/01.RES.84.3.329; Gorenflo M, 2001, J CARDIOVASC PHARM, V37, P489, DOI 10.1097/00005344-200104000-00016; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; HERVE P, 1995, AM J MED, V99, P249, DOI 10.1016/S0002-9343(99)80156-9; Jefferson JA, 2004, HIGH ALT MED BIOL, V5, P61, DOI 10.1089/152702904322963690; Kielstein JT, 2005, ARTERIOSCL THROM VAS, V25, P1414, DOI 10.1161/01.ATV.0000168414.06853.f0; Konigshoff M, 2010, THORAX, V65, P949, DOI 10.1136/thx.2009.134353; Lee SL, 1998, FREE RADICAL BIO MED, V24, P855, DOI 10.1016/S0891-5849(97)00359-6; Lemarie CA, 2008, J MOL MED, V86, P673, DOI 10.1007/s00109-008-0323-5; Leon-Velarde F, 2010, PROG CARDIOVASC DIS, V52, P540, DOI 10.1016/j.pcad.2010.02.012; Linz W, 1999, CARDIOVASC RES, V43, P549, DOI 10.1016/S0008-6363(99)00091-7; MACGREGOR GA, 1981, NATURE, V291, P329, DOI 10.1038/291329a0; MacLean MR, 2007, INT J CLIN PRACT, V61, P27, DOI 10.1111/j.1742-1241.2007.01497.x; Marcos E, 2004, CIRC RES, V94, P1263, DOI 10.1161/01.RES.0000126847.27660.69; MILLEDGE JS, 1982, J APPL PHYSIOL, V52, P320, DOI 10.1152/jappl.1982.52.2.320; Mishra A, 2012, CLIN SCI, V122, P299, DOI 10.1042/CS20110205; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Montuschi P, 2004, FASEB J, V18, P1791, DOI 10.1096/fj.04-2330rev; Moore LG, 1998, YEARB PHYS ANTHROPOL, V41, P25; Morrell NW, 2009, J AM COLL CARDIOL, V54, pS20, DOI 10.1016/j.jacc.2009.04.018; Morrow JD, 2002, AM J RESP CRIT CARE, V166, pS25, DOI 10.1164/rccm.2206011; Nakanishi I, 1995, J PHYSIOL-LONDON, V489, P869, DOI 10.1113/jphysiol.1995.sp021099; Pasha MAQ, 2003, CURR SCI INDIA, V85, P502; Pasha MAQ, 2001, ANN HUM GENET, V65, P531, DOI 10.1017/S0003480001008879; Rajput C, 2006, BIOCHEM BIOPH RES CO, V341, P1218, DOI 10.1016/j.bbrc.2006.01.086; ROCK PB, 1993, J APPL PHYSIOL, V75, P1208, DOI 10.1152/jappl.1993.75.3.1208; Sartori C, 1999, CIRCULATION, V99, P2665, DOI 10.1161/01.CIR.99.20.2665; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Skoro-Sajer N, 2007, AM J RESP CRIT CARE, V176, P1154, DOI 10.1164/rccm.200702-278OC; Struthers AD, 2004, CARDIOVASC RES, V61, P663, DOI 10.1016/j.cardiores.2003.11.037; Suda O, 2004, ARTERIOSCL THROM VAS, V24, P1682, DOI 10.1161/01.ATV.0000136656.26019.6e; Vallance P, 2004, ARTERIOSCL THROM VAS, V24, P1023, DOI 10.1161/01.ATV.0000128897.54893.26; Zakrzewicz Dariusz, 2009, BMC Pulm Med, V9, P5, DOI 10.1186/1471-2466-9-5	46	35	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44049	10.1371/journal.pone.0044049	http://dx.doi.org/10.1371/journal.pone.0044049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984459	Green Submitted, Green Published, gold			2022-12-25	WOS:000308638700040
J	Yu, J; Walter, K; Omura, N; Hong, SM; Young, A; Li, A; Vincent, A; Goggins, M				Yu, Jun; Walter, Kimberly; Omura, Noriyuki; Hong, Seung-Mo; Young, Angela; Li, Ang; Vincent, Audrey; Goggins, Michael			Unlike Pancreatic Cancer Cells Pancreatic Cancer Associated Fibroblasts Display Minimal Gene Induction after 5-Aza-2 '-Deoxycytidine	PLOS ONE			English	Article							TUMOR-STROMAL INTERACTIONS; DUCTAL ADENOCARCINOMA; ABERRANT METHYLATION; DNA METHYLATION; BREAST-CANCER; PROMOTER METHYLATION; BLADDER-CANCER; MULTIPLE GENES; CARCINOMA; EXPRESSION	Purpose: Cancer associated stromal fibroblasts (CAFs) undergo transcriptional and phenotypic changes that contribute to tumor progression, but the mechanisms responsible for these changes are not well understood. Aberrant DNA methylation is an important cause of transcriptional alterations in cancer cells but it is not known how important DNA methylation alterations are to CAF behavior. Experimental Design: We used Affymetrix exon arrays to compare genes induced by the DNA methylation inhibitor 5-aza-dC in cultured pancreatic cancer associated fibroblasts, pancreatic control fibroblasts and pancreatic cancer cell lines. Results: We found that pancreatic CAFs and control pancreatic fibroblasts were less responsive to 5-aza-dC-mediated gene reactivation than pancreatic cancer cells (mean+/2SD of genes induced >= 5-fold was 9 +/- 10 genes in 10 pancreatic CAF cultures, 17 +/- 14 genes in 3 control pancreatic fibroblast cultures, and 134 +/- 85 genes in 4 pancreatic cancer cell lines). We examined differentially expressed genes between CAFs and control fibroblasts for candidate methylated genes and identified the disintegrin and metalloprotease, ADAM12 as hypomethylated and overexpressed in pancreatic CAF lines and overexpressed in fibroblasts adjacent to primary pancreatic adenocarcinomas. Conclusions: Compared to pancreatic cancer cells, few genes are reactivated by DNMT1 inhibition in pancreatic CAFs suggesting these cells do not harbor many functionally important alterations in DNA methylation. CAFs may also not be very responsive to therapeutic targeting with DNA methylation inhibitors.	[Yu, Jun; Walter, Kimberly; Omura, Noriyuki; Hong, Seung-Mo; Young, Angela; Li, Ang; Vincent, Audrey; Goggins, Michael] Johns Hopkins Med Inst, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA; [Goggins, Michael] Johns Hopkins Med Inst, Dept Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA; [Goggins, Michael] Johns Hopkins Med Inst, Dept Oncol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Yu, J (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD USA.	mgoggins@jhmi.edu	Vincent, Audrey/I-2934-2016	Vincent, Audrey/0000-0003-0058-2058; Hong, Seung-Mo/0000-0002-8888-6007	National Cancer Institute [CA62924, RC2148346]; Michael Rolfe Foundation; NATIONAL CANCER INSTITUTE [P50CA062924] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Michael Rolfe Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute grants (CA62924 and RC2148346), and the Michael Rolfe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Bender CM, 1998, CANCER RES, V58, P95; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Boyd ZS, 2009, J MOL DIAGN, V11, P290, DOI 10.2353/jmoldx.2009.080124; Campbell I, 2009, CANCER RES, V69, P6765, DOI 10.1158/0008-5472.CAN-08-4253; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Cohen SJ, 2008, PANCREAS, V37, P154, DOI 10.1097/MPA.0b013e31816618ce; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Eyden B, 2008, J CELL MOL MED, V12, P22, DOI 10.1111/j.1582-4934.2007.00213.x; Ferguson AT, 2000, P NATL ACAD SCI USA, V97, P6049, DOI 10.1073/pnas.100566997; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Frohlich C, 2006, CLIN CANCER RES, V12, P7359, DOI 10.1158/1078-0432.CCR-06-1066; Fujita H, 2010, PANCREAS; Fukushima N, 2002, AM J PATHOL, V160, P1573, DOI 10.1016/S0002-9440(10)61104-2; Hanson JA, 2006, JNCI-J NATL CANCER I, V98, P255, DOI 10.1093/jnci/djj051; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Iacobuzio-Donahue CA, 2002, CANCER RES, V62, P5351; Iba K, 1999, AM J PATHOL, V154, P1489, DOI 10.1016/S0002-9440(10)65403-X; Infante JR, 2007, J CLIN ONCOL, V25, P319, DOI 10.1200/JCO.2006.07.8824; Issa JPJ, 2001, CANCER RES, V61, P3573; Jiang L, 2008, CANCER RES, V68, P9900, DOI 10.1158/0008-5472.CAN-08-1319; Jin BL, 2009, CANCER RES, V69, P7412, DOI 10.1158/0008-5472.CAN-09-0116; Jones PA, 2009, NAT REV GENET, V10, P805, DOI 10.1038/nrg2651; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kanda M, 2009, INT J ONCOL, V35, P477, DOI 10.3892/ijo_00000359; Kelloff Gary J., 2007, Cancer Biomarkers, V3, P1; Kim ST, 2007, P NATL ACAD SCI USA, V104, P17052, DOI 10.1073/pnas.0708293104; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Lau JCY, 2004, NUCLEIC ACIDS RES, V32, P3376, DOI 10.1093/nar/gkh671; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Liang G, 2002, CANCER RES, V62, P961; Maegawa S, 2010, GENOME RES, V20, P332, DOI 10.1101/gr.096826.109; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Matsubayashi H, 2005, CLIN CANCER RES, V11, P573; Menigatti M, 2009, ONCOGENE, V28, P899, DOI 10.1038/onc.2008.444; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Ohuchida K, 2004, CANCER RES, V64, P3215, DOI 10.1158/0008-5472.CAN-03-2464; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Omura N, 2009, INT J CLIN EXP PATHO, V2, P310; Omura Noriyuki, 2008, Proceedings of the American Association for Cancer Research Annual Meeting, V49, P7; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pietras K, 2008, PLOS MED, V5, P123, DOI 10.1371/journal.pmed.0050019; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Sato N, 2003, CANCER RES, V63, P4158; Sato N, 2006, GASTROENTEROLOGY, V130, P548, DOI 10.1053/j.gastro.2005.11.008; Sato N, 2005, CLIN CANCER RES, V11, P4681, DOI 10.1158/1078-0432.CCR-04-2471; Sato N, 2005, ONCOGENE, V24, P850, DOI 10.1038/sj.onc.1208050; Sato N, 2004, AM J PATHOL, V164, P903, DOI 10.1016/S0002-9440(10)63178-1; Sato N, 2003, CANCER RES, V63, P3735; Sato N, 2003, ONCOGENE, V22, P5021, DOI 10.1038/sj.onc.1206807; Sun WY, 2010, CLIN CANCER RES, V16, P857, DOI 10.1158/1078-0432.CCR-09-2604; Tian H, 2009, P NATL ACAD SCI USA, V106, P4254, DOI 10.1073/pnas.0813203106; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Vincent A, 2011, CLIN CANCER RES, V17, P4341, DOI 10.1158/1078-0432.CCR-10-3431; Walter K, 2008, CANCER BIOL THER, V7, P882, DOI 10.4161/cbt.7.6.5869; Walter K, 2010, CLIN CANCER RES, V16, P1781, DOI 10.1158/1078-0432.CCR-09-1913; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Yu J, 2012, CLIN CANCER RES, V18, P981, DOI 10.1158/1078-0432.CCR-11-2347; Yu J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-169; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zhu JK, 2009, ANNU REV GENET, V43, P143, DOI 10.1146/annurev-genet-102108-134205	72	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43456	10.1371/journal.pone.0043456	http://dx.doi.org/10.1371/journal.pone.0043456			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984426	Green Published, gold, Green Submitted			2022-12-25	WOS:000308638700020
J	Ueti, MW; Mealey, RH; Kappmeyer, LS; White, SN; Kumpula-McWhirter, N; Pelzel, AM; Grause, JF; Bunn, TO; Schwartz, A; Traub-Dargatz, JL; Hendrickson, A; Espy, B; Guthrie, AJ; Fowler, WK; Knowles, DP				Ueti, Massaro W.; Mealey, Robert H.; Kappmeyer, Lowell S.; White, Stephen N.; Kumpula-McWhirter, Nancy; Pelzel, Angela M.; Grause, Juanita F.; Bunn, Thomas O.; Schwartz, Andy; Traub-Dargatz, Josie L.; Hendrickson, Amy; Espy, Benjamin; Guthrie, Alan J.; Fowler, W. Kent; Knowles, Donald P.			Re-Emergence of the Apicomplexan Theileria equi in the United States: Elimination of Persistent Infection and Transmission Risk	PLOS ONE			English	Article							PIROPLASMOSIS BABESIA-EQUI; IMIDOCARB DIPROPIONATE; BOOPHILUS-MICROPLUS; YELLOW-FEVER; HORSES; BUPARVAQUONE; EXPRESSION; RESERVOIRS; MOSQUITOS; EFFICACY	Arthropod-borne apicomplexan pathogens that cause asymptomatic persistent infections present a significant challenge due to their life-long transmission potential. Although anti-microbials have been used to ameliorate acute disease in animals and humans, chemotherapeutic efficacy for apicomplexan pathogen elimination from a persistently infected host and removal of transmission risk is largely unconfirmed. The recent re-emergence of the apicomplexan Theileria equi in U. S. horses prompted testing whether imidocarb dipropionate was able to eliminate T. equi from naturally infected horses and remove transmission risk. Following imidocarb treatment, levels of T. equi declined from a mean of 10(4.9) organisms/ml of blood to undetectable by nested PCR in 24 of 25 naturally infected horses. Further, blood transfer from treated horses that became nested PCR negative failed to transmit to naive splenectomized horses. Although these results were consistent with elimination of infection in 24 of 25 horses, T. equi-specific antibodies persisted in the majority of imidocarb treated horses. Imidocarb treatment was unsuccessful in one horse which remained infected as measured by nested PCR and retained the ability to infect a naive recipient via intravenous blood transfer. However, a second round of treatment eliminated T. equi infection. These results support the utility of imidocarb chemotherapy for assistance in the control and eradication of this tick-borne pathogen. Successful imidocarb dipropionate treatment of persistently infected horses provides a tool to aid the global equine industry by removing transmission risk associated with infection and facilitating international movement of equids between endemic and non-endemic regions.	[Ueti, Massaro W.; Kappmeyer, Lowell S.; White, Stephen N.; Knowles, Donald P.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA; [Ueti, Massaro W.; Mealey, Robert H.; White, Stephen N.; Kumpula-McWhirter, Nancy; Knowles, Donald P.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Pelzel, Angela M.] Vet Serv, US Dept Agr Anim & Plant Hlth Inspect Serv, Western Reg Off, Ft Collins, CO USA; [Grause, Juanita F.; Bunn, Thomas O.] Vet Serv, Anim & Plant Hlth Inspect Serv, Natl Vet Serv Labs, Ames, IA USA; [Schwartz, Andy] Texas Anim Hlth Commiss, Austin, TX USA; [Traub-Dargatz, Josie L.] Colorado State Univ, Anim Populat Hlth Inst, Dept Clin Sci, Ft Collins, CO 80523 USA; [Hendrickson, Amy] Natl Assoc State Dept Agr, Washington, DC USA; [Espy, Benjamin] Equine Reprod, San Antonio, TX USA; [Guthrie, Alan J.] Univ Pretoria, Fac Vet Sci, Equine Res Ctr, ZA-0110 Onderstepoort, South Africa; [Fowler, W. Kent] Calif Dept Food & Agr, Sacramento, CA 95814 USA	United States Department of Agriculture (USDA); Washington State University; United States Department of Agriculture (USDA); Colorado State University; University of Pretoria; California Department of Food & Agriculture	Ueti, MW (corresponding author), ARS, Anim Dis Res Unit, USDA, Pullman, WA USA.	massaro@vetmed.wsu.edu	Mealey, Robert/H-1454-2016; Guthrie, Alan/J-6375-2013; Kappmeyer, Lowell/AAF-2115-2020	Mealey, Robert/0000-0002-7571-1689; Guthrie, Alan/0000-0001-7729-9918; Kappmeyer, Lowell/0000-0002-4081-4995; White, Stephen N./0000-0001-9255-6054	United States Department of Agriculture-Agricultural Research Service [5348-32000-034-00D]	United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by United States Department of Agriculture-Agricultural Research Service 5348-32000-034-00D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS LG, 1981, RES VET SCI, V31, P54, DOI 10.1016/S0034-5288(18)32521-9; Baird JK, 2003, TRENDS PARASITOL, V19, P115, DOI 10.1016/S1471-4922(03)00005-9; Bowman MC, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000970; Bruning A, 1996, BRIT VET J, V152, P139, DOI 10.1016/S0007-1935(96)80070-4; Butler CM, 2008, VET PARASITOL, V151, P320, DOI 10.1016/j.vetpar.2007.11.010; Calder JAM, 1996, J CLIN MICROBIOL, V34, P2748, DOI 10.1128/JCM.34.11.2748-2755.1996; CHEEVERS WP, 1985, REV INFECT DIS, V7, P83; ERIKS IS, 1989, J CLIN MICROBIOL, V27, P279, DOI 10.1128/JCM.27.2.279-284.1989; FRERICHS WM, 1973, VET REC, V93, P73, DOI 10.1136/vr.93.3.73; Futse JE, 2008, P NATL ACAD SCI USA, V105, P2123, DOI 10.1073/pnas.0710333105; Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001; Gubbels MJ, 2001, PARASITOLOGY, V123, P553, DOI 10.1017/S0031182001008757; Holbrook A A, 1968, Proc Annu Meet U S Anim Health Assoc, V72, P220; Howell JM, 2007, J CLIN MICROBIOL, V45, P3155, DOI 10.1128/JCM.00766-07; Kumar S, 2003, J VET MED SCI, V65, P1171, DOI 10.1292/jvms.65.1171; KUTTLER KL, 1987, AM J VET RES, V48, P1613; Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8; Mehlhorn H, 1998, PARASITOL RES, V84, P467, DOI 10.1007/s004360050431; Ndungu FM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000690; Nicolaiewsky TB, 2001, VET PARASITOL, V101, P9, DOI 10.1016/S0304-4017(01)00471-X; Palacpac NMQ, 2006, MOL BIOCHEM PARASIT, V150, P353, DOI 10.1016/j.molbiopara.2006.07.006; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617; Schwint ON, 2009, ANTIMICROB AGENTS CH, V53, P4327, DOI 10.1128/AAC.00404-09; Scoles GA, 2011, EMERG INFECT DIS, V17, P1903, DOI 10.3201/eid1710.101182; Short MA, 2012, JAVMA-J AM VET MED A, V240, P588, DOI 10.2460/javma.240.5.588; SIMPSON CF, 1980, AM J VET RES, V41, P267; Slifka MK, 1998, CURR OPIN IMMUNOL, V10, P252, DOI 10.1016/S0952-7915(98)80162-3; Stiller D, 2002, J MED ENTOMOL, V39, P667, DOI 10.1603/0022-2585-39.4.667; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Ueti MW, 2008, INFECT IMMUN, V76, P3525, DOI 10.1128/IAI.00251-08; Ueti MW, 2005, J CLIN MICROBIOL, V43, P3755, DOI 10.1128/JCM.43.8.3755-3759.2005; Ueti MW, 2003, J CLIN MICROBIOL, V41, P5803, DOI 10.1128/JCM.41.12.5803-5809.2003; Vasconcelos PFC, 2004, EMERG INFECT DIS, V10, P1578, DOI 10.3201/eid1009.040197; ZAUGG JL, 1992, AM J VET RES, V53, P1396	35	39	44	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44713	10.1371/journal.pone.0044713	http://dx.doi.org/10.1371/journal.pone.0044713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970295	gold, Green Submitted, Green Published			2022-12-25	WOS:000308458400110
J	Zaritsky, A; Natan, S; Ben-Jacob, E; Tsarfaty, I				Zaritsky, Assaf; Natan, Sari; Ben-Jacob, Eshel; Tsarfaty, Ilan			Emergence of HGF/SF-Induced Coordinated Cellular Motility	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; COLLECTIVE MIGRATION; C-MET; CELLS; METASTASIS; MODEL; MICROENVIRONMENT; INVASION; BEHAVIOR; FORCES	Collective cell migration plays a major role in embryonic morphogenesis, tissue remodeling, wound repair and cancer invasion. Despite many decades of extensive investigations, only few analytical tools have been developed to enhance the biological understanding of this important phenomenon. Here we present a novel quantitative approach to analyze long term kinetics of bright field time-lapse wound healing. Fully-automated spatiotemporal measures and visualization of cells' motility and implicit morphology were proven to be sound, repetitive and highly informative compared to single-cell tracking analysis. We study cellular collective migration induced by tyrosine kinase-growth factor signaling (Met-Hepatocyte Growth Factor/Scatter Factor (HGF/SF)). Our quantitative approach is applied to demonstrate that collective migration of the adenocarcinoma cell lines is characterized by simple morpho-kinetics. HGF/SF induces complex morpho-kinetic coordinated collective migration: cells at the front move faster and are more spread than those further away from the wound edge. As the wound heals, distant cells gradually accelerate and enhance spread and elongation -resembling the epithelial to mesenchymal transition (EMT), and then the cells become more spread and maintain higher velocity than cells located closer to the wound. Finally, upon wound closure, front cells halt, shrink and round up (resembling mesenchymal to epithelial transition (MET) phenotype) while distant cells undergo the same process gradually. Met inhibition experiments further validate that Met signaling dramatically alters the morpho-kinetic dynamics of the healing wound. Machine-learning classification was applied to demonstrate the generalization of our findings, revealing even subtle changes in motility patterns induced by Met-inhibition. It is concluded that activation of Met-signaling induces an elaborated model in which cells lead a coordinated increased motility along with gradual differentiation-based collective cell motility dynamics. Our quantitative phenotypes may guide future investigation on the molecular and cellular mechanisms of tyrosine kinase-induced coordinate cell motility and morphogenesis in metastasis.	[Zaritsky, Assaf] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Natan, Sari; Tsarfaty, Ilan] Tel Aviv Univ, Sackler Sch Med, Dept Clin Microbiol & Immunol, IL-69978 Tel Aviv, Israel; [Ben-Jacob, Eshel] Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Sch Phys & Astron, IL-69978 Tel Aviv, Israel; [Ben-Jacob, Eshel] Rice Univ, Ctr Theoret Biol Phys, Houston, TX USA; [Ben-Jacob, Eshel] Assaf Harofeh Med Ctr, Res & Dev Unit, IL-70300 Zerifin, Israel; [Ben-Jacob, Eshel] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Rice University; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Tel Aviv University	Zaritsky, A (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.	ilants@post.tau.ac.il		Natan, Sari/0000-0001-9419-3808; Zaritsky, Assaf/0000-0002-1477-5478; Tsarfaty, Ilan/0000-0002-5230-7093	Breast Cancer Research Foundation; Federico Foundation Grants; United States Israel Binational Science Foundation; Tauber Family Foundation; Division Of Physics [1308264] Funding Source: National Science Foundation	Breast Cancer Research Foundation; Federico Foundation Grants; United States Israel Binational Science Foundation(US-Israel Binational Science Foundation); Tauber Family Foundation; Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by research grants from the Breast Cancer Research Foundation, the Federico Foundation Grants, the United States Israel Binational Science Foundation and the Tauber Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benazeraf B, 2010, NATURE, V466, P248, DOI 10.1038/nature09151; Benvenuti S, 2007, J CELL PHYSIOL, V213, P316, DOI 10.1002/jcp.21183; Bindschadler M, 2007, J CELL SCI, V120, P876, DOI 10.1242/jcs.03395; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Chiou KK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002512; Crosswell HE, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-411; Deisboeck TS, 2009, BIOESSAYS, V31, P190, DOI 10.1002/bies.200800084; Driscoll MK, 2012, AGING-US, V4, P119, DOI 10.18632/aging.100434; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Firon M, 2000, ONCOGENE, V19, P2386, DOI 10.1038/sj.onc.1203557; FRIEDL P, 1995, CANCER RES, V55, P4557; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; FU YX, 1990, CANCER RES, V50, P227; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Gov NS, 2009, HFSP J, V3, P223, DOI 10.2976/1.3185785; Gov NS, 2007, P NATL ACAD SCI USA, V104, P15970, DOI 10.1073/pnas.0708037104; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Inaki M, 2012, P NATL ACAD SCI USA, V109, P2027, DOI 10.1073/pnas.1115260109; Jung KH, 2012, ARCH PHARM RES, V35, P595, DOI 10.1007/s12272-012-0402-6; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lecaudey V, 2006, CURR OPIN CELL BIOL, V18, P102, DOI 10.1016/j.ceb.2005.12.001; Lee P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002007; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Loerke D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002677; Mark S, 2010, BIOPHYS J, V98, P361, DOI 10.1016/j.bpj.2009.10.022; Matsubayashi Y, 2011, J CELL SCI, V124, P1017, DOI 10.1242/jcs.080853; MCCORMACK SA, 1992, AM J PHYSIOL, V263, pG426, DOI 10.1152/ajpgi.1992.263.3.G426; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Omelchenko T, 2003, P NATL ACAD SCI USA, V100, P10788, DOI 10.1073/pnas.1834401100; Pathak A, 2012, P NATL ACAD SCI USA, V109, P10334, DOI 10.1073/pnas.1118073109; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Petitjean L, 2010, BIOPHYS J, V98, P1790, DOI 10.1016/j.bpj.2010.01.030; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Reffay M, 2011, BIOPHYS J, V100, P2566, DOI 10.1016/j.bpj.2011.04.047; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Serra-Picamal X, 2012, NAT PHYS; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Trepat X, 2011, TRENDS CELL BIOL; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Tsarfaty I, 2012, P NATL ACAD SCI USA, V109, P6790, DOI 10.1073/pnas.1202337109; Vitorino P, 2008, GENE DEV, V22, P3268, DOI 10.1101/gad.1725808; Yao D, 2011, MOL CANC RES; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Zaritsky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027593	51	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44671	10.1371/journal.pone.0044671	http://dx.doi.org/10.1371/journal.pone.0044671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970283	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400104
J	Yang, J; McNeish, B; Butterfield, C; Moses, MA				Yang, Jiang; McNeish, Brendan; Butterfield, Catherine; Moses, Marsha A.			Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer	FASEB JOURNAL			English	Article						vascular endothelial growth factor; hypoxia-inducible factor 1 alpha; extracellular signal-regulated kinase	GELATINASE-ASSOCIATED LIPOCALIN; TUMOR ANGIOGENESIS; GENE; NGAL; RAS; EXPRESSION; INHIBITOR; INVASION; COMPLEX; KINASE	Lipocalin 2 (Lcn2), a member of the lipocalin family, is up-regulated in a variety of epithelial cancers. We have previously reported that Lcn2 induces the epithelial to mesenchymal transition in breast cancer through the estrogen receptor alpha/Slug axis and that it is a potential noninvasive biomarker of this disease. Here, we report the novel finding that Lcn2 regulates breast cancer angiogenesis. Vascular endothelial growth factor (VEGF), a key angiogenic activator, was significantly increased with Lcn2 expression in MCF-7 human breast cancer cells as well as in an angiogenic line derived from MDA-MB-436 cells. Treatment with a VEGF-neutralizing antibody demonstrates that VEGF is essential for the angiogenic activity of Lcn2. We further demonstrate that Lcn2-induced VEGF is mediated through hypoxia-inducible factor 1 alpha (HIF-1 alpha) and that Lcn2 regulates HIF-1 alpha through extracellular signal-regulated kinase (Erk). The regulation of HIF-1 alpha and VEGF by Lcn2 was also demonstrated in the aggressive MDA-MB-231 cell line. Using the mouse corneal pocket assay, we found that Lcn2 significantly enhanced the angiogenesis induced by VEGF. Taken together, these results are the first to demonstrate that Lcn2 promotes angiogenesis in vitro and in vivo and suggest a novel mechanism through which Lcn2 may promote tumor progression.-Yang, J., McNeish, B., Butterfield, C., Moses, M. A. Lipocalin 2 is a novel regulator of angiogenesis in human breast cancer. FASEB J. 27, 45-50 (2013). www.fasebj.org	[Yang, Jiang; McNeish, Brendan; Butterfield, Catherine; Moses, Marsha A.] Childrens Hosp, Vasc Biol Program, Boston, MA 02115 USA; [Yang, Jiang; McNeish, Brendan; Butterfield, Catherine; Moses, Marsha A.] Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Yang, Jiang; Moses, Marsha A.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Moses, MA (corresponding author), Childrens Hosp, Vasc Biol Program, 300 Longwood Ave,Karp 12-129, Boston, MA 02115 USA.	marsha.moses@childrens.harvard.edu		McNeish, Brendan/0000-0002-8285-168X	U.S. National Institutes of Health [R01 CA118764, P01 CA045548]; JoAnn Webb Fund for Angiogenesis Research; S. Elizabeth O'Brien Trust; Advanced Medical Foundation; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P01CA045548, R01CA118764] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JoAnn Webb Fund for Angiogenesis Research; S. Elizabeth O'Brien Trust; Advanced Medical Foundation; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. Dipak Panigrahy for his guidance and help with the in vivo studies. The authors gratefully acknowledge the following financial support: U.S. National Institutes of Health grants R01 CA118764 and P01 CA045548, the JoAnn Webb Fund for Angiogenesis Research, the S. Elizabeth O'Brien Trust, the Advanced Medical Foundation, and the Breast Cancer Research Foundation.	Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Berger T, 2010, P NATL ACAD SCI USA, V107, P2995, DOI 10.1073/pnas.1000101107; Ebrahem Q, 2010, AM J PATHOL, V176, P496, DOI 10.2353/ajpath.2010.080642; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Fernandez CA, 2003, J BIOL CHEM, V278, P40989, DOI 10.1074/jbc.M306176200; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gruvberger S, 2001, CANCER RES, V61, P5979; Harper J, 2006, EXP SUPPL, V96, P223; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Hu LM, 2009, LAB INVEST, V89, P531, DOI 10.1038/labinvest.2009.17; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Klausen P, 2005, EUR J HAEMATOL, V75, P332, DOI 10.1111/j.1600-0609.2005.00511.x; KOZMA SC, 1987, NUCLEIC ACIDS RES, V15, P5963; Lannetti A, 2008, P NATL ACAD SCI USA, V105, P14058, DOI 10.1073/pnas.0710846105; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; Moniaux N, 2008, BRIT J CANCER, V98, P1540, DOI 10.1038/sj.bjc.6604329; Moses MA, 1999, P NATL ACAD SCI USA, V96, P2645, DOI 10.1073/pnas.96.6.2645; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Roy R, 2006, EXP CELL RES, V312, P608, DOI 10.1016/j.yexcr.2005.11.022; Roy R, 2009, J CLIN ONCOL, V27, P5287, DOI 10.1200/JCO.2009.23.5556; Tong ZM, 2008, CANCER RES, V68, P6100, DOI 10.1158/0008-5472.CAN-08-0540; Tong ZM, 2005, BIOCHEM J, V391, P441, DOI 10.1042/BJ20051020; Venkatesha S, 2006, MOL CANCER RES, V4, P821, DOI 10.1158/1541-7786.MCR-06-0110; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yang J, 2009, CELL CYCLE, V8, P2347, DOI 10.4161/cc.8.15.9224; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106	29	78	80	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					45	50		10.1096/fj.12-211730	http://dx.doi.org/10.1096/fj.12-211730			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	22982376	Green Published			2022-12-25	WOS:000313103200006
J	Ares, GR; Ortiz, PA				Ares, Gustavo R.; Ortiz, Pablo A.			Dynamin2, Clathrin, and Lipid Rafts Mediate Endocytosis of the Apical Na/K/2Cl Cotransporter NKCC2 in Thick Ascending Limbs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL NA+-K+-2CL(-) COTRANSPORTER; COATED VESICLE FORMATION; UT-A1 UREA TRANSPORTER; NA+/H+ EXCHANGER NHE3; SALT-SENSITIVE RATS; NA-K-2CL COTRANSPORTER; CHOLESTEROL DEPLETION; CONSTITUTIVE ENDOCYTOSIS; DEPENDENT ENDOCYTOSIS; SURFACE EXPRESSION	Steady- state surface levels of the apical Na/K/2Cl cotransporter NKCC2 regulate NaCl reabsorption by epithelial cells of the renal thick ascending limb (THAL). We reported that constitutive endocytosis of NKCC2 controls NaCl absorption in native THALs; however, the pathways involved in NKCC2 endocytosis are unknown. We hypothesized that NKCC2 endocytosis at the apical surface depends on dynamin-2 and clathrin. Measurements of steady-state surface NKCC2 and the rate of NKCC2 endocytosis in freshly isolated rat THALs showed that inhibition of endogenous dynamin-2 with dynasore blunted NKCC2 endocytosis by 56 +/- 11% and increased steady-state surface NKCC2 by 67 +/- 27% (p < 0.05). Expression of the dominant negative Dyn2K44A in THALs slowed the rate of NKCC2 endocytosis by 38 +/- 8% and increased steady-state surface NKCC2 by 37 +/- 8%, without changing total NKCC2 expression. Inhibition of clathrin-mediated endocytosis with chlorpromazine blunted NKCC2 endocytosis by 54 +/- 6%, while preventing clathrin from interacting with synaptojanin also blunted NKCC2 endocytosis by 52 +/- 5%. Disruption of lipid rafts blunted NKCC2 endocytosis by 39 +/- 4% and silencing caveolin-1 by 29 +/- 4%. Simultaneous inhibition of clathrin- and lipid raft-mediated endocytosis completely blocked NKCC2 internalization. We concluded that dynamin-2, clathrin, and lipid rafts mediate NKCC2 endocytosis and maintain steady-state apical surface NKCC2 in native THALs. These are the first data identifying the endocytic pathway for apical NKCC2 endocytosis.	[Ares, Gustavo R.; Ortiz, Pablo A.] Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, Detroit, MI 48202 USA; [Ortiz, Pablo A.] Wayne State Univ, Dept Physiol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Wayne State University	Ortiz, PA (corresponding author), Henry Ford Hosp, Dept Internal Med, Hypertens & Vasc Res Div, 2799 W Grand Blvd, Detroit, MI 48202 USA.	portiz1@hfhs.org		Ortiz, Pablo/0000-0002-7512-7255	National Institutes of Health [R0-1 HL080409]; American Heart Association [0715579Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080409] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R0-1 HL080409 (to P. A. O.).; Supported in part by a Predoctoral Fellowship Grant 0715579Z from the American Heart Association.	Ares GR, 2008, AM J PHYSIOL-RENAL, V295, pF877, DOI 10.1152/ajprenal.00449.2007; Ares GR, 2010, AM J PHYSIOL-RENAL, V299, pF1193, DOI 10.1152/ajprenal.00307.2010; Aviv A, 2004, HYPERTENSION, V43, P707, DOI 10.1161/01.HYP.0000120155.48024.6f; Benziane B, 2007, J BIOL CHEM, V282, P33817, DOI 10.1074/jbc.M700195200; Bosch B, 2008, ANTIVIR RES, V80, P185, DOI 10.1016/j.antiviral.2008.06.004; Bullis BL, 2002, EUR J BIOCHEM, V269, P4887, DOI 10.1046/j.1432-1033.2002.03202.x; Caceres PS, 2009, J BIOL CHEM, V284, P24965, DOI 10.1074/jbc.M109.037135; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Cao H, 2007, J CELL SCI, V120, P4167, DOI 10.1242/jcs.010686; Cao H, 2010, MOL CELL BIOL, V30, P781, DOI 10.1128/MCB.00330-09; Chan SA, 2003, J PHYSIOL-LONDON, V553, P707, DOI 10.1113/jphysiol.2003.053918; Chen JJ, 2007, ARTERIOSCL THROM VAS, V27, P2005, DOI 10.1161/ATVBAHA.107.145961; Cheng ZJ, 2010, J BIOL CHEM, V285, P15119, DOI 10.1074/jbc.M109.069427; Chow CW, 1999, J BIOL CHEM, V274, P37551, DOI 10.1074/jbc.274.53.37551; Chun TY, 2008, HYPERTENSION, V52, P241, DOI 10.1161/HYPERTENSIONAHA.108.109801; Collazo R, 2000, J BIOL CHEM, V275, P31601, DOI 10.1074/jbc.M000600200; COOK TA, 1994, P NATL ACAD SCI USA, V91, P644, DOI 10.1073/pnas.91.2.644; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; Ecelbarger CA, 1996, AM J PHYSIOL-RENAL, V271, pF619, DOI 10.1152/ajprenal.1996.271.3.F619; Feng XY, 2009, AM J PHYSIOL-RENAL, V296, pF1514, DOI 10.1152/ajprenal.00068.2009; Fulop T, 2008, ARCH BIOCHEM BIOPHYS, V477, P146, DOI 10.1016/j.abb.2008.04.039; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gundelfinger ED, 2003, NAT REV MOL CELL BIO, V4, P127, DOI 10.1038/nrm1016; Hansen GH, 2000, J BIOL CHEM, V275, P5136, DOI 10.1074/jbc.275.7.5136; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Hoagland KM, 2004, HYPERTENSION, V43, P860, DOI 10.1161/01.HYP.0000120123.44945.47; Howes MT, 2010, J CELL BIOL, V190, P675, DOI 10.1083/jcb.201002119; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Huang HD, 2010, AM J PHYSIOL-RENAL, V299, pF1389, DOI 10.1152/ajprenal.00718.2009; Inoue M, 2004, J BIOL CHEM, V279, P49160, DOI 10.1074/jbc.M408942200; Karpushev AV, 2008, BIOCHEM BIOPH RES CO, V377, P521, DOI 10.1016/j.bbrc.2008.10.014; KIRCHNER KA, 1990, J AM SOC NEPHROL, V1, P180; KIRCHNER KA, 1992, AM J PHYSIOL, V262, pR263, DOI 10.1152/ajpregu.1992.262.2.R263; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; Li XH, 2001, J PHYSIOL-LONDON, V537, P537, DOI 10.1111/j.1469-7793.2001.00537.x; Lukacs GL, 1997, BIOCHEM J, V328, P353; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; Murtazina R, 2006, J BIOL CHEM, V281, P17845, DOI 10.1074/jbc.M601740200; Nevins AK, 2006, J BIOL CHEM, V281, P18961, DOI 10.1074/jbc.M603604200; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Nielsen S, 1998, AM J PHYSIOL-RENAL, V275, pF885, DOI 10.1152/ajprenal.1998.275.6.F885; Obermuller N, 1996, J CLIN INVEST, V98, P635, DOI 10.1172/JCI118834; Okamoto PM, 1997, J BIOL CHEM, V272, P11629; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Ortiz PA, 2003, HYPERTENSION, V42, P674, DOI 10.1161/01.HYP.0000085561.00001.81; Ortiz PA, 2003, KIDNEY INT, V63, P1141, DOI 10.1046/j.1523-1755.2003.00827.x; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Pressler CA, 2006, J AM SOC NEPHROL, V17, P2136, DOI 10.1681/ASN.2005101071; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rangarajan ES, 2010, J BIOL CHEM, V285, P11983, DOI 10.1074/jbc.M109.092049; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Sonalker PA, 2004, J PHARMACOL EXP THER, V311, P1052, DOI 10.1124/jpet.104.071209; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P1419, DOI 10.1097/01.ASN.0000064948.39199.A0; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sun TX, 2002, AM J PHYSIOL-RENAL, V282, pF998, DOI 10.1152/ajprenal.00257.2001; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; von Kleist L, 2011, CELL, V146, P471, DOI 10.1016/j.cell.2011.06.025; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Weder AB, 2009, HYPERTENSION, V53, P715, DOI 10.1161/HYPERTENSIONAHA.108.121665; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; Weller SG, 2010, P NATL ACAD SCI USA, V107, P5863, DOI 10.1073/pnas.0915123107; Yu MJ, 2008, AM J PHYSIOL-CELL PH, V295, pC661, DOI 10.1152/ajpcell.90650.2007	78	38	38	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.386425	http://dx.doi.org/10.1074/jbc.M112.386425			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977238	hybrid, Green Published			2022-12-25	WOS:000310642200020
J	Greenfield, LK; Richards, MR; Vinogradov, E; Wakarchuk, WW; Lowary, TL; Whitfield, C				Greenfield, Laura K.; Richards, Michele R.; Vinogradov, Evgeny; Wakarchuk, Warren W.; Lowary, Todd L.; Whitfield, Chris			Domain Organization of the Polymerizing Mannosyltransferases Involved in Synthesis of the Escherichia coli O8 and O9a Lipopolysaccharide O-antigens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECONDARY STRUCTURE PREDICTION; 2 ACTIVE-SITES; PASTEURELLA-MULTOCIDA; BIOCHEMICAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; GENE-CLUSTER; SACCHAROMYCES-CEREVISIAE; KLEBSIELLA-PNEUMONIAE; POLYSACCHARIDE CHAIN; POLYACRYLAMIDE GELS	The Escherichia coli O9a and O8 polymannose O-polysaccharides (O-PSs) serve as model systems for the biosynthesis of bacterial polysaccharides by ATP-binding cassette transporter-dependent pathways. Both O-PSs contain a conserved primer-adaptor domain at the reducing terminus and a serotype-specific repeat unit domain. The repeat unit domain is polymerized by the serotype-specific WbdA mannosyltransferase. In serotype O9a, WbdA is a bifunctional alpha-(1 -> 2)-, alpha-(1 -> 3)-mannosyltransferase, and its counterpart in serotype O8 is trifunctional (alpha-(1 -> 2), alpha-(1 -> 3), and beta-(1 -> 2)). Little is known about the detailed structures or mechanisms of action of the WbdA polymerases, and here we establish that they are multidomain enzymes. WbdA(O9a) contains two separable and functionally active domains, whereas WbdA(O8) possesses three. In WbdC(O9a) and WbdB(O9a), substitution of the first Glu of the EX7E motif had detrimental effects on the enzyme activity, whereas substitution of the second had no significant effect on activity in vivo. Mutation of the Glu residues in the EX7E motif of the N-terminal WbdA(O9a) domain resulted in WbdA variants unable to synthesize O-PS. In contrast, mutation of the Glu residues in the motif of the C-terminal WbdA(O9a) domain generated an enzyme capable of synthesizing an altered O-PS repeat unit consisting of only alpha-(1 -> 2) linkages. In vitro assays with synthetic acceptors unequivocally confirmed that the N-terminal domain of WbdA(O9a) possesses alpha-(1 -> 2)-mannosyltransferase activity. Together, these studies form a framework for detailed structure-function studies on individual domains and a strategy applicable for dissection and analysis of other multidomain glycosyltransferases.	[Greenfield, Laura K.; Whitfield, Chris] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Richards, Michele R.; Lowary, Todd L.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Richards, Michele R.; Lowary, Todd L.] Univ Alberta, Alberta Glyc Ctr, Edmonton, AB T6G 2G2, Canada; [Vinogradov, Evgeny; Wakarchuk, Warren W.] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Guelph; University of Alberta; University of Alberta; National Research Council Canada	Whitfield, C (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex, Guelph, ON N1G 2W1, Canada.	cwhitfie@uoguelph.ca	Wakarchuk, Warren/Q-9514-2017; Wakarchuk, Warren/AAO-2774-2020; Lowary, Todd L/F-9608-2019; Richards, Mickey/E-8140-2011	Wakarchuk, Warren/0000-0002-1539-1679; Wakarchuk, Warren/0000-0002-1539-1679; Lowary, Todd L/0000-0002-8331-8211; Richards, Mickey/0000-0002-1973-5678; Vinogradov, Evgeny/0000-0002-5364-1376	Natural Sciences and Engineering Research Council; Alberta Glycomics Centre; Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council; Alberta Innovates Health Solutions Ph.D. Studentship	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Glycomics Centre; Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council; Alberta Innovates Health Solutions Ph.D. Studentship	This work was supported in part by grants from the Natural Sciences and Engineering Research Council (to C. W. and T. L. L.) and by the Alberta Glycomics Centre (to T. L. L.); Recipient of an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council.; Recipient of an Alberta Innovates Health Solutions Ph.D. Studentship.	Abdian PL, 2000, J BIOL CHEM, V275, P40568, DOI 10.1074/jbc.M007496200; Absmanner B, 2010, BIOCHEM J, V426, P205, DOI 10.1042/BJ20091121; ALEXANDER DC, 1994, J BACTERIOL, V176, P7079, DOI 10.1128/JB.176.22.7079-7084.1994; Batt SM, 2010, J BIOL CHEM, V285, P37741, DOI 10.1074/jbc.M110.165407; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; BREW K, 1968, P NATL ACAD SCI USA, V59, P491, DOI 10.1073/pnas.59.2.491; Buchan DWA, 2010, NUCLEIC ACIDS RES, V38, pW563, DOI 10.1093/nar/gkq427; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chavaroche AAE, 2012, APPL MICROBIOL BIOT, V95, P1199, DOI 10.1007/s00253-011-3813-2; Chavaroche AAE, 2011, J BIOL CHEM, V286, P1777, DOI 10.1074/jbc.M110.136754; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Chua TK, 2008, PLANT CELL, V20, P1059, DOI 10.1105/tpc.107.051193; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; Cieslewicz M, 1997, MOL MICROBIOL, V26, P237, DOI 10.1046/j.1365-2958.1997.5651942.x; Clarke BR, 2004, J BIOL CHEM, V279, P35709, DOI 10.1074/jbc.M404738200; Clarke BR, 2011, J BIOL CHEM, V286, P41391, DOI 10.1074/jbc.M111.295857; Clarke BR, 2009, J BIOL CHEM, V284, P30662, DOI 10.1074/jbc.M109.052878; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; Cuthbertson L, 2010, MICROBIOL MOL BIOL R, V74, P341, DOI 10.1128/MMBR.00009-10; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geremia RA, 1996, BIOCHEM J, V318, P133, DOI 10.1042/bj3180133; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Greenfield LK, 2012, J BIOL CHEM, V287, P35078, DOI 10.1074/jbc.M112.401000; Greenfield LK, 2012, CARBOHYD RES, V356, P12, DOI 10.1016/j.carres.2012.02.027; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hagelueken G., 2012, MOL MICROBI IN PRESS; Hashimoto K, 2010, J MOL BIOL, V399, P196, DOI 10.1016/j.jmb.2010.03.059; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Hodson N, 2000, J BIOL CHEM, V275, P27311; Hou DJ, 2008, CARBOHYD RES, V343, P1778, DOI 10.1016/j.carres.2008.02.025; JANN K, 1979, BIOCHEM BIOPH RES CO, V86, P1185, DOI 10.1016/0006-291X(79)90242-0; JANN K, 1982, EUR J BIOCHEM, V127, P157, DOI 10.1111/j.1432-1033.1982.tb06850.x; JANSSON PE, 1985, CARBOHYD RES, V145, P59, DOI 10.1016/S0008-6215(00)90412-9; Jansson PE, 2006, CARBOHYD RES, V341, P1003, DOI 10.1016/j.carres.2006.02.034; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kampf M, 2009, J BIOL CHEM, V284, P11900, DOI 10.1074/jbc.M806416200; Kane TA, 2006, J BIOL CHEM, V281, P33192, DOI 10.1074/jbc.M606897200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kido N, 1998, MOL MICROBIOL, V27, P1213, DOI 10.1046/j.1365-2958.1998.00765.x; KIDO N, 1995, J BACTERIOL, V177, P2178, DOI 10.1128/jb.177.8.2178-2187.1995; Kido N, 2000, J BACTERIOL, V182, P2567, DOI 10.1128/JB.182.9.2567-2573.2000; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kostova Z, 2003, EUR J BIOCHEM, V270, P4507, DOI 10.1046/j.1432-1033.2003.03844.x; Kubler-Kielb J, 2012, CARBOHYD RES, V347, P186, DOI 10.1016/j.carres.2011.11.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SJ, 2011, PROTEINS, V79, P2321, DOI 10.1002/prot.23038; Liu CJ, 2007, CARBOHYD RES, V342, P2818, DOI 10.1016/j.carres.2007.08.020; Lundborg M, 2011, ANAL CHEM, V83, P1514, DOI 10.1021/ac1032534; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Martinez-Fleites C, 2006, CHEM BIOL, V13, P1143, DOI 10.1016/j.chembiol.2006.09.005; MEIERDIETER U, 1990, J BIOL CHEM, V265, P13490; Miller J. H., 1972, EXPT MOL GENETICS, P432; ORSKOV I, 1977, BACTERIOL REV, V41, P667, DOI 10.1128/MMBR.41.3.667-710.1977; Ouali M, 2000, PROTEIN SCI, V9, P1162, DOI 10.1110/ps.9.6.1162; PAROLIS LAS, 1986, CARBOHYD RES, V155, P272, DOI 10.1016/S0008-6215(00)90158-7; Parsonage D, 2010, BIOCHEMISTRY-US, V49, P8398, DOI 10.1021/bi100698n; PREHM P, 1976, EUR J BIOCHEM, V67, P53, DOI 10.1111/j.1432-1033.1976.tb10631.x; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RESKE K, 1972, EUR J BIOCHEM, V31, P320, DOI 10.1111/j.1432-1033.1972.tb02536.x; RICK PD, 1994, J BACTERIOL, V176, P2877, DOI 10.1128/JB.176.10.2877-2884.1994; Ruane KM, 2008, PROTEINS, V73, P784, DOI 10.1002/prot.22171; SAEKI A, 1993, MICROBIOL IMMUNOL, V37, P601, DOI 10.1111/j.1348-0421.1993.tb01682.x; SCHANBAC.FL, 1970, J BIOL CHEM, V245, P5057; Shatzman A. R., 2001, CURRENT PROTOCOLS MO; Sobhany M, 2008, J BIOL CHEM, V283, P32328, DOI 10.1074/jbc.M804332200; Sobhany M, 2012, J BIOL CHEM, V287, P36022, DOI 10.1074/jbc.M112.375873; Sperandeo P, 2009, BBA-MOL CELL BIOL L, V1791, P594, DOI 10.1016/j.bbalip.2009.01.011; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Sugiura N, 2010, J BIOL CHEM, V285, P1597, DOI 10.1074/jbc.M109.023002; Troutman JM, 2009, BIOCHEMISTRY-US, V48, P2807, DOI 10.1021/bi802284d; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vetting MW, 2008, J BIOL CHEM, V283, P15834, DOI 10.1074/jbc.M801017200; Vinogradov E, 2002, J BIOL CHEM, V277, P25070, DOI 10.1074/jbc.M202683200; Westphal O., 1965, METHODS CARBOHYDRATE, V5, P83, DOI DOI 10.1016/J.WATRES.2010.04.030; Woo EJ, 2010, J MOL BIOL, V404, P247, DOI 10.1016/j.jmb.2010.09.056; Xiang Y, 2010, J VIROL, V84, P12265, DOI 10.1128/JVI.01303-10; Zheng Y, 2011, J BIOL CHEM, V286, P36108, DOI 10.1074/jbc.M111.275974	87	30	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.412577	http://dx.doi.org/10.1074/jbc.M112.412577			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989876	hybrid, Green Published			2022-12-25	WOS:000310642200047
J	Horvath, SE; Bottinger, L; Vogtle, FN; Wiedemann, N; Meisinger, C; Becker, T; Daum, G				Horvath, Susanne E.; Boettinger, Lena; Voegtle, F. -Nora; Wiedemann, Nils; Meisinger, Chris; Becker, Thomas; Daum, Guenther			Processing and Topology of the Yeast Mitochondrial Phosphatidylserine Decarboxylase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNTHETIC LETHAL INTERACTION; SACCHAROMYCES-CEREVISIAE; PROTEIN-IMPORT; BIOCHEMICAL-CHARACTERIZATION; CARDIOLIPIN BIOSYNTHESIS; PREPROTEIN TRANSLOCASE; PHOSPHOLIPID-SYNTHESIS; DIFFERENT PATHWAYS; MEMBRANE-PROTEINS; NULL ALLELE	The inner mitochondrial membrane plays a crucial role in cellular lipid homeostasis through biosynthesis of the non-bilayer-forming lipids phosphatidylethanolamine and cardiolipin. In the yeast Saccharomyces cerevisiae, the majority of cellular phosphatidylethanolamine is synthesized by the mitochondrial phosphatidylserine decarboxylase 1 (Psd1). The biogenesis of Psd1 involves several processing steps. It was speculated that the Psd1 precursor is sorted into the inner membrane and is subsequently released into the intermembrane space by proteolytic removal of a hydrophobic sorting signal. However, components involved in the maturation of the Psd1 precursor have not been identified. We show that processing of Psd1 involves the action of the mitochondrial processing peptidase and Oct1 and an autocatalytic cleavage at a highly conserved LGST motif yielding the alpha- and beta-subunit of the enzyme. The Psd1 beta-subunit (Psd1 beta) forms the membrane anchor, which binds the intermembrane space-localized alpha-subunit (Psd1 alpha). Deletion of a transmembrane segment in the beta-subunit results in mislocalization of Psd1 and reduced enzymatic activity. Surprisingly, autocatalytic cleavage does not depend on proper localization to the inner mitochondrial membrane. In summary, membrane integration of Psd1 is crucial for its functionality and for maintenance of mitochondrial lipid homeostasis.	[Horvath, Susanne E.; Boettinger, Lena; Voegtle, F. -Nora; Wiedemann, Nils; Meisinger, Chris; Becker, Thomas] Univ Freiburg, ZMBZ, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Horvath, Susanne E.; Daum, Guenther] Graz Univ Technol, Inst Biochem, A-8010 Graz, Austria; [Boettinger, Lena] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Voegtle, F. -Nora; Wiedemann, Nils; Meisinger, Chris; Becker, Thomas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; Graz University of Technology; University of Freiburg; University of Freiburg	Becker, T (corresponding author), Univ Freiburg, ZMBZ, Inst Biochem & Mol Biol, Stefan Meier Str 17, D-79104 Freiburg, Germany.	thomas.becker@biochemie.uni-freiburg.de; guenther.daum@tugraz.at	Meisinger, Chris/J-1110-2014; Becker, Thomas/AAS-9404-2020; Vögtle, F.-Nora/T-4290-2017	Meisinger, Chris/0000-0002-8326-3548; Vögtle, F.-Nora/0000-0002-5062-3287; Wiedemann, Nils/0000-0001-8305-6728	Austrian Science Fund [21429]; DK Molecular Enzymology [W901-B05]; Deutsche Forschungsgemeinschaft, Sonderforschungs-bereich [746]; Excellence Initiative of the German Federal and State Governments [EXC 294 BIOSS]; Austrian Science Fund (FWF) [W 901, P 21429] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); DK Molecular Enzymology(Austrian Science Fund (FWF)); Deutsche Forschungsgemeinschaft, Sonderforschungs-bereich(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (project 21429 and DK Molecular Enzymology W901-B05 (to G. D.)), the Deutsche Forschungsgemeinschaft, Sonderforschungs-bereich 746, and the Excellence Initiative of the German Federal and State Governments (EXC 294 BIOSS).	Baker MJ, 2007, TRENDS CELL BIOL, V17, P456, DOI 10.1016/j.tcb.2007.07.010; Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660; Becker T, 2011, J CELL BIOL, V194, P387, DOI 10.1083/jcb.201102044; Birner R, 2003, MOL BIOL CELL, V14, P370, DOI 10.1091/mbc.E02-05-0263; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Brink-van der Laan EV, 2004, BBA-BIOMEMBRANES, V1666, P275, DOI 10.1016/j.bbamem.2004.06.010; BROEKHUYSE RM, 1968, BIOCHIM BIOPHYS ACTA, V152, P307, DOI 10.1016/0005-2760(68)90038-6; Burgermeister M, 2004, BBA-MOL CELL BIOL L, V1686, P161, DOI 10.1016/j.bbalip.2004.09.007; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Choi JY, 2012, J BIOL CHEM, V287, P222, DOI 10.1074/jbc.M111.313676; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Daum G, 1998, YEAST, V14, P1471, DOI 10.1002/(SICI)1097-0061(199812)14:16<1471::AID-YEA353>3.0.CO;2-Y; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; DOWHAN W, 1992, METHOD ENZYMOL, V209, P348; Dowhan W, 1997, METHOD ENZYMOL, V280, P81; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; FOLCH J, 1957, J BIOL CHEM, V226, P497; Frazier AE, 2003, MOL CELL BIOL, V23, P7818, DOI 10.1128/MCB.23.21.7818-7828.2003; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gallas MR, 2006, MOL BIOL CELL, V17, P4051, DOI 10.1091/mbc.E06-04-0366; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gohil VM, 2009, J CELL BIOL, V184, P468, DOI 10.1083/jcb.200901127; Gohil VM, 2005, J BIOL CHEM, V280, P35410, DOI 10.1074/jbc.M505478200; Gulshan K, 2008, MOL CELL BIOL, V28, P5851, DOI 10.1128/MCB.00405-08; IGARASHI K, 1995, J BIOL CHEM, V270, P29075, DOI 10.1074/jbc.270.49.29075; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; KELLY BL, 1990, BIOCHIM BIOPHYS ACTA, V1046, P144, DOI 10.1016/0005-2760(90)90181-V; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kim KS, 1999, J BIOL CHEM, V274, P14857, DOI 10.1074/jbc.274.21.14857; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; KUCHLER K, 1986, J BACTERIOL, V165, P901, DOI 10.1128/jb.165.3.901-910.1986; Kuge O, 1996, BIOCHEM J, V319, P33, DOI 10.1042/bj3190033; Kuroda T, 2011, MOL MICROBIOL, V80, P248, DOI 10.1111/j.1365-2958.2011.07569.x; Kutik S, 2008, J CELL BIOL, V183, P1213, DOI 10.1083/jcb.200806048; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; LI QX, 1990, J BIOL CHEM, V265, P4111; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Mossmann D, 2012, BBA-GENE REGUL MECH, V1819, P1098, DOI 10.1016/j.bbagrm.2011.11.007; Nebauer R, 2007, FEBS J, V274, P6180, DOI 10.1111/j.1742-4658.2007.06138.x; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nguyen TT, 2012, TRAFFIC, V13, P880, DOI 10.1111/j.1600-0854.2012.01352.x; Osman C, 2011, J CELL BIOL, V192, P7, DOI 10.1083/jcb.201006159; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Rajakumari S, 2010, MOL BIOL CELL, V21, P501, DOI 10.1091/mbc.E09-09-0775; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Rontein D, 2003, PLANT PHYSIOL, V132, P1678, DOI 10.1104/pp.103.023242; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027; Schuiki I, 2010, BBA-MOL CELL BIOL L, V1801, P480, DOI 10.1016/j.bbalip.2009.12.008; Schuiki I, 2009, IUBMB LIFE, V61, P151, DOI 10.1002/iub.159; SIMBENI R, 1993, BIOCHIM BIOPHYS ACTA, V1145, P1, DOI 10.1016/0005-2736(93)90374-9; Steenbergen R, 2005, J BIOL CHEM, V280, P40032, DOI 10.1074/jbc.M506510200; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; TAMAI KT, 1990, BIOCHIM BIOPHYS ACTA, V1046, P214, DOI 10.1016/0005-2760(90)90192-Z; Tamura Y, 2006, J CELL BIOL, V174, P631, DOI 10.1083/jcb.200603087; Thornton N, 2010, J MOL BIOL, V396, P540, DOI 10.1016/j.jmb.2009.12.026; TROTTER PJ, 1995, J BIOL CHEM, V270, P6071, DOI 10.1074/jbc.270.11.6071; TROTTER PJ, 1995, J BIOL CHEM, V270, P6062, DOI 10.1074/jbc.270.11.6062; TROTTER PJ, 1993, J BIOL CHEM, V268, P21416; Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Vogtle FN, 2011, MOL BIOL CELL, V22, P2135, DOI 10.1091/mbc.E11-02-0169; Vogtle FN, 2009, CELL, V139, P428, DOI 10.1016/j.cell.2009.07.045; VOELKER DR, 1984, P NATL ACAD SCI-BIOL, V81, P2669, DOI 10.1073/pnas.81.9.2669; Voelker DR, 1997, BBA-LIPID LIPID MET, V1348, P236, DOI 10.1016/S0005-2760(97)00101-X; WITTE C, 1988, EMBO J, V7, P1439, DOI 10.1002/j.1460-2075.1988.tb02961.x; Yamamoto H, 2009, J BIOL CHEM, V284, P31635, DOI 10.1074/jbc.M109.041756; ZBOROWSKI J, 1983, FEBS LETT, V157, P179, DOI 10.1016/0014-5793(83)81141-7; ZINSER E, 1991, J BACTERIOL, V173, P2026, DOI 10.1128/jb.173.6.2026-2034.1991; ZINSER E, 1995, YEAST, V11, P493, DOI 10.1002/yea.320110602	83	49	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36744	36755		10.1074/jbc.M112.398107	http://dx.doi.org/10.1074/jbc.M112.398107			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22984266	hybrid, Green Published			2022-12-25	WOS:000310588500012
J	Huber, O; Brunner, A; Maier, P; Kaufmann, R; Couraud, PO; Cremer, C; Fricker, G				Huber, Olga; Brunner, Alexander; Maier, Patrick; Kaufmann, Rainer; Couraud, Pierre-Olivier; Cremer, Christoph; Fricker, Gert			Localization Microscopy (SPDM) Reveals Clustered Formations of P-Glycoprotein in a Human Blood-Brain Barrier Model	PLOS ONE			English	Article							OPTICAL RECONSTRUCTION MICROSCOPY; ENDOTHELIAL-CELL LINE; MULTIDRUG TRANSPORTER; FLUORESCENT PROTEIN; SIN VECTOR; RESOLUTION; MEMBRANE; LIMIT	P-glycoprotein (Pgp; also known as MDR1, ABCB1) is the most important and best studied efflux transporter at the blood-brain barrier (BBB); however, the organization of Pgp is unknown. The aim of this study was to employ the recently developed super-resolution fluorescence microscopy method spectral precision distance microscopy/spectral position determination microscopy (SPDM) to investigate the spatial distribution of Pgp in the luminal plasma membrane of brain capillary endothelial cells. Potential disturbing effects of cell membrane curvatures on the distribution analysis are addressed with computer simulations. Immortalized human cerebral microvascular endothelial cells (hCMEC/D3) served as a model of human BBB. hCMEC/D3 cells were transduced with a Pgp-green fluorescent protein (GFP) fusion protein incorporated in a lentivirus-derived vector. The expression and localization of the Pgp-GFP fusion protein was visualized by SPDM. The limited resolution of SPDM in the z-direction leads to a projection during the imaging process affecting the appeared spatial distribution of fluorescence molecules in the super-resolution images. Therefore, simulations of molecule distributions on differently curved cell membranes were performed and their projected spatial distribution was investigated. Function of the fusion protein was confirmed by FACS analysis after incubation of cells with the fluorescent probe eFluxx-ID Gold in absence and presence of verapamil. More than 112,000 single Pgp-GFP molecules (corresponding to approximately 5,600 Pgp-GFP molecules per cell) were detected by SPDM with an averaged spatial resolution of approximately 40 nm in hCMEC/D3 cells. We found that Pgp-GFP is distributed in clustered formations in hCMEC/D3 cells while the influence of present random cell membrane curvatures can be excluded based on the simulation results. Individual formations are distributed randomly over the cell membrane.	[Huber, Olga; Cremer, Christoph; Fricker, Gert] Univ Heidelberg, Inst Pharm & Mol Biotechnol, Heidelberg, Germany; [Brunner, Alexander; Kaufmann, Rainer; Cremer, Christoph] Univ Heidelberg, Kirchhoff Inst Phys, Heidelberg, Germany; [Brunner, Alexander] German Canc Res Ctr, Dept Med Phys Radiol, Heidelberg, Germany; [Maier, Patrick] Univ Heidelberg, Mannheim Med Ctr, Dept Radiat Oncol, D-6800 Mannheim, Germany; [Kaufmann, Rainer] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Couraud, Pierre-Olivier] Univ Paris 05, Dept Cell Biol, Paris, France; [Cremer, Christoph] Inst Mol Biol, Mainz, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; University of Oxford; UDICE-French Research Universities; Universite Paris Cite; Institute of Molecular Biology (IMB)	Huber, O (corresponding author), Univ Heidelberg, Inst Pharm & Mol Biotechnol, Heidelberg, Germany.	gert.fricker@uni-hd.de	Kaufmann, Rainer/U-6406-2019; Fricker, Gert/N-4157-2018; Kaufmann, Rainer/N-8911-2014	Kaufmann, Rainer/0000-0002-4165-0195; Fricker, Gert/0000-0003-3894-961X; Kaufmann, Rainer/0000-0002-4165-0195	University of Heidelberg	University of Heidelberg	This work has been supported by a Frontier Project grant (University of Heidelberg) to Gert Fricker and Christoph Cremer (http://www.uni-heidelberg.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Baddeley D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020645; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bornfleth H, 1998, J MICROSC-OXFORD, V189, P118, DOI 10.1046/j.1365-2818.1998.00276.x; Cremer C, 1999, 40 PRINCIPLES SPECTR; Doyle LA, 2003, ONCOGENE, V22, P7340, DOI 10.1038/sj.onc.1206938; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Kaufmann R, 2011, J MICROSC-OXFORD, V242, P46, DOI 10.1111/j.1365-2818.2010.03436.x; Kaufmann R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031128; Lebedeva IV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022429; Lemmer P, 2008, APPL PHYS B-LASERS O, V93, P1, DOI 10.1007/s00340-008-3152-x; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1602/neurorx.2.1.86; Maier P, 2008, RADIAT RES, V169, P301, DOI 10.1667/RR1067.1; Maier P, 2010, RADIAT RES, V173, P612, DOI 10.1667/RR1952.1; Matsuda A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012768; Miller DS, 2008, PHARMACOL REV, V60, P196, DOI 10.1124/pr.107.07109; Miller DS, 2010, TRENDS PHARMACOL SCI, V31, P246, DOI 10.1016/j.tips.2010.03.003; Miller DS, 2000, MOL PHARMACOL, V58, P1357, DOI 10.1124/mol.58.6.1357; Orlowski S, 2006, CELL MOL LIFE SCI, V63, P1038, DOI 10.1007/s00018-005-5554-9; Peterman EJG, 1999, J PHYS CHEM A, V103, P10553, DOI 10.1021/jp991968o; Reymann J, 2008, CHROMOSOME RES, V16, P367, DOI 10.1007/s10577-008-1238-2; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sai Y, 1999, J CELL SCI, V112, P4535; Sharom FJ, 1997, J MEMBRANE BIOL, V160, P161, DOI 10.1007/s002329900305; Slimane TA, 2003, MOL BIOL CELL, V14, P611, DOI 10.1091/mbc.E02-08-0528; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Zastre JA, 2009, J NEUROSCI RES, V87, P1023, DOI 10.1002/jnr.21898	30	22	22	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44776	10.1371/journal.pone.0044776	http://dx.doi.org/10.1371/journal.pone.0044776			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984556	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500083
J	Lu, YT; Wang, LY; He, MY; Huang, WH; Li, H; Wang, YK; Kong, JM; Qi, ST; Ouyang, J; Qiu, XZ				Lu, Yuntao; Wang, Leyu; He, Minyi; Huang, Wenhua; Li, Hong; Wang, Yongkui; Kong, Jiming; Qi, Songtao; Ouyang, Jun; Qiu, Xiaozhong			Nix Protein Positively Regulates NF-kappa B Activation in Gliomas	PLOS ONE			English	Article							CELL-DEATH; SIGNALING PATHWAY; BNIP3; EXPRESSION; CANCER; APOPTOSIS; AUTOPHAGY; HYPOXIA; GENE; CHEMORESISTANCE	Previous reports indicate that the NIX/BNIP3L gene acts as a pro-apoptotic factor by interacting with BCL2 and BCL-XL, playing an important role in hypoxia-dependent cell death and acting as a tumor suppressor. However, many studies also showed that NIX is linked to a protective role and cell survival in cancer cells. Nuclear factor-kappa B (NF-kappa B) can attenuate apoptosis in human cancers in response to chemotherapeutic agents and ionizing radiation. We observed an absence of i-kappa B alpha (NF-kappa B activation inhibitor) expression, but a greater expression of Nix and p-NF-kappa B proteins in the Nix-wt U251 cells, which was not observed in the Nix-kn cells under hypoxic conditions. Using electrophoretic mobility shift assay (EMSA) and luciferase detection, the activation of NF-kappa B was detected only in the Nix-wt U251 cells with hypoxia. These data imply that Nix protein might play a role in the positive regulation of the NF-kappa B pathway. Moreover, 46 cases of glioma also showed high levels of Nix protein expression, which was always accompanied by high p-NF-kappa B expression. Patients with Nix (+) showed less tissue apoptosis behavior in glioblastoma (GBM), unlike that observed in the Nix-negative patients (-). The same apoptotic tendency was also identified in anaplastic astrocytoma (AA) groups, but not in astrocytoma (AS). On analyzing the Kaplan-Meier curve, better tumor-free survival was observed only in cases of astrocytoma, and not in AA and GBM. Thus, our study indicates that Nix protein might have multiple functions in regulating glioma behaviors. In the low-grade gliomas (astrocytoma) with low expression of NF-kappa B, the cell death-inducing function that occurs through a Bax mechanism might predominate and act as a tumor suppressor. While in the malignant gliomas (AA and GBM), with higher expression of the NIX gene and with activity of the NF-kappa B pathway, the oncogene function of Nix was predominant.	[Lu, Yuntao; Wang, Leyu; He, Minyi; Huang, Wenhua; Wang, Yongkui; Ouyang, Jun; Qiu, Xiaozhong] So Med Univ, Dept Anat, Key Lab Construct & Detect Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Lu, Yuntao; Li, Hong; Qi, Songtao] So Med Univ, Dept Neurosurg, Affiliated Nangfang Hosp, Guangzhou, Guangdong, Peoples R China; [He, Minyi] So Med Univ, Dept Organ Transplantat, Zhujiang Hosp, Guangzhou, Guangdong, Peoples R China; [Kong, Jiming] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; University of Manitoba	Lu, YT (corresponding author), So Med Univ, Dept Anat, Key Lab Construct & Detect Guangdong Prov, Guangzhou, Guangdong, Peoples R China.	qqiuxzh@yahoo.com.cn	huang, wenhua/AAO-5990-2020; qiu, xiaozhong/B-8466-2014	huang, wenhua/0000-0003-2382-9180; Lu, Yuntao/0000-0003-4125-304X; Kong, Jiming/0000-0002-2859-9831	National Natural Science Foundation of China [81101921]; Science Technology Program of Guangzhou Municipality [11C32120736]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Program of Guangzhou Municipality	This work was financially supported by National Natural Science Foundation of China (81101921), and Science Technology Program of Guangzhou Municipality (11C32120736). The funding is supported by the government. The government had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All study related design, data collection and analysis, decision to publish or preparation of the manuscript are finished by the authors.	Angileri FF, 2008, CANCER-AM CANCER SOC, V112, P2258, DOI 10.1002/cncr.23407; Arlt A, 2002, INT J CLIN PHARM TH, V40, P336; Bacon AL, 2007, ONCOGENE, V26, P132, DOI 10.1038/sj.onc.1209761; Bacon AL, 2004, ANN MED, V36, P530, DOI 10.1080/07853890410018231; Biswas DK, 2004, P NATL ACAD SCI USA, V101, P10137, DOI 10.1073/pnas.0403621101; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Coupienne I, 2010, BIOCH PHARM; Diwan A, 2007, P NATL ACAD SCI USA, V104, P6794, DOI 10.1073/pnas.0610666104; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Esencay M, 2010, J NEURO-ONCOL, V99, P33, DOI 10.1007/s11060-010-0111-2; Fei PW, 2004, CANCER CELL, V6, P597, DOI 10.1016/j.ccr.2004.10.012; Galvez AS, 2006, J BIOL CHEM, V281, P1442, DOI 10.1074/jbc.M509056200; Hayashi S, 2001, NEUROL MED-CHIR, V41, P187, DOI 10.2176/nmc.41.187; Korkolopoulou P, 2008, HUM PATHOL, V39, P1143, DOI 10.1016/j.humpath.2008.01.020; Koul D, 2006, BIOCHEM BIOPH RES CO, V350, P463, DOI 10.1016/j.bbrc.2006.09.077; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Mazure NM, 2010, CURR OPIN CELL BIOL, V22, P177, DOI 10.1016/j.ceb.2009.11.015; Murai M, 2005, CLIN CANCER RES, V11, P1021; Nihei N, 1996, GENE CHROMOSOME CANC, V17, P260, DOI 10.1002/(SICI)1098-2264(199612)17:4<260::AID-GCC8>3.0.CO;2-1; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Ren YF, 2019, ANTIOXID REDOX SIGN, V31, P771, DOI 10.1089/ars.2019.7731; Sarkar FH, 2008, INT REV IMMUNOL, V27, P293, DOI 10.1080/08830180802276179; Schweers RL, 2007, P NATL ACAD SCI USA, V104, P19500, DOI 10.1073/pnas.0708818104; Shen HM, 2009, APOPTOSIS, V14, P348, DOI 10.1007/s10495-009-0315-0; Sowter HM, 2001, CANCER RES, V61, P6669; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Tracy K, 2007, AUTOPHAGY, V3, P616, DOI 10.4161/auto.4892; Wong MLH, 2007, J CLIN NEUROSCI, V14, P301, DOI 10.1016/j.jocn.2006.11.005; Xue J, 2010, GASTROENTEROLOGY, V138, P606, DOI 10.1053/j.gastro.2009.09.049; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16; Ziegler DS, 2008, J CLIN ONCOL, V26, P493, DOI 10.1200/JCO.2007.13.9717	33	8	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44559	10.1371/journal.pone.0044559	http://dx.doi.org/10.1371/journal.pone.0044559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984526	gold, Green Submitted, Green Published			2022-12-25	WOS:000308738500065
J	Marcellin, D; Abramowski, D; Young, D; Richter, J; Weiss, A; Marcel, A; Maassen, J; Kauffmann, M; Bibel, M; Shimshek, DR; Faull, RLM; Bates, GP; Kuhn, RR; Van der Putten, PH; Schmid, P; Lotz, GP				Marcellin, David; Abramowski, Dorothee; Young, Douglas; Richter, Jens; Weiss, Andreas; Marcel, Audrey; Maassen, Julia; Kauffmann, Muriel; Bibel, Miriam; Shimshek, Derya R.; Faull, Richard L. M.; Bates, Gillian P.; Kuhn, Rainer R.; Van der Putten, P. Herman; Schmid, Peter; Lotz, Gregor P.			Fragments of HdhQ150 Mutant Huntingtin Form a Soluble Oligomer Pool That Declines with Aggregate Deposition upon Aging	PLOS ONE			English	Article							IN MOUSE MODEL; INTRANUCLEAR INCLUSIONS; NEURONAL DYSFUNCTION; POLYGLUTAMINE TRACT; TRANSGENIC MICE; DISEASE; PROTEIN; CELLS; EXON-1; PHENOTYPES	Cleavage of the full-length mutant huntingtin (mhtt) protein into smaller, soluble aggregation-prone mhtt fragments appears to be a key process in the neuropathophysiology of Huntington's Disease (HD). Recent quantification studies using TR-FRET-based immunoassays showed decreasing levels of soluble mhtt correlating with an increased load of aggregated mhtt in the aging HdhQ150 mouse brain. To better characterize the nature of these changes at the level of native mhtt species, we developed a detection method that combines size exclusion chromatography (SEC) and time-resolved fluorescence resonance energy transfer (TR-FRET) that allowed us to resolve and define the formation, aggregation and temporal dynamics of native soluble mhtt species and insoluble aggregates in the brain of the HdhQ150 knock-in mouse. We found that mhtt fragments and not full-length mhtt form oligomers in the brains of one month-old mice long before disease phenotypes and mhtt aggregate histopathology occur. As the HdhQ150 mice age, brain levels of soluble full-length mhtt protein remain similar. In contrast, the soluble oligomeric pool of mhtt fragments slightly increases during the first two months before it declines between 3 and 8 months of age. This decline inversely correlates with the formation of insoluble mhtt aggregates. We also found that the pool-size of soluble mhtt oligomers is similar in age-matched heterozygous and homozygous HdhQ150 mouse brains whereas insoluble aggregate formation is greatly accelerated in the homozygous mutant brain. The capacity of the soluble mhtt oligomer pool therefore seems exhausted already in the heterozygous state and likely kept constant by changes in flux and, as a consequence, increased rate of insoluble aggregate formation. We demonstrate that our novel findings in mice translate to human HD brain but not HD patient fibroblasts.	[Marcellin, David; Abramowski, Dorothee; Young, Douglas; Richter, Jens; Weiss, Andreas; Marcel, Audrey; Maassen, Julia; Kauffmann, Muriel; Bibel, Miriam; Shimshek, Derya R.; Kuhn, Rainer R.; Van der Putten, P. Herman; Schmid, Peter; Lotz, Gregor P.] Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland; [Faull, Richard L. M.] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand; [Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England	Novartis; University of Auckland; University of London; King's College London	Marcellin, D (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland.	gregor.lotz@novartis.com	; Bates, Gillian/E-1146-2012	Faull, Richard/0000-0003-3385-9498; Bates, Gillian/0000-0002-4041-6305; Lotz, Gregor/0000-0002-0231-5503; Shimshek, Derya/0000-0001-8602-7850	CHDI foundation	CHDI foundation	We thank the CHDI foundation for support and Taconic Artemis for providing the Rosa26 ES cell lines.	Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; Baldo B, 2012, J BIOL CHEM, V287, P1406, DOI 10.1074/jbc.M111.294801; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Burke KA, 2011, METHODS, V53, P275, DOI 10.1016/j.ymeth.2010.12.028; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Hands SL, 2010, ACTA NEUROPATHOL, V120, P419, DOI 10.1007/s00401-010-0703-0; Herrera F, 2011, PLOS CURR, V11, P3; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lotz GP, 2010, J BIOL CHEM, V285, P38183, DOI 10.1074/jbc.M110.160218; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Mitsui K, 2006, METHOD ENZYMOL, V412, P63, DOI 10.1016/S0076-6879(06)12005-4; MYERS RH, 1988, NEUROLOGY, V38, P341, DOI 10.1212/WNL.38.3.341; Olshina MA, 2010, J BIOL CHEM, V285, P21807, DOI 10.1074/jbc.M109.084434; Paganetti P, 2009, CHEMBIOCHEM, V10, P1678, DOI 10.1002/cbic.200900131; Pouladi MA, 2009, BRAIN, V132, P919, DOI 10.1093/brain/awp006; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Sathasivam K, 1999, HUM MOL GENET, V8, P813, DOI 10.1093/hmg/8.5.813; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Squitieri F, 2003, BRAIN, V126, P946, DOI 10.1093/brain/awg077; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Weiss A, 2011, ANAL BIOCHEM, V410, P304, DOI 10.1016/j.ab.2010.11.044; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Weiss A, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-11; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	43	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44457	10.1371/journal.pone.0044457	http://dx.doi.org/10.1371/journal.pone.0044457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984513	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500060
J	Michel, MJ; Knouft, JH				Michel, Matt J.; Knouft, Jason H.			Niche Variability and Its Consequences for Species Distribution Modeling	PLOS ONE			English	Article							CLIMATE-CHANGE; MICROHABITAT USE; FISH ASSEMBLAGE; EXTINCTION RISK; PREDICT	When species distribution models (SDMs) are used to predict how a species will respond to environmental change, an important assumption is that the environmental niche of the species is conserved over evolutionary time-scales. Empirical studies conducted at ecological time-scales, however, demonstrate that the niche of some species can vary in response to environmental change. We use habitat and locality data of five species of stream fishes collected across seasons to examine the effects of niche variability on the accuracy of projections from Maxent, a popular SDM. We then compare these predictions to those from an alternate method of creating SDM projections in which a transformation of the environmental data to similar scales is applied. The niche of each species varied to some degree in response to seasonal variation in environmental variables, with most species shifting habitat use in response to changes in canopy cover or flow rate. SDMs constructed from the original environmental data accurately predicted the occurrences of one species across all seasons and a subset of seasons for two other species. A similar result was found for SDMs constructed from the transformed environmental data. However, the transformed SDMs produced better models in ten of the 14 total SDMs, as judged by ratios of mean probability values at known presences to mean probability values at all other locations. Niche variability should be an important consideration when using SDMs to predict future distributions of species because of its prevalence among natural populations. The framework we present here may potentially improve these predictions by accounting for such variability.	[Michel, Matt J.; Knouft, Jason H.] St Louis Univ, Dept Biol, St Louis, MO 63103 USA	Saint Louis University	Michel, MJ (corresponding author), St Louis Univ, Dept Biol, St Louis, MO 63103 USA.	mmichel3@slu.edu		Knouft, Jason/0000-0002-3737-5696	United States National Science Foundation [DEB-0844644]	United States National Science Foundation(National Science Foundation (NSF))	This work was supported by funding from the United States National Science Foundation to JHK (DEB-0844644). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly David D., 2003, International Journal of Plant Sciences, V164, pS165, DOI 10.1086/368401; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Gelman A., 2007, DATA ANAL USING REGR; Gogol-Prokurat M, 2011, ECOL APPL, V21, P33, DOI 10.1890/09-1190.1; Gotelli NJ, 2013, ECOSIMR 1 00; GROSSMAN GD, 1987, J ZOOL, V212, P151, DOI 10.1111/j.1469-7998.1987.tb05121.x; Grossman GD, 1998, ECOL MONOGR, V68, P395, DOI 10.1890/0012-9615(1998)068[0395:AOISFE]2.0.CO;2; GROSSMAN GD, 1987, OECOLOGIA, V73, P501, DOI 10.1007/BF00379407; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Knouft JH, 2011, METHODS ECOL EVOL, V2, P303, DOI 10.1111/j.2041-210X.2010.00076.x; Kulhanek SA, 2011, ECOL APPL, V21, P203, DOI 10.1890/09-1639.1; Martin TE, 2001, ECOLOGY, V82, P175, DOI 10.2307/2680095; MATTHEWS WJ, 1994, ENVIRON BIOL FISH, V39, P381, DOI 10.1007/BF00004807; Overpeck JT, 2011, SCIENCE, V331, P700, DOI 10.1126/science.1197869; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; R Development Core Team, 2009, R FDN STAT COMP; Rodder D, 2010, TROP ZOOL, V23, P35; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, GLOBAL ECOL BIOGEOGR, V14, P347, DOI 10.1111/j.1466-822x.2005.00162.x; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Zurell D, 2009, ECOGRAPHY, V32, P733, DOI 10.1111/j.1600-0587.2009.05810.x; [No title captured]	30	5	5	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44932	10.1371/journal.pone.0044932	http://dx.doi.org/10.1371/journal.pone.0044932			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970325	Green Published, Green Submitted, gold			2022-12-25	WOS:000308748400036
J	Timoneda, O; Balcells, I; Cordoba, S; Castello, A; Sanchez, A				Timoneda, Oriol; Balcells, Ingrid; Cordoba, Sarai; Castello, Anna; Sanchez, Armand			Determination of Reference microRNAs for Relative Quantification in Porcine Tissues	PLOS ONE			English	Article							QUANTITATIVE RT-PCR; REFERENCE GENES; EXPRESSION; IDENTIFICATION; NORMALIZATION; BIOGENESIS; IDENTIFY; MIRNAS	Relative quantification is the strategy of choice for processing RT-qPCR data in microRNAs (miRNAs) expression studies. Normalisation of relative quantification data is performed by using reference genes. In livestock species, such as pigs, the determination of reference miRNAs and the optimal number of them has not been widely studied. In this study, the stability of ten miRNAs (Ssc-let-7a, Ssc-miR-103, Ssc-miR-17-3p, Hsa-miR-25, Hsa-miR-93, Ssc-miR-106a, Ssc-miR-191, Ssc-miR-16, Ssc-miR-26a and Ssc-miR-17-5p) was investigated by RT-qPCR in different tissues (skeletal muscle, kidney, liver, ovary and uterus) and in different pig breeds (Iberian, Landrace, Large White, Meishan and Vietnamese) as variation factors. Stability values were calculated with geNorm and NormFinder algorithms obtaining high correlation between them (r(2) = 0.99). The analyses showed that tissue is an important variability factor in miRNAs expression stability whereas breed is not a determinant factor. All ten miRNAs analysed had good stability values and, therefore, can be used as reference miRNAs. When all tissues were considered, miR-93 was the most stable miRNA. Dividing data set by tissues, let-7a was the most stable in skeletal muscle and ovary, miR-17-5p in kidney, miR-26a in liver and miR-103 in uterus. Moreover, the optimal number of reference miRNAs to be used for proper normalisation data was determined. It is suggested the use of five reference miRNAs (miR-93, miR-25, miR-106a, miR-17-5p and miR-26a) in multi-tissue experimental designs and the use of three reference miRNAs as the optimal number in single tissues studies (let-7a, miR-17-5p and miR-25 in skeletal muscle; miR-17-5p, miR-93 and miR-26a in kidney, miR-26a, miR-103 and let-7a in liver, let-7a, miR-25 and miR-106a in ovary and miR-103, let-7a and miR-93 in uterus). Overall, this study provides valuable information about the porcine reference miRNAs that can be used in order to perform a proper normalisation when relative quantification by RT-qPCR studies is undertaken.	[Timoneda, Oriol; Balcells, Ingrid; Cordoba, Sarai; Castello, Anna; Sanchez, Armand] Univ Autonoma Barcelona, Dept Genet Anim, Ctr Recerca AgriGen CRAG, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG)	Timoneda, O (corresponding author), Univ Autonoma Barcelona, Dept Genet Anim, Ctr Recerca AgriGen CRAG, E-08193 Barcelona, Spain.	oriol.timoneda@uab.cat	Farré, Anna Castelló/K-9637-2015; Sanchez, Armand/L-7905-2015	Farré, Anna Castelló/0000-0001-8497-6251; Sanchez, Armand/0000-0001-9160-1124; Cordoba, Sarai/0000-0002-8786-9889	Consolider-Ingenio program from Ministerio de Ciencia e Innovacion [CSD2007-00036]; PhD fellowship (Programa de Formacion al Personal Investigador - FPI) from the Spanish government;  [AGL2007-66371-C02-01];  [AGL2010-22358-C02-01]	Consolider-Ingenio program from Ministerio de Ciencia e Innovacion; PhD fellowship (Programa de Formacion al Personal Investigador - FPI) from the Spanish government; ; 	This work was supported by the projects AGL2007-66371-C02-01 and AGL2010-22358-C02-01 and by the Consolider-Ingenio 2010 program (CSD2007-00036) from Ministerio de Ciencia e Innovacion. OT is recipient of PhD fellowship (Programa de Formacion al Personal Investigador - FPI) from the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Balcells I, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-70; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chang KH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-173; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Curry E, 2011, THERIOGENOLOGY, V76, P1532, DOI 10.1016/j.theriogenology.2011.06.025; de Planell-Saguer M, 2011, ANAL CHIM ACTA, V699, P134, DOI 10.1016/j.aca.2011.05.025; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Fendler A, 2011, CLIN CHEM, V57, P954, DOI 10.1373/clinchem.2010.157727; Feng RH, 2010, CANCER LETT, V298, P50, DOI 10.1016/j.canlet.2010.06.004; Glazov EA, 2010, J GEN VIROL, V91, P32, DOI 10.1099/vir.0.014290-0; Gu YR, 2011, ANIM SCI J, V82, P722, DOI 10.1111/j.1740-0929.2011.00908.x; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Luo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011744; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Patel N, 2011, J NUCL ACIDS INVESTI, V2, pe1; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Podolska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014494; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Schaefer A, 2010, EXP MOL MED, V42, P749, DOI 10.3858/emm.2010.42.11.076; Sharkey JW, 2012, BIOMARKERS; Shen YM, 2011, EXP MOL MED, V43, P358, DOI 10.3858/emm.2011.43.6.039; Song JN, 2012, DIGEST DIS SCI, V57, P897, DOI 10.1007/s10620-011-1981-7; Stowe HM, 2012, GENE, V501, P198, DOI 10.1016/j.gene.2012.03.058; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Viprey VF, 2012, ANAL BIOCHEM, V421, P566, DOI 10.1016/j.ab.2011.10.022; Wotschofsky Z, 2011, ANAL BIOCHEM, V417, P233, DOI 10.1016/j.ab.2011.06.009	34	42	44	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44413	10.1371/journal.pone.0044413	http://dx.doi.org/10.1371/journal.pone.0044413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970213	Green Published, gold, Green Submitted			2022-12-25	WOS:000308748400017
J	Acosta, EG; Castilla, V; Damonte, EB				Acosta, Eliana G.; Castilla, Viviana; Damonte, Elsa B.			Differential Requirements in Endocytic Trafficking for Penetration of Dengue Virus	PLOS ONE			English	Article							INFECTIOUS ENTRY; EARLY ENDOSOME; JUNIN VIRUS; PATHWAY; CELLS; RAB5; TRANSFERRIN; INHIBITION; PROTEINS; FUSION	The entry of DENV into the host cell appears to be a very complex process which has been started to be studied in detail. In this report, the route of functional intracellular trafficking after endocytic uptake of dengue virus serotype 1 (DENV-1) strain HW, DENV-2 strain NGC and DENV-2 strain 16681 into Vero cells was studied by using a susceptibility to ammonium chloride assay, dominant negative mutants of several members of the family of cellular Rab GTPases that participate in regulation of transport through endosome vesicles and immunofluorescence colocalization. Together, the results presented demonstrate that in spite of the different internalization route among viral serotypes in Vero cells and regardless of the viral strain, DENV particles are first transported to early endosomes in a Rab5-dependent manner. Then a Rab7-dependent pathway guides DENV-2 16681 to late endosomes, whereas a yet unknown sorting event controls the transport of DENV-2 NGC, and most probably DENV-1 HW, to the perinuclear recycling compartments where fusion membrane would take place releasing nucleocapsid into the cytoplasm. Besides the demonstration of a different intracellular trafficking for two DENV-2 strains that shared the initial clathrin-independent internalization route, these studies proved for the first time the involvement of the slow recycling pathway for DENV-2 productive infection.	[Acosta, Eliana G.; Castilla, Viviana; Damonte, Elsa B.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Virol Lab, Buenos Aires, DF, Argentina	University of Buenos Aires	Acosta, EG (corresponding author), Heidelberg Univ, Dept Infect Dis, Heidelberg, Germany.	edamonte@qb.fcen.uba.ar			Agencia Nacional para la Promocion Cientifica y Tecnologica [PICT 985]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [CONICET-PID 0467]; Universidad de Buenos Aires, Argentina [UBACYT 00145]	Agencia Nacional para la Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad de Buenos Aires, Argentina(University of Buenos Aires)	This research was supported by Agencia Nacional para la Promocion Cientifica y Tecnologica (PICT 985), Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET-PID 0467) and Universidad de Buenos Aires (UBACYT 00145), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0; Acosta EG, 2011, VIRUS RES, V160, P173, DOI 10.1016/j.virusres.2011.06.008; Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x; Altmeyer R, 2004, CURR PHARM DESIGN, V10, P3701, DOI 10.2174/1381612043382729; Ang F, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-24; Benmerah A, 1999, J CELL SCI, V112, P1303; Brabec M, 2006, BIOCHEM BIOPH RES CO, V348, P741, DOI 10.1016/j.bbrc.2006.07.125; BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999; CASTILLA V, 1994, ARCH VIROL, V136, P363, DOI 10.1007/BF01321064; Clemente R, 2009, J VIROL, V83, P10406, DOI 10.1128/JVI.00990-09; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gastaldelli M, 2008, TRAFFIC, V9, P2265, DOI 10.1111/j.1600-0854.2008.00835.x; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GRIFFITHS G, 1989, J CELL BIOL, V109, P2703, DOI 10.1083/jcb.109.6.2703; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Johannsdottir HK, 2009, J VIROL, V83, P440, DOI 10.1128/JVI.01864-08; Johns HL, 2009, J VIROL, V83, P6247, DOI 10.1128/JVI.02460-08; Jovic M, 2010, HISTOL HISTOPATHOL, V25, P99, DOI 10.14670/HH-25.99; KO KK, 1979, ARCH VIROL, V62, P41, DOI 10.1007/BF01314902; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lozach PY, 2010, CELL HOST MICROBE, V7, P488, DOI 10.1016/j.chom.2010.05.007; Magadan JG, 2006, MOL CELL BIOL, V26, P2595, DOI 10.1128/MCB.26.7.2595-2614.2006; Mannova P, 2003, J VIROL, V77, P1672, DOI 10.1128/JVI.77.3.1672-1681.2003; Martinez M. Guadalupe, 2009, Biotechnology Journal, V4, P866, DOI 10.1002/biot.200800357; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004; Quirin K, 2008, VIROLOGY, V378, P21, DOI 10.1016/j.virol.2008.04.046; SANCHEZ A, 1989, J GEN VIROL, V70, P1125, DOI 10.1099/0022-1317-70-5-1125; Shpetner H, 1996, J CELL BIOL, V132, P595, DOI 10.1083/jcb.132.4.595; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; SINGH I, 1992, J VIROL, V66, P7049, DOI 10.1128/JVI.66.12.7049-7058.1992; SMITH TJ, 1970, J VIROL, V5, P524, DOI 10.1128/JVI.5.4.524-532.1970; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Umareddy I, 2008, J GEN VIROL, V89, P3052, DOI 10.1099/vir.0.2008/001594-0; van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131	52	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44835	10.1371/journal.pone.0044835	http://dx.doi.org/10.1371/journal.pone.0044835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970315	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000051
J	Zuo, XR; Wang, Q; Cao, Q; Yu, YZ; Wang, H; Bi, LQ; Xie, WP; Wang, H				Zuo, Xiang-Rong; Wang, Qiang; Cao, Quan; Yu, Yan-Zhe; Wang, Hui; Bi, Li-Qing; Xie, Wei-Ping; Wang, Hong			Nicorandil Prevents Right Ventricular Remodeling by Inhibiting Apoptosis and Lowering Pressure Overload in Rats with Pulmonary Arterial Hypertension	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; SENSITIVE POTASSIUM CHANNELS; RIGHT-HEART-FAILURE; CARDIAC MYOCYTES; MOLECULAR-MECHANISMS; RECEPTOR BLOCKADE; OXIDATIVE STRESS; CELL-SURVIVAL; MONOCROTALINE; DYSFUNCTION	Background: Most of the deaths among patients with severe pulmonary arterial hypertension (PAH) are caused by progressive right ventricular (RV) pathological remodeling, dysfunction, and failure. Nicorandil can inhibit the development of PAH by reducing pulmonary artery pressure and RV hypertrophy. However, whether nicorandil can inhibit apoptosis in RV cardiomyocytes and prevent RV remodeling has been unclear. Methodology/Principal Findings: RV remodeling was induced in rats by intraperitoneal injection of monocrotaline (MCT). RV systolic pressure (RVSP) was measured at the end of each week after MCT injection. Blood samples were drawn for brain natriuretic peptide (BNP) ELISA analysis. The hearts were excised for histopathological, ultrastructural, immunohistochemical, and Western blotting analyses. The MCT-injected rats exhibited greater mortality and less weight gain and showed significantly increased RVSP and RV hypertrophy during the second week. These worsened during the third week. MCT injection for three weeks caused pathological RV remodeling, characterized by hypertrophy, fibrosis, dysfunction, and RV mitochondrial impairment, as indicated by increased levels of apoptosis. Nicorandil improved survival, weight gain, and RV function, ameliorated RV pressure overload, and prevented maladaptive RV remodeling in PAH rats. Nicorandil also reduced the number of apoptotic cardiomyocytes, with a concomitant increase in Bcl-2/Bax ratio. 5-hydroxydecanoate (5-HD) reversed these beneficial effects of nicorandil in MCT-injected rats. Conclusions/Significance: Nicorandil inhibits PAH-induced RV remodeling in rats not only by reducing RV pressure overload but also by inhibiting apoptosis in cardiomyocytes through the activation of mitochondrial ATP-sensitive K+ (mitoK(ATP)) channels. The use of a mitoK(ATP) channel opener such as nicorandil for PAH-associated RV remodeling and dysfunction may represent a new therapeutic strategy for the amelioration of RV remodeling during the early stages of PAH.	[Zuo, Xiang-Rong; Wang, Qiang; Yu, Yan-Zhe; Wang, Hui; Bi, Li-Qing; Xie, Wei-Ping; Wang, Hong] Nanjing Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanjing, Jiangsu, Peoples R China; [Zuo, Xiang-Rong; Cao, Quan] Nanjing Med Univ, Affiliated Hosp 1, Dept Crit Care Med, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Zuo, XR (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanjing, Jiangsu, Peoples R China.	xieweiping2002@yahoo.com; wanghong.njmu@gmail.com			National Natural Science Foundation of China (NSFC) [30971319]; "Six Talent Peak" Project of Jiangsu Province [08-B]; Open Project Program of the key discipline of Public Health Department of Jiangsu Province [XK13_200902]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); "Six Talent Peak" Project of Jiangsu Province; Open Project Program of the key discipline of Public Health Department of Jiangsu Province	This work was partially supported by the National Natural Science Foundation of China (NSFC) (http://www.nsfc.gov.cn, No. 30971319, HW), and by a research fund from the "Six Talent Peak" Project of Jiangsu Province (http://www.jshrss.gov.cn, No. 08-B, WX). This work was also partially supported by the grant from Open Project Program of the key discipline of Public Health Department of Jiangsu Province (www.jswst.gov.cn, No. XK13_200902, XZ). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Akao M, 2002, J AM COLL CARDIOL, V40, P803, DOI 10.1016/S0735-1097(02)02007-7; Ardehali H, 2005, J MOL CELL CARDIOL, V39, P7, DOI 10.1016/j.yjmcc.2004.12.003; Bogaard HJ, 2010, AM J RESP CRIT CARE, V182, P652, DOI 10.1164/rccm.201003-0335OC; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Bogaard HJ, 2009, CHEST, V135, P794, DOI 10.1378/chest.08-0492; Braun MU, 2003, CARDIOVASC RES, V59, P658, DOI 10.1016/S0008-6363(03)00470-X; Buermans HPJ, 2005, PHYSIOL GENOMICS, V21, P314, DOI 10.1152/physiolgenomics.00185.2004; Bussani R, 2003, J CLIN PATHOL, V56, P672, DOI 10.1136/jcp.56.9.672; Campian ME, 2009, J NUCL MED, V50, P1371, DOI 10.2967/jnumed.108.061366; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; Dore A, 2005, CIRCULATION, V112, P2411, DOI 10.1161/CIRCULATIONAHA.105.543470; Dorn GW, 2009, CARDIOVASC RES, V81, P465, DOI 10.1093/cvr/cvn243; Eguchi Y, 2009, CIRC J, V73, P554, DOI 10.1253/circj.CJ-08-0843; Gross A, 2001, IUBMB LIFE, V52, P231, DOI 10.1080/15216540152846046; Handoko ML, 2008, PFLUG ARCH EUR J PHY, V455, P951, DOI 10.1007/s00424-007-0334-z; Hardziyenka M, 2006, J AM SOC ECHOCARDIOG, V19, P1272, DOI 10.1016/j.echo.2006.04.036; Haworth SG, 2007, EUR HEART J SUPPL, V9, pH10, DOI 10.1093/eurheartj/sum025; Henkens IR, 2007, AM J PHYSIOL-HEART C, V293, pH1300, DOI 10.1152/ajpheart.01359.2006; Hessel MHM, 2006, AM J PHYSIOL-HEART C, V291, pH2424, DOI 10.1152/ajpheart.00369.2006; HONDA M, 1992, JPN CIRC J, V56, P392, DOI 10.1253/jcj.56.392; Hongo M, 2005, J CARDIOVASC PHARM, V46, P452, DOI 10.1097/01.fjc.0000176728.74690.09; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Ikeda S, 1999, LIFE SCI, V65, P925, DOI 10.1016/S0024-3205(99)00322-7; Jing ZC, 2007, CHEST, V132, P373, DOI 10.1378/chest.06-2913; Kret M, 2007, J CARDIOVASC PHARM T, V12, P5, DOI 10.1177/1074248406298293; Lee JK, 1999, AM J PHYSIOL-HEART C, V277, pH1725, DOI 10.1152/ajpheart.1999.277.5.H1725; Lee TM, 2008, J AM COLL CARDIOL, V51, P1309, DOI 10.1016/j.jacc.2007.11.067; Lourenco AP, 2006, AM J PHYSIOL-HEART C, V291, pH1587, DOI 10.1152/ajpheart.01004.2005; McLaughlin VV, 2009, J AM COLL CARDIOL, V53, P1573, DOI 10.1016/j.jacc.2009.01.004; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; MIYAUCHI T, 1993, CIRC RES, V73, P887, DOI 10.1161/01.RES.73.5.887; Nagata K, 2003, J MOL CELL CARDIOL, V35, P1505, DOI 10.1016/j.yjmcc.2003.09.018; Nagaya N, 1998, J AM COLL CARDIOL, V31, P202, DOI 10.1016/S0735-1097(97)00452-X; Nagaya N, 2000, CIRCULATION, V102, P865; Nishikawa S, 2006, J MOL CELL CARDIOL, V40, P510, DOI 10.1016/j.yjmcc.2006.01.020; Noordegraaf AV, 2008, RHEUMATOLOGY, V47, pV42, DOI 10.1093/rheumatology/ken284; Okada M, 2009, J PHARMACOL SCI, V111, P193, DOI 10.1254/jphs.09112FP; Piao L, 2010, J MOL MED, V88, P1011, DOI 10.1007/s00109-010-0679-1; Reesink HJ, 2007, ANN THORAC SURG, V84, P537, DOI 10.1016/j.athoracsur.2007.04.006; Rhodes CJ, 2009, PHARMACOL THERAPEUT, V121, P69, DOI 10.1016/j.pharmthera.2008.10.002; Saeed M, 2002, RADIOLOGY, V224, P830, DOI 10.1148/radiol.2243011372; Sahara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033367; Sanada S, 2002, J AM COLL CARDIOL, V40, P991, DOI 10.1016/S0735-1097(02)02057-0; Sanbe A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018922; Shiina Y, 2009, INT J CARDIOL, V135, P53, DOI 10.1016/j.ijcard.2008.03.090; Simon MA, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/568095; Tsutsui H, 2009, CARDIOVASC RES, V81, P449, DOI 10.1093/cvr/cvn280; van Wolferen SA, 2007, EUR HEART J, V28, P1250, DOI 10.1093/eurheartj/ehl477; Voelkel NF, 2011, RIGHT VENTRICLE PULM, P525; Voelkel NF, 2006, CIRCULATION, V114, P1883, DOI 10.1161/CIRCULATIONAHA.106.632208; Yap LB, 2004, HEART FAIL REV, V9, P99, DOI 10.1023/B:HREV.0000046364.68371.b0	53	22	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44485	10.1371/journal.pone.0044485	http://dx.doi.org/10.1371/journal.pone.0044485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970229	Green Published, Green Submitted, gold			2022-12-25	WOS:000308462000025
J	Araki, J; Nishizawa, Y; Nakamura, T; Sato, T; Naito, M; Fujii, S; Mihara, M; Koshima, I				Araki, Jun; Nishizawa, Yuji; Nakamura, Tatsuo; Sato, Tomoyuki; Naito, Munekazu; Fujii, Satoshi; Mihara, Makoto; Koshima, Isao			The Development of a Canine Anorectal Autotransplantation Model Based on Blood Supply: A Preliminary Case Report	PLOS ONE			English	Article							INTESTINAL TRANSPLANTATION; FOLLOW-UP; COLON; ALLOTRANSPLANTATION; SPHINCTER; HAND	Colostomy is conventionally the only treatment for anal dysfunction. Recently, a few trials of anorectal transplantation in animals have been published; however, further development of this technique is required. Moreover, it is crucial to perform this research in dogs, which resemble humans in anorectal anatomy and biology. We designed a canine anorectal transplantation model, wherein anorectal autotransplantation was performed by anastomoses of the rectum, inferior mesenteric artery (IMA) and vein, and pudendal nerves. Resting pressure in the anal canal and anal canal pressure fluctuation were measured before and after surgery. Graft pathology was examined three days after surgery. The anal blood supply was compared with that in three beagles using indocyanine green (ICG) fluorescence angiography. The anorectal graft had sufficient arterial blood supply from the IMA; however, the graft's distal end was congested and necrotized. Functional examination demonstrated reduced resting pressure and the appearance of an irregular anal canal pressure wave after surgery. ICG angiography showed that the pudendal arteries provided more blood flow than the IMA to the anal segment. This is the first canine model of preliminary anorectal autotransplantation, and it demonstrates the possibility of establishing a transplantation model in dogs using appropriate vascular anastomoses, thus contributing to the progress of anorectal transplantation.	[Araki, Jun; Mihara, Makoto; Koshima, Isao] Univ Tokyo, Dept Plast Surg, Tokyo, Japan; [Nishizawa, Yuji; Nakamura, Tatsuo] Kyoto Univ, Inst Frontier Med Sci, Dept Bioartificial Organs, Kyoto, Japan; [Sato, Tomoyuki] Saitama Shinkaibashi Clin, Saitama, Japan; [Naito, Munekazu] Tokyo Med Univ, Dept Anat, Tokyo, Japan; [Fujii, Satoshi] Natl Canc Ctr Hosp E, Res Ctr Innovat Oncol, Div Pathol, Chiba, Japan	University of Tokyo; Kyoto University; Tokyo Medical University; National Cancer Center - Japan	Araki, J (corresponding author), Univ Tokyo, Dept Plast Surg, Tokyo, Japan.	arakij-pla@h.u-tokyo.ac.jp			Princess Takamatsu Cancer Research Fund; Kawano Masanori Memorial Foundation for Promotion of Pediatrics	Princess Takamatsu Cancer Research Fund; Kawano Masanori Memorial Foundation for Promotion of Pediatrics(Kawano Masanori Memorial Foundation for Promotion of Pediatrics)	This work was supported by grants from the Princess Takamatsu Cancer Research Fund and the Kawano Masanori Memorial Foundation for Promotion of Pediatrics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki J, 2011, TRANSPL P, V43, P3552, DOI 10.1016/j.transproceed.2011.08.042; Bartha I, 1995, Orv Hetil, V136, P1995; Cavadas PC, 2011, AM J TRANSPLANT, V11, P1085, DOI 10.1111/j.1600-6143.2011.03503.x; Chang EI, 2011, NAT MED, V17, P1147, DOI 10.1038/nm.2424; Chapman AE, 2002, BRIT J SURG, V89, P138, DOI 10.1046/j.1365-2168.2002.02018.x; Delaere P, 2010, NEW ENGL J MED, V362, P138, DOI 10.1056/NEJMoa0810653; Devesa J M, 2005, Tech Coloproctol, V9, P149, DOI 10.1007/s10151-005-0215-4; Eid KR, 2010, AM J TRANSPLANT, V10, P1940, DOI 10.1111/j.1600-6143.2010.03167.x; Fattah A, 2011, AM J TRANSPLANT, V11, P2762, DOI 10.1111/j.1600-6143.2011.03782.x; Galvao FHF, 2009, TECH COLOPROCTOL, V13, P55, DOI 10.1007/s10151-009-0459-5; Galvao FHF, 2012, MICROSURG, V32, P77, DOI 10.1002/micr.20958; Fishbein TM, 2009, NEW ENGL J MED, V361, P998, DOI 10.1056/NEJMra0804605; HURNY C, 1985, CA-CANCER J CLIN, V35, P170, DOI 10.3322/canjclin.35.3.170; Jones JW, 2000, NEW ENGL J MED, V343, P468, DOI 10.1056/NEJM200008173430704; Kato T, 2008, TRANSPLANTATION, V86, P293, DOI 10.1097/TP.0b013e31817ef01c; Kisu I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035124; Lange MM, 2009, EJSO-EUR J SURG ONC, V35, P456, DOI 10.1016/j.ejso.2008.09.012; MCHUGH SM, 1987, GUT, V28, P1234, DOI 10.1136/gut.28.10.1234; Mihara M, 2011, HUM REPROD, V26, P3019, DOI 10.1093/humrep/der276; Miles W E, 1971, CA Cancer J Clin, V21, P361, DOI 10.3322/canjclin.21.6.361; O'Bichere A, 2000, BRIT J SURG, V87, P1534, DOI 10.1046/j.1365-2168.2000.01557.x; Petruzzo P, 2011, AM J TRANSPLANT, V11, P808, DOI 10.1111/j.1600-6143.2011.03469.x; Romano G, 2003, DIS COLON RECTUM, V46, P730, DOI 10.1007/s10350-004-6649-3; Sato T, 2005, SURGERY, V137, P8, DOI 10.1016/j.surg.2004.05.046; Siemionow M, 2009, LANCET, V374, P203, DOI 10.1016/S0140-6736(09)61155-7; Strome M, 2001, NEW ENGL J MED, V344, P1676, DOI 10.1056/NEJM200105313442204; TODO S, 1994, TRANSPLANTATION, V57, P840, DOI 10.1097/00007890-199403270-00012	27	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44310	10.1371/journal.pone.0044310	http://dx.doi.org/10.1371/journal.pone.0044310			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970198	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400057
J	Boe, CA; Knutsen, JHJ; Boye, E; Grallert, B				Boe, Cathrine A.; Knutsen, Jon Halvor J.; Boye, Erik; Grallert, Beata			Hpz1 Modulates the G1-S Transition in Fission Yeast	PLOS ONE			English	Article							SCHIZOSACCHAROMYCES-POMBE; DNA-REPLICATION; CELL-CYCLE; S-PHASE; POLY(ADP-RIBOSE) POLYMERASE; UV-IRRADIATION; GENE; KINASES; ATR; ORIGINS	Here we characterize a novel protein in S. pombe. It has a high degree of homology with the Zn-finger domain of the human Poly(ADP-ribose) polymerase (PARP). Surprisingly, the gene for this protein is, in many fungi, fused with and in the same reading frame as that encoding Rad3, the homologue of the human ATR checkpoint protein. We name the protein Hpz1 (Homologue of PARP-type Zn-finger). Hpz1 does not possess PARP activity, but is important for resistance to ultraviolet light in the G1 phase and to treatment with hydroxyurea, a drug that arrests DNA replication forks in the S phase. However, we find no evidence of a checkpoint function of Hpz1. Furthermore, absence of Hpz1 results in an advancement of S-phase entry after a G1 arrest as well as earlier recovery from a hydroxyurea block. The hpz1 gene is expressed mainly in the G1 phase and Hpz1 is localized to the nucleus. We conclude that Hpz1 regulates the initiation of the S phase and may cooperate with Rad3 in this function.	[Boe, Cathrine A.; Knutsen, Jon Halvor J.; Boye, Erik; Grallert, Beata] Inst Canc Res, Dept Cell Biol, Oslo, Norway; [Boe, Cathrine A.; Knutsen, Jon Halvor J.; Boye, Erik; Grallert, Beata] Univ Oslo, Inst Mol Biosci, N-0316 Oslo, Norway	University of Oslo	Boe, CA (corresponding author), Inst Canc Res, Dept Cell Biol, Oslo, Norway.	beata.grallert@rr-research.no			Norwegian Cancer Society; Research Council of Norway; South-Eastern Norway Regional Health Authority	Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); South-Eastern Norway Regional Health Authority	This work received funding from The Norwegian Cancer Society (www.kreftforeningen.no), from The Research Council of Norway (www.forskningsradet.no), and from the South-Eastern Norway Regional Health Authority (www.helse-sorost.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2002, EMBO J, V21, P5745, DOI 10.1093/emboj/cdf564; AVILA MA, 1994, YEAST, V10, P1003, DOI 10.1002/yea.320100803; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Caspari T, 2000, MOL CELL BIOL, V20, P1254, DOI 10.1128/MCB.20.4.1254-1262.2000; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Citarelli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-308; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Cross FR, 2011, PHILOS T R SOC B, V366, P3532, DOI 10.1098/rstb.2011.0078; Davies SL, 2004, MOL CELL BIOL, V24, P1279, DOI 10.1128/MCB.24.3.1279-1291.2004; Domingo-Sananes MR, 2011, PHILOS T R SOC B, V366, P3584, DOI 10.1098/rstb.2011.0087; ENOCH T, 1992, GENE DEV, V6, P2035, DOI 10.1101/gad.6.11.2035; FANTES P, 1979, NATURE, V279, P428, DOI 10.1038/279428a0; Feng WY, 2007, METHODS, V41, P151, DOI 10.1016/j.ymeth.2006.07.023; Fukuura M, 2011, MOL BIOL CELL, V22, P2620, DOI 10.1091/mbc.E10-12-0995; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hayashi M, 2007, EMBO J, V26, P1327, DOI 10.1038/sj.emboj.7601585; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; Javle M, 2011, BRIT J CANCER, V105, P1114, DOI 10.1038/bjc.2011.382; Kearsey SE, 2000, EMBO J, V19, P1681, DOI 10.1093/emboj/19.7.1681; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; KIPPERT F, 1995, FEMS MICROBIOL LETT, V132, P215; Knutsen JHJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017175; Kuznetsov IB, 2006, BIOINFORMATICS, V22, P1055, DOI 10.1093/bioinformatics/btl049; Kuznetsov IB, 2008, BIOINFORMATICS, V24, P1534, DOI 10.1093/bioinformatics/btn233; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li WH, 2004, J CELL BIOL, V165, P801, DOI 10.1083/jcb.200402095; Lindner K, 2002, MOL BIOL CELL, V13, P435, DOI 10.1091/mbc.01-11-0537; LOWNDES NF, 1992, NATURE, V355, P449, DOI 10.1038/355449a0; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Nguewa PA, 2005, PROG BIOPHYS MOL BIO, V88, P143, DOI 10.1016/j.pbiomolbio.2004.01.001; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Nilssen EA, 2003, P NATL ACAD SCI USA, V100, P10758, DOI 10.1073/pnas.1833769100; O'Farrell PH, 2001, TRENDS CELL BIOL, V11, P512, DOI 10.1016/S0962-8924(01)02142-0; Petermann E, 2006, CELL CYCLE, V5, P2203, DOI 10.4161/cc.5.19.3256; Pichierri P, 2003, ONCOGENE, V22, P1491, DOI 10.1038/sj.onc.1206169; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; REYMOND A, 1992, MOL GEN GENET, V234, P449, DOI 10.1007/BF00538705; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Shechter D, 2005, CELL CYCLE, V4, P235; SKOOG L, 1971, EUR J BIOCHEM, V19, P81, DOI 10.1111/j.1432-1033.1971.tb01290.x; Tanaka S, 2010, CHROMOSOMA, V119, P565, DOI 10.1007/s00412-010-0291-8; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Tvegard T, 2007, GENE DEV, V21, P649, DOI 10.1101/gad.421807; UEMURA T, 1984, EMBO J, V3, P1737, DOI 10.1002/j.1460-2075.1984.tb02040.x; Uhlmann F, 2011, PHILOS T R SOC B, V366, P3572, DOI 10.1098/rstb.2011.0082; Wu PYJ, 2009, CELL, V136, P852, DOI 10.1016/j.cell.2009.01.017; Wu X, 2007, ONCOGENE, V26, P757, DOI 10.1038/sj.onc.1209828; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	54	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44539	10.1371/journal.pone.0044539	http://dx.doi.org/10.1371/journal.pone.0044539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970243	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400086
J	Kuscu, C; Evensen, N; Kim, D; Hu, YJ; Zucker, S; Cao, J				Kuscu, Cem; Evensen, Nikki; Kim, Deborah; Hu, You-Jun; Zucker, Stanley; Cao, Jian			Transcriptional and Epigenetic Regulation of KIAA1199 Gene Expression in Human Breast Cancer	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; NF-KAPPA-B; DNA METHYLATION; PROMOTER HYPOMETHYLATION; GC BOX; CARCINOGENESIS; IDENTIFICATION; DEMETHYLATION; REPRESSION; DISEASE	Emerging evidence has demonstrated that upregulated expression of KIAA1199 in human cancer bodes for poor survival. The regulatory mechanism controlling KIAA1199 expression in cancer remains to be characterized. In the present study, we have isolated and characterized the human KIAA1199 promoter in terms of regulation of KIAA1199 gene expression. A 3.3 kb fragment of human genomic DNA containing the 5'-flanking sequence of the KIAA1199 gene possesses both suppressive and activating elements. Employing a deletion mutagenesis approach, a 1.4 kb proximal region was defined as the basic KIAA1199 promoter containing a TATA-box close to the transcription start site. A combination of 5'-primer extension study with 5'RACE DNA sequencing analysis revealed one major transcription start site that is utilized in the human KIAA1199 gene. Bioinformatics analysis suggested that the 1.4 kb KIAA1199 promoter contains putative activating regulatory elements, including activator protein-1(AP-1), Twist-1, and NF-kappa B sites. Sequential deletion and site-direct mutagenesis analysis demonstrated that the AP-1 and distal NF-kappa B sites are required for KIAA1199 gene expression. Further analyses using an electrophoretic mobility-shift assay and chromatin immunoprecipitation confirmed the requirement of these cis- and trans-acting elements in controlling KIAA1199 gene expression. Finally, we found that upregulated KIAA1199 expression in human breast cancer specimens correlated with hypomethylation of the regulatory region. Involvement of DNA methylation in regulation of KIAA1199 expression was recapitulated in human breast cancer cell lines. Taken together, our study unraveled the regulatory mechanisms controlling KIAA1199 gene expression in human cancer.	[Kuscu, Cem; Evensen, Nikki; Kim, Deborah; Cao, Jian] SUNY Stony Brook, Dept Med Canc Prevent, Stony Brook, NY 11794 USA; [Hu, You-Jun; Cao, Jian] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Zucker, Stanley] SUNY Stony Brook, Dept Med Hematol & Oncol, Stony Brook, NY 11794 USA; [Zucker, Stanley] Vet Affairs Med Ctr, Dept Res, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kuscu, C (corresponding author), SUNY Stony Brook, Dept Med Canc Prevent, Stony Brook, NY 11794 USA.	jian.cao@sunysb.edu		KUSCU, CEM/0000-0001-7154-6762; Kim, Deborah/0000-0002-9388-5391	National Institutes of Health/National Cancer Institute [R01CA113553, R01CA166936]; Carol Baldwin Breast Cancer Foundation; Department of Veterans Affairs; NATIONAL CANCER INSTITUTE [R01CA113553, R01CA166936] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Carol Baldwin Breast Cancer Foundation; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by National Institutes of Health/National Cancer Institute grants (R01CA113553 and R01CA166936) and the Carol Baldwin Breast Cancer Foundation (to JC); and a Merit Review grant from the Department of Veterans Affairs (to SZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abe S, 2003, J HUM GENET, V48, P564, DOI 10.1007/s10038-003-0079-2; Adib TR, 2004, BRIT J CANCER, V90, P686, DOI 10.1038/sj.bjc.6601603; Birkenkamp-Demtroder K, 2011, BRIT J CANCER, V105, P552, DOI 10.1038/bjc.2011.268; Broadbent S, 2010, J MICROBIOL METH, V81, P256, DOI 10.1016/j.mimet.2010.03.021; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Fatemi M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni180; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Ginos MA, 2004, CANCER RES, V64, P55, DOI 10.1158/0008-5472.CAN-03-2144; Grutzmann R, 2004, NEOPLASIA, V6, P611, DOI 10.1593/neo.04295; Guo JH, 2006, FEBS LETT, V580, P581, DOI 10.1016/j.febslet.2005.12.076; HANADA M, 1993, BLOOD, V82, P1820; Harbeck N, 2008, J CLIN ONCOL, V26, P5036, DOI 10.1200/JCO.2007.14.1697; Hasegawa H, 2009, EXP CELL RES, V315, P1384, DOI 10.1016/j.yexcr.2009.02.019; He QY, 2006, BIOINFORMATICS, V22, P2189, DOI 10.1093/bioinformatics/btl123; Honda T, 2004, BRIT J CANCER, V90, P838, DOI 10.1038/sj.bjc.6601600; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jun HJ, 2009, CANCER RES, V69, P2180, DOI 10.1158/0008-5472.CAN-08-3351; Kawaji H, 2006, NUCLEIC ACIDS RES, V34, pD632, DOI 10.1093/nar/gkj034; Ko YG, 2010, PLACENTA, V31, P969, DOI 10.1016/j.placenta.2010.08.010; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Matsuzaki S, 2009, ANN SURG ONCOL, V16, P2042, DOI 10.1245/s10434-009-0469-6; Michishita E, 2006, CANCER LETT, V239, P71, DOI 10.1016/j.canlet.2005.07.028; Miyajima A, 2009, DRUG METAB PHARMACOK, V24, P269, DOI 10.2133/dmpk.24.269; Muckenfuss H, 2007, NUCLEIC ACIDS RES, V35, P3784, DOI 10.1093/nar/gkm340; Nakayama M, 2002, GENOME RES, V12, P1773, DOI 10.1101/gr.406902; Nishigaki M, 2005, CANCER RES, V65, P2115, DOI 10.1158/0008-5472.CAN-04-3340; Ponticos M, 2009, NUCLEIC ACIDS RES, V37, P5378, DOI 10.1093/nar/gkp544; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Rupon JW, 2006, P NATL ACAD SCI USA, V103, P6617, DOI 10.1073/pnas.0509322103; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Skrzypczak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013091; Smith IM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004961; SUZUKI S, 1995, MOL ENDOCRINOL, V9, P1288, DOI 10.1210/me.9.10.1288; Tabu K, 2008, CELL RES, V18, P1037, DOI 10.1038/cr.2008.270; Vaiopoulos AG, 2010, INT J BIOCHEM CELL B, V42, P1061, DOI 10.1016/j.biocel.2010.03.018; WATT F, 1988, GENE DEV, V2, P1136, DOI 10.1101/gad.2.9.1136; Watt PM, 2000, GENE CHROMOSOME CANC, V29, P371, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1050>3.0.CO;2-Y; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Zhou H, 2001, ONCOGENE, V20, P6009, DOI 10.1038/sj.onc.1204830	47	44	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44661	10.1371/journal.pone.0044661	http://dx.doi.org/10.1371/journal.pone.0044661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970280	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400102
J	McGuire, CR; Nufio, CR; Bowers, MD; Guralnick, RP				McGuire, Chris R.; Nufio, Cesar R.; Bowers, M. Deane; Guralnick, Robert P.			Elevation-Dependent Temperature Trends in the Rocky Mountain Front Range: Changes over a 56-and 20-Year Record	PLOS ONE			English	Article							CLIMATE-CHANGE; COLORADO; SEASON; PRECIPITATION; VARIABILITY; INDICATORS; SNOWPACK; IMPACTS; REGIONS; TIME	Determining the magnitude of climate change patterns across elevational gradients is essential for an improved understanding of broader climate change patterns and for predicting hydrologic and ecosystem changes. We present temperature trends from five long-term weather stations along a 2077-meter elevational transect in the Rocky Mountain Front Range of Colorado, USA. These trends were measured over two time periods: a full 56-year record (1953-2008) and a shorter 20-year (1989-2008) record representing a period of widely reported accelerating change. The rate of change of biological indicators, season length and accumulated growing-degree days, were also measured over the 56 and 20-year records. Finally, we compared how well interpolated Parameter-elevation Regression on Independent Slopes Model (PRISM) datasets match the quality controlled and weather data from each station. Our results show that warming signals were strongest at mid-elevations over both temporal scales. Over the 56-year record, most sites show warming occurring largely through increases in maximum temperatures, while the 20-year record documents warming associated with increases in maximum temperatures at lower elevations and increases in minimum temperatures at higher elevations. Recent decades have also shown a shift from warming during springtime to warming in July and November. Warming along the gradient has contributed to increases in growing-degree days, although to differing degrees, over both temporal scales. However, the length of the growing season has remained unchanged. Finally, the actual and the PRISM interpolated yearly rates rarely showed strong correlations and suggest different warming and cooling trends at most sites. Interpretation of climate trends and their seasonal biases in the Rocky Mountain Front Range are dependent on both elevation and the temporal scale of analysis. Given mismatches between interpolated data and the directly measured station data, we caution against an over-reliance on interpolation methods for documenting local patterns of climatic change.	[McGuire, Chris R.; Nufio, Cesar R.; Bowers, M. Deane; Guralnick, Robert P.] Univ Colorado, Nat Hist Museum, Boulder, CO 80309 USA; [McGuire, Chris R.] Univ Colorado, Environm Studies Program, Boulder, CO 80309 USA; [Nufio, Cesar R.; Bowers, M. Deane; Guralnick, Robert P.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	McGuire, CR (corresponding author), Univ Colorado, Nat Hist Museum, Boulder, CO 80309 USA.	nufio@colorado.edu		BOWERS, M/0000-0002-5697-888X	National Science Foundation [1543813]; University of Colorado Museum of Natural History's Walker Van Riper research grant; Chancellor's Office of the University of Colorado at Boulder; Direct For Biological Sciences [1027341] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); University of Colorado Museum of Natural History's Walker Van Riper research grant; Chancellor's Office of the University of Colorado at Boulder; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by National Science Foundation Grant #1543813, the University of Colorado Museum of Natural History's Walker Van Riper research grant and a post-doctoral diversity fellowship from the Chancellor's Office of the University of Colorado at Boulder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahas R, 2002, INT J CLIMATOL, V22, P1727, DOI 10.1002/joc.818; Beniston M, 1996, THEOR APPL CLIMATOL, V53, P231, DOI 10.1007/BF00871739; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Bonhomme R, 2000, EUR J AGRON, V13, P1, DOI 10.1016/S1161-0301(00)00058-7; Bryant SR, 1998, J APPL ECOL, V35, P921, DOI 10.1111/j.1365-2664.1998.tb00009.x; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Chase TN, 1999, J GEOPHYS RES-ATMOS, V104, P16673, DOI 10.1029/1999JD900118; Chen B, 2003, CLIM DYNAM, V20, P401, DOI 10.1007/s00382-002-0282-4; Clow DW, 2010, J CLIMATE, V23, P2293, DOI 10.1175/2009JCLI2951.1; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Daly C, 2006, INT J CLIMATOL, V26, P707, DOI 10.1002/joc.1322; DEGAETANO AT, 1993, AGR FOREST METEOROL, V66, P1, DOI 10.1016/0168-1923(93)90079-W; Di Luzio M, 2008, J APPL METEOROL CLIM, V47, P475, DOI 10.1175/2007JAMC1356.1; Diaz HF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GLO31253; Diaz HF, 1997, CLIMATIC CHANGE, V36, P253, DOI 10.1023/A:1005335731187; Diaz HF, 2003, CLIMATIC CHANGE, V59, P33, DOI 10.1023/A:1024460010140; Easterling DR, 1997, SCIENCE, V277, P364, DOI 10.1126/science.277.5324.364; Easterling DR, 2002, B AM METEOROL SOC, V83, P1327, DOI 10.1175/1520-0477(2002)083&lt;1327:RCIFDA&gt;2.3.CO;2; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Feng S, 2004, THEOR APPL CLIMATOL, V78, P247, DOI 10.1007/s00704-004-0061-8; Fyfe JC, 1999, J CLIMATE, V12, P230, DOI 10.1175/1520-0442-12.1.230; Giorgi F, 1997, J CLIMATE, V10, P288, DOI 10.1175/1520-0442(1997)010<0288:EDOTSC>2.0.CO;2; GREENLAND D, 1989, ARCTIC ALPINE RES, V21, P380, DOI 10.2307/1551647; Guisan A, 2000, INTEGRATED ASSESSMEN, V1, P307, DOI [DOI 10.1023/A:1018912114948, 10.1023/A:1018912114948]; Hamlet AF, 2005, J CLIMATE, V18, P4545, DOI 10.1175/JCLI3538.1; IPCC, 2001, CLIMATE CHANGE 2001, DOI DOI 10.1017/CBO9781107415379; IPCC, 2007, CLIM CHANG 2007 PHYS; Kittel TG, 2002, ROCKY MOUNTAIN FUTUR; Linderholm HW, 2006, AGR FOREST METEOROL, V137, P1, DOI 10.1016/j.agrformet.2006.03.006; Marr JW, 1968, DATA MOUNTAIN ENV, P181; Marr JW, 1968, DATA MOUNTAIN ENV, P169; Marr JW, 1967, DATA MOUNTAIN ENV, P110; Marr JW, 1961, ECOSYSTEMS E SLOPE F, P124; McMaster GS, 1997, AGR FOREST METEOROL, V87, P291, DOI 10.1016/S0168-1923(97)00027-0; Menzel A, 2001, GLOBAL CHANGE BIOL, V7, P657, DOI 10.1046/j.1365-2486.2001.00430.x; Mix K, 2010, WATER AIR SOIL POLL, V205, P289, DOI 10.1007/s11270-009-0074-0; Mote PW, 2005, B AM METEOROL SOC, V86, P39, DOI 10.1175/BAMS-86-1-39; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pepin N, 2002, INT J CLIMATOL, V22, P311, DOI 10.1002/joc.740; Pepin N, 2000, ARCT ANTARCT ALP RES, V32, P135, DOI 10.2307/1552445; Pepin NC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034026; Pepin N. C., 2005, J GEOPHYS RES ATMOSP, V110; Pielke RA, 1998, J GEOPHYS RES-ATMOS, V103, P16927, DOI 10.1029/98JD01645; Pielke RA, 2002, INT J CLIMATOL, V22, P421, DOI 10.1002/joc.706; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Ritchie J.T., 1991, AGRON MONOGR, V31, P5, DOI [10.2134/AGRONMONOGR31.C2, DOI 10.2134/AGR0NM0N0GR31.C2]; Robeson SM, 2002, CLIMATIC CHANGE, V52, P219, DOI 10.1023/A:1013088011223; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; SAS Institute, 1989, JMP VERS 8 02; Schlenker W, 2007, CLIMATIC CHANGE, V81, P19, DOI 10.1007/s10584-005-9008-z; Schwartz MD, 2000, INT J CLIMATOL, V20, P929, DOI 10.1002/1097-0088(20000630)20:8&lt;929::AID-JOC557&gt;3.0.CO;2-5; SEGAL M, 1989, MON WEATHER REV, V117, P809, DOI 10.1175/1520-0493(1989)117<0809:TIOCAI>2.0.CO;2; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Snyder MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014431; Still CJ, 1999, NATURE, V398, P608, DOI 10.1038/19293; Stohlgren TJ, 1998, GLOBAL CHANGE BIOL, V4, P495, DOI 10.1046/j.1365-2486.1998.00182.x; Trudgill DL, 2005, ANN APPL BIOL, V146, P1, DOI 10.1111/j.1744-7348.2005.04088.x; Vuille M, 2000, GEOPHYS RES LETT, V27, P3885, DOI 10.1029/2000GL011871; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	61	85	86	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44370	10.1371/journal.pone.0044370	http://dx.doi.org/10.1371/journal.pone.0044370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970205	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400062
J	Satchi-Fainaro, R; Ferber, S; Segal, E; Ma, LL; Dixit, N; Ijaz, A; Hlatky, L; Abdollahi, A; Almog, N				Satchi-Fainaro, Ronit; Ferber, Shiran; Segal, Ehud; Ma, Lili; Dixit, Niharika; Ijaz, Ambreen; Hlatky, Lynn; Abdollahi, Amir; Almog, Nava			Prospective Identification of Glioblastoma Cells Generating Dormant Tumors	PLOS ONE			English	Article							ANGIOGENIC SWITCH; THERAPEUTIC TARGET; METASTATIC GROWTH; HUMAN LIPOSARCOMA; CANCER DORMANCY; IN-VIVO; MICROMETASTASES; TRANSITION; PHENOTYPE; MECHANISM	Although dormant tumors are highly prevalent within the human population, the underlying mechanisms are still mostly unknown. We have previously identified the consensus gene expression pattern of dormant tumors. Here, we show that this gene expression signature could be used for the isolation and identification of clones which generate dormant tumors. We established single cell-derived clones from the aggressive tumor-generating U-87 MG human glioblastoma cell line. Based only on the expression pattern of genes which were previously shown to be associated with tumor dormancy, we identified clones which generate dormant tumors. We show that very high expression levels of thrombospondin and high expression levels of angiomotin and insulin-like growth factor binding protein 5 (IGFBP5), together with low levels of endothelial specific marker (ESM) 1 and epithelial growth factor receptor (EGFR) characterize the clone which generates dormant U-87 MG derived glioblastomas. These tumors remained indolent both in subcutaneous and orthotopic intracranial sites, in spite of a high prevalence of proliferating cells. We further show that tumor cells which form U-87 MG derived dormant tumors have an impaired angiogenesis potential both in vitro and in vivo and have a slower invasion capacity. This work demonstrates that fast-growing tumors contain tumor cells that when isolated will form dormant tumors and serves as a proof-of-concept for the use of transcriptome profiles in the identification of such cells. Isolating the tumor cells that form dormant tumors will facilitate understanding of the underlying mechanisms of dormant micro-metastases, late recurrence, and changes in rate of tumor progression.	[Satchi-Fainaro, Ronit; Ferber, Shiran; Segal, Ehud] Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Ma, Lili; Dixit, Niharika; Ijaz, Ambreen; Hlatky, Lynn; Abdollahi, Amir; Almog, Nava] Tufts Univ, Sch Med, St Elizabeths Med Ctr, Steward Res & Specialty Projects Corp,Ctr Canc Sy, Boston, MA 02111 USA; [Abdollahi, Amir] Univ Heidelberg, Sch Med, Heidelberg, Germany; [Abdollahi, Amir] German Canc Res Ctr, Dept Radiat Oncol, D-6900 Heidelberg, Germany	Tel Aviv University; Sackler Faculty of Medicine; St. Elizabeth's Medical Center; Tufts University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Satchi-Fainaro, R (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	nava.almog@tufts.edu	Dixit, Niharika/AAF-7057-2019; Satchi-Fainaro, Ronit/F-9137-2011	Satchi-Fainaro, Ronit/0000-0002-7360-7837	National Cancer Institute [U54CA149233]; Chief Scientist Office of the Ministry of Health, Israel [5145-300000]; Israel Science Foundation [1309/10]; The Swiss Bridge Award; The Israel Cancer Research Fund; NATIONAL CANCER INSTITUTE [U54CA149233] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chief Scientist Office of the Ministry of Health, Israel; Israel Science Foundation(Israel Science Foundation); The Swiss Bridge Award; The Israel Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Authors wish to thank Janusz Weremowicz and Clare Lamont for assisting with animal work. The project described was supported (in part) by Award Number U54CA149233 from the National Cancer Institute (LH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. This study was supported (in part) by grant no. 5145-300000 from the Chief Scientist Office of the Ministry of Health, Israel, by the Israel Science Foundation (grant No. 1309/10), The Swiss Bridge Award and The Israel Cancer Research Fund given to RSF. The authors disclose any commercial affiliations or financial interests that may be considered conflict of interest regarding this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilles EG, 2001, J NATL CANCER I, V93, P1075, DOI 10.1093/jnci/93.14.1075; Aguirre-Ghiso JA, 2007, NAT REV CANCER, V7, P834, DOI 10.1038/nrc2256; Almog N, 2010, CANC LETT; Almog N, 2006, FASEB J, V20, P947, DOI 10.1096/fj.05-3946fje; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; Barkan D, 2010, CANCER RES, V70, P5706, DOI 10.1158/0008-5472.CAN-09-2356; Barkan D, 2010, EUR J CANCER, V46, P1181, DOI 10.1016/j.ejca.2010.02.027; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; Brackstone M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1677; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; FOLKMAN J, 1989, NATURE, V339, P58, DOI 10.1038/339058a0; Folkman J, 2004, NATURE, V427, P787, DOI 10.1038/427787a; GIMBRONE MA, 1972, J EXP MED, V136, P261, DOI 10.1084/jem.136.2.261; Goss PE, 2010, NAT REV CANCER, V10, P871, DOI 10.1038/nrc2933; HARACH HR, 1985, CANCER-AM CANCER SOC, V56, P531, DOI 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3; Hart IR, 1999, J PATHOL, V187, P91, DOI 10.1002/(SICI)1096-9896(199901)187:1<91::AID-PATH234>3.0.CO;2-J; HOLMGREN L, 1995, NAT MED, V1, P149, DOI 10.1038/nm0295-149; Kaur B, 2009, CANCER RES, V69, P1212, DOI 10.1158/0008-5472.CAN-08-1166; Kenny PA, 2003, INT J CANCER, V107, P688, DOI 10.1002/ijc.11491; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Moserle L, 2009, CURR MOL MED, V9, P935, DOI 10.2174/156652409789712800; Naumov GN, 2006, JNCI-J NATL CANCER I, V98, P316, DOI 10.1093/jnci/djj068; Naumov GN, 2001, SEMIN CANCER BIOL, V11, P271, DOI 10.1006/scbi.2001.0382; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Quesnel B, 2008, CANCER LETT, V267, P10, DOI 10.1016/j.canlet.2008.02.055; Ribatti D, 2007, LEUKEMIA, V21, P44, DOI 10.1038/sj.leu.2404402; Segal E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005233; Townson JL, 2006, CELL CYCLE, V5, P1744, DOI 10.4161/cc.5.16.2864; Udagawa T, 2002, FASEB J, V16, P1361, DOI 10.1096/fj.01-0813com; Uhr JW, 1997, NAT MED, V3, P505, DOI 10.1038/nm0597-505; Uhr JW, P NATL ACAD SCI US; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Wikman H, 2008, APMIS, V116, P754, DOI 10.1111/j.1600-0463.2008.01033.x	34	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44395	10.1371/journal.pone.0044395	http://dx.doi.org/10.1371/journal.pone.0044395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970208	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400064
J	Granit, RZ; Gabai, Y; Hadar, T; Karamansha, Y; Liberman, L; Waldhorn, I; Gat-Viks, I; Regev, A; Maly, B; Darash-Yahana, M; Peretz, T; Ben-Porath, I				Granit, R. Z.; Gabai, Y.; Hadar, T.; Karamansha, Y.; Liberman, L.; Waldhorn, I.; Gat-Viks, I.; Regev, A.; Maly, B.; Darash-Yahana, M.; Peretz, T.; Ben-Porath, I.			EZH2 promotes a bi-lineage identity in basal-like breast cancer cells	ONCOGENE			English	Article						basal-like; breast cancer; differentiation; EZH2; Polycomb; GATA3	STEM-CELLS; POLYCOMB; GATA-3; MUTATION; FATE; DIFFERENTIATION; IDENTIFICATION; MORPHOGENESIS; PROGENITORS; POPULATION	The mechanisms regulating breast cancer differentiation state are poorly understood. Of particular interest are molecular regulators controlling the highly aggressive and poorly differentiated traits of basal-like breast carcinomas. Here we show that the Polycomb factor EZH2 maintains the differentiation state of basal-like breast cancer cells, and promotes the expression of progenitor-associated and basal-lineage genes. Specifically, EZH2 regulates the composition of basal-like breast cancer cell populations by promoting a 'bi-lineage' differentiation state, in which cells co-express basal- and luminal-lineage markers. We show that human basal-like breast cancers contain a subpopulation of bi-lineage cells, and that EZH2-deficient cells give rise to tumors with a decreased proportion of such cells. Bi-lineage cells express genes that are active in normal luminal progenitors, and possess increased colony-formation capacity, consistent with a primitive differentiation state. We found that GATA3, a driver of luminal differentiation, performs a function opposite to EZH2, acting to suppress bi-lineage identity and luminal-progenitor gene expression. GATA3 levels increase upon EZH2 silencing, mediating a decrease in bi-lineage cell numbers. Our findings reveal a novel role for EZH2 in controlling basal-like breast cancer differentiation state and intra-tumoral cell composition.	[Granit, R. Z.; Gabai, Y.; Hadar, T.; Karamansha, Y.; Liberman, L.; Waldhorn, I.; Ben-Porath, I.] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel; [Hadar, T.] Hadassah Med Ctr, Dept Surg, IL-91120 Jerusalem, Israel; [Gat-Viks, I.; Regev, A.] Broad Inst Harvard & MIT, Cambridge, MA USA; [Gat-Viks, I.; Regev, A.] MIT, Dept Biol, Cambridge, MA USA; [Maly, B.] Hadassah Med Ctr, Dept Pathol, IL-91120 Jerusalem, Israel; [Darash-Yahana, M.; Peretz, T.] Hadassah Med Ctr, Sharett Inst Oncol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center	Ben-Porath, I (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel.	ittaibp@mail.huji.ac.il		Granit, Roy Zvi/0000-0002-6487-2559	Israel Science Foundation [1560/07]; Israel Cancer Association; Israel Cancer Research Foundation; Joint Research Fund IMRIC-Hadassah	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Israel Cancer Research Foundation; Joint Research Fund IMRIC-Hadassah	We thank Eli Pikarsky, Yuval Dor and Yehudit Bergman for critical reviewing of the manuscript, Marius Wernig for the Fip-EZH2 construct, Alex Roesch and Meenhard Herlyn for the pLU-JARID1Bp-GFP-Blast<SUP>R</SUP> construct and Sabine Werner for the CK14 promoter plasmid. We thank Norma E. Kidess-Bassir for histological support. This study was supported by the Israel Science Foundation (Grant 1560/07), the Israel Cancer Association, the Israel Cancer Research Foundation, and the Joint Research Fund IMRIC-Hadassah.	Alford SH, 2012, BREAST CANCER RES TR, V132, P429, DOI 10.1007/s10549-011-1591-2; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Asselin-Labat ML, 2011, MOL CELL BIOL, V31, P4609, DOI 10.1128/MCB.05766-11; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gonzalez ME, 2009, ONCOGENE, V28, P843, DOI 10.1038/onc.2008.433; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041; Gusterson B, 2009, NAT REV CANCER, V9, P128, DOI 10.1038/nrc2571; Hock H, 2012, GENE DEV, V26, P751, DOI 10.1101/gad.191163.112; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Mehra R, 2005, CANCER RES, V65, P11259, DOI 10.1158/0008-5472.CAN-05-2495; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Pietersen AM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2214; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Rakha EA, 2009, BREAST CANCER RES TR, V113, P411, DOI 10.1007/s10549-008-9952-1; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Spike BT, 2012, CELL STEM CELL, V10, P183, DOI 10.1016/j.stem.2011.12.018; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Yu J, 2007, CANCER CELL, V12, P419, DOI 10.1016/j.ccr.2007.10.016; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	44	26	28	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 15	2013	32	33					3886	3895		10.1038/onc.2012.390	http://dx.doi.org/10.1038/onc.2012.390			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	202JH	22986524	Green Submitted			2022-12-25	WOS:000323210200011
J	Saandi, T; Baraille, F; Derbal-Wolfrom, L; Cattin, AL; Benahmed, F; Martin, E; Cardot, P; Duclos, B; Ribeiro, A; Freund, JN; Duluc, I				Saandi, T.; Baraille, F.; Derbal-Wolfrom, L.; Cattin, A-L; Benahmed, F.; Martin, E.; Cardot, P.; Duclos, B.; Ribeiro, A.; Freund, J-N; Duluc, I.			Regulation of the tumor suppressor homeogene Cdx2 by HNF4 alpha in intestinal cancer	ONCOGENE			English	Article						intestine; hepatocyte nuclear factor; tumor suppressor; homeobox gene	HEPATOCYTE NUCLEAR FACTOR-4-ALPHA; IV GENE-TRANSCRIPTION; HOMEOBOX GENE; COLORECTAL-CANCER; CHROMOSOMAL INSTABILITY; EPITHELIAL-CELLS; GUT DEVELOPMENT; DOWN-REGULATION; MUTANT MICE; EXPRESSION	The gut-specific homeotic transcription factor Cdx2 is a crucial regulator of intestinal development and homeostasis, which is downregulated in colorectal cancers (CRC) and exhibits a tumor suppressor function in the colon. We have previously established that several endodermal transcription factors, including HNF4 alpha and GATA6, are involved in Cdx2 regulation in the normal gut. Here we have studied the role of HNF4 alpha in the mechanism of deregulation of Cdx2 in colon cancers. Crossing Apc(Delta 14/+) mice prone to spontaneous intestinal tumor development with pCdx2-9LacZ transgenic mice containing the LacZ reporter under the control of the 9.3-kb Cdx2 promoter showed that this promoter segment contains sequences recapitulating the decrease of Cdx2 expression in intestinal cancers. Immunohistochemistry revealed that HNF4 alpha, unlike GATA6, exhibited a similar decrease to Cdx2 in genetic (Apc(min/+) and Apc(Delta 14/+)) and chemically induced (Azoxymethane (AOM) treatment) models of intestinal tumors in mice. HNF4 alpha and Cdx2 also exhibited a comparable deregulated pattern in human CRC. Correlated patterns were observed between HNF4 alpha and Cdx2 in several experimental models of human colon cancer cell lines: xenografts in nude mice, wound healing and glucose starvation. Furthermore, Cdx2 decreased by knocking down HNF4 alpha in human colon cancer cells using siRNA and in the colon of mice conditionally knocked out for the Hnf4 alpha gene in the adult intestine (Hnf4 alpha(f/f); VilCre(ERT2) mice). Finally, the conditionally knocked out mice Hnf4 alpha(f/f); VilCre(ERT2) treated with the carcinogen AOM developed colorectal tumors earlier than wild-type mice, as previously reported for mice with a reduced Cdx2 expression. In conclusion, this study provides evidence that the downregulation of HNF4 alpha is an important determinant of the reduced expression of the Cdx2 tumor suppressor gene in intestinal cancers. Consistently, similar to Cdx2, HNF4 alpha exerts a tumor suppressor function in the colon in that its loss of function facilitates tumor progression.	[Saandi, T.; Derbal-Wolfrom, L.; Benahmed, F.; Martin, E.; Duclos, B.; Freund, J-N; Duluc, I.] INSERM, U682, F-67200 Strasbourg, France; [Saandi, T.; Derbal-Wolfrom, L.; Martin, E.; Duclos, B.; Freund, J-N; Duluc, I.] Univ Strasbourg, Fac Med, Strasbourg, France; [Baraille, F.; Cattin, A-L; Cardot, P.; Ribeiro, A.] Ctr Rech Cordeliers, INSERM, UMRS 872, Paris, France; [Baraille, F.; Cattin, A-L; Cardot, P.; Ribeiro, A.] Univ Paris 06, UMRS 872, Paris, France; [Baraille, F.; Cattin, A-L; Cardot, P.; Ribeiro, A.] Univ Paris 05, UMRS 872, Paris, France; [Benahmed, F.] Hosp Special Surg, Autoimmun & Inflammat Program, New York, NY 10021 USA; [Duclos, B.] CHU Strasbourg, Serv Gastroenterol, F-67000 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Duluc, I (corresponding author), INSERM, U682, 3 Ave Moliere, F-67200 Strasbourg, France.	isabelle.duluc@inserm.fr	Ribeiro, Agnès/Q-9702-2017; Duluc, Isabelle/O-1972-2017; DULUC, Isabelle/AAA-7062-2022; Freund, Jean-Noel/R-4383-2016	Ribeiro, Agnès/0000-0003-2063-6084; Duluc, Isabelle/0000-0001-8396-6385; DULUC, Isabelle/0000-0001-8396-6385; Freund, Jean-Noel/0000-0002-0971-3774	Inserm; Ligue contre le Cancer du Haut-Rhin; Canceropole Grand-Est (France); Association for International Cancer Research (AICR, UK); Departement de Mayotte (France); Canceropole Ile-de-France	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ligue contre le Cancer du Haut-Rhin; Canceropole Grand-Est (France); Association for International Cancer Research (AICR, UK); Departement de Mayotte (France); Canceropole Ile-de-France(Region Ile-de-France)	This work was supported by Inserm, Ligue contre le Cancer du Haut-Rhin and the Canceropole Grand-Est (France). TS was funded by the Association for International Cancer Research (AICR, UK) and by the Departement de Mayotte (France), and Fl B by the Canceropole Ile-de-France.	Ahn SH, 2008, INFLAMM BOWEL DIS, V14, P908, DOI 10.1002/ibd.20413; Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Archer A, 2005, MOL ENDOCRINOL, V19, P2320, DOI 10.1210/me.2004-0462; Beck F, 1999, P NATL ACAD SCI USA, V96, P7318, DOI 10.1073/pnas.96.13.7318; Benahmed F, 2008, GASTROENTEROLOGY, V135, P1238, DOI 10.1053/j.gastro.2008.06.045; Benahmed F, 2007, AM J PATHOL, V170, P733, DOI 10.2353/ajpath.2007.060696; Bonhomme C, 2008, ONCOGENE, V27, P4497, DOI 10.1038/onc.2008.78; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Boyd M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-68; Brabletz T, 2004, CANCER RES, V64, P6973, DOI 10.1158/0008-5472.CAN-04-1132; Calon A, 2007, GUT, V56, P1688, DOI 10.1136/gut.2007.125542; Carriere V, 2005, J BIOL CHEM, V280, P5406, DOI 10.1074/jbc.M408002200; Cattin AL, 2009, MOL CELL BIOL, V29, P6294, DOI 10.1128/MCB.00939-09; Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180; da Costa LT, 1999, ONCOGENE, V18, P5010, DOI 10.1038/sj.onc.1202872; Darsigny M, 2010, CANCER RES, V70, P9423, DOI 10.1158/0008-5472.CAN-10-1697; Drewes T, 1996, MOL CELL BIOL, V16, P925; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Garrison WD, 2006, GASTROENTEROLOGY, V130, P1207, DOI 10.1053/j.gastro.2006.01.003; Gross I, 2008, ONCOGENE, V27, P107, DOI 10.1038/sj.onc.1210601; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Hinoi T, 2001, AM J PATHOL, V159, P2239, DOI 10.1016/S0002-9440(10)63074-X; Kim S, 2002, GASTROENTEROLOGY, V123, P1163, DOI 10.1053/gast.2002.36043; Lazarevich N. L., 2010, Experimental Oncology, V32, P167; Li TG, 2010, J LIPID RES, V51, P832, DOI 10.1194/jlr.M002782; Lorentz O, 1999, ONCOGENE, V18, P87, DOI 10.1038/sj.onc.1202280; Neuville A, 2011, HUM PATHOL, V42, P244, DOI 10.1016/j.humpath.2010.07.003; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Stringer EJ, 2012, DEVELOPMENT, V139, P465, DOI 10.1242/dev.070722; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Subtil C, 2007, CANCER LETT, V247, P197, DOI 10.1016/j.canlet.2006.04.004; Tanaka T, 2006, INT J CANCER, V118, P25, DOI 10.1002/ijc.21282; Tanaka T, 2006, J PATHOL, V208, P662, DOI 10.1002/path.1928; TARAVIRAS S, 1994, MECH DEVELOP, V48, P67, DOI 10.1016/0925-4773(94)90017-5; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006	36	32	38	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 8	2013	32	32					3782	3788		10.1038/onc.2012.401	http://dx.doi.org/10.1038/onc.2012.401			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	198EH	22986531	Bronze			2022-12-25	WOS:000322904400012
J	Zaun, HC; Shrier, A; Orlowski, J				Zaun, Hans C.; Shrier, Alvin; Orlowski, John			N-Myristoylation and Ca2+ Binding of Calcineurin B Homologous Protein CHP3 Are Required to Enhance Na+/H+ Exchanger NHE1 Half-life and Activity at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-BINDING PROTEIN; ESSENTIAL COFACTOR; ION TRANSLOCATION; PH REGULATION; CALCIUM; TESCALCIN; GENE; CELLS; DIFFERENTIATION; ACTIVATION	Calcineurin B homologous proteins (CHP) are N-myristoylated, EF-hand Ca2+-binding proteins that regulate multiple cellular processes, including intracellular pH homeostasis. Previous work has shown that the heart-enriched isoform, CHP3, regulates the plasmalemmal Na+/H+ exchanger NHE1 isoform by enhancing its rate of oligosaccharide maturation and exocytosis as well as its half-life and transport activity at the cell surface (Zaun, H. C., Shrier, A., and Orlowski, J. (2008) J. Biol. Chem. 283, 12456-12467). However, the molecular basis for this effect is not well understood. In this report, we investigated whether the N-myristoylation and Ca2+-binding domains of CHP3 are important elements for regulating NHE1. Mutation of residues essential for either N-myristoylation (G2A) or calcium binding (D123A) did not prevent the interaction of CHP3 with NHE1, although the D123A mutant no longer showed elevated binding to NHE1 in the presence of Ca2+ when assessed using in vitro binding assays. Disruption of either site also did not impair the ability of CHP3 to stimulate the biosynthetic processing and trafficking of NHE1 to the plasma membrane nor did it affect the H+ sensitivity of the exchanger. However, they did significantly reduce the cell surface half-life and near maximal transport velocity of NHE1 to a similar extent. Simultaneous mutation of both sites (G2A/D123A) gave results identical to the individual substitutions. This finding suggests that both domains in CHP3 are interdependent and may function cooperatively as a Ca2+ myristoyl switch mechanism to selectively stabilize the NHE1 center dot CHP3 complex at the cell surface in a conformation that promotes optimal transport activity.	[Zaun, Hans C.; Shrier, Alvin; Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	McGill University	Orlowski, J (corresponding author), McGill Univ, Dept Physiol, McIntyre Med Sci Bldg,3655 Promenade Sir William, Montreal, PQ H3G 1Y6, Canada.	john.orlowski@mcgill.ca		Orlowski, John/0000-0001-7371-175X	Canadian Institutes for Health Research [MOP 11221, MOP 86589]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grants MOP 11221 (to J. O.) and MOP 86589 (to A. S.) from the Canadian Institutes for Health Research.	Aharonovitz O, 2000, J CELL BIOL, V150, P213, DOI 10.1083/jcb.150.1.213; Ames JB, 2012, FRONT MOL NEUROSCI, V5, DOI [10.3389/fnmol.2012.00010, 10.1016/j.bbagen.2011.10.003]; Ames JB, 2002, ADV EXP MED BIOL, V514, P333; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Andrade J, 2004, BIOCHEM J, V384, P327, DOI 10.1042/BJ20040622; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; Di Sole F, 2012, AM J PHYSIOL-RENAL, V303, pF165, DOI 10.1152/ajprenal.00628.2011; DYCK JRB, 1995, J BIOL CHEM, V270, P10420, DOI 10.1074/jbc.270.18.10420; Gutierrez-Ford C, 2003, BIOCHEMISTRY-US, V42, P14553, DOI 10.1021/bi034870f; Inoue H, 2003, BIOL PHARM BULL, V26, P148, DOI 10.1248/bpb.26.148; Jin Q, 2007, IN VIVO, V21, P593; KAPUS A, 1994, J BIOL CHEM, V269, P23544; LADANT D, 1995, J BIOL CHEM, V270, P3179; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Levay K, 2007, J CLIN INVEST, V117, P2672, DOI 10.1172/JCI27465; Li GD, 2008, J BIOL CHEM, V283, P32660, DOI 10.1074/jbc.M806684200; Li XJ, 2009, AM J PHYSIOL-HEART C, V296, pH159, DOI 10.1152/ajpheart.00375.2008; Lin X, 1999, J BIOL CHEM, V274, P36125, DOI 10.1074/jbc.274.51.36125; Mailander J, 2001, FEBS LETT, V507, P331, DOI 10.1016/S0014-5793(01)02986-6; Matsushita M, 2011, AM J PHYSIOL-CELL PH, V301, pC280, DOI 10.1152/ajpcell.00404.2010; Maurer-Stroh S, 2002, J MOL BIOL, V317, P541, DOI 10.1006/jmbi.2002.5426; Meima ME, 2007, CURR OPIN NEPHROL HY, V16, P365, DOI 10.1097/MNH.0b013e3281bd888d; Mishima M, 2007, J BIOL CHEM, V282, P2741, DOI 10.1074/jbc.M604092200; Niki I, 1996, J BIOCHEM, V120, P685; O'Callaghan DW, 2003, BIOCHEM SOC T, V31, P963; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; ORLOWSKI J, 1993, J BIOL CHEM, V268, P16369; Orlowski J, 2011, COMPR PHYSIOL, V1, P2083, DOI 10.1002/cphy.c110020; Pang TX, 2004, BIOCHEMISTRY-US, V43, P3628, DOI 10.1021/bi0360004; Pang TX, 2002, J BIOL CHEM, V277, P43771, DOI 10.1074/jbc.M208313200; Pang TX, 2001, J BIOL CHEM, V276, P17367, DOI 10.1074/jbc.M100296200; Perera EM, 2001, ENDOCRINOLOGY, V142, P455, DOI 10.1210/en.142.1.455; Putney LK, 2003, J BIOL CHEM, V278, P44645, DOI 10.1074/jbc.M308099200; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; Schelling JR, 2008, AM J PHYSIOL-RENAL, V295, pF625, DOI 10.1152/ajprenal.90212.2008; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Tominaga T, 1998, MOL BIOL CELL, V9, P2287, DOI 10.1091/mbc.9.8.2287; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P13710; Wu KL, 2003, AM J PHYSIOL-RENAL, V284, pF829, DOI 10.1152/ajprenal.00314.2002; Zaun HC, 2008, J BIOL CHEM, V283, P12456, DOI 10.1074/jbc.M800267200	44	20	21	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36883	36895		10.1074/jbc.M112.394700	http://dx.doi.org/10.1074/jbc.M112.394700			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22984264	Green Published, hybrid			2022-12-25	WOS:000310588500025
J	Brummel-Ziedins, KE; Orfeo, T; Callas, PW; Gissel, M; Mann, KG; Bovill, EG				Brummel-Ziedins, Kathleen E.; Orfeo, Thomas; Callas, Peter W.; Gissel, Matthew; Mann, Kenneth G.; Bovill, Edwin G.			The Prothrombotic Phenotypes in Familial Protein C Deficiency Are Differentiated by Computational Modeling of Thrombin Generation	PLOS ONE			English	Article							RECURRENT VENOUS THROMBOEMBOLISM; DEEP-VEIN THROMBOSIS; BLOOD-COAGULATION; ANTICOAGULANT PATHWAY; PULMONARY-EMBOLISM; ANTITHROMBIN-III; LINKAGE ANALYSIS; PLASMA FACTOR; RISK; THROMBOPHILIA	The underlying cause of thrombosis in a large protein C (PC) deficient Vermont kindred appears to be multicausal and not explained by PC deficiency alone. We evaluated the contribution of coagulation factors to thrombin generation in this population utilizing a mathematical model that incorporates a mechanistic description of the PC pathway. Thrombin generation profiles for each individual were generated with and without the contribution of the PC pathway. Parameters that describe thrombin generation: maximum level (MaxL) and rate (MaxR), their respective times (TMaxL, TMaxR), area under the curve (AUC) and clotting time (CT) were examined in individuals +/- PC mutation, +/- prothrombin G20210A polymorphism and +/- thrombosis history (DVT or PE). This family (n = 364) is shifted towards greater thrombin generation relative to the mean physiologic control. When this family was analyzed with the PC pathway, our results showed that: carriers of the PC mutation (n = 81) had higher MaxL and MaxR and greater AUC (all p<0.001) than non-carriers (n = 283); and individuals with a DVT and/or PE history (n = 13) had higher MaxL (p = 0.005) and greater AUC (p<0.001) than individuals without a thrombosis history (n = 351). These differences were further stratified by gender, with women in all categories generating more thrombin than males. These results show that all individuals within this family with or without PC deficiency have an increased baseline procoagulant potential reflective of increased thrombin generation. In addition, variations within the plasma composition of each individual can further segregate out increased procoagulant phenotypes, with gender-associated plasma compositional differences playing a large role.	[Brummel-Ziedins, Kathleen E.; Orfeo, Thomas; Gissel, Matthew; Mann, Kenneth G.] Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA; [Bovill, Edwin G.] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Callas, Peter W.] Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA	University of Vermont; University of Vermont; University of Vermont	Brummel-Ziedins, KE (corresponding author), Univ Vermont, Coll Med, Dept Biochem, Burlington, VT 05405 USA.	Kathleen.brummel@uvm.edu			National Institutes of Health [HL46703]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL046703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Program Project grant HL46703 (Project 5) from the National Institutes of Health (KBZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAART CF, 1995, BRIT MED J, V311, P910; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Berntorp E, 2008, SEMIN THROMB HEMOST, V34, P670, DOI 10.1055/s-0028-1104546; BOVILL EG, 1989, BLOOD, V73, P712; Bovill EG, 1999, THROMB HAEMOSTASIS, V82, P662; Bovill EG, 2000, THROMB HAEMOSTASIS, V83, P366; Bravo MC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-45; Brummel KE, 2002, BLOOD, V100, P148, DOI 10.1182/blood.V100.1.148; Brummel-Ziedins K, 2008, J THROMB HAEMOST, V6, P104; Brummel-Ziedins K, 2005, J THROMB HAEMOST, V3, P1472, DOI 10.1111/j.1538-7836.2005.01249.x; Brummel-Ziedins KE, 2005, J THROMB HAEMOST, V3, P2497, DOI 10.1111/j.1538-7836.2005.01584.x; Butenas S, 2004, J BIOL CHEM, V279, P22875, DOI 10.1074/jbc.M400531200; Chatterjee MS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000950; Christiansen SC, 2010, J THROMB HAEMOST, V8, P2159, DOI 10.1111/j.1538-7836.2010.03994.x; Cote HCF, 1997, J BIOL CHEM, V272, P6194, DOI 10.1074/jbc.272.10.6194; DAHLBACK B, 1993, P NATL ACAD SCI USA, V90, P1004, DOI 10.1073/pnas.90.3.1004; Dahlback B, 2005, ARTERIOSCL THROM VAS, V25, P1311, DOI 10.1161/01.ATV.0000168421.13467.82; Danforth CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030385; Danforth CM, 2009, MATH MED BIOL, V26, P323, DOI 10.1093/imammb/dqp011; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; EGEBERG O, 1965, THROMB DIATH HAEMOST, V13, P516, DOI 10.1055/s-0038-1656297; ESMON CT, 1992, ARTERIOSCLER THROMB, V12, P135, DOI 10.1161/01.ATV.12.2.135; ESMON CT, 1989, J BIOL CHEM, V264, P4743; Evans A, 2003, TWIN RES, V6, P432, DOI 10.1375/136905203770326439; Gissel M, 2010, THROMB RES, V126, P262, DOI 10.1016/j.thromres.2010.07.002; Hasstedt SJ, 2007, THROMB HAEMOSTASIS, V98, P587, DOI 10.1160/TH07-02-0134; Hasstedt SJ, 2009, BLOOD, V114, P3084, DOI 10.1182/blood-2009-05-219485; Hasstedt SJ, 2004, J THROMB HAEMOST, V2, P868, DOI 10.1111/j.1538-7836.2004.00663.x; Hasstedt SJ, 1998, AM J HUM GENET, V63, P569, DOI 10.1086/301947; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; LEIPOLD RJ, 1995, J BIOL CHEM, V270, P25383, DOI 10.1074/jbc.270.43.25383; LU D, 1994, J BIOL CHEM, V269, P29032; Luan D, 2007, PLOS COMPUT BIOL, V3, P1347, DOI 10.1371/journal.pcbi.0030142; Mann KG, 2011, CIRCULATION, V124, P225, DOI 10.1161/CIRCULATIONAHA.110.952648; Mann KG, 2003, CHEST, V124, p4S, DOI 10.1378/chest.124.3_suppl.4S; Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1; Middeldorp S, 1998, CARDIOVASCULAR THROM, P59; MILETICH J, 1987, NEW ENGL J MED, V317, P991, DOI 10.1056/NEJM198710153171604; Mitrophanov AY, 2012, TRANSFUSION, V52, P2475, DOI 10.1111/j.1537-2995.2012.03610.x; Mitrophanov AY, 2011, THROMB RES, V128, P381, DOI 10.1016/j.thromres.2011.05.013; Nagashima H, 2002, J BIOL CHEM, V277, P50439, DOI 10.1074/jbc.M208222200; Orfeo T, 2004, J BIOL CHEM, V279, P19580, DOI 10.1074/jbc.M400727200; Orfeo T, 2010, J THROMB HAEMOST, V8, P1745, DOI 10.1111/j.1538-7836.2010.03917.x; Orfeo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027852; Pabinger I, 1996, ARTERIOSCL THROM VAS, V16, P742, DOI 10.1161/01.ATV.16.6.742; Panteleev MA, 2006, BIOPHYS J, V90, P1489, DOI 10.1529/biophysj.105.069062; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Rosendaal FR, 1999, THROMB HAEMOSTASIS, V82, P610; Scott BT, 2002, BLOOD COAGUL FIBRIN, V13, P519, DOI 10.1097/00001721-200209000-00007; Scott BT, 2001, THROMB HAEMOSTASIS, V85, P82, DOI 10.1055/s-0037-1612908; Segal JB, 2009, JAMA-J AM MED ASSOC, V301, P2472, DOI 10.1001/jama.2009.853; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; SVENSSON PJ, 1994, NEW ENGL J MED, V330, P517, DOI 10.1056/NEJM199402243300801; TAIT RC, 1995, THROMB HAEMOSTASIS, V73, P87; Thompson AR, 1994, HEMOSTASIS THROMBOSI, P55; TOMCZAK JA, 1994, THROMB RES, V74, P243, DOI 10.1016/0049-3848(94)90112-0; TRAUSCHTVANHORN JJ, 1992, AM J OBSTET GYNECOL, V167, P968, DOI 10.1016/S0002-9378(12)80021-4; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; vandenBelt AGM, 1996, CLIN APPL THROMB-HEM, V2, P227, DOI 10.1177/107602969600200402; Vossen CY, 2005, J THROMB HAEMOST, V3, P459, DOI 10.1111/j.1538-7836.2005.01197.x; Vossen CY, 2004, J THROMB HAEMOST, V2, P242, DOI 10.1111/j.1538-7933.2003.00592.x; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Wolberg AS, 2007, THROMB RES, V119, P663, DOI 10.1016/j.thromres.2006.07.003; Wong JH, 2008, J CLIN INVEST, V118, P2969, DOI 10.1172/JCI34957	66	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44378	10.1371/journal.pone.0044378	http://dx.doi.org/10.1371/journal.pone.0044378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984498	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500051
J	Hatori, A; Yui, JJ; Yamasaki, T; Xie, L; Kumata, K; Fujinaga, M; Yoshida, Y; Ogawa, M; Nengaki, N; Kawamura, K; Fukumura, T; Zhang, MR				Hatori, Akiko; Yui, Joji; Yamasaki, Tomoteru; Xie, Lin; Kumata, Katsushi; Fujinaga, Masayuki; Yoshida, Yuichiro; Ogawa, Masanao; Nengaki, Nobuki; Kawamura, Kazunori; Fukumura, Toshimitsu; Zhang, Ming-Rong			PET Imaging of Lung Inflammation with [F-18]FEDAC, a Radioligand for Translocator Protein (18 kDa)	PLOS ONE			English	Article							PERIPHERAL BENZODIAZEPINE-RECEPTOR; POSITRON-EMISSION-TOMOGRAPHY; LYMPHOID-TISSUE; LIPOPOLYSACCHARIDE; INJURY; MACROPHAGES; RESPONSES; KINETICS; OUTCOMES; BRAIN	Purpose: The translocator protein (18 kDa) (TSPO) is highly expressed on the bronchial and bronchiole epithelium, submucosal glands in intrapulmonary bronchi, pneumocytes and alveolar macrophages in human lung. This study aimed to perform positron emission tomography (PET) imaging of lung inflammation with [F-18]FEDAC, a specific TSPO radioligand, and to determine cellular sources enriching TSPO expression in the lung. Methods: An acute lung injury model was prepared by intratracheal administration of lipopolysaccharide (LPS) to rat. Uptake of radioactivity in the rat lungs was measured with small-animal PET after injection of [F-18] FEDAC. Presence of TSPO was examined in the lung tissue using Western blot and immunohistochemical assays. Results: The uptake of [F-18] FEDAC increased in the lung with the progress of inflammation by treatment with LPS. Pretreatment with a TSPO-selective ligand PK11195 showed a significant decrease in the lung uptake of [F-18] FEDAC due to competitive binding to TSPO. TSPO expression was elevated in the inflamed lung section and its level responded to the [F-18] FEDAC uptake and severity of inflammation. Increase of TSPO expression was mainly found in the neutrophils and macrophages of inflamed lungs. Conclusion: From this study we conclude that PET with [F-18] FEDAC may be a useful tool for imaging TSPO expression and evaluating progress of lung inflammation. Study on human lung using [F-18] FEDAC-PET is promising.	[Hatori, Akiko; Yui, Joji; Yamasaki, Tomoteru; Xie, Lin; Kumata, Katsushi; Fujinaga, Masayuki; Yoshida, Yuichiro; Ogawa, Masanao; Nengaki, Nobuki; Kawamura, Kazunori; Fukumura, Toshimitsu; Zhang, Ming-Rong] Natl Inst Radiol Sci, Mol Imaging Ctr, Dept Mol Probes, Chiba 260, Japan	National Institutes for Quantum Science & Technology	Hatori, A (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Dept Mol Probes, Chiba 260, Japan.	zhang@nirs.go.jp	Fukumura, Toshimitsu/E-2847-2012	, Lin/0000-0002-6472-322X				Banfi A, 2009, EXP LUNG RES, V35, P186, DOI 10.1080/01902140802495862; Bribes E, 2004, J HISTOCHEM CYTOCHEM, V52, P19, DOI 10.1177/002215540405200103; CAMSONNE R, 1984, J LABELLED COMPD RAD, V21, P985, DOI 10.1002/jlcr.2580211012; CANAT X, 1993, LIFE SCI, V52, P107, DOI 10.1016/0024-3205(93)90293-C; Chen DL, 2009, AM J RESP CRIT CARE, V180, P533, DOI 10.1164/rccm.200904-0501OC; Chen DL, 2004, AM J PHYSIOL-LUNG C, V286, pL834, DOI 10.1152/ajplung.00339.2003; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Hardwick Matthew J, 2005, Mol Imaging, V4, P432; HARMSEN AG, 1988, INFECT IMMUN, V56, P1858, DOI 10.1128/IAI.56.8.1858-1863.1988; Harris RS, 2011, J NUCL MED, V52, P1713, DOI 10.2967/jnumed.110.086355; Hicks RJ, 2009, J NUCL MED, V50, p31S, DOI 10.2967/jnumed.108.057216; Huang KL, 2008, AM J CHINESE MED, V36, P301, DOI 10.1142/S0192415X08005783; Husain A.N, 2010, ROBBINS COTRAN PATHO, P677; Itoh T, 2007, AM J PHYSIOL-LUNG C, V293, pL446, DOI 10.1152/ajplung.00412.2005; IWATA M, 1991, INFECT IMMUN, V59, P1514, DOI 10.1128/IAI.59.4.1514-1520.1991; Jansson AH, 2004, LUNG, V182, P163, DOI 10.1007/s00408-004-1803-1; Ji B, 2008, J NEUROSCI, V28, P12255, DOI 10.1523/JNEUROSCI.2312-08.2008; JONES HA, 1994, AM J RESP CRIT CARE, V149, P1635, DOI 10.1164/ajrccm.149.6.7516252; Jones HA, 1997, EUR RESPIR J, V10, P795; Jones HA, 2003, EUR RESPIR J, V21, P567, DOI 10.1183/09031936.03.00048502; Jones HA, 2002, TOXICOL APPL PHARM, V183, P46, DOI 10.1006/taap.2002.9462; Jones Hazel A, 2005, Toxicol Appl Pharmacol, V207, P230, DOI 10.1016/j.taap.2005.02.027; Kumar V, 2010, ROBBINS COTRAN PATHO, P43; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; MAK JCW, 1990, J PHARMACOL EXP THER, V252, P880; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; RUFF MR, 1985, SCIENCE, V229, P1281, DOI 10.1126/science.2994216; Schuster DP, 2004, AM J RESP CELL MOL, V30, P129, DOI 10.1165/rcmb.2003-0213TR; Wang HF, 2009, BIOCHEM BIOPH RES CO, V389, P80, DOI 10.1016/j.bbrc.2009.08.102; Yanamoto K, 2010, NUCL MED BIOL, V37, P853, DOI 10.1016/j.nucmedbio.2010.04.183; Yanamoto K, 2009, BIOORG MED CHEM LETT, V19, P1707, DOI 10.1016/j.bmcl.2009.01.093; Yui J, 2010, J NUCL MED, V51, P1301, DOI 10.2967/jnumed.109.072223	35	55	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45065	10.1371/journal.pone.0045065	http://dx.doi.org/10.1371/journal.pone.0045065			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984611	Green Published, gold			2022-12-25	WOS:000308738500112
J	Kaschner, K; Quick, NJ; Jewell, R; Williams, R; Harris, CM				Kaschner, Kristin; Quick, Nicola J.; Jewell, Rebecca; Williams, Rob; Harris, Catriona M.			Global Coverage of Cetacean Line-Transect Surveys: Status Quo, Data Gaps and Future Challenges	PLOS ONE			English	Article							EASTERN TROPICAL PACIFIC; POPULATION-DENSITY; HARBOR PORPOISE; WHALE ABUNDANCE; MARINE MAMMALS; DOLPHINS; TRENDS; WATERS; RECAPTURE; DIVERSITY	Knowledge of abundance, trends and distribution of cetacean populations is needed to inform marine conservation efforts, ecosystem models and spatial planning. We compiled a geo-spatial database of published data on cetacean abundance from dedicated visual line-transect surveys and encoded >1100 abundance estimates for 47 species from 430 surveys conducted worldwide from 1975-2005. Our subsequent analyses revealed large spatial, temporal and taxonomic variability and gaps in survey coverage. With the exception of Antarctic waters, survey coverage was biased toward the northern hemisphere, especially US and northern European waters. Overall, <25% of the world's ocean surface was surveyed and only 6% had been covered frequently enough (>= 5 times) to allow trend estimation. Almost half the global survey effort, defined as total area (km(2)) covered by all survey study areas across time, was concentrated in the Eastern Tropical Pacific (ETP). Neither the number of surveys conducted nor the survey effort had increased in recent years. Across species, an average of 10% of a species' predicted range had been covered by at least one survey, but there was considerable variation among species. With the exception of three delphinid species, <1% of all species' ranges had been covered frequently enough for trend analysis. Sperm whales emerged from our analyses as a relatively data-rich species. This is a notoriously difficult species to survey visually, and we use this as an example to illustrate the challenges of using available data from line-transect surveys for the detection of trends or for spatial planning. We propose field and analytical methods to fill in data gaps to improve cetacean conservation efforts.	[Kaschner, Kristin] Univ Freiburg, Inst Biol Zool 1, Evolutionary Biol & Ecol Lab, Freiburg, Germany; [Quick, Nicola J.; Jewell, Rebecca] SMRU Ltd, New Technol Ctr, St Andrews, Fife, Scotland; [Williams, Rob; Harris, Catriona M.] Univ St Andrews, Sea Mammal Res Unit, Scottish Oceans Inst, St Andrews, Fife, Scotland; [Quick, Nicola J.; Jewell, Rebecca; Harris, Catriona M.] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland	University of Freiburg; University of St Andrews; University of St Andrews	Kaschner, K (corresponding author), Univ Freiburg, Inst Biol Zool 1, Evolutionary Biol & Ecol Lab, Albertstr 21A, Freiburg, Germany.	Kristin.kaschner@biologie.uni-freiburg.de	Kaschner, Kristin/GQQ-6475-2022; Williams, Rob/C-5882-2011	Williams, Rob/0000-0001-7496-453X; Quick, Nicola/0000-0003-3840-6711; Kaschner, Kristin/0000-0002-4061-626X; Harris, Catriona/0000-0001-9198-2414	Pew Charitable Trusts of Philadelphia through the Sea Around Us Project; United Kingdom Hydrographic Office; E&P Sound and Marine Life Programme [JIP22 06-10]; German Research Foundation (DFG); Albert-Ludwigs-University of Freiburg	Pew Charitable Trusts of Philadelphia through the Sea Around Us Project; United Kingdom Hydrographic Office; E&P Sound and Marine Life Programme; German Research Foundation (DFG)(German Research Foundation (DFG)); Albert-Ludwigs-University of Freiburg	Financial support for data collection was provided by Pew Charitable Trusts of Philadelphia through the Sea Around Us Project, the United Kingdom Hydrographic Office, and the E&P Sound and Marine Life Programme under contract reference JIP22 06-10. The article processing charge was funded by the German Research Foundation (DFG) and the Albert-Ludwigs-University of Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angliss RP, 2005, NOAATMNMFSAFSC161 US; [Anonymous], 2008, SCANS 2 SMALL CETACE; Ardron J. A., 2010, MARXAN GOOD PRACTICE; Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Barlow J, 2006, MAR MAMMAL SCI, V22, P446, DOI 10.1111/j.1748-7692.2006.00032.x; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Barlow J, 2003, LJ0313 SWFSC NMFS NO; Barlow J, 2007, FISH B-NOAA, V105, P509; Barlow Jay, 2005, Journal of Cetacean Research and Management, V7, P239; Blaylock RA, 1995, NMFSSEFSC363 US DEP; Branch T. A., 2001, Journal of Cetacean Research and Management, V3, P143; Branch T. A., 2001, Journal of Cetacean Research and Management, V3, P251; Buckland S.T., 1993, Reports of the International Whaling Commission Special Issue, V14, P33; Buckland S. T., 2002, Journal of Cetacean Research and Management, V4, P41; Buckland S.T., 2001, pi; Buckland S.T., 1993, International North Pacific Fisheries Commission Bulletin, V53, P387; Buckland ST, 2005, PHILOS T R SOC B, V360, P243, DOI 10.1098/rstb.2004.1589; Butterworth DS, 1995, SC46SH24; Butterworth DS, 1989, SC41O20; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Carretta JV, 2005, NOAATMNMFSSWFSC388 U; Danil K, 2006, MAR ECOL PROG SER, V318, P277, DOI 10.3354/meps318277; Davis RW, 2000, MMS2000003USGSBRDCR1, VII; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Evans PGH, 2004, MAMMAL REV, V34, P131, DOI 10.1046/j.0305-1838.2003.00027.x; Ferguson MC, 2005, CETACEAN POPULATION; George JCC, 2004, MAR MAMMAL SCI, V20, P755, DOI 10.1111/j.1748-7692.2004.tb01191.x; Gerrodette T, 2005, MAR ECOL PROG SER, V291, P1, DOI 10.3354/meps291001; Gerrodette T, 2002, LJ0206 SWFSC NMFS NO; Gerrodette T, 2002, LJ0220 SWFSC NMFS NO; Gerrodette T, 2005, LJ0505 SWFSC NMFS NO; Gilles A, 2009, MAR ECOL PROG SER, V383, P295, DOI 10.3354/meps08020; Grand J, 2007, ECOL LETT, V10, P364, DOI 10.1111/j.1461-0248.2007.01025.x; Gunnlaugsson T., 1993, REPORT INT WHALING C, V43, P315; Gunnlaugsson T, 1990, REPORTS INT WHALING, V40, P481; Hammond P.S., 2009, CETACEAN OFFSHORE DI; Hammond PS, 2002, J APPL ECOL, V39, P361, DOI 10.1046/j.1365-2664.2002.00713.x; Hansen LJ, 1995, ESTIMATES CETACCAN A; Hedley Sharon L., 1999, Journal of Cetacean Research and Management, V1, P255; Jewell R, 2012, MAR ECOL PROG SER, V453, P227, DOI 10.3354/meps09636; KASAMATSU F, 1995, ANTARCT SCI, V7, P365, DOI 10.1017/S0954102095000514; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Kaschner K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019653; Kot CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012990; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marques TA, 2009, J ACOUST SOC AM, V125, P1982, DOI 10.1121/1.3089590; Matkin CO, 2008, MAR ECOL PROG SER, V356, P269, DOI 10.3354/meps07273; MOBLEY JR, 2000, LJ0014C SW FISH SCI; Mollett A, 2009, ENV RISK MANAGEMENT; Moore JE, 2011, J APPL ECOL, V48, P1195, DOI 10.1111/j.1365-2664.2011.02018.x; Pressey RL, 1996, NAT CONSERV SER, V4, P23; Redfern JV, 2008, MAR ECOL PROG SER, V363, P1, DOI 10.3354/meps07495; Reeves RR, 2005, GLOBAL PRIORTTIES RE; Rosales-Nanduca H, 2011, MAR ECOL PROG SER, V431, P281, DOI 10.3354/meps09120; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Siebert U, 2006, J SEA RES, V56, P65, DOI 10.1016/j.seares.2006.01.003; Sigurjonsson J., 1989, International Whaling Commission Report of the Commission, V39, P395; Smith TD, 1999, MAR MAMMAL SCI, V15, P1, DOI 10.1111/j.1748-7692.1999.tb00779.x; Taylor BL, 2007, MAR MAMMAL SCI, V23, P157, DOI 10.1111/j.1748-7692.2006.00092.x; Thomas Len, 2007, Journal of Cetacean Research and Management, V9, P1; Underwood JG, 2010, CONSERV BIOL, V24, P162, DOI 10.1111/j.1523-1739.2009.01303.x; Wade P.R., 1993, REPORTS INT WHALING, V43, P477; Wade PR, 2007, MAR ECOL PROG SER, V343, P1, DOI 10.3354/meps07069; WADE PR, 1995, FISH B-NOAA, V93, P345; Wade PR, 1998, MAR MAMMAL SCI, V14, P1, DOI 10.1111/j.1748-7692.1998.tb00688.x; Waring GT, 2005, NMFSNE194 US DEP COM; Whitehead H, 2002, MAR ECOL PROG SER, V242, P295, DOI 10.3354/meps242295; Williams R, 2011, MAR POLLUT BULL, V62, P1303, DOI 10.1016/j.marpolbul.2011.02.029; Williams R, 2011, CONSERV BIOL, V25, P526, DOI 10.1111/j.1523-1739.2011.01656.x; Williams R, 2009, BIOL CONSERV, V142, P1542, DOI 10.1016/j.biocon.2008.12.028	70	82	86	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44075	10.1371/journal.pone.0044075	http://dx.doi.org/10.1371/journal.pone.0044075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984461	Green Published, gold			2022-12-25	WOS:000308738500028
J	Wu, H; Zhang, HJ; Zhang, XM; Xu, HF; Wang, M; Huang, JD; Zheng, BJ				Wu, Hao; Zhang, Hao-Jie; Zhang, Xiao-min; Xu, Hui-fang; Wang, Ming; Huang, Jian-dong; Zheng, Bo-Jian			Identification of Drug Resistant Mutations in HIV-1 CRF07_BC Variants Selected by Nevirapine In Vitro	PLOS ONE			English	Article							TRANSCRIPTASE INHIBITOR RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS-1; REVERSE-TRANSCRIPTASE; NONNUCLEOSIDE INHIBITORS; GENOTYPIC ANALYSIS; GENETIC DIVERSITY; PROTEASE; SUBTYPE; SUSCEPTIBILITIES; STRAINS	Since the antiretroviral therapy (ART) was introduced to patients infected by human immunodeficiency virus (HIV), the HIV related mortality and morbidity have been significantly reduced. The major obstacle for long-term successful anti-HIV treatment is the emergence of drug resistant mutants. Current data of drug resistance was mainly obtained on HIV-1 subtype B but rarely on non-B virus, even more rare with newly emerged circulating recombinant forms (CRFs). The lack of such data limits the rational management of ART for the increasing number of patients infected by non-subtype B virus. In this study, a HIV-1 CRF07_BC strain CNGZD was isolated from a HIV patient and its genome was sequenced and deposited in GenBank (JQ423923). Potential drug resistant mutants of this CRF07_BC virus strain were selected in PBMCs cultures in the presence of Nevirapine (NVP), which is the most frequently used antiretroviral drug in China. Four combination profiles of mutations were identified in the NVP-selected mutants, which were initiated with A98G, V108I, Y181C and I135T/I382L and followed by more than two other mutations at the end of the selections, respectively. A total of seven previously reported mutations (A98G, V106M, V108I, I135T, Y181C, V189I, K238N) and seven novel mutations (P4H, T48I, I178M, V314A, I382L/V, T386A) in the reverse transcriptase gene were found in these NVP-selected mutants. Phenotypic analysis in the NVP-selected mutants showed that all the mutations, except P4H, contribute to NVP resistance. Among them, V106M and Y181C reduce NVP susceptibility for more than 20-fold, while the other mutations cause less than 20 folds drug resistance. Although the information obtained in this in vitro selection study may not fully cover resistant mutations which will actually occur in patients, it has still provided useful information for rational management of ART in patients infected with HIV CRF_BC subtype.	[Wu, Hao; Zhang, Hao-Jie; Zhang, Xiao-min; Zheng, Bo-Jian] Univ Hong Kong, Dept Microbiol, Guangzhou, Guangdong, Peoples R China; [Huang, Jian-dong] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wu, H (corresponding author), Univ Hong Kong, Dept Microbiol, Guangzhou, Guangdong, Peoples R China.	bzheng@hkucc.hku.hk	/C-4277-2009	/0000-0001-7531-2816	AIDS Trust Fund, Hong Kong SAR Government	AIDS Trust Fund, Hong Kong SAR Government	This work was financially supported by by AIDS Trust Fund, Hong Kong SAR Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azijn H, 2010, ANTIMICROB AGENTS CH, V54, P718, DOI 10.1128/AAC.00986-09; BYRNES VW, 1994, ANTIMICROB AGENTS CH, V38, P1404, DOI 10.1128/AAC.38.6.1404; Casado JL, 2000, AIDS, V14, pF1, DOI 10.1097/00002030-200001280-00001; Ceccherini-Silberstein F, 2007, J VIROL, V81, P11507, DOI 10.1128/JVI.00303-07; Chen JHK, 2007, J CLIN VIROL, V39, P125, DOI 10.1016/j.jcv.2007.03.008; Conway B, 2001, AIDS, V15, P1269, DOI 10.1097/00002030-200107060-00008; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Grossman Z, 2004, AIDS, V18, P909, DOI 10.1097/00002030-200404090-00008; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Iglesias-Ussel MD, 2002, J GEN VIROL, V83, P93, DOI 10.1099/0022-1317-83-1-93; JR Ye, 2011, AIDS RES HUM RETROVI; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Kleim JP, 1996, P NATL ACAD SCI USA, V93, P34, DOI 10.1073/pnas.93.1.34; Li TS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003918; Liao LJ, 2007, AIDS RES HUM RETROV, V23, P1062, DOI 10.1089/aid.2007.0050; Loemba H, 2002, ANTIMICROB AGENTS CH, V46, P2087, DOI 10.1128/AAC.46.7.2087-2094.2002; Martinez-Cajas JL, 2008, AIDS REV, V10, P212; MELLORS JW, 1992, MOL PHARMACOL, V41, P446; Michael N, 1999, HIV PROTOCOLS; Reuman EC, 2010, J ANTIMICROB CHEMOTH, V65, P1477, DOI 10.1093/jac/dkq140; Rhee SY, 2006, AIDS, V20, P643, DOI 10.1097/01.aids.0000216363.36786.2b; RICHMAN D, 1991, P NATL ACAD SCI USA, V88, P11241, DOI 10.1073/pnas.88.24.11241; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Services DoHaH, 2011, GUID US ANT AG HIV 1, P174; Shafer RW, 2008, AIDS REV, V10, P67; Staden R, 2000, Methods Mol Biol, V132, P115; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; Tombuyzer L, 2009, ANTIVIR THER, V14, P103; van't Wout AB, 2008, NAT PROTOC, V3, P363, DOI 10.1038/nprot.2008.3; Vergne L, 2000, J CLIN MICROBIOL, V38, P3919, DOI 10.1128/JCM.38.11.3919-3925.2000; Vergne L, 2006, J CLIN VIROL, V36, P43, DOI 10.1016/j.jcv.2006.01.012; Yu G, 2009, AIDS RES HUM RETROV, V25, P869, DOI 10.1089/aid.2008.0312; Zhang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006108; Zhang QW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031233	36	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44333	10.1371/journal.pone.0044333	http://dx.doi.org/10.1371/journal.pone.0044333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984494	Green Published, gold			2022-12-25	WOS:000308738500048
J	Ceci, ML; Pedraza, M; de Carlos, JA				Ceci, Maria Laura; Pedraza, Maria; de Carlos, Juan A.			The Embryonic Septum and Ventral Pallium, New Sources of Olfactory Cortex Cells	PLOS ONE			English	Article							CAJAL-RETZIUS CELLS; CORTICAL GABAERGIC INTERNEURONS; MAMMALIAN TELENCEPHALON; PREOPTIC AREA; MIGRATION; EXPRESSION; ORIGINS; ROLES; MOUSE	The mammalian olfactory cortex is a complex structure located along the rostro-caudal extension of the ventrolateral prosencephalon, which is divided into several anatomically and functionally distinct areas: the anterior olfactory nucleus, piriform cortex, olfactory tubercle, amygdaloid olfactory nuclei, and the more caudal entorhinal cortex. Multiple forebrain progenitor domains contribute to the cellular diversity of the olfactory cortex, which is invaded simultaneously by cells originating in distinct germinal areas in the dorsal and ventral forebrain. Using a combination of dye labeling techniques, we identified two novel areas that contribute cells to the developing olfactory cortices, the septum and the ventral pallium, from which cells migrate along a radial and then a tangential path. We characterized these cell populations by comparing their expression of calretinin, calbindin, reelin and Tbr1 with that of other olfactory cell populations.	[Ceci, Maria Laura] Univ Chile, Santiago, Chile; [Pedraza, Maria; de Carlos, Juan A.] Inst Cajal Consejo Super Invest Cient, Dept Mol Cellular & Dev Neurobiol, Madrid, Spain	Universidad de Chile; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Ceci, ML (corresponding author), Univ Chile, Santiago, Chile.	decarlos@cajal.csic.es	De Carlos, Juan A./Q-8999-2018	De Carlos, Juan A./0000-0001-9096-5372; Pedraza, Maria/0000-0002-1973-3269	Spanish Ministerio de Ciencia e Innovacion [BFU2010-21377]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by grant BFU2010-21377 from the Spanish Ministerio de Ciencia e Innovacion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Carney RSE, 2006, J NEUROSCI, V26, P11562, DOI 10.1523/JNEUROSCI.3092-06.2006; De Carlos JA, 2009, DEV DEGENERATION REG, P19; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Moreno FG, 2008, CEREB CORTEX, V18, P1239, DOI 10.1093/cercor/bhm154; Garcia-Moreno F, 2010, NAT NEUROSCI, V13, P680, DOI 10.1038/nn.2556; Garcia-Moreno F, 2007, J COMP NEUROL, V500, P419, DOI 10.1002/cne.21128; Gelman D, 2011, J NEUROSCI, V31, P16570, DOI 10.1523/JNEUROSCI.4068-11.2011; Gelman DM, 2009, J NEUROSCI, V29, P9380, DOI 10.1523/JNEUROSCI.0604-09.2009; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Ceci ML, 2010, CEREB CORTEX, V20, P2348, DOI 10.1093/cercor/bhp305; Meyer G, 2004, J NEUROSCI, V24, P9878, DOI 10.1523/JNEUROSCI.3060-04.2004; Meyer G, 2002, CEREB CORTEX, V12, P1225, DOI 10.1093/cercor/12.12.1225; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Ramony Cajal S., 1890, GACETA MED CATALANA, V13, P737; Retzius G., 1893, BIOL UNTERSUCH, V5, P1; Rubin AN, 2010, J NEUROSCI, V30, P12050, DOI 10.1523/JNEUROSCI.6178-09.2010; Stoykova A, 2000, J NEUROSCI, V20, P8042; Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004; Teissier A, 2010, J NEUROSCI, V30, P10563, DOI 10.1523/JNEUROSCI.0776-10.2010; Yun K, 2001, DEVELOPMENT, V128, P193; Zimmer C, 2010, DEVELOPMENT, V137, P293, DOI 10.1242/dev.041178	23	25	25	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44716	10.1371/journal.pone.0044716	http://dx.doi.org/10.1371/journal.pone.0044716			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984546	Green Submitted, gold, Green Published			2022-12-25	WOS:000308638700078
J	Cossu, G; Boria, S; Copioli, C; Bracceschi, R; Giuberti, V; Santelli, E; Gallese, V				Cossu, Giuseppe; Boria, Sonia; Copioli, Cristiana; Bracceschi, Roberta; Giuberti, Virginia; Santelli, Erica; Gallese, Vittorio			Motor Representation of Actions in Children with Autism	PLOS ONE			English	Article							EMOTIONAL FACIAL EXPRESSIONS; MIRROR NEURON DYSFUNCTION; INTENTIONAL ATTUNEMENT; IMITATION; RECOGNITION; ORGANIZATION; COGNITION; DISORDER; DEFICITS; SYSTEM	Background: Children with Autistic Spectrum Disorders (ASD) are frequently hampered by motor impairment, with difficulties ranging from imitation of actions to recognition of motor intentions. Such a widespread inefficiency of the motor system is likely to interfere on the ontogeny of both motor planning and understanding of the goals of actions, thus delivering its ultimate effects on the emergence of social cognition. Methodology/Principal Findings: We investigate the organization of action representation in 15 high functioning ASD (mean age: 8.11) and in two control samples of typically developing (TD) children: the first one, from a primary school, was matched for chronological age (CA), the second one, from a kindergarten, comprised children of much younger age (CY). We used nine newly designed behavioural motor tasks, aiming at exploring three domains of motor cognition: 1) imitation of actions, 2) production of pantomimes, and 3) comprehension of pantomimes. The findings reveal that ASD children fare significantly worse than the two control samples in each of the inspected components of the motor representation of actions, be it the imitation of gestures, the self-planning of pantomimes, or the (verbal) comprehension of observed pantomimes. In the latter task, owing to its cognitive complexity, ASD children come close to the younger TD children's level of performance; yet they fare significantly worse with respect to their age-mate controls. Overall, ASD children reveal a profound damage to the mechanisms that control both production and pre-cognitive "comprehension" of the motor representation of actions. Conclusions/Significance: Our findings suggest that many of the social cognitive impairments manifested by ASD individuals are likely rooted in their incapacity to assemble and directly grasp the intrinsic goal-related organization of motor behaviour. Such impairment of motor cognition might be partly due to an early damage of the Mirror Neuron Mechanism (MNM).	[Cossu, Giuseppe; Boria, Sonia; Copioli, Cristiana; Bracceschi, Roberta; Gallese, Vittorio] Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy; [Giuberti, Virginia; Santelli, Erica] AUSL Reggio Emilia, Unita Neuropsichiat Infantile, Reggio Emilia, Italy; [Gallese, Vittorio] Italian Inst Technol, Brain Ctr Social & Motor Cognit, Parma, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT	Cossu, G (corresponding author), Univ Parma, Dipartimento Neurosci, I-43100 Parma, Italy.	giuseppe.cossu@unipr.it	Gallese, Vittorio/ABD-5097-2021	Gallese, Vittorio/0000-0003-4815-3607	Fondazione Monte Parma (FMP); Regione Emilia Romagna; MIUR (Ministero Italiano dell'Universita e della Ricerca); EU grants	Fondazione Monte Parma (FMP); Regione Emilia Romagna(Regione Emilia Romagna); MIUR (Ministero Italiano dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR)); EU grants	The study was supported by Fondazione Monte Parma (FMP), by Regione Emilia Romagna, by MIUR (Ministero Italiano dell'Universita e della Ricerca) and EU grants NESTCOM and DISCOS (to V.G.). The authors thank A.M. Dalla Vecchia for her clinical contribution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Beall PM, 2008, J EXP CHILD PSYCHOL, V101, P206, DOI 10.1016/j.jecp.2008.04.004; Bernier R, 2007, BRAIN COGNITION, V64, P228, DOI 10.1016/j.bandc.2007.03.004; Bird G, 2007, P ROY SOC B-BIOL SCI, V274, P3027, DOI 10.1098/rspb.2007.1019; Boria S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005596; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Buccino G, 2004, NEURON, V42, P323, DOI 10.1016/S0896-6273(04)00181-3; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; DEMYER MK, 1972, J AUTISM CHILD SCHIZ, V2, P264, DOI 10.1007/BF01537618; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 2006, BRAIN RES, V1079, P15, DOI 10.1016/j.brainres.2006.01.054; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gallese V, 2003, PHILOS T R SOC B, V358, P1231, DOI 10.1098/rstb.2003.1315; Gallese V, 2002, ATTENTION PERFORM, V19, P334; Gallese V, 2012, DEV MED CHI IN PRESS; Gallese V, 2007, J AM PSYCHOANAL ASS, V55, P131, DOI 10.1177/00030651070550010601; Gallese V, 2009, DEV PSYCHOL, V45, P103, DOI 10.1037/a0014436; Grezes J, 2009, NEUROPSYCHOLOGIA, V47, P1816, DOI 10.1016/j.neuropsychologia.2009.02.021; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Ingersoll B, 2003, J AUTISM DEV DISORD, V33, P673, DOI 10.1023/B:JADD.0000006003.26667.f8; Kanner L, 1943, NERV CHILD, V2, P217; Kilner JM, 2009, J NEUROSCI, V29, P10153, DOI 10.1523/JNEUROSCI.2668-09.2009; Leighton J, 2008, NEUROPSYCHOLOGIA, V46, P1041, DOI 10.1016/j.neuropsychologia.2007.11.013; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; MacNeil LK, 2012, NEUROPSYCHOLOGY, V26, P165, DOI 10.1037/a0026955; Martineau J, 2008, INT J PSYCHOPHYSIOL, V68, P35, DOI 10.1016/j.ijpsycho.2008.01.002; McIntosh DN, 2006, DEVELOPMENTAL SCI, V9, P295, DOI 10.1111/j.1467-7687.2006.00492.x; Moll J, 2000, NEUROLOGY, V54, P1331, DOI 10.1212/WNL.54.6.1331; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Nielsen M, 2008, J EXP CHILD PSYCHOL, V101, P165, DOI 10.1016/j.jecp.2008.06.004; Oberman LM, 2008, NEUROPSYCHOLOGIA, V46, P1558, DOI 10.1016/j.neuropsychologia.2008.01.010; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Press C, 2010, NEUROPSYCHOLOGIA, V48, P3291, DOI 10.1016/j.neuropsychologia.2010.07.012; RAVEN JC, 1984, COLOURED PROGR MATRI; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G., 2000, NEW COGNITIVE NEUROS, P539; Rogers S. J., 1991, DEV PSYCHOPATHOL, V3, P137, DOI DOI 10.1017/S0954579400000043; Rogers S. J., 2006, IMITATION SOCIAL MIN, P277; Rogers SJ, 2010, DEV PSYCHOPATHOL, V22, P71, DOI 10.1017/S0954579409990277; Rubini V, 1986, WECHSLER INTELLIGENC; Sevlever M, 2010, RES DEV DISABIL, V31, P976, DOI 10.1016/j.ridd.2010.04.014; Theoret H, 2005, CURR BIOL, V15, pR84, DOI 10.1016/j.cub.2005.01.022; Watkins KE, 2002, BRAIN, V125, P452, DOI 10.1093/brain/awf058; Whiten A., 1999, INTERSUBJECTIVE COMM; Williams JHG, 2004, J AUTISM DEV DISORD, V34, P285, DOI 10.1023/B:JADD.0000029551.56735.3a	51	44	45	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44779	10.1371/journal.pone.0044779	http://dx.doi.org/10.1371/journal.pone.0044779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005KD	22970304	Green Published, gold, Green Submitted			2022-12-25	WOS:000308748400029
J	Tsompanidou, E; Denham, EL; Sibbald, MJJB; Yang, XM; Seinen, J; Friedrich, AW; Buist, G; van Dijl, JM				Tsompanidou, Eleni; Denham, Emma L.; Sibbald, Mark J. J. B.; Yang, Xiao-mei; Seinen, Jolien; Friedrich, Alexander W.; Buist, Girbe; van Dijl, Jan Maarten			The Sortase A Substrates FnbpA, FnbpB, ClfA and ClfB Antagonize Colony Spreading of Staphylococcus aureus	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; FIBRONECTIN-BINDING PROTEINS; I SIGNAL PEPTIDASES; SURFACE-PROTEINS; CELL-WALL; EPIDERMIDIS BIOFILMS; INDEPENDENT BIOFILM; TRANSPEPTIDASE-SRTA; FIBRINOGEN-BINDING; SORTING SIGNAL	Staphylococcus aureus is an important human pathogen that is renowned both for its rapid transmission within hospitals and the community, and for the formation of antibiotic resistant biofilms on medical implants. Recently, it was shown that S. aureus is able to spread over wet surfaces. This motility phenomenon is promoted by the surfactant properties of secreted phenol-soluble modulins (PSMs), which are also known to inhibit biofilm formation. The aim of the present studies was to determine whether any cell surface-associated S. aureus proteins have an impact on colony spreading. To this end, we analyzed the spreading capabilities of strains lacking non-essential components of the protein export and sorting machinery. Interestingly, our analyses reveal that the absence of sortase A (SrtA) causes a hyper-spreading phenotype. SrtA is responsible for covalent anchoring of various proteins to the staphylococcal cell wall. Accordingly, we show that the hyper-spreading phenotype of srtA mutant cells is an indirect effect that relates to the sortase substrates FnbpA, FnbpB, ClfA and ClfB. These surface-exposed staphylococcal proteins are known to promote biofilm formation, and cell-cell interactions. The hyper-spreading phenotype of srtA mutant staphylococcal cells was subsequently validated in Staphylococcus epidermidis. We conclude that cell wall-associated factors that promote a sessile lifestyle of S. aureus and S. epidermidis antagonize the colony spreading motility of these bacteria.	[Tsompanidou, Eleni; Denham, Emma L.; Yang, Xiao-mei; Seinen, Jolien; Friedrich, Alexander W.; Buist, Girbe; van Dijl, Jan Maarten] Univ Groningen, Dept Med Microbiol, Groningen, Netherlands; [Tsompanidou, Eleni; Denham, Emma L.; Yang, Xiao-mei; Seinen, Jolien; Friedrich, Alexander W.; Buist, Girbe; van Dijl, Jan Maarten] Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Sibbald, Mark J. J. B.] Univ Groningen, Dept Pharmaceut Biol, Groningen, Netherlands; [Yang, Xiao-mei] Fudan Univ, Shanghai Med Coll, Key Lab Mol Virol, Shanghai 200433, Peoples R China	University of Groningen; University of Groningen; University of Groningen; Fudan University	Tsompanidou, E (corresponding author), Univ Groningen, Dept Med Microbiol, Groningen, Netherlands.	J.M.van.dijl01@umcg.nl	van Dijl, Jan Maarten/G-1205-2013; Friedrich, Alex/ABG-9823-2020; Denham, Emma/P-3979-2014	Denham, Emma/0000-0002-5123-4099	CEU [LSHM-CT-2006-019064, LSHG-CT-2006-037469]; Top Institute Pharma project [T4-213]	CEU; Top Institute Pharma project	E. T., E. L. D., M.J.J.B.S, X.Y., G. B. and J.M.v.D. were in part supported by the CEU projects LSHM-CT-2006-019064, and LSHG-CT-2006-037469, the transnational SysMO initiative through the BACELL SysMO projects 1 and 2, and the Top Institute Pharma project T4-213. E. T. and A. W. F. were supported through the INTERREG-IVa Euregio-project Safeguard MRSAVetMed-net with reference no. 34-INTERREG IV A-II-2-05=025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; CHEUNG AL, 1992, P NATL ACAD SCI USA, V89, P6462, DOI 10.1073/pnas.89.14.6462; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; Corrigan RM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-22; Dreisbach A, 2011, PROTEOMICS, V11, P3154, DOI 10.1002/pmic.201000823; Dreisbach A, 2010, PROTEOMICS, V10, P3082, DOI 10.1002/pmic.201000062; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Dunman PM, 2001, J BACTERIOL, V183, P7341, DOI 10.1128/JB.183.24.7341-7353.2001; Eidhin DN, 1998, MOL MICROBIOL, V30, P245; FISCHETTI VA, 1990, MOL MICROBIOL, V4, P1603, DOI 10.1111/j.1365-2958.1990.tb02072.x; Fitzpatrick F, 2005, J CLIN MICROBIOL, V43, P1973, DOI 10.1128/JCM.43.4.1973-1976.2005; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Frankel BA, 2005, BIOCHEMISTRY-US, V44, P11188, DOI 10.1021/bi050141j; George NPE, 2006, ARTERIOSCL THROM VAS, V26, P2394, DOI 10.1161/01.ATV.0000237606.90523.94; Grundmeier M, 2004, INFECT IMMUN, V72, P7155, DOI 10.1128/IAI.72.12.7155-7163.2004; Hanada M, 1996, FEBS LETT, V381, P25, DOI 10.1016/0014-5793(96)00066-X; HousePompeo K, 1996, J BIOL CHEM, V271, P1379, DOI 10.1074/jbc.271.3.1379; Josefsson E, 1998, MICROBIOL-UK, V144, P3387, DOI 10.1099/00221287-144-12-3387; Kaito C, 2007, J BACTERIOL, V189, P2553, DOI 10.1128/JB.01635-06; Komatsuzawa H, 2000, FEMS MICROBIOL LETT, V188, P35, DOI 10.1016/S0378-1097(00)00194-4; Kouwen TRHM, 2009, ANTIMICROB AGENTS CH, V53, P4702, DOI 10.1128/AAC.00439-09; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; McGavin MJ, 1997, INFECT IMMUN, V65, P2621, DOI 10.1128/IAI.65.7.2621-2628.1997; Merino N, 2009, J BACTERIOL, V191, P832, DOI 10.1128/JB.01222-08; Meulemans L, 2007, VET MICROBIOL, V125, P333, DOI 10.1016/j.vetmic.2007.05.024; Naik MT, 2006, J BIOL CHEM, V281, P1817, DOI 10.1074/jbc.M506123200; Nandakumar R, 2005, J PROTEOME RES, V4, P250, DOI 10.1021/pr049866k; NOVICK RP, 1991, METHOD ENZYMOL, V204, P587; O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; O'Neill E, 2009, J MED MICROBIOL, V58, P399, DOI 10.1099/jmm.0.005504-0; Paetzel M, 2000, PHARMACOL THERAPEUT, V87, P27, DOI 10.1016/S0163-7258(00)00064-4; Papanikou E, 2007, NAT REV MICROBIOL, V5, P839, DOI 10.1038/nrmicro1771; Peacock SJ, 2001, TRENDS MICROBIOL, V9, P605, DOI 10.1016/S0966-842X(01)02254-5; Periasamy S, 2012, P NATL ACAD SCI US; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Rusch SL, 2007, BIOCHEMISTRY-US, V46, P9665, DOI 10.1021/bi7010064; Sardis MF, 2010, MOL MICROBIOL, V76, P1070, DOI 10.1111/j.1365-2958.2010.07176.x; Savolainen K, 2001, INFECT IMMUN, V69, P3013, DOI 10.1128/IAI.69.5.3013-3020.2001; Scott JR, 2006, ANNU REV MICROBIOL, V60, P397, DOI 10.1146/annurev.micro.60.080805.142256; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Sibbald MJJB, 2010, J BACTERIOL, V192, P3788, DOI 10.1128/JB.01452-09; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Toledo-Arana A, 2005, J BACTERIOL, V187, P5318, DOI 10.1128/JB.187.15.5318-5329.2005; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Tsompanidou E, 2011, J BACTERIOL, V193, P1267, DOI 10.1128/JB.01276-10; Tuteja R, 2005, ARCH BIOCHEM BIOPHYS, V441, P107, DOI 10.1016/j.abb.2005.07.013; van Roosmalen ML, 2004, BBA-MOL CELL RES, V1694, P279, DOI 10.1016/j.bbamcr.2004.05.006; Vancraeynest D, 2004, VET MICROBIOL, V103, P241, DOI 10.1016/j.vetmic.2004.09.002; Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009; Vergara-Irigaray M, 2009, INFECT IMMUN, V77, P3978, DOI 10.1128/IAI.00616-09; Wolz C, 1996, INFECT IMMUN, V64, P3142, DOI 10.1128/IAI.64.8.3142-3147.1996; Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945	59	35	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44646	10.1371/journal.pone.0044646	http://dx.doi.org/10.1371/journal.pone.0044646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970276	Green Published, gold, Green Submitted			2022-12-25	WOS:000308462000040
J	Zhang, GC; Hu, YW; Wang, HP; Zhang, L; Bao, YX; Zhou, XM				Zhang, Guocui; Hu, Yunwen; Wang, Hongping; Zhang, Lu; Bao, Yixi; Zhou, Xiaoming			High Incidence of Multiple Viral Infections Identified in Upper Respiratory Tract Infected Children under Three Years of Age in Shanghai, China	PLOS ONE			English	Article							REAL-TIME PCR; HUMAN METAPNEUMOVIRUS; SYNCYTIAL-VIRUS; INFLUENZA-B; NESTED-PCR; ASSAY; DIAGNOSIS; SYSTEM; SARS	Background: Upper respiratory tract infection (URTI) is a major reason for hospitalization in childhood. More than 80% of URTIs are viral. Etiological diagnosis of URTIs is important to make correct clinical decisions on treatment methods. However, data for viral spectrum of URTIs are very limited in Shanghai children. Methods: Nasopharyngeal swabs were collected from a group of 164 children aged below 3 years who were hospitalized due to acute respiratory infection from May 2009 to July 2010 in Shanghai. A VRDAL multiplex PCR for 10 common respiratory viruses was performed on collected specimens compared with the Seeplex (R) RV15 ACE Detection kit for 15 respiratory viruses. Results: Viruses were detected in 84 (51.2%) patients by VRDAL multiplex PCR, and 8 (4.9%) of cases were mixed infections. Using the Seeplex (R) RV15 ACE Detection kit, viruses were detected in 129 (78.7%) patients, 49 (29.9%) were co-infected cases. Identified viruses included 37 of human rhinovirus (22.6% of cases), 32 of influenza A virus (19.5%), 30 of parainfluenzavirus-2 (18.3%), 23 of parainfluenzavirus-3 (14.0%), 15 of human enterovirus (9.1%), 14 each of parainfluenzavirus-1, respiratory syncytial virus B and adenovirus (8.5%), 8 of coronavirus 229E/NL63 (4.9%), 6 of human bocavirus (3.7%), 5 each of influenza B virus and respiratory syncytial virus A (3.0%), 3 of parainfluenzavirus-4 (1.8%), 2 of coronavirus OC43/HKU1 (1.2%), and 1 human metapneumovirus (0.6%). Conclusions: A high frequency of respiratory infections (78.7%) and co-infections (29.9%) was detected in children with acute respiratory infection symptoms in Shanghai. The Seeplex (R) RV15 ACE detection method was found to be a more reliable high throughput tool than VRDAL method to simultaneously detect multiple respiratory viruses.	[Zhang, Guocui; Hu, Yunwen; Wang, Hongping; Zhang, Lu; Zhou, Xiaoming] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China; [Zhang, Guocui; Bao, Yixi] Chongqing Med Univ, Affiliated Hosp 2, Dept Clin Lab, Chongqing, Peoples R China	Fudan University; Chongqing Medical University	Zhang, GC (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200433, Peoples R China.	xmzhou@shmu.edu.cn			Chinese National R&D Programme for Key Technologies from Chinese Government, Ministry of Science and Technology [2009ZX10004-104]	Chinese National R&D Programme for Key Technologies from Chinese Government, Ministry of Science and Technology	This work was funded by Chinese National R&D Programme for Key Technologies (No. 2009ZX10004-104) from Chinese Government, Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccala GP, 2008, J CLIN VIROL, V43, P407, DOI 10.1016/j.jcv.2008.08.010; Brittain-Long R, 2008, J CLIN VIROL, V41, P53, DOI 10.1016/j.jcv.2007.10.029; Chan PKS, 2004, EMERG INFECT DIS, V10, P497, DOI 10.3201/eid1003.030513; Coiras MT, 2003, J MED VIROL, V69, P132, DOI 10.1002/jmv.10255; Dominguez SR, 2008, J CLIN VIROL, V43, P219, DOI 10.1016/j.jcv.2008.06.007; Druce J, 2005, J MED VIROL, V75, P122, DOI 10.1002/jmv.20246; Fox JD, 2007, J CLIN VIROL, V40, pS15, DOI 10.1016/S1386-6532(07)70005-7; Kim SR, 2009, J VIROL METHODS, V156, P111, DOI 10.1016/j.jviromet.2008.11.007; Lam WY, 2007, J CLIN MICROBIOL, V45, P3631, DOI 10.1128/JCM.00280-07; Lassauniere R, 2010, J VIROL METHODS, V165, P254, DOI 10.1016/j.jviromet.2010.02.005; Lee N, 2007, J CLIN VIROL, V40, P333, DOI 10.1016/j.jcv.2007.08.015; Li PQ, 2008, DIAGN MICR INFEC DIS, V62, P44, DOI 10.1016/j.diagmicrobio.2008.04.017; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; Nolte FS, 2007, J CLIN MICROBIOL, V45, P2779, DOI 10.1128/JCM.00669-07; Roh KH, 2008, ANN CLIN LAB SCI, V38, P41; Shi WX, 2008, CHIN J HLTH LAB TECH, V18, P1263; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Wang W, 2010, J CLIN VIROL, V49, P211, DOI 10.1016/j.jcv.2010.08.005; Wang W, 2009, J VIROL METHODS, V162, P40, DOI 10.1016/j.jviromet.2009.07.004; [曾玫 ZENG Mei], 2008, [中华传染病杂志, Chinese Journal of Infections Diseases], V26, P527	21	33	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44568	10.1371/journal.pone.0044568	http://dx.doi.org/10.1371/journal.pone.0044568			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970251	Green Published, gold, Green Submitted			2022-12-25	WOS:000308462000030
J	D'Cruz, TS; Weibley, BN; Kimball, SR; Barber, AJ				D'Cruz, Travis S.; Weibley, Brittany N.; Kimball, Scot R.; Barber, Alistair J.			Post-Translational Processing of Synaptophysin in the Rat Retina Is Disrupted by Diabetes	PLOS ONE			English	Article							SYNAPTIC VESICLE PROTEIN; MEMBRANE-PROTEIN; TRANSLATION; CELLS; EXPRESSION; BINDING; MICE; DISTRIBUTIONS; SYNAPTOPORIN; ENDOCYTOSIS	Synaptophysin, is an abundant presynaptic protein involved in synaptic vesicle recycling and neurotransmitter release. Previous work shows that its content is significantly reduced in the rat retina by streptozotocin (STZ)-diabetes. This study tested the hypothesis that STZ-diabetes alters synaptophysin protein turnover and glycosylation in the rat retina. Whole explant retinas from male Sprague-Dawley rats were used in this study. Rats were made diabetic by a single intraperitoneal STZ injection (65 mg/kg body weight in 10 mM sodium citrate, pH 4.5). mRNA translation was measured using a S-35-methionine labeling assay followed by synaptophysin immunoprecipitation and autoradiography. A pulse-chase study was used to determine the depletion of newly synthesized synaptophysin. Depletion of total synaptophysin was determined after treatment with cycloheximide. Mannose rich N-glycosylated synaptophysin was detected by treating retinal lysates with endoglycosidase H followed by immunoblot analysis. Synaptophysin mRNA translation was significantly increased after 1 month (p<0.001) and 2 months (p<0.05) of STZ-diabetes, compared to age-matched controls. Newly synthesized synaptophysin degradation was significantly accelerated in the retina after 1 and 2 months of diabetes compared to controls (p<0.05). Mannose rich glycosylated synaptophysin was significantly increased after 1 month of STZ-diabetes compared to controls (p<0.05). These data suggest that diabetes increases mRNA translation of synaptophysin in the retina, resulting in an accumulation of mannose rich glycosylated synaptophysin, a transient post-translational state of the protein. This diabetes-induced irregularity in post-translational processing could explain the accelerated degradation of retinal synaptophysin in diabetes.	[D'Cruz, Travis S.; Weibley, Brittany N.; Barber, Alistair J.] Milton S Hershey Med Ctr, Penn State Hershey Coll Med, Penn State Hershey Eye Ctr, Dept Ophthalmol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	D'Cruz, TS (corresponding author), Milton S Hershey Med Ctr, Penn State Hershey Coll Med, Penn State Hershey Eye Ctr, Dept Ophthalmol, Hershey, PA 17033 USA.	abarber@psu.edu		Barber, Alistair/0000-0003-4235-2293	American Diabetes Association [7-09-BS-09]; Juvenile Diabetes Research Foundation [1-2008-294]; PA Lions Sight Conservation Eye Research Foundation	American Diabetes Association(American Diabetes Association); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); PA Lions Sight Conservation Eye Research Foundation	This work was supported by the American Diabetes Association (7-09-BS-09 to AJB), Juvenile Diabetes Research Foundation (1-2008-294 to AJB), and PA Lions Sight Conservation Eye Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama TO, 2006, P NATL ACAD SCI USA, V103, P8983, DOI 10.1073/pnas.0603248103; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; BRAND SH, 1993, EMBO J, V12, P3753, DOI 10.1002/j.1460-2075.1993.tb06053.x; Brandstatter JH, 1996, J COMP NEUROL, V370, P1, DOI 10.1002/(SICI)1096-9861(19960617)370:1<1::AID-CNE1>3.0.CO;2-7; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; CUTLER DF, 1990, J CELL BIOL, V110, P721, DOI 10.1083/jcb.110.3.721; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; Daly C, 2000, P NATL ACAD SCI USA, V97, P6120, DOI 10.1073/pnas.97.11.6120; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; FYKSE EM, 1993, J NEUROSCI, V13, P4997; Gastinger MJ, 2006, INVEST OPHTH VIS SCI, V47, P3143, DOI 10.1167/iovs.05-1376; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; KIVELA T, 1989, INVEST OPHTH VIS SCI, V30, P212; KLEEMANN R, 1993, FEBS LETT, V328, P9, DOI 10.1016/0014-5793(93)80954-S; KNAUS P, 1990, NEURON, V5, P453, DOI 10.1016/0896-6273(90)90084-S; LEUBE RE, 1987, EMBO J, V6, P3261, DOI 10.1002/j.1460-2075.1987.tb02644.x; Li JM, 2009, FEBS LETT, V583, P1521, DOI 10.1016/j.febslet.2009.04.007; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Martin PM, 2004, INVEST OPHTH VIS SCI, V45, P3330, DOI 10.1167/iovs.04-0247; Molinari M, 2003, SCIENCE, V299, P1397, DOI 10.1126/science.1079474; Nag TC, 2001, J BIOSCIENCES, V26, P179, DOI 10.1007/BF02703642; REHM H, 1986, EMBO J, V5, P535, DOI 10.1002/j.1460-2075.1986.tb04243.x; Schrufer TL, 2010, DIABETES, V59, P2107, DOI 10.2337/db10-0148; Singleton DR, 1997, J CELL SCI, V110, P2099; Spiwoks-Becker I, 2001, NEUROSCIENCE, V107, P127, DOI 10.1016/S0306-4522(01)00345-1; Stenius K, 1995, J CELL BIOL, V131, P1801, DOI 10.1083/jcb.131.6.1801; SUDHOF TC, 1987, SCIENCE, V238, P1142, DOI 10.1126/science.3120313; VanGuilder HD, 2008, EUR J NEUROSCI, V28, P1, DOI 10.1111/j.1460-9568.2008.06322.x; WASHBOURNE P, 1995, BIOCHEM J, V305, P721, DOI 10.1042/bj3050721; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9	33	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44711	10.1371/journal.pone.0044711	http://dx.doi.org/10.1371/journal.pone.0044711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970294	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400109
J	Katz, SG; Fisher, JK; Correll, M; Bronson, RT; Ligon, KL; Walensky, LD				Katz, S. G.; Fisher, J. K.; Correll, M.; Bronson, R. T.; Ligon, K. L.; Walensky, L. D.			Brain and testicular tumors in mice with progenitor cells lacking BAX and BAK	ONCOGENE			English	Article						BAX; BAK; neural progenitor cell; apoptosis; tumorigenesis	NEURAL STEM-CELLS; ABUNDANT NEUROPIL; MALIGNANT GLIOMA; TRANSGENIC MICE; NERVOUS-SYSTEM; EMBRYONIC STEM; TRUE ROSETTES; LEYDIG-CELLS; MOUSE MODEL; IN-VIVO	The proapoptotic BCL-2 family proteins BAX and BAK serve as essential gatekeepers of the intrinsic apoptotic pathway and, when activated, transform into pore-forming homo-oligomers that permeabilize the mitochondrial outer membrane. Deletion of Bax and Bak causes marked resistance to death stimuli in a variety of cell types. Bax(-/-) Bak(-/-) mice are predominantly non-viable and survivors exhibit multiple developmental abnormalities characterized by cellular excess, including accumulation of neural progenitor cells in the periventricular, hippocampal, cerebellar and olfactory bulb regions of the brain. To explore the long-term pathophysiological consequences of BAX/BAK deficiency in a stem cell niche, we generated Bak(-/-) mice with conditional deletion of Bax in Nestin-positive cells. Aged Nestin(Cre)Bax(fl/fl)Bak(-/-) mice manifest progressive brain enlargement with a profound accumulation of NeuN- and Sox2-positive neural progenitor cells within the subventricular zone (SVZ). One-third of the mice develop frank masses comprised of neural progenitors, and in 20% of these cases, more aggressive, hypercellular tumors emerged. Unexpectedly, 60% of Nestin(Cre)Bax(fl/fl)Bak(-/-) mice harbored high-grade tumors within the testis, a peripheral site of Nestin expression. This in vivo model of severe apoptotic blockade highlights the constitutive role of BAX/BAK in long-term regulation of Nestin-positive progenitor cell pools, with loss of function predisposing to adult-onset tumorigenesis.	[Katz, S. G.; Fisher, J. K.; Walensky, L. D.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02215 USA; [Katz, S. G.; Fisher, J. K.; Walensky, L. D.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02215 USA; [Katz, S. G.; Ligon, K. L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Correll, M.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Bronson, R. T.; Ligon, K. L.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Ligon, K. L.] Harvard Univ, Sch Med, Dept Med Oncol, Boston, MA USA; [Ligon, K. L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Walensky, LD (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, 450 Brookline Ave,Mayer 664, Boston, MA 02215 USA.	Loren_Walensky@dfci.harvard.edu			NIH [5R01CA050239, 1P01CA142536, 5K08HL103847]; Todd J Schwartz Memorial Fund; NATIONAL CANCER INSTITUTE [R01CA050239, P01CA142536] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL103847] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Todd J Schwartz Memorial Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank E Smith for editorial and graphics assistance, R Segal, R Folkerth and C Stiles for helpful discussions, and S Rodig and the Harvard Medical School Rodent Histopathology and Brigham and Women's Hospital, Specialized Histopathology cores for technical support. This work was supported by NIH Grants 5R01CA050239 and 1P01CA142536 to LDW, NIH Grant 5K08HL103847 to SGK and the Todd J Schwartz Memorial Fund.	ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; Amoh Y, 2005, CANCER RES, V65, P5352, DOI 10.1158/0008-5472.CAN-05-0821; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burness ML, 2010, SEMIN CANCER BIOL, V20, P107, DOI 10.1016/j.semcancer.2010.05.006; Cartron PF, 2002, HUM MOL GENET, V11, P675, DOI 10.1093/hmg/11.6.675; Carvalho BS, BIOINFORMATICS, V26, P2363; Culhane AC, 2012, NUCLEIC ACIDS RES, V40, pD1060, DOI 10.1093/nar/gkr901; Dansen TB, 2006, J BIOL CHEM, V281, P10890, DOI 10.1074/jbc.M513655200; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; Degenhardt K, 2002, CANCER CELL, V2, P193, DOI 10.1016/S1535-6108(02)00126-5; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Eberhart CG, 2000, PEDIATR DEVEL PATHOL, V3, P346, DOI 10.1007/s100249910049; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gessi M, 2009, AM J SURG PATHOL, V33, P211, DOI 10.1097/PAS.0b013e318186235b; Gil-Perotin S, 2006, J NEUROSCI, V26, P1107, DOI 10.1523/JNEUROSCI.3970-05.2006; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Lindsten T, 2003, J NEUROSCI, V23, P11112; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Lobo MVT, 2004, CELL TISSUE RES, V316, P369, DOI 10.1007/s00441-003-0848-4; McCall MN, 2011, NUCLEIC ACIDS RES, V39, pD1011, DOI 10.1093/nar/gkq1259; Mehta S, 2011, CANCER CELL, V19, P359, DOI 10.1016/j.ccr.2011.01.035; Meijerink JPP, 1998, BLOOD, V91, P2991, DOI 10.1182/blood.V91.8.2991.2991_2991_2997; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Preusser M, 2003, ACTA NEUROPATHOL, V106, P506, DOI 10.1007/s00401-003-0758-2; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Reyes NA, 2010, J CLIN INVEST, V120, P3673, DOI 10.1172/JCI42986; Sauvageot CM, 2007, NEUROL CLIN, V25, P891, DOI 10.1016/j.ncl.2007.07.014; Shibata MA, 1999, EMBO J, V18, P2692, DOI 10.1093/emboj/18.10.2692; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yin CY, 1997, NATURE, V385, P637, DOI 10.1038/385637a0; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	42	6	6	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	AUG 29	2013	32	35					4078	4085		10.1038/onc.2012.421	http://dx.doi.org/10.1038/onc.2012.421			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IG	22986529	Green Accepted			2022-12-25	WOS:000323748500003
J	Verbitskiy, D; Zehrmann, A; Hartel, B; Brennicke, A; Takenaka, M				Verbitskiy, Daniil; Zehrmann, Anja; Haertel, Barbara; Brennicke, Axel; Takenaka, Mizuki			Two Related RNA-editing Proteins Target the Same Sites in Mitochondria of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; DYW PROTEIN; PPR PROTEIN; PLANT-MITOCHONDRIA; GENE; DOMAIN; GENOME; IDENTIFICATION; TRANSCRIPT; STABILIZES	The facilitators for specific cytosine-to-uridine RNA-editing events in plant mitochondria and plastids are pentatricopeptide repeat (PPR)-containing proteins with specific additional C-terminal domains. Here we report the related PPR proteins mitochondrial editing factor 8 (MEF8) and MEF8S with only five such repeats each to be both involved in RNA editing at the same two sites in mitochondria of Arabidopsis thaliana. Mutants of MEF8 show diminished editing in leaves but not in pollen, whereas mutants of the related protein MEF8S show reduced RNA editing in pollen but not in leaves. Overexpressed MEF8 or MEF8S both increase editing at the two target sites in a mef8 mutant. Double mutants of MEF8 and MEF8S are not viable although both identified target sites are in mRNAs for nonessential proteins. This suggests that MEF8 and MEF8S may have other essential functions beyond these two editing sites in complex I mRNAs.	[Verbitskiy, Daniil; Zehrmann, Anja; Haertel, Barbara; Brennicke, Axel; Takenaka, Mizuki] Univ Ulm, D-89069 Ulm, Germany	Ulm University	Takenaka, M (corresponding author), Univ Ulm, D-89069 Ulm, Germany.	mizuki.takenaka@uni-ulm.de	Takenaka, Mizuki/B-2636-2013; Takenaka, Mizuki/AAK-9884-2020	Takenaka, Mizuki/0000-0002-3242-5092; Takenaka, Mizuki/0000-0002-3242-5092	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (to M. T. and A. B.).	Beick S, 2008, MOL CELL BIOL, V28, P5337, DOI 10.1128/MCB.00563-08; Bentolila S, 2010, PLANT PHYSIOL, V154, P1966, DOI 10.1104/pp.110.165969; Berg M, 2005, PLANT J, V44, P866, DOI 10.1111/j.1365-313X.2005.02580.x; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Bock R, 1996, EMBO J, V15, P5052, DOI 10.1002/j.1460-2075.1996.tb00885.x; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Doniwa Y, 2010, GENE, V454, P39, DOI 10.1016/j.gene.2010.01.008; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Grewe F, 2011, NUCLEIC ACIDS RES, V39, P2890, DOI 10.1093/nar/gkq1227; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Kagi C, 2010, P NATL ACAD SCI USA, V107, P22350, DOI 10.1073/pnas.1012795108; Khrouchtchova A, 2012, RNA, V18, P1197, DOI 10.1261/rna.032623.112; Kim SR, 2009, PLANT J, V59, P738, DOI 10.1111/j.1365-313X.2009.03909.x; Knoop V, 2010, FEBS LETT, V584, P4287, DOI 10.1016/j.febslet.2010.09.041; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Nakamura T, 2008, FEBS LETT, V582, P4163, DOI 10.1016/j.febslet.2008.11.017; Neuwirt J, 2005, RNA, V11, P1563, DOI 10.1261/rna.2740905; O'Toole N, 2008, MOL BIOL EVOL, V25, P1120, DOI 10.1093/molbev/msn057; Ohtani S, 2010, PLANT CELL PHYSIOL, V51, P1942, DOI 10.1093/pcp/pcq142; Okuda K, 2007, P NATL ACAD SCI USA, V104, P8178, DOI 10.1073/pnas.0700865104; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Okuda K, 2012, NUCLEIC ACIDS RES, V40, P5052, DOI 10.1093/nar/gks164; Okuda K, 2010, PLANT J, V61, P339, DOI 10.1111/j.1365-313X.2009.04059.x; Okuda K, 2009, PLANT CELL, V21, P146, DOI 10.1105/tpc.108.064667; Pfalz J, 2009, EMBO J, V28, P2042, DOI 10.1038/emboj.2009.121; Rivals E, 2006, PLANT PHYSIOL, V141, P825, DOI 10.1104/pp.106.077826; Robbins JC, 2009, RNA, V15, P1142, DOI 10.1261/rna.1533909; Rudinger M, 2008, MOL BIOL EVOL, V25, P1405, DOI 10.1093/molbev/msn084; Rudinger M, 2011, PLANT J, V67, P370, DOI 10.1111/j.1365-313X.2011.04600.x; Salone V, 2007, FEBS LETT, V581, P4132, DOI 10.1016/j.febslet.2007.07.075; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Shikanai T, 2006, CELL MOL LIFE SCI, V63, P698, DOI 10.1007/s00018-005-5449-9; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Takenaka M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn975; Takenaka M, 2008, MITOCHONDRION, V8, P35, DOI 10.1016/j.mito.2007.09.004; Takenaka M, 2007, METHOD ENZYMOL, V424, P439, DOI 10.1016/S0076-6879(07)24020-0; Takenaka M, 2012, NAT PROTOC, V7, P1931, DOI 10.1038/nprot.2012.117; Takenaka M, 2012, P NATL ACAD SCI USA, V109, P5104, DOI 10.1073/pnas.1202452109; Takenaka M, 2011, METHODS MOL BIOL, V718, P163, DOI 10.1007/978-1-61779-018-8_10; Takenaka M, 2011, METHODS MOL BIOL, V718, P151, DOI 10.1007/978-1-61779-018-8_9; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Takenaka M, 2010, PLANT PHYSIOL, V152, P939, DOI 10.1104/pp.109.151175; Tasaki E, 2010, PLANT J, V62, P560, DOI 10.1111/j.1365-313X.2010.04175.x; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; van der Merwe JA, 2006, FEBS LETT, V580, P268, DOI 10.1016/j.febslet.2005.12.011; Verbitskiy D, 2010, PLANT SIGNAL BEHAV, V5, P558, DOI 10.4161/psb.11095; Verbitskiy D, 2011, FEBS LETT, V585, P700, DOI 10.1016/j.febslet.2011.01.037; Verbitskiy D, 2010, PLANT J, V61, P446, DOI 10.1111/j.1365-313X.2009.04076.x; Yu QB, 2009, PLANT J, V59, P1011, DOI 10.1111/j.1365-313X.2009.03930.x; Zehrmann A, 2011, RNA BIOL, V8, P67, DOI 10.4161/rna.8.1.14298; Zehrmann A, 2010, FEBS LETT, V584, P4181, DOI 10.1016/j.febslet.2010.08.049; Zehrmann A, 2009, PLANT CELL, V21, P558, DOI 10.1105/tpc.108.064535; Zhou WB, 2009, PLANT J, V58, P82, DOI 10.1111/j.1365-313X.2008.03766.x	60	31	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.397992	http://dx.doi.org/10.1074/jbc.M112.397992			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977245	hybrid, Green Published			2022-12-25	WOS:000310642200040
J	Xiao, SY; Charonko, JJ; Fu, XP; Salmanzadeh, A; Davalos, RV; Vlachos, PP; Finkielstein, CV; Capelluto, DGS				Xiao, Shuyan; Charonko, John J.; Fu, Xiangping; Salmanzadeh, Alireza; Davalos, Rafael V.; Vlachos, Pavlos P.; Finkielstein, Carla V.; Capelluto, Daniel G. S.			Structure, Sulfatide Binding Properties, and Inhibition of Platelet Aggregation by a Disabled-2 Protein-derived Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARAMAGNETIC RELAXATION ENHANCEMENT; SOLUTION NMR-SPECTROSCOPY; MEMBRANE-LIKE ENVIRONMENT; CRYSTAL-STRUCTURE; CELL-ADHESION; KAPPA-CASEIN; PTB DOMAINS; MYOSIN-VI; FIBRINOGEN; RECEPTOR	Disabled-2 (Dab2) targets membranes and triggers a wide range of biological events, including endocytosis and platelet aggregation. Dab2, through its phosphotyrosine-binding (PTB) domain, inhibits platelet aggregation by competing with fibrinogen for alpha(IIb)beta(3) integrin receptor binding. We have recently shown that the N-terminal region, including the PTB domain (N-PTB), drives Dab2 to the platelet membrane surface by binding to sulfatides through two sulfatide-binding motifs, modulating the extent of platelet aggregation. The three-dimensional structure of a Dab2-derived peptide encompassing the sulfatide-binding motifs has been determined in dodecylphosphocholine micelles using NMR spectroscopy. Dab2 sulfatide-binding motif contains two helices when embedded in micelles, reversibly binds to sulfatides with moderate affinity, lies parallel to the micelle surface, and when added to a platelet mixture, reduces the number and size of sulfatide-induced aggregates. Overall, our findings identify and structurally characterize a minimal region in Dab2 that modulates platelet homotypic interactions, all of which provide the foundation for rational design of a new generation of anti-aggregatory low-molecular mass molecules for therapeutic purposes.	[Xiao, Shuyan; Capelluto, Daniel G. S.] Virginia Tech, Dept Biol Sci, Wake Forest Sch Biomed Engn, Prot Signaling Domains Lab, Blacksburg, VA 24061 USA; [Charonko, John J.; Vlachos, Pavlos P.] Virginia Tech, Adv Expt Thermofluid Engn Res Lab, Wake Forest Sch Biomed Engn, Dept Mech Engn, Blacksburg, VA 24061 USA; [Fu, Xiangping; Finkielstein, Carla V.] Virginia Tech, Integrated Cellular Responses Lab, Wake Forest Sch Biomed Engn, Dept Biol Sci, Blacksburg, VA 24061 USA; [Salmanzadeh, Alireza; Davalos, Rafael V.] Virginia Tech, Bioelectromech Syst Lab, Wake Forest Sch Biomed Engn, Blacksburg, VA 24061 USA; [Salmanzadeh, Alireza; Davalos, Rafael V.] Virginia Tech, Dept Engn Sci & Mech, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Capelluto, DGS (corresponding author), Virginia Tech, Dept Biol Sci, Wake Forest Sch Biomed Engn, Prot Signaling Domains Lab, 1981 Kraft Dr,Rm 2007, Blacksburg, VA 24061 USA.	capellut@vt.edu	Charonko, John/D-6701-2013; Vlachos, Pavlos P/G-3779-2010	Charonko, John/0000-0002-0396-9672; Vlachos, Pavlos P/0000-0002-8040-9257; finkielstein, carla/0000-0002-8417-4643	American Heart Association [11BGIA6160000]	American Heart Association(American Heart Association)	This work was supported by American Heart Association Grant 11BGIA6160000 (to D. G. S. C.).	Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Alajlouni R, 2011, BBA-BIOMEMBRANES, V1808, P2734, DOI 10.1016/j.bbamem.2011.07.029; ANDRIEUX A, 1989, J BIOL CHEM, V264, P9258; ARUFFO A, 1991, CELL, V67, P35, DOI 10.1016/0092-8674(91)90570-O; Basani RB, 2001, J BIOL CHEM, V276, P13975, DOI 10.1074/jbc.M011511200; Beswick V, 1998, EUR BIOPHYS J BIOPHY, V28, P48, DOI 10.1007/s002490050182; Boesze-Battaglia K, 1997, J EXP BIOL, V200, P2927; Cho SY, 2000, BIOCHEM J, V352, P645, DOI 10.1042/0264-6021:3520645; COX D, 1994, MED RES REV, V14, P195, DOI 10.1002/med.2610140203; DEJANA E, 1990, BLOOD, V75, P1509; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiNitto JP, 2006, BBA-MOL CELL BIOL L, V1761, P850, DOI 10.1016/j.bbalip.2006.04.008; Drahos KE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008007; Eckhardt M, 2008, MOL NEUROBIOL, V37, P93, DOI 10.1007/s12035-008-8022-3; FAUVEL J, 1986, BIOCHIM BIOPHYS ACTA, V856, P155, DOI 10.1016/0005-2736(86)90022-2; Gautier A, 2010, NAT STRUCT MOL BIOL, V17, P768, DOI 10.1038/nsmb.1807; Goddar T. D., 2008, SPARKY 3; Hasson T, 2003, J CELL SCI, V116, P3453, DOI 10.1242/jcs.00669; Hocevar BA, 2001, EMBO J, V20, P2789, DOI 10.1093/emboj/20.11.2789; Huang CL, 2006, J CELL SCI, V119, P4420, DOI 10.1242/jcs.03195; Huisman JG, 2000, BIOCHEMISTRY-US, V39, P10866, DOI 10.1021/bi0004504; JOLLES P, 1986, EUR J BIOCHEM, V158, P379, DOI 10.1111/j.1432-1033.1986.tb09764.x; Kim HJ, 2009, PROG NUCL MAG RES SP, V55, P335, DOI 10.1016/j.pnmrs.2009.07.002; LAUTERWEIN J, 1979, BIOCHIM BIOPHYS ACTA, V556, P244, DOI 10.1016/0005-2736(79)90046-4; LEONIL J, 1990, BIOCHEM J, V271, P247, DOI 10.1042/bj2710247; Lerch M, 2005, BIOCHEMISTRY-US, V44, P9255, DOI 10.1021/bi0501232; Liang BY, 2006, J AM CHEM SOC, V128, P4389, DOI 10.1021/ja0574825; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Marrink SJ, 2000, J PHYS CHEM B, V104, P12165, DOI 10.1021/jp001898h; Merten M, 2001, CIRCULATION, V104, P2955, DOI 10.1161/hc4901.100383; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; MOK SC, 1994, GYNECOL ONCOL, V52, P247, DOI 10.1006/gyno.1994.1040; Moody DB, 2005, NAT REV IMMUNOL, V5, P387, DOI 10.1038/nri1605; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Mozsolits H, 2001, BBA-BIOMEMBRANES, V1512, P64, DOI 10.1016/S0005-2736(01)00303-0; Muranyi A, 2000, BIOCHEMISTRY-US, V39, P15742, DOI 10.1021/bi0004450; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; PLOW EF, 1981, J BIOL CHEM, V256, P9477; ROBERTS DD, 1985, J BIOL CHEM, V260, P9405; ROBERTS DD, 1988, ARCH BIOCHEM BIOPHYS, V267, P405, DOI 10.1016/0003-9861(88)90046-X; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SEGREST JP, 1994, ADV PROTEIN CHEM, V45, P303; SHATTIL SJ, 1975, J CLIN INVEST, V55, P636, DOI 10.1172/JCI107971; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sheng ZJ, 2000, ONCOGENE, V19, P4847, DOI 10.1038/sj.onc.1203853; Snook CF, 2006, BBA-MOL CELL BIOL L, V1761, P927, DOI 10.1016/j.bbalip.2006.06.004; Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756; Stolt PC, 2004, BIOCHEMISTRY-US, V43, P10979, DOI 10.1021/bi049092l; Stolt PC, 2003, STRUCTURE, V11, P569, DOI 10.1016/S0969-2126(03)00068-6; Tengel T, 2002, EUR J BIOCHEM, V269, P3659, DOI 10.1046/j.1432-1033.2002.03051.x; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Wang CH, 2006, J BIOL CHEM, V281, P656, DOI 10.1074/jbc.M507880200; Welsh JD, 2011, BRIT J HAEMATOL, V154, P122, DOI 10.1111/j.1365-2141.2011.08705.x; WILLIAMSON P, 1995, BIOCHEMISTRY-US, V34, P10448, DOI 10.1021/bi00033a017; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625	60	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.385609	http://dx.doi.org/10.1074/jbc.M112.385609			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977233	hybrid, Green Published			2022-12-25	WOS:000310642200009
J	Yadav, PK; Xie, P; Banerjee, R				Yadav, Pramod Kumar; Xie, Peter; Banerjee, Ruma			Allosteric Communication between the Pyridoxal 5 '-Phosphate (PLP) and Heme Sites in the H2S Generator Human Cystathionine beta-Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX REGULATION; LIGAND SWITCH; CBS DOMAINS; BINDING; MUTATIONS; PROTEIN; HOMOCYSTINURIA; ENZYME; FLUORESCENCE; SPECTROSCOPY	Human cystathionine beta-synthase (CBS) is a unique pyridoxal 5'-phosphate (PLP)-dependent enzyme that has a regulatory heme cofactor. Previous studies have demonstrated the importance of Arg-266, a residue at the heme pocket end of alpha-helix 8, for communication between the heme and PLP sites. In this study, we have examined the role of the conserved Thr-257 and Thr-260 residues, located at the other end of alpha-helix 8 on the heme electronic environment and on activity. The mutations at the two positions destabilize PLP binding, leading to lower PLP content and similar to 2-to similar to 500-fold lower activity compared with the wild-type enzyme. Activity is unresponsive to PLP supplementation, consistent with the pyridoxine-nonresponsive phenotype of the T257M mutation in a homocystinuric patient. The H2S-producing activities, also impacted by the mutations, show a different pattern of inhibition compared with the canonical transsulfuration reaction. Interestingly, the mutants exhibit contrasting sensitivities to the allosteric effector, S-adenosylmethionine (AdoMet); whereas T257M and T257I are inhibited, the other mutants are hyperactivated by AdoMet. All mutants showed an increased propensity of the ferrous heme to form an inactive species with a 424 nm Soret peak and exhibited significantly reduced enzyme activity in the ferrous and ferrous-CO states. Our results provide the first evidence for bidirectional transmission of information between the cofactor binding sites, suggest the additional involvement of this region in allosteric communication with the regulatory AdoMet-binding domain, and reveal the potential for independent modulation of the canonical transsulfuration versus H2S-generating reactions catalyzed by CBS.	[Yadav, Pramod Kumar; Xie, Peter; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Med Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Med Ctr, 3320B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Yadav, Pramod K./A-6166-2010	Yadav, Pramod K./0000-0003-0026-1684	National Institutes of Health [HL58984]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL58984.	Banerjee R, 2003, BBA-PROTEINS PROTEOM, V1647, P30, DOI 10.1016/S1570-9639(03)00044-X; Cherney MM, 2007, BIOCHEMISTRY-US, V46, P13199, DOI 10.1021/bi701159y; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Evande R, 2004, ARCH BIOCHEM BIOPHYS, V427, P188, DOI 10.1016/j.abb.2004.04.027; FINKELSTEIN JD, 1975, BIOCHEM BIOPH RES CO, V66, P81, DOI 10.1016/S0006-291X(75)80297-X; Green EL, 2001, BIOCHEMISTRY-US, V40, P459, DOI 10.1021/bi0010874; Janosik M, 2001, AM J HUM GENET, V68, P1506, DOI 10.1086/320597; Kabil O, 2011, BIOCHEMISTRY-US, V50, P8261, DOI 10.1021/bi201270q; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kery V, 1999, BIOCHEMISTRY-US, V38, P2716, DOI 10.1021/bi981808n; KERY V, 1994, J BIOL CHEM, V269, P25283; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Kraus JP, 1999, HUM MUTAT, V13, P362; MCCLURE GD, 1994, BIOCHEMISTRY-US, V33, P1674, DOI 10.1021/bi00173a009; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Miles EW, 2004, J BIOL CHEM, V279, P29871, DOI 10.1074/jbc.R400005200; Ojha S, 2002, BIOCHEMISTRY-US, V41, P4649, DOI 10.1021/bi011827o; Ojha S, 2000, BIOCHEMISTRY-US, V39, P10542, DOI 10.1021/bi000831h; Pazicni S, 2005, BIOCHEMISTRY-US, V44, P16785, DOI 10.1021/bi051305z; Pazicni S, 2004, BIOCHEMISTRY-US, V43, P14684, DOI 10.1021/bi0488496; Puranik M, 2004, J BIOL CHEM, V279, P21096, DOI 10.1074/jbc.M400613200; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; SEBASTIO G, 1995, AM J HUM GENET, V56, P1324; Sen S, 2007, BIOCHEMISTRY-US, V46, P4110, DOI 10.1021/bi602617f; Shan XY, 1998, NAT GENET, V19, P91, DOI 10.1038/ng0598-91; Singh S, 2007, NAT PROD REP, V24, P631, DOI 10.1039/b604182p; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2009, J INORG BIOCHEM, V103, P689, DOI 10.1016/j.jinorgbio.2009.01.009; STRAMBINI GB, 1992, BIOCHEMISTRY-US, V31, P7527, DOI 10.1021/bi00148a013; Taoka S, 1999, BIOCHEMISTRY-US, V38, P2738, DOI 10.1021/bi9826052; Taoka S, 1998, J BIOL CHEM, V273, P25179, DOI 10.1074/jbc.273.39.25179; Taoka S, 1999, BIOCHEMISTRY-US, V38, P13155, DOI 10.1021/bi990865t; Taoka S, 2002, BIOCHEMISTRY-US, V41, P10454, DOI 10.1021/bi026052d; Taoka S, 2001, J INORG BIOCHEM, V87, P245, DOI 10.1016/S0162-0134(01)00335-X; Weeks CL, 2009, J AM CHEM SOC, V131, P12809, DOI 10.1021/ja904468w	35	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.414706	http://dx.doi.org/10.1074/jbc.M112.414706			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22977242	Green Published, hybrid			2022-12-25	WOS:000310642200003
J	Baek, KH; Lee, H; Yang, S; Lim, SB; Lee, W; Lee, JE; Lim, JJ; Jun, K; Lee, DR; Chung, Y				Baek, Kwang-Hyun; Lee, Heyjin; Yang, Sunmee; Lim, Soo-Bin; Lee, Wonwoo; Lee, Jeoung Eun; Lim, Jung-Jin; Jun, Kisun; Lee, Dong-Ryul; Chung, Young			Embryonic Demise Caused by Targeted Disruption of a Cysteine Protease Dub-2	PLOS ONE			English	Article							DEUBIQUITINATING ENZYMES; PREIMPLANTATION LETHALITY; PROTEOLYTIC PATHWAY; UBIQUITIN PATHWAY; CANCER-THERAPY; SYSTEM; PROLIFERATION; DEGRADATION; ACTIVATION; APOPTOSIS	Background: A plethora of biological metabolisms are regulated by the mechanisms of ubiquitination, wherein this process is balanced with the action of deubiquitination system. Dub-2 is an IL-2-inducible, immediate-early gene that encodes a deubiquitinating enzyme with growth regulatory activity. DUB-2 presumably removes ubiquitin from ubiquitin-conjugated target proteins regulating ubiquitin-mediated proteolysis, but its specific target proteins are unknown yet. Methodology/Principal Findings: To elucidate the functional role of Dub-2, we generated genetically modified mice by introducing neo cassette into the second exon of Dub-2 and then homologous recombination was done to completely abrogate the activity of DUB-2 proteins. We generated Dub-2+/- heterozygous mice showing a normal phenotype and are fertile, whereas new born mouse of Dub-2-/- homozygous alleles could not survive. In addition, Dub-2-/- embryo could not be seen between E6.5 and E12.5 stages. Furthermore, the number of embryos showing normal embryonic development for further stages is decreased in heterozygotes. Even embryonic stem cells from inner cell mass of Dub-2-/- embryos could not be established. Conclusions: Our study suggests that the targeted disruption of Dub-2 may cause embryonic lethality during early gestation, possibly due to the failure of cell proliferation during hatching process.	[Baek, Kwang-Hyun; Lee, Heyjin; Yang, Sunmee; Lim, Soo-Bin; Lee, Wonwoo; Lee, Jeoung Eun; Lim, Jung-Jin; Jun, Kisun; Lee, Dong-Ryul; Chung, Young] CHA Univ, CHA Gen Hosp, CHA Stem Cell Inst, Dept Biomed Sci, Gyeonggi Do, South Korea	Pochon Cha University	Baek, KH (corresponding author), CHA Univ, CHA Gen Hosp, CHA Stem Cell Inst, Dept Biomed Sci, Gyeonggi Do, South Korea.	baek@cha.ac.kr		Baek, Kwang-Hyun/0000-0001-7662-7190	Basic Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0015312]	Basic Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by Basic Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0015312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Ande SR, 2009, EUR J PHARMACOL, V625, P199, DOI 10.1016/j.ejphar.2009.08.042; Ardley HC, 2004, NEURODEGENER DIS, V1, P71, DOI 10.1159/000080048; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Ayton P, 2001, GENESIS, V30, P201, DOI 10.1002/gene.1066; Baek KH, 2006, CURR PROTEIN PEPT SC, V7, P171, DOI 10.2174/138920306776359740; Baek KH, 2004, J BIOL CHEM, V279, P2368, DOI 10.1074/jbc.M304774200; Balakirev MY, 2003, EMBO REP, V4, P517, DOI 10.1038/sj.embor.embor824; Burrows JF, 2009, J BIOL CHEM, V284, P9587, DOI 10.1074/jbc.M807216200; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Ciechanover A, 2000, J CELL BIOCHEM, P40; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; de la Coste A, 2006, IMMUNOL LETT, V102, P1, DOI 10.1016/j.imlet.2005.06.014; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HANDYSIDE AH, 1984, J EXP ZOOL, V231, P429, DOI 10.1002/jez.1402310317; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Kawaguchi M, 2007, GENE, V392, P77, DOI 10.1016/j.gene.2006.11.012; Kawamura K, 2003, DEV BIOL, V256, P331, DOI 10.1016/S0012-1606(02)00135-5; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kon N, 2010, ONCOGENE, V29, P1270, DOI 10.1038/onc.2009.427; Layfield R, 2001, NEUROPATH APPL NEURO, V27, P171, DOI 10.1046/j.1365-2990.2001.00335.x; Levy R, 2001, INT REV CYTOL, V210, P1; Lindsay LL, 2001, DEV GROWTH DIFFER, V43, P305; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Mbikay M, 2007, DEV BIOL, V306, P584, DOI 10.1016/j.ydbio.2007.03.523; Migone TS, 2001, BLOOD, V98, P1935, DOI 10.1182/blood.V98.6.1935; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ramakrishna S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037772; Ramakrishna S, 2011, J BIOL CHEM, V286, P10505, DOI 10.1074/jbc.M110.162321; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Schwartz AL, 1999, ANNU REV MED, V50, P57; Sharma N, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-61; Sorokin AV, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1411, DOI 10.1134/S000629790913001X; Tripathi R, 2009, J REPROD IMMUNOL, V83, P31, DOI 10.1016/j.jri.2009.05.009; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; Zhu Y, 1996, P NATL ACAD SCI USA, V93, P3275, DOI 10.1073/pnas.93.8.3275; Zhu Y, 1996, MOL CELL BIOL, V16, P4808; Zhu YA, 1997, J BIOL CHEM, V272, P51	41	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44223	10.1371/journal.pone.0044223	http://dx.doi.org/10.1371/journal.pone.0044223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984479	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500039
J	Buckley, RC; Castley, JG; Pegas, FD; Mossaz, AC; Steven, R				Buckley, Ralf C.; Castley, J. Guy; Pegas, Fernanda de Vasconcellos; Mossaz, Alexa C.; Steven, Rochelle			A Population Accounting Approach to Assess Tourism Contributions to Conservation of IUCN-Redlisted Mammal Species	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; GLOBAL BIODIVERSITY; TRADE-OFFS; AREA	Over 1,000 mammal species are red-listed by IUCN, as Critically Endangered, Endangered or Vulnerable. Conservation of many threatened mammal species, even inside protected areas, depends on costly active day-to-day defence against poaching, bushmeat hunting, invasive species and habitat encroachment. Many parks agencies worldwide now rely heavily on tourism for routine operational funding: >50% in some cases. This puts rare mammals at a new risk, from downturns in tourism driven by external socioeconomic factors. Using the survival of individual animals as a metric or currency of successful conservation, we calculate here what proportions of remaining populations of IUCN-redlisted mammal species are currently supported by funds from tourism. This proportion is >= 5% for over half of the species where relevant data exist, >= 15% for one fifth, and up to 66% in a few cases. Many of these species, especially the most endangered, survive only in one single remaining subpopulation. These proportions are not correlated either with global population sizes or recognition as wildlife tourism icons. Most of the more heavily tourism-dependent species, however, are medium sized (>7.5 kg) or larger. Historically, biological concern over the growth of tourism in protected areas has centered on direct disturbance to wildlife. These results show that conservation of threatened mammal species has become reliant on revenue from tourism to a previously unsuspected degree. On the one hand, this provides new opportunities for conservation funding; but on the other, dependence on such an uncertain source of funding is a new, large and growing threat to red-listed species.	[Buckley, Ralf C.; Castley, J. Guy; Pegas, Fernanda de Vasconcellos; Mossaz, Alexa C.; Steven, Rochelle] Griffith Univ, Int Ctr Ecotourism Res, Gold Coast, Qld, Australia	Griffith University	Buckley, RC (corresponding author), Griffith Univ, Int Ctr Ecotourism Res, Gold Coast, Qld, Australia.	r.buckley@griffith.edu.au	Steven, Rochelle/AAD-5898-2020; Castley, James Guy/A-7056-2010; Buckley, Ralf/G-7032-2014	Castley, James Guy/0000-0002-8418-5828; Buckley, Ralf/0000-0003-0442-5818; Steven, Rochelle/0000-0002-3474-6818				Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Barrett MA, 2009, NATURE, V461, P470, DOI 10.1038/461470a; Bourton J, 2009, BBC NEWS; Bovarnick A, 2010, FINANCIAL SUSTAINABI; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; Buckley R, 2010, NATURE, V467, P1047, DOI 10.1038/4671047d; Buckley R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000143; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Clements GR, 2011, FRONT ECOL ENVIRON, V9, P521, DOI 10.1890/100177; Conde DA, 2011, SCIENCE, V331, P1390, DOI 10.1126/science.1200674; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Doak DF, 2010, NATURE, V467, P959, DOI 10.1038/nature09439; Dudley JP, 2002, CONSERV BIOL, V16, P319, DOI 10.1046/j.1523-1739.2002.00306.x; Ferreira S., 2004, GeoJournal, V60, P301, DOI 10.1023/B:GEJO.0000034736.23918.05; Flather CH, 2011, TRENDS ECOL EVOL, V26, P307, DOI 10.1016/j.tree.2011.03.001; Fletcher J, 2008, INT J TOUR RES, V10, P537, DOI 10.1002/jtr.699; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Gordon A, 2011, BIOL CONSERV, V144, P558, DOI 10.1016/j.biocon.2010.10.011; Hayward MW, 2011, BIODIVERS CONSERV, V20, P2563, DOI 10.1007/s10531-011-0091-3; He FL, 2011, NATURE, V473, P368, DOI 10.1038/nature09985; Hodgson JA, 2011, J APPL ECOL, V48, P148, DOI 10.1111/j.1365-2664.2010.01919.x; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; Jenkins RKB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027570; Karanth KU, 2011, SCIENCE, V332, P791, DOI 10.1126/science.332.6031.791-a; Mansourian S., 2008, PUBLIC FUNDS PROTECT; McDonald RI, 2011, BIOL CONSERV, V144, P383, DOI 10.1016/j.biocon.2010.09.016; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Mooney H, 2009, SCIENCE, V325, P1474, DOI 10.1126/science.1180935; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Perrings C, 2011, SCIENCE, V331, P1139, DOI 10.1126/science.1202400; Persha L, 2011, SCIENCE, V331, P1606, DOI 10.1126/science.1199343; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Willis KJ, 2009, SCIENCE, V326, P806, DOI 10.1126/science.1178838	39	60	60	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44134	10.1371/journal.pone.0044134	http://dx.doi.org/10.1371/journal.pone.0044134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984467	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500032
J	DePape, AMR; Hall, GBC; Tillmann, B; Trainor, LJ				DePape, Anne-Marie R.; Hall, Geoffrey B. C.; Tillmann, Barbara; Trainor, Laurel J.			Auditory Processing in High-Functioning Adolescents with Autism Spectrum Disorder	PLOS ONE			English	Article							ABSOLUTE PITCH; SPEECH-PERCEPTION; MUSIC ACQUISITION; EARLY RECOGNITION; ASPERGER-SYNDROME; CHILDREN; INFANTS; LANGUAGE; DISCRIMINATION; INTEGRATION	Autism Spectrum Disorder (ASD) is a pervasive developmental disorder including abnormalities in perceptual processing. We measure perception in a battery of tests across speech (filtering, phoneme categorization, multisensory integration) and music (pitch memory, meter categorization, harmonic priming). We found that compared to controls, the ASD group showed poorer filtering, less audio-visual integration, less specialization for native phonemic and metrical categories, and a higher instance of absolute pitch. No group differences were found in harmonic priming. Our results are discussed in a developmental framework where culture-specific knowledge acquired early compared to late in development is most impaired, perhaps because of early-accelerated brain growth in ASD. These results suggest that early auditory remediation is needed for good communication and social functioning.	[DePape, Anne-Marie R.; Hall, Geoffrey B. C.; Trainor, Laurel J.] McMaster Univ, Hamilton, ON, Canada; [Trainor, Laurel J.] Baycrest Hosp, Rotman Res Inst, Toronto, ON, Canada; [Tillmann, Barbara] Univ Lyon 1, INSERM U1028, CNRS UMR 5292, Lyon Neurosci Res Ctr,Auditory Cognit & Psychoaco, F-69365 Lyon, Rhone Alpes, France	McMaster University; University of Toronto; University Toronto Affiliates; Baycrest; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet	DePape, AMR (corresponding author), McMaster Univ, Hamilton, ON, Canada.	ljt@mcmaster.ca		Trainor, Laurel/0000-0003-3397-2079; /0000-0002-3398-6692	Natural Sciences and Engineering Research Council of Canada; Social Sciences and Humanities Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was supported by a grant from the Natural Sciences and Engineering Research Council of Canada to LJT and a graduate fellowship from the Social Sciences and Humanities Research Council of Canada to ARD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara JI, 2004, J CHILD PSYCHOL PSYC, V45, P1107, DOI 10.1111/j.1469-7610.2004.t01-1-00303.x; Allen R, 2010, MUSIC PERCEPT, V27, P251, DOI 10.1525/MP.2010.27.4.251; Allen R, 2009, AUTISM, V13, P21, DOI 10.1177/1362361307098511; Ashburner J, 2008, AM J OCCUP THER, V62, P564, DOI 10.5014/ajot.62.5.564; BACHEM A, 1955, J ACOUST SOC AM, V27, P1180, DOI 10.1121/1.1908155; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Baker AEZ, 2008, J AUTISM DEV DISORD, V38, P867, DOI 10.1007/s10803-007-0459-0; Baranek GT, 2007, AM J MENT RETARD, V112, P233, DOI 10.1352/0895-8017(2007)112[233:HSPIYC]2.0.CO;2; Baranek GT, 1999, J AUTISM DEV DISORD, V29, P213, DOI 10.1023/A:1023080005650; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; BaronCohen S, 1997, J COGNITIVE NEUROSCI, V9, P548, DOI 10.1162/jocn.1997.9.4.548; Best CT, 2001, J ACOUST SOC AM, V109, P775, DOI 10.1121/1.1332378; Bigand E, 1999, J EXP PSYCHOL HUMAN, V25, P184, DOI 10.1037/0096-1523.25.1.184; Bigand E, 2003, J EXP PSYCHOL HUMAN, V29, P159, DOI 10.1037/0096-1523.29.1.159; Bird G, 2006, NEUROIMAGE, V31, P1614, DOI 10.1016/j.neuroimage.2006.02.037; Boddaert N, 2004, AM J PSYCHIAT, V161, P2117, DOI 10.1176/appi.ajp.161.11.2117; Brenton JN, 2008, PEDIATR NEUROL, V39, P137, DOI 10.1016/j.pediatrneurol.2008.05.004; Brown WA, 2003, J AUTISM DEV DISORD, V33, P163, DOI 10.1023/A:1022987309913; Calvert GA, 2000, CURR BIOL, V10, P649, DOI 10.1016/S0960-9822(00)00513-3; Casanova MF, 2004, EUR ARCH PSY CLIN N, V254, P148, DOI 10.1007/s00406-004-0457-6; Casanova MF, 2002, NEUROLOGY, V58, P428, DOI 10.1212/WNL.58.3.428; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Clayton M., 2000, TIME INDIAN MUSIC; Constantino JN, 2007, J AUTISM DEV DISORD, V37, P1256, DOI 10.1007/s10803-006-0269-9; Cook EH, 2009, AUTISM RES, V2, P178, DOI 10.1002/aur.82; Corrigall KA, 2010, MUSIC PERCEPT, V28, P195, DOI 10.1525/mp.2010.28.2.195; Costa-Giomi E, 2003, ANN NY ACAD SCI, V999, P477, DOI 10.1196/annals.1284.058; Courchesne E, 2005, CURR OPIN NEUROBIOL, V15, P225, DOI 10.1016/j.conb.2005.03.001; Courchesne E, 2004, MENT RETARD DEV D R, V10, P106, DOI 10.1002/mrdd.20020; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Dawson G, 2005, DEV NEUROPSYCHOL, V27, P403, DOI 10.1207/s15326942dn2703_6; Dawson G, 2004, DEV PSYCHOL, V40, P271, DOI 10.1037/0012-1649.40.2.271; Dawson G, 1998, J AUTISM DEV DISORD, V28, P479, DOI 10.1023/A:1026043926488; Dawson G., 1989, AUTISM NATURE DIAGNO, P49; de Gelder B., 1991, EUROPEAN J COGNITIVE, V3, P69, DOI [10.1080/09541449108406220, DOI 10.1080/09541449108406220]; DEMANY L, 1982, INFANT BEHAV DEV, V5, P261, DOI 10.1016/S0163-6383(82)80036-2; Dunn L. M., 1997, BRIT PICTURE VOCABUL, V3rd; Fassbender C., 1993, AUDITORY GROUPING SE; Finnigan E, 2010, AUTISM, V14, P321, DOI 10.1177/1362361309357747; Folland NA, 2012, J ACOUST SOC AM, V131, P993, DOI 10.1121/1.3651254; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Gerry DW, 2010, DEVELOPMENTAL SCI, V13, P545, DOI 10.1111/j.1467-7687.2009.00912.x; Gomes E, 2004, ARQ NEURO-PSIQUIAT, V62, P797, DOI 10.1590/S0004-282X2004000500011; Gopnik A., 1999, SCI CRIB MINDS BRAIN; Griffiths TD, 2007, NEURON, V56, P580, DOI 10.1016/j.neuron.2007.11.004; Groen WB, 2009, J AUTISM DEV DISORD, V39, P742, DOI 10.1007/s10803-008-0682-3; Han LA, 1998, SCAND AUDIOL, V27, P105, DOI 10.1080/010503998420342; Hannon EE, 2005, P NATL ACAD SCI USA, V102, P12639, DOI 10.1073/pnas.0504254102; Hannon EE, 2005, PSYCHOL SCI, V16, P48, DOI 10.1111/j.0956-7976.2005.00779.x; Hannon EE, 2007, TRENDS COGN SCI, V11, P466, DOI 10.1016/j.tics.2007.08.008; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Heaton P, 1999, NEUROCASE, V5, P503, DOI 10.1080/13554799908402745; Heaton P, 2008, COGN NEUROPSYCHOL, V25, P771, DOI 10.1080/02643290802336277; Heaton P, 2007, J AUTISM DEV DISORD, V37, P1355, DOI 10.1007/s10803-006-0283-y; Heaton P, 2009, PHILOS T R SOC B, V364, P1443, DOI 10.1098/rstb.2008.0327; Herbert MR, 2002, ANN NEUROL, V52, P588, DOI 10.1002/ana.10349; Iarocci G, 2006, J AUTISM DEV DISORD, V36, P77, DOI 10.1007/s10803-005-0044-3; Iarocci G, 2010, AUTISM, V14, P305, DOI 10.1177/1362361309353615; Jarvinen-Pasley A, 2007, DEVELOPMENTAL SCI, V10, P786, DOI 10.1111/j.1467-7687.2007.00637.x; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kawabe T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009503; Kern JK, 2006, AUTISM, V10, P480, DOI 10.1177/1362361306066564; Kirschner S, 2010, EVOL HUM BEHAV, V31, P354, DOI 10.1016/j.evolhumbehav.2010.04.004; Kirschner S, 2009, J EXP CHILD PSYCHOL, V102, P299, DOI 10.1016/j.jecp.2008.07.005; Kuhl PK, 2003, P NATL ACAD SCI USA, V100, P9096, DOI 10.1073/pnas.1532872100; Lane AE, 2010, J AUTISM DEV DISORD, V40, P112, DOI 10.1007/s10803-009-0840-2; Lepisto T, 2009, BIOL PSYCHOL, V82, P301, DOI 10.1016/j.biopsycho.2009.09.004; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Loui P, 2011, J COGNITIVE NEUROSCI, V23, P1015, DOI 10.1162/jocn.2010.21500; McAdams S, 1997, J ACOUST SOC AM, V102, P2945, DOI 10.1121/1.420349; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; McIntosh D. N., 1999, SENSORY PROFILE USER, P59; Mottron L, 1999, NEUROCASE, V5, P485, DOI 10.1093/neucas/5.6.485; Neurobehavioral Systems, 2007, PRES 11 0; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Osterling JA, 2002, DEV PSYCHOPATHOL, V14, P239, DOI 10.1017/S0954579402002031; Overy K, 2009, MUSIC PERCEPT, V26, P489, DOI 10.1525/MP.2009.26.5.489; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; Peppe S, 2007, J SPEECH LANG HEAR R, V50, P1015, DOI 10.1044/1092-4388(2007/071); Pfordresher PQ, 2009, MUSIC PERCEPT, V25, P95; Pierce K, 2011, ARCH GEN PSYCHIAT, V68, P101, DOI 10.1001/archgenpsychiatry.2010.113; Plaisted K, 1999, J CHILD PSYCHOL PSYC, V40, P733, DOI 10.1111/1469-7610.00489; Plantinga J, 2008, MUSIC PERCEPT, V26, P121, DOI 10.1525/MP.2008.26.2.121; Poulin-Charronnat B, 2005, COGNITION, V94, pB67, DOI 10.1016/j.cognition.2004.05.003; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; RIMLAND B, 1995, J AUTISM DEV DISORD, V25, P61, DOI 10.1007/BF02178168; Rimland B, 1984, MENTAL RETARDATION D, P55; Rogers SJ, 2003, J AUTISM DEV DISORD, V33, P631, DOI 10.1023/B:JADD.0000006000.38991.a7; Roid G, 2005, LEITER INT PERFORMAN; Rosenblum LD, 1997, PERCEPT PSYCHOPHYS, V59, P347, DOI 10.3758/BF03211902; Rosenhall U, 1999, J AUTISM DEV DISORD, V29, P349, DOI 10.1023/A:1023022709710; Ross DA, 2004, J ACOUST SOC AM, V116, P1793, DOI 10.1121/1.1758973; Russo N, 2009, DEVELOPMENTAL SCI, V12, P557, DOI 10.1111/j.1467-7687.2008.00790.x; Russo N, 2009, J AUTISM DEV DISORD, V39, P1185, DOI 10.1007/s10803-009-0737-0; Rutherford MD, 2005, NEUROCASE, V11, P129, DOI 10.1080/13554790590925529; Schachner A, 2009, CURR BIOL, V19, P831, DOI 10.1016/j.cub.2009.03.061; Schellenberg EG, 2005, DEVELOPMENTAL SCI, V8, P551, DOI 10.1111/j.1467-7687.2005.00447.x; Schoen SA, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.029.2009; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; Shukla DK, 2011, J CHILD PSYCHOL PSYC, V52, P286, DOI 10.1111/j.1469-7610.2010.02342.x; Simpson K, 2010, J DEV PHYS DISABIL, V22, P165, DOI 10.1007/s10882-009-9173-5; Smith EG, 2007, J CHILD PSYCHOL PSYC, V48, P813, DOI 10.1111/j.1469-7610.2007.01766.x; Smith NA, 2011, INFANCY, V16, P655, DOI 10.1111/j.1532-7078.2011.00067.x; Sussman E, 2007, HEARING RES, V225, P117, DOI 10.1016/j.heares.2006.12.013; Teder-Salejarvi WA, 2005, COGNITIVE BRAIN RES, V23, P221, DOI 10.1016/j.cogbrainres.2004.10.021; Tillmann B, 2006, EUR J COGN PSYCHOL, V18, P343, DOI 10.1080/09541440500269548; Tillmann B, 2007, COGNITIVE NEUROPSYCH, V24, P1; Trainor LJ, 2010, SPRINGER HANDB AUDIT, V36, P89, DOI 10.1007/978-1-4419-6114-3_4; TRAINOR LJ, 1992, J EXP PSYCHOL HUMAN, V18, P394, DOI 10.1037/0096-1523.18.2.394; TRAINOR LJ, 1994, PERCEPT PSYCHOPHYS, V56, P125, DOI 10.3758/BF03213891; Trehub SE, 2009, CORTEX, V45, P110, DOI 10.1016/j.cortex.2008.05.012; Trehub SE, 2001, ANN NY ACAD SCI, V930, P1; TREHUB SE, 1984, CHILD DEV, V55, P821, DOI 10.2307/1130133; Tucker-Davis Technologies, 2007, PROGR ATT; Wan CY, 2010, FUTUR NEUROL, V5, P797, DOI 10.2217/FNL.10.55; Wan CY, 2010, BRAIN RES BULL, V82, P161, DOI 10.1016/j.brainresbull.2010.04.010; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wechsler D, 1997, DIGIT SPAN SUBTEST W; WERKER JF, 1988, DEV PSYCHOL, V24, P672, DOI 10.1037/0012-1649.24.5.672; Werker JF, 2005, DEV PSYCHOBIOL, V46, P233, DOI 10.1002/dev.20060; Werner E, 2000, J AUTISM DEV DISORD, V30, P157, DOI 10.1023/A:1005463707029; Willeford J., 1977, CENTRAL AUDITORY DYS, P43; Williams JHG, 2004, RES DEV DISABIL, V25, P559, DOI 10.1016/j.ridd.2004.01.008; Winkler I, 2003, P NATL ACAD SCI USA, V100, P11812, DOI 10.1073/pnas.2031891100; YOUNG RL, 1995, J AUTISM DEV DISORD, V25, P231, DOI 10.1007/BF02179286; Zwaigenbaum L, 2009, PEDIATRICS, V123, P1383, DOI 10.1542/peds.2008-1606	130	61	62	1	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44084	10.1371/journal.pone.0044084	http://dx.doi.org/10.1371/journal.pone.0044084			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984462	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500029
J	Forbes, EK; de Cassan, SC; Llewellyn, D; Biswas, S; Goodman, AL; Cottingham, MG; Long, CA; Pleass, RJ; Hill, AVS; Hill, F; Draper, SJ				Forbes, Emily K.; de Cassan, Simone C.; Llewellyn, David; Biswas, Sumi; Goodman, Anna L.; Cottingham, Matthew G.; Long, Carole A.; Pleass, Richard J.; Hill, Adrian V. S.; Hill, Fergal; Draper, Simon J.			T Cell Responses Induced by Adenoviral Vectored Vaccines Can Be Adjuvanted by Fusion of Antigen to the Oligomerization Domain of C4b-Binding Protein	PLOS ONE			English	Article							PRIME-BOOST IMMUNIZATION; AMYLOID-P COMPONENT; IN-VITRO; MEDIATED PROTECTION; PLASMODIUM-BERGHEI; FC-RECEPTORS; MALARIA; IMMUNOGENICITY; ANTIBODY; C4BP	Viral vectored vaccines have been shown to induce both T cell and antibody responses in animals and humans. However, the induction of even higher level T cell responses may be crucial in achieving vaccine efficacy against difficult disease targets, especially in humans. Here we investigate the oligomerization domain of the alpha-chain of C4b-binding protein (C4 bp) as a candidate T cell "molecular adjuvant" when fused to malaria antigens expressed by human adenovirus serotype 5 (AdHu5) vectored vaccines in BALB/c mice. We demonstrate that i) C-terminal fusion of an oligomerization domain can enhance the quantity of antigen-specific CD4(+) and CD8(+) T cell responses induced in mice after only a single immunization of recombinant AdHu5, and that the T cells maintain similar functional cytokine profiles; ii) an adjuvant effect is observed for AdHu5 vectors expressing either the 42 kDa C-terminal domain of Plasmodium yoelii merozoite surface protein 1 (PyMSP1(42)) or the 83 kDa ectodomain of P. falciparum strain 3D7 apical membrane antigen 1 (PfAMA1), but not a candidate 128kDa P. falciparum MSP1 biallelic fusion antigen; iii) following two homologous immunizations of AdHu5 vaccines, antigen-specific T cell responses are further enhanced, however, in both BALB/c mice and New Zealand White rabbits no enhancement of functional antibody responses is observed; and iv) that the T cell adjuvant activity of C4 bp is not dependent on a functional Fc-receptor gamma-chain in the host, but is associated with the oligomerization of small (<80 kDa) antigens expressed by recombinant AdHu5. The oligomerization domain of C4 bp can thus adjuvant T cell responses induced by AdHu5 vectors against selected antigens and its clinical utility as well as mechanism of action warrant further investigation.	[Forbes, Emily K.; de Cassan, Simone C.; Llewellyn, David; Biswas, Sumi; Goodman, Anna L.; Cottingham, Matthew G.; Hill, Adrian V. S.; Draper, Simon J.] Univ Oxford, Jenner Inst, Oxford, England; [Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Pleass, Richard J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Hill, Fergal] Imaxio SA, Lyon, France	University of Oxford; Jenner Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Liverpool School of Tropical Medicine; University of Liverpool	Forbes, EK (corresponding author), Univ Oxford, Jenner Inst, Oxford, England.	ekforbes@hotmail.com	Draper, Simon J/F-1758-2011; Hill, Fergal/AAI-1329-2021; Pleass, Richard/N-7831-2019; Pleass, Richard J/L-4148-2015	Draper, Simon J/0000-0002-9415-1357; Pleass, Richard/0000-0001-7438-8296; Pleass, Richard J/0000-0001-7438-8296; Cottingham, Matthew/0000-0003-0766-6465; Goodman, Anna/0000-0003-0643-9017	Wellcome Trust; EMVDA (European Malaria Vaccine Development Association, a European Commission); European Community [242095]; Division of Intramural Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health; PATH Malaria Vaccine Initiative; MRC [G0700735, G0300145, G1000527, G0600424] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001020] Funding Source: NIH RePORTER; Medical Research Council [G0300145, G1000527, G0700735, G0600424] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10233] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); EMVDA (European Malaria Vaccine Development Association, a European Commission); European Community(European Commission); Division of Intramural Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PATH Malaria Vaccine Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by the Wellcome Trust and the EMVDA (European Malaria Vaccine Development Association, a European Commission FP6-funded consortium). The research leading to these results has also received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No 242095. In addition, this work was supported in part by the Division of Intramural Research, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, and also by the PATH Malaria Vaccine Initiative who support the GIA Reference Center. AVSH and SJD are Jenner Investigators. AVSH is a Wellcome Trust Principal Research Fellow. SJD is a MRC Career Development Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except that the design of the rabbit study and the GIA analysis was performed following discussion with PATH MVI.	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Barnes E, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003155; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Biswas S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020977; Blom AM, 2004, MOL IMMUNOL, V40, P1333, DOI 10.1016/j.molimm.2003.12.002; Brodeur SR, 2003, IMMUNITY, V18, P837, DOI 10.1016/S1074-7613(03)00149-3; Capone S, 2010, VACCINE, V29, P256, DOI 10.1016/j.vaccine.2010.10.041; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; Christiansen D, 2000, J VIROL, V74, P4672, DOI 10.1128/JVI.74.10.4672-4678.2000; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Cassan SC, 2011, J IMMUNOL, V187, P2602, DOI 10.4049/jimmunol.1101004; Dicks MDJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040385; Douglas AD, 2010, VACCINE, V28, P7167, DOI 10.1016/j.vaccine.2010.08.068; Draper SJ, 2008, NAT MED, V14, P819, DOI 10.1038/nm.1850; Draper SJ, 2010, J IMMUNOL, V185, P7583, DOI 10.4049/jimmunol.1001760; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Dutta S, 2003, P NATL ACAD SCI USA, V100, P12295, DOI 10.1073/pnas.2032858100; Forbes EK, 2011, J IMMUNOL, V187, P3738, DOI 10.4049/jimmunol.1003783; Goodman AL, 2010, INFECT IMMUN, V78, P4601, DOI 10.1128/IAI.00315-10; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Kask L, 2002, BIOCHEMISTRY-US, V41, P9349, DOI 10.1021/bi025980+; Libyh MT, 1997, BLOOD, V90, P3978, DOI 10.1182/blood.V90.10.3978; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Lu JH, 2008, NATURE, V456, P989, DOI 10.1038/nature07468; Miura K, 2009, CLIN VACCINE IMMUNOL, V16, P963, DOI 10.1128/CVI.00042-09; Moore AC, 2005, J IMMUNOL, V175, P7264, DOI 10.4049/jimmunol.175.11.7264; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Ogun SA, 2008, INFECT IMMUN, V76, P3817, DOI 10.1128/IAI.01369-07; Ophorst OJAE, 2007, VACCINE, V25, P6501, DOI 10.1016/j.vaccine.2007.06.019; Oudin S, 2000, J IMMUNOL, V164, P1505, DOI 10.4049/jimmunol.164.3.1505; Pleass RJ, 2009, PARASITE IMMUNOL, V31, P529, DOI 10.1111/j.1365-3024.2009.01101.x; Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09; Roederer M, 2011, CYTOMETRY A; Rotman HL, 1998, J IMMUNOL, V161, P1908; SCHWALBE RA, 1990, J BIOL CHEM, V265, P21749; Sheehy SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031208; Sheehy SH, 2011, MOL THER, V19, P2269, DOI 10.1038/mt.2011.176; Sjoberg AP, 2006, J IMMUNOL, V176, P7612, DOI 10.4049/jimmunol.176.12.7612; Sorensen IJ, 1996, SCAND J IMMUNOL, V44, P401, DOI 10.1046/j.1365-3083.1996.d01-326.x; Spencer AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033555; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; Wille-Reece U, 2006, J EXP MED, V203, P1249, DOI 10.1084/jem.20052433; Yewdell JW, 1999, ADV IMMUNOL, V73, P1, DOI 10.1016/S0065-2776(08)60785-3; Yoneto T, 2001, J IMMUNOL, V166, P6236, DOI 10.4049/jimmunol.166.10.6236	45	22	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44943	10.1371/journal.pone.0044943	http://dx.doi.org/10.1371/journal.pone.0044943			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984589	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000308738500096
J	Souquiere, S; Makuwa, M; Salle, B; Kazanji, M				Souquiere, Sandrine; Makuwa, Maria; Salle, Bettina; Kazanji, Mirdad			New Strain of Simian Immunodeficiency Virus Identified in Wild-Born Chimpanzees from Central Africa	PLOS ONE			English	Article							PAN-TROGLODYTES-TROGLODYTES; HIV-1 NEF; INFECTED CHIMPANZEES; CAPTURED CHIMPANZEE; TYPE-1 INFECTION; SOOTY MANGABEYS; DOWN-REGULATION; GENE FLOW; LENTIVIRUS; SIVCPZ	Studies of primate lentiviruses continue to provide information about the evolution of simian immunodeficiency viruses (SIVs) and the origin and emergence of HIV since chimpanzees in west-central Africa (Pan troglodytes troglodytes) were recognized as the reservoir of SIVcpzPtt viruses, which have been related phylogenetically to HIV-1. Using in-house peptide ELISAs to study SIV prevalence, we tested 104 wild-born captive chimpanzees from Gabon and Congo. We identified two new cases of SIVcpz infection in Gabon and characterized a new SIVcpz strain, SIVcpzPtt-Gab4. The complete sequence (9093 bp) was obtained by a PCR-based 'genome walking' approach to generate 17 overlapping fragments. Phylogenetic analyses of separated genes (gag, pol-vif and env-nef) showed that SIVcpzPtt-Gab4 is closely related to SIVcpzPtt-Gab1 and SIVcpzPtt-Gab2. No significant variation in viral load was observed during 3 years of follow-up, but a significantly lower CD4+ T cells count was found in infected than in uninfected chimpanzees (p < 0.05). No clinical symptoms of SIV infection were observed in the SIV-positive chimpanzees. Further field studies with non-invasive methods are needed to determine the prevalence, geographic distribution, species association, and natural history of SIVcpz strains in the chimpanzee habitat in Gabon.	[Souquiere, Sandrine; Makuwa, Maria; Kazanji, Mirdad] Ctr Int Rech Med Franceville, Unite Retrovirol, Franceville, Gabon; [Salle, Bettina] Ctr Int Rech Med Franceville, Ctr Primatol, Franceville, Gabon; [Kazanji, Mirdad] Reseau Int Inst Pasteur, Inst Pasteur Bangui, Bangui, Cent Afr Republ		Souquiere, S (corresponding author), Ctr Int Rech Med Franceville, Unite Retrovirol, BP 769, Franceville, Gabon.	mirdad.kazanji@pasteur.fr			Gabonese Government; Total-Gabon; French Foreign Ministry	Gabonese Government; Total-Gabon; French Foreign Ministry	The CIRMF is funded by the Gabonese Government, Total-Gabon and the French Foreign Ministry. The funders had no role in study design, data collection or analysis, the decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Apetrei C, 2004, FRONT BIOSCI-LANDMRK, V9, P225, DOI 10.2741/1154; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Bibollet-Ruche F, 2004, AIDS RES HUM RETROV, V20, P1377, DOI 10.1089/aid.2004.20.1377; Bibollet-Ruche F, 2012, J CLIN INVEST, V122, P1644, DOI 10.1172/JCI61429; Chahroudi A, 2011, J VIROL, V85, P5757, DOI 10.1128/JVI.02690-10; Chan ML, 2010, P ROY SOC B-BIOL SCI, V277, P3773, DOI 10.1098/rspb.2010.0972; Corbet S, 2000, J VIROL, V74, P529, DOI 10.1128/JVI.74.1.529-534.2000; Courgnaud V, 2001, J VIROL, V75, P857, DOI 10.1128/JVI.75.2.857-866.2001; Dimmic MW, 2002, J MOL EVOL, V55, P65, DOI 10.1007/s00239-001-2304-y; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000856; Etienne L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-4; FRANSEN K, 1994, MOL CELL PROBE, V8, P317, DOI 10.1006/mcpr.1994.1043; Gagneux P, 2001, PHILOS T R SOC B, V356, P889, DOI 10.1098/rstb.2001.0865; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Goldstein S, 2000, J VIROL, V74, P11744, DOI 10.1128/JVI.74.24.11744-11753.2000; Greenberg M, 1998, CURR BIOL, V8, P1239, DOI 10.1016/S0960-9822(07)00518-0; Hahn BH, 2000, SCIENCE, V287, P607, DOI 10.1126/science.287.5453.607; Heeney JL, 2006, J VIROL, V80, P7208, DOI 10.1128/JVI.00382-06; HUET T, 1990, NATURE, V345, P356, DOI 10.1038/345356a0; JANSSENS W, 1994, AIDS RES HUM RETROV, V10, P1191, DOI 10.1089/aid.1994.10.1191; Jeang K T, 1994, Curr Top Microbiol Immunol, V188, P123; Jia B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000429; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KEELE BF, 2006, SCIENCE; Keele BF, 2009, NATURE, V460, P515, DOI 10.1038/nature08200; Kirchhoff F, 2004, J VIROL, V78, P6864, DOI 10.1128/JVI.78.13.6864-6874.2004; Klatt NR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007153; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Liu WM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000097; MORIN PA, 1994, SCIENCE, V265, P1193, DOI 10.1126/science.7915048; Mouinga-Ondeme A, 2012, J VIROL, V86, P1255, DOI 10.1128/JVI.06016-11; Muller-Trutwin MC, 2000, J MED PRIMATOL, V29, P166, DOI 10.1034/j.1600-0684.2000.290310.x; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Neel C, 2010, J VIROL, V84, P1464, DOI 10.1128/JVI.02129-09; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nerrienet E, 2005, J VIROL, V79, P1312, DOI 10.1128/JVI.79.2.1312-1319.2005; Oates JF, 2009, PRIMATES, V50, P78, DOI 10.1007/s10329-008-0116-z; Ondoa P, 2001, J MED PRIMATOL, V30, P243, DOI 10.1034/j.1600-0684.2001.d01-56.x; PEETERS M, 1989, AIDS, V3, P625, DOI 10.1097/00002030-198910000-00001; PEETERS M, 1992, AIDS, V6, P447, DOI 10.1097/00002030-199205000-00002; Plantier JC, 2009, NAT MED, V15, P871, DOI 10.1038/nm.2016; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Rudicell RS, 2011, J VIROL, V85, P9918, DOI 10.1128/JVI.05475-11; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Salemi M, 2003, J VIROL, V77, P7202, DOI 10.1128/JVI.77.13.7202-7213.2003; Santiago ML, 2003, J VIROL, V77, P7545, DOI 10.1128/JVI.77.13.7545-7562.2003; Sauter D, 2009, CELL HOST MICROBE, V6, P409, DOI 10.1016/j.chom.2009.10.004; Schmokel J, 2011, J VIROL, V85, P742, DOI 10.1128/JVI.02087-10; Sharp PM, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006841; Sharp PM, 2005, J VIROL, V79, P3891, DOI 10.1128/JVI.79.7.3891-3902.2005; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon F, 2001, AIDS RES HUM RETROV, V17, P937, DOI 10.1089/088922201750290050; Simon F, 1998, NAT MED, V4, P1032, DOI 10.1038/2017; Souquiere S, 2001, J VIROL, V75, P7086, DOI 10.1128/JVI.75.15.7086-7096.2001; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Taaffe J, 2010, J VIROL, V84, P5476, DOI 10.1128/JVI.00039-10; Takehisa J, 2009, J VIROL, V83, P1635, DOI 10.1128/JVI.02311-08; Terio KA, 2011, J ZOO WILDLIFE MED, V42, P597, DOI 10.1638/2010-0237.1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van Heuverswyn F, 2007, VIROLOGY, V368, P155, DOI 10.1016/j.virol.2007.06.018; Van Heuverswyn F, 2006, NATURE, V444, P164, DOI 10.1038/444164a; VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06; Wain LV, 2007, MOL BIOL EVOL, V24, P1853, DOI 10.1093/molbev/msm110; Yang CF, 1999, J CLIN MICROBIOL, V37, P2581, DOI 10.1128/JCM.37.8.2581-2586.1999; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	67	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44298	10.1371/journal.pone.0044298	http://dx.doi.org/10.1371/journal.pone.0044298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984489	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500045
J	Sulzner, K; Johnson, CK; Bonde, RK; Gomez, NA; Powell, J; Nielsen, K; Luttrell, MP; Osterhaus, ADME; Aguirre, AA				Sulzner, Kathryn; Johnson, Christine Kreuder; Bonde, Robert K.; Gomez, Nicole Auil; Powell, James; Nielsen, Klaus; Luttrell, M. Page; Osterhaus, A. D. M. E.; Aguirre, A. Alonso			Health Assessment and Seroepidemiologic Survey of Potential Pathogens in Wild Antillean Manatees (Trichechus manatus manatus)	PLOS ONE			English	Article							TOXOPLASMA-GONDII INFECTION; DUGONGS DUGONG-DUGON; FLORIDA MANATEE; MARINE MAMMALS; SERUM CHEMISTRY; CALIFORNIA; LEPTOSPIROSIS; ANTIBODIES; LATIROSTRIS; DISEASE	The Antillean manatee (Trichechus manatus manatus), a subspecies of the West Indian manatee, inhabits fresh, brackish, and warm coastal waters distributed along the eastern border of Central America, the northern coast of South America, and throughout the Wider Caribbean Region. Threatened primarily by human encroachment, poaching, and habitat degradation, Antillean manatees are listed as endangered by the International Union for the Conservation of Nature. The impact of disease on population viability remains unknown in spite of concerns surrounding the species' ability to rebound from a population crash should an epizootic occur. To gain insight on the baseline health of this subspecies, a total of 191 blood samples were collected opportunistically from wild Antillean manatees in Belize between 1997 and 2009. Hematologic and biochemical reference intervals were established, and antibody prevalence to eight pathogens with zoonotic potential was determined. Age was found to be a significant factor of variation in mean blood values, whereas sex, capture site, and season contributed less to overall differences in parameter values. Negative antibody titers were reported for all pathogens surveyed except for Leptospira bratislava, L. canicola, and L. icterohemorrhagiae, Toxoplasma gondii, and morbillivirus. As part of comprehensive health assessment in manatees from Belize, this study will serve as a benchmark aiding in early disease detection and in the discernment of important epidemiologic patterns in the manatees of this region. Additionally, it will provide some of the initial tools to explore the broader application of manatees as sentinel species of nearshore ecosystem health.	[Sulzner, Kathryn; Johnson, Christine Kreuder] Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA; [Bonde, Robert K.] US Geol Survey, Sirenia Project, Gainesville, FL USA; [Gomez, Nicole Auil; Powell, James] Sea Shore Alliance, St Petersburg, FL USA; [Nielsen, Klaus] Canadian Food Inspect Agcy, Nepean, ON, Canada; [Luttrell, M. Page] Univ Georgia, Coll Vet Med, SE Cooperat Wildlife Dis Study, Dept Populat Hlth, Athens, GA USA; [Osterhaus, A. D. M. E.] Erasmus MC, Rotterdam, Netherlands; [Aguirre, A. Alonso] Smithsonian Mason Sch Conservat, Front Royal, VA USA; [Aguirre, A. Alonso] George Mason Univ, Dept Environm Sci & Policy, Fairfax, VA 22030 USA	University of California System; University of California Davis; United States Department of the Interior; United States Geological Survey; Canadian Food Inspection Agency; University System of Georgia; University of Georgia; Erasmus University Rotterdam; Erasmus MC; Smithsonian Institution; George Mason University	Sulzner, K (corresponding author), Univ Calif Davis, Wildlife Hlth Ctr, Sch Vet Med, Davis, CA 95616 USA.	aaguirr3@gmu.edu		Bonde, Robert/0000-0001-9179-4376	University of California, Davis, CA; Wildlife Health Center's Wildlife Fellowship Fund; Preventive Veterinary Department, University of California, Davis, CA	University of California, Davis, CA(University of California System); Wildlife Health Center's Wildlife Fellowship Fund; Preventive Veterinary Department, University of California, Davis, CA	Financial support for many of the serological assays performed in this study was provided in part by the University of California, Davis, CA, Wildlife Health Center's Wildlife Fellowship Fund and by a grant from the Preventive Veterinary Department, University of California, Davis, CA. Additional laboratory tests and services were offered in-kind by Dr. Pat Conrad, Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine, University of California, Davis, CA; Dr. William Reisen, Center for Vectorborne Disease Research, University of California, Davis, CA; Dr. Dave Stallknecht and Page Luttrell, Department of Population Health, College of Veterinary Medicine, University of Georgia, Athens, GA; Dr. Klaus Nielsen, Canadian Food Inspection Agency, Nepean, Ontario, Canada; and Dr. A. D. M. E Osterhaus, Department of Virology, Erasmus Medical Centre, Rotterdam, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AA, 2008, MECH AGEING DEV, V129, P656, DOI 10.1016/j.mad.2008.09.004; Aguirre AA, 2002, CONSERVATION MEDICINE, P79; Aguirre AA, 2003, VERH BER ERKRG ZOOTI, V41, P1; Alves-Stanley CD, 2010, MAR ECOL PROG SER, V402, P255, DOI 10.3354/meps08450; Arnold J, 1999, 13 BIENN C BIOL MAR, P66; Auil N, 1998, BELIZE MANATEE RECOV, P1; Auil NE, 2004, THESIS TEXAS A M U C; Bacchus Marie-Lys C., 2009, Aquatic Mammals, V35, P62, DOI 10.1578/AM.35.1.2009.62; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bonde R.K., 2004, ECOHEALTH, V1, P255, DOI [10.1007/s10393-004-0095-5.2, DOI 10.1007/S10393-004-0095-5.2]; Bonde RK, 2001, 14 BIENN C BIOL MAR, P29; Bossart G.D., 2007, MICROBE, V2, P544, DOI 10.1128/microbe.2.544.1; Bossart GD, 2001, CRC HANDBOOK OF MARINE MAMMAL MEDICINE, SECOND EDITION, P383, DOI 10.1201/9781420041637.sec4; Bossart GD, 1999, J AM VET MED ASSOC, V214, P1178; Bossart GD, 2002, EXP MOL PATHOL, V72, P37, DOI 10.1006/exmp.2001.2407; Bossart GD, 1998, TOXICOL PATHOL, V26, P276, DOI 10.1177/019262339802600214; Bradley JE, 2006, IMMUNOLOGY, P277; BUERGELT CD, 1983, J AM VET MED ASSOC, V183, P1294; Cameron CE, 2008, J CLIN MICROBIOL, V46, P1728, DOI 10.1128/JCM.02022-07; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Colegrove KM, 2005, J WILDLIFE DIS, V41, P426, DOI 10.7589/0090-3558-41.2.426; Conrad PA, 2005, INT J PARASITOL, V35, P1155, DOI 10.1016/j.ijpara.2005.07.002; CONVERSE LJ, 1994, J ZOO WILDLIFE MED, V25, P423; Dabritz HA, 2008, J PARASITOL, V94, P675, DOI 10.1645/GE-1342.1; Deutsch CJ, 2008, IUCN 2010; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; DIXON WJ, 1953, BIOMETRICS, V9, P74, DOI 10.2307/3001634; Dona MG, 2011, J WILDLIFE DIS, V47, P673, DOI 10.7589/0090-3558-47.3.673; Dubey JP, 2008, VET PARASITOL, V153, P147, DOI 10.1016/j.vetpar.2008.01.030; Dubey JP, 2004, VET PARASITOL, V126, P57, DOI 10.1016/j.vetpar.2004.09.005; Dubey JP, 2003, VET PARASITOL, V116, P275, DOI 10.1016/S0304-4017(03)00263-2; Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X; DUIGNAN PJ, 1995, MAR MAMMAL SCI, V11, P441, DOI 10.1111/j.1748-7692.1995.tb00668.x; Godinez CR, 1999, J WILDLIFE DIS, V35, P108, DOI 10.7589/0090-3558-35.1.108; Gomez Nicole Auil, 2011, University of British Columbia Fisheries Centre Research Reports, V19, P19; Gulland FMD, 1996, J WILDLIFE DIS, V32, P572, DOI 10.7589/0090-3558-32.4.572; Halvorsen Katherine M., 2008, Aquatic Mammals, V34, P412, DOI 10.1578/AM.34.4.2008.412; Harr K, 2006, J ZOO WILDLIFE MED, V37, P151, DOI 10.1638/05-023.1; Harr KE, 2008, J ZOO WILDLIFE MED, V39, P180, DOI 10.1638/2007-0134R.1; Harr KE, 2011, J WILDLIFE DIS, V47, P1026, DOI 10.7589/0090-3558-47.4.1026; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvey JW, 2007, J ZOO WILDLIFE MED, V38, P269, DOI 10.1638/1042-7260(2007)038[0269:CBIHMT]2.0.CO;2; Harvey JW, 2009, VET CLIN PATH, V38, P183, DOI 10.1111/j.1939-165X.2009.00113.x; Hunter ME, 2010, ANIM CONSERV, V13, P592, DOI 10.1111/j.1469-1795.2010.00383.x; INSKEEP W, 1990, J WILDLIFE DIS, V26, P377, DOI 10.7589/0090-3558-26.3.377; JAIN N.C., 1993, ESSENTIALS VET HEMAT, P19; JARQUE CM, 1987, INT STAT REV, V55, P163, DOI 10.2307/1403192; Johnson CK, 2009, P NATL ACAD SCI USA, V106, P2242, DOI 10.1073/pnas.0806449106; Keller M, 2005, THESIS U FLORIDA GAI; KJERFVE B, 1989, MAR GEOL, V88, P187, DOI 10.1016/0025-3227(89)90097-2; Lanyon JM, 2010, AQUAT MAMM, V36, P46, DOI 10.1578/AM.36.1.2010.46; Lanyon Janet M., 2009, Aquatic Mammals, V35, P187, DOI 10.1578/AM.35.2.2009.187; Lassen ED, 2006, VET HEMATOLOGY CLIN, P355; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Lloyd-Smith JO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-125; Lounsbury VJ, 2005, MARINE MAMMALS ASHOR, P129; Marmontel M, 1997, CONSERV BIOL, V11, P467, DOI 10.1046/j.1523-1739.1997.96019.x; Mathews PD, 2012, J ZOO WILDLIFE MED, V43, P85, DOI 10.1638/2011-0178.1; Mayo Clinic Staff, 2009, FDN MED ED RES 1998; MEDWAY W, 1982, J WILDLIFE DIS, V18, P229, DOI 10.7589/0090-3558-18.2.229; MIGAKI G, 1990, VET PATHOL, V27, P463, DOI 10.1177/030098589902700615; MIGAKI G, 1977, AM J VET RES, V38, P135; Mignucci-Giannoni AA, 2002, ENVIRON MANAGE, V25; Mikaelian I, 2000, J COMP PATHOL, V122, P73, DOI 10.1053/jcpa.1999.0341; Miller MA, 2002, J PARASITOL, V88, P594, DOI 10.1645/0022-3395(2002)088[0594:EOAIFA]2.0.CO;2; Moore SE, 2008, J MAMMAL, V89, P534, DOI 10.1644/07-MAMM-S-312R1.1; Nielsen O, 2001, J WILDLIFE DIS, V37, P89, DOI 10.7589/0090-3558-37.1.89; Ortiz RM, 1999, J EXP BIOL, V202, P33; Osterhaus A, 1997, NATURE, V388, P838, DOI 10.1038/42163; OSTERHAUS ADME, 1990, VET MICROBIOL, V23, P343, DOI 10.1016/0378-1135(90)90165-R; Reep R.L., 2006, FLORIDA MANATEE BIOL; Reynolds JE, 1991, MANATEES DUGONGS, p[29, 51]; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rodas-Trejo J, 2008, TROP CONSERV SCI, V1, P321, DOI 10.1177/194008290800100403; Self-Sullivan C, 2008, THESIS TEXAS A M U C; SHAPIRO SS, 1968, J AM STAT ASSOC, V63, P1343, DOI 10.2307/2285889; Silva FMO, 2007, J VET MED A, V54, P119, DOI 10.1111/j.1439-0442.2007.00891.x; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Sukthana Yaowalark, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P314; Taylor J. A., 2000, SCHALMS VET HEMATOLO, P391; Uranga RM, 2010, CURR GERONTOL GERIAT, V2010, P1; Van Dolah FM, 2000, ENVIRON HEALTH PERSP, V108, P133, DOI 10.1289/ehp.00108s1133; Vidya TNC, 2002, J BIOSCIENCES, V27, P521, DOI 10.1007/BF02705050; VISSER IKG, 1993, VET RES, V24, P169; Walsh Michael T., 1999, P507; Wilson M. L., 2001, Ecosystem change and public health: a global perspective, P283; Wong AW, 2012, AQUAT MAMM, V38, P1, DOI 10.1578/AM.38.1.2012.1; Woodruff RA, 2005, J WILDLIFE DIS, V41, P437, DOI 10.7589/0090-3558-41.2.437	88	22	22	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44517	10.1371/journal.pone.0044517	http://dx.doi.org/10.1371/journal.pone.0044517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984521	Green Published, gold			2022-12-25	WOS:000308738500062
J	Zhao, J; Chen, J				Zhao, Jin; Chen, Jin			Interspecific Variation in Compensatory Regrowth to Herbivory Associated with Soil Nutrients in Three Ficus (Moraceae) Saplings	PLOS ONE			English	Article							MANDUCA-SEXTA LEPIDOPTERA; HOST NICOTIANA-ATTENUATA; PLANT MESSENGER-RNAS; MOLECULAR-INTERACTIONS; ARTHROPOD HERBIVORY; BIOMASS ALLOCATION; RESOURCE AVAILABILITY; EUCALYPTUS-GLOBULUS; SUCCESSIONAL STATUS; TROPICAL FOREST	Plant compensatory regrowth is an induced process that enhances plant tolerance to herbivory. Plant behavior against herbivores differs between species and depends on resource availability, thus making general predictions related to plant compensatory regrowth difficult. To understand how soil nutrients determine the degree of compensatory regrowth for different plant species, we selected saplings of three Ficus species and treated with herbivore insects and artificial injury in both glasshouse conditions and in the field at two soil nutrient levels. Compensatory regrowth was calculated by biomass, relative growth rate and photosynthetic characteristics. A similar pattern was found in both the glasshouse and in the field for species F. hispida, where overcompensatory regrowth was triggered only under fertile conditions, and full compensatory regrowth occurred under infertile conditions. For F. auriculata, overcompensatory regrowth was stimulated only under infertile conditions and full compensatory regrowth occurred under fertile conditions. Ficus racemosa displayed full compensatory regrowth in both soil nutrient levels, but without overcompensatory regrowth following any of the treatments. The three Ficus species differed in biomass allocation following herbivore damage and artificial injury. The root/shoot ratio of F. hispida decreased largely following herbivore damage and artificial injury, while the root/shoot ratio for F. auriculata increased against damage treatments. The increase of shoot and root size for F. hispida and F. auriculata, respectively, appeared to be caused by a significant increase in photosynthesis. The results indicated that shifts in biomass allocation and increased photosynthesis are two of the mechanisms underlying compensatory regrowth. Contrasting patterns among the three Ficus species suggest that further theoretical and empirical work is necessary to better understand the complexity of the plant responses to herbivore damage.	[Zhao, Jin; Chen, Jin] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China; [Zhao, Jin] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhao, J (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China.	cj@xtbg.org.cn			National Natural Science Foundation of China (NSFC) [30570361]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NSFC, 30570361) (http://www.nsfc.gov.cn/nsfc/cen/00/download.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldea M, 2006, OECOLOGIA, V149, P221, DOI 10.1007/s00442-006-0444-x; Anttonen S, 2002, CAN J FOREST RES, V32, P498, DOI [10.1139/x01-217, 10.1139/X01-217]; Barton KE, 2008, OIKOS, V117, P917, DOI 10.1111/j.0030-1299.2008.16324.x; BASSMAN JH, 1982, FOREST SCI, V28, P599; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; Boege K, 2005, TRENDS ECOL EVOL, V20, P441, DOI 10.1016/j.tree.2005.05.001; CHAPIN FS, 1989, OECOLOGIA, V79, P551, DOI 10.1007/BF00378674; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; COLEY PD, 1988, OECOLOGIA, V74, P531, DOI 10.1007/BF00380050; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; COWAN IR, 1982, ENCY PLANT PHYSL, P589; CRAWLEY MJ, 1997, PLANT ECOL, P736; Dumas J. B. A, 1831, ANN CHIM PHYS, V2, P198; Dungan RJ, 2007, J ECOL, V95, P603, DOI 10.1111/j.1365-2745.2007.01243.x; EDWARDSJONES G, 1993, OIKOS, V66, P463, DOI 10.2307/3544941; Eichhorn MP, 2010, ECOLOGY, V91, P1092, DOI 10.1890/09-0300.1; Evans G.C., 1972, QUANTITATIVE ANAL PL, P734; Eyles A, 2009, TREE PHYSIOL, V29, P753, DOI 10.1093/treephys/tpp014; Fay PA, 1996, ECOLOGY, V77, P521, DOI 10.2307/2265627; Ferraro DO, 2002, OIKOS, V98, P125, DOI 10.1034/j.1600-0706.2002.980113.x; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Garrido E, 2012, NEW PHYTOL, V193, P445, DOI 10.1111/j.1469-8137.2011.03923.x; GLEESON SK, 1994, FUNCT ECOL, V8, P543, DOI 10.2307/2390080; Glynn C, 2003, OIKOS, V101, P385, DOI 10.1034/j.1600-0706.2003.12089.x; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; GRIME JP, 1977, AM NAT, V111, P1169, DOI 10.1086/283244; Halitschke R, 2003, PLANT PHYSIOL, V131, P1894, DOI 10.1104/pp.102.018184; Haukioja E, 2000, EVOL ECOL, V14, P551, DOI 10.1023/A:1011091606022; Hawkes CV, 2001, ECOLOGY, V82, P2045, DOI 10.1890/0012-9658(2001)082[2045:TIOHOP]2.0.CO;2; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hermsmeier D, 2001, PLANT PHYSIOL, V125, P683, DOI 10.1104/pp.125.2.683; HILBERT DW, 1981, OECOLOGIA, V51, P14, DOI 10.1007/BF00344645; Hoffmann WA, 2003, J ECOL, V91, P475, DOI 10.1046/j.1365-2745.2003.00777.x; Hui X, 2004, ANN BOT-LONDON, V94, P377, DOI 10.1093/aob/mch153; KOZLOWSKI TT, 1992, BOT REV, V58, P107, DOI 10.1007/BF02858600; Lehtila K, 2000, OIKOS, V90, P160, DOI 10.1034/j.1600-0706.2000.900116.x; Leps J, 2001, J ECOL, V89, P186, DOI 10.1046/j.1365-2745.2001.00540.x; Mabry CM, 1997, OECOLOGIA, V111, P225, DOI 10.1007/s004420050229; MASCHINSKI J, 1989, AM NAT, V134, P1, DOI 10.1086/284962; McCloud ES, 1997, PLANTA, V203, P430, DOI 10.1007/s004250050210; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; MEYER GA, 1993, ECOLOGY, V74, P1117, DOI 10.2307/1940481; MUTIKAINEN P, 1995, OECOLOGIA, V104, P487, DOI 10.1007/BF00341346; Nabity PD, 2009, ANN BOT-LONDON, V103, P655, DOI 10.1093/aob/mcn127; Ozaki K, 2004, ECOL RES, V19, P225, DOI 10.1111/j.1440-1703.2003.00627.x; Pilson D, 2000, EVOL ECOL, V14, P457, DOI 10.1023/A:1010953714344; Pinkard EA, 2007, TREE PHYSIOL, V27, P1053, DOI 10.1093/treephys/27.7.1053; Rand TA, 2004, ECOLOGY, V85, P2046, DOI 10.1890/03-3087; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Roda A, 2004, MOL ECOL, V13, P2421, DOI 10.1111/j.1365-294X.2004.02260.x; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; Schittko U, 2001, PLANT PHYSIOL, V125, P701, DOI 10.1104/pp.125.2.701; Sixto H, 2005, FORESTRY, V78, P93, DOI 10.1093/forestry/cpi009; Snyder KA, 2007, FOREST ECOL MANAG, V246, P222, DOI 10.1016/j.foreco.2007.04.032; Stowe KA, 2000, ANNU REV ECOL SYST, V31, P565, DOI 10.1146/annurev.ecolsys.31.1.565; Strauss SY, 1999, TRENDS ECOL EVOL, V14, P179, DOI 10.1016/S0169-5347(98)01576-6; Thomson VP, 2003, OECOLOGIA, V134, P167, DOI 10.1007/s00442-002-1102-6; Tiffin P, 2000, EVOL ECOL, V14, P523, DOI 10.1023/A:1010881317261; TRUMBLE JT, 1993, ANNU REV ENTOMOL, V38, P93, DOI 10.1146/annurev.en.38.010193.000521; Valladares F, 2006, PLANT BIOLOGY, V8, P688, DOI 10.1055/s-2006-924107; VANDERMEIJDEN E, 1988, OIKOS, V51, P355, DOI 10.2307/3565318; Wise MJ, 2007, AM NAT, V169, P443, DOI 10.1086/512044; Wise MJ, 2005, OIKOS, V109, P417, DOI 10.1111/j.0030-1299.2005.13878.x; Xia Shang-Wen, 2007, Acta Botanica Yunnanica, V29, P694; Zangerl AR, 2002, P NATL ACAD SCI USA, V99, P1088, DOI 10.1073/pnas.022647099; Zeiger E, 1987, STOMATAL FUNCTION	66	16	17	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45092	10.1371/journal.pone.0045092	http://dx.doi.org/10.1371/journal.pone.0045092			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984616	Green Submitted, gold, Green Published			2022-12-25	WOS:000308738500116
J	Derrett, S; Samaranayaka, A; Wilson, S; Langley, J; Ameratunga, S; Cameron, ID; Lilley, R; Wyeth, E; Davie, G				Derrett, Sarah; Samaranayaka, Ari; Wilson, Suzanne; Langley, John; Ameratunga, Shanthi; Cameron, Ian D.; Lilley, Rebbecca; Wyeth, Emma; Davie, Gabrielle			Prevalence and Predictors of Sub-Acute Phase Disability after Injury among Hospitalised and Non-Hospitalised Groups: A Longitudinal Cohort Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; HEALTH-STATUS; FUNCTIONAL CONSEQUENCES; GENERAL HEALTH; MAJOR TRAUMA; WORK STATUS; DETERMINANTS; POPULATION; OUTCOMES; RECOVERY	Introduction: To reduce the burden on injury survivors and their supporters, factors associated with poor outcomes need to be identified so that timely post-injury interventions can be implemented. To date, few studies have investigated outcomes for both those who were hospitalised and those who were not. Aim: To describe the prevalence and to identify pre-injury and injury-related predictors of disability among hospitalised and non-hospitalised people, three months after injury. Methods: Participants in the Prospective Outcomes of Injury Study were aged 18-64 years and on an injury entitlement claims register with New Zealand's no-fault injury compensation insurer, following referral by healthcare professionals. A wide range of pre-injury demographic, health and injury-related characteristics were collected at interview. Participants were categorised as 'hospitalised' if they were placed on New Zealand's National Minimum Data Set within seven days of the injury event. Injury severity scores (NISS) and 12 injury categories were derived from ICD-10 codes. WHODAS assessed disability. Multivariable analyses examined relationships between explanatory variables and disability. Results: Of 2856 participants, 2752 (96%) had WHODAS scores available for multivariable analysis; 673 were hospitalised; 2079 were not. Disability was highly prevalent among hospitalised (53.6%) and non-hospitalised (39.4%) participants, three-months after injury. In both groups, pre-injury disability, obesity and higher injury severity were associated with increased odds of post-injury disability. A range of other factors were associated with disability in only one group: e. g. female, >= 2 chronic conditions and leg fracture among hospitalised; aged 35-54 years, trouble accessing healthcare, spine or lower extremity sprains/dislocations and assault among non-hospitalised. Significance: Disability was highly prevalent among both groups yet, with a few exceptions, factors associated with disability were not common to both groups. Where possible, including a range of injured people in studies, hospitalised and not, will increase understanding of the burden of disability in the sub-acute phase.	[Derrett, Sarah; Samaranayaka, Ari; Wilson, Suzanne; Langley, John; Lilley, Rebbecca; Davie, Gabrielle] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin, New Zealand; [Ameratunga, Shanthi] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Auckland 1, New Zealand; [Cameron, Ian D.] Univ Sydney, Sydney Med Sch, Rehabil Studies Unit, Sydney, NSW 2006, Australia; [Wyeth, Emma] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Te Roopu Rangahau Hauora Maori Ngai Tahu Ngai Ta, Dunedin, New Zealand	University of Otago; University of Auckland; University of Sydney; University of Otago	Derrett, S (corresponding author), Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Injury Prevent Res Unit, Dunedin, New Zealand.	sarah.derrett@otago.ac.nz	Wyeth, Emma/GLU-8874-2022	Ameratunga, Shanthi/0000-0001-8042-2251; Derrett, Sarah/0000-0003-2867-0498; Wyeth, Emma/0000-0002-6869-5190; Davie, Gabrielle/0000-0001-5466-5364	Health Research Council of New Zealand; Accident Compensation Corporation, New Zealand; Health Research Council of New Zealand Eru Pomare Research Fellowship; ACC Early Research Career Post-Doctoral Fellowship; Australian National Health and Medical Research Council Practitioner Fellowship	Health Research Council of New Zealand(Health Research Council of New Zealand); Accident Compensation Corporation, New Zealand; Health Research Council of New Zealand Eru Pomare Research Fellowship; ACC Early Research Career Post-Doctoral Fellowship; Australian National Health and Medical Research Council Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study is funded by the Health Research Council of New Zealand (2007-2013), and was co-funded by the Accident Compensation Corporation, New Zealand (2007-2010). The views and conclusions expressed herein are the authors' and may not reflect those of the funders. EW was supported by a Health Research Council of New Zealand Eru Pomare Research Fellowship, RL by an ACC Early Research Career Post-Doctoral Fellowship and IDC by an Australian National Health and Medical Research Council Practitioner Fellowship. The Accident Compensation Corporation sent out invitations to eligible potential participants on the research team's behalf, and also provided, following participants' consent, information from the electronic record about participants' injuries. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Accident Compensation Corporation, 2010, ANN REP 2010 ACC COM; Accident Compensation Corporation, 2009, ANN REP 2009 ACC COM; Ameratunga SN, 2006, ANN EMERG MED, V48, P729, DOI 10.1016/j.annemergmed.2006.07.001; American Psychiatric Association Committee of Nomenclature and Statistics, 1980, DIAGN STAT MAN MENT; Andrews G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008343; [Anonymous], 2009, STAT REL 11 STAT SOF; Association for the Advancement of Automotive Medicine, 1990, ABBR INJ SCAL 1990 R; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Black JA, 2011, J TRAUMA, V71, P1003, DOI 10.1097/TA.0b013e3182238833; Bradley KA, 2007, ALCOHOL CLIN EXP RES, V31, P1208, DOI 10.1111/j.1530-0277.2007.00403.x; Cripps RA, 2008, INJURY CHRONIC HLTH; Derrett S, 2009, INJURY PREV, V15, DOI [10.1136/ip.2009.022558a, 10.1136/ip.2009.022558]; Derrett S, 2011, INJURY PREV, V17, P415, DOI 10.1136/injuryprev-2011-040044; Edmondson D, 2008, PSYCHO-ONCOL, V17, P161, DOI 10.1002/pon.1197; European Center for Injury Prevention, 2011, ICD MAP; Federici S, 2010, DISABIL REHABIL, V32, P687, DOI 10.3109/09638280903290012; Fingerhut LA, 2006, INJURY PREV, V12, P24, DOI 10.1136/ip.2005.009076; Fitchett G, 1999, REHABIL PSYCHOL, V44, P333, DOI 10.1037//0090-5550.44.4.333; Gennarelli TA, 2008, ABBREVIATED INJURY S; Gofin R, 1997, Inj Prev, V3, P120, DOI 10.1136/ip.3.2.120; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Krahn GL, 2009, DISABIL HEALTH J, V2, P49, DOI 10.1016/j.dhjo.2008.12.003; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Langley J, 2012, INJURY PREV, V18, P73, DOI 10.1136/injuryprev-2011-040278; Langley J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-68; Lilley R, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000400; Lyons RA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001140; MacKenzie EJ, 2000, EPIDEMIOL REV, V22, P112, DOI 10.1093/oxfordjournals.epirev.a018006; MacKenzie EJ, 1998, AM J PUBLIC HEALTH, V88, P1630, DOI 10.2105/AJPH.88.11.1630; Malm Sigrun, 2008, Ann Adv Automot Med, V52, P93; Meerding WJ, 2006, EUR J PUBLIC HEALTH, V16, P271, DOI 10.1093/eurpub/ckl006; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; Michaels AJ, 2000, J TRAUMA, V48, P841, DOI 10.1097/00005373-200005000-00007; Ministry of Health, 2008, PORTR HLTH KEY RES 2; Ministry of Health, 2011, NAT COLL GLOSS APP B; Ministry of Social Development, 2000, DIR MEAS LIV STAND N; O'Donnell ML, 2005, J TRAUMA, V59, P1328, DOI 10.1097/01.ta.0000197621.94561.4e; Overgaard M, 2011, J TRAUMA, V71, P435, DOI 10.1097/TA.0b013e31820e7ec3; Pape HC, 2010, J TRAUMA, V69, P1243, DOI 10.1097/TA.0b013e3181ce1fa1; Pargament KI, 2001, J SCI STUD RELIG, V40, P497, DOI 10.1111/0021-8294.00073; Peterman AH, 2002, ANN BEHAV MED, V24, P49, DOI 10.1207/S15324796ABM2401_06; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; Portney KE, 1997, AM BEHAV SCI, V40, P632, DOI 10.1177/0002764297040005009; Pukk Karin, 2003, Qual Manag Health Care, V12, P225; Robinson D, 1997, J AM MED INFORM ASSN, V4, P465, DOI 10.1136/jamia.1997.0040465; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schwarzer R., 1995, CAUSAL CONTROL BELIE, P35, DOI DOI 10.1037/T00393-000; Smith DL, 2008, DISABIL HEALTH J, V1, P79, DOI 10.1016/j.dhjo.2008.01.001; Soberg HL, 2007, J TRAUMA, V62, P461, DOI 10.1097/01.ta.0000222916.30253.ea; Sport and Recreation New Zealand, 2004, NZ PHYS ACT QUEST; Statistics New Zealand, 2006, 2006 CENS QUEST; Statistics New Zealand, 2006, 2006 CENS POP DWELL; Stevenson M, 2001, Inj Prev, V7, P10, DOI 10.1136/ip.7.1.10; Ustun B., 2010, MEASURING HLTH DISAB; Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Watson WL, 2007, INJURY PREV, V13, P45, DOI 10.1136/ip.2005.010157; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Health Organisation (WHO), 2001, INT CLASS FUNCT DIS; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2011, BMI CLASS	64	54	54	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44909	10.1371/journal.pone.0044909	http://dx.doi.org/10.1371/journal.pone.0044909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	003VE	22984584	gold, Green Published			2022-12-25	WOS:000308638700099
J	Kumar, A; Mocklinghoff, S; Yumoto, F; Jaroszewski, L; Farr, CL; Grzechnik, A; Nguyen, P; Weichenberger, CX; Chiu, HJ; Klock, HE; Elsliger, MA; Deacon, AM; Godzik, A; Lesley, SA; Conklin, BR; Fletterick, RJ; Wilson, IA				Kumar, Abhinav; Moecklinghoff, Sabine; Yumoto, Fumiaki; Jaroszewski, Lukasz; Farr, Carol L.; Grzechnik, Anna; Phuong Nguyen; Weichenberger, Christian X.; Chiu, Hsiu-Ju; Klock, Heath E.; Elsliger, Marc-Andre; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Conklin, Bruce R.; Fletterick, Robert J.; Wilson, Ian A.			Structure of a Novel Winged-Helix Like Domain from Human NFRKB Protein	PLOS ONE			English	Article							CHROMATIN REMODELING COMPLEX; INO80; TRANSCRIPTION; PREDICTION; REVEALS; DIFFRACTION; GENOMICS; SYSTEM	The human nuclear factor related to kappa-B-binding protein (NFRKB) is a 1299-residue protein that is a component of the metazoan INO80 complex involved in chromatin remodeling, transcription regulation, DNA replication and DNA repair. Although full length NFRKB is predicted to be around 65% disordered, comparative sequence analysis identified several potentially structured sections in the N-terminal region of the protein. These regions were targeted for crystallographic studies, and the structure of one of these regions spanning residues 370-495 was determined using the JCSG high-throughput structure determination pipeline. The structure reveals a novel, mostly helical domain reminiscent of the winged-helix fold typically involved in DNA binding. However, further analysis shows that this domain does not bind DNA, suggesting it may belong to a small group of winged-helix domains involved in protein-protein interactions.	[Kumar, Abhinav; Jaroszewski, Lukasz; Farr, Carol L.; Grzechnik, Anna; Weichenberger, Christian X.; Chiu, Hsiu-Ju; Klock, Heath E.; Elsliger, Marc-Andre; Deacon, Ashley M.; Godzik, Adam; Lesley, Scott A.; Wilson, Ian A.] Joint Ctr Struct Genom, La Jolla, CA USA; [Kumar, Abhinav; Chiu, Hsiu-Ju; Deacon, Ashley M.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [Moecklinghoff, Sabine; Yumoto, Fumiaki; Phuong Nguyen; Fletterick, Robert J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Farr, Carol L.; Grzechnik, Anna; Elsliger, Marc-Andre; Lesley, Scott A.; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Klock, Heath E.; Lesley, Scott A.] Novartis Res Fdn, Genom Inst, Prot Sci Dept, San Diego, CA USA; [Jaroszewski, Lukasz; Weichenberger, Christian X.; Godzik, Adam] Sanford Burnham Med Res Inst, Program Bioinformat & Syst Biol, La Jolla, CA USA; [Godzik, Adam] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA; [Yumoto, Fumiaki; Conklin, Bruce R.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Conklin, Bruce R.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; University of California System; University of California San Francisco; Scripps Research Institute; Novartis; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kumar, A (corresponding author), Joint Ctr Struct Genom, La Jolla, CA USA.	Flett@msg.UCSF.edu; wilson@scripps.edu	Conklin, Bruce/E-4738-2019; Godzik, Adam/A-7279-2009; Godzik, Adam/AAW-1467-2020	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Weichenberger, Christian X./0000-0002-2176-0274; Elsliger, Marc Andre/0000-0002-1989-7626; Conklin, Bruce/0000-0003-1463-6061	National Institutes of Health, National Institute of General Medical Sciences, Protein Structure Initiative [U01 GM094614, U54 GM094586]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; National Center for Research Resources [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, U54GM094586, U01GM094614] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences, Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, National Institute of General Medical Sciences, Protein Structure Initiative grants U01 GM094614 to Robert Fletterick and U54 GM094586 to the Joint Center for Structural Genomics (JCSG). The Stanford Synchrotron Radiation Lightsource (SSRL) Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (including P41GM103393) and the National Center for Research Resources (P41RR001209). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao YH, 2007, MUTAT RES-FUND MOL M, V618, P18, DOI 10.1016/j.mrfmmm.2006.10.006; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Chen L, 2011, J BIOL CHEM, V286, P11283, DOI 10.1074/jbc.M111.222505; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Silva RS, 2005, J BIOL CHEM, V280, P13779, DOI 10.1074/jbc.M413781200; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232; Safo MK, 2006, ACTA CRYSTALLOGR F, V62, P320, DOI 10.1107/S1744309106009742; Santarsiero BD, 2002, J APPL CRYSTALLOGR, V35, P278, DOI 10.1107/S0021889802001474; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shen XT, 2000, NATURE, V406, P541, DOI 10.1038/35020123; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1174, DOI 10.1107/S0907444903009922; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Walter TS, 2006, STRUCTURE, V14, P1617, DOI 10.1016/j.str.2006.09.005; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yang YD, 2011, BIOINFORMATICS, V27, P2076, DOI 10.1093/bioinformatics/btr350; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a	43	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43761	10.1371/journal.pone.0043761	http://dx.doi.org/10.1371/journal.pone.0043761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984442	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700029
J	Okoro, EU; Zhao, YF; Guo, ZM; Zhou, LC; Lin, XH; Yang, H				Okoro, Emmanuel Ugochukwu; Zhao, Yanfeng; Guo, ZhongMao; Zhou, Lichun; Lin, Xinghua; Yang, Hong			Apolipoprotein E4 Is Deficient in Inducing Macrophage ABCA1 Expression and Stimulating the Sp1 Signaling Pathway	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; MONOCYTE-DERIVED MACROPHAGES; TRANSPORTER A1 EXPRESSION; HUMAN-E APOPROTEIN; CHOLESTEROL EFFLUX; LDL-RECEPTOR; TANGIER-DISEASE; LIPID EFFLUX; E GENOTYPES; BINDING	ATP binding cassette A1 (ABCA1) is a membrane protein that promotes cellular cholesterol efflux. Using RAW 264.7 macrophages, we studied the relative effects of apolipoprotein (apo) E3 and apoE4 on ABCA1 and on the signaling pathway that regulates its expression. Both lipid-associated and lipid-free apoE4 forms induced similar to 30% lower levels of ABCA1 protein and mRNA than apoE3 forms. Phosphorylated levels of phosphoinositol 3-kinase (PI3K), protein kinase C zeta (PKC zeta) and specificity protein 1 (Sp1) were also lower when treated with apoE4 compared to apoE3. The reduced ability of apoE4 to induce ABCA1 expression, PKC zeta and Sp1 phosphorylation were confirmed in human THP-1 monocytes/macrophages. Sequential phosphorylation of PI3K, PKC zeta and Sp1 has been suggested as a mechanism for upregulation of ABCA1 expression. Both apoE3 and apoE4 reduced total cholesterol and cholesterol esters in lipid-laden RAW 264.7 cells, and induced apoAI-mediated cholesterol efflux. However, the cholesterol esters and cholesterol efflux in apoE4-treated cells were similar to 50% and similar to 24% lower, respectively, compared to apoE3-treated cells. Accumulation of cholesterol esters in macrophages is a mechanism for foam cell formation. Thus the reduced ability of apoE4 to activate the PI3K-PKC zeta-Sp1 signaling pathway and induce ABCA1 expression likely impairs cholesterol ester removal, and increases foam cell formation.	[Okoro, Emmanuel Ugochukwu; Zhao, Yanfeng; Guo, ZhongMao; Zhou, Lichun; Lin, Xinghua; Yang, Hong] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA	Meharry Medical College	Okoro, EU (corresponding author), Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA.	hyang@mmc.edu			United States National Institutes of Health [F32HL105044, R01ES014471, R01HL089382, SC1HL101431]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089382, SC1HL101431, F32HL105044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES014472] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by United States National Institutes of Health grants: F32HL105044 (EO), R01ES014471, R01HL089382 (ZMG) and SC1HL101431 (HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASU SK, 1981, P NATL ACAD SCI-BIOL, V78, P7545, DOI 10.1073/pnas.78.12.7545; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Blacklow SC, 2007, CURR OPIN STRUC BIOL, V17, P419, DOI 10.1016/j.sbi.2007.08.017; BLUE ML, 1983, P NATL ACAD SCI-BIOL, V80, P283, DOI 10.1073/pnas.80.1.283; Brooks-Wilson A, 1999, NAT GENET, V22, P336, DOI 10.1038/11905; Chen W, 2001, J BIOL CHEM, V276, P43564, DOI 10.1074/jbc.M107938200; Chen XP, 2011, J BIOL CHEM, V286, P8917, DOI 10.1074/jbc.M110.214429; Chen XP, 2012, J BIOL CHEM, V287, P3751, DOI 10.1074/jbc.M111.310888; CLAVEY V, 1995, ARTERIOSCL THROM VAS, V15, P963, DOI 10.1161/01.ATV.15.7.963; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; FOLCH J, 1957, J BIOL CHEM, V226, P497; FUNKE H, 1984, ARTERIOSCLEROSIS, V4, P452, DOI 10.1161/01.ATV.4.5.452; GHISELLI G, 1982, J CLIN INVEST, V70, P474, DOI 10.1172/JCI110638; Gong JS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-9; GREEN PHR, 1979, J CLIN INVEST, V64, P233, DOI 10.1172/JCI109444; Gregg RE, 1986, J CLIN INVEST, V78, P3; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Heeren J, 1999, J CELL SCI, V112, P349; Heeren J, 2006, ARTERIOSCL THROM VAS, V26, P442, DOI 10.1161/01.ATV.0000201282.64751.47; Heeren J, 2004, J BIOL CHEM, V279, P55483, DOI 10.1074/jbc.M409324200; Heeren J, 2003, J BIOL CHEM, V278, P14370, DOI 10.1074/jbc.M209006200; Heeren J, 2001, J BIOL CHEM, V276, P42333, DOI 10.1074/jbc.M107461200; Huang ZH, 2006, ARTERIOSCL THROM VAS, V26, P157, DOI 10.1161/01.ATV.0000193627.12516.1d; KRUTH HS, 1994, J BIOL CHEM, V269, P24511; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; LILLYSTAUDERMAN M, 1993, J LIPID RES, V34, P190; Linton MF, 1998, J CLIN INVEST, V101, P1726, DOI 10.1172/JCI2181; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Mamotte CDS, 1999, AM J PHYSIOL-ENDOC M, V276, pE553, DOI 10.1152/ajpendo.1999.276.3.E553; MAZZONE T, 1987, J BIOL CHEM, V262, P11657; Minagawa Hirohisa, 2009, J Neurosci Res, V87, P2498, DOI 10.1002/jnr.22073; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Oram JF, 2000, BBA-MOL CELL BIOL L, V1529, P321, DOI 10.1016/S1388-1981(00)00157-8; Rellin L, 2008, BBA-MOL CELL BIOL L, V1781, P232, DOI 10.1016/j.bbalip.2008.02.001; RUBINSZTEIN DC, 1990, J CLIN INVEST, V86, P1306, DOI 10.1172/JCI114839; Selva DM, 2004, J LIPID RES, V45, P1040, DOI 10.1194/jlr.M400007-JLR200; SHELBURNE FA, 1974, J BIOL CHEM, V249, P1428; SHORE VG, 1973, BIOCHEMISTRY-US, V12, P502, DOI 10.1021/bi00727a022; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; TAKAHASHI S, 1992, P NATL ACAD SCI USA, V89, P9252, DOI 10.1073/pnas.89.19.9252; TSUCHIYA S, 1982, CANCER RES, V42, P1530; UTERMANN G, 1975, FEBS LETT, V56, P352, DOI 10.1016/0014-5793(75)81125-2; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Vedhachalam C, 2007, BIOCHEMISTRY-US, V46, P2583, DOI 10.1021/bi602407r; WEISGRABER KH, 1977, ATHEROSCLEROSIS, V28, P121, DOI 10.1016/0021-9150(77)90150-2; WEISGRABER KH, 1984, J CLIN INVEST, V73, P1024, DOI 10.1172/JCI111287; WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; Weisgraber KH, 1981, J BIOL CHEM, V257, P4171; Willis F, 2003, J NATL MED ASSOC, V95, P71; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; WILSON PWF, 1994, JAMA-J AM MED ASSOC, V272, P1666, DOI 10.1001/jama.272.21.1666; Wu DF, 2005, J LIPID RES, V46, P1380, DOI 10.1194/jlr.M400430-JLR200; Yamamoto T, 2008, ANAL BIOCHEM, V372, P222, DOI 10.1016/j.ab.2007.09.005; Yamamoto T, 2007, BIOCHEM BIOPH RES CO, V354, P820, DOI 10.1016/j.bbrc.2007.01.066; Yamamura T, 1999, J LIPID RES, V40, P253; Yancey PG, 2007, ARTERIOSCL THROM VAS, V27, P1123, DOI 10.1161/ATVBAHA.107.139592; ZANNIS VI, 1982, J LIPID RES, V23, P911; Zhang WY, 1996, J BIOL CHEM, V271, P28641, DOI 10.1074/jbc.271.45.28641; ZHAO Y, 2011, PLOS ONE, V6	60	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44430	10.1371/journal.pone.0044430	http://dx.doi.org/10.1371/journal.pone.0044430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984509	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700061
J	Tremblay, P; Ferrier-Pages, C; Maguer, JF; Rottier, C; Legendre, L; Grover, R				Tremblay, Pascale; Ferrier-Pages, Christine; Maguer, Jean Francois; Rottier, Cecile; Legendre, Louis; Grover, Renaud			Controlling Effects of Irradiance and Heterotrophy on Carbon Translocation in the Temperate Coral Cladocora caespitosa	PLOS ONE			English	Article							ANEMONE ANTHOPLEURA-ELEGANTISSIMA; SHADE-ADAPTED COLONIES; STYLOPHORA-PISTILLATA; SEA-ANEMONE; SYMBIOTIC CORAL; OCULINA-PATAGONICA; AIPTASIA-PALLIDA; ALGAL SYMBIONTS; ZOOXANTHELLAE; LIGHT	Temperate symbiotic corals, such as the Mediterranean species Cladocora caespitosa, live in seasonally changing environments, where irradiance can be ten times higher in summer than winter. These corals shift from autotrophy in summer to heterotrophy in winter in response to light limitation of the symbiont's photosynthesis. In this study, we determined the autotrophic carbon budget under different conditions of irradiance (20 and 120 mu mol photons m(-2) s(-1)) and feeding (fed three times a week with Artemia salina nauplii, and unfed). Corals were incubated in (HCO3-)-C-13-enriched seawater, and the fate of C-13 was followed in the symbionts and the host tissue. The total amount of carbon fixed by photosynthesis and translocated was significantly higher at high than low irradiance (ca. 13 versus 2.5-4.5 mu g cm(-2) h(-1)), because the rates of photosynthesis and carbon fixation were also higher. However, the percent of carbon translocation was similar under the two irradiances, and reached more than 70% of the total fixed carbon. Host feeding induced a decrease in the percentage of carbon translocated under low irradiance (from 70 to 53%), and also a decrease in the rates of carbon translocation per symbiont cell under both irradiances. The fate of autotrophic and heterotrophic carbon differed according to irradiance. At low irradiance, autotrophic carbon was mostly respired by the host and the symbionts, and heterotrophic feeding led to an increase in host biomass. Under high irradiance, autotrophic carbon was both respired and released as particulate and dissolved organic carbon, and heterotrophic feeding led to an increase in host biomass and symbiont concentration. Overall, the maintenance of high symbiont concentration and high percentage of carbon translocation under low irradiance allow this coral species to optimize its autotrophic carbon acquisition, when irradiance conditions are not favourable to photosynthesis.	[Tremblay, Pascale; Ferrier-Pages, Christine; Rottier, Cecile; Grover, Renaud] Ctr Sci Monaco, Ecophysiol Team, Monaco, Monaco; [Tremblay, Pascale; Ferrier-Pages, Christine; Grover, Renaud] LEA CSM CNRS BIOSENSIB, Monaco, Monaco; [Maguer, Jean Francois] Inst Univ Europeen Mer, LEMAR UMR UBO CNRS IRD 6539, Plouzane, France; [Legendre, Louis] Univ Paris 06, UMR 7093, Lab Oceanog Villefranche, Villefranche Sur Mer, France; [Legendre, Louis] CNRS, UMR 7093, Lab Oceanog Villefranche, Villefranche Sur Mer, France	Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Tremblay, P (corresponding author), Ctr Sci Monaco, Ecophysiol Team, Monaco, Monaco.	pascale_tremblay@globetrotter.net		Jean-Francois, Maguer/0000-0003-3069-2821; Ferrier-Pages, Christine/0000-0002-0357-4486	Centre Scientifique de Monaco; Institut Universitaire Europeen de la Mer; Natural Sciences and Engineering Research Council of Canada [ES D3 - 378797-2009]	Centre Scientifique de Monaco; Institut Universitaire Europeen de la Mer; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for this project was provided by the Centre Scientifique de Monaco (http://www.centrescientifique.mc/), the Institut Universitaire Europeen de la Mer (http://www.univ-brest.fr/IUEM/UMR6539/), and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp; grant # ES D3 - 378797-2009 to P.T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Bachar A, 2007, J EXP MAR BIOL ECOL, V349, P295, DOI 10.1016/j.jembe.2007.05.030; Bianchi C. N., 1994, MEMORIE DESCRITTIVE, V52, P59; Coma R, 2003, OIKOS, V101, P205, DOI 10.1034/j.1600-0706.2003.12028.x; CROSSLAND CJ, 1987, CORAL REEFS, V6, P35, DOI 10.1007/BF00302210; CROSSLAND CJ, 1980, MAR BIOL, V60, P81, DOI 10.1007/BF00389151; DAVIES PS, 1991, MAR BIOL, V108, P137, DOI 10.1007/BF01313481; DAVIES PS, 1984, CORAL REEFS, V2, P181; Davy SK, 1996, MAR BIOL, V126, P773, DOI 10.1007/BF00351344; Davy SK, 2001, MAR BIOL, V139, P999; Davy SK, 2001, COMP BIOCHEM PHYS A, V129, P487, DOI 10.1016/S1095-6433(01)00285-9; Dimond J, 2008, CORAL REEFS, V27, P601, DOI 10.1007/s00338-008-0363-x; Dubinsky Z, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P1, DOI 10.1007/978-94-007-0114-4; DUBINSKY Z, 1984, PROC R SOC SER B-BIO, V222, P203, DOI 10.1098/rspb.1984.0059; EDMUNDS PJ, 1986, MAR BIOL, V92, P339, DOI 10.1007/BF00392674; Engebretson HP, 1999, BIOL BULL, V197, P72, DOI 10.2307/1542998; EREZ J, 1978, NATURE, V273, P199, DOI 10.1038/273199a0; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; Ferrier-Pages C, 1998, MAR ECOL PROG SER, V172, P265, DOI 10.3354/meps172265; Ferrier-Pages C, 2011, LIMNOL OCEANOGR, V56, P1429, DOI 10.4319/lo.2011.56.4.1429; Ferrier-Pages C, 2012, LIFE MEDITERRANNEAN, P387; Furla P, 2000, J EXP BIOL, V203, P3445; Hoogenboom M, 2010, CORAL REEFS, V29, P21, DOI 10.1007/s00338-009-0558-9; Hoogenboom M, 2010, J EXP BIOL, V213, P2399, DOI 10.1242/jeb.040147; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Hughes AD, 2010, MAR ECOL PROG SER, V420, P91, DOI 10.3354/meps08866; Ishikura M, 1999, MAR BIOL, V133, P665, DOI 10.1007/s002270050507; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kersting D-K, 2012, MAR ECOL; Kruzic P, 2003, CORAL REEFS, V22, P536, DOI 10.1007/s00338-003-0345-y; MCCLOSKEY LR, 1984, PROC R SOC SER B-BIO, V222, P215, DOI 10.1098/rspb.1984.0060; MCCLOSKEY LR, 1994, MAR BIOL, V119, P13, DOI 10.1007/BF00350101; Morri C, 1994, BIOL MAR MEDIT, V1, P371; Muller-Parker G, 2001, INVERTEBR BIOL, V120, P104, DOI 10.1111/j.1744-7410.2001.tb00115.x; MUSCATINE L, 1984, PROC R SOC SER B-BIO, V222, P181, DOI 10.1098/rspb.1984.0058; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; MUSCATINE L, 1983, ENDOCYTOBIOLOGY 2, V0002, P00649; Peirano A, 1999, MAR ECOL PROG SER, V185, P195, DOI 10.3354/meps185195; Peirano A, 2005, CORAL REEFS, V24, P404, DOI 10.1007/s00338-005-0020-6; Peirano A, 2007, SCI MAR, V71, P629, DOI 10.3989/scimar.2007.71n4629; Rodolfo-Metalpa R, 2008, CORAL REEFS, V27, P17, DOI 10.1007/s00338-007-0283-1; Rodolfo-Metalpa R, 2008, MAR ECOL PROG SER, V369, P103, DOI 10.3354/meps07608; Rodolfo-Metalpa R, 2008, J EXP BIOL, V211, P1579, DOI 10.1242/jeb.016345; Rodolfo-Metalpa R, 2006, MAR BIOL, V150, P45, DOI 10.1007/s00227-006-0329-x; Rossi S, 2006, MAR BIOL, V149, P643, DOI 10.1007/s00227-005-0229-5; Sachs JL, 2006, P ROY SOC B-BIOL SCI, V273, P425, DOI 10.1098/rspb.2005.3346; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Smith SV, 1978, MONOGR OCEANOGR METH, V5, P469; Tambutte S, 2011, J EXP MAR BIOL ECOL, V408, P58, DOI 10.1016/j.jembe.2011.07.026; Treignier C, 2008, LIMNOL OCEANOGR, V53, P2702, DOI 10.4319/lo.2008.53.6.2702; Tremblay P, 2011, MAR ECOL PROG SER, V422, P165, DOI 10.3354/meps08902; Tremblay P, 2012, J EXP BIOL, V215, P1384, DOI 10.1242/jeb.065201; Underwood A.J., 1997, EXPT ECOLOGY THEIR L, DOI DOI 10.1017/CBO9780511806407; Verde EA, 1996, J EXP MAR BIOL ECOL, V195, P187, DOI 10.1016/0022-0981(95)00080-1; ZIBROWIUS H, 1980, Memoires de l'Institut Oceanographique (Monaco), P1	57	18	19	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44672	10.1371/journal.pone.0044672	http://dx.doi.org/10.1371/journal.pone.0044672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970284	Green Submitted, Green Published, gold			2022-12-25	WOS:000308748400028
J	Charlebois, A; Jalbert, LA; Harel, J; Masson, L; Archambault, M				Charlebois, Audrey; Jalbert, Louis-Alexandre; Harel, Josee; Masson, Luke; Archambault, Marie			Characterization of Genes Encoding for Acquired Bacitracin Resistance in Clostridium perfringens	PLOS ONE			English	Article							UNDECAPRENYL PYROPHOSPHATE PHOSPHATASE; GROWTH-PROMOTING ANTIBIOTICS; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; ABC TRANSPORTER; ENTEROCOCCUS-FAECIUM; ANTIMICROBIAL SUSCEPTIBILITY; HUMAN HEALTH; BACA GENE; LICHENIFORMIS	Phenotypic bacitracin resistance has been reported in Clostridium perfringens. However, the genes responsible for the resistance have not yet been characterized. Ninety-nine C. perfringens isolates recovered from broilers and turkeys were tested for phenotypic bacitracin resistance. Bacitracin MIC90 (>256 mg/ml) was identical for both turkey and chicken isolates; whereas MIC50 was higher in turkey isolates (6 mu g/ml) than in chicken isolates (3 mu g/ml). Twenty-four of the 99 isolates showed high-level bacitracin resistance (MIC breakpoint >256 mu g/ml) and the genes encoding for this resistance were characterized in C. perfringens c1261_A strain using primer walking. Sequence analysis and percentages of amino acid identity revealed putative genes encoding for both an ABC transporter and an overproduced undecaprenol kinase in C. perfringens c1261_A strain. These two mechanisms were shown to be both encoded by the putative bcrABD operon under the control of a regulatory gene, bcrR. Efflux pump inhibitor thioridazine was shown to increase significantly the susceptibility of strain c1261_A to bacitracin. Upstream and downstream from the bcr cluster was an IS1216-like element, which may play a role in the dissemination of this resistance determinant. Pulsed-field gel electrophoresis with prior double digestion with I-CeuI/MluI enzymes followed by hybridization analyses revealed that the bacitracin resistance genes bcrABDR were located on the chromosome. Semi-quantitative RT-PCR demonstrated that this gene cluster is expressed under bacitracin stress. Microarray analysis revealed the presence of these genes in all bacitracin resistant strains. This study reports the discovery of genes encoding for a putative ABC transporter and an overproduced undecaprenol kinase associated with high-level bacitracin resistance in C. perfringens isolates from turkeys and broiler chickens.	[Charlebois, Audrey; Jalbert, Louis-Alexandre; Harel, Josee; Archambault, Marie] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, CRIP, St Hyacinthe, PQ J2S 7C6, Canada; [Masson, Luke] Biotechnol Res Inst, Montreal, PQ H4P 2R2, Canada	Universite de Montreal; National Research Council Canada	Charlebois, A (corresponding author), Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, CRIP, St Hyacinthe, PQ J2S 7C6, Canada.	marie.archambault@umontreal.ca	Harel, Josée/H-1933-2011	Harel, Josée/0000-0002-7822-3795	Natural Sciences and Engineering Research Council of Canada [RGPIN-191461]; Poultry Industry Council of Canada [PIC-212]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Poultry Industry Council of Canada	This work was funded by grants from the Natural Sciences and Engineering Research Council of Canada to M. Archambault (RGPIN-191461) and the Poultry Industry Council (PIC-212) of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Bernard R, 2005, J BIOL CHEM, V280, P28852, DOI 10.1074/jbc.M413750200; Bernard R, 2003, FEMS MICROBIOL LETT, V228, P93, DOI 10.1016/S0378-1097(03)00738-9; Bernard R, 2007, J BACTERIOL, V189, P8636, DOI 10.1128/JB.01132-07; Bruant G, 2006, APPL ENVIRON MICROB, V72, P3780, DOI 10.1128/AEM.72.5.3780-3784.2006; Bywater R, 2005, J ANTIMICROB CHEMOTH, V56, P538, DOI 10.1093/jac/dki273; CAIN BD, 1993, J BACTERIOL, V175, P3784, DOI 10.1128/JB.175.12.3784-3789.1993; Cao M, 2002, J BACTERIOL, V184, P6123, DOI 10.1128/JB.184.22.6123-6129.2002; Chalmers G, 2008, J CLIN MICROBIOL, V46, P3957, DOI 10.1128/JCM.01548-08; Chalmers G, 2007, VET MICROBIOL; Champagne J, 2011, APPL ENVIRON MICROB, V77, P2625, DOI 10.1128/AEM.00263-11; Dahan A, 2009, MOL PHARMACEUT, V6, P19, DOI 10.1021/mp800088f; El Ghachi M, 2004, J BIOL CHEM, V279, P30106, DOI 10.1074/jbc.M401701200; Engberg RM, 2000, POULTRY SCI, V79, P1311, DOI 10.1093/ps/79.9.1311; FIEDLER W, 1988, J BIOL CHEM, V263, P14684; Frye JG, 2006, INT J ANTIMICROB AG, V27, P138, DOI 10.1016/j.ijantimicag.2005.09.021; Garmory HS, 2000, EPIDEMIOL INFECT, V124, P61, DOI 10.1017/S0950268899003295; Garneau P, 2010, J ZOONOSES IN PRESS, pSP; Harel YM, 1999, J BACTERIOL, V181, P6176, DOI 10.1128/JB.181.19.6176-6178.1999; Hendricks O, 2005, BASIC CLIN PHARMACOL, V96, P33, DOI 10.1111/j.1742-7843.2005.pto960105.x; Johansson A, 2004, VET MICROBIOL, V99, P251, DOI 10.1016/j.vetmic.2004.01.009; Kaatz Glenn W, 2002, Expert Opin Emerg Drugs, V7, P223, DOI 10.1517/14728214.7.2.223; Kather EJ, 2006, VET MICROBIOL, V113, P97, DOI 10.1016/j.vetmic.2005.10.021; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Kulkarni RS, 1998, WORLD J MICROB BIOT, V14, P255; Lepp D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010795; Letowski J, 2004, J MICROBIOL METH, V57, P269, DOI 10.1016/j.mimet.2004.02.002; Lis M, 2003, INFECT IMMUN, V71, P1938, DOI 10.1128/IAI.71.4.1938-1943.2003; Lismond A, 2008, ANTIMICROB AGENTS CH, V52, P3040, DOI 10.1128/AAC.00105-08; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; LYRISTIS M, 1994, MOL MICROBIOL, V12, P761, DOI 10.1111/j.1365-2958.1994.tb01063.x; Manson JM, 2004, APPL ENVIRON MICROB, V70, P5764, DOI 10.1128/AEM.70.10.5764-5768.2004; Manson JM, 2004, ANTIMICROB AGENTS CH, V48, P3743, DOI 10.1128/AAC.48.10.3743-3748.2004; Matos R, 2009, INT J ANTIMICROB AG, V34, P142, DOI 10.1016/j.ijantimicag.2009.02.008; Maynard C, 2003, ANTIMICROB AGENTS CH, V47, P3214, DOI 10.1128/AAC.47.10.3214-3221.2003; Myers GSA, 2006, GENOME RES, V16, P1031, DOI 10.1101/gr.5238106; Neumuller AM, 2001, EUR J BIOCHEM, V268, P3180, DOI 10.1046/j.1432-1327.2001.02203.x; ODONOVAN CA, 1994, DIAGN MICR INFEC DIS, V18, P105, DOI 10.1016/0732-8893(94)90074-4; Pavli V, 2006, BIOL PHARM BULL, V29, P2160, DOI 10.1248/bpb.29.2160; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; Phillips I, 1999, J ANTIMICROB CHEMOTH, V44, P725, DOI 10.1093/jac/44.6.725; Phillips I, 2007, INT J ANTIMICROB AG, V30, P101, DOI 10.1016/j.ijantimicag.2007.02.018; PODLESEK Z, 1995, MOL MICROBIOL, V16, P969, DOI 10.1111/j.1365-2958.1995.tb02322.x; POLLOCK TJ, 1994, J BACTERIOL, V176, P6229, DOI 10.1128/jb.176.20.6229-6237.1994; ROOD JI, 1991, MICROBIOL REV, V55, P621, DOI 10.1128/MMBR.55.4.621-648.1991; Slavic D, 2011, CAN J VET RES, V75, P89; SLOAN J, 1994, MOL MICROBIOL, V11, P403, DOI 10.1111/j.1365-2958.1994.tb00320.x; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; Spigaglia P, 2005, ANTIMICROB AGENTS CH, V49, P2550, DOI 10.1128/AAC.49.6.2550-2553.2005; STONE KJ, 1972, P NATL ACAD SCI USA, V69, P1287, DOI 10.1073/pnas.69.5.1287; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; Thanacoody HKR, 2007, BRIT J CLIN PHARMACO, V64, P566, DOI 10.1111/j.1365-2125.2007.03021.x; Tsuda H, 2002, ANTIMICROB AGENTS CH, V46, P3756, DOI 10.1128/AAC.46.12.3756-3764.2002; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Watkins KL, 1997, VET MICROBIOL, V54, P195, DOI 10.1016/S0378-1135(96)01276-X	56	40	43	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44449	10.1371/journal.pone.0044449	http://dx.doi.org/10.1371/journal.pone.0044449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970221	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400072
J	Ho, WY; Yeap, SK; Ho, CL; Rahim, RA; Alitheen, NB				Ho, Wan Yong; Yeap, Swee Keong; Ho, Chai Ling; Rahim, Raha Abdul; Alitheen, Noorjahan Banu			Development of Multicellular Tumor Spheroid (MCTS) Culture from Breast Cancer Cell and a High Throughput Screening Method Using the MTT Assay	PLOS ONE			English	Article							IN-VITRO; MODEL; GENERATION; INHIBITOR; APOPTOSIS; EVALUATE; THERAPY; GROWTH	In comparison to monolayer cells, MCTS has been claimed as more suitable candidate for studying drug penetration due to the high resemblance to solid tumors. However, the cultivation of MCTS is cumbersome, time consuming, and most technique fail to generate spheroids with uniform sizes. Therefore, the application of spheroid cultures in high throughput screening has been rather limiting. Besides, the lack of a well established screening protocol method that is applicable to spheroid could also be attributed to this limitation. Here we report a simple way of cultivating homogenous MCTS cultures with compact and rigid structure from the MCF-7 cells. Besides, we had also made some modifications to the standard MTT assay to realize high throughput screening of these spheroids. Using the modified protocol, tamoxifen showed cytotoxicity effect towards MCTS cultures from MCF-7 with high consistency. The results correlated well with the cultures' response assessed by LDH release assay but the latter assay was not ideal for detecting a wide range of cytotoxicity due to high basal background reading. The MTT assay emerged as a better indicator to apoptosis event in comparison to the LDH release assay. Therefore, the method for spheroid generation and the modified MTT assay we reported here could be potentially applied to high throughput screening for response of spheroid cultures generated from MCF-7 as well as other cancer cell lines towards cytotoxic stimuli.	[Ho, Wan Yong; Ho, Chai Ling; Rahim, Raha Abdul; Alitheen, Noorjahan Banu] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia; [Yeap, Swee Keong] Univ Putra Malaysia, Inst Biosci, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Ho, WY (corresponding author), Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Dept Cell & Mol Biol, Serdang, Selangor, Malaysia.	noorjahan@biotech.upm.edu.my	Ho, Wan Yong/I-1050-2016; Yeap, Swee Keong/H-9285-2013; Alitheen, Noorjahan/AAL-3713-2020	Ho, Wan Yong/0000-0001-5768-0738; Yeap, Swee Keong/0000-0002-4736-0674; 	Research University Grant Scheme under Universiti Putra Malaysia (UPM) [05-01-09-0796RU]; Malaysian Toray Science Foundation (MTSF)	Research University Grant Scheme under Universiti Putra Malaysia (UPM); Malaysian Toray Science Foundation (MTSF)	This research and development project was funded by the Research University Grant Scheme (Project No: 05-01-09-0796RU) under Universiti Putra Malaysia (UPM) and Malaysian Toray Science Foundation (MTSF) grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron M, 2012, ECOTOXICOLOGY, P1; Braidy N, 2009, INT J TRYPTOPHAN RES, V2, P61; Ciurana CLF, 2004, EUR J IMMUNOL, V34, P2609, DOI 10.1002/eji.200425045; Dufau I, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-15; Fracasso G, 2000, CRIT REV ONCOL HEMAT, V36, P159, DOI 10.1016/S1040-8428(00)00084-6; Herrmann R, 2008, J BIOMOL SCREEN, V13, P1, DOI 10.1177/1087057107310442; Ho WY, 2011, J MED PLANTS RES, V5, P5741; Howes AL, 2007, MOL CANCER THER, V6, P2505, DOI 10.1158/1535-7163.MCT-06-0698; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Jin C, 2010, BIOMEDICINE PHARMACO; Kelm JM, 2003, BIOTECHNOL BIOENG, V83, P173, DOI 10.1002/bit.10655; Khaitan D, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-12; Kim JB, 2004, BREAST CANCER RES TR, V85, P281, DOI 10.1023/B:BREA.0000025418.88785.2b; Kunz-Schughart LA, 2004, J BIOMOL SCREEN, V9, P273, DOI 10.1177/1087057104265040; Lam JT, 2007, CANCER GENE THER, V14, P421, DOI 10.1038/sj.cgt.7701028; Lee J, 2009, BIOMATERIALS, V30, P4687, DOI 10.1016/j.biomaterials.2009.05.024; Madsen SJ, 2006, LASER SURG MED, V38, P555, DOI 10.1002/lsm.20350; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mueller-Klieser W, 2000, CRIT REV ONCOL HEMAT, V36, P123, DOI 10.1016/S1040-8428(00)00082-2; Nigro P, 2007, LIFE SCI, V81, P873, DOI 10.1016/j.lfs.2007.07.010; Onozuka H, 2011, CANCER SCI, V102, P975, DOI 10.1111/j.1349-7006.2011.01880.x; Scherliess R, 2011, INT J PHARMACEUT, V411, P98, DOI 10.1016/j.ijpharm.2011.03.053; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; Xiao Yan, 2007, Ai Zheng, V26, P386	25	116	122	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44640	10.1371/journal.pone.0044640	http://dx.doi.org/10.1371/journal.pone.0044640			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970274	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400099
J	Hohn, C; Petrie-Hanson, L				Hohn, Claudia; Petrie-Hanson, Lora			Rag1(-/-) Mutant Zebrafish Demonstrate Specific Protection following Bacterial Re-Exposure	PLOS ONE			English	Article							ADAPTIVE IMMUNITY; ENTERIC SEPTICEMIA; INNATE; MODEL; RESPONSES; RECEPTOR; GENES	Background: Recombination activation gene 1 deficient (rag1(-/-)) mutant zebrafish have a reduced lymphocyte-like cell population that lacks functional B and T lymphocytes of the acquired immune system, but includes Natural Killer (NK)-like cells and Non-specific cytotoxic cells (NCC) of the innate immune system. The innate immune system is thought to lack the adaptive characteristics of an acquired immune system that provide enhanced protection to a second exposure of the same pathogen. It has been shown that NK cells have the ability to mediate adaptive immunity to chemical haptens and cytomegalovirus in murine models. In this study we evaluated the ability of rag1(-/-) mutant zebrafish to mount a protective response to the facultative intracellular fish bacterium Edwardsiella ictaluri. Methodology/Principal Findings: Following secondary challenge with a lethal dose of homologous bacteria 4 and 8 weeks after a primary vaccination, rag1(-/-) mutant zebrafish demonstrated protective immunity. Heterologous bacterial exposures did not provide protection. Adoptive leukocyte transfers from previously exposed mutants conferred protective immunity to naive mutants when exposed to homologous bacteria. Conclusions/Significance: Our findings show that a component of the innate immune system mounted a response that provided significantly increased survival when rag1(-/-) mutant zebrafish were re-exposed to the same bacteria. Further, adoptive cell transfers demonstrated that kidney interstitial leukocytes from previously exposed rag1-/-mutant zebrafish transferred this protective immunity. This is the first report of any rag1(-/-) mutant vertebrate mounting a protective secondary immune response to a bacterial pathogen, and demonstrates that a type of zebrafish innate immune cell can mediate adaptive immunity in the absence of T and B cells.	[Hohn, Claudia; Petrie-Hanson, Lora] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA	Mississippi State University	Hohn, C (corresponding author), Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS 39762 USA.	lora@cvm.msstate.edu						Bengten E, 2006, DEV COMP IMMUNOL, V30, P77, DOI 10.1016/j.dci.2005.06.016; Boudinot P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022022; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Cannon JP, 2008, IMMUNITY, V29, P228, DOI 10.1016/j.immuni.2008.05.018; Esin S, 2008, INFECT IMMUN, V76, P1719, DOI 10.1128/IAI.00870-07; Hohn C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004314; Jima DD, 2009, MOL IMMUNOL, V46, P1505, DOI 10.1016/j.molimm.2008.12.021; Klesius PH, 1999, ADV VETER MED AP, V41, P523; Kroemer A, 2008, J IMMUNOL, V180, P7818, DOI 10.4049/jimmunol.180.12.7818; Laing KJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-42; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2009, NAT REV IMMUNOL, V9, P302, DOI 10.1038/nri2547; Mackey RB, 2002, SPECIFICITY DEV CHAN; Neely MN, 2002, INFECT IMMUN, V70, P3904, DOI 10.1128/IAI.70.7.3904-3914.2002; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Paust S, 2011, NAT IMMUNOL, V12, P500, DOI 10.1038/ni.2032; Paust S, 2010, IMMUNOL REV, V235, P286, DOI 10.1111/j.0105-2896.2010.00906.x; Petrie-Hanson L, 2007, J AQUAT ANIM HEALTH, V19, P151, DOI 10.1577/H06-026.1; Petrie-Hanson L, 2001, VET IMMUNOL IMMUNOP, V81, P113, DOI 10.1016/S0165-2427(01)00331-2; Petrie-Hanson L, 1999, FISH SHELLFISH IMMUN, V9, P579, DOI 10.1006/fsim.1999.0215; Petrie-Hanson L, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-8; Pressley ME, 2005, DEV COMP IMMUNOL, V29, P501, DOI 10.1016/j.dci.2004.10.007; ROSS AJ, 1966, CAN J MICROBIOL, V12, P763, DOI 10.1139/m66-103; Sha ZX, 2009, DEV COMP IMMUNOL, V33, P991, DOI 10.1016/j.dci.2009.04.004; Stavnezer J, 2004, SEMIN IMMUNOL, V16, P257, DOI 10.1016/j.smim.2004.08.005; Sun JC, 2010, IMMUNOL REV, V236, P83, DOI 10.1111/j.1600-065X.2010.00900.x; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Ugolini S, 2009, NATURE, V457, P544, DOI 10.1038/457544a; van der Aa LM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-7; van der Sar AM, 2003, CELL MICROBIOL, V5, P601, DOI 10.1046/j.1462-5822.2003.00303.x; Vivier E, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00018; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Whyte SK, 2007, FISH SHELLFISH IMMUN, V23, P1127, DOI 10.1016/j.fsi.2007.06.005; Wienholds E, 2002, SCIENCE, V297, P99, DOI 10.1126/science.1071762; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Yoder JA, 2008, IMMUNOGENETICS, V60, P257, DOI 10.1007/s00251-008-0285-3; Yoder JA, 2009, DEV COMP IMMUNOL, V33, P135, DOI 10.1016/j.dci.2008.09.004	37	32	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44451	10.1371/journal.pone.0044451	http://dx.doi.org/10.1371/journal.pone.0044451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970222	gold, Green Published, Green Submitted			2022-12-25	WOS:000308458400073
J	Crowley, BE; McGoogan, KC; Lehman, SM				Crowley, Brooke E.; McGoogan, Keriann C.; Lehman, Shawn M.			Edge Effects on Foliar Stable Isotope Values in a Madagascan Tropical Dry Forest	PLOS ONE			English	Article							CARBON-ISOTOPE; NATURAL-ABUNDANCE; RAIN-FOREST; NITROGEN; PLANTS; SOIL; FRAGMENTATION; VEGETATION; N-15; PATTERNS	Edge effects represent an inevitable and important consequence of habitat loss and fragmentation. These effects include changes in microclimate, solar radiation, or temperature. Such abiotic effects can, in turn, impact biotic factors. They can have a substantial impact on species, communities, and ecosystems. Here we examine clinal variations in stable carbon and nitrogen isotope values for trees along an edge-interior gradient in the dry deciduous forest at Ankarafantsika National Park. We predicted that soil respiration and differences in solar irradiance would result in stratified delta C-13 values where leaves collected close to the forest floor would have lower delta C-13 values than those growing higher up in the canopy. We also anticipated that plants growing at the savannah-forest boundary would have higher delta C-13 and delta N-15 values than plants growing in the forest interior. As expected, we detected a small but significant canopy effect. Leaves growing below 2 m from the forest floor exhibit delta C-13 values that are, on average, 1.1% lower than those growing above this threshold. We did not, however, find any relationship between foliar delta C-13 and distance from the edge. Unpredictably, we detected a striking positive relationship between foliar delta N-15 values and increasing distance into the forest interior. Variability in physiology among species, anthropogenic influence, organic input, and rooting depth cannot adequately explain this trend. Instead, this unexpected relationship most likely reflects decreasing nutrient or water availability, or a shift in N-sources with increasing distance from the savannah. Unlike most forest communities, the trees at Ampijoroa are growing in nutrient-limited sands. In addition to being nutrient poor, these well-drained soils likely decrease the amount of soil water available to forest vegetation. Continued research on plant responses to edge effects will improve our understanding of the conservation biology of forest ecosystems in Madagascar.	[Crowley, Brooke E.] Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA; [Crowley, Brooke E.] Univ Cincinnati, Dept Anthropol, Cincinnati, OH 45221 USA; [McGoogan, Keriann C.; Lehman, Shawn M.] Univ Toronto, Dept Anthropol, Toronto, ON M5S 1A1, Canada	University of Cincinnati; University of Cincinnati; University of Toronto	Crowley, BE (corresponding author), Univ Cincinnati, Dept Geol, Cincinnati, OH 45221 USA.	brooke.crowley@uc.edu		Crowley, Brooke/0000-0002-8462-6806; Lehman, Shawn/0000-0003-0191-7139	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this project was provided by an NSERC Discovery Grant awarded to SML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso LA, 2002, MADAGASCAR RAP B BIO, V23, P28; Amundson R, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001903; Aranibar JN, 2008, J ARID ENVIRON, V72, P326, DOI 10.1016/j.jaridenv.2007.06.007; Aranibar JN, 2004, GLOBAL CHANGE BIOL, V10, P359, DOI 10.1111/j.1365-2486.2003.00698.x; Bloesch U, 1999, APPL VEG SCI, V2, P117, DOI 10.2307/1478888; Bond WJ, 2008, J BIOGEOGR, V35, P1743, DOI 10.1111/j.1365-2699.2008.01923.x; BROADMEADOW MSJ, 1992, OECOLOGIA, V89, P435, DOI 10.1007/BF00317423; Brundrett MC, 2009, PLANT SOIL, V320, P37, DOI 10.1007/s11104-008-9877-9; Codron J, 2005, J ARCHAEOL SCI, V32, P1757, DOI 10.1016/j.jas.2005.06.006; Crowley BE, 2011, J BIOGEOGR, V38, P2106, DOI 10.1111/j.1365-2699.2011.02551.x; Dignan P, 2003, FOREST ECOL MANAG, V179, P95, DOI 10.1016/S0378-1127(02)00491-7; DuPuy DJ, 1996, COLLOQ SEMI, P205; EHLERINGER JR, 1986, OECOLOGIA, V70, P520, DOI 10.1007/BF00379898; Elmqvist T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000402; Evans RD, 2007, ECOL METHOD CONCEPT, P83, DOI 10.1002/9780470691854.ch4; EVANS RD, 1994, OECOLOGIA, V99, P233, DOI 10.1007/BF00627735; Ewers RM, 2006, BIOL REV, V81, P117, DOI 10.1017/S1464793105006949; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fox-Dobbs K, 2010, ECOLOGY, V91, P1296, DOI 10.1890/09-0653.1; Gade DW, 1996, MT RES DEV, V16, P101, DOI 10.2307/3674005; GARTEN CT, 1992, OECOLOGIA, V90, P1, DOI 10.1007/BF00317801; Gascon C, 2000, SCIENCE, V288, P1356, DOI 10.1126/science.288.5470.1356; Gehlhausen SM, 2000, PLANT ECOL, V147, P21, DOI 10.1023/A:1009846507652; Handley LL, 1999, AUST J PLANT PHYSIOL, V26, P185, DOI 10.1071/PP98146; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Harper KA, 2005, CONSERV BIOL, V19, P768, DOI 10.1111/j.1523-1739.2005.00045.x; Hartley MJ, 1998, CONSERV BIOL, V12, P465, DOI 10.1046/j.1523-1739.1998.96373.x; KAPOS V, 1993, J ECOL, V81, P425, DOI 10.2307/2261521; KOECHLIN J, 1972, P145; Kohn MJ, 2010, P NATL ACAD SCI USA, V107, P19691, DOI 10.1073/pnas.1004933107; Kolb KJ, 2002, NEW PHYTOL, V156, P57, DOI 10.1046/j.1469-8137.2002.00490.x; LAURANCE WF, 1991, BIOL CONSERV, V57, P205, DOI 10.1016/0006-3207(91)90139-Z; Lehman SM, 2006, INT J PRIMATOL, V27, P1569, DOI 10.1007/s10764-006-9099-z; Lehman SM, 2006, AM J PHYS ANTHROPOL, V129, P232, DOI 10.1002/ajpa.20241; Lehtinen RM, 2003, BIODIVERS CONSERV, V12, P1357, DOI 10.1023/A:1023673301850; Leopold A., 1933, GAME MANAGEMENT; Li QL, 2007, FOREST ECOL MANAG, V242, P99, DOI 10.1016/j.foreco.2006.11.022; Lipson D, 2001, OECOLOGIA, V128, P305, DOI 10.1007/s004420100693; Lourenco WR, 2006, ZOOL ANZ, V244, P181, DOI 10.1016/j.jcz.2005.09.001; Martinelli LA, 1999, BIOGEOCHEMISTRY, V46, P45, DOI 10.1023/A:1006100128782; McGoogan K. C., 2011, EDGE EFFECTS BEHAV E; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Muzuka ANN, 1999, J AFR EARTH SCI, V28, P757, DOI 10.1016/S0899-5362(99)00044-5; Pardo LH, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P221, DOI 10.1007/978-90-481-3354-3_11; Pons P, 2003, OSTRICH, V74, P146, DOI 10.2989/00306520309485386; Ramanamanjato JB, 2001, ANIM CONSERV, V4, P175, DOI 10.1017/S1367943001001202; Rendigs A, 2003, INT J PRIMATOL, V24, P47, DOI 10.1023/A:1021494428294; Riitters K, 2000, CONSERV ECOL, V4, DOI 10.5751/ES-00209-040203; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Schulze ED, 1998, AUST J PLANT PHYSIOL, V25, P413, DOI 10.1071/PP97113; SELLES F, 1986, SOIL SCI SOC AM J, V50, P105, DOI 10.2136/sssaj1986.03615995005000010020x; SHEARER G, 1978, SOIL SCI SOC AM J, V42, P899, DOI 10.2136/sssaj1978.03615995004200060013x; Swap RJ, 2004, GLOBAL CHANGE BIOL, V10, P350, DOI 10.1111/j.1365-2486.2003.00702.x; Turner IM, 1996, J APPL ECOL, V33, P200, DOI 10.2307/2404743; VANDERMERWE NJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1091, DOI 10.1016/0016-7037(89)90213-5; Vincelette, 2007, BIODIVERSITY ECOLOGY, P337; Watson JEM, 2004, BIOL CONSERV, V120, P311, DOI 10.1016/j.biocon.2004.03.004; Wiedemeier DB, 2012, J BIOGEOGR, V39, P247, DOI 10.1111/j.1365-2699.2011.02583.x; Wilcove D, 1997, HUMAN IMPACT READER, P237; Williams-Linera G, 2009, BIODIVERS CONSERV, V18, P3269, DOI 10.1007/s10531-009-9641-3; Wooller MJ, 2005, OECOLOGIA, V145, P100, DOI 10.1007/s00442-005-0105-5	63	19	19	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44538	10.1371/journal.pone.0044538	http://dx.doi.org/10.1371/journal.pone.0044538			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973460	Green Published, gold, Green Submitted			2022-12-25	WOS:000308577600067
J	Roth, SD; Schuttrumpf, J; Milanov, P; Abriss, D; Ungerer, C; Quade-Lyssy, P; Simpson, JC; Pepperkok, R; Seifried, E; Tonn, T				Roth, Stefanie D.; Schuettrumpf, Joerg; Milanov, Peter; Abriss, Daniela; Ungerer, Christopher; Quade-Lyssy, Patricia; Simpson, Jeremy C.; Pepperkok, Rainer; Seifried, Erhard; Tonn, Torsten			Chemical Chaperones Improve Protein Secretion and Rescue Mutant Factor VIII in Mice with Hemophilia A	PLOS ONE			English	Article							COAGULATION-FACTOR-VIII; GENE-THERAPY; MOUSE MODEL; FACTOR-V; TRAFFICKING; RECOMBINANT; EXPRESSION; MUTATIONS; BETAINE; DISEASE	Inefficient intracellular protein trafficking is a critical issue in the pathogenesis of a variety of diseases and in recombinant protein production. Here we investigated the trafficking of factor VIII (FVIII), which is affected in the coagulation disorder hemophilia A. We hypothesized that chemical chaperones may be useful to enhance folding and processing of FVIII in recombinant protein production, and as a therapeutic approach in patients with impaired FVIII secretion. A tagged B-domain-deleted version of human FVIII was expressed in cultured Chinese Hamster Ovary cells to mimic the industrial production of this important protein. Of several chemical chaperones tested, the addition of betaine resulted in increased secretion of FVIII, by increasing solubility of intracellular FVIII aggregates and improving transport from endoplasmic reticulum to Golgi. Similar results were obtained in experiments monitoring recombinant full-length FVIII. Oral betaine administration also increased FVIII and factor IX (FIX) plasma levels in FVIII or FIX knockout mice following gene transfer. Moreover, in vitro and in vivo applications of betaine were also able to rescue a trafficking-defective FVIII mutant (FVIIIQ305P). We conclude that chemical chaperones such as betaine might represent a useful treatment concept for hemophilia and other diseases caused by deficient intracellular protein trafficking.	[Roth, Stefanie D.; Schuettrumpf, Joerg; Milanov, Peter; Abriss, Daniela; Ungerer, Christopher; Quade-Lyssy, Patricia; Seifried, Erhard; Tonn, Torsten] Clin Johann Wolfgang Goethe Univ, Inst Transfus Med & Immune Hematol, German Red Cross Blood Donor Serv Baden Wuerttemb, Frankfurt, Hesse, Germany; [Schuettrumpf, Joerg] Biomed Res Inst Georg Speyer Haus, Frankfurt, Hesse, Germany; [Simpson, Jeremy C.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland; [Pepperkok, Rainer] European Mol Biol Lab, Cell Biol & Biophys Dept, Heidelberg, Baden Wuerttemb, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University College Dublin; European Molecular Biology Laboratory (EMBL)	Roth, SD (corresponding author), Clin Johann Wolfgang Goethe Univ, Inst Transfus Med & Immune Hematol, German Red Cross Blood Donor Serv Baden Wuerttemb, Frankfurt, Hesse, Germany.	joerg_schuettrumpf@biotest.de		Simpson, Jeremy/0000-0002-7956-7805; Pepperkok, Rainer/0000-0002-9762-3583; Schuettrumpf, Joerg/0000-0002-8855-4096	Deutsche Forschungsgemeinschaft [GK-1172]; Stiftung Hamotherapie-Forschung e.V.; Excellence Cluster Cardio-Pulmonary System (ECCPS, Deutsche Forschungsgemeinschaft); Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE)Center for Cell and Gene Therapy, Frankfurt; Hessisches Ministerium fur Wissenschaft und Kunst [III L 4-518/17.004]; Bayer	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Stiftung Hamotherapie-Forschung e.V.; Excellence Cluster Cardio-Pulmonary System (ECCPS, Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE)Center for Cell and Gene Therapy, Frankfurt; Hessisches Ministerium fur Wissenschaft und Kunst; Bayer(Bayer AG)	SR, DA, CU and PQL are students within the graduate study program GK-1172 funded by the Deutsche Forschungsgemeinschaft. The research was supported by the Stiftung Hamotherapie-Forschung e.V. to JS. ES and TT received funding through the Excellence Cluster Cardio-Pulmonary System (ECCPS, Deutsche Forschungsgemeinschaft). ES and JS received support from the Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE)Center for Cell and Gene Therapy, Frankfurt, funded by the Hessisches Ministerium fur Wissenschaft und Kunst, funding reference number: III L 4-518/17.004 (2010). JS receives funding from Bayer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Becker S, 2004, THROMB HAEMOSTASIS, V92, P23, DOI 10.1160/th03-06-0360; Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615; BI L, 1995, NAT GENET, V10, P119, DOI 10.1038/ng0595-119; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Chen ZY, 2005, HUM GENE THER, V16, P126, DOI 10.1089/hum.2005.16.126; CHUAH MKL, 1995, HUM GENE THER, V6, P1363, DOI 10.1089/hum.1995.6.11-1363; Collins P, 2010, J THROMB HAEMOST, V8, P83, DOI 10.1111/j.1538-7836.2009.03650.x; Connelly S, 1998, BLOOD, V91, P3273, DOI 10.1182/blood.V91.9.3273.3273_3273_3281; Dooriss KL, 2009, HUM GENE THER, V20, P465, DOI 10.1089/hum.2008.150; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Engin F, 2010, DIABETES OBES METAB, V12, P108, DOI 10.1111/j.1463-1326.2010.01282.x; Enjolras N, 2004, J THROMB HAEMOST, V2, P1143, DOI 10.1111/j.1538-7836.2004.00756.x; Fakharzadeh SS, 2000, SEMIN THROMB HEMOST, V26, P167, DOI 10.1055/s-2000-9819; Furusho K, 2005, NEUROBIOL DIS, V20, P170, DOI 10.1016/j.nbd.2005.02.011; Graw J, 2005, NAT REV GENET, V6, P488, DOI 10.1038/nrg1617; Guillet B, 2006, HUM MUTAT, V27, P676, DOI 10.1002/humu.20345; Heinz S, 2009, THROMB HAEMOSTASIS, V102, P925, DOI 10.1160/TH08-12-0807; Jia LY, 2009, INVEST OPHTH VIS SCI, V50, P3743, DOI 10.1167/iovs.08-3151; Leandro P, 2008, MINI-REV MED CHEM, V8, P901, DOI 10.2174/138955708785132783; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Miao HZ, 2004, BLOOD, V103, P3412, DOI 10.1182/blood-2003-10-3591; Mitta B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf112; Mulugeta S, 2007, AM J PHYSIOL-LUNG C, V293, pL720, DOI 10.1152/ajplung.00025.2007; Norez C, 2006, TRAFFIC, V7, P562, DOI 10.1111/j.1600-0854.2006.00409.x; O'Mahony B, 2005, SEMIN THROMB HEMOST, V31, P561, DOI 10.1055/s-2005-922228; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Pipe SW, 1998, J BIOL CHEM, V273, P8537, DOI 10.1074/jbc.273.14.8537; PITTMAN DD, 1993, BLOOD, V81, P2925; Plantier JL, 2005, THROMB HAEMOSTASIS, V93, P824, DOI 10.1160/TH04-09-0579; Rajan RS, 2011, CURR MED CHEM, V18, P1; Rubenstein RC, 1998, AM J RESP CRIT CARE, V157, P484, DOI 10.1164/ajrccm.157.2.9706088; Ryu JS, 2000, BIOTECHNOL BIOENG, V70, P167, DOI 10.1002/1097-0290(20001020)70:2<167::AID-BIT6>3.0.CO;2-P; Santana A, 2003, P NATL ACAD SCI USA, V100, P7277, DOI 10.1073/pnas.1131968100; Schatz SM, 2004, BRIT J HAEMATOL, V125, P629, DOI 10.1111/j.1365-2141.2004.04959.x; Schuettrumpf J, 2005, BLOOD, V105, P2316, DOI 10.1182/blood-2004-08-2990; Schuttrumpf J, 2011, HUM GENE THER, V22, P101, DOI 10.1089/hum.2009.212; Schwab U, 2006, J NUTR, V136, P34, DOI 10.1093/jn/136.1.34; Singh LR, 2007, MOL GENET METAB, V91, P335, DOI 10.1016/j.ymgme.2007.04.011; Soukharev S, 2002, BLOOD CELL MOL DIS, V28, P234, DOI 10.1006/bcmd.2002.0508; Swaroop M, 1997, J BIOL CHEM, V272, P24121, DOI 10.1074/jbc.272.39.24121; Tamarappoo BK, 1998, J CLIN INVEST, V101, P2257, DOI 10.1172/JCI2303; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Tonn T, 2002, J HEMATOTH STEM CELL, V11, P695, DOI 10.1089/15258160260194848; Wang JW, 2011, J BIOL CHEM, V286, P24180, DOI 10.1074/jbc.M110.215194; Zeisel SH, 2003, J NUTR, V133, P1302; Zhang B, 2006, BLOOD, V107, P1903, DOI 10.1182/blood-2005-09-3620; Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200; Zhang XM, 2003, J BIOL CHEM, V278, P51232, DOI 10.1074/jbc.M309076200	51	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44505	10.1371/journal.pone.0044505	http://dx.doi.org/10.1371/journal.pone.0044505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973456	Green Submitted, gold, Green Published			2022-12-25	WOS:000308577600063
J	Ye, MM; Yang, YL; Zhang, Y; Zhang, TQ; Shao, WY				Ye, Miaomiao; Yang, Yulong; Zhang, Yan; Zhang, Tuqiao; Shao, Weiyun			Hydrothermal Synthesis of Hydrangea-Like F-Doped Titania Microspheres for the Photocatalytic Degradation of Carbamazepine under UV and Visible Light Irradiation	JOURNAL OF NANOMATERIALS			English	Article							TIO2 POWDERS; SURFACE FLUORINATION; FABRICATION; OXIDATION; WATER	Hydrangea-like F-doped TiO2 microspheres have been synthesized on a large scale by a simple hydrothermal process using potassium titanium oxalate as the titanium source, ammonium fluoride and hydrogen peroxide as the etchant. The photocatalytic activities were evaluated using carbamazepine as the target organic molecule under UV and visible light irradiation. Structural characterization indicates that the hydrangea-like TiO2 microspheres, with an average diameter of 2.80 mu m, are composed of numerous anatase TiO2 petals. Moreover, it is found that both the NH4F and H2O2 dosages have important effects on the formation of the hydrangea-like structures. In addition, photocatalytic experiments show that the hydrangea-like TiO2 microspheres calcined at 500 degrees C exhibit high photocatalytic efficiency under both UV and visible light irradiation. The enhanced photocatalytic activity can be attributed to the successful fluorine doping, good crystallinity, and the unique nanostructures.	[Ye, Miaomiao; Yang, Yulong; Zhang, Yan; Zhang, Tuqiao; Shao, Weiyun] Zhejiang Univ, Inst Municipal Engn, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Shao, WY (corresponding author), Zhejiang Univ, Inst Municipal Engn, Hangzhou 310058, Zhejiang, Peoples R China.	shaowy@zju.edu.cn	Fei, Zhangjun/H-5152-2012; Ye, Miaomiao/A-9123-2016; Ye, Miaomiao/G-8865-2015	Ye, Miaomiao/0000-0002-5546-1133; 	National Natural Science Foundation of China [51108406]; Fundamental Research Funds for the Central Universities [2011FZA4022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the National Natural Science Foundation of China (Grant no. 51108406) and the Fundamental Research Funds for the Central Universities (2011FZA4022), to the authors we are grateful.	Chen YJ, 2008, APPL CATAL B-ENVIRON, V80, P147, DOI 10.1016/j.apcatb.2007.11.010; Guo YP, 2011, J NANOMATER, V2011, DOI 10.1155/2011/296953; Huo YN, 2009, APPL CATAL B-ENVIRON, V89, P543, DOI 10.1016/j.apcatb.2009.01.019; Li XZ, 2003, ENVIRON SCI TECHNOL, V37, P3989, DOI 10.1021/es0262941; Liu SW, 2011, CHEM MATER, V23, P4085, DOI 10.1021/cm200597m; Liu SW, 2010, J AM CHEM SOC, V132, P11914, DOI 10.1021/ja105283s; Liu ZY, 2007, CHEM-EUR J, V13, P1851, DOI 10.1002/chem.200601092; Livraghi S, 2006, J AM CHEM SOC, V128, P15666, DOI 10.1021/ja064164c; Markowska-Szczupak A, 2011, CATAL TODAY, V169, P249, DOI 10.1016/j.cattod.2010.11.055; Pan JH, 2008, J AM CHEM SOC, V130, P11256, DOI 10.1021/ja803582m; Park H, 2004, J PHYS CHEM B, V108, P4086, DOI 10.1021/jp036735i; Ryu J, 2004, ENVIRON SCI TECHNOL, V38, P2928, DOI 10.1021/es034725p; Sakthivel S, 2004, J PHYS CHEM B, V108, P19384, DOI 10.1021/jp046857q; SERPONE N, 1995, J PHYS CHEM-US, V99, P16646, DOI 10.1021/j100045a026; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Xiang QJ, 2011, CHEM COMMUN, V47, P4532, DOI 10.1039/c1cc10501a; Xie Y, 2007, J MOL CATAL A-CHEM, V277, P119, DOI 10.1016/j.molcata.2007.07.031; Yang GD, 2010, APPL CATAL B-ENVIRON, V96, P458, DOI 10.1016/j.apcatb.2010.03.004; Yang HM, 2009, J MATER CHEM, V19, P6907, DOI 10.1039/b911709a; Ye MM, 2011, MATER LETT, V65, P2384, DOI 10.1016/j.matlet.2011.04.073; Ye MM, 2010, J HAZARD MATER, V184, P612, DOI 10.1016/j.jhazmat.2010.08.080; Ye MM, 2010, CHEM-EUR J, V16, P6243, DOI 10.1002/chem.200903516; Ye MM, 2009, J HAZARD MATER, V167, P1021, DOI 10.1016/j.jhazmat.2009.01.091; Yu JC, 2002, CHEM MATER, V14, P3808, DOI 10.1021/cm020027c; Yu JG, 2006, J MOL CATAL A-CHEM, V246, P176, DOI 10.1016/j.molcata.2005.10.034; Yu JG, 2007, J PHYS CHEM C, V111, P10582, DOI 10.1021/jp0707889; Yu JG, 2006, ADV FUNCT MATER, V16, P2035, DOI 10.1002/adfm.200600552; Yu JG, 2009, J PHYS CHEM C, V113, P6743, DOI 10.1021/jp900136q	28	644	663	22	198	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	1687-4110	1687-4129		J NANOMATER	J. Nanomater.		2012	2012								583417	10.1155/2012/583417	http://dx.doi.org/10.1155/2012/583417			8	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Materials Science	908GX	22984514	Green Submitted, gold			2022-12-25	WOS:000301480000001
J	Abutbul-Ionita, I; Rujiviphat, J; Nir, I; McQuibban, GA; Danino, D				Abutbul-Ionita, Inbal; Rujiviphat, Jarungjit; Nir, Iftach; McQuibban, G. Angus; Danino, Dganit			Membrane Tethering and Nucleotide-dependent Conformational Changes Drive Mitochondrial Genome Maintenance (Mgm1) Protein-mediated Membrane Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; DYNAMIN; GTP; CONSTRICTION; TUBULATION; FISSION; ENDOCYTOSIS; HYDROLYSIS; MECHANISM; STALK	Cellular membrane remodeling events such as mitochondrial dynamics, vesicle budding, and cell division rely on the large GTPases of the dynamin superfamily. Dynamins have long been characterized as fission molecules; however, how they mediate membrane fusion is largely unknown. Here we have characterized by cryo-electron microscopy and in vitro liposome fusion assays how the mitochondrial dynamin Mgm1 may mediate membrane fusion. Using cryo-EM, we first demonstrate that the Mgm1 complex is able to tether opposing membranes to a gap of similar to 15 nm, the size of mitochondrial cristae folds. We further show that the Mgm1 oligomer undergoes a dramatic GTP-dependent conformational change suggesting that s-Mgm1 interactions could overcome repelling forces at fusion sites and that ultrastructural changes could promote the fusion of opposing membranes. Together our findings provide mechanistic details of the two known in vivo functions of Mgm1, membrane fusion and cristae maintenance, and more generally shed light onto how dynamins may function as fusion proteins.	[Rujiviphat, Jarungjit; McQuibban, G. Angus] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Abutbul-Ionita, Inbal; Nir, Iftach; Danino, Dganit] Technion Israel Inst Technol, Dept Biotechnol & Food Engn Technion, IL-32000 Haifa, Israel; [Danino, Dganit] Technion Israel Inst Technol, Russell Berrie Nanotechnol Inst, IL-32000 Haifa, Israel	University of Toronto; Technion Israel Institute of Technology; Technion Israel Institute of Technology	McQuibban, GA (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	angus.mcquibban@utoronto.ca; dganitd@tx.technion.ac.il	Danino, Dganit/D-6832-2016	Danino, Dganit/0000-0002-9782-4940; Ionita, Inbal/0000-0001-7359-0142	Canadian Institutes of Health Research; Israel Science Foundation; Charles H. Revson Foundation [530/03]; Russell Berrie Nanotechnology Institute at the Technion	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Israel Science Foundation(Israel Science Foundation); Charles H. Revson Foundation; Russell Berrie Nanotechnology Institute at the Technion	Supported by an Operating Grant from the Canadian Institutes of Health Research. To whom correspondence may be addressed. E-mail: angus.mcquibban@utoronto.ca.; Supported by the Israel Science Foundation, the Charles H. Revson Foundation (Grant 530/03), and the Russell Berrie Nanotechnology Institute at the Technion. To whom correspondence may be addressed. E-mail: dganitd@tx.technion.ac.il.	Avinoam O, 2011, SCIENCE, V332, P589, DOI 10.1126/science.1202333; Ban T, 2010, HUM MOL GENET, V19, P2113, DOI 10.1093/hmg/ddq088; Bueler SA, 2008, BIOCHEMISTRY-US, V47, P11804, DOI 10.1021/bi801665x; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; Danino D, 2001, COLLOID SURFACE A, V183, P113, DOI 10.1016/S0927-7757(01)00543-X; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020; He B, 2010, MOL BIOL CELL, V21, P610, DOI 10.1091/mbc.E09-05-0440; Ingerman E, 2005, J CELL BIOL, V170, P1021, DOI 10.1083/jcb.200506078; Lenz M, 2009, FEBS LETT, V583, P3839, DOI 10.1016/j.febslet.2009.11.012; Low HH, 2009, CELL, V139, P1342, DOI 10.1016/j.cell.2009.11.003; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Marsden HR, 2011, CHEM SOC REV, V40, P1572, DOI 10.1039/c0cs00115e; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Meglei G, 2009, BIOCHEMISTRY-US, V48, P1774, DOI 10.1021/bi801723d; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Rujiviphat J, 2009, J BIOL CHEM, V284, P28682, DOI 10.1074/jbc.M109.044933; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; von der Malsburg A, 2011, J BIOL CHEM, V286, P37858, DOI 10.1074/jbc.M111.249037; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; Zick M, 2009, FEBS LETT, V583, P2237, DOI 10.1016/j.febslet.2009.05.053	32	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 26	2012	287	44					36634	36638		10.1074/jbc.C112.406769	http://dx.doi.org/10.1074/jbc.C112.406769			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	030RT	22977249	hybrid, Green Published			2022-12-25	WOS:000310588500001
J	Balasubramanian, S; Quinones, L; Kasiganesan, H; Zhang, YH; Pleasant, DL; Sundararaj, KP; Zile, MR; Bradshaw, AD; Kuppuswamy, D				Balasubramanian, Sundaravadivel; Quinones, Lakeya; Kasiganesan, Harinath; Zhang, Yuhua; Pleasant, Dorea L.; Sundararaj, Kamala P.; Zile, Michael R.; Bradshaw, Amy D.; Kuppuswamy, Dhandapani			beta 3 Integrin in Cardiac Fibroblast Is Critical for Extracellular Matrix Accumulation during Pressure Overload Hypertrophy in Mouse	PLOS ONE			English	Article							FOCAL ADHESION KINASE; BETA(3) INTEGRIN; TYROSINE KINASE; ALPHA(V)BETA(3) INTEGRIN; CELL-ADHESION; ACTIVATION; GROWTH; SRC; SURVIVAL; COMPLEX	The adhesion receptor beta 3 integrin regulates diverse cellular functions in various tissues. As beta 3 integrin has been implicated in extracellular matrix (ECM) remodeling, we sought to explore the role of beta 3 integrin in cardiac fibrosis by using wild type (WT) and b3 integrin null (beta 3-/-) mice for in vivo pressure overload (PO) and in vitro primary cardiac fibroblast phenotypic studies. Compared to WT mice, beta 3-/- mice upon pressure overload hypertrophy for 4 wk by transverse aortic constriction (TAC) showed a substantially reduced accumulation of interstitial fibronectin and collagen. Moreover, pressure overloaded LV from beta 3-/- mice exhibited reduced levels of both fibroblast proliferation and fibroblast-specific protein-1 (FSP1) expression in early time points of PO. To test if the observed impairment of ECM accumulation in beta 3-/- mice was due to compromised cardiac fibroblast function, we analyzed primary cardiac fibroblasts from WT and beta 3-/- mice for adhesion to ECM proteins, cell spreading, proliferation, and migration in response to platelet derived growth factor-BB (PDGF, a growth factor known to promote fibrosis) stimulation. Our results showed that beta 3-/- cardiac fibroblasts exhibited a significant reduction in cell-matrix adhesion, cell spreading, proliferation and migration. In addition, the activation of PDGF receptor associated tyrosine kinase and non-receptor tyrosine kinase Pyk2, upon PDGF stimulation were impaired in beta 3-/- cells. Adenoviral expression of a dominant negative form of Pyk2 (Y402F) resulted in reduced accumulation of fibronectin. These results indicate that beta 3 integrin-mediated Pyk2 signaling in cardiac fibroblasts plays a critical role in PO-induced cardiac fibrosis.	[Balasubramanian, Sundaravadivel; Quinones, Lakeya; Kasiganesan, Harinath; Zhang, Yuhua; Pleasant, Dorea L.; Sundararaj, Kamala P.; Zile, Michael R.; Bradshaw, Amy D.; Kuppuswamy, Dhandapani] Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, Charleston, SC 29425 USA; [Zile, Michael R.; Bradshaw, Amy D.] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Balasubramanian, S (corresponding author), Med Univ S Carolina, Gazes Cardiac Res Inst, Dept Med, Div Cardiol, Charleston, SC 29425 USA.	kuppusd@musc.edu		Jenkins, Dorea/0000-0001-9510-8601; Zile, Michael/0000-0001-7076-221X	National Institutes of Health [R01 RHL092124A]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM072643] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by National Institutes of Health R01 RHL092124A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthis NJ, 2011, TRENDS BIOCHEM SCI, V36, P191, DOI 10.1016/j.tibs.2010.11.002; Arslan F, 2011, CIRC RES, V108, P582, DOI 10.1161/CIRCRESAHA.110.224428; Balasubramanian S, 2003, J BIOL CHEM, V278, P42214, DOI 10.1074/jbc.M303428200; Borges E, 2000, J BIOL CHEM, V275, P39867, DOI 10.1074/jbc.M007040200; Bowers SLK, 2010, J MOL CELL CARDIOL, V48, P474, DOI 10.1016/j.yjmcc.2009.08.024; Bradshaw AD, 1999, MOL BIOL CELL, V10, P1569, DOI 10.1091/mbc.10.5.1569; Bradshaw AD, 2009, CIRCULATION, V119, P269, DOI 10.1161/CIRCULATIONAHA.108.773424; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Montero JC, 2011, CLIN CANCER RES, V17, P5546, DOI 10.1158/1078-0432.CCR-10-2616; Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978; Dalla Costa AP, 2010, CARDIOVASC RES, V86, P421, DOI 10.1093/cvr/cvp416; Danen EHJ, 2005, J CELL BIOL, V169, P515, DOI 10.1083/jcb.200412081; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Gil-Henn H, 2007, J CELL BIOL, V178, P1053, DOI 10.1083/jcb.200701148; Gopal U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017649; Gough W, 2011, J BIOMOL SCREEN, V16, P155, DOI 10.1177/1087057110393340; Hauselmann SP, 2011, FREE RADICAL BIO MED, V51, P609, DOI 10.1016/j.freeradbiomed.2011.05.007; Harris BS, 2011, AM J PHYSIOL-HEART C, V301, pH841, DOI 10.1152/ajpheart.01247.2010; Harston RK, 2011, J SIGNAL TRANSDUCT, V2011; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Hsueh WA, 1998, HYPERTENSION, V31, P176, DOI 10.1161/01.HYP.31.1.176; Huntley BK, 2010, J CELL PHYSIOL, V225, P251, DOI 10.1002/jcp.22253; Ishigaki T, 2011, J CELL PHYSIOL, V226, P2617, DOI 10.1002/jcp.22614; Johnston RK, 2009, FASEB J, V23, P2759, DOI 10.1096/fj.08-127480; Kuppuswamy D, 2002, CIRC RES, V90, P1240, DOI 10.1161/01.RES.0000025080.78636.23; Lipinski CA, 2010, EXPERT OPIN THER TAR, V14, P95, DOI 10.1517/14728220903473194; Majhen D, 2011, LIFE SCI, V89, P241, DOI 10.1016/j.lfs.2011.06.009; Manso AM, 2009, J INVEST MED, V57, P856, DOI 10.2310/JIM.0b013e3181c5e61f; Manso AM, 2009, AM J PHYSIOL-HEART C, V296, pH627, DOI 10.1152/ajpheart.00444.2008; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Morgan EA, 2010, FASEB J, V24, P1117, DOI 10.1096/fj.09-138420; Mulgrew K, 2006, MOL CANCER THER, V5, P3122, DOI 10.1158/1535-7163.MCT-06-0356; Murasawa S, 2000, J BIOL CHEM, V275, P26856; Nyberg P, 2008, FRONT BIOSCI, V13, P6537, DOI 10.2741/3173; Ren J, 2007, J MOL CELL CARDIOL, V42, P367, DOI 10.1016/j.yjmcc.2006.11.002; Roe MT, 2008, CIRCULATION, V117, P886, DOI 10.1161/CIRCULATIONAHA.107.759167; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Schneider M, 2007, CARDIOVASC RES, V75, P40, DOI 10.1016/j.cardiores.2007.03.027; Shai SY, 2002, CIRC RES, V90, P458, DOI 10.1161/hh0402.105790; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Stewart JA, 2010, CELL TISSUE RES, V340, P117, DOI 10.1007/s00441-010-0943-2; Suryakumar G, 2010, J CARDIOVASC PHARM, V55, P567, DOI 10.1097/FJC.0b013e3181d9f5d4; Taddei ML, 2011, J PATHOLOGY; WEBER KT, 1992, J AM COLL CARDIOL, V20, P3, DOI 10.1016/0735-1097(92)90130-F; Willey CD, 2003, J MOL CELL CARDIOL, V35, P671, DOI 10.1016/S0022-2828(03)00112-3; Willey CD, 2008, INT J BIOL SCI, V4, P184; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6; Zile MR, 2012, AM J PHYSIOL-HEART C, V302, pH1429, DOI 10.1152/ajpheart.00580.2011	49	38	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45076	10.1371/journal.pone.0045076	http://dx.doi.org/10.1371/journal.pone.0045076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984613	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500114
J	Bano-Polo, M; Baeza-Delgado, C; Orzaez, M; Marti-Renom, MA; Abad, C; Mingarro, I				Bano-Polo, Manuel; Baeza-Delgado, Carlos; Orzaez, Mar; Marti-Renom, Marc A.; Abad, Concepcion; Mingarro, Ismael			Polar/Ionizable Residues in Transmembrane Segments: Effects on Helix-Helix Packing	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; GLYCOPHORIN-A DIMERIZATION; ALPHA-HELICES; BIOLOGICAL MEMBRANE; PROTEIN INTEGRATION; POLAR RESIDUES; ER MEMBRANE; WEB SERVER; ASSOCIATION; SEQUENCE	The vast majority of membrane proteins are anchored to biological membranes through hydrophobic alpha-helices. Sequence analysis of high-resolution membrane protein structures show that ionizable amino acid residues are present in transmembrane (TM) helices, often with a functional and/or structural role. Here, using as scaffold the hydrophobic TM domain of the model membrane protein glycophorin A (GpA), we address the consequences of replacing specific residues by ionizable amino acids on TM helix insertion and packing, both in detergent micelles and in biological membranes. Our findings demonstrate that ionizable residues are stably inserted in hydrophobic environments, and tolerated in the dimerization process when oriented toward the lipid face, emphasizing the complexity of protein-lipid interactions in biological membranes.	[Bano-Polo, Manuel; Baeza-Delgado, Carlos; Abad, Concepcion; Mingarro, Ismael] Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Burjassot, Spain; [Orzaez, Mar] Ctr Invest Principe Felipe, Valencia, Spain; [Marti-Renom, Marc A.] Ctr Nacl Anal Genom, Struct Genom Team, Genome Biol Grp, Barcelona, Spain; [Marti-Renom, Marc A.] Ctr Genom Regulat, Struct Genom Grp, Barcelona, Spain	University of Valencia; Prince Felipe Research Center; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Bano-Polo, M (corresponding author), Univ Valencia, Dept Bioquim & Biol Mol, E-46100 Burjassot, Spain.	Ismael.Mingarro@uv.es	Mingarro, Ismael/B-4745-2014; Orzaez, Mar/B-4992-2014; Baeza-Delgado, Carlos/O-8473-2019; Polo, Manuel Bano/P-5346-2016; Baeza-Delgado, Carlos/U-1452-2018; Marti-Renom, Marc A./Y-8803-2019; Marti-Renom, Marc/A-1836-2010	Mingarro, Ismael/0000-0002-1910-1229; Orzaez, Mar/0000-0003-3231-5835; Polo, Manuel Bano/0000-0002-4840-4480; Baeza-Delgado, Carlos/0000-0001-8551-9124; Marti-Renom, Marc A./0000-0002-0151-4279; Marti-Renom, Marc/0000-0002-0151-4279	Spanish Ministry of Science and Innovation (MICINN) [BFU2009-08401, BFU2010-19310]; European Union; Generalitat Valenciana [PROMETEO/2010/005]; MICINN	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	This work was supported by grants BFU2009-08401 (to IM) and BFU2010-19310 (to MAM-R) from the Spanish Ministry of Science and Innovation (MICINN, ERDF supported by the European Union), as well as by PROMETEO/2010/005 (to IM) from the Generalitat Valenciana. MB-P and CB-D were recipients of FPU and FPI predoctoral fellowships from the MICINN, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeza-Delgado C, 2013, EUR BIOPHYS J BIOPHY, V42, P199, DOI 10.1007/s00249-012-0813-9; Caputo GA, 2004, BIOCHEMISTRY-US, V43, P8794, DOI 10.1021/bi049696p; Chin CN, 2000, J MOL BIOL, V303, P1, DOI 10.1006/jmbi.2000.4122; Cymer F, 2012, BBA-BIOMEMBRANES, V1818, P963, DOI 10.1016/j.bbamem.2011.07.035; DeGrado WF, 2003, PROTEIN SCI, V12, P647, DOI 10.1110/ps.0236503; Duong MT, 2007, J MOL BIOL, V371, P422, DOI 10.1016/j.jmb.2007.05.026; Gafvelin G, 1997, J BIOL CHEM, V272, P6119, DOI 10.1074/jbc.272.10.6119; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Hermansson M, 2003, J MOL BIOL, V334, P803, DOI 10.1016/j.jmb.2003.10.019; Herrmann JR, 2010, J MOL BIOL, V396, P452, DOI 10.1016/j.jmb.2009.11.054; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Illergard K, 2011, PROTEINS, V79, P79, DOI 10.1002/prot.22859; Jayasinghe S, 2001, PROTEIN SCI, V10, P455, DOI 10.1110/ps.43501; JOHANSSON M, 1993, MOL GEN GENET, V239, P251, DOI 10.1007/BF00281625; Johnson RM, 2006, BIOCHEMISTRY-US, V45, P8507, DOI 10.1021/bi060063f; KOLMAR H, 1995, EMBO J, V14, P3895, DOI 10.1002/j.1460-2075.1995.tb00061.x; Langosch D, 1996, J MOL BIOL, V263, P525, DOI 10.1006/jmbi.1996.0595; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; LEMMON MA, 1992, BIOCHEMISTRY-US, V31, P12719, DOI 10.1021/bi00166a002; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; MacKenzie KR, 2006, CHEM REV, V106, P1931, DOI 10.1021/cr0404388; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Martinez-Gil L, 2008, BIOPHYS J, V95, pL36, DOI 10.1529/biophysj.108.138602; Martinez-Gil L, 2011, FEBS J, V278, P3846, DOI 10.1111/j.1742-4658.2011.08185.x; Mingarro I, 1996, PROTEIN SCI, V5, P1339, DOI 10.1002/pro.5560050712; Monne M, 1998, J MOL BIOL, V284, P1177, DOI 10.1006/jmbi.1998.2218; Orzaez M, 2005, FEBS LETT, V579, P1633, DOI 10.1016/j.febslet.2005.01.078; Orzaez M, 2004, J MOL BIOL, V335, P631, DOI 10.1016/j.jmb.2003.10.062; Orzaez M, 2000, PROTEIN SCI, V9, P1246, DOI 10.1110/ps.9.6.1246; POPOT JL, 1990, BIOCHEMISTRY-US, V29, P4031, DOI 10.1021/bi00469a001; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Smith SO, 2001, BIOCHEMISTRY-US, V40, P6553, DOI 10.1021/bi010357v; Sulistijo ES, 2003, J BIOL CHEM, V278, P51950, DOI 10.1074/jbc.M308429200; Tulumello DV, 2009, BIOCHEMISTRY-US, V48, P12096, DOI 10.1021/bi9013819; Vilar M, 2002, J BIOL CHEM, V277, P23447, DOI 10.1074/jbc.M202935200; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Wong WC, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-57; Zhang JM, 2009, BIOPHYS J, V96, P4418, DOI 10.1016/j.bpj.2009.03.008; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	44	23	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44263	10.1371/journal.pone.0044263	http://dx.doi.org/10.1371/journal.pone.0044263			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984481	Green Published, gold			2022-12-25	WOS:000308738500040
J	Hector, A; von Felten, S; Hautier, Y; Weilenmann, M; Bruelheide, H				Hector, Andy; von Felten, Stefanie; Hautier, Yann; Weilenmann, Maja; Bruelheide, Helge			Effects of Dominance and Diversity on Productivity along Ellenberg's Experimental Water Table Gradients	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; PLANT; COMPLEMENTARITY; BIODIVERSITY; SELECTION	Heinz Ellenberg's historically important work on changes in the abundances of a community of grass species growing along experimental gradients of water table depth has played an important role in helping to identify the hydrological niches of plant species in wet meadows. We present a previously unpublished complete version of Ellenberg's dataset from the 1950s together with the results of a series of modern statistical analyses testing for hypothesized overyielding of aboveground net primary production as a consequence of resource-based niche differentiation. Interactions of species with water table depth and soil type in the results of our analyses are qualitatively consistent with earlier interpretations of evidence for differences in the fundamental and realized niches of species. Arrhenatherum elatius tended to dominate communities and this effect was generally positively related to increasing water table depth. There was little overyielding of aboveground net primary production during the two repeats of the experiment conducted in successive single growing seasons. Examination of how the effects of biodiversity on ecosystem processes vary across environmental gradients is an underutilized approach - particularly where the gradient is thought to be an axis of niche differentiation as is the case with water availability. Furthermore, advances in ecology and statistics during the 60 years since Ellenberg's classic experiment was performed suggest that it may be worth repeating over a longer duration and with modern experimental design and methodologies.	[Hector, Andy; von Felten, Stefanie; Hautier, Yann; Weilenmann, Maja] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Hector, Andy] Microsoft Res, Cambridge, England; [Bruelheide, Helge] Univ Halle Wittenberg, Inst Biol Geobot & Bot Garden, Halle, Saale, Germany	University of Zurich; Microsoft; Martin Luther University Halle Wittenberg	Hector, A (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	andrew.hector@uzh.ch	Hector, Andrew/H-4199-2011; von Felten, Stefanie/L-3514-2019; Hautier, Yann/D-5426-2015; Hautier, Yann/I-2526-2019; von Felten, Stefanie/D-2701-2009; Bruelheide, Helge/G-3907-2013	Hector, Andrew/0000-0002-1309-7716; von Felten, Stefanie/0000-0002-5264-6394; Hautier, Yann/0000-0003-4347-7741; Hautier, Yann/0000-0003-4347-7741; Bruelheide, Helge/0000-0003-3135-0356				Auckland P, 1978, 78 CSIRO DIV LAND US, V78, P1; Austin MP, 2006, ECOL MODEL, V199, P197, DOI 10.1016/j.ecolmodel.2006.05.023; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Carroll IT, 2011, ECOLOGY, V92, P1157; Ellenberg H., 1953, BER DT BOT GES, V65, P351, DOI 10.1111/j.1438-8677.1953.tb00671.x; Ellenberg H, 1954, PLANT ECOL, V5, P199, DOI [10.1007/BF00299574, DOI 10.1007/BF00299574]; Fox JW, 2005, ECOL LETT, V8, P846, DOI 10.1111/j.1461-0248.2005.00795.x; Fox JW, 2008, ECOLOGY, P1139; Harper J. L, 1977, POPULATION BIOL PLAN; Hector Andy, 2009, P94; Hutchinson GE, 1957, QUANTITATIVE BIOL, V22, P515; LIETH H., 1958, Zeitschrift fur Acker- und Pflanzenbau, V106, P205; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2011, ECOLOGY, V92, P1157; Moore JL, 2001, OIKOS, V94, P303, DOI 10.1034/j.1600-0706.2001.940211.x; Mueller-Dombios D, 1974, AIMS METHODS VEGETAT, P150; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Development Core Team, 2010, LANG ENV STAT COMP; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Trenbath B. R., 1974, Advances in Agronomy, V26, P177, DOI 10.1016/S0065-2113(08)60871-8; Vandermeer J.H., 1989, ECOLOGY INTERCROPPIN, DOI [10.1017/CBO9780511623523, DOI 10.1017/CBO9780511623523]; [No title captured]; [No title captured]	23	9	10	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43358	10.1371/journal.pone.0043358	http://dx.doi.org/10.1371/journal.pone.0043358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984421	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000308738500011
J	Khalaf, H; Bengtsson, T				Khalaf, Hazem; Bengtsson, Torbjorn			Altered T-Cell Responses by the Periodontal Pathogen Porphyromonas gingivalis	PLOS ONE			English	Article							NF-KAPPA-B; PROTEINASE-ACTIVATED RECEPTOR-2; ENDOTHELIAL-CELLS; VIRULENCE FACTORS; EPITHELIAL-CELLS; GINGIPAINS; ATHEROSCLEROSIS; INVASION; AP-1; TRANSCRIPTION	Several studies support an association between the chronic inflammatory diseases periodontitis and atherosclerosis with a crucial role for the periodontal pathogen Porphyromonas gingivalis. However, the interplay between this pathogen and the adaptive immune system, including T-cells, is sparsely investigated. Here we used Jurkat T-cells to determine the effects of P. gingivalis on T-cell-mediated adaptive immune responses. We show that viable P. gingivalis targets IL-2 expression at the protein level. Initial cellular events, including ROS production and [Ca2+](i), were elevated in response to P. gingivalis, but AP-1 and NF-kappa B activity dropped below basal levels and T-cells were unable to sustain stable IL-2 accumulation. IL-2 was partially restored by Leupeptin, but not by Cathepsin B Inhibitor, indicating an involvement of Rgp proteinases in the suppression of IL-2 accumulation. This was further confirmed by purified Rgp that caused a dose-dependent decrease in IL-2 levels. These results provide new insights of how this periodontal pathogen evades the host adaptive immune system by inhibiting IL-2 accumulation and thus attenuating T-cell proliferation and cellular communication.	[Khalaf, Hazem; Bengtsson, Torbjorn] Univ Orebro, Sch Hlth & Med Sci, Div Clin Med, Orebro, Sweden	Orebro University	Khalaf, H (corresponding author), Univ Orebro, Sch Hlth & Med Sci, Div Clin Med, Orebro, Sweden.	hazem.khalaf@oru.se		Khalaf, Hazem/0000-0002-3373-7864	Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Fund for Research without Animal Experiments; Swedish Heart and Lung Association; Foundation of Olle Engkvist	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Fund for Research without Animal Experiments; Swedish Heart and Lung Association(Swedish Heart-Lung Foundation); Foundation of Olle Engkvist	This work was supported by grants from the Swedish Research Council, the Swedish Heart-Lung Foundation, the Swedish Fund for Research without Animal Experiments, the Swedish Heart and Lung Association and the Foundation of Olle Engkvist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2006, NAT MED, V12, P178, DOI 10.1038/nm1343; Andrukhov O, 2011, J PERIODONTOL, V82, P885, DOI 10.1902/jop.2010.100425; Aoki Y, 2010, BIOCHEM BIOPH RES CO, V398, P86, DOI 10.1016/j.bbrc.2010.06.040; Belibasakis GN, 2011, INFLAMMATION, V34, P133, DOI 10.1007/s10753-010-9216-1; Calkins CC, 1998, J BIOL CHEM, V273, P6611, DOI 10.1074/jbc.273.12.6611; Cui J, 2002, J BIOL CHEM, V277, P47175, DOI 10.1074/jbc.M205870200; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; Deshpande RG, 1998, INFECT IMMUN, V66, P5337, DOI 10.1128/IAI.66.11.5337-5343.1998; Gemmell E, 2007, PERIODONTOL 2000, V43, P14, DOI 10.1111/j.1600-0757.2006.00173.x; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Hansson GK, 2009, ARTERIOSCL THROM VAS, V29, P1714, DOI 10.1161/ATVBAHA.108.179713; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Jagels MA, 1996, INFECT IMMUN, V64, P1984, DOI 10.1128/IAI.64.6.1984-1991.1996; JAIN J, 1992, J EXP MED, V175, P853, DOI 10.1084/jem.175.3.853; Kadowaki T, 2000, J BIOCHEM, V128, P153, DOI 10.1093/oxfordjournals.jbchem.a022735; Khalaf H, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-26; Kitamura Y, 2002, J PERIODONTAL RES, V37, P464, DOI 10.1034/j.1600-0765.2002.01364.x; Kobayashi-Sakamoto M, 2003, CURR MICROBIOL, V46, P109, DOI 10.1007/s00284-002-3782-x; Kuramitsu HK, 1998, ORAL MICROBIOL IMMUN, V13, P263, DOI 10.1111/j.1399-302X.1998.tb00706.x; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Lourbakos A, 1998, FEBS LETT, V435, P45, DOI 10.1016/S0014-5793(98)01036-9; Macian F, 2004, CURR OPIN IMMUNOL, V16, P209, DOI 10.1016/j.coi.2004.01.013; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Nilsson J, 2009, TRENDS CARDIOVAS MED, V19, P272, DOI 10.1016/j.tcm.2010.02.010; Oda T, 2003, ORAL MICROBIOL IMMUN, V18, P30, DOI 10.1034/j.1399-302X.2003.180105.x; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pae HO, 2004, J IMMUNOL, V172, P4744, DOI 10.4049/jimmunol.172.8.4744; Patrussi L, 2008, IMMUNOL LETT, V115, P75, DOI 10.1016/j.imlet.2007.10.012; Pores-Fernando AT, 2009, IMMUNOL REV, V231, P160, DOI 10.1111/j.1600-065X.2009.00809.x; Quintana A, 2009, CELL CALCIUM, V45, P109, DOI 10.1016/j.ceca.2008.07.003; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sareila O, 2011, ANTIOXID REDOX SIGN, V15, P2197, DOI 10.1089/ars.2010.3635; Sasaki N, 2009, CIRCULATION, V120, P1996, DOI 10.1161/CIRCULATIONAHA.109.863431; Shpacovitch VM, 2002, J INVEST DERMATOL, V118, P380, DOI 10.1046/j.0022-202x.2001.01658.x; Stathopoulou PG, 2009, ORAL MICROBIOL IMMUN, V24, P11, DOI 10.1111/j.1399-302X.2008.00467.x; Sugawara S, 2000, J IMMUNOL, V165, P411, DOI 10.4049/jimmunol.165.1.411; Tam V, 2009, INFECT IMMUN, V77, P1451, DOI 10.1128/IAI.01377-08; Tonetti MS, 2009, J CLIN PERIODONTOL, V36, P15, DOI 10.1111/j.1600-051X.2009.01417.x; Weinberg A, 1997, INFECT IMMUN, V65, P313, DOI 10.1128/IAI.65.1.313-316.1997; Yun LWP, 2007, CLIN EXP IMMUNOL, V150, P217, DOI 10.1111/j.1365-2249.2007.03488.x; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	43	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45192	10.1371/journal.pone.0045192	http://dx.doi.org/10.1371/journal.pone.0045192			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984628	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500126
J	Marshall, JAR; Bogacz, R; Gilchrist, ID				Marshall, James A. R.; Bogacz, Rafal; Gilchrist, Iain D.			Consistent Implementation of Decisions in the Brain	PLOS ONE			English	Article							SPEED-ACCURACY TRADEOFF; PERCEPTUAL DECISION; NEURAL BASIS; AREA LIP; CHOICE; MODELS; TIME; MICROSTIMULATION; PERFORMANCE; TASK	Despite the complexity and variability of decision processes, motor responses are generally stereotypical and independent of decision difficulty. How is this consistency achieved? Through an engineering analogy we consider how and why a system should be designed to realise not only flexible decision-making, but also consistent decision implementation. We specifically consider neurobiologically-plausible accumulator models of decision-making, in which decisions are made when a decision threshold is reached. To trade-off between the speed and accuracy of the decision in these models, one can either adjust the thresholds themselves or, equivalently, fix the thresholds and adjust baseline activation. Here we review how this equivalence can be implemented in such models. We then argue that manipulating baseline activation is preferable as it realises consistent decision implementation by ensuring consistency of motor inputs, summarise empirical evidence in support of this hypothesis, and suggest that it could be a general principle of decision making and implementation. Our goal is therefore to review how neurobiologically-plausible models of decision-making can manipulate speed-accuracy trade-offs using different mechanisms, to consider which of these mechanisms has more desirable decision-implementation properties, and then review the relevant neuroscientific data on which mechanism brains actually use.	[Marshall, James A. R.] Univ Sheffield, Dept Comp Sci, Kroto Res Inst, Sheffield S10 2TN, S Yorkshire, England; [Bogacz, Rafal] Univ Bristol, Dept Comp Sci, Bristol, Avon, England; [Gilchrist, Iain D.] Univ Bristol, Sch Expt Psychol, Bristol, Avon, England	University of Sheffield; University of Bristol; University of Bristol	Marshall, JAR (corresponding author), Univ Sheffield, Dept Comp Sci, Kroto Res Inst, Sheffield S10 2TN, S Yorkshire, England.	James.Marshall@sheffield.ac.uk	Gilchrist, Iain/E-8627-2010	Gilchrist, Iain D./0000-0003-2070-6679; Marshall, James/0000-0002-1506-167X	Biotechnology and Biological Sciences Research Council (BBSRC) Career Development Fellowship; Engineering and Physical Sciences Research Council (EPSRC) [EP/I032622/1]; BBSRC [BB/G02166X/2, BB/G02166X/1] Funding Source: UKRI; EPSRC [EP/I032622/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G02166X/1, BB/G02166X/2] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I032622/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) Career Development Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	IG is supported by a Biotechnology and Biological Sciences Research Council (BBSRC) Career Development Fellowship. RB and IG are supported by Engineering and Physical Sciences Research Council (EPSRC) grant EP/I032622/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHILL A T, 1975, Mathematical Biosciences, V24, P191, DOI 10.1016/0025-5564(75)90075-9; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Bogacz R, 2010, TRENDS NEUROSCI, V33, P10, DOI 10.1016/j.tins.2009.09.002; Brown P., 2001, STOCH DYNAM, V1, P159, DOI 10.1142/S0219493701000102; Brown S, 2005, PSYCHOL REV, V112, P117, DOI 10.1037/0033-295X.112.1.117; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Ditterich J, 2003, NAT NEUROSCI, V6, P891, DOI 10.1038/nn1094; Ditterich J, 2006, NEURAL NETWORKS, V19, P981, DOI 10.1016/j.neunet.2006.05.042; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Fortsmann BU, 2010, P NATL ACAD SCI USA, V107, P15916; Frank MJ, 2007, PHILOS T R SOC B, V362, P1641, DOI 10.1098/rstb.2007.2058; Furman M, 2008, NEURON, V60, P1153, DOI 10.1016/j.neuron.2008.12.003; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; GRICE GR, 1968, PSYCHOL REV, V75, P359, DOI 10.1037/h0026287; Hanks TD, 2006, NAT NEUROSCI, V9, P682, DOI 10.1038/nn1683; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Ivanoff J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002635; Ludwig CJH, 2009, COGNITIVE PSYCHOL, V59, P180, DOI 10.1016/j.cogpsych.2009.04.002; Ludwig CJH, 2005, J NEUROSCI, V25, P9907, DOI 10.1523/JNEUROSCI.2197-05.2005; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; McNamara JM, 2009, TRENDS ECOL EVOL, V24, P670, DOI 10.1016/j.tree.2009.05.011; PARKER GA, 1990, NATURE, V348, P27, DOI 10.1038/348027a0; Purcell BA, 2010, PSYCHOL REV, V117, P1113, DOI 10.1037/a0020311; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Roxin A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000046; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; van Veen V, 2008, J COGNITIVE NEUROSCI, V20, P1952, DOI 10.1162/jocn.2008.20146; VICKERS D, 1970, Ergonomics, V13, P37, DOI 10.1080/00140137008931117; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	33	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43443	10.1371/journal.pone.0043443	http://dx.doi.org/10.1371/journal.pone.0043443			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	005GJ	22984425	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000308738500014
J	Begcy, K; Mariano, ED; Gentile, A; Lembke, CG; Zingaretti, SM; Souza, GM; Menossi, M				Begcy, Kevin; Mariano, Eduardo D.; Gentile, Agustina; Lembke, Carolina G.; Zingaretti, Sonia Marli; Souza, Glaucia M.; Menossi, Marcelo			A Novel Stress-Induced Sugarcane Gene Confers Tolerance to Drought, Salt and Oxidative Stress in Transgenic Tobacco Plants	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; WATER-USE EFFICIENCY; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; LOW-TEMPERATURE; GAS-EXCHANGE; EXPRESSION; RESPONSES; SALINITY; OVEREXPRESSION	Background: Drought is a major abiotic stress that affects crop productivity worldwide. Sugarcane can withstand periods of water scarcity during the final stage of culm maturation, during which sucrose accumulation occurs. Meanwhile, prolonged periods of drought can cause severe plant losses. Methodology/Principal Findings: In a previous study, we evaluated the transcriptome of drought-stressed plants to better understand sugarcane responses to drought. Among the up-regulated genes was Scdr1 (sugarcane drought-responsive 1). The aim of the research reported here was to characterize this gene. Scdr1 encodes a putative protein containing 248 amino acids with a large number of proline (19%) and cysteine (13%) residues. Phylogenetic analysis showed that ScDR1is in a clade with homologs from other monocotyledonous plants, separate from those of dicotyledonous plants. The expression of Scdr1 in different varieties of sugarcane plants has not shown a clear association with drought tolerance. Conclusions/Significance: The overexpression of Scdr1 in transgenic tobacco plants increased their tolerance to drought, salinity and oxidative stress, as demonstrated by increased photosynthesis, water content, biomass, germination rate, chlorophyll content and reduced accumulation of ROS. Physiological parameters, such as transpiration rate (E), net photosynthesis (A), stomatal conductance (gs) and internal leaf CO2 concentration, were less affected by abiotic stresses in transgenic Scdr1 plants compared with wild-type plants. Overall, our results indicated that Scdr1 conferred tolerance to multiple abiotic stresses, highlighting the potential of this gene for biotechnological applications.	[Begcy, Kevin; Mariano, Eduardo D.; Gentile, Agustina; Menossi, Marcelo] Univ Estadual Campinas, Inst Biol, Dept Genet Evolucao & Bioagentes, Lab Genoma Func, Campinas, SP, Brazil; [Lembke, Carolina G.; Souza, Glaucia M.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Lab Transducao Sinal, BR-01498 Sao Paulo, Brazil; [Zingaretti, Sonia Marli] Univ Ribeirao Preto, Unidade Biotecnol, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Ribeirao Preto	Begcy, K (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Genet Evolucao & Bioagentes, Lab Genoma Func, Campinas, SP, Brazil.	menossi@unicamp.br	Menossi, Marcelo/A-4364-2012; Begcy, Kevin/AAK-6264-2020; zingaretti, sonia m/C-1123-2013; Lembke, Carolina G/O-3845-2014; Mariano, Eduardo D/B-8382-2012; Menossi, Marcelo/C-6305-2014; Gentile, Agustina/G-7174-2012; Lembke, Carolina/AFO-3103-2022; zingaretti, sonia marli/AAE-4433-2022; Souza, Glaucia/E-6780-2012	Menossi, Marcelo/0000-0002-9211-3787; Begcy, Kevin/0000-0002-5046-8029; zingaretti, sonia m/0000-0001-6755-4153; Mariano, Eduardo D/0000-0002-6465-6397; Menossi, Marcelo/0000-0002-9211-3787; Lembke, Carolina/0000-0002-0653-2353; zingaretti, sonia marli/0000-0001-6755-4153; Souza, Glaucia/0000-0001-6903-9913	National Council for Scientific and Technological Development (CNPq); Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP) [2008/5798-6, 2008/57908-6]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [574002/2008-1, 552802/2007-7]; Financiadora de Estudos e Projetos (FINEP) [815/07]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep))	KB received a fellowship from National Council for Scientific and Technological Development (CNPq). This research was developed as part of a research network involving grants 2008/5798-6 and 2008/57908-6 from Fundacao de Amparo a Pesquisa de Sao Paulo (FAPESP), 574002/2008-1 and 552802/2007-7 from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and 815/07 from Financiadora de Estudos e Projetos (FINEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affenzeller MJ, 2009, J EXP BOT, V60, P939, DOI 10.1093/jxb/ern348; Ahmad S, 1999, INT J AGRIC BIOL, V2, P1; Alscher RG, 1997, PHYSIOL PLANTARUM, V100, P224, DOI 10.1034/j.1399-3054.1997.1000203.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Atkin OK, 2009, ANN BOT-LONDON, V103, P581, DOI 10.1093/aob/mcn094; Begcy K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023776; BLISS RD, 1986, PLANT CELL ENVIRON, V9, P721, DOI 10.1111/j.1365-3040.1986.tb02104.x; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; BRADFORD KJ, 1990, PLANT PHYSIOL, V94, P840, DOI 10.1104/pp.94.2.840; Brandalise M, 2003, J BIOENERG BIOMEMBR, V35, P203, DOI 10.1023/A:1024603530043; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; BRUGNOLI E, 1991, PLANT PHYSIOL, V95, P628, DOI 10.1104/pp.95.2.628; Chandra A, 2008, ACTA PHYSIOL PLANT, V30, P63, DOI 10.1007/s11738-007-0091-9; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chaves M, 2010, FUNCT PLANT BIOL, V37, pIII, DOI 10.1071/FPv37n2_FO; Cumbie WP, 2011, HEREDITY, V107, P105, DOI 10.1038/hdy.2010.168; Ebdon JS, 2004, CROP SCI, V44, P1754, DOI 10.2135/cropsci2004.1754; Farquhar GD, 2003, PLANT CELL ENVIRON, V26, P801; Flexas J, 2006, PHYSIOL PLANTARUM, V127, P343, DOI 10.1111/j.1399-3054.2006.00621.x; Foolad MR, 1998, PLANT BREEDING, V117, P171, DOI 10.1111/j.1439-0523.1998.tb01473.x; Fravolinil A, 2002, J EXP BOT, V53, P2261, DOI 10.1093/jxb/erf084; Gao JP, 2007, J INTEGR PLANT BIOL, V49, P742, DOI 10.1111/j.1744-7909.2007.00495.x; Gay C, 1999, ANAL BIOCHEM, V273, P149, DOI 10.1006/abio.1999.4208; Ghannoum O, 2002, FUNCT PLANT BIOL, V29, P1337, DOI 10.1071/FP02056; Giraud E, 2008, PLANT PHYSIOL, V147, P595, DOI 10.1104/pp.107.115121; Guo QF, 2008, J PLANT PHYSIOL, V165, P1745, DOI 10.1016/j.jplph.2007.10.002; HAIGH AM, 1987, AUST J PLANT PHYSIOL, V14, P485, DOI 10.1071/PP9870485; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Jia JP, 2006, PLANT J, V48, P710, DOI 10.1111/j.1365-313X.2006.02905.x; JONES RA, 1986, EUPHYTICA, V35, P575, DOI 10.1007/BF00021866; Koussevitzky S, 2008, J BIOL CHEM, V283, P34197, DOI 10.1074/jbc.M806337200; Lakshmanan P, 2005, IN VITRO CELL DEV-PL, V41, P345, DOI 10.1079/IVP2005643; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; LIPTAY A, 1983, PLANT PHYSIOL, V73, P935, DOI 10.1104/pp.73.4.935; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAYBANK J, 1995, ATMOS OCEAN, V33, P195, DOI 10.1080/07055900.1995.9649532; MEINZER FC, 1994, PLANT PHYSIOL, V104, P521, DOI 10.1104/pp.104.2.521; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mito T, 2010, PLANT BIOTECHNOL J; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Monti A, 2006, J EXP BOT, V57, P1253, DOI 10.1093/jxb/erj091; Morran S, 2011, PLANT BIOTECHNOL J, V9, P230, DOI 10.1111/j.1467-7652.2010.00547.x; Pastore D, 2007, J EXP BOT, V58, P195, DOI 10.1093/jxb/erl273; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Poss JA, 2000, TREE PHYSIOL, V20, P1121; Priyanka B, 2010, PLANT BIOTECHNOL J, V8, P76, DOI 10.1111/j.1467-7652.2009.00467.x; Quan RD, 2010, PLANT BIOTECHNOL J, V8, P476, DOI 10.1111/j.1467-7652.2009.00492.x; Rocha FR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-71; Rodrigues FA, 2011, BIOL PLANTARUM, V55, P43, DOI 10.1007/s10535-011-0006-x; Sekhar K, 2010, PLANT CELL ENVIRON, V33, P1324, DOI 10.1111/j.1365-3040.2010.02151.x; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Solari LI, 2006, TREE PHYSIOL, V26, P1333, DOI 10.1093/treephys/26.10.1333; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; Trujillo LE, 2008, PLANT CELL PHYSIOL, V49, P512, DOI 10.1093/pcp/pcn025; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; UNGAR IA, 1978, BOT REV, V44, P233, DOI 10.1007/BF02919080; Waclawovsky AJ, 2010, PLANT BIOTECHNOL J, V8, P263, DOI 10.1111/j.1467-7652.2009.00491.x; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Williams DG, 2001, NEW PHYTOL, V150, P285, DOI 10.1046/j.1469-8137.2001.00093.x; Yang H, 2011, J EXP BOT, V62, P4143, DOI 10.1093/jxb/err102; Zhang XX, 2008, PLANT MOL BIOL, V68, P131, DOI 10.1007/s11103-008-9357-x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	64	34	36	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44697	10.1371/journal.pone.0044697	http://dx.doi.org/10.1371/journal.pone.0044697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984543	Green Submitted, gold, Green Published			2022-12-25	WOS:000308638700077
J	Elshorbagy, AK; Valdivia-Garcia, M; Refsum, H; Butte, N				Elshorbagy, Amany K.; Valdivia-Garcia, Maria; Refsum, Helga; Butte, Nancy			The Association of Cysteine with Obesity, Inflammatory Cytokines and Insulin Resistance in Hispanic Children and Adolescents	PLOS ONE			English	Article							HOMOCYSTEINE S-METHYLTRANSFERASE; BODY-COMPOSITION; ENERGY-EXPENDITURE; OXIDATIVE STRESS; ADIPOSE-TISSUE; HORDALAND HOMOCYSTEINE; METHIONINE RESTRICTION; LIPID-METABOLISM; DEFICIENT MICE; RISK	Context: Plasma total cysteine (tCys) independently relates to fat mass in adults. Dietary cyst(e)ine promotes adiposity and decreases glucose tolerance in some rodent models, but alleviates insulin resistance in others. Objective: To investigate whether the association of tCys with body fat extends to children at particular risk of obesity, and whether tCys is associated with insulin resistance and obesity-associated inflammation. Methods: We explored the cross-sectional relations of fasting plasma tCys and related metabolites with body composition measured by dual-energy X-ray absorptiometry in 984 Hispanic children and adolescents aged 4-19 years from the Viva La Familia Study. Linear and logistic regression and dose-response curves were used to evaluate relations of tCys with obesity, insulin resistance and inflammatory markers including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), monocyte chemoattractant protein-1 (MCP-1) and C-reactive protein (CRP). Results: tCys, methionine and total homocysteine (tHcy) increased with age. Upper tCys quartile was independently associated with a 5-fold increased risk of obesity (95% CI 3.5-8.0, P<0.001), and 2-fold risk of insulin resistance (95% CI: 1.6-5.0, P<0.001; adjusted for body fat%). Within the overweight/obese subgroup, but not in normal-weight children, tCys accounted for 9% of the variability in body fat% (partial r = 0.30, P<0.001; adjusted for age and gender). tCys correlated positively with serum non-esterified fatty acids and leptin, partly independent of body fat, but was not associated with serum IL-6, TNF-alpha or MCP-1. A positive correlation with CRP disappeared after adjustment for BMI. Conclusion: tCys is independently associated with obesity and insulin resistance in Hispanic children and adolescents, highlighting a previously underappreciated link between the sulfur amino acid metabolic pathway and obesity and cardiometabolic risk.	[Elshorbagy, Amany K.; Valdivia-Garcia, Maria; Refsum, Helga] Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; [Elshorbagy, Amany K.] Univ Alexandria, Fac Med, Dept Physiol, Alexandria, Egypt; [Refsum, Helga] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Butte, Nancy] Baylor Coll Med, Dept Pediat, USDA ARS, Childrens Nutr Res Ctr, Houston, TX 77030 USA	University of Oxford; Egyptian Knowledge Bank (EKB); Alexandria University; University of Oslo; Baylor College of Medicine; United States Department of Agriculture (USDA)	Elshorbagy, AK (corresponding author), Univ Oxford, Dept Pharmacol, S Parks Rd, Oxford OX1 3QT, England.	amany.elshorbagy@pharm.ox.ac.uk	Refsum, Helga/A-4073-2010; Elshorbagy, Amany/A-4117-2015	Elshorbagy, Amany/0000-0002-8624-860X	National Institutes of Health (NIH) [DK59264, DK080457]; USDA/ARS [6250-51000-053]; Research Council of Norway; Johan Throne Holst Foundation for Nutrition Research; Charles Wolfson Charitable Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080457, R01DK059264] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA/ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Research Council of Norway(Research Council of Norway); Johan Throne Holst Foundation for Nutrition Research; Charles Wolfson Charitable Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health (NIH) [DK59264, DK080457], and the USDA/ARS [Cooperative Agreement 6250-51000-053]. This study has also received support from The Research Council of Norway, The Johan Throne Holst Foundation for Nutrition Research and the Charles Wolfson Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoniades C, 2009, CIRCULATION, V119, P2507, DOI 10.1161/CIRCULATIONAHA.108.808675; Battezzati A, 2007, NUTR METAB CARDIOVAS, V17, P525, DOI 10.1016/j.numecd.2006.03.006; Blouet C, 2007, FREE RADICAL BIO MED, V42, P1089, DOI 10.1016/j.freeradbiomed.2007.01.006; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Butte NF, 2006, AM J CLIN NUTR, V84, P646, DOI 10.1093/ajcn/84.3.646; Cai GW, 2008, CYTOKINE, V44, P242, DOI 10.1016/j.cyto.2008.08.006; Di Renzo L, 2010, OBESITY, V18, P2125, DOI 10.1038/oby.2010.50; El-Khairy L, 2003, CLIN CHEM, V49, P113, DOI 10.1373/49.1.113; Elshorbagy AK, 2011, NUTR METAB IN PRESS, DOI [10.1016/j.numecd.20111001.1008, DOI 10.1016/J.NUMECD.2011.1001.1008]; Elshorbagy AK, 2008, AM J CLIN NUTR, V88, P738, DOI 10.1093/ajcn/88.3.738; Elshorbagy AK, 2012, J NUTR BIOCHEM, V23, P332, DOI 10.1016/j.jnutbio.2010.12.009; Elshorbagy AK, 2012, CURR OPIN CLIN NUTR, V15, P49, DOI 10.1097/MCO.0b013e32834d199f; Elshorbagy AK, 2011, J LIPID RES, V52, P104, DOI 10.1194/jlr.M010215; Elshorbagy AK, 2009, OBESITY, V17, P1435, DOI 10.1038/oby.2008.671; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gupta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027598; Hammarqvist F, 2010, AMINO ACIDS, V39, P359, DOI 10.1007/s00726-009-0446-1; Haque JA, 2010, LAB INVEST, V90, P1704, DOI 10.1038/labinvest.2010.112; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Johnson RK, 1996, J AM DIET ASSOC, V96, P1140, DOI 10.1016/S0002-8223(96)00293-3; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Karelis AD, 2008, LANCET, V372, P1281, DOI 10.1016/S0140-6736(08)61531-7; Kendig EL, 2011, TOXICOL APPL PHARM, V257, P338, DOI 10.1016/j.taap.2011.09.017; Kerr MA, 2009, PEDIATRICS, V123, P627, DOI 10.1542/peds.2008-1049; Keskin M, 2005, PEDIATRICS, V115, pE500, DOI 10.1542/peds.2004-1921; KNITTLE JL, 1979, J CLIN INVEST, V63, P239, DOI 10.1172/JCI109295; Lieberman MW, 1996, P NATL ACAD SCI USA, V93, P7923, DOI 10.1073/pnas.93.15.7923; Liu J, 2011, J CLIN ENDOCR METAB, V96, P438, DOI 10.1210/jc.2010-1174; Maffeis C, 2008, J PEDIATR-US, V152, P207, DOI 10.1016/j.jpeds.2007.09.021; Malloy VL, 2006, AGING CELL, V5, P305, DOI 10.1111/j.1474-9726.2006.00220.x; Mani S, 2011, FREE RADICAL BIO MED, V50, P1280, DOI 10.1016/j.freeradbiomed.2011.01.038; Matsubara Y, 2009, ANN NUTR METAB, V54, P258, DOI 10.1159/000229506; Molgaard C, 1998, APPL RADIAT ISOTOPES, V49, P577, DOI 10.1016/S0969-8043(97)00076-6; Ogden Cynthia L, 2010, Natl Health Stat Report, P1; OLEFSKY JM, 1979, HORM METAB RES, V11, P209, DOI 10.1055/s-0028-1092709; Puyau MR, 2004, MED SCI SPORT EXER, V36, P1625, DOI 10.1249/01.MSS.0000139898.30804.60; Sampath H, 2011, ANN NY ACAD SCI, V1243, P47, DOI 10.1111/j.1749-6632.2011.06303.x; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Team RDC, 2004, R LANG ENV STAT; Teng YW, 2012, J BIOL CHEM, V287, P16187, DOI 10.1074/jbc.M111.303255; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Ueki I, 2011, AM J PHYSIOL-ENDOC M, V301, pE668, DOI 10.1152/ajpendo.00151.2011; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307	46	48	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44166	10.1371/journal.pone.0044166	http://dx.doi.org/10.1371/journal.pone.0044166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984471	gold, Green Published, Green Submitted			2022-12-25	WOS:000308638700047
J	Iida, J; Dorchak, J; Lehman, JR; Clancy, R; Luo, CQ; Chen, YQ; Somiari, S; Ellsworth, RE; Hu, H; Mural, RJ; Shriver, CD				Iida, Joji; Dorchak, Jesse; Lehman, John R.; Clancy, Rebecca; Luo, Chunqing; Chen, Yaqin; Somiari, Stella; Ellsworth, Rachel E.; Hu, Hai; Mural, Richard J.; Shriver, Craig D.			FH535 Inhibited Migration and Growth of Breast Cancer Cells	PLOS ONE			English	Article							CHONDROITIN SULFATE PROTEOGLYCAN; HUMAN-MELANOMA INVASION; METAPLASTIC CARCINOMAS; WNT PATHWAY; STEM-CELLS; INTEGRIN; COLLAGEN; TARGET; MOTILITY; ADHESION	There is substantial evidence indicating that the WNT signaling pathway is activated in various cancer cell types including breast cancer. Previous studies reported that FH535, a small molecule inhibitor of the WNT signaling pathway, decreased growth of cancer cells but not normal fibroblasts, suggesting this pathway plays a role in tumor progression and metastasis. In this study, we tested FH535 as a potential inhibitor for malignant phenotypes of breast cancer cells including migration, invasion, and growth. FH535 significantly inhibited growth, migration, and invasion of triple negative (TN) breast cancer cell lines (MDA-MB231 and HCC38) in vitro. We demonstrate that FH535 was a potent growth inhibitor for TN breast cancer cell lines (HCC38 and MDA-MB-231) but not for other, non-TN breast cancer cell lines (MCF-7, T47D or SK-Br3) when cultured in three dimensional (3D) type I collagen gels. Western blotting analyses suggest that treatment of MDA-MB-231 cells with FH535 markedly inhibited the expression of NEDD9 but not activations of FAK, Src, or downstream targets such as p38 and Erk1/2. We demonstrated that NEDD9 was specifically associated with CSPG4 but not with b1 integrin or CD44 in MDA-MB-231 cells. Analyses of gene expression profiles in breast cancer tissues suggest that CSPG4 expression is higher in Basal-type breast cancers, many of which are TN, than any other subtypes. These results suggest not only a mechanism for migration and invasion involving the canonical WNT-signaling pathways but also novel strategies for treating patients who develop TN breast cancer.	[Iida, Joji; Dorchak, Jesse; Lehman, John R.; Clancy, Rebecca] Windber Res Inst, Dept Cell Biol, Windber, PA USA; [Luo, Chunqing; Chen, Yaqin; Hu, Hai] Windber Res Inst, Dept Biomed Informat, Windber, PA USA; [Somiari, Stella] Windber Res Inst, Dept Tissue Bank, Windber, PA USA; [Ellsworth, Rachel E.] Windber Res Inst, Dept Genet, Windber, PA USA; [Shriver, Craig D.] Walter Reed Natl Mil Med Ctr, Dept Surg, Bethesda, MD USA	Windber Research Institute; Windber Research Institute; Windber Research Institute; Windber Research Institute; Walter Reed National Military Medical Center	Iida, J (corresponding author), Windber Res Inst, Dept Cell Biol, Windber, PA USA.	g.iida@wriwindber.org		Hu, Hai/0000-0001-5345-8371	United States Department of Defense (Military Molecular Medicine Initiative) [MDA W81XWHH-05-2-0075, Protocol 01-20006]	United States Department of Defense (Military Molecular Medicine Initiative)(United States Department of Defense)	This research was supported by a grant from the United States Department of Defense (Military Molecular Medicine Initiative MDA W81XWHH-05-2-0075, Protocol 01-20006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Bissell MJ, 2005, CANCER CELL, V7, P17, DOI 10.1016/j.ccr.2004.12.013; Bissell MJ, 1999, AM J PATHOL, V155, P675, DOI 10.1016/S0002-9440(10)65164-4; Bravo-Cordero JJ, 2007, EMBO J, V26, P1499, DOI 10.1038/sj.emboj.7601606; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Campoli M, 2010, ADV CANCER RES, V109, P73, DOI 10.1016/B978-0-12-380890-5.00003-X; CARTER WG, 1990, J CELL BIOL, V110, P1387, DOI 10.1083/jcb.110.4.1387; Chang JX, 2012, MED ONCOL; Cooney CA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2895; Eck SM, 2009, BREAST CANCER RES TR, V116, P79, DOI 10.1007/s10549-008-0085-3; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; Hayes MJ, 2008, CLIN CANCER RES, V14, P4038, DOI 10.1158/1078-0432.CCR-07-4379; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; IIDA J, 1995, CANCER RES, V55, P2177; Iida J, 1998, J BIOL CHEM, V273, P5955, DOI 10.1074/jbc.273.10.5955; Iida J, 2004, J INVEST DERMATOL, V122, P167, DOI 10.1046/j.0022-202X.2003.22114.x; Iida J, 1996, SEMIN CANCER BIOL, V7, P155, DOI 10.1006/scbi.1996.0021; Iida J, 2001, J BIOL CHEM, V276, P18786, DOI 10.1074/jbc.M010053200; Iida J, 2007, BIOCHEM J, V403, P553, DOI 10.1042/BJ20061176; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Izumchenko E, 2009, CANCER RES, V69, P7198, DOI 10.1158/0008-5472.CAN-09-0795; KEELY PJ, 1995, J CELL SCI, V108, P595; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; King TD, 2011, J CELL BIOCH; Klemm F, 2011, CARCINOGENESIS, V32, P434, DOI 10.1093/carcin/bgq269; Knutson JR, 1996, MOL BIOL CELL, V7, P383, DOI 10.1091/mbc.7.3.383; Kong CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022666; Lacroix-Triki M, 2010, MODERN PATHOL, V23, P1438, DOI 10.1038/modpathol.2010.141; LANGUINO LR, 1989, J CELL BIOL, V109, P2455, DOI 10.1083/jcb.109.5.2455; Legg J, 2003, DEVELOPMENT, V130, P6049, DOI 10.1242/dev.00837; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li Y, 2011, ONCOGENE, V30, P2633, DOI 10.1038/onc.2010.632; Lim SK, 2011, FASEB J, V25, P3004, DOI 10.1096/fj.10-169136; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Paquette B, 2011, BRIT J CANCER, V105, P534, DOI 10.1038/bjc.2011.260; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; Price MA, 2011, PIGM CELL MELANOMA R, V24, P1148, DOI 10.1111/j.1755-148X.2011.00929.x; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2009, TRENDS CELL BIOL, V19, P638, DOI 10.1016/j.tcb.2009.08.009; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Svendsen A, 2011, ACTA NEUROPATHOL, V122, P495, DOI 10.1007/s00401-011-0867-2; Vaid M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023000; Wang X, 2010, CURR MOL MED, V10, P419, DOI 10.2174/156652410791316977; Wang XH, 2010, JNCI-J NATL CANCER I, V102, P1496, DOI 10.1093/jnci/djq343; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Yang JB, 2004, J CELL BIOL, V165, P881, DOI 10.1083/jcb.200403174; Yang JB, 2009, CANCER RES, V69, P7538, DOI 10.1158/0008-5472.CAN-08-4626	54	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44418	10.1371/journal.pone.0044418	http://dx.doi.org/10.1371/journal.pone.0044418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984505	gold, Green Published, Green Submitted			2022-12-25	WOS:000308638700059
J	Javier, AL; Doan, LT; Luong, M; de Mochel, NSR; Sun, AX; Monuki, ES; Cho, KWY				Javier, Anna L.; Doan, Linda T.; Luong, Mui; de Mochel, N. Soledad Reyes; Sun, Aixu; Monuki, Edwin S.; Cho, Ken W. Y.			Bmp Indicator Mice Reveal Dynamic Regulation of Transcriptional Response	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-4; MOTOR-NEURON INDUCTION; CHICK LIMB DEVELOPMENT; PRIMORDIAL GERM-CELLS; DORSAL SPINAL-CORD; TGF-BETA; MOUSE EMBRYO; WNT/BETA-CATENIN; DISTINCT ROLES; SMAD PROTEINS	Cellular responses to Bmp ligands are regulated at multiple levels, both extracellularly and intracellularly. Therefore, the presence of these growth factors is not an accurate indicator of Bmp signaling activity. While a common approach to detect Bmp signaling activity is to determine the presence of phosphorylated forms of Smad1, 5 and 8 by immunostaining, this approach is time consuming and not quantitative. In order to provide a simpler readout system to examine the presence of Bmp signaling in developing animals, we developed BRE-gal mouse embryonic stem cells and a transgenic mouse line that specifically respond to Bmp ligand stimulation. Our reporter identifies specific transcriptional responses that are mediated by Smad1 and Smad4 with the Schnurri transcription factor complex binding to a conserved Bmp-Responsive Element (BRE), originally identified among Drosophila, Xenopus and human Bmp targets. Our BRE-gal mES cells specifically respond to Bmp ligands at concentrations as low as 5 ng/ml; and BRE-gal reporter mice, derived from the BRE-gal mES cells, show dynamic activity in many cellular sites, including extraembryonic structures and mammary glands, thereby making this a useful scientific tool.	[Javier, Anna L.; Doan, Linda T.; Luong, Mui; de Mochel, N. Soledad Reyes; Sun, Aixu; Monuki, Edwin S.; Cho, Ken W. Y.] Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Doan, Linda T.; Monuki, Edwin S.] Univ Calif Irvine, Sch Med, Dept Pathol & Lab Med, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Javier, AL (corresponding author), Univ Calif Irvine, Sch Biol Sci, Dept Dev & Cell Biol, Irvine, CA 92717 USA.	kwcho@uci.edu		Doan, Linda/0000-0003-0274-2529; Monuki, Edwin/0000-0001-5130-781X	National Institutes of Health [RO1HD056219]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056219] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by National Institutes of Health RO1HD056219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2001, DEVELOPMENT, V128, P4449; Alexander C, 2011, DEVELOPMENT, V138, P5135, DOI 10.1242/dev.067801; Blitz IL, 2009, DEV DYNAM, V238, P1321, DOI 10.1002/dvdy.21984; Bosman EA, 2006, DEVELOPMENT, V133, P3399, DOI 10.1242/dev.02497; Cai XQ, 2011, DEV BIOL, V360, P381, DOI 10.1016/j.ydbio.2011.09.023; Chesnutt C, 2004, DEV BIOL, V274, P334, DOI 10.1016/j.ydbio.2004.07.019; Correia AC, 2007, DEV DYNAM, V236, P2493, DOI 10.1002/dvdy.21256; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Danesh SM, 2009, GENE EXPR PATTERNS, V9, P255, DOI 10.1016/j.gep.2009.04.002; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; Dunn NR, 1997, DEV BIOL, V188, P235, DOI 10.1006/dbio.1997.8664; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Fernandes M, 2007, DEVELOPMENT, V134, P3789, DOI 10.1242/dev.004325; Finley MFA, 1999, J NEUROBIOL, V40, P271, DOI 10.1002/(SICI)1097-4695(19990905)40:3<271::AID-NEU1>3.0.CO;2-C; Fujiwara T, 2001, P NATL ACAD SCI USA, V98, P13739, DOI 10.1073/pnas.241508898; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Gao S, 2005, J BIOL CHEM, V280, P36158, DOI 10.1074/jbc.M506882200; Guha U, 2002, DEV BIOL, V249, P108, DOI 10.1006/dbio.2002.0752; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; HAWLEY SHB, 1995, GENE DEV, V9, P2923, DOI 10.1101/gad.9.23.2923; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hayashi K, 2002, MECH DEVELOP, V118, P99, DOI 10.1016/S0925-4773(02)00237-X; Hens JR, 2005, BREAST CANCER RES, V7, P220, DOI 10.1186/bcr1306; Holzschuh J, 2005, DEVELOPMENT, V132, P3731, DOI 10.1242/dev.01936; Ille F, 2007, DEV BIOL, V304, P394, DOI 10.1016/j.ydbio.2006.12.045; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Johnson K, 1999, J BIOL CHEM, V274, P20709, DOI 10.1074/jbc.274.29.20709; Kaartinen V, 2004, DEVELOPMENT, V131, P3481, DOI 10.1242/dev.01214; Kaufman M.H., 1992, ATLAS MOUSE DEV; Kawakami Y, 1996, DEVELOPMENT, V122, P3557; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Larrain J, 2001, DEVELOPMENT, V128, P4439; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Lorda-Diez CI, 2009, INT J DEV BIOL, V53, P1495, DOI 10.1387/ijdb.072415cl; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; LYONS KM, 1990, DEVELOPMENT, V109, P833; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; Macias D, 1997, DEVELOPMENT, V124, P1109; Madabhushi M, 2011, DEV CELL, V21, P907, DOI 10.1016/j.devcel.2011.08.027; Mailleux AA, 2002, DEVELOPMENT, V129, P53; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Mikkola ML, 2007, SEMIN CELL DEV BIOL, V18, P225, DOI 10.1016/j.semcdb.2007.01.007; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Monteiro RM, 2004, J CELL SCI, V117, P4653, DOI 10.1242/jcs.01337; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nagy A., 2003, MANIPULATING MOUSE E; Nakahiro T, 2010, BIOCHEM BIOPH RES CO, V399, P416, DOI 10.1016/j.bbrc.2010.07.090; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nakayama T, 1998, GENES CELLS, V3, P387, DOI 10.1046/j.1365-2443.1998.00196.x; Oelgeschlager M, 2003, DEV CELL, V4, P219, DOI 10.1016/S1534-5807(02)00404-5; Ohuchi H, 2003, BIOCHEM BIOPH RES CO, V302, P562, DOI 10.1016/S0006-291X(03)00183-9; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Pizette S, 2000, DEV BIOL, V219, P237, DOI 10.1006/dbio.2000.9610; Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008; Tomas AR, 2011, DEV BIOL, V355, P324, DOI 10.1016/j.ydbio.2011.04.031; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Selever J, 2004, DEV BIOL, V276, P268, DOI 10.1016/j.ydbio.2004.08.024; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Tremblay KD, 2001, DEVELOPMENT, V128, P3609; von Bubnoff A, 2005, DEV BIOL, V281, P210, DOI 10.1016/j.ydbio.2005.02.014; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Xu X, 1998, GENE DEV, V12, P2354, DOI 10.1101/gad.12.15.2354; Yao LC, 2006, DEVELOPMENT, V133, P4025, DOI 10.1242/dev.02561; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P3203, DOI 10.1242/dev.008177; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Ying Y, 2001, DEV BIOL, V232, P484, DOI 10.1006/dbio.2001.0173; Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1; Zhang HB, 1996, DEVELOPMENT, V122, P2977; Zhao W, 2007, FEBS LETT, V581, P4960, DOI 10.1016/j.febslet.2007.09.033; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; Zou HY, 1997, GENE DEV, V11, P2191, DOI 10.1101/gad.11.17.2191	79	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e42566	10.1371/journal.pone.0042566	http://dx.doi.org/10.1371/journal.pone.0042566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984405	Green Published, gold			2022-12-25	WOS:000308638700007
J	Zhu, Y; Du, P; Nakhleh, L				Zhu, Yun; Du, Peng; Nakhleh, Luay			Gene Duplicability-Connectivity-Complexity across Organisms and a Neutral Evolutionary Explanation	PLOS ONE			English	Article							DUPLICATE GENES; NETWORKS; ROBUSTNESS; PRESERVATION; REDUNDANCY; MODEL	Gene duplication has long been acknowledged by biologists as a major evolutionary force shaping genomic architectures and characteristics across the Tree of Life. Major research has been conducting on elucidating the fate of duplicated genes in a variety of organisms, as well as factors that affect a gene's duplicability-that is, the tendency of certain genes to retain more duplicates than others. In particular, two studies have looked at the correlation between gene duplicability and its degree in a protein-protein interaction network in yeast, mouse, and human, and another has looked at the correlation between gene duplicability and its complexity (length, number of domains, etc.) in yeast. In this paper, we extend these studies to six species, and two trends emerge. There is an increase in the duplicability-connectivity correlation that agrees with the increase in the genome size as well as the phylogenetic relationship of the species. Further, the duplicability-complexity correlation seems to be constant across the species. We argue that the observed correlations can be explained by neutral evolutionary forces acting on the genomic regions containing the genes. For the duplicability-connectivity correlation, we show through simulations that an increasing trend can be obtained by adjusting parameters to approximate genomic characteristics of the respective species. Our results call for more research into factors, adaptive and non-adaptive alike, that determine a gene's duplicability.	[Zhu, Yun; Nakhleh, Luay] Rice Univ, Dept Comp Sci, Houston, TX 77251 USA; [Du, Peng] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan	Rice University; Hokkaido University	Zhu, Y (corresponding author), Rice Univ, Dept Comp Sci, Houston, TX 77251 USA.	yun.zhu@rice.edu; nakhleh@rice.edu			National Science Foundation grant [CCF-0622037]; Alfred P. Sloan Research Fellowship	National Science Foundation grant(National Science Foundation (NSF)); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation)	This work was supported in part by National Science Foundation grant CCF-0622037 and an Alfred P. Sloan Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Bergthorsson U, 2007, P NATL ACAD SCI USA, V104, P17004, DOI 10.1073/pnas.0707158104; Bhan A, 2002, BIOINFORMATICS, V18, P1486, DOI 10.1093/bioinformatics/18.11.1486; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Chia N, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021906; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; D'Antonio M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002029; Dittmar K, 2010, EVOLUTION AFTER GENE DUPLICATION, P1, DOI 10.1002/9780470619902; Force A, 1999, GENETICS, V151, P1531; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Hanada K, 2011, MOL BIOL EVOL, V28, P377, DOI 10.1093/molbev/msq204; He XL, 2005, CURR BIOL, V15, P1016, DOI 10.1016/j.cub.2005.04.035; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Kitami T, 2002, NAT GENET, V32, P191, DOI 10.1038/ng945; Li W. H, 1997, MOL EVOLUTION; Liang H, 2007, TRENDS GENET, V23, P375, DOI 10.1016/j.tig.2007.04.005; Liao BY, 2007, TRENDS GENET, V23, P378, DOI 10.1016/j.tig.2007.05.006; Light S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-159; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2001, GENETICS, V159, P1789; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Mahadevan R, 2008, BIOPHYS J, V94, P1216, DOI 10.1529/biophysj.107.118414; Mithani A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000868; Navlakha S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001119; Ohno S., 1970, EVOLUTION GENE DUPLI; Ohta T, 2000, GENE, V259, P45, DOI 10.1016/S0378-1119(00)00428-5; OHTA T, 1987, GENETICS, V115, P207; Ohta T, 1992, MOL PHYLOGENET EVOL, V1, P305, DOI 10.1016/1055-7903(92)90006-3; Paps J, 2009, MOL BIOL EVOL, V26, P2397, DOI 10.1093/molbev/msp150; Prachumwat A, 2006, MOL BIOL EVOL, V23, P30, DOI 10.1093/molbev/msi249; Ratmann O, 2007, PLOS COMPUT BIOL, V3, P2266, DOI 10.1371/journal.pcbi.0030230; Roth C, 2007, J EXP ZOOL PART B, V308B, P58, DOI 10.1002/jez.b.21124; STRING-database, 2012, GEN DUPL CONN COMPL, V9; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; VanderSluis B, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.82; Wagner A, 2005, BIOESSAYS, V27, P176, DOI 10.1002/bies.20170; Wagner A, 2008, BIOESSAYS, V30, P367, DOI 10.1002/bies.20728; WALSH JB, 1995, GENETICS, V139, P421; Wang Z, 2009, GENOME BIOL EVOL, V1, P23, DOI 10.1093/gbe/evp002; Wiuf C, 2006, P NATL ACAD SCI USA, V103, P7566, DOI 10.1073/pnas.0600061103; WYSOCKI LJ, 1989, ANNU REV BIOCHEM, V58, P509; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhang Z, 2005, MOL BIOL EVOL, V22, P501, DOI 10.1093/molbev/msi034	46	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44491	10.1371/journal.pone.0044491	http://dx.doi.org/10.1371/journal.pone.0044491			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984517	gold, Green Published, Green Submitted			2022-12-25	WOS:000308638700065
J	Lee, I; Hendrix, A; Kim, J; Yoshimoto, J; You, YJ				Lee, Inhwan; Hendrix, Amber; Kim, Jeongho; Yoshimoto, Jennifer; You, Young-Jai			Metabolic Rate Regulates L1 Longevity in C-elegans	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; CELLULAR-ENERGY; LIFE-SPAN; ARREST; GROWTH; IDENTIFICATION; GERMLINE; SURVIVAL; DIAPAUSE	Animals have to cope with starvation. The molecular mechanisms by which animals survive long-term starvation, however, are not clearly understood. When they hatch without food, C. elegans arrests development at the first larval stage (L1) and survives more than two weeks. Here we show that the survival span of arrested L1s, which we call L1 longevity, is a starvation response regulated by metabolic rate during starvation. A high rate of metabolism shortens the L1 survival span, whereas a low rate of metabolism lengthens it. The longer worms are starved, the slower they grow once they are fed, suggesting that L1 arrest has metabolic costs. Furthermore, mutants of genes that regulate metabolism show altered L1 longevity. Among them, we found that AMP-dependent protein kinase (AMPK), as a key energy sensor, regulates L1 longevity by regulating this metabolic arrest. Our results suggest that L1 longevity is determined by metabolic rate and that AMPK as a master regulator of metabolism controls this arrest so that the animals survive long-term starvation.	[Lee, Inhwan; Hendrix, Amber; You, Young-Jai] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23284 USA; [Kim, Jeongho] Inha Univ, Dept Biol Sci, Inchon, South Korea; [Yoshimoto, Jennifer] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA	Virginia Commonwealth University; Inha University; University of Michigan System; University of Michigan	Lee, I (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23284 USA.	yjyou@vcu.edu		Yoshimoto, Jennifer/0000-0003-1718-5171; you, young/0000-0002-5716-5418	American Heart Association [09SDG2150070]	American Heart Association(American Heart Association)	IL and YY received support from the American Heart Association grant (09SDG2150070). No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; AVERY L, 1993, GENETICS, V133, P897; Baugh LR, 2009, SCIENCE, V324, P92, DOI 10.1126/science.1169628; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Castro PV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029984; Cho SC, 2010, P NATL ACAD SCI USA, V107, P19326, DOI 10.1073/pnas.1005078107; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Kang C, 2009, AUTOPHAGY, V5, P565, DOI 10.4161/auto.5.4.8171; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lee BH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000213; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Narbonne P, 2006, DEVELOPMENT, V133, P611, DOI 10.1242/dev.02232; Narbonne P, 2009, NATURE, V457, P210, DOI 10.1038/nature07536; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Sambrook J., 2002, MOL CLONING LAB MANU; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Watts JL, 2000, DEVELOPMENT, V127, P1467; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; You YJ, 2006, CELL METAB, V3, P237, DOI 10.1016/j.cmet.2006.02.012; Zhang XC, 2011, P NATL ACAD SCI USA, V108, P17997, DOI 10.1073/pnas.1105982108	26	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44720	10.1371/journal.pone.0044720	http://dx.doi.org/10.1371/journal.pone.0044720			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970296	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400111
J	Zager, MG; Barton, HA				Zager, Michael G.; Barton, Hugh A.			A Multiscale, Mechanism-Driven, Dynamic Model for the Effects of 5 alpha-Reductase Inhibition on Prostate Maintenance	PLOS ONE			English	Article							ANDROGEN RECEPTOR REGULATION; CANCER PREVENTION TRIAL; ADULT MALE RATS; STEROID 5-ALPHA-REDUCTASE; IN-VIVO; MATHEMATICAL-MODEL; MOLECULAR-BIOLOGY; VENTRAL PROSTATE; HORMONAL-CONTROL; MENSTRUAL-CYCLE	A systems-level mathematical model is presented that describes the effects of inhibiting the enzyme 5 alpha-reductase (5aR) on the ventral prostate of the adult male rat under chronic administration of the 5aR inhibitor, finasteride. 5aR is essential for androgen regulation in males, both in normal conditions and disease states. The hormone kinetics and downstream effects on reproductive organs associated with perturbing androgen regulation are complex and not necessarily intuitive. Inhibition of 5aR decreases the metabolism of testosterone (T) to the potent androgen 5 alpha-dihydrotestosterone (DHT). This results in decreased cell proliferation, fluid production and 5aR expression as well as increased apoptosis in the ventral prostate. These regulatory changes collectively result in decreased prostate size and function, which can be beneficial to men suffering from benign prostatic hyperplasia (BPH) and could play a role in prostate cancer. There are two distinct isoforms of 5aR in male humans and rats, and thus developing a 5aR inhibitor is a challenging pursuit. Several inhibitors are on the market for treatment of BPH, including finasteride and dutasteride. In this effort, comparisons of simulated vs. experimental T and DHT levels and prostate size are depicted, demonstrating the model accurately described an approximate 77% decrease in prostate size and nearly complete depletion of prostatic DHT following 21 days of daily finasteride dosing in rats. This implies T alone is not capable of maintaining a normal prostate size. Further model analysis suggests the possibility of alternative dosing strategies resulting in similar or greater effects on prostate size, due to complex kinetics between T, DHT and gene occupancy. With appropriate scaling and parameterization for humans, this model provides a multiscale modeling platform for drug discovery teams to test and generate hypotheses about drugging strategies for indications like BPH and prostate cancer, such as compound binding properties, dosing regimens, and target validation.	[Zager, Michael G.] Pfizer Inc, Worldwide Res & Dev, Dynam & Metab, Pharmacokinet, San Diego, CA USA; [Barton, Hugh A.] Pfizer Inc, Worldwide Res & Dev, Dynam & Metab, Pharmacokinet, Groton, CT 06340 USA	Pfizer; Pfizer	Zager, MG (corresponding author), Pfizer Inc, Worldwide Res & Dev, Dynam & Metab, Pharmacokinet, San Diego, CA USA.	michael.zager@pfizer.com		Barton, Hugh/0000-0002-9948-4724	Environmental Protection Agency/University of North Carolina Toxicology Research Program [T 829472]; Curriculum in Toxicology, University of North Carolina at Chapel Hill	Environmental Protection Agency/University of North Carolina Toxicology Research Program; Curriculum in Toxicology, University of North Carolina at Chapel Hill	MGZ was funded by the Environmental Protection Agency/University of North Carolina Toxicology Research Program, Training Agreement T 829472, with the Curriculum in Toxicology, University of North Carolina at Chapel Hill. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attard G, 2009, CANCER CELL, V16, P458, DOI 10.1016/j.ccr.2009.11.006; Azzolina B, 1997, J STEROID BIOCHEM, V61, P55, DOI 10.1016/S0960-0760(97)00002-2; Barton HA, 1998, TOXICOL SCI, V45, P174, DOI 10.1093/toxsci/45.2.174; BERMAN DM, 1993, P NATL ACAD SCI USA, V90, P9359, DOI 10.1073/pnas.90.20.9359; Bull HG, 1996, J AM CHEM SOC, V118, P2359, DOI 10.1021/ja953069t; Burd CJ, 2006, P NATL ACAD SCI USA, V103, P2190, DOI 10.1073/pnas.0506281103; Clark LH, 2003, B MATH BIOL, V65, P157, DOI 10.1006/bulum.2002.0326; Cohen YC, 2007, J NATL CANCER I, V99, P1366, DOI 10.1093/jnci/djm130; Eikenberry SE, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-24; Fell D., 1997, UNDERSTANDING CONTRO; Frye S V, 1998, Pharm Biotechnol, V11, P393; FRYE SV, 1995, J MED CHEM, V38, P2621, DOI 10.1021/jm00014a015; GEORGE FW, 1991, P NATL ACAD SCI USA, V88, P8044, DOI 10.1073/pnas.88.18.8044; Gisleskog PO, 1999, BRIT J CLIN PHARMACO, V47, P53, DOI 10.1046/j.1365-2125.1999.00843.x; Gregory CW, 2001, CANCER RES, V61, P2892; Gregory CW, 2001, CANCER RES, V61, P4315; GRINO PB, 1990, ENDOCRINOLOGY, V126, P1165, DOI 10.1210/endo-126-2-1165; Gubbay J, 1998, ENDOCRINOLOGY, V139, P2935, DOI 10.1210/en.139.6.2935; Habib FK, 1998, J ENDOCRINOL, V156, P509, DOI 10.1677/joe.0.1560509; Heinrich R., 1996, REGULATION CELLULAR; Hunter PJ, 2003, NAT REV MOL CELL BIO, V4, P237, DOI 10.1038/nrm1054; ISAACS JT, 1984, PROSTATE, V5, P545, DOI 10.1002/pros.2990050510; Jain HV, 2011, P NATL ACAD SCI USA, V108, P19701, DOI 10.1073/pnas.1115750108; Kaplan SA, 2009, UROLOGY, V73, P935, DOI 10.1016/j.urology.2008.09.079; Kholodenko B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002961; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Nnane IP, 1998, CANCER RES, V58, P3826; NORMINGTON K, 1992, J BIOL CHEM, V267, P19548; ORLOWSKI J, 1988, J ENDOCRINOL, V116, P81, DOI 10.1677/joe.0.1160081; Petre-Draviam CE, 2003, CANCER RES, V63, P4903; Pinsky P, 2008, CANCER PREV RES, V1, P182, DOI 10.1158/1940-6207.CAPR-07-0007; Potter LK, 2006, AM J PHYSIOL-ENDOC M, V291, pE952, DOI 10.1152/ajpendo.00545.2005; Pozzi P, 2003, J NEUROENDOCRINOL, V15, P882, DOI 10.1046/j.1365-2826.2003.01074.x; PRINS GS, 1989, J STEROID BIOCHEM, V33, P319, DOI 10.1016/0022-4731(89)90319-1; RITTMASTER RS, 1995, ENDOCRINOLOGY, V136, P741, DOI 10.1210/en.136.2.741; Sadar MD, 1999, ENDOCR-RELAT CANCER, V6, P487, DOI 10.1677/erc.0.0060487; Scher HI, 2005, J CLIN ONCOL, V23, P8253, DOI 10.1200/JCO.2005.03.4777; SEGAL IH, 1975, ENZYME KINETICS BEHA; Selgrade JF, 2009, J THEOR BIOL, V260, P572, DOI 10.1016/j.jtbi.2009.06.017; Stuart JD, 2001, BIOCHEM PHARMACOL, V62, P933; SUDDUTH SL, 1993, PHARMACOTHERAPY, V13, P309; Suzuki K, 1997, TOHOKU J EXP MED, V183, P159, DOI 10.1620/tjem.183.159; Suzuki R, 2010, DRUG METAB PHARMACOK, V25, P208, DOI 10.2133/dmpk.25.208; TENNISWOOD M, 1982, J STEROID BIOCHEM, V16, P617, DOI 10.1016/0022-4731(82)90096-6; Thomas LN, 2008, J UROLOGY, V179, P147, DOI 10.1016/j.juro.2007.08.155; Thompson IM, 2008, UROLOGY, V71, P854, DOI 10.1016/j.urology.2008.01.025; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Tindall DJ, 2008, J UROLOGY, V179, P1235, DOI 10.1016/j.juro.2007.11.033; Torres JM, 2003, BIOCHEM BIOPH RES CO, V308, P469, DOI 10.1016/S0006-291X(03)01423-2; Turner TT, 2002, UROLOGY, V60, P186, DOI 10.1016/S0090-4295(02)01673-4; VERMEULEN A, 1991, EUR UROL, V20, P82; Westerhoff HV, 2004, NAT BIOTECHNOL, V22, P1249, DOI 10.1038/nbt1020; Wright AS, 1996, J CLIN INVEST, V98, P2558, DOI 10.1172/JCI119074; Xu Y, 2006, CLIN CANCER RES, V12, P4072, DOI 10.1158/1078-0432.CCR-06-0184	54	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44359	10.1371/journal.pone.0044359	http://dx.doi.org/10.1371/journal.pone.0044359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970204	Green Published, Green Submitted, gold			2022-12-25	WOS:000308458400061
J	Maftei, M; Thurm, F; Leirer, VM; von Arnim, CAF; Elbert, T; Przybylski, M; Kolassa, IT; Manea, M				Maftei, Madalina; Thurm, Franka; Leirer, Vera Maria; von Arnim, Christine A. F.; Elbert, Thomas; Przybylski, Michael; Kolassa, Iris-Tatjana; Manea, Marilena			Antigen-Bound and Free beta-Amyloid Autoantibodies in Serum of Healthy Adults	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; A-BETA; ANTIBODIES; PEPTIDE; IMMUNOGLOBULIN; RECOGNITION; COMPLEXES; DIAGNOSIS; DECLINE	Physiological beta-amyloid autoantibodies (A beta-autoantibodies) are currently investigated as potential diagnostic and therapeutic tools for Alzheimer's disease (AD). In previous studies, their determination in serum and cerebrospinal fluid (CSF) using indirect ELISA has provided controversial results, which may be due to the presence of preformed A beta antigen-antibody immune complexes. Based on the epitope specificity of the A beta-autoantibodies, recently elucidated in our laboratory, we developed (a) a sandwich ELISA for the determination of circulating A beta-IgG immune complexes and (b) an indirect ELISA for the determination of free A beta-autoantibodies. This methodology was applied to the analysis of serum samples from healthy individuals within the age range of 18 to 89 years. Neuropsychological examination of the participants in this study indicated non-pathological, age-related cognitive decline, revealed especially by tests of visual memory and executive function, as well as speed-related tasks. The ELISA serum determinations showed significantly higher levels of A beta-IgG immune complexes compared to free Ab-autoantibodies, while no correlation with age or cognitive performance of the participants was found.	[Maftei, Madalina; Przybylski, Michael; Manea, Marilena] Univ Konstanz, Dept Chem, Lab Analyt Chem & Biopolymer Struct Anal, Constance, Germany; [Maftei, Madalina] Univ Konstanz, Steinbeis Res Ctr Biopolymer Anal, Constance, Germany; [Thurm, Franka; Leirer, Vera Maria; Elbert, Thomas; Kolassa, Iris-Tatjana] Univ Konstanz, Dept Psychol, Constance, Germany; [Thurm, Franka; Kolassa, Iris-Tatjana] Univ Ulm, Inst Psychol & Educ, Ulm, Germany; [von Arnim, Christine A. F.] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany	University of Konstanz; University of Konstanz; University of Konstanz; Ulm University; Ulm University	Maftei, M (corresponding author), Univ Konstanz, Dept Chem, Lab Analyt Chem & Biopolymer Struct Anal, Constance, Germany.	iris.kolassa@uni-ulm.de; marilena.manea@uni-konstanz.de	Elbert, Thomas/C-8556-2009; Kolassa, Iris Tatjana/Y-3032-2018	Elbert, Thomas/0000-0003-1332-4939; Glockner, Franka/0000-0001-9684-7705	interdisciplinary project within the WIN-Kolleg (Junior Academy for Young Scholars and Scientists) of the Heidelberg Academy of Sciences, Heidelberg, Germany; Zukunftskolleg; Research Center Proteostasis, University of Konstanz	interdisciplinary project within the WIN-Kolleg (Junior Academy for Young Scholars and Scientists) of the Heidelberg Academy of Sciences, Heidelberg, Germany; Zukunftskolleg; Research Center Proteostasis, University of Konstanz	This research was funded as an interdisciplinary project within the WIN-Kolleg (Junior Academy for Young Scholars and Scientists) of the Heidelberg Academy of Sciences, Heidelberg, Germany, awarded to IK, M. Manea and CvA, by the Zukunftskolleg (IK and M. Manea) and Research Center Proteostasis (MP), University of Konstanz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackenheil M., 1999, MINI MINIINTERNATION; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Backman L, 2004, AGING NEUROPSYCHOL C, V11, P212, DOI 10.1080/13825580490511099; Baril L, 2004, NEUROSCI LETT, V355, P226, DOI 10.1016/j.neulet.2003.10.071; Beneduce L, 2007, CANCER DETECT PREV, V31, P402, DOI 10.1016/j.cdp.2007.10.005; Brettschneider S, 2005, BIOL PSYCHIAT, V57, P813, DOI 10.1016/j.biopsych.2004.12.008; Burkle Alexander, 2007, Immun Ageing, V4, P4, DOI 10.1186/1742-4933-4-4; Castaldi F, 2005, INT J BIOL MARKER, V20, P204, DOI 10.1177/172460080502000402; Christensen H, 2001, AUST NZ J PSYCHIAT, V35, P768, DOI 10.1046/j.1440-1614.2001.00966.x; Corral M, 2006, DEV NEUROPSYCHOL, V29, P479, DOI 10.1207/s15326942dn2903_6; Dodel R, 2008, European Patent Office, Patent No. [WO/2008/084402, 2008084402]; Dodel R, 2008, Patent International Application, Patent No. [PCT/IB2008/000456, 200800456]; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Dodel R, 2010, DRUGS, V70, P513, DOI 10.2165/11533070-000000000-00000; Du Y, 2001, NEUROLOGY, V57, P801, DOI 10.1212/WNL.57.5.801; Du YS, 2003, BRAIN, V126, P1935, DOI 10.1093/brain/awg191; Gustaw KA, 2008, J NEUROCHEM, V106, P1350, DOI 10.1111/j.1471-4159.2008.05477.x; Gustaw-Rothenberg KA, 2010, EXP GERONTOL, V45, P47, DOI 10.1016/j.exger.2009.10.003; HOLM S, 1979, SCAND J STAT, V6, P65; Hyman BT, 2001, ANN NEUROL, V49, P808, DOI 10.1002/ana.1061; Jolles S, 2005, CLIN EXP IMMUNOL, V142, P1, DOI 10.1111/j.1365-2249.2005.02834.X; Klaver AC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-93; Leirer VM, 2011, BRAIN IMAGING BEHAV, V5, P222, DOI 10.1007/s11682-011-9126-3; Lv JP, 2006, ALZ DIS ASSOC DIS, V20, P127, DOI 10.1097/00002093-200607000-00001; Manea M, 2008, J MED CHEM, V51, P1150, DOI 10.1021/jm070196e; McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790; Mruthinti S, 2004, NEUROBIOL AGING, V25, P1023, DOI 10.1016/j.neurobiolaging.2003.11.001; Muhamuda K, 2006, J CLIN VIROL, V37, P162, DOI 10.1016/j.jcv.2006.06.010; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Pinheiro J., 2011, NLME LINEAR NONLINEA; Przybylski M, 2007, 7 AUSTR PEPT S CAIRN, P32; Relkin NR, 2009, NEUROBIOL AGING, V30, P1728, DOI 10.1016/j.neurobiolaging.2007.12.021; Richartz E, 2005, J PSYCHIATR RES, V39, P535, DOI 10.1016/j.jpsychires.2004.12.005; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Song MS, 2007, J INT MED RES, V35, P301, DOI 10.1177/147323000703500303; Steck PH, 2005, ARCH CLIN NEUROPSYCH, V20, P409, DOI 10.1016/j.acn.2004.09.009; Stefanescu R, 2007, EUR J MASS SPECTROM, V13, P69, DOI 10.1255/ejms.849; Tewes U., 1994, HAMBURG WECHSLER INT; Weksler ME, 2002, EXP GERONTOL, V37, P943, DOI 10.1016/S0531-5565(02)00029-3; WELSH KA, 1994, NEUROLOGY, V44, P609, DOI 10.1212/WNL.44.4.609; Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	42	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44516	10.1371/journal.pone.0044516	http://dx.doi.org/10.1371/journal.pone.0044516			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	002ZJ	22973459	gold, Green Submitted, Green Published			2022-12-25	WOS:000308577600066
J	Kang, H; Louie, J; Weisman, A; Sheu-Gruttadauria, J; Davis-Dusenbery, BN; Lagna, G; Hata, A				Kang, Hara; Louie, Justin; Weisman, Alexandra; Sheu-Gruttadauria, Jessica; Davis-Dusenbery, Brandi N.; Lagna, Giorgio; Hata, Akiko			Inhibition of MicroRNA-302 (miR-302) by Bone Morphogenetic Protein 4 (BMP4) Facilitates the BMP Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE-CELL DIFFERENTIATION; PLURIPOTENT STEM-CELLS; CANCER-CELLS; BETA; EXPRESSION; TARGETS; FAMILY; IDENTIFICATION; MODULATION; MATURATION	The signaling pathway mediated by BMPs plays an essential role during development as well as the maintenance of homeostasis in adult. Aberrant activation or inactivation of BMP signaling can lead to developmental defects and various human disorders. To fine-tune its activity, BMP signaling is regulated both positively and negatively by extrinsic and intrinsic regulatory factors that modulate binding of ligand to the receptors, and the activity of receptors and their dedicated signal transducers, the Smad proteins. Upon BMP binding to the receptor complex, Smad proteins translocate to the nucleus and modulate gene expression transcriptionally by directly associating with the promoter region of target genes, or post-transcriptionally through modulation of microRNA (miRNA) synthesis. In this study, we demonstrate that BMP signaling down-regulates transcription of the miRNA-302 similar to 367 gene cluster. We show that the type II BMP receptor (BMPRII) is a novel target of miR-302. Upon overexpression, miR-302 targets a partially complementary sequence localized in the 3'-untranslated region (UTR) of BMPRII transcripts and leads to destabilization of the transcripts and down-regulation of BMP signaling. We propose that the negative regulatory loop of BMP4-miR-302-BMPRII is a potential mechanism for the maintenance and fine-tuning of the BMP signaling pathway in various systems.	[Louie, Justin; Sheu-Gruttadauria, Jessica; Lagna, Giorgio; Hata, Akiko] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Kang, Hara; Weisman, Alexandra; Davis-Dusenbery, Brandi N.; Lagna, Giorgio; Hata, Akiko] Tufts Univ, Sch Med, Mol Cardiol Res Inst, Tufts Med Ctr, Boston, MA 02111 USA; [Hata, Akiko] Tufts Univ, Sch Med, Dept Biochem, Boston, MA 02111 USA	University of California System; University of California San Francisco; Tufts Medical Center; Tufts University; Tufts University	Hata, A (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 555 Mission Bay Blvd S,Rm 252T, San Francisco, CA 94158 USA.	akiko.hata@ucsf.edu	Davis-Dusenbery, Brandi/N-2798-2013	Davis-Dusenbery, Brandi/0000-0001-7811-8613	NHLBI, National Institutes of Health Grant [HL093154]; LeDucq Foundation; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108317, R01HL093154] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health Grant; LeDucq Foundation(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by NHLBI, National Institutes of Health Grant HL093154, the LeDucq Foundation, and the American Heart Association (to A. H.).	Barroso-delJesus A, 2008, MOL CELL BIOL, V28, P6609, DOI 10.1128/MCB.00398-08; Barroso-delJesus A, 2011, FASEB J, V25, P1497, DOI 10.1096/fj.10-172221; Blahna MT, 2012, FEBS LETT, V586, P1906, DOI 10.1016/j.febslet.2012.01.041; Chan MC, 2010, EMBO J, V29, P559, DOI 10.1038/emboj.2009.370; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2010, MOL CELL, V39, P373, DOI 10.1016/j.molcel.2010.07.011; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Davis-Dusenbery BN, 2010, J BIOCHEM, V148, P381, DOI 10.1093/jb/mvq096; Golestaneh AF, 2012, CELL BIOCHEM FUNCT, V30, P411, DOI 10.1002/cbf.2815; HOGAN BLM, 1994, DEVELOPMENT, P53; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Jesus ABD, 2009, CELL CYCLE, V8, P394; Kang H, 2012, J BIOL CHEM, V287, P3976, DOI 10.1074/jbc.M111.303156; Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kuo CH, 2012, BIOCHEM BIOPH RES CO, V417, P11, DOI 10.1016/j.bbrc.2011.11.058; Lagna G, 2007, J BIOL CHEM, V282, P37244, DOI 10.1074/jbc.M708137200; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Lin SL, 2011, NUCLEIC ACIDS RES, V39, P1054, DOI 10.1093/nar/gkq850; Lipchina I, 2012, CELL CYCLE, V11, P1517, DOI 10.4161/cc.19846; Lipchina I, 2011, GENE DEV, V25, P2173, DOI 10.1101/gad.17221311; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Murray MJ, 2011, AM J CLIN PATHOL, V135, P119, DOI 10.1309/AJCPOE11KEYZCJHT; Neuman NA, 2009, J BIOL CHEM, V284, P13202, DOI 10.1074/jbc.M900282200; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Palmer RD, 2010, CANCER RES, V70, P2911, DOI 10.1158/0008-5472.CAN-09-3301; Rosa A, 2011, EMBO J, V30, P237, DOI 10.1038/emboj.2010.319; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Subramanyam D, 2011, NAT BIOTECHNOL, V29, P443, DOI 10.1038/nbt.1862; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247	33	46	49	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 9	2012	287	46					38656	38664		10.1074/jbc.M112.390898	http://dx.doi.org/10.1074/jbc.M112.390898			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	035WJ	22988237	Green Published, hybrid			2022-12-25	WOS:000310982800025
J	Qin, SY; Hu, D; Matsumoto, K; Takeda, K; Matsumoto, N; Yamaguchi, Y; Yamamoto, K				Qin, Sheng-Ying; Hu, Dan; Matsumoto, Kana; Takeda, Koh; Matsumoto, Naoki; Yamaguchi, Yoshiki; Yamamoto, Kazuo			Malectin Forms a Complex with Ribophorin I for Enhanced Association with Misfolded Glycoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; N-GLYCOSYLATION; BINDING PROTEIN; QUALITY-CONTROL; MRH DOMAIN; HUMAN OS-9; OLIGOSACCHARYLTRANSFERASE; ALPHA-1-ANTITRYPSIN; DEGRADATION; EFFICIENT	Malectin is an endoplasmic reticulum-resident lectin, which recognizes di-glucosylated Glc(2)Man(9)GlcNAc(2) (G2M9) N-glycans on newly synthesized glycoproteins. Wepreviously demonstrated that malectin preferentially associates with misfolded glycoproteins and inhibits their secretion (Chen, Y., Hu, D., Yabe, R., Tateno, H., Qin, S. Y., Matsumoto, N., Hirabayashi, J., and Yamamoto, K. (2011) Mol. Biol. Cell 22, 3559-3570). The sugar binding activity of malectin is required for this process. However, because G2M9 N-glycans are generated at the very early stage of processing and are typically found on both misfolded glycoproteins and glycoproteins undergoing folding, other mechanisms must underlie the preference of malectin for misfolded glycoproteins. Here, we searched for proteins that were co-immunoprecipitated with malectin, and we found that malectin formed a stable complex with an endoplasmic reticulum-resident transmembrane protein, ribophorin I. Co-expression of malectin and ribophorin I significantly enhanced the association between malectin and a folding-defective alpha 1-antitrypsin variant (null Hong Kong) and reduced its secretion; however, secretion of wild-type alpha 1-antitrypsin was not affected. The enhanced association and reduced secretion were counteracted by siRNA-mediated down-regulation of ribophorin I. Also, a reporter assay revealed that ribophorin I preferentially interacted with misfolded ribonuclease A but not with the native form, suggesting that ribophorin I may function as a chaperone that recognizes misfolded proteins inside cells. These results provide the first evidence of the mechanism by which malectin preferentially associates with misfolded glycoproteins.	[Qin, Sheng-Ying; Hu, Dan; Takeda, Koh; Matsumoto, Naoki; Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; [Matsumoto, Kana; Yamaguchi, Yoshiki] RIKEN, Adv Sci Inst, Struct Glycobiol Team, Wako, Saitama 3510198, Japan	University of Tokyo; RIKEN	Yamamoto, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan.	yamamoto@k.u-tokyo.ac.jp	Yamaguchi, Yoshiki/N-5246-2015	Yamaguchi, Yoshiki/0000-0003-0100-5439	Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology, Japan [21390173, 24390015]	Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from Core Research for Evolutional Science and Technology of the Japan Science and Technology Agency and Grants-in-aid for Scientific Research 21390173 and 24390015 (to K. Y.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Chen Y, 2011, MOL BIOL CELL, V22, P3559, DOI 10.1091/mbc.E11-03-0201; Galli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016304; Gauss R, 2011, MOL CELL, V42, P782, DOI 10.1016/j.molcel.2011.04.027; Hebert DN, 2010, SEMIN CELL DEV BIOL, V21, P526, DOI 10.1016/j.semcdb.2009.12.007; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Hu D, 2009, GLYCOBIOLOGY, V19, P1127, DOI 10.1093/glycob/cwp104; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; KELLEHER DJ, 1992, CELL, V69, P55, DOI 10.1016/0092-8674(92)90118-V; Mikami K, 2010, GLYCOBIOLOGY, V20, P310, DOI 10.1093/glycob/cwp175; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muller LN, 2010, ORG BIOMOL CHEM, V8, P3294, DOI 10.1039/c004502k; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Oliver JD, 1999, MOL BIOL CELL, V10, P2573, DOI 10.1091/mbc.10.8.2573; Schallus T, 2008, MOL BIOL CELL, V19, P3404, DOI 10.1091/mbc.E08-04-0354; Schallus T, 2010, GLYCOBIOLOGY, V20, P1010, DOI 10.1093/glycob/cwq059; Serve O, 2010, J MOL BIOL, V396, P361, DOI 10.1016/j.jmb.2009.11.049; SOUSA MC, 1992, BIOCHEMISTRY-US, V31, P97, DOI 10.1021/bi00116a015; Wilson CM, 2005, J BIOL CHEM, V280, P4195, DOI 10.1074/jbc.M410329200; Wilson CM, 2008, P NATL ACAD SCI USA, V105, P9534, DOI 10.1073/pnas.0711846105; Wilson CM, 2007, J CELL SCI, V120, P648, DOI 10.1242/jcs.000729; Yamaguchi D, 2010, GLYCOBIOLOGY, V20, P348, DOI 10.1093/glycob/cwp182	24	45	45	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.394288	http://dx.doi.org/10.1074/jbc.M112.394288			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22988243	hybrid, Green Published			2022-12-25	WOS:000310642200042
J	Cui, LN; Zhou, XM; Li, JG; Wang, LY; Wang, JB; Li, Q; Chu, JD; Zheng, LH; Wu, Q; Han, ZY; Shi, YQ; Han, Y; Fan, DM				Cui, Lina; Zhou, Xinmin; Li, Jinge; Wang, Liuyi; Wang, Jingbo; Li, Qiang; Chu, Jindong; Zheng, Linhua; Wu, Qiong; Han, Zheyi; Shi, Yongquan; Han, Ying; Fan, Daiming			Dynamic microRNA Profiles of Hepatic Differentiated Human Umbilical Cord Lining-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							HEPATOCYTE-LIKE CELLS; LIVER-REGENERATION; STROMAL CELLS; PROLIFERATION; PLURIPOTENCY; MOUSE	Despite the extensive hepatic differentiation potential of human umbilical cord lining-derived mesenchymal stem cells (hUC-MSC), little is known about the molecular mechanisms of hUC-MSC differentiation. At the post-transcriptional level, microRNAs are key players in the control of cell fate determination during differentiation. In this study, we aimed to identify microRNAs involved in the hepatic differentiation of hUC-MSCs. After successfully isolating hUC-MSCs, we induced hepatocyte formation in vitro with growth factors. After 26 days of induction, hUC-MSCs could express hepatocyte-specific genes, synthesize urea and glycogen and uptake low-density lipoprotein. Cellular total RNA from hUC-MSCs and hepatic differentiated hUC-MSCs was collected at 7 time points, including 2 days, 6 days, 10 days, 14 days, 22 days and 26 days, for microRNA microarray analysis. Dynamic microRNA profiles were identified that did not overlap or only partially overlapped with microRNAs reported to be involved in human liver development, hepatocyte regeneration or hepatic differentiation of liver-derived progenitor cells. A total of 61 microRNAs among 1205 human and 144 human viral microRNAs displayed consistent changes and were altered at least 2-fold between hUC-MSCs and hepatic differentiated hUC-MSCs. Among these microRNAs, 25 were over-expressed; this over-expression occurred either gradually or increased sharply and was maintained at a high level. A total of 36 microRNAs were under-expressed, with an expression pattern similar to that of the over-expressed microRNAs. The expression of the altered expressed microRNAs was also confirmed by quantitative reverse-transcription polymerase chain reaction. We also found that microRNAs involved in hepatic differentiation were not enriched in hepatocyte or hepatocellular carcinoma cells and can potentially target liver-enriched transcription factors and genes. The elucidation of the microRNA profile during the hepatic differentiation of hUC-MSCs provides the basis for clarifying the role of microRNAs in hUC-MSC hepatic differentiation and specific microRNA selection for the conversion of hUC-MSCs to hepatocytes.	[Cui, Lina; Zhou, Xinmin; Li, Jinge; Wang, Jingbo; Li, Qiang; Chu, Jindong; Zheng, Linhua; Wu, Qiong; Han, Zheyi; Shi, Yongquan; Han, Ying; Fan, Daiming] Fourth Mil Med Univ, State Key Lab Canc Biol, Xijing Hosp Digest Dis, Xian 710032, Shaanxi Provinc, Peoples R China; [Wang, Liuyi] Yanan Univ, Dept Gastroenterol, Affiliated Hosp, Yanan, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Yanan University	Cui, LN (corresponding author), Fourth Mil Med Univ, State Key Lab Canc Biol, Xijing Hosp Digest Dis, Xian 710032, Shaanxi Provinc, Peoples R China.	hanying@fmmu.edu.cn	wang, jing/GRS-7509-2022; Shi, Yongquan/AAE-3954-2020; 金华, 郑/GWM-7529-2022		National Natural Science Foundation of China [81070326]; "863" Program of China [2011AA020111]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "863" Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China (No. 81070326) and "863" Program of China (2011AA020111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Campard D, 2008, GASTROENTEROLOGY, V134, P833, DOI 10.1053/j.gastro.2007.12.024; Castro RE, 2010, AM J PHYSIOL-GASTR L, V299, pG887, DOI 10.1152/ajpgi.00216.2010; Chen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020238; Chen YX, 2010, LIVER TRANSPLANT, V16, P1086, DOI 10.1002/lt.22111; DEUSE T, 2010, CELL TRANSPLANT; Jung KH, 2011, INT J ONCOL; Kim YJ, 2009, J BONE MINER RES, V24, P816, DOI 10.1359/JBMR.081230; Kita K, 2010, STEM CELLS DEV, V19, P491, DOI 10.1089/scd.2009.0192; Li CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031292; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Peng L, 2011, HEPATOLOGY; Song GS, 2010, HEPATOLOGY, V51, P1735, DOI 10.1002/hep.23547; Tsai PC, 2009, LIVER TRANSPLANT, V15, P484, DOI 10.1002/lt.21715; Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xie CQ, 2011, STEM CELLS DEV, V20, P205, DOI 10.1089/scd.2010.0283; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhang YN, 2009, CYTOTHERAPY, V11, P548, DOI 10.1080/14653240903051533; Zhao QJ, 2009, CYTOTHERAPY, V11, P414, DOI 10.1080/14653240902849754	21	36	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44737	10.1371/journal.pone.0044737	http://dx.doi.org/10.1371/journal.pone.0044737			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984549	Green Submitted, gold, Green Published			2022-12-25	WOS:000308738500078
J	Kemirembe, K; Liebmann, K; Bootes, A; Smith, WA; Suzuki, Y				Kemirembe, Karen; Liebmann, Kate; Bootes, Abigail; Smith, Wendy A.; Suzuki, Yuichiro			Amino Acids and TOR Signaling Promote Prothoracic Gland Growth and the Initiation of Larval Molts in the Tobacco Hornworm Manduca sexta	PLOS ONE			English	Article							JUVENILE-HORMONE; CRITICAL WEIGHT; BODY-SIZE; PUBERTY; SILKWORM; ECDYSONE; ECDYSTEROIDOGENESIS; METAMORPHOSIS; STIMULATION; NUTRITION	Molting in arthropods is orchestrated by a series of endocrine changes that occur towards the end of an instar. However, little is understood about the mechanisms that trigger these endocrine changes. Here, nutritional inputs were manipulated to investigate the minimal nutritional inputs required for a Manduca sexta larva to initiate a molt. Amino acids were found to be necessary for a larva to molt, indicating the involvement of an amino acid sensitive pathway. Feeding rapamycin, an inhibitor of the target of rapamycin (TOR) signaling, delayed the onset of a molt and resulted in abnormally larger larvae. Rapamycin also suppressed the growth of the prothoracic glands relative to the whole body growth, and this was accompanied by suppression of ecdysone production and secretion. Higher doses of rapamycin also slowed the growth rate, indicating that TOR signaling also plays a role in systemic growth. TOR signaling therefore couples the nutritional status of the larva to the endocrine system to regulate the timing of a molt.	[Kemirembe, Karen; Liebmann, Kate; Suzuki, Yuichiro] Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA; [Bootes, Abigail; Smith, Wendy A.] Northeastern Univ, Dept Biol, Boston, MA 02115 USA	Wellesley College; Northeastern University	Kemirembe, K (corresponding author), Wellesley Coll, Dept Biol Sci, Wellesley, MA 02181 USA.	ysuzuki@wellesley.edu		Suzuki, Yuichiro/0000-0002-0957-3564	Sherman Fairchild Summer Research Award; Mentoring in the Sciences AT&T Research Grant; Susan Todd Horton Class of 1910 Trust (Bartels) fund; Wellesley College; Brachman-Hoffman foundation; National Science Foundation [IOS-1027453]; Direct For Biological Sciences [1027453] Funding Source: National Science Foundation	Sherman Fairchild Summer Research Award; Mentoring in the Sciences AT&T Research Grant; Susan Todd Horton Class of 1910 Trust (Bartels) fund; Wellesley College; Brachman-Hoffman foundation; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The study was supported by Sherman Fairchild Summer Research Award to K. K. and K. L. L.; the Mentoring in the Sciences AT&T Research Grant to K. K.; the Susan Todd Horton Class of 1910 Trust (Bartels) fund to K. L. L.; grants from Wellesley College, the Brachman-Hoffman foundation and the National Science Foundation IOS-1027453 to Y.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002498; AGUI N, 1979, P NATL ACAD SCI USA, V76, P5694, DOI 10.1073/pnas.76.11.5694; Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200; Bateman JM, 2004, CELL, V119, P87, DOI 10.1016/j.cell.2004.08.028; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Callier V, 2011, P NATL ACAD SCI USA, V108, P14664, DOI 10.1073/pnas.1106556108; CARROW GM, 1981, P NATL ACAD SCI-BIOL, V78, P5866, DOI 10.1073/pnas.78.9.5866; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; Ebling FJP, 2005, REPRODUCTION, V129, P675, DOI 10.1530/rep.1.00367; Gajdos ZKZ, 2010, MOL CELL ENDOCRINOL, V324, P21, DOI 10.1016/j.mce.2010.01.038; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; GRUETZMACHER MC, 1984, J INSECT PHYSIOL, V30, P771, DOI 10.1016/0022-1910(84)90013-1; Gu SH, 2012, INSECT BIOCHEM MOLEC, V42, P296, DOI 10.1016/j.ibmb.2011.12.010; Gu SH, 2011, INSECT BIOCHEM MOLEC, V41, P197, DOI 10.1016/j.ibmb.2010.12.004; Gu SH, 2009, INSECT BIOCHEM MOLEC, V39, P171, DOI 10.1016/j.ibmb.2008.10.012; Heming BS., 2003, INSECT DEV EVOLUTION; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; KIRKWOOD RN, 1987, P NUTR SOC, V46, P177, DOI 10.1079/PNS19870026; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Masumura M, 2000, GEN COMP ENDOCR, V118, P393, DOI 10.1006/gcen.1999.7438; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Nijhout H.F., 1998, INSECT HORMONES, P280; NIJHOUT HF, 1979, J INSECT PHYSIOL, V25, P277, DOI 10.1016/0022-1910(79)90055-6; NIJHOUT HF, 1981, AM ZOOL, V21, P631; NIJHOUT HF, 1974, J EXP BIOL, V61, P493; Parker NF, 2011, DEV BIOL, V357, P318, DOI 10.1016/j.ydbio.2011.07.002; Plant TM, 2002, J ADOLESCENT HEALTH, V31, P185, DOI 10.1016/S1054-139X(02)00484-6; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Riddiford LM, 2008, J INSECT PHYSIOL, V54, P895, DOI 10.1016/j.jinsphys.2008.01.014; Roa J, 2009, ENDOCRINOLOGY, V150, P5016, DOI 10.1210/en.2009-0096; Roa JA, 2010, TRENDS ENDOCRIN MET, V21, P519, DOI 10.1016/j.tem.2010.05.003; SAKURAI S, 1989, ARCH INSECT BIOCHEM, V10, P179, DOI 10.1002/arch.940100303; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; Sharpe RM, 2002, NAT CELL BIOL, V4, pS33, DOI 10.1038/ncb-nm-fertilityS33; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Smith W., 2011, INSECT ENDOCRINOLOGY, P1; SONG QS, 1994, DEV GENET, V15, P332, DOI 10.1002/dvg.1020150404; Teles MG, 2011, MOL CELL ENDOCRINOL, V346, P84, DOI 10.1016/j.mce.2011.05.019; TRUMAN JW, 1981, AM ZOOL, V21, P655; Walsh AL, 2011, J INSECT PHYSIOL, V57, P809, DOI 10.1016/j.jinsphys.2011.03.009; WARREN JT, 1984, EXPERIENTIA, V40, P393, DOI 10.1007/BF01952570; WARREN JT, 1988, P NATL ACAD SCI USA, V85, P958, DOI 10.1073/pnas.85.3.958; WATSON RD, 1985, J INSECT PHYSIOL, V31, P487, DOI 10.1016/0022-1910(85)90097-6; Wigglesworth VB, 1934, Q J MICROSC SCI, V77, P191; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501	49	30	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44429	10.1371/journal.pone.0044429	http://dx.doi.org/10.1371/journal.pone.0044429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984508	Green Submitted, Green Published, gold			2022-12-25	WOS:000308738500056
J	Lemasson, A; Remeuf, K; Rossard, A; Zimmermann, E				Lemasson, Alban; Remeuf, Kevin; Rossard, Arnaud; Zimmermann, Elke			Cross-Taxa Similarities in Affect-Induced Changes of Vocal Behavior and Voice in Arboreal Monkeys	PLOS ONE			English	Article							CERCOPITHECUS-CAMPBELLI-CAMPBELLI; SHREWS TUPAIA-BELANGERI; RUMBLE VOCALIZATIONS; LOXODONTA-AFRICANA; DISTURBANCE CALLS; SOCIAL-ISOLATION; CAPTIVE GROUP; ALARM CALLS; EXPRESSION; EMOTION	Measuring the affective state of an individual across species with comparable non-invasive methods is a current challenge in animal communication research. This study aims to explore to which extent affect intensity is conveyed in the vocal behaviours of three nonhuman primate species (Campbell's monkeys, De Brazza's monkeys, red-capped mangabeys), which vary in body size, ecological niche and social system. Similarly in the three species, we experimentally induced a change in captive social groups' affect by locking all group members together in their outside enclosure. The two experimental conditions which varied in affect intensity consisted in imposing a pre-reunion 90 mn-separation by splitting up the respective group into two subgroups (High affect condition) or not (Low affect condition). We measured call rates as well as voice features at the time of reunion in both conditions. The three studied species reacted in a very similar way. Across species, call rates changed significantly between the behaviourally defined states. Furthermore, contact call duration and, to some extent, voice pitch increased. Our results suggest, for the first time in arboreal Old World monkeys, that affect intensity is conveyed reliably in vocal behaviour and specific acoustic characteristics of voice, irrespective of body size and ecological niche differences between species. Cross-taxa similarities in acoustic cues of affect intensity point to phylogenetic constraints and inheritance from a common ancestor, whereas variations in vocal behaviour and affect intensity-related acoustic cues between species may be an adaptation to specific social requirements and depend on social systems. Our findings as well as a comparison with published works on acoustic communication in other vertebrate groups support the hypothesis that affect intensity in human voice originates from precursors already found deep inside the vertebrate phylogeny.	[Lemasson, Alban; Remeuf, Kevin; Rossard, Arnaud] Univ Rennes 1, CNRS, UMR 6552, Stn Biol Paimpont, Paimpont, France; [Lemasson, Alban] Inst Univ France, Paris, France; [Zimmermann, Elke] Univ Vet Med Hannover, Inst Zool, Hannover, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Institut Universitaire de France; University of Veterinary Medicine Hannover, Foundation	Lemasson, A (corresponding author), Univ Rennes 1, CNRS, UMR 6552, Stn Biol Paimpont, Paimpont, France.	alban.lemasson@univ-rennes1.fr			Agence Nationale de la Recherche; Institut Universitaire de France	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut Universitaire de France	This research was funded by the 'Agence Nationale de la Recherche' and the 'Institut Universitaire de France'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenmuller E, 2013, EVOLUTION E IN PRESS; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Aureli F, 2007, BIOL LETTERS, V3, P147, DOI 10.1098/rsbl.2007.0041; Bachorowski JA, 1999, CURR DIR PSYCHOL SCI, V8, P53, DOI 10.1111/1467-8721.00013; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Bastian A, 2008, J ACOUST SOC AM, V124, P598, DOI 10.1121/1.2924123; BEIER EG, 1972, J CONSULT CLIN PSYCH, V39, P166, DOI 10.1037/h0033170; BOLINGER JJ, 1978, IEEE T POWER AP SYST, V97, P1245, DOI 10.1109/TPAS.1978.354607; Bortz J, 1993, STAT SOZIALWISSENSCH; Bouchet H, 2012, AM J PRIMATOL, V74, P12, DOI 10.1002/ajp.21002; Bouchet H, 2010, AM J PRIMATOL, V72, P360, DOI 10.1002/ajp.20791; Colonnello V, 2010, DEV PSYCHOBIOL, V52, P1, DOI 10.1002/dev.20406; Coude G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026822; De Marco A, 2011, AM J PHYS ANTHROPOL, V146, P457, DOI 10.1002/ajpa.21606; DuBois AL, 2009, BIOL LETTERS, V5, P163, DOI 10.1098/rsbl.2008.0626; EAST ML, 1993, BEHAV ECOL SOCIOBIOL, V33, P355; Esch HC, 2009, J MAMMAL, V90, P638, DOI 10.1644/08-MAMM-A-069R.1; EWBANK R, 1971, ANIM PROD, V13, P685, DOI 10.1017/S0003356100000179; Fichtel C, 2001, BEHAVIOUR, V138, P97, DOI 10.1163/15685390151067094; FISCHER J, 1995, ETHOLOGY, V101, P51, DOI 10.1111/j.1439-0310.1995.tb00345.x; Fitch WT, 2000, PHONETICA, V57, P205; Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058; Galat G., 1985, TERRE ET LA VIE, V40, P3; Gautier-Hion, 1999, HIST NATURELLE PRIMA; Glenn ME, 1998, AM J PHYS ANTHROPOL, V105, P481, DOI 10.1002/(SICI)1096-8644(199804)105:4<481::AID-AJPA6>3.3.CO;2-L; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Gouzoules H, 2000, ANIM BEHAV, V59, P501, DOI 10.1006/anbe.1999.1318; Haccou P, 1994, STAT ANAL BEHAV DATA; Harnmerschmidt K, 2007, J VOICE, V21, P531, DOI 10.1016/j.jvoice.2006.03.002; Hatfield E., 1994, REV PERSONALITY SOCI; Johnstone T, 2000, PSYCHOPHYSIOLOGY, V37, pS52; Jurgens U, 2002, NEUROSCI BIOBEHAV R, V26, P235, DOI 10.1016/S0149-7634(01)00068-9; Juslin PN, 2001, EMOTION, V1, P381, DOI 10.1037//1528-3542.1.4.381; Juslin PN, 2003, ANN NY ACAD SCI, V1000, P279, DOI 10.1196/annals.1280.025; Laukka P, 2004, THESIS U UPPSALA; Leavesley AJ, 2005, ANIM BEHAV, V70, P365, DOI 10.1016/j.anbehav.2004.10.017; Leighty KA, 2008, ANIM BEHAV, V76, P1601, DOI 10.1016/j.anbehav.2008.06.022; Lemasson A, 2005, APPL ANIM BEHAV SCI, V91, P289, DOI 10.1016/j.applanim.2004.10.011; Lemasson A, 2011, J ACOUST SOC AM, V129, P3341, DOI 10.1121/1.3569704; Lemasson A, 2006, AM J PRIMATOL, V68, P1161, DOI 10.1002/ajp.20315; Lemasson A, 2011, ADV INTERACT STUD, V1, P39; Lemasson A, 2010, NATURWISSENSCHAFTEN, V97, P1023, DOI 10.1007/s00114-010-0715-6; Manser MB, 2001, P ROY SOC B-BIOL SCI, V268, P2315, DOI 10.1098/rspb.2001.1773; Manteuffel G, 2004, APPL ANIM BEHAV SCI, V88, P163, DOI 10.1016/j.applanim.2004.02.012; Marx G, 2001, APPL ANIM BEHAV SCI, V75, P61, DOI 10.1016/S0168-1591(01)00180-0; McNaughton N, 2004, NEUROSCI BIOBEHAV R, V28, P285, DOI 10.1016/j.neubiorev.2004.03.005; Moss C, 1988, ELEPHANT MEMORIES 13; Muller MN, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P112, DOI 10.1017/CBO9780511606397.012; Okamoto K, 2001, PRIMATES, V42, P161, DOI 10.1007/BF02558143; Ouattara K, 2009, P NATL ACAD SCI USA, V106, P22026, DOI 10.1073/pnas.0908118106; Perez EC, 2012, HORM BEHAV, V61, P573, DOI 10.1016/j.yhbeh.2012.02.004; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; Richard J-P, 1991, BIOACOUSTICS, V3, P45, DOI DOI 10.1080/09524622.1991.9753156; Rowell TE, 1988, PRIMATE RAD EVOLUTIO, P439; Sauter DA, 2010, P NATL ACAD SCI USA, V107, P2408, DOI 10.1073/pnas.0908239106; Schehka S, 2007, J COMP PHYSIOL A, V193, P845, DOI 10.1007/s00359-007-0236-8; Schehka S, 2009, BEHAV BRAIN RES, V203, P223, DOI 10.1016/j.bbr.2009.05.007; SCHERER KR, 1986, PSYCHOL BULL, V99, P143, DOI 10.1037/0033-2909.99.2.143; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; Scherer KR, 2001, J CROSS CULT PSYCHOL, V32, P76, DOI 10.1177/0022022101032001009; Soltis J, 2009, J COMP PSYCHOL, V123, P222, DOI 10.1037/a0015223; Stoeger AS, 2011, J ACOUST SOC AM, V130, P1700, DOI 10.1121/1.3605538; Suzuki TN, 2012, ANIM BEHAV, V84, P53, DOI 10.1016/j.anbehav.2012.03.030; Watwood SL, 2003, THESIS MIT; Weib BM, 2007, J ACOUST SOC AM, V122, P3710, DOI 10.1121/1.2799907; Wilson DR, 2012, ANIM BEHAV, V83, P535, DOI 10.1016/j.anbehav.2011.11.033; Zimmermann E, 2013, EVOLUTION E IN PRESS; Zimmermann E, 2010, HBK BEHAV NEUROSCI, V19, P215, DOI 10.1016/B978-0-12-374593-4.00022-X	68	20	20	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e45106	10.1371/journal.pone.0045106	http://dx.doi.org/10.1371/journal.pone.0045106			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984618	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500117
J	Lian, H; Ma, YW; Feng, J; Dong, W; Yang, Q; Lu, D; Zhang, LF				Lian, Hong; Ma, Yuanwu; Feng, Juan; Dong, Wei; Yang, Qing; Lu, Dan; Zhang, Lianfeng			Heparin-Binding EGF-Like Growth Factor Induces Heart Interstitial Fibrosis via an Akt/mTor/p70s6k Pathway	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; FACTOR RECEPTOR; IN-VITRO; HB-EGF; KERATINOCYTE MIGRATION; DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; TRANSGENIC MICE; LIVER FIBROSIS; MESSENGER-RNA	Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is essential for maintaining normal function of the adult heart and is known to play an important role in myocardial remodeling. In the present study, we observed that heart-specific HB-EGF transgenic (TG) mice had systolic dysfunction with decreased fractional shortening (FS%), increased end-systolic diameter (LVIDs) at 5 months of age, increased heart fibrosis, and increased mRNA expression of Col1 alpha 1 and Col3 alpha 1 at 1, 3, 5 and 7 months of age compared to nontransgenic (NTG) littermates. However, the left ventricular anterior wall thickness at end-systole (LVAWs) of the TG mice was not different than the NTG mice. Phosphorylation levels of Akt, mTor and p70s6k were increased due to HB-EGF expression in TG mice compared with the NTG mice at 3 and 7 months of age. Additionally, activated Akt, mTor and p70s6k were co-localized with vimentin to cardiac fibroblasts isolated from TG mice. Furthermore, HB-EGF significantly increased phosphorylation levels of Akt, mTor and p70s6k and increased expression of type I collagen in cultured primary cardiac fibroblasts. Rapamycin (Rapa) and CRM197, inhibitors of mTor and HB-EGF respectively, could inhibit the expression of type I collagen in the cultured primary cardiac fibroblasts and Rapa suppressed interstitial fibrosis of the heart tissues in vivo. In addition, a BrdU assay showed that HB-EGF increased proliferation of cardiac fibroblasts by 30% compared with cells without HB-EGF treatment. HB-EGF-induced proliferation was completely diminished in the presence of Rapa. These results suggest that HB-EGF induced heart fibrosis and proliferation of cardiac fibroblasts occurs through activation of the Akt/mTor/p70s6k pathway.	[Lian, Hong; Ma, Yuanwu; Feng, Juan; Dong, Wei; Yang, Qing; Lu, Dan; Zhang, Lianfeng] Chinese Acad Med Sci, Inst Lab Anim Sci, Minist Hlth, Key Lab Human Dis Comparat Med, Beijing 100730, Peoples R China; [Lian, Hong; Ma, Yuanwu; Feng, Juan; Dong, Wei; Yang, Qing; Lu, Dan; Zhang, Lianfeng] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhang, Lianfeng] Chinese Acad Med Sci, Inst Lab Anim Sci, State Adm Tradit Chinese Med, Key Lab Human Dis Anim Model, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS	Lian, H (corresponding author), Chinese Acad Med Sci, Inst Lab Anim Sci, Minist Hlth, Key Lab Human Dis Comparat Med, Beijing 100730, Peoples R China.	Zhanglf@cnilas.org		LU, Dan/0000-0002-5204-2574; Ma, Yuanwu/0000-0002-1882-1777	Ministry of Health Foundation [200802036]	Ministry of Health Foundation	The present work was supported by the Ministry of Health Foundation (200802036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM JA, 1993, BIOCHEM BIOPH RES CO, V190, P125, DOI 10.1006/bbrc.1993.1020; Asakura M, 2002, NAT MED, V8, P35, DOI 10.1038/nm0102-35; Biecker E, 2005, J PHARMACOL EXP THER, V313, P952, DOI 10.1124/jpet.104.079616; Blaine SA, 2009, AM J PHYSIOL-GASTR L, V297, pG434, DOI 10.1152/ajpgi.00152.2009; Bridle KR, 2006, J LAB CLIN MED, V147, P234, DOI 10.1016/j.lab.2005.12.009; Bridle KR, 2009, LIVER TRANSPLANT, V15, P1315, DOI 10.1002/lt.21804; Caiazza F, 2010, MOL ENDOCRINOL, V24, P953, DOI 10.1210/me.2009-0293; DAS SK, 1994, DEVELOPMENT, V120, P1071; Fu SL, 1999, P NATL ACAD SCI USA, V96, P5716, DOI 10.1073/pnas.96.10.5716; Fujino T, 1998, CARDIOVASC RES, V38, P365, DOI 10.1016/S0008-6363(98)00010-8; Gabele E, 2005, J BIOL CHEM, V280, P13374, DOI 10.1074/jbc.M409444200; GORDON JW, 1981, SCIENCE, V214, P1244, DOI 10.1126/science.6272397; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; HIGASHIYAMA S, 1993, J CELL BIOL, V122, P933, DOI 10.1083/jcb.122.4.933; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Iwamoto R, 2000, CYTOKINE GROWTH F R, V11, P335, DOI 10.1016/S1359-6101(00)00013-7; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jin KL, 2005, J NEUROSCI RES, V81, P497, DOI 10.1002/jnr.20510; Juan F, 2008, INT J CARDIOL, V128, P83, DOI 10.1016/j.ijcard.2008.03.006; Kirkland G, 1998, J AM SOC NEPHROL, V9, P1464; Kiso S, 2003, GASTROENTEROLOGY, V124, P701, DOI 10.1053/gast.2003.50097; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; Means AL, 2003, GASTROENTEROLOGY, V124, P1020, DOI 10.1053/gast.2003.50150; Mine N, 2005, DEVELOPMENT, V132, P4317, DOI 10.1242/dev.02030; MIYAGAWA J, 1995, J CLIN INVEST, V95, P404, DOI 10.1172/JCI117669; Mulder GM, 2011, NEPHROL DIAL TRANSPL; Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004; Neef M, 2006, J HEPATOL, V45, P786, DOI 10.1016/j.jhep.2006.07.030; Pauschinger M, 1999, CIRCULATION, V99, P2750, DOI 10.1161/01.CIR.99.21.2750; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Reynolds CM, 2002, HYPERTENSION, V39, P525, DOI 10.1161/hy0202.103076; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; Shegogue D, 2004, J BIOL CHEM, V279, P23166, DOI 10.1074/jbc.M401238200; Shillingford Jonathan M, 2010, J AM SOC NEPHROL, V21, P489; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; Su EJ, 2003, AM J PHYSIOL-HEART C, V284, pH1429, DOI 10.1152/ajpheart.00885.2002; Takemura T, 2001, J AM SOC NEPHROL, V12, P964, DOI 10.1681/ASN.V125964; Tanaka N, 2002, BIOCHEM BIOPH RES CO, V297, P375, DOI 10.1016/S0006-291X(02)02197-6; Taniyama Y, 2002, HYPERTENSION, V40, P47, DOI 10.1161/01.HYP.0000020755.56955.BF; Tokumaru S, 2000, J CELL BIOL, V151, P209, DOI 10.1083/jcb.151.2.209; Ushikoshi H, 2005, LAB INVEST, V85, P862, DOI 10.1038/labinvest.3700282; VAUGHAN TJ, 1992, BIOCHEM J, V287, P681, DOI 10.1042/bj2870681; Wang SN, 2010, AM J PHYSIOL-RENAL, V298, pF142, DOI 10.1152/ajprenal.00320.2009; Wei S, 1999, J CARD FAIL, V5, P117, DOI 10.1016/S1071-9164(99)90034-9; Xiang XX, 2011, ACTA BIOCH BIOPH SIN, V43, P501, DOI 10.1093/abbs/gmr041; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104; Zhao HP, 2010, J PHARMACOL SCI, V112, P214, DOI 10.1254/jphs.09314FP; Zhu JL, 1999, GASTROENTEROLOGY, V117, P1198, DOI 10.1016/S0016-5085(99)70406-3	50	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44946	10.1371/journal.pone.0044946	http://dx.doi.org/10.1371/journal.pone.0044946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984591	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500098
J	Rieucau, G; Blanchard, P; Martin, JGA; Favreau, FR; Goldizen, AW; Pays, O				Rieucau, Guillaume; Blanchard, Pierrick; Martin, Julien G. A.; Favreau, Francois-Rene; Goldizen, Anne W.; Pays, Olivier			Investigating Differences in Vigilance Tactic Use within and between the Sexes in Eastern Grey Kangaroos	PLOS ONE			English	Article							GROUP-SIZE; PREDATION RISK; GRAY KANGAROO; BEHAVIOR; COMPETITION; SEGREGATION; DILUTION; JUNCOS; COSTS; MODEL	Aggregation is thought to enhance an animal's security through effective predator detection and the dilution of risk. A decline in individual vigilance as group size increases is commonly reported in the literature and called the group size effect. However, to date, most of the research has only been directed toward examining whether this effect occurs at the population level. Few studies have explored the specific contributions of predator detection and risk dilution and the basis of individual differences in the use of vigilance tactics. We tested whether male and female (non-reproductive or with young) eastern grey kangaroos (Macropus giganteus) adopted different vigilance tactics when in mixed-sex groups and varied in their reliance on predator detection and/or risk dilution as group size changed. This species exhibits pronounced sexual dimorphism with females being much smaller than males, making them differentially vulnerable toward predators. We combined field observations with vigilance models describing the effects of detection and dilution on scanning rates as group size increased. We found that females with and without juveniles relied on predator detection and risk dilution, but the latter adjusted their vigilance to the proportion of females with juveniles within their group. Two models appeared to equally support the data for males suggesting that males, similarly to females, relied on predator detection and risk dilution but may also have adjusted their vigilance according to the proportion of mothers within their group. Differential vulnerability may cause sex differences in vigilance tactic use in this species. The presence of males within a group that do not, or only partially, contribute to predator detection and are less at risk may cause additional security costs to females. Our results call for reexamination of the classical view of the safety advantages of grouping to provide a more detailed functional interpretation of gregariousness.	[Rieucau, Guillaume] Inst Marine Res, N-5024 Bergen, Norway; [Rieucau, Guillaume; Blanchard, Pierrick] Univ Toulouse, CNRS, ENFA, Lab Evolut & Divers Biol,UMR 5174, Toulouse, France; [Martin, Julien G. A.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Favreau, Francois-Rene] Univ Lyon 1, CNRS, Lab Biometrie & Biol Evolut, UMR5558, F-69622 Villeurbanne, France; [Favreau, Francois-Rene; Goldizen, Anne W.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Favreau, Francois-Rene; Pays, Olivier] Univ Angers, Grp Ecol & Conservat, Angers, France	Institute of Marine Research - Norway; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of Queensland; Universite d'Angers	Rieucau, G (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	guillaume.rieucau@imr.no	Martin, Julien GA/H-5843-2019; Goldizen, Anne/G-7366-2012	Martin, Julien GA/0000-0001-7726-6809; Goldizen, Anne/0000-0003-0101-4108; Rieucau, Guillaume/0000-0002-8968-4992; Rieucau, Guillaume/0000-0002-7995-1065	Fyssen Foundation; Institute of Marine Research, Bergen, Norway; Fonds de recherche du Quebec Nature et technologies (FQRNT); National Science Foundation; University of Queensland	Fyssen Foundation; Institute of Marine Research, Bergen, Norway; Fonds de recherche du Quebec Nature et technologies (FQRNT); National Science Foundation(National Science Foundation (NSF)); University of Queensland(University of Queensland)	GR was financially supported by a Fyssen Foundation postdoctoral fellowship and by a postdoctoral fellowship from the Institute of Marine Research, Bergen, Norway. GR and PB are at the Laboratoire Evolution et Diversite Biologique (EDB) part of the "Laboratoire d'Excellence" (LABEX) entitled TULIP (ANR-10-LABX-41). JM was funded by an Fonds de recherche du Quebec Nature et technologies (FQRNT) fellowship and an National Science Foundation - Long-Term Research in Environmental Biology (NSF-LTREB) grant. AWG and F-RF were supported by research funds from the University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Beauchamp G, 2008, BEHAV ECOL, V19, P1361, DOI 10.1093/beheco/arn096; Blanchard P, 2008, BEHAV ECOL SOCIOBIOL, V62, P1863, DOI 10.1007/s00265-008-0615-3; Blumstein DT, 2010, J EVOLUTION BIOL, V23, P879, DOI 10.1111/j.1420-9101.2010.01967.x; Caro Tim, 2005, pXIII; Carter AJ, 2009, BEHAV ECOL SOCIOBIOL, V64, P237, DOI 10.1007/s00265-009-0840-4; Carter AJ, 2009, ANIM BEHAV, V77, P839, DOI 10.1016/j.anbehav.2008.12.007; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; COLAGROSS AML, 1993, AUST J ZOOL, V41, P325, DOI 10.1071/ZO9930325; Cripps JK, 2011, BIOL LETTERS, V7, P859, DOI 10.1098/rsbl.2011.0526; DEHN MM, 1990, BEHAV ECOL SOCIOBIOL, V26, P337; DUNCAN P, 1990, OECOLOGIA, V84, P411, DOI 10.1007/BF00329768; Fairbanks B, 2007, ANIM BEHAV, V73, P115, DOI 10.1016/j.anbehav.2006.07.002; Favreau FR, 2010, P ROY SOC B-BIOL SCI, V277, P2089, DOI 10.1098/rspb.2009.2337; Fernandez-Juricic E, 2004, BEHAV ECOL SOCIOBIOL, V55, P502, DOI 10.1007/s00265-003-0698-9; FITZGIBBON CD, 1990, ANIM BEHAV, V40, P837, DOI 10.1016/S0003-3472(05)80984-4; Fortin D, 2004, OIKOS, V107, P172, DOI 10.1111/j.0030-1299.2004.12976.x; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Jarman P.J., 1986, P399; JARMAN PJ, 1989, KANGAROOS, WALLABIES AND RAT-KANGAROOS, VOLS 1 AND 2, P433; JARMAN PJ, 1987, ANIM BEHAV, V35, P1044, DOI 10.1016/S0003-3472(87)80161-6; Krebs JR, 1993, INTRO BEHAV ECOLOGY; Lima SL, 1999, BEHAV ECOL SOCIOBIOL, V46, P110, DOI 10.1007/s002650050599; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1995, ANIM BEHAV, V49, P11, DOI 10.1016/0003-3472(95)80149-9; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lopez P, 2005, ANIM BEHAV, V69, P1, DOI 10.1016/j.anbehav.2004.05.010; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Michelena P, 2004, ANIM BEHAV, V68, P1371, DOI 10.1016/j.anbehav.2004.04.008; Michelena P, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016014, 10.1371/journal.pone.0018631]; Pays O, 2008, BEHAV ECOL SOCIOBIOL, V62, P757, DOI 10.1007/s00265-007-0501-4; Pays O, 2007, P ROY SOC B-BIOL SCI, V274, P1287, DOI 10.1098/rspb.2006.0204; Pays O, 2009, BEHAV ECOL, V20, P469, DOI 10.1093/beheco/arp019; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; PULLIAM HR, 1982, J THEOR BIOL, V95, P89, DOI 10.1016/0022-5193(82)90289-2; Quinn JL, 2005, BEHAVIOUR, V142, P1377, DOI 10.1163/156853905774539391; Rieucau G, 2008, OIKOS, V117, P501, DOI 10.1111/j.0030-1299.2008.16274.x; Rieucau G, 2010, BEHAV ECOL, V21, P684, DOI 10.1093/beheco/arq039; Ruckstuhl KE, 2002, BIOL REV, V77, P77, DOI 10.1017/S1464793101005814; SHORT J, 1985, J APPL ECOL, V22, P435, DOI 10.2307/2403176	40	18	18	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44801	10.1371/journal.pone.0044801	http://dx.doi.org/10.1371/journal.pone.0044801			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984563	Green Published, gold			2022-12-25	WOS:000308738500087
J	Everett, DB; Cornick, J; Denis, B; Chewapreecha, C; Croucher, N; Harris, S; Parkhill, J; Gordon, S; Carrol, ED; French, N; Heyderman, RS; Bentley, SD				Everett, Dean B.; Cornick, Jennifer; Denis, Brigitte; Chewapreecha, Claire; Croucher, Nicholas; Harris, Simon; Parkhill, Julian; Gordon, Stephen; Carrol, Enitan D.; French, Neil; Heyderman, Robert S.; Bentley, Stephen D.			Genetic Characterisation of Malawian Pneumococci Prior to the Roll-Out of the PCV13 Vaccine Using a High-Throughput Whole Genome Sequencing Approach	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; CONJUGATE VACCINE; BACTERIAL-MENINGITIS; DISEASE; CHILDREN; CLONES; IDENTIFICATION; EVOLUTION; DYNAMICS	Background: Malawi commenced the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) into the routine infant immunisation schedule in November 2011. Here we have tested the utility of high throughput whole genome sequencing to provide a high-resolution view of pre-vaccine pneumococcal epidemiology and population evolutionary trends to predict potential future change in population structure post introduction. Methods: One hundred and twenty seven (127) archived pneumococcal isolates from randomly selected adults and children presenting to the Queen Elizabeth Central Hospital, Blantyre, Malawi underwent whole genome sequencing. Results: The pneumococcal population was dominated by serotype 1 (20.5% of invasive isolates) prior to vaccine introduction. PCV13 is likely to protect against 62.9% of all circulating invasive pneumococci (78.3% in under-5-year-olds). Several Pneumococcal Molecular Epidemiology Network (PMEN) clones are now in circulation in Malawi which were previously undetected but the pandemic multidrug resistant PMEN1 lineage was not identified. Genome analysis identified a number of novel sequence types and serotype switching. Conclusions: High throughput genome sequencing is now feasible and has the capacity to simultaneously elucidate serotype, sequence type and as well as detailed genetic information. It enables population level characterization, providing a detailed picture of population structure and genome evolution relevant to disease control. Post-vaccine introduction surveillance supported by genome sequencing is essential to providing a comprehensive picture of the impact of PCV13 on pneumococcal population structure and informing future public health interventions.	[Everett, Dean B.; Cornick, Jennifer; Denis, Brigitte; Heyderman, Robert S.] Malawi Liverpool Wellcome Clin Res Programme, Blantyre, Malawi; [Everett, Dean B.; Cornick, Jennifer; French, Neil; Bentley, Stephen D.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Chewapreecha, Claire; Croucher, Nicholas; Harris, Simon; Parkhill, Julian; Bentley, Stephen D.] Wellcome Trust Sanger Inst, Cambridge, England; [Gordon, Stephen; Heyderman, Robert S.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Carrol, Enitan D.] Univ Liverpool, Inst Child Hlth, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England	University of Liverpool; Wellcome Trust Sanger Institute; Liverpool School of Tropical Medicine; University of Liverpool; University of Liverpool	Everett, DB (corresponding author), Malawi Liverpool Wellcome Clin Res Programme, Blantyre, Malawi.	Dean.Everett@liverpool.ac.uk	Parkhill, Julian/G-4703-2011; Chewapreecha, Claire/D-6446-2016; Harris, Simon R/K-1318-2013	Parkhill, Julian/0000-0002-7069-5958; Chewapreecha, Claire/0000-0002-1313-4011; Harris, Simon R/0000-0003-1512-6194; Croucher, Nicholas/0000-0001-6303-8768; Heyderman, Robert/0000-0003-4573-449X; Carrol, Enitan/0000-0001-8357-7726; Gordon, Stephen/0000-0001-6576-1116; Everett, Dean/0000-0002-8458-6779; French, Neil/0000-0003-4814-8293; Cornick, Jen/0000-0001-6841-9842	MLW Clinical Research Programme Core Grant from the Wellcome Trust [084679/Z/08/Z]; Wellcome Trust	MLW Clinical Research Programme Core Grant from the Wellcome Trust; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the MLW Clinical Research Programme Core Grant (award no: 084679/Z/08/Z) from the Wellcome Trust and funding to the Sanger Institute from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	All-Party Parliamentary Group on Pneumococcal Disease Prevention in the Developing World, 2008, IMPR GLOB HLTH PREV, P1; APPELBAUM PC, 1992, CLIN INFECT DIS, V15, P77, DOI 10.1093/clinids/15.1.77; Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Carrol ED, 2007, PEDIATR INFECT DIS J, V26, P416, DOI 10.1097/01.inf.0000260253.22994.61; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Everett DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017765; Gordon SB, 2000, CLIN INFECT DIS, V31, P53, DOI 10.1086/313910; Gordon SB, 2003, EMERG INFECT DIS, V9, P747; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; HEINEMAN HS, 1973, NEW ENGL J MED, V288, P1027; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Klugman Keith P., 2008, P317; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lalitha MK, 1996, B WORLD HEALTH ORGAN, V74, P387; LUND E, 1960, Bull World Health Organ, V23, P5; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; McIntosh EDG, 2011, EXPERT REV VACCINES, V10, P109, DOI 10.1586/ERV.10.145; Molyneux EM, 2002, LANCET, V360, P211, DOI 10.1016/S0140-6736(02)09458-8; MUNOZ R, 1991, J INFECT DIS, V164, P302, DOI 10.1093/infdis/164.2.302; Neufeld F, 1902, Z HYG INFEKTIONSKR, V40, P54; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2008, MMWR-MORBID MORTAL W, V57, P144; Paton JC, 2008, PROTEIN VACCINES; Shi ZY, 1998, J CLIN MICROBIOL, V36, P3514, DOI 10.1128/JCM.36.12.3514-3519.1998; SORENSEN UBS, 1993, J CLIN MICROBIOL, V31, P2097; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	37	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 10	2012	7	9							e44250	10.1371/journal.pone.0044250	http://dx.doi.org/10.1371/journal.pone.0044250			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005KD	22970189	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000308748400014
J	Fujimori, K; Yano, M; Ueno, T				Fujimori, Ko; Yano, Mutsumi; Ueno, Toshiyuki			Synergistic Suppression of Early Phase of Adipogenesis by Microsomal PGE Synthase-1 (PTGES1)-Produced PGE(2) and Aldo-Keto Reductase 1B3-Produced PGF(2 alpha)	PLOS ONE			English	Article							PROSTAGLANDIN E-2 SYNTHASE; POSITIVE FEEDBACK LOOP; ADIPOCYTE DIFFERENTIATION; CYCLOOXYGENASE-2 EXPRESSION; ADIPOSE-TISSUE; RECEPTOR; IDENTIFICATION; FAT; PROSTACYCLIN; OBESITY	We recently reported that aldo-keto reductase 1B3-produced prostaglandin (PG) F-2 alpha suppressed the early phase of adipogenesis. PGE(2) is also known to suppress adipogenesis. In this study, we found that microsomal PGE(2) synthase (PGES)-1 (mPGES-1; PTGES1) acted as the PGES in adipocytes and that PGE(2) and PGF(2 alpha) synergistically suppressed the early phase of adipogenesis. PGE(2) production was detected in preadipocytes and transiently enhanced at 3 h after the initiation of adipogenesis of mouse adipocytic 3T3-L1 cells, followed by a quick decrease; and its production profile was similar to the expression of the cyclooxygenase-2 (PTGS2) gene. When 3T3-L1 cells were transfected with siRNAs for any one of the three major PTGESs, i.e., PTGES1, PTGES2 (mPGES-2), and PTGES3 (cytosolic PGES), only PTGES1 siRNA suppressed PGE(2) production and enhanced the expression of adipogenic genes. AE1-329, a PTGER4 (EP4) receptor agonist, increased the expression of the Ptgs2 gene with a peak at 1 h after the initiation of adipogenesis. PGE(2)-mediated enhancement of the PTGS2 expression was suppressed by the co-treatment with L-161982, a PTGER4 receptor antagonist. Moreover, AE1-329 enhanced the expression of the Ptgs2 gene by binding of the cyclic AMP response element (CRE)-binding protein to the CRE of the Ptgs2 promoter; and its binding was suppressed by co-treatment with L-161982, which was demonstrated by promoter luciferase and chromatin immunoprecipitation assays. Furthermore, when 3T3-L1 cells were caused to differentiate into adipocytes in medium containing both PGE(2) and PGF(2 alpha), the expression of the adipogenic genes and the intracellular triglyceride level were decreased to a greater extent than in medium containing either of them, revealing that PGE(2) and PGF(2 alpha) independently suppressed adipogenesis. These results indicate that PGE(2) was synthesized by PTGES1 in adipocytes and synergistically suppressed the early phase of adipogenesis of 3T3-L1 cells in cooperation with PGF(2 alpha) through receptor-mediated activation of PTGS2 expression.	[Fujimori, Ko; Yano, Mutsumi; Ueno, Toshiyuki] Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, Takatsuki, Osaka, Japan	Osaka University of Pharmaceutical Sciences	Fujimori, K (corresponding author), Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, Takatsuki, Osaka, Japan.	fujimori@gly.oups.ac.jp	Fujimori, Ko/AAD-5428-2021	Fujimori, Ko/0000-0002-2506-0769	Ministry of Education, Culture, Sports, Science and Technology of Japan [21570151, 23116516]; Japan Foundation for Applied Enzymology; Takeda Science Foundation; Naito Foundation; Research Foundation for Pharmaceutical Sciences	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); Research Foundation for Pharmaceutical Sciences	This work was supported in part by Grant-in-Aid for Scientific Research (21570151) and Scientific Research on Innovative Areas (23116516) from The Ministry of Education, Culture, Sports, Science and Technology of Japan, and by grants from Japan Foundation for Applied Enzymology, Takeda Science Foundation, The Naito Foundation, and The Research Foundation for Pharmaceutical Sciences (KF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Christodoulides C, 2010, MOL CELL ENDOCRINOL, V318, P61, DOI 10.1016/j.mce.2009.09.014; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; FLETCHER BS, 1992, J BIOL CHEM, V267, P4338; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; Fujimori K, 2012, GENE, V505, P46, DOI 10.1016/j.gene.2012.05.052; Fujimori K, 2010, PROSTAG OTH LIPID M, V93, P52, DOI 10.1016/j.prostaglandins.2010.06.005; Fujimori K, 2010, J BIOL CHEM, V285, P8880, DOI 10.1074/jbc.M109.077164; Fujitani Y, 2010, FEBS J, V277, P1410, DOI 10.1111/j.1742-4658.2010.07565.x; Hara S, 2010, BIOCHIMIE, V92, P651, DOI 10.1016/j.biochi.2010.02.007; Hetu PO, 2007, OBESITY, V15, P60, DOI 10.1038/oby.2007.514; Inazumi T, 2011, J LIPID RES, V52, P1500, DOI 10.1194/jlr.M013615; Jabbour HN, 2005, ENDOCRINOLOGY, V146, P4657, DOI 10.1210/en.2005-0804; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kudo I, 2005, J BIOCHEM MOL BIOL, V38, P633; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Legler DF, 2010, INT J BIOCHEM CELL B, V42, P198, DOI 10.1016/j.biocel.2009.09.015; Murakami M, 2002, PROSTAG OTH LIPID M, V68-9, P383, DOI 10.1016/S0090-6980(02)00043-6; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Sales KJ, 2008, MOL CELL ENDOCRINOL, V285, P51, DOI 10.1016/j.mce.2008.01.016; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Tanikawa N, 2002, BIOCHEM BIOPH RES CO, V291, P884, DOI 10.1006/bbrc.2002.6531; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tsuboi H, 2004, BIOCHEM BIOPH RES CO, V322, P1066, DOI 10.1016/j.bbrc.2004.08.018; Ueno N, 2005, BIOCHEM BIOPH RES CO, V338, P70, DOI 10.1016/j.bbrc.2005.08.152; Ueno T, 2011, FEBS J, V278, P2901, DOI 10.1111/j.1742-4658.2011.08213.x; VASSAUX G, 1992, J BIOL CHEM, V267, P11092; VASSAUX G, 1992, ENDOCRINOLOGY, V131, P2393, DOI 10.1210/en.131.5.2393; Xie Y, 2006, DIABETES OBES METAB, V8, P83, DOI 10.1111/j.1463-1326.2005.00472.x	36	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44698	10.1371/journal.pone.0044698	http://dx.doi.org/10.1371/journal.pone.0044698			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970288	Green Published, gold, Green Submitted			2022-12-25	WOS:000308462000045
J	Sieni, E; Cetica, V; Piccin, A; Gherlinzoni, F; Sasso, FC; Rabusin, M; Attard, L; Bosi, A; Pende, D; Moretta, L; Arico, M				Sieni, Elena; Cetica, Valentina; Piccin, Andrea; Gherlinzoni, Filippo; Sasso, Ferdinando Carlo; Rabusin, Marco; Attard, Luciano; Bosi, Alberto; Pende, Daniela; Moretta, Lorenzo; Arico, Maurizio			Familial Hemophagocytic Lymphohistiocytosis May Present during Adulthood: Clinical and Genetic Features of a Small Series	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; MUTATIONS; MUNC13-4; CHILDREN; ONSET; EXPRESSION; STXBP2; PRF1; FORM; FHL	Familial Hemophagocytic lymphohistiocytosis (FHL) is a rare immune deficiency with defective cytotoxic function. The age at onset is usually young and the natural course is rapidly fatal if untreated. A later onset of the disease has been sporadically reported even in adolescents and adults. We report the results of our retrospective data collection of all cases diagnosed with FHL at an age of 18 years or older and enrolled in the Italian Registry of HLH. All cases were diagnosed with FHL based on evidence of genetic defect in one FHL-related gene. A total of 11 patients were diagnosed with FHL. They were 9 males and 2 females, from 10 unrelated families; their age ranged between 18 and 43 years (median, 23 years). Family history was unremarkable in eight families at the time of the diagnosis. Their genetic diagnoses are: FHL2 (n = 6), FHL3 (n = 2), FHL5 (n = 1), XLP1 (n = 2). Clinical, molecular and functional data are described. These data confirm that FHL may present beyond the pediatric age and up to the fifth decade. FHL2 due to perforin defect is the most frequently reported subtype. Adult specialists should consider FHL in the differential diagnosis of patients with cytopenia and liver or central nervous system disorders, especially when a lymphoproliferative disease is suspected but eventually not confirmed. FHL may turn to be fatal within a short time course even in adults. This risk, together with the continuous improvement in the transplant technique, especially in the area of transplant from matched unrelated donor, resulting in reduced treatment related mortality, might suggest a wider use of SCT in this population. Current diagnostic approach allows prompt identification of patients by flow-cytometry screening, then confirmed by the genetic study, and treatment with chemo-immunotherapy followed by stem cell transplantation.	[Sieni, Elena; Cetica, Valentina; Arico, Maurizio] Azienda Osped Univ A Meyer Children Hosp, Dept Pediat Hematol Oncol, Florence, Italy; [Piccin, Andrea] San Maurizio Reg Hosp, Dept Hematol, Bolzano, South Tyrol, Italy; [Piccin, Andrea] San Maurizio Reg Hosp, BMT Unit, Bolzano, South Tyrol, Italy; [Gherlinzoni, Filippo] ULSS 9 Osped S Maria di Ca Foncello, Dept Med Specialist, Div Ematol, Treviso, Italy; [Sasso, Ferdinando Carlo] Univ Naples 2, Dept Internal & Expt Med, Naples, Italy; [Rabusin, Marco] IRCCS Burlo Garofolo, UO Pediat Hematooncol, Trieste, Italy; [Attard, Luciano] Azienda Osped Univ S Orsola Malpighi, Bologna, Italy; [Bosi, Alberto] Azienda Osped Univ Careggi, Dept Hematol, Florence, Italy; [Pende, Daniela] IRCCS AOU San Martino IST, Genoa, Italy; [Moretta, Lorenzo] IRCCS Giannina Gaslini, Genoa, Italy	Krankenhaus Bozen; Krankenhaus Bozen; ULSS 2 Marca TV; Ospedale Ca' Foncello Treviso; Universita della Campania Vanvitelli; IRCCS Burlo Garofolo; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS Istituto Giannina Gaslini	Sieni, E (corresponding author), Azienda Osped Univ A Meyer Children Hosp, Dept Pediat Hematol Oncol, Florence, Italy.	m.arico@meyer.it	Sasso, Ferdinando Carlo/AAA-8423-2020; Cetica, Valentina/J-2885-2018; Arico, Maurizio/S-3039-2019; Piccin, Andrea/L-1632-2018; Sieni, Elena/J-8729-2018; Moretta, Lorenzo/AAA-7239-2020; Pende, Daniela/J-7429-2016; Sasso, Ferdinando Carlo/AAE-5665-2019	Cetica, Valentina/0000-0001-8549-4158; Arico, Maurizio/0000-0002-1908-6671; Piccin, Andrea/0000-0002-2645-8496; Sieni, Elena/0000-0002-6192-9812; Moretta, Lorenzo/0000-0003-4658-1747; Pende, Daniela/0000-0003-1565-451X; Sasso, Ferdinando Carlo/0000-0002-9142-7848; BOSI, ALBERTO/0000-0002-5486-4838	Antonio Pinzino - Associazione per la Ricerca sulle Sindromi Emofagocitiche (ARSE); Italian Ministry of Health, Progetti di ricerca finalizzata; Bando Malattie Rare [RF-TOS-2008-1219488]; A.O.U. Meyer	Antonio Pinzino - Associazione per la Ricerca sulle Sindromi Emofagocitiche (ARSE); Italian Ministry of Health, Progetti di ricerca finalizzata; Bando Malattie Rare; A.O.U. Meyer	This study was supported by the following: Antonio Pinzino - Associazione per la Ricerca sulle Sindromi Emofagocitiche (ARSE); Italian Ministry of Health, Progetti di ricerca finalizzata 2008, Bando Malattie Rare RF-TOS-2008-1219488; A.O.U. Meyer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2001, HAEMATOLOGICA, V86, P499; Arico M, 1996, LEUKEMIA, V10, P197; Arico M, 2001, BRIT J HAEMATOL, V114, P761, DOI 10.1046/j.1365-2141.2001.02936.x; Arico M, 2001, BLOOD, V97, P1131, DOI 10.1182/blood.V97.4.1131; Bryceson YT, 2012, BLOOD, V119, P2754, DOI 10.1182/blood-2011-08-374199; Cesaro S, 2008, HAEMATOL-HEMATOL J, V93, P1694, DOI 10.3324/haematol.13142; Cetica V, 2010, J MED GENET, V47, P595, DOI 10.1136/jmg.2009.075341; Cetica V, 2010, HAEMATOL-HEMATOL J, V95, P538, DOI 10.3324/haematol.2009.019562; Clementi R, 2002, BLOOD, V100, P2266, DOI 10.1182/blood-2002-04-1030; Cooper N, 2006, BLOOD, V107, P1233, DOI 10.1182/blood-2005-05-1819; Cote M, 2009, J CLIN INVEST, V119, P3765, DOI 10.1172/JCI40732; de Saint Basile G, 2010, NAT REV IMMUNOL, V10, P568, DOI 10.1038/nri2803; FARQUHAR JW, 1952, ARCH DIS CHILD, V27, P519, DOI 10.1136/adc.27.136.519; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Filipovich AH, 2010, BLOOD, V116, P3398, DOI 10.1182/blood-2010-03-275909; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Henter JI, 2002, BLOOD, V100, P2367, DOI 10.1182/blood-2002-01-0172; Imashuku S, 1999, BLOOD, V93, P1869; Kogawa K, 2002, BLOOD, V99, P61, DOI 10.1182/blood.V99.1.61; Mahlaoui N, 2007, PEDIATRICS, V120, pE622, DOI 10.1542/peds.2006-3164; Marcenaro S, 2006, BLOOD, V108, P2316, DOI 10.1182/blood-2006-04-015693; Santoro A, 2006, J MED GENET, V43, P953, DOI 10.1136/jmg.2006.041863; Sieni E, 2012, CELL MOL LIFE SCI, V69, P29, DOI 10.1007/s00018-011-0835-y; Sieni E, 2011, J MED GENET, V48, P343, DOI 10.1136/jmg.2010.085456; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Trambas C, 2005, BLOOD, V106, P932, DOI 10.1182/blood-2004-09-3713; Trizzino A, 2008, J MED GENET, V45, P15, DOI 10.1136/jmg.2007.052670; Trottestam H, 2011, BLOOD, V118, P4577, DOI 10.1182/blood-2011-06-356261; Ueda I, 2007, AM J HEMATOL, V82, P427, DOI 10.1002/ajh.20878; Zhang KJ, 2011, BLOOD, V118, P5794, DOI 10.1182/blood-2011-07-370148; zur Stadt U, 2005, HUM MOL GENET, V14, P827, DOI 10.1093/hmg/ddi076; zur Stadt U, 2009, AM J HUM GENET, V85, P482, DOI 10.1016/j.ajhg.2009.09.005	32	52	65	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44649	10.1371/journal.pone.0044649	http://dx.doi.org/10.1371/journal.pone.0044649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970278	Green Published, gold, Green Submitted			2022-12-25	WOS:000308462000041
J	Tromas, A; Parizot, B; Diagne, N; Champion, A; Hocher, V; Cissoko, M; Crabos, A; Prodjinoto, H; Lahouze, B; Bogusz, D; Laplaze, L; Svistoonoff, S				Tromas, Alexandre; Parizot, Boris; Diagne, Nathalie; Champion, Antony; Hocher, Valerie; Cissoko, Maimouna; Crabos, Amandine; Prodjinoto, Hermann; Lahouze, Benoit; Bogusz, Didier; Laplaze, Laurent; Svistoonoff, Sergio			Heart of Endosymbioses: Transcriptomics Reveals a Conserved Genetic Program among Arbuscular Mycorrhizal, Actinorhizal and Legume-Rhizobial Symbioses	PLOS ONE			English	Article							MEDICAGO-TRUNCATULA; PHOSPHATE TRANSPORTER; CASUARINA-GLAUCA; CORTICAL-CELLS; CHITINASE GENE; EXPRESSION; INFECTION; COMMON; ROOTS; PROTEIN	To improve their nutrition, most plants associate with soil microorganisms, particularly fungi, to form mycorrhizae. A few lineages, including actinorhizal plants and legumes are also able to interact with nitrogen-fixing bacteria hosted intracellularly inside root nodules. Fossil and molecular data suggest that the molecular mechanisms involved in these root nodule symbioses (RNS) have been partially recycled from more ancient and widespread arbuscular mycorrhizal (AM) symbiosis. We used a comparative transcriptomics approach to identify genes involved in establishing these 3 endosymbioses and their functioning. We analysed global changes in gene expression in AM in the actinorhizal tree C. glauca. A comparison with genes induced in AM in Medicago truncatula and Oryza sativa revealed a common set of genes induced in AM. A comparison with genes induced in nitrogen-fixing nodules of C. glauca and M. truncatula also made it possible to define a common set of genes induced in these three endosymbioses. The existence of this core set of genes is in accordance with the proposed recycling of ancient AM genes for new functions related to nodulation in legumes and actinorhizal plants.	[Tromas, Alexandre; Diagne, Nathalie; Champion, Antony; Cissoko, Maimouna; Crabos, Amandine; Prodjinoto, Hermann; Laplaze, Laurent] UCAD, ISRA, IRD, Ctr Rech Bel Air,Lab Commun Microbiol, Dakar, Senegal; [Tromas, Alexandre; Champion, Antony; Hocher, Valerie; Lahouze, Benoit; Bogusz, Didier; Laplaze, Laurent; Svistoonoff, Sergio] IRD, UMR DIADE, Equipe Rhizogenese, Montpellier, France; [Parizot, Boris] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Parizot, Boris] Univ Ghent, Dept Plant Biotechnol & Genet, B-9000 Ghent, Belgium	Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Flanders Institute for Biotechnology (VIB); Ghent University	Tromas, A (corresponding author), UCAD, ISRA, IRD, Ctr Rech Bel Air,Lab Commun Microbiol, Dakar, Senegal.	laurent.laplaze@ird.fr	Bogusz, Didier/O-6055-2017; Champion, Antony/E-4148-2015; TROMAS, Alexandre/L-5767-2015; SVISTOONOFF, Sergio/X-9659-2019; Laplaze, Laurent/I-5435-2016	Bogusz, Didier/0000-0002-9094-5870; Champion, Antony/0000-0002-3731-1510; TROMAS, Alexandre/0000-0002-9084-3874; SVISTOONOFF, Sergio/0000-0001-8554-2922; Laplaze, Laurent/0000-0002-6568-6504; PARIZOT, Boris/0000-0003-1445-6925	Institut de Recherche pour le Developpement (IRD); AIRD - Department of Capacity-Building for Southern Scientific Communities (IRD-DPF); Agence Nationale de la Recherche [ANR-08-JCJC-0070-01, ANR-2010 BLAN-1708-01]; Centre National de la Recherche Scientifique (EC2CO-MicrobiEn)	Institut de Recherche pour le Developpement (IRD); AIRD - Department of Capacity-Building for Southern Scientific Communities (IRD-DPF); Agence Nationale de la Recherche(French National Research Agency (ANR)); Centre National de la Recherche Scientifique (EC2CO-MicrobiEn)	This study was funded by the Institut de Recherche pour le Developpement (IRD; http://www.ird.fr), and grants from the AIRD - Department of Capacity-Building for Southern Scientific Communities (IRD-DPF to ND; http://www.aird.fr), the Agence Nationale de la Recherche (ANR-08-JCJC-0070-01; ANR-2010 BLAN-1708-01; http://www.agence-nationale-recherche.fr/) and the Centre National de la Recherche Scientifique (EC2CO-MicrobiEn; http://www.cnrs.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Bonanomi A, 2001, PLANT BIOLOGY, V3, P194, DOI 10.1055/s-2001-12902; BRUNDRETT MC, 1984, CAN J BOT, V62, P2128, DOI 10.1139/b84-290; Catoira R, 2000, PLANT CELL, V12, P1647, DOI 10.1105/tpc.12.9.1647; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Deguchi Y, 2007, DNA RES, V14, P117, DOI 10.1093/dnares/dsm014; Diagne N, 2011, MYCORRHIZA, V21, P315, DOI 10.1007/s00572-010-0357-8; Doyle JJ, 2011, MOL PLANT MICROBE IN, V24, P1289, DOI 10.1094/MPMI-05-11-0114; DUC G, 1989, PLANT SCI, V60, P207, DOI 10.1016/0168-9452(89)90168-4; Elfstrand M, 2005, NEW PHYTOL, V167, P557, DOI 10.1111/j.1469-8137.2005.01397.x; Fiorilli V, 2009, NEW PHYTOL, V184, P975, DOI 10.1111/j.1469-8137.2009.03031.x; Geurts R, 2012, CURR OPIN PLANT BIOL, V15, P438, DOI 10.1016/j.pbi.2012.04.004; Gherbi H, 2008, P NATL ACAD SCI USA, V105, P4928, DOI 10.1073/pnas.0710618105; Gomez SK, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-10; Guerra JCP, 2010, PLANT PHYSIOL, V152, P1574, DOI 10.1104/pp.109.151399; Guether M, 2009, NEW PHYTOL, V182, P200, DOI 10.1111/j.1469-8137.2008.02725.x; Guimil S, 2005, P NATL ACAD SCI USA, V102, P8066, DOI 10.1073/pnas.0502999102; Harrison MJ, 2002, PLANT CELL, V14, P2413, DOI 10.1105/tpc.004861; Held M, 2010, TRENDS PLANT SCI, V15, P540, DOI 10.1016/j.tplants.2010.08.001; Hocher V, 2011, PLANT PHYSIOL, V156, P700, DOI 10.1104/pp.111.174151; Hogekamp C, 2011, PLANT PHYSIOL, V157, P2023, DOI 10.1104/pp.111.186635; Javot H, 2007, P NATL ACAD SCI USA, V104, P1720, DOI 10.1073/pnas.0608136104; Kiss E, 2009, PLANT PHYSIOL, V151, P1239, DOI 10.1104/pp.109.143933; Laplaze L, 2000, MOL PLANT MICROBE IN, V13, P113, DOI 10.1094/MPMI.2000.13.1.113; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Manthey K, 2004, MOL PLANT MICROBE IN, V17, P1063, DOI 10.1094/MPMI.2004.17.10.1063; Markmann K, 2008, PLOS BIOL, V6, P497, DOI 10.1371/journal.pbio.0060068; Maurel C, 2011, NEW PHYTOL, V190, P815, DOI 10.1111/j.1469-8137.2011.03731.x; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Paszkowski U, 2002, P NATL ACAD SCI USA, V99, P13324, DOI 10.1073/pnas.202474599; Pawlowski K, 2012, PROTOPLASMA IN PRESS; Perrine-Walker F, 2011, CURR PROTEIN PEPT SC, V12, P156, DOI 10.2174/138920311795684896; Qian WF, 2010, TRENDS GENET, V26, P425, DOI 10.1016/j.tig.2010.07.002; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Sanchez-Fernandez R, 2001, J BIOL CHEM, V276, P30231, DOI 10.1074/jbc.M103104200; Schafer P, 2009, PLANT J, V59, P461, DOI 10.1111/j.1365-313X.2009.03887.x; Svistoonoff S, 2003, MOL PLANT MICROBE IN, V16, P600, DOI 10.1094/MPMI.2003.16.7.600; Svistoonoff S, 2010, MOL PLANT MICROBE IN, V23, P740, DOI 10.1094/MPMI-23-6-0740; Takeda N, 2009, PLANT J, V58, P766, DOI 10.1111/j.1365-313X.2009.03824.x; Uehlein N, 2007, PHYTOCHEMISTRY, V68, P122, DOI 10.1016/j.phytochem.2006.09.033; Wang LS, 2011, PLANT PHYSIOL, V157, P1283, DOI 10.1104/pp.111.183723; Xiao Kai, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P99; Yokota K, 2011, CELL MOL LIFE SCI, V68, P1341, DOI 10.1007/s00018-011-0651-4; Zhang Q, 2010, PLANT CELL, V22, P1483, DOI 10.1105/tpc.110.074955	45	49	51	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44742	10.1371/journal.pone.0044742	http://dx.doi.org/10.1371/journal.pone.0044742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001KC	22970303	Green Published, gold, Green Submitted			2022-12-25	WOS:000308458400117
J	Porth, I; White, R; Jaquish, B; Alfaro, R; Ritland, C; Ritland, K				Porth, Ilga; White, Richard; Jaquish, Barry; Alfaro, Rene; Ritland, Carol; Ritland, Kermit			Genetical Genomics Identifies the Genetic Architecture for Growth and Weevil Resistance in Spruce	PLOS ONE			English	Article							WHITE-PINE WEEVIL; MEDIATED PLANT DEFENSE; WOOD PROPERTY TRAITS; PISSODES-STROBI; ARABIDOPSIS-THALIANA; INTERIOR SPRUCE; CONIFER DEFENSE; LINKAGE MAPS; TRADE-OFFS; TAEDA L.	In plants, relationships between resistance to herbivorous insect pests and growth are typically controlled by complex interactions between genetically correlated traits. These relationships often result in tradeoffs in phenotypic expression. In this study we used genetical genomics to elucidate genetic relationships between tree growth and resistance to white pine terminal weevil (Pissodes strobi Peck.) in a pedigree population of interior spruce (Picea glauca, P. engelmannii and their hybrids) that was growing at Vernon, B.C. and segregating for weevil resistance. Genetical genomics uses genetic perturbations caused by allelic segregation in pedigrees to co-locate quantitative trait loci (QTLs) for gene expression and quantitative traits. Bark tissue of apical leaders from 188 trees was assayed for gene expression using a 21.8K spruce EST-spotted microarray; the same individuals were genotyped for 384 SNP markers for the genetic map. Many of the expression QTLs (eQTL) co-localized with resistance trait QTLs. For a composite resistance phenotype of six attack and oviposition traits, 149 positional candidate genes were identified. Resistance and growth QTLs also overlapped with eQTL hotspots along the genome suggesting that: 1) genetic pleiotropy of resistance and growth traits in interior spruce was substantial, and 2) master regulatory genes were important for weevil resistance in spruce. These results will enable future work on functional genetic studies of insect resistance in spruce, and provide valuable information about candidate genes for genetic improvement of spruce.	[Porth, Ilga; Ritland, Carol; Ritland, Kermit] Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada; [White, Richard] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; [Jaquish, Barry] Columbia Minist Forests Lands & Nat Resource Oper, Kalamalka Forestry Ctr, Vernon, BC, Canada; [Alfaro, Rene] Canadian Forest Serv, Pacific Forestry Ctr, Victoria, BC, Canada	University of British Columbia; University of British Columbia; Natural Resources Canada; Canadian Forest Service	Porth, I (corresponding author), Univ British Columbia, Dept Forest Sci, Vancouver, BC V6T 1W5, Canada.	porth@mail.ubc.ca	Porth, Ilga M/N-4862-2015	Porth, Ilga M/0000-0002-9344-6348	Genome British Columbia; Genome Canada	Genome British Columbia; Genome Canada(Genome Canada)	This work was carried out with financial support from Genome British Columbia and Genome Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams E, 2007, ADVANCES IN PLANT ETHYLENE RESEARCH, P81, DOI 10.1007/978-1-4020-6014-4_18; Alfaro RI, 2008, FOREST ECOL MANAG, V255, P1749, DOI 10.1016/j.foreco.2007.11.032; Alfaro RI, 2004, FOREST ECOL MANAG, V202, P369, DOI 10.1016/j.foreco.2004.08.001; ALFARO RI, 1995, CAN J FOREST RES, V25, P1725, DOI 10.1139/x95-186; Alfaro RI, 1997, CAN J BOT, V75, P568, DOI 10.1139/b97-063; Baum G, 1996, PLANT PHYSIOL, V111, P15; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; Bergelson J, 1996, AM NAT, V148, P536, DOI 10.1086/285938; Bown AW, 2006, TRENDS PLANT SCI, V11, P424, DOI 10.1016/j.tplants.2006.07.002; Chae H, 2005, TRENDS PLANT SCI, V10; Chagne D, 2003, MOL BREEDING, V12, P185, DOI 10.1023/A:1026318327911; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Cornell HV, 2003, AM NAT, V161, P507, DOI 10.1086/368346; Dicke M, 2000, BIOCHEM SYST ECOL, V28, P601, DOI 10.1016/S0305-1978(99)00106-4; Doebley J, 1998, PLANT CELL, V10, P1075, DOI 10.1105/tpc.10.7.1075; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Dreher K, 2007, ANN BOT-LONDON, V99, P787, DOI 10.1093/aob/mcl255; Drost DR, 2010, P NATL ACAD SCI USA, V107, P8492, DOI 10.1073/pnas.0914709107; Farrall M, 2004, HUM MOL GENET, V13, pR1, DOI 10.1093/hmg/ddh084; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Ferreira FJ, 2008, PLANT PHYSIOL, V147, P585, DOI 10.1104/pp.108.118661; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Fu JY, 2006, GENETICS, V172, P1993, DOI 10.1534/genetics.105.047001; Gardner KM, 2007, MOL ECOL, V16, P4195, DOI 10.1111/j.1365-294X.2007.03499.x; Gibson G, 2005, TRENDS GENET, V21, P616, DOI 10.1016/j.tig.2005.08.010; Gonzalez-Martinez SC, 2007, GENETICS, V175, P399, DOI 10.1534/genetics.106.061127; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; He FL, 2000, ECOL APPL, V10, P225, DOI 10.1890/1051-0761(2000)010[0225:WPWAOW]2.0.CO;2; HERMS DA, 1992, Q REV BIOL, V67, P478; Holliday JA, 2008, NEW PHYTOL, V178, P103, DOI 10.1111/j.1469-8137.2007.02346.x; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Hu XS, 2004, THEOR APPL GENET, V109, P996, DOI 10.1007/s00122-004-1705-x; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Jennings DB, 1998, P NATL ACAD SCI USA, V95, P15129, DOI 10.1073/pnas.95.25.15129; Karrenberg S, 2008, CURR OPIN PLANT BIOL, V11, P156, DOI 10.1016/j.pbi.2008.01.004; Kazan K, 2008, PLANT PHYSIOL, V146, P1459, DOI 10.1104/pp.107.115717; Kempel A, 2011, P NATL ACAD SCI USA, V108, P5685, DOI 10.1073/pnas.1016508108; Kirst M, 2004, PLANT PHYSIOL, V135, P2368, DOI 10.1104/pp.103.037960; KISS GK, 1991, CAN J FOREST RES, V21, P230, DOI 10.1139/x91-028; Kliebenstein D, 2009, ANNU REV PLANT BIOL, V60, P93, DOI 10.1146/annurev.arplant.043008.092114; Kolosova N, 2004, BIOTECHNIQUES, V36, P821, DOI 10.2144/04365ST06; Koricheva J, 2004, AM NAT, V163, pE64, DOI 10.1086/382601; Koutaniemi S, 2007, PLANT MOL BIOL, V65, P311, DOI 10.1007/s11103-007-9220-5; Lieutier F, 2003, TREE PHYSIOL, V23, P247, DOI 10.1093/treephys/23.4.247; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; McKay JK, 2003, MOL ECOL, V12, P1137, DOI 10.1046/j.1365-294X.2003.01833.x; Miernyk JA, 2001, CELL STRESS CHAPERON, V6, P209, DOI 10.1379/1466-1268(2001)006<0209:TJDPOA>2.0.CO;2; MitchellOlds T, 1996, EVOLUTION, V50, P140, DOI [10.2307/2410788, 10.1111/j.1558-5646.1996.tb04480.x]; MOLE S, 1994, OIKOS, V71, P3, DOI 10.2307/3546166; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Naranjo MA, 2006, PLANT CELL ENVIRON, V29, P1890, DOI 10.1111/j.1365-3040.2006.01565.x; Pauwels L, 2011, PLANT CELL, V23, P3089, DOI 10.1105/tpc.111.089300; Porth I, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-608; Pot D, 2005, NEW PHYTOL, V167, P101, DOI 10.1111/j.1469-8137.2005.01417.x; Potokina E, 2008, PLANT J, V53, P90, DOI 10.1111/j.1365-313X.2007.03315.x; Ralph S, 2006, PLANT MOL BIOL, V60, P21, DOI 10.1007/s11103-005-2226-y; Ralph SG, 2007, PHYTOCHEMISTRY, V68, P1975, DOI 10.1016/j.phytochem.2007.04.042; Ralph SG, 2006, PLANT CELL ENVIRON, V29, P1545, DOI 10.1111/j.1365-3040.2006.01532.x; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Saha D, 2007, PLANT PHYSIOL BIOCH, V45, P521, DOI 10.1016/j.plaphy.2007.03.026; Schmelz EA, 2007, PLANT PHYSIOL, V144, P793, DOI 10.1104/pp.107.097154; Sewell MM, 1999, GENETICS, V151, P321; Sewell MM, 2002, THEOR APPL GENET, V104, P214, DOI 10.1007/s001220100697; Shanmugam V, 2005, MICROBIOL RES, V160, P83, DOI 10.1016/j.micres.2004.09.014; STAM P, 1993, PLANT J, V3, P739, DOI 10.1111/j.1365-313X.1993.00739.x; Steppuhn Anke, 2008, P61, DOI 10.1007/978-1-4020-8182-8_3; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Street NR, 2006, PLANT J, V48, P321, DOI 10.1111/j.1365-313X.2006.02864.x; Thaler JS, 2002, ECOL LETT, V5, P764, DOI 10.1046/j.1461-0248.2002.00388.x; Tiffin P, 1999, AM NAT, V154, P700, DOI 10.1086/303271; Van Zandt PA, 2007, ECOLOGY, V88, P1984, DOI 10.1890/06-1329.1; vanAkker L, 2004, CAN J FOREST RES, V34, P855, DOI 10.1139/X03-245; VANDERSAR TJD, 1977, CAN J ZOOL, V55, P2042, DOI 10.1139/z77-265; Worley AC, 2003, AM NAT, V161, P153, DOI 10.1086/345461; Xiao S, 2004, PLANT CELL, V16, P1132, DOI 10.1105/tpc.020370; Yang Z, 2005, PLANT MOL BIOL, V58, P585, DOI 10.1007/s11103-005-7294-5; Zangerl AR, 1997, OECOLOGIA, V109, P433, DOI 10.1007/s004420050103; Zhao JM, 1996, PLANT CELL, V8, P2235, DOI 10.1105/tpc.8.12.2235	82	17	18	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44397	10.1371/journal.pone.0044397	http://dx.doi.org/10.1371/journal.pone.0044397			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973444	gold, Green Published, Green Submitted			2022-12-25	WOS:000308577600048
J	Hudson, RS; Yi, M; Esposito, D; Glynn, SA; Starks, AM; Yang, Y; Schetter, AJ; Watkins, SK; Hurwitz, AA; Dorsey, TH; Stephens, RM; Croce, CM; Ambs, S				Hudson, R. S.; Yi, M.; Esposito, D.; Glynn, S. A.; Starks, A. M.; Yang, Y.; Schetter, A. J.; Watkins, S. K.; Hurwitz, A. A.; Dorsey, T. H.; Stephens, R. M.; Croce, C. M.; Ambs, S.			MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer	ONCOGENE			English	Article						prostate cancer; microRNA; apoptosis; disease outcome	MICRORNAS; OVEREXPRESSION; APOPTOSIS; PROFILE; GROWTH; LEADS; MCM7; BIM	The miR-106b-25 microRNA (miRNA) cluster is a candidate oncogene in human prostate cancer. Here, we report that miRNAs encoded by miR-106b-25 are upregulated in both primary tumors and distant metastasis. Moreover, increased tumor miR-106b expression was associated with disease recurrence and the combination of high miR-106b and low CASP7 (caspase-7) expressions in primary tumors was an independent predictor of early disease recurrence (adjusted hazard ratio = 4.1; 95% confidence interval: 1.6-12.3). To identify yet unknown oncogenic functions of miR-106b, we overexpressed it in LNCaP human prostate cancer cells to examine miR-106b-induced global expression changes among protein-coding genes. The approach revealed that CASP7 is a direct target of miR-106b, which was confirmed by western blot analysis and a 3'-untranslated region reporter assay. Moreover, selected phenotypes induced by miR-106b knockdown in DU145 human prostate cancer cells did not develop when both miR-106b and CASP7 expression were inhibited. Further analyses showed that CASP7 is downregulated in primary prostate tumors and metastatic lesions across multiple data sets and is by itself associated with disease recurrence and disease-specific survival. Using bioinformatics, we also observed that miR-106b-25 may specifically influence focal adhesion-related pathways. This observation was experimentally examined using miR-106b-25-transduced 22Rv1 human prostate cancer cells. After infection with a miR-106b-25 lentiviral expression construct, 22Rv1 cells showed increased adhesion to basement membrane-and bone matrix-related filaments and enhanced soft agar growth. In summary, miR-106b-25 was found to be associated with prostate cancer progression and disease outcome and may do so by altering apoptosis-and focal adhesion-related pathways.	[Hudson, R. S.; Glynn, S. A.; Starks, A. M.; Yang, Y.; Schetter, A. J.; Dorsey, T. H.; Ambs, S.] NCI, Human Carcinogenesis Lab, Ctr Canc Res CRC, NIH, Bethesda, MD 20892 USA; [Yi, M.; Stephens, R. M.] NCI, Adv Biomed Comp Ctr, SAIC Frederick Inc, Frederick, MD 21701 USA; [Esposito, D.] NCI, Protein Express Lab, Adv Technol Program, SAIC Frederick Inc, Frederick, MD 21701 USA; [Watkins, S. K.; Hurwitz, A. A.] NCI, Mol Immunoregulat Lab, Frederick, MD 21701 USA; [Croce, C. M.] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Ambs, S (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res CRC, Bldg 37 Room 3050B, Bethesda, MD 20892 USA.	ambss@mail.nih.gov	Young, Richard A/F-6495-2012; Glynn, Sharon A/D-7136-2013	Young, Richard A/0000-0001-8855-8647; Glynn, Sharon A/0000-0003-1459-2580; Ambs, Stefan/0000-0001-7651-9309; Starks, Adrienne/0000-0002-2640-6928; Esposito, Dominic/0000-0002-9987-1687; Yi, Ming/0000-0001-9098-1364	NIH, National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [U01CA152758, ZIABC010499, ZIABC010954, ZIABC010886] Funding Source: NIH RePORTER	NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Barbara J Taylor at the NCI FACS Core Laboratory for technical help. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Gocek E, 2011, CANCER RES, V71, P6230, DOI 10.1158/0008-5472.CAN-11-1717; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jalava SE, 2012, ONCOGENE, V31, P4460, DOI 10.1038/onc.2011.624; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Li BQ, 2011, PROSTATE, V71, P567, DOI 10.1002/pros.21272; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Martens-Uzunova ES, 2012, ONCOGENE, V31, P978, DOI 10.1038/onc.2011.304; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Ren B, 2006, ONCOGENE, V25, P1090, DOI 10.1038/sj.onc.1209134; Ribas J, 2009, CANCER RES, V69, P7165, DOI 10.1158/0008-5472.CAN-09-1448; Sboner A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-8; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Trompeter HI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016138; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	35	96	99	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 29	2013	32	35					4139	4147		10.1038/onc.2012.424	http://dx.doi.org/10.1038/onc.2012.424			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	209IG	22986525	Green Accepted			2022-12-25	WOS:000323748500009
J	Lai, KC; Liu, CJ; Chang, KW; Lee, TC				Lai, K. C.; Liu, C. J.; Chang, K. W.; Lee, T. C.			Depleting IFIT2 mediates atypical PKC signaling to enhance the migration and metastatic activity of oral squamous cell carcinoma cells	ONCOGENE			English	Article						IFIT2; oral squamous cell carcinoma; epithelial-mesenchymal transition; migration; invasion; atypical PKC	EPITHELIAL-MESENCHYMAL TRANSITION; GLYCOGEN-SYNTHASE KINASE-3; BREAST-CANCER; E-CADHERIN; HEAD; EXPRESSION; SURVIVAL; INVASION; GENES; CDC42	Interferon-induced protein with tetratricopeptide repeats 2 (IFIT2) is one of the most highly responsive interferon-stimulated genes, but its biological functions are poorly understood. In this study, we aimed to explore the underlying mechanisms by which depleting IFIT2 induces the migration of oral squamous cell carcinoma (OSCC) cells. Stable IFIT2-depleted cells underwent epithelial-mesenchymal transition (EMT) and exhibited enhanced cell motility and invasiveness compared with control cells. Furthermore, our results indicated that atypical protein kinase C (aPKC) was activated in IFIT2-depleted cells. Inhibition of aPKC using a specific myristoylated PKC zeta pseudosubstrate or aPKC-targeting small interfering RNA (siRNA) abolished IFIT2 depletion-induced EMT, migration and invasion, indicating that the activation of aPKC has an essential role in regulating the cellular responses induced by IFIT2 depletion. Following tail-vein injection, IFIT2-depleted OSCC cells colonized not only the lungs but also the heart, head and neck, retroperitoneal, and peritoneal cavities; whereas control cells predominantly localized in the lungs. IFIT2 mRNA and protein expression was positively associated with E-cadherin expression in OSCC patient specimens. The loss of E-cadherin and IFIT2 expression was observed at the invasive front of OSCC tumors, suggesting that the loss of IFIT2 may induce EMT and lead to the metastasis of OSCCs. OSCC patients possessing reduced IFIT2-expression levels (IFIT2 <50%) exhibited greater rates of distant metastasis and poor prognoses compared with OSCC patients who expressed greater levels of IFIT2 (IFIT2 >= 50%). These results demonstrate that IFIT2 depletion activates the aPKC pathway and consequently induces EMT, cell migration and invasion. Most importantly, depleting IFIT2 may participate in OSCC tumor progression, particularly during metastasis. Taken together, our study demonstrates that IFIT2, a protein responsible for interferon stimulation, may prevent OSCC metastasis and serve as a valuable prognostic marker.	[Lai, K. C.] Tzu Chi Univ, Dept Pharmacol, Hualien, Taiwan; [Lai, K. C.; Lee, T. C.] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Liu, C. J.] Mackay Mem Hosp, Dept Oral & Maxillofacial Surg, Taipei, Taiwan; [Chang, K. W.] Natl Yang Ming Univ, Sch Dent, Inst Oral Biol, Taipei 112, Taiwan	Tzu Chi University; Academia Sinica - Taiwan; Mackay Memorial Hospital; National Yang Ming Chiao Tung University	Lee, TC (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Sect 2,Acad Rd Nankang, Taipei 115, Taiwan.	bmtcl@ibms.sinica.edu.tw	Lee, Te-Chang/B-3245-2011	Lee, Te-Chang/0000-0003-4448-1507	Academia Sinica; National Science Council, Taiwan, ROC [NSC 93-3112-B-001-036, NSC 98-2320-B-001-002-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	We thank the Pathological Core Laboratory supported by Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, ROC for their excellent technical assistance on pathological examination. We also thank Dr Michael Hsiao (Genomics Research Center, Academia Sinica, Taipei, Taiwan, ROC) for providing lentiviral particles and experimental assistance. This work was also supported by the Academia Sinica and grants from the National Science Council, Taiwan, ROC (NSC 93-3112-B-001-036; NSC 98-2320-B-001-002-MY3).	ALBINI A, 1987, CANCER RES, V47, P3239; Bagan JV, 2009, ORAL ONCOL, V45, pE45, DOI 10.1016/j.oraloncology.2008.12.012; BEHRENS J, 1989, J CELL BIOL, V108, P2435, DOI 10.1083/jcb.108.6.2435; Bell RB, 2007, J ORAL MAXIL SURG, V65, P229, DOI 10.1016/j.joms.2005.11.094; Chang SY, 2009, CYTOKINE, V45, P32, DOI 10.1016/j.cyto.2008.10.013; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Department of Health TEY, 2010, CANC REG ANN REP TAI; Doble BW, 2007, CELLS TISSUES ORGANS, V185, P73, DOI 10.1159/000101306; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fan S, 2011, INT J ORAL SCI, V3, P180, DOI 10.4248/IJOS11068; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Ferlito A, 2001, ORL J OTO-RHINO-LARY, V63, P189, DOI 10.1159/000055738; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gonzalez-Garcia R, 2009, HEAD NECK-J SCI SPEC, V31, P1168, DOI 10.1002/hed.21088; Kim D W, 2001, Exp Mol Med, V33, P101; Korsching E, 2005, J PATHOL, V206, P451, DOI 10.1002/path.1797; Lai KC, 2008, MOL CANCER RES, V6, P1; Leon X, 1999, HEAD NECK-J SCI SPEC, V21, P204, DOI 10.1002/(SICI)1097-0347(199905)21:3<204::AID-HED4>3.0.CO;2-7; LEVY D, 1986, P NATL ACAD SCI USA, V83, P8929, DOI 10.1073/pnas.83.23.8929; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lorusso G, 2012, SEMIN CANCER BIOL, V22, P226, DOI 10.1016/j.semcancer.2012.03.007; Lu X, 2007, J MAMMARY GLAND BIOL, V12, P153, DOI 10.1007/s10911-007-9047-3; Ma C, 2007, CANCER RES, V67, P7756, DOI 10.1158/0008-5472.CAN-06-4665; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Mishra R, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-144; Ohira T, 2003, P NATL ACAD SCI USA, V100, P10429, DOI 10.1073/pnas.1734137100; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Parri M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-23; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rao DN, 1998, BRIT J CANCER, V77, P1514, DOI 10.1038/bjc.1998.249; Rosse C, 2010, NAT REV MOL CELL BIO, V11, P103, DOI 10.1038/nrm2847; Saha S, 2006, J GEN VIROL, V87, P3285, DOI 10.1099/vir.0.82107-0; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Sanjiv K, 2012, INT J CANCER, V130, P1440, DOI 10.1002/ijc.26142; Sano D, 2007, CANCER METAST REV, V26, P645, DOI 10.1007/s10555-007-9082-y; Schmalhofer O, 2009, CANCER METAST REV, V28, P151, DOI 10.1007/s10555-008-9179-y; Shingaki S, 2003, AM J SURG, V185, P278, DOI 10.1016/S0002-9610(02)01378-8; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Suzuki A, 2001, J CELL BIOL, V152, P1183, DOI 10.1083/jcb.152.6.1183; Taki M, 2003, CANCER SCI, V94, P593, DOI 10.1111/j.1349-7006.2003.tb01488.x; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Tsuji T, 2009, CANCER RES, V69, P7135, DOI 10.1158/0008-5472.CAN-09-1618; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Yonezawa Tomo, 2009, Recent Pat DNA Gene Seq, V3, P96	52	44	48	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 8	2013	32	32					3686	3697		10.1038/onc.2012.384	http://dx.doi.org/10.1038/onc.2012.384			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	198EH	22986528				2022-12-25	WOS:000322904400004
J	Peigneur, S; Beress, L; Moller, C; Mari, F; Forssmann, WG; Tytgat, J				Peigneur, Steve; Beress, Laszlo; Moeller, Carolina; Mari, Frank; Forssmann, Wolf-Georg; Tytgat, Jan			A natural point mutation changes both target selectivity and mechanism of action of sea anemone toxins	FASEB JOURNAL			English	Article						voltage-gated sodium channel; voltage-gated potassium channel; ion channel inhibitor; ion channel modulator	NEURONAL SODIUM-CHANNELS; ANTHOPLEURA-ELEGANTISSIMA; HUWENTOXIN-IV; INFLAMMATORY PAIN; VOLTAGE-SENSOR; PEPTIDE TOXINS; ION CHANNELS; K+ CHANNEL; NA+; VENOM	APETx3, a novel peptide isolated from the sea anemone Anthopleura elegantissima, is a naturally occurring mutant from APETx1, only differing by a Thr to Pro substitution at position 3. APETx1 is believed to be a selective modulator of human ether-a-go-go related gene (hERG) potassium channels with a K-d of 34 nM. In this study, APETx1, 2, and 3 have been subjected to an electrophysiological screening on a wide range of 24 ion channels expressed in Xenopus laevis oocytes: 10 cloned voltage-gated sodium channels (Na-V 1.2-Na(V)1.8, the insect channels DmNa(V)1, BgNa(V)1-1a, and the arachnid channel VdNa(V)1) and 14 cloned voltage-gated potassium channels (K(V)1.1-K(V)1.6, K(V)2.1, K(V)3.1, K(V)4.2, K(V)4.3, K(V)7.2, K(V)7.4, hERG, and the insect channel Shaker IR). Surprisingly, the Thr3Pro substitution results in a complete abolishment of APETx3 modulation on hERG channels and provides this toxin the ability to become a potent (EC50 276 nM) modulator of voltage-gated sodium channels (Na(V)s) because it slows down the inactivation of mammalian and insect Na-V channels. Our study also shows that the homologous toxins APETx1 and APETx2 display promiscuous properties since they are also capable of recognizing Na-V channels with IC50 values of 31 nM and 114 nM, respectively, causing an inhibition of the sodium conductance without affecting the inactivation. Our results provide new insights in key residues that allow these sea anemone toxins to recognize distinct ion channels with similar potency but with different modulatory effects. Furthermore, we describe for the first time the target promiscuity of a family of sea anemone toxins thus far believed to be highly selective.-Peigneur, S., Beress, L., Moller, C., Mari, F., Forssmann, W.-G., Tytgat, J. A natural point mutation changes both target selectivity and mechanism of action of sea anemone toxins. FASEB J. 26, 5141-5151 (2012). www.fasebj.org	[Peigneur, Steve; Tytgat, Jan] Katholieke Univ Leuven, Toxicol Lab, B-3000 Louvain, Belgium; [Beress, Laszlo; Forssmann, Wolf-Georg] Hannover Med Sch, Dept Immunol & Rheumatol, Hannover, Germany; [Beress, Laszlo; Forssmann, Wolf-Georg] Pharis Biotec GmbH, Hannover, Germany; [Moeller, Carolina; Mari, Frank] Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA	KU Leuven; Hannover Medical School; State University System of Florida; Florida Atlantic University	Tytgat, J (corresponding author), Katholieke Univ Leuven, Toxicol Lab, Campus Gasthuisberg O&N2,Herestr 49,POB 922, B-3000 Louvain, Belgium.	jan.tytgat@pharm.kuleuven.be		Tytgat, Jan/0000-0003-1778-6022; Peigneur, Steve/0000-0003-0504-5702	Fonds Wetenschappelijk Onderzoek Vlaanderen [G.0433.12]; Inter-University Attraction Poles (IUAP) Program (Belgian State, Belgian Science Policy) [7/19]; Katholieke Universiteit Leuven [OT/12/081]	Fonds Wetenschappelijk Onderzoek Vlaanderen(FWO); Inter-University Attraction Poles (IUAP) Program (Belgian State, Belgian Science Policy); Katholieke Universiteit Leuven(KU Leuven)	The authors thank John N. Wood (University College London, London, UK) for sharing rNa<INF>V</INF>1.8; A. L. Goldin (University of California, Irvine, CA, USA) for sharing rNa<INF>V</INF>1.2, rNa<INF>V</INF>1.3, and mNa<INF>V</INF>1.6; G. Mandel (State University of New York, Stony Brook, NY, USA) for sharing rNa<INF>V</INF>1.4; R. G. Kallen (Roche Institute of Molecular Biology, Nutley, NJ, USA) for sharing hNa<INF>V</INF>1.5; S. H. Heinemann (Friedrich-Schiller-Universitat Jena, Jena, Germany) for sharing the rat beta 1 subunit; S. C. Cannon (University of Texas Southwestern Medical Center, Dallas, TX, USA) for sharing the h beta 1 subunit; M. Keating (University of Utah, Salt Lake City, UT, USA) for sharing hERG; and Martin S. Williamson (Rothhamsted Research, Harpenden, UK) for providing the Para and tipE clone. The Na<INF>V</INF>1.7 clone was kindly provided by Roche (Basel, Switzerland). The authors are grateful to K. Dong (Michigan State University, East Lansing, MI, USA) for sharing BgNa<INF>V</INF>1.1 and VdNa<INF>V</INF>1. The authors thank Dr. Piet Herdewyn and Dr. Eveline Lescrinier for help with experiments. The authors are grateful to Dr. Bert Billen for constructive discussions. The authors thank Sarah Debaveye for her work in molecular biology. The authors thank Dr. Sylvie Diochot (Universite de Nice-Sophia-Antipolis, Valbonne, France) for sharing APETx1. This work was supported by the following grants: G.0433.12 (Fonds Wetenschappelijk Onderzoek Vlaanderen), Inter-University Attraction Poles (IUAP) Program 7/19 (Belgian State, Belgian Science Policy), and OT/12/081 (Katholieke Universiteit Leuven).	Rodriguez AA, 2012, PEPTIDES, V34, P26, DOI 10.1016/j.peptides.2011.10.011; Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; Billen B, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00133; Blanchard MG, 2011, BRIT J PHARMACOL, V165, P2167; Bosmans F, 2007, TOXICON, V49, P550, DOI 10.1016/j.toxicon.2006.11.029; Bruhn T, 2001, TOXICON, V39, P693, DOI 10.1016/S0041-0101(00)00199-9; Campos FV, 2008, J GEN PHYSIOL, V132, P251, DOI 10.1085/jgp.200809995; Castaneda O, 2009, TOXICON, V54, P1119, DOI 10.1016/j.toxicon.2009.02.032; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Chagot B, 2005, PROTEINS, V59, P380, DOI 10.1002/prot.20425; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Diochot S, 1998, J BIOL CHEM, V273, P6744, DOI 10.1074/jbc.273.12.6744; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Diochot S, 2003, MOL PHARMACOL, V64, P59, DOI 10.1124/mol.64.1.59; Diochot S., 2009, V46, P99, DOI 10.1007/978-3-540-87895-7_4; Ekberg J, 2006, INT J BIOCHEM CELL B, V38, P2005, DOI 10.1016/j.biocel.2006.06.008; Fozzard HA, 2010, MAR DRUGS, V8, P219, DOI 10.3390/md8020219; French RJ, 2010, MAR DRUGS, V8, P2153, DOI 10.3390/md8072153; Honma T, 2006, MAR BIOTECHNOL, V8, P1, DOI 10.1007/s10126-005-5093-2; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Karczewski J, 2010, BRIT J PHARMACOL, V161, P950, DOI 10.1111/j.1476-5381.2010.00918.x; Kozlov S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-88; LIANG SP, 1993, TOXICON, V31, P969, DOI 10.1016/0041-0101(93)90256-I; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu M, 2011, PAIN MED, V12, pS93, DOI 10.1111/j.1526-4637.2011.01158.x; Liu P, 2012, J NEUROPHYSIOL, V107, P3155, DOI 10.1152/jn.00785.2011; Oliveira JS, 2006, BBA-PROTEINS PROTEOM, V1764, P1592, DOI 10.1016/j.bbapap.2006.08.010; Peigneur S., 2012, INSECTICIDES ADV INT; Peigneur S, 2011, BIOCHEM PHARMACOL, V82, P81, DOI 10.1016/j.bcp.2011.03.023; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Prikhod'ko EA, 1999, J VIROL, V73, P6691; Redaelli E, 2010, J BIOL CHEM, V285, P4130, DOI 10.1074/jbc.M109.054718; Salceda E, 2006, BRAIN RES, V1110, P136, DOI 10.1016/j.brainres.2006.06.113; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Stevens M, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00071; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Van Der Haegen A, 2011, FEBS J, V278, P3408, DOI 10.1111/j.1742-4658.2011.08264.x; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Wang MC, 2012, PEPTIDES, V34, P19, DOI 10.1016/j.peptides.2011.10.029; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Xiao YC, 2011, J BIOL CHEM, V286, P27301, DOI 10.1074/jbc.M111.246876; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Zhang M, 2007, MOL PHARMACOL, V72, P259, DOI 10.1124/mol.107.035840	46	61	65	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					5141	5151		10.1096/fj.12-218479	http://dx.doi.org/10.1096/fj.12-218479			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22972919				2022-12-25	WOS:000311838300034
J	Suter, MA; Chen, AS; Burdine, MS; Choudhury, M; Harris, RA; Lane, RH; Friedman, JE; Grove, KL; Tackett, AJ; Aagaard, KM				Suter, Melissa A.; Chen, Aishe; Burdine, Marie S.; Choudhury, Mahua; Harris, R. Alan; Lane, Robert H.; Friedman, Jacob E.; Grove, Kevin L.; Tackett, Alan J.; Aagaard, Kjersti M.			A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates	FASEB JOURNAL			English	Article						epigenetics; developmental origins of adult disease; NAFLD; histone modification; sirtuins	MAMMALIAN SIRTUIN-1; GENE-EXPRESSION; CELL-SURVIVAL; DBC1; P53; METABOLISM; ACTIVATION; REGULATOR; LIVER; MODEL	In nonhuman primates, we previously demonstrated that a maternal high-fat diet (MHFD) induces fetal nonalcoholic fatty liver disease (NAFLD) and alters the fetal metabolome. These changes are accompanied by altered acetylation of histone H3 (H3K14ac). However, the mechanism behind this alteration in acetylation remains unknown. As SIRT1 is both a lysine deacetylase and a crucial sensor of cellular metabolism, we hypothesized that SIRT1 may be involved in fetal epigenomic alterations. Here we show that in utero exposure to a MHFD, but not maternal obesity per se, increases fetal H3K14ac with concomitant decreased SIRT1 expression and diminished in vitro protein and histone deacetylase activity. MHFD increased H3K14ac and DBC1-SIRT1 complex formation in fetal livers, both of which were abrogated with diet reversal despite persistent maternal obesity. Moreover, MHFD was associated with altered expression of known downstream effectors deregulated in NAFLD and modulated by SIRT1 (e.g., PPARA, PPARG, SREBF1, CYP7A1, FASN, and SCD). Finally, ex vivo purified SIRT1 retains deacetylase activity on an H3K14ac peptide substrate with preferential activity toward acetylated histone H3; mutagenesis of the catalytic domain of SIRT1 (H363Y) abrogates H3K14ac deacetylation. Our data implicate SIRT1 as a likely molecular mediator of the fetal epigenome and metabolome under MHFD conditions.-Suter, M. A., Chen, A., Burdine, M. S., Choudhury, M., Harris, R. A., Lane, R. H., Friedman, J. E., Grove, K. L., Tackett, A. J., Aagaard, K. M. A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates. FASEB J. 26, 5106-5114 (2012). www.fasebj.org	[Suter, Melissa A.; Chen, Aishe; Harris, R. Alan; Aagaard, Kjersti M.] Baylor Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; [Harris, R. Alan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Burdine, Marie S.; Tackett, Alan J.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA; [Choudhury, Mahua; Friedman, Jacob E.] Univ Colorado, Sch Med, Dept Pediat Biochem & Mol Genet, Aurora, CO USA; [Lane, Robert H.] Univ Utah, Dept Pediat, Div Neonatol, Salt Lake City, UT USA; [Grove, Kevin L.] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Beaverton, OR USA	Baylor College of Medicine; Baylor College of Medicine; University of Arkansas System; University of Arkansas Medical Sciences; University of Colorado System; University of Colorado Anschutz Medical Campus; Utah System of Higher Education; University of Utah; Oregon Health & Science University; Oregon National Primate Research Center	Aagaard, KM (corresponding author), Baylor Coll Med, Div Maternal Fetal Med, Dept Obstet & Gynecol, 1 Baylor Plaza,Jones 314, Houston, TX 77030 USA.	aagaardt@bcm.tmc.edu	Burdine, Marie Schluterman/GLU-1812-2022; Harris, R. Alan/AAI-2784-2020	Burdine, Marie Schluterman/0000-0002-3940-5748; Harris, R. Alan/0000-0002-7333-4752	U.S. National Institutes of Health (NIH) [DP2120OD001500-01]; U.S. National Institute of Child Health and Human Development/National Institute of Diabetes and Digestive and Kidney Diseases [R01DK080558-01]; NIH [DK79194, R000163, R01DA025755, 5R01DK078590, R24DK090964, K12 GM084897]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079194, R01DK080558, R24DK090964, R01DK078590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM084897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025755] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001500] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Institute of Child Health and Human Development/National Institute of Diabetes and Digestive and Kidney Diseases; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge the helpful comments of members of the laboratories of K. M. A. and Shannon Hawkins at Baylor College of Medicine, Diana Takahashi for coordination of sample acquisition, and Dr. Tony Kouzarides (University of Cambridge, Cambridge, UK) for the SIRT1 plasmid. This work was supported by the U.S. National Institutes of Health (NIH) Director New Innovator Award (DP2120OD001500-01; to K. M. A.); U.S. National Institute of Child Health and Human Development/National Institute of Diabetes and Digestive and Kidney Diseases grant R01DK080558-01 (to R. H. L and K. M. A.); NIH grants DK79194 (to K. L. G.), R000163 (to K. L. G.), R01DA025755 (to A. J. T.), 5R01DK078590 (to J. E. F.), and R24DK090964 (to K. L. G. and J. E. F.); and NIH Reasearch Education and Career Horizon Institutional Research and Academic Career Development Award grant K12 GM084897 (to M. A. S.). In addition, the authors acknowledge the University of Arkansas for Medical Sciences Proteomics Facility for mass spectrometric support. The authors report no conflicts of interest.	Aagaard-Tillery KM, 2008, J MOL ENDOCRINOL, V41, P91, DOI 10.1677/JME-08-0025; Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Belden WJ, 2008, CELL, V134, P212, DOI 10.1016/j.cell.2008.07.010; Blair LP, 2009, BIOCHEMISTRY-US, V48, P2321, DOI 10.1021/bi801919s; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Chanda D, 2010, NUCLEIC ACIDS RES, V38, P4607, DOI 10.1093/nar/gkq227; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cox J, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.041; Dilworth DJ, 2005, J CELL BIOL, V171, P955, DOI 10.1083/jcb.200509061; Dominy JE, 2010, BBA-PROTEINS PROTEOM, V1804, P1676, DOI 10.1016/j.bbapap.2009.11.023; Draper S, 2010, BRAIN RES, V1350, P139, DOI 10.1016/j.brainres.2010.03.082; Escande C, 2010, J CLIN INVEST, V120, P545, DOI 10.1172/JCI39319; Frias AE, 2011, ENDOCRINOLOGY, V152, P2456, DOI 10.1210/en.2010-1332; Gradolatto A, 2009, MOL CELL BIOL, V29, P4604, DOI 10.1128/MCB.00160-09; Grant WF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017261; Grayson BE, 2010, ENDOCRINOLOGY, V151, P1622, DOI 10.1210/en.2009-1019; Green MF, 2013, J GERONTOL A-BIOL, V68, P105, DOI 10.1093/gerona/gls132; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; INOUE A, 1969, BIOCHEM BIOPH RES CO, V36, P146, DOI 10.1016/0006-291X(69)90661-5; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Menssen A, 2012, P NATL ACAD SCI USA, V109, pE187, DOI 10.1073/pnas.1105304109; Nin V, 2012, J BIOL CHEM, V287, P23489, DOI 10.1074/jbc.M112.365874; Palou M., 2012, BR J NUTR; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Pruitt K, 2006, PLOS GENET, V2, P344, DOI 10.1371/journal.pgen.0020040; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Schug TT, 2011, ANN MED, V43, P198, DOI 10.3109/07853890.2010.547211; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359; Sullivan EL, 2011, NEUROENDOCRINOLOGY, V93, P1, DOI 10.1159/000322038; Sullivan EL, 2010, J NEUROSCI, V30, P3826, DOI 10.1523/JNEUROSCI.5560-09.2010; Suter M., 2012, MOL ENDOCRI IN PRESS; Suter M, 2011, FASEB J, V25, P714, DOI 10.1096/fj.10-172080; Tackett AJ, 2005, J CELL BIOL, V169, P35, DOI 10.1083/jcb.200502104; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yao YL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/146493; You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007; You M, 2008, J NUTR, V138, P497, DOI 10.1093/jn/138.3.497; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	53	118	120	4	47	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2012	26	12					5106	5114		10.1096/fj.12-212878	http://dx.doi.org/10.1096/fj.12-212878			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	047KD	22982377	Green Published			2022-12-25	WOS:000311838300031
J	Mccue, HV; Patel, P; Herbert, AP; Lian, LY; Burgoyne, RD; Haynes, LP				McCue, Hannah V.; Patel, Pryank; Herbert, Andrew P.; Lian, Lu-Yun; Burgoyne, Robert D.; Haynes, Lee P.			Solution NMR Structure of the Ca2+-bound N-terminal Domain of CaBP7 A REGULATOR OF GOLGI TRAFFICKING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CALCIUM SENSOR-1; SEQUENCE-INDEPENDENT RECOGNITION; CRYSTAL-STRUCTURE; BINDING PROTEINS; EF-HAND; PHOSPHATIDYLINOSITOL 4-KINASE-BETA; 3-DIMENSIONAL STRUCTURE; MOLECULAR-MECHANISM; CA(V)2.1 CHANNELS; CA(V)1.3 CHANNELS	Calcium-binding protein 7 (CaBP7) is a member of the calmodulin (CaM) superfamily that harbors two high affinity EF-hand motifs and a C-terminal transmembrane domain. CaBP7 has been previously shown to interact with and modulate phosphatidylinositol 4-kinase III-beta (PI4KIII beta) activity in in vitro assays and affects vesicle transport in neurons when overexpressed. Here we show that the N-terminal domain (NTD) of CaBP7 is sufficient to mediate the interaction of CaBP7 with PI4KIII beta. CaBP7 NTD encompasses the two high affinity Ca2+ binding sites, and structural characterization through multi-angle light scattering, circular dichroism, and NMR reveals unique properties for this domain. CaBP7 NTD binds specifically to Ca2+ but not Mg2+ and undergoes significant conformational changes in both secondary and tertiary structure upon Ca2+ binding. The Ca2+-bound form of CaBP7 NTD is monomeric and exhibits an open conformation similar to that of CaM. Ca2+-bound CaBP7 NTD has a solvent-exposed hydrophobic surface that is more expansive than observed in CaM or CaBP1. Within this hydrophobic pocket, there is a significant reduction in the number of methionine residues that are conserved in CaM and CaBP1 and shown to be important for target recognition. In CaBP7 NTD, these residues are replaced with isoleucine and leucine residues with branched side chains that are intrinsically more rigid than the flexible methionine side chain. We propose that these differences in surface hydrophobicity, charge, and methionine content may be important in determining highly specific interactions of CaBP7 with target proteins, such as PI4KIII beta.	[Lian, Lu-Yun] Univ Liverpool, Inst Integrat Biol, NMR Ctr Struct Biol, Liverpool L69 3BX, Merseyside, England; [McCue, Hannah V.; Patel, Pryank; Herbert, Andrew P.; Burgoyne, Robert D.; Haynes, Lee P.] Univ Liverpool, Inst Translat Med, Dept Cellular & Mol Physiol, Physiol Lab, Liverpool L69 3BX, Merseyside, England	University of Liverpool; University of Liverpool	Lian, LY (corresponding author), Univ Liverpool, Inst Integrat Biol, NMR Ctr Struct Biol, Liverpool L69 3BX, Merseyside, England.	lu-yun.lian@liverpool.ac.uk; leeh@liverpool.ac.uk	Herbert, Andrew P/C-4755-2008; Burgoyne, Robert D/P-6641-2019; Herbert, Andy P/F-6693-2010; Burgoyne, Robert/C-6706-2008	Herbert, Andrew P/0000-0002-4549-6965; Burgoyne, Robert D/0000-0002-9219-0387; Herbert, Andy P/0000-0002-4549-6965; Burgoyne, Robert/0000-0002-9219-0387; McCue, Hannah/0000-0001-5237-3261	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust prize Ph.D. studentship (to H. V. M.).	Ames JB, 2012, BBA-GEN SUBJECTS, V1820, P1205, DOI 10.1016/j.bbagen.2011.10.003; Ames JB, 1999, J BIOL CHEM, V274, P19329, DOI 10.1074/jbc.274.27.19329; Aravind P, 2008, J MOL BIOL, V376, P1100, DOI 10.1016/j.jmb.2007.12.033; Asmara H, 2010, J PHARMACOL SCI, V112, P397, DOI 10.1254/jphs.09342FP; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Cardy TJA, 1998, BIOCHEM J, V334, P447, DOI 10.1042/bj3340447; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Cheung MS, 2010, J MAGN RESON, V202, P223, DOI 10.1016/j.jmr.2009.11.008; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; de Barry J, 2006, J BIOL CHEM, V281, P18098, DOI 10.1074/jbc.M509842200; DIETER P, 1985, PLANTA, V166, P216, DOI 10.1007/BF00397351; Feric M, 2011, AM J PHYSIOL-CELL PH, V300, pC755, DOI 10.1152/ajpcell.00360.2010; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Findeisen F, 2010, STRUCTURE, V18, P1617, DOI 10.1016/j.str.2010.09.012; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; GELLMAN SH, 1991, BIOCHEMISTRY-US, V30, P6633, DOI 10.1021/bi00241a001; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Haynes LP, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00009; Haynes LP, 2006, PROTEOMICS, V6, P1822, DOI 10.1002/pmic.200500489; Haynes LP, 2005, J BIOL CHEM, V280, P6047, DOI 10.1074/jbc.M413090200; Haynes LP, 2004, J BIOL CHEM, V279, P547, DOI 10.1074/jbc.M309617200; Hradsky J, 2011, J BIOL CHEM, V286, P36762, DOI 10.1074/jbc.M111.280339; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; Kasri NN, 2004, MOL PHARMACOL, V66, P276, DOI 10.1124/mol.66.2.276; Kim EY, 2008, STRUCTURE, V16, P1455, DOI 10.1016/j.str.2008.07.010; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Lee A, 2002, NAT NEUROSCI, V5, P210, DOI 10.1038/nn805; Li CM, 2009, J BIOL CHEM, V284, P2472, DOI 10.1074/jbc.M806513200; Lim S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208868; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Liu ZH, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00038; Lusin JD, 2008, BIOCHEMISTRY-US, V47, P2252, DOI 10.1021/bi7017267; Mccue HV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017853; McCue HV, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004085; McCue Hannah V, 2010, BMC Res Notes, V3, P118, DOI 10.1186/1756-0500-3-118; Mccue HV, 2009, BIOCHEM BIOPH RES CO, V380, P825, DOI 10.1016/j.bbrc.2009.01.177; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Mikhaylova M, 2006, BBA-MOL CELL RES, V1763, P1229, DOI 10.1016/j.bbamcr.2006.08.047; Mikhaylova M, 2009, P NATL ACAD SCI USA, V106, P9093, DOI 10.1073/pnas.0903001106; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; PALMITER RD, 1974, BIOCHEMISTRY-US, V13, P3606, DOI 10.1021/bi00714a032; Park S, 2011, PROTEIN SCI, V20, P1356, DOI 10.1002/pro.662; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schwenk J, 2008, J BIOL CHEM, V283, P18937, DOI 10.1074/jbc.M800976200; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; Stephen R, 2006, J MOL BIOL, V359, P266, DOI 10.1016/j.jmb.2006.03.042; Strahl T, 2007, J BIOL CHEM, V282, P30949, DOI 10.1074/jbc.M705499200; Takeuchi T, 2008, FEBS LETT, V582, P591, DOI 10.1016/j.febslet.2008.01.026; Taverna E, 2002, J CELL SCI, V115, P3909, DOI 10.1242/jcs.00072; Tippens AL, 2007, J BIOL CHEM, V282, P8464, DOI 10.1074/jbc.M611384200; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; WEISENBE.RC, 1970, BIOCHEMISTRY-US, V9, P4110, DOI 10.1021/bi00823a012; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Wu YQ, 2001, MOL GENET METAB, V72, P343, DOI 10.1006/mgme.2001.3160; Yang J, 2002, P NATL ACAD SCI USA, V99, P7711, DOI 10.1073/pnas.102006299; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; ZHANG MJ, 1994, J BIOL CHEM, V269, P15546; Zhao XH, 2001, J BIOL CHEM, V276, P40183, DOI 10.1074/jbc.M104048200; Zheng Q, 2005, J NEUROCHEM, V92, P442, DOI 10.1111/j.1471-4159.2004.02897.x; Zhou H, 2005, J BIOL CHEM, V280, P29612, DOI 10.1074/jbc.M504167200; Zhou H, 2004, J NEUROSCI, V24, P4698, DOI 10.1523/JNEUROSCI.5523-03.2004; Zweckstetter M, 2008, NAT PROTOC, V3, P679, DOI 10.1038/nprot.2008.36	74	5	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.402289	http://dx.doi.org/10.1074/jbc.M112.402289			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22989873	Green Published, hybrid			2022-12-25	WOS:000310642200056
J	Chen, YC; Chien, YW; Chang, PJ; Hsieh, WS; Chen, PC				Chen, Yi-Chun; Chien, Yi-Wen; Chang, Pei-Jen; Hsieh, Wu-Shiun; Chen, Pau-Chung			Probiotic Supplement Use among Young Children in Taiwan: A Prospective Cohort Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; VITAMIN; MARKETPLACE; ADOLESCENTS; PREVENTION; MANAGEMENT; PREBIOTICS; BACTERIA; GUIDANCE	Objectives: The objective of this study is to provide details on probiotic supplement use among young children in Taiwan. Participants and Methods: This study is based on the Taiwan Birth Cohort Study database. We used questionnaires to collect information on probiotic supplement use among young children from birth to 18 months of age, while also considering their demographic characteristics and other covariates. Low-birth-weight infants, preterm infants, those with birth defects, and those with caregivers who returned incomplete questionnaires were excluded. The final valid sample comprised 16,991 cases. Results: Approximately half the children received probiotic supplements before the age of 18 months. Only 6.3% of the children received probiotic supplements during the two periods of birth to 6 months and 7 to 18 months. Firstborn children, native mothers, mothers with higher educational levels, higher family income, and parents who lead healthy lifestyles were positively related to probiotic supplement use among children. Young children who were breastfed, with eczema, or with gastrointestinal tract problems were significantly positively associated with probiotic supplement use. Conclusion: The findings show that probiotic supplement usage among young children is associated with a more socially advantaged circumstance and certain child health factors, such as eczema, diarrhea, and constipation. Parents might use probiotic supplements for prevention or treatment of child diseases. The findings of this research could serve as a baseline for future studies, and provide insight into probiotic supplement use behavior for health professionals caring for infants and young children.	[Chen, Yi-Chun; Chien, Yi-Wen] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan; [Chang, Pei-Jen] Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan; [Hsieh, Wu-Shiun] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Taipei 10764, Taiwan; [Hsieh, Wu-Shiun] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Pau-Chung] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Coll Publ Hlth, Taipei 10764, Taiwan	Taipei Medical University; National Taipei University of Nursing & Health Science (NTUNHS); National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University	Chen, YC (corresponding author), Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan.	yichun@tmu.edu.tw	Chen, Pau-Chung/H-5686-2011	Chen, Pau-Chung/0000-0002-6242-5974; HSIEH, WU-SHIUN/0000-0002-0609-3311	Bureau of Health Promotion, Department of Health, Taiwan	Bureau of Health Promotion, Department of Health, Taiwan	The study was supported by a grant from the Bureau of Health Promotion, Department of Health, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003048.pub3; Amagase H, 2008, CLIN INFECT DIS, V46, pS73, DOI 10.1086/523338; Asp NG, 2008, J NUTR, V138, p1210S, DOI 10.1093/jn/138.6.1210S; Bar-on ME, 2001, PEDIATRICS, V107, P423, DOI 10.1542/peds.107.2.423; Boyle RJ, 2006, CLIN EXP ALLERGY, V36, P568, DOI 10.1111/j.1365-2222.2006.02472.x; Boyle RJ, 2006, AM J CLIN NUTR, V83, P1256, DOI 10.1093/ajcn/83.6.1256; Braegger C, 2011, J PEDIATR GASTR NUTR, V52, P238, DOI 10.1097/MPG.0b013e3181fb9e80; Briefel R, 2006, J AM DIET ASSOC, V106, pS52, DOI 10.1016/j.jada.2005.09.041; Chmielewska A, 2010, WORLD J GASTROENTERO, V16, P69, DOI 10.3748/wjg.v16.i1.69; Chuang CH, 2012, J PEDIATR GASTR NUTR, V54, P71, DOI 10.1097/MPG.0b013e31822dbafe; Degnan FH, 2008, CLIN INFECT DIS, V46, pS133, DOI 10.1086/523324; FAO/WHO, 2001, REG CLIN ASP DAIR PR; Ghisolfi J, 2002, J PEDIATR GASTR NUTR, V35, P467, DOI 10.1097/00005176-200210000-00001; Gunther S, 2004, J AM DIET ASSOC, V104, P27, DOI 10.1016/j.jada.2003.10.009; Joint FAO/WHO Working Group, 2002, GUID EV PROB FOOD; Jordan AB, 2006, PEDIATRICS, V118, pE1303, DOI 10.1542/peds.2006-0732; Kalliomaki M, 2010, J NUTR, V140, p713S, DOI 10.3945/jn.109.113761; Kim SH, 2002, NUTR RES, V22, P433, DOI 10.1016/S0271-5317(01)00322-0; Lee J, 2008, J ALLERGY CLIN IMMUN, V121, P116, DOI 10.1016/j.jaci.2007.10.043; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Lung FW, 2011, RES DEV DISABIL, V32, P2697, DOI 10.1016/j.ridd.2011.06.002; Marteau P, 2002, BRIT J NUTR, V87, pS153, DOI 10.1079/BJN2002531; Martin R, 2005, J HUM LACT, V21, P8, DOI 10.1177/0890334404272393; Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028; Michail S, 2006, J PEDIATR GASTR NUTR, V43, P550, DOI 10.1097/01.mpg.0000239990.35517.bf; Osborn DA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006475.pub2; Picciano MF, 2007, ARCH PEDIAT ADOL MED, V161, P978, DOI 10.1001/archpedi.161.10.978; Rabot S, 2010, J NUTR, V140, p677S, DOI 10.3945/jn.109.113738; Radimer K, 2004, AM J EPIDEMIOL, V160, P339, DOI 10.1093/aje/kwh207; Radimer KL, 2005, J AM DIET ASSOC, V105, P703, DOI 10.1016/j.jada.2005.03.037; Saavedra JM, 2004, AM J CLIN NUTR, V79, P261; Saxelin M, 2008, CLIN INFECT DIS, V46, pS76, DOI 10.1086/523337; Shaikh U, 2009, ARCH PEDIAT ADOL MED, V163, P150, DOI 10.1001/archpediatrics.2008.523; Stanton C, 2001, AM J CLIN NUTR, V73, p476S, DOI 10.1093/ajcn/73.2.476s; Thomas DW, 2010, PEDIATRICS, V126, P1217, DOI 10.1542/peds.2010-2548; Wallace B, 2009, NUTR CLIN PRACT, V24, P50, DOI 10.1177/0884533608329298; Yu SM, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.5.e4	37	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43885	10.1371/journal.pone.0043885	http://dx.doi.org/10.1371/journal.pone.0043885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984450	gold, Green Published, Green Submitted			2022-12-25	WOS:000308738500027
J	Garcia, MB; Espadaler, X; Olesen, JM				Garcia, Maria B.; Espadaler, Xavier; Olesen, Jens M.			Extreme Reproduction and Survival of a True Cliffhanger: The Endangered Plant Borderea chouardii (Dioscoreaceae)	PLOS ONE			English	Article							ANT-POLLINATION; SEEDS	Cliff sides are extreme habitats, often sheltering a rich and unique flora. One example is the dioecious herb Borderea chouardii (Dioscoreaceae), which is a Tertiary, tropical relict, occurring only on two adjacent vertical cliffs in the world. We studied its reproductive biology, which in some aspects is extreme, especially the unusual double mutualistic role of ants as both pollinators and dispersers. We made a 2-year pollination census and four years of seed-dispersal experiments, recording flower visitors and dispersal rates. Fruit and seed set, self-sowing of seeds, seedling recruitment, and fate of seedlings from seeds sowed by different agents were scored over a period of 17 years. The ants Lasius grandis and L. cinereus were the main pollinators, whereas another ant Pheidole pallidula dispersed seeds. Thus ants functioned as double mutualists. Two thirds of all new seedlings came from self-sown seeds, and 1/3 was dispersed by ants, which gathered the seeds with their oil-rich elaiosome. Gravity played a minor role to dispersal. Both ant dispersal and self-sowing resulted in the same survival rate of seedlings. A double mutualism is a risky reproductive strategy, but B. chouardii buffers that by an unusual long-term demographic stability (some individuals exceed 300 years in lifespan) and its presence in a climatically very stable habitat, inaccessible to large herbivores. Such a combination of traits and habitat properties may explain the persistence of this relict species.	[Garcia, Maria B.] Spanish Natl Res Council, Pyrenean Inst Ecol, Zaragoza, Spain; [Espadaler, Xavier] Univ Autonoma Barcelona, Ctr Ecol Res & Forestry Applicat, Bellaterra, Spain; [Olesen, Jens M.] Aarhus Univ, Inst Biosci, Aarhus, Denmark	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); Autonomous University of Barcelona; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Aarhus University	Garcia, MB (corresponding author), Spanish Natl Res Council, Pyrenean Inst Ecol, Zaragoza, Spain.	mariab@ipe.csic.es	Espadaler, Xavier/F-1898-2011; Garcia, Maria Begoña/B-6630-2015; Olesen, Jens M/A-3011-2009	Espadaler, Xavier/0000-0002-7681-5957; Garcia, Maria Begoña/0000-0003-4231-6006; Olesen, Jens M/0000-0003-1998-1083; Olesen, Jes/0000-0002-6712-2702	Spanish Ministry of Science; CYTED program; Danish National Research Council; Regional Government of Aragon; INAGA	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CYTED program; Danish National Research Council(Danmarks Grundforskningsfond); Regional Government of Aragon(Gobierno de Aragon); INAGA	The staff of Regional Government of Aragon (in particular J. Guiral, J. Inchausti, M. Alcantara, D. Guzman, J. Puente and the INAGA) provided permits and most of the funding for this study over years. The Spanish Ministry of Science, the CYTED program, and the Danish National Research Council also supported the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; BEATTIE AJ, 1984, AM J BOT, V71, P421, DOI 10.2307/2443499; BHATKAR A, 1970, Florida Entomologist, V53, P229, DOI 10.2307/3493193; BOND WJ, 1989, OECOLOGIA, V81, P412, DOI 10.1007/BF00377092; BURKILL I. H., 1960, JOUR LINNEAN SOC LONDON BOT, V56, P319; CULVER DC, 1980, AM J BOT, V67, P710, DOI 10.2307/2442664; DAVIDSON DW, 1977, ECOLOGY, V58, P711, DOI 10.2307/1936208; DETRAIN C, 1990, INSECT SOC, V37, P315, DOI 10.1007/BF02225995; ERIKSSON O, 1992, OECOLOGIA, V91, P360, DOI 10.1007/BF00317624; Garcia MB, 2003, CONSERV BIOL, V17, P1672, DOI 10.1111/j.1523-1739.2003.00030.x; Garcia MB, 1995, PLANT SYST EVOL, V198, P17, DOI 10.1007/BF00985105; GAUSSEN HENRI, 1952, BULL SOC BOT FRANCE, V99, P23; Gomez C, 1998, J BIOGEOGR, V25, P573, DOI 10.1046/j.1365-2699.1998.2530573.x; Gomez JM, 1996, OECOLOGIA, V105, P236, DOI 10.1007/BF00328552; GOMEZ JM, 1992, OECOLOGIA, V91, P410, DOI 10.1007/BF00317631; Hagerup O. Myre-Best[theta]vning, 1943, BOT TIDSSKR, V46, P116; Hansen DM, 2009, BIOTROPICA, V41, P202, DOI 10.1111/j.1744-7429.2008.00473.x; HICKMAN JC, 1974, SCIENCE, V184, P1290, DOI 10.1126/science.184.4143.1290; Holldobler B, 1984, PSYCHE, V91, P2; Hutcheon JM, 1994, BATS, V12, P10; Larson DW, 2000, J BIOGEOGR, V27, P319, DOI 10.1046/j.1365-2699.2000.00401.x; Larson DW, 2000, CLIFF ECOLOGY PATTEN; Lengyel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005480; Mark S, 1996, OECOLOGIA, V107, P95, DOI 10.1007/BF00582239; Olesen JM, 2012, PERSPECT PLANT ECOL, V14, P169, DOI 10.1016/j.ppees.2012.01.003; Pinheiro J, 2001, MIXED EFFECTS MODELS; Proctor M., 1996, NATURAL HIST POLLINA; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Segarra JG, 2005, FLORA IBERICA PLANTA, V21; Sernander R., 1906, KGL SVENSK VETENSK, V41, P1; STRONG DR, 1975, SCIENCE, V190, P804, DOI 10.1126/science.190.4216.804; Wojcik DP, 2008, FORMIS; WYATT R, 1981, AM J BOT, V68, P1212, DOI 10.2307/2443043	33	35	36	5	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44657	10.1371/journal.pone.0044657	http://dx.doi.org/10.1371/journal.pone.0044657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984539	Green Published, gold			2022-12-25	WOS:000308738500072
J	Imoukhuede, PI; Popel, AS				Imoukhuede, Princess I.; Popel, Aleksander S.			Expression of VEGF Receptors on Endothelial Cells in Mouse Skeletal Muscle	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-1; STOCHASTIC GENE-EXPRESSION; TYROSINE KINASE; SIGNAL-TRANSDUCTION; LIPID RAFTS; STRAIN DIFFERENCES; CEREBRAL-ISCHEMIA; COMPARTMENT MODEL; PROTEIN-KINASE; STEM-CELLS	VEGFR surface localization plays a critical role in converting extracellular VEGF signaling towards angiogenic outcomes, and the quantitative characterization of these parameters is critical for advancing computational models; however the levels of these receptors on blood vessels is currently unknown. Therefore our aim is to quantitatively determine the VEGFR localization on endothelial cells from mouse hindlimb skeletal muscles. We contextualize this VEGFR quantification through comparison to VEGFR-levels on cells in vitro. Using quantitative fluorescence we measure and compare the levels of VEGFR1 and VEGFR2 on endothelial cells isolated from C57BL/6 and BALB/c gastrocnemius and tibialis anterior hindlimb muscles. Fluorescence measurements are calibrated using beads with known numbers of phycoerythrin molecules. The data show a 2-fold higher VEGFR1 surface localization relative to VEGFR2 with 2,000-3,700 VEGFR1/endothelial cell and 1,300-2,000 VEGFR2/endothelial cell. We determine that endothelial cells from the highly glycolytic muscle, tibialis anterior, contain 30% higher number of VEGFR1 surface receptors than gastrocnemius; BALB/c mice display similar to 17% higher number of VEGFR1 than C57BL/6. When we compare these results to mouse fibroblasts in vitro, we observe high levels of VEGFR1 (35,800/cell) and very low levels of VEGFR2 (700/cell), while in human endothelial cells in vitro, we observe that the balance of VEGFRs is inverted, with higher levels VEGFR2 (5,800/cell) and lower levels of VEGFR1 (1,800/cell). Our studies also reveal significant cell-to-cell heterogeneity in receptor expression, and the quantification of these dissimilarities ex vivo for the first time provides insight into the balance of anti-angiogenic or modulatory (VEGFR1) and pro-angiogenic (VEGFR2) signaling.	[Imoukhuede, Princess I.] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Popel, Aleksander S.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	University of Illinois System; University of Illinois Urbana-Champaign; Johns Hopkins University	Imoukhuede, PI (corresponding author), Univ Illinois, Dept Bioengn, Urbana, IL USA.	pii@illinois.edu	Popel, Aleksander S/A-6724-2009; Imoukhuede, P I/T-7580-2017	Imoukhuede, P I/0000-0002-4257-1085; Popel, Aleksander/0000-0002-6706-9235	National institutes of Health [R01 HL101200, R01 CA138264]; UNCF/Merck; FASEB; NIH [T32 HL007581]; NATIONAL CANCER INSTITUTE [R01CA138264] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007581, R01HL101200] Funding Source: NIH RePORTER	National institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNCF/Merck(Merck & Company); FASEB; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is supported by National institutes of Health grants R01 HL101200 and R01 CA138264 to A. S. Popel and by a UNCF/Merck Postdoctoral Fellowship, FASEB Postdoctoral Professional Development Award, and T32 HL007581 (The T32 HL007581 is from the NIH) to PII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annex BH, 1998, AM J PHYSIOL-HEART C, V274, pH860, DOI 10.1152/ajpheart.1998.274.3.H860; Aronowski JW, 2003, ILAR J, V44, P105, DOI 10.1093/ilar.44.2.105; BALANDA KP, 1988, AM STAT, V42, P111, DOI 10.2307/2684482; BARONE FC, 1993, J CEREBR BLOOD F MET, V13, P683, DOI 10.1038/jcbfm.1993.87; Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Bernatchez PN, 2007, J BIOL CHEM, V282, P30745, DOI 10.1074/jbc.M704798200; Berthaut A, 2009, MOL VIS, V15, P1997; Bhattacharya R, 2005, FASEB J, V19, P1692, DOI 10.1096/fj.05-3889fje; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962; BOBIK A, 1993, PHARMACOL REV, V45, P1; BROCKHOFF G, 1994, CYTOMETRY, V17, P75, DOI 10.1002/cyto.990170110; Bruns AF, 2009, BIOCHEM SOC T, V37, P1193, DOI 10.1042/BST0371193; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Casalou C, 2011, MOL CANCER RES, V9, P215, DOI 10.1158/1541-7786.MCR-10-0155; Chalothorn D, 2007, PHYSIOL GENOMICS, V30, P179, DOI 10.1152/physiolgenomics.00047.2007; Chen JH, 2001, CELL BIOL INT, V25, P257, DOI 10.1006/cbir.2000.0617; Cherwek DH, 2000, AM J PHYSIOL-HEART C, V279, pH932, DOI 10.1152/ajpheart.2000.279.3.H932; Chu CL, 2004, BIOCHEM J, V379, P331, DOI 10.1042/BJ20031082; CLAUSS M, 1990, J EXP MED, V172, P1535, DOI 10.1084/jem.172.6.1535; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; DeCarlo LT, 1997, PSYCHOL METHODS, V2, P292, DOI 10.1037/1082-989X.2.3.292; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; DOKUN AO, 2008, NY TIMES        1026, V117, P1207; Dunk C, 2001, AM J PATHOL, V158, P265, DOI 10.1016/S0002-9440(10)63965-X; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Ewan LC, 2006, TRAFFIC, V7, P1270, DOI 10.1111/j.1600-0854.2006.00462.x; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Finley SD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-193; Fukino K, 2003, BIOCHEM BIOPH RES CO, V310, P143, DOI 10.1016/j.bbrc.2003.08.134; Gampel A, 2006, BLOOD, V108, P2624, DOI 10.1182/blood-2005-12-007484; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gevertz JL, 2006, J THEOR BIOL, V243, P517, DOI 10.1016/j.jtbi.2006.07.002; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Grayson WL, 2004, BIOTECHNOL PROGR, V20, P905, DOI 10.1021/bp034296z; Helisch A, 2006, ARTERIOSCL THROM VAS, V26, P520, DOI 10.1161/01.ATV.0000202677.55012.a0; Hetheridge C, 2011, BIOCHEM SOC T, V39, P1597, DOI 10.1042/BST20110738; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hiratsuka S, 2001, CANCER RES, V61, P1207; Huang K, 2001, INT J BIOCHEM CELL B, V33, P315, DOI 10.1016/S1357-2725(01)00019-X; HUDLICKA O, 1985, J EXP BIOL, V115, P215; Hynes RO, 1999, TRENDS BIOCHEM SCI, V24, pM33, DOI 10.1016/S0968-0004(99)01479-6; Imoukhuede PI, 2011, EXP CELL RES, V317, P955, DOI 10.1016/j.yexcr.2010.12.014; Janes KA, 2010, NAT METHODS, V7, P311, DOI [10.1038/nmeth.1442, 10.1038/NMETH.1442]; Jeong JH, 2012, ADV MATER, V24, P58, DOI 10.1002/adma.201103207; Jin X, 2007, J MOL CELL CARDIOL, V43, P292, DOI 10.1016/j.yjmcc.2007.06.002; Jones MC, 2009, TRAFFIC, V10, P754, DOI 10.1111/j.1600-0854.2009.00898.x; Jopling HM, 2011, BIOCHEM BIOPH RES CO, V410, P170, DOI 10.1016/j.bbrc.2011.04.093; Jopling HM, 2009, ARTERIOSCL THROM VAS, V29, P1119, DOI 10.1161/ATVBAHA.109.186239; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Labrecque L, 2003, MOL BIOL CELL, V14, P334, DOI 10.1091/mbc.E02-07-0379; Lajoie P, 2009, J CELL BIOL, V185, P381, DOI 10.1083/jcb.200811059; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Li S, 2002, FASEB J; Liu PS, 1997, P NATL ACAD SCI USA, V94, P13666, DOI 10.1073/pnas.94.25.13666; Lloyd PG, 2003, AM J PHYSIOL-HEART C, V284, pH1668, DOI 10.1152/ajpheart.00743.2002; Mac Gabhann F, 2007, ANN BIOMED ENG, V35, P982, DOI 10.1007/s10439-007-9303-0; Mac Gabhann F, 2007, BIOPHYS CHEM, V128, P125, DOI 10.1016/j.bpc.2007.03.010; Mac Gabhann F, 2010, WIRES SYST BIOL MED, V2, P694, DOI 10.1002/wsbm.92; Mac Gabhann F, 2010, MICROCIRCULATION, V17, P333, DOI 10.1111/j.1549-8719.2010.00034.x; Majid A, 2000, STROKE, V31, P2707, DOI 10.1161/01.STR.31.11.2707; Majka SM, 2003, J CLIN INVEST, V111, P71, DOI 10.1172/JCI200316157; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Meyer RD, 2006, J BIOL CHEM, V281, P867, DOI 10.1074/jbc.M506454200; Miljan Erik A, 2002, Sci STKE, V2002, pre15, DOI 10.1126/stke.2002.160.re15; Mitsuda T, 2002, J BIOL CHEM, V277, P11239, DOI 10.1074/jbc.M107756200; Mittar S, 2009, EXP CELL RES, V315, P877, DOI 10.1016/j.yexcr.2008.12.020; Murakami S, 2010, ACTA MED OKAYAMA, V64, P11; Neagoe PE, 2005, J BIOL CHEM, V280, P9904, DOI 10.1074/jbc.M412017200; NICOSIA RF, 1994, AM J PATHOL, V145, P1023; Nielsen JS, 2008, J CELL SCI, V121, P3683, DOI 10.1242/jcs.037507; Nielsen JS, 2009, MICROCIRCULATION, V16, P487, DOI 10.1080/10739680902941737; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; Nilsson I, 2010, EMBO J, V29, P1377, DOI 10.1038/emboj.2010.30; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Pannu KK, 2001, CYTOMETRY, V45, P250, DOI 10.1002/1097-0320(20011201)45:4<250::AID-CYTO10021>3.0.CO;2-T; Peirce S, 2008, MICROCIRCULATION, V15, P739, DOI 10.1080/10739680802220331; Pilpel Y, 2011, METHODS MOL BIOL, V759, P407, DOI 10.1007/978-1-61779-173-4_23; Prahst C, 2008, J BIOL CHEM, V283, P25110, DOI 10.1074/jbc.C800137200; Quinn PJ, 2010, PROG LIPID RES, V49, P390, DOI 10.1016/j.plipres.2010.05.002; Quitub AA, 2009, IEEE ENG MED BIOL, V28, P14, DOI 10.1109/MEMB.2009.931791; Raghu H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-647; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rose NL, 2003, TRANSPL P, V35, P2455, DOI 10.1016/j.transproceed.2003.08.025; Rush JS, 2012, J BIOL CHEM, V287, P712, DOI 10.1074/jbc.M111.294470; Sawano A, 1996, CELL GROWTH DIFFER, V7, P213; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Scholz D, 2002, J MOL CELL CARDIOL, V34, P775, DOI 10.1006/jmcc.2002.2013; SEETHARAM L, 1995, ONCOGENE, V10, P135; Semenza GL, 2004, J APPL PHYSIOL, V96, P1173, DOI 10.1152/japplphysiol.00770.2003; Shibuya Masaubmi, 2006, Angiogenesis, V9, P225, DOI 10.1007/s10456-006-9055-8; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242; Sonveaux P, 2004, CIRC RES, V95, P154, DOI 10.1161/01.RES.0000136344.27825.72; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stefanini MO, 2010, CANCER RES, V70, P9886, DOI 10.1158/0008-5472.CAN-10-1419; Stefanini MO, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000622; Stefanini MO, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-77; Sugimori H, 2004, BRAIN RES PROTOC, V13, P189, DOI 10.1016/j.brainresprot.2004.06.001; Sundberg C, 2009, AM J PATHOL, V175, P171, DOI 10.2353/ajpath.2009.080769; Takahashi T, 1997, ONCOGENE, V14, P2079, DOI 10.1038/sj.onc.1201047; VAISMAN N, 1990, J BIOL CHEM, V265, P19461; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; VILLASCHI S, 1994, LAB INVEST, V71, P291; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang LL, 2006, CYTOM PART B-CLIN CY, V70B, P410, DOI 10.1002/cyto.b.20140; Wu FTH, 2010, AM J PHYSIOL-HEART C, V298, pH2174, DOI 10.1152/ajpheart.00365.2009; Wu FTH, 2009, METHOD ENZYMOL, V467, P461, DOI 10.1016/S0076-6879(09)67018-X; Wu FTH, 2009, PHYSIOL GENOMICS, V38, P29, DOI 10.1152/physiolgenomics.00031.2009; Wu FTH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005108; Zajchowski LD, 2002, EUR J BIOCHEM, V269, P737, DOI 10.1046/j.0014-2956.2001.02715.x; Zhang Z, 2010, CELL DEATH DIFFER, V17, P499, DOI 10.1038/cdd.2009.152	120	40	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44791	10.1371/journal.pone.0044791	http://dx.doi.org/10.1371/journal.pone.0044791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984559	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500085
J	Saifudeen, Z; Liu, J; Dipp, S; Yao, X; Li, YW; McLaughlin, N; Aboudehen, K; El-Dahr, SS				Saifudeen, Zubaida; Liu, Jiao; Dipp, Susana; Yao, Xiao; Li, Yuwen; McLaughlin, Nathaniel; Aboudehen, Karam; El-Dahr, Samir S.			A p53-Pax2 Pathway in Kidney Development: Implications for Nephrogenesis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR P53; NEPHRON PROGENITOR POPULATION; DEVELOPING MOUSE KIDNEY; GENE-EXPRESSION; MAMMALIAN KIDNEY; CELL-SURVIVAL; TRANSCRIPTIONAL ACTIVATION; BRANCHING MORPHOGENESIS; INTERMEDIATE MESODERM; EMBRYONIC KIDNEY	Congenital reduction in nephron number (renal hypoplasia) is a predisposing factor for chronic kidney disease and hypertension. Despite identification of specific genes and pathways in nephrogenesis, determinants of final nephron endowment are poorly understood. Here, we report that mice with germ-line p53 deletion (p53(-/-)) manifest renal hypoplasia; the phenotype can be recapitulated by conditional deletion of p53 from renal progenitors in the cap mesenchyme (CMp53-/-). Mice or humans with germ-line heterozygous mutations in Pax2 exhibit renal hypoplasia. Since both transcription factors are developmentally expressed in the metanephros, we tested the hypothesis that p53 and Pax2 cooperate in nephrogenesis. In this study, we provide evidence for the presence of genetic epistasis between p53 and Pax2: a) p53(-/-) and CMp53-/- embryos express lower Pax2 mRNA and protein in nephron progenitors than their wild-type littermates; b) ChIP-Seq identified peaks of p53 occupancy in chromatin regions of the Pax2 promoter and gene in embryonic kidneys; c) p53 binding to Pax2 gene is significantly more enriched in Pax2 -expressing than non-expressing metanephric mesenchyme cells; d) in transient transfection assays, Pax2 promoter activity is stimulated by wild-type p53 and inhibited by a dominant negative mutant p53; e) p53 knockdown in cultured metanephric mesenchyme cells down-regulates endogenous Pax2 expression; f) reduction of p53 gene dosage worsens the renal hypoplasia in Pax2(+/-) mice. Bioinformatics identified a set of developmental renal genes likely to be co-regulated by p53 and Pax2. We propose that the cross-talk between p53 and Pax2 provides a transcriptional platform that promotes nephrogenesis, thus contributing to nephron endowment.	[Saifudeen, Zubaida; Liu, Jiao; Dipp, Susana; Yao, Xiao; Li, Yuwen; McLaughlin, Nathaniel; Aboudehen, Karam; El-Dahr, Samir S.] Tulane Univ, Hlth Sci Ctr, Dept Pediat, Sect Pediat Nephrol, New Orleans, LA 70118 USA; [Saifudeen, Zubaida; Liu, Jiao; El-Dahr, Samir S.] Tulane Univ, Hlth Sci Ctr, Hypertens & Renal Ctr Excellence, New Orleans, LA 70118 USA	Tulane University; Tulane University	Saifudeen, Z (corresponding author), Tulane Univ, Hlth Sci Ctr, Dept Pediat, Sect Pediat Nephrol, New Orleans, LA 70118 USA.	zubisaif@tulane.edu	li, yuwen/HGU-6435-2022; Li, yu/HHZ-5236-2022	aboudehen, karam/0000-0003-4975-464X	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK62550]; National Institutes of Health National Center for Research Resources (NIH-NCRR) Center of Biomedical Research Excellence [P20RR017659]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017659] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health National Center for Research Resources (NIH-NCRR) Center of Biomedical Research Excellence; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01DK62550 to SED and by National Institutes of Health National Center for Research Resources (NIH-NCRR) Center of Biomedical Research Excellence grant support P20RR017659 to ZS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboudehen K, 2012, AM J PHYSIOL-RENAL, V302, pF928, DOI 10.1152/ajprenal.00642.2011; Almog N, 1997, BBA-REV CANCER, V1333, pF1, DOI 10.1016/S0304-419X(97)00012-7; Armata HL, 2010, MOL CELL BIOL, V30, P5787, DOI 10.1128/MCB.00347-10; Baatout S, 2002, IN VIVO, V16, P215; Bouchard M, 2000, DEVELOPMENT, V127, P3703; Bouchard M, 2002, GENE DEV, V16, P2958, DOI 10.1101/gad.240102; Bouchard M, 2005, DEVELOPMENT, V132, P2633, DOI 10.1242/dev.01833; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Boyle SC, 2011, DEVELOPMENT, V138, P4245, DOI 10.1242/dev.070433; Brodbeck S, 2004, PEDIATR NEPHROL, V19, P249, DOI 10.1007/s00467-003-1374-z; Brophy PD, 2001, DEVELOPMENT, V128, P4747; Chen SW, 2011, J BIOL CHEM, V286, P32775, DOI 10.1074/jbc.M111.248278; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Choi J, 1999, CELL MOL LIFE SCI, V55, P38, DOI 10.1007/s000180050268; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clark P, 2004, J AM SOC NEPHROL, V15, P299, DOI 10.1097/01.ASN.0000111248.23454.19; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; DRESSLER GR, 1992, P NATL ACAD SCI USA, V89, P1179, DOI 10.1073/pnas.89.4.1179; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gong KQ, 2007, MOL CELL BIOL, V27, P7661, DOI 10.1128/MCB.00465-07; Grieshammer U, 2005, DEVELOPMENT, V132, P3847, DOI 10.1242/dev.01944; Hilliard S, 2011, DEV BIOL, V353, P354, DOI 10.1016/j.ydbio.2011.03.017; HOEVER M, 1994, ONCOGENE, V9, P109; HOLLANDER MC, 1993, J BIOL CHEM, V268, P24385; Horn HF, 2007, ONCOGENE, V26, P1306, DOI 10.1038/sj.onc.1210263; Ikeda S, 1999, INVEST OPHTH VIS SCI, V40, P1874; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; LUNA RMD, 1995, NATURE, V378, P203; Mah SP, 2000, DEV BIOL, V223, P38, DOI 10.1006/dbio.2000.9738; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Morris GF, 1996, P NATL ACAD SCI USA, V93, P895, DOI 10.1073/pnas.93.2.895; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Muratovska A, 2003, ONCOGENE, V22, P7989, DOI 10.1038/sj.onc.1206766; Naim E, 2005, KIDNEY INT, V68, P955, DOI 10.1111/j.1523-1755.2005.00489.x; Narlis M, 2007, J AM SOC NEPHROL, V18, P1121, DOI 10.1681/ASN.2006070739; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Park D, 2006, DEVELOPMENT, V133, P4193, DOI 10.1242/dev.02614; Patel SR, 2004, DEV BIOL, V267, P505, DOI 10.1016/j.ydbio.2003.11.002; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Pfeffer PL, 2002, DEVELOPMENT, V129, P307; Poladia DP, 2006, DEV BIOL, V291, P325, DOI 10.1016/j.ydbio.2005.12.034; Porteous S, 2000, HUM MOL GENET, V9, P1, DOI 10.1093/hmg/9.1.1; Qin QY, 2009, J NEUROSCI, V29, P5183, DOI 10.1523/JNEUROSCI.0420-09.2009; Reidy KJ, 2009, SEMIN NEPHROL, V29, P321, DOI 10.1016/j.semnephrol.2009.03.009; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Saifudeen Z, 2005, J BIOL CHEM, V280, P23094, DOI 10.1074/jbc.M414575200; Saifudeen Z, 2005, AM J PHYSIOL-RENAL, V288, pF899, DOI 10.1152/ajprenal.00370.2004; Saifudeen Z, 2002, J CLIN INVEST, V109, P1021, DOI 10.1172/JCI200213972; Saifudeen Z, 2000, J BIOL CHEM, V275, P15557, DOI 10.1074/jbc.M909810199; Saifudeen Z, 2009, J AM SOC NEPHROL, V20, P2328, DOI 10.1681/ASN.2008121224; SANYANUSIN P, 1995, NAT GENET, V9, P358, DOI 10.1038/ng0495-358; Sasai N, 2008, CELL, V133, P878, DOI 10.1016/j.cell.2008.03.035; SCHMID P, 1991, DEVELOPMENT, V113, P857; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Sims-Lucas S, 2011, DEV DYNAM, V240, P240, DOI 10.1002/dvdy.22501; Sorenson CM, 2004, J BIOL CHEM, V279, P11368, DOI 10.1074/jbc.M310079200; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; STUART ET, 1995, EMBO J, V14, P5638, DOI 10.1002/j.1460-2075.1995.tb00251.x; Takebayashi-Suzuki K, 2003, DEVELOPMENT, V130, P3929, DOI 10.1242/dev.00615; Teodoro JG, 2006, SCIENCE, V313, P968, DOI 10.1126/science.1126391; Thornborrow EC, 1999, J BIOL CHEM, V274, P33747, DOI 10.1074/jbc.274.47.33747; Torban E, 2006, J BIOL CHEM, V281, P12705, DOI 10.1074/jbc.M513181200; Torres M, 1995, DEVELOPMENT, V121, P4057; Torres MA, 1996, DEVELOPMENT, V122, P3381; Valerius M. Todd, 2002, Mechanisms of Development, V112, P219, DOI 10.1016/S0925-4773(02)00008-4; Wallingford JB, 1997, CURR BIOL, V7, P747, DOI 10.1016/S0960-9822(06)00333-2; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; ZAUBERMAN A, 1995, NUCLEIC ACIDS RES, V23, P2584, DOI 10.1093/nar/23.14.2584; Zhang LL, 2000, CANCER RES, V60, P3655; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao TBA, 2010, TRENDS CELL BIOL, V20, P170, DOI 10.1016/j.tcb.2009.12.004; Zhao Z, 2010, GENE DEV, V24, P1389, DOI 10.1101/gad.1940710	81	31	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44869	10.1371/journal.pone.0044869	http://dx.doi.org/10.1371/journal.pone.0044869			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984579	Green Published, Green Submitted, gold			2022-12-25	WOS:000308738500093
J	Zhou, T; Zhang, W; Sweiss, NJ; Chen, ES; Moller, DR; Knox, KS; Ma, SF; Wade, MS; Noth, I; Machado, RF; Garcia, JGN				Zhou, Tong; Zhang, Wei; Sweiss, Nadera J.; Chen, Edward S.; Moller, David R.; Knox, Kenneth S.; Ma, Shwu-Fan; Wade, Michael S.; Noth, Imre; Machado, Roberto F.; Garcia, Joe G. N.			Peripheral Blood Gene Expression as a Novel Genomic Biomarker in Complicated Sarcoidosis	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; IDIOPATHIC PULMONARY-FIBROSIS; C CHEMOKINE RECEPTOR-2; MEDICAL PROGRESS; RISK-FACTOR; ACE GENE; POLYMORPHISMS; ASSOCIATION; CANCER; INJURY	Sarcoidosis, a systemic granulomatous syndrome invariably affecting the lung, typically spontaneously remits but in similar to 20% of cases progresses with severe lung dysfunction or cardiac and neurologic involvement (complicated sarcoidosis). Unfortunately, current biomarkers fail to distinguish patients with remitting (uncomplicated) sarcoidosis from other fibrotic lung disorders, and fail to identify individuals at risk for complicated sarcoidosis. We utilized genome-wide peripheral blood gene expression analysis to identify a 20-gene sarcoidosis biomarker signature distinguishing sarcoidosis (n = 39) from healthy controls (n = 35, 86% classification accuracy) and which served as a molecular signature for complicated sarcoidosis (n = 17). As aberrancies in T cell receptor (TCR) signaling, JAK-STAT (JS) signaling, and cytokine-cytokine receptor (CCR) signaling are implicated in sarcoidosis pathogenesis, a 31-gene signature comprised of T cell signaling pathway genes associated with sarcoidosis (TCR/JS/CCR) was compared to the unbiased 20-gene biomarker signature but proved inferior in prediction accuracy in distinguishing complicated from uncomplicated sarcoidosis. Additional validation strategies included significant association of single nucleotide polymorphisms (SNPs) in signature genes with sarcoidosis susceptibility and severity (unbiased signature genes -CX3CR1, FKBP1A, NOG, RBM12B, SENS3, TSHZ2; T cell/JAK-STAT pathway genes such as AKT3, CBLB, DLG1, IFNG, IL2RA, IL7R, ITK, JUN, MALT1, NFATC2, PLCG1, SPRED1). In summary, this validated peripheral blood molecular gene signature appears to be a valuable biomarker in identifying cases with sarcoidoisis and predicting risk for complicated sarcoidosis.	[Zhou, Tong; Wade, Michael S.; Machado, Roberto F.; Garcia, Joe G. N.] Univ Illinois, Inst Personalized Resp Med, Chicago, IL USA; [Zhou, Tong; Wade, Michael S.; Machado, Roberto F.; Garcia, Joe G. N.] Univ Illinois, Dept Med, Sect Pulm Crit Care Sleep & Allergy, Chicago, IL USA; [Zhang, Wei] Univ Illinois, Inst Human Genet, Chicago, IL USA; [Zhang, Wei] Univ Illinois, Dept Pediat, Chicago, IL USA; [Sweiss, Nadera J.] Univ Illinois, Dept Med, Rheumatol Sect, Chicago, IL USA; [Chen, Edward S.; Moller, David R.] Johns Hopkins Univ, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Knox, Kenneth S.] Univ Arizona, Dept Med, Sect Pulm & Crit Care, Tucson, AZ USA; [Ma, Shwu-Fan; Noth, Imre] Univ Chicago, Dept Med, Sect Pulm Crit Care, Chicago, IL 60637 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; University of Arizona; University of Chicago	Zhou, T (corresponding author), Univ Illinois, Inst Personalized Resp Med, Chicago, IL USA.	jggarcia@uic.edu		Machado, Roberto/0000-0002-3722-5954; Sweiss, Nadera/0000-0003-2215-0221	National Institutes of Health [NHLBI HL58094, R01HL112051, HL68019, HL83870, U01 HL105371-01, RC2 HL101740-01, NHLBI K23HL098454]; Johns Hopkins Sarcoidosis gene bank/database; Hospital for the Consumptives of Maryland (Eudowood); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105371, RC2HL101740, R01HL068019, R01HL083870] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Sarcoidosis gene bank/database; Hospital for the Consumptives of Maryland (Eudowood); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health grants: NHLBI HL58094 (JGNG), R01HL112051 (WZ), HL68019 (DRM), HL83870 (DRM), U01 HL105371-01 (JGNG), RC2 HL101740-01 (JGNG), NHLBI K23HL098454 (RM). This work was also supported by the Johns Hopkins Sarcoidosis gene bank/database and the Hospital for the Consumptives of Maryland (Eudowood). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahoshi M, 2004, HUM GENET, V114, P503, DOI 10.1007/s00439-004-1099-5; Antoniou KM, 2006, CHEST, V130, P982, DOI 10.1378/chest.130.4.982; Arbustini E, 1996, AM J RESP CRIT CARE, V153, P851, DOI 10.1164/ajrccm.153.2.8564143; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BESNER G, 1990, CELL REGUL, V1, P811, DOI 10.1091/mbc.1.11.811; Bombieri C, 2000, EUR J HUM GENET, V8, P717, DOI 10.1038/sj.ejhg.5200524; BREWERTON DA, 1977, CLIN EXP IMMUNOL, V27, P227; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duan S, 2008, AM J HUM GENET, V82, P1101, DOI 10.1016/j.ajhg.2008.03.006; Furuya K, 1996, THORAX, V51, P777, DOI 10.1136/thx.51.8.777; Grunewald J, 2004, AM J RESP CRIT CARE, V169, P696, DOI 10.1164/rccm.200303-459OC; Grunewald Johan, 2007, Proc Am Thorac Soc, V4, P461, DOI 10.1513/pats.200606-130MS; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; HIGASHIYAMA S, 1993, J CELL BIOL, V122, P933, DOI 10.1083/jcb.122.4.933; HOMMA T, 1995, J CLIN INVEST, V96, P1018, DOI 10.1172/JCI118087; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunninghake GW, 1999, AM J RESP CRIT CARE, V160, P736; Hutyrova B, 2002, AM J RESP CRIT CARE, V165, P148, DOI 10.1164/ajrccm.165.2.2106004; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Iannuzzi Michael C, 2007, Proc Am Thorac Soc, V4, P108, DOI 10.1513/pats.200607-141JG; ITO N, 1994, BIOCHEM BIOPH RES CO, V198, P25, DOI 10.1006/bbrc.1994.1004; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KATARIA YP, 1976, ANN NY ACAD SCI, V278, P69, DOI 10.1111/j.1749-6632.1976.tb47017.x; Kelly DM, 2005, AM J RESP CRIT CARE, V172, P1299, DOI 10.1164/rccm.200411-1594OC; KISO S, 1995, HEPATOLOGY, V22, P1584, DOI 10.1016/0270-9139(95)90168-X; Koth LL, 2011, AM J RESP CRIT CARE, V184, P1153, DOI 10.1164/rccm.201106-1143OC; Kruit A, 2006, CHEST, V129, P1584, DOI 10.1378/chest.129.6.1584; Lockstone HE, 2010, AM J RESP CRIT CARE, V181, P1367, DOI 10.1164/rccm.200912-1855OC; Maliarik MJ, 2000, AM J RESP CELL MOL, V22, P672, DOI 10.1165/ajrcmb.22.6.3745; MARIKOVSKY M, 1993, P NATL ACAD SCI USA, V90, P3889, DOI 10.1073/pnas.90.9.3889; McCarthy DW, 1996, J INVEST DERMATOL, V106, P49, DOI 10.1111/1523-1747.ep12327214; McGrath DS, 2001, AM J RESP CRIT CARE, V164, P197, DOI 10.1164/ajrccm.164.2.2011009; Morgenthau AS, 2011, CHEST, V139, P174, DOI 10.1378/chest.10-0188; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Morohashi K, 2003, CHEST, V123, P1520, DOI 10.1378/chest.123.5.1520; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Nunes H, 2010, SEMIN RESP CRIT CARE, V31, P428, DOI 10.1055/s-0030-1262211; Pabst S, 2006, CLIN EXP IMMUNOL, V143, P420, DOI 10.1111/j.1365-2249.2006.03008.x; R Development Core Team, 2005, R LANG ENV STAT COMP; Rossman MD, 2003, AM J HUM GENET, V73, P720, DOI 10.1086/378097; Schurmann M, 2002, EUR J HUM GENET, V10, P729, DOI 10.1038/sj.ejhg.5200868; Schurmann M, 2001, AM J RESP CRIT CARE, V164, P840, DOI 10.1164/ajrccm.164.5.2007056; Sharma SM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2855; Spagnolo P, 2003, AM J RESP CRIT CARE, V168, P1162, DOI 10.1164/rccm.200303-456OC; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sweiss NJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009088; Thuerigen O, 2006, J CLIN ONCOL, V24, P1839, DOI 10.1200/JCO.2005.04.7019; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valentonyte R, 2005, AM J RESP CRIT CARE, V171, P1136, DOI 10.1164/rccm.200405-658OC; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Vapnik V., 1998, STAT LEARNING THEORY; WILSON SE, 1994, EXP EYE RES, V59, P665, DOI 10.1006/exer.1994.1152; Zajicek JP, 1999, QJM-INT J MED, V92, P103, DOI 10.1093/qjmed/92.2.103; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015; Zhang XG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-197	58	60	60	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e44818	10.1371/journal.pone.0044818	http://dx.doi.org/10.1371/journal.pone.0044818			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22984568	Green Published, gold, Green Submitted			2022-12-25	WOS:000308738500089
J	Chatfield, MWH; Moler, P; Richards-Zawacki, CL				Chatfield, Matthew W. H.; Moler, Paul; Richards-Zawacki, Corinne L.			The Amphibian Chytrid Fungus, Batrachochytrium dendrobatidis, in Fully Aquatic Salamanders from Southeastern North America	PLOS ONE			English	Article							FROG RANA-PIPIENS; CRYPTOBRANCHUS-ALLEGANIENSIS; SIREN-INTERMEDIA; POPULATION CHARACTERISTICS; INFECTIOUS-DISEASE; CHYTRIDIOMYCOSIS; HELLBENDER; PATHOGEN; DECLINES; BIODIVERSITY	Little is known about the impact that the pathogenic amphibian chytrid fungus, Batrachochytrium dendrobatidis (Bd), has on fully aquatic salamander species of the eastern United States. As a first step in determining the impacts of Bd on these species, we aimed to determine the prevalence of Bd in wild populations of fully aquatic salamanders in the genera Amphiuma, Necturus, Pseudobranchus, and Siren. We sampled a total of 98 salamanders, representing nine species from sites in Florida, Mississippi, and Louisiana. Overall, infection prevalence was found to be 0.34, with significant differences among genera but no clear geographic pattern. We also found evidence for seasonal variation, but additional sampling throughout the year is needed to clarify this pattern. The high rate of infection discovered in this study is consistent with studies of other amphibians from the southeastern United States. Coupled with previously published data on life histories and population densities, the results presented here suggest that fully aquatic salamanders may be serving as important vectors of Bd and the interaction between these species and Bd warrants additional research.	[Chatfield, Matthew W. H.; Richards-Zawacki, Corinne L.] Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA; [Moler, Paul] Florida Fish & Wildlife Conservat Commiss, Wildlife Res Lab, Gainesville, FL USA	Tulane University; Florida Fish & Wildlife Conservation Commission	Chatfield, MWH (corresponding author), Tulane Univ, Dept Ecol & Evolutionary Biol, New Orleans, LA 70118 USA.	mattchat@tulane.edu	Richards-Zawacki, Corinne/F-2731-2011	Richards-Zawacki, Corinne/0000-0002-4212-041X	Tulane University	Tulane University	This study was funded by Tulane University through start-up funds given to C.L.R.-Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bodinof CM, 2011, DIS AQUAT ORGAN, V96, P1, DOI 10.3354/dao02380; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brannelly LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038473; Briggler Jeffrey T., 2008, Herpetological Review, V39, P443; Briggler Jeffrey T., 2007, Herpetological Review, V38, P174; Burgmeier NG, 2011, J WILDLIFE DIS, V47, P836, DOI 10.7589/0090-3558-47.4.836; Daszak P, 2004, HERPETOL J, V14, P201; Daszak P, 2003, DIVERS DISTRIB, V9, P141, DOI 10.1046/j.1472-4642.2003.00016.x; ETHERIDGE K, 1990, HERPETOLOGICA, V46, P407; Fontenot CL, 2011, HERPETOL CONSERV BIO, V6, P395; Foster RL, 2009, J HERPETOL, V43, P579, DOI 10.1670/08-156.1; Frese PW, 2003, SOUTHWEST NAT, V48, P534, DOI 10.1894/0038-4909(2003)048<0534:PCGASA>2.0.CO;2; Gaertner James P., 2009, Herpetological Review, V40, P184; Garland S, 2010, DIS AQUAT ORGAN, V92, P113, DOI 10.3354/dao02053; GEHLBACH F R, 1978, Southwestern Naturalist, V23, P423, DOI 10.2307/3670250; Gehlbach FR, 1973, SIREN INTERMEDIA; Goka K, 2009, MOL ECOL, V18, P4757, DOI 10.1111/j.1365-294X.2009.04384.x; Gonynor Jessica L., 2011, Herpetological Review, V42, P58; Hampton PM, 2009, J HERPETOL, V43, P704, DOI 10.1670/08-168.1; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; HUTCHISON V H, 1976, Herpetologica, V32, P327; Johnson ML, 2003, DIS AQUAT ORGAN, V57, P255, DOI 10.3354/dao057255; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Mendelson JR, 2006, SCIENCE, V313, P48, DOI 10.1126/science.1128396; Murray KA, 2009, CONSERV BIOL, V23, P1242, DOI 10.1111/j.1523-1739.2009.01211.x; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Parris MJ, 2006, CAN J ZOOL, V84, P58, DOI 10.1139/Z05-175; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Pullen KD, 2010, DIS AQUAT ORGAN, V91, P9, DOI 10.3354/dao02249; RENO HW, 1972, COPEIA, P625; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Sheafor B, 2008, J WILDLIFE DIS, V44, P226, DOI 10.7589/0090-3558-44.2.226; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Sorensen K, 2004, SOUTHEAST NAT, V3, P249, DOI 10.1656/1528-7092(2004)003[0249:PCOSLA]2.0.CO;2; SPEARE R, 2000, GLOBAL DISTRIBUTION; Talley Brooke L., 2011, Herpetological Review, V42, P216; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Woodhams Douglas C., 2008, Herpetological Review, V39, P66	43	19	24	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44821	10.1371/journal.pone.0044821	http://dx.doi.org/10.1371/journal.pone.0044821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984569	gold, Green Published			2022-12-25	WOS:000308638700088
J	Dahboul, F; Leroy, P; Gate, KM; Boudier, A; Gaucher, C; Liminana, P; Lartaud, I; Pompella, A; Perrin-Sarrado, C				Dahboul, Fatima; Leroy, Pierre; Gate, Katy Maguin; Boudier, Ariane; Gaucher, Caroline; Liminana, Patrick; Lartaud, Isabelle; Pompella, Alfonso; Perrin-Sarrado, Caroline			Endothelial gamma-Glutamyltransferase Contributes to the Vasorelaxant Effect of S-Nitrosoglutathione in Rat Aorta	PLOS ONE			English	Article							AGONIST-EVOKED CONTRACTION; NITRIC-OXIDE; SMOOTH-MUSCLE; GLUTATHIONE; TRANSPEPTIDASE; SYSTEM; RELAXATION; INCUBATION; SUBSTRATE; DISEASES	S-nitrosoglutathione (GSNO) involved in storage and transport of nitric oxide (N NO) plays an important role in vascular homeostasis. Breakdown of GSNO can be catalyzed by gamma-glutamyltransferase (GGT). We investigated whether vascular GGT influences the vasorelaxant effect of GSNO in isolated rat aorta. Histochemical localization of GGT and measurement of its activity were performed by using chromogenic substrates in sections and in aorta homogenates, respectively. The role of GGT in GSNO metabolism was evaluated by measuring GSNO consumption rate (absorbance decay at 334 nm), (NO)-N-center dot release was visualized and quantified with the fluorescent probe 4,5-diaminofluorescein diacetate. The vasorelaxant effect of GSNO was assayed using isolated rat aortic rings (in the presence or absence of endothelium). The role of GGT was assessed by stimulating enzyme activity with cosubstrate glycylglycine, as well as using two independent inhibitors, competitive serine borate complex and non-competitive acivicin. Specific GGT activity was histochemically localized in the endothelium. Consumption of GSNO and release of free (NO)-N-center dot decreased and increased in presence of serine borate complex and glycylglycine, respectively. In vasorelaxation experiments with endothelium-intact aorta, the half maximal effective concentration of GSNO (EC50 = 3.2 +/- 0.5.10(-7) M) increased in the presence of the two distinct GGT inhibitors, serine borate complex (1.6 +/- 0.2.10(-6) M) and acivicin (8.3 +/- 0.6.10(-7) M), while it decreased with glycylglycine (4.7 +/- 0.9.10(-8) M). In endothelium-denuded aorta, EC50 for GSNO alone increased to 2.3 +/- 0.3.10(-6) M, with no change in the presence of serine borate complex. These data demonstrate the important role of endothelial GGT activity in mediating the vasorelaxant effect of GSNO in rat aorta under physiological conditions. Because therapeutic treatments based on GSNO are presently under development, this endothelium-dependent mechanism involved in the vascular effects of GSNO should be taken into account in a pharmacological perspective.	[Dahboul, Fatima; Leroy, Pierre; Gate, Katy Maguin; Boudier, Ariane; Gaucher, Caroline; Liminana, Patrick; Lartaud, Isabelle; Pompella, Alfonso; Perrin-Sarrado, Caroline] Univ Lorraine, Fac Pharm, CITHEFOR Drug Targets Formulat & Preclin Assessme, Nancy, France	Universite de Lorraine	Dahboul, F (corresponding author), Univ Lorraine, Fac Pharm, CITHEFOR Drug Targets Formulat & Preclin Assessme, Nancy, France.	Caroline.Perrin-Sarrado@univ-lorraine.fr	DAHBOUL, Fatima/GWV-1482-2022	perrin-sarrado, caroline/0000-0002-3483-1211; Gaucher, Caroline/0000-0002-0886-5522; Lartaud, Isabelle/0000-0001-9257-6311	National Agency for Research (ANR, NanoSNO project); French Ministry of Education, Research and Technology (Paris, France) [EA3452]; Lorraine Regional Development Committee (Metz, France) [CPER 2007-13 PRST]; Universite de Lorraine (Nancy, France) [UHP_2010_BMS_EA3452_0047]	National Agency for Research (ANR, NanoSNO project)(French National Research Agency (ANR)); French Ministry of Education, Research and Technology (Paris, France); Lorraine Regional Development Committee (Metz, France); Universite de Lorraine (Nancy, France)	The authors are grateful to Melanie THOMAS and Anais DURET for their helpful contribution to experimental studies. The authors acknowledge the National Agency for Research (ANR, NanoSNO project), the French Ministry of Education, Research and Technology (Paris, France, EA3452), the Lorraine Regional Development Committee (Metz, France) (CPER 2007-13 PRST "Ingenierie Moleculaire et Therapeutique - Sante" Pr. P. NETTER, axe "Molecules et Ciblage Therapeutique" Dr. Y. CHAPLEUR), and Universite de Lorraine (Nancy, France) (project UHP_2010_BMS_EA3452_0047).	Alencar JL, 2003, J PHARMACOL EXP THER, V307, P152, DOI 10.1124/jpet.103.052605; Angeli V, 2009, ARCH BIOCHEM BIOPHYS, V481, P191, DOI 10.1016/j.abb.2008.10.027; ARNOLD WP, 1977, P NATL ACAD SCI USA, V74, P3203, DOI 10.1073/pnas.74.8.3203; Bramanti E, 2009, ARCH BIOCHEM BIOPHYS, V487, P146, DOI 10.1016/j.abb.2009.05.012; Corti A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034772; COTGREAVE IA, 1994, BBA-MOL CELL RES, V1222, P375, DOI 10.1016/0167-4889(94)90043-4; Dominici S, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-7; Franzini M, 2009, ATHEROSCLEROSIS, V202, P119, DOI 10.1016/j.atherosclerosis.2008.03.023; Gate KM, 2011, BRAIN RES, V1369, P95, DOI 10.1016/j.brainres.2010.10.100; Gaucher C, 2012, CURR PHARM IN PRESS; Ginnan R, 2008, FREE RADICAL BIO MED, V44, P1232, DOI 10.1016/j.freeradbiomed.2007.12.025; GRIFFITH OW, 1979, P NATL ACAD SCI USA, V76, P5606, DOI 10.1073/pnas.76.11.5606; Hanspal IS, 2002, NITRIC OXIDE-BIOL CH, V6, P263, DOI 10.1006/niox.2001.0412; HART TW, 1985, TETRAHEDRON LETT, V26, P2013, DOI 10.1016/S0040-4039(00)98368-0; Heikal L, 2011, BIOMACROMOLECULES, V12, P2103, DOI 10.1021/bm200159h; Hogg N, 1997, BIOCHEM J, V323, P477, DOI 10.1042/bj3230477; HUSEBY NE, 1974, SCAND J CLIN LAB INV, V34, P357, DOI 10.3109/00365517409049892; KREJCY K, 1995, ARTERIOSCL THROM VAS, V15, P2063, DOI 10.1161/01.ATV.15.11.2063; Lartaud I, 2007, FUND CLIN PHARMACOL, V21, P273, DOI 10.1111/j.1472-8206.2007.00484.x; Marozkina NV, 2012, BBA-GEN SUBJECTS, V1820, P722, DOI 10.1016/j.bbagen.2011.06.017; MCANINLY J, 1993, J CHEM SOC CHEM COMM, P1758, DOI 10.1039/c39930001758; Nikitovic D, 1996, J BIOL CHEM, V271, P19180, DOI 10.1074/jbc.271.32.19180; ORLOWSKI M, 1963, BIOCHIM BIOPHYS ACTA, V73, P679; Pompella A, 2004, CLIN CHEM LAB MED, V42, P1085, DOI 10.1515/CCLM.2004.224; Rassaf T, 2006, EUR HEART J, V27, P1699, DOI 10.1093/eurheartj/ehl096; Resende AC, 2004, LIFE SCI, V76, P9, DOI 10.1016/j.lfs.2004.04.058; Rodriguez J, 2005, FREE RADICAL BIO MED, V38, P356, DOI 10.1016/j.freeradbiomed.2004.10.036; Snyder AH, 2002, AM J RESP CRIT CARE, V165, P922, DOI 10.1164/ajrccm.165.7.2105032; Sogo N, 2000, BRIT J PHARMACOL, V131, P1236, DOI 10.1038/sj.bjp.0703700; TATE SS, 1978, P NATL ACAD SCI USA, V75, P4806, DOI 10.1073/pnas.75.10.4806; Tran NNP, 1998, J PHYSIOL-LONDON, V507, P163, DOI 10.1111/j.1469-7793.1998.163bu.x; Wang CH, 2004, FUND CLIN PHARMACOL, V18, P679, DOI 10.1111/j.1472-8206.2004.00293.x; Xu AM, 2000, HYPERTENSION, V36, P291, DOI 10.1161/01.HYP.36.2.291	33	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43190	10.1371/journal.pone.0043190	http://dx.doi.org/10.1371/journal.pone.0043190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984412	Green Submitted, gold, Green Published			2022-12-25	WOS:000308638700014
J	Petroli, CD; Sansaloni, CP; Carling, J; Steane, DA; Vaillancourt, RE; Myburg, AA; da Silva, OB; Pappas, GJ; Kilian, A; Grattapaglia, D				Petroli, Cesar D.; Sansaloni, Carolina P.; Carling, Jason; Steane, Dorothy A.; Vaillancourt, Rene E.; Myburg, Alexander A.; da Silva, Orzenil Bonfim, Jr.; Pappas, Georgios Joannis, Jr.; Kilian, Andrzej; Grattapaglia, Dario			Genomic Characterization of DArT Markers Based on High-Density Linkage Analysis and Physical Mapping to the Eucalyptus Genome	PLOS ONE			English	Article							ARRAYS TECHNOLOGY DART; DIVERSITY ARRAYS; HIGH-THROUGHPUT; PSEUDO-BACKCROSS; GENETIC-MAP; GRANDIS; GLOBULUS; RAPD; RFLP; AFLP	Diversity Arrays Technology (DArT) provides a robust, high throughput, cost-effective method to query thousands of sequence polymorphisms in a single assay. Despite the extensive use of this genotyping platform for numerous plant species, little is known regarding the sequence attributes and genome-wide distribution of DArT markers. We investigated the genomic properties of the 7,680 DArT marker probes of a Eucalyptus array, by sequencing them, constructing a high density linkage map and carrying out detailed physical mapping analyses to the Eucalyptus grandis reference genome. A consensus linkage map with 2,274 DArT markers anchored to 210 microsatellites and a framework map, with improved support for ordering, displayed extensive collinearity with the genome sequence. Only 1.4 Mbp of the 75 Mbp of still unplaced scaffold sequence was captured by 45 linkage mapped but physically unaligned markers to the 11 main Eucalyptus pseudochromosomes, providing compelling evidence for the quality and completeness of the current Eucalyptus genome assembly. A highly significant correspondence was found between the locations of DArT markers and predicted gene models, while most of the 89 DArT probes unaligned to the genome correspond to sequences likely absent in E. grandis, consistent with the pan-genomic feature of this multi-Eucalyptus species DArT array. These comprehensive linkage-to-physical mapping analyses provide novel data regarding the genomic attributes of DArT markers in plant genomes in general and for Eucalyptus in particular. DArT markers preferentially target the gene space and display a largely homogeneous distribution across the genome, thereby providing superb coverage for mapping and genome-wide applications in breeding and diversity studies. Data reported on these ubiquitous properties of DArT markers will be particularly valuable to researchers working on less-studied crop species who already count on DArT genotyping arrays but for which no reference genome is yet available to allow such detailed characterization.	[Petroli, Cesar D.; Sansaloni, Carolina P.; da Silva, Orzenil Bonfim, Jr.; Pappas, Georgios Joannis, Jr.; Grattapaglia, Dario] EMBRAPA Genet Resources & Biotechnol, Plant Genet Lab, Brasilia, DF, Brazil; [Petroli, Cesar D.; Sansaloni, Carolina P.; Grattapaglia, Dario] Univ Brasilia, Dept Cell Biol, Brasilia, DF, Brazil; [Carling, Jason; Kilian, Andrzej] Div Arrays Technology Pty Ltd, Yarralumla, Russia; [Steane, Dorothy A.; Vaillancourt, Rene E.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia; [Steane, Dorothy A.; Vaillancourt, Rene E.] Univ Tasmania, CRC Forestry, Hobart, Tas, Australia; [Steane, Dorothy A.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn ML12, Maroochydore, Qld, Australia; [Myburg, Alexander A.] Univ Pretoria, Forestry & Agr Biotechnol Inst, Dept Genet, ZA-0002 Pretoria, South Africa; [Grattapaglia, Dario] Univ Catolica Brasilia, Genom Sci Program, Brasilia, DF, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; University of Tasmania; University of Tasmania; University of the Sunshine Coast; University of Pretoria; Universidade Catolica de Brasilia	Petroli, CD (corresponding author), EMBRAPA Genet Resources & Biotechnol, Plant Genet Lab, Brasilia, DF, Brazil.	dario.grattapaglia@embrapa.br	Vaillancourt, Rene E/J-7456-2014; Grattapaglia, Dario/B-5864-2014; Silva-Junior, Orzenil/B-3488-2013; Vaillancourt, Rene E/C-6123-2013; Grattapaglia, Dario/AAB-6805-2020; Steane, Dorothy/N-9940-2013; Myburg, Alexander A/C-5426-2008; Pappas, Georgios J/D-5933-2016; Pappas, Georgios J./N-8071-2019	Vaillancourt, Rene E/0000-0002-1159-9149; Grattapaglia, Dario/0000-0002-0050-970X; Silva-Junior, Orzenil/0000-0002-2104-2010; Vaillancourt, Rene E/0000-0002-1159-9149; Grattapaglia, Dario/0000-0002-0050-970X; Myburg, Alexander A/0000-0003-0644-5003; Pappas, Georgios J/0000-0002-1100-976X; Pappas, Georgios J./0000-0002-1100-976X; Kilian, Andrzej/0000-0002-2730-7462; Steane, Dorothy/0000-0002-8061-8454	Brazilian Ministry of Science and Technology (CNPq) [559245/2008-4, 560831/2008-0]; PRONEX FAP-DF Project Grant [193.000.570/2009]; CAPES (Brazilian Ministry of Education); CNPq	Brazilian Ministry of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PRONEX FAP-DF Project Grant; CAPES (Brazilian Ministry of Education)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The project was supported by the Brazilian Ministry of Science and Technology (CNPq Project Grants 559245/2008-4 and 560831/2008-0) and PRONEX FAP-DF Project Grant "NEXTREE" 193.000.570/2009 to DG. This study was carried out as part of Cesar Petroli's doctoral thesis at the University of Brasilia. CPS and CDP had doctoral fellowships from CAPES (Brazilian Ministry of Education) and DG a productivity research fellowship from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Bartos J, 2011, THEOR APPL GENET, V122, P1133, DOI 10.1007/s00122-010-1518-z; Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; Bolibok-Bragoszewska H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-578; Brondani RPV, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-20; Brondani RPV, 2001, BIOTECHNIQUES, V31, P793; Bundock PC, 2000, SILVAE GENET, V49, P223; BYRNE M, 1995, THEOR APPL GENET, V91, P869, DOI 10.1007/BF00223894; Cao J, 2011, NAT GENET, V43, P956, DOI 10.1038/ng.911; Cheema J, 2009, BRIEF BIOINFORM, V10, P595, DOI 10.1093/bib/bbp045; Drost DR, 2009, PLANT J, V58, P1054, DOI 10.1111/j.1365-313X.2009.03828.x; Drummond A. J., 2012, GENEIOUS V5 6; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Faria DA, 2010, J HERED, V101, P512, DOI 10.1093/jhered/esq024; Faria DA, 2011, TREE GENET GENOMES, V7, P63, DOI 10.1007/s11295-010-0315-9; Freeman JS, 2006, SILVAE GENET, V55, P202, DOI 10.1515/sg-2006-0028; Ganal MW, 2009, CURR OPIN PLANT BIOL, V12, P211, DOI 10.1016/j.pbi.2008.12.009; GRATTAPAGLIA D, 1994, CAN J FOREST RES, V24, P1074, DOI 10.1139/x94-142; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Grattapaglia D, 2008, NEW PHYTOL, V179, P911, DOI 10.1111/j.1469-8137.2008.02503.x; Grattapaglia Dario, 2004, Genet Mol Res, V3, P369; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; Grattapaglia D, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-65; Hackett CA, 2003, HEREDITY, V90, P33, DOI 10.1038/sj.hdy.6800173; Hippolyte I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-65; Howard EL, 2011, THEOR APPL GENET, V122, P1265, DOI 10.1007/s00122-011-1529-4; Hudson C, 2011, TREE GENET GENOMES, P1; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; James KE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001682; Jones N, 2009, NEW PHYTOL, V183, P935, DOI 10.1111/j.1469-8137.2009.02933.x; KEATS BJB, 1991, GENOMICS, V9, P557, DOI 10.1016/0888-7543(91)90426-F; Kilian A, 2009, CAM INTELLECT PROP, P204, DOI 10.1017/CBO9780511581182.016; Kullan ARK, 2012, TREE GENET GENOMES, V8, P163, DOI 10.1007/s11295-011-0430-2; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Mace ES, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-13; Mantovani P, 2008, MOL BREEDING, V22, P629, DOI 10.1007/s11032-008-9205-3; Marques CM, 1998, THEOR APPL GENET, V96, P727, DOI 10.1007/s001220050795; Milczarski P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028495; Morgante M, 2007, CURR OPIN PLANT BIOL, V10, P149, DOI 10.1016/j.pbi.2007.02.001; Myburg AA, 2004, GENETICS, V166, P1405, DOI 10.1534/genetics.166.3.1405; Myburg AA, 2003, THEOR APPL GENET, V107, P1028, DOI 10.1007/s00122-003-1347-4; Neves LG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-189; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Potts BM., 2004, ENCY FOREST SCI, P1480, DOI [10.1016/B0-12-145160-7/00084-3, DOI 10.1016/B0-12-145160-7/00084-3]; Rafalski A, 2004, TRENDS GENET, V20, P103, DOI 10.1016/j.tig.2003.12.002; Reddy UK, 2011, GENOME, V54, P349, DOI [10.1139/G11-001, 10.1139/g11-001]; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Sansaloni CP, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-16; Sansaloni CP, 2011, BMC P S7, V5, P54, DOI [10.1186/1753-6561-5-S7-P54, DOI 10.1186/1753-6561-5-S7-P54]; Schouten HJ, 2012, MOL BREEDING, V29, P645, DOI 10.1007/s11032-011-9579-5; Steane DA, 2011, MOL PHYLOGENET EVOL, V59, P206, DOI 10.1016/j.ympev.2011.02.003; Supriya A, 2011, THEOR APPL GENET, V123, P239, DOI 10.1007/s00122-011-1580-1; TANKSLEY SD, 1989, BIO-TECHNOL, V7, P257, DOI 10.1038/nbt0389-257; Thamarus KA, 2002, THEOR APPL GENET, V104, P379, DOI 10.1007/s001220100717; Tinker NA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-39; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Van Schalkwyk A, 2012, THEOR APPL GENET, V124, P947, DOI 10.1007/s00122-011-1759-5; Verhaegen D, 1996, GENOME, V39, P1051, DOI 10.1139/g96-132; Vision TJ, 2000, GENETICS, V155, P407; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Wittenberg AHJ, 2005, MOL GENET GENOMICS, V274, P30, DOI 10.1007/s00438-005-1145-6; Xia L, 2005, THEOR APPL GENET, V110, P1092, DOI 10.1007/s00122-005-1937-4; Yang SY, 2011, J GENET, V90, P103, DOI 10.1007/s12041-011-0050-5	69	53	55	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e44684	10.1371/journal.pone.0044684	http://dx.doi.org/10.1371/journal.pone.0044684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984541	Green Published, Green Submitted, gold			2022-12-25	WOS:000308638700076
J	Wang, Q; Lei, Y; Xu, XW; Wang, GJ; Chen, LL				Wang, Qian; Lei, Yang; Xu, Xiwen; Wang, Gejiao; Chen, Ling-Ling			Theoretical Prediction and Experimental Verification of Protein-Coding Genes in Plant Pathogen Genome Agrobacterium tumefaciens Strain C58	PLOS ONE			English	Article							CODON USAGE; RECOGNITION; PROKARYOTES; ANNOTATION; SEQUENCES; BACTERIAL	Agrobacterium tumefaciens strain C58 is a Gram-negative soil bacterium capable of inducing tumors (crown galls) on many dicotyledonous plants. The genome of A. tumefaciens strain C58 was re-annotated based on the Z-curve method. First, all the 'hypothetical genes' were re-identified, and 29 originally annotated 'hypothetical genes' were recognized to be non-coding open reading frames (ORFs). Theoretical evidence obtained from principal component analysis, clusters of orthologous groups of proteins occupation, and average length distribution showed that these non-coding ORFs were highly unlikely to encode proteins. Results from the reverse transcription-polymerase chain reaction (RT-PCR) experiments on three different growth stages of A. tumefaciens C58 confirmed that 23 (79%) of the identified non-coding ORFs have no transcripts in these growth stages. In addition, using theoretical prediction, 19 potential protein-coding genes were predicted to be new protein-coding genes. Fifteen (79%) of these genes were verified with RT-PCR experiments. The RT-PCR experimental results confirmed the reliability of our theoretical prediction, indicating that false-positive prediction and missing genes always exist in the annotation of A. tumefaciens C58 genome. The improved annotation will serve as a valuable resource for the research of the lifestyle, metabolism, and pathogenicity of A. tumefaciens C58. The re-annotation of A. tumefaciens C58 can be obtained from http://211.69.128.148/Atum/.	[Wang, Qian; Lei, Yang; Xu, Xiwen; Wang, Gejiao; Chen, Ling-Ling] Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Lei, Yang; Xu, Xiwen; Chen, Ling-Ling] Huazhong Agr Univ, Ctr Bioinformat, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Wang, Q (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	gejiao@mail.hzau.edu.cn; llchen@mail.hzau.edu.cn	Wang, Qian/AAC-9717-2021; Chen, Ling-Ling/AAY-3547-2021	Wang, Qian/0000-0003-4507-0523; 	National Natural Science Foundation of China [31010103903, 31071659]; National Basic Research Program of China [2010CB126100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the Major International Joint Research Project, National Natural Science Foundation of China (31010103903, 31071659), and the National Basic Research Program of China (2010CB126100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Chen LL, 2003, J BIOMOL STRUCT DYN, V21, P99, DOI 10.1080/07391102.2003.10506908; Chiusano ML, 2000, GENE, V261, P63, DOI 10.1016/S0378-1119(00)00521-7; Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; Dillon W., 1984, MULTIVARIATE ANAL ME, DOI [10.1002/bimj.4710290617, DOI 10.1002/BIMJ.4710290617]; Goodner B, 2001, SCIENCE, V294, P2323, DOI 10.1126/science.1066803; Gupta SK, 2000, BIOCHEM BIOPH RES CO, V269, P692, DOI 10.1006/bbrc.2000.2351; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Jones CE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-170; Klusener S, 2010, MOL GENET GENOMICS, V283, P575, DOI 10.1007/s00438-010-0542-7; Liu Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r64; Nagy A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-353; Nielsen P, 2005, BIOINFORMATICS, V21, P4322, DOI 10.1093/bioinformatics/bti701; Palleja A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-335; Poptsova MS, 2010, MICROBIOL-SGM, V156, P1909, DOI 10.1099/mic.0.033811-0; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Rosen R, 2004, PROTEOMICS, V4, P1061, DOI 10.1002/pmic.200300640; Rosen R, 2011, PROTEOMICS, V11, P3134, DOI 10.1002/pmic.201100019; Salzberg SL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-102; Sambrook J, 2001, MOL CLONING LAB MANU; Skovgaard M, 2001, TRENDS GENET, V17, P425, DOI 10.1016/S0168-9525(01)02372-1; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Wood DW, 2001, SCIENCE, V294, P2317, DOI 10.1126/science.1066804; Yu JF, 2011, DNA RES, V18, P435, DOI 10.1093/dnares/dsr030; ZHANG CT, 1991, NUCLEIC ACIDS RES, V19, P6313, DOI 10.1093/nar/19.22.6313; ZHANG CT, 1994, J MOL BIOL, V238, P1, DOI 10.1006/jmbi.1994.1263; Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x	29	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e43176	10.1371/journal.pone.0043176	http://dx.doi.org/10.1371/journal.pone.0043176			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	22984411	Green Submitted, gold, Green Published			2022-12-25	WOS:000308638700013
J	Kovalenko, M; Dragileva, E; St Claire, J; Gillis, T; Guide, JR; New, J; Dong, HL; Kucherlapati, R; Kucherlapati, MH; Ehrlich, ME; Lee, JM; Wheeler, VC				Kovalenko, Marina; Dragileva, Ella; St Claire, Jason; Gillis, Tammy; Guide, Jolene R.; New, Jaclyn; Dong, Hualing; Kucherlapati, Raju; Kucherlapati, Melanie H.; Ehrlich, Michelle E.; Lee, Jong-Min; Wheeler, Vanessa C.			Msh2 Acts in Medium-Spiny Striatal Neurons as an Enhancer of CAG Instability and Mutant Huntingtin Phenotypes in Huntington's Disease Knock-In Mice	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; REPEAT INSTABILITY; SOMATIC INSTABILITY; LENGTH; EXPANSION; AGE; VULNERABILITY; ONSET; VARIABILITY; CONTRACTION	The CAG trinucleotide repeat mutation in the Huntington's disease gene (HTT) exhibits age-dependent tissue-specific expansion that correlates with disease onset in patients, implicating somatic expansion as a disease modifier and potential therapeutic target. Somatic HTT CAG expansion is critically dependent on proteins in the mismatch repair (MMR) pathway. To gain further insight into mechanisms of somatic expansion and the relationship of somatic expansion to the disease process in selectively vulnerable MSNs we have crossed HTT CAG knock-in mice (HdhQ111) with mice carrying a conditional (floxed) Msh2 allele and D9-Cre transgenic mice, in which Cre recombinase is expressed specifically in MSNs within the striatum. Deletion of Msh2 in MSNs eliminated Msh2 protein in those neurons. We demonstrate that MSN-specific deletion of Msh2 was sufficient to eliminate the vast majority of striatal HTT CAG expansions in HdhQ111 mice. Furthermore, MSN-specific deletion of Msh2 modified two mutant huntingtin phenotypes: the early nuclear localization of diffusely immunostaining mutant huntingtin was slowed; and the later development of intranuclear huntingtin inclusions was dramatically inhibited. Therefore, Msh2 acts within MSNs as a genetic enhancer both of somatic HTT CAG expansions and of HTT CAG-dependent phenotypes in mice. These data suggest that the selective vulnerability of MSNs may be at least in part contributed by the propensity for somatic expansion in these neurons, and imply that intervening in the expansion process is likely to have therapeutic benefit.	[Kovalenko, Marina; Dragileva, Ella; St Claire, Jason; Gillis, Tammy; Guide, Jolene R.; New, Jaclyn; Dong, Hualing; Lee, Jong-Min; Wheeler, Vanessa C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kucherlapati, Raju; Kucherlapati, Melanie H.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Ehrlich, Michelle E.] Thomas Jefferson Univ, Coll Med, Farber Inst Neurosci, Philadelphia, PA 19107 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Jefferson University	Kovalenko, M (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	Wheeler@chgr.mgh.harvard.edu	Kucherlapati, Raju/ABC-8807-2021; Kucherlapati, Melanie/GXN-1132-2022		National Institutes of Health [NS049206]; CHDI Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHDI Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health [NS049206] and the CHDI Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogush AI, 2005, GENESIS, V42, P37, DOI 10.1002/gene.20118; Chung DW, 2011, HUM MOL GENET, V20, P3467, DOI 10.1093/hmg/ddr263; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Fortune MT, 2000, HUM MOL GENET, V9, P439, DOI 10.1093/hmg/9.3.439; Gonitel R, 2008, P NATL ACAD SCI USA, V105, P3467, DOI 10.1073/pnas.0800048105; Goula AV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000749; Harper PS, 1999, PHILOS T ROY SOC B, V354, P957, DOI 10.1098/rstb.1999.0446; Hubert L, 2011, HUM MOL GENET, V20, P4822, DOI 10.1093/hmg/ddr421; Jung J, 2007, SCIENCE, V315, P1857, DOI 10.1126/science.1139517; Jung J, 2011, GENETICS, V187, P61, DOI 10.1534/genetics.110.121418; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kennedy L, 2000, HUM MOL GENET, V9, P2539, DOI 10.1093/hmg/9.17.2539; Kucherlapati MH, 2010, GASTROENTEROLOGY, V138, P993, DOI 10.1053/j.gastro.2009.11.009; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Lee JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023647; Lee JM, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-29; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Lloret A, 2006, HUM MOL GENET, V15, P2015, DOI 10.1093/hmg/ddl125; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MACDONALD ME, 1993, J MED GENET, V30, P982, DOI 10.1136/jmg.30.12.982; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; McFarland Karen N, 2011, Handb Clin Neurol, V100, P25, DOI 10.1016/B978-0-444-52014-2.00003-3; Nakamori M, 2011, MOL THER, V19, P2222, DOI 10.1038/mt.2011.191; Nakamori M, 2011, HUM MOL GENET, V20, P580, DOI 10.1093/hmg/ddq501; Owen BAL, 2005, NAT STRUCT MOL BIOL, V12, P663, DOI 10.1038/nsmb965; Rosas HD, 2003, NEUROLOGY, V60, P1615, DOI 10.1212/01.WNL.0000065888.88988.6E; Sassone J, 2009, EXP NEUROL, V219, P385, DOI 10.1016/j.expneurol.2009.05.012; Shelbourne PF, 2007, HUM MOL GENET, V16, P1133, DOI 10.1093/hmg/ddm054; Silva-Fernandes A, 2010, NEUROBIOL DIS, V40, P163, DOI 10.1016/j.nbd.2010.05.021; Smits R, 2000, GENE CHROMOSOME CANC, V29, P229, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1033>3.0.CO;2-R; Swami M, 2009, HUM MOL GENET, V18, P3039, DOI 10.1093/hmg/ddp242; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; Veitch NJ, 2007, DNA REPAIR, V6, P789, DOI 10.1016/j.dnarep.2007.01.002; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Watase K, 2003, HUM MOL GENET, V12, P2789, DOI 10.1093/hmg/ddg300; Wei K, 2002, TRENDS MOL MED, V8, P346, DOI 10.1016/S1471-4914(02)02359-6; Wheeler VC, 2007, J MED GENET, V44, P695, DOI 10.1136/jmg.2007.050930; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Wheeler VC, 2003, HUM MOL GENET, V12, P273, DOI 10.1093/hmg/ddg056; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; ZUHLKE C, 1993, HUM MOL GENET, V2, P2063, DOI 10.1093/hmg/2.12.2063	44	51	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44273	10.1371/journal.pone.0044273	http://dx.doi.org/10.1371/journal.pone.0044273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970194	gold, Green Published, Green Submitted			2022-12-25	WOS:000308462000017
J	Lin, LL; Huang, HC; Juan, HF				Lin, Li-Ling; Huang, Hsuan-Cheng; Juan, Hsueh-Fen			Revealing the Molecular Mechanism of Gastric Cancer Marker Annexin A4 in Cancer Cell Proliferation Using Exon Arrays	PLOS ONE			English	Article							HELICOBACTER-PYLORI; EXPRESSION; IV; CALCIUM; OVEREXPRESSION; KINASE; AKT; ACTIVATION; PACLITAXEL; CARCINOMA	Gastric cancer is a malignant disease that arises from the gastric epithelium. A potential biomarker for gastric cancer is the protein annexin A4 (ANXA4), an intracellular Ca2+ sensor. ANXA4 is primarily found in epithelial cells, and is known to be involved in various biological processes, including apoptosis, cell cycling and anticoagulation. In respect to cancer, ANXA4-overexpression has been observed in cancers of various origins, including gastric tumors associated with Helicobacter pylori infection. H. pylori induces ANXA4 expression and intracellular [Ca2+](i) elevation, and is an important risk factor for carcinogenesis that results in gastric cancer. Despite this correlation, the role of ANXA4 in the progression of gastric tumors remains unclear. In this study, we have investigated whether ANXA4 can mediate the rate of cell growth and whether ANXA4 downstream signals are involved in tumorigenesis. After observing the rate of cell growth in real-time, we determined that ANXA4 promotes cell proliferation. The transcription gene profile of ANXA4-overexpressing cells was measured and analyzed by human exon arrays. From this transcriptional gene data, we show that overexpression of ANXA4 regulates genes that are known to be related to cancer, for example the activation of hyaluronan mediated motility receptor (RHAMM), AKT, and cyclin-dependent kinase 1 (CDK1) as well as the suppression of p21. The regulation of these genes further induces cancer cell proliferation. We also found Ca2+ could regulate the transmission of downstream signals by ANXA4. We suggest that ANXA4 triggers a signaling cascade, leading to increased epithelial cell proliferation, ultimately promoting carcinogenesis. These results might therefore provide a new insight for gastric cancer therapy, specifically through the modification of ANXA4 activity.	[Lin, Li-Ling; Juan, Hsueh-Fen] Natl Taiwan Univ, Dept Life Sci, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Huang, Hsuan-Cheng] Natl Yang Ming Univ, Inst Biomed Informat, Ctr Syst & Synthet Biol, Taipei 112, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University	Lin, LL (corresponding author), Natl Taiwan Univ, Dept Life Sci, Inst Mol & Cellular Biol, Taipei 10764, Taiwan.	hsuancheng@ym.edu.tw; yukijuan@ntu.edu.tw	Huang, Hsuan-Cheng/C-7266-2011	Huang, Hsuan-Cheng/0000-0002-3386-0934; Lin, Li-Ling/0000-0001-9891-5900; JUAN, HSUEH-FEN/0000-0003-4876-3309	National Science Council of Taiwan [NSC 99-2621-B-002-005-MY3, NSC 99-2621-B-010-001-MY3]; National Taiwan University Cutting-Edge Steering Research Project [10R70602C3]; National Health Research Institute, Taiwan [NHRIEX100-9819PI]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Cutting-Edge Steering Research Project; National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by the National Science Council of Taiwan (NSC 99-2621-B-002-005-MY3, NSC 99-2621-B-010-001-MY3), the National Taiwan University Cutting-Edge Steering Research Project (10R70602C3) and the National Health Research Institute, Taiwan (NHRIEX100-9819PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Maxwell CA, 2008, J CELL SCI, V121, P925, DOI 10.1242/jcs.022038; Banerjee SK, 2000, AM J PATHOL, V156, P217, DOI 10.1016/S0002-9440(10)64722-0; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Chen YR, 2006, J PROTEOME RES, V5, P2727, DOI 10.1021/pr060212g; Cinti C, 2008, VIRCHOWS ARCH, V453, P449, DOI 10.1007/s00428-008-0676-8; de Graauw M, 2010, P NATL ACAD SCI USA, V107, P6340, DOI 10.1073/pnas.0913360107; Dreier R, 1998, HISTOCHEM CELL BIOL, V110, P137, DOI 10.1007/s004180050275; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; EBERHARD DA, 1994, AM J PATHOL, V145, P640; Emoto K, 2001, ANTICANCER RES, V21, P1339; Fan XG, 1996, GUT, V38, P19, DOI 10.1136/gut.38.1.19; Fatimathas L, 2010, HISTOL HISTOPATHOL, V25, P527, DOI 10.14670/HH-25.527; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Giannakakou P, 2001, ONCOGENE, V20, P3806, DOI 10.1038/sj.onc.1204487; HALL CL, 1995, CELL, V82, P19, DOI 10.1016/0092-8674(95)90048-9; Han EKH, 2000, BRIT J CANCER, V83, P83; Heliez C, 2003, ONCOGENE, V22, P3260, DOI 10.1038/sj.onc.1206409; Herrera V, 2009, CLIN MICROBIOL INFEC, V15, P971, DOI 10.1111/j.1469-0691.2009.03031.x; HUNTER T, 1991, CELL, V66, P1071, DOI 10.1016/0092-8674(91)90028-W; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jeon YJ, 2010, CELL MOL LIFE SCI, V67, P2271, DOI 10.1007/s00018-010-0331-9; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Khau T, 2011, FASEB J, V25, P483, DOI 10.1096/fj.09-154096; Kim A, 2009, INT J CANCER, V125, P2316, DOI 10.1002/ijc.24587; Kim SS, 2011, CANCER LETT, V305, P228, DOI 10.1016/j.canlet.2010.07.014; Kondapaka SB, 2003, MOL CANCER THER, V2, P1093; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Li H, 2000, INT J ONCOL, V17, P927; Li WW, 1999, MOL PHARMACOL, V55, P1088, DOI 10.1124/mol.55.6.1088; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lin LL, 2008, PROTEOM CLIN APPL, V2, P619, DOI 10.1002/prca.200780088; Lin LL, 2012, J PROTEOMICS, V75, P3081, DOI 10.1016/j.jprot.2012.03.046; LIU CM, 1978, J BIOL CHEM, V253, P5892; Liu GY, 2003, NUCLEIC ACIDS RES, V31, P82, DOI 10.1093/nar/gkg121; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Marlink KL, 2003, AM J PHYSIOL-GASTR L, V285, pG163, DOI 10.1152/ajpgi.00257.2002; Masuda J, 2004, THROMB HAEMOSTASIS, V91, P1129, DOI 10.1160/TH03-12-0778; Matteo RG, 2000, CARDIOVASC RES, V45, P961, DOI 10.1016/S0008-6363(99)00409-5; Miao Y, 2009, INT J GYNECOL CANCER, V19, P1545, DOI 10.1111/IGC.0b013e3181a844c8; Monastyrskaya K, 2007, CELL CALCIUM, V41, P207, DOI 10.1016/j.ceca.2006.06.008; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; Ohkawa H, 2002, BBA-MOL BASIS DIS, V1588, P217, DOI 10.1016/S0925-4439(02)00168-0; Ono M, 2010, CARDIOVASC RES, V87, P609, DOI 10.1093/cvr/cvq108; Ortiz-Zapater E, 2007, AM J PATHOL, V170, P1573, DOI 10.2353/ajpath.2007.060850; Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857; Richardson PG, 2011, J CLIN ONCOL, V29, P4243, DOI 10.1200/JCO.2010.33.9788; Sampson HA, 2011, J ALLERGY CLIN IMMUN, V127, P1309, DOI 10.1016/j.jaci.2011.01.051; Shen JJ, 2004, CANCER RES, V64, P9018, DOI 10.1158/0008-5472.CAN-04-3262; Shinwari Z, 2008, J NEURO-ONCOL, V87, P123, DOI 10.1007/s11060-007-9502-4; Smits VAJ, 2000, J BIOL CHEM, V275, P30638, DOI 10.1074/jbc.M005437200; Tanaka T, 2004, ONCOGENE, V23, P3980, DOI 10.1038/sj.onc.1207555; Toyama A, 2012, CANCER SCI, V103, P747, DOI 10.1111/j.1349-7006.2012.02224.x; VERITY MA, 1992, NEUROTOXICOLOGY, V13, P139; Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3; Yamashita T, 2012, BIOCHEM BIOPH RES CO, V421, P140, DOI 10.1016/j.bbrc.2012.03.144; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Zhai HY, 2011, J NEUROSCI, V31, P14346, DOI 10.1523/JNEUROSCI.3299-11.2011; Zhai SP, 2002, ANN PHARMACOTHER, V36, P905; Zimmermann U, 2004, CANCER LETT, V209, P111, DOI 10.1016/j.canlet.2003.12.002	63	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44615	10.1371/journal.pone.0044615	http://dx.doi.org/10.1371/journal.pone.0044615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970268	gold, Green Published, Green Submitted			2022-12-25	WOS:000308462000038
J	Wang, XY; Xiong, WL; Ma, XC; Wei, ML; Chen, YX; Lu, L; Debnath, AK; Jiang, SB; Pan, CG				Wang, Xiaoyi; Xiong, Weiliang; Ma, Xiaochu; Wei, Meili; Chen, Yanxia; Lu, Lu; Debnath, Asim K.; Jiang, Shibo; Pan, Chungen			The Conserved Residue Arg46 in the N-Terminal Heptad Repeat Domain of HIV-1 gp41 Is Critical for Viral Fusion and Entry	PLOS ONE			English	Article							ALANINE-SCANNING MUTAGENESIS; TRANSMEMBRANE PROTEIN GP41; COILED-COIL DOMAIN; ENVELOPE GLYCOPROTEIN; MEMBRANE-FUSION; INTERHELICAL INTERACTIONS; HELICAL INTERACTIONS; FUNCTIONAL-ANALYSIS; INHIBITORY-ACTIVITY; ATOMIC-STRUCTURE	During the process of HIV-1 fusion with the target cell, the N-terminal heptad repeat (NHR) of gp41 interacts with the C-terminal heptad repeat (CHR) to form fusogenic six-helix bundle (6-HB) core. We previously identified a crucial residue for 6-HB formation and virus entry - Lys63 (K63) in the C-terminal region of NHR (aa 54-70), which forms a hydrophobic cavity. It can form an important salt bridge with Asp121 (D121) in gp41 CHR. Here, we found another important conserved residue for virus fusion and entry, Arg46 (R46), in the N-terminal region of NHR (aa 35-53), which forms a hydrogen bond with a polar residue, Asn43 (N43), in NHR, as a part of the hydrogen-bond network. R46 can also form a salt bridge with a negatively charged residue, Glu137 (E137), in gp41 CHR. Substitution of R46 with the hydrophobic residue Ala (R46A) or the negatively charged residue Glu (R46E) resulted in disruption of the hydrogen bond network, breakage of the salt bridge and reduction of 6-HB's stability, leading to impairment of viral fusion and decreased inhibition of N36, an NHR peptide. Similarly, CHR peptide C34 with substitution of E137 for Ala (E137A) or Arg (E137R) also exhibited reduced inhibitory activity against HIV-1 infection and HIV-1-mediated cell-to-cell fusion. These results suggest that the positively charged residue R46 and its hydrogen bond network, together with the salt bridge between R46 and E137, are important for viral fusion and entry and may therefore serve as a target for designing novel HIV fusion/entry inhibitors.	[Wang, Xiaoyi; Xiong, Weiliang; Ma, Xiaochu; Wei, Meili; Chen, Yanxia; Pan, Chungen] Sun Yat Sen Univ, Dept Biochem, Key Lab Trop Dis Control MOE, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Xiaoyi; Xiong, Weiliang; Ma, Xiaochu; Wei, Meili; Chen, Yanxia; Pan, Chungen] Sun Yat Sen Univ, Zhongshan Sch Med, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China; [Lu, Lu; Jiang, Shibo] Fudan Univ, Key Lab Med Mol Virol, Minist Educ & Hlth, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Lu, Lu; Jiang, Shibo] Fudan Univ, Inst Med Microbiol, Shanghai 200433, Peoples R China; [Lu, Lu; Debnath, Asim K.; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA	Sun Yat Sen University; Sun Yat Sen University; Fudan University; Fudan University; New York Blood Center	Wang, XY (corresponding author), Sun Yat Sen Univ, Dept Biochem, Key Lab Trop Dis Control MOE, Guangzhou 510275, Guangdong, Peoples R China.	Shibojiang@fudan.edu.cn; Panchung@mail.sysu.edu.cn	lu, lu/HII-7530-2022; lu, lu/HGA-0894-2022; Jiang, Shibo/L-4500-2014; Wang, Xiaoyi/AAD-9977-2019; Lu, Lu/K-7070-2014	Jiang, Shibo/0000-0001-8283-7135; Wang, Xiaoyi/0000-0001-9373-8730; Lu, Lu/0000-0002-2255-0391	Guangdong Recruitment Program of Creative Research Groups [50000-3210004]; National 973 Program [2012CB519001, 2012CB519002]; National Natural Science Foundation of China [81173098]	Guangdong Recruitment Program of Creative Research Groups; National 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Guangdong Recruitment Program of Creative Research Groups (50000-3210004) to CP, the National 973 Program (#2012CB519001 and 2012CB519002) to SJ and CP, respectively, and the National Natural Science Foundation of China (#81173098) to SJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi E, 2005, P NATL ACAD SCI USA, V102, P12903, DOI 10.1073/pnas.0502449102; CAO J, 1993, J VIROL, V67, P2747, DOI 10.1128/JVI.67.5.2747-2755.1993; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; Chang DK, 2000, BBA-PROTEIN STRUCT M, V1478, P39, DOI 10.1016/S0167-4838(99)00286-1; Dai SJ, 2005, ACTA PHARMACOL SIN, V26, P1274, DOI 10.1111/j.1745-7254.2005.00163.x; Dimitrov DS, 1997, CELL, V91, P721, DOI 10.1016/S0092-8674(00)80460-2; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Esser MT, 1999, J VIROL, V73, P4360, DOI 10.1128/JVI.73.5.4360-4371.1999; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Follis KE, 2002, J VIROL, V76, P7356, DOI 10.1128/JVI.76.14.7356-7362.2002; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Gochin M, 2009, J MED CHEM, V52, P4338, DOI 10.1021/jm900190q; He YX, 2007, J BIOL CHEM, V282, P25631, DOI 10.1074/jbc.M703781200; He YX, 2003, VACCINE, V21, P4421, DOI 10.1016/S0264-410X(03)00451-1; Ji H, 1999, J VIROL, V73, P8578, DOI 10.1128/JVI.73.10.8578-8586.1999; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Liu J, 2001, BIOCHEMISTRY-US, V40, P2797, DOI 10.1021/bi0024759; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Lu M, 2001, J VIROL, V75, P11146, DOI 10.1128/JVI.75.22.11146-11156.2001; Malashkevich VN, 1998, P NATL ACAD SCI USA, V95, P9134, DOI 10.1073/pnas.95.16.9134; Pan CG, 2009, J VIROL, V83, P7862, DOI 10.1128/JVI.00168-09; Sen J, 2010, BIOCHEMISTRY-US, V49, P5057, DOI 10.1021/bi1005267; Shu W, 2000, BIOCHEMISTRY-US, V39, P1634, DOI 10.1021/bi9921687; Suntoke TR, 2005, J BIOL CHEM, V280, P19852, DOI 10.1074/jbc.M502196200; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Wang SL, 2002, BIOCHEMISTRY-US, V41, P7283, DOI 10.1021/bi025648y; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weissenhorn W, 1997, P NATL ACAD SCI USA, V94, P6065, DOI 10.1073/pnas.94.12.6065; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; Weng YK, 2000, J VIROL, V74, P5368, DOI 10.1128/JVI.74.11.5368-5372.2000; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884	36	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2012	7	9							e44874	10.1371/journal.pone.0044874	http://dx.doi.org/10.1371/journal.pone.0044874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	001LK	22970321	Green Submitted, Green Published, gold			2022-12-25	WOS:000308462000053
J	He, YG; Wang, WR; Li, R; Wang, SJ; Jin, L				He, Yungang; Wang, Wei R.; Li, Ran; Wang, Sijia; Jin, Li			Genetic Divergence Disclosing a Rapid Prehistorical Dispersion of Native Americans in Central and South America	PLOS ONE			English	Article							MODERN HUMANS; ALLELE FREQUENCIES; FLOW; HISTORY; ORIGIN; SINGLE; MODEL; MICROSATELLITES; EVOLUTION; ASIA	An accurate estimate of the divergence time between Native Americans is important for understanding the initial entry and early dispersion of human beings in the New World. Current methods for estimating the genetic divergence time of populations could seriously depart from a linear relationship with the true divergence for multiple populations of a different population size and significant population expansion. Here, to address this problem, we propose a novel measure to estimate the genetic divergence time of populations. Computer simulation revealed that the new measure maintained an excellent linear correlation with the population divergence time in complicated multi-population scenarios with population expansion. Utilizing the new measure and microsatellite data of 21 Native American populations, we investigated the genetic divergences of the Native American populations. The results indicated that genetic divergences between North American populations are greater than that between Central and South American populations. None of the divergences, however, were large enough to constitute convincing evidence supporting the two-wave or multi-wave migration model for the initial entry of human beings into America. The genetic affinity of the Native American populations was further explored using Neighbor-Net and the genetic divergences suggested that these populations could be categorized into four genetic groups living in four different ecologic zones. The divergence of the population groups suggests that the early dispersion of human beings in America was a multi-step procedure. Further, the divergences suggest the rapid dispersion of Native Americans in Central and South Americas after a long standstill period in North America.	[He, Yungang; Wang, Wei R.; Li, Ran; Jin, Li] Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci & Max Planck Soc CAS MPG, Partner Inst Computat Biol, Shanghai, Peoples R China; [He, Yungang; Wang, Wei R.; Li, Ran; Jin, Li] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China; [Wang, Sijia] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Jin, Li] Fudan Univ, Sch Life Sci, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Jin, Li] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Harvard University; Fudan University; Fudan University	He, YG (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Chinese Acad Sci & Max Planck Soc CAS MPG, Partner Inst Computat Biol, Shanghai, Peoples R China.	yunganghe@picb.ac.cn; lijin.fudan@gmail.com	Jin, Li/C-1468-2009; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; He, Yungang/0000-0002-2931-2871	Shanghai Institutes of Biological Sciences [2010KIP206]; National Natural Science Foundation of China [30890034, 30625016, 81100997, 31171279]; Shanghai Leading Academic Discipline Project [B111]; Center for Evolutionary Biology at Fudan University; SA-SIBS scholarship program; Youth Innovation Promotion Association, CAS	Shanghai Institutes of Biological Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Center for Evolutionary Biology at Fudan University; SA-SIBS scholarship program; Youth Innovation Promotion Association, CAS	This work was supported by grants from Shanghai Institutes of Biological Sciences (2010KIP206 to YH) and National Natural Science Foundation of China (30890034 and 30625016 to LJ, 81100997 and 31171279 to YH). LJ was also supported by Shanghai Leading Academic Discipline Project (B111) and the Center for Evolutionary Biology at Fudan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the individuals who contributed genetic subjects and members of investigation teams who published the data set. We also thank anonymous reviewers for their comments, which improved the study and the manuscript. Y.H. gratefully acknowledges the support of SA-SIBS scholarship program and Youth Innovation Promotion Association, CAS.	Barton NH, 2008, GENET RES, V90, P139, DOI 10.1017/S0016672307009081; Beaumont MA, 1999, GENETICS, V153, P2013; Bonatto SL, 1997, P NATL ACAD SCI USA, V94, P1866, DOI 10.1073/pnas.94.5.1866; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Campbell MC, 2010, CURR BIOL, V20, pR166, DOI 10.1016/j.cub.2009.11.050; Diamond J, 2011, NATURE, V476, P291, DOI 10.1038/476291a; DILLEHAY TD, 1992, J WORLD PREHIST, V6, P145, DOI 10.1007/BF00975549; Dillehay TD, 1999, EVOL ANTHROPOL, V7, P206, DOI 10.1002/(SICI)1520-6505(1999)7:6<206::AID-EVAN5>3.0.CO;2-G; Dillehay TD, 2009, P NATL ACAD SCI USA, V106, P971, DOI 10.1073/pnas.0808424106; Fagundes NJR, 2008, AM J HUM GENET, V82, P583, DOI 10.1016/j.ajhg.2007.11.013; Forster P, 1996, AM J HUM GENET, V59, P935; Galantai A, 2000, J COMPUT APPL MATH, V124, P25, DOI 10.1016/S0377-0427(00)00435-0; Gayden T, 2007, AM J HUM GENET, V80, P884, DOI 10.1086/516757; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; GREENBERG JH, 1986, CURR ANTHROPOL, V27, P477, DOI 10.1086/203472; Haynes G., 2002, EARLY SETTLEMENT N A; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Hunley K, 2011, AM J PHYS ANTHROPOL, V146, P530, DOI 10.1002/ajpa.21506; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kumar S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-293; Lewis M. P., 2009, ETHNOLOGUE LANGUAGES; Majumder PP, 2010, CURR BIOL, V20, pR184, DOI 10.1016/j.cub.2009.11.053; MERRIWETHER DA, 1995, AM J PHYS ANTHROPOL, V98, P411, DOI 10.1002/ajpa.1330980404; Mulligan CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003199; Neves W, 1993, AM J PHYS ANTHR S, V16, P150; O'Rourke DH, 2010, CURR BIOL, V20, pR202, DOI 10.1016/j.cub.2009.11.051; Perego UA, 2010, GENOME RES, V20, P1174, DOI 10.1101/gr.109231.110; Ray N, 2010, MOL BIOL EVOL, V27, P337, DOI 10.1093/molbev/msp238; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; SLATKIN M, 1995, GENETICS, V139, P457; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Stoneking M, 2010, CURR BIOL, V20, pR188, DOI 10.1016/j.cub.2009.11.052; STOTHERT KE, 1985, AM ANTIQUITY, V50, P613, DOI 10.2307/280325; Sun JX, 2009, MOL BIOL EVOL, V26, P1017, DOI 10.1093/molbev/msp025; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; VALDES AM, 1993, GENETICS, V133, P737; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WILLIAMS RC, 1992, AM J HUM GENET, V51, P101; Zegura SL, 2004, MOL BIOL EVOL, V21, P164, DOI 10.1093/molbev/msh009; Zhivotovsky LA, 2003, AM J HUM GENET, V72, P1171, DOI 10.1086/375120; Zhivotovsky LA, 2001, MOL BIOL EVOL, V18, P700, DOI 10.1093/oxfordjournals.molbev.a003852	43	2	2	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2012	7	9							e44788	10.1371/journal.pone.0044788	http://dx.doi.org/10.1371/journal.pone.0044788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	001KC	22970308	gold, Green Submitted, Green Published			2022-12-25	WOS:000308458400121
J	Hu, YC; Li, YP; Lin, HF; Yang, ZH; Cheng, LX				Hu, Yuncui; Li, Yanpeng; Lin, Hongfei; Yang, Zhihao; Cheng, Liangxi			Integrating Various Resources for Gene Name Normalization	PLOS ONE			English	Article							KNOWLEDGE	The recognition and normalization of gene mentions in biomedical literature are crucial steps in biomedical text mining. We present a system for extracting gene names from biomedical literature and normalizing them to gene identifiers in databases. The system consists of four major components: gene name recognition, entity mapping, disambiguation and filtering. The first component is a gene name recognizer based on dictionary matching and semi-supervised learning, which utilizes the co-occurrence information of a large amount of unlabeled MEDLINE abstracts to enhance feature representation of gene named entities. In the stage of entity mapping, we combine the strategies of exact match and approximate match to establish linkage between gene names in the context and the EntrezGene database. For the gene names that map to more than one database identifiers, we develop a disambiguation method based on semantic similarity derived from the Gene Ontology and MEDLINE abstracts. To remove the noise produced in the previous steps, we design a filtering method based on the confidence scores in the dictionary used for NER. The system is able to adjust the trade-off between precision and recall based on the result of filtering. It achieves an F-measure of 83% (precision: 82.5% recall: 83.5%) on BioCreative II Gene Normalization (GN) dataset, which is comparable to the current state-of-the-art.	[Hu, Yuncui; Li, Yanpeng; Lin, Hongfei; Yang, Zhihao] Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China; [Cheng, Liangxi] Dalian Univ Technol, Dept Biomed Engn, Dalian, Liaoning, Peoples R China	Dalian University of Technology; Dalian University of Technology	Hu, YC (corresponding author), Dalian Univ Technol, Sch Comp Sci & Technol, Dalian, Liaoning, Peoples R China.	huyuncui@mail.dlut.edu.cn			Natural Science Foundation of China [60673039, 61070098]; National High Tech Research and Development Plan of China [2006AA01Z151]; Fundamental Research Funds for the Central Universities [DUT10JS09]; Liaoning Province Doctor Startup Fund [20091015]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Tech Research and Development Plan of China(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Liaoning Province Doctor Startup Fund	This work was supported by grant from the Natural Science Foundation of China (No. 60673039 and 61070098)(http://www.nsfc.gov.cn/Portal0/default124.htm), the National High Tech Research and Development Plan of China (No. 2006AA01Z151)(http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm), the Fundamental Research Funds for the Central Universities (No. DUT10JS09) and Liaoning Province Doctor Startup Fund (No. 20091015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando RK, 2007, P 2 BIOCREATIVE CHAL, V23, P101; Carpenter B, 2004, P 13 ANN TEXT RETR C; Cohen AM, 2005, BRIEF BIOINFORM, V6, P57, DOI 10.1093/bib/6.1.57; Cohen AM, 2007, P 2 BIOCREATIVE CHAL, P169; Fang H. R., 2006, P BIONLP WORKSH LINK, P41; Fluck J., 2007, P 2 BIOCREATIVE CHAL, P149; Fundel K, 2007, P 2 BIOCREATIVE CHAL, P153; Ganchev K., 2007, P 2 BIOCREATIVE CHAL, P119; Gonzalez G, 2007, P 2 BIOCREATIVE CHAL, P227; Grover C., 2007, P 2 BIOCREATIVE CHAL, P273; Hakenberg J, 2011, BIOINFORMATICS; Hakenberg J., 2007, P 2 BIOCREATIVE CHAL, P141; Hakenberg J, 2008, BIOINFORMATICS, V24, pI126, DOI 10.1093/bioinformatics/btn299; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S1; Hirschman L, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S1-S11; Huang HS, 2007, P 2 BIOCREATIVE CHAL, P109; Huang ML, 2011, BIOINFORMATICS, V27, P1032, DOI 10.1093/bioinformatics/btr042; Klinger R., 2007, P 2 BIOCREATIVE CHAL, P89; Kuo CJ, 2007, P 2 BIOCREATIVE CHAL; Kuo CJ, 2007, P 2 BIOCREATIVE CHAL, P105; Lau W, 2007, P 2 BIOCR CHALL EV W, P165; Li YP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-223; Luong T, 2007, P 2 BIOCREATIVE CHAL, P145; Morgan AA, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S3; Nakov P, 2007, P 2 BIOCR CHALL EV W, P297; Neves ML, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-157; Schuemie M.J., 2007, P 2 BIOCREATIVE CHAL, P131; Settles B, 2005, BIOINFORMATICS, V21, P3191, DOI 10.1093/bioinformatics/bti475; Smith L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S2; Sparck-Jones K, 2000, INFORM PROCESS MANAG, V36, P779, DOI 10.1016/S0306-4573(00)00015-7; SPARCKJONES K, 1972, J DOC, V28, P11, DOI 10.1108/eb026526; Wermter J, 2009, BIOINFORMATICS, V25, P815, DOI 10.1093/bioinformatics/btp071; Xu H, 2007, BIOINFORMATICS, V23, P1015, DOI 10.1093/bioinformatics/btm056	33	106	113	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2012	7	9							e43558	10.1371/journal.pone.0043558	http://dx.doi.org/10.1371/journal.pone.0043558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	005GJ	22384115	Green Published, gold			2022-12-25	WOS:000308738500017
J	Rau, TF; Lu, Q; Sharma, S; Sun, XT; Leary, G; Beckman, ML; Hou, YL; Wainwright, MS; Kavanaugh, M; Poulsen, DJ; Black, SM				Rau, Thomas F.; Lu, Qing; Sharma, Shruti; Sun, Xutong; Leary, Gregory; Beckman, Matthew L.; Hou, Yali; Wainwright, Mark S.; Kavanaugh, Michael; Poulsen, David J.; Black, Stephen M.			Oxygen Glucose Deprivation in Rat Hippocampal Slice Cultures Results in Alterations in Carnitine Homeostasis and Mitochondrial Dysfunction	PLOS ONE			English	Article							ACETYL-L-CARNITINE; OLD RATS; PULMONARY-HYPERTENSION; OXIDATIVE STRESS; ENERGY DEPLETION; NEURONAL DEATH; BRAIN-INJURY; LIPOIC ACID; ISCHEMIA; DECAY	Mitochondrial dysfunction characterized by depolarization of mitochondrial membranes and the initiation of mitochondrial-mediated apoptosis are pathological responses to hypoxia-ischemia (HI) in the neonatal brain. Carnitine metabolism directly supports mitochondrial metabolism by shuttling long chain fatty acids across the inner mitochondrial membrane for beta-oxidation. Our previous studies have shown that HI disrupts carnitine homeostasis in neonatal rats and that L-carnitine can be neuroprotective. Thus, this study was undertaken to elucidate the molecular mechanisms by which HI alters carnitine metabolism and to begin to elucidate the mechanism underlying the neuroprotective effect of L-carnitine (LCAR) supplementation. Utilizing neonatal rat hippocampal slice cultures we found that oxygen glucose deprivation (OGD) decreased the levels of free carnitines (FC) and increased the acylcarnitine (AC): FC ratio. These changes in carnitine homeostasis correlated with decreases in the protein levels of carnitine palmitoyl transferase (CPT) 1 and 2. LCAR supplementation prevented the decrease in CPT1 and CPT2, enhanced both FC and the AC: FC ratio and increased slice culture metabolic viability, the mitochondrial membrane potential prior to OGD and prevented the subsequent loss of neurons during later stages of reperfusion through a reduction in apoptotic cell death. Finally, we found that LCAR supplementation preserved the structural integrity and synaptic transmission within the hippocampus after OGD. Thus, we conclude that LCAR supplementation preserves the key enzymes responsible for maintaining carnitine homeostasis and preserves both cell viability and synaptic transmission after OGD.	[Rau, Thomas F.; Leary, Gregory; Beckman, Matthew L.; Kavanaugh, Michael; Poulsen, David J.] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Lu, Qing; Sharma, Shruti; Sun, Xutong; Hou, Yali; Black, Stephen M.] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA; [Wainwright, Mark S.] Northwestern Univ, Childrens Mem Hosp, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA	University of Montana System; University of Montana; University System of Georgia; Augusta University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine	Rau, TF (corresponding author), Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA.	david.poulsen@umontana.edu; sblack@georgiahealth.edu		Sharma, Shruti/0000-0001-8200-108X; Verma, Vipin/0000-0002-3296-5494	United States National Institutes of Health [HD039110, HL60190, HL67841, HL084739, HD057406]; Fondation LeDucq; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039110, R21HD057406] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067841, R01HL084739, R01HL060190] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation LeDucq(Leducq Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported in part by grants HD039110 (SMB), HL60190 (SMB), HL67841 (SMB), HL084739 (SMB), and HD057406 (SMB) all from the United States National Institutes of Health and by a grant from the Fondation LeDucq (SMB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Majed AA, 2006, CLIN EXP PHARMACOL P, V33, P725, DOI 10.1111/j.1440-1681.2006.04425.x; Ambalavanan N, 2006, PEDIATRICS, V118, P2084, DOI 10.1542/peds.2006-1591; Ames BN, 1998, TOXICOL LETT, V103, P5, DOI 10.1016/S0378-4274(98)00282-3; Ames BN, 2004, ANN NY ACAD SCI, V1019, P406, DOI 10.1196/annals.1297.073; Ames BN, 2004, ARCH BIOCHEM BIOPHYS, V423, P227, DOI 10.1016/j.abb.2003.11.002; Ames BN, 2003, J NUTR, V133, p1544S, DOI 10.1093/jn/133.5.1544S; Bayes R, 2001, EARLY HUM DEV, V65, pS103, DOI 10.1016/S0378-3782(01)00212-2; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Brand MD, 2004, BIOCHEM SOC SYMP, V71, P203; Brennan LA, 2003, CIRC RES, V92, P683, DOI 10.1161/01.RES.0000063424.28903.BB; Budd SL, 1998, PHARMACOL THERAPEUT, V80, P203, DOI 10.1016/S0163-7258(98)00029-1; Burda J, 2009, CELL MOL NEUROBIOL, V29, P821, DOI 10.1007/s10571-009-9363-9; Cam H, 2005, J TROP PEDIATRICS, V51, P106, DOI 10.1093/tropej/fmh089; Cronberg T, 2004, STROKE, V35, P753, DOI 10.1161/01.STR.0000117576.09512.32; Domorakova I, 2009, CELL MOL NEUROBIOL, V29, P837, DOI 10.1007/s10571-009-9365-7; Dutta A, 2009, INT J BIOMETEOROL, V53, P397, DOI 10.1007/s00484-009-0224-5; Grobe AC, 2006, AM J PHYSIOL-LUNG C, V290, pL1069, DOI 10.1152/ajplung.00408.2005; Hagen TM, 2002, P NATL ACAD SCI USA, V99, P7184; Hagen TM, 1998, P NATL ACAD SCI USA, V95, P9562, DOI 10.1073/pnas.95.16.9562; HOSHIDA S, 1993, AM J PHYSIOL, V264, pH33, DOI 10.1152/ajpheart.1993.264.1.H33; Hoshida S, 2002, CARDIOVASC RES, V55, P495, DOI 10.1016/S0008-6363(02)00337-1; HOSHIDA S, 1993, HEART VESSELS, V8, P115, DOI 10.1007/BF01744795; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; Hwang YC, 2002, CORONARY ARTERY DIS, V13, P313, DOI 10.1097/00019501-200209000-00002; Kim JH, 2007, NEUROSCI LETT, V411, P56, DOI 10.1016/j.neulet.2006.10.004; Kim JH, 2006, NEUROSCI LETT, V400, P1, DOI 10.1016/j.neulet.2006.01.035; Korde AS, 2005, J NEUROCHEM, V94, P1676, DOI 10.1111/j.1471-4159.2005.03328.x; Liu JK, 2002, ANN NY ACAD SCI, V959, P133, DOI 10.1111/j.1749-6632.2002.tb02090.x; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Long JG, 2009, NEUROCHEM RES, V34, P755, DOI 10.1007/s11064-008-9850-2; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; McLean C, 2004, SEMIN PERINATOL, V28, P425, DOI 10.1053/j.semperi.2004.10.005; Nabetani M, 1997, BRAIN RES, V769, P158, DOI 10.1016/S0006-8993(97)00819-6; Nadtochiy SM, 2006, BIOCHEM J, V395, P611, DOI 10.1042/BJ20051927; Northington FJ, 2005, BRAIN RES REV, V50, P244, DOI 10.1016/j.brainresrev.2005.07.003; Pogatsa G, 2001, CORONARY ARTERY DIS, V12, pS29; Ramsay Rona R., 2004, Molecular Aspects of Medicine, V25, P475, DOI 10.1016/j.mam.2004.06.002; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Singh N, 2012, CELL MOL NEUROBIOL; SOMJEN GG, 1993, RES P ARNMD, V71, P51; Stubbs M, 2010, ADV ENZYME REGUL, V50, P44, DOI 10.1016/j.advenzreg.2009.10.027; Sud N, 2008, AM J PHYSIOL-CELL PH, V294, pC1407, DOI 10.1152/ajpcell.00384.2007; VALLEE L, 1994, EUR J PEDIATR, V153, P598, DOI 10.1007/BF02190669; Wainwright MS, 2003, PEDIATR RES, V54, P688, DOI 10.1203/01.PDR.0000085036.07561.9C; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211	45	70	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 11	2012	7	9							e40881	10.1371/journal.pone.0040881	http://dx.doi.org/10.1371/journal.pone.0040881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	003VE	23112863	gold, Green Published, Green Submitted			2022-12-25	WOS:000308638700001
J	Li, LQ; Zhang, Y; Zou, LY; Li, CQ; Yu, B; Zheng, XQ; Zhou, Y				Li, Liqi; Zhang, Yuan; Zou, Lingyun; Li, Changqing; Yu, Bo; Zheng, Xiaoqi; Zhou, Yue			An Ensemble Classifier for Eukaryotic Protein Subcellular Location Prediction Using Gene Ontology Categories and Amino Acid Hydrophobicity	PLOS ONE			English	Article							SUPPORT VECTOR MACHINE; LOCALIZATION PREDICTION; MULTIPLE SITES; WEB SERVER; EUK-MPLOC; PSI-BLAST; SEQUENCE; FEATURES; PLOC; COMPLEXITY	With the rapid increase of protein sequences in the post-genomic age, it is challenging to develop accurate and automated methods for reliably and quickly predicting their subcellular localizations. Till now, many efforts have been tried, but most of which used only a single algorithm. In this paper, we proposed an ensemble classifier of KNN (k-nearest neighbor) and SVM (support vector machine) algorithms to predict the subcellular localization of eukaryotic proteins based on a voting system. The overall prediction accuracies by the one-versus-one strategy are 78.17%, 89.94% and 75.55% for three benchmark datasets of eukaryotic proteins. The improved prediction accuracies reveal that GO annotations and hydrophobicity of amino acids help to predict subcellular locations of eukaryotic proteins.	[Li, Liqi; Zhang, Yuan; Li, Changqing; Zhou, Yue] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China; [Zou, Lingyun] Third Mil Med Univ, Coll Basic Med Sci, Dept Microbiol, Chongqing, Peoples R China; [Yu, Bo] Yichun Peoples Hosp, Dept Orthoped, Yichun, Peoples R China; [Zheng, Xiaoqi] Shanghai Normal Univ, Dept Math, Shanghai, Peoples R China; [Zheng, Xiaoqi] Sci Comp Key Lab Shanghai Univ, Shanghai, Peoples R China	Army Medical University; Army Medical University; Shanghai Normal University; Shanghai Key Laboratory of Scalable Computing & System	Li, LQ (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China.	xqzheng@shnu.edu.cn; zhouyxq@163.com			National Natural Science Foundation of China [30901512, 31100953]; Shanghai Leading Academic Discipline Project [S30405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by grants from the National Natural Science Foundation of China (No. 30901512 and No. 31100953) and the Shanghai Leading Academic Discipline Project (No. S30405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari HR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-160; B Panwar, 2011, AMINO ACIDS; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Bulashevska A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-298; Cai YD, 2005, J THEOR BIOL, V234, P145, DOI 10.1016/j.jtbi.2004.11.017; Cai Yu-Dong, 2000, Molecular Cell Biology Research Communications, V4, P172, DOI 10.1006/mcbr.2001.0269; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Chou KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018258; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Cuo Jian, 2006, Journal of Bioinformatics and Computational Biology, V4, P1181; Currie RA, 2005, REPROD TOXICOL, V20, P433, DOI 10.1016/j.reprotox.2005.03.014; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Gu Q, 2010, AMINO ACIDS, V38, P975, DOI 10.1007/s00726-008-0209-4; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016036; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang WL, 2009, BIOSYSTEMS, V98, P73, DOI 10.1016/j.biosystems.2009.06.007; Jia PL, 2007, BIOCHEM BIOPH RES CO, V357, P366, DOI 10.1016/j.bbrc.2007.03.139; Khan A, 2011, COMPUT BIOL CHEM, V35, P218, DOI 10.1016/j.compbiolchem.2011.05.003; Khan A, 2010, AMINO ACIDS, V38, P347, DOI 10.1007/s00726-009-0238-7; Kim JK, 2006, PATTERN RECOGN LETT, V27, P996, DOI 10.1016/j.patrec.2005.11.014; Laurila K, 2011, AMINO ACIDS, V40, P975, DOI 10.1007/s00726-010-0724-y; Lei ZD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-491; Liao B, 2011, PROTEIN PEPTIDE LETT, V18, P1086, DOI 10.2174/092986611797200931; Lin TH, 2011, IEEE ACM T COMPUT BI, V8, P441, DOI 10.1109/TCBB.2009.82; Liqi L., 2011, J COMPUT BIOL BIOINF, V3, P15; Marinov M, 2001, HUM HERED, V51, P169, DOI 10.1159/000053338; Mei SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-44; Mount D.W., 2009, COLD SPRING HARB PRO; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Park KJ, 2003, BIOINFORMATICS, V19, P1656, DOI 10.1093/bioinformatics/btg222; Pierleoni A, 2011, BIOINFORMATICS, V27, P1224, DOI 10.1093/bioinformatics/btr108; Qian ZL, 2006, BIOCHEM BIOPH RES CO, V348, P1034, DOI 10.1016/j.bbrc.2006.07.149; Qiu JD, 2010, AMINO ACIDS, V38, P1201, DOI 10.1007/s00726-009-0331-y; Rao HB, 2011, NUCLEIC ACIDS RES, V39, pW385, DOI 10.1093/nar/gkr284; Rashid M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-337; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Seo MJ, 2005, GYNECOL ONCOL, V96, P621, DOI 10.1016/j.ygyno.2004.11.032; Shen HB, 2007, AMINO ACIDS, V33, P57, DOI 10.1007/s00726-006-0478-8; Shen HB, 2009, ANAL BIOCHEM, V394, P269, DOI 10.1016/j.ab.2009.07.046; Shen YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-563; Shi RJ, 2011, PROTEIN PEPTIDE LETT, V18, P625, DOI 10.2174/092986611795222768; Shi SP, 2011, BBA-MOL CELL RES, V1813, P424, DOI 10.1016/j.bbamcr.2011.01.011; SMITH TF, 1980, NATURE, V285, P620, DOI 10.1038/285620a0; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024498; Wang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018476; Wang T, 2010, PROTEIN PEPTIDE LETT, V17, P32, DOI 10.2174/092986610789909494; Wang W, 2011, PROTEIN PEPTIDE LETT, V18, P480, DOI 10.2174/092986611794927947; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359; Xu QA, 2011, IEEE ACM T COMPUT BI, V8, P748, DOI 10.1109/TCBB.2010.22; Yu NY, 2011, NUCLEIC ACIDS RES, V39, pD241, DOI 10.1093/nar/gkq1093; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Yu X., 2011, AMINO ACIDS; Yuan Z, 1999, FEBS LETT, V451, P23, DOI 10.1016/S0014-5793(99)00506-2; Zhang Y, 2010, ACTA BIOMATER, V6, P776, DOI 10.1016/j.actbio.2009.08.025; Zhang Y, 2009, BIOSCI BIOTECH BIOCH, V73, P1999, DOI 10.1271/bbb.90187; Zheng XQ, 2009, AMINO ACIDS, V37, P427, DOI 10.1007/s00726-008-0172-0; Zhou XB, 2008, AMINO ACIDS, V35, P383, DOI 10.1007/s00726-007-0608-y; Zou Lingyun, 2007, Journal of Genetics and Genomics, V34, P1080, DOI 10.1016/S1673-8527(07)60123-4	62	93	98	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 30	2012	7	1							e31057	10.1371/journal.pone.0031057	http://dx.doi.org/10.1371/journal.pone.0031057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	912BU	22303481	Green Submitted, gold, Green Published			2022-12-25	WOS:000301770300007
J	Chatterjee, M; Hedrich, CM; Rauen, T; Ioannidis, C; Terhorst, C; Tsokos, GC				Chatterjee, Madhumouli; Hedrich, Christian M.; Rauen, Thomas; Ioannidis, Christina; Terhorst, Cox; Tsokos, George C.			CD3-T Cell Receptor Co-stimulation through SLAMF3 and SLAMF6 Receptors Enhances ROR gamma t Recruitment to the IL17A Promoter in Human T Lymphocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; EFFECTOR FUNCTIONS; NFAT; TH17; DIFFERENTIATION; SAP; DISEASE; IL-17; ACTIVATION; MECHANISMS	Th17 lymphocytes play a key role during immune responses against bacteria and fungi and are involved in the pathophysiology of multiple autoimmune disorders. The co-stimulatory molecules SLAMF3 and SLAMF6 have been implicated in the formation of Th17 phenotypes and IL-17A expression. Increased surface expression of SLAMF3 and SLAMF6 has been linked with disease activity in systemic lupus erythematosus. Here we demonstrate that in human total T lymphocytes the canonical CD28 and the non-canonical SLAMF3/SLAMF6 co-stimulatory pathways cooperate in the recruitment of the transcription factor NFAT1 to the IL17A promoter. Furthermore, the dominance of the SLAMF3/SLAMF6 pathway in inducing IL-17A production can be attributed to an increased nuclear abundance and recruitment of ROR gamma t to the IL17A promoter. Thus, we have identified an additional mechanism that may be central for the specific control of IL17A gene regulation in systemic lupus erythematosus T lymphocytes.	[Chatterjee, Madhumouli; Hedrich, Christian M.; Rauen, Thomas; Ioannidis, Christina; Tsokos, George C.] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Rheumatol, Sch Med, Boston, MA 02215 USA; [Terhorst, Cox] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Med, Div Immunol,Med Sch, Boston, MA 02215 USA; [Rauen, Thomas] Rheinisch Westfael Tech Hsch Aachen Univ, Dept Nephrol & Clin Immunol, D-52056 Aachen, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; RWTH Aachen University	Tsokos, GC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Div Rheumatol, Sch Med, Boston, MA 02215 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013; Szczesny, Bartosz/D-1026-2012; BANERJEE, DIBYENDU/C-6656-2012; Rauen, Thomas/GLR-8682-2022; Chatterjee, Arpita/GPS-9141-2022; Hedrich, Christian/AAD-6855-2019; Hedrich, Christian/AAW-3958-2020; Banerjee, Dibyendu/Y-4652-2019; Mandal, Santi M./AAF-7156-2020	tsokos, george C/0000-0001-9589-2360; Banerjee, Dibyendu/0000-0003-4244-9714; Hedrich, Christian/0000-0002-1295-6179; Hegde, Muralidhar/0000-0001-7333-8123; Gustafsson, Claes/0000-0003-3531-8468; Dixit, Pavana/0000-0003-0811-3942	National Institutes of Health [R01 AI49954, P01 AI065687]; Deutsche Forschungsgemeinschaft [RA1927-1/1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI49954 and P01 AI065687. This work was also supported by Deutsche Forschungsgemeinschaft Grant RA1927-1/1 (to T. R.).	Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Calpe S, 2008, ADV IMMUNOL, V97, P177, DOI 10.1016/S0065-2776(08)00004-7; Chatterjee M, 2012, J IMMUNOL, V188, P1206, DOI 10.4049/jimmunol.1102773; Chatterjee M, 2011, AUTOIMMUNITY, V44, P211, DOI 10.3109/08916934.2010.530627; Cippa PE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.38; Collins M, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-223; Crispin JC, 2008, J IMMUNOL, V181, P8761, DOI 10.4049/jimmunol.181.12.8761; Detre C, 2010, SEMIN IMMUNOPATHOL, V32, P157, DOI 10.1007/s00281-009-0193-0; Dong C, 2011, EXP MOL MED, V43, P1, DOI 10.3858/emm.2011.43.1.007; Garrett-Sinha LA, 2008, CURR OPIN RHEUMATOL, V20, P519, DOI 10.1097/BOR.0b013e328304b6b5; Graef IA, 2001, CURR OPIN GENET DEV, V11, P505, DOI 10.1016/S0959-437X(00)00225-2; Graham DB, 2006, J IMMUNOL, V176, P291, DOI 10.4049/jimmunol.176.1.291; Henning G, 2001, EUR J IMMUNOL, V31, P2741, DOI 10.1002/1521-4141(200109)31:9<2741::AID-IMMU2741>3.0.CO;2-6; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; Howie D, 2002, BLOOD, V100, P2899, DOI 10.1182/blood-2002-02-0445; Howie D, 2005, J IMMUNOL, V174, P5931, DOI 10.4049/jimmunol.174.10.5931; Kayama H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000514; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; LUCAS PJ, 1995, J IMMUNOL, V154, P5757; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Rauen T, 2012, GENES IMMUN, V13, P346, DOI 10.1038/gene.2011.85; Rauen T, 2011, J BIOL CHEM, V286, P43437, DOI 10.1074/jbc.M111.299313; Rudensky AY, 2006, CELL, V126, P253, DOI 10.1016/j.cell.2006.07.005; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Sundrud MS, 2007, CURR OPIN IMMUNOL, V19, P287, DOI 10.1016/j.coi.2007.04.014; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Valdez PA, 2004, J BIOL CHEM, V279, P18662, DOI 10.1074/jbc.M312313200; Veillette A, 2002, ANNU REV IMMUNOL, V20, P669, DOI 10.1146/annurev.immunol.20.081501.130710; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Wilke CM, 2011, TRENDS IMMUNOL, V32, P603, DOI 10.1016/j.it.2011.08.003; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016	36	84	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 2	2012	287	45								10.1074/jbc.M112.415067	http://dx.doi.org/10.1074/jbc.M112.415067			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	031LP	22130663	hybrid, Green Published			2022-12-25	WOS:000310642200050
J	Jun, HJ; Kim, J; Hoang, MH; Lee, SJ				Jun, Hee-Jin; Kim, Jinyoung; Hoang, Minh-Hien; Lee, Sung-Joon			Hepatic Lipid Accumulation Alters Global Histone H3 Lysine 9 and 4 Trimethylation in the Peroxisome Proliferator-Activated Receptor Alpha Network	PLOS ONE			English	Article							FATTY LIVER-DISEASE; GENE-EXPRESSION; ACID OXIDATION; CARDIOVASCULAR-DISEASE; HUMAN HEPATOCYTE; CELL-LINES; METABOLISM; METHYLATION; CANCER; MICE	Recent data suggest that the etiology of several metabolic diseases is closely associated with transcriptome alteration by aberrant histone methylation. We performed DNA microarray and ChIP-on-chip analyses to examine transcriptome profiling and trimethylation alterations to identify the genomic signature of nonalcoholic fatty liver disease (NAFLD), the most common form of chronic liver disease. Transcriptome analysis showed that steatotic livers in high-fat diet-fed apolipoprotein E2 mice significantly altered the expression of approximately 70% of total genes compared with normal diet-fed control livers, suggesting that hepatic lipid accumulation induces dramatic alterations in gene expression in vivo. Also, pathway analysis suggested that genes encoding chromatin-remodeling enzymes, such as jumonji C-domain-containing histone demethylases that regulate histone H3K9 and H3K4 trimethylation (H3K9me3, H3K4me3), were significantly altered in steatotic livers. Thus, we further investigated the global H3K9me3 and H3K4me3 status in lipid-accumulated mouse primary hepatocytes by ChIP-on-chip analysis. Results showed that hepatic lipid accumulation induced aberrant H3K9me3 and H3K4me3 status in peroxisome proliferator-activated receptor alpha and hepatic lipid catabolism network genes, reducing their mRNA expression compared with non-treated control hepatocytes. This study provides the first evidence that epigenetic regulation by H3K9me3 and H3K4me3 in hepatocytes may be involved in hepatic steatosis and the pathogenesis of NAFLD. Thus, control of H3K9me3 and H3K4me3 represents a potential novel NAFLD prevention and treatment strategy.	[Jun, Hee-Jin; Kim, Jinyoung; Hoang, Minh-Hien; Lee, Sung-Joon] Korea Univ, Dept Biotechnol, Grad Sch Life Sci & Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea	Korea University	Jun, HJ (corresponding author), Korea Univ, Dept Biotechnol, Grad Sch Life Sci & Biotechnol, Coll Life Sci & Biotechnol, Seoul, South Korea.	junelee@korea.ac.kr	Lee, Sung-Joon/F-2435-2013		Technology Development Program for Fisheries of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (iPET) [F20926409H220000110]; Basic Science Research Program of the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [20100028180]	Technology Development Program for Fisheries of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (iPET)(Institute of Planning & Evaluation for Technology in Food, Agriculture, Forestry, & Fisheries (iPET), Republic of Korea); Basic Science Research Program of the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by the Technology Development Program for Fisheries of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (iPET, F20926409H220000110), and the Basic Science Research Program of the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (20100028180). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2007, MED CLIN N AM, V91, P1125, DOI 10.1016/j.mcna.2007.06.001; Al-Adsani A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013650; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Assy N, 2000, DIGEST DIS SCI, V45, P1929, DOI 10.1023/A:1005661516165; Boess F, 2003, TOXICOL SCI, V73, P386, DOI 10.1093/toxsci/kfg064; Casciano DA, 2000, DRUG METAB REV, V32, P1, DOI 10.1081/DMR-100100561; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Fayard E, 2004, TRENDS CELL BIOL, V14, P250, DOI 10.1016/j.tcb.2004.03.008; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Fujimoto Y, 2006, BIOL PHARM BULL, V29, P2174, DOI 10.1248/bpb.29.2174; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; Hake SB, 2004, BRIT J CANCER, V90, P761, DOI 10.1038/sj.bjc.6601575; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kelder Bruce, 2007, Comp Hepatol, V6, P4, DOI 10.1186/1476-5926-6-4; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Larter CZ, 2011, J GASTROENTEROL HEPA; Le May C, 2000, FEBS LETT, V475, P163, DOI 10.1016/S0014-5793(00)01648-3; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Marz W, 1993, TRANSPLANTATION, V55, P2848; MASLANSKY CJ, 1982, IN VITRO CELL DEV B, V18, P683; Nakamuta M, 2008, INT J MOL MED, V22, P663, DOI 10.3892/ijmm_00000070; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Olsavsky KM, 2007, TOXICOL APPL PHARM, V222, P42, DOI 10.1016/j.taap.2007.03.032; Pogribny IP, 2006, CARCINOGENESIS, V27, P1180, DOI 10.1093/carcin/bgi364; Pons D, 2009, EUR HEART J, V30, P266, DOI 10.1093/eurheartj/ehn603; Preiss D, 2008, CLIN SCI, V115, P141, DOI 10.1042/CS20070402; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	40	33	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2012	7	9							e44345	10.1371/journal.pone.0044345	http://dx.doi.org/10.1371/journal.pone.0044345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	002ZJ	22973438	Green Submitted, Green Published, gold			2022-12-25	WOS:000308577600040
J	Tian, DL; Peiffer, M; Shoemaker, E; Tooker, J; Haubruge, E; Francis, F; Luthe, DS; Felton, GW				Tian, Donglan; Peiffer, Michelle; Shoemaker, Erica; Tooker, John; Haubruge, Eric; Francis, Frederic; Luthe, Dawn S.; Felton, Gary W.			Salivary Glucose Oxidase from Caterpillars Mediates the Induction of Rapid and Delayed-Induced Defenses in the Tomato Plant	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; TRANSCRIPTIONAL RESPONSES; HELICOVERPA-ARMIGERA; GLANDULAR TRICHOMES; GENE-EXPRESSION; HOST-PLANT; CROSS-TALK; ARMS-RACE; JASMONATE; HERBIVORY	Caterpillars produce oral secretions that may serve as cues to elicit plant defenses, but in other cases these secretions have been shown to suppress plant defenses. Ongoing work in our laboratory has focused on the salivary secretions of the tomato fruitworm, Helicoverpa zea. In previous studies we have shown that saliva and its principal component glucose oxidase acts as an effector by suppressing defenses in tobacco. In this current study, we report that saliva elicits a burst of jasmonic acid (JA) and the induction of late responding defense genes such as proteinase inhibitor 2 (Pin2). Transcripts encoding early response genes associated with the JA pathway were not affected by saliva. We also observed a delayed response to saliva with increased densities of Type VI glandular trichomes in newly emerged leaves. Proteomic analysis of saliva revealed glucose oxidase (GOX) was the most abundant protein identified and we confirmed that it plays a primary role in the induction of defenses in tomato. These results suggest that the recognition of GOX in tomato may represent a case for effector-triggered immunity. Examination of saliva from other caterpillar species indicates that saliva from the noctuids Spodoptera exigua and Heliothis virescens also induced Pin2 transcripts.	[Tian, Donglan; Peiffer, Michelle; Shoemaker, Erica; Tooker, John; Luthe, Dawn S.; Felton, Gary W.] Penn State Univ, Dept Entomol, Ctr Chem Ecol, University Pk, PA 16802 USA; [Haubruge, Eric; Francis, Frederic] Univ Liege, Gembloux Agrobio Tech, Liege, Belgium; [Luthe, Dawn S.] Penn State Univ, Dept Crop & Soil Sci, Ctr Chem Ecol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Liege; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Tian, DL (corresponding author), Penn State Univ, Dept Entomol, Ctr Chem Ecol, University Pk, PA 16802 USA.	gwf10@psu.edu	Felton, Gary W./E-8575-2013; Tooker, John/P-6421-2014; Han, Xingguo/K-7552-2016	Tooker, John/0000-0002-9303-6699; Haubruge, Eric/0000-0002-8138-0476; Han, Xingguo/0000-0002-1836-975X	United States Department of Agriculture and Food Research Initiative program [2010-65105-20639, 2011-67013-30352]	United States Department of Agriculture and Food Research Initiative program	Support by the United States Department of Agriculture and Food Research Initiative program (2010-65105-20639 and 2011-67013-30352) awarded to GWF and DSL made this research possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, ECOLOGY, V80, P1713, DOI 10.1890/0012-9658(1999)080[1713:IRTHIW]2.0.CO;2; Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Alborn HT, 2003, J CHEM ECOL, V29, P1357, DOI 10.1023/A:1024209302628; Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Bassel GW, 2004, PLANT PHYSIOL, V136, P2782, DOI 10.1104/pp.103.034876; Bede JC, 2006, PLANT MOL BIOL, V60, P519, DOI 10.1007/s11103-005-4923-y; Bjorkman C, 2008, NEW PHYTOL, V179, P176, DOI 10.1111/j.1469-8137.2008.02442.x; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Bonaventure G, 2011, TRENDS PLANT SCI, V16, P294, DOI 10.1016/j.tplants.2011.01.006; Boughton AJ, 2005, J CHEM ECOL, V31, P2211, DOI 10.1007/s10886-005-6228-7; Brooks DM, 2005, MOL PLANT PATHOL, V6, P629, DOI [10.1111/j.1364-3703.2005.00311.x, 10.1111/J.1364-3703.2005.00311.X]; Campos ML, 2009, J EXP BOT, V60, P4346, DOI 10.1093/jxb/erp270; Celorio-Mancera MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026676; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung SH, 2011, J CHEM ECOL, V37, P378, DOI 10.1007/s10886-011-9937-0; CONSTABEL CP, 1995, P NATL ACAD SCI USA, V92, P407, DOI 10.1073/pnas.92.2.407; Dalin P, 2003, OECOLOGIA, V134, P112, DOI 10.1007/s00442-002-1093-3; Delphia CM, 2006, PLANT SIGNAL BEHAV, V1, P243, DOI 10.4161/psb.1.5.3279; Diaz J, 2002, PLANT PHYSIOL, V129, P1341, DOI 10.1104/pp.001453; Diez-Diaz M, 2004, PHYTOCHEMISTRY, V65, P1919, DOI 10.1016/j.phytochem.2004.06.007; Diezel C, 2009, PLANT PHYSIOL, V150, P1576, DOI 10.1104/pp.109.139550; DOARES SH, 1995, PLANT PHYSIOL, V108, P1741, DOI 10.1104/pp.108.4.1741; Eichenseer H, 1999, ARCH INSECT BIOCHEM, V42, P99, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;99::AID-ARCH10&gt;3.0.CO;2-B; Eichenseer H, 2002, J INSECT PHYSIOL, V48, P311, DOI 10.1016/S0022-1910(01)00178-0; Eichenseer H, 2010, J CHEM ECOL, V36, P885, DOI 10.1007/s10886-010-9830-2; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Farmer EE, 2007, NATURE, V448, P659, DOI 10.1038/448659a; Felton Gary W., 2008, P369, DOI 10.1007/978-1-4020-8182-8_18; Felton GW, 2005, P NATL ACAD SCI USA, V102, P18771, DOI 10.1073/pnas.0509895102; FELTON GW, 1989, J CHEM ECOL, V15, P2667, DOI 10.1007/BF01014725; Felton GW, 1999, CURR BIOL, V9, P317, DOI 10.1016/S0960-9822(99)80140-7; FELTON GW, 1993, J CHEM ECOL, V19, P1553, DOI 10.1007/BF00984896; FELTON GW, 1992, J CHEM ECOL, V18, P571, DOI 10.1007/BF00987820; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; Gurr GM, 2002, ENTOMOL EXP APPL, V103, P35, DOI 10.1023/A:1019819722203; Halitschke R, 2003, PLANT PHYSIOL, V131, P1894, DOI 10.1104/pp.102.018184; Harmel N, 2008, INSECT MOL BIOL, V17, P165, DOI 10.1111/j.1365-2583.2008.00790.x; Holeski LM, 2007, J EVOLUTION BIOL, V20, P2092, DOI 10.1111/j.1420-9101.2007.01434.x; Howe G-A, 1996, PLANT CELL; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; Howe GA, 1996, PLANT CELL, V8, P2067, DOI 10.1105/tpc.8.11.2067; Jia YL, 1999, PLANT MOL BIOL, V40, P455, DOI 10.1023/A:1006213324555; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaloshian I, 2005, ANNU REV PHYTOPATHOL, V43, P491, DOI 10.1146/annurev.phyto.43.040204.135944; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Korth KL, 1997, PLANT PHYSIOL, V115, P1299, DOI 10.1104/pp.115.4.1299; Lawrence SD, 2007, J CHEM ECOL, V33, P1041, DOI 10.1007/s10886-007-9285-2; Leitner M, 2005, NEW PHYTOL, V167, P597, DOI 10.1111/j.1469-8137.2005.01426.x; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; LIGHTNER J, 1993, MOL GEN GENET, V241, P595, DOI 10.1007/BF00279902; Lin L, 2008, J CHEM ECOL, V34, P353, DOI 10.1007/s10886-008-9439-x; Liu F, 2004, J CHEM ECOL, V30, P2439, DOI 10.1007/s10886-004-7944-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mithofer A, 2008, PLANT PHYSIOL, V146, P825, DOI 10.1104/pp.107.113118; Mori N, 2001, J INSECT PHYSIOL, V47, P749, DOI 10.1016/S0022-1910(00)00171-2; Musser RO, 2005, ARCH INSECT BIOCHEM, V58, P128, DOI 10.1002/arch.20039; Musser RO, 2002, NATURE, V416, P599, DOI 10.1038/416599a; Narvaez-Vasquez J, 2005, P NATL ACAD SCI USA, V102, P12974, DOI 10.1073/pnas.0505248102; Narvaez-Vasquez J, 2004, PLANTA, V218, P360, DOI 10.1007/s00425-003-1115-3; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Orozco-Cardenas M, 1999, P NATL ACAD SCI USA, V96, P6553, DOI 10.1073/pnas.96.11.6553; Orozco-Cardenas ML, 2001, PLANT CELL, V13, P179, DOI 10.1105/tpc.13.1.179; Orozco-Cardenas ML, 2002, PLANT PHYSIOL, V130, P487, DOI 10.1104/pp.008375; PAUTOT V, 1993, P NATL ACAD SCI USA, V90, P9906, DOI 10.1073/pnas.90.21.9906; Pearce G, 2003, J BIOL CHEM, V278, P30044, DOI 10.1074/jbc.M304159200; Peiffer M, 2005, ARCH INSECT BIOCHEM, V58, P106, DOI 10.1002/arch.20034; Peiffer M, 2009, J CHEM ECOL, V35, P326, DOI 10.1007/s10886-009-9604-x; Qu N, 2004, PLANT PHYSIOL, V135, P539, DOI 10.1104/pp.103.037036; Rasmann S, 2012, PLANT PHYSIOL, V158, P854, DOI 10.1104/pp.111.187831; Rose USR, 2005, PLANTA, V222, P327, DOI 10.1007/s00425-005-1528-2; Rotenberg D, 2006, J VIROL METHODS, V138, P49, DOI 10.1016/j.jviromet.2006.07.017; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sagi M, 2004, PLANT CELL, V16, P616, DOI 10.1105/tpc.019398; Schmelz EA, 2006, P NATL ACAD SCI USA, V103, P8894, DOI 10.1073/pnas.0602328103; Schmelz EA, 2003, P NATL ACAD SCI USA, V100, P10552, DOI 10.1073/pnas.1633615100; Schmidt DD, 2005, PLANT PHYSIOL, V138, P1763, DOI 10.1104/pp.105.061192; Simmons AT, 2004, AUST J ENTOMOL, V43, P196, DOI 10.1111/j.1440-6055.2004.00414.x; TAYLOR BH, 1993, PLANT MOL BIOL, V23, P1005, DOI 10.1007/BF00021815; Thaler J-S, 2001, ECOLOGICAL ENTOMOLOG; Thaler JS, 2004, ECOLOGY, V85, P48, DOI 10.1890/02-0710; Thaler JS, 2002, OECOLOGIA, V131, P227, DOI 10.1007/s00442-002-0885-9; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thipyapong P, 2007, MOLECULES, V12, P1569, DOI 10.3390/12081569; Tooker JF, 2005, J CHEM ECOL, V31, P2753, DOI 10.1007/s10886-005-8553-2; Traw MB, 2002, OECOLOGIA, V131, P526, DOI 10.1007/s00442-002-0924-6; Vandenabeele S, 2003, P NATL ACAD SCI USA, V100, P16113, DOI 10.1073/pnas.2136610100; Vellosillo T, 2010, PLANT PHYSIOL, V154, P444, DOI 10.1104/pp.110.161273; Victoriano E, 2002, ARTHROPOD STRUCT DEV, V31, P15, DOI 10.1016/S1467-8039(02)00013-0; VINCENT R, 1983, ANAL BIOCHEM, V135, P355, DOI 10.1016/0003-2697(83)90696-6; Walling LL, 2000, J PLANT GROWTH REGUL, V19, P195; Weech MH, 2008, J EXP BOT, V59, P2437, DOI 10.1093/jxb/ern108; Yoshinaga N, 2007, J CHEM ECOL, V33, P1376, DOI 10.1007/s10886-007-9321-2	93	96	107	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 30	2012	7	4							e36168	10.1371/journal.pone.0036168	http://dx.doi.org/10.1371/journal.pone.0036168			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UL	22558369	gold, Green Published			2022-12-25	WOS:000305340200046
J	Mandal, SM; Hegde, ML; Chatterjee, A; Hegde, PM; Szczesny, B; Banerjee, D; Boldogh, I; Gao, R; Falkenberg, M; Gustafsson, CM; Sarkar, PS; Hazra, TK				Mandal, Santi M.; Hegde, Muralidhar L.; Chatterjee, Arpita; Hegde, Pavana M.; Szczesny, Bartosz; Banerjee, Dibyendu; Boldogh, Istvan; Gao, Rui; Falkenberg, Maria; Gustafsson, Claes M.; Sarkar, Partha S.; Hazra, Tapas K.			Role of Human DNA Glycosylase Nei-like 2 (NEIL2) and Single Strand Break Repair Protein Polynucleotide Kinase 3 '-Phosphatase in Maintenance of Mitochondrial Genome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; MAMMALIAN-CELLS; OXIDATIVE DAMAGE; OXIDIZED BASES; TRANSCRIPTION FACTORS; IN-VITRO; KAPPA-B; NUCLEAR; IDENTIFICATION; GENE	The repair of reactive oxygen species-induced base lesions and single strand breaks (SSBs) in the nuclear genome via the base excision (BER) and SSB repair (SSBR) pathways, respectively, is well characterize, and important for maintaining genomic integrity. However, the role of mitochondrial (mt) BER and SSBR proteins in mt genome maintenance is not completely clear. Here we show the presence of the oxidized base-specific DNA glycosylase Nei-like 2 (NEIL2) and the DNA end-processing enzyme polynucleotide kinase 3'-phosphatase (PNKP) in purified human mitochondrial extracts (MEs). Confocal microscopy revealed co-localization of PNKP and NEIL2 with the mitochondrion-specific protein cytochrome c oxidase subunit 2 (MT-CO2). Further, chromatin immunoprecipitation analysis showed association of NEIL2 and PNKP with the mitochondrial genes MT-CO2 and MT-CO3 (cytochrome c oxidase subunit 3); importantly, both enzymes also associated with the mitochondrion-specific DNA polymerase gamma. In cell association of NEIL2 and PNKP with polymerase gamma was further confirmed by proximity ligation assays. PNKP-depleted ME showed a significant decrease in both BER and SSBR activities, and PNKP was found to be the major 3'-phosphatase in human ME. Furthermore, individual depletion of NEIL2 and PNKP in human HEK293 cells caused increased levels of oxidized bases and SSBs in the mt genome, respectively. Taken together, these studies demonstrate the critical role of NEIL2 and PNKP in maintenance of the mammalian mitochondrial genome.	[Hazra, Tapas K.] Univ Texas Med Branch, Div Pulm & Crit Care Med, Sealy Ctr Mol Med, Dept Internal Med, Galveston, TX 77555 USA; [Hegde, Muralidhar L.; Hegde, Pavana M.; Szczesny, Bartosz; Banerjee, Dibyendu; Hazra, Tapas K.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Gao, Rui; Sarkar, Partha S.] Univ Texas Med Branch, Dept Neurol & Neurosci & Cell Biol, Galveston, TX 77555 USA; [Falkenberg, Maria; Gustafsson, Claes M.] Univ Gothenburg, Inst Biomed, SE-40530 Gothenburg, Sweden	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Gothenburg	Hazra, TK (corresponding author), Univ Texas Med Branch, Div Pulm & Crit Care Med, Sealy Ctr Mol Med, Dept Internal Med, 6-136 Med Res Bldg,Route 1079, Galveston, TX 77555 USA.	tkhazra@utmb.edu	tsokos, george C/O-3360-2013; Szczesny, Bartosz/D-1026-2012; BANERJEE, DIBYENDU/C-6656-2012; Rauen, Thomas/GLR-8682-2022; Chatterjee, Arpita/GPS-9141-2022; Hedrich, Christian/AAD-6855-2019; Hedrich, Christian/AAW-3958-2020; Banerjee, Dibyendu/Y-4652-2019; Mandal, Santi M./AAF-7156-2020	tsokos, george C/0000-0001-9589-2360; Banerjee, Dibyendu/0000-0003-4244-9714; Hedrich, Christian/0000-0002-1295-6179; Hegde, Muralidhar/0000-0001-7333-8123; Gustafsson, Claes/0000-0003-3531-8468; Dixit, Pavana/0000-0003-0811-3942	National Institutes of Health from the USPHS [CA102271, ES017353, CA81063, ES018948]	National Institutes of Health from the USPHS	This work was supported, in whole or in part, by National Institutes of Health Grants CA102271 and ES017353 (to T. K. H.), CA81063 (to S. M. M.), and ES018948 (to I. B.) from the USPHS.	Banerjee D, 2011, J BIOL CHEM, V286, P6006, DOI 10.1074/jbc.M110.198796; BARRY MA, 1993, ARCH BIOCHEM BIOPHYS, V300, P440, DOI 10.1006/abbi.1993.1060; Bohr VA, 2002, FREE RADICAL BIO MED, V32, P804, DOI 10.1016/S0891-5849(02)00787-6; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Bottero V, 2001, J BIOL CHEM, V276, P21317, DOI 10.1074/jbc.M005850200; BREEN AP, 1995, FREE RADICAL BIO MED, V18, P1033, DOI 10.1016/0891-5849(94)00209-3; Cadet JL, 1998, NEUROCHEM INT, V32, P117, DOI 10.1016/S0197-0186(97)00031-4; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Caldecott KW, 2001, BIOESSAYS, V23, P447, DOI 10.1002/bies.1063; Chattopadhyay R, 2006, NUCLEIC ACIDS RES, V34, P2067, DOI 10.1093/nar/gkl177; Copeland WC, 2010, METHODS, V51, P363, DOI 10.1016/j.ymeth.2010.07.008; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; De Bosscher K, 2003, ENDOCR REV, V24, P488, DOI 10.1210/er.2002-0006; de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DODSON ML, 1994, J BIOL CHEM, V269, P32709; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Dou H, 2008, J BIOL CHEM, V283, P3130, DOI 10.1074/jbc.M709186200; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; GILONI L, 1981, J BIOL CHEM, V256, P8608; Gordon DM, 2001, BIOCHEM J, V356, P207, DOI 10.1042/0264-6021:3560207; Hazra IK, 1998, NUCLEIC ACIDS RES, V26, P5116, DOI 10.1093/nar/26.22.5116; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hegde ML, 2010, J BIOL CHEM, V285, P28812, DOI 10.1074/jbc.M110.126664; HENNER WD, 1983, J BIOL CHEM, V258, P5198; Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200; Jilani A, 1999, J BIOL CHEM, V274, P24176, DOI 10.1074/jbc.274.34.24176; Johansson H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013678; Kaneko M, 1998, TOXICOL LETT, V99, P15, DOI 10.1016/S0378-4274(98)00132-5; Karimi-Busheri F, 1999, J BIOL CHEM, V274, P24187, DOI 10.1074/jbc.274.34.24187; Korhonen JA, 2004, EMBO J, V23, P2423, DOI 10.1038/sj.emboj.7600257; Kumar D, 2009, J BIOL CHEM, V284, P1853, DOI 10.1074/jbc.M806289200; Longley MJ, 1998, P NATL ACAD SCI USA, V95, P12244, DOI 10.1073/pnas.95.21.12244; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mitra S, 2002, FREE RADICAL BIO MED, V33, P15, DOI 10.1016/S0891-5849(02)00819-5; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Patrick ME, 2004, EMERG INFECT DIS, V10, P1; Pohjanpelto P, 1996, EMBO J, V15, P1193, DOI 10.1002/j.1460-2075.1996.tb00458.x; Psarra AMG, 2008, BBA-MOL CELL RES, V1783, P1, DOI 10.1016/j.bbamcr.2007.10.021; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Santos Janine H, 2006, Methods Mol Biol, V314, P183; Scovassi AI, 2004, FASEB J, V18, P1487, DOI 10.1096/fj.04-1841rev; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001; Sykora P, 2011, P NATL ACAD SCI USA, V108, P7437, DOI 10.1073/pnas.1100084108; Szczesny B, 2008, J BIOL CHEM, V283, P26349, DOI 10.1074/jbc.M803491200; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; Wallace Douglas C, 2002, Methods Mol Biol, V197, P3, DOI 10.1385/1-59259-284-8:003; Wang HX, 2003, J BIOL CHEM, V278, P28686, DOI 10.1074/jbc.M302844200; Weinfeld M, 2011, TRENDS BIOCHEM SCI, V36, P262, DOI 10.1016/j.tibs.2011.01.006; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024	62	84	88	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 20	2012	287	4					2819	2829		10.1074/jbc.M111.272179	http://dx.doi.org/10.1074/jbc.M111.272179			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	892NG	22130663	hybrid, Green Published			2022-12-25	WOS:000300292300053
J	Hu, Y; Duan, JH; Zhan, QM; Wang, FD; Lu, X; Yang, XD				Hu, Yan; Duan, Jinhong; Zhan, Qimin; Wang, Fengdan; Lu, Xin; Yang, Xian-Da			Novel MUC1 Aptamer Selectively Delivers Cytotoxic Agent to Cancer Cells In Vitro	PLOS ONE			English	Article							TARGETED DRUG-DELIVERY; EXPRESSION; DESIGN; ACID	Chemotherapy is a primary treatment for cancer, but its efficacy is often limited by the adverse effects of cytotoxic agents. Targeted drug delivery may reduce the non-specific toxicity of chemotherapy by selectively directing anticancer drugs to tumor cells. MUC1 protein is an attractive target for tumor-specific drug delivery owning to its overexpression in most adenocarcinomas. In this study, a novel MUC1 aptamer is exploited as the targeting ligand for carrying doxorubicin (Dox) to cancer cells. We developed an 86-base DNA aptamer (MA3) that bound to a peptide epitope of MUC1 with a K-d of 38.3 nM and minimal cross reactivity to albumin. Using A549 lung cancer and MCF-7 breast cancer cells as MUC1-expressing models, MA3 was found to preferentially bind to MUC1-positive but not MUC1-negative cells. An aptamer-doxorubicin complex (Apt-Dox) was formulated by intercalating doxorubicin into the DNA structure of MA3. Apt-Dox was found capable of carrying doxorubicin into MUC1-positive tumor cells, while significantly reducing the drug intake by MUC1-negative cells. Moreover, Apt-Dox retained the efficacy of doxorubicin against MUC1-positive tumor cells, but lowered the toxicity to MUC1-negative cells (P<0.01). The results suggest that the MUC1 aptamer may have potential utility as a targeting ligand for selective delivery of cytotoxic agent to MUC1-expressing tumors.	[Hu, Yan; Duan, Jinhong; Yang, Xian-Da] Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China; [Hu, Yan; Duan, Jinhong; Zhan, Qimin; Wang, Fengdan; Lu, Xin; Yang, Xian-Da] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhan, Qimin] Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Wang, Fengdan; Lu, Xin] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Hu, Y (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100730, Peoples R China.	ayangmd@gmail.com			Chinese Ministry of Science and Technology [2011CB933504, 2011CB911004, 2011CB911003]; Natural Science Foundation of China [81071870]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the Chinese Ministry of Science and Technology (2011CB933504, 2011CB911004, 2011CB911003) and the Natural Science Foundation of China (81071870).	Adams GP, 2005, NAT BIOTECHNOL, V23, P1147, DOI 10.1038/nbt1137; Brown KC, 2010, CURR PHARM DESIGN, V16, P1040, DOI 10.2174/138161210790963788; Burchell JM, 2001, J MAMMARY GLAND BIOL, V6, P355, DOI 10.1023/A:1011331809881; Cao Y, 1999, VIRCHOWS ARCH, V434, P503, DOI 10.1007/s004280050375; Croce MV, 2001, BREAST CANCER RES TR, V69, P1, DOI 10.1023/A:1012220902991; Dassie JP, 2009, NAT BIOTECHNOL, V27, P839, DOI 10.1038/nbt.1560; Davis KA, 1996, NUCLEIC ACIDS RES, V24, P702, DOI 10.1093/nar/24.4.702; Dhar S, 2008, P NATL ACAD SCI USA, V105, P17356, DOI 10.1073/pnas.0809154105; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Farokhzad OC, 2006, EXPERT OPIN DRUG DEL, V3, P311, DOI 10.1517/17425247.3.3.311; Ferreira CSM, 2006, TUMOR BIOL, V27, P289, DOI 10.1159/000096085; Ferreira CSM, 2009, NUCLEIC ACIDS RES, V37, P866, DOI 10.1093/nar/gkn967; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Haj HTB, 2003, CHEM-BIOL INTERACT, V145, P349, DOI 10.1016/S0009-2797(03)00061-9; Huang YF, 2009, CHEMBIOCHEM, V10, P862, DOI 10.1002/cbic.200800805; Lee Y, 2008, BIOCONJUGATE CHEM, V19, P525, DOI 10.1021/bc700382z; Levy-Nissenbaum E, 2008, TRENDS BIOTECHNOL, V26, P442, DOI 10.1016/j.tibtech.2008.04.006; Murray A, 1998, J PEPT RES, V52, P375; Osborne SE, 1997, CURR OPIN CHEM BIOL, V1, P5, DOI 10.1016/S1367-5931(97)80102-0; Ren J, 2004, CANCER CELL, V5, P163, DOI 10.1016/S1535-6108(04)00020-0; Ren LF, 1997, CHEM-BIOL INTERACT, V104, P55, DOI 10.1016/S0009-2797(97)03767-8; SENTER PD, 1995, BIOCONJUGATE CHEM, V6, P389, DOI 10.1021/bc00034a008; Sudimack J, 2000, ADV DRUG DELIVER REV, V41, P147, DOI 10.1016/S0169-409X(99)00062-9; Taylor-Papadimitriou J, 1999, BBA-MOL BASIS DIS, V1455, P301, DOI 10.1016/S0925-4439(99)00055-1; Vasir JK, 2005, TECHNOL CANCER RES T, V4, P363, DOI 10.1177/153303460500400405; Vogel CL, 2009, J CLIN ONCOL, V27; Ye Xin, 2009, Cardiovascular & Hematological Disorders - Drug Targets, V9, P206	28	106	113	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2012	7	2							e31970	10.1371/journal.pone.0031970	http://dx.doi.org/10.1371/journal.pone.0031970			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	926ZZ	22384115	Green Published, Green Submitted, gold			2022-12-25	WOS:000302875500060
J	Lee, HP; Pancholi, N; Esposito, L; Previll, LA; Wang, XL; Zhu, XW; Smith, MA; Lee, HG				Lee, Hyun-Pil; Pancholi, Neel; Esposito, Luke; Previll, Laura A.; Wang, Xinglong; Zhu, Xiongwei; Smith, Mark A.; Lee, Hyoung-gon			Early Induction of Oxidative Stress in Mouse Model of Alzheimer Disease with Reduced Mitochondrial Superoxide Dismutase Activity	PLOS ONE			English	Article							LIPID-PEROXIDATION; TRANSGENIC MICE; NEURODEGENERATIVE DISEASES; PLAQUE-FORMATION; DNA-DAMAGE; IN-VIVO; REDUCTION; PATHOLOGY; PROTEINS; DYSFUNCTION	While oxidative stress has been linked to Alzheimer's disease, the underlying pathophysiological relationship is unclear. To examine this relationship, we induced oxidative stress through the genetic ablation of one copy of mitochondrial antioxidant superoxide dismutase 2 (Sod2) allele in mutant human amyloid precursor protein (hAPP) transgenic mice. The brains of young (5-7 months of age) and old (25-30 months of age) mice with the four genotypes, wild-type (Sod2(+/+)), hemizygous Sod2 (Sod2(+/-)), hAPP/wild-type (Sod2(+/+)), and hAPP/hemizygous (Sod2(+/-)) were examined to assess levels of oxidative stress markers 4-hydroxy-2-nonenal and heme oxygenase-1. Sod2 reduction in young hAPP mice resulted in significantly increased oxidative stress in the pyramidal neurons of the hippocampus. Interestingly, while differences resulting from hAPP expression or Sod2 reduction were not apparent in the neurons in old mice, oxidative stress was increased in astrocytes in old, but not young hAPP mice with either Sod2(+/+) or Sod2(+/-). Our study shows the specific changes in oxidative stress and the causal relationship with the pathological progression of these mice. These results suggest that the early neuronal susceptibility to oxidative stress in the hAPP/Sod2(+/-) mice may contribute to the pathological and behavioral changes seen in this animal model.	[Lee, Hyun-Pil; Pancholi, Neel; Previll, Laura A.; Wang, Xinglong; Zhu, Xiongwei; Smith, Mark A.; Lee, Hyoung-gon] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Esposito, Luke] Univ Calif San Francisco, Dept Neurol & Neurosci, Gladstone Inst Neurol Dis, San Francisco, CA 94143 USA	Case Western Reserve University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Lee, HP (corresponding author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.	hyoung-gon.lee@case.edu	Lee, Hyoung-gon/A-9637-2009; Meyer, Axel/C-9826-2009	Wang, Xinglong/0000-0001-8657-0159; Meyer, Axel/0000-0002-0888-8193; WU, LI-TZY/0000-0002-5909-2259; Oh, Yu-Kyoung/0000-0002-0969-3339; Previll, Laura/0000-0001-5541-8111	National Institutes of Health [AG028679]; Alzheimer's Association [NIRG-09-132727]; Dr. Robert M. Kohrman Memorial Fund; NATIONAL INSTITUTE ON AGING [R01AG028679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Dr. Robert M. Kohrman Memorial Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Work in the authors' laboratories is supported by the National Institutes of Health (AG028679 to Dr. Hyoung-gon Lee), the Alzheimer's Association (NIRG-09-132727 to Dr. Hyoung-gon Lee), and the Dr. Robert M. Kohrman Memorial Fund (to Dr. Zhu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Dumont M, 2009, FASEB J, V23, P2459, DOI 10.1096/fj.09-132928; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Kokoszka JE, 2001, P NATL ACAD SCI USA, V98, P2278, DOI 10.1073/pnas.051627098; Lee HG, 2006, J NEUROSCI RES, V84, P1856, DOI 10.1002/jnr.21072; Li F, 2004, J NEUROCHEM, V89, P1308, DOI 10.1111/j.1471-4159.2004.02455.x; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Massaad CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010561; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Myung NH, 2008, AGE, V30, P209, DOI 10.1007/s11357-008-9050-7; Nunomura A, 1999, J NEUROSCI, V19, P1959; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Omar Rawhi A., 1999, J Alzheimers Dis, V1, P139; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Pappolla MA, 1998, AM J PATHOL, V152, P871; Pratico D, 2001, J NEUROSCI, V21, P4183, DOI 10.1523/JNEUROSCI.21-12-04183.2001; Pratico D, 2000, ANN NEUROL, V48, P809, DOI 10.1002/1531-8249(200011)48:5<809::AID-ANA19>3.0.CO;2-9; Reed TT, 2009, BRAIN RES, V1274, P66, DOI 10.1016/j.brainres.2009.04.009; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Sayre LM, 1997, J NEUROCHEM, V68, P2092; Sayre LM, 1996, CHEM RES TOXICOL, V9, P1194, DOI 10.1021/tx960094j; Simpson JE, 2010, NEUROPATH APPL NEURO, V36, P25, DOI 10.1111/j.1365-2990.2009.01030.x; Smith MA, 1998, J NEUROCHEM, V70, P2212, DOI 10.1046/j.1471-4159.1998.70052212.x; SMITH MA, 1995, TRENDS NEUROSCI, V18, P172, DOI 10.1016/0166-2236(95)93897-7; SMITH MA, 1994, AM J PATHOL, V145, P42; Smith MA, 2010, J ALZHEIMERS DIS, V19, P363, DOI 10.3233/JAD-2010-1239; STEELE ML, 2010, NEUROBIOL A IN PRESS; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132	36	113	115	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2012	7	1							e28033	10.1371/journal.pone.0028033	http://dx.doi.org/10.1371/journal.pone.0028033			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907YS	22970282	Green Submitted, Green Published, gold			2022-12-25	WOS:000301457200001
J	Wang, XM; Mao, XO; Xie, L; Sun, F; Greenberg, DA; Jin, KL				Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin			Conditional Depletion of Neurogenesis Inhibits Long-Term Recovery after Experimental Stroke in Mice	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; SUBVENTRICULAR ZONE; FOREBRAIN NEUROGENESIS; BRAIN; CELLS; REPLACEMENT; PRECURSORS; MIGRATION; NEURONS	We reported previously that ablation of doublecortin (DCX)-immunopositive newborn neurons in mice worsens anatomical and functional outcome measured 1 day after experimental stroke, but whether this effect persists is unknown. We generated transgenic mice that express herpes simplex virus thymidine kinase under control of the DCX promoter (DCX-TK transgenic mice). DCX-expressing and recently divided cells in the rostral subventricular zone (SVZ) and hippocampus of DCX-TK transgenic mice, but not wild-type mice, were specifically depleted after ganciclovir (GCV) treatment for 14 days. Focal cerebral ischemia was induced by permanent distal middle cerebral artery occlusion (MCAO) on day 14 of vehicle or GCV treatment, and mice were killed 12 weeks after MCAO. Infarct volume was significantly increased and neurologic deficits were more severe in GCV- compared to vehicle-treated DCX-TK transgenic mice at first 8 weeks, after depletion of DCX- and bromodeoxyuridine-immunoreactive cells in the SVZ and dentate gyrus following focal ischemia. Our results indicate that endogenous neurogenesis in a critical period following experimental stroke influences the course of long-term recovery.	[Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Sun, Fen; Greenberg, David A.; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Jin, Kunlin] Univ N Texas Hlth Sci Ctr Ft Worth, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA	Buck Institute for Research on Aging; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	Wang, XM (corresponding author), Buck Inst Res Aging, Novato, CA USA.	kunlin.jin@unthsc.edu	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	United States Public Health Service Grant [NS57186, AG21980, NS44921, NS62414]	United States Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by United States Public Health Service Grants NS57186 and AG21980 (to KJ) and NS44921 and NS62414 (to DAG). The URL of any funder's website is www.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gu WG, 2000, J CEREBR BLOOD F MET, V20, P1166, DOI 10.1097/00004647-200008000-00002; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING CELL, V9, P1076, DOI 10.1111/j.1474-9726.2010.00638.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Lai B, 2008, NEUROSCI LETT, V442, P305, DOI 10.1016/j.neulet.2008.07.032; Liu JL, 1998, J NEUROSCI, V18, P7768; Mayo NE, 1999, DISABIL REHABIL, V21, P258; MCDERMOTT KW, 1991, J ANAT, V178, P45; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Raber J, 2004, ANN NEUROL, V55, P381, DOI 10.1002/ana.10853; REARDON JE, 1989, J BIOL CHEM, V264, P19039; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yoshimura S, 2001, P NATL ACAD SCI USA, V98, P5874, DOI 10.1073/pnas.101034998; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhu CL, 2009, J NEUROCHEM, V111, P1447, DOI 10.1111/j.1471-4159.2009.06413.x	26	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2012	7	6							e38932	10.1371/journal.pone.0038932	http://dx.doi.org/10.1371/journal.pone.0038932			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	963VI	23029330	Green Published, gold, Green Submitted			2022-12-25	WOS:000305652700041
J	Wang, XJ; Wei, DL; Song, ZG; Jiao, HC; Lin, H				Wang, Xiao Juan; Wei, Dai Lin; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai			Effects of Fatty Acid Treatments on the Dexamethasone-Induced Intramuscular Lipid Accumulation in Chickens	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SKELETAL-MUSCLE CELLS; INDUCED INSULIN-RESISTANCE; MAMMALIAN TARGET; GENE-EXPRESSION; DOWN-REGULATION; PPAR-ALPHA; RAT; RECEPTOR; LIVER	Background: Glucocorticoid has an important effect on lipid metabolism in muscles, and the type of fatty acid likely affects mitochondrial utilization. Therefore, we hypothesize that the different fatty acid types treatment may affect the glucocorticoid induction of intramuscular lipid accumulation. Methodology/Principal Findings: The effect of dexamethasone (DEX) on fatty acid metabolism and storage in skeletal muscle of broiler chickens (Gallus gallus domesticus) was investigated with and without fatty acid treatments. Male Arbor Acres chickens (31 d old) were treated with either palmitic acid (PA) or oleic acid (OA) for 7 days, followed by DEX administration for 3 days (35-37 d old). The DEX-induced lipid uptake and oxidation imbalance, which was estimated by increased fatty acid transport protein 1 (FATP1) expression and decreased carnitine palmitoyl transferase 1 activity, contributed to skeletal muscle lipid accumulation. More sensitive than glycolytic muscle, the oxidative muscle in DEX-treated chickens showed a decrease in the AMP to ATP ratio, a decrease in AMP-activated protein kinase (AMPK) alpha phosphorylation and its activity, as well as an increase in the phosphorylation of mammalian target of rapamycin (mTOR) and ribosomal p70S6 kinase, without Akt activation. DEX-stimulated lipid deposition was augmented by PA, but alleviated by OA, in response to pathways that were regulated differently, including AMPK, mTOR and FATP1. Conclusions: DEX-induced intramuscular lipid accumulation was aggravated by SFA but alleviated by unsaturated fatty acid. The suppressed AMPK and augmented mTOR signaling pathways were involved in glucocortcoid-mediated enhanced intramuscular fat accumulation.	[Wang, Xiao Juan; Song, Zhi Gang; Jiao, Hong Chao; Lin, Hai] Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China; [Wei, Dai Lin] Taian Cent Hosp, Dept Endocrine, Tai An, Shandong, Peoples R China	Shandong Agricultural University	Wang, XJ (corresponding author), Shandong Agr Univ, Dept Anim Sci, Tai An, Shandong, Peoples R China.	hailin@sdau.edu.cn	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China [2004CB117507]; National Natural Science Foundation of China [30771573]; Research Fund for the Doctoral Program of Higher Education of China	Shandong Science Fund for Distinguished Youth Scholars; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the Shandong Science Fund for Distinguished Youth Scholars, the National Basic Research Program of China (2004CB117507), the National Natural Science Foundation of China (No.30771573), and Research Fund for the Doctoral Program of Higher Education of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring agencies.	Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498; Berthiaume M, 2007, AM J PHYSIOL-ENDOC M, V293, pE1045, DOI 10.1152/ajpendo.00276.2007; BIEBER LL, 1972, ANAL BIOCHEM, V50, P509, DOI 10.1016/0003-2697(72)90061-9; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bowes SB, 1996, J ENDOCRINOL, V148, P501, DOI 10.1677/joe.0.1480501; Braun EJ, 2008, COMP BIOCHEM PHYS B, V151, P1, DOI 10.1016/j.cbpb.2008.05.007; Cai YL, 2009, COMP BIOCHEM PHYS C, V150, P164, DOI 10.1016/j.cbpc.2009.04.005; Caton PW, 2011, BIOCHEM J, V437, P521, DOI 10.1042/BJ20110702; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; Chuang JC, 2010, J LIPID RES, V51, P1344, DOI 10.1194/jlr.M002196; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Close B, 1997, LAB ANIM-UK, V31, P1, DOI 10.1258/002367797780600297; Coll T, 2006, DIABETES, V55, P2779, DOI 10.2337/db05-1494; Cota D, 2009, OBESITY, V17, P1641, DOI 10.1038/oby.2009.84; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; de Oliveira C, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-11; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Dupont J, 1999, J ENDOCRINOL, V162, P67, DOI 10.1677/joe.0.1620067; Dupont JL, 2004, DOMEST ANIM ENDOCRIN, V26, P127, DOI 10.1016/j.domaniend.2003.09.004; Dupont J, 2008, J ENDOCRINOL, V197, P531, DOI 10.1677/JOE-08-0055; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Foucaud L, 1998, BBA-LIPID LIPID MET, V1391, P204, DOI 10.1016/S0005-2760(97)00213-0; Gao D, 2009, BRIT J NUTR, V102, P1557, DOI 10.1017/S0007114509990948; Gaster M, 2005, DIABETES, V54, P648, DOI 10.2337/diabetes.54.3.648; GRIFFIN HD, 1982, BRIT POULTRY SCI, V23, P307, DOI 10.1080/00071688208447962; Halevy O, 2000, J NUTR, V130, P858, DOI 10.1093/jn/130.4.858; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hayat MA, 1973, PRINCIPLES TECHNIQUE, V3, P237; Hickson-Bick DLM, 2000, J MOL CELL CARDIOL, V32, P511, DOI 10.1006/jmcc.1999.1098; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Hu ZY, 2009, J CLIN INVEST, V119, P3059, DOI 10.1172/JCI38770; HUNNICUTT JW, 1994, DIABETES, V43, P540, DOI 10.2337/diabetes.43.4.540; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Kamara K, 1998, PHYSIOL BEHAV, V64, P1, DOI 10.1016/S0031-9384(97)00534-9; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Koh EH, 2003, DIABETES, V52, P2331, DOI 10.2337/diabetes.52.9.2331; Korach-Andre M, 2005, AM J PHYSIOL-ENDOC M, V288, pE106, DOI 10.1152/ajpendo.00089.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee WJ, 2006, BIOCHEM BIOPH RES CO, V340, P291, DOI 10.1016/j.bbrc.2005.12.011; Lillie RD, 1976, HISTOPATHOLOGIC TECH, Vfourth, P559; Lin H, 2004, COMP BIOCHEM PHYS B, V139, P737, DOI 10.1016/j.cbpc.2004.09.013; Liu ZQ, 2004, AM J PHYSIOL-ENDOC M, V287, pE275, DOI 10.1152/ajpendo.00457.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004; Nader N, 2010, MOL ENDOCRINOL, V24, P1748, DOI 10.1210/me.2010-0192; Nakken GN, 2010, J APPL PHYSIOL, V108, P298, DOI 10.1152/japplphysiol.00906.2009; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Prasad SSSV, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-111; Proszkowiec-Weglarz M, 2006, COMP BIOCHEM PHYS B, V143, P92, DOI 10.1016/j.cbpb.2005.10.009; Qi D, 2004, DIABETES, V53, P1790, DOI 10.2337/diabetes.53.7.1790; Qi D, 2006, AM J PHYSIOL-ENDOC M, V291, P420; Rivas DA, 2009, J ENDOCRINOL, V202, P441, DOI 10.1677/JOE-09-0202; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Ruderman NB, 2006, OBESITY, V14, p25S, DOI 10.1038/oby.2006.279; Rutter GA, 2003, BIOCHEM J, V375, P1, DOI 10.1042/BJ20030048; RYDER JM, 1985, J AGR FOOD CHEM, V33, P678, DOI 10.1021/jf00064a027; Saha AK, 2003, MOL CELL BIOCHEM, V253, P65, DOI 10.1023/A:1026053302036; Schwartz GJ, 2008, CELL METAB, V8, P281, DOI 10.1016/j.cmet.2008.08.005; Sekulic A, 2000, CANCER RES, V60, P3504; Shah OJ, 2000, AM J PHYSIOL, V279, P74; SIMON J, 1974, ENDOCRINOLOGY, V95, P1439, DOI 10.1210/endo-95-5-1439; Sipula IJ, 2006, METABOLISM, V55, P1637, DOI 10.1016/j.metabol.2006.08.002; SMOLENSKI RT, 1993, BIOMED CHROMATOGR, V7, P189, DOI 10.1002/bmc.1130070404; Staiger H, 2005, DIABETOLOGIA, V48, P2115, DOI 10.1007/s00125-005-1895-z; Stuart M, 2010, END ABSTR, V21, P180; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang XJ, 2012, STRESS, V15, P443, DOI 10.3109/10253890.2011.639413; Wang XJ, 2010, COMP BIOCHEM PHYS C, V151, P447, DOI 10.1016/j.cbpc.2010.01.010; Watt MJ, 2006, J PHYSIOL-LONDON, V574, P139, DOI 10.1113/jphysiol.2006.107318; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006; Zhang JL, 2004, AM J PHYSIOL-ENDOC M, V286, pE168, DOI 10.1152/ajpendo.00232.2003; Zhao JP, 2009, COMP BIOCHEM PHYS C, V149, P448, DOI 10.1016/j.cbpc.2008.10.106	75	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 18	2012	7	5							e36663	10.1371/journal.pone.0036663	http://dx.doi.org/10.1371/journal.pone.0036663			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VG	23029330	gold, Green Submitted, Green Published			2022-12-25	WOS:000305343500022
J	Wang, XL; Wurmser, C; Pausch, H; Jung, S; Reinhardt, F; Tetens, J; Thaller, G; Fries, R				Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Reinhardt, Friedrich; Tetens, Jens; Thaller, Georg; Fries, Ruedi			Identification and Dissection of Four Major QTL Affecting Milk Fat Content in the German Holstein-Friesian Population	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCUS; GROWTH-HORMONE RECEPTOR; MISSENSE MUTATION; GENE; DGAT1; AGPAT6; YIELD; TRANSCRIPTION; EXPRESSION; TISSUE	Milk composition traits exhibit a complex genetic architecture with a small number of major quantitative trait loci (QTL) explaining a large fraction of the genetic variation and numerous QTL with minor effects. In order to identify QTL for milk fat percentage (FP) in the German Holstein-Friesian (HF) population, a genome-wide association study (GWAS) was performed. The study population consisted of 2327 progeny-tested bulls. Genotypes were available for 44,280 SNPs. Phenotypes in the form of estimated breeding values (EBVs) for FP were used as highly heritable traits. A variance components-based approach was used to account for population stratification. The GWAS identified four major QTL regions explaining 46.18% of the FP EBV variance. Besides two previously known FP QTL on BTA14 (P = 8.91x10-(198)) and BTA20 (P = 7.03x10(-12)) within DGAT1 and GHR, respectively, we uncovered two additional QTL regions on BTA5 (P = 2.00x10(-13)) and BTA27 (P = 9.83x10(-5)) encompassing EPS8 and GPAT4, respectively. EPS8 and GPAT4 are involved in lipid metabolism in mammals. Re-sequencing of EPS8 and GPAT4 revealed 50 polymorphisms. Genotypes for five of them were inferred for the entire study population. Two polymorphisms affecting potential transcription factor binding sites of EPS8 (P = 1.40x10(-12)) and GPAT4 (P = 5.18x10(-5)), respectively, were highly significantly associated with the FP EBV. Our results provide evidence that alteration of regulatory sites is an important aspect of genetic variation of complex traits in cattle.	[Wang, Xiaolong; Wurmser, Christine; Pausch, Hubert; Jung, Simone; Fries, Ruedi] Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany; [Reinhardt, Friedrich] Vereinigte Informat Syst Tierhaltung wV, Verden, Germany; [Tetens, Jens; Thaller, Georg] Univ Kiel, Inst Anim Breeding & Husb, Kiel, Germany	Technical University of Munich; University of Kiel	Wang, XL (corresponding author), Tech Univ Muenchen, Chair Anim Breeding, Freising Weihenstephan, Germany.	xiaolong.wang@tierzucht.tum.de	Sun, Fen/I-8516-2016; Pausch, Hubert/U-5934-2019; Lizier, Joseph/B-8093-2008; Wang, Xuelong/GQB-3574-2022; Wang, X. Rosalind/B-7097-2008; Zeng, Maomao/M-1422-2013; Prokopenko, Mikhail/A-3995-2008	Pausch, Hubert/0000-0002-0501-6760; Yu, Zhuowei/0000-0002-9152-6491; Lizier, Joseph/0000-0002-9910-8972; Tetens, Jens/0000-0001-5352-464X; Wang, Xuelong/0000-0003-4616-1531; SUN, FEN/0000-0003-2094-9494; Kou, Xiaoxing/0000-0001-9680-0077; Tang, Hailiang/0000-0003-1852-3128; Fries, Ruedi/0000-0002-4657-1787; Wang, X. Rosalind/0000-0001-5454-6197; Yan, Jizhou/0000-0001-7482-7842; Zeng, Maomao/0000-0001-9259-1992; Mao, Ying/0000-0001-8055-115X; Prokopenko, Mikhail/0000-0002-4215-0344; Wurmser, Christine/0000-0003-0649-6206; Miller, Jennifer/0000-0003-2110-3693	German Ministry of Education and Research, BMBF [0315134A, 0315134D, 0315131A]; Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Forderverein Biotechnologieforschung e.V. (FBF), Bonn; Lohmann Tierzucht GmbH, Cuxhaven; China Scholarship Council (CSC)(China Scholarship Council)	This study is part of the projects FUGATO-plus GenoTrack and FUGATO-plus MeGA-M and was financially supported by the German Ministry of Education and Research, BMBF (grants 0315134A, 0315134D and 0315131A), the Forderverein Biotechnologieforschung e.V. (FBF), Bonn, and Lohmann Tierzucht GmbH, Cuxhaven. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the vit w.V. Verden for providing phenotype data and the China Scholarship Council (CSC) for supporting X. Wang by a grant.	Beigneux AP, 2006, J LIPID RES, V47, P734, DOI 10.1194/jlr.M500556-JLR200; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Blott S, 2003, GENETICS, V163, P253; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buttchereit N, 2010, J DAIRY SCI, V93, P1702, DOI 10.3168/jds.2009-2198; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chatterjee S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005197; Cohen-Zinder M, 2005, GENOME RES, V15, P936, DOI 10.1101/gr.3806705; Ed L, 2009, BIOINFORMATICS, V25, P1836, DOI 10.1093/bioinformatics/btp314; FAZIOLI F, 1993, EMBO J, V12, P3799, DOI 10.1002/j.1460-2075.1993.tb06058.x; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gremme G, 2005, INFORM SOFTWARE TECH, V47, P965, DOI 10.1016/j.infsof.2005.09.005; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Guo DL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000446; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Loor JJ, 2005, PHYSIOL GENOMICS, V23, P217, DOI 10.1152/physiolgenomics.00132.2005; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Portales-Casamar E, 2009, JASPAR 2010 GREATLY; Quackenbush J, 2001, NUCLEIC ACIDS RES, V29, P159, DOI 10.1093/nar/29.1.159; Schennink A, 2007, ANIM GENET, V38, P467, DOI 10.1111/j.1365-2052.2007.01635.x; Schennink A, 2009, ANIM GENET, V40, P909, DOI 10.1111/j.1365-2052.2009.01940.x; Schug Jonathan, 2008, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0206s21; Signorelli F, 2009, LIVEST SCI, V125, P74, DOI 10.1016/j.livsci.2009.02.014; Thaller G, 2003, J ANIM SCI, V81, P1911; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Vergnes L, 2006, J LIPID RES, V47, P745, DOI 10.1194/jlr.M500553-JLR200; Viitala S, 2006, GENETICS, V173, P2151, DOI 10.1534/genetics.105.046730; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	35	658	680	35	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 11	2012	7	7							e40711	10.1371/journal.pone.0040711	http://dx.doi.org/10.1371/journal.pone.0040711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973LU	23029330	Green Submitted, Green Published, gold			2022-12-25	WOS:000306362400093
